PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, JH; Zhang, Q; Yu, YJ; Li, KL; Liao, H; Jiang, LY; Hong, L; Du, XH; Hu, XH; Chen, SF; Yin, S; Gao, QM; Yin, XD; Luo, HS; Huizinga, JD				Chen, Ji-Hong; Zhang, Qian; Yu, Yuanjie; Li, Kongling; Liao, Hong; Jiang, Longying; Hong, Lu; Du, Xiaohui; Hu, Xinghai; Chen, Sifeng; Yin, Sheng; Gao, Qingmin; Yin, Xiangdong; Luo, Hesheng; Huizinga, Jan D.			Neurogenic and Myogenic Properties of Pan-Colonic Motor Patterns and Their Spatiotemporal Organization in Rats	PLOS ONE			English	Article							GIANT MIGRATING CONTRACTIONS; INTERSTITIAL-CELLS; SMOOTH-MUSCLE; CAJAL; MOTILITY; COMPLEXES; GENERATION; INTESTINE; REFLEXES; ICC	Background and Aims: Better understanding of intrinsic control mechanisms of colonic motility will lead to better treatment options for colonic dysmotility. The aim was to investigate neurogenic and myogenic control mechanisms underlying pan-colonic motor patterns. Methods: Analysis of in vitro video recordings of whole rat colon motility was used to explore motor patterns and their spatiotemporal organizations and to identify mechanisms of neurogenic and myogenic control using pharmacological tools. Results: Study of the pan-colonic spatiotemporal organization of motor patterns revealed: fluid-induced or spontaneous rhythmic propulsive long distance contractions (LDCs, 0.4-1.5/min, involving the whole colon), rhythmic propulsive motor complexes (RPMCs) (0.8-2.5/min, dominant in distal colon), ripples (10-14/min, dominant in proximal colon), segmentation and retrograde contractions (0.1-0.8/min, prominent in distal and mid colon). Spontaneous rhythmic LDCs were the dominant pattern, blocked by tetrodotoxin, lidocaine or blockers of cholinergic, nitrergic or serotonergic pathways. Change from propulsion to segmentation and distal retrograde contractions was most prominent after blocking 5-HT3 receptors. In the presence of all neural blockers, bethanechol consistently evoked rhythmic LDC-like propulsive contractions in the same frequency range as the LDCs, indicating the existence of myogenic mechanisms of initiation and propulsion. Conclusions: Neurogenic and myogenic control systems orchestrate distinct and variable motor patterns at different regions of the pan-colon. Cholinergic, nitrergic and serotonergic pathways are essential for rhythmic LDCs to develop. Rhythmic motor patterns in presence of neural blockade indicate the involvement of myogenic control systems and suggest a role for the networks of interstitial cells of Cajal as pacemakers.	[Chen, Ji-Hong; Zhang, Qian; Yu, Yuanjie; Li, Kongling; Liao, Hong; Jiang, Longying; Hong, Lu; Du, Xiaohui; Chen, Sifeng; Yin, Sheng; Gao, Qingmin; Yin, Xiangdong; Luo, Hesheng; Huizinga, Jan D.] Wuhan Univ, Renmin Hosp, Dept Gastroenterol & Hepatol, Wuhan 430072, Hubei, Peoples R China; [Chen, Ji-Hong; Zhang, Qian; Yu, Yuanjie; Li, Kongling; Liao, Hong; Jiang, Longying; Hong, Lu; Du, Xiaohui; Chen, Sifeng; Yin, Sheng; Gao, Qingmin; Yin, Xiangdong; Luo, Hesheng; Huizinga, Jan D.] Wuhan Univ, Inst Digest & Liver Dis, Wuhan 430072, Hubei, Peoples R China; [Hu, Xinghai] Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Hubei, Peoples R China; [Huizinga, Jan D.] McMaster Univ, Dept Med, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada	Wuhan University; Wuhan University; Huazhong University of Science & Technology; McMaster University	Chen, JH (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol & Hepatol, Wuhan 430072, Hubei, Peoples R China.	chenjihong2@medmail.com.cn	Hong, LU/HDM-0673-2022		National Natural Science Foundation of China (NSFC) [81170249]; Canadian Institutes of Health Research (CIHR) [MOP12874]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The study was financially supported by a grant from the National Natural Science Foundation of China (NSFC) # 81170249 to JHC and from the Canadian Institutes of Health Research (CIHR) # MOP12874 to JDH. Support was received from McMaster University for the sabbatical of JDH. The funders had no direct role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bayguinov PO, 2010, J PHYSIOL-LONDON, V588, P4453, DOI 10.1113/jphysiol.2010.196824; BUENO L, 1980, GUT, V21, P480, DOI 10.1136/gut.21.6.480; Camilleri M, 2008, NEUROGASTROENT MOTIL, V20, P417, DOI 10.1111/j.1365-2982.2008.01134.x; D'Antona G, 2001, NEUROGASTROENT MOTIL, V13, P483, DOI 10.1046/j.1365-2982.2001.00282.x; Davidson JB, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01651.x; Dickson EJ, 2010, AM J PHYSIOL-GASTR L, V298, pG222, DOI 10.1152/ajpgi.00399.2009; Dinning PG, 2012, AM J PHYSIOL-GASTR L, V303, pG83, DOI 10.1152/ajpgi.00429.2011; Dinning PG, 2009, NEUROGASTROENT MOTIL, V21, P20, DOI 10.1111/j.1365-2982.2009.01401.x; Epperson A, 2000, AM J PHYSIOL-CELL PH, V279, pC529, DOI 10.1152/ajpcell.2000.279.2.C529; FAUSSONEPELLEGRINI MS, 1990, ACTA ANAT, V139, P31; Fida R, 1997, NEUROGASTROENT MOTIL, V9, P99, DOI 10.1046/j.1365-2982.1997.d01-25.x; Furness J.B., 2006, ENTERIC NERVOUS SYST; Furness JB, 2002, AUTON NEUROSCI-BASIC, V97, P19, DOI 10.1016/S1566-0702(02)00003-6; Gagliardi J A, 1994, Hawaii Med J, V53, P278; Galligan JJ, 2007, NEUROGASTROENT MOTIL, V19, P1, DOI 10.1111/j.1365-2982.2006.00888.x; Geeraerts B, 2006, NEUROGASTROENT MOTIL, V18, P957, DOI 10.1111/j.1365-2982.2006.00854.x; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Gil V, 2010, AM J PHYSIOL-GASTR L, V299, pG158, DOI 10.1152/ajpgi.00448.2009; Hennig GW, 2010, NEUROGASTROENT MOTIL, V22, pe207, DOI 10.1111/j.1365-2982.2009.01453.x; Heredia DJ, 2010, J PHYSIOL-LONDON, V588, P2919, DOI 10.1113/jphysiol.2010.191445; Horowitz B, 1999, ANNU REV PHYSIOL, V61, P19, DOI 10.1146/annurev.physiol.61.1.19; Huizinga JD, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00093; HUIZINGA JD, 1986, GASTROENTEROLOGY, V90, P1197, DOI 10.1016/0016-5085(86)90385-9; HUIZINGA JD, 1985, GASTROENTEROLOGY, V88, P500, DOI 10.1016/0016-5085(85)90513-X; Huizinga JD, 1997, TRENDS PHARMACOL SCI, V18, P393, DOI 10.1016/S0165-6147(97)90668-4; Keating DJ, 2010, GASTROENTEROLOGY, V138, P659, DOI 10.1053/j.gastro.2009.09.020; Keating DJ, 2010, GASTROENTEROLOGY, V138; Knowles CH, 2011, BEST PRACT RES CL GA, V25, P43, DOI 10.1016/j.bpg.2010.12.001; Kunze WAA, 1999, J PHYSIOL-LONDON, V517, P547, DOI 10.1111/j.1469-7793.1999.0547t.x; Lentle RG, 2008, J COMP PHYSIOL B, V178, P257, DOI 10.1007/s00360-007-0217-9; Li M, 2002, AM J PHYSIOL-GASTR L, V283, pG544, DOI 10.1152/ajpgi.00114.2001; Liu HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024928; Lyford GL, 2002, GUT, V51, P496, DOI 10.1136/gut.51.4.496; McKay CM, 2006, J PHARMACOL EXP THER, V319, P1112, DOI 10.1124/jpet.106.109322; McKnight Scott T, 2011, Radiol Case Rep, V6, P557, DOI 10.2484/rcr.v6i4.557; Pluja L, 2001, AM J PHYSIOL-GASTR L, V281, pG255, DOI 10.1152/ajpgi.2001.281.1.G255; Powell AK, 2003, NEUROGASTROENT MOTIL, V15, P257, DOI 10.1046/j.1365-2982.2003.00412.x; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; Rae MG, 1998, J PHYSIOL-LONDON, V510, P309, DOI 10.1111/j.1469-7793.1998.309bz.x; Roberts RR, 2007, AM J PHYSIOL-GASTR L, V292, pG930, DOI 10.1152/ajpgi.00444.2006; RUMESSEN JJ, 1994, DAN MED BULL, V41, P275; Spiller R, 2002, BRIT J CLIN PHARMACO, V54, P11, DOI 10.1046/j.1365-2125.2002.01612.x; TOMARU A, 1993, JPN J PHARMACOL, V63, P525, DOI 10.1254/jjp.63.525; Tonini M, 1996, NEUROSCIENCE, V73, P287, DOI 10.1016/0306-4522(96)00040-1; Torihashi S, 1999, J AUTONOM NERV SYST, V75, P38, DOI 10.1016/S0165-1838(98)00174-X; TRUELOVE SC, 1966, PHYSIOL REV, V46, P457; Wang XY, 2009, J CELL MOL MED, V13, P3528, DOI 10.1111/j.1582-4934.2009.00689.x; Wouters MM, 2007, NEUROGASTROENT MOTIL, V19, P5, DOI 10.1111/j.1365-2982.2007.00963.x; Yoneda S, 2004, NEUROGASTROENT MOTIL, V16, P621, DOI 10.1111/j.1365-2982.2004.00546.x	49	36	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60474	10.1371/journal.pone.0060474	http://dx.doi.org/10.1371/journal.pone.0060474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577116	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800055
J	Ganopoulos, I; Aravanopoulos, F; Madesis, P; Pasentsis, K; Bosmali, I; Ouzounis, C; Tsaftaris, A				Ganopoulos, Ioannis; Aravanopoulos, Filippos; Madesis, Panagiotis; Pasentsis, Konstantinos; Bosmali, Irene; Ouzounis, Christos; Tsaftaris, Athanasios			Taxonomic Identification of Mediterranean Pines and Their Hybrids Based on the High Resolution Melting (HRM) and trnL Approaches: From Cytoplasmic Inheritance to Timber Tracing	PLOS ONE			English	Article							CURVE-ANALYSIS; SPECIES IDENTIFICATION; CHLOROPLAST DNA; RAPID DETECTION; PINUS PINACEAE; MICROSATELLITE; ORIGIN; POLYMORPHISM; PATTERNS; PLANTS	Fast and accurate detection of plant species and their hybrids using molecular tools will facilitate the assessment and monitoring of local biodiversity in an era of climate and environmental change. Herein, we evaluate the utility of the plastid trnL marker for species identification applied to Mediterranean pines (Pinus spp.). Our results indicate that trnL is a very sensitive marker for delimiting species biodiversity. Furthermore, High Resolution Melting (HRM) analysis was exploited as a molecular fingerprint for fast and accurate discrimination of Pinus spp. DNA sequence variants. The trnL approach and the HRM analyses were extended to wood samples of two species (Pinus nigra and Pinus sylvestris) with excellent results, congruent to those obtained using leaf tissue. Both analyses demonstrate that hybrids from the P. brutia (maternal parent) x P. halepensis (paternal parent) cross, exhibit the P. halepensis profile, confirming paternal plastid inheritance in Group Halepensis pines. Our study indicates that a single one-step reaction method and DNA marker are sufficient for the identification of Mediterranean pines, their hybrids and the origin of pine wood. Furthermore, our results underline the potential for certain DNA regions to be used as novel biological information markers combined with existing morphological characters and suggest a relatively reliable and open taxonomic system that can link DNA variation to phenotype-based species or hybrid assignment status and direct taxa identification from recalcitrant tissues such as wood samples.	[Ganopoulos, Ioannis; Aravanopoulos, Filippos; Madesis, Panagiotis; Pasentsis, Konstantinos; Bosmali, Irene; Ouzounis, Christos; Tsaftaris, Athanasios] Ctr Res & Technol Hellas CERTH, Inst Appl Biosci, Thessaloniki, Greece; [Ganopoulos, Ioannis; Tsaftaris, Athanasios] Aristotle Univ Thessaloniki, Dept Genet & Plant Breeding, Thessaloniki, Greece; [Aravanopoulos, Filippos] Aristotle Univ Thessaloniki, Lab Forest Genet & Tree Breeding, Fac Forestry & Nat Environm, Thessaloniki, Greece; [Ouzounis, Christos] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	Centre for Research & Technology Hellas; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; University of Toronto	Tsaftaris, A (corresponding author), Ctr Res & Technol Hellas CERTH, Inst Appl Biosci, Thessaloniki, Greece.	tsaft@certh.gr	Ouzounis, Christos A/G-2302-2010; Madesis, Panagiotis/AAL-5980-2020	Ouzounis, Christos A/0000-0002-0086-8657; Madesis, Panagiotis/0000-0003-1447-3514; Ganopoulos, Ioannis/0000-0001-7967-5702; ARAVANOPOULOS, FILIPPOS/0000-0001-7194-2642				Aravanopoulos FA, 2000, P 2 BALK BOT C IST T, V2, P195, DOI [10.13140/RG.2.1.2021.7041, DOI 10.13140/RG.2.1.2021.7041]; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barbero M, 2000, PINES MEDITERRANEAN; Bucci G, 1998, MOL ECOL, V7, P1633, DOI 10.1046/j.1365-294x.1998.00466.x; Chen J, 2002, THEOR APPL GENET, V104, P1307, DOI 10.1007/s00122-002-0893-5; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; Deguilloux MF, 2004, ANN FOREST SCI, V61, P97, DOI 10.1051/forest:2003089; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Eckert AJ, 2006, MOL PHYLOGENET EVOL, V40, P166, DOI 10.1016/j.ympev.2006.03.009; Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Farjon A, 2001, WORLD CHECKLIST BIBL; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Finkeldey R, 2010, APPL MICROBIOL BIOT, V85, P1251, DOI 10.1007/s00253-009-2328-6; Frankis Michael, 1999, Curtis's Botanical Magazine, V16, P173, DOI 10.1111/1467-8748.00216; Ganopoulos I, 2012, FOOD CHEM IN PRESS; Ganopoulos I, 2011, FOOD CHEM, V129, P652, DOI 10.1016/j.foodchem.2011.04.109; Ganopoulos I, 2011, FOOD CONTROL, V22, P532, DOI 10.1016/j.foodcont.2010.09.040; Geada Lopez G, 2002, PHYLOGENETIC RELATIO; Gernandt DS, 2009, SYST BOT, V34, P481, DOI 10.1600/036364409789271290; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gordon D, 2002, CURRENT PROTOCOLS BI; Hewson K, 2009, ARCH VIROL, V154, P649, DOI 10.1007/s00705-009-0357-1; Jaakola L, 2010, FOOD CHEM, V123, P494, DOI 10.1016/j.foodchem.2010.04.069; Jeffery N, 2007, MICROBIOL-SGM, V153, P2679, DOI 10.1099/mic.0.2006/005140-0; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Le Maitre D, 1998, PINES CULTIVATION GL; Liston A, 1999, MOL PHYLOGENET EVOL, V11, P95, DOI 10.1006/mpev.1998.0550; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Little DP, 2010, BIOINFORMATICS, V26, P2780, DOI 10.1093/bioinformatics/btq507; Little EL, 1969, SUBDIVISIONS GENUS P; Mackay JF, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-8; Mader E, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-69; Mirov N. T., 1967, GENUS PINUS; Moulalis D, 1998, P 8 PANH FOR SCI SOC, P354; NEALE DB, 1989, THEOR APPL GENET, V77, P212, DOI 10.1007/BF00266189; Neophytou C, 2010, FOREST ECOL MANAG, V259, P2026, DOI 10.1016/j.foreco.2010.02.013; Olivieri C, 2012, J FORENSIC SCI, V57, P222, DOI 10.1111/j.1556-4029.2011.01964.x; Panetsos K, 1997, SILVAE GENETICA, V46; Papajoannou J, 1936, EXTRAIT PRAKTIKA ACA, V11, P14; Plomion C., 2007, V7, P29; Price A, 2000, PHYLOGENY SYSTEMATIC; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Rachmayanti Y, 2006, PLANT MOL BIOL REP, V24, P45, DOI 10.1007/BF02914045; Rachmayanti Y, 2009, FORENSIC SCI INT-GEN, V3, P185, DOI 10.1016/j.fsigen.2009.01.002; Ran JH, 2010, J INTEGR PLANT BIOL, V52, P1109, DOI 10.1111/j.1744-7909.2010.00995.x; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Robertson T, 2009, J APPL MICROBIOL, V107, P2017, DOI 10.1111/j.1365-2672.2009.04388.x; Ronning SB, 2005, J AGR FOOD CHEM, V53, P8874, DOI 10.1021/jf0514569; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Spaniolas S, 2010, FOOD CHEM, V122, P850, DOI 10.1016/j.foodchem.2010.02.039; Stephens AJ, 2008, CLIN CHEM, V54, P432, DOI 10.1373/clinchem.2007.093658; STRAUSS SH, 1990, EVOLUTION, V44, P1081, DOI [10.2307/2409568, 10.1111/j.1558-5646.1990.tb03827.x]; Strid A., 1997, FLORA HELLENICA, VVolume 1; Sun M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019671; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Theodoropoulos K, 2004, INT SCI S BOT GARD A, P37; Vijayan K, 2010, CURR SCI INDIA, V99, P1530; Wang XR, 2000, PLANT SYST EVOL, V220, P21, DOI 10.1007/BF00985368; Ward J, 2005, FORENSIC SCI INT, V152, P121, DOI 10.1016/j.forsciint.2004.07.015; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White T. L., 2007, FOREST GENETICS; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wong KN, 2009, MOL ECOL RESOUR, V9, P360, DOI 10.1111/j.1755-0998.2008.02491.x; Yoshida K., 2007, International symposium on development of improved methods to identify Shorea species wood and its origin, Yayoi Auditorium Ichijo Hall, The University of Tokyo, Tokyo, Japan, 25-26 September, 2007, P27; Zhou LM, 2005, CLIN CHEM, V51, P1770, DOI 10.1373/clinchem.2005.054924	73	32	32	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60945	10.1371/journal.pone.0060945	http://dx.doi.org/10.1371/journal.pone.0060945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577179	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800114
J	Jackson, RE; Willey, CR; Cormack, LK				Jackson, Russell E.; Willey, Chela R.; Cormack, Lawrence K.			Learning and Exposure Affect Environmental Perception Less than Evolutionary Navigation Costs	PLOS ONE			English	Article							DISTANCE PERCEPTION; ORIENTATION; EXPERIENCE; WALKING	Most behaviors are conditional upon successful navigation of the environment, which depends upon distance perception learned over repeated trials. Unfortunately, we understand little about how learning affects distance perception-especially in the most common human navigational scenario, that of adult navigation in familiar environments. Further, dominant theories predict mutually exclusive effects of learning on distance perception, especially when the risks or costs of navigation differ. We tested these competing predictions in four experiments in which we also presented evolutionarily relevant navigation costs. Methods included within- and between-subjects comparisons and longitudinal designs in laboratory and real-world settings. Data suggested that adult distance estimation rapidly reflects evolutionarily relevant navigation costs and repeated exposure does little to change this. Human distance perception may have evolved to reflect navigation costs quickly and reliably in order to provide a stable signal to other behaviors and with little regard for objective accuracy.	[Jackson, Russell E.] Univ Idaho, Psychol & Commun Studies Dept, Moscow, ID 83843 USA; [Willey, Chela R.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Cormack, Lawrence K.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA	Idaho; University of Idaho; University of California System; University of California Los Angeles; University of Texas System; University of Texas Austin	Jackson, RE (corresponding author), Univ Idaho, Psychol & Commun Studies Dept, Moscow, ID 83843 USA.	rjackson@uidaho.edu		Willey, Chela/0000-0002-7339-1503				Adolph KE, 2000, PSYCHOL SCI, V11, P290, DOI 10.1111/1467-9280.00258; [Anonymous], [No title captured]; Bridgeman B, 2005, BEHAV BRAIN SCI, V28, P129, DOI 10.1017/S0140525X0526003X; Bridgeman B, 2008, Q J EXP PSYCHOL, V61, P851, DOI 10.1080/17470210701623712; CAMPOS JJ, 1992, PSYCHOL SCI, V3, P61, DOI 10.1111/j.1467-9280.1992.tb00259.x; CHAPANIS A, 1967, PERCEPT PSYCHOPHYS, V2, P249, DOI 10.3758/BF03212474; COLLINS JK, 1976, AUST J PSYCHOL, V28, P109, DOI 10.1080/00049537608255269; De Camp J.E., 1920, PSYCHOBIOLOGY, V2, P245, DOI [10.1037/h0075411, DOI 10.1037/H0075411]; GARLING T, 1983, J APPL PSYCHOL, V68, P177; GAULIN SJC, 1988, HUMAN REPROD BEHAV D, P129; GIBSON EJ, 1960, SCI AM, V202, P64, DOI 10.1038/scientificamerican0460-64; GILINSKY AS, 1951, PSYCHOL REV, V58, P460, DOI 10.1037/h0061505; Hansen BC, 2004, J VISION, V4, P1044, DOI 10.1167/4.12.5; HARWAY NI, 1963, J EXP PSYCHOL, V65, P385, DOI 10.1037/h0046363; Higashiyama A, 1996, PERCEPT PSYCHOPHYS, V58, P259, DOI 10.3758/BF03211879; Jackson R, 2007, THESIS U TEXAS AUSTI; Jackson R, 2013, PLOS ONE, V8, P1, DOI [10.1371/journal.pone.005, DOI 10.1371/J0URNAL.P0NE.005]; Jackson R. E., 2005, STUDIES PERCEPTION A, VVIII, P241; Jackson RE, 2008, EVOL HUM BEHAV, V29, P299, DOI 10.1016/j.evolhumbehav.2008.03.001; Jackson RE, 2007, PERCEPT PSYCHOPHYS, V69, P353, DOI 10.3758/BF03193756; Jackson RE, 2011, COGNITION, V119, P288, DOI 10.1016/j.cognition.2010.11.003; Jackson RE, 2010, J VISION, V10, DOI 10.1167/10.5.9; Jackson RE, 2009, P R SOC B, V276, P1665, DOI 10.1098/rspb.2009.0004; Kudoh N, 2005, PERCEPTION, V34, P1399, DOI 10.1068/p5444; LOOMIS JM, 1992, J EXP PSYCHOL HUMAN, V18, P906, DOI 10.1037/0096-1523.18.4.906; MANKIN DA, 1969, PERCEPT PSYCHOPHYS, V5, P149, DOI 10.3758/BF03209546; New J, 2007, P ROY SOC B-BIOL SCI, V274, P2679, DOI 10.1098/rspb.2007.0826; Pietrzak RH, 2008, ARCH CLIN NEUROPSYCH, V23, P433, DOI 10.1016/j.acn.2008.03.002; Rieser JJ, 2000, INFANCY, V1, P231, DOI 10.1207/S15327078IN0102_4; van Asselen M, 2006, PSYCHOL RES-PSYCH FO, V70, P151, DOI 10.1007/s00426-004-0199-0; Witherington DC, 2005, INFANCY, V7, P285, DOI 10.1207/s15327078in0703_4	31	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59690	10.1371/journal.pone.0059690	http://dx.doi.org/10.1371/journal.pone.0059690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RZ	23577070	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800014
J	Cao, SY; Yin, XX; Wang, YX; Zhou, HF; Song, FJ; Lu, ZX				Cao, Shiyi; Yin, Xiaoxu; Wang, Yunxia; Zhou, Hongfeng; Song, Fujian; Lu, Zuxun			Smoking and Risk of Erectile Dysfunction: Systematic Review of Observational Studies with Meta-Analysis	PLOS ONE			English	Article							PUBLICATION BIAS; IMPOTENCE	Background: There are many recent observational studies on smoking and risk of erectile dysfunction (ED) and whether smoking increases the risk of ED is still inconclusive. The objective of this meta-analysis was to synthesize evidence from studies that evaluated the association between smoking and the risk of ED. Methods: We searched PubMed, Embase, Web of Science, and Scopus in January 2013 to identify cohort and case-control studies that evaluated the association between smoking and ED. Study quality of included studies was assessed by the Newcastle-Ottawa scale. Random-effects meta-analyses were used to combine the results of included studies. Results: Four prospective cohort studies and four case-control studies involving 28, 586 participants were included. Because of significant heterogeneity after including case-control studies in meta-analysis, the consistent results of prospective cohort studies were considered more accurate, Because of significant heterogeneity after including case-control studies in meta-analysis, the consistent results of prospective cohort studies were considered more accurate, Compared with non-smokers, the overall odd ratio of ED in prospective cohort studies was 1.51(95% CI: 1.34 to 1.71) for current smokers, and it was 1.29 (95% CI: 1.07 to 1.47) for former smokers. Evidence of publication bias was not found. Conclusion: Evidence from epidemiological studies suggests that smoking, especially current smoking, may significantly increase the risk of ED	[Cao, Shiyi; Yin, Xiaoxu; Wang, Yunxia; Zhou, Hongfeng; Lu, Zuxun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Song, Fujian] Univ E Anglia, Norwich Med Sch, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England	Huazhong University of Science & Technology; University of East Anglia	Lu, ZX (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	zuxunlu@yahoo.com	Song, Fujian/B-3516-2013					[Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Bacon CG, 2006, J UROLOGY, V176, P217, DOI 10.1016/S0022-5347(06)00589-1; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong JY, 2011, J AM COLL CARDIOL, V58, P1378, DOI 10.1016/j.jacc.2011.06.024; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Elbendary MA, 2009, J ANDROL, V30, P520, DOI 10.2164/jandrol.108.007195; Feldman HA, 2000, PREV MED, V30, P328, DOI 10.1006/pmed.2000.0643; Gades NM, 2005, AM J EPIDEMIOL, V161, P346, DOI 10.1093/aje/kwi052; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; KIRBY RS, 1994, BRIT MED J, V308, P957, DOI 10.1136/bmj.308.6934.957; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Polsky JY, 2005, BJU INT, V96, P1355, DOI 10.1111/j.1464-410X.2005.05820.x; Shiri R, 2005, INT J IMPOT RES, V17, P164, DOI 10.1038/sj.ijir.3901280; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tengs TO, 2001, PREV MED, V32, P447, DOI 10.1006/pmed.2001.0830; Zambon JP, 2010, SAO PAULO MED J, V128, P137, DOI 10.1590/S1516-31802010000300006; Zedan H., 2010, Eastern Mediterranean Health Journal, V16, P281	19	46	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60443	10.1371/journal.pone.0060443	http://dx.doi.org/10.1371/journal.pone.0060443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573257	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100073
J	Weik, U; Kuepper, Y; Hennig, J; Deinzer, R				Weik, Ulrike; Kuepper, Yvonne; Hennig, Juergen; Deinzer, Renate			Effects of Pre-Experience of Social Exclusion on Hypothalamus-Pituitary-Adrenal Axis and Catecholaminergic Responsiveness to Public Speaking Stress	PLOS ONE			English	Article							PSYCHOSOCIAL STRESS; SUBJECTIVE RESPONSES; CORTISOL RESPONSES; GENDER-DIFFERENCES; EMOTIONAL SUPPORT; SALIVARY CORTISOL; SELF-ESTEEM; OSTRACISM; REJECTION; WOMEN	Backround: Being socially excluded is associated with a variety of psychological changes and with an increased risk of disease. Today, the immediate physiological consequences of being socially excluded are not well understood. In two recent studies employing a standardized exclusion paradigm (Cyberball) we found social exclusion in this virtual game did not alter cortisol secretion directly. However, exclusion pre-experience suppresses the normal cortisol response to public speaking stress in women. The present study aims to replicate our previous finding and further elucidate it by analyzing for the first time whether this alteration of cortisol-responsiveness is associated to ACTH and whether the catecholaminergic system is affected as well. Methods: Women were randomly assigned to Cyberball-induced exclusion (SE, n = 22) or inclusion (SI, n = 21), respectively. Immediately afterwards they were subjected to public speaking stress. Salivary cortisol, plasma ACTH, catecholamines and estradiol were assessed as were psychological distress and mood. Results: Cyberball exclusion led to a highly significant immediate increase in negative affect in excluded women. After public speaking negative affect in included women increased as well and groups no longer differed. We replicate our previous finding of cortisol non-responsiveness to public speaking stress after exclusion pre-experience and find this effect to be significantly correlated with ACTH alterations. No such effects are observed for catecholamines. Conclusions: We replicated our previous study result of a supressed cortisol stress response after a short exclusion experience via Cyberball, thereby underlining the profound effects of social exclusion on a subsequent cortisol stress response. This further demonstrates that these alterations are associated with ACTH. Lack of effects on catecholamines is discussed in view of the tend-and-befriend hypothesis but also from a methodological perspective.	[Weik, Ulrike; Deinzer, Renate] Univ Giessen, Inst Med Psychol, D-35390 Giessen, Germany; [Kuepper, Yvonne; Hennig, Juergen] Univ Giessen, Ctr Psychobiol & Behav Med, Dept Psychol, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Weik, U (corresponding author), Univ Giessen, Inst Med Psychol, D-35390 Giessen, Germany.	ulrike.weik@psycho.med.uni-giessen.de		, Renate/0000-0002-2867-4029				Alvares GA, 2010, EXP CLIN PSYCHOPHARM, V18, P316, DOI 10.1037/a0019719; Blackhart GC, 2007, BIOL PSYCHOL, V75, P267, DOI 10.1016/j.biopsycho.2007.03.005; Bolling DZ, 2011, NEUROIMAGE, V54, P2462, DOI 10.1016/j.neuroimage.2010.10.049; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; Boyes ME, 2009, PERS INDIV DIFFER, V47, P396, DOI 10.1016/j.paid.2009.04.005; Deinzer R, 2004, BRAIN BEHAV IMMUN, V18, P458, DOI 10.1016/j.bbi.2003.11.008; Denton M, 2004, SOC SCI MED, V58, P2585, DOI 10.1016/j.socscimed.2003.09.008; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Ditzen B, 2008, J PSYCHOSOM RES, V64, P479, DOI 10.1016/j.jpsychores.2007.11.011; Ditzen B, 2007, PSYCHONEUROENDOCRINO, V32, P565, DOI 10.1016/j.psyneuen.2007.03.011; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fydrich T, 2007, FRAGEBOGEN SOZIALEN; Geniole SN, 2011, BIOL PSYCHOL, V87, P137, DOI 10.1016/j.biopsycho.2011.02.020; Goldstein D, 2010, ADRENALINE NORADRENA, DOI [10.1002/9780470015902.a0001401.pub2, DOI 10.1002/9780470015902.A0001401.PUB2]]; Hawthorne G, 2008, SOC PSYCH PSYCH EPID, V43, P140, DOI 10.1007/s00127-007-0279-8; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; KIRSCHBAUM C, 1995, PSYCHOSOM MED, V57, P23, DOI 10.1097/00006842-199501000-00004; Klein Laura Cousino, 2002, Curr Psychiatry Rep, V4, P441, DOI 10.1007/s11920-002-0072-z; Krampen G., 1981, IPC FRAGEBOGEN KONTR; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Lau G, 2009, EMOTION, V9, P430, DOI 10.1037/a0015350; Leserman J, 2000, AM J PSYCHIAT, V157, P1221, DOI 10.1176/appi.ajp.157.8.1221; Levenson H, 1973, P 80 ANN CONV APA PU, P261; Masten CL, 2009, SOC COGN AFFECT NEUR, V4, P143, DOI 10.1093/scan/nsp007; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Merten J., 1993, DAS DIFFERENTIELLE A; Montoya P, 2004, ARTHRITIS RHEUM, V50, P4035, DOI 10.1002/art.20660; Onoda K, 2010, SOC COGN AFFECT NEUR, V5, P385, DOI 10.1093/scan/nsq002; Onoda K, 2009, SOC NEUROSCI-UK, V4, P443, DOI 10.1080/17470910902955884; Prins JB, 2004, PSYCHOTHER PSYCHOSOM, V73, P174, DOI 10.1159/000076455; REYNOLDS P, 1990, BEHAV MED, V16, P101, DOI 10.1080/08964289.1990.9934597; Sebastian C, 2010, BRAIN COGNITION, V72, P134, DOI 10.1016/j.bandc.2009.06.008; Sorkin D, 2002, ANN BEHAV MED, V24, P290, DOI 10.1207/S15324796ABM2404_05; Steyer, 1997, MEHRDIMENSIONALE BEF; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Torgrud Laine J., 2004, Cognitive Behaviour Therapy, V33, P87, DOI 10.1080/16506070410029577; Troisi A, 2001, PHYSIOL BEHAV, V73, P443, DOI 10.1016/S0031-9384(01)00459-0; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; Weik U, 2008, PSYCHOSOM MED, V70, P906, DOI 10.1097/PSY.0b013e3181835bf3; Weik U, 2010, HORM BEHAV, V58, P891, DOI 10.1016/j.yhbeh.2010.08.018; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2005, SYDNEY S SOCIAL PSYC, P19; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006; Zoller C, 2010, PSYCHONEUROENDOCRINO, V35, P1294, DOI 10.1016/j.psyneuen.2010.02.019; Zwolinski J, 2012, AGGRESSIVE BEHAV, V38, P108, DOI 10.1002/ab.21411	48	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60433	10.1371/journal.pone.0060433	http://dx.doi.org/10.1371/journal.pone.0060433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23573255	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100071
J	Weissgerber, TL; Gandley, RE; McGee, PL; Spong, CY; Myatt, L; Leveno, KJ; Thorp, JM; Mercer, BM; Peaceman, AM; Ramin, SM; Carpenter, MW; Samuels, P; Sciscione, A; Harper, M; Tolosa, JE; Saade, G; Sorokin, Y				Weissgerber, Tracey L.; Gandley, Robin E.; McGee, Paula L.; Spong, Catherine Y.; Myatt, Leslie; Leveno, Kenneth J.; Thorp, John M., Jr.; Mercer, Brian M.; Peaceman, Alan M.; Ramin, Susan M.; Carpenter, Marshall W.; Samuels, Philip; Sciscione, Anthony; Harper, Margaret; Tolosa, Jorge E.; Saade, George; Sorokin, Yoram		Eunice Kennedy Shriver Natl Inst	Haptoglobin Phenotype, Preeclampsia Risk and the Efficacy of Vitamin C and E Supplementation to Prevent Preeclampsia in a Racially Diverse Population	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; MIDDLE-AGED INDIVIDUALS; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; PREGNANT-WOMEN; ASCORBIC-ACID; THERAPY; ASSOCIATION; ATHEROSCLEROSIS; ANTIOXIDANTS	Haptoglobin's (Hp) antioxidant and pro-angiogenic properties differ between the 1-1, 2-1, and 2-2 phenotypes. Hp phenotype affects cardiovascular disease risk and treatment response to antioxidant vitamins in some non-pregnant populations. We previously demonstrated that preeclampsia risk was doubled in white Hp 2-1 women, compared to Hp 1-1 women. Our objectives were to determine whether we could reproduce this finding in a larger cohort, and to determine whether Hp phenotype influences lack of efficacy of antioxidant vitamins in preventing preeclampsia and serious complications of pregnancy-associated hypertension (PAH). This is a secondary analysis of a randomized controlled trial in which 10,154 low-risk women received daily vitamin C and E, or placebo, from 9-16 weeks gestation until delivery. Hp phenotype was determined in the study prediction cohort (n = 2,393) and a case-control cohort (703 cases, 1,406 controls). The primary outcome was severe PAH, or mild or severe PAH with elevated liver enzymes, elevated serum creatinine, thrombocytopenia, eclampsia, fetal growth restriction, medically indicated preterm birth or perinatal death. Preeclampsia was a secondary outcome. Odds ratios were estimated by logistic regression. Sampling weights were used to reduce bias from an overrepresentation of women with preeclampsia or the primary outcome. There was no relationship between Hp phenotype and the primary outcome or preeclampsia in Hispanic, white/other or black women. Vitamin supplementation did not reduce the risk of the primary outcome or preeclampsia in women of any phenotype. Supplementation increased preeclampsia risk (odds ratio 3.30; 95% confidence interval 1.61-6.82, p<0.01) in Hispanic Hp 2-2 women. Hp phenotype does not influence preeclampsia risk, or identify a subset of women who may benefit from vitamin C and E supplementation to prevent preeclampsia.	[Weissgerber, Tracey L.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Gandley, Robin E.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [McGee, Paula L.] George Washington Univ, Ctr Biostat, Washington, DC USA; [Spong, Catherine Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Myatt, Leslie] Univ Cincinnati, Dept Obstet & Gynecol, Cincinnati, OH USA; [Leveno, Kenneth J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Thorp, John M., Jr.] Univ N Carolina, Chapel Hill, NC USA; [Mercer, Brian M.] Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH USA; [Peaceman, Alan M.] Northwestern Univ, Chicago, IL 60611 USA; [Ramin, Susan M.] Univ Texas Hlth Sci Ctr Houston, Childrens Mem Hermann Hosp, Houston, TX USA; [Carpenter, Marshall W.] Brown Univ, Providence, RI 02912 USA; [Samuels, Philip] Ohio State Univ, Columbus, OH 43210 USA; [Sciscione, Anthony] Drexel Univ, Philadelphia, PA 19104 USA; [Harper, Margaret] Wake Forest Univ Hlth Sci, Winston Salem, NC USA; [Tolosa, Jorge E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Saade, George] Univ Texas Med Branch, Galveston, TX 77555 USA; [Sorokin, Yoram] Wayne State Univ, Detroit, MI USA	Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Washington University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; MetroHealth System; Northwestern University; University of Texas System; University of Texas Health Science Center Houston; Brown University; University System of Ohio; Ohio State University; Drexel University; Wake Forest University; Wake Forest University School of Medicine; Oregon Health & Science University; University of Texas System; University of Texas Medical Branch Galveston; Wayne State University	Weissgerber, TL (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA.	weissgerber.tracey@mayo.edu	Samuels, Philip/E-4011-2011; Weissgerber, Tracey L/D-2324-2014	Weissgerber, Tracey L/0000-0002-7490-2600; Peaceman, Alan/0000-0002-4515-4850; Wapner, Ronald/0000-0003-0727-1244	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [P01 HD030367, HD34208, HD27869, HD40485, HD40560, HD40544, HD34116, HD40512, HD21410, HD40545, HD40500, HD27915, HD34136, HD27860, HD53118, HD53097, HD27917, HD36801]; National Heart, Lung, and Blood Institute; National Center for Research Resources [M01 RR00080, UL1 RR024153, UL1 RR024989]; Canadian Institute of Health Research Fellowship; Amy Roberts Health Promotion Research Award; Office of Women's Health Research (Building Interdisciplinary Careers in Women's Health award) [K12HD065987]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD040512, UG1HD040560, U10HD040560, K12HD065987, UG1HD027869, UG1HD053097, U10HD027917, U10HD034116, U10HD034208, UG1HD040485, U10HD021410, UG1HD040544, U10HD036801, P01HD030367, U10HD040485, U10HD053118, U10HD040545, U10HD027869, U10HD027915, R24HD050924, U10HD040500, UG1HD040500, U10HD040544, UG1HD040545, UG1HD027915, UG1HD034208, UG1HD034116, U10HD053097, UG1HD040512] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD021410, U01HD036801, U10HD027860, U10HD034136] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080, UL1RR024989, UL1RR024153] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Canadian Institute of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); Amy Roberts Health Promotion Research Award; Office of Women's Health Research (Building Interdisciplinary Careers in Women's Health award); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD: http://www.nichd.nih.gov/Pages/index.aspx) (P01 HD030367, HD34208, HD27869, HD40485, HD40560, HD40544, HD34116, HD40512, HD21410, HD40545, HD40500, HD27915, HD34136, HD27860, HD53118, HD53097, HD27917, and HD36801); the National Heart, Lung, and Blood Institute; and the National Center for Research Resources (M01 RR00080, UL1 RR024153, UL1 RR024989). Its contents do not necessarily represent the official view of NICHD, NHLBI, NCRR or NIH. As the program scientist, Catherine Y. Spong (NICHD) participated in the design of the study and development of the protocol and data forms; monitored the collection of the data; participated in the analysis, review, writing and critique of the manuscript and approval of its final version. She also oversees funding for all MFMU Network study sites and trials. Tracey Weissgerber was supported by a Canadian Institute of Health Research Fellowship, an Amy Roberts Health Promotion Research Award, and the Office of Women's Health Research (Building Interdisciplinary Careers in Women's Health award K12HD065987).	Asleh R, 2008, DIABETES, V57, P2794, DOI 10.2337/db08-0450; Beazley D, 2005, AM J OBSTET GYNECOL, V192, P520, DOI 10.1016/j.ajog.2004.09.005; Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176; Blum S, 2008, ARTERIOSCL THROM VAS, V28, pE18, DOI 10.1161/ATVBAHA.107.159905; Blum S, 2010, ATHEROSCLEROSIS, V211, P25, DOI 10.1016/j.atherosclerosis.2010.02.018; Blum S, 2010, PHARMACOGENOMICS, V11, P675, DOI [10.2217/pgs.10.17, 10.2217/PGS.10.17]; Castellan S, 1988, NONPARAMETRIC STAT B; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Chappell LC, 2002, AM J OBSTET GYNECOL, V187, P127, DOI 10.1067/mob.2002.122969; CID MC, 1993, J CLIN INVEST, V91, P977, DOI 10.1172/JCI116319; Depypere HT, 2006, CLIN CHEM LAB MED, V44, P924, DOI 10.1515/CCLM.2006.182; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; GAENSSLEN RE, 1987, J FORENSIC SCI, V32, P1754; Goldenstein H, 2012, ADV BIOSCI BIOTECHNO, V3, P1037; Gupta S, 2009, OBSTET GYNECOL SURV, V64, P750, DOI 10.1097/OGX.0b013e3181bea0ac; Hauth JC, 2000, OBSTET GYNECOL, V95, P24, DOI 10.1016/S0029-7844(99)00462-7; Jensen DM, 2010, DIABETES CARE, V33, P90, DOI 10.2337/dc09-1219; Knuist M, 1998, INT J GYNECOL OBSTET, V61, P127, DOI 10.1016/S0020-7292(98)00024-1; Landon MB, 2011, OBSTET GYNECOL, V118, P1379, DOI 10.1097/AOG.0b013e31823974e2; Langlois MR, 1996, CLIN CHEM, V42, P1589; Levy AP, 2010, ANTIOXID REDOX SIGN, V12, P293, DOI 10.1089/ars.2009.2793; Levy AP, 2004, DIABETES CARE, V27, P2767, DOI 10.2337/diacare.27.11.2767; Levy AP, 2004, DIABETES CARE, V27, P925, DOI 10.2337/diacare.27.4.925; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Milman U, 2008, ARTERIOSCL THROM VAS, V28, P341, DOI 10.1161/ATVBAHA.107.153965; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Myatt L, 2012, OBSTET GYNECOL, V119, P1234, DOI 10.1097/AOG.0b013e3182571669; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Raijmakers MTM, 2003, J MED GENET, V40, P214, DOI 10.1136/jmg.40.3.214; RAO JNK, 1981, J AM STAT ASSOC, V76, P221, DOI 10.2307/2287815; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; Rumbold AR, 2006, NEW ENGL J MED, V354, P1796, DOI 10.1056/NEJMoa054186; Sammour RN, 2010, ENDOCRINE, V38, P303, DOI 10.1007/s12020-010-9392-7; Simon JA, 2004, AM J EPIDEMIOL, V159, P581, DOI 10.1093/aje/kwh079; Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f; Thomas Lumley., 2010, COMPLEX SURVEYS GUID; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432; Weissgerber TL, HAPTOGLOBIN IN PRESS; Weissgerber TL, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.009; Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23; World Health Organisation, 2005, WORLD HLTH REP MAK E; Xu HR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.050; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	48	15	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60479	10.1371/journal.pone.0060479	http://dx.doi.org/10.1371/journal.pone.0060479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573260	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000318840100077
J	Orth, D; Davids, K; Wheat, J; Seifert, L; Liukkonen, J; Jaakkola, T; Ashford, D; Kerr, G				Orth, Dominic; Davids, Keith; Wheat, Jon; Seifert, Ludovic; Liukkonen, Jarmo; Jaakkola, Timo; Ashford, Derek; Kerr, Graham			The Role of Textured Material in Supporting Perceptual-Motor Functions	PLOS ONE			English	Article							POSTURAL CONTROL; PLANTAR PRESSURE; SPIKE INSOLES; QUIET STANCE; OLDER-ADULTS; FOOT; BALANCE; ANKLE; STABILITY; FEEDBACK	Simple deformation of the skin surface with textured materials can improve human perceptual-motor performance. The implications of these findings are inexpensive, adaptable and easily integrated clothing, equipment and tools for improving perceptual-motor functionality. However, some clarification is needed because mixed results have been reported in the literature, highlighting positive, absent and/or negative effects of added texture on measures of perceptual-motor performance. Therefore the aim of this study was to evaluate the efficacy of textured materials for enhancing perceptual-motor functionality. The systematic review uncovered two variables suitable for sub-group analysis within and between studies: participant age (groupings were 18-51 years and 64.7-79.4 years) and experimental task (upright balance and walking). Evaluation of studies that observed texture effects during upright balance tasks, uncovered two additional candidate sub-groups for future work: vision (eyes open and eyes closed) and stability (stable and unstable). Meta-analysis (random effects) revealed that young participants improve performance by a small to moderate amount in upright balance tasks with added texture (SMD = 0.28, 95%CI = 0.46-0.09, Z = 2.99, P = 0.001; Tau(2) = 0.02; Chi(2) = 9.87, df = 6, P = 0.13; I-2 = 39.22). Significant heterogeneity was found in, the overall effect of texture: Tau(2) = 0.13; Chi(2) = 130.71, df = 26, P<0.0001; I-2 = 85.98%, pooled samples in upright balance tasks: Tau(2) = 0.09; Chi(2) = 101.57, df = 13, P<0.001; I-2 = 72.67%, and in elderly in upright balance tasks: Tau(2) = 0.16; Chi(2) = 39.42, df = 5, P<0.001; I-2 = 83.05%. No effect was shown for walking tasks: Tau(2) = 0.00; Chi(2) = 3.45, df = 4, P = 0.27, I-2 = 22.99%. Data provides unequivocal support for utilizing textured materials in young healthy populations for improving perceptual-motor performance. Future research is needed in young healthy populations under conditions where visual and proprioceptive information is challenged, as in high-speed movements, or where use of equipment mediates the performer-environment interaction or where dysfunctional information sources 'compete' for attention. In elderly and ailing populations data suggests further research is required to better understand contexts where texture can facilitate improved perceptual-motor performance.	[Orth, Dominic; Seifert, Ludovic] Univ Rouen, Fac Sports Sci, EA 3832, CETAPS, Rouen, Haute Normandie, France; [Orth, Dominic; Davids, Keith; Kerr, Graham] Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia; [Davids, Keith; Liukkonen, Jarmo; Jaakkola, Timo] Univ Jyvaskyla, Fac Sport & Hlth Sci, FiDiPro Programme, Jyvaskyla, Central Finland, Finland; [Wheat, Jon] Sheffield Hallam Univ, Ctr Sports Engn Res, Sheffield S1 1WB, S Yorkshire, England; [Ashford, Derek] Manchester Metropolitan Univ, Inst Biophys & Clin Res Human Movement, Alsager, North West Engl, England; [Kerr, Graham] Queensland Univ Technol, Movement Neurosci Program, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Universite de Rouen Normandie; Queensland University of Technology (QUT); University of Jyvaskyla; Sheffield Hallam University; Manchester Metropolitan University; Queensland University of Technology (QUT)	Orth, D (corresponding author), Univ Rouen, Fac Sports Sci, EA 3832, CETAPS, Rouen, Haute Normandie, France.	d.orth@qut.edu.au	SEIFERT, Ludovic/AAI-7486-2020	SEIFERT, Ludovic/0000-0003-1712-5013; Kerr, Graham/0000-0002-1008-256X; Davids, Keith/0000-0003-1398-6123; Wheat, Jon/0000-0002-1107-6452; Jaakkola, Timo/0000-0003-1227-2460	Faculty of Sport and Health Science, University of Jyvaskyla, Finland	Faculty of Sport and Health Science, University of Jyvaskyla, Finland	The lead author would like to thank and acknowledge the support the Faculty of Sport and Health Science, University of Jyvaskyla, Finland, whose funding facilitated preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfuth M, 2012, FOOTWEAR SCI, V4, P1, DOI 10.1080/19424280.2011.653990; Baudry L, 2006, J SPORT SCI, V24, P149, DOI 10.1080/02640410500130979; BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; Borenstein M, 2009, SUBGROUP ANAL INTRO; Carroll TJ, 2001, P ROY SOC B-BIOL SCI, V268, P221, DOI 10.1098/rspb.2000.1356; CHEN H, 1995, CLIN BIOMECH, V10, P271, DOI 10.1016/0268-0033(95)99806-D; Cheung RTH, 2011, BRIT J SPORT MED, V45, P743, DOI 10.1136/bjsm.2010.079780; Chiviacowsky S, 2010, GAIT POSTURE, V32, P572, DOI 10.1016/j.gaitpost.2010.08.004; Corbin DM, 2007, J SPORT REHABIL, V16, P363, DOI 10.1123/jsr.16.4.363; Davids K, 2004, BRIT J SPORT MED, V38, P601, DOI 10.1136/bjsm.2003.007427; Dixon J, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.521; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; Fallon JB, 2005, J NEUROPHYSIOL, V94, P3795, DOI 10.1152/jn.00359.2005; Gatev P, 1999, J PHYSIOL-LONDON, V514, P915, DOI 10.1111/j.1469-7793.1999.915ad.x; Gori M, 2008, CURR BIOL, V18, P694, DOI 10.1016/j.cub.2008.04.036; Gutierrez EM, 2001, CLIN BIOMECH, V16, P522, DOI 10.1016/S0268-0033(01)00034-1; HAMALAINEN H, 1992, HUM MOVEMENT SCI, V11, P549, DOI 10.1016/0167-9457(92)90015-4; Hartmann A, 2010, DISABIL REHABIL, V32, P755, DOI 10.3109/09638280903295441; Hatton AL, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-11; Hatton AL, 2011, AGE AGEING, V40, P363, DOI 10.1093/ageing/afr026; Hatton AL, 2009, J ELECTROMYOGR KINES, V19, P957, DOI 10.1016/j.jelekin.2008.04.012; Hedges LV, 1981, J EDUC STAT, V6, P107, DOI [10.2307/1164588, DOI 10.2307/1164588, 10.3102/10769986006002107]; Hijmans JM, 2007, GAIT POSTURE, V25, P316, DOI 10.1016/j.gaitpost.2006.03.010; HONGO T, 1990, J PHYSIOL-LONDON, V420, P471, DOI 10.1113/jphysiol.1990.sp017923; Jenkins ME, 2009, PARKINSONISM RELAT D, V15, P697, DOI 10.1016/j.parkreldis.2009.04.004; Kande IE, 1991, PRINCIPLES NEURAL SC, P430; Kavounoudias A, 2001, J PHYSIOL-LONDON, V532, P869, DOI 10.1111/j.1469-7793.2001.0869e.x; Kelleher KJ, 2010, GAIT POSTURE, V32, P67, DOI 10.1016/j.gaitpost.2010.03.008; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; LOONEY MA, 1994, RES Q EXERCISE SPORT, V65, P363, DOI 10.1080/02701367.1994.10607641; Lord S, 2001, FALLS OLDER PEOPLE R; Lord SR, 1996, AGE AGEING, V25, P292, DOI 10.1093/ageing/25.4.292; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mackey DC, 2005, CLIN BIOMECH, V20, P776, DOI 10.1016/j.clinbiomech.2005.05.002; Maki BE, 1999, J GERONTOL A-BIOL, V54, pM281, DOI 10.1093/gerona/54.6.M281; Maki BE, 2008, J ELECTROMYOGR KINES, V18, P243, DOI 10.1016/j.jelekin.2007.06.005; Maki BE, 2008, IND HEALTH, V46, P40, DOI 10.2486/indhealth.46.40; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Maurer C, 2000, NEUROSCI LETT, V281, P99, DOI 10.1016/S0304-3940(00)00814-4; McKeon PO, 2012, J SPORT REHABIL, V21, P1, DOI 10.1123/jsr.21.1.1; Medell JL, 2000, J GERONTOL A-BIOL, V55, pM429, DOI 10.1093/gerona/55.8.M429; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Nurse MA, 2005, J ELECTROMYOGR KINES, V15, P496, DOI 10.1016/j.jelekin.2004.12.003; Nurse MA, 2001, CLIN BIOMECH, V16, P719, DOI 10.1016/S0268-0033(01)00090-0; Palluel E, 2008, AGE, V30, P53, DOI 10.1007/s11357-008-9047-2; Palluel E, 2009, BEHAV NEUROSCI, V123, P1141, DOI 10.1037/a0017115; Paterson K, 2011, FOOTWEAR SCI, V3, P7; Perry SD, 2006, NEUROSCI LETT, V392, P62, DOI 10.1016/j.neulet.2005.08.060; Perry SD, 2008, J GERONTOL A-BIOL, V63, P595, DOI 10.1093/gerona/63.6.595; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pinsault N, 2008, EXP BRAIN RES, V191, P99, DOI 10.1007/s00221-008-1500-z; Pinsault N, 2010, EXP BRAIN RES, V202, P253, DOI 10.1007/s00221-009-2122-9; Preszner-Domjan A, 2012, EUR J APPL PHYSIOL, V112, P2979, DOI 10.1007/s00421-011-2277-5; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Qiu F, 2012, GAIT POSTURE, V35, P630, DOI 10.1016/j.gaitpost.2011.12.013; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; Ritchie C, 2011, GAIT POSTURE, V33, P576, DOI 10.1016/j.gaitpost.2011.01.012; Seigle B, 2009, GAIT POSTURE, V30, P223, DOI 10.1016/j.gaitpost.2009.05.005; Simoneau G., 1995, GAIT POSTURE, V3, P115, DOI [DOI 10.1016/0966-6362(95)99061-O, 10.1016/0966-6362(95)99061-O]; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Tremblay F, 2004, EXP BRAIN RES, V157, P275, DOI 10.1007/s00221-004-1830-4; Vuillerme N, 2008, EUR J APPL PHYSIOL, V104, P119, DOI 10.1007/s00421-008-0768-9; Vuillerme N, 2007, EXP BRAIN RES, V183, P323, DOI 10.1007/s00221-007-1047-4; Waddington G, 2003, BRIT J SPORT MED, V37, P170, DOI 10.1136/bjsm.37.2.170; Waddington G., 2000, PHYS THER SPORT, V1, P119, DOI 10.1054/ptsp.2000.0020; WATANABE I, 1981, ANN NY ACAD SCI, V374, P855, DOI 10.1111/j.1749-6632.1981.tb30926.x; Welch TDJ, 2009, J NEUROPHYSIOL, V101, P3294, DOI 10.1152/jn.90775.2008; Williams S, 2012, SPORTS MED, V42, P153, DOI 10.2165/11594960-000000000-00000; Wilson ML, 2008, GAIT POSTURE, V27, P36, DOI 10.1016/j.gaitpost.2006.12.006; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; WOOLLACOTT MH, 1990, PHYS THER, V70, P799, DOI 10.1093/ptj/70.12.799	72	21	21	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60349	10.1371/journal.pone.0060349	http://dx.doi.org/10.1371/journal.pone.0060349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565232	Green Submitted, gold, Green Published			2022-12-27	WOS:000317717300102
J	Park, B; Kim, SY; Shin, JY; Sanson-Fisher, RW; Shin, DW; Cho, J; Park, JH				Park, Boyoung; Kim, So Young; Shin, Ji-Yeon; Sanson-Fisher, Robert W.; Shin, Dong Wook; Cho, Juhee; Park, Jong Hyock			Suicidal Ideation and Suicide Attempts in Anxious or Depressed Family Caregivers of Patients with Cancer: A Nationwide Survey in Korea	PLOS ONE			English	Article							QUALITY-OF-LIFE; RISK-FACTORS; CONTRIBUTING FACTORS; ANXIETY DISORDERS; POPULATION; PREVALENCE; UNEMPLOYMENT; EMPLOYMENT; EXPERIENCE; DIAGNOSIS	Purpose: To describe the prevalence of suicidal ideation and suicide attempts in family caregivers (FCs) of patients with cancer and to identify the factors associated with suicidal ideation and suicide attempts in FCs with anxiety or depression. Methods: A national, multicenter survey administered to 897 FCs asked questions concerning suicidal ideation and suicide attempts during the previous year and assessed anxiety, depression, socio-demographic factors, caregiving burden, patient factors, and quality of life (QOL). Results: A total of 17.7% FCs reported suicidal ideation, and 2.8% had attempted suicide during the previous year. Among FCs with anxiety, 31.9% had suicidal ideation and 4.7% attempted suicide; the corresponding values for FCs with depression were 20.4% and 3.3%, respectively. Compared with FCs without anxiety and depression, FCs with anxiety or depression showed a higher adjusted odds ratios (aOR) for suicidal ideation (aOR = 4.07 and 1.93, respectively) and attempts (OR = 3.00 and 2.43, respectively). Among FCs with anxiety or depression, being female, unmarried, unemployed during caregiving, and having a low QOL were associated with increased odds of suicidal ideation. FCs with anxiety who became unemployed during caregiving constituted a high-risk group for suicide. Being unmarried and having a low QOL with respect to financial matters were associated with increased suicide attempts among FCs with depression. Conclusion: FCs with anxiety or depression were at high risk of suicide. Interventions to enhance social support and to improve perceived QOL may help prevent suicide and manage suicidal ideation in FCs with anxiety or depression.	[Park, Boyoung; Kim, So Young; Shin, Ji-Yeon; Park, Jong Hyock] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea; [Sanson-Fisher, Robert W.] Univ Newcastle, Prior Res Ctr Hlth Behav, Callaghan, NSW 2308, Australia; [Sanson-Fisher, Robert W.] Hunter Med Res Inst, Sydney, NSW, Australia; [Shin, Dong Wook] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Shin, Dong Wook] Seoul Natl Univ Canc Hosp, Seoul, South Korea; [Cho, Juhee] Sungkyunkwan Univ, Sch Med, Seoul, South Korea	National Cancer Center - Korea (NCC); University of Newcastle; Hunter Medical Research Institute; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU)	Park, JH (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea.	whitemiso@ncc.re.kr	Cho, Juhee/ABD-2280-2021; farjad, farshad/AGC-9105-2022	Sanson-Fisher, Rob/0000-0001-6022-2949	National Cancer Center, Korea [1210150-1]; National R&D Program for Cancer Control [296 1020010]	National Cancer Center, Korea; National R&D Program for Cancer Control(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by the National Cancer Center, Korea (Grant 295 No. 1210150-1), a grant from the National R&D Program for Cancer Control (Grant No. 296 1020010), and the Ministry of Health and Welfare, Korea (administrative support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akechi T, 2004, CANCER, V100, P183, DOI 10.1002/cncr.11890; Akechi T, 1999, PSYCHIAT CLIN NEUROS, V53, P569, DOI 10.1046/j.1440-1819.1999.00607.x; Akechi T, 2002, JPN J CLIN ONCOL, V32, P506, DOI 10.1093/jjco/hyf106; Bernal M, 2007, J AFFECT DISORDERS, V101, P27, DOI 10.1016/j.jad.2006.09.018; Bolton JM, 2008, DEPRESS ANXIETY, V25, P477, DOI 10.1002/da.20314; Borges G, 2008, J AFFECT DISORDERS, V105, P25, DOI 10.1016/j.jad.2007.01.036; BRESLOW N, 1982, ANNU REV PUBL HEALTH, V3, P29, DOI 10.1146/annurev.pu.03.050182.000333; Cannuscio CC, 2004, SOC SCI MED, V58, P1247, DOI 10.1016/S0277-9536(03)00317-4; Carlson LE, 2001, CANCER NURS, V24, P231, DOI 10.1097/00002820-200106000-00010; Choi HY, 2011, PSYCHIAT INVEST, V8, P320, DOI 10.4306/pi.2011.8.4.320; Choi-Kwon S, 2005, ARCH PHYS MED REHAB, V86, P1043, DOI 10.1016/j.apmr.2004.09.013; Edwards B, 2004, PSYCHO-ONCOLOGY, V13, P562, DOI 10.1002/pon.773; Filiberti A, 2002, TUMORI J, V88, P193, DOI 10.1177/030089160208800303; Furlanetto LM, 2011, GEN HOSP PSYCHIAT, V33, P572, DOI 10.1016/j.genhosppsych.2011.08.002; Glajchen Myra, 2004, J Support Oncol, V2, P145; Kim Y, 2010, PSYCHO-ONCOLOGY, V19, P431, DOI 10.1002/pon.1576; Kolves K, 2006, SOC SCI MED, V62, P2887, DOI 10.1016/j.socscimed.2005.11.048; Kposowa AJ, 2001, PSYCHOL MED, V31, P127, DOI 10.1017/S0033291799002925; Madeira N, 2011, J PSYCHOSOC ONCOL, V29, P636, DOI 10.1080/07347332.2011.615381; Ministry of Health & Selfare Seoul National University, 2011, EP SURV MENT DIS KOR; MUI AC, 1992, GERONTOLOGIST, V32, P203, DOI 10.1093/geront/32.2.203; Nijboer C, 1998, PSYCHO-ONCOL, V7, P3, DOI 10.1002/(SICI)1099-1611(199801/02)7:1<3::AID-PON320>3.0.CO;2-5; Nock MK, 2006, J ABNORM PSYCHOL, V115, P616, DOI 10.1037/0021-843X.115.3.616; Oh SM, 1999, J KOREAN NEUROPSYCHI, V38, P289; PLATT S, 1992, SOC SCI MED, V34, P1191, DOI 10.1016/0277-9536(92)90312-E; Rhee YS, 2005, QUAL LIFE RES, V14, P899, DOI 10.1007/s11136-004-1264-2; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; SCHARLACH AE, 1994, GERONTOLOGIST, V34, P378, DOI 10.1093/geront/34.3.378; SKAFF MM, 1992, GERONTOLOGIST, V32, P656, DOI 10.1093/geront/32.5.656; Stenberg U, 2010, PSYCHO-ONCOLOGY, V19, P1013, DOI 10.1002/pon.1670; ten Have M, 2009, CAN J PSYCHIAT, V54, P824, DOI 10.1177/070674370905401205; Thomas HV, 2002, SOC PSYCH PSYCH EPID, V37, P351, DOI 10.1007/s00127-002-0556-5; Weissman MM, 1999, PSYCHOL MED, V29, P9, DOI 10.1017/S0033291798007867; Yun YH, 2004, QUAL LIFE RES, V13, P863, DOI 10.1023/B:QURE.0000021692.81214.70; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	26	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60230	10.1371/journal.pone.0060230	http://dx.doi.org/10.1371/journal.pone.0060230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565204	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300073
J	Wasserman, RJ; Noyon, M; Avery, TS; Froneman, PW				Wasserman, Ryan J.; Noyon, Margaux; Avery, Trevor S.; Froneman, P. William			Trophic Level Stability-Inducing Effects of Predaceous Early Juvenile Fish in an Estuarine Mesocosm Study	PLOS ONE			English	Article							PLANKTONIC FOOD WEBS; INTRAGUILD PREDATION; INTERSPECIFIC COMPETITION; TEMPORAL VARIABILITY; POPULATION-DYNAMICS; COMMUNITY STABILITY; ANIMAL POPULATIONS; CASCADES; ECOSYSTEMS; MARINE	Background: Classically, estuarine planktonic research has focussed largely on the physico-chemical drivers of community assemblages leaving a paucity of information on important biological interactions. Methodology/Principal Findings: Within the context of trophic cascades, various treatments using in situ mesocosms were established in a closed estuary to highlight the importance of predation in stabilizing estuarine plankton abundances. Through either the removal (filtration) or addition of certain planktonic groups, five different trophic systems were established. These treatments contained varied numbers of trophic levels and thus different "predators" at the top of the food chain. The abundances of zooplankton (copepod and polychaete), ciliate, micro-flagellate, nano-flagellate and bacteria were investigated in each treatment, over time. The reference treatment containing apex zooplanktivores (early juvenile mullet) and plankton at natural densities mimicked a natural, stable state of an estuary. Proportional variability (PV) and coefficient of variation (CV) of temporal abundances were calculated for each taxon and showed that apex predators in this experimental ecosystem, when compared to the other systems, induced stability. The presence of these predators therefore had consequences for multiple trophic levels, consistent with trophic cascade theory. Conclusions/Significance: PV and CV proved useful indices for comparing stability. Apex predators exerted a stabilizing pressure through feeding on copepods and polychaetes which cascaded through the ciliates, micro-flagellates, nano-flagellates and bacteria. When compared with treatments without apex predators, the role of predation in structuring planktonic communities in closed estuaries was highlighted.	[Wasserman, Ryan J.; Noyon, Margaux; Froneman, P. William] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Avery, Trevor S.] Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada	Rhodes University; Acadia University	Wasserman, RJ (corresponding author), Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa.	ryanwas21@gmail.com	Avery, Trevor/ABE-1125-2020; Froneman, William/GLS-0460-2022; Froneman, William/C-9085-2012; Noyon, Margaux/AAN-9261-2021	Froneman, William/0000-0003-0615-1355; Noyon, Margaux/0000-0002-0761-4174; Wasserman, Ryan/0000-0002-4162-1503	Rhodes University	Rhodes University	Funding for this project was provided by the Rhodes University science focus grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDDINGTON JR, 1976, J ANIM ECOL, V45, P791, DOI 10.2307/3581; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Blaustein L, 1996, OIKOS, V76, P392, DOI 10.2307/3546211; Brucet S, 2008, MAR ECOL PROG SER, V355, P183, DOI 10.3354/meps07225; Caceres CE, 1998, OECOLOGIA, V115, P233, DOI 10.1007/s004420050512; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Castilho-Noll MSM, 2007, AQUAT ECOL, V41, P587, DOI 10.1007/s10452-007-9112-4; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; Cottingham KL, 2000, ECOLOGY, V81, P183, DOI 10.2307/177143; Davis M, 1996, MAR ECOL PROG SER, V130, P97, DOI 10.3354/meps130097; DIEHL S, 1993, OIKOS, V68, P151, DOI 10.2307/3545321; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Eveleigh ES, 2007, P NATL ACAD SCI USA, V104, P16976, DOI 10.1073/pnas.0704301104; FENCHEL T, 1982, MAR ECOL PROG SER, V9, P35, DOI 10.3354/meps009035; Fey K, 2009, ECOGRAPHY, V32, P546, DOI 10.1111/j.1600-0587.2008.05637.x; Froneman PW, 2002, ESTUAR COAST SHELF S, V55, P535, DOI 10.1006/ecss.2001.0921; GASTON KJ, 1994, PHILOS T R SOC B, V345, P335, DOI 10.1098/rstb.1994.0114; Graneli E, 2002, MAR ECOL PROG SER, V239, P57, DOI 10.3354/meps239057; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; HANSSON LA, 1992, ECOLOGY, V73, P241, DOI 10.2307/1938735; Heath JP, 2006, OIKOS, V115, P573; Henninger TO, 2008, AFR ZOOL, V43, P202, DOI 10.3377/1562-7020-43.2.202; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; HU SXS, 1995, ECOLOGY, V76, P2278, DOI 10.2307/1941702; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; LAMPERT W, 1989, FUNCT ECOL, V3, P21, DOI 10.2307/2389671; Lauth JR, 1996, ENVIRON TOXICOL CHEM, V15, P630, DOI [10.1897/1551-5028(1996)015&lt;0630:AMEM&gt;2.3.CO;2, 10.1002/etc.5620150504]; LINK WA, 1994, OIKOS, V69, P539, DOI 10.2307/3545869; LORENZEN CARL J., 1966, DEEP SEA RES, V13, P223, DOI 10.1016/0011-7471(66)91102-8; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; Martin D, 1996, MAR ECOL PROG SER, V143, P239, DOI 10.3354/meps143239; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MCARDLE BH, 1990, J ANIM ECOL, V59, P439, DOI 10.2307/4873; Meyers DG, TROPHIC INTERACTIONS, P97; Morin P, 1999, ECOLOGY, V80, P752, DOI 10.2307/177014; NISHINO SF, 1986, APPL ENVIRON MICROB, V52, P602, DOI 10.1128/AEM.52.3.602-604.1986; Pagano M, 2003, ESTUAR COAST SHELF S, V56, P433, DOI 10.1016/S0272-7714(02)00193-2; Perissinotto R, 2003, ACTA OECOL, V24, pS307, DOI 10.1016/S1146-609X(03)00028-6; Persson L, 1999, OIKOS, V85, P385, DOI 10.2307/3546688; PERSSON L, 1992, AM NAT, V140, P59, DOI 10.1086/285403; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Polis GA, 2000, TRENDS ECOL EVOL, V15, P473, DOI 10.1016/S0169-5347(00)01971-6; POLIS GA, 1992, TRENDS ECOL EVOL, V7, P151, DOI 10.1016/0169-5347(92)90208-S; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; POLIS GA, 1994, AUST J ECOL, V19, P121; PORTER KG, 1985, J PROTOZOOL, V32, P409, DOI 10.1111/j.1550-7408.1985.tb04036.x; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; REID FMH, 1983, J PLANKTON RES, V5, P235, DOI 10.1093/plankt/5.2.235; Ripple William J., 2010, P141; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Sommer U, 2008, INT REV HYDROBIOL, V93, P506, DOI 10.1002/iroh.200711039; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Tranvik LJ, 1997, OIKOS, V79, P347, DOI 10.2307/3546018; Turley C. M., 1993, HDB METHODS AQUATIC, P143; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; WESTMAN WE, 1978, BIOSCIENCE, V28, P705, DOI 10.2307/1307321; Whitfield A. K., 1992, Southern African Journal of Aquatic Sciences, V18, P89; WOOLDRIDGE T, 1979, Journal of Plankton Research, V1, P329, DOI 10.1093/plankt/1.4.329; Zollner E, 2009, LIMNOL OCEANOGR, V54, P262, DOI 10.4319/lo.2009.54.1.0262	60	28	30	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e61019	10.1371/journal.pone.0061019	http://dx.doi.org/10.1371/journal.pone.0061019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565294	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300167
J	Bisson, MJ; van Heuven, WJB; Conklin, K; Tunney, RJ				Bisson, Marie-Josee; van Heuven, Walter J. B.; Conklin, Kathy; Tunney, Richard J.			Incidental Acquisition of Foreign Language Vocabulary through Brief Multi-Modal Exposure	PLOS ONE			English	Article							CASCADE MODEL; SAVINGS; PICTURES; FORGOTTEN; ACTIVATION; MEMORY; WORDS	First language acquisition requires relatively little effort compared to foreign language acquisition and happens more naturally through informal learning. Informal exposure can also benefit foreign language learning, although evidence for this has been limited to speech perception and production. An important question is whether informal exposure to spoken foreign language also leads to vocabulary learning through the creation of form-meaning links. Here we tested the impact of exposure to foreign language words presented with pictures in an incidental learning phase on subsequent explicit foreign language learning. In the explicit learning phase, we asked adults to learn translation equivalents of foreign language words, some of which had appeared in the incidental learning phase. Results revealed rapid learning of the foreign language words in the incidental learning phase showing that informal exposure to multi-modal foreign language leads to foreign language vocabulary acquisition. The creation of form-meaning links during the incidental learning phase is discussed.	[Bisson, Marie-Josee; van Heuven, Walter J. B.; Tunney, Richard J.] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Conklin, Kathy] Univ Nottingham, Sch English, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Bisson, MJ (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.	lpxmb@nottingham.ac.uk	van Heuven, Walter J B/K-9034-2013	van Heuven, Walter J B/0000-0003-3183-4449; Conklin, Kathy/0000-0003-2347-8018; Tunney, Richard/0000-0003-4673-757X				[Anonymous], 2004, INT J BILINGUAL, DOI DOI 10.1177/13670069040080031101; Au TKF, 2002, PSYCHOL SCI, V13, P238, DOI 10.1111/1467-9280.00444; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley AD, 2002, EUR PSYCHOL, V7, P85, DOI 10.1027//1016-9040.7.2.85; Bisson MJ, 2014, APPL PSYCHOLINGUIST, V35, P399, DOI 10.1017/S0142716412000434; Bles M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-20; Bowers JS, 2009, PSYCHOL SCI, V20, P1064, DOI 10.1111/j.1467-9280.2009.02407.x; Brown R, 2008, READ FOREIGN LANG, V20, P136; Davis MH, 2009, PHILOS T R SOC B, V364, P3773, DOI 10.1098/rstb.2009.0111; De Bot K, 2000, APPL LINGUIST, V21, P333, DOI 10.1093/applin/21.3.333; Dobel C, 2010, J COGNITIVE NEUROSCI, V22, P1251, DOI 10.1162/jocn.2009.21297; Ebbinghaus H., 1964, MEMORY CONTRIBUTION; Graddol D, 2006, ENGLISH NEXT, V62; GRONINGER LK, 1980, B PSYCHONOMIC SOC, V15, P263; Hansen L, 2002, LANG LEARN, V52, P653, DOI 10.1111/1467-9922.00200; Horst M, 2005, CAN MOD LANG REV, V61, P355, DOI 10.1353/cml.2005.0018; Kuipers JR, 2009, LANG COGNITIVE PROC, V24, P120, DOI 10.1080/01690960802234177; Kweon SO, 2008, READ FOREIGN LANG, V20, P191; MACLEOD CM, 1988, J EXP PSYCHOL LEARN, V14, P195, DOI 10.1037/0278-7393.14.2.195; Macmillan N. A., 1991, DETECTION THEORY USE; McLaughlin J, 2004, NAT NEUROSCI, V7, P703, DOI 10.1038/nn1264; Meyer AS, 2007, MEM COGNITION, V35, P494, DOI 10.3758/BF03193289; Mitterer H, 2009, PLOS ONE, V4, pA146, DOI 10.1371/journal.pone.0007785; Morsella E, 2002, J EXP PSYCHOL LEARN, V28, P555, DOI 10.1037//0278-7393.28.3.555; Nation I.S.P., 2013, LEARNING VOCABULARY; Navarrete E, 2005, J MEM LANG, V53, P359, DOI 10.1016/j.jml.2005.05.001; NELSON TO, 1978, J EXP PSYCHOL-HUM L, V4, P453, DOI 10.1037/0278-7393.4.5.453; NELSON TO, 1985, J EXP PSYCHOL LEARN, V11, P472, DOI 10.1037/0278-7393.11.3.472; Pellicer-Sanchez A, 2010, READ FOREIGN LANG, V22, P31; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Veroude K, 2010, BRAIN LANG, V113, P21, DOI 10.1016/j.bandl.2009.12.005	31	26	26	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60912	10.1371/journal.pone.0060912	http://dx.doi.org/10.1371/journal.pone.0060912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130FG	23579363	Green Published, Green Accepted, gold			2022-12-27	WOS:000317898000083
J	Hullugundi, SK; Ferrari, MD; van den Maagdenberg, AMJM; Nistri, A				Hullugundi, Swathi K.; Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.; Nistri, Andrea			The Mechanism of Functional Up-Regulation of P2X3 Receptors of Trigeminal Sensory Neurons in a Genetic Mouse Model of Familial Hemiplegic Migraine Type 1 (FHM-1)	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GANGLION NEURONS; NEUROTROPHIC FACTOR; SPREADING DEPRESSION; P2X(3) RECEPTORS; TNF-ALPHA; PEPTIDE; PAIN; EXPRESSION; PATHOPHYSIOLOGY	A knock-in (KI) mouse model of FHM-1 expressing the R192Q missense mutation of the Cacna1a gene coding for the alpha 1 subunit of Ca(V)2.1 channels shows, at the level of the trigeminal ganglion, selective functional up-regulation of ATP -gated P2X3 receptors of sensory neurons that convey nociceptive signals to the brainstem. Why P2X3 receptors are constitutively more responsive, however, remains unclear as their membrane expression and TRPV1 nociceptor activity are the same as in wildtype (WT) neurons. Using primary cultures of WT or KI trigeminal ganglia, we investigated whether soluble compounds that may contribute to initiating (or maintaining) migraine attacks, such as TNF alpha, CGRP, and BDNF, might be responsible for increasing P2X3 receptor responses. Exogenous application of TNF alpha potentiated P2X3 receptor-mediated currents of WT but not of KI neurons, most of which expressed both the P2X3 receptor and the TNF alpha receptor TNFR2. However, sustained TNF alpha neutralization failed to change WT or KI P2X3 receptor currents. This suggests that endogenous TNF alpha does not regulate P2X3 receptor responses. Nonetheless, on cultures made from both genotypes, exogenous TNF alpha enhanced TRPV1 receptor-mediated currents expressed by a few neurons, suggesting transient amplification of TRPV1 nociceptor responses. CGRP increased P2X3 receptor currents only in WT cultures, although prolonged CGRP receptor antagonism or BDNF neutralization reduced KI currents to WT levels. Our data suggest that, in KI trigeminal ganglion cultures, constitutive up-regulation of P2X3 receptors probably is already maximal and is apparently contributed by basal CGRP and BDNF levels, thereby rendering these neurons more responsive to extracellular ATP.	[Hullugundi, Swathi K.; Nistri, Andrea] Int Sch Adv Studies SISSA, Dept Neurosci, Trieste, Italy; [Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [van den Maagdenberg, Arn M. J. M.] Leiden Genet Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands	International School for Advanced Studies (SISSA); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Nistri, A (corresponding author), Int Sch Adv Studies SISSA, Dept Neurosci, Trieste, Italy.	nistri@sissa.it	van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Hullugundi, Swathi/I-6281-2019; Ferrari, Michel D./ABE-3758-2021	Ferrari, Michel D./0000-0001-9691-9449; hullugundi, swathi/0000-0003-0697-9988	Telethon Foundation [GGP10082]; Cariplo Foundation [2011-0505]; Fund for Transregional Cooperation (MINA project); ARRS grant [J3-2376-1540]; Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)	Telethon Foundation(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo); Fund for Transregional Cooperation (MINA project); ARRS grant(Slovenian Research Agency - Slovenia); Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Telethon Foundation (grant GGP10082 to AN), the Cariplo Foundation (2011-0505 to AN), the Fund for Transregional Cooperation (MINA project to A. Nistri), and by an ARRS grant J3-2376-1540 (to EF) and a grant from the Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkowiec-Iskra E, 2011, NEUROSCIENCE, V180, P322, DOI 10.1016/j.neuroscience.2011.02.028; Barclay J, 2002, J NEUROSCI, V22, P8139; Blandini F, 2006, CEPHALALGIA, V26, P136, DOI 10.1111/j.1468-2982.2005.01006.x; Bowen EJ, 2006, J NEUROCHEM, V96, P65, DOI 10.1111/j.1471-4159.2005.03524.x; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; Buldyrev I, 2006, J NEUROCHEM, V99, P1338, DOI 10.1111/j.1471-4159.2006.04161.x; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; Ceruti S, 2011, J NEUROSCI, V31, P3638, DOI 10.1523/JNEUROSCI.6440-10.2011; CHIBA T, 1989, AM J PHYSIOL, V256, pE331, DOI 10.1152/ajpendo.1989.256.2.E331; Cutrer FM, 2010, CEPHALALGIA, V30, P1155, DOI 10.1177/0333102410365014; D'Arco M, 2007, J NEUROSCI, V27, P8190, DOI 10.1523/JNEUROSCI.0713-07.2007; Fabbretti E, 2006, J NEUROSCI, V26, P6163, DOI 10.1523/JNEUROSCI.0647-06.2006; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Fioretti B, 2011, J PHYSIOL-LONDON, V589, P5879, DOI 10.1113/jphysiol.2011.220533; Fischer M, 2012, J HEADACHE PAIN, V13, P469, DOI 10.1007/s10194-012-0454-5; Franceschini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052394; Franceschini A, 2013, PURINERG SIGNAL, V9, P7, DOI 10.1007/s11302-012-9328-1; Franceschini A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-143; Giniatullin R, 2008, MOL NEUROBIOL, V37, P83, DOI 10.1007/s12035-008-8020-5; Inchauspe CG, 2012, J NEUROPHYSIOL, V108, P2967, DOI 10.1152/jn.01183.2011; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hagenacker T, 2010, BRAIN RES BULL, V81, P157, DOI 10.1016/j.brainresbull.2009.09.012; Hans M, 1999, J NEUROSCI, V19, P1610; Hansen JM, 2011, HEADACHE, V51, P544, DOI 10.1111/j.1526-4610.2011.01861.x; Hansen JM, 2008, NEUROLOGY, V71, P841, DOI 10.1212/01.wnl.0000325482.64106.3f; Hensellek S, 2007, MOL CELL NEUROSCI, V36, P381, DOI 10.1016/j.mcn.2007.07.010; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Hu YM, 2010, AM J PHYSIOL-LUNG C, V299, pL483, DOI 10.1152/ajplung.00111.2010; Khan AA, 2008, NEUROSCIENCE, V155, P503, DOI 10.1016/j.neuroscience.2008.05.036; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lemos C, 2010, CEPHALALGIA, V30, P1375, DOI 10.1177/0333102410368443; Lessmann V, 1998, GEN PHARMACOL-VASC S, V31, P667; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; Mathew R, 2011, CEPHALALGIA, V31, P1368, DOI 10.1177/0333102411418847; Meents JE, 2010, TRENDS MOL MED, V16, P153, DOI 10.1016/j.molmed.2010.02.004; MOSKOWITZ MA, 1984, ANN NEUROL, V16, P157, DOI 10.1002/ana.410160202; Moskowitz Michael A, 2010, Handb Clin Neurol, V97, P253, DOI 10.1016/S0072-9752(10)97021-8; Nair A, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-48; Obata K, 2006, NEUROSCI RES, V55, P1, DOI 10.1016/j.neures.2006.01.005; Olesen J, 2011, TRENDS PHARMACOL SCI, V32, P352, DOI 10.1016/j.tips.2011.02.016; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Perini F, 2005, HEADACHE, V45, P926, DOI 10.1111/j.1526-4610.2005.05135.x; Raddant AC, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002067; Schafers M, 2008, NEUROSCI LETT, V437, P188, DOI 10.1016/j.neulet.2008.03.052; Simonetti M, 2008, J BIOL CHEM, V283, P18743, DOI 10.1074/jbc.M800296200; Simonetti M, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-11; Takei N, 1998, J BIOL CHEM, V273, P27620, DOI 10.1074/jbc.273.42.27620; Tanure MTA, 2010, J HEADACHE PAIN, V11, P427, DOI 10.1007/s10194-010-0233-0; Tarsa L, 2010, NEUROSCIENCE, V167, P1205, DOI 10.1016/j.neuroscience.2010.03.002; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhang XC, 2011, PAIN, V152, P140, DOI 10.1016/j.pain.2010.10.002	54	27	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60677	10.1371/journal.pone.0060677	http://dx.doi.org/10.1371/journal.pone.0060677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577145	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800086
J	Lee, J; Lee, J				Lee, Juyong; Lee, Jooyoung			Hidden Information Revealed by Optimal Community Structure from a Protein-Complex Bipartite Network Improves Protein Function Prediction	PLOS ONE			English	Article							GENE ONTOLOGY; ANNOTATION; ORGANIZATION; TOOL	The task of extracting the maximal amount of information from a biological network has drawn much attention from researchers, for example, predicting the function of a protein from a protein-protein interaction (PPI) network. It is well known that biological networks consist of modules/communities, a set of nodes that are more densely inter-connected among themselves than with the rest of the network. However, practical applications of utilizing the community information have been rather limited. For protein function prediction on a network, it has been shown that none of the existing community-based protein function prediction methods outperform a simple neighbor-based method. Recently, we have shown that proper utilization of a highly optimal modularity community structure for protein function prediction can outperform neighbor-assisted methods. In this study, we propose two function prediction approaches on bipartite networks that consider the community structure information as well as the neighbor information from the network: 1) a simple screening method and 2) a random forest based method. We demonstrate that our community-assisted methods outperform neighbor-assisted methods and the random forest method yields the best performance. In addition, we show that using the optimal community structure information is essential for more accurate function prediction for the protein-complex bipartite network of Saccharomyces cerevisiae. Community detection can be carried out either using a modified modularity for dealing with the original bipartite network or first projecting the network into a single-mode network (i.e., PPI network) and then applying community detection to the reduced network. We find that the projection leads to the loss of information in a significant way. Since our prediction methods rely only on the network topology, they can be applied to various fields where an efficient network-based analysis is required.	[Lee, Juyong; Lee, Jooyoung] Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea	Korea Institute for Advanced Study (KIAS)	Lee, J (corresponding author), Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea.	jlee@kias.re.kr	Lee, Juyong/A-7869-2013	Lee, Juyong/0000-0003-1174-4358	National Research Foundation of Korea (NRF); Korea government (MEST) [20120001222]; KISTI Supercomputing Center [KSC-2012-C3-01]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); KISTI Supercomputing Center(Korea Institute of Science & Technology Information (KISTI))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 20120001222). The authors thank Korea Institute for Advanced Study for providing computing resources (KIAS Center for Advanced Computation Linux Cluster) for this work. The authors also would like to acknowledge the support from the KISTI Supercomputing Center (KSC-2012-C3-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Aldecoa R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024195; Aloise D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046112; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chua HN, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S8; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Deng MH, 2004, J COMPUT BIOL, V11, P463, DOI 10.1089/1066527041410346; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Hannum G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000782; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jaeger S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-717; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Karni S, 2009, J COMPUT BIOL, V16, P181, DOI 10.1089/cmb.2008.05TT; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lee J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.080201; Lee J, 1997, J COMPUT CHEM, V18, P1222, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1222::AID-JCC10>3.0.CO;2-7; Lee J, 2012, ARXIV12092873; Lee J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056702; Lee J, 2011, PROTEINS, V79, P2403, DOI 10.1002/prot.23059; Lee SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-126; Lee SA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S11; Lewis ACF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-100; Ma'ayan A, 2007, MT SINAI J MED, V74, P27, DOI 10.1002/msj.20002; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Nacher Jose C., 2008, BMC Pharmacology, V8, P5, DOI 10.1186/1471-2210-8-5; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhou X, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-246	47	24	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60372	10.1371/journal.pone.0060372	http://dx.doi.org/10.1371/journal.pone.0060372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577106	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800046
J	Madadi, P; Hildebrandt, D; Lauwers, AE; Koren, G				Madadi, Parvaz; Hildebrandt, Doris; Lauwers, Albert E.; Koren, Gideon			Characteristics of Opioid-Users Whose Death Was Related to Opioid-Toxicity: A Population-Based Study in Ontario, Canada	PLOS ONE			English	Article							UNITED-STATES; MORTALITY; ABUSE; RISK; PAIN; ANALGESICS; OXYCODONE; OVERDOSES; EPIDEMIC; PATTERNS	Background: The impact of the prescription opioid public health crisis has been illustrated by the dramatic increase in opioid-related deaths in North America. We aimed to identify patterns and characteristics amongst opioid-users whose cause of death was related to opioid toxicity. Methods: This was a population-based study of Ontarians between the years 2006 and 2008. All drug-related deaths which occurred during this time frame were reviewed at the Office of the Chief Coroner of Ontario, and opioid-related deaths were identified. Medical, toxicology, pathology, and police reports were comprehensively reviewed. Narratives, semi-quantitative, and quantitative variables were extracted, tabulated, and analyzed. Results: Out of 2330 drug-related deaths in Ontario, 58% were attributed either in whole or in part, to opioids (n = 1359). Oxycodone was involved in approximately one-third of all opioid-related deaths. At least 7% of the entire cohort used opioids that were prescribed for friends and/or family, 19% inappropriately self-administered opioids (injection, inhalation, chewed patch), 3% were recently released from jail, and 5% had been switched from one opioid to another near the time of death. Accidental deaths were significantly associated with personal history of substance abuse, enrollment in methadone maintenance programs, cirrhosis, hepatitis, and cocaine use. Suicides were significantly associated with mental illness, previous suicide attempts, chronic pain, and a history of cancer. Significance/Conclusion: These results identify novel, susceptible groups of opioid-users whose cause of death was related to opioids in Ontario and provide the first evidence to assist in quantifying the contribution of opioid misuse and diversion amongst opioid-related mortality in Canada. Multifaceted prevention strategies need to be developed based on subpopulations of opioid users.	[Madadi, Parvaz; Koren, Gideon] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Hildebrandt, Doris; Lauwers, Albert E.] Off Chief Coroner Ontario, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Madadi, P (corresponding author), Hosp Sick Children, Div Clin Pharmacol & Toxicol, Dept Pediat, Toronto, ON M5G 1X8, Canada.	parvaz.madadi@gmail.com	Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875	Canadian Institutes for Health Research; Canadian Pain Society; Canadian Pharmacogenomics Network for Drug Safety; Quebec Training Network in Perinatal Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Pain Society; Canadian Pharmacogenomics Network for Drug Safety; Quebec Training Network in Perinatal Research	PM is the recipient of a Postdoctoral Fellowship from the Canadian Institutes for Health Research and has also received Postdoctoral funding from the Canadian Pain Society, the Canadian Pharmacogenomics Network for Drug Safety, and the Quebec Training Network in Perinatal Research. Dr. Koren is the holder of the Ivey Chair in Molecular Toxicology at Western University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; College of Physicians and Surgeons of Ontario, AV AB ACH BAL TACKL; Dhalla IA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5142; Dhalla IA, 2011, CAN FAM PHYSICIAN, V57, pE92; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784; Fischer B, 2012, INT J DRUG POLICY, V23, P495, DOI 10.1016/j.drugpo.2012.07.008; Fischer B, 2010, CAN J PSYCHIAT, V55, P606, DOI 10.1177/070674371005500909; Fischer B, 2009, CAN MED ASSOC J, V181, P881, DOI 10.1503/cmaj.091791; Gomes Tara, 2011, Open Med, V5, pe13; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Gomes Tara, 2011, Healthc Q, V14, P22; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Kuehn BM, 2010, JAMA-J AM MED ASSOC, V303, P495, DOI 10.1001/jama.2010.71; Kurdyak P, 2012, ADDICTION, V107, P776, DOI 10.1111/j.1360-0443.2011.03707.x; Martin TL, 2006, J ANAL TOXICOL, V30, P603, DOI 10.1093/jat/30.8.603; Noble M, 2010, COCHRANE DB SYST REV, V20; Pain & Policy Studies Group University of Wisconsin/WHO Collaborating Center, 2012, MG CAP CONS METH CAN; Pain & Policy Studies Group University of Wisconsin/WHO Collaborating Center, 2012, MG CAP CONS FENT CAN; Pain & Policy Studies Group University of Wisconsin/WHO Collaborating Center, 2012, MG CAP CONS HYDR CAN; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Paulozzi LJ, 2012, PAIN MED, V13, P87, DOI 10.1111/j.1526-4637.2011.01260.x; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Rich JD, 2011, NEW ENGL J MED, V364, P2081, DOI 10.1056/NEJMp1102385; Sproule B, 2009, CAN FAM PHYS, V55; Sproule B, 2009, CAN FAM PHYSICIAN, V55, P68; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1346, DOI 10.1001/jama.2011.369; Warner Margaret, 2009, NCHS Data Brief, P1; Webster LR, 2005, PAIN MED, V6, P432, DOI 10.1111/j.1526-4637.2005.00072.x; Webster PC, 2012, CAN MED ASSOC J, V184, P285, DOI 10.1503/cmaj.109-4088; Woodall KL, 2008, J FORENSIC SCI, V53, P222, DOI 10.1111/j.1556-4029.2007.00597.x; World Health Organization (WHO), 2010, PREV AC DRUG REL MOR	31	75	77	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60600	10.1371/journal.pone.0060600	http://dx.doi.org/10.1371/journal.pone.0060600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577131	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800071
J	Pilly, PK; Grossberg, S				Pilly, Praveen K.; Grossberg, Stephen			Spiking Neurons in a Hierarchical Self-Organizing Map Model Can Learn to Develop Spatial and Temporal Properties of Entorhinal Grid Cells and Hippocampal Place Cells	PLOS ONE			English	Article							DEPENDENT SYNAPTIC PLASTICITY; THETA PHASE PRECESSION; SUBTHRESHOLD OSCILLATIONS; PATH-INTEGRATION; STELLATE CELLS; H-CURRENT; LAYER-II; HCN1 CHANNELS; CORTEX; FREQUENCY	Medial entorhinal grid cells and hippocampal place cells provide neural correlates of spatial representation in the brain. A place cell typically fires whenever an animal is present in one or more spatial regions, or places, of an environment. A grid cell typically fires in multiple spatial regions that form a regular hexagonal grid structure extending throughout the environment. Different grid and place cells prefer spatially offset regions, with their firing fields increasing in size along the dorsoventral axes of the medial entorhinal cortex and hippocampus. The spacing between neighboring fields for a grid cell also increases along the dorsoventral axis. This article presents a neural model whose spiking neurons operate in a hierarchy of self-organizing maps, each obeying the same laws. This spiking GridPlaceMap model simulates how grid cells and place cells may develop. It responds to realistic rat navigational trajectories by learning grid cells with hexagonal grid firing fields of multiple spatial scales and place cells with one or more firing fields that match neurophysiological data about these cells and their development in juvenile rats. The place cells represent much larger spaces than the grid cells, which enable them to support navigational behaviors. Both self-organizing maps amplify and learn to categorize the most frequent and energetic co-occurrences of their inputs. The current results build upon a previous rate-based model of grid and place cell learning, and thus illustrate a general method for converting rate-based adaptive neural models, without the loss of any of their analog properties, into models whose cells obey spiking dynamics. New properties of the spiking GridPlaceMap model include the appearance of theta band modulation. The spiking model also opens a path for implementation in brain-emulating nanochips comprised of networks of noisy spiking neurons with multiple-level adaptive weights for controlling autonomous adaptive robots capable of spatial navigation.	[Pilly, Praveen K.] Boston Univ, Ctr Adapt Syst, Ctr Computat Neurosci & Neural Technol, Boston, MA 02215 USA; [Grossberg, Stephen] Boston Univ, Dept Math, Ctr Computat Neurosci & Neural Technol, Ctr Adapt Syst, Boston, MA 02215 USA	Boston University; Boston University	Grossberg, S (corresponding author), Boston Univ, Dept Math, Ctr Computat Neurosci & Neural Technol, Ctr Adapt Syst, Boston, MA 02215 USA.	steve@bu.edu			SyNAPSE program of DARPA [HR0011-09-C-0001]	SyNAPSE program of DARPA	Supported in part by the SyNAPSE program of DARPA (HR0011-09-C-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; [Anonymous], [No title captured]; Arthur JV, 2012, P INT JT C IN PRESS; Barry C, 2006, REV NEUROSCIENCE, V17, P71; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BLAND BH, 1988, BRAIN RES, V447, P364, DOI 10.1016/0006-8993(88)91141-9; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CABALLEROBLEDA M, 1993, J COMP NEUROL, V328, P115, DOI 10.1002/cne.903280109; CABALLEROBLEDA M, 1994, EXP BRAIN RES, V101, P93; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; DAVIS S, 1992, J NEUROSCI, V12, P21; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Fenton AA, 2008, J NEUROSCI, V28, P11250, DOI 10.1523/JNEUROSCI.2862-08.2008; Garden DLF, 2008, NEURON, V60, P875, DOI 10.1016/j.neuron.2008.10.044; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Giocomo LM, 2008, J NEUROSCI, V28, P9414, DOI 10.1523/JNEUROSCI.3196-08.2008; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Giocomo LM, 2011, CELL, V147, P1159, DOI 10.1016/j.cell.2011.08.051; Gorchetchnikov A, 2007, NEURAL NETWORKS, V20, P182, DOI 10.1016/j.neunet.2006.11.007; Grossberg S, 2003, CEREB CORTEX, V13, P852, DOI 10.1093/cercor/13.8.852; GROSSBERG S, 1976, BIOL CYBERN, V23, P121, DOI 10.1007/BF00344744; Grossberg S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002648; Grossberg S, 2009, HIPPOCAMPUS, V19, P881, DOI 10.1002/hipo.20602; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; JAHR CE, 1990, J NEUROSCI, V10, P3178; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kim KH, 2012, NANO LETT, V12, P389, DOI 10.1021/nl203687n; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mhatre H, 2012, HIPPOCAMPUS, V22, P320, DOI 10.1002/hipo.20901; Molter C, 2008, HIPPOCAMPUS, V18, P919, DOI 10.1002/hipo.20450; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Palma J, 2012, J COMPUT NEUROSCI, V32, P253, DOI 10.1007/s10827-011-0354-8; Park E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022349; Parron C, 2004, EXP BRAIN RES, V159, P349, DOI 10.1007/s00221-004-1960-8; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; Pilly PK, 2012, J COGNITIVE NEUROSCI, V24, P1031, DOI 10.1162/jocn_a_00200; RANCK J B JR, 1984, Society for Neuroscience Abstracts, V10, P599; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Reifenstein ET, 2012, P NATL ACAD SCI USA, V109, P6301, DOI 10.1073/pnas.1109599109; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Skaggs WE, 1993, ADV NEURAL INFORM PR, V5, P1030, DOI DOI 10.1109/PROC.1977.10559; Song PC, 2005, J NEUROSCI, V25, P1002, DOI 10.1523/JNEUROSCI.4172-04.2005; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; TAUBE JS, 1990, J NEUROSCI, V10, P420; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; TUCKWELL HC, 1988, INTRO THEORETICAL NE, V1, P85; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Yoshida M, 2011, J NEUROSCI, V31, P12683, DOI 10.1523/JNEUROSCI.1654-11.2011	86	25	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60599	10.1371/journal.pone.0060599	http://dx.doi.org/10.1371/journal.pone.0060599			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577130	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800070
J	Rungrassamee, W; Klanchui, A; Chaiyapechara, S; Maibunkaew, S; Tangphatsornruang, S; Jiravanichpaisal, P; Karoonuthaisiri, N				Rungrassamee, Wanilada; Klanchui, Amornpan; Chaiyapechara, Sage; Maibunkaew, Sawarot; Tangphatsornruang, Sithichoke; Jiravanichpaisal, Pikul; Karoonuthaisiri, Nitsara			Bacterial Population in Intestines of the Black Tiger Shrimp (Penaeus monodon) under Different Growth Stages	PLOS ONE			English	Article							PACIFIC WHITE SHRIMP; MICROBIAL DIVERSITY; COMMUNITY STRUCTURE; VIBRIO-HARVEYI; GUT MICROBIOTA; PCR-DGGE; GENES; VIRULENCE; GRADIENT; PATHOGEN	Intestinal bacterial communities in aquaculture have been drawn to attention due to potential benefit to their hosts. To identify core intestinal bacteria in the black tiger shrimp (Penaeus monodon), bacterial populations of disease-free shrimp were characterized from intestines of four developmental stages (15-day-old post larvae (PL15), 1-(J1), 2-(J2), and 3-month-old (J3) juveniles) using pyrosequencing, real-time PCR and denaturing gradient gel electrophoresis (DGGE) approaches. A total of 25,121 pyrosequencing reads (reading length = 442 +/- 24 bases) were obtained, which were categorized by barcode for PL15 (7,045 sequences), J1 (3,055 sequences), J2 (13,130 sequences) and J3 (1,890 sequences). Bacteria in the phyla Bacteroides, Firmicutes and Proteobacteria were found in intestines at all four growth stages. There were 88, 14, 27, and 20 bacterial genera associated with the intestinal tract of PL15, J1, J2 and J3, respectively. Pyrosequencing analysis revealed that Proteobacteria (class Gammaproteobacteria) was a dominant bacteria group with a relative abundance of 89% for PL15 and 99% for J1, J2 and J3. Real-time PCR assay also confirmed that Gammaproteobacteria had the highest relative abundance in intestines from all growth stages. Intestinal bacterial communities from the three juvenile stages were more similar to each other than that of the PL shrimp based on PCA analyses of pyrosequencing results and their DGGE profiles. This study provides descriptive bacterial communities associated to the black tiger shrimp intestines during these growth development stages in rearing facilities.	[Rungrassamee, Wanilada; Klanchui, Amornpan; Maibunkaew, Sawarot; Karoonuthaisiri, Nitsara] Natl Ctr Genet Engn & Biotechnol, Microarray Lab, Khlong Luang, Pathum Thani, Thailand; [Chaiyapechara, Sage; Jiravanichpaisal, Pikul] Natl Ctr Genet Engn & Biotechnol, Aquat Mol Genet & Biotechnol Lab, Khlong Luang, Pathum Thani, Thailand; [Tangphatsornruang, Sithichoke] Natl Ctr Genet Engn & Biotechnol, Genom Res Lab, Khlong Luang, Pathum Thani, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Karoonuthaisiri, N (corresponding author), Natl Ctr Genet Engn & Biotechnol, Microarray Lab, Khlong Luang, Pathum Thani, Thailand.	nitsara.kar@biotec.or.th	Tangphatsornruang, Sithichoke/G-3633-2010; Rungrassamee, Wanilada/E-1718-2011	Tangphatsornruang, Sithichoke/0000-0003-2673-0012; Rungrassamee, Wanilada/0000-0002-5802-4342; Chaiyapechara, Sage/0000-0002-6836-2759	National Center for Genetic Engineering and Biotechnology (BIOTEC) [P-10-10722, P-11-00671]; Thailand Research Fund (TRF) [DBG5380030, TRG5480014]	National Center for Genetic Engineering and Biotechnology (BIOTEC); Thailand Research Fund (TRF)(Thailand Research Fund (TRF))	This research was co-supported by the National Center for Genetic Engineering and Biotechnology (BIOTEC, grant numbers P-10-10722 and P-11-00671) and the Thailand Research Fund (TRF, grant numbers DBG5380030 and TRG5480014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; Bates JM, 2006, DEV BIOL, V297, P374, DOI 10.1016/j.ydbio.2006.05.006; Browdy CL, 1998, AQUACULTURE, V164, P3, DOI 10.1016/S0044-8486(98)00174-4; Brune A, 2000, CURR OPIN MICROBIOL, V3, P263, DOI 10.1016/S1369-5274(00)00087-4; CAHILL MM, 1990, MICROB ECOL, V19, P21, DOI 10.1007/BF02015051; Chaiyapechara S, 2012, MICROB ECOL, V63, P938, DOI 10.1007/s00248-011-9936-2; Chang ES, 1995, J EXP MAR BIOL ECOL, V193, P1, DOI 10.1016/0022-0981(95)00106-9; Chen Houng-Yung, 1993, Journal of the World Aquaculture Society, V24, P231, DOI 10.1111/j.1749-7345.1993.tb00012.x; Cleary DFR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029380; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FAO, 2003, SUST SHRIMP CULT DEV; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Gillilland MG, 2012, APPL ENVIRON MICROB, V78, P2359, DOI 10.1128/AEM.05239-11; Gomez-Gil B, 2000, AQUACULTURE, V191, P259, DOI 10.1016/S0044-8486(00)00431-2; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; HARRIS JM, 1993, MICROB ECOL, V25, P195, DOI 10.1007/BF00171889; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hoj L, 2009, AQUACULTURE, V293, P278, DOI 10.1016/j.aquaculture.2009.04.024; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hughes JB, 2002, APPL ENVIRON MICROB, V68, P448, DOI 10.1128/AEM.68.1.448; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jiravanichpaisal P., 1994, Journal of Aquatic Animal Health, V6, P27, DOI 10.1577/1548-8667(1994)006&lt;0027:HBAPOV&gt;2.3.CO;2; Jiravanichpaisal P, 2007, FISH SHELLFISH IMMUN, V23, P815, DOI 10.1016/j.fsi.2007.03.003; Johnson CN, 2008, J WORLD AQUACULT SOC, V39, P251, DOI 10.1111/j.1749-7345.2008.00155.x; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kauserud H, 2012, MYCORRHIZA, V22, P309, DOI 10.1007/s00572-011-0403-1; Kim DH, 2007, J APPL MICROBIOL, V102, P1654, DOI 10.1111/j.1365-2672.2006.03185.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lavilla-Pitogo CR, 1998, AQUACULTURE, V164, P337, DOI 10.1016/S0044-8486(98)00198-7; Laycock G, 2012, VET IMMUNOL IMMUNOP, V149, P216, DOI 10.1016/j.vetimm.2012.07.004; Leite AMO, 2012, FOOD MICROBIOL, V31, P215, DOI 10.1016/j.fm.2012.03.011; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Liu HD, 2011, AQUACULTURE, V317, P32, DOI 10.1016/j.aquaculture.2011.04.008; Lopez-Torres MA, 2001, AQUACULTURE, V194, P11, DOI 10.1016/S0044-8486(00)00505-6; LOVETT DL, 1990, BIOL BULL, V178, P160, DOI 10.2307/1541974; Manefield M, 2000, APPL ENVIRON MICROB, V66, P2079, DOI 10.1128/AEM.66.5.2079-2084.2000; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Muyzer G, 1999, CURR OPIN MICROBIOL, V2, P317, DOI 10.1016/S1369-5274(99)80055-1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Naqvi A, 2010, CHEM BIODIVERS, V7, P1076, DOI 10.1002/cbdv.200900321; Navarrete P, 2009, MICROB ECOL, V57, P550, DOI 10.1007/s00248-008-9448-x; Oxley APA, 2002, J APPL MICROBIOL, V93, P214, DOI 10.1046/j.1365-2672.2002.01673.x; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Perez T, 2010, MUCOSAL IMMUNOL, V3, P355, DOI 10.1038/mi.2010.12; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rengpipat S, 1998, AQUACULTURE, V167, P301, DOI 10.1016/S0044-8486(98)00305-6; Rengpipat S, 2003, DIS AQUAT ORGAN, V55, P169, DOI 10.3354/dao055169; Ribeiro F, 2010, DEV MORPHOLOGY ONCOG; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Soonthornchai W, 2010, DEV COMP IMMUNOL, V34, P19, DOI 10.1016/j.dci.2009.07.007; Soto-Rodriguez SA, 2012, J INVERTEBR PATHOL, V109, P307, DOI 10.1016/j.jip.2012.01.006; Tanticharoen Morakot, 2008, International Journal of Biotechnology, V10, P588, DOI 10.1504/IJBT.2008.022494; Telias A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-81; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Tkavc R, 2011, FEMS MICROBIOL ECOL, V77, P310, DOI 10.1111/j.1574-6941.2011.01112.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilkenfeld J.S., 1984, Journal of the World Mariculture Society, V15, P31; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Zhang XJ, 2011, APPL MICROBIOL BIOT, V91, P425, DOI 10.1007/s00253-011-3296-1	76	106	117	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60802	10.1371/journal.pone.0060802	http://dx.doi.org/10.1371/journal.pone.0060802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577162	Green Submitted, gold, Green Published			2022-12-27	WOS:000319109800100
J	Albano, GD; Di Sano, C; Bonanno, A; Riccobono, L; Gagliardo, R; Chanez, P; Gjomarkaj, M; Montalbano, AM; Anzalone, G; La Grutta, S; Ricciardolo, FLM; Profita, M				Albano, Giusy Daniela; Di Sano, Caterina; Bonanno, Anna; Riccobono, Loredana; Gagliardo, Rosalia; Chanez, Pascal; Gjomarkaj, Mark; Montalbano, Angela Marina; Anzalone, Giulia; La Grutta, Stefania; Ricciardolo, Fabio Luigi Massimo; Profita, Mirella			Th17 Immunity in Children with Allergic Asthma and Rhinitis: A Pharmacological Approach	PLOS ONE			English	Article							REGULATORY T-CELLS; AIRWAY INFLAMMATION; T(H)17 CELLS; IL-17; VALIDITY; FLUID	Th17 cells and IL-17A play a role in the development and progression of allergic diseases. We analyzed the IL-17A levels in sputum supernatants (Ss), nasal wash (NW) and plasma (P) from Healthy Controls (HC) and children with Asthma/Rhinitis. We tested the expression of IL-17A, ROR gamma(t) and FOXP3 in peripheral blood T-lymphocytes from intermittent and mild-moderate asthma. The effect of Budesonide and Formoterol was tested "in vitro" on IL-17A, ROR gamma(t) and FOXP3 expression in cultured T-lymphocytes from mild-moderate asthma/persistent rhinitis patients, and on nasal and bronchial epithelial cells stimulated with NW and Ss from mild-moderate asthma/persistent rhinitis. Further, the effect of 12 weeks of treatment with Budesonide and Formoterol was tested "in vivo" in T-lymphocytes from mild-moderate asthma/persistent rhinitis patients. IL-17A was increased in Ss, NW and P from children with mild-moderate asthma compared with intermittent and HC. In cultured T-lymphocytes IL-17A and ROR gamma(t) expression were higher in mild-moderate asthma/persistent rhinitis than in mild-moderate asthma/intermittent rhinitis, while FOXP3 was reduced. Budesonide with Formoterol reduced IL-17A and ROR gamma(t), while increased FOXP3 in cultured T-lymphocytes from mild-moderate asthma/persistent rhinitis, and reduced the IL-8 release mediated by IL-17A present in NW and Ss from mild-moderate asthma/persistent rhinitis in nasal and bronchial epithelial cells. Finally, Budesonide with Formoterol reduced IL-17A levels in P and Ss, CD4(+)IL-17A(+)T-cells, in naive children with mild-moderate asthma/persistent rhinitis after 12 weeks of treatment. Th17 mediated immunity may be involved in the airway disease of children with allergic asthma and allergic rhinitis. Budesonide with Formoterol might be a useful tool for its therapeutic control.	[Albano, Giusy Daniela; Di Sano, Caterina; Bonanno, Anna; Riccobono, Loredana; Gagliardo, Rosalia; Gjomarkaj, Mark; Montalbano, Angela Marina; Anzalone, Giulia; La Grutta, Stefania; Profita, Mirella] Italian Natl Res Council, Inst Biomed & Mol Immunol, Unit Ex Vivo In Vitro Models Study Immunopathol P, Palermo, Italy; [Albano, Giusy Daniela] Univ Palermo, Dipartimento Biomed Med Interna & Specialist, Sez Pneumol, Palermo, Italy; [Chanez, Pascal] Univ Mediterranee, AP HM, Dept Malad Resp, Marseille, France; [Chanez, Pascal] Univ Mediterranee, INSERM, U600, CNRS,UMR6212, Marseille, France; [La Grutta, Stefania] ARPA Palermo, Environm Hlth Unit, Palermo, Italy; [Ricciardolo, Fabio Luigi Massimo] Univ Turin, Dept Clin & Biol Sci, Div Resp Dis, Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Palermo; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Regional Environmental Protection Agency - Italy; University of Turin	Profita, M (corresponding author), Italian Natl Res Council, Inst Biomed & Mol Immunol, Unit Ex Vivo In Vitro Models Study Immunopathol P, Palermo, Italy.	profita@ibim.cnr.it	Abano, Giusy Daniela/AAY-3896-2020; bonanno, anna/F-7613-2015; Profita, Mirella/D-8957-2018; Profita, Mirella/AAY-3165-2020; DI SANO, CATERINA/AAX-7536-2020; Ricciardolo, F. L. M./K-5330-2018; Gagliardo, Rosalia/AAX-7244-2020; Bonanno, Anna/AAV-9474-2020; Montalbano, Angela Marina/AAY-3905-2020; La Grutta, Stefania/N-3615-2014; Riccobono, Loredana/F-7950-2015; Profita, Mirella/AFU-7423-2022	Abano, Giusy Daniela/0000-0001-6944-4118; bonanno, anna/0000-0003-3448-283X; Profita, Mirella/0000-0002-7821-8283; Ricciardolo, F. L. M./0000-0003-1826-5018; Montalbano, Angela Marina/0000-0001-5950-4834; La Grutta, Stefania/0000-0001-8026-0715; Riccobono, Loredana/0000-0002-0012-3591; DI SANO, CATERINA/0000-0003-3904-3465; chanez, pascal/0000-0003-4059-0917	Italian National Research Council	Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR))	The research funds received by M. Profita were from the Italian National Research Council.	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Belda J, 2001, CLIN EXP ALLERGY, V31, P1111, DOI 10.1046/j.1365-2222.2001.01133.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bourdin A, 2009, THORAX, V64, P999, DOI 10.1136/thx.2008.112862; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Bruno A, 2009, J ALLERGY CLIN IMMUN, V124, P230, DOI 10.1016/j.jaci.2009.04.032; Chung K Fan, 2004, Treat Respir Med, V3, P279, DOI 10.2165/00151829-200403050-00002; Damoiseaux J, 2006, NETH J MED, V64, P4; DREBORG S, 1993, ALLERGY, V48, P473, DOI 10.1111/j.1398-9995.1993.tb01102.x; Ducharme FM, 2010, COCHRANE DB SYST REV, V12; Eisenstein EM, 2009, PEDIATR RES, V65, p26R, DOI 10.1203/PDR.0b013e31819e76c7; Gagliardo R, 2009, PEDIAT ALLERG IMM-UK, V20, P780, DOI 10.1111/j.1399-3038.2009.00945.x; (GINA) GINA, REV 2006 GLOB STRAT; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hung LY, 2008, CRIT REV IMMUNOL, V28, P269, DOI 10.1615/CritRevImmunol.v28.i4.10; Kawaguchi M, 2001, J ALLERGY CLIN IMMUN, V108, P804, DOI 10.1067/mai.2001.119027; Linden A, 2000, EUR RESPIR J, V15, P973, DOI 10.1034/j.1399-3003.2000.15e28.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Oboki Keisuke, 2008, Allergol Int, V57, P121, DOI 10.2332/allergolint.R-07-160; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Ouyang WJ, 2009, EUR J IMMUNOL, V39, P670, DOI 10.1002/eji.200839105; Pace E, 2012, ALLERGY, V67, P878, DOI 10.1111/j.1398-9995.2012.02842.x; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Profita M, 2005, ALLERGY, V60, P1361, DOI 10.1111/j.1398-9995.2005.00892.x; Redington AE, 2001, DRUGS, V61, P1231, DOI 10.2165/00003495-200161090-00001; Robinson DS, 2009, CLIN EXP ALLERGY, V39, P1314, DOI 10.1111/j.1365-2222.2009.03301.x; Wang YH, 2011, CURR ALLERGY ASTHM R, V11, P388, DOI 10.1007/s11882-011-0210-y; Wang YH, 2008, CURR OPIN IMMUNOL, V20, P697, DOI 10.1016/j.coi.2008.09.004; Zhao Y, 2010, INT ARCH ALLERGY IMM, V151, P297, DOI 10.1159/000250438; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	32	39	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e58892	10.1371/journal.pone.0058892	http://dx.doi.org/10.1371/journal.pone.0058892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573194	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100013
J	Yanagimachi, MD; Niwa, A; Tanaka, T; Honda-Ozaki, F; Nishimoto, S; Murata, Y; Yasumi, T; Ito, J; Tomida, S; Oshima, K; Asaka, I; Goto, H; Heike, T; Nakahata, T; Saito, MK				Yanagimachi, Masakatsu D.; Niwa, Akira; Tanaka, Takayuki; Honda-Ozaki, Fumiko; Nishimoto, Seiko; Murata, Yuuki; Yasumi, Takahiro; Ito, Jun; Tomida, Shota; Oshima, Koichi; Asaka, Isao; Goto, Hiroaki; Heike, Toshio; Nakahata, Tatsutoshi; Saito, Megumu K.			Robust and Highly-Efficient Differentiation of Functional Monocytic Cells from Human Pluripotent Stem Cells under Serum- and Feeder Cell-Free Conditions	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; DENDRITIC CELLS; IPS CELLS; IN-VITRO; GENERATION; MACROPHAGES; HEMATOPOIESIS; GRANULOCYTE; MATURATION; LINES	Monocytic lineage cells (monocytes, macrophages and dendritic cells) play important roles in immune responses and are involved in various pathological conditions. The development of monocytic cells from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) is of particular interest because it provides an unlimited cell source for clinical application and basic research on disease pathology. Although the methods for monocytic cell differentiation from ESCs/iPSCs using embryonic body or feeder co-culture systems have already been established, these methods depend on the use of xenogeneic materials and, therefore, have a relatively poor-reproducibility. Here, we established a robust and highly-efficient method to differentiate functional monocytic cells from ESCs/iPSCs under serum-and feeder cell-free conditions. This method produced 1.3 x 10(6) +/- 0.3 x 10(6) floating monocytes from approximately 30 clusters of ESCs/iPSCs 5-6 times per course of differentiation. Such monocytes could be differentiated into functional macrophages and dendritic cells. This method should be useful for regenerative medicine, disease-specific iPSC studies and drug discovery.	[Yanagimachi, Masakatsu D.; Niwa, Akira; Tanaka, Takayuki; Honda-Ozaki, Fumiko; Nishimoto, Seiko; Ito, Jun; Tomida, Shota; Oshima, Koichi; Nakahata, Tatsutoshi; Saito, Megumu K.] Kyoto Univ, Dept Clinilcal Applicat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Asaka, Isao] Kyoto Univ, Dept Fundamental Cell Technol, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Murata, Yuuki; Yasumi, Takahiro; Heike, Toshio] Kyoto Univ, Dept Pediat, Grad Sch Med, Kyoto, Japan; [Yanagimachi, Masakatsu D.; Goto, Hiroaki] Yokohama City Univ, Grad Sch Med, Dept Pediat, Yokohama, Kanagawa 232, Japan	Kyoto University; Kyoto University; Kyoto University; Yokohama City University	Saito, MK (corresponding author), Kyoto Univ, Dept Clinilcal Applicat, Ctr iPS Cell Res & Applicat, Kyoto, Japan.	msaito@cira.kyoto-u.ac.jp	Oshima, Koichi/AAT-5670-2020	Yasumi, Takahiro/0000-0003-3257-5071	Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Leading Project of MEXT; Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program) of Japan Society for the Promotion of Science (JSPS); JSPS; MKS; Takeda foundation; Mitsubishi Pharma Research Foundation; Suzuken memorial foundation; Japan Society for the Promotion of Science from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22591159, 22249042] Funding Source: KAKEN	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Leading Project of MEXT; Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program) of Japan Society for the Promotion of Science (JSPS); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MKS; Takeda foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Suzuken memorial foundation; Japan Society for the Promotion of Science from the Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by grants from the Ministry of Health, Labour and Welfare to TN, a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to TN, grants from the Leading Project of MEXT to TN, a grant from Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program) of Japan Society for the Promotion of Science (JSPS) to TN, grants from JSPS to TN and MKS, grants from the Takeda foundation, Mitsubishi Pharma Research Foundation and Suzuken memorial foundation to MKS and grants from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to MDY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Boudreau JE, 2011, MOL THER, V19, P841, DOI 10.1038/mt.2011.57; Choi KD, 2009, J CLIN INVEST, V119, P2818, DOI 10.1172/JCI38591; Collin M, 2011, NAT REV IMMUNOL, V11, P575, DOI 10.1038/nri3046; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Jiang Y, 2012, STEM CELLS, V30, P599, DOI 10.1002/stem.1053; Li GB, 2010, CELL IMMUNOL, V264, P4, DOI 10.1016/j.cellimm.2010.05.009; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Morishima T, 2011, J CELL PHYSIOL, V226, P1283, DOI 10.1002/jcp.22456; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Niwa A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022261; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Orlovskaya I, 2008, METHODS, V45, P159, DOI 10.1016/j.ymeth.2008.03.002; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pessach IM, 2011, J ALLERGY CLIN IMMUN, V127, P1400, DOI 10.1016/j.jaci.2010.11.008; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Royer PJ, 2006, SCAND J IMMUNOL, V63, P401, DOI 10.1111/j.1365-3083.2006.001757.x; Senju S, 2011, GENE THER, V18, P874, DOI 10.1038/gt.2011.22; Su Z, 2008, CLIN CANCER RES, V14, P6207, DOI 10.1158/1078-0432.CCR-08-0309; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanaka T., 2012, BLOOD; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tseng SY, 2009, REGEN MED, V4, P513, DOI 10.2217/RME.09.25; Umeda K, 2004, DEVELOPMENT, V131, P1869, DOI 10.1242/dev.01065; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zhong WX, 2009, CELL MOL BIOL LETT, V14, P587, DOI 10.2478/s11658-009-0023-3; Zou JZ, 2011, BLOOD, V117, P5561, DOI 10.1182/blood-2010-12-328161	34	88	97	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59243	10.1371/journal.pone.0059243	http://dx.doi.org/10.1371/journal.pone.0059243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573196	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100015
J	Gousias, IS; Hammers, A; Counsell, SJ; Srinivasan, L; Rutherford, MA; Heckemann, RA; Hajnal, JV; Rueckert, D; Edwards, AD				Gousias, Ioannis S.; Hammers, Alexander; Counsell, Serena J.; Srinivasan, Latha; Rutherford, Mary A.; Heckemann, Rolf A.; Hajnal, Jo V.; Rueckert, Daniel; Edwards, A. David			Magnetic Resonance Imaging of the Newborn Brain: Automatic Segmentation of Brain Images into 50 Anatomical Regions	PLOS ONE			English	Article							SPATIAL NORMALIZATION; PROBABILISTIC ATLAS; MRI SEGMENTATION; WHITE-MATTER; GRAY-MATTER; TEMPLATE; REGISTRATION; VOLUMES; TERM; SELECTION	We studied methods for the automatic segmentation of neonatal and developing brain images into 50 anatomical regions, utilizing a new set of manually segmented magnetic resonance (MR) images from 5 term-born and 15 preterm infants imaged at term corrected age called ALBERTs. Two methods were compared: individual registrations with label propagation and fusion; and template based registration with propagation of a maximum probability neonatal ALBERT (MPNA). In both cases we evaluated the performance of different neonatal atlases and MPNA, and the approaches were compared with the manual segmentations by means of the Dice overlap coefficient. Dice values, averaged across regions, were 0.81 +/- 0.02 using label propagation and fusion for the preterm population, and 0.81 +/- 0.02 using the single registration of a MPNA for the term population. Segmentations of 36 further unsegmented target images of developing brains yielded visibly high-quality results. This registration approach allows the rapid construction of automatically labeled age-specific brain atlases for neonates and the developing brain.	[Gousias, Ioannis S.; Hammers, Alexander; Counsell, Serena J.; Srinivasan, Latha; Rutherford, Mary A.; Heckemann, Rolf A.; Hajnal, Jo V.; Edwards, A. David] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Gousias, Ioannis S.; Hammers, Alexander; Counsell, Serena J.; Srinivasan, Latha; Rutherford, Mary A.; Heckemann, Rolf A.; Hajnal, Jo V.; Edwards, A. David] Hammersmith Hosp, MRC, Ctr Clin Sci, London, England; [Gousias, Ioannis S.; Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England; [Hammers, Alexander; Heckemann, Rolf A.] CERMEP Imagerie Vivant, Neurodis Fdn, Lyon, France; [Counsell, Serena J.; Rutherford, Mary A.; Hajnal, Jo V.; Edwards, A. David] Kings Coll London, Ctr Dev Brain, London WC2R 2LS, England	Imperial College London; Imperial College London; Imperial College London; University of London; King's College London	Gousias, IS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England.	ioannis.gousias04@imperial.ac.uk	Hammers, Alexander/D-9982-2015; counsell, serena j/I-9012-2014; Heckemann, Rolf Andreas/H-9022-2019; Edwards, Anthony/HCI-9626-2022; Hajnal, Joseph/P-6251-2018	Hammers, Alexander/0000-0001-9530-4848; Heckemann, Rolf Andreas/0000-0003-3582-3683; Hajnal, Joseph/0000-0002-2690-5495; Counsell, Serena/0000-0002-8033-5673; rutherford, mary/0000-0003-3361-1337; Edwards, Anthony David/0000-0003-4801-7066; Rueckert, Daniel/0000-0002-5683-5889	United Kingdom Engineering and Physical Sciences Research Council; Action Medical Research United Kingdom; Henry Smith Charity; "General Arnaoutis'' Foundation; Medical Research Council; Imperial College Comprehensive Biomedical Research Centre; MRC [G108/585, MC_U120085812] Funding Source: UKRI; Medical Research Council [G108/585, MC_U120085812] Funding Source: researchfish; Action Medical Research [1772, 1748] Funding Source: researchfish	United Kingdom Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Action Medical Research United Kingdom; Henry Smith Charity; "General Arnaoutis'' Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial College Comprehensive Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research	ISG was supported by the United Kingdom Engineering and Physical Sciences Research Council, Action Medical Research United Kingdom and the Henry Smith Charity. He was also funded by a research scholarship from the "General Arnaoutis'' Foundation. MR image data was collected with financial support from the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the parents and children whose images were used in the study and the nurses and staff of the Hammersmith Hospital Neonatal Unit and Neonatal Imaging Centre. They would like to thank the Imperial College Comprehensive Biomedical Research Centre for the support. Dr. Ioannis Spyridon Gousias would also like to thank Mr. Alvertos Gousias.	Ahsan RL, 2007, NEUROIMAGE, V38, P261, DOI 10.1016/j.neuroimage.2007.06.004; Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Allen JS, 2008, NEUROIMAGE, V42, P535, DOI 10.1016/j.neuroimage.2008.05.047; Altaye M, 2008, NEUROIMAGE, V43, P721, DOI 10.1016/j.neuroimage.2008.07.060; Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; BAJCSY R, 1983, J COMPUT ASSIST TOMO, V7, P618, DOI 10.1097/00004728-198308000-00008; Bhatia KK, 2007, LECT NOTES COMPUT SC, V4792, P544; Bhatia KK, 2007, LECT NOTES COMPUT SC, V4791, P532; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Collins DL, 1999, LECT NOTES COMPUT SC, V1613, P210; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Faria AV, 2010, NEUROIMAGE, V52, P415, DOI 10.1016/j.neuroimage.2010.04.238; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Gaillard WD, 2001, NEUROIMAGE, V13, P239, DOI 10.1006/nimg.2000.0681; Gousias I. S., 2012, Proceedings of the 2012 IEEE International Conference on Imaging Systems and Techniques (IST), P95, DOI 10.1109/IST.2012.6295511; Gousias I. S., 2010, 2010 IEEE International Conference on Imaging Systems and Techniques (IST 2010), P290, DOI 10.1109/IST.2010.5548493; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Gousias IS, 2012, NEUROIMAGE, V62, P1499, DOI 10.1016/j.neuroimage.2012.05.083; Guimond A, 2000, COMPUT VIS IMAGE UND, V77, P192, DOI 10.1006/cviu.1999.0815; Hammers A, 2002, HUM BRAIN MAPP, V15, P165, DOI 10.1002/hbm.10016; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hammers A, 2007, HUM BRAIN MAPP, V28, P34, DOI 10.1002/hbm.20254; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Hoeksma MR, 2005, CLIN NEUROPHYSIOL, V116, P1188, DOI 10.1016/j.clinph.2004.12.021; Holden M, 2002, IEEE T MED IMAGING, V21, P1292, DOI 10.1109/TMI.2002.806281; Huppi PS, 1998, ANN NEUROL, V43, P224, DOI 10.1002/ana.410430213; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Iosifescu DV, 1997, NEUROIMAGE, V6, P13, DOI 10.1006/nimg.1997.0274; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Kazemi K, 2007, NEUROIMAGE, V37, P463, DOI 10.1016/j.neuroimage.2007.05.004; Kazemi K, 2011, COMPUT MED IMAG GRAP, V35, P237, DOI 10.1016/j.compmedimag.2010.11.007; Ketonen L. M., 2005, PEDIAT BRAIN SPINE A; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Kuklisova-Murgasova M, 2011, NEUROIMAGE, V54, P2750, DOI 10.1016/j.neuroimage.2010.10.019; Machilsen B, 2007, NEUROIMAGE, V35, P686, DOI 10.1016/j.neuroimage.2006.12.037; MILLER MI, 1993, P NATL ACAD SCI USA, V90, P11944, DOI 10.1073/pnas.90.24.11944; Mitchell TN, 2003, AM J NEURORADIOL, V24, P410; Morra JH, 2008, NEUROIMAGE, V43, P59, DOI 10.1016/j.neuroimage.2008.07.003; Muzik O, 2000, NEUROIMAGE, V12, P538, DOI 10.1006/nimg.2000.0651; Nishida M, 2006, NEUROIMAGE, V32, P1041, DOI 10.1016/j.neuroimage.2006.05.020; Oishi K, 2011, NEUROIMAGE, V56, P8, DOI 10.1016/j.neuroimage.2011.01.051; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Pohl KA, 2006, NEUROIMAGE, V31, P228, DOI 10.1016/j.neuroimage.2005.11.044; Powell S, 2008, NEUROIMAGE, V39, P238, DOI 10.1016/j.neuroimage.2007.05.063; Prastawa M, 2005, MED IMAGE ANAL, V9, P457, DOI 10.1016/j.media.2005.05.007; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Rueckert D, 2003, IEEE T MED IMAGING, V22, P1014, DOI 10.1109/TMI.2003.815865; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rutherford M., 2002, MRI NEONATAL BRAIN; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Srinivasan L, 2007, PEDIATRICS, V119, P759, DOI 10.1542/peds.2006-2508; Studholme C, 1997, MED PHYS, V24, P25, DOI 10.1118/1.598130; Svarer C, 2005, NEUROIMAGE, V24, P969, DOI 10.1016/j.neuroimage.2004.10.017; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Wang Q, 2005, LECT NOTES COMPUT SC, V3565, P689; Warfield SK, 2000, MED IMAGE ANAL, V4, P43, DOI 10.1016/S1361-8415(00)00003-7; Weisenfeld NI, 2006, LECT NOTES COMPUT SC, V4190, P199; Wilke M, 2003, NEUROREPORT, V14, P1887, DOI 10.1097/00001756-200310270-00001; Wilke M, 2003, MAGN RESON MED, V50, P749, DOI 10.1002/mrm.10606; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Wu J, 2009, NEUROIMAGE; Wu MJ, 2007, NEUROIMAGE, V34, P1612, DOI 10.1016/j.neuroimage.2006.07.050; Yoon U, 2009, NEUROIMAGE, V45, P769, DOI 10.1016/j.neuroimage.2008.12.046	74	65	65	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59990	10.1371/journal.pone.0059990	http://dx.doi.org/10.1371/journal.pone.0059990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565180	gold, Green Submitted, Green Published			2022-12-27	WOS:000317717300049
J	Grunberg, J; Jeger, S; Sarko, D; Dennler, P; Zimmermann, K; Mier, W; Schibli, R				Gruenberg, Juergen; Jeger, Simone; Sarko, Dikran; Dennler, Patrick; Zimmermann, Kurt; Mier, Walter; Schibli, Roger			DOTA-Functionalized Polylysine: A High Number of DOTA Chelates Positively Influences the Biodistribution of Enzymatic Conjugated Anti-Tumor Antibody chCE7agl	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; TUMOR UPTAKE; MOLECULE; TRANSGLUTAMINASES; FRAGMENTS; BACTERIAL; PROTEINS; THERAPY; BINDING; LYSINE	Site-specific enzymatic reactions with microbial transglutaminase (mTGase) lead to a homogenous species of immunoconjugates with a defined ligand/antibody ratio. In the present study, we have investigated the influence of different numbers of 1,4,7,10-tetraazacyclododecane-N-N'-N ''-N'''-tetraacetic acid (DOTA) chelats coupled to a decalysine backbone on the in vivo behavior of the chimeric monoclonal anti-L1CAM antibody chCE7agl. The enzymatic conjugation of (DOTA)(1)-decalysine, (DOTA)(3)-decalysine or (DOTA)(5)-decalysine to the antibody heavy chain (via Gln295/297) gave rise to immunoconjugates containing two, six or ten DOTA moieties respectively. Radiolabeling of the immunoconjugates with Lu-177 yielded specific activities of approximately 70 MBq/mg, 400 MBq/mg and 700 MBq/mg with increasing numbers of DOTA chelates. Biodistribution experiments in SKOV3ip human ovarian cancer cell xenografts demonstrated a high and specific accumulation of radioactivity at the tumor site for all antibody derivatives with a maximal tumor accumulation of 43.6 +/- 4.3% ID/g at 24 h for chCE7agl-[(DOTA)-decalysine](2), 30.6 +/- 12.0% ID/g at 24 h for chCE7agl-[(DOTA)(3)-decalysine](2) and 49.9 +/- 3.1% ID/g at 48 h for chCE7agl-[(DOTA)(5)-decalysine)](2). The rapid elimination from the blood of chCE7agl-[(DOTA)decalysine](2) (1.0 +/- 0.1% ID/g at 24 h) is associated with a high liver accumulation (23.2 +/- 4.6% ID/g at 24 h). This behavior changed depending on the numbers of DOTA moieties coupled to the decalysine peptide with a slower blood clearance (5.1 +/- 1.0 (DOTA)(3) versus 11.7 +/- 1.4% ID/g (DOTA)(5), p<0.005 at 24 h) and lower radioactivity levels in the liver (21.4 +/- 3.4 (DOTA)(3) versus 5.8 +/- 0.7 (DOTA)(5), p<0.005 at 24 h). We conclude that the site-specific and stoichiometric uniform conjugation of the highly DOTA-substituted decalysine ((DOTA) 5-decalysine) to an anti-tumor antibody leads to the formation of immunoconjugates with high specific activity and excellent in vivo behavior and is a valuable option for radioimmunotherapy and potentially antibody-drug conjugates (ADCs).	[Gruenberg, Juergen; Jeger, Simone; Dennler, Patrick; Zimmermann, Kurt; Schibli, Roger] Paul Scherrer Inst, Ctr Radiopharmaceut Sci ETH PSI USZ, Villigen, Switzerland; [Sarko, Dikran; Mier, Walter] Univ Heidelberg Hosp, Dept Nucl Med, Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Ruprecht Karls University Heidelberg	Schibli, R (corresponding author), Paul Scherrer Inst, Ctr Radiopharmaceut Sci ETH PSI USZ, Villigen, Switzerland.	roger.schibli@PSI.ch		Schibli, Roger/0000-0002-1537-3833	Swiss National Science Foundation [132611]; Cancer Research Foundation [KFS-2546-02-2010]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Research Foundation	This work was supported by the Swiss National Science Foundation (Project No. 132611) to Roger Schibli and Cancer Research Foundation (Project No. KFS-2546-02-2010) to Jurgen Grunberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Boswell CA, 2011, BIOCONJUGATE CHEM, V22, P1994, DOI 10.1021/bc200212a; Carter PJ, 2008, CANCER J, V14, P154, DOI 10.1097/PPO.0b013e318172d704; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Ducry L, 2010, BIOCONJUGATE CHEM, V21, P5, DOI 10.1021/bc9002019; Firestone RA, 1996, J CONTROL RELEASE, V39, P251, DOI 10.1016/0168-3659(95)00160-3; Fischer E, 2012, INT J CANCER, V130, P2715, DOI 10.1002/ijc.26321; Fontana A, 2008, ADV DRUG DELIVER REV, V60, P13, DOI 10.1016/j.addr.2007.06.015; Garnett MC, 2001, ADV DRUG DELIVER REV, V53, P171, DOI 10.1016/S0169-409X(01)00227-7; GROOTJANS JJ, 1995, J BIOL CHEM, V270, P22855, DOI 10.1074/jbc.270.39.22855; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; Jeger S, 2010, ANGEW CHEM INT EDIT, V49, P9995, DOI 10.1002/anie.201004243; Junutula JR, 2008, J IMMUNOL METHODS, V332, P41, DOI 10.1016/j.jim.2007.12.011; Knogler K, 2007, CLIN CANCER RES, V13, P603, DOI 10.1158/1078-0432.CCR-06-1486; Knogler K, 2006, NUCL MED BIOL, V33, P883, DOI 10.1016/j.nucmedbio.2006.08.001; KUKIS DL, 1995, CANCER RES, V55, P878; Li G, 2002, VOX SANG, V83, P332, DOI 10.1046/j.1423-0410.2002.00241.x; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; MEARES CF, 1984, J PROTEIN CHEM, V3, P215, DOI 10.1007/BF01040501; Mier W, 2004, TETRAHEDRON LETT, V45, P5453, DOI 10.1016/j.tetlet.2004.05.034; Mindt TL, 2008, BIOCONJUGATE CHEM, V19, P271, DOI 10.1021/bc700306n; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; Ramli M, 2009, BIOCONJUGATE CHEM, V20, P868, DOI 10.1021/bc800337d; RODWELL JD, 1985, BIO-TECHNOL, V3, P889, DOI 10.1038/nbt1085-889; Slinkin MA, 1990, BIOCONJUGATE CHEM, V1, P291, DOI 10.1021/bc00004a011; SLINKIN MA, 1993, NUCL MED BIOL, V20, P443, DOI 10.1016/0969-8051(93)90075-6; Spolaore B, 2012, BIOCHEMISTRY-US, V51, P8679, DOI 10.1021/bi301005z; vanGog FB, 1996, J NUCL MED, V37, P352; Wangler C, 2008, BIOCONJUGATE CHEM, V19, P813, DOI 10.1021/bc700308q; Zimmermann K, 1999, NUCL MED BIOL, V26, P943, DOI 10.1016/S0969-8051(99)00067-0	32	21	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60350	10.1371/journal.pone.0060350	http://dx.doi.org/10.1371/journal.pone.0060350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565233	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300103
J	Jin, J; Fu, BQ; Mei, XY; Yue, T; Sun, R; Tian, ZG; Wei, HM				Jin, Jing; Fu, Binqing; Mei, Xinyu; Yue, Ting; Sun, Rui; Tian, Zhigang; Wei, Haiming			CD11b(-)CD27(-) NK Cells Are Associated with the Progression of Lung Carcinoma	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; GAMMA PRODUCTION; CANCER; DIFFERENTIATION; EXPRESSION; MATURATION; SUBSETS; RESPONSIVENESS; SURVEILLANCE; TOLERANCE	NK cells are a major component of the antitumour immune response that limits tumour progression. However, it has been reported that tumour-infiltrating NK (TINK) cells from patients with non-small-cell lung carcinoma (NSCLC) exhibit profound defects in degranulation and IFN-gamma production. In support of this notion, we report a novel mechanism associated with tumour escape from NK cell-mediated antitumour immunity in lung carcinoma. In this study, we investigated the phenotypic profile of TINK cells based on the expression of the NK-cell maturation markers CD11b and CD27. Interestingly, we found a substantial CD11b(-)CD27(-) (DN) NK-cell population harboured within the tumour tissues. The presence of this CD11b(-)CD27(-) NK subset indicated that the TINK cells were of an immature and inactive phenotype. Remarkably, we determined that the presence of DN NK cells had an impact on the clinical outcomes of patients with NSCLC, as the frequency of tumour-infiltrating DN NK cells was positively correlated with the tumour stage and tumour size. We further used a murine Lewis lung cancer (LLC) model to confirm the correlation between the frequency of tumour-infiltrating DN NK cells and the progression of lung carcinoma. Together, our findings demonstrate that the tumour microenvironment may render TINK cells less tumouricidal and thereby contribute to cancer progression.	[Jin, Jing; Fu, Binqing; Yue, Ting; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Sch Life Sci, Inst Immunol, Hefei 230026, Anhui, Peoples R China; [Fu, Binqing; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Mei, Xinyu] Anhui Prov Hosp, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Tian, ZG (corresponding author), Univ Sci & Technol China, Sch Life Sci, Inst Immunol, Hefei 230026, Anhui, Peoples R China.	tzg@ustc.edu.cn; ustcwhm@ustc.edu.cn	Tian, Zhigang/J-3512-2013		Natural Science Foundation of China [31021061, 30730084]; Ministry of Science and Technology of China [2009CB522403, 2012CB519004]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the Natural Science Foundation of China (31021061, 30730084) and Ministry of Science and Technology of China (973 Basic Science Project 2009CB522403, 2012CB519004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan DSJ, 2010, EUR J IMMUNOL, V40, P2289, DOI 10.1002/eji.200939910; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Carrega P, 2008, CANCER-AM CANCER SOC, V112, P863, DOI 10.1002/cncr.23239; Cerwenka A, 2007, EUR J IMMUNOL, V37, P1161, DOI 10.1002/eji.200790017; Chan CJ, 2008, EUR J IMMUNOL, V38, P2964, DOI 10.1002/eji.200838764; CHEN L, 2011, PLOS ONE, V6; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Crozat K, 2011, BLOOD, V117, P2874, DOI 10.1182/blood-2010-10-315457; Di Santo JP, 2008, EUR J IMMUNOL, V38, P2948, DOI 10.1002/eji.200838830; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Fu BQ, 2011, IMMUNOLOGY, V133, P350, DOI 10.1111/j.1365-2567.2011.03446.x; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Hayakawa Y, 2011, CANCER SCI, V102, P1967, DOI 10.1111/j.1349-7006.2011.02042.x; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Jonsson AH, 2009, ADV IMMUNOL, V101, P27, DOI 10.1016/S0065-2776(08)01002-X; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Le Maux Chansac B, 2005, J IMMUNOL, V175, P5790, DOI 10.4049/jimmunol.175.9.5790; Lee SH, 2010, EUR J IMMUNOL, V40, P923, DOI 10.1002/eji.201040304; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Mamessier E, 2011, J CLIN INVEST, V121, P3609, DOI 10.1172/JCI45816; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Parizot C, 2010, PLOS ONE, V5; Passlick B, 1996, EUR J CANCER, V32A, P141, DOI 10.1016/0959-8049(95)00551-X; Platonova S, 2011, CANCER RES, V71, P5412, DOI 10.1158/0008-5472.CAN-10-4179; Richards JO, 2006, BLOOD, V108, P246, DOI 10.1182/blood-2005-11-4535; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Soderquest K, 2011, BLOOD, V117, P4511, DOI 10.1182/blood-2010-10-312264; Sun JC, 2009, EUR J IMMUNOL, V39, P2059, DOI 10.1002/eji.200939435; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; VIVIER E, 1991, J IMMUNOL, V146, P206; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vossen MTM, 2008, J IMMUNOL, V180, P3739, DOI 10.4049/jimmunol.180.6.3739; Xia Y, 2002, J IMMUNOL, V169, P6417, DOI 10.4049/jimmunol.169.11.6417	50	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e61024	10.1371/journal.pone.0061024	http://dx.doi.org/10.1371/journal.pone.0061024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565296	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300169
J	Raeder, H; Vesterhus, M; El Ouaamari, A; Paulo, JA; McAllister, FE; Liew, CW; Hu, J; Kawamori, D; Molven, A; Gygi, SP; Njolstad, PR; Kahn, CR; Kulkarni, RN				Raeder, Helge; Vesterhus, Mette; El Ouaamari, Abdelfattah; Paulo, Joao A.; McAllister, Fiona E.; Liew, Chong Wee; Hu, Jiang; Kawamori, Dan; Molven, Anders; Gygi, Steven P.; Njolstad, Pal R.; Kahn, C. Ronald; Kulkarni, Rohit N.			Absence of Diabetes and Pancreatic Exocrine Dysfunction in a Transgenic Model of Carboxyl-Ester Lipase-MODY (Maturity-Onset Diabetes of the Young)	PLOS ONE			English	Article							GENE-EXPRESSION; CRE RECOMBINASE; MUTATIONS; KNOCKOUT; MOUSE; ABSORPTION; RECEPTOR; STRAINS	Background: CEL-MODY is a monogenic form of diabetes with exocrine pancreatic insufficiency caused by mutations in CARBOXYL-ESTER LIPASE (CEL). The pathogenic processes underlying CEL-MODY are poorly understood, and the global knockout mouse model of the CEL gene (CELKO) did not recapitulate the disease. We therefore aimed to create and phenotype a mouse model specifically over-expressing mutated CEL in the pancreas. Methods: We established a monotransgenic floxed (flanking LOX sequences) mouse line carrying the human CEL mutation c.1686delT and crossed it with an elastase-Cre mouse to derive a bitransgenic mouse line with pancreas-specific overexpression of CEL carrying this disease-associated mutation (TgCEL). Following confirmation of murine pancreatic expression of the human transgene by real-time quantitative PCR, we phenotyped the mouse model fed a normal chow and compared it with mice fed a 60% high fat diet (HFD) as well as the effects of short-term and long-term cerulein exposure. Results: Pancreatic exocrine function was normal in TgCEL mice on normal chow as assessed by serum lipid and lipid-soluble vitamin levels, fecal elastase and fecal fat absorption, and the normoglycemic mice exhibited normal pancreatic morphology. On 60% HFD, the mice gained weight to the same extent as controls, had normal pancreatic exocrine function and comparable glucose tolerance even after resuming normal diet and follow up up to 22 months of age. The cerulein-exposed TgCEL mice gained weight and remained glucose tolerant, and there were no detectable mutation-specific differences in serum amylase, islet hormones or the extent of pancreatic tissue inflammation. Conclusions: In this murine model of human CEL-MODY diabetes, we did not detect mutation-specific endocrine or exocrine pancreatic phenotypes, in response to altered diets or exposure to cerulein.	[Raeder, Helge; Vesterhus, Mette; El Ouaamari, Abdelfattah; Liew, Chong Wee; Hu, Jiang; Kawamori, Dan; Molven, Anders; Njolstad, Pal R.; Kahn, C. Ronald; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Raeder, Helge; Vesterhus, Mette; Molven, Anders; Njolstad, Pal R.] Univ Bergen, Dept Clin Med, KG Jebsen Ctr Diabet Res, Bergen, Norway; [Raeder, Helge; Vesterhus, Mette; Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Raeder, Helge] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Paulo, Joao A.; McAllister, Fiona E.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Molven, Anders] Univ Bergen, Gade Inst, Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Njolstad, Pal R.] Broad Inst Harvard & MIT, Cambridge, MA USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Harvard University; Harvard Medical School; University of Bergen; University of Bergen; Haukeland University Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Raeder, H (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA.	helge.rader@uib.no	Raeder, Helge/ABE-3601-2020; Raeder, Helge/AFQ-6279-2022; Vesterhus, Mette/AAX-8767-2020; Paulo, Joao/AAO-3981-2020; Kahn, Ronald/AAY-2435-2021	Vesterhus, Mette/0000-0003-1493-2303; Paulo, Joao/0000-0002-4291-413X; Kahn, Ronald/0000-0002-7583-9228; Liew, Chong Wee/0000-0001-9904-0958	National Institutes of Health (NIH) [RO1 DK67536]; Norwegian Research Foundation; Haukeland University Hospital; Innovest; University of Bergen, Norway; ESPE Sabbatical Leave Programme; Fulbright Foundation; Norwegian Research Council; Western Norway Regional Health Authority grant; Norwegian Endocrine Society; National Institutes of Health [DK33201, DK55545]; Joslin Diabetes and Endocrinology Research Center [DK34834]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055545, R01DK033201, R01DK067536, P30DK036836] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Research Foundation; Haukeland University Hospital; Innovest; University of Bergen, Norway; ESPE Sabbatical Leave Programme; Fulbright Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Western Norway Regional Health Authority grant; Norwegian Endocrine Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Diabetes and Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funds to develop some reagents in this study were supported by National Institutes of Health (NIH) Grant RO1 DK67536 (to RNK). This study was supported in part by funds from the Norwegian Research Foundation, Haukeland University Hospital, Innovest, and University of Bergen, Norway, and an ESPE Sabbatical Leave Programme and the Fulbright Foundation (to PRN), a Leiv Eiriksson Mobility Grant from The Norwegian Research Council (to MV and HR), a Western Norway Regional Health Authority grant (to HR), a Norwegian Endocrine Society grant (to HR), a Fulbright Foundation grant (to HR), and by National Institutes of Health Grants DK33201 and DK55545 (to CRK), and the Joslin Diabetes and Endocrinology Research Center Grant DK34834. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonarakis SE, 2006, NAT REV GENET, V7, P277, DOI 10.1038/nrg1826; Durie PR, 2004, AM J PATHOL, V164, P1481, DOI 10.1016/S0002-9440(10)63234-8; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Graf A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-390; Grippo PJ, 2002, GENESIS, V32, P277, DOI 10.1002/gene.10080; Haldorsen IS, 2012, NAT REV ENDOCRINOL, V8, P148, DOI 10.1038/nrendo.2011.197; Heller RS, 2001, DIABETES, V50, P1553, DOI 10.2337/diabetes.50.7.1553; Holmes RS, 2011, CHOLESTEROL, DOI 10.1155/2011/781643; Howles PN, 1996, J BIOL CHEM, V271, P7196, DOI 10.1074/jbc.271.12.7196; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Johansson BB, 2011, J BIOL CHEM, V286, P34593, DOI 10.1074/jbc.M111.222679; Kannius-Janson M, 2000, BIOCHEM J, V351, P367, DOI 10.1042/0264-6021:3510367; Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LEITER EH, 1989, ENDOCRINOLOGY, V124, P912, DOI 10.1210/endo-124-2-912; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li F, 1998, BIOCHEM J, V329, P675, DOI 10.1042/bj3290675; Li L, 2008, METABOLISM, V57, P1361, DOI 10.1016/j.metabol.2008.05.003; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Raeder H, 2007, DIABETES, V56, P444, DOI 10.2337/db06-0859; Raeymaekers L, 2000, MOL BIOTECHNOL, V15, P115, DOI 10.1385/MB:15:2:115; Roep BO, 2007, ANN N Y ACAD SCI; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Shamir R, 1996, J CLIN INVEST, V97, P1696, DOI 10.1172/JCI118596; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strobel O, 2010, GASTROENTEROLOGY, V138, P1166, DOI 10.1053/j.gastro.2009.12.005; Vesterhus M, 2010, PANCREATOLOGY, V10, P467, DOI 10.1159/000266284; Weng W, 1999, BIOCHEMISTRY-US, V38, P4143, DOI 10.1021/bi981679a; Yamamoto K, 2007, BIOCHEM BIOPH RES CO, V363, P908, DOI 10.1016/j.bbrc.2007.09.056; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60229	10.1371/journal.pone.0060229	http://dx.doi.org/10.1371/journal.pone.0060229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565203	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300072
J	Ma, QG; Gao, CQ; Zhang, JY; Zhao, LH; Hao, WB; Ji, C				Ma, Qiugang; Gao, Chunqi; Zhang, Jianyun; Zhao, Lihong; Hao, Wenbo; Ji, Cheng			Detection of Transgenic and Endogenous Plant DNA Fragments and Proteins in the Digesta, Blood, Tissues, and Eggs of Laying Hens Fed with Phytase Transgenic Corn	PLOS ONE			English	Article							GENETICALLY-MODIFIED MAIZE; NUTRITIONAL EQUIVALENCY; FINISHING PIGS; CANOLA-MEAL; FED DIETS; FATE; FEED; PERFORMANCE; GRAIN; PHOSPHORUS	The trials were conducted to assess the effects of long-term feeding with phytase transgenic corn (PTC) to hens on laying performance and egg quality, and investigate the fate of transgenic DNA and protein in digesta, blood, tissues, and eggs. Fifty-week old laying hens (n = 144) were fed with a diet containing 62.4% PTC or non-transgenic isogenic control corn (CC) for 16 weeks. We observed that feeding PTC to laying hens had no adverse effect on laying performance or egg quality (P>0.05) except on yolk color (P<0.05). Transgenic phyA2 gene and protein were rapidly degraded in the digestive tract and were not detected in blood, heart, liver, spleen, kidney, breast muscle, and eggs of laying hens fed with diet containing PTC. It was concluded that performance of hens fed diets containing PTC, as measured by egg production and egg quality, was similar to that of hens fed diets formulated with CC. There was no evidence of phyA2 gene or protein translocation to the blood, tissues, and eggs of laying hens.	[Ma, Qiugang; Gao, Chunqi; Zhang, Jianyun; Zhao, Lihong; Hao, Wenbo; Ji, Cheng] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100094, Peoples R China	China Agricultural University	Ji, C (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100094, Peoples R China.	jicheng@cau.edu.cn	Ma, Qiugang/AER-9979-2022; Gao, Chun/AAP-2262-2020		Genetically Modified Organisms Evaluation Major Projects [2009ZX08011-005B-01]; Yangtz River Scholar and Innovation Research Team Development Program [IRT0945]; China Agriculture Research System [CARS-41-K15]; China Agriculture Research System-Beijing Team for Poultry Industry	Genetically Modified Organisms Evaluation Major Projects; Yangtz River Scholar and Innovation Research Team Development Program; China Agriculture Research System; China Agriculture Research System-Beijing Team for Poultry Industry	This work was financed by the Genetically Modified Organisms Evaluation Major Projects (No. 2009ZX08011-005B-01), Yangtz River Scholar and Innovation Research Team Development Program (NO. IRT0945), China Agriculture Research System (CARS-41-K15), and China Agriculture Research System-Beijing Team for Poultry Industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbacher K, 2005, POULTRY SCI, V84, P385, DOI 10.1093/ps/84.3.385; Appenzeller LM, 2008, FOOD CHEM TOXICOL, V46, P2201, DOI 10.1016/j.fct.2008.02.017; Ash J, 2003, J APPL POULTRY RES, V12, P242, DOI 10.1093/japr/12.2.242; Augspurger NR, 2007, J ANIM SCI, V85, P1192, DOI 10.2527/jas.2006-340; Brown PB, 2003, J AGR FOOD CHEM, V51, P4268, DOI 10.1021/jf034018f; Buzoianu SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033668; Castillo AR, 2004, J DAIRY SCI, V87, P1778, DOI 10.3168/jds.S0022-0302(04)73333-0; Chambers PA, 2002, J ANTIMICROB CHEMOTH, V49, P161, DOI 10.1093/jac/49.1.161; Chen RM, 2008, TRANSGENIC RES, V17, P633, DOI 10.1007/s11248-007-9138-3; Chowdhury EH, 2003, J ANIM SCI, V81, P2546; Einspanier R, 2004, EUR FOOD RES TECHNOL, V218, P269, DOI 10.1007/s00217-003-0842-9; Engelen AJ, 2001, J AOAC INT, V84, P629; Erickson GE, 2003, J ANIM SCI, V81, P2600; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Gao CQ, 2012, POULTRY SCI, V91, P1142, DOI 10.3382/ps.2011-01915; Herman L, 2004, POULTRY SCI, V83, P2083, DOI 10.1093/ps/83.12.2083; Hurst CD, 1999, MOL BREEDING, V5, P579, DOI 10.1023/A:1009654623025; Jacobs CM, 2008, POULTRY SCI, V87, P475, DOI 10.3382/ps.2007-00217; Jennings JC, 2003, J ANIM SCI, V81, P1447; Jennings JC, 2003, POULTRY SCI, V82, P371, DOI 10.1093/ps/82.3.371; Li J, 1997, PLANT PHYSIOL, V114, P1103, DOI 10.1104/pp.114.3.1103; Maenz D. D., 2001, Enzymes in farm animal nutrition, P61, DOI 10.1079/9780851993935.0061; McNaughton J, 2008, POULTRY SCI, V87, P2562, DOI 10.3382/ps.2008-00017; McNaughton J, 2011, POULTRY SCI, V90, P1701, DOI [10.3382/ps.2010-00973, 10.3382/ps.2010-00917]; National Research Council, 1994, NUTR REQ POULTR; Nemeth A, 2004, J AGR FOOD CHEM, V52, P6129, DOI 10.1021/jf049567f; Netherwood T, 2004, NAT BIOTECHNOL, V22, P204, DOI 10.1038/nbt934; Nyannor EKD, 2009, POULTRY SCI, V88, P1413, DOI 10.3382/ps.2009-00003; Peeler HT, 1972, J ANIM SCI, V77, P83; PEN J, 1993, BIO-TECHNOL, V11, P811, DOI 10.1038/nbt0793-811; Phipps RH, 2003, J DAIRY SCI, V86, P4070, DOI 10.3168/jds.S0022-0302(03)74019-3; RAVINDRAN V, 1995, POULTRY SCI, V74, P1820, DOI 10.3382/ps.0741820; Reuter T, 2003, EUR FOOD RES TECHNOL, V216, P185, DOI 10.1007/s00217-002-0642-7; Rossi F, 2005, POULTRY SCI, V84, P1022, DOI 10.1093/ps/84.7.1022; Scheideler SE, 2008, J APPL POULTRY RES, V17, P383, DOI 10.3382/japr.2007-00080; Schubbert R, 1997, P NATL ACAD SCI USA, V94, P961, DOI 10.1073/pnas.94.3.961; Sharma R, 2006, J AGR FOOD CHEM, V54, P1699, DOI 10.1021/jf052459o; Stein HH, 2009, J ANIM SCI, V87, P1254, DOI 10.2527/jas.2008-0966; Surai P. F., 1999, Proceedings of the Nutrition Society, V58, p30A; TAO R, 2009, AQUAC RES, V40, P1350; Tony MA, 2003, ARCH ANIM NUTR, V57, P235, DOI 10.1080/00039420310001594397; U.S. Department of Agriculture, 2011, AD GEN ENG CROPS US, P2011; Walsh MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036141; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011; Walsh MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027177; Wiedemann S, 2006, J ANIM SCI, V84, P135, DOI 10.2527/2006.841135x; Wiedemann S, 2009, MAMM BIOL, V74, P193, DOI 10.1016/j.mambio.2008.07.002; Withers PJ, 1995, PROC; Yao B, 1998, SCI CHINA SER C, V41, P330, DOI 10.1007/BF02895110; Yonemochi C, 2010, ANIM SCI J, V81, P94, DOI 10.1111/j.1740-0929.2009.00718.x; Zhang ZB, 2000, POULTRY SCI, V79, P709, DOI 10.1093/ps/79.5.709	51	18	22	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61138	10.1371/journal.pone.0061138	http://dx.doi.org/10.1371/journal.pone.0061138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577200	gold, Green Submitted, Green Published			2022-12-27	WOS:000317898000104
J	Ong, SH; Kukkillaya, VU; Wilm, A; Lay, C; Ho, EXP; Low, L; Hibberd, ML; Nagarajan, N				Ong, Swee Hoe; Kukkillaya, Vinutha Uppoor; Wilm, Andreas; Lay, Christophe; Ho, Eliza Xin Pei; Low, Louie; Hibberd, Martin Lloyd; Nagarajan, Niranjan			Species Identification and Profiling of Complex Microbial Communities Using Shotgun Illumina Sequencing of 16S rRNA Amplicon Sequences	PLOS ONE			English	Article							GUT MICROBIOTA; GENE; DIVERSITY; GENERATION; DATABASE; DESIGN	The high throughput and cost-effectiveness afforded by short-read sequencing technologies, in principle, enable researchers to perform 16S rRNA profiling of complex microbial communities at unprecedented depth and resolution. Existing Illumina sequencing protocols are, however, limited by the fraction of the 16S rRNA gene that is interrogated and therefore limit the resolution and quality of the profiling. To address this, we present the design of a novel protocol for shotgun Illumina sequencing of the bacterial 16S rRNA gene, optimized to amplify more than 90% of sequences in the Greengenes database and with the ability to distinguish nearly twice as many species-level OTUs compared to existing protocols. Using several in silico and experimental datasets, we demonstrate that despite the presence of multiple variable and conserved regions, the resulting shotgun sequences can be used to accurately quantify the constituents of complex microbial communities. The reconstruction of a significant fraction of the 16S rRNA gene also enabled high precision (>90%) in species-level identification thereby opening up potential application of this approach for clinical microbial characterization.	[Ong, Swee Hoe; Kukkillaya, Vinutha Uppoor; Wilm, Andreas; Ho, Eliza Xin Pei; Low, Louie; Hibberd, Martin Lloyd; Nagarajan, Niranjan] Genome Inst Singapore, Singapore, Singapore; [Lay, Christophe] Danone Res Ctr Specialised Nutr, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Danone Nutricia	Nagarajan, N (corresponding author), Genome Inst Singapore, Genome 02-01, Singapore, Singapore.	nagarajann@gis.a-star.edu.sg		Wilm, Andreas/0000-0002-7344-3764; Hibberd, Martin/0000-0001-8587-1849; Ong, Swee Hoe/0000-0002-3629-5387; Nagarajan, Niranjan/0000-0003-0850-5604	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work is supported by grants from the Agency for Science, Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Illumina Inc, 2008, MULT SEQ ILL GEN AN; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160	37	77	80	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60811	10.1371/journal.pone.0060811	http://dx.doi.org/10.1371/journal.pone.0060811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23579286	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000317898000072
J	Vosika, ZB; Lazovic, GM; Misevic, GN; Simic-Krstic, JB				Vosika, Zoran B.; Lazovic, Goran M.; Misevic, Gradimir N.; Simic-Krstic, Jovana B.			Fractional Calculus Model of Electrical Impedance Applied to Human Skin	PLOS ONE			English	Article							DIELECTRIC RESPONSE	Fractional calculus is a mathematical approach dealing with derivatives and integrals of arbitrary and complex orders. Therefore, it adds a new dimension to understand and describe basic nature and behavior of complex systems in an improved way. Here we use the fractional calculus for modeling electrical properties of biological systems. We derived a new class of generalized models for electrical impedance and applied them to human skin by experimental data fitting. The primary model introduces new generalizations of: 1) Weyl fractional derivative operator, 2) Cole equation, and 3) Constant Phase Element (CPE). These generalizations were described by the novel equation which presented parameter (beta) related to remnant memory and corrected four essential parameters (R-0, R-infinity, alpha, tau(alpha)). We further generalized single generalized element by introducing specific partial sum of Maclaurin series determined by parameters (beta(*), gamma,delta ...). We defined individual primary model elements and their serial combination models by the appropriate equations and electrical schemes. Cole equation is a special case of our generalized class of models for beta* = gamma = delta = ... = 0. Previous bioimpedance data analyses of living systems using basic Cole and serial Cole models show significant imprecisions. Our new class of models considerably improves the quality of fitting, evaluated by mean square errors, for bioimpedance data obtained from human skin. Our models with new parameters presented in specific partial sum of Maclaurin series also extend representation, understanding and description of complex systems electrical properties in terms of remnant memory effects.	[Vosika, Zoran B.; Simic-Krstic, Jovana B.] Univ Belgrade, Dept Biomed Engn, Fac Mech Engn, Belgrade, Serbia; [Lazovic, Goran M.] Univ Belgrade, Fac Mech Engn, Dept Math, Belgrade, Serbia; [Misevic, Gradimir N.] Gimmune GmbH, Dept Res, Zug, Switzerland	University of Belgrade; University of Belgrade	Misevic, GN (corresponding author), Gimmune GmbH, Dept Res, Zug, Switzerland.	gradimir@gimmune.com	Misevic, Gradimir/D-8294-2016; Lazovic, Goran/CAI-2428-2022; Lazovic, Goran/CAF-6762-2022	Misevic, Gradimir/0000-0001-5047-2936; Lazovic, Goran/0000-0002-6556-4056; Lazovic, Goran/0000-0002-6556-4056	Ministry of Education and Science of the Republic of Serbia [III 4100]; GNM private funds	Ministry of Education and Science of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); GNM private funds	This work is supported by the Ministry of Education and Science of the Republic of Serbia through Project No. III 41006 and is also partially supported by GNM private funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanackovic TM, 2002, CONTINUUM MECH THERM, V14, P137, DOI 10.1007/s001610100056; Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII; Bohannan GW, 2000, AIP CONF PROC, V535, P250, DOI 10.1063/1.1324461; Butzer P. L., 1971, FOURIER ANAL APPROXI, V1; Butzer PL, 1975, FRACTIONAL CALCULUS, P116; Cole K. S., 1940, Cold Spring Harbor Symposia on Quantitative Biology, V8, P110; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; Desmeulles G, 2003, J INVEST DERMATOL, V121, P1570; DISSADO LA, 1995, PHYS MED BIOL, V40, P1067, DOI 10.1088/0031-9155/40/6/008; El-Lakkani A, 2001, BIOELECTROMAGNETICS, V22, P272, DOI 10.1002/bem.50; El-Sayed AMA, 2009, COMMUN THEOR PHYS, V52, P992, DOI 10.1088/0253-6102/52/6/04; Freed AD, 2006, BIOMECH MODEL MECHAN, V5, P203, DOI 10.1007/s10237-005-0011-0; Fricke R, 1932, PHILOS MAG, V14, P310; Glade N, 2002, ACTA BIOTHEOR, V50, P239, DOI 10.1023/A:1022608400954; Grimnes S., 2008, BIOIMPEDANCE BIOELEC, V2nd ed, DOI [10.1016/B978-0-12-374004-5.X0001-3, DOI 10.1016/B978-0-12-374004-5.X0001-3]; Hilfer R., 2000, APPL FRACTIONAL CALC; Kanzow C, 2004, J COMPUT APPL MATH, V172, P375, DOI 10.1016/j.cam.2004.02.013; Kilbas AA., 1993, FRACTIONAL INTEGRAL; Lundstrom BN, 2008, NAT NEUROSCI, V11, P1335, DOI 10.1038/nn.2212; Magin Richard L., 2004, Critical Reviews in Biomedical Engineering, V32, P1, DOI 10.1615/CritRevBiomedEng.v32.10; Magin Richard L., 2004, Critical Reviews in Biomedical Engineering, V32, P105, DOI 10.1615/CritRevBiomedEng.v32.i2.10; Montagna W., 1974, STRUCTURE FUNCTION S, V3rd, P28; Nigmatullin RR, 2007, ADVANCES IN FRACTIONAL CALCULUS, P155, DOI 10.1007/978-1-4020-6042-7_11; Nigmatullin RR, 2004, MAGN RESON SOLIDS, V6, P165; Podlubny I., 1999, FRACTIONAL DIFFERENT; Popovic JK, 2011, EUR J DRUG METAB PH, V36, P189, DOI 10.1007/s13318-011-0057-6; Richard C.A., 2005, PARAMETER ESTIMATION; Sebaa N, 2006, SIGNAL PROCESS, V86, P2668, DOI 10.1016/j.sigpro.2006.02.015; Voet D., 2011, BIOCHEMISTRY; WEINBERG A. M., 1941, BULL MATH BIOPHYS, V3, P129, DOI 10.1007/BF02477932; YAMAMOTO T, 1976, MED BIOL ENG, V14, P151, DOI 10.1007/BF02478741; YAMAMOTO Y, 1986, MED BIOL ENG COMPUT, V24, P71, DOI 10.1007/BF02441608	32	42	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59483	10.1371/journal.pone.0059483	http://dx.doi.org/10.1371/journal.pone.0059483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577065	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800009
J	Zhuang, LL; Jin, R; Zhu, LH; Xu, HG; Li, Y; Gao, S; Liu, JY; Zhou, GP				Zhuang, Li-Li; Jin, Rui; Zhu, Liang-Hua; Xu, Hua-Guo; Li, Yue; Gao, Shan; Liu, Jia-Yin; Zhou, Guo-Ping			Promoter Characterization and Role of cAMP/PKA/CREB in the Basal Transcription of the Mouse ORMDL3 Gene	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; ASSOCIATION; EXPRESSION; ASTHMA; OCCUPANCY; LOCI	Orosomucoid 1-like 3 (ORMDL3) gene was strongly linked with the development of asthma in genetic association studies, and its expression could be significantly induced by allergen in airway epithelial cells of mice. However, the expression mechanism of ORMDL3 was still unclear. Here we have identified and characterized the mouse ORMDL3 gene promoter. Deletion constructs of the 5' anking region were fused to a luciferase reporter gene. After transient transfection in mouse fibroblast cell line NIH3T3, a CRE (-27/-20) binding CREB was identified in the core promoter region. Deletion or mutation of the CRE consensus sequence resulted in a significant loss of the promoter activity. EMSA and ChIP assays demonstrated the binding of CREB to the core promoter. Knocking down endogenous CREB led to a reduction in ORMDL3 expression. Conversely, overexpression of CREB up-regulated ORMDL3 expression. Moreover, forskolin, a PKA activator, could facilitate the phosphorylation of CREB, which in turn heightens ORMDL3 expression. H-89, a PKA-specific inhibitor, could significantly inhibit ORMDL3 expression. This study delineates the characterization of mouse ORMDL3 gene promoter and shows signaling pathway cAMP/PKA/CREB plays an important role in regulating ORMDL3 expression, which will be helpful for future animal model studies regarding the regulation or function of ORMDL3 gene.	[Zhuang, Li-Li; Jin, Rui; Zhu, Liang-Hua; Li, Yue; Gao, Shan; Zhou, Guo-Ping] Nanjing Med Univ, Affiliated Hosp 1, Dept Pediat, Nanjing, Jiangsu, Peoples R China; [Xu, Hua-Guo] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Liu, Jia-Yin] Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhou, GP (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Pediat, Nanjing, Jiangsu, Peoples R China.	gpzhou2003@yahoo.com.cn			National Natural Science Foundation of China [30872804, 81170661]; Specialized Research Fund for the Doctoral Program of Higher Education [20113234110010]; Jiangsu Province Innovation Project for Graduate Student of China [CXZZ11_0714]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jiangsu Province Innovation Project for Graduate Student of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (30872804 and 81170661 to GPZ), Specialized Research Fund for the Doctoral Program of Higher Education (20113234110010 to GPZ), the Jiangsu Province Innovation Project for Graduate Student of China (CXZZ11_0714 to LLZ) and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billington CK, 2012, PULM PHARM THER; Brauner EV, 2012, GENES IMMUN, V13, P94, DOI 10.1038/gene.2011.51; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Contoli M, 2005, CLIN EXP ALLERGY, V35, P137, DOI 10.1111/j.1365-2222.2005.02163.x; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Jin R, 2012, INT J BIOCH CELL BIO; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; Kurreeman FAS, 2012, AM J HUM GENET, V90, P524, DOI 10.1016/j.ajhg.2012.01.010; Kuscu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044661; Laukens D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013795; Lluis A, 2011, J ALLERGY CLIN IMMUN, V127, P1587, DOI 10.1016/j.jaci.2011.03.015; Mahn K, 2009, P NATL ACAD SCI USA, V106, P10775, DOI 10.1073/pnas.0902295106; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Martianov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-530; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Saleh NM, 2011, DIABETES-METAB RES, V27, P838, DOI 10.1002/dmrr.1259; Sathish V, 2009, AM J PHYSIOL-LUNG C, V297, pL26, DOI 10.1152/ajplung.00026.2009; Siow DL, 2012, J BIOL CHEM; Xue HP, 2011, INT J BIOCHEM CELL B, V43, P348, DOI 10.1016/j.biocel.2010.11.002; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	26	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60630	10.1371/journal.pone.0060630	http://dx.doi.org/10.1371/journal.pone.0060630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577138	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800078
J	Keurentjes, JC; Fiocco, M; So-Osman, C; Onstenk, R; Koopman-Van Gemert, AWMM; Poll, RG; Kroon, HM; Vlieland, TPMV; Nelissen, RG				Keurentjes, J. Christiaan; Fiocco, Marta; So-Osman, Cynthia; Onstenk, Ron; Koopman-Van Gemert, Ankie W. M. M.; Poll, Ruud G.; Kroon, Herman M.; Vlieland, Thea P. M. Vliet; Nelissen, Rob G.			Patients with Severe Radiographic Osteoarthritis Have a Better Prognosis in Physical Functioning after Hip and Knee Replacement: A Cohort-Study	PLOS ONE			English	Article							CLINICALLY IMPORTANT DIFFERENCES; QUALITY-OF-LIFE; PATIENTS EXPECTATIONS; JOINT REPLACEMENT; HEALTH SURVEY; ARTHROPLASTY; SATISFACTION; SF-36; RESPONSIVENESS; PARTICIPATION	Introduction: Although Total Hip and Knee Replacements (THR/TKR) improve Health-Related Quality of Life (HRQoL) at the group level, up to 30% of patients are dissatisfied after surgery due to unfulfilled expectations. We aimed to assess whether the pre-operative radiographic severity of osteoarthritis (OA) is related to the improvement in HRQoL after THR or TKR, both at the population and individual level. Methods: In this multi-center observational cohort study, HRQoL of OA patients requiring THR or TKR was measured 2 weeks before surgery and at 2-5 years follow-up, using the Short-Form 36 (SF36). Additionally, we measured patient satisfaction on a 11-point Numeric Rating Scale (NRSS). The radiographic severity of OA was classified according to Kellgren and Lawrence (KL) by an independent experienced musculoskeletal radiologist, blinded for the outcome. We compared the mean improvement and probability of a relevant improvement (defined as a patients change score >= Minimal Clinically Important Difference) between patients with mild OA (KL Grade 0-2) and severe OA (KL Grade 3+4), whilst adjusting for confounders. Results: Severe OA patients improved more and had a higher probability of a relevant improvement in physical functioning after both THR and TKR. For TKR patients with severe OA, larger improvements were found in General Health, Vitality and the Physical Component Summary Scale. The mean NRSS was also higher in severe OA TKR patients. Discussion: Patients with severe OA have a better prognosis after THR and TKR than patients with mild OA. These findings might help to prevent dissatisfaction after THR and TKR by means of patient selection or expectation management.	[Keurentjes, J. Christiaan; Vlieland, Thea P. M. Vliet; Nelissen, Rob G.] Leiden Univ Med Ctr, Dept Orthopaed Surg, Leiden, Netherlands; [Fiocco, Marta] Leiden Univ Med Ctr, Dept Med Stat & BioInformat, Leiden, Netherlands; [So-Osman, Cynthia] Sanquin Blood Supply South West Reg, Dept Res & Dev, Leiden, Netherlands; [Onstenk, Ron] Groene Hart Hosp, Dept Orthopaed Surg, Gouda, Netherlands; [Koopman-Van Gemert, Ankie W. M. M.] Albert Schweitzer Hosp, Dept Anaesthesiol, Dordrecht, Netherlands; [Poll, Ruud G.] Slotervaart Hosp, Dept Orthopaed Surg, Amsterdam, Netherlands; [Kroon, Herman M.] Leiden Univ Med Ctr, Dept Radiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Albert Schweitzer Ziekenhuis; Slotervaart Hospital; Leiden University; Leiden University Medical Center (LUMC)	Keurentjes, JC (corresponding author), Leiden Univ Med Ctr, Dept Orthopaed Surg, Leiden, Netherlands.	j.c.keurentjes@lumc.nl	Nelissen, Rob/AAD-8134-2020; Vlieland, Thea Vliet/AAJ-8119-2020; Dijkstra, Sander/F-2513-2017	Nelissen, Rob/0000-0003-1228-4162; Vlieland, Thea Vliet/0000-0001-6322-3859; Dijkstra, Sander/0000-0001-5368-757X	Dutch Arthritis Association [LLP-13]; ZON-MW, The Netherlands Organization for Health Research and Development; Roche Nederland BV; Sanquin Bloodbank Amsterdam; Haemonetics BV; Dutch Arthritis Association	Dutch Arthritis Association; ZON-MW, The Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government); Roche Nederland BV; Sanquin Bloodbank Amsterdam; Haemonetics BV; Dutch Arthritis Association	This study was funded by a grant from the Dutch Arthritis Association (Grant-number: LLP-13). Both the sponsors of the previous trial (ZON-MW, The Netherlands Organization for Health Research and Development; Roche Nederland BV; Sanquin Bloodbank Amsterdam; Haemonetics BV) and the sponsor of the current study (Dutch Arthritis Association) had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study. All authors had final responsibility for the decision to submit for publication.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Baker PN, 2007, J BONE JOINT SURG BR, V89B, P893, DOI 10.1302/0301-620X.89B7.19091; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Bini SA, 2011, J ARTHROPLASTY, V26, P124, DOI 10.1016/j.arth.2011.03.043; Brokelman RBG, 2003, J BONE JOINT SURG BR, V85B, P495, DOI 10.1302/0301-620X.85B4.13411; Bruyere O, 2012, ARCH ORTHOPAEDIC TRA; CHARNLEY J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P61; de Beer J, 2012, J ARTHROPLASTY, V27, P865, DOI 10.1016/j.arth.2011.12.031; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dunbar MJ, 2004, ACTA ORTHOP SCAND, V75, P119, DOI 10.1080/00016470412331294355; Escobar A, 2007, OSTEOARTHR CARTILAGE, V15, P273, DOI 10.1016/j.joca.2006.09.001; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gandhi R, 2008, J RHEUMATOL, V35, P2415, DOI 10.3899/jrheum.080295; Garellick G, 2000, CLIN ORTHOP RELAT R, P157; Gossec L, 2011, J RHEUMATOL, V38, P1765, DOI 10.3899/jrheum.110403; Hartge P, 2006, EPIDEMIOLOGY, V17, P252, DOI 10.1097/01.ede.0000209441.24307.92; Hobbs T, TWELVE YEAR REPORT; Honaker J, 2011, J STAT SOFTW, V45, P1; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jones J, 1996, J Health Soc Policy, V8, P49, DOI 10.1300/J045v08n01_05; Judge A, 2012, ARTHRIT CARE RES, V64, P881, DOI 10.1002/acr.21594; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Keurentjes JC, 2012, BONE JOINT RES, V1, P71, DOI 10.1302/2046-3758.15.2000065; Keurentjes JC, 2012, BONE JOINT RES, V1, P258, DOI 10.1302/2046-3758.110.2000104; Keurentjes JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056785; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; King MT, 2011, EXPERT REV PHARM OUT, V11, P171, DOI [10.1586/ERP.11.9, 10.1586/erp.11.9]; Lingard EA, 2006, J BONE JOINT SURG AM, V88A, P1201, DOI 10.2106/JBJS.E.00147; Malchau H, 2005, CLIN ORTHOP RELAT R, P19, DOI 10.1097/01.blo.0000193517.19556.e4; Mancuso CA, 1997, J ARTHROPLASTY, V12, P387, DOI 10.1016/S0883-5403(97)90194-7; Meding JB, 2000, CLIN ORTHOP RELAT R, P156; Ng CY, 2007, J BONE JOINT SURG BR, V89B, P868, DOI 10.1302/0301-620X.89B7.18482; Nilsdotter AK, 2001, ANN RHEUM DIS, V60, P228, DOI 10.1136/ard.60.3.228; Nilsdotter AK, 2009, ACTA ORTHOP, V80, P55, DOI 10.1080/17453670902805007; Noble PC, 2006, CLIN ORTHOP RELAT R, P35, DOI 10.1097/011.blo.0000238825.63648.1e; Quintana JM, 2005, OSTEOARTHR CARTILAGE, V13, P1076, DOI 10.1016/j.joca.2005.06.012; Rubin DB, 2004, MULTIPLE IMPUTATION; Schreurs BW, 2009, J BONE JOINT SURG BR, V91B, P1148, DOI 10.1302/0301-620X.91B9.21750; Scott CEH, 2012, J BONE JOINT SURG BR, V94B, P974, DOI 10.1302/0301-620X.94B7.28219; Team RC, 2012, R LANG ENV STAT COMP; Vissers MM, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-121; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wolterbeek N, 2011, CLIN BIOMECHANICS BR, DOI [10.1016/j.clinbiomech.2011.10.013, DOI 10.1016/J.CLINBI0-MECH.2011.10.013]	44	71	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59500	10.1371/journal.pone.0059500	http://dx.doi.org/10.1371/journal.pone.0059500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573200	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100019
J	LaRue, MA; Ainley, DG; Swanson, M; Dugger, KM; Lyver, PO; Barton, K; Ballard, G				LaRue, Michelle A.; Ainley, David G.; Swanson, Matt; Dugger, Katie M.; Lyver, Phil O'B.; Barton, Kerry; Ballard, Grant			Climate Change Winners: Receding Ice Fields Facilitate Colony Expansion and Altered Dynamics in an Adelie Penguin Metapopulation	PLOS ONE			English	Article							ANTARCTIC PENINSULA; SOUTHERN-OCEAN; ROSS SEA; PYGOSCELIS-ADELIAE; POPULATION; SIZE; SURVIVAL; MODELS	There will be winners and losers as climate change alters the habitats of polar organisms. For an Adelie penguin (Pygoscelis adeliae) colony on Beaufort Island (Beaufort), part of a cluster of colonies in the southern Ross Sea, we report a recent population increase in response to increased nesting habitat as glaciers have receded. Emigration rates of birds banded as chicks on Beaufort to colonies on nearby Ross Island decreased after 2005 as available habitat on Beaufort increased, leading to altered dynamics of the metapopulation. Using aerial photography beginning in 1958 and modern satellite imagery, we measured change in area of available nesting habitat and population size of the Beaufort colony. Population size varied with available habitat, and both increased rapidly since the 1990s. In accord with glacial retreat, summer temperatures at nearby McMurdo Station increased by similar to 0.50 degrees C per decade since the mid-1980s. Although the Ross Sea is likely to be the last ocean with an intact ecosystem, the recent retreat of ice fields at Beaufort that resulted in increased breeding habitat exemplifies a process that has been underway in the Ross Sea during the entire Holocene. Furthermore, our results are in line with predictions that major ice shelves and glaciers will retreat rapidly elsewhere in the Antarctic, potentially leading to increased breeding habitat for Adelie penguins. Results further indicated that satellite imagery may be used to estimate large changes in Adelie penguin populations, facilitating our understanding of metapopulation dynamics and environmental factors that influence regional populations.	[LaRue, Michelle A.; Swanson, Matt] Univ Minnesota, Dept Earth Sci, Polar Geospatial Ctr, St Paul, MN 55108 USA; [Ainley, David G.] HT Harvey & Associates, Los Gatos, CA USA; [Dugger, Katie M.] Oregon State Univ, Dept Fisheries & Wildlife, Oregon Cooperat Fish & Wildlife Res Unit, US Geol Survey, Corvallis, OR 97331 USA; [Lyver, Phil O'B.] Landcare Res, Lincoln, New Zealand; [Barton, Kerry] Bartonk Solut, Nelson, New Zealand; [Ballard, Grant] PRBO Conservat Sci, Petaluma, CA USA	University of Minnesota System; University of Minnesota Twin Cities; Oregon State University; United States Department of the Interior; United States Geological Survey; Landcare Research - New Zealand	LaRue, MA (corresponding author), Univ Minnesota, Dept Earth Sci, Polar Geospatial Ctr, St Paul, MN 55108 USA.	larue010@umn.edu			National Science Foundation [ANT-1043681, ANT-0944411, ANT-0440643]; New Zealand's Ministry for Business, Innovation and Employment [C09X0510, C01X0505, C01X1001]; Helicopters NZ; NZ Defense Force (Squadron 40); Directorate For Geosciences [0944411] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [0944358] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); New Zealand's Ministry for Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Helicopters NZ; NZ Defense Force (Squadron 40); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Science Foundation (ANT-1043681, ANT-0944411, ANT-0440643) and New Zealand's Ministry for Business, Innovation and Employment (C09X0510, C01X0505, C01X1001). PRBO contribution # 1926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Field logistics were provided by the US Antarctic Program, and for the New Zealand team by Antarctica New Zealand, supported by Helicopters NZ and the NZ Defense Force (Squadron 40). We thank C. Kelleher for creating the location map, and J. Pundsack for reviewing previous drafts of this manuscript. The Polar Geospatial Center facilitated the use of imagery for analysis. All penguin survey, capture and handling methods performed during data collection for this study were approved under appropriate ACA permits and by Oregon State University's Institutional Animal Care and Use Committee (ACUP # 3049, 3672, 4130). The use of trade names or products does not constitute endorsement by the U.S. Government.	Ainley D. G., 2002, Marine Ornithology, V30, P55; Ainley D.G., 2002, ADELIE PENGUIN BELLW, DOI DOI 10.7312/AINL12306; Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Ainley DG, 2013, FISH FISH, V14, P343, DOI 10.1111/j.1467-2979.2012.00474.x; Ainley DG, 1995, AUK, V112, P171, DOI 10.2307/4088776; Ainley DG, 2005, ANTARCT SCI, V17, P335, DOI 10.1017/S0954102005002750; Ainley DG, 2005, ANTARCT SCI, V17, P171, DOI 10.1017/S0954102005002567; Ainley DG, 2003, CONDOR, V105, P95, DOI 10.1650/0010-5422(2003)105[95:SATVOD]2.0.CO;2; Ainley DG, 2010, WGEMM1011162, P1; Ballance LT, 2009, J AVIAN BIOL, V40, P279, DOI 10.1111/j.1600-048X.2008.04538.x; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Dugger KM, 2006, AUK, V123, P858, DOI 10.1642/0004-8038(2006)123[858:EOFBOF]2.0.CO;2; Dugger KM, 2010, P NATL ACAD SCI USA, V107, P12375, DOI 10.1073/pnas.1000623107; Emslie SD, 2007, GEOLOGY, V35, P61, DOI 10.1130/G23011A.1; Fraser William R., 1997, P445; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Glantz MH, 1995, STUD ENVIRON SCI, V65, P41, DOI 10.1016/S0166-1116(06)80193-7; Jacobs S, 2006, PHILOS T R SOC A, V364, P1657, DOI 10.1098/rsta.2006.1794; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Jenouvrier S, 2012, GLOBAL CHANGE BIOL, V18, P2756, DOI 10.1111/j.1365-2486.2012.02744.x; La Mesa M, 2004, POLAR BIOL, V27, P321, DOI 10.1007/s00300-004-0599-z; LaRue MA, 2011, POLAR BIOL, V34, P1727, DOI 10.1007/s00300-011-1023-0; Lynch HJ, 2012, POLAR BIOL, V35, P963, DOI 10.1007/s00300-011-1138-3; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; Millar CD, 2012, INTEGR ZOOL, V7, P113, DOI 10.1111/j.1749-4877.2012.00288.x; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Naveen R, 2012, POLAR BIOL, V35, P1879, DOI 10.1007/s00300-012-1230-3; Parkinson CL, 2002, ANN GLACIOL, V34, P435, DOI 10.3189/172756402781817482; Shepherd LD, 2005, P NATL ACAD SCI USA, V102, P16717, DOI 10.1073/pnas.0502281102; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Stammerjohn S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050874; TAYLOR RH, 1990, NEW ZEAL J ECOL, V14, P25; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Turner J, 2007, INT J CLIMATOL, V27, P277, DOI 10.1002/joc.1406	36	60	63	1	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60568	10.1371/journal.pone.0060568	http://dx.doi.org/10.1371/journal.pone.0060568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573267	Green Published, gold			2022-12-27	WOS:000318840100085
J	Moore, SJ; Leung, CL; Norton, HK; Cochran, JR				Moore, Sarah J.; Leung, Cheuk Lun; Norton, Heidi K.; Cochran, Jennifer R.			Engineering Agatoxin, a Cystine-Knot Peptide from Spider Venom, as a Molecular Probe for In Vivo Tumor Imaging	PLOS ONE			English	Article							AGOUTI-RELATED PROTEIN; INTEGRIN ALPHA(V)BETA(3); FIBRONECTIN DOMAIN; AFFINITY; PET; EXPRESSION; DESIGN; ALPHA-V-BETA-3; ALPHA-5-BETA-1; MICROPROTEINS	Background: Cystine-knot miniproteins, also known as knottins, have shown great potential as molecular scaffolds for the development of targeted therapeutics and diagnostic agents. For this purpose, previous protein engineering efforts have focused on knottins based on the Ecballium elaterium trypsin inhibitor (EETI) from squash seeds, the Agouti-related protein (AgRP) neuropeptide from mammals, or the Kalata B1 uterotonic peptide from plants. Here, we demonstrate that Agatoxin (AgTx), an ion channel inhibitor found in spider venom, can be used as a molecular scaffold to engineer knottins that bind with high-affinity to a tumor-associated integrin receptor. Methodology/Principal Findings: We used a rational loop-grafting approach to engineer AgTx variants that bound to alpha(v)beta(3) integrin with affinities in the low nM range. We showed that a disulfide-constrained loop from AgRP, a structurally-related knottin, can be substituted into AgTx to confer its high affinity binding properties. In parallel, we identified amino acid mutations required for efficient in vitro folding of engineered integrin-binding AgTx variants. Molecular imaging was used to evaluate in vivo tumor targeting and biodistribution of an engineered AgTx knottin compared to integrin-binding knottins based on AgRP and EETI. Knottin peptides were chemically synthesized and conjugated to a near-infrared fluorescent dye. Integrin-binding AgTx, AgRP, and EETI knottins all generated high tumor imaging contrast in U87MG glioblastoma xenograft models. Interestingly, EETI-based knottins generated significantly lower non-specific kidney imaging signals compared to AgTx and AgRP-based knottins. Conclusions/Significance: In this study, we demonstrate that AgTx, a knottin from spider venom, can be engineered to bind with high affinity to a tumor-associated receptor target. This work validates AgTx as a viable molecular scaffold for protein engineering, and further demonstrates the promise of using tumor-targeting knottins as probes for in vivo molecular imaging.	[Moore, Sarah J.; Norton, Heidi K.; Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Leung, Cheuk Lun; Cochran, Jennifer R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Cochran, Jennifer R.] Stanford Canc Inst, Stanford, CA USA; [Cochran, Jennifer R.] Bio X Program, Stanford, CA USA	Stanford University; Stanford University; Stanford Cancer Institute	Cochran, JR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	jennifer.cochran@stanford.edu			Developmental Project Grant from the Stanford In Vivo Cellular and Molecular Imaging Center [NIH/NCI P50 CA114747, NIH/NCI R21 CA143498]; NSF Graduate Research Fellowship; Stanford Graduate Fellowship; Siebel Scholars Fellowship; Gerald J. Lieberman Fellowship; Stanford Bio-X Undergraduate Research Fellowship; Stanford Materials Science VPUE Summer Research Fellowship; NATIONAL CANCER INSTITUTE [P50CA114747, R21CA143498] Funding Source: NIH RePORTER	Developmental Project Grant from the Stanford In Vivo Cellular and Molecular Imaging Center; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); Siebel Scholars Fellowship; Gerald J. Lieberman Fellowship; Stanford Bio-X Undergraduate Research Fellowship; Stanford Materials Science VPUE Summer Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by a Developmental Project Grant from the Stanford In Vivo Cellular and Molecular Imaging Center NIH/NCI P50 CA114747, and NIH/NCI R21 CA143498. S.J.M. was supported by an NSF Graduate Research Fellowship, a Stanford Graduate Fellowship (Medtronic Fellow), a Siebel Scholars Fellowship, and a Gerald J. Lieberman Fellowship. C.L.L. was supported by an NSF Graduate Research Fellowship. H.K.N. was supported by a Stanford Bio-X Undergraduate Research Fellowship and by a Stanford Materials Science VPUE Summer Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ME, 1993, MOL PHARMACOL, V44, P681; Akizawa H, 2008, ADV DRUG DELIVER REV, V60, P1319, DOI 10.1016/j.addr.2008.04.005; Batra SK, 2002, CURR OPIN BIOTECH, V13, P603, DOI 10.1016/S0958-1669(02)00352-X; Beer AJ, 2008, CANCER METAST REV, V27, P631, DOI 10.1007/s10555-008-9158-3; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cai WB, 2006, MOL CANCER THER, V5, P2624, DOI 10.1158/1535-7163.MCT-06-0395; Chen K, 2010, CURR TOP MED CHEM, V10, P1227, DOI 10.2174/156802610791384225; Cochran FV, 2010, BIOTECHNOL GENET ENG, V27, P57, DOI 10.1080/02648725.2010.10648145; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2012, EXPERT OPIN DRUG DIS, V7, P179, DOI 10.1517/17460441.2012.661554; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; FAVEL A, 1989, INT J PEPT PROT RES, V33, P202; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Friedman M, 2009, BIOTECHNOL APPL BIOC, V53, P1, DOI 10.1042/BA20080287; Gaertner FC, 2010, Q J NUCL MED MOL IMA; Getz JA, 2011, ACS CHEM BIOL, V6, P837, DOI 10.1021/cb200039s; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Hackel BJ, 2012, PROTEIN ENG DES SEL, V25, P639, DOI 10.1093/protein/gzs036; Hackel BJ, 2012, RADIOLOGY, V263, P179, DOI 10.1148/radiol.12111504; Haubner R, 1997, ANGEW CHEM INT EDIT, V36, P1375; Haubner R, 2006, EUR J NUCL MED MOL I, V33, pS54, DOI 10.1007/s00259-006-0136-0; Jackson PJ, 2002, BIOCHEMISTRY-US, V41, P7565, DOI 10.1021/bi012000x; Jiang H, 2012, AMINO ACIDS, DOI [10.1007/s00726-00012-01391-y, DOI 10.1007/S00726-00012-01391-Y]; Jiang L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/368075; Jiang L, 2010, J NUCL MED, V51, P251, DOI 10.2967/jnumed.109.069831; Kaur S, 2012, CANCER LETT, V315, P97, DOI 10.1016/j.canlet.2011.10.017; KIM JI, 1995, J MOL BIOL, V250, P659, DOI 10.1006/jmbi.1995.0406; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kimura RH, 2012, CLIN CANCER RES, V18, P839, DOI 10.1158/1078-0432.CCR-11-1116; Kimura RH, 2010, BIOCONJUGATE CHEM, V21, P436, DOI 10.1021/bc9003102; Kimura RH, 2009, PROTEINS, V77, P359, DOI 10.1002/prot.22441; Kimura RH, 2009, CANCER RES, V69, P2435, DOI 10.1158/0008-5472.CAN-08-2495; Kolmar H, 2011, CURR PHARM DESIGN, V17, P4329, DOI 10.2174/138161211798999465; Kolmar H, 2010, EXPERT REV MOL DIAGN, V10, P361, DOI 10.1586/ERM.10.15; LENGUYEN D, 1990, BIOCHIMIE, V72, P431, DOI 10.1016/0300-9084(90)90067-Q; Liu SL, 2011, THERANOSTICS, V1, P403, DOI 10.7150/thno/v01p0403; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; MAILLERE B, 1995, TOXICON, V33, P475, DOI 10.1016/0041-0101(94)00186-C; McNulty JC, 2005, J MOL BIOL, V346, P1059, DOI 10.1016/j.jmb.2004.12.030; Miao Z., 2010, AMINO ACIDS; Miao Z, 2009, BIOCONJUGATE CHEM, V20, P2342, DOI 10.1021/bc900361g; Moore S.J., 2011, DRUG DISCOV TODAY TE, V9, pe3; Moore SJ, 2012, METHOD ENZYMOL, V503, P223, DOI 10.1016/B978-0-12-396962-0.00009-4; Nielsen CH, 2010, CANCER RES, V70, P9022, DOI 10.1158/0008-5472.CAN-10-1338; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Reinwarth M, 2012, MOLECULES, V17, P12533, DOI 10.3390/molecules171112533; Reynolds F, 2011, MOL IMAGING, V10, P407, DOI 10.2310/7290.2011.00003; RINK H, 1984, TETRAHEDRON LETT, V25, P621, DOI 10.1016/S0040-4039(00)99954-4; Rubina A.Yu., 2000, RUSSIAN J BIOORGANIC, V26, P235, DOI [10.1007/BF02759162, DOI 10.1007/BF02759162]; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Silverman AP, 2009, J MOL BIOL, V385, P1064, DOI 10.1016/j.jmb.2008.11.004; Vegt E, 2010, J NUCL MED, V51, P1049, DOI 10.2967/jnumed.110.075101; Veiseh M, 2007, CANCER RES, V67, P6882, DOI 10.1158/0008-5472.CAN-06-3948; Werle M, 2006, J DRUG TARGET, V14, P137, DOI 10.1080/10611860600648254; Williams JA, 2008, EXPERT OPIN PHARMACO, V9, P1575, DOI 10.1517/14656566.9.9.1575 ; Willmann JK, 2010, J NUCL MED, V51, P433, DOI 10.2967/jnumed.109.068007; Wittrup KD, 2012, METHOD ENZYMOL, V503, P255, DOI 10.1016/B978-0-12-396962-0.00010-0; Wood DLA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-375; Wu AM, 2008, CANCER J, V14, P191, DOI 10.1097/PPO.0b013e31817b07ae; Xiong JP, 2003, J THROMB HAEMOST, V1, P1642, DOI 10.1046/j.1538-7836.2003.00277.x; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724; Zhang XZ, 2006, J NUCL MED, V47, P113; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje	70	32	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60498	10.1371/journal.pone.0060498	http://dx.doi.org/10.1371/journal.pone.0060498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573262	Green Published, gold			2022-12-27	WOS:000318840100080
J	Sigurdsson, V; Ingthorsson, S; Hilmarsdottir, B; Gustafsdottir, SM; Franzdottir, SR; Arason, AJ; Steingrimsson, E; Magnusson, MK; Gudjonsson, T				Sigurdsson, Valgardur; Ingthorsson, Saevar; Hilmarsdottir, Bylgja; Gustafsdottir, Sigrun M.; Franzdottir, Sigridur Rut; Arason, Ari Jon; Steingrimsson, Eirikur; Magnusson, Magnus K.; Gudjonsson, Thorarinn			Expression and Functional Role of Sprouty-2 in Breast Morphogenesis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GLAND BRANCHING MORPHOGENESIS; KINASE PATHWAY; CELL LINE; GROWTH; PROTEINS; CANCER; REGULATORS; INHIBITOR; FGF7	Branching morphogenesis is a mechanism used by many species for organogenesis and tissue maintenance. Receptor tyrosine kinases (RTKs), including epidermal growth factor receptor (EGFR) and the sprouty protein family are believed to be critical regulators of branching morphogenesis. The aim of this study was to analyze the expression of Sprouty-2 (SPRY2) in the mammary gland and study its role in branching morphogenesis. Human breast epithelial cells, breast tissue and mouse mammary glands were used for expression studies using immunoblotting, real rime PCR and immunohistochemistry. Knockdown of SPRY2 in the breast epithelial stem cell line D492 was done by lentiviral transduction of shRNA constructs targeting SPRY2. Three dimensional culture of D492 with or without endothelial cells was done in reconstituted basement membrane matrix. We show that in the human breast, SPRY2 is predominantly expressed in the luminal epithelial cells of both ducts and lobuli. In the mouse mammary gland, SPRY2 expression is low or absent in the virgin state, while in the pregnant mammary gland SPRY2 is expressed at branching epithelial buds with increased expression during lactation. This expression pattern is closely associated with the activation of the EGFR pathway. Using D492 which generates branching structures in three-dimensional (3D) culture, we show that SPRY2 expression is low during initiation of branching with subsequent increase throughout the branching process. Immunostaining locates expression of phosphorylated SPRY2 and EGFR at the tip of lobular-like, branching ends. SPRY2 knockdown (KD) resulted in increased migration, increased pERK and larger and more complex branching structures indicating a loss of negative feedback control during branching morphogenesis. In D492 co-cultures with endothelial cells, D492 SPRY2 KD generates spindle-like colonies that bear hallmarks of epithelial to mesenchymal transition. These data indicate that SPRY2 is an important regulator of branching morphogenesis and epithelial to mesenchymal transition in the mammary gland.	[Sigurdsson, Valgardur; Ingthorsson, Saevar; Hilmarsdottir, Bylgja; Gustafsdottir, Sigrun M.; Franzdottir, Sigridur Rut; Arason, Ari Jon; Magnusson, Magnus K.; Gudjonsson, Thorarinn] Univ Iceland, Fac Med, BioMed Ctr, Stem Cell Res Unit, Reykjavik, Iceland; [Sigurdsson, Valgardur; Ingthorsson, Saevar; Hilmarsdottir, Bylgja; Franzdottir, Sigridur Rut; Arason, Ari Jon; Gudjonsson, Thorarinn] Landspitali Univ Hosp, Dept Lab Hematol, Reykjavik, Iceland; [Steingrimsson, Eirikur] Univ Iceland, Fac Med, Dept Biochem & Mol Biol, Reykjavik, Iceland; [Steingrimsson, Eirikur] Univ Iceland, Fac Med, BioMed Ctr, Reykjavik, Iceland; [Magnusson, Magnus K.] Univ Iceland, Fac Med, Dept Pharmacol, Reykjavik, Iceland	University of Iceland; Landspitali National University Hospital; University of Iceland; University of Iceland; University of Iceland	Magnusson, MK (corresponding author), Univ Iceland, Fac Med, BioMed Ctr, Stem Cell Res Unit, Reykjavik, Iceland.	magnuskm@hi.is; tgudjons@hi.is	Franzdottir, Sigridur/M-2534-2015; Hilmarsdottir, Bylgja/AAV-7406-2020	Ingthorsson, Saevar/0000-0001-8480-9680; Magnusson, Magnus Karl/0000-0001-8593-4934; Steingrimsson, Eirikur/0000-0001-5826-7486; Sigurdsson, Valgardur/0000-0003-4146-7179; Gudjonsson, Thorarinn/0000-0001-9645-9665; Hilmarsdottir, Bylgja/0000-0001-8693-5541	Landspitali University Hospital Science Fund; University of Iceland Research Fund; Science and Technology Policy Council-Thematic program in postgenomic biomedicine; Science and Technology Policy Council Research fund; European Science Foundation (EuroCORES program, EuroSTELLS); Gongum saman a supporting group for breast cancer research in Iceland	Landspitali University Hospital Science Fund; University of Iceland Research Fund; Science and Technology Policy Council-Thematic program in postgenomic biomedicine; Science and Technology Policy Council Research fund; European Science Foundation (EuroCORES program, EuroSTELLS); Gongum saman a supporting group for breast cancer research in Iceland	This work was supported by grants from Landspitali University Hospital Science Fund, University of Iceland Research Fund, Science and Technology Policy Council-Thematic program in postgenomic biomedicine, Science and Technology Policy Council Research fund, European Science Foundation (EuroCORES program, EuroSTELLS), Gongum saman a supporting group for breast cancer research in Iceland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BRIAND P, 1987, IN VITRO CELL DEV B, V23, P181, DOI 10.1007/BF02623578; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Davies JA, 2002, BIOESSAYS, V24, P937, DOI 10.1002/bies.10161; Dillon C, 2004, J MAMMARY GLAND BIOL, V9, P207, DOI 10.1023/B:JOMG.0000037163.56461.1e; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Faratian D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023772; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Franzdottir SR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-162; Gray RS, 2010, CURR OPIN CELL BIOL, V22, P640, DOI 10.1016/j.ceb.2010.08.019; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Gutierrez C, 2011, ARCH PATHOL LAB MED, V135, P55, DOI 10.1043/2010-0454-RAR.1; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horowitz A, 2009, CIRC RES, V104, pE21, DOI 10.1161/CIRCRESAHA.108.191494; Hsu JCF, 2010, INT J ORAL SCI, V2, P117, DOI 10.4248/IJOS10042; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Ingthorsson Saevar, 2010, BMC Res Notes, V3, P184, DOI 10.1186/1756-0500-3-184; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Lu PF, 2006, J MAMMARY GLAND BIOL, V11, P213, DOI 10.1007/s10911-006-9027-z; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Miin Wong Esther Sook, 2006, V327, P61; Pechoux C, 1999, DEV BIOL, V206, P88, DOI 10.1006/dbio.1998.9133; Ronnov-Jessen L, 2009, TRENDS MOL MED, V15, P5, DOI 10.1016/j.molmed.2008.11.001; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Sigurdsson V, 2006, IN VITRO CELL DEV-AN, V42, P332; Sigurdsson V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023833; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Taniguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P896, DOI 10.1016/j.bbrc.2006.11.107; Tefft D, 2002, AM J PHYSIOL-LUNG C, V283, pL700, DOI 10.1152/ajplung.00372.2001; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	52	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60798	10.1371/journal.pone.0060798	http://dx.doi.org/10.1371/journal.pone.0060798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573284	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100104
J	Yuki, K; Bu, WM; Shimaoka, M; Eckenhoff, R				Yuki, Koichi; Bu, Weiming; Shimaoka, Motomu; Eckenhoff, Roderic			Volatile Anesthetics, Not Intravenous Anesthetic Propofol Bind to and Attenuate the Activation of Platelet Receptor Integrin alpha IIb beta 3	PLOS ONE			English	Article							ENDOSCOPIC SINUS SURGERY; GLYCOPROTEIN-IIB-IIIA; PERCUTANEOUS CORONARY INTERVENTION; SURGICAL CONDITIONS; GENERAL-ANESTHESIA; BLOOD-LOSS; IN-VITRO; SEVOFLURANE ANESTHESIA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS	Background: In clinical reports, the usage of isoflurane and sevoflurane was associated with more surgical field bleeding in endoscopic sinus surgeries as compared to propofol. The activation of platelet receptor alpha IIb beta 3 is a crucial event for platelet aggregation and clot stability. Here we studied the effect of isoflurane, sevoflurane, and propofol on the activation of alpha IIb beta 3. Methods: The effect of anesthetics on the activation of alpha IIb beta 3 was probed using the activation sensitive antibody PAC-1 in both cell-based (platelets and alpha IIb beta 3 transfectants) and cell-free assays. The binding sites of isoflurane on alpha IIb beta 3 were explored using photoactivatable isoflurane (azi-isoflurane). The functional implication of revealed isoflurane binding sites were studied using alanine-scanning mutagenesis. Results: Isoflurane and sevoflurane diminished the binding of PAC-1 to wild-type alpha IIb beta 3 transfectants, but not to the high-affinity mutant, beta 3-N305T. Both anesthetics also impaired PAC-1 binding in a cell-free assay. In contrast, propofol did not affect the activation of alpha IIb beta 3. Residues adducted by azi-isoflurane were near the calcium binding site (an important regulatory site termed SyMBS) just outside of the ligand binding site. The mutagenesis experiments demonstrated that these adducted residues were important in regulating integrin activation. Conclusions: Isoflurane and sevoflurane, but not propofol, impaired the activation of alpha IIb beta 3. Azi-isoflurane binds to the regulatory site of integrin alpha IIb beta 3, thereby suggesting that isoflurane blocks ligand binding of alpha IIb beta 3 in not a competitive, but an allosteric manner.	[Yuki, Koichi; Shimaoka, Motomu] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Bu, Weiming; Eckenhoff, Roderic] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shimaoka, Motomu] Mie Univ, Dept Mol Pathobiol & Cell Adhes Biol, Grad Sch Med, Tsu, Mie 514, Japan	Harvard University; Boston Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Mie University	Yuki, K (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA.	yuki.koichi@gmail.com		Eckenhoff, Roderic/0000-0002-5581-746X	National Institute of Health [P01GM55876, K08GM101345]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM101345, P01GM055876] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24590579] Funding Source: KAKEN	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is in part supported by the National Institute of Health, P01GM55876 and K08GM101345. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahn HJ, 2008, BRIT J ANAESTH, V100, P50, DOI 10.1093/bja/aem304; ALBANESE J, 1990, ANESTHESIOLOGY, V73, P214, DOI 10.1097/00000542-199008000-00004; Artoni A, 2004, P NATL ACAD SCI USA, V101, P13114, DOI 10.1073/pnas.0404201101; Baker EK, 1997, P NATL ACAD SCI USA, V94, P1973, DOI 10.1073/pnas.94.5.1973; BLACKWELL KE, 1993, AM J OTOLARYNG, V14, P262, DOI 10.1016/0196-0709(93)90072-F; Boersma E, 1999, CIRCULATION, V100, P2045, DOI 10.1161/01.CIR.100.20.2045; CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X; Dogan IV, 1999, ANESTH ANALG, V88, P432, DOI 10.1097/00000539-199902000-00039; Eberhart LHJ, 2003, LARYNGOSCOPE, V113, P1369, DOI 10.1097/00005537-200308000-00019; Eckenhoff R G, 2001, Mol Interv, V1, P258; Eckenhoff RG, ACS CHEM NEUROSCI, V1, P139; Eckenhoff RG, METHODS MOL BIOL, V617, P437; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; GEPTS E, 1987, EUR J ANAESTH, V4, P35; GINSBERG MH, 1990, BLOOD, V76, P2017; HIRAKATA H, 1995, ANESTH ANALG, V81, P114, DOI 10.1097/00000539-199507000-00023; Hirakata H, 1996, ANESTHESIOLOGY, V85, P1447, DOI 10.1097/00000542-199612000-00027; Horn NA, 2001, ANESTHESIOLOGY, V95, P1220, DOI 10.1097/00000542-200111000-00028; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Kleiman NS, 2000, CIRCULATION, V101, P751, DOI 10.1161/01.CIR.101.7.751; Law NL, 2001, BRIT J ANAESTH, V86, P94, DOI 10.1093/bja/86.1.94; Leclerc JR, 2002, CRIT CARE MED, V30, pS332, DOI 10.1097/00003246-200205001-00025; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Manola M, 2005, ORL-J OTO-RHIN-LARYN, V67, P83, DOI 10.1159/000084576; Michelson AD, 1996, BLOOD, V87, P4925, DOI 10.1182/blood.V87.12.4925.bloodjournal87124925; Nozuchi S, 2000, ANESTHESIOLOGY, V92, P164, DOI 10.1097/00000542-200001000-00028; Pan Y, P NATL ACAD SCI US, V107, P21388; Pavlin JD, 1999, AM J OTOLARYNG, V20, P96, DOI 10.1016/S0196-0709(99)90018-2; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; Raborn J, 2011, BIOCHEMISTRY-US, V50, P2084, DOI 10.1021/bi2000092; Scarborough RM, 2000, J MED CHEM, V43, P3453, DOI 10.1021/jm000022w; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; SHORT TG, 1994, BRIT J ANAESTH, V72, P302, DOI 10.1093/bja/72.3.302; Sivaci R, 2004, SAUDI MED J, V25, P1995; SMITH JW, 1990, J BIOL CHEM, V265, P12267; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Tirelli G, 2004, Acta Otorhinolaryngol Ital, V24, P137; Topol EJ, 1999, LANCET, V353, P227, DOI 10.1016/S0140-6736(98)11086-3; Tuerkan H SA, 1995, BRIT J ANAESTH, V74, pS81; UEDA I, 1971, ANESTHESIOLOGY, V34, P405, DOI 10.1097/00000542-197105000-00006; Wagner CL, 1996, BLOOD, V88, P907; Wormald PJ, 2005, AM J RHINOL, V19, P514, DOI 10.1177/194589240501900516; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yuki K, 2012, FASEB J; Yuki K, 2010, ANESTHESIOLOGY, V113, P600, DOI 10.1097/ALN.0b013e3181e89a77; Yuki K, 2008, FASEB J, V22, P4109, DOI 10.1096/fj.08-113324; Zhang HM, 2009, FASEB J, V23, P2735, DOI 10.1096/fj.09-129908; Zhu J, BLOOD, V116, P5050; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	52	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60415	10.1371/journal.pone.0060415	http://dx.doi.org/10.1371/journal.pone.0060415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573252	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100067
J	Brunsteiner, M; Flock, M; Nidetzky, B				Brunsteiner, Michael; Flock, Michaela; Nidetzky, Bernd			Structure Based Descriptors for the Estimation of Colloidal Interactions and Protein Aggregation Propensities	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; DIPOLE-MOMENTS; FREE-ENERGY; DATA-BANK; SOLUBILITY; PREDICTION; STABILITY; SURFACE; RATIONALIZATION; GENERATION	The control of protein aggregation is an important requirement in the development of bio-pharmaceutical formulations. Here a simple protein model is proposed that was used in molecular dynamics simulations to obtain a quantitative assessment of the relative contributions of proteins' net-charges, dipole-moments, and the size of hydrophobic or charged surface patches to their colloidal interactions. The results demonstrate that the strength of these interactions correlate with net-charge and dipole moment. Variation of both these descriptors within ranges typical for globular proteins have a comparable effect. By comparison no clear trends can be observed upon varying the size of hydrophobic or charged patches while keeping the other parameters constant. The results are discussed in the context of experimental literature data on protein aggregation. They provide a clear guide line for the development of improved algorithms for the prediction of aggregation propensities.	[Brunsteiner, Michael] Res Ctr Pharmaceut Engn, Graz, Austria; [Flock, Michaela] Graz Univ Technol, Inst Inorgan Chem, A-8010 Graz, Austria; [Brunsteiner, Michael; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria	Research Center for Pharmaceutical Engineering (RCPE); Graz University of Technology; Graz University of Technology	Nidetzky, B (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Brunsteiner, Michael/0000-0002-1149-7847; Nidetzky, Bernd/0000-0002-5030-2643; Flock, Michaela/0000-0002-2799-1479	FFG,(Osterreichische Forschungsf orderungsgesellschaft); Sandoz GmbH (Kundl, Austria)	FFG,(Osterreichische Forschungsf orderungsgesellschaft); Sandoz GmbH (Kundl, Austria)	This work was supported by the FFG,(Osterreichische Forschungsf orderungsgesellschaft). Land Steiermark, Steirische Wirtschaftsforderung (SFG) and A Sandoz GmbH (Kundl, Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially funded by Sandoz GmbH (Kundl, Austria, pharmaceutical company, www.sandoz.at). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agostini F, 2012, J MOL BIOL, V421, P237, DOI 10.1016/j.jmb.2011.12.005; ANTOSIEWICZ J, 1995, BIOPHYS J, V69, P1344, DOI 10.1016/S0006-3495(95)80001-9; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arosio P, 2012, BIOPHYS CHEM, V168, P19, DOI 10.1016/j.bpc.2012.05.004; Banks DD, 2012, J PHARM SCI-US, V101, P2720, DOI 10.1002/jps.23219; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bostrom M, 2003, BIOPHYS J, V85, P686, DOI 10.1016/S0006-3495(03)74512-3; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Chi EY, 2003, PROTEIN SCI, V12, P903, DOI 10.1110/ps.0235703; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Connolly BD, 2012, BIOPHYS J, V103, P69, DOI 10.1016/j.bpj.2012.04.047; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Elcock AH, 2001, BIOPHYS J, V80, P613, DOI 10.1016/S0006-3495(01)76042-0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Felder CE, 2007, NUCLEIC ACIDS RES, V35, pW512, DOI 10.1093/nar/gkm307; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2009, P NATL ACAD SCI USA, V106, P13296, DOI 10.1073/pnas.0902904106; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang ND, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3684893; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim YC, 2008, BRAIN BEHAV IMMUN, V22, P629; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kumar V, 2011, INT J PHARMACEUT, V421, P82, DOI 10.1016/j.ijpharm.2011.09.017; Lauer TM, 2012, J PHARM SCI-US, V101, P102, DOI 10.1002/jps.22758; Lehermayr C, 2011, J PHARM SCI-US, V100, P2551, DOI 10.1002/jps.22506; Li Y, 2010, J PHARM SCI-US, V99, P645, DOI 10.1002/jps.21869; Long WF, 2010, J COMPUT AID MOL DES, V24, P907, DOI 10.1007/s10822-010-9383-z; Lund M, 2003, BIOPHYS J, V85, P2940, DOI 10.1016/S0006-3495(03)74714-6; Makowski M, 2010, J PHYS CHEM B, V114, P993, DOI 10.1021/jp907794h; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pearlman R., 1996, FORMULATION CHARACTE; Persson BA, 2009, PHYS CHEM CHEM PHYS, V11, P8879, DOI 10.1039/b909179c; Price W Nicholson 2nd, 2011, Microb Inform Exp, V1, P6, DOI 10.1186/2042-5783-1-6; R Core Team, 2012, R LANG ENV STAT COMP; Randolph TW, 2012, J PHARM SCI; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Sahin E, 2010, J PHARM SCI-US, V99, P4830, DOI 10.1002/jps.22198; Samra HS, 2012, MOL PHARMACEUT, V9, P696, DOI 10.1021/mp200404c; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Stultz CM, 2004, J PHYS CHEM B, V108, P16525, DOI 10.1021/jp047126t; TAKASHIMA S, 1993, BIOPOLYMERS, V33, P59, DOI 10.1002/bip.360330107; TANAKA H, 1987, J CHEM PHYS, V86, P1512, DOI 10.1063/1.452188; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Thusberg J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/humu.20938; Topp EM, 2012, MOL PHARM, V9, P1; Trevino SR, 2007, J MOL BIOL, V366, P449, DOI 10.1016/j.jmb.2006.10.026; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Winzor DJ, 2004, ANAL BIOCHEM, V325, P1, DOI 10.1016/j.ab.2003.09.035; Yadav S, 2012, MOL PHARMACEUT, V9, P791, DOI 10.1021/mp200566k; Yadav S, 2012, J PHARM SCI-US, V101, P998, DOI 10.1002/jps.22831; Yadav S, 2011, PHARM RES-DORDR, V28, P1973, DOI 10.1007/s11095-011-0424-7; Yeh IC, 1999, J CHEM PHYS, V111, P3155, DOI 10.1063/1.479595	65	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59797	10.1371/journal.pone.0059797	http://dx.doi.org/10.1371/journal.pone.0059797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565169	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300038
J	Derbidge, R; Feiten, L; Conradt, O; Heusser, P; Baumgartner, S				Derbidge, Renatus; Feiten, Linus; Conradt, Oliver; Heusser, Peter; Baumgartner, Stephan			Assessment of Shape Changes of Mistletoe Berries: A New Software Approach to Automatize the Parameterization of Path Curve Shaped Contours	PLOS ONE			English	Article								Photographs of mistletoe (Viscum album L.) berries taken by a permanently fixed camera during their development in autumn were subjected to an outline shape analysis by fitting path curves using a mathematical algorithm from projective geometry. During growth and maturation processes the shape of mistletoe berries can be described by a set of such path curves, making it possible to extract changes of shape using one parameter called Lambda. Lambda describes the outline shape of a path curve. Here we present methods and software to capture and measure these changes of form over time. The present paper describes the software used to automatize a number of tasks including contour recognition, optimization of fitting the contour via hill-climbing, derivation of the path curves, computation of Lambda and blinding the pictures for the operator. The validity of the program is demonstrated by results from three independent measurements showing circadian rhythm in mistletoe berries. The program is available as open source and will be applied in a project to analyze the chronobiology of shape in mistletoe berries and the buds of their host trees.	[Derbidge, Renatus; Heusser, Peter; Baumgartner, Stephan] Univ Witten Herdecke, Ctr Integrat Med, Witten, Germany; [Derbidge, Renatus] Goetheanum, Sci Sect, Res Inst, Dornach, Switzerland; [Feiten, Linus] Univ Freiburg, Fac Engn, Chair Comp Architecture, D-79106 Freiburg, Germany; [Conradt, Oliver] Goetheanum, Sect Math & Astron, Dornach, Switzerland; [Baumgartner, Stephan] Soc Canc Res, Hiscia Inst, Arlesheim, Switzerland	Witten Herdecke University; University of Freiburg	Derbidge, R (corresponding author), Univ Witten Herdecke, Ctr Integrat Med, Witten, Germany.	renatus.derbidge@goetheanum.ch	Feiten, Linus/Z-6331-2019		"Software AG Stiftung", Darmstadt, Germany; "Hiscia Institute", Society for Cancer Research, Arlesheim, Switzerland	"Software AG Stiftung", Darmstadt, Germany; "Hiscia Institute", Society for Cancer Research, Arlesheim, Switzerland	This paper is part of a research project funded by the "Software AG Stiftung", Darmstadt, Germany (http://www.software-ag-stiftung.com/) and the "Hiscia Institute", Society for Cancer Research, Arlesheim, Switzerland (http://www.vfk.ch/hiscia/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almon C., 1994, OPEN SYST INF DYN, V2, P265; [Anonymous], DIST TRANSF MISC IM; [Anonymous], 2012, FIND CONT STRUCT AN; Arber A., 1950, NATURAL PHILOS PLANT; Baumgartner S., 2004, ARCHETYPE, V10, P1; Chambers J. M., 1983, GRAPHICAL METHODS DA, P94; de Boer L, 2004, MATH PHYS KORRESPOND, V219, P4; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Edwards L., 2003, PROJECTIVE GEOMETRY; Edwards L., 2006, VORTEX LIFE NATURES; Fluckiger H., 2003, ARCHETYPE, V9, P1; Kappraff J, 2002, MEASURE GUIDED TOUR; Klein F, 2006, LECT NONEUCLIDEAN GE; Klein F, 2006, INTRO HIGHER GEOMETR; Sonder G, 1993, ELEMENTE NATURWISSEN, V58, P37	15	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60522	10.1371/journal.pone.0060522	http://dx.doi.org/10.1371/journal.pone.0060522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565255	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300126
J	Gong, WF; Zhong, JH; Xiang, BD; Ma, L; You, XM; Zhang, QM; Li, LQ				Gong, Wen-Feng; Zhong, Jian-Hong; Xiang, Bang-De; Ma, Liang; You, Xue-Mei; Zhang, Qiu-Ming; Li, Le-Qun			Single Nucleotide Polymorphism 8q24 rs13281615 and Risk of Breast Cancer: Meta-Analysis of More than 100,000 Cases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; CHINESE; SNPS; MORTALITY; ALLELES; TRENDS; BRCA2; FGFR2	Background: The onset and progression of breast cancer (BC) is influenced by many factors, including the single nucleotide polymorphism (SNP) rs13281615 at 8q24. However, studies of the potential association between rs13281615 at 8q24 and risk of BC have given inconsistent results. We performed a meta-analysis to address this controversy. Methods: PubMed, EMBASE and the Chinese National Knowledge Infrastructure databases were systematically searched to identify relevant studies. Two curators independently extracted data, and odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated to assess the strength of the association between rs13281615 at 8q24 and risk of BC. Results: Fourteen studies are included in the meta-analysis, involving 44,283 cases (5,170 Chinese and 39,113 mixed) and 55,756 controls (5,589 Chinese and 50,167 mixed). The GG and G-allele genotypes of rs13281615 at 8q24 are significantly associated with increased risk of BC (GG vs. AG+AA, OR 1.13, 95% CI 1.08-1.19, P<0.001; G-allele vs. A-allele, OR 1.10, 95% CI 1.06-1.14, P<0.001; GG vs. AA, OR 1.20, 95% CI 1.12-1.29, P<0.001). Conversely, the AA genotype is significantly associated with decreased risk of BC (AA vs. AG+GG, OR 0.89, 95% CI 0.84-0.93, P<0.001). Conclusion: G-allele genotypes of rs13281615 at 8q24 polymorphism are a risk factor for developing BC, while the AA genotype is a protective factor. Further large and well-designed studies are required to confirm this conclusion.	[Gong, Wen-Feng; Zhong, Jian-Hong; Xiang, Bang-De; Ma, Liang; You, Xue-Mei; Li, Le-Qun] Guangxi Med Univ, Tumor Hosp, Dept Surg Oncol, Nanning, Peoples R China; [Zhang, Qiu-Ming] Guangxi Med Univ, Affiliated Hosp 10, Ward Senior Dept, Qinzhou, Peoples R China	Guangxi Medical University; Guangxi Medical University	Li, LQ (corresponding author), Guangxi Med Univ, Tumor Hosp, Dept Surg Oncol, Nanning, Peoples R China.	xitongpingjia@163.com	Zhong, Jian-Hong/D-6641-2018; li, li/HII-4157-2022; Li, Li/AEM-3636-2022; LI, LI QING/GRR-8855-2022; LI, LI/GVS-5344-2022	Zhong, Jian-Hong/0000-0002-1494-6396; 	National Natural Science Foundation of China [81160262/H1602]; Guangxi Natural Science Foundation [2011GXNSFD018032]; Ministry of Health of Guangxi Province [Z2012345]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Ministry of Health of Guangxi Province	This work was supported by the grants from the National Natural Science Foundation of China (Project No: 81160262/H1602) and Guangxi Natural Science Foundation (Project No: 2011GXNSFD018032) to Le-Qun Li, and the Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province (Project No: Z2012345) to Jian-Hong Zhong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2009, HUM MOL GENET, V18, P4442, DOI 10.1093/hmg/ddp372; Berclaz G, 2004, ANN ONCOL, V15, P875, DOI 10.1093/annonc/mdh222; Campa D, 2011, JNCI-J NATL CANCER I, V103, P1252, DOI 10.1093/jnci/djr265; Chan M, 2012, BREAST CANCER RES TR, V136, P209, DOI 10.1007/s10549-012-2234-y; Cheung KL, 2007, BREAST, V16, P327, DOI 10.1016/j.breast.2007.03.004; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fletcher O, 2008, CANCER EPIDEM BIOMAR, V17, P702, DOI 10.1158/1055-9965.EPI-07-2564; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Gorodnova TV, 2010, CANCER GENET CYTOGEN, V199, P69, DOI 10.1016/j.cancergencyto.2010.01.020; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hankinson SE, 2008, ADV EXP MED BIOL, V617, P161, DOI 10.1007/978-0-387-69080-3_15; Harlid S, 2012, BRIT J CANCER, V106, P389, DOI 10.1038/bjc.2011.461; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang YD, 2011, BREAST CANCER RES TR, V128, P251, DOI 10.1007/s10549-010-1327-8; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Long JR, 2010, CANCER EPIDEM BIOMAR, V19, P2357, DOI 10.1158/1055-9965.EPI-10-0054; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; Mcinerney N, 2009, BREAST CANCER RES TR, V117, P151, DOI 10.1007/s10549-008-0235-7; Meyer A, 2009, UROL ONCOL-SEMIN ORI, V27, P373, DOI 10.1016/j.urolonc.2008.04.010; Pabalan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032389; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Saadat M, 2012, CANCER EPIDEMIOL, V36, pE101, DOI 10.1016/j.canep.2011.10.015; Shan JX, 2012, BREAST CANCER RES TR, V135, P715, DOI 10.1007/s10549-012-2202-6; Silva ID, 2008, PLOS MED, V5, P1372, DOI 10.1371/journal.pmed.0050193; Smigal C, 2006, CA-CANCER J CLIN, V56, P168, DOI 10.3322/canjclin.56.3.168; Sole X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-12; Sturgeon SR, 2004, CANCER CAUSE CONTROL, V15, P987, DOI 10.1007/s10552-004-1092-2; Tamimi RM, 2010, CANCER CAUSE CONTROL, V21, P689, DOI 10.1007/s10552-009-9496-7; Teraoka SN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3057; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; Zaman Khalil, 2012, Rev Med Suisse, V8, P1101; Zhao EJ, 2012, MOL BIOL REP, V39, P3471, DOI 10.1007/s11033-011-1119-1; Ziv E, 2006, CANCER EPIDEM BIOMAR, V15, P1878, DOI 10.1158/1055-9965.EPI-06-0092; 李莉华, 2011, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V34, P73	36	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60108	10.1371/journal.pone.0060108	http://dx.doi.org/10.1371/journal.pone.0060108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565189	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300058
J	Paz, N; Zabala, A; Royo, F; Garcia-Orad, A; Zugaza, JL; Parada, LA				Paz, Nerea; Zabala, Amaia; Royo, Felix; Garcia-Orad, Africa; Zugaza, Jose L.; Parada, Luis A.			Combined Fluorescent-Chromogenic In Situ Hybridization for Identification and Laser Microdissection of Interphase Chromosomes	PLOS ONE			English	Article							GENOME ORGANIZATION; EXPRESSION; FISH	Chromosome territories constitute the most conspicuous feature of nuclear architecture, and they exhibit non-random distribution patterns in the interphase nucleus. We observed that in cell nuclei from humans with Down Syndrome two chromosomes 21 frequently localize proximal to one another and distant from the third chromosome. To systematically investigate whether the proximally positioned chromosomes were always the same in all cells, we developed an approach consisting of sequential FISH and CISH combined with laser-microdissection of chromosomes from the interphase nucleus and followed by subsequent chromosome identification by microsatellite allele genotyping. This approach identified proximally positioned chromosomes from cultured cells, and the analysis showed that the identity of the chromosomes proximally positioned varies. However, the data suggest that there may be a tendency of the same chromosomes to be positioned close to each other in the interphase nucleus of trisomic cells. The protocol described here represents a powerful new method for genome analysis.	[Paz, Nerea; Garcia-Orad, Africa] Univ Basque Country, Fac Med & Dent, Dept Genet, Leioa, Spain; [Zabala, Amaia; Royo, Felix] CIC BioGUNE CIBERehd, Derio, Spain; [Zugaza, Jose L.] Univ Basque Country, Fac Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Zugaza, Jose L.] Achucarro Basque Ctr Neurosci, Zamudio, Spain; [Parada, Luis A.] UNSa CONICET, Inst Expt Pathol, Salta, Argentina; [Zugaza, Jose L.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; University of Basque Country; Basque Foundation for Science	Parada, LA (corresponding author), UNSa CONICET, Inst Expt Pathol, Salta, Argentina.	lparada@unsa.edu.ar	Royo, Felix/ABE-8064-2021; Zabala, Amaia/AAA-4172-2019; Royo, Felix/A-7198-2015; Bustelo, Xose R./A-9526-2010	Royo, Felix/0000-0001-9769-4165; Zabala, Amaia/0000-0003-2088-5195; Royo, Felix/0000-0001-9769-4165; Bustelo, Xose R./0000-0001-9398-6072; Garcia.Orad, Africa/0000-0002-5575-3080; ZUGAZA GURRUCHAGA, JOSE LUIS/0000-0003-2287-6671	Research Council of the University of Salta [2064-2012]; Argentine Agency for Science and Technology [PICT2011-1897]; Basque Government [IT-463-07, 2006111015]	Research Council of the University of Salta; Argentine Agency for Science and Technology; Basque Government(Basque Government)	This work was supported by funding from the Research Council of the University of Salta (PNo2064-2012); Argentine Agency for Science and Technology (PICT2011-1897) to LAP; Basque Government (IT-463-07; 2006111015) to AG-O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Goetze S, 2007, SEMIN CELL DEV BIOL, V18, P707, DOI 10.1016/j.semcdb.2007.08.007; Gribble S, 2004, CHROMOSOME RES, V12, P143, DOI 10.1023/B:CHRO.0000013167.12527.f0; Laakso M, 2006, J PATHOL, V210, P3, DOI 10.1002/path.2022; Langer S, 2005, LAB INVEST, V85, P582, DOI 10.1038/labinvest.3700249; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Ma L, 2010, NAT METHODS, V7, P299, DOI [10.1038/NMETH.1443, 10.1038/nmeth.1443]; Mann K, 2004, EUR J HUM GENET, V12, P907, DOI 10.1038/sj.ejhg.5201224; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Nagele RG, 1998, CHROMOSOMA, V107, P330, DOI 10.1007/s004120050315; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Parada LA, 2004, EXP CELL RES, V296, P64, DOI 10.1016/j.yexcr.2004.03.013; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Royo F, 2009, CHROMOSOMA, V118, P711, DOI 10.1007/s00412-009-0229-1; Schermelleh L, 1999, BIOTECHNIQUES, V27, P362, DOI 10.2144/99272rr04; Tanner M, 2000, AM J PATHOL, V157, P1467, DOI 10.1016/S0002-9440(10)64785-2; Teller K, 2007, P NATL ACAD SCI USA, V104, P14970, DOI 10.1073/pnas.0704285104; Volpi EV, 2008, BIOTECHNIQUES, V45, P385, DOI 10.2144/000112811; Weise A, 2008, EXPERT REV MOL DIAGN, V8, P355, DOI 10.1586/14737159.8.4.355; Zhou RN, 2007, CURR GENOMICS, V8, P67, DOI 10.2174/138920207780076929	24	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60238	10.1371/journal.pone.0060238	http://dx.doi.org/10.1371/journal.pone.0060238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565206	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300075
J	Tian, R; Fu, M; Zhang, Z; Ren, J; An, JG; Liu, YF; Li, W				Tian, Rong; Fu, Meng; Zhang, Zhuo; Ren, Jing; An, Jingang; Liu, Yufeng; Li, Wei			In Situ IgM Production and Clonal Expansion of B-1 Cells in Peritoneal Cavity Promote Elimination of C. albicans Infection in IgH Transgenic Mice with V-H Derived from a Natural Antibody	PLOS ONE			English	Article							POSITIVE SELECTION; IMMUNOGLOBULIN-M; MARGINAL ZONE; B-CELLS; PHAGOCYTOSIS; CANDIDIASIS; IDENTIFICATION; PRECURSORS; DEFENSE; GUT	B-1 cells are innate-like cells that play important roles in host defense against infection. However, the function of B-1 cells in fungi infection remains unclear. Previously we produced IgH transgenic mice TgV(H)3B4 with V-H derived from a natural antibody 3B4 that can identify C. albicans, and found that TgV(H)3B4 mice were resistant to intraperitoneal (i.p.) and intravenous C. albicans infection. Most of the peritoneal cavity (PEC) B-1 cells in TgV(H)3B4 mice express transgenic BCR that binds C. albicans. In the present study, we explored the response of B-1 cells to C. albicans infection by applying i.p. inoculation of fungi in TgV(H)3B4 mice. We found that C. albicans was cleared more efficiently in TgV(H)3B4 mice after i.p. inoculation than that of littermate control. The level of C. albicans-reactive IgM in PEC of TgV(H)3B4 mice was much higher than that of control, and the number of B-1a B cells was also elevated in TgV(H)3B4 mice, which was mainly due to enhanced proliferation of B-1 cells. Additionally, numbers of C. albicans-specific B cells increased greatly in TgV(H)3B4 mice after C. albicans inoculation. Our data suggested that in situ IgM production and clonal expansion of B-1 cells in PEC participate in host defense against C. albicans infection.	[Tian, Rong; Li, Wei] Gen Hosp AF, Dept Dermatol, Beijing, Peoples R China; [Tian, Rong; Fu, Meng; Ren, Jing; An, Jingang; Liu, Yufeng; Li, Wei] Xijing Hosp, Dept Dermatol, Xian, Peoples R China; [Zhang, Zhuo] Tangdu Hosp, Dept Neurol, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Li, W (corresponding author), Gen Hosp AF, Dept Dermatol, Beijing, Peoples R China.	liwei1@fmmu.edu.cn			National Natural Science Foundation of China [30771949, 31070793, 30872299, 30972641]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (30771949 and 31070793 for W. Li; 30872299 and 30972641 for Y.F. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Belperron AA, 2001, INFECT IMMUN, V69, P6456, DOI 10.1128/IAI.69.10.6456-6462.2001; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Binder CJ, 2005, J LIPID RES, V46, P1353, DOI 10.1194/jlr.R500005-JLR200; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Fu M, 2007, APOPTOSIS, V12, P355, DOI 10.1007/s10495-006-0581-z; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hayakawa K, 2003, J EXP MED, V197, P87, DOI 10.1084/jem.20021459; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Janeway CA, 2001, IMMUNOBIOLOGY; Kawahara T, 2003, J IMMUNOL, V171, P5406, DOI 10.4049/jimmunol.171.10.5406; Kozel TR, 2004, INFECT IMMUN, V72, P209, DOI 10.1128/IAI.72.1.209-218.2004; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Lepper PM, 2003, FEMS IMMUNOL MED MIC, V35, P93, DOI 10.1016/S0928-8244(02)00459-5; Li W, 2007, CELL MICROBIOL, V9, P306, DOI 10.1111/j.1462-5822.2006.00786.x; MAITI PK, 1985, MYCOPATHOLOGIA, V91, P79, DOI 10.1007/BF00436540; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Paciorkowski N, 2000, J EXP MED, V191, P731, DOI 10.1084/jem.191.4.731; Quintana FJ, 2004, BIOMED PHARMACOTHER, V58, P276, DOI 10.1016/j.biopha.2004.04.011; Rowley B, 2007, J AUTOIMMUN, V29, P236, DOI 10.1016/j.jaut.2007.07.020; Shibuya A, 2000, NAT IMMUNOL, V1, P441, DOI 10.1038/80886; Taborda CP, 2002, IMMUNITY, V16, P791, DOI 10.1016/S1074-7613(02)00328-X; Wagner RD, 1996, J INFECT DIS, V174, P589, DOI 10.1093/infdis/174.3.589; Wen LJ, 2005, J IMMUNOL, V174, P6918, DOI 10.4049/jimmunol.174.11.6918; Xing Y, 2009, MOL IMMUNOL, V46, P1120, DOI 10.1016/j.molimm.2008.10.031; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zhang MX, 2006, INFECT IMMUN, V74, P362, DOI 10.1128/IAI.74.1.362-369.2006; Zhang MX, 1997, INFECT IMMUN, V65, P3822, DOI 10.1128/IAI.65.9.3822-3827.1997	33	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60779	10.1371/journal.pone.0060779	http://dx.doi.org/10.1371/journal.pone.0060779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565274	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300146
J	Wu, CS; Chen, HM; Sun, H; Zhu, J; Jew, CP; Wager-Miller, J; Straiker, A; Spencer, C; Bradshaw, H; Mackie, K; Lu, HC				Wu, Chia-Shan; Chen, Hongmei; Sun, Hao; Zhu, Jie; Jew, Chris P.; Wager-Miller, James; Straiker, Alex; Spencer, Corinne; Bradshaw, Heather; Mackie, Ken; Lu, Hui-Chen			GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination	PLOS ONE			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; N-ARACHIDONOYL GLYCINE; CANNABINOID RECEPTOR; ENDOGENOUS CANNABINOIDS; METABOTROPIC GLUTAMATE; TYROSINE-HYDROXYLASE; PREPULSE INHIBITION; SENSORY NEURONS; NERVOUS-SYSTEM; PURKINJE-CELLS	The G-protein coupled receptor 55 (GPR55) is activated by lysophosphatidylinositols and some cannabinoids. Recent studies found prominent roles for GPR55 in neuropathic/inflammatory pain, cancer and bone physiology. However, little is known about the role of GPR55 in CNS development and function. To address this question, we performed a detailed characterization of GPR55 knockout mice using molecular, anatomical, electrophysiological, and behavioral assays. Quantitative PCR studies found that GPR55 mRNA was expressed (in order of decreasing abundance) in the striatum, hippocampus, forebrain, cortex, and cerebellum. GPR55 deficiency did not affect the concentrations of endocannabinoids and related lipids or mRNA levels for several components of the endocannabinoid system in the hippocampus. Normal synaptic transmission and short-term as well as long-term synaptic plasticity were found in GPR55 knockout CA1 pyramidal neurons. Deleting GPR55 function did not affect behavioral assays assessing muscle strength, gross motor skills, sensory-motor integration, motor learning, anxiety or depressive behaviors. In addition, GPR55 null mutant mice exhibited normal contextual and auditory-cue conditioned fear learning and memory in a Pavlovian conditioned fear test. In contrast, when presented with tasks requiring more challenging motor responses, GPR55 knockout mice showed impaired movement coordination. Taken together, these results suggest that GPR55 plays a role in motor coordination, but does not strongly regulate CNS development, gross motor movement or several types of learned behavior.	[Wu, Chia-Shan; Chen, Hongmei; Sun, Hao; Zhu, Jie; Jew, Chris P.; Lu, Hui-Chen] Baylor Coll Med, Cain Fdn Labs, Houston, TX 77030 USA; [Wu, Chia-Shan; Chen, Hongmei; Sun, Hao; Zhu, Jie; Jew, Chris P.; Spencer, Corinne; Lu, Hui-Chen] Texas Childrens Hosp, Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Wu, Chia-Shan; Chen, Hongmei; Sun, Hao; Zhu, Jie; Jew, Chris P.; Lu, Hui-Chen] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lu, Hui-Chen] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Lu, Hui-Chen] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Spencer, Corinne] Baylor Coll Med, Dept Genet, Houston, TX 77030 USA; [Wager-Miller, James; Straiker, Alex; Bradshaw, Heather; Mackie, Ken] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Indiana University System; Indiana University Bloomington	Lu, HC (corresponding author), Baylor Coll Med, Cain Fdn Labs, Houston, TX 77030 USA.	hclu@bcm.edu	Wu, Chia Shan/AAH-7825-2020; Sun, Hao/F-7926-2013	Wu, Chia Shan/0000-0002-6034-939X; Sun, Hao/0000-0002-3670-2886	NIH [DA029381, HD065561, NS048884, DA011322, DA021696]; NARSAD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029381, R01DA011322, R01DA021285, K05DA021696] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by the NIH DA029381 (HCL, KM), HD065561 (HCL, KM), NS048884 (HCL), DA011322 (KM), DA021696 (KM), and NARSAD (HCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; BLANCHARD V, 1994, MOL BRAIN RES, V22, P29, DOI 10.1016/0169-328X(94)90029-9; Bradshaw HB, 2006, AM J PHYSIOL-REG I, V291, pR349, DOI 10.1152/ajpregu.00933.2005; Bradshaw HB, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-14; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Diaz-Arteaga A, 2012, DIABETES OBES METAB, V14, P234, DOI 10.1111/j.1463-1326.2011.01515.x; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; DRMOTA T, 2004, SCREENING ASSAYS CAN; Flores JM, 2012, ONCOGENE; Geyer MA, 2002, MOL PSYCHIATR, V7, P1039, DOI 10.1038/sj.mp.4001159; Hardisty-Hughes RE, 2010, NAT PROTOC, V5, P177, DOI 10.1038/nprot.2009.204; Henstridge CM, 2012, PHARMACOLOGY, V89, P179, DOI 10.1159/000336872; Henstridge CM, 2011, MOL ENDOCRINOL, V25, P1835, DOI 10.1210/me.2011-1197; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Hu G, 2011, ONCOGENE, V30, P139, DOI 10.1038/onc.2010.502; Idris AI, 2010, CALCIFIED TISSUE INT, V87, P285, DOI 10.1007/s00223-010-9378-8; Ito M, 1984, CEREBELLUM NEURAL CO; Jensen TP, 2011, NEUR M PLANN; Johns DG, 2007, BRIT J PHARMACOL, V152, P825, DOI 10.1038/sj.bjp.0707419; Kamens HM, 2007, NAT PROTOC, V2, P277, DOI 10.1038/nprot.2007.19; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kishimoto Y, 2006, J NEUROSCI, V26, P8829, DOI 10.1523/JNEUROSCI.1236-06.2006; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kress M, 2009, EXP BRAIN RES, V196, P79, DOI 10.1007/s00221-009-1762-0; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Mangleri RA, 2007, PHARMACOL RES, V56, P360, DOI 10.1016/j.phrs.2007.09.003; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; MASSERANO JM, 1983, MOL CELL BIOCHEM, V53-4, P129; McHugh D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-44; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Milman G, 2006, P NATL ACAD SCI USA, V103, P2428, DOI 10.1073/pnas.0510676103; Minasyan A, 2009, J STEROID BIOCHEM, V114, P161, DOI 10.1016/j.jsbmb.2009.01.020; Neumann S, 1996, NATURE, V384, P360, DOI 10.1038/384360a0; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; O'Leary D, 2010, EUR J NEUROSCI; Oesch S, 2009, J PHARM PHARMACOL, V61, P839, DOI 10.1211/jpp/61.07.0002; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Patent U, 2003, IDENTIFICATION MODUL; Pau H, 2004, OTOL NEUROTOL, V25, P707, DOI 10.1097/00129492-200409000-00010; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Paylor R, 1998, LEARN MEMORY, V5, P302; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rimmerman N, 2008, MOL PHARMACOL, V74, P213, DOI 10.1124/mol.108.045997; Romero-Zerbo SY, 2011, J ENDOCRINOL, V211, P177, DOI 10.1530/JOE-11-0166; Ross RA, 2011, TRENDS PHARMACOL SCI, V32, P265, DOI 10.1016/j.tips.2011.01.005; Ruscheweyh R, 2007, J COMP NEUROL, V502, P325, DOI 10.1002/cne.21311; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Safo PK, 2006, CEREBELLUM, V5, P134, DOI 10.1080/14734220600791477; Sawzdargo M, 1999, MOL BRAIN RES, V64, P193, DOI 10.1016/S0169-328X(98)00277-0; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Smoum R, 2010, P NATL ACAD SCI USA, V107, P17710, DOI 10.1073/pnas.0912479107; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Straiker A, 2005, J PHYSIOL-LONDON, V569, P501, DOI 10.1113/jphysiol.2005.091918; Sylantyev S, 2011, NEUR M PLANN; Tritto T, 2004, NICOTINE TOB RES, V6, P145, DOI 10.1080/14622200310001656966; Watanabe K, 1999, BIOL PHARM BULL, V22, P366; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Yoshida T, 2002, J NEUROSCI, V22, P1690, DOI 10.1523/JNEUROSCI.22-05-01690.2002	68	77	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60314	10.1371/journal.pone.0060314	http://dx.doi.org/10.1371/journal.pone.0060314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565223	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300093
J	Yu, K; Zhang, T				Yu, Ke; Zhang, Tong			Construction of Customized Sub-Databases from NCBI-nr Database for Rapid Annotation of Huge Metagenomic Datasets Using a Combined BLAST and MEGAN Approach	PLOS ONE			English	Article							SEQUENCES; RESOURCE	We developed a fast method to construct local sub-databases from the NCBI-nr database for the quick similarity search and annotation of huge metagenomic datasets based on BLAST-MEGAN approach. A three-step sub-database annotation pipeline (SAP) was further proposed to conduct the annotation in a much more time-efficient way which required far less computational capacity than the direct NCBI-nr database BLAST-MEGAN approach. The 1st BLAST of SAP was conducted using the original metagenomic dataset against the constructed sub-database for a quick screening of candidate target sequences. Then, the candidate target sequences identified in the 1st BLAST were subjected to the 2nd BLAST against the whole NCBI-nr database. The BLAST results were finally annotated using MEGAN to filter out those mistakenly selected sequences in the 1st BLAST to guarantee the accuracy of the results. Based on the tests conducted in this study, SAP achieved a speedup of similar to 150-385 times at the BLAST e-value of 1e-5, compared to the direct BLAST against NCBI-nr database. The annotation results of SAP are exactly in agreement with those of the direct NCBI-nr database BLAST-MEGAN approach, which is very time-consuming and computationally intensive. Selecting rigorous thresholds (e. g. e-value of 1e-10) would further accelerate SAP process. The SAP pipeline may also be coupled with novel similarity search tools (e. g. RAPsearch) other than BLAST to achieve even faster annotation of huge metagenomic datasets. Above all, this sub-database construction method and SAP pipeline provides a new time-efficient and convenient annotation similarity search strategy for laboratories without access to high performance computing facilities. SAP also offers a solution to high performance computing facilities for the processing of more similarity search tasks.	[Yu, Ke; Zhang, Tong] Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Zhang, T (corresponding author), Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China.	zhangt@hku.hk	Zhang, Tong/HGC-1090-2022; 張彤, Tong Zhang/C-6786-2008	Zhang, Tong/0000-0003-1148-4322	Research Grants Council of the Hong Kong Special Administrative Region, China [HKU7190/12E]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work described in this paper was substantially supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. HKU7190/12E). No additional external funding received for this study.	Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Li Ming, 2004, J Bioinform Comput Biol, V2, P417, DOI 10.1142/S0219720004000661; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Scholz MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/j.copbio.2011.11.013; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Tamaki H, 2012, ENVIRON MICROBIOL, V14, P441, DOI 10.1111/j.1462-2920.2011.02630.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	18	34	35	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59831	10.1371/journal.pone.0059831	http://dx.doi.org/10.1371/journal.pone.0059831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573212	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900028
J	Novakova, J; Flegr, J				Novakova, Julie; Flegr, Jaroslav			How Much Is Our Fairness Worth? The Effect of Raising Stakes on Offers by Proposers and Minimum Acceptable Offers in Dictator and Ultimatum Games	PLOS ONE			English	Article							SIZE MATTER; ALLOCATION; BEHAVIOR; RISK	Background: The aim of this study was to determine whether people respond differently to low and high stakes in Dictator and Ultimatum Games. We assumed that if we raised the stakes high enough, we would observe more self-orientated behavior because fairness would become too costly, in spite of a possible risk of a higher punishment. Methods: A questionnaire was completed by a sample of 524 university students of biology. A mixed linear model was used to test the relation between the amount at stake (CZK 20, 200, 2,000, 20,000 and 200,000, i.e., approximately $1-$10,000) and the shares, as well as the subjects' gender and the design of the study (single vs. multiple games for different amounts). Results: We have discovered a significant relationship between the amount at stake and the minimum acceptable offer in the Ultimatum Game and the proposed shares in both Ultimatum and Dictator Games (p = 0.001, p<0.001, p = 0.0034). The difference between playing a single game or more games with several amounts at stake did not influence the relation between the stakes and the offered and minimum acceptable shares. Women proved significantly more generous than men in their offers in the Dictator Game (p = 0.007). Conclusion: Our results suggest that people's behavior in the Dictator and Ultimatum Games depends on the amount at stake. The players tended to lower their relative proposed shares, as well as their relative minimum acceptable offers. We propose that the Responders' sense of equity and fair play depends on the stakes because of the costs of maintaining fairness. However, our results also suggest that the price of fairness is very high and that it is very difficult, probably even impossible, to buy the transition of Homo sociologicus into Homo economicus.	[Novakova, Julie; Flegr, Jaroslav] Charles Univ Prague, Fac Sci, Dept Biol, Prague, Czech Republic	Charles University Prague	Novakova, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Biol, Prague, Czech Republic.	julie.novakova@gmail.com	Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126; Nekola Novakova, Julie/0000-0002-1984-9739	Charles University in Prague [UNCE 204004]	Charles University in Prague	This research was funded by Charles University in Prague project UNCE 204004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; Andersen S, 2011, AM ECON REV, V101, P3427, DOI 10.1257/aer.101.7.3427; Bekkers R., 2007, SURVEY RES METHODS, V1, P139, DOI DOI 10.18148/SRM/2007.V1I3.54; Bekkers R, 2006, NONPROF VOLUNT SEC Q, V35, P533, DOI 10.1177/0899764006288286; BINSWANGER HP, 1980, AM J AGR ECON, V62, P395, DOI 10.2307/1240194; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Brown E, 2005, GIFTS TIME MONEY ROL; CAMERER C, 1995, J ECON PERSPECT, V9, P209, DOI 10.1257/jep.9.2.209; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Camerer CF, 1999, J RISK UNCERTAINTY, V19, P7, DOI 10.1023/A:1007850605129; Cameron LA, 1999, ECON INQ, V37, P47, DOI 10.1111/j.1465-7295.1999.tb01415.x; Carpenter J, 2005, ECON LETT, V86, P393, DOI 10.1016/j.econlet.2004.08.007; Eckel CC, 2001, ECON INQ, V39, P171, DOI 10.1093/ei/39.2.171; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Falk A, 2003, ECON INQ, V41, P20, DOI 10.1093/ei/41.1.20; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Flegr J, 2010, NEUROENDOCRINOL LETT, V31, P577; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Guth W, 1998, J MATH PSYCHOL, V42, P227, DOI 10.1006/jmps.1998.1212; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hertwig R, 2001, BEHAV BRAIN SCI, V24, P383, DOI 10.1017/S0140525X01004149; Hoffman E, 1996, INT J GAME THEORY, V25, P289, DOI 10.1007/BF02425259; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Johansson-Stenman O, 2005, ECON LETT, V88, P365, DOI 10.1016/j.econlet.2005.03.007; Kagel JH, 1996, GAME ECON BEHAV, V13, P100, DOI 10.1006/game.1996.0026; KAHNEMAN D, 1986, AM ECON REV, V76, P728; Kocher MG, 2008, ECON LETT, V99, P508, DOI 10.1016/j.econlet.2007.09.048; Levine DK, 1998, REV ECON DYNAM, V1, P593; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Lindova J, 2010, FOLIA PARASIT, V57, P136, DOI 10.14411/fp.2010.017; List JA, 2008, J ECON BEHAV ORGAN, V65, P1, DOI 10.1016/j.jebo.2003.09.021; Munier B, 2002, THEOR DECIS, V53, P187, DOI 10.1023/A:1022815832351; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; RABIN M, 1993, AM ECON REV, V83, P1281; Rotemberg JJ, 2008, J ECON BEHAV ORGAN, V66, P457, DOI 10.1016/j.jebo.2006.06.008; ROTH AE, 1995, GAME ECON BEHAV, V8, P164, DOI 10.1016/S0899-8256(05)80020-X; Slonim R, 1998, ECONOMETRICA, V66, P569, DOI 10.2307/2998575; TOMPKINSON P, 1995, J ECON BEHAV ORGAN, V27, P439, DOI 10.1016/0167-2681(94)00035-D	40	23	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60966	10.1371/journal.pone.0060966	http://dx.doi.org/10.1371/journal.pone.0060966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130FG	23580080	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000086
J	Santos, PS; Sena, AAS; Nascimento, R; Araujo, TG; Mendes, MM; Martins, JRS; Mineo, TWP; Mineo, JR; Goulart, LR				Santos, Paula S.; Sena, Angela A. S.; Nascimento, Rafael; Araujo, Thaise G.; Mendes, Mirian M.; Martins, Joao R. S.; Mineo, Tiago W. P.; Mineo, Jose R.; Goulart, Luiz R.			Epitope-Based Vaccines with the Anaplasma marginale MSP1a Functional Motif Induce a Balanced Humoral and Cellular Immune Response in Mice	PLOS ONE			English	Article							NEUTRALIZATION-SENSITIVE EPITOPE; HUMAN GRANULOCYTIC EHRLICHIOSIS; MAJOR SURFACE-PROTEINS; CD8(+) T-CELLS; PROTECTIVE IMMUNITY; MOLECULAR-BASIS; IFN-GAMMA; INFECTION; IMMUNIZATION; CATTLE	Bovine anaplasmosis is a hemoparasitic disease that causes considerable economic loss to the dairy and beef industries. Cattle immunized with the Anaplasma marginale MSP1 outer membrane protein complex presents a protective humoral immune response; however, its efficacy is variable. Immunodominant epitopes seem to be a key-limiting factor for the adaptive immunity. We have successfully demonstrated that critical motifs of the MSP1a functional epitope are essential for antibody recognition of infected animal sera, but its protective immunity is yet to be tested. We have evaluated two synthetic vaccine formulations against A. marginale, using epitope-based approach in mice. Mice infection with bovine anaplasmosis was demonstrated by qPCR analysis of erythrocytes after 15-day exposure. A proof-of-concept was obtained in this murine model, in which peptides conjugated to bovine serum albumin were used for immunization in three 15-day intervals by intraperitoneal injections before challenging with live bacteria. Blood samples were analyzed for the presence of specific IgG2a and IgG1 antibodies, as well as for the rickettsemia analysis. A panel containing the cytokines' transcriptional profile for innate and adaptive immune responses was carried out through qPCR. Immunized BALB/c mice challenged with A. marginale presented stable body weight, reduced number of infected erythrocytes, and no mortality; and among control groups mortality rates ranged from 15% to 29%. Additionally, vaccines have significantly induced higher IgG2a than IgG1 response, followed by increased expression of pro-inflammatory cytokines. This is a successful demonstration of epitope-based vaccines, and protection against anaplasmosis may be associated with elicitation of effector functions of humoral and cellular immune responses in murine model.	[Santos, Paula S.; Sena, Angela A. S.; Nascimento, Rafael; Araujo, Thaise G.; Goulart, Luiz R.] Univ Fed Uberlandia, Inst Genet & Biochem, Lab Nanobiotechnol, BR-38400 Uberlandia, MG, Brazil; [Mendes, Mirian M.] Univ Fed Uberlandia, Inst Genet & Biochem, Lab Prot Chem & Nat Prod, BR-38400 Uberlandia, MG, Brazil; [Martins, Joao R. S.] Inst Vet Res Desiderio Finamor, Parasitol Lab, Eldorado Do Sul, RS, Brazil; [Mineo, Tiago W. P.; Mineo, Jose R.] Univ Fed Uberlandia, Inst Biomed Sci, Lab Immunoparasitol, BR-38400 Uberlandia, MG, Brazil; [Goulart, Luiz R.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; University of California System; University of California Davis	Goulart, LR (corresponding author), Univ Fed Uberlandia, Inst Genet & Biochem, Lab Nanobiotechnol, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	lrgoulart@ufu.br	Santos, Paula/D-6011-2013; Mendes, Mirian Machado/AAI-6249-2021; Mineo, Jose R/B-4151-2009; Mineo, Tiago W. P./B-4153-2009; Goulart, Luiz R/G-7357-2012; Nascimento, Rafael/E-2167-2011; Mendes, Mirian Machado/G-9781-2012; Araújo, Thaise Gonçalves/GNM-6598-2022; Nascimento, Rafael/AAF-5801-2020	Santos, Paula/0000-0003-2650-6635; Mendes, Mirian Machado/0000-0003-2878-1999; Mineo, Jose R/0000-0002-9010-7228; Mineo, Tiago W. P./0000-0002-2339-2743; Goulart, Luiz R/0000-0002-1803-4861; Nascimento, Rafael/0000-0003-3650-9354; Nascimento, Rafael/0000-0003-3650-9354; Araujo, Thaise/0000-0002-7593-1403	CNPq (National Agency for Scientific and Technological Development); MAPA (Ministry of Agriculture and Livestock Production); FAPEMIG (Minas Gerais State Agency for Research Development - PRONEX); CAPES (Brazilian Federal Agency for the Support and Evaluation of Graduate Education, Rede Nanobiotec/Brasil)	CNPq (National Agency for Scientific and Technological Development); MAPA (Ministry of Agriculture and Livestock Production); FAPEMIG (Minas Gerais State Agency for Research Development - PRONEX)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Brazilian Federal Agency for the Support and Evaluation of Graduate Education, Rede Nanobiotec/Brasil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding provided by CNPq (National Agency for Scientific and Technological Development); MAPA (Ministry of Agriculture and Livestock Production); FAPEMIG (Minas Gerais State Agency for Research Development - PRONEX); CAPES (Brazilian Federal Agency for the Support and Evaluation of Graduate Education, Rede Nanobiotec/Brasil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER H, 1994, BIOCHEM BIOPH RES CO, V198, P510, DOI 10.1006/bbrc.1994.1075; Akkoyunlu M, 2000, INFECT IMMUN, V68, P1827, DOI 10.1128/IAI.68.4.1827-1833.2000; ALLRED DR, 1990, P NATL ACAD SCI USA, V87, P3220, DOI 10.1073/pnas.87.8.3220; Angulo I, 2002, CLIN DIAGN LAB IMMUN, V9, P1145, DOI 10.1128/CDLI.9.6.1145-1152.2002; Arulkanthan A, 1999, INFECT IMMUN, V67, P3481, DOI 10.1128/IAI.67.7.3481-3487.1999; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Blas-Machado U, 2007, VET PATHOL, V44, P64, DOI 10.1354/vp.44-1-64; Brown W, 2001, CRIT INQUIRY, V28, P1; Brown WC, 1998, INFECT IMMUN, V66, P5406, DOI 10.1128/IAI.66.11.5406-5413.1998; CANTOR GH, 1993, VET IMMUNOL IMMUNOP, V37, P343, DOI 10.1016/0165-2427(93)90206-J; Coetzee JF, 2005, VET PARASITOL, V127, P61, DOI 10.1016/j.vetpar.2004.08.017; De Andrade GM, 2004, ANN NY ACAD SCI, V1026, P257, DOI 10.1196/annals.1307.040; de la Fuente J, 2003, VET MICROBIOL, V91, P265, DOI 10.1016/S0378-1135(02)00309-7; de la Fuente J, 2001, INT J PARASITOL, V31, P145, DOI 10.1016/S0020-7519(00)00162-4; de la Fuente Jose, 2005, Anim Health Res Rev, V6, P75; Dumler JS, 2007, CLIN INFECT DIS, V45, P199, DOI 10.1086/518834; Dumler JS, 2000, CLIN DIAGN LAB IMMUN, V7, P6, DOI 10.1128/CDLI.7.1.6-8.2000; ERIKS IS, 1993, J CLIN MICROBIOL, V31, P2091, DOI 10.1128/JCM.31.8.2091-2096.1993; ESTES DM, 1994, CELL IMMUNOL, V154, P287, DOI 10.1006/cimm.1994.1078; Hamza T, 2010, INT J MOL SCI, V11, P789, DOI 10.3390/ijms11030789; Kano FS, 2008, VACCINE, V26, P3522, DOI 10.1016/j.vaccine.2008.04.047; Kawasaki PM, 2007, RES VET SCI, V83, P347, DOI 10.1016/j.rvsc.2007.02.002; Kocan KM, 2010, VET PARASITOL, V167, P95, DOI 10.1016/j.vetpar.2009.09.012; Kocan KM, 2003, CLIN MICROBIOL REV, V16, P698, DOI 10.1128/CMR.16.4.698-712.2003; Komai-Koma M, 2003, J IMMUNOL, V170, P1084, DOI 10.4049/jimmunol.170.2.1084; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lepidi H, 2000, AM J TROP MED HYG, V62, P29, DOI 10.4269/ajtmh.2000.62.29; Li C, 2003, INFECT IMMUN, V71, P4850, DOI 10.1128/IAI.71.9.4850-4856.2003; Martin ME, 2001, AM J PATHOL, V158, P1881, DOI 10.1016/S0002-9440(10)64145-4; MCGAREY DJ, 1994, INFECT IMMUN, V62, P4587, DOI 10.1128/IAI.62.10.4587-4593.1994; MCGAREY DJ, 1994, INFECT IMMUN, V62, P4594, DOI 10.1128/IAI.62.10.4594-4601.1994; Onate AA, 2003, INFECT IMMUN, V71, P4857, DOI 10.1128/IAI.71.9.4857-4861.2003; PALMER GH, 1987, INT J PARASITOL, V17, P1279, DOI 10.1016/0020-7519(87)90093-2; PALMER GH, 1995, VET PARASITOL, V57, P233, DOI 10.1016/0304-4017(94)03123-E; PALMER GH, 1986, SCIENCE, V231, P1299, DOI 10.1126/science.3945825; PALMER GH, 1989, INFECT IMMUN, V57, P3666, DOI 10.1128/IAI.57.11.3666-3669.1989; Pedra JHF, 2007, J IMMUNOL, V179, P4783, DOI 10.4049/jimmunol.179.7.4783; Raue HP, 2004, J IMMUNOL, V173, P6873, DOI 10.4049/jimmunol.173.11.6873; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Sambrook J., 2006, COMMONLY USED TECHNI, DOI 10.1101/pdb.prot4455; Santos PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033045; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Singh RP, 2002, J IMMUNOL, V168, P4674, DOI 10.4049/jimmunol.168.9.4674; Stich RW, 1998, INFECT IMMUN, V66, P4130; Sun W, 1997, J CLIN INVEST, V100, P3014, DOI 10.1172/JCI119855; Tamekuni K, 2009, BRAZ ARCH BIOL TECHN, V52, P113, DOI 10.1590/S1516-89132009000700016; Tamekuni K, 2009, RES VET SCI, V86, P98, DOI 10.1016/j.rvsc.2008.05.016; TEBELE N, 1991, INFECT IMMUN, V59, P3199, DOI 10.1128/IAI.59.9.3199-3204.1991; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; VIDOTTO MC, 1994, INFECT IMMUN, V62, P2940, DOI 10.1128/IAI.62.7.2940-2946.1994; Yip HC, 1999, J IMMUNOL, V162, P3942	51	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60311	10.1371/journal.pone.0060311	http://dx.doi.org/10.1371/journal.pone.0060311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23579784	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000026
J	Chen, CY; Cheng, A; Huang, SY; Sheng, WH; Liu, JH; Ko, BS; Yao, M; Chou, WC; Lin, HC; Chen, YC; Tsay, W; Tang, JL; Chang, SC; Tien, HF				Chen, Chien-Yuan; Cheng, Aristine; Huang, Shang-Yi; Sheng, Wang-Huei; Liu, Jia-Hau; Ko, Bo-Sheng; Yao, Ming; Chou, Wen-Chien; Lin, Hui-Chi; Chen, Yee-Chun; Tsay, Woei; Tang, Jih-Luh; Chang, Shan-Chwen; Tien, Hwei-Fang			Clinical and Microbiological Characteristics of Perianal Infections in Adult Patients with Acute Leukemia	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; ANORECTAL ABSCESS; MANAGEMENT; CHILDREN; RARE; MRI	Background: Perianal infection is a common problem for patients with acute leukemia. However, neutropenia and bleeding tendency are relatively contraindicated to surgical intervention. The epidemiology, microbiology, clinical manifestations and outcomes of perianal infection in leukemic patients are also rarely discussed. Method: The medical records of 1102 adult patients with acute leukemia at a tertiary medical center in Taiwan between 2001 and 2010 were retrospectively reviewed and analyzed. Result: The prevalence of perianal infection was 6.7% (74 of 1102) in adult patients with acute leukemia. Twenty-three (31%) of the 74 patients had recurrent episodes of perianal infections. Patients with acute myeloid leukemia had higher recurrent rates than acute lymphoblastic leukemia patients (p = 0.028). More than half (n = 61, 53%) of the perianal infections were caused by gram-negative bacilli, followed by gram-positive cocci (n = 36, 31%), anaerobes (n = 18, 15%) and Candida (n = 1, 1%) from pus culture. Eighteen patients experienced bacteremia (n = 24) or candidemia (n = 1). Overall 41 (68%) of 60 patients had polymicrobial infection. Escherichia coli (25%) was the most common micro-organism isolated, followed by Enterococcus species (22%), Klebsiella pneumoniae (13%), and Bacteroides species (11%). Twenty-five (34%) of 74 patients received surgical intervention. Acute leukemia patients with surgically managed anal fistulas tended to have fewer recurrences (p = 0.067). Four (5%) patients died within 30 days after diagnosis of perianal infection. Univariate analysis of 30-day survival revealed the elderly (>= 65 years) (p = 0.015) and patients with shock (p<0.001) had worse outcome. Multivariate analysis showed septic shock to be the independent predictive factor of 30-day crude mortality of perianal infections (p = 0.016). Conclusion: Perianal infections were common and had high recurrence rate in adult patients with acute leukemia. Empirical broad-spectrum antibiotics with anaerobic coverage should be considered. Shock independently predicted 30-day crude mortality. Surgical intervention for perianal infection remains challenging in patients with acute leukemia.	[Chen, Chien-Yuan; Huang, Shang-Yi; Sheng, Wang-Huei; Liu, Jia-Hau; Ko, Bo-Sheng; Yao, Ming; Chou, Wen-Chien; Chen, Yee-Chun; Tsay, Woei; Tang, Jih-Luh; Chang, Shan-Chwen; Tien, Hwei-Fang] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Cheng, Aristine] Far East Mem Hosp, Div Infect Dis, Dept Internal Med, New Taipei City, Taiwan; [Chou, Wen-Chien] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Liu, Jia-Hau; Lin, Hui-Chi] Natl Taiwan Univ Hosp, Infect Control Ctr, Taipei, Taiwan; [Tang, Jih-Luh] Natl Taiwan Univ Hosp, Tai Cheng Stem Cell Therapy Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Sheng, WH (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	whsheng@ntu.edu.tw	Chen, Yee-Chun/AGW-7535-2022	Chen, Yee-Chun/0000-0002-1816-9010; YAO, MING/0000-0003-2932-0019; CHOU, WEN-CHIEN/0000-0003-2967-698X; CHANG, SHAN-CHWEN/0000-0001-6505-4139; SHENG, WANG-HUEI/0000-0002-5605-7853; Cheng, Aristine/0000-0002-1182-7375; TANG, JIH-LUH/0000-0003-4021-3281; Chen, Chien-Yuan/0000-0003-2831-8822; Huang, Shang-Yi/0000-0001-5688-3410; TIEN, HWEI-FANG/0000-0002-1384-5593	Taiwan National Scientific Council [NSC 99-2314-B-002-027-MY3]	Taiwan National Scientific Council	This study was supported in part by the Taiwan National Scientific Council (grant NSC 99-2314-B-002-027-MY3). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES SG, 1984, ANN INTERN MED, V100, P515, DOI 10.7326/0003-4819-100-4-515; BODDIE AW, 1986, J SURG ONCOL, V33, P53, DOI 10.1002/jso.2930330115; Bodey GP, 2000, INT J ANTIMICROB AG, V16, P93, DOI 10.1016/S0924-8579(00)00241-7; Buyukasik Y, 1998, DIS COLON RECTUM, V41, P81, DOI 10.1007/BF02236900; Chen CY, 2010, EPIDEMIOL INFECT, V138, P1044, DOI 10.1017/S0950268809991208; Chen CY, 2004, J FORMOS MED ASSOC, V103, P526; Coremans G, 2005, DIS COLON RECTUM, V48, P575, DOI 10.1007/s10350-004-0809-3; EYKYN SJ, 1986, ANN ROY COLL SURG, V68, P237; George U, 2011, J MED IMAG RADIAT ON, V55, P391, DOI 10.1111/j.1754-9485.2011.02268.x; Lin CY, 2006, ANN HEMATOL, V85, P547, DOI 10.1007/s00277-006-0104-6; Liu CK, 2011, J MICROBIOL IMMUNOL, V44, P204, DOI 10.1016/j.jmii.2011.01.024; Malik AI, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006827.pub2; Nada EMS, 2007, J PAIN SYMPTOM MANAG, V34, P457, DOI 10.1016/j.jpainsymman.2007.07.003; North JH, 1996, J AM COLL SURGEONS, V183, P322; O'Riordan JM, 2012, DIS COLON RECTUM, V55, P351, DOI 10.1097/DCR.0b013e318239d1e4; Oliver I, 2003, INT J COLORECTAL DIS, V18, P107, DOI 10.1007/s00384-002-0429-0; PARKS AG, 1976, BRIT J SURG, V63, P1, DOI 10.1002/bjs.1800630102; Paul M, 2011, ACTA HAEMATOL-BASEL, V125, P80, DOI 10.1159/000318900; PJ RL, 2012, COLORECTAL DIS, V14, P1445; Prato AP, 2012, J PEDIATR SURG, V47, pE23, DOI 10.1016/j.jpedsurg.2012.05.034; Rizzo JA, 2010, SURG CLIN N AM, V90, P45, DOI 10.1016/j.suc.2009.10.001; Schubert MC, 2009, WORLD J GASTROENTERO, V15, P3201, DOI 10.3748/wjg.15.3201; Siddiqui MRS, 2012, DIS COLON RECTUM, V55, P576, DOI 10.1097/DCR.0b013e318249d26c; SLATER DN, 1984, BRIT MED J, V289, P1682, DOI 10.1136/bmj.289.6459.1682; Spasova MI, 2009, J BUON, V14, P411; VANHEUVERZWYN R, 1980, DIS COLON RECTUM, V23, P310, DOI 10.1007/BF02586835	26	35	39	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60624	10.1371/journal.pone.0060624	http://dx.doi.org/10.1371/journal.pone.0060624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577135	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800075
J	Danger, R; Paul, C; Giral, M; Lavault, A; Foucher, Y; Degauque, N; Pallier, A; Durand, M; Castagnet, S; Van Huyen, JPD; Delahousse, M; Renaudin, K; Soulillou, JP; Brouard, S				Danger, Richard; Paul, Chloe; Giral, Magali; Lavault, Amelie; Foucher, Yohann; Degauque, Nicolas; Pallier, Annaick; Durand, Maxim; Castagnet, Stephanie; Van Huyen, Jean-Paul Duong; Delahousse, Michel; Renaudin, Karine; Soulillou, Jean-Paul; Brouard, Sophie			Expression of miR-142-5p in Peripheral Blood Mononuclear Cells from Renal Transplant Patients with Chronic Antibody-Mediated Rejection	PLOS ONE			English	Article							MICRORNA EXPRESSION; HLA ANTIBODIES; UP-REGULATION; T-CELLS; PROFILES; CD4(+); GRAFT; IDENTIFICATION; RECIPIENTS; TOLERANCE	In renal transplantation, the unresponsiveness of patients undergoing chronic antibody mediated rejection (CAMR) to classical treatment stress on the need for accurate biomarkers to improve its diagnosis. We aim to determine whether microRNA expression patterns may be associated with a diagnosis of CAMR. We performed expression profiling of miRNAs in peripheral blood mononuclear cells (PBMC) of kidney transplant recipients with CAMR or stable graft function. Among 257 expressed miRNAs, 10 miRNAs associated with CAMR were selected. Among them, miR-142-5p was increased in PBMC and biopsies of patients with CAMR as well as in a rodent model of CAMR. The lack of modulation of miR-142-5p in PBMC of patients with renal failure, suggests that its over-expression in CAMR was associated with immunological disorders rather than renal dysfunction. A ROC curve analysis performed on independent samples showed that miR-142-5p is a potential biomarker of CAMR allowing a very good discrimination of the patients with CAMR (AUC = 0.74; p = 0.0056). Moreover, its expression was decreased in PHA-activated blood cells and was not modulated in PBMC from patients with acute rejection, excluding a non-specific T cell activation expression. The absence of modulation of this miRNA in immunosuppressed patients suggests that its expression was not influenced by treatment. Finally, the analysis of miR-142-5p predicted targets under-expressed in CAMR PBMC in a published microarray dataset revealed an enrichment of immune-related genes. Altogether, these data suggest that miR-142-5p could be used as a biomarker in CAMR and these finding may improve our understanding of chronic rejection mechanisms.	[Danger, Richard; Paul, Chloe; Giral, Magali; Lavault, Amelie; Foucher, Yohann; Degauque, Nicolas; Pallier, Annaick; Durand, Maxim; Castagnet, Stephanie; Renaudin, Karine; Soulillou, Jean-Paul; Brouard, Sophie] INSERM, U1064, Nantes, France; [Danger, Richard; Paul, Chloe; Giral, Magali; Lavault, Amelie; Foucher, Yohann; Degauque, Nicolas; Pallier, Annaick; Durand, Maxim; Castagnet, Stephanie; Renaudin, Karine; Soulillou, Jean-Paul; Brouard, Sophie] ITUN, Nantes, France; [Giral, Magali; Foucher, Yohann; Durand, Maxim; Soulillou, Jean-Paul] Univ Nantes, Fac Med, Nantes, France; [Giral, Magali; Castagnet, Stephanie; Renaudin, Karine; Soulillou, Jean-Paul; Brouard, Sophie] Ctr Hosp Univ, Hotel Dieu, Nantes, France; [Van Huyen, Jean-Paul Duong] Hop Europeen Georges Pompidou, Serv Anat Pathol, Paris, France; [Delahousse, Michel] Hop Foch, Serv Nephrol & Transplantat Renale, Suresnes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch	Brouard, S (corresponding author), Ctr Hosp Univ, Hotel Dieu, Nantes, France.	sophie.brouard@univ-nantes.fr	Foucher, Yohann/G-2714-2013; Degauque, Nicolas/R-4944-2017; brouard, sophie c/Q-1285-2016; Foucher, Yohann/L-8995-2015; Foucher, Yohann/ABB-6362-2021	Foucher, Yohann/0000-0003-0330-7457; Degauque, Nicolas/0000-0003-2990-3513; Foucher, Yohann/0000-0003-0330-7457; Danger, Richard/0000-0002-5058-795X	"Fondation Centaure" (RTRS); "Fondation pour la Recherche Medicale" (FRM); Agence de la Biomedecine Francaise (ABM); CESTI (Centre Europeen des Sciences de la Transplantation et de l'Immunologie); Transplantex Labex	"Fondation Centaure" (RTRS); "Fondation pour la Recherche Medicale" (FRM)(Fondation pour la Recherche Medicale); Agence de la Biomedecine Francaise (ABM); CESTI (Centre Europeen des Sciences de la Transplantation et de l'Immunologie); Transplantex Labex	R.D. and A.L. were supported by the "Fondation Centaure" (RTRS; www.fondation-centaure.org/ http://www.fondation-centaure.org/) which supports a French research network in transplantation. R.D. was also supported by a grant from the "Fondation pour la Recherche Medicale" (FRM; www.frm.org/ http://www.frm.org/). This study was supported by the Agence de la Biomedecine Francaise (ABM, www.agence-biomedecine.fr/http://www.agence-biomedecine.fr/), CESTI (Centre Europeen des Sciences de la Transplantation et de l'Immunologie) and Transplantex Labex (www.labex-transplantex.org/ http://www.labex-transplantex.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglicheau D, 2009, P NATL ACAD SCI USA, V106, P5330, DOI 10.1073/pnas.0813121106; Ashton-Chess J, 2008, J AM SOC NEPHROL, V19, P1116, DOI 10.1681/ASN.2007101056; Ashton-Chess J, 2010, KIDNEY INT, V77, P880, DOI 10.1038/ki.2010.15; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Ballet C, 2009, AM J TRANSPLANT, V9, P697, DOI 10.1111/j.1600-6143.2009.02556.x; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; Ben-Dov IZ, 2012, TRANSPLANTATION, V94, P1086, DOI 10.1097/TP.0b013e3182751efd; Braudeau C, 2008, TRANSPLANTATION, V86, P130, DOI 10.1097/TP.0b013e31817b8dc5; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Danger R, 2012, J AM SOC NEPHROL, V23, P597, DOI 10.1681/ASN.2011060543; Ding S, 2012, ARTHRITIS R IN PRESS; Einecke G, 2009, AM J TRANSPLANT, V9, P2520, DOI 10.1111/j.1600-6143.2009.02799.x; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Friedrich ML, 2007, J BIOL CHEM, V282, P4573, DOI 10.1074/jbc.M606675200; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Hamano K, 1996, TRANSPLANTATION, V62, P856, DOI 10.1097/00007890-199609270-00026; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Lorenzen JM, 2011, AM J TRANSPLANT, V11, P2221, DOI 10.1111/j.1600-6143.2011.03679.x; Loupy A, 2011, AM J TRANSPLANT, V11, P56, DOI 10.1111/j.1600-6143.2010.03364.x; Lozano JJ, 2011, AM J TRANSPLANT, V11, P1916, DOI 10.1111/j.1600-6143.2011.03638.x; Malin S, 2010, CURR OPIN IMMUNOL, V22, P168, DOI 10.1016/j.coi.2010.02.004; Mao Q, 2007, AM J TRANSPLANT, V7, P864, DOI 10.1111/j.1600-6143.2006.01711.x; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Olive D, 1999, EUR J IMMUNOL, V29, P2443; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Scian MJ, 2011, AM J TRANSPLANT, V11, P2110, DOI 10.1111/j.1600-6143.2011.03666.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Sui WG, 2008, TRANSPL IMMUNOL, V19, P81, DOI 10.1016/j.trim.2008.01.007; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Winkler JM, 2012, J NEUROIMMUNE PHARM, V7, P372, DOI 10.1007/s11481-012-9344-5; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zhang X, 2011, ANN ONCOL, V22, P2257, DOI 10.1093/annonc/mdq758	39	72	78	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60702	10.1371/journal.pone.0060702	http://dx.doi.org/10.1371/journal.pone.0060702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577151	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800093
J	Mutwa, PR; Van Nuil, JI; Asiimwe-Kateera, B; Kestelyn, E; Vyankandondera, J; Pool, R; Ruhirimbura, J; Kanakuze, C; Reiss, P; Geelen, S; van de Wijgert, J; Boer, KR				Mutwa, Philippe R.; Van Nuil, Jennifer Ilo; Asiimwe-Kateera, Brenda; Kestelyn, Evelyne; Vyankandondera, Joseph; Pool, Robert; Ruhirimbura, John; Kanakuze, Chantal; Reiss, Peter; Geelen, Sibyl; van de Wijgert, Janneke; Boer, Kimberly R.			Living Situation Affects Adherence to Combination Antiretroviral Therapy in HIV-Infected Adolescents in Rwanda: A Qualitative Study	PLOS ONE			English	Article							MEDICATION ADHERENCE; CHILDREN; IMPACT; FACILITATORS; DISCLOSURE; RESPONSES; BARRIERS; OUTCOMES; CHENNAI	Introduction: Adherence to combination antiretroviral therapy (cART) is vital for HIV-infected adolescents for survival and quality of life. However, this age group faces many challenges to remain adherent. We used multiple data sources (role-play, focus group discussions (FGD), and in-depth interviews (IDI)) to better understand adherence barriers for Rwandan adolescents. Forty-two HIV positive adolescents (ages 12-21) and a selection of their primary caregivers were interviewed. All were perinatally-infected and received (cART) for >= 12 months. Topics discussed during FGDs and IDIs included learning HIV status, disclosure and stigma, care and treatment issues, cART adherence barriers. Results: Median age was 17 years, 45% female, 45% orphaned, and 48% in boarding schools. We identified three overarching but inter-related themes that appeared to influence adherence. Stigma, perceived and experienced, and inadvertent disclosure of HIV status hampered adolescents from obtaining and taking their drugs, attending clinic visits, carrying their cARTs with them in public. The second major theme was the need for better support, in particular for adolescents with different living situations, (orphanages, foster-care, and boarding schools). Lack of privacy to keep and take medication came out as major barrier for adolescents living in congested households, as well the institutionalization of boarding schools where privacy is almost non-existent. The third important theme was the desire to be 'normal' and not be recognized as an HIV-infected individual, and to have a normal life not perturbed by taking a regimen of medications or being forced to disclose where others would treat them differently. Conclusions: We propose better management of HIV-infected adolescents integrated into boarding school, orphanages, and foster care; training of school-faculty on how to support students and allow them privacy for taking their medications. To provide better care and support, HIV programs should stimulate caregivers of HIV-infected adolescents to join them for their clinic visits.	[Mutwa, Philippe R.; Vyankandondera, Joseph] KUTH, Dept Pediat, Kigali, Rwanda; [Mutwa, Philippe R.; Asiimwe-Kateera, Brenda; Kestelyn, Evelyne; Reiss, Peter; Geelen, Sibyl; van de Wijgert, Janneke; Boer, Kimberly R.] Acad Med Ctr, Amsterdam Inst Global Hlth & Dev AMC AIGHD, Dept Global Hlth, Kigali, Rwanda; [Mutwa, Philippe R.; Asiimwe-Kateera, Brenda; Kestelyn, Evelyne; Reiss, Peter; Geelen, Sibyl; van de Wijgert, Janneke; Boer, Kimberly R.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev AMC AIGHD, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Van Nuil, Jennifer Ilo] Wayne State Univ, Dept Anthropol, Detroit, MI USA; [Van Nuil, Jennifer Ilo; van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Van Nuil, Jennifer Ilo; Kestelyn, Evelyne; Vyankandondera, Joseph; van de Wijgert, Janneke] Projet Rinda Ubuzima, Kigali, Rwanda; [Geelen, Sibyl] Univ Utrecht, Childrens Hosp, UMCU, Utrecht, Netherlands; [Boer, Kimberly R.] Royal Trop Inst KIT, Epidemiol Unit, Amsterdam, Netherlands; [Ruhirimbura, John; Kanakuze, Chantal] Treatment & Res HIV AIDS Ctr TRAC Plus, Outpatients Clin, Kigali, Rwanda; [Vyankandondera, Joseph] Belgian Dev Agcy, Kigali, Rwanda; [Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Wayne State University; University of Liverpool; Unilever; Utrecht University; Utrecht University Medical Center; University of Amsterdam	Mutwa, PR (corresponding author), KUTH, Dept Pediat, Kigali, Rwanda.	mutwaph@gmail.com	Asiimwe-Kateera, Brenda/H-3378-2019; Kestelyn, Evelyne/AAD-6052-2019	Kestelyn, Evelyne/0000-0002-5728-0918; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Asiimwe Kateera, Brenda/0000-0001-6134-1042	Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP); European Developing Countries Clinical Trials Partnership (EDCTP)	Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP); European Developing Countries Clinical Trials Partnership (EDCTP)	This study was funded by The Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP) and the European Developing Countries Clinical Trials Partnership (EDCTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily represent the official position of the funders.	Ballif M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008275; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Birungi H, 2011, SOCIAL PSYCHOL ASPEC; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Curioso WH, 2010, BMC PUBLIC HEALTH, V10, P1471; Davies MA, 2011, JAIDS-J ACQ IMM DEF, V56, P270, DOI 10.1097/QAI.0b013e3182060610; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; Fetzer BC, 2011, AIDS PATIENT CARE ST, V25, P611, DOI 10.1089/apc.2011.0083; Fielding KL, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-93; Haberer Jessica, 2009, Curr HIV/AIDS Rep, V6, P194, DOI 10.1007/s11904-009-0026-8; Haubrich RH, 1999, AIDS, V13, P1099, DOI 10.1097/00002030-199906180-00014; Kikuchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041998; Krueger RA, 1994, FOCUS GROUPS PRACTIC, V2nd; Kumarasamy N, 2005, AIDS PATIENT CARE ST, V19, P526, DOI 10.1089/apc.2005.19.526; Lucas GM, 2005, J ANTIMICROB CHEMOTH, V55, P413, DOI 10.1093/jac/dki042; Malee K, 2011, AIDS PATIENT CARE ST, V25, P191, DOI 10.1089/apc.2010.0181; Meyers TM, 2011, PEDIATR INFECT DIS J, V30, P974, DOI 10.1097/INF.0b013e31822539f6; Mutwa PR, 2012, LONG TERM EFFECTIVEN; Nugent Nicole R, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P113, DOI 10.1177/1545109709357472; Palladino C, 2009, AIDS RES HUM RETROV, V25, P1091, DOI 10.1089/aid.2009.0070; Paterson D., 1999, 6 C RETR OPP INF CHI; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Rwanda Ministry of Health, 2011, RWAND MIN HLTH ANN R; Rwanda Ministry of Health, 2008, RWAND NAT STRAT PLAN; Safren SA, 2005, AIDS CARE, V17, P853, DOI 10.1080/09540120500038439; Shet A, 2006, CURR OPIN INVESTIG D, V7, P709; Taniguchi T, 2012, AIDS RES HUM RETROV, V28, P259, DOI 10.1089/aid.2011.0022; Unge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013613; Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9; Vreeman RC, 2008, JAIDS-J ACQ IMM DEF, V49, P163, DOI 10.1097/QAI.0b013e318183a996; Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Wasti SP, 2012, TROP MED INT HEALTH, V17, P71, DOI 10.1111/j.1365-3156.2011.02888.x; Weigel R, 2009, BMC PEDIATR, V9, p[1471, 45]; Williams PL, 2006, PEDIATRICS, V118, pE1745, DOI 10.1542/peds.2006-0493; Wood E, 2004, JAIDS-J ACQ IMM DEF, V35, P261, DOI 10.1097/00126334-200403010-00006	39	58	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60073	10.1371/journal.pone.0060073	http://dx.doi.org/10.1371/journal.pone.0060073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23573232	gold, Green Submitted, Green Published			2022-12-27	WOS:000318840100046
J	Abadi, A; Crane, JD; Ogborn, D; Hettinga, B; Akhtar, M; Stokl, A; MacNeil, L; Safdar, A; Tarnopolsky, M				Abadi, Arkan; Crane, Justin D.; Ogborn, Daniel; Hettinga, Bart; Akhtar, Mahmood; Stokl, Andrew; MacNeil, Lauren; Safdar, Adeel; Tarnopolsky, Mark			Supplementation with alpha-Lipoic Acid, CoQ10, and Vitamin E Augments Running Performance and Mitochondrial Function in Female Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; OXIDATIVE STRESS; KAPPA-B; ANTIOXIDANT SUPPLEMENTATION; INSULIN SENSITIVITY; EXERCISE; BIOGENESIS; PHOSPHORYLATION; ADAPTATIONS	Antioxidant supplements are widely consumed by the general public; however, their effects of on exercise performance are controversial. The aim of this study was to examine the effects of an antioxidant cocktail (alpha-lipoic acid, vitamin E and coenzyme Q10) on exercise performance, muscle function and training adaptations in mice. C57Bl/J6 mice were placed on antioxidant supplement or placebo-control diets (n = 36/group) and divided into trained (8 wks treadmill running) (n = 12/group) and untrained groups (n = 24/group). Antioxidant supplementation had no effect on the running performance of trained mice nor did it affect training adaptations; however, untrained female mice that received antioxidants performed significantly better than placebo-control mice (p <= 0.05). Furthermore, antioxidant-supplemented females (untrained) showed elevated respiratory capacity in freshly excised muscle fibers (quadriceps femoris) (p <= 0.05), reduced oxidative damage to muscle proteins (p <= 0.05), and increased expression of mitochondrial proteins (p <= 0.05) compared to placebo-controls. These changes were attributed to increased expression of proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) (p <= 0.05) via activation of AMP-activated protein kinase (AMPK) (p <= 0.05) by antioxidant supplementation. Overall, these results indicate that this antioxidant supplement exerts gender specific effects; augmenting performance and mitochondrial function in untrained females, but does not attenuate training adaptations.	[Abadi, Arkan; Crane, Justin D.; Ogborn, Daniel; Hettinga, Bart; Akhtar, Mahmood; Stokl, Andrew; MacNeil, Lauren; Safdar, Adeel; Tarnopolsky, Mark] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	McMaster University	Tarnopolsky, M (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON, Canada.	tarnopol@mcmaster.ca		Safdar, Adeel/0000-0002-7453-7770; Crane, Justin/0000-0002-5380-5676; Safdar, Adeel/0000-0003-2469-0467	Canadian Institute of Health Research (CIHR); Endowed Chair from the Hamilton Health Sciences Foundation; McMaster Child Health Research Institute (MCHRI); Canadian Foundation for Innovation; Warren Lammert and Family; Dan Wright Family	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Endowed Chair from the Hamilton Health Sciences Foundation; McMaster Child Health Research Institute (MCHRI); Canadian Foundation for Innovation(Canada Foundation for Innovation); Warren Lammert and Family; Dan Wright Family	This research was supported in part by the Canadian Institute of Health Research (CIHR). Dr. Tarnopolsky is partially supported through an Endowed Chair from the Hamilton Health Sciences Foundation and Michael DeGroote. Dr. A. Abadi is sponsored by a post-doctoral fellowship from the McMaster Child Health Research Institute (MCHRI). Infrastructure support was provided from grants and donations from the Canadian Foundation for Innovation, Mr. Warren Lammert and Kathy Corkins. No other sources of funding were utilized in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the logistical and material support provided by Suzanne Southward who was instrumental to the success and efficiency of the experiments in this report. The study was partially funded from donations for mitochondrial research from Warren Lammert and Family and Dan Wright Family.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Azzi A, 2004, ANN NY ACAD SCI, V1031, P86, DOI 10.1196/annals.1331.009; Azzi A, 2002, FEBS LETT, V519, P8, DOI 10.1016/S0014-5793(02)02706-0; Bailey DM, 2011, EUR J APPL PHYSIOL, V111, P925, DOI 10.1007/s00421-010-1718-x; Bhagavan HN, 2006, FREE RADICAL RES, V40, P445, DOI 10.1080/10715760600617843; Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Booth FW, 2010, J APPL PHYSIOL, V108, P219, DOI 10.1152/japplphysiol.00125.2009; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; BURTON GW, 1983, CIBA F SYMP, V101, P4; BURTON GW, 1982, LANCET, V2, P327; Chae CH, 2008, NUTR RES, V28, P399, DOI 10.1016/j.nutres.2008.02.010; Comitato R, 2009, AM J PHYSIOL-ENDOC M, V297, pE427, DOI 10.1152/ajpendo.00187.2009; Espinosa A, 2006, J CELL PHYSIOL, V209, P379, DOI 10.1002/jcp.20745; Garcia-Roves PM, 2008, J BIOL CHEM, V283, P35724, DOI 10.1074/jbc.M805078200; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; GUNSALUS IC, 1953, J CELL COMPAR PHYSL, V41, pA113, DOI 10.1002/jcp.1030410409; Hardie DG, 2011, P NUTR SOC, V70, P92, DOI 10.1017/S0029665110003915; HARTMANN A, 1995, MUTAT RES LETT, V346, P195, DOI 10.1016/0165-7992(95)90035-7; Higashida K, 2011, AM J PHYSIOL-ENDOC M, V301, pE779, DOI 10.1152/ajpendo.00655.2010; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jensen TE, 2009, ACTA PHYSIOL, V196, P155, DOI 10.1111/j.1748-1716.2009.01979.x; Ji LL, 2007, APPL PHYSIOL NUTR ME, V32, P930, DOI 10.1139/H07-098; KAGAN V, 1990, BIOCHEM BIOPH RES CO, V169, P851, DOI 10.1016/0006-291X(90)91971-T; Kamzalov S, 2003, J NUTR, V133, P3175, DOI 10.1093/jn/133.10.3175; Knab AM, 2009, PHYSIOL BEHAV, V98, P433, DOI 10.1016/j.physbeh.2009.07.006; Kramer HF, 2007, J APPL PHYSIOL, V103, P388, DOI 10.1152/japplphysiol.00085.2007; Kwong LK, 2002, FREE RADICAL BIO MED, V33, P627, DOI 10.1016/S0891-5849(02)00916-4; Lee WJ, 2005, BIOCHEM BIOPH RES CO, V332, P885, DOI 10.1016/j.bbrc.2005.05.035; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Liu JK, 2005, NUTR NEUROSCI, V8, P67, DOI 10.1080/10284150500047161; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; MEYDANI M, 1993, AM J PHYSIOL, V264, pR992, DOI 10.1152/ajpregu.1993.264.5.R992; Nieman DC, 2004, MED SCI SPORT EXER, V36, P1328, DOI 10.1249/01.MSS.0000135778.57355.CA; Niemann B, 2011, BASIC RES CARDIOL; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Osorio-Fuentealba C, 2009, J APPL PHYSIOL, V106, P1301, DOI 10.1152/japplphysiol.91224.2008; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Papa L, 2011, J CELL SCI, V124, P1396, DOI 10.1242/jcs.078220; Pedram A, 2006, MOL BIOL CELL, V17, P2125, DOI 10.1091/mbc.E05-11-1013; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Radak Z, 2000, ARCH BIOCHEM BIOPHYS, V383, P114, DOI 10.1006/abbi.2000.2042; REED LJ, 1957, ADV ENZYMOL REL S BI, V18, P319; Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688; Ryan MJ, 2010, EXP GERONTOL, V45, P882, DOI 10.1016/j.exger.2010.08.002; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Schneider D, 2000, ANTIOXID REDOX SIGN, V2, P327, DOI 10.1089/ars.2000.2.2-327; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shen QWW, 2007, AM J PHYSIOL-CELL PH, V293, pC1395, DOI 10.1152/ajpcell.00115.2007; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Strobel NA, 2011, MED SCI SPORT EXER, V43, P1017, DOI 10.1249/MSS.0b013e318203afa3; Sun M., 2011, SCAND J MED SCI SPOR; Survey NHANE, 2011, NCCAM PUB D, VD450; Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001; Theodorou AA, 2011, AM J CLIN NUTR, V93, P1373, DOI 10.3945/ajcn.110.009266; Vinayagamoorthi R, 2008, J ENDOCRINOL, V197, P287, DOI 10.1677/JOE-08-0061; Wadley GD, 2010, J APPL PHYSIOL, V108, P1719, DOI 10.1152/japplphysiol.00127.2010; Wang Y, 2010, METABOLISM, V59, P967, DOI 10.1016/j.metabol.2009.10.018; Yfanti C, 2011, AM J PHYSIOL-ENDOC M, V300, pE761, DOI 10.1152/ajpendo.00207.2010; Ying ZK, 2011, INFLAMM RES, V60, P219, DOI 10.1007/s00011-010-0256-7; Zanuso S, 2010, ACTA DIABETOL, V47, P15, DOI 10.1007/s00592-009-0126-3; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	64	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60722	10.1371/journal.pone.0060722	http://dx.doi.org/10.1371/journal.pone.0060722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565271	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300142
J	Castro, R; Takizawa, F; Chaara, W; Lunazzi, A; Dang, TH; Koellner, B; Quillet, E; Six, A; Fischer, U; Boudinot, P				Castro, Rosario; Takizawa, Fumio; Chaara, Wahiba; Lunazzi, Aurelie; Thi Huong Dang; Koellner, Bernd; Quillet, Edwige; Six, Adrien; Fischer, Uwe; Boudinot, Pierre			Contrasted TCR beta Diversity of CD8(+) and CD8(-) T Cells in Rainbow Trout	PLOS ONE			English	Article							GINBUNA CRUCIAN CARP; CARASSIUS-AURATUS-LANGSDORFII; TELEOST FISH; TRANSCRIPTION FACTORS; ONCORHYNCHUS-MYKISS; EXPRESSION ANALYSIS; CEREBRAL MALARIA; REPERTOIRE; CD8-ALPHA; CD4(+)	Teleost fish express highly diverse naive TCR beta (TRB) repertoires and mount strong public and private clonal responses upon infection with pathogens. Fish T cells express typical markers such as CD8, CD4-1 and CD4-2, CD3, CD28 and CTLA4. Fish CD8(+) T cells have been shown to be responsible for antigen-specific cell-mediated cytotoxicity in in vitro systems using histo-compatible effector and target cells. We compare here the complexity of TRB repertoires between FACS sorted CD8(+) and CD8(-) T cells from spleen and pronephros of rainbow trout. In contrast to human, while the TRB repertoire is highly diverse and polyclonal in CD8(+) T cells of naive fish, it appeared very different in CD8(-) lymphocytes with irregular CDR3 length distributions suggesting a dominance of activated clones already in naive fish or the presence of non conventional T cells. After infection with a systemic virus, CD8(+) T cells mount a typical response with significant skewing of CDR3 length profiles. The infection also induces significant modifications of the TRB repertoire expressed by the CD8(-) fraction, but for a different set of V/J combinations. In this fraction, the antiviral response results in an increase of the peak diversity of spectratypes. This unusual observation reflects the presence of a number of T cell expansions that rise the relative importance of minor peaks of the highly skewed distributions observed in unchallenged animals. These results suggest that the diversity of TRB expressed by CD8(+) and CD8(-) alpha beta T cells may be subjected to different regulatory patterns in fish and in mammals.	[Castro, Rosario; Lunazzi, Aurelie] INRA Virol & Immunol Mol, Jouy En Josas, France; [Takizawa, Fumio; Thi Huong Dang; Koellner, Bernd; Fischer, Uwe; Boudinot, Pierre] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Infectiol, Greifswald, Germany; [Chaara, Wahiba; Six, Adrien] Univ Paris 06, UMR 7211, Paris, France; [Chaara, Wahiba; Six, Adrien] CNRS, UMR 7211, Paris, France; [Chaara, Wahiba] Hop La Pitie Salpetriere, AP HP, Serv Biotherapie, Paris, France; [Quillet, Edwige] INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France	INRAE; Friedrich Loeffler Institute; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Fischer, U (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Infectiol, Greifswald, Germany.	Uwe.Fischer@fli.bund.de; pierre.boudinot@jouy.inra.fr	Fischer, Uwe/AAQ-2695-2020; boudinot, pierre/L-4246-2016	Takizawa, Fumio/0000-0002-0988-2770; boudinot, pierre/0000-0002-7490-9677; Six, Adrien/0000-0001-5898-555X	Institut National de la Recherche Agronomique; Friedrich-Loeffler-Institut; European Community [CT-2005-007103, 222719, 311993]; Alexander von Humboldt Foundation of Germany; German Research Council (ACIRO) [FI 604/6-1]	Institut National de la Recherche Agronomique; Friedrich-Loeffler-Institut; European Community(European Commission); Alexander von Humboldt Foundation of Germany(Alexander von Humboldt Foundation); German Research Council (ACIRO)	This work was supported by Institut National de la Recherche Agronomique, Friedrich-Loeffler-Institut, European Community's Sixth and Seventh Framework Programs (IMAQUANIM, Grant Agreement CT-2005-007103; LIFECYCLE, Grant Agreement 222719; and Targetfish, Grant Agreement 311993), Alexander von Humboldt Foundation of Germany and German Research Council (ACIRO, FI 604/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2008, DEV COMP IMMUNOL, V32, P850, DOI 10.1016/j.dci.2007.12.005; Bagot S, 2004, INFECT IMMUN, V72, P2817, DOI 10.1128/IAI.72.5.2817-2826.2004; Bernard D, 2006, J IMMUNOL, V176, P4191, DOI 10.4049/jimmunol.176.7.4191; Boudinot P, 2004, J GEN VIROL, V85, P3099, DOI 10.1099/vir.0.80135-0; Boudinot P, 2002, J IMMUNOL, V169, P6244, DOI 10.4049/jimmunol.169.11.6244; Boudinot P, 2001, J IMMUNOL, V167, P6202, DOI 10.4049/jimmunol.167.11.6202; Collette A, 2004, J IMMUNOL, V173, P4568, DOI 10.4049/jimmunol.173.7.4568; Collette A, 2002, BIOINFORMATICS, V18, P329, DOI 10.1093/bioinformatics/18.2.329; Currier JR, 1999, HUM IMMUNOL, V60, P209, DOI 10.1016/S0198-8859(98)00109-8; DEKINKELIN P, 1980, J VIROL, V36, P652, DOI 10.1128/JVI.36.3.652-658.1980; DESVAUX FX, 1983, DEV COMP IMMUNOL, V7, P563, DOI 10.1016/0145-305X(83)90041-1; Diaz-Rosales P, 2009, FISH SHELLFISH IMMUN, V27, P414, DOI 10.1016/j.fsi.2009.06.008; Dijkstra JM, 2006, MOL IMMUNOL, V43, P410, DOI 10.1016/j.molimm.2005.03.005; Fischer U, 2003, DEV COMP IMMUNOL, V27, P323, DOI 10.1016/S0145-305X(02)00100-3; Gapin L, 2009, PLOS BIOL, V7, P435, DOI 10.1371/journal.pbio.1000070; Gorochov G, 1998, NAT MED, V4, P215, DOI 10.1038/nm0298-215; GORSKI J, 1994, J IMMUNOL, V152, P5109; Hansen JD, 2000, J IMMUNOL, V164, P3132, DOI 10.4049/jimmunol.164.6.3132; Hansen JD, 2011, DEV COMP IMMUNOL, V35, P452, DOI 10.1016/j.dci.2010.11.014; Hayashi N, 2010, FISH SHELLFISH IMMUN, V28, P72, DOI 10.1016/j.fsi.2009.09.020; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Koppang EO, 2010, J ANAT, V217, P728, DOI 10.1111/j.1469-7580.2010.01305.x; Kumari J, 2009, MOL IMMUNOL, V46, P3099, DOI 10.1016/j.molimm.2009.06.008; Laing KJ, 2006, J IMMUNOL, V177, P3939, DOI 10.4049/jimmunol.177.6.3939; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; LUCAS B, 1993, J IMMUNOL, V151, P4574; Mitra S, 2010, FEBS J, V277, P128, DOI 10.1111/j.1742-4658.2009.07460.x; Moore LJ, 2005, MOL IMMUNOL, V42, P1225, DOI 10.1016/j.molimm.2004.11.017; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Naumov YN, 1996, HUM IMMUNOL, V48, P52, DOI 10.1016/0198-8859(96)00088-2; NEAVE B, 1995, MECH DEVELOP, V51, P169, DOI 10.1016/0925-4773(95)00351-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quillet E, 2007, FISH SHELLFISH IMMUN, V22, P510, DOI 10.1016/j.fsi.2006.07.002; Quiniou SMA, 2011, FISH SHELLFISH IMMUN, V30, P894, DOI 10.1016/j.fsi.2011.01.011; Schwab R, 1997, J IMMUNOL, V158, P4493; Secombes C, 2008, FISH SHELLFISH IMMUN, V25, P409, DOI 10.1016/j.fsi.2008.05.001; Somamoto T, 2005, DEV COMP IMMUNOL, V29, P693, DOI 10.1016/j.dci.2004.11.006; Somamoto T, 2006, VIROLOGY, V348, P370, DOI 10.1016/j.virol.2006.01.019; Stuge TB, 2000, J IMMUNOL, V164, P2971, DOI 10.4049/jimmunol.164.6.2971; Takizawa F, 2011, DEV COMP IMMUNOL, V35, P752, DOI 10.1016/j.dci.2011.02.008; Toda H, 2009, DEV COMP IMMUNOL, V33, P646, DOI 10.1016/j.dci.2008.11.008; Toda H, 2011, DEV COMP IMMUNOL, V35, P650, DOI 10.1016/j.dci.2011.01.013; Toda H, 2011, DEV COMP IMMUNOL, V35, P88, DOI 10.1016/j.dci.2010.08.010; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Wang TH, 2010, FISH SHELLFISH IMMUN, V29, P705, DOI 10.1016/j.fsi.2010.06.016; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zinkernagel R, 1974, NATURE, V19, P248	47	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60175	10.1371/journal.pone.0060175	http://dx.doi.org/10.1371/journal.pone.0060175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565199	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300068
J	Chen, JM; Du, ZY; Sun, SS; Gituru, RW; Wang, QF				Chen, Jin-Ming; Du, Zhi-Yuan; Sun, Shan-Shan; Gituru, Robert Wahiti; Wang, Qing-Feng			Chloroplast DNA Phylogeography Reveals Repeated Range Expansion in a Widespread Aquatic Herb Hippuris vulgaris in the Qinghai-Tibetan Plateau and Adjacent Areas	PLOS ONE			English	Article							POTENTILLA-FRUTICOSA; GENETIC CONSEQUENCES; QUATERNARY CLIMATE; POPULATION-GROWTH; NONCODING REGIONS; MITOCHONDRIAL; EVOLUTION; UPLIFT; RATES; GLACIATION	Background: The Qinghai-Tibetan Plateau (QTP) is one of the most extensive habitats for alpine plants in the world. Climatic oscillations during the Quaternary ice age had a dramatic effect on species ranges on the QTP and the adjacent areas. However, how the distribution ranges of aquatic plant species shifted on the QTP in response to Quaternary climatic changes remains almost unknown. Methodology and Principal Findings: We studied the phylogeography and demographic history of the widespread aquatic herb Hippuris vulgaris from the QTP and adjacent areas. Our sampling included 385 individuals from 47 natural populations of H. vulgaris. Using sequences from four chloroplast DNA (cpDNA) non-coding regions, we distinguished eight different cpDNA haplotypes. From the cpDNA variation in H. vulgaris, we found a very high level of population differentiation (G(ST) = 0.819) but the phylogeographical structure remained obscure (N-ST = 0.853>G(ST) = 0.819, P > 0.05). Phylogenetic analyses revealed two main cpDNA haplotype lineages. The split between these two haplotype groups can be dated back to the mid-to-late Pleistocene (ca. 0.480 Myr). Mismatch distribution analyses showed that each of these had experienced a recent range expansion. These two expansions (ca. 0.12 and 0.17 Myr) might have begun from the different refugees before the Last Glacial Maximum (LGM). Conclusions/Significance: This study initiates a research on the phylogeography of aquatic herbs in the QTP and for the first time sheds light on the response of an alpine aquatic seed plant species in the QTP to Quaternary climate oscillations.	[Chen, Jin-Ming; Du, Zhi-Yuan; Sun, Shan-Shan; Wang, Qing-Feng] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei, Peoples R China; [Sun, Shan-Shan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Gituru, Robert Wahiti] Jomo Kenyatta Univ Agr & Technol, Dept Bot, Nairobi, Kenya	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jomo Kenyatta University of Agriculture & Technology	Wang, QF (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei, Peoples R China.	qfwang@wbgcas.cn			Chinese Academy of Sciences [KSCX2-YW-Z-0805]; Strategic pilot science and technology projects of CAS [XDAO5090305]; National Natural Science Foundation of China [30970195, 30970202]	Chinese Academy of Sciences(Chinese Academy of Sciences); Strategic pilot science and technology projects of CAS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from One Hundred Person Project of the Chinese Academy of Sciences granted to WQF (KSCX2-YW-Z-0805), Strategic pilot science and technology projects of CAS (number XDAO5090305) and from the National Natural Science Foundation of China (numbers 30970195 and 30970202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], 2014, TRACER V1 6; Avise J, 2004, MOL MARKERS NATURAL; BARRETT SCH, 1993, AQUAT BOT, V44, P105, DOI 10.1016/0304-3770(93)90068-8; Chen JR, 2000, FLORA REIPUBLICAE PO, V53; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; CRANDALL KA, 1993, GENETICS, V134, P959; DONNELLY P, 1986, ADV APPL PROBAB, V18, P1, DOI 10.2307/1427237; Dorken ME, 2004, MOL ECOL, V13, P2699, DOI 10.1111/j.1365-294X.2004.02246.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L., 2006, ARLEQUIN VERSION 3 1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gao QB, 2012, BOT J LINN SOC, V168, P204, DOI 10.1111/j.1095-8339.2011.01193.x; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; HARPENDING HC, 1994, HUM BIOL, V66, P591; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li C, 2010, J PLANT ECOL, V3, P9, DOI 10.1093/jpe/rtp022; Li J., 1995, UPLIFT QINGHAI XIZAN; Liu X, 2004, J BIOGEOGR, V31, P1239, DOI 10.1111/j.1365-2699.2004.01115.x; Lopez-Pujol J, 2006, BIODIVERS CONSERV, V15, P3983, DOI 10.1007/s10531-005-3015-2; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Mittermeier R, 2005, HOTSPOTS REVISITED E; MOLNAR P, 1975, SCIENCE, V189, P419, DOI 10.1126/science.189.4201.419; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nylander JAA., 2004, BIOINFORMATICS; Owen LA, 2005, QUATERNARY SCI REV, V24, P1391, DOI 10.1016/j.quascirev.2004.10.014; Pons O, 1996, GENETICS, V144, P1237; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Royden LH, 2008, SCIENCE, V321, P1054, DOI 10.1126/science.1155371; RUDDIMAN WF, 1991, SCI AM, V264, P66, DOI 10.1038/scientificamerican0391-66; Schneider S, 1999, GENETICS, V152, P1079; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Shi YF., 1990, ANN GLACIOL, V14, P261, DOI [10.3189/S0260305500008715, DOI 10.3189/S0260305500008715]; Shimono A, 2010, HEREDITY, V104, P534, DOI 10.1038/hdy.2009.158; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Sun YS, 2010, PLANT ECOL DIVERS, V3, P249, DOI 10.1080/17550874.2010.516279; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tang LY, 1996, ACTA MICROPALAEONTOL, V13, P321; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang D., 2003, THESIS WUHAN U WUHAN; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025896; Wang LY, 2009, J INTEGR PLANT BIOL, V51, P698, DOI 10.1111/j.1744-7909.2009.00818.x; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wang S.M., 1998, LAKES OF CHINA, V1st ed; Williams MA, 1993, QUATERNARY ENV; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu, 1988, J JPN BOT, V63, P297; Wu Su-Gong, 1995, Acta Botanica Yunnanica, V17, P233; Wu YQ, 2001, GEOMORPHOLOGY, V36, P203, DOI 10.1016/S0169-555X(00)00057-X; Yamane K, 2006, DNA RES, V13, P197, DOI 10.1093/dnares/dsl012; Yang FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037196; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang LC, 2011, POL J ECOL, V59, P753; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009; Zhang YH, 2010, MOL PHYLOGENET EVOL, V57, P1162, DOI 10.1016/j.ympev.2010.08.033; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zheng D, 1996, SCI CHINA SER D, V39, P410; Zhuo Z, 1998, EPISODES, V21, P152	84	20	24	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60948	10.1371/journal.pone.0060948	http://dx.doi.org/10.1371/journal.pone.0060948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565290	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300163
J	Eckle, VS; Hauser, S; Drexler, B; Antkowiak, B; Grasshoff, C				Eckle, Veit-Simon; Hauser, Sabrina; Drexler, Berthold; Antkowiak, Bernd; Grasshoff, Christian			Opposing Actions of Sevoflurane on GABAergic and Glycinergic Synaptic Inhibition in the Spinal Ventral Horn	PLOS ONE			English	Article							ALVEOLAR ANESTHETIC CONCENTRATION; INHALATIONAL GENERAL-ANESTHETICS; GATED ION CHANNELS; ACID TYPE-A; INHALED ANESTHETICS; IN-VITRO; VOLATILE ANESTHETICS; GABA(A) RECEPTOR; ORGANOTYPIC CULTURES; NEURONAL NETWORKS	Background: The ventral horn is a major substrate in mediating the immobilizing properties of the volatile anesthetic sevoflurane in the spinal cord. In this neuronal network, action potential firing is controlled by GABA(A) and glycine receptors. Both types of ion channels are sensitive to volatile anesthetics, but their role in mediating anesthetic-induced inhibition of spinal locomotor networks is not fully understood. Methodology/Principal Findings: To compare the effects of sevoflurane on GABAergic and glycinergic inhibitory postsynaptic currents (IPSCs) whole-cell voltage-clamp recordings from ventral horn interneurons were carried out in organotypic spinal cultures. At concentrations close to MAC (minimum alveolar concentration), decay times of both types of IPSCs were significantly prolonged. However, at 1.5 MAC equivalents, GABAergic IPSCs were decreased in amplitude and reduced in frequency. These effects counteracted the prolongation of the decay time, thereby decreasing the time-averaged GABAergic inhibition. In contrast, amplitudes and frequency of glycinergic IPSCs were not significantly altered by sevoflurane. Furthermore, selective GABA(A) and glycine receptor antagonists were tested for their potency to reverse sevoflurane-induced inhibition of spontaneous action potential firing in the ventral horn. These experiments confirmed a weak impact of GABA(A) receptors and a prominent role of glycine receptors at a high sevoflurane concentration. Conclusions: At high concentrations, sevoflurane mediates neuronal inhibition in the spinal ventral horn primarily via glycine receptors, and less via GABA(A) receptors. Our results support the hypothesis that the impact of GABA(A) receptors in mediating the immobilizing properties of volatile anesthetics is less essential in comparison to glycine receptors.	[Eckle, Veit-Simon; Hauser, Sabrina; Drexler, Berthold; Antkowiak, Bernd; Grasshoff, Christian] Univ Tubingen, Tubingen Univ Hosp, Dept Anesthesiol & Intens Care, Expt Anesthesiol Sect, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Drexler, B (corresponding author), Univ Tubingen, Tubingen Univ Hosp, Dept Anesthesiol & Intens Care, Expt Anesthesiol Sect, Tubingen, Germany.	berthold.drexler@uni-tuebingen.de	Drexler, Berthold/AAF-8358-2020	Drexler, Berthold/0000-0001-7202-1511				Antkowiak B, 1999, ANESTHESIOLOGY, V91, P500, DOI 10.1097/00000542-199908000-00025; Antkowiak B, 1997, J NEUROPHYSIOL, V77, P2525, DOI 10.1152/jn.1997.77.5.2525; Ballerini L, 1999, J PHYSIOL-LONDON, V517, P459, DOI 10.1111/j.1469-7793.1999.0459t.x; Banks MI, 1999, ANESTHESIOLOGY, V90, P120, DOI 10.1097/00000542-199901000-00018; BRASCHLER UF, 1989, J NEUROSCI METH, V29, P121, DOI 10.1016/0165-0270(89)90023-X; Cheng G, 2002, BRIT J PHARMACOL, V136, P673, DOI 10.1038/sj.bjp.0704760; CRAWFORD MW, 1992, ANESTH ANALG, V75, P1000; Czarnecki A, 2008, EUR J NEUROSCI, V27, P2076, DOI 10.1111/j.1460-9568.2008.06171.x; Darbon P, 2002, EUR J NEUROSCI, V15, P671, DOI 10.1046/j.1460-9568.2002.01904.x; Downie DL, 1996, BRIT J PHARMACOL, V118, P493, DOI 10.1111/j.1476-5381.1996.tb15430.x; Drexler B, 2010, CURR MED CHEM, V17, P4538, DOI 10.2174/092986710794183042; Drexler B, 2006, ANESTHESIOLOGY, V105, P297, DOI 10.1097/00000542-200608000-00012; Eger EI, 2008, ANESTH ANALG, V107, P832, DOI 10.1213/ane.0b013e318182aedb; Eger EJ, 2008, ANESTH ANALG, V107, P479, DOI 10.1213/01.ane.0000295805.70887.65; Evers AS, 1999, ANESTHESIOLOGY, V90, P1, DOI 10.1097/00000542-199901000-00002; Franks NP, 1996, ANESTHESIOLOGY, V84, P716, DOI 10.1097/00000542-199603000-00027; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Grasshoff C, 2004, ANESTHESIOLOGY, V101, P1167, DOI 10.1097/00000542-200411000-00017; Grasshoff C, 2006, BRIT J ANAESTH, V97, P687, DOI 10.1093/bja/ael239; Grasshoff C, 2007, MOL PHARMACOL, V72, P780, DOI 10.1124/mol.107.037648; Grasshoff C, 2010, ANESTH ANALG, V110, P638, DOI 10.1213/ANE.0b013e3181c531c8; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; HALL AC, 1994, BRIT J PHARMACOL, V112, P906, DOI 10.1111/j.1476-5381.1994.tb13166.x; HARRISON NL, 1993, MOL PHARMACOL, V44, P628; Hemmings HC, 2009, BRIT J ANAESTH, V103, P61, DOI 10.1093/bja/aep144; Jenkins A, 2008, ANESTH ANALG, V107, P486, DOI 10.1213/ane.0b013e31817b70c1; Jinks SL, 2005, ANESTHESIOLOGY, V103, P567, DOI 10.1097/00000542-200509000-00020; Jinks SL, 2008, ANESTHESIOLOGY, V108, P1016, DOI 10.1097/ALN.0b013e3181730297; Kendig JJ, 2002, BRIT J ANAESTH, V89, P91, DOI 10.1093/bja/aef158; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Lazarenko RM, 2010, J NEUROSCI, V30, P7691, DOI 10.1523/JNEUROSCI.1655-10.2010; Linden AM, 2006, J PHARMACOL EXP THER, V317, P615, DOI 10.1124/jpet.105.098525; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; MAZZE RI, 1985, ANESTHESIOLOGY, V62, P339, DOI 10.1097/00000542-198503000-00021; Michels G, 2007, CRIT REV BIOCHEM MOL, V42, P3, DOI 10.1080/10409230601146219; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Nishikawa K, 2001, ANESTHESIOLOGY, V94, P340, DOI 10.1097/00000542-200102000-00025; Oose Y, 2012, EUR J NEUROSCI, V35, P1396, DOI 10.1111/j.1460-9568.2012.08065.x; Raines DE, 1999, ANESTHESIOLOGY, V90, P135, DOI 10.1097/00000542-199901000-00019; Sibilla S, 2009, PROG NEUROBIOL, V89, P46, DOI 10.1016/j.pneurobio.2009.06.001; Sonner JM, 2003, ANESTH ANALG, V97, P718, DOI 10.1213/01.ANE.0000081063.76651.33; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Talpalar AE, 2011, NEURON, V71, P1071, DOI 10.1016/j.neuron.2011.07.011; WAKAMORI M, 1991, J NEUROPHYSIOL, V66, P2014, DOI 10.1152/jn.1991.66.6.2014; Zhang Y, 2004, ANESTH ANALG, V99, P85, DOI 10.1213/01.ANE.0000118108.64886.42; Zhang Y, 2003, ANESTH ANALG, V96, P97, DOI 10.1097/00000539-200301000-00021; ZIMMERMAN SA, 1994, J PHARMACOL EXP THER, V270, P987	47	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60286	10.1371/journal.pone.0060286	http://dx.doi.org/10.1371/journal.pone.0060286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565218	Green Published, gold			2022-12-27	WOS:000317717300087
J	Hongo, C; Yamano, H				Hongo, Chuki; Yamano, Hiroya			Species-Specific Responses of Corals to Bleaching Events on Anthropogenically Turbid Reefs on Okinawa Island, Japan, over a 15-year Period (1995-2009)	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; RECOVERY; WINNERS; ACCLIMATIZATION; REPRODUCTION; RESILIENCE; PACIFIC; IMPACTS; DECLINE	Coral bleaching, triggered by elevated sea-surface temperatures (SSTs) has caused a decline in coral cover and changes in the abundances of corals on reefs worldwide. Coral decline can be exacerbated by the effects of local stressors like turbidity, yet some reefs with a natural history of turbidity can support healthy and resilient coral communities. However, little is known about responses of coral communities to bleaching events on anthropogenically turbid reefs as a result of recent (post World War II) terrestrial runoff. Analysis of region-scale coral cover and species abundance at 17-20 sites on the turbid reefs of Okinawa Island (total of 79 species, 30 genera, and 13 families) from 1995 to 2009 indicates that coral cover decreased drastically, from 24.4% to 7.5% (1.1%/ year), subsequent to bleaching events in 1998 and 2001. This dramatic decrease in coral cover corresponded to the demise of Acropora species (e. g., A. digitifera) by 2009, when Acropora had mostly disappeared from turbid reefs on Okinawa Island. In contrast, Merulinidae species (e. g., Dipsastraea pallida/speciosa/favus) and Porites species (e. g., P. lutea/australiensis), which are characterized by tolerance to thermal stress, survived on turbid reefs of Okinawa Island throughout the period. Our results suggest that high turbidity, influenced by recent terrestrial runoff, could have caused a reduction in resilience of Acropora species to severe thermal stress events, because the corals could not have adapted to a relatively recent decline in water quality. The coral reef ecosystems of Okinawa Island will be severely impoverished if Acropora species fail to recover.	[Hongo, Chuki; Yamano, Hiroya] NIES, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan	National Institute for Environmental Studies - Japan	Hongo, C (corresponding author), NIES, Ctr Environm Biol & Ecosyst Studies, 16-2 Onogawa, Tsukuba, Ibaraki, Japan.	g123001@sci.u-ryukyu.ac.jp	Hongo, Chuki/AAO-8380-2020	Hongo, Chuki/0000-0002-9293-4163; Yamano, Hiroya/0000-0002-1549-2429	Ministry of the Environment, Japan (Environmental Research and Technology Development Fund, S9); JSPS [24-4044]; Grants-in-Aid for Scientific Research [20121006] Funding Source: KAKEN	Ministry of the Environment, Japan (Environmental Research and Technology Development Fund, S9); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this research was awarded to C. Hongo and H. Yamano by the Ministry of the Environment, Japan (Environmental Research and Technology Development Fund, S9) and to C. Hongo by JSPS Fellowships for Young Scientists (24-4044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L., 2011, REEFS RISK REVISITED; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Dimond JL, 2012, J EXP BIOL, V215, P2247, DOI 10.1242/jeb.067991; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gates RD, 1999, AM ZOOL, V39, P30; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hongo C, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001902; Hongo C, 2012, QUATERNARY SCI REV, V35, P82, DOI 10.1016/j.quascirev.2012.01.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kayanne H, 2002, MAR ECOL PROG SER, V239, P93, DOI 10.3354/meps239093; Kinjo K, 2005, NEWSLETTER OKINAWA P, V39, P63; Larcombe P, 1999, AUST J EARTH SCI, V46, P141, DOI 10.1046/j.1440-0952.1999.00694.x; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 1997, J EXP MAR BIOL ECOL, V209, P103, DOI 10.1016/S0022-0981(96)02663-9; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Nakano Y., 2004, CORAL REEFS JAPAN, P42; Omija T, 2004, CORAL REEFS OF JAPAN, P64; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Perry CT, 2008, GEOLOGY, V36, P691, DOI 10.1130/G24907A.1; RICHMOND RH, 1987, B MAR SCI, V41, P594; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron J. E. N., 1992, HERMATYPIC CORALS JA; Veron JEN, 1993, TOWNSVILLE BIOGEOGRA; Wilkinson C., 1998, 1997 1998 MASS BLEAC; WWF Japan, 2009, NANS ISL BIOL DIV FI; Yamano H, 2012, GEOLOGY, V40, P835, DOI 10.1130/G33293.1; Yara Y., 2009, J JAPANESE CORAL REE, V11, P131; Yokochi H, 2004, CORAL REEFS JAPAN, P49	49	59	60	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60952	10.1371/journal.pone.0060952	http://dx.doi.org/10.1371/journal.pone.0060952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565291	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300164
J	Martire, SI; Holmes, N; Westbrook, RF; Morris, MJ				Martire, Sarah I.; Holmes, Nathan; Westbrook, R. Fred; Morris, Margaret J.			Altered Feeding Patterns in Rats Exposed to a Palatable Cafeteria Diet: Increased Snacking and Its Implications for Development of Obesity	PLOS ONE			English	Article							BEHAVIORAL SATIETY SEQUENCE; SENSORY-SPECIFIC SATIETY; ENERGY-INTAKE; MEAL PATTERNS; FOOD-INTAKE; FAT; ADOLESCENTS; APPETITE; CD36; BSS	Background: Rats prefer energy-rich foods over chow and eat them to excess. The pattern of eating elicited by this diet is unknown. We used the behavioral satiety sequence to classify an eating bout as a meal or snack and compared the eating patterns of rats fed an energy rich cafeteria diet or chow. Methods: Eight week old male Sprague Dawley rats were exposed to lab chow or an energy-rich cafeteria diet (plus chow) for 16 weeks. After 5, 10 and 15 weeks, home-cage overnight feeding behavior was recorded. Eating followed by grooming then resting or sleeping was classified as a meal; whereas eating not followed by the full sequence was classified as a snack. Numbers of meals and snacks, their duration, and waiting times between feeding bouts were compared between the two conditions. Results: Cafeteria-fed rats ate more protein, fat and carbohydrate, consistently ingesting double the energy of chow-fed rats, and were significantly heavier by week 4. Cafeteria-fed rats tended to take multiple snacks between meals and ate fewer meals than chow-fed rats. They also ate more snacks at 5 weeks, were less effective at compensating for snacking by reducing meals, and the number of snacks in the majority of the cafeteria-fed rats was positively related to terminal body weights. Conclusions: Exposure to a palatable diet had long-term effects on feeding patterns. Rats became overweight because they initially ate more frequently and ultimately ate more of foods with higher energy density. The early increased snacking in young cafeteria-fed rats may represent the establishment of eating habits that promote weight gain.	[Martire, Sarah I.; Holmes, Nathan; Westbrook, R. Fred] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Morris, Margaret J.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Morris, MJ (corresponding author), Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW 2052, Australia.	m.morris@unsw.edu.au	Morris, Margaret J/J-4285-2013	Morris, Margaret/0000-0003-2285-5117; Holmes, Nathan/0000-0002-0592-2026; Westbrook, Fred/0000-0002-6880-9274	National Health and Medical Research Council of Australia [568728]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a project grant #568728 of the National Health and Medical Research Council of Australia to MJM and RFW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; Berteus-Forslund H, 2005, INT J OBESITY, V29, P711, DOI 10.1038/sj.ijo.0802950; Berthoud HR, 2011, AM J PHYSIOL-REG I, V300, pR1266, DOI 10.1152/ajpregu.00028.2011; BLUNDELL JE, 1985, BRAIN RES BULL, V15, P371, DOI 10.1016/0361-9230(85)90004-8; BOLLES RC, 1960, J COMP PHYSIOL PSYCH, V53, P306, DOI 10.1037/h0045421; Chapelot D, 2011, J NUTR, V141, P158, DOI 10.3945/jn.109.114330; de Graaf C, 2004, AM J CLIN NUTR, V79, P946; de Graaf C, 2006, APPETITE, V47, P18, DOI 10.1016/j.appet.2006.02.007; Forslund HB, 2002, EUR J CLIN NUTR, V56, P740, DOI 10.1038/sj.ejcn.1601387; Halford JCG, 1998, PHARMACOL BIOCHEM BE, V61, P159, DOI 10.1016/S0091-3057(98)00032-X; Hansen MJ, 2004, J NEUROCHEM, V88, P909, DOI 10.1046/j.1471-4159.2003.02217.x; Ishii Y, 2003, PHYSIOL BEHAV, V80, P37, DOI 10.1016/S0031-9384(03)00207-5; Koliaki Chrysi, 2010, Int J Pept, V2010, DOI 10.1155/2010/710852; Little TJ, 2011, PHYSIOL BEHAV, V104, P613, DOI 10.1016/j.physbeh.2011.04.038; Marmonier C, 2000, APPETITE, V34, P161, DOI 10.1006/appe.1999.0302; Martire SI, 2010, BEHAV BRAIN RES, V209, P131, DOI 10.1016/j.bbr.2010.01.034; McConahy KL, 2002, J PEDIATR-US, V140, P340, DOI 10.1067/mpd.2002.122467; Nielsen AJ, 2003, JAMA-J AM MED ASSOC, V289, P450; Nielsen SJ, 2002, PREV MED, V35, P107, DOI 10.1006/pmed.2002.1037; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Rodgers RJ, 2010, PHARMACOL BIOCHEM BE, V97, P3, DOI 10.1016/j.pbb.2010.03.001; ROGERS PJ, 1984, NEUROSCI BIOBEHAV R, V8, P441, DOI 10.1016/0149-7634(84)90003-4; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; ROLLS BJ, 1983, PHYSIOL BEHAV, V31, P21, DOI 10.1016/0031-9384(83)90091-4; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Rozin P., 2004, INT ENCY SOCIAL BEHA, pp. 5719, DOI [10.1016/B0-08-043076-7/03671-8, DOI 10.1016/B0-08-043076-7/03671-8]; Savige G, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-36; Schwartz GJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE967, DOI 10.1152/ajpendo.00177.2009; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; South T, 2012, PHYSIOL BEHAV, V105, P1052, DOI 10.1016/j.physbeh.2011.11.019; Stubbs RJ, 1998, P NUTR SOC, V57, P341, DOI 10.1079/PNS19980052; WesterterpPlantenga MS, 1996, EUR J CLIN NUTR, V50, P401; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246; Zandstra EH, 2011, APPETITE, V57, P45, DOI 10.1016/j.appet.2011.03.007; Zhang XJ, 2011, ACTA HISTOCHEM, V113, P663, DOI 10.1016/j.acthis.2010.09.007; Zizza C, 2001, PREV MED, V32, P303, DOI 10.1006/pmed.2000.0817	36	53	54	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60407	10.1371/journal.pone.0060407	http://dx.doi.org/10.1371/journal.pone.0060407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565243	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300113
J	Gu, JD; Wen, YJ; Zhu, SW; Hua, F; Zhao, H; Xu, HR; You, JC; Sun, LL; Wang, WQ; Chen, J; Zhou, QH				Gu, Jundong; Wen, Yanjun; Zhu, Siwei; Hua, Feng; Zhao, Hui; Xu, Hongrui; You, Jiacong; Sun, Linlin; Wang, Weiqiang; Chen, Jun; Zhou, Qinghua			Association between P-16INK4a Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							HYPERMETHYLATION; P16(INK4A); GENE; TUMOR; SPUTUM; STAGE; P16; INACTIVATION; EPIGENETICS; MARKER	Background: Aberrant methylation of CpG islands acquired in tumor cells in promoter regions plays an important role in carcinogenesis. Accumulated evidence demonstrates P-16INK4a gene promoter hypermethylation is involved in non-small cell lung carcinoma (NSCLC), indicating it may be a potential biomarker for this disease. The aim of this study is to evaluate the frequency of P-16INK4a gene promoter methylation between cancer tissue and autologous controls by summarizing published studies. Methods: By searching Medline, EMBSE and CNKI databases, the open published studies about P-16INK4a gene promoter methylation and NSCLC were identified using a systematic search strategy. The pooled odds of P-16INK4A promoter methylation in lung cancer tissue versus autologous controls were calculated by meta-analysis method. Results: Thirty-four studies, including 2 652 NSCLC patients with 5 175 samples were included in this meta-analysis. Generally, the frequency of P-16INK4A promoter methylation ranged from 17% to 80% (median 44%) in the lung cancer tissue and 0 to 80% (median 15%) in the autologous controls, which indicated the methylation frequency in cancer tissue was much higher than that in autologous samples. We also find a strong and significant correlation between tumor tissue and autologous controls of P-16INK4A promoter methylation frequency across studies (Correlation coefficient 0.71, 95% CI: 0.51-0.83, P < 0.0001). And the pooled odds ratio of P-16INK4A promoter methylation in cancer tissue was 3.45 (95% CI: 2.63-4.54) compared to controls under random-effect model. Conclusion: Frequency of P-16INK4a promoter methylation in cancer tissue was much higher than that in autologous controls, indicating promoter methylation plays an important role in carcinogenesis of the NSCLC. Strong and significant correlation between tumor tissue and autologous samples of P-16INK4A promoter methylation demonstrated a promising biomarker for NSCLC.	[Gu, Jundong; You, Jiacong; Sun, Linlin; Wang, Weiqiang; Chen, Jun; Zhou, Qinghua] Tianjin Med Univ Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China; [Wen, Yanjun] Tianjin Med Univ Gen Hosp, Neurol Inst, Dept Neuropathol, Tianjin, Peoples R China; [Zhu, Siwei] Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R China; [Hua, Feng] Shandong Canc Hosp, Dept Thorac Surg, Jinan, Shandong, Peoples R China; [Gu, Jundong; Zhao, Hui; Xu, Hongrui] Tianjin Union Med Ctr, Dept Thorac Surg, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences	Zhou, QH (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China.	zhouqh1016@yahoo.com.cn						Bearzatto A, 2002, CLIN CANCER RES, V8, P3782; Belinsky SA, 2007, BRIT J CANCER, V96, P1278, DOI 10.1038/sj.bjc.6603721; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Brambilla E, 1999, J PATHOL, V188, P351, DOI 10.1002/(SICI)1096-9896(199908)188:4<351::AID-PATH385>3.0.CO;2-W; Cai ZX, 2003, CHINA CANC, V12, P536; Chen JT, 2002, INT J CANCER, V98, P724, DOI 10.1002/ijc.10262; Chen SH, 2010, CHIN J LAB DIAGN, V14, P1035; Cirincione R, 2006, INT J CANCER, V118, P1248, DOI 10.1002/ijc.21473; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gazzeri S, 1998, ONCOGENE, V16, P497, DOI 10.1038/sj.onc.1201559; Georgiou E, 2007, EUR J CANCER PREV, V16, P396, DOI 10.1097/01.cej.0000236260.26265.d6; Guo MF, 2010, MMJC, V12, P82; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763; Guo XJ, 2008, HEBEI MED J, V30, P757; Harden SV, 2003, CLIN CANCER RES, V9, P1370; He JY, 2011, J GUANGDONG MED COLL, V35, P321; He Y, 2002, CHINESE J HLTH LAB T, V12, P294; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hong YS, 2007, J KOREAN MED SCI, V22, pS32, DOI 10.3346/jkms.2007.22.S.S32; Hsu HS, 2007, J PATHOL, V213, P412, DOI 10.1002/path.2246; Hsu HS, 2007, CANCER-AM CANCER SOC, V110, P2019, DOI 10.1002/cncr.23001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim DS, 2007, LUNG CANCER, V58, P1, DOI 10.1016/j.lungcan.2007.04.008; Li WF, 2006, J GUANGDONG MED COLL, V27, P855; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Liu Jin-Yi, 2004, Zhonghua Zhongliu Zazhi, V26, P75; Liu Y, 2003, CARCINOGENESIS, V24, P1897, DOI 10.1093/carcin/bgg169; Ng CSH, 2002, J SURG ONCOL, V79, P101, DOI 10.1002/jso.10046; Risch A, 2008, INT J CANCER, V123, P1, DOI 10.1002/ijc.23605; Russo AL, 2005, CLIN CANCER RES, V11, P2466, DOI 10.1158/1078-0432.CCR-04-1962; Sapari NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036275; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Seike M, 2000, CLIN CANCER RES, V6, P4307; Su Changqing, 2000, Zhonghua Zhongliu Zazhi, V22, P471; Sun N, 2012, PROG MOD BIOMED, V12, P2503; Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085; Trinquart L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035219; Ulivi P, 2006, J CELL PHYSIOL, V206, P611, DOI 10.1002/jcp.20503; Wang Y, 2008, CANCER-AM CANCER SOC, V112, P1325, DOI 10.1002/cncr.23312; Wang YS, 2006, ACTA U MED ANHUI, V41, P619; Yang ZhenHua, 2007, Journal of Practical Oncology, V22, P153; Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028882; Zhang Chen-ye, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P23, DOI 10.3760/cma.j.issn.1003-9406.2011.01.006; Zhang L, 2007, MED J QILU, V22, P347; Zhang W, 2004, MED J AIR FORCE, V20, P25; Zhang ZX, 2006, CHINA J MODERN MED, V16, P1338; Zochbauer-Muller S, 2001, CANCER RES, V61, P249	51	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60107	10.1371/journal.pone.0060107	http://dx.doi.org/10.1371/journal.pone.0060107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577085	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800028
J	Liu, T; Zhang, J; Zhang, J; Mu, X; Su, H; Hu, XD; Liu, WL; Zhao, EB; Li, WM				Liu, Tong; Zhang, Jian; Zhang, Jing; Mu, Xin; Su, Hui; Hu, Xiaoding; Liu, Wenli; Zhao, Enbing; Li, Weimin			RNA Interference against Platelet-Derived Growth Factor Receptor alpha mRNA Inhibits Fibroblast Transdifferentiation in Skin Lesions of Patients with Systemic Sclerosis	PLOS ONE			English	Article							SCLERODERMA FIBROBLASTS; PDGF; FIBROSIS; BETA; PATHOGENESIS; IMATINIB	Objective: To down-regulate expression of mRNA for the platelet-derived growth factor receptor (PDGFR)-alpha, block the signalling pathway of PDGF and its receptor, and study their influence on fibroblast transdifferentiation to myofibroblasts in systemic sclerosis (SSc). Methods: Fibroblasts from skin lesions of SSc patients and health adult controls were cultured in vitro, and alpha-smooth muscle actin (alpha-SMA) expression was determined by immunocytochemistry. Both groups of fibroblasts were stimulated with PDGF-AA, transforming growth factor beta(1) (TGF-beta(1)), and costimulated with PDGF-AA and TGF-beta(1), then PDGFR-alpha and alpha-SMA mRNA and protein expression were detected with RT-PCR and WB respectively. Three pairs of siRNAs targeting different PDGFR-alpha mRNA sequences were synthesized for RNAi. SSc and control fibroblasts were transfected with PDGFR-alpha siRNA; stimulated with PDGF-AA; and assessed for PDGFR-alpha and alpha-SMA mRNA and protein expression. Results: Although the fibroblasts from both groups had similar morphology, the SSc skin lesions had significantly more myofibroblasts than control skin lesions. PDGF-AA stimulation, TGF-beta(1) stimulation, and costimulation significantly up-regulated PDGFR-alpha and alpha-SMA mRNA and protein expression in SSc fibroblasts compared to control (P<0.05), and costimulation had the strongest effects (P<0.05). All three pairs of siRNAs suppressed PDGFR-alpha mRNA and protein expression (P<0.05), but siRNA(1495) had the highest gene-silencing efficiency (P<0.05). PDGFR-alpha siRNA attenuated the effects of PDGF-AA through up-regulating PDGFR-alpha and alpha-SMA mRNA and protein expression and inhibiting fibroblast transdifferentiation to myofibroblasts in SSc (P<0.05). Conclusions: PDGFR-alpha over-expression in SSc fibroblasts bound PDGF-AA more efficiently and promoted fibroblast transdifferentiation, which was enhanced by TGF-beta(1). PDGFR-alpha siRNA down-regulated PDGFR-alpha expression, blocked binding to PDGF-AA, and inhibited fibroblast transdifferentiation to myofibroblasts.	[Liu, Tong; Zhang, Jian; Zhang, Jing; Mu, Xin; Hu, Xiaoding; Liu, Wenli; Zhao, Enbing; Li, Weimin] Xi An Jiao Tong Univ, Dept Dermatol, Coll Med, Affiliated Hosp 1, Xian 710049, Shaanxi Provinc, Peoples R China; [Su, Hui] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Dermatol, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Liu, T (corresponding author), Xi An Jiao Tong Univ, Dept Dermatol, Coll Med, Affiliated Hosp 1, Xian 710049, Shaanxi Provinc, Peoples R China.	tonyl1220@sina.com			Science and Technology program from Science and Technology Department of Shaanxi Province of China [2008K15-06]	Science and Technology program from Science and Technology Department of Shaanxi Province of China	The contract grant sponsor for this study was the Science and Technology program from Science and Technology Department of Shaanxi Province of China, contract grant number 2008K15-06. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Chen SW, 2008, LIVER INT, V28, P1446, DOI 10.1111/j.1478-3231.2008.01759.x; Czochra P, 2006, J HEPATOL, V45, P419, DOI 10.1016/j.jhep.2006.04.010; Gordon J, 2011, CURR RHEUMATOL REP, V13, P51, DOI 10.1007/s11926-010-0146-6; Ihn H, 2008, J DERMATOL SCI, V49, P103, DOI 10.1016/j.jdermsci.2007.05.014; Kawaguchi Y, 1999, J CLIN INVEST, V103, P1253, DOI 10.1172/JCI4304; Leask A, 2011, J CELL COMMUN SIGNAL, V5, P125, DOI 10.1007/s12079-011-0122-6; Leask A, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-8; LeBleu VS, 2011, KIDNEY INT, V80, P1119, DOI 10.1038/ki.2011.300; Liakouli V, 2011, AUTOIMMUN REV, V10, P590, DOI 10.1016/j.autrev.2011.04.019; LUDWICKA A, 1995, J RHEUMATOL, V22, P1876; Mimura Y, 2005, J INVEST DERMATOL, V124, P886, DOI 10.1111/j.0022-202X.2005.23701.x; Reich N, 2010, ARTHRITIS RHEUM-US, V62, P280, DOI 10.1002/art.25056; Schulz SW, 2009, CURR MED CHEM, V16, P3986, DOI 10.2174/092986709789352259; Sfikakis PP, 2008, RHEUMATOLOGY, V47, P735, DOI 10.1093/rheumatology/ken104; Shan G, 2010, INT J BIOCHEM CELL B, V42, P1243, DOI 10.1016/j.biocel.2009.04.023; Spiera RF, 2011, ANN RHEUM DIS, V70, P1003, DOI 10.1136/ard.2010.143974; Trojanowska M, 2008, RHEUMATOLOGY, V47, pV2, DOI 10.1093/rheumatology/ken265; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; YAMAKAGE A, 1992, J EXP MED, V175, P1227, DOI 10.1084/jem.175.5.1227	20	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60414	10.1371/journal.pone.0060414	http://dx.doi.org/10.1371/journal.pone.0060414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577108	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800048
J	Salvador, GHM; Fernandes, CAH; Magro, AJ; Marchi-Salvador, DP; Cavalcante, WLG; Fernandez, RM; Gallacci, M; Soares, AM; Oliveira, CLP; Fontes, MRM				Salvador, Guilherme H. M.; Fernandes, Carlos A. H.; Magro, Angelo J.; Marchi-Salvador, Daniela P.; Cavalcante, Walter L. G.; Fernandez, Roberto M.; Gallacci, Marcia; Soares, Andreimar M.; Oliveira, Cristiano L. P.; Fontes, Marcos R. M.			Structural and Phylogenetic Studies with MjTX-I Reveal a Multi-Oligomeric Toxin - a Novel Feature in Lys49-PLA(2)s Protein Class	PLOS ONE			English	Article							LYS49 PHOSPHOLIPASE A(2); MEMBRANE-DAMAGING ACTIVITIES; SNAKE-VENOM; CRYSTAL-STRUCTURE; MYOTOXIN-II; LYS(49)-PHOSPHOLIPASE A(2); BOTHROPS; EVOLUTION; CRYSTALLIZATION; HOMOLOG	The mortality caused by snakebites is more damaging than many tropical diseases, such as dengue haemorrhagic fever, cholera, leishmaniasis, schistosomiasis and Chagas disease. For this reason, snakebite envenoming adversely affects health services of tropical and subtropical countries and is recognized as a neglected disease by the World Health Organization. One of the main components of snake venoms is the Lys49-phospholipases A(2), which is catalytically inactive but possesses other toxic and pharmacological activities. Preliminary studies with MjTX-I from Bothrops moojeni snake venom revealed intriguing new structural and functional characteristics compared to other bothropic Lys49-PLA(2)s. We present in this article a comprehensive study with MjTX-I using several techniques, including crystallography, small angle X-ray scattering, analytical size-exclusion chromatography, dynamic light scattering, myographic studies, bioinformatics and molecular phylogenetic analyses. Based in all these experiments we demonstrated that MjTX-I is probably a unique Lys49-PLA(2), which may adopt different oligomeric forms depending on the physical-chemical environment. Furthermore, we showed that its myotoxic activity is dramatically low compared to other Lys49-PLA(2)s, probably due to the novel oligomeric conformations and important mutations in the C-terminal region of the protein. The phylogenetic analysis also showed that this toxin is clearly distinct from other bothropic Lys49-PLA(2)s, in conformity with the peculiar oligomeric characteristics of MjTX-I and possible emergence of new functionalities inresponse to environmental changes and adaptation to new preys.	[Salvador, Guilherme H. M.; Fernandes, Carlos A. H.; Magro, Angelo J.; Marchi-Salvador, Daniela P.; Cavalcante, Walter L. G.; Fernandez, Roberto M.; Fontes, Marcos R. M.] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil; [Cavalcante, Walter L. G.; Gallacci, Marcia] Univ Estadual Paulista, UNESP, Dept Farmacol, Botucatu, SP, Brazil; [Soares, Andreimar M.] Univ Fed Rondonia UNIR, Fundaco Oswaldo Cruz FIOCRUZ Rondonia, Porto Velho, RO, Brazil; [Soares, Andreimar M.] Univ Fed Rondonia UNIR, Ctr Estudos Biomol Aplicadas CEBio, Porto Velho, RO, Brazil; [Oliveira, Cristiano L. P.] Univ Sao Paulo, USP, Inst Fis, Dept Fis Expt, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Fundacao Oswaldo Cruz; Universidade Federal de Rondonia; Universidade Federal de Rondonia; Universidade de Sao Paulo	Fontes, MRM (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil.	fontes@ibb.unesp.br	Soares, Andreimar M/K-5556-2014; Magro, Angelo J./J-9710-2012; Oliveira, Cristiano L P/B-4403-2008; Fernandez, Roberto/K-2308-2014; Gallacci, Márcia/C-8479-2013; Fontes, Marcos Roberto/B-1941-2009; Salvador, Guilherme H M/O-1843-2015; Marchi Salvador, Guilherme Henrique/ABB-8567-2021; Soares, Andreimar/AAE-4657-2021; Soares, Andrei/ABG-3545-2020; Cavalcante, Walter L G/B-1212-2013; Fernandes, Carlos/AAY-6730-2020	Oliveira, Cristiano L P/0000-0002-3426-6507; Gallacci, Márcia/0000-0001-6149-4030; Fontes, Marcos Roberto/0000-0002-4634-6221; Salvador, Guilherme H M/0000-0001-7459-7637; Marchi Salvador, Guilherme Henrique/0000-0001-7459-7637; Cavalcante, Walter L G/0000-0002-2354-636X; Fernandes, Carlos/0000-0001-6515-6872; Soares, Andreimar/0000-0003-1032-2188; Magro, Angelo Jose/0000-0002-4253-6992	FAPESP; CNPq; Capes	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by FAPESP, CNPq and Capes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio ALB, 2005, J BIOL CHEM, V280, P7326, DOI 10.1074/jbc.M410588200; Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0; Arni RK, 1999, ARCH BIOCHEM BIOPHYS, V366, P177, DOI 10.1006/abbi.1999.1210; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavalcante WLG, 2007, J ETHNOPHARMACOL, V112, P490, DOI 10.1016/j.jep.2007.04.002; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chioato L, 2002, BIOCHEM J, V366, P971, DOI 10.1042/BJ20020092; Chioato L, 2007, BBA-BIOMEMBRANES, V1768, P1247, DOI 10.1016/j.bbamem.2007.01.023; Craievich A, 2005, HDB SOL GEL SCI TECH; D'Alessio G, 1999, PROG BIOPHYS MOL BIO, V72, P271, DOI 10.1016/S0079-6107(99)00009-7; da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I; deOliveira RC, 2009, ANIMAIS PECONHENTOS; dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858; dos Santos JI, 2009, PROTEIN PEPTIDE LETT, V16, P887, DOI 10.2174/092986609788923310; dos Santos JI, 2009, J STRUCT BIOL, V167, P106, DOI 10.1016/j.jsb.2009.04.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenwick AM, 2009, ZOOL J LINN SOC-LOND, V156, P617, DOI 10.1111/j.1096-3642.2008.00495.x; Fernandes CA, 2010, J STRUCTURAL BIOL; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2009, J PROTEOMICS, V72, P127, DOI 10.1016/j.jprot.2009.01.009; Gallacci M, 2006, EXP TOXICOL PATHOL, V57, P239, DOI 10.1016/j.etp.2005.09.004; Gallacci M, 2010, TOXICON, V55, P1, DOI 10.1016/j.toxicon.2009.10.025; GLATTER O, 1977, ACTA PHYS AUSTRIACA, V47, P83; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; HARVEY AL, 1994, TOXICON, V32, P257, DOI 10.1016/0041-0101(94)90078-7; HOLLAND DR, 1990, J BIOL CHEM, V265, P17649; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee WH, 2001, BIOCHEMISTRY-US, V40, P28, DOI 10.1021/bi0010470; Lomonte B, 2003, TOXICON, V42, P307, DOI 10.1016/S0041-0101(03)00149-1; Maddison WP, 2011, MESQUITE MODULAR SYS; Magro AJ, 2003, BIOCHEM BIOPH RES CO, V311, P713, DOI 10.1016/j.bbrc.2003.10.047; Marchi-Salvador DP, 2009, BBA-PROTEINS PROTEOM, V1794, P1583, DOI 10.1016/j.bbapap.2009.07.005; Marchi-Salvador DP, 2005, ACTA CRYSTALLOGR F, V61, P882, DOI 10.1107/S174430910502717X; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; McPHERSON A, 1989, CRYSTALLIZATION BIOL; Mihel J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-21; Murakami MT, 2007, TOXICON, V49, P378, DOI 10.1016/j.toxicon.2006.10.011; Murakami MT, 2005, J MOL BIOL, V350, P416, DOI 10.1016/j.jmb.2005.04.072; Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6; Ogawa T, 1996, TOXICON, V34, P1229, DOI 10.1016/S0041-0101(96)00112-2; Oliveira CLP, 2009, J MOL BIOL, V387, P147, DOI 10.1016/j.jmb.2009.01.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Saude F.N.d, 2001, MAN DIAGN TRAT AC AN; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schwartz AS, 2007, BIOINFORMATICS, V23, pE24, DOI 10.1093/bioinformatics/btl311; Soares AM, 2000, ARCH BIOCHEM BIOPHYS, V373, P7, DOI 10.1006/abbi.1999.1492; Soares AM, 1998, TOXICON, V36, P503, DOI 10.1016/S0041-0101(97)00133-5; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Uetz P., 2012, REPTILE DATABASE; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089; Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; WL D, 2002, PYMOL MOL GRAPHICS S	64	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60610	10.1371/journal.pone.0060610	http://dx.doi.org/10.1371/journal.pone.0060610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573271	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100090
J	Wang, Y; Ye, XS; Ding, GD; Xu, FS				Wang, Yi; Ye, Xiangsheng; Ding, Guangda; Xu, Fangsen			Overexpression of phyA and appA Genes Improves Soil Organic Phosphorus Utilisation and Seed Phytase Activity in Brassica napus	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; EXTRACELLULAR PHYTASE; TRANSGENIC EXPRESSION; PLANTS; GROWTH; ACQUISITION; ROOTS; ACID; ARABIDOPSIS; SECRETION	Phytate is the major storage form of organic phosphorus in soils and plant seeds, and phosphorus (P) in this form is unavailable to plants or monogastric animals. In the present study, the phytase genes phyA and appA were introduced into Brassica napus cv Westar with a signal peptide sequence and CaMV 35S promoter, respectively. Three independent transgenic lines, P3 and P11 from phyA and a18 from appA, were selected. The three transgenic lines exhibited significantly higher exuded phytase activity when compared to wild-type (WT) controls. A quartz sand culture experiment demonstrated that transgenic Brassica napus had significantly improved P uptake and plant biomass. A soil culture experiment revealed that seed yields of transgenic lines P11 and a18 increased by 20.9% and 59.9%, respectively, when compared to WT. When phytate was used as the sole P source, P accumulation in seeds increased by 20.6% and 46.9% with respect to WT in P11 and a18, respectively. The P3 line accumulated markedly more P in seeds than WT, while no significant difference was observed in seed yields when phytate was used as the sole P source. Phytase activities in transgenic canola seeds ranged from 1,138 to 1,605 U kg(-1) seeds, while no phytase activity was detected in WT seeds. Moreover, phytic acid content in P11 and a18 seeds was significantly lower than in WT. These results introduce an opportunity for improvement of soil and seed phytate-P bioavailability through genetic manipulation of oilseed rape, thereby increasing plant production and P nutrition for monogastric animals.	[Wang, Yi; Ye, Xiangsheng; Ding, Guangda; Xu, Fangsen] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Wang, Yi; Ye, Xiangsheng; Ding, Guangda; Xu, Fangsen] Huazhong Agr Univ, Microelement Res Ctr, Wuhan, Peoples R China; [Wang, Yi] Henan Agr Univ, Coll Resources & Environm Sci, Zhengzhou, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Henan Agricultural University	Xu, FS (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	fangsenxu@mail.hzau.edu.cn	Ding, Guangda/AAH-5026-2021; Ding, Guangda/ABG-3651-2020	Ding, Guangda/0000-0003-3702-5087	National Basic Research and Development Program [2011CB100301]; National Natural Science Foundation of China, China [31172019]	National Basic Research and Development Program(National Basic Research Program of China); National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from National Basic Research and Development Program (2011CB100301 (http://www.973.gov.cn/Default_3. aspx) and National Natural Science Foundation of China (31172019), China (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon, 1950, WATER CULTURE METHOD, V347, DOI DOI 10.1073/PNAS.1211132109; Bilyeu KD, 2008, PLANT PHYSIOL, V146, P468, DOI 10.1104/pp.107.113480; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinch-Pedersen H, 2006, J AGR FOOD CHEM, V54, P4624, DOI 10.1021/jf0600152; Brinch-Pedersen H, 2000, MOL BREEDING, V6, P195, DOI 10.1023/A:1009690730620; Brinch-Pedersen H, 2002, TRENDS PLANT SCI, V7, P118, DOI 10.1016/S1360-1385(01)02222-1; CHEN J, 1985, EMBO J, V4, P2145, DOI 10.1002/j.1460-2075.1985.tb03908.x; Chen RM, 2008, TRANSGENIC RES, V17, P633, DOI 10.1007/s11248-007-9138-3; Chiera JM, 2004, PLANT MOL BIOL, V56, P895, DOI 10.1007/s11103-004-5293-6; Dalal R. C., 1977, Advances in Agronomy, V29, P83; George Timothy S., 2008, V7, P247; George TS, 2005, PLANT BIOTECHNOL J, V3, P129, DOI 10.1111/j.1467-7652.2004.00116.x; George TS, 2004, PLANT CELL ENVIRON, V27, P1351, DOI 10.1111/j.1365-3040.2004.01225.x; Golovan S, 2000, CAN J MICROBIOL, V46, P59, DOI 10.1139/cjm-46-1-59; Hayes JE, 2000, PLANT SOIL, V220, P165, DOI 10.1023/A:1004782324030; Hong CY, 2004, TRANSGENIC RES, V13, P29, DOI 10.1023/B:TRAG.0000017158.96765.67; Idriss EE, 2002, MICROBIOL-SGM, V148, P2097, DOI 10.1099/00221287-148-7-2097; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kwanyuen P, 2005, J AM OIL CHEM SOC, V82, P81, DOI 10.1007/s11746-005-1046-9; LATTA M, 1980, J AGR FOOD CHEM, V28, P1313, DOI 10.1021/jf60232a049; Lei X.G., 2007, IND ENZYMES STRUCTUR, P505, DOI DOI 10.1007/1-4020-5377-0_; Li GL, 2009, BIOTECHNOL LETT, V31, P1295, DOI 10.1007/s10529-009-9992-6; Li MG, 1997, PLANT SOIL, V195, P161, DOI 10.1023/A:1004264002524; Liu JF, 2011, PLANT CELL TISS ORG, V106, P207, DOI 10.1007/s11240-010-9908-0; Lott JNA, 2000, SEED SCI RES, V10, P11, DOI 10.1017/S0960258500000039; Ma XF, 2009, PLANT SCI, V176, P479, DOI 10.1016/j.plantsci.2009.01.001; Mudge SR, 2003, PLANT SCI, V165, P871, DOI 10.1016/S0168-9452(03)00286-3; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Peng RH, 2006, PLANT CELL REP, V25, P124, DOI 10.1007/s00299-005-0036-y; Ponstein AS, 2002, MOL BREEDING, V10, P31, DOI 10.1023/A:1020326219687; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Richardson AE, 2000, PLANT CELL ENVIRON, V23, P397, DOI 10.1046/j.1365-3040.2000.00557.x; Richardson AE, 2001, PLANT J, V25, P641, DOI 10.1046/j.1365-313x.2001.00998.x; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Unno Y, 2005, ENVIRON MICROBIOL, V7, P396, DOI 10.1111/j.1462-2920.2004.00701.x; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Wang Y, 2013, PLANT SOIL, V362, P231, DOI 10.1007/s11104-012-1289-1; Westerman RL, 1990, SOIL SCI SOC AM BOOK, V3; Wyss M, 1999, APPL ENVIRON MICROB, V65, P359; Xiao K, 2005, PLANTA, V222, P27, DOI 10.1007/s00425-005-1511-y; Yang M, 2010, THEOR APPL GENET, V121, P181, DOI 10.1007/s00122-010-1301-1; Zimmermann P, 2003, PLANT BIOTECHNOL J, V1, P353, DOI 10.1046/j.1467-7652.2003.00033.x	43	20	21	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60801	10.1371/journal.pone.0060801	http://dx.doi.org/10.1371/journal.pone.0060801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573285	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100105
J	Cho, GJ; Kim, LY; Hong, HR; Lee, CE; Hong, SC; Oh, MJ; Kim, HJ				Cho, Geum Joon; Kim, Log Young; Hong, Hye-Ri; Lee, Chang Eun; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong			Trends in the Rates of Peripartum Hysterectomy and Uterine Artery Embolization	PLOS ONE			English	Article							POSTPARTUM HEMORRHAGE; CESAREAN DELIVERY; RISK-FACTORS; MANAGEMENT	The objective of this study was to determine the trends in national rates of peripartum hysterectomy (PH) and uterine arterial embolization (UAE) in Korea. We used data collected by the Health Insurance Review & Assessment Service of Korea and analyzed data from patients who gave birth during the period from 2005 to 2008. There were 1785,178 deliveries during the study period, including 2636 cases of PH (1.48 per 1000 deliveries). The PH rate in 2005 was 1.57 per 1000 deliveries and in 2008 it was 1.33 per 1000 deliveries. UAE was performed in 161 women (incidence, 0.38 per 1000 deliveries) and 447 women (incidence, 0.98 per 1000 deliveries) in 2005 and 2008, respectively. In Korea, the rate of PH decreased slightly, while the rate of UAE rate increased dramatically during the period from 2005 to 2008. Further studies are needed to evaluate the effects of UAE on the rate of PH performed.	[Cho, Geum Joon; Hong, Hye-Ri; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong] Korea Univ, Coll Med, Dept Obstet & Gynecol, Guro Hosp, Seoul 136705, South Korea; [Kim, Log Young] Hlth Insurance Review & Assessment Serv Korea, Seoul, South Korea; [Lee, Chang Eun] Dongnam Hlth Univ, Suwon, South Korea	Korea University; Korea University Medicine (KU Medicine)	Oh, MJ (corresponding author), Korea Univ, Coll Med, Dept Obstet & Gynecol, Guro Hosp, Seoul 136705, South Korea.	mjohmd@korea.ac.kr	Rhim, Sonny H./W-9532-2019	Cho, Geum Joon/0000-0001-6761-0944				Bai SW, 2003, J REPROD MED, V48, P148; Bauer ST, 2009, SEMIN PERINATOL, V33, P88, DOI 10.1053/j.semperi.2008.12.003; Bodelon C, 2009, OBSTET GYNECOL, V114, P115, DOI 10.1097/AOG.0b013e3181a81cdd; CHESTNUT DH, 1985, OBSTET GYNECOL, V65, P365; Choi NK, 2007, ANN PHARMACOTHER, V41, P667, DOI 10.1345/aph.1H247; Flood KM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.001; Francois K, 2005, OBSTET GYNECOL, V105, P1369, DOI 10.1097/01.AOG.0000161311.31894.31; Glaze S, 2008, OBSTET GYNECOL, V111, P732, DOI 10.1097/AOG.0b013e31816569f2; Winograd RH, 2008, BEST PRACT RES CL OB, V22, P1119, DOI 10.1016/j.bpobgyn.2008.08.009; Hunter LA, 2010, J PERINAT NEONAT NUR, V24, P207, DOI 10.1097/JPN.0b013e3181e8c994; Jou HJ, 2008, INT J GYNECOL OBSTET, V101, P269, DOI 10.1016/j.ijgo.2007.12.004; Kacmar J, 2003, OBSTET GYNECOL, V102, P141, DOI 10.1016/S0029-7844(03)00404-6; Kim JY, 2006, CONSTRUCTION NATL SU; Mercier Frederic J, 2008, Anesthesiol Clin, V26, P53, DOI 10.1016/j.anclin.2007.11.008; O'Leary CM, 2007, BJOG-INT J OBSTET GY, V114, P855, DOI 10.1111/j.1471-0528.2007.01307.x; Orbach A, 2011, J MATERN-FETAL NEO M, V24, P480, DOI 10.3109/14767058.2010.501128; Pelage JP, 1998, RADIOLOGY, V208, P359, DOI 10.1148/radiology.208.2.9680559; Sakse A, 2007, ACTA OBSTET GYN SCAN, V86, P1472, DOI 10.1080/00016340701692651; Sheiner E, 2005, J MATERN-FETAL NEO M, V18, P149, DOI 10.1080/14767050500170088; Sidhu HK, 2010, ACTA OBSTET GYN SCAN, V89, P1096, DOI 10.3109/00016349.2010.481015; Stivanello E, 2010, ACTA OBSTET GYN SCAN, V89, P321, DOI 10.3109/00016340903508627; Tang SL, 2006, AM J OBSTET GYNECOL, V195, P1527, DOI 10.1016/j.ajog.2006.03.044; Whiteman MK, 2006, OBSTET GYNECOL, V108, P1486, DOI 10.1097/01.AOG.0000245445.36116.c6; ZELOP CM, 1993, AM J OBSTET GYNECOL, V168, P1443, DOI 10.1016/S0002-9378(11)90779-0; Zeteroglu S, 2005, EUR J OBSTET GYN R B, V120, P57, DOI 10.1016/j.ejogrb.2004.08.011; Zorlu CG, 1998, ACTA OBSTET GYN SCAN, V77, P186, DOI 10.1034/j.1600-0412.1998.770211.x; Zwart JJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.003	27	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60512	10.1371/journal.pone.0060512	http://dx.doi.org/10.1371/journal.pone.0060512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565254	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300125
J	Farley, JH; Williams, AJ; Hoyle, SD; Davies, CR; Nicol, SJ				Farley, Jessica H.; Williams, Ashley J.; Hoyle, Simon D.; Davies, Campbell R.; Nicol, Simon J.			Reproductive Dynamics and Potential Annual Fecundity of South Pacific Albacore Tuna (Thunnus alalunga)	PLOS ONE			English	Article							BATCH FECUNDITY; YELLOWFIN TUNA; FREQUENCY; OCEAN; BIOLOGY; ATRESIA	The reproductive biology of albacore tuna, Thunnus alalunga, in the South Pacific Ocean was investigated with samples collected during broad-scale sampling between 2006 and 2011. Histology was done in a single laboratory according to standard protocols and the data analysed using generalized linear mixed-effects models. The sex ratio of albacore was female biased for fish smaller than approximately 60 cm FL and between 85 and 95 cm, and progressively more male biased above 95 cm FL. Spawning activity was synchronised across the region between 10 degrees S and 25 degrees S during the austral spring and summer where sea surface temperatures were >= 24 degrees C. The average gonad index varied among regions, with fish in easterly longitudes having heavier gonads for their size than fish in westerly longitudes. Albacore, while capable of spawning daily, on average spawn every 1.3 days during the peak spawning months of October to December. Spawning occurs around midnight and the early hours of the morning. Regional variation in spawning frequency and batch fecundity were not significant. The proportion of active females and the spawning fraction increased with length and age, and mature small and young fish were less active at either end of the spawning season than larger, older fish. Batch fecundity estimates ranged from 0.26 to 2.83 million oocytes with a mean relative batch fecundity of 64.4 oocytes per gram of body weight. Predicted batch fecundity and potential annual fecundity increased with both length and age. This extensive set of reproductive parameter estimates provides many of the first quantitative estimates for this population and will substantially improve the quality of biological inputs to the stock assessment for South Pacific albacore.	[Farley, Jessica H.; Davies, Campbell R.] CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia; [Williams, Ashley J.; Hoyle, Simon D.; Nicol, Simon J.] Secretariat Pacific Commun, Ocean Fisheries Programme, Noumea, New Caledonia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Farley, JH (corresponding author), CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia.	Jessica.Farley@csiro.au	Hoyle, Simon D/G-1201-2015; Williams, Ashley J/J-7565-2013; Williams, Ashley J/G-2017-2014; Farley, Jessica/E-4957-2014; Williams, Ashley/ABA-5921-2020; Davies, Campbell R/N-8086-2013	Hoyle, Simon D/0000-0002-1787-6565; Williams, Ashley J/0000-0002-5530-0073; Farley, Jessica/0000-0002-5047-746X; Williams, Ashley/0000-0002-5530-0073; Davies, Campbell R/0000-0002-2028-1060; Nicol, Simon/0000-0001-8193-8719	CSIRO Wealth from Oceans Flagship; Australian Fisheries Research and Development Corporation [2009/012]; 9th European Union Development Fund (SCIFISH project); Western and Central Pacific Fisheries Commission	CSIRO Wealth from Oceans Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Fisheries Research and Development Corporation; 9th European Union Development Fund (SCIFISH project); Western and Central Pacific Fisheries Commission	This work was supported by funding from CSIRO Wealth from Oceans Flagship, the Australian Fisheries Research and Development Corporation (Project #2009/012), the 9th European Union Development Fund (SCIFISH project), and the Western and Central Pacific Fisheries Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2012, LME4 LINEAR MIXED EF; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAREY FG, 1971, AM ZOOL, V11, P137; Chen IC, 2005, FISH OCEANOGR, V14, P71, DOI 10.1111/j.1365-2419.2004.00322.x; Chen KS, 2010, J FISH BIOL, V77, P119, DOI 10.1111/j.1095-8649.2010.02662.x; CHOW S, 1995, MAR BIOL, V123, P39, DOI 10.1007/BF00350321; Collette BB, 1983, FAO SPECIES CATALOGU, V2; Davies CA, 2011, MAR BIOL, V158, P2727, DOI 10.1007/s00227-011-1772-x; Davis T, 2001, SIZE 1 MATURITY RECR; DEMARTINI EE, 1981, FISH B-NOAA, V79, P547; Donlon C, 2007, B AM METEOROL SOC, V88, P1197, DOI 10.1175/BAMS-88-8-1197; Farley J.H., 2012, POPULATION BIOL ALBA; Farley JH, 1998, FISH B-NOAA, V96, P223; Farley JH, J FISH BIOL; FITZHUGH GR, 1995, FISH B-NOAA, V93, P568; Goldberg S. R., 1986, P ICCAT C INT SKIPJ, P248; Gordoa A, 2009, ICES J MAR SCI, V66, P2205, DOI 10.1093/icesjms/fsp211; Harley S.J., 2011, 11 SECR PAC COMM; Hillary RM, 2008, IOTC2008WPTE09; Hobday AJ, 2006, SDODE SPATIAL DYNAMI; Hoyle S, 2011, 7 SCI COMM M W CENTR; Hoyle S, 2009, 5 SCI COMM M W CENTR; Hoyle S, 2008, 4 SCI COMM M W CENTR; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P79; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P67; HUNTER JR, 1985, FISH B-NOAA, V83, P119; HUNTER JR, 1986, FISH B-NOAA, V84, P895; ICCAT, 2012, REP 2011 ICCAT S ATL, P491; ICCAT, 2010, ICCAT COLL VOL SCI P, V65, P1113; ISC, 2010, ISC ALB WORK GROUP W; ISSF, 2011, 201105 ISSF; Itano DG, 2000, JIMAR CONTRIBUTION; JONES JB, 1991, MAR BIOL, V111, P1, DOI 10.1007/BF01986338; Knaggs EH, 1973, 3 CAL DEP FISH GAM; Langley AD, 2003, 16 M STAND COMM TUN; LENARZ WH, 1979, FISH B-NOAA, V76, P807; MacCall AD, 1980, NMFSSWFC4 NOAA; Maunder MN, 2003, INTERAM TROP TUNA CO, V2, P151; MCPHERSON GR, 1991, AUST J MAR FRESH RES, V42, P465, DOI 10.1071/MF9910465; Miyake M.P., 2004, 467 FAO; Murray T., 1994, 3362 FAO, V336, P188; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; NIKAIDO H, 1991, B NATL RES I FAR SEA, V28, P47; Nishikawa Y., 1985, FAR SEAS FISH RES LA, V12, P1; Otsu T., 1959, Fishery Bulletin United States, V59, P287; Otsu T., 1962, Fishery Bulletin United States, V62, P151; Punt AE, 2003, FISH RES, V65, P391, DOI 10.1016/j.fishres.2003.09.028; Ramon D, 1996, FISH B-NOAA, V94, P725; RAVAGLIA MA, 1995, J FISH DIS, V18, P117, DOI 10.1111/j.1365-2761.1995.tb00269.x; Saidapur S K, 1978, Int Rev Cytol, V54, P225, DOI 10.1016/S0074-7696(08)60169-2; SCHAEFER K M, 1987, Inter-American Tropical Tuna Commission Bulletin, V19, P169; Schaefer KM, 1996, FISH B-NOAA, V94, P98; Schaefer KM, 1998, B INTERAMERICAN TROP, V21, P201; Schaefer Kurt M., 2005, Inter-American Tropical Tuna Commission Bulletin, V23, P3; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Sun C.L., 2005, SC1BIWP1 WCPFC FED S; Sun CL, 2006, 2 SCI COMM M W CENTR; UEYANAGI S, 1969, Bulletin Far Seas Fisheries Research Laboratory (Shimizu), V2, P177; Ueyanagi S, 1957, REP NANKAI REG FISH, V6, P113; WATSON JJ, 1992, J FISH BIOL, V40, P591, DOI 10.1111/j.1095-8649.1992.tb02608.x; Williams TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026742	61	57	59	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60577	10.1371/journal.pone.0060577	http://dx.doi.org/10.1371/journal.pone.0060577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565258	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000317717300129
J	Gvozdenovic, A; Arlt, MJE; Campanile, C; Brennecke, P; Husmann, K; Born, W; Muff, R; Fuchs, B				Gvozdenovic, Ana; Arlt, Matthias J. E.; Campanile, Carmen; Brennecke, Patrick; Husmann, Knut; Born, Walter; Muff, Roman; Fuchs, Bruno			Silencing of CD44 Gene Expression in Human 143-B Osteosarcoma Cells Promotes Metastasis of Intratibial Tumors in SCID Mice	PLOS ONE			English	Article							CANCER PROGRESSION; SUPPRESSOR GENE; BREAST-CANCER; IN-VITRO; MERLIN; ADHESION; TUMORIGENICITY; INHIBITION; VARIANTS; SURVIVAL	Osteosarcoma (OS) is the most frequent primary malignant bone cancer in children and adolescents with a high propensity for lung metastasis. Therefore, it is of great importance to identify molecular markers leading to increased metastatic potential in order to devise more effective therapeutic strategies that suppress metastasis, the major cause of death in OS. CD44, the principal receptor for the extracellular matrix component hyaluronan (HA), is frequently found overexpressed in tumor cells and has been implicated in metastatic spread in various cancer types. Here, we investigated the effects of stable shRNA-mediated silencing of CD44 gene products on in vitro and in vivo metastatic properties of the highly metastatic human 143-B OS cell line. In vitro, CD44 knockdown resulted in a 73% decrease in the adhesion to HA, a 57% decrease in the migration rate in a trans-filter migration assay, and a 28% decrease in the cells' capacity for anchorage-independent growth in soft agar compared to the control cells, implicating that CD44 expression contributes to the metastatic activity of 143-B cells. However, making use of an orthotopic xenograft OS mouse model, we demonstrated that reduced CD44 expression facilitated primary tumor growth and formation of pulmonary metastases. The enhanced malignant phenotype was associated with decreased adhesion to HA and reduced expression of the tumor suppressor merlin in vivo. In conclusion, our study identified CD44 as a metastasis suppressor in this particular experimental OS model.	[Gvozdenovic, Ana; Arlt, Matthias J. E.; Campanile, Carmen; Brennecke, Patrick; Husmann, Knut; Born, Walter; Muff, Roman; Fuchs, Bruno] Balgrist Univ Hosp, Dept Orthoped, Lab Orthoped Res, Zurich, Switzerland	University of Zurich	Fuchs, B (corresponding author), Balgrist Univ Hosp, Dept Orthoped, Lab Orthoped Res, Zurich, Switzerland.	bfuchs@research.balgrist.ch			Zurcher Krebsliga (Zurich, Switzerland); Swiss National Science Foundation (SNF) [31003A-120403]; University of Zurich; Schweizerischer Verein Balgrist (Zurich, Switzerland); Walter L. & Johanna Wolf Foundation (Zurich, Switzerland); Lydia Hochstrasser Stiftung (Zurich, Switzerland); HSM Program for Musculoskeletal Oncology of the Kanton Zurich (Switzerland)	Zurcher Krebsliga (Zurich, Switzerland); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); University of Zurich; Schweizerischer Verein Balgrist (Zurich, Switzerland); Walter L. & Johanna Wolf Foundation (Zurich, Switzerland); Lydia Hochstrasser Stiftung (Zurich, Switzerland); HSM Program for Musculoskeletal Oncology of the Kanton Zurich (Switzerland)	This work was supported in part by the Zurcher Krebsliga (Zurich, Switzerland), the Swiss National Science Foundation (SNF Grant Nr. 31003A-120403), the University of Zurich, the Schweizerischer Verein Balgrist (Zurich, Switzerland), the Walter L. & Johanna Wolf Foundation (Zurich, Switzerland), the Lydia Hochstrasser Stiftung (Zurich, Switzerland) and the HSM Program for Musculoskeletal Oncology of the Kanton Zurich (Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt M, 2002, CANCER RES, V62, P5543; Arlt MJE, 2011, J ORTHOP RES, V29, P938, DOI 10.1002/jor.21304; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Boldrini E, 2010, J PEDIAT HEMATOL ONC, V32, pE213, DOI 10.1097/MPH.0b013e3181e5e247; CANNISTRA SA, 1993, CANCER RES, V53, P3830; De Marzo AM, 1998, PROSTATE, V34, P162; Gao AC, 1997, CANCER RES, V57, P846; HEIDER KH, 1993, CANCER RES, V53, P4197; Hosono K, 2007, AM J PATHOL, V171, P274, DOI 10.2353/ajpath.2007.060828; Janiszewska M, 2010, J BIOL CHEM, V285, P30548, DOI 10.1074/jbc.M109.075838; Kim HS, 2002, CLIN ORTHOP RELAT R, P184; KRUGER A, 1994, INT J CANCER, V58, P275, DOI 10.1002/ijc.2910580222; Kuryu M, 1999, J CANCER RES CLIN, V125, P646, DOI 10.1007/s004320050329; Lim SD, 2008, VIRCHOWS ARCH, V452, P49, DOI 10.1007/s00428-007-0530-4; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Lopez JI, 2005, CANCER RES, V65, P6755, DOI 10.1158/0008-5472.CAN-05-0863; Marhaba R, 2004, J MOL HISTOL, V35, P211; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrow KA, 2012, BBA-REV CANCER, V1826, P400, DOI 10.1016/j.bbcan.2012.06.005; Morrow KA, 2011, J BIOL CHEM, V286, P40376, DOI 10.1074/jbc.M111.250035; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Nishida Y, 2005, EXP CELL RES, V307, P194, DOI 10.1016/j.yexcr.2005.03.026; PENNO MB, 1994, CANCER RES, V54, P1381; Picci P, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-6; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; RALL CJN, 1995, CANCER RES, V55, P1831; Reidy K, 2012, PHOTOCHEM PHOTOBIOL, V88, P721, DOI 10.1111/j.1751-1097.2012.01096.x; RHIM JS, 1975, INT J CANCER, V15, P23, DOI 10.1002/ijc.2910150104; Shen XD, 2009, CLIN INVEST MED, V32, pE180; SHTIVELMAN E, 1991, MOL CELL BIOL, V11, P5446, DOI 10.1128/MCB.11.11.5446; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Stemmer-Rachamimov AO, 1998, NEUROGENETICS, V2, P73, DOI 10.1007/s100480050054; TIKOO A, 1994, J BIOL CHEM, V269, P23387; Tofuku K, 2006, INT J ONCOL, V29, P175; WIELENGA VJM, 1993, CANCER RES, V53, P4754; Yuan J, 2009, CANCER INVEST, V27, P435, DOI 10.1080/07357900802491477	38	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60329	10.1371/journal.pone.0060329	http://dx.doi.org/10.1371/journal.pone.0060329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565227	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000317717300097
J	Ivancso, I; Toldi, G; Bohacs, A; Eszes, N; Muller, V; Rigo, J; Vasarhelyi, B; Losonczy, G; Tamasi, L				Ivancso, Istvan; Toldi, Gergely; Bohacs, Aniko; Eszes, Noemi; Mueller, Veronika; Rigo, Janos, Jr.; Vasarhelyi, Barna; Losonczy, Gyoergy; Tamasi, Lilla			Relationship of Circulating Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels to Disease Control in Asthma and Asthmatic Pregnancy	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CANCER-PATIENTS; UNITED-STATES; SERUM; INFLAMMATION; PLASMA; WOMEN; PREECLAMPSIA; ASSOCIATION; MORTALITY	Asthma has a high burden of morbidity if not controlled and may frequently complicate pregnancy, posing a risk for pregnancy outcomes. Elevated plasma level of the inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is related to a worse prognosis in many conditions such as infectious, autoimmune, or pregnancy-related diseases; however the value of suPAR in asthma and asthmatic pregnancy is unknown. The present study aimed to investigate the suPAR, CRP and IL-6 levels in asthma (asthmatic non-pregnant, ANP; N = 38; female N = 27) and asthmatic pregnancy (AP; N = 15), compared to healthy non-pregnant controls (HNP; N = 29; female N = 19) and to healthy pregnant women (HP; N = 58). The relationship between suPAR levels and asthma control was also evaluated. The diagnostic efficacy of suPAR in asthma control was analyzed using ROC analysis. IL-6 and CRP levels were comparable in all study groups. Circulating suPAR levels were lower in HP and AP than in HNP and ANP subjects, respectively (2.01 [1.81-2.38] and 2.39 [2.07-2.69] vs. 2.60 [1.82-3.49] and 2.84 [2.33-3.72] ng/mL, respectively, p = 0.0001). suPAR and airway resistance correlated in ANP (r = 0.47, p = 0.004). ROC analysis of suPAR values in ANP patients with PEF above and below 80% yielded an AUC of 0.75 (95% CI: 0.57-0.92, p = 0.023) and with ACT total score above and below 20 an AUC of 0.80 (95% CI: 0.64-0.95, p = 0.006). The cut-off value of suPAR to discriminate between controlled and not controlled AP and ANP was 4.04 ng/mL. In conclusion, suPAR may help the objective assessment of asthma control, since it correlates with airway resistance and has good sensitivity in the detection of impaired asthma control. Decrease in circulating suPAR levels detected both in healthy and asthmatic pregnant women presumably represents pregnancy induced immune tolerance.	[Ivancso, Istvan; Bohacs, Aniko; Eszes, Noemi; Mueller, Veronika; Losonczy, Gyoergy; Tamasi, Lilla] Semmelweis Univ, Dept Pulmonol, H-1085 Budapest, Hungary; [Toldi, Gergely] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary; [Rigo, Janos, Jr.] Semmelweis Univ, Dept Obstet & Gynecol 1, H-1085 Budapest, Hungary; [Vasarhelyi, Barna] Semmelweis Univ, Dept Lab Med, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University	Tamasi, L (corresponding author), Semmelweis Univ, Dept Pulmonol, H-1085 Budapest, Hungary.	tamasi@pulm.sote.hu		Bohacs, Aniko/0000-0002-8229-4254; Muller, Veronika/0000-0002-1398-3187; Toldi, Gergely/0000-0003-0178-1243	Hungarian Scientific Research Fund (OTKA) [101661]; Hungarian Respiratory Society	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Respiratory Society	This work was supported by the Hungarian Scientific Research Fund (OTKA; grant number 101661; Web site: http://www.otka.hu/) and by a Hungarian Respiratory Society grant (to N. E.; Web site: http://www.tudogyogyasz.hu/). GT is an International Society for the Advancement of Cytometry (ISAC) Scholar (Web site: http://isac-net.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam MH, 2009, RESP MED, V103, P1878, DOI 10.1016/j.rmed.2009.06.020; Backes Y, 2012, INTENS CARE MED, V38, P1418, DOI 10.1007/s00134-012-2613-1; Balabanov R, 2001, CLIN DIAGN LAB IMMUN, V8, P1196, DOI 10.1128/CDLI.8.6.1196-1203.2001; Behrendt N, 1998, FIBRINOLYSIS PROTEOL, V12, P191, DOI 10.1016/S0268-9499(98)80013-1; Breton MC, 2009, THORAX, V64, P101, DOI 10.1136/thx.2008.102970; Cloutier MM, 2012, J ALLERGY CLIN IMMUN, V129, pS24, DOI 10.1016/j.jaci.2011.12.980; DANO K, 1994, FIBRINOLYSIS, V8, P189, DOI 10.1016/0268-9499(94)90717-X; Demissie K, 1998, AM J RESP CRIT CARE, V158, P1091, DOI 10.1164/ajrccm.158.4.9802053; Eugen-Olsen J, 2002, INT J TUBERC LUNG D, V6, P686; Ford ES, 2003, J ASTHMA, V40, P733, DOI 10.1081/JAS-120023497; Higashimoto Y, 2008, RESPIROLOGY, V13, P128, DOI 10.1111/j.1440-1843.2007.01170.x; Kony S, 2004, THORAX, V59, P892, DOI 10.1136/thx.2003.015768; Kwon HL, 2003, ANN EPIDEMIOL, V13, P317, DOI 10.1016/S1047-2797(03)00008-5; Light RW, 2005, CHEST MED ESSENTIALS, P24; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Murphy VE, 2011, CLIN CHEST MED, V32, P93, DOI 10.1016/j.ccm.2010.10.001; Murphy VE, 2006, THORAX, V61, P169, DOI 10.1136/thx.2005.049718; Neveu WA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-28; Odden N, 2012, ACTA OBSTET GYN SCAN, V91, P1226, DOI 10.1111/j.1600-0412.2012.01504.x; Ostergaard C, 2004, SCAND J INFECT DIS, V36, P14, DOI 10.1080/00365540310017366; Ostrowski SR, 2006, SCAND J INFECT DIS, V38, P1028, DOI 10.1080/00365540600868305; Ostrowski SR, 2005, J INFECT DIS, V191, P1331, DOI 10.1086/428854; Ostrowski SR, 2004, JAIDS-J ACQ IMM DEF, V35, P337, DOI 10.1097/00126334-200404010-00002; Rifai N, 2003, CLIN CHEM, V49, P666, DOI 10.1373/49.4.666; Riisbro R, 2001, INT J BIOL MARKER, V16, P233, DOI 10.1177/172460080101600402; RONNE E, 1995, BRIT J HAEMATOL, V89, P576, DOI 10.1111/j.1365-2141.1995.tb08366.x; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Schatz M, 2010, J ASTHMA, V47, P46, DOI 10.3109/02770900903483758; Sier CFM, 1999, LAB INVEST, V79, P717; Sier CFM, 1998, CANCER RES, V58, P1843; Stephens RW, 1997, CLIN CHEM, V43, P1876; Takemura M, 2006, EUR RESPIR J, V27, P908, DOI 10.1183/09031936.06.00114405; Tamasi L, 2005, CLIN EXP ALLERGY, V35, P1197, DOI 10.1111/j.1365-2222.2005.02322.x; Tamasi L, 2011, RESP MED, V105, P159, DOI 10.1016/j.rmed.2010.11.006; Tamasi L, 2010, CELL STRESS CHAPERON, V15, P295, DOI 10.1007/s12192-009-0143-8; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Toldi G, 2012, CLIN CHEM LAB MED, V0, P1, DOI DOI 10.1515/CCLM-2012-0221; Toldi G, 2011, CLIN CHEM LAB MED, V49, P1873, DOI 10.1515/CCLM.2011.656; Toldi G, 2011, INT IMMUNOL, V23, P669, DOI 10.1093/intimm/dxr074; YOKOYAMA A, 1995, AM J RESP CRIT CARE, V151, P1354, DOI 10.1164/ajrccm.151.5.7735584	40	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60697	10.1371/journal.pone.0060697	http://dx.doi.org/10.1371/journal.pone.0060697			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565268	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300139
J	Lim, CK; Kelley, RL				Lim, Chiat Koo; Kelley, Richard L.			The Drosophila Over Compensating Males Gene Genetically Inhibits Dosage Compensation in Males	PLOS ONE			English	Article							X-CHROMOSOMAL GENES; MSL COMPLEX; HISTONE ACETYLTRANSFERASE; FUNCTIONAL-INTEGRATION; ROX RNAS; TRANSCRIPTION; ACETYLATION; CHROMATIN; PROTEIN; DOMAIN	Male Drosophila are monosomic for the X chromosome, but survive due to dosage compensation. They use the Male Specific Lethal (MSL) complex composed of noncoding roX RNA and histone modifying enzymes to hypertranscribe most genes along the X similar to 1.6-1.8 fold relative to each female allele. It is not known how the MSL complex achieves this precise adjustment to a large and diverse set of target genes. We carried out a genetic screen searching for novel factors that regulate dosage compensation in flies. This strategy generated thirty alleles in a previously uncharacterized gene, over compensating males (ocm) that antagonizes some aspect of MSL activity. The mutations were initially recovered because they derepressed an MSL-dependent eye color reporter. Null ocm mutations are lethal to both sexes early in development revealing an essential function. Combinations of hypomorphic ocm alleles display a male specific lethality similar to mutations in the classic msl genes, but ocm males die due to excessive, rather than lack of dosage compensation. Males that die due to very low MSL activity can be partially rescued by ocm mutations. Likewise, males that would die from ocm mutations can be rescued by reducing the dose of various msl and roX genes. ocm encodes a large nuclear protein that shares a novel cysteine rich motif with known transcription factors.	[Lim, Chiat Koo; Kelley, Richard L.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Kelley, Richard L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Lim, CK (corresponding author), Harvard Univ, Sch Med, Dept Genet, Brigham & Womens Hospial, Boston, MA 02115 USA.	leonlimck@bics.bwh.harvard.edu			NIH [5RO1GM071538]; Baylor College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The initial phase of this work was supported by NIH grant 5RO1GM071538 to RLK and completed with funds from Baylor College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Birchler J, 2011, J GENET GENOMICS, V38, P327, DOI 10.1016/j.jgg.2011.07.001; Chao AT, 2003, GENETICS, V165, P601; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Conrad T, 2012, SCIENCE, V337, P742, DOI 10.1126/science.1221428; Conrad T, 2012, DEV CELL, V22, P610, DOI 10.1016/j.devcel.2011.12.016; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Deng XX, 2006, GENETICS, V174, P1859, DOI 10.1534/genetics.106.064568; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Fauth T, 2010, NUCLEIC ACIDS RES, V38, P3209, DOI 10.1093/nar/gkq026; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Kelley RL, 2008, MECH DEVELOP, V125, P1009, DOI 10.1016/j.mod.2008.08.003; Kelley RL, 2003, GENETICS, V164, P565; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Larschan E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002830; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Lim CK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002564; Marin I, 2003, J MOL EVOL, V56, P527, DOI 10.1007/s00239-002-2422-1; Meller VH, 2000, CURR BIOL, V10, P136, DOI 10.1016/S0960-9822(00)00311-0; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Morales V, 2005, MOL CELL BIOL, V25, P5947, DOI 10.1128/MCB.25.14.5947-5954.2005; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Morra R, 2008, MOL CELL BIOL, V28, P958, DOI 10.1128/MCB.00995-07; Muller M, 2012, MOL CELL, P1, DOI [10.1016/j.molcel.2012.09.012, DOI 10.1016/J.MOL-CEL.2012.09.012]; Oh K, 2003, GENE DEV, V17, P1334, DOI 10.1101/gad.1082003; Park Y, 2002, SCIENCE, V298, P1620, DOI 10.1126/science.1076686; Prabhakaran M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-80; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Scott MJ, 2000, EMBO J, V19, P144, DOI 10.1093/emboj/19.1.144; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Straub T, 2005, GENE DEV, V19, P2284, DOI 10.1101/gad.1343105; Sural TH, 2008, NAT STRUCT MOL BIOL, V15, P1318, DOI 10.1038/nsmb.1520; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Wu LP, 2011, MOL CELL, V43, P132, DOI 10.1016/j.molcel.2011.05.015; XU T, 1994, METHOD CELL BIOL, V44, P655, DOI 10.1016/S0091-679X(08)60937-1	45	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60450	10.1371/journal.pone.0060450	http://dx.doi.org/10.1371/journal.pone.0060450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565249	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300119
J	Zhou, Q; Su, XQ; Wang, AH; Xu, J; Ning, K				Zhou, Qian; Su, Xiaoquan; Wang, Anhui; Xu, Jian; Ning, Kang			QC-Chain: Fast and Holistic Quality Control Method for Next-Generation Sequencing Data	PLOS ONE			English	Article							ULTRAFAST; ALIGNMENT	Next-generation sequencing (NGS) technologies have been widely used in life sciences. However, several kinds of sequencing artifacts, including low-quality reads and contaminating reads, were found to be quite common in raw sequencing data, which compromise downstream analysis. Therefore, quality control (QC) is essential for raw NGS data. However, although a few NGS data quality control tools are publicly available, there are two limitations: First, the processing speed could not cope with the rapid increase of large data volume. Second, with respect to removing the contaminating reads, none of them could identify contaminating sources de novo, and they rely heavily on prior information of the contaminating species, which is usually not available in advance. Here we report QC-Chain, a fast, accurate and holistic NGS data quality-control method. The tool synergeticly comprised of user-friendly tools for (1) quality assessment and trimming of raw reads using Parallel-QC, a fast read processing tool; (2) identification, quantification and filtration of unknown contamination to get high-quality clean reads. It was optimized based on parallel computation, so the processing speed is significantly higher than other QC methods. Experiments on simulated and real NGS data have shown that reads with low sequencing quality could be identified and filtered. Possible contaminating sources could be identified and quantified de novo, accurately and quickly. Comparison between raw reads and processed reads also showed that subsequent analyses (genome assembly, gene prediction, gene annotation, etc.) results based on processed reads improved significantly in completeness and accuracy. As regard to processing speed, QC-Chain achieves 7-8 time speed-up based on parallel computation as compared to traditional methods. Therefore, QC-Chain is a fast and useful quality control tool for read quality process and de novo contamination filtration of NGS reads, which could significantly facilitate downstream analysis. QC-Chain is publicly available at: http://www.computationalbioenergy.org/qc-chain.html.	[Zhou, Qian; Su, Xiaoquan; Wang, Anhui; Xu, Jian; Ning, Kang] Chinese Acad Sci, CAS Key Lab Biofuels, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Shandong, Peoples R China; [Zhou, Qian; Su, Xiaoquan; Wang, Anhui; Xu, Jian; Ning, Kang] Chinese Acad Sci, Shandong Key Lab Energy Genet, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Shandong, Peoples R China; [Wang, Anhui] China Three Gorges Univ, Coll Comp & Informat Technol, Yichang, Hubei, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; China Three Gorges University	Ning, K (corresponding author), Chinese Acad Sci, CAS Key Lab Biofuels, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Shandong, Peoples R China.	ningkang@qibebt.ac.cn	Xu, Jian/G-8430-2012; Su, Xiaoquan/CAF-9832-2022; Ning, Kang/ABD-3446-2020	Xu, Jian/0000-0002-0548-8477; Su, Xiaoquan/0000-0003-2144-1991; Zhou, Qian/0000-0002-2035-2009; zhou, qian/0000-0002-1481-6014; Ning, Kang/0000-0003-3325-5387	Shandong Natural Science Foundation [BS2009SW022]; Chinese Academy of Sciences' e-Science grant [INFO-115-D01-Z006]; Ministry of Science and Technology's high-tech (863) grant [2009AA02Z310]; Natural Science Foundation of China [61103167, 31271410]	Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province); Chinese Academy of Sciences' e-Science grant; Ministry of Science and Technology's high-tech (863) grant; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Shandong Natural Science Foundation grant BS2009SW022, Chinese Academy of Sciences' e-Science grant INFO-115-D01-Z006, Ministry of Science and Technology's high-tech (863) grant 2009AA02Z310, Natural Science Foundation of China grant 61103167 and 31271410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mende DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031386; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Su XQ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S1-S16; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	17	52	57	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60234	10.1371/journal.pone.0060234	http://dx.doi.org/10.1371/journal.pone.0060234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565205	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300074
J	Ren, SH; Chen, XL; Wang, HL; Qu, XC; Wang, G; Liang, JM; Tian, J				Ren, Shenghan; Chen, Xueli; Wang, Hailong; Qu, Xiaochao; Wang, Ge; Liang, Jimin; Tian, Jie			Molecular Optical Simulation Environment (MOSE): A Platform for the Simulation of Light Propagation in Turbid Media	PLOS ONE			English	Article							FLUORESCENCE TOMOGRAPHY; BIOLOGICAL TISSUE; TIME-DOMAIN; DISTRIBUTIONS; TRANSPORT; EQUATION; PROBE; MICE	The study of light propagation in turbid media has attracted extensive attention in the field of biomedical optical molecular imaging. In this paper, we present a software platform for the simulation of light propagation in turbid media named the "Molecular Optical Simulation Environment (MOSE)". Based on the gold standard of the Monte Carlo method, MOSE simulates light propagation both in tissues with complicated structures and through free-space. In particular, MOSE synthesizes realistic data for bioluminescence tomography (BLT), fluorescence molecular tomography (FMT), and diffuse optical tomography (DOT). The user-friendly interface and powerful visualization tools facilitate data analysis and system evaluation. As a major measure for resource sharing and reproducible research, MOSE aims to provide freeware for research and educational institutions, which can be downloaded at http://www.mosetm.net.	[Ren, Shenghan; Chen, Xueli; Wang, Hailong; Qu, Xiaochao; Liang, Jimin; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Wang, Ge] Rensselaer Polytech Inst, Biomed Imaging Ctr, Troy, NY 12180 USA	Xidian University; Chinese Academy of Sciences; Institute of Automation, CAS; Rensselaer Polytechnic Institute	Wang, G (corresponding author), Rensselaer Polytech Inst, Biomed Imaging Ctr, Troy, NY 12180 USA.	wangg6@rpi.edu; jimleung@mail.xidian.edu.cn; tian@ieee.org	Wang, Ge/AAH-8592-2020; Tian, Jie/M-5675-2013; Chen, Xueli/T-9706-2019; Tian, Jie/H-1190-2011; Life, MC/M-9554-2013; Chen, Charles/M-9152-2013; Liang, Jimin/B-5394-2014	Wang, Ge/0000-0002-2656-7705; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804	Program of the National Basic Research and Development Program of China (973) [2011CB707702]; National Natural Science Foundation of China [81090272, 81227901, 81101083]; Fundamental Research Funds for the Central Universities	Program of the National Basic Research and Development Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Program of the National Basic Research and Development Program of China (973) under Grant No. 2011CB707702, the National Natural Science Foundation of China under Grant Nos. 81090272, 81227901, 81101083, and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; ARRIDGE SR, 1993, MED PHYS, V20, P299, DOI 10.1118/1.597069; Bloch S, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2070148; Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; Chen J, 2011, BIOMED OPT EXPRESS, V2, P871, DOI 10.1364/BOE.2.000871; Chen XL, 2009, OPT EXPRESS, V17, P16266, DOI 10.1364/OE.17.016266; Cong WX, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907168; Doronin A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.090504; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Firbank M, 1996, PHYS MED BIOL, V41, P767, DOI 10.1088/0031-9155/41/4/012; Gibson AP, 2005, PHYS MED BIOL, V50, pR1, DOI 10.1088/0031-9155/50/4/R01; Graves EE, 2003, MED PHYS, V30, P901, DOI 10.1118/1.1568977; Gu XJ, 2004, ACAD RADIOL, V11, P53, DOI 10.1016/S1076-6332(03)00562-2; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; KEIJZER M, 1989, LASER SURG MED, V9, P148, DOI 10.1002/lsm.1900090210; Keren S, 2008, IEEE T MED IMAGING, V27, P58, DOI 10.1109/TMI.2007.902800; Kienle A, 2001, OPT LETT, V26, P1571, DOI 10.1364/OL.26.001571; Klose AD, 2003, OPT LETT, V28, P1019, DOI 10.1364/OL.28.001019; Klose AD, 2006, J COMPUT PHYS, V220, P441, DOI 10.1016/j.jcp.2006.07.007; Klose AD, 2010, J QUANT SPECTROSC RA, V111, P1852, DOI 10.1016/j.jqsrt.2010.01.020; Lam S, 2005, OPT EXPRESS, V13, P2263, DOI 10.1364/OPEX.13.002263; Meyer H, 2007, APPL OPTICS, V46, P3617, DOI 10.1364/AO.46.003617; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Nvidia, 2010, CUDA PROGR GUID VERS; Patwardhan SV, 2005, OPT EXPRESS, V13, P2564, DOI 10.1364/OPEX.13.002564; Ren NN, 2010, OPT EXPRESS, V18, P6811, DOI 10.1364/OE.18.006811; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Riley J, 2000, OPT EXPRESS, V7, P462, DOI 10.1364/OE.7.000462; Ripoll J, 2004, MOD PHYS LETT B, V18, P1403, DOI 10.1142/S0217984904007864; Shen H, 2010, PHYS MED BIOL, V55, P947, DOI 10.1088/0031-9155/55/4/003; Siebers JV, 1999, PHYS MED BIOL, V44, P3009, DOI 10.1088/0031-9155/44/12/311; Tian J, 2008, IEEE ENG MED BIOL, V27, P48, DOI 10.1109/MEMB.2008.923962; Wang G, 2003, RADIOLOGY, V229, P566; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F	34	53	56	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61304	10.1371/journal.pone.0061304	http://dx.doi.org/10.1371/journal.pone.0061304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577215	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000122
J	Kristensen, PL; Pedersen-Bjergaard, U; Kjaer, TW; Olsen, NV; Dela, F; Holst, JJ; Faber, J; Tarnow, L; Thorsteinsson, B				Kristensen, Peter Lommer; Pedersen-Bjergaard, Ulrik; Kjaer, Troels Wesenberg; Olsen, Niels Vidiendal; Dela, Flemming; Holst, Jens Juul; Faber, Jens; Tarnow, Lise; Thorsteinsson, Birger			Influence of Erythropoietin on Cognitive Performance during Experimental Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Randomized Cross-Over Trial	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; CEREBROSPINAL-FLUID; BRAIN; AWARENESS; RECEPTOR; SYSTEM; SLICE; CELLS; RISK	Introduction: The incidence of severe hypoglycemia in type 1 diabetes has not decreased over the past decades. New treatment modalities minimizing the risk of hypoglycemic episodes and attenuating hypoglycemic cognitive dysfunction are needed. We studied if treatment with the neuroprotective hormone erythropoietin (EPO) enhances cognitive function during hypoglycemia. Materials and Methods: Eleven patients with type 1 diabetes, hypoglycemia unawareness and recurrent severe hypoglycemia completed the study. In a double-blind, randomized, balanced, cross-over study using clamped hypoglycemia they were treated with 40,000 IU of EPO or placebo administered intravenously six days before the two experiments. Cognitive function (primary endpoint), hypoglycemic symptoms, and counter-regulatory hormonal response were recorded. Results: Compared with placebo, EPO treatment was associated with a significant reduction in errors in the most complex reaction time task (-4.7 (-8.1 to -1.3), p = 0.01) and a less reaction time prolongation (-66 (-117 to -16) msec, p = 0.02). EPO treatment did not change performance in other measures of cognition. Hypoglycemic symptoms, EEG-changes, and counter-regulatory hormone concentrations did not differ between EPO and placebo treatment. Conclusion: In patients with type 1 diabetes and hypoglycemia unawareness, treatment with EPO is associated with a beneficial effect on cognitive function in a complex reaction time task assessing sustained attention/working memory. Hypoglycemic symptoms and hormonal responses were not changed by EPO treatment.	[Kristensen, Peter Lommer; Pedersen-Bjergaard, Ulrik; Thorsteinsson, Birger] Cent Hosp Hillerod, Dept Cardiol Nephrol & Endocrinol, Endocrinol Sect, Hillerod, Denmark; [Kjaer, Troels Wesenberg] Copenhagen Univ Hosp, Neurosci Ctr, Clin Neurophysiol, Rigshosp, Copenhagen, Denmark; [Olsen, Niels Vidiendal] Copenhagen Univ Hosp, Dept Neuroanaesthesia, Neurosci Ctr, Rigshosp, Copenhagen, Denmark; [Dela, Flemming] Univ Copenhagen, Fac Hlth Sci, Dept Med Sci, Ctr Hlth Aging, DK-1168 Copenhagen, Denmark; [Holst, Jens Juul] Univ Copenhagen, Fac Hlth Sci, Dept Med Physiol, Copenhagen, Denmark; [Tarnow, Lise] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Thorsteinsson, Birger] Univ Copenhagen, Fac Hlth Sci, Dept Orthopaed & Internal Med, Copenhagen, Denmark; [Olsen, Niels Vidiendal] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Kristensen, Peter Lommer; Faber, Jens] Herlev Univ Hosp, Dept Internal Med O, DK-2730 Herlev, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Kristensen, PL (corresponding author), Cent Hosp Hillerod, Dept Cardiol Nephrol & Endocrinol, Endocrinol Sect, Hillerod, Denmark.	pelk@hih.regionh.dk	Dela, Flemming/B-3239-2008; Dela, Flemming/AAU-1691-2021; Holst, Jens/AAA-8022-2022; Pedersen-Bjergaard, Ulrik/AAI-2425-2019; Kristensen, Peter/V-5630-2019	Dela, Flemming/0000-0001-9970-9535; Dela, Flemming/0000-0001-9970-9535; Kristensen, Peter/0000-0001-5431-824X; Holst, Jens Juul/0000-0001-6853-3805; Tarnow, Lise/0000-0002-8735-966X; Olsen, Niels Vidiendal/0000-0001-7724-3981; Pedersen-Bjergaard, Ulrik/0000-0003-0588-4880	Tvergaard Foundation; Foundation of Harald Jensen and Wife; Foundation of Hans Christensen; Foundation of King Christian 10th; Research Foundation of Hillerod Hospital; Brodrene Hartmann Foundation; Olga Bryde Nielsen Foundation	Tvergaard Foundation; Foundation of Harald Jensen and Wife; Foundation of Hans Christensen; Foundation of King Christian 10th; Research Foundation of Hillerod Hospital; Brodrene Hartmann Foundation; Olga Bryde Nielsen Foundation	The study was funded by grants from the Tvergaard Foundation, Foundation of Harald Jensen and Wife, Foundation of Hans Christensen, Foundation of King Christian 10th, Research Foundation of Hillerod Hospital, Brodrene Hartmann Foundation, and Olga Bryde Nielsen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Banck-Petersen P, 2007, EUR DIABETES NURS, V4, P113, DOI DOI 10.1002/EDN.91; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Cryer PE, 1999, DIABETES-METAB RES, V15, P42, DOI 10.1002/(SICI)1520-7560(199901/02)15:1<42::AID-DMRR1>3.0.CO;2-B; Ehrenreich H, 2007, MOL PSYCHIATR, V12, P206, DOI 10.1038/sj.mp.4001907; Fruehwald-Schultes B, 2000, DIABETES CARE, V23, P1059, DOI 10.2337/diacare.23.8.1059; GHOSAL J, 1987, BIOCHEM MED METAB B, V38, P134, DOI 10.1016/0885-4505(87)90072-7; GOLDEN CJ, 1975, J PERS ASSESS, V39, P386, DOI 10.1207/s15327752jpa3904_10; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Hoi-Hansen T, 2009, J RENIN-ANGIO-ALDO S, V10, P216, DOI 10.1177/1470320309343007; Jorgensen HV, 2003, DIABETES CARE, V26, P1106, DOI 10.2337/diacare.26.4.1106; Kristensen PL, 2012, DIABETES RES CLIN PR, V96, P17, DOI 10.1016/j.diabres.2011.10.046; Kristensen PL, 2009, DIABETES RES CLIN PR, V85, P75, DOI 10.1016/j.diabres.2009.01.008; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; McCrimmon RJ, 2003, DIABETIC MED, V20, P507, DOI 10.1046/j.1464-5491.2003.00955_3.x; Miskowiak K, 2008, NEUROPSYCHOPHARMACOL, V33, P611, DOI 10.1038/sj.npp.1301439; Miskowiak K, 2008, EXP BRAIN RES, V184, P313, DOI 10.1007/s00221-007-1102-1; Miskowiak KW, 2010, PSYCHOPHARMACOLOGY, V210, P419, DOI 10.1007/s00213-010-1842-7; Pedersen-Bjergaard U, 2004, DIABETES-METAB RES, V20, P479, DOI 10.1002/dmrr.482; Pedersen-Bjergaard U, 2003, DIABETES-METAB RES, V19, P232, DOI 10.1002/dmrr.377; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; PRAMMING S, 1991, DIABETIC MED, V8, P217, DOI 10.1111/j.1464-5491.1991.tb01575.x; Reynolds CR, 2002, COMPREHENSIVE TRAIL; Silverstein JM, 2011, NEUROSCI LETT, V492, P23, DOI 10.1016/j.neulet.2011.01.045; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Springborg JB, 2003, BRAIN RES, V984, P143, DOI 10.1016/S0006-8993(03)03124-X; Strauss E, 2006, COMPENDIUM NEUROPSYC, P477; ter Braak EWMT, 2000, DIABETES CARE, V23, P1467, DOI 10.2337/diacare.23.10.1467; Weber A, 2002, BRAIN RES, V958, P305, DOI 10.1016/S0006-8993(02)03604-1; Xenocostas A, 2005, EUR J CLIN PHARMACOL, V61, P189, DOI 10.1007/s00228-005-0896-7; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x; Yamamoto M, 2000, NEUROSCI LETT, V292, P131, DOI 10.1016/S0304-3940(00)01441-5	33	18	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59672	10.1371/journal.pone.0059672	http://dx.doi.org/10.1371/journal.pone.0059672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577069	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800013
J	Kushki, A; Drumm, E; Mobarak, MP; Tanel, N; Dupuis, A; Chau, T; Anagnostou, E				Kushki, Azadeh; Drumm, Ellen; Mobarak, Michele Pla; Tanel, Nadia; Dupuis, Annie; Chau, Tom; Anagnostou, Evdokia			Investigating the Autonomic Nervous System Response to Anxiety in Children with Autism Spectrum Disorders	PLOS ONE			English	Article							AMYGDALA VOLUME; HEART-RATE; ASSOCIATION; SYMPTOMS; DEFICITS; AROUSAL; STRESS; STROOP; ADULTS; PUPIL	Assessment of anxiety symptoms in autism spectrum disorders (ASD) is a challenging task due to the symptom overlap between the two conditions as well as the difficulties in communication and awareness of emotions in ASD. This motivates the development of a physiological marker of anxiety in ASD that is independent of language and does not require observation of overt behaviour. In this study, we investigated the feasibility of using indicators of autonomic nervous system (ANS) activity for this purpose. Specially, the objectives of the study were to 1) examine whether or not anxiety causes significant measurable changes in indicators of ANS in an ASD population, and 2) characterize the pattern of these changes in ASD. We measured three physiological indicators of the autonomic nervous system response (heart rate, electrodermal activity, and skin temperature) during a baseline (movie watching) and anxiety condition (Stroop task) in a sample of typically developing children (n = 17) and children with ASD (n = 12). The anxiety condition caused significant changes in heart rate and electrodermal activity in both groups, however, a differential pattern of response was found between the two groups. In particular, the ASD group showed elevated heart rate during both baseline and anxiety conditions. Elevated and blunted phasic electrodermal activity were found in the ASD group during baseline and anxiety conditions, respectively. Finally, the ASD group did not show the typical decrease in skin temperature in response to anxiety. These results suggest that 1) signals of the autonomic nervous system may be used as indicators of anxiety in children with ASD, and 2) ASD may be associated with an atypical autonomic response to anxiety that is most consistent with sympathetic over-arousal and parasympathetic under-arousal.	[Kushki, Azadeh; Drumm, Ellen; Mobarak, Michele Pla; Tanel, Nadia; Dupuis, Annie; Chau, Tom; Anagnostou, Evdokia] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Dupuis, Annie] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Chau, Tom] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Anagnostou, Evdokia] Univ Toronto, Dept Pediat, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Kushki, A (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada.	akushki@hollandbloorview.ca	Chau, Tom TK/C-8426-2009	Chau, Tom TK/0000-0002-7486-0316; Dupuis, Annie/0000-0002-8704-078X	Bloorview Research Institute; Ontario Brain Institute; Seaside Therapeutics	Bloorview Research Institute; Ontario Brain Institute; Seaside Therapeutics	This study was funded in part by the Bloorview Research Institute and the Ontario Brain Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors AK, ED, MM, NT, AD and TC have declared that no competing interests exist. EA has consulted without fees to Proximagen, Neuropharm and NOVARTIS and has received a consultation fee from Seaside Therapeutics. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adams NC, 2009, J AUTISM DEV DISORD, V39, P1112, DOI 10.1007/s10803-009-0721-8; Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Amaral DG, 2003, NOVART FDN SYMP, V251, P177; Anderson CJ, 2009, DEV PSYCHOBIOL, V51, P207, DOI 10.1002/dev.20352; Bal E, 2010, J AUTISM DEV DISORD, V40, P358, DOI 10.1007/s10803-009-0884-3; Boutcher YN, 2006, BIOL PSYCHOL, V73, P235, DOI 10.1016/j.biopsycho.2006.04.005; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Bryson S. E., 2000, AUTISM, V4, P117, DOI [DOI 10.1177/1362361300004002002, 10.1177/1362361300004002002]; Christ SE, 2007, J AUTISM DEV DISORD, V37, P1155, DOI 10.1007/s10803-006-0259-y; Dawson M.E., 2000, HDB PSYCHOPHYSIOLOGY, V2, P200; Farrugia S., 2006, FOCUS AUTISM OTHER D, V21, P25, DOI [10.1177/10883576060210010401, DOI 10.1177/10883576060210010401]; Fechir M, 2010, NEUROIMAGE, V50, P847, DOI 10.1016/j.neuroimage.2009.12.004; Franchini K.G., 2011, PRIMER AUTONOMIC NER, V2nd ed., P134; Franchini KG, 2011, PRIMER AUTONOMIC NER, P139; Gillott A, 2001, AUTISM, V5, P277, DOI 10.1177/1362361301005003005; Gillott A, 2007, J INTELLECT DISABILI, V11, P359, DOI 10.1177/1744629507083585; Goodwin M.S., 2006, FOCUS AUTISM DEV DIS, V21, P100, DOI DOI 10.1177/10883576060210020101; Haznedar MM, 2000, AM J PSYCHIAT, V157, P1994, DOI 10.1176/appi.ajp.157.12.1994; Helverschou SB, 2011, RES AUTISM SPECT DIS, V5, P377, DOI 10.1016/j.rasd.2010.05.003; Hess J, 2010, RES AUTISM SPECTRUM; Hirstein W, 2001, P ROY SOC B-BIOL SCI, V268, P1883, DOI 10.1098/rspb.2001.1724; Jansen LMC, 2003, NEUROPSYCHOPHARMACOL, V28, P582, DOI 10.1038/sj.npp.1300046; Jansen LMC, 2006, J AUTISM DEV DISORD, V36, P891, DOI 10.1007/s10803-006-0124-z; Juranek J, 2006, J CHILD NEUROL, V21, P1051, DOI 10.1177/7010.2006.00237; Kistler A, 1998, INT J PSYCHOPHYSIOL, V29, P35, DOI 10.1016/S0167-8760(97)00087-1; Kleinhans NM, 2010, NEUROPSYCHOLOGIA, V48, P3665, DOI 10.1016/j.neuropsychologia.2010.07.022; Kylliainen A, 2006, J AUTISM DEV DISORD, V36, P517, DOI 10.1007/s10803-006-0091-4; Lang R, 2010, DEV NEUROREHABIL, V13, P53, DOI 10.3109/17518420903236288; Levine TP, 2012, RES AUTISM SPECT DIS, V6, P177, DOI 10.1016/j.rasd.2011.04.003; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; MacNeil BM, 2009, RES AUTISM SPECT DIS, V3, P1, DOI 10.1016/j.rasd.2008.06.001; Ming X, 2005, BRAIN DEV-JPN, V27, P509, DOI 10.1016/j.braindev.2005.01.003; Mosconi MW, 2009, ARCH GEN PSYCHIAT, V66, P509, DOI 10.1001/archgenpsychiatry.2009.19; Ozonoff S, 1999, J AUTISM DEV DISORD, V29, P171, DOI 10.1023/A:1023052913110; Porges SW, 2003, PHYSIOL BEHAV, V79, P503, DOI 10.1016/S0031-9384(03)00156-2; Reaven JA, 2009, J SPEC PEDIATR NURS, V14, P192, DOI 10.1111/j.1744-6155.2009.00197.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sukhodolsky DG, 2008, J ABNORM CHILD PSYCH, V36, P117, DOI 10.1007/s10802-007-9165-9; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Toichi M, 2003, J AUTISM DEV DISORD, V33, P417, DOI 10.1023/A:1025062812374; Hecke AV, 2009, CHILD DEV, V80, P1118, DOI 10.1111/j.1467-8624.2009.01320.x; Vetrugno R, 2003, CLIN AUTON RES, V13, P256, DOI 10.1007/s10286-003-0107-5; White SW, 2009, J AUTISM DEV DISORD, V39, P1006, DOI 10.1007/s10803-009-0713-8; White SW, 2009, CLIN PSYCHOL REV, V29, P216, DOI 10.1016/j.cpr.2009.01.003; Yang TT, 2007, NEUROSCI LETT, V428, P109, DOI 10.1016/j.neulet.2007.09.039	45	99	101	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59730	10.1371/journal.pone.0059730	http://dx.doi.org/10.1371/journal.pone.0059730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577072	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800016
J	Martinez-Nicolas, A; Ortiz-Tudela, E; Rol, MA; Madrid, JA				Martinez-Nicolas, Antonio; Ortiz-Tudela, Elisabet; Angeles Rol, Maria; Antonio Madrid, Juan			Uncovering Different Masking Factors on Wrist Skin Temperature Rhythm in Free-Living Subjects	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; CORE TEMPERATURE; LIGHT EXPOSURE; HEART-RATE; BODY-TEMPERATURE; SLEEP-WAKE; MOTOR-ACTIVITY; HUMANS; TIME; PURIFICATION	Most circadian rhythms are controlled by a major pacemaker located in the hypothalamic suprachiasmatic nucleus. Some of these rhythms, called marker rhythms, serve to characterize the timing of the internal temporal order. However, these variables are susceptible to masking effects as the result of activity, body position, light exposure, environmental temperature and sleep. Recently, wrist skin temperature (WT) has been proposed as a new index for evaluating circadian system status. In light of previous evidence suggesting the important relationship between WT and core body temperature regulation, the aim of this work was to purify the WT pattern in order to obtain its endogenous rhythm with the application of multiple demasking procedures. To this end, 103 subjects (18-24 years old) were recruited and their WT, activity, body position, light exposure, environmental temperature and sleep were recorded under free-living conditions for 1 week. WT demasking by categories or intercepts was applied to simulate a "constant routine'' protocol (awakening, dim light, recumbent position, low activity and warm environmental temperature). Although the overall circadian pattern of WT was similar regardless of the masking effects, its amplitude was the rhythmic parameter most affected by environmental conditions. The acrophase and mesor were determined to be the most robust parameters for characterizing this rhythm. In addition, a circadian modulation of the masking effect was found for each masking variable. WT rhythm exhibits a strong endogenous component, despite the existence of multiple external influences. This was evidenced by simultaneously eliminating the influence of activity, body position, light exposure, environmental temperature and sleep. We therefore propose that it could be considered a valuable and minimally-invasive means of recording circadian physiology in ambulatory conditions.	[Martinez-Nicolas, Antonio; Ortiz-Tudela, Elisabet; Angeles Rol, Maria; Antonio Madrid, Juan] Univ Murcia, Coll Biol, Dept Physiol, Chronobiol Lab, Murcia, Spain	University of Murcia	Rol, MA (corresponding author), Univ Murcia, Coll Biol, Dept Physiol, Chronobiol Lab, Murcia, Spain.	angerol@um.es	ROL, ANGELES/ABH-6431-2020; ROL, ANGELES/C-6718-2009; Martinez-Nicolas, Antonio/A-7560-2012	ROL, ANGELES/0000-0002-9343-3918; ROL, ANGELES/0000-0002-9343-3918; Martinez-Nicolas, Antonio/0000-0002-8213-3370; Madrid, Juan Antonio/0000-0002-9286-1371	Ministry of Economy and Competitivity; Instituto de Salud Carlos III - RETICEF (The Ageing and Frailty Cooperative Research Network) [RD06/0013/0019, RD12/0043/0011]; Ministry of Education and Science; Ministry of Economy and Competitivity [BFU2010-21945-C02-01, IPT-2011-0833-900000]; FEDER;  [AP2008-2850]	Ministry of Economy and Competitivity; Instituto de Salud Carlos III - RETICEF (The Ageing and Frailty Cooperative Research Network); Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Economy and Competitivity; FEDER(European Commission); 	This work was supported by the Ministry of Economy and Competitivity and the Instituto de Salud Carlos III - RETICEF (The Ageing and Frailty Cooperative Research Network, RD06/0013/0019 and RD12/0043/0011), the Ministry of Education and Science and the Ministry of Economy and Competitivity (BFU2010-21945-C02-01, IPT-2011-0833-900000), including FEDER cofunding granted to J. A. Madrid, and the research fellowship awarded to Antonio Martinez-Nicolas (University of Murcia) and to E. Ortiz-Tudela (AP2008-2850). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders D, 2010, CHRONOBIOL INT, V27, P1609, DOI 10.3109/07420528.2010.504317; ASCHOFF J, 1983, J THERM BIOL, V8, P143, DOI 10.1016/0306-4565(83)90094-3; Blazquez A, 2012, CHRONOBIOL INT, V29, P747, DOI 10.3109/07420528.2012.679328; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Buijs RM, 2003, J COMP NEUROL, V464, P36, DOI 10.1002/cne.10765; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Cajochen C, 2001, NEUROREPORT, V12, P2277, DOI 10.1097/00001756-200107200-00046; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; FRANKEN P, 1992, J BIOL RHYTHM, V7, P341, DOI 10.1177/074873049200700407; Gompper B, 2010, CHRONOBIOL INT, V27, P1778, DOI 10.3109/07420528.2010.520786; Goulet G, 2007, J BIOL RHYTHM, V22, P151, DOI 10.1177/0748730406297780; Gradisar M, 2004, J BIOL RHYTHM, V19, P157, DOI 10.1177/0748730403261560; Graw P, 1998, J AFFECT DISORDERS, V48, P69, DOI 10.1016/S0165-0327(97)00142-0; Hebert M, 1998, CHRONOBIOL INT, V15, P59; Heil DP, 2002, APPL ERGON, V33, P357, DOI 10.1016/S0003-6870(02)00007-8; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Huang YL, 2002, PHYSIOL BEHAV, V76, P597, DOI 10.1016/S0031-9384(02)00733-3; Jasper I, 2010, CHRONOBIOL INT, V27, P653, DOI 10.3109/07420521003663793; Kim HE, 2007, COLLEGIUM ANTROPOL, V31, P145; Klerman EB, 1999, J BIOL RHYTHM, V14, P260, DOI 10.1177/074873099129000678; Kondo Masayuki, 2007, Journal of Physiological Anthropology, V26, P429, DOI 10.2114/jpa2.26.429; Krauchi K, 2007, PHYSIOL BEHAV, V90, P236, DOI 10.1016/j.physbeh.2006.09.005; Krauchi K, 2000, AM J PHYSIOL-REG I, V278, pR741, DOI 10.1152/ajpregu.2000.278.3.R741; Krauchi K, 2005, CLIN SPORT MED, V24, P287, DOI 10.1016/j.csm.2004.12.009; Krauchi K, 2001, NEUROPSYCHOPHARMACOL, V25, pS92, DOI 10.1016/S0893-133X(01)00315-3; Krauchi K, 2010, FRONT BIOSCI-LANDMRK, V15, P604, DOI 10.2741/3636; Lavie P., 1985, ULTRADIAN RHYTHMS PH, V12, P148, DOI DOI 10.1007/978-3-642-70483-3_11; Martinez-Nicolas A, 2011, CHRONOBIOL INT, V28, P617, DOI 10.3109/07420528.2011.593278; MILLS JN, 1978, J PHYSIOL-LONDON, V285, P455, DOI 10.1113/jphysiol.1978.sp012582; MINORS DS, 1989, CHRONOBIOL INT, V6, P29, DOI 10.3109/07420528909059140; MINORS DS, 1992, CHRONOBIOL INT, V9, P55, DOI 10.3109/07420529209064516; Moore RY, 2002, CHRONOBIOL INT, V19, P345, DOI 10.1081/CBI-120002876; Mormont MC, 2002, CHRONOBIOL INT, V19, P141, DOI 10.1081/CBI-120002593; Munch M, 2005, NEUROBIOL AGING, V26, P1307, DOI 10.1016/j.neurobiolaging.2005.03.004; OKUDAIRA N, 1983, AM J PHYSIOL, V245, pR613, DOI 10.1152/ajpregu.1983.245.4.R613; Ortiz-Tudela E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000996; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; Raymann RJEM, 2008, BRAIN, V131, P500, DOI 10.1093/brain/awm315; Reilly T, 2009, J THERM BIOL, V34, pCP1, DOI 10.1016/j.jtherbio.2009.01.005; Reiter Russel J., 2007, Critical Reviews in Oncogenesis, V13, P303; RIETVELD WJ, 1993, CHRONOBIOL INT, V10, P306, DOI 10.3109/07420529309059713; Romeijn N, 2011, J BIOL RHYTHM, V26, P68, DOI 10.1177/0748730410391894; Ruger M, 2006, AM J PHYSIOL-REG I, V290, pR1413, DOI 10.1152/ajpregu.00121.2005; Sarabia JA, 2008, PHYSIOL BEHAV, V95, P570, DOI 10.1016/j.physbeh.2008.08.005; SAVIDES TJ, 1986, PHYSIOL BEHAV, V38, P571, DOI 10.1016/0031-9384(86)90427-0; Scheer FAJL, 1999, J BIOL RHYTHM, V14, P202, DOI 10.1177/074873099129000614; Shechter A, 2011, J BIOL RHYTHM, V26, P260, DOI 10.1177/0748730411404677; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Lichtenbelt WDV, 2006, PHYSIOL BEHAV, V88, P489, DOI 10.1016/j.physbeh.2006.04.026; Van Someren EJW, 2000, CHRONOBIOL INT, V17, P313, DOI 10.1081/CBI-100101050; Wakamura T, 2002, J THERM BIOL, V27, P439, DOI 10.1016/S0306-4565(02)00014-1; Waterhouse J, 1999, CHRONOBIOL INT, V16, P461, DOI 10.3109/07420529908998721; Waterhouse J, 2005, CHRONOBIOL INT, V22, P829, DOI 10.1080/07420520500263375; Waterhouse J, 2000, CHRONOBIOL INT, V17, P539, DOI 10.1081/CBI-100101063; Waterhouse J, 2001, BIOL RHYTHM RES, V32, P511, DOI 10.1076/brhm.32.5.511.1293; Weinert D, 1998, PHYSIOL BEHAV, V63, P837, DOI 10.1016/S0031-9384(97)00546-5; Weinert D, 2003, CHRONOBIOL INT, V20, P249, DOI 10.1081/CBI-120018649; Weinert D, 2007, PHYSIOL BEHAV, V90, P246, DOI 10.1016/j.physbeh.2006.09.003; Zornoza-Moreno M, 2011, CHRONOBIOL INT, V28, P330, DOI 10.3109/07420528.2011.565895	62	48	48	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61142	10.1371/journal.pone.0061142	http://dx.doi.org/10.1371/journal.pone.0061142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577201	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800125
J	Pitzalis, S; Sdoia, S; Bultrini, A; Committeri, G; Di Russo, F; Fattori, P; Galletti, C; Galati, G				Pitzalis, Sabrina; Sdoia, Stefano; Bultrini, Alessandro; Committeri, Giorgia; Di Russo, Francesco; Fattori, Patrizia; Galletti, Claudio; Galati, Gaspare			Selectivity to Translational Egomotion in Human Brain Motion Areas	PLOS ONE			English	Article							FUNCTIONAL MAGNETIC-RESONANCE; VENTRAL INTRAPARIETAL AREA; SUPERIOR TEMPORAL AREA; SURFACE-BASED ANALYSIS; CORTICAL CONNECTIONS; POSTERIOR PARIETAL; VISUAL-MOTION; MST NEURONS; OPTIC FLOW; HUMAN MT	The optic flow generated when a person moves through the environment can be locally decomposed into several basic components, including radial, circular, translational and spiral motion. Since their analysis plays an important part in the visual perception and control of locomotion and posture it is likely that some brain regions in the primate dorsal visual pathway are specialized to distinguish among them. The aim of this study is to explore the sensitivity to different types of egomotion-compatible visual stimulations in the human motion-sensitive regions of the brain. Event-related fMRI experiments, 3D motion and wide-field stimulation, functional localizers and brain mapping methods were used to study the sensitivity of six distinct motion areas (V6, MT, MST+, V3A, CSv and an Intra-Parietal Sulcus motion [IPSmot] region) to different types of optic flow stimuli. Results show that only areas V6, MST+ and IPSmot are specialized in distinguishing among the various types of flow patterns, with a high response for the translational flow which was maximum in V6 and IPSmot and less marked in MST+. Given that during egomotion the translational optic flow conveys differential information about the near and far external objects, areas V6 and IPSmot likely process visual egomotion signals to extract information about the relative distance of objects with respect to the observer. Since area V6 is also involved in distinguishing object-motion from self-motion, it could provide information about location in space of moving and static objects during self-motion, particularly in a dynamically unstable environment.	[Pitzalis, Sabrina; Sdoia, Stefano; Bultrini, Alessandro; Di Russo, Francesco] Univ Rome Foro Italico, Dept Motor Human & Hlth Sci, Rome, Italy; [Pitzalis, Sabrina; Galati, Gaspare] Santa Lucia Fdn, Neuropsychol Ctr, Rome, Italy; [Committeri, Giorgia] Univ G DAnnunzio, Lab Neuropsychol & Cognit Neurosci, Dept Neurosci & Imaging, Chieti, Italy; [Committeri, Giorgia] Fdn G dAnnunzio, ITAB, Chieti, Italy; [Fattori, Patrizia; Galletti, Claudio] Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy; [Galati, Gaspare] Univ Roma La Sapienza, Dept Psychol, Rome, Italy	Foro Italico University of Rome; IRCCS Santa Lucia; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Bologna; Sapienza University Rome	Pitzalis, S (corresponding author), Univ Rome Foro Italico, Dept Motor Human & Hlth Sci, Rome, Italy.	sabrina.pitzalis@iusm.it	Committeri, Giorgia/AAC-1035-2022; Galati, Gaspare/F-3277-2011; Di Russo, Francesco/N-6686-2015; Fattori, Patrizia/Q-8947-2017; Pitzalis, Sabrina/AAA-9406-2019	Galati, Gaspare/0000-0002-0640-4247; Di Russo, Francesco/0000-0002-3127-9433; Fattori, Patrizia/0000-0002-0079-3755; pitzalis, sabrina/0000-0002-4445-0391; GALLETTI, CLAUDIO/0000-0001-8927-3408; SDOIA, STEFANO/0000-0001-9275-8350	University of Rome "Foro Italico"; Ministero dell'Istruzione, dell'Universita e della Ricerca [2008PBT985_002]; Fondazione del Monte di Bologna e Ravenna, Italy; Italian Ministry of Health	University of Rome "Foro Italico"; Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondazione del Monte di Bologna e Ravenna, Italy; Italian Ministry of Health(Ministry of Health, Italy)	This research was supported by grants from the University of Rome "Foro Italico" to SP and FDR, from Ministero dell'Istruzione, dell'Universita e della Ricerca (prot. 2008PBT985_002) and the Fondazione del Monte di Bologna e Ravenna, Italy to CG and PF, and from the Italian Ministry of Health (RC2008-2009) to G.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Beer J, 2002, EXP BRAIN RES, V143, P78, DOI 10.1007/s00221-001-0947-y; Brandt T, 1998, ARCH NEUROL-CHICAGO, V55, P1126, DOI 10.1001/archneur.55.8.1126; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Breveglieri R, 2002, NEUROREPORT, V13, P2113, DOI 10.1097/00001756-200211150-00024; Breveglieri R, 2012, J NEUROSCI, V32, P159, DOI 10.1523/JNEUROSCI.4028-11.2012; Cardin V, 2012, J NEUROPHYSIOL; Cardin V, 2011, J NEUROPHYSIOL, V106, P1240, DOI 10.1152/jn.01120.2010; Cardin V, 2010, CEREB CORTEX, V20, P1964, DOI 10.1093/cercor/bhp268; Castriota-Scanderbeg A, 2005, NEUROIMAGE, V25, P570, DOI 10.1016/j.neuroimage.2004.11.045; CHENG K, 1995, J NEUROPHYSIOL, V74, P413, DOI 10.1152/jn.1995.74.1.413; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEJONG BM, 1994, BRAIN, V117, P1039; Deutschlander A, 2004, HUM BRAIN MAPP, V21, P143, DOI 10.1002/hbm.10155; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Eifuku S, 1998, J NEUROPHYSIOL, V80, P282, DOI 10.1152/jn.1998.80.1.282; Fischer E, 2012, CEREB CORTEX, V22, P865, DOI 10.1093/cercor/bhr154; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Galati G, 2011, EUR J NEUROSCI, V34, P1871, DOI 10.1111/j.1460-9568.2011.07885.x; Galletti C, 2004, CORTEX, V40, P216, DOI 10.1016/S0010-9452(08)70956-0; Galletti C, 2003, NEUROPSYCHOLOGIA, V41, P1717, DOI 10.1016/S0028-3932(03)00174-X; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; Galletti C, 1999, EUR J NEUROSCI, V11, P3922, DOI 10.1046/j.1460-9568.1999.00817.x; Gamberini M, 2009, J COMP NEUROL, V513, P622, DOI 10.1002/cne.21980; Gibson J.J., 1966, SENSES CONSIDERED PE; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Grossberg S, 1999, CEREB CORTEX, V9, P878, DOI 10.1093/cercor/9.8.878; Hadjidimitrakis K, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00037; Hadjidimitrakis K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023335; Hagler DJ, 2006, NEUROIMAGE, V29, P567, DOI 10.1016/j.neuroimage.2005.08.058; Helfrich R.F., 2012, BRAIN TOPOGR; Hixson WC, 1966, MONOGRAPH NAVEL AERO, V14; Huk AC, 2002, J NEUROSCI, V22, P7195; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Kennedy RS, 1996, J VESTIBUL RES-EQUIL, V6, P331, DOI 10.1016/0957-4271(96)00002-X; Kleinschmidt A, 2002, NEUROIMAGE, V16, P873, DOI 10.1006/nimg.2002.1181; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Kovacs G, 2008, CEREB CORTEX, V18, P1779, DOI 10.1093/cercor/bhm203; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Nelissen K, 2006, J NEUROSCI, V26, P5929, DOI 10.1523/JNEUROSCI.0824-06.2006; Nover H, 2005, J NEUROSCI, V25, P10049, DOI 10.1523/JNEUROSCI.1661-05.2005; ORBAN GA, 1992, P NATL ACAD SCI USA, V89, P2595, DOI 10.1073/pnas.89.7.2595; Passarelli L, 2011, J NEUROSCI, V31, P1790, DOI 10.1523/JNEUROSCI.4784-10.2011; Peuskens H, 2001, J NEUROSCI, V21, P2451, DOI 10.1523/JNEUROSCI.21-07-02451.2001; Pitzalis S, 2010, CEREB CORTEX, V20, P411, DOI 10.1093/cercor/bhp112; Pitzalis S, 2013, NEUROIMAGE, V67, P89, DOI 10.1016/j.neuroimage.2012.11.022; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; Previc FH, 2000, EXP BRAIN RES, V131, P393, DOI 10.1007/s002219900298; Priebe NJ, 2004, J NEUROSCI, V24, P1907, DOI 10.1523/JNEUROSCI.4233-03.2004; Ptito M, 2001, NEUROIMAGE, V14, P1409, DOI 10.1006/nimg.2001.0947; SAITO H, 1986, J NEUROSCI, V6, P145; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shipp S, 1998, EUR J NEUROSCI, V10, P3171, DOI 10.1046/j.1460-9568.1998.00327.x; Smith AT, 2012, CEREB CORTEX, V22, P1068, DOI 10.1093/cercor/bhr179; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Talairach J., 1988, COPLANAR STEREOTAXIC; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; von Pfostl V, 2009, NEUROIMAGE, V45, P1253, DOI 10.1016/j.neuroimage.2008.12.058; Wall MB, 2008, EUR J NEUROSCI, V27, P2747, DOI 10.1111/j.1460-9568.2008.06249.x; Wall MB, 2008, CURR BIOL, V18, P191, DOI 10.1016/j.cub.2007.12.053; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79	84	62	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60241	10.1371/journal.pone.0060241	http://dx.doi.org/10.1371/journal.pone.0060241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577096	gold, Green Published			2022-12-27	WOS:000319109800038
J	Yuan, Q; Hong, SJ; Shi, BY; Kers, J; Li, ZL; Pei, XK; Xu, L; Wei, X; Cai, M				Yuan, Qing; Hong, Shanjuan; Shi, Bingyi; Kers, Jesper; Li, Zhouli; Pei, Xiangke; Xu, Liang; Wei, Xing; Cai, Ming			CD4(+)CD25(-)Nrp1(+) T Cells Synergize with Rapamycin to Prevent Murine Cardiac Allorejection in Immunocompetent Recipients	PLOS ONE			English	Article							TOLEROGENIC DENDRITIC CELLS; TRANSPLANTATION TOLERANCE; ORGAN-TRANSPLANTATION; ALLOGRAFT SURVIVAL; IN-VIVO; NEUROPILIN-1; MECHANISMS; THERAPY; SEMAPHORIN-3A; INHIBITION	Besides CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs), other immunosuppressive T cells also participated in the regulation of immune tolerance. Reportedly, neuropilin-1 (Nrp1) might be one of the molecules by which regulatory cells exert their suppressive effects. Indeed, CD4(+)CD25(-)Nrp1(+) T cells exhibit potent suppressive function in autoimmune inflammatory responses. Here we investigated the specific role of CD4(+)CD25(-)Nrp1(+) T cells in the setting of the transplant immune response. Through MLR assays, we found that CD4(+)CD25(+)Nrp1(+) T cells suppressed the proliferation of naive CD4(+)CD25(-) T cells activated by allogeneic antigen-stimulation. Adoptive transfer of CD4(+)CD25(-)Nrp1(+) T cells synergized with rapamycin to induce long-term graft survival in fully MHC-mismatched murine heart transplantation, which was associated with decreased IFN-gamma, IL-17 and increased IL-10, TGF-beta, Foxp3 and Nrp1 expression in the grafts. Importantly, our data indicated that CD4(+)CD25(-)Nrp1(+) T cell transfer augments the accumulation of Tregs in the recipient, and creates conditions that favored induction of hyporesponsiveness of the T effector cells. In conclusion, this translational study indicates the possible therapeutic potential of CD4(+)CD25(-)Nrp1(+) T cells in preventing allorejection. CD4(+)Nrp1(+) T cells might therefore be used in bulk as a population of immunosuppressive cells with more beneficial properties concerning ex vivo isolation as compared to Foxp3(+) Tregs.	[Yuan, Qing; Shi, Bingyi; Li, Zhouli; Xu, Liang; Wei, Xing; Cai, Ming] 309th Hosp PLA, Organ Transplant Inst PLA, Organ Transplant Ctr, Beijing, Peoples R China; [Hong, Shanjuan] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Kers, Jesper] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Pei, Xiangke] 281th Hosp PLA, Organ Transplant Ctr, Qinhuangdao, Hebei, Peoples R China	Naval Medical University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Cai, M (corresponding author), 309th Hosp PLA, Organ Transplant Inst PLA, Organ Transplant Ctr, Beijing, Peoples R China.	caiming309@gmail.com	Kers, Jesper/F-1995-2010		National Key Technology R&D Program of Chinese PLA [06G115]; National Key Technology R&D Program of China [2008BAI60B04]; National Natural Science Foundation of China [81200547]; RISET consortium on Transplantation Tolerance; ERA-EDTA fellowship; Dutch Kidney Foundation	National Key Technology R&D Program of Chinese PLA(National Key Technology R&D Program); National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); RISET consortium on Transplantation Tolerance; ERA-EDTA fellowship; Dutch Kidney Foundation	This work was supported by grants from the National Key Technology R&D Program of Chinese PLA (06G115) and the National Key Technology R&D Program of China (2008BAI60B04), the National Natural Science Foundation of China (81200547), the RISET consortium on Transplantation Tolerance (www.nds.ox.ac.uk/riset), an ERA-EDTA fellowship and a grant from the Dutch Kidney Foundation (awarded to J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae D, 2008, J BIOL CHEM, V283, P28074, DOI 10.1074/jbc.M804203200; Battaglia A, 2008, IMMUNOLOGY, V123, P129, DOI 10.1111/j.1365-2567.2007.02737.x; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Catalano A, 2006, BLOOD, V107, P3321, DOI 10.1182/blood-2005-06-2445; Chen ZHK, 1996, TRANSPLANTATION, V62, P1200, DOI 10.1097/00007890-199611150-00002; Ezzelarab M, 2011, SEMIN IMMUNOL, V23, P252, DOI 10.1016/j.smim.2011.06.007; Fan HM, 2011, SEMIN IMMUNOL, V23, P453, DOI 10.1016/j.smim.2011.08.012; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; HALL BM, 1990, J EXP MED, V171, P141, DOI 10.1084/jem.171.1.141; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Kapp JA, 1997, RES IMMUNOL, V148, P561, DOI 10.1016/S0923-2494(98)80150-8; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Lepelletier Y, 2006, EUR J IMMUNOL, V36, P1782, DOI 10.1002/eji.200535601; Li LQ, 2011, CLIN IMMUNOL, V141, P244, DOI 10.1016/j.clim.2011.08.011; Ma AL, 2009, INT IMMUNOPHARMACOL, V9, P553, DOI 10.1016/j.intimp.2009.01.033; Manns RPC, 2012, J NEUROSCI, V32, P8554, DOI 10.1523/JNEUROSCI.5964-11.2012; Milpied P, 2009, EUR J IMMUNOL, V39, P1466, DOI 10.1002/eji.200839040; Min SI, 2009, EXP MOL MED, V41, P707, DOI 10.3858/emm.2009.41.10.077; Ming C, 2009, MED J CHIN PLA, V34, P1276; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Raimondi G, 2010, J IMMUNOL, V184, P624, DOI 10.4049/jimmunol.0900936; Regateiro FS, 2011, CURR OPIN IMMUNOL, V23, P660, DOI 10.1016/j.coi.2011.07.003; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Solomon BD, 2011, P NATL ACAD SCI USA, V108, P2040, DOI 10.1073/pnas.1008721108; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wood KJ, 2011, TRANSPL P, V43, P2135, DOI 10.1016/j.transproceed.2011.06.050; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Xia G, 2008, AM J TRANSPLANT, V8, P298, DOI 10.1111/j.1600-6143.2007.02088.x; Xiangke P, 2008, CHIN J CELL MOL IMMU, V24, P3; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zhang CT, 2010, CELL IMMUNOL, V264, P111, DOI 10.1016/j.cellimm.2010.05.014; Zhang ZX, 2011, TRANSPL IMMUNOL, V24, P119, DOI 10.1016/j.trim.2010.11.003; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513	37	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61151	10.1371/journal.pone.0061151	http://dx.doi.org/10.1371/journal.pone.0061151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577203	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800126
J	Cohen, SS; Matthews, CE; Signorello, LB; Schlundt, DG; Blot, WJ; Buchowski, MS				Cohen, Sarah S.; Matthews, Charles E.; Signorello, Lisa B.; Schlundt, David G.; Blot, William J.; Buchowski, Maciej S.			Sedentary and Physically Active Behavior Patterns Among Low-Income African-American and White Adults Living in the Southeastern United States	PLOS ONE			English	Article							SOUTHERN COMMUNITY COHORT; LEISURE-TIME; ENERGY-EXPENDITURE; SOCIAL-CLASS; ALL-CAUSE; MORTALITY; HEALTH; SPENT; RISK; RACE/ETHNICITY	Increased sedentary behavior and lack of physical activity are associated with increased risk for many chronic diseases. Differences in leisure-time physical activity between African American and white adults have been suggested to partially explain racial disparities in chronic disease outcomes, but expanding the definition of physical activity to include household and occupational activities may reduce or even eliminate racial differences in total physical activity. The objective of this study was to describe patterns of active and sedentary behaviors in black and white adults and to examine these behaviors across demographic measures. Sedentary and physically active behaviors were obtained from a validated physical activity questionnaire in 23,021 black men, 9,899 white men, 32,214 black women, and 15,425 white women (age 40-79) at enrollment into the Southern Community Cohort Study. Descriptive statistics for sedentary time; light, moderate, and vigorous household/occupational activity; sports/exercise; total activity; and meeting current physical activity recommendations via sports/exercise were examined for each race-sex group. Adjusted means were calculated using multiple linear regression models across demographic measures. Study participants spent approximately 60% of waking time in sedentary behaviors. Blacks reported more television viewing time than whites (45 minutes for females, 15 minutes for males), but when sitting time was expressed as a proportion of overall awake time, minimal racial differences were found. Patterns of light, moderate, and vigorous household/occupational activity were similar in all race/sex groups. 2008 Physical Activity Guidelines for Americans were followed by 16% of women and 25% of men independent of race. Overall, black and white men and women in this study spent the majority of their daily time in sedentary behaviors and less than one-fourth followed current guidelines for physical activity. These results indicate that public health campaigns should focus on both reducing sedentary behavior and increasing physical activity in all adult US populations.	[Cohen, Sarah S.; Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Matthews, Charles E.] NCI, Div Canc Epidemiol & Genet, Nutr Epidemiol Branch, Rockville, MD USA; [Signorello, Lisa B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Schlundt, David G.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Blot, William J.; Buchowski, Maciej S.] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37240 USA; [Blot, William J.; Buchowski, Maciej S.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Buchowski, Maciej S.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Cohen, SS (corresponding author), Int Epidemiol Inst, Rockville, MD USA.	sarah@iei.us	matthews, Charles e/E-8073-2015	matthews, Charles e/0000-0001-8037-3103; Buchowski, Maciej/0000-0002-0566-1743; Cohen, Sarah/0000-0003-0421-1983	National Cancer Institute [R01CA092447]; NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Southern Community Cohort Study is funded by the National Cancer Institute (R01CA092447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Bowman Shanthy A, 2006, Prev Chronic Dis, V3, pA38; Brownson RC, 2000, AM J PUBLIC HEALTH, V90, P264, DOI 10.2105/AJPH.90.2.264; Buchowski MS, 2012, J PHYS ACT HEALTH, V9, P765, DOI 10.1123/jpah.9.6.765; Buchowski MS, 1999, OBES RES, V7, P23, DOI 10.1002/j.1550-8528.1999.tb00387.x; Carlson SA, 2010, AM J PREV MED, V39, P305, DOI 10.1016/j.amepre.2010.06.006; Crespo CJ, 2000, AM J PREV MED, V18, P46, DOI 10.1016/S0749-3797(99)00105-1; Eheman C, 2012, CANCER; Evenson KR, 2003, ANN EPIDEMIOL, V13, P351, DOI 10.1016/S1047-2797(02)00438-6; Ferrari P, 2007, AM J EPIDEMIOL, V166, P832, DOI 10.1093/aje/kwm148; FORD ES, 1991, AM J EPIDEMIOL, V133, P1246, DOI 10.1093/oxfordjournals.aje.a115836; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; He XXZ, 2005, J GEN INTERN MED, V20, P259, DOI 10.1111/j.1525-1497.2005.40198.x; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Li Chaoyang, 2011, Morbidity and Mortality Weekly Report, V60, P1; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Marshall SJ, 2007, MED SCI SPORT EXER, V39, P44, DOI 10.1249/01.mss.0000239401.16381.37; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Ransdell LB, 1998, MED SCI SPORT EXER, V30, P1608, DOI 10.1097/00005768-199811000-00009; Sidney S, 1996, ANN EPIDEMIOL, V6, P154, DOI 10.1016/1047-2797(95)00135-2; Signorello LB, 2005, J NATL MED ASSOC, V97, P972; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tukey JW, 1977, EXPLORATORY DATA ANA; Walsh MC, 2004, AM J CLIN NUTR, V79, P1013; Winzer BM, 2011, CANCER CAUSE CONTROL, V22, P811, DOI 10.1007/s10552-011-9761-4	35	39	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59975	10.1371/journal.pone.0059975	http://dx.doi.org/10.1371/journal.pone.0059975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573224	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100038
J	Duncan, NW; Wiebking, C; Tiret, B; Marjanska, M; Hayes, DJ; Lyttleton, O; Doyon, J; Northoff, G				Duncan, Niall W.; Wiebking, Christine; Tiret, Brice; Marjanska, Malgoranza; Hayes, Dave J.; Lyttleton, Oliver; Doyon, Julien; Northoff, Georg			Glutamate Concentration in the Medial Prefrontal Cortex Predicts Resting-State Cortical-Subcortical Functional Connectivity in Humans	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; BRAIN ACTIVATION PATTERNS; NUCLEUS-ACCUMBENS; EYES-OPEN; COGNITIVE CONTROL; NMDA-RECEPTORS; DEFAULT MODE; DOPAMINE; KETAMINE; NETWORK	Communication between cortical and subcortical regions is integral to a wide range of psychological processes and has been implicated in a number of psychiatric conditions. Studies in animals have provided insight into the biochemical and connectivity processes underlying such communication. However, to date no experiments that link these factors in humans in vivo have been carried out. To investigate the role of glutamate in individual differences in communication between the cortex - specifically the medial prefrontal cortex (mPFC) - and subcortical regions in humans, a combination of resting-state fMRI, DTI and MRS was performed. The subcortical target regions were the nucleus accumbens (NAc), dorsomedial thalamus (DMT), and periaqueductal grey (PAG). It was found that functional connectivity between the mPFC and each of the NAc and DMT was positively correlated with mPFC glutamate concentrations, whilst functional connectivity between the mPFC and PAG was negatively correlated with glutamate concentration. The correlations involving mPFC glutamate and FC between the mPFC and each of the DMT and PAG were mirrored by correlations with structural connectivity, providing evidence that the glutamatergic relationship may, in part, be due to direct connectivity. These results are in agreement with existing results from animal studies and may have relevance for MDD and schizophrenia.	[Duncan, Niall W.; Wiebking, Christine; Hayes, Dave J.; Lyttleton, Oliver; Northoff, Georg] Univ Ottawa, Mental Hlth Res Inst, Mind Brain Imaging & Neuroeth Res Unit, Ottawa, ON, Canada; [Duncan, Niall W.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Wiebking, Christine] Free Univ Berlin, Dept Biol, Berlin, Germany; [Tiret, Brice; Doyon, Julien] Univ Montreal, Funct Neuroimaging Unit, Montreal, PQ, Canada; [Tiret, Brice; Doyon, Julien] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Marjanska, Malgoranza] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN USA; [Marjanska, Malgoranza] Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA	University of Ottawa; Carleton University; Free University of Berlin; Universite de Montreal; Universite de Montreal; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Duncan, NW (corresponding author), Univ Ottawa, Mental Hlth Res Inst, Mind Brain Imaging & Neuroeth Res Unit, Ottawa, ON, Canada.	niall.w.duncan@gmail.com	; hayes, dave/C-7809-2013	Duncan, Niall/0000-0002-3225-9119; Marjanska, Malgorzata/0000-0002-4727-2447; hayes, dave/0000-0001-9474-8770; Wiebking, Christine/0000-0002-6340-7356; Tiret, Brice/0000-0002-4843-9130	Canadian Institute of Health Research; Michael Smith Foundation; Biotechnology Research Center (BTRC) grant [P41 RR008079, P41 EB015894]; NCC [P30 NS057091]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091, P30NS076408] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation(Michael Smith Foundation for Health Research); Biotechnology Research Center (BTRC) grant; NCC; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by grants to G.N. from the Canadian Institute of Health Research and the Michael Smith Foundation. M.M. acknowledges the support from Biotechnology Research Center (BTRC) grant P41 RR008079 (NCRR) and P41 EB015894 (NIBIB), and NCC P30 NS057091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto S, 2005, PSYCHOPHARMACOLOGY, V182, P375, DOI 10.1007/s00213-005-0092-6; Albrecht J, 2011, NEURON GLIA BIOL, P1; Alcaro A, 2010, NEUROSCI BIOBEHAV R, V34, P592, DOI 10.1016/j.neubiorev.2009.11.023; An X, 1998, J COMP NEUROL, V401, P455; Asher A, 2011, AUSTR TEL NETW APPL, P1; Aslan S, 2011, NEUROIMAGE, V56, P1145, DOI 10.1016/j.neuroimage.2011.02.082; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Barry RJ, 2011, CLIN NEUROPHYSIOL, V122, P2010, DOI 10.1016/j.clinph.2011.02.036; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bozkurt A, 2005, NEUROIMAGE, V25, P219, DOI 10.1016/j.neuroimage.2004.10.040; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Butler RK, 2011, PHYSIOL BEHAV, V104, P1075, DOI 10.1016/j.physbeh.2011.05.028; Chen J-L, 2012, HUM BRAIN MAPP; Chiba T, 2001, BRAIN RES, V888, P83, DOI 10.1016/S0006-8993(00)03013-4; Clinton SM, 2004, SCHIZOPHR RES, V69, P237, DOI 10.1016/j.schres.2003.09.017; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corti C, 2011, SCHIZOPHR RES, V128, P7, DOI 10.1016/j.schres.2011.01.021; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Coutinho MR, 2010, BEHAV BRAIN RES, V208, P237, DOI 10.1016/j.bbr.2009.11.047; Cronenwett WJ, 2010, CURR TOP BEHAV NEURO, V4, P509, DOI 10.1007/7854_2010_55; Cummings JL, 1995, ANN NY ACAD SCI, V769, P1, DOI 10.1111/j.1749-6632.1995.tb38127.x; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; David HN, 2009, CURR NEUROPHARMACOL, V7, P132, DOI 10.2174/157015909788848893; Dawson N, 2011, SCHIZOPHR B, V6, P1; del Arco A, 2005, J NEURAL TRANSM, V112, P97, DOI 10.1007/s00702-004-0172-5; Del Arco A, 2009, J NEURAL TRANSM, V116, P941, DOI 10.1007/s00702-009-0243-8; Donahue MJ, 2012, HUM BRAIN MAPP, V33, P511, DOI 10.1002/hbm.21228; Duncan NW, 2011, HUM BRAIN MAPP, V32, P2172, DOI 10.1002/hbm.21179; Enzi B, 2012, NEUROSCIENCE, V227, P102, DOI 10.1016/j.neuroscience.2012.09.039; Feenstra MGP, 2002, NEUROPHARMACOLOGY, V42, P752, DOI 10.1016/S0028-3908(02)00029-1; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Floresco SB, 2009, BEHAV BRAIN RES, V204, P396, DOI 10.1016/j.bbr.2008.12.001; Fu CHY, 2005, PSYCHOPHARMACOLOGY, V183, P92, DOI 10.1007/s00213-005-0154-9; George DN, 2011, BEHAV BRAIN RES, V225, P47, DOI 10.1016/j.bbr.2011.06.028; Gibbons AS, 2012, J AFFECT DISORDERS, V136, P1232, DOI 10.1016/j.jad.2011.10.001; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; GROENEWEGEN HJ, 1982, NEUROSCIENCE, V7, P977, DOI 10.1016/0306-4522(82)90055-0; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; Gruber AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005062; Gruetter R, 2000, MAGNET RESON MED, V43, P319, DOI 10.1002/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1; Hadjipavlou G, 2006, PAIN, V123, P169, DOI 10.1016/j.pain.2006.02.027; Hao X, 2011, HUM BRAIN MAPP; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; Hayes DJ, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00049; Hayes DJ, 2013, NEUROPSYCHOPHARMACOL; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Horn DI, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00033; Hufner K, 2008, EXP BRAIN RES, V186, P419, DOI 10.1007/s00221-007-1247-y; Hufner K, 2009, NEUROSCI LETT, V466, P30, DOI 10.1016/j.neulet.2009.09.010; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; Jodo E, 2010, NEUROSCIENCE, V170, P1153, DOI 10.1016/j.neuroscience.2010.08.017; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Jolles DD, 2011, HUM BRAIN MAPP, DOI 10.1002/hbm.21444; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kargieman L, 2007, P NATL ACAD SCI USA, V104, P14843, DOI 10.1073/pnas.0704848104; Katayama T, 2007, NEUROSCIENCE, V150, P442, DOI 10.1016/j.neuroscience.2007.09.007; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kong J, 2010, BEHAV BRAIN RES, V211, P215, DOI 10.1016/j.bbr.2010.03.042; Kuhn S, 2011, SCHIZOPHR B, P1; Langsjo JW, 2004, ANESTHESIOLOGY, V100, P1065, DOI 10.1097/00000542-200405000-00006; Lemogne C, 2012, J AFFECT DISORDERS, V136, pE1, DOI 10.1016/j.jad.2010.11.034; Lesh TA, 2011, NEUROPSYCHOPHARMACOL, V36, P316, DOI 10.1038/npp.2010.156; Li C.-s. R, 2012, NEUROIMAGE; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Louvel J, 2001, NEUROSCIENCE, V105, P803, DOI 10.1016/S0306-4522(01)00247-0; Mainero C, 2011, ANN NEUROL, V70, P838, DOI 10.1002/ana.22537; Marek GJ, 2010, EUR J PHARMACOL, V639, P81, DOI 10.1016/j.ejphar.2010.02.058; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Marjanska M, 2007, P INT SOC MAG RESON, V15; Martini N, 2012, NEUROIMAGE, V60, P922, DOI 10.1016/j.neuroimage.2012.01.060; Marx E, 2004, NEUROIMAGE, V21, P1818, DOI 10.1016/j.neuroimage.2003.12.026; Marx E, 2003, NEUROIMAGE, V19, P924, DOI 10.1016/S1053-8119(03)00150-2; McAvoy M, 2008, J NEUROPHYSIOL, V100, P922, DOI 10.1152/jn.90426.2008; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Mescher M, 1996, P ISMRM 4 SCI M EXH, P384; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Mota-Ortiz SR, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/612698; Musso F, 2011, NEUROIMAGE, V58, P508, DOI 10.1016/j.neuroimage.2011.06.045; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Northoff G, 2011, NEUROSCI BIOBEHAV R, V35, P1929, DOI 10.1016/j.neubiorev.2010.12.007; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Palomero-Gallagher N, 2009, HUM BRAIN MAPP, V30, P2336, DOI 10.1002/hbm.20667; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Papatheodoropoulos C, 2007, NEUROSCI LETT, V414, P197, DOI 10.1016/j.neulet.2006.10.036; Price JL, 2007, ANN NY ACAD SCI, V1121, P54, DOI 10.1196/annals.1401.008; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Qin PM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00337; Roberts AC, 2007, J COMP NEUROL, V502, P86, DOI 10.1002/cne.21300; ROOM P, 1985, J COMP NEUROL, V242, P40, DOI 10.1002/cne.902420104; Rousselet GA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00119; Salvadore G, 2010, NEUROPSYCHOPHARMACOL, V35, P1415, DOI 10.1038/npp.2010.24; Schmidt HD, 2010, ANN NY ACAD SCI, V1187, P35, DOI 10.1111/j.1749-6632.2009.05144.x; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Spoletini I, 2011, SCHIZOPHRENIA BULL, V37, P118, DOI 10.1093/schbul/sbp058; Stone JM, 2012, MOL PSYCHIATR, V17, P664, DOI 10.1038/mp.2011.171; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Volk DW, 2010, AM J PSYCHIAT, V167, P1489, DOI 10.1176/appi.ajp.2010.10030318; Walter M, 2009, ARCH GEN PSYCHIAT, V66, P478, DOI 10.1001/archgenpsychiatry.2009.39; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wiesmann M, 2006, NEUROIMAGE, V32, P293, DOI 10.1016/j.neuroimage.2006.03.022; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wright JS, 2011, NEUROSCI BIOBEHAV R, V35, P1902, DOI 10.1016/j.neubiorev.2011.08.004; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhao J, 2012, J AFFECT DISORDERS, V138, P494, DOI 10.1016/j.jad.2012.01.013	120	75	75	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60312	10.1371/journal.pone.0060312	http://dx.doi.org/10.1371/journal.pone.0060312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573246	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100060
J	Elias-Sonnenschein, LS; Helisalmi, S; Natunen, T; Hall, A; Paajanen, T; Herukka, SK; Laitinen, M; Remes, AM; Koivisto, AM; Mattila, KM; Lehtimaki, T; Verhey, FRJ; Visser, PJ; Soininen, H; Hiltunen, M				Elias-Sonnenschein, Lyzel S.; Helisalmi, Seppo; Natunen, Teemu; Hall, Anette; Paajanen, Teemu; Herukka, Sanna-Kaisa; Laitinen, Marjo; Remes, Anne M.; Koivisto, Anne M.; Mattila, Kari M.; Lehtimaki, Terho; Verhey, Frans R. J.; Visser, Pieter Jelle; Soininen, Hilkka; Hiltunen, Mikko			Genetic Loci Associated with Alzheimer's Disease and Cerebrospinal Fluid Biomarkers in a Finnish Case-Control Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; COMMON VARIANTS; TAU LEVELS; SORL1; RISK; POLYMORPHISMS; A-BETA(42); BINDING; PROTEIN	Objectives: To understand the relation between risk genes for Alzheimer's disease (AD) and their influence on biomarkers for AD, we examined the association of AD in the Finnish cohort with single nucleotide polymorphisms (SNPs) from top AlzGene loci, genome-wide association studies (GWAS), and candidate gene studies; and tested the correlation between these SNPs and AD markers A beta(1-42), total tau (t-tau), and phosphorylated tau (p-tau) in cerebrospinal fluid (CSF). Methods: We tested 25 SNPs for genetic association with clinical AD in our cohort comprised of 890 AD patients and 701-age matched healthy controls using logistic regression. For the correlational study with biomarkers, we tested 36 SNPs in a subset of 222 AD patients with available CSF using mixed models. Statistical analyses were adjusted for age, gender and APOE status. False discovery rate for multiple testing was applied. All participants were from academic hospital and research institutions in Finland. Results: APOE-epsilon 4, CLU rs11136000, and MS4A4A rs2304933 correlated with significantly decreased A beta(1-42) (corrected p<0.05). At an uncorrected p<0.05, PPP3R1 rs1868402 and MAPT rs2435211 were related with increased t-tau; while SORL1 rs73595277 and MAPT rs16940758, with increased p-tau. Only TOMM40 rs2075650 showed association with clinical AD after adjusting for APOE-epsilon 4 (p = 0.007), but not after multiple test correction (p>0.05). Conclusions: We provide evidence that APOE-epsilon 4, CLU and MS4A4A, which have been identified in GWAS to be associated with AD, also significantly reduced CSF A beta(1-42) in AD. None of the other AlzGene and GWAS loci showed significant effects on CSF tau. The effects of other SNPs on CSF biomarkers and clinical AD diagnosis did not reach statistical significance. Our findings suggest that APOE-epsilon 4, CLU and MS4A4A influence both AD risk and CSF A beta(1-42).	[Elias-Sonnenschein, Lyzel S.; Verhey, Frans R. J.; Visser, Pieter Jelle] Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Helisalmi, Seppo; Natunen, Teemu; Hall, Anette; Paajanen, Teemu; Herukka, Sanna-Kaisa; Laitinen, Marjo; Remes, Anne M.; Koivisto, Anne M.; Soininen, Hilkka; Hiltunen, Mikko] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Helisalmi, Seppo; Natunen, Teemu; Hall, Anette; Paajanen, Teemu; Herukka, Sanna-Kaisa; Laitinen, Marjo; Remes, Anne M.; Koivisto, Anne M.; Soininen, Hilkka; Hiltunen, Mikko] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Mattila, Kari M.; Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, Fimlab Labs, FIN-33101 Tampere, Finland; [Mattila, Kari M.; Lehtimaki, Terho] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Visser, Pieter Jelle] Vrije Univ Amsterdam, Med Ctr Amsterdam, Alzheimer Ctr, Dept Neurol, Amsterdam, Netherlands	Maastricht University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Tampere University; Tampere University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Helisalmi, S (corresponding author), Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland.	seppo.helisalmi@uef.fi	Visser, Pieter J/C-8541-2015; Lehtimäki, Terho/AAD-1094-2022; Visser, Pieter Jelle/S-5242-2019	Visser, Pieter J/0000-0001-8008-9727; Lehtimäki, Terho/0000-0002-2555-4427; Visser, Pieter Jelle/0000-0001-8008-9727	Health Research Council of Academy of Finland; EVO from Kuopio University Hospital [5772708]; University of Eastern Finland; Finnish Medical Association; EVO grant of Oulu University Hospital; EVO grant of Tampere University Hospital Medical Fund [9N035]; EVO grant of Zon-Mw as part of the BIOMARKAPD project in the frame of the European Joint Programming Initiative on Neurodegenerative Disorders (JPND); Alzheimer Nederland; Internationale Stichting Alzheimer Onderzoek	Health Research Council of Academy of Finland; EVO from Kuopio University Hospital; University of Eastern Finland; Finnish Medical Association; EVO grant of Oulu University Hospital; EVO grant of Tampere University Hospital Medical Fund; EVO grant of Zon-Mw as part of the BIOMARKAPD project in the frame of the European Joint Programming Initiative on Neurodegenerative Disorders (JPND); Alzheimer Nederland; Internationale Stichting Alzheimer Onderzoek	The study was in part funded by the Health Research Council of Academy of Finland, EVO-funding from Kuopio University Hospital, 5772708, and strategic funding from University of Eastern Finland for UEFBRAIN (HS); Finnish Medical Association and EVO grants of Oulu University Hospital (AMR); Tampere University Hospital Medical Fund, 9N035 (TL); and Zon-Mw (PJV) as part of the BIOMARKAPD project in the frame of the European Joint Programming Initiative on Neurodegenerative Disorders (JPND). Alzheimer Nederland and the Internationale Stichting Alzheimer Onderzoek provided financial assistance for the internship of LSES at the Institute of Clinical Medicine-Neurology, University of Eastern Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos P, 2011, DEMENT GERIATR COGN, V32, P164, DOI 10.1159/000332017; Bekris LM, 2012, AM J MED GENET B, V159B, P874, DOI 10.1002/ajmg.b.32094; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blomqvist MEL, 2005, NEUROBIOL AGING, V26, P795, DOI 10.1016/j.neurobiolaging.2004.07.011; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cruchaga C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001101; Cuenco KT, 2008, ARCH NEUROL-CHICAGO, V65, P1640, DOI 10.1001/archneur.65.12.1640; Elias-Sonnenschein LS, 2012, BIOMARK MED, V6, P477, DOI [10.2217/BMM.12.56, 10.2217/bmm.12.56]; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Han MR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-90; Helisalmi S, 2006, J NEUROL NEUROSUR PS, V77, P421, DOI 10.1136/jnnp.2005.071928; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Iivonen S, 2004, NEUROLOGY, V62, P1170, DOI 10.1212/01.WNL.0000118208.16939.60; Johansson A, 2004, HUM GENET, V114, P581, DOI 10.1007/s00439-004-1107-9; Jun GyunGah, 2012, Archives of Neurology, V69, P1; Karch CM, 2012, NEUROBIOL AGING; Kauwe JSK, 2008, P NATL ACAD SCI USA, V105, P8050, DOI 10.1073/pnas.0801227105; Kauwe JSK, 2010, J ALZHEIMERS DIS, V21, P833, DOI 10.3233/JAD-2010-091711; Kauwe JSK, 2009, NEUROGENETICS, V10, P13, DOI 10.1007/s10048-008-0150-4; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Kolsch H, 2008, NEUROSCI LETT, V440, P68, DOI 10.1016/j.neulet.2008.05.049; Kramer PL, 2011, NEUROBIOL AGING, V32, P2113, DOI 10.1016/j.neurobiolaging.2010.01.010; Lambert JC, 2011, CURR OPIN GENET DEV, V21, P295, DOI 10.1016/j.gde.2011.02.002; Lambert JC, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.11.022; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lenth RV., 2006, JAVA APPLETS POWER S; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Olgiati Paolo, 2011, Int J Alzheimers Dis, V2011, P832379, DOI 10.4061/2011/832379; Olgiati P, 2012, CURR ALZHEIMER RES, V9, P491, DOI 10.2174/156720512800492431; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Reese LC, 2011, CURR NEUROPHARMACOL, V9, P685, DOI 10.2174/157015911798376316; Reitz C, 2011, ARCH NEUROL-CHICAGO, V68, P99, DOI 10.1001/archneurol.2010.346; Rosenthal Samantha L, 2012, Am J Neurodegener Dis, V1, P191; Schellenberg GD, 2012, ACTA NEUROPATHOL; Schjeide BMM, 2011, ARCH GEN PSYCHIAT, V68, P207, DOI 10.1001/archgenpsychiatry.2010.196; Schmidt C, 2012, DEMENT GERIATR COGN, V33, P84, DOI 10.1159/000336790; Schott JM, 2011, NEUROBIOL AGING; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Vepsalainen S, 2005, J NEUROL, V252, P423, DOI 10.1007/s00415-005-0667-5; Vepsalainen S, 2009, J NEUROL NEUROSUR PS, V80, P1268, DOI 10.1136/jnnp.2008.160002; Vepsalainen S, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.048470	49	52	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59676	10.1371/journal.pone.0059676	http://dx.doi.org/10.1371/journal.pone.0059676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573206	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100025
J	Guan, MM; Xie, LY; Diao, CF; Wang, N; Hu, WY; Zheng, YQ; Jin, LT; Yan, ZH; Gao, HC				Guan, Mimi; Xie, Liyun; Diao, Chengfeng; Wang, Na; Hu, Wenyi; Zheng, Yongquan; Jin, Litai; Yan, Zhihan; Gao, Hongchang			Systemic Perturbations of Key Metabolites in Diabetic Rats During the Evolution of Diabetes Studied by Urine Metabonomics	PLOS ONE			English	Article							IN-VIVO; STREPTOZOTOCIN; METABOLOMICS; H-1-NMR; AGE; BIOMARKERS; EXCRETION; PROFILES; TAURINE; ACETATE	Background: Elucidation of metabolic profiles during diabetes progression helps understand the pathogenesis of diabetes mellitus. In this study, urine metabonomics was used to identify time-related metabolic changes that occur during the development of diabetes mellitus and characterize the biochemical process of diabetes on a systemic, metabolic level. Methodology/Principal Findings: Urine samples were collected from diabetic rats and age-matched controls at different time points: 1, 5, 10, and 15 weeks after diabetes modeling. H-1 nuclear magnetic resonance (H-1 NMR) spectra of the urine samples were obtained and analyzed by multivariate data analysis and quantitative statistical analysis. The metabolic patterns of diabetic groups are separated from the controls at each time point, suggesting that the metabolic profiles of diabetic rats were markedly different from the controls. Moreover, the samples from the diabetic 1-wk group are closely associated, whereas those of the diabetic 15-wk group are scattered, suggesting that the presence of various of complications contributes significantly to the pathogenesis of diabetes. Quantitative analysis indicated that urinary metabolites related to energy metabolism, tricarboxylic acid (TCA) cycle, and methylamine metabolism are involved in the evolution of diabetes. Conclusions/Significance: The results highlighted that the numbers of metabolic changes were related to diabetes progression, and the perturbed metabolites represent potential metabolic biomarkers and provide clues that can elucidate the mechanisms underlying the generation and development of diabetes as well as its complication.	[Guan, Mimi; Xie, Liyun; Diao, Chengfeng; Wang, Na; Hu, Wenyi; Zheng, Yongquan; Jin, Litai; Gao, Hongchang] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China; [Yan, Zhihan] Wenzhou Med Coll, Dept Radiol, Affiliated Hosp 2, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Yan, ZH (corresponding author), Wenzhou Med Coll, Dept Radiol, Affiliated Hosp 2, Wenzhou, Peoples R China.	zhihanyan@hotmail.com; gaohc27@gmail.com			National Natural Science Foundation of China [21175099, 81171306]; Zhejiang Provicial Project of Key Scientific Group [2010R50042]; Medicine and Health Special Foundation of Zhejiang Province [2010QNA016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provicial Project of Key Scientific Group; Medicine and Health Special Foundation of Zhejiang Province	This work was supported by the National Natural Science Foundation of China (Nos. 21175099 and 81171306), Zhejiang Provicial Project of Key Scientific Group (2010R50042), the Medicine and Health Special Foundation of Zhejiang Province (2010QNA016). The funder(s) supported the rats and reagents in this study.	Abolfathi AA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/740671; Akira K, 2012, HYPERTENS RES, V35, P404, DOI 10.1038/hr.2011.182; ASATOOR AM, 1965, BIOCHIM BIOPHYS ACTA, V111, P384, DOI 10.1016/0304-4165(65)90048-6; BLOXAM DL, 1972, BRIT J NUTR, V27, P249, DOI 10.1079/BJN19720091; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; BRIGGS JP, 1977, AM J PHYSIOL, V233, pF373, DOI 10.1152/ajprenal.1977.233.5.F373; BROSNAN JT, 1983, AM J PHYSIOL, V244, pE151, DOI 10.1152/ajpendo.1983.244.2.E151; BUCKLEY BM, 1977, BIOCHEM J, V166, P539, DOI 10.1042/bj1660539; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Chen P, 2007, ADV THER, V24, P1036, DOI 10.1007/BF02877709; Gao HC, 2008, ANAL CHIM ACTA, V624, P269, DOI 10.1016/j.aca.2008.06.051; Gavaghan CL, 2000, FEBS LETT, V484, P169, DOI 10.1016/S0014-5793(00)02147-5; Griffin JL, 2008, PHYSIOL GENOMICS, V34, P1, DOI 10.1152/physiolgenomics.00009.2008; Han X, 2006, ACTA PHYSIOL, V187, P61, DOI 10.1111/j.1748-1716.2006.01573.x; Hansen SH, 2001, DIABETES-METAB RES, V17, P330, DOI 10.1002/dmrr.229; JUNOD A, 1969, J CLIN INVEST, V48, P2129, DOI 10.1172/JCI106180; KORNER A, 1994, DIABETES, V43, P629, DOI 10.2337/diabetes.43.5.629; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; LAU AL, 1984, J NUTR, V114, P224, DOI 10.1093/jn/114.1.224; Messana I, 1998, CLIN CHEM, V44, P1529; NAIR KS, 1984, DIABETOLOGIA, V27, P13, DOI 10.1007/BF00253494; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; PERRY RE, 1987, EXP EYE RES, V44, P269, DOI 10.1016/S0014-4835(87)80011-8; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Psihogios NG, 2008, NMR BIOMED, V21, P195, DOI 10.1002/nbm.1176; PUGLIESE G, 1991, DIABETES METAB REV, V7, P35, DOI 10.1002/dmr.5610070106; RENNIE MJ, 1977, BIOCHEM J, V168, P161, DOI 10.1042/bj1680161; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; TIMBRELL JA, 1995, GEN PHARMACOL-VASC S, V26, P453, DOI 10.1016/0306-3623(94)00203-Y; van der Graaf M, 2004, NMR BIOMED, V17, P405, DOI 10.1002/nbm.896; van Doorn M, 2007, BRIT J CLIN PHARMACO, V63, P562, DOI 10.1111/j.1365-2125.2006.02816.x; Villeneuve Louisa M, 2010, Expert Rev Endocrinol Metab, V5, P137; Williams RE, 2006, MOL BIOSYST, V2, P193, DOI 10.1039/b517195d; Williams RE, 2005, MOL BIOSYST, V1, P166, DOI 10.1039/b500852b; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Xiao CN, 2009, ANALYST, V134, P916, DOI 10.1039/b818802e; Xu JJ, 2009, ANAL BIOANAL CHEM, V393, P1657, DOI 10.1007/s00216-009-2623-1; Yang J, 2004, J CHROMATOGR B, V813, P53, DOI 10.1016/j.jchromb.2004.09.023; Zhang SC, 2008, ANAL BIOCHEM, V383, P76, DOI 10.1016/j.ab.2008.07.041; Zhao LC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/431894; Zhao LC, 2011, AM J PHYSIOL-RENAL, V300, pF947, DOI 10.1152/ajprenal.00551.2010; Zhao LC, 2010, ANAL SCI, V26, P1277, DOI 10.2116/analsci.26.1277	43	49	53	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60409	10.1371/journal.pone.0060409	http://dx.doi.org/10.1371/journal.pone.0060409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573250	Green Submitted, gold, Green Published			2022-12-27	WOS:000318840100065
J	Hamaguchi, Y; Fujimoto, M; Matsushita, T; Kaji, K; Komura, K; Hasegawa, M; Kodera, M; Muroi, E; Fujikawa, K; Seishima, M; Yamada, H; Yamada, R; Sato, S; Takehara, K; Kuwana, M				Hamaguchi, Yasuhito; Fujimoto, Manabu; Matsushita, Takashi; Kaji, Kenzo; Komura, Kazuhiro; Hasegawa, Minoru; Kodera, Masanari; Muroi, Eiji; Fujikawa, Keita; Seishima, Mariko; Yamada, Hidehiro; Yamada, Ryo; Sato, Shinichi; Takehara, Kazuhiko; Kuwana, Masataka			Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; IDIOPATHIC INFLAMMATORY MYOPATHY; MYOSITIS-SPECIFIC AUTOANTIBODIES; JAPANESE PATIENTS; ANTISYNTHETASE SYNDROME; DERMATOMYOSITIS; POLYMYOSITIS; CLASSIFICATION; PROTEIN; IDENTIFICATION	Objective: To identify similarities and differences in the clinical features of adult Japanese patients with individual anti-aminoacyl-tRNA synthetase antibodies (anti-ARS Abs). Methods: This was a retrospective analysis of 166 adult Japanese patients with anti-ARS Abs detected by immunoprecipitation assays. These patients had visited Kanazawa University Hospital or collaborating medical centers from 2003 to 2009. Results: Anti-ARS Ab specificity included anti-Jo-1 (36%), anti-EJ (23%), anti-PL-7 (18%), anti-PL-12 (11%), anti-KS (8%), and anti-OJ (5%). These anti-ARS Abs were mutually exclusive, except for one serum Ab that had both anti-PL-7 and PL-12 reactivity. Myositis was closely associated with anti-Jo-1, anti-EJ, and anti-PL-7, while interstitial lung disease (ILD) was correlated with all 6 anti-ARS Abs. Dermatomyositis (DM)-specific skin manifestations (heliotrope rash and Gottron's sign) were frequently observed in patients with anti-Jo-1, anti-EJ, anti-PL-7, and anti-PL-12. Therefore, most clinical diagnoses were polymyositis or DM for anti-Jo-1, anti-EJ, and anti-PL-7; clinically amyopathic DM or ILD for anti-PL-12; and ILD for anti-KS and anti-OJ. Patients with anti-Jo-1, anti-EJ, and anti-PL-7 developed myositis later if they had ILD alone at the time of disease onset, and most patients with anti-ARS Abs eventually developed ILD if they did not have ILD at disease onset. Conclusion: Patients with anti-ARS Abs are relatively homogeneous. However, the distribution and timing of myositis, ILD, and rashes differ among patients with individual anti-ARS Abs. Thus, identification of individual anti-ARS Abs is beneficial to define this rather homogeneous subset and to predict clinical outcomes within the "anti-synthetase syndrome."	[Hamaguchi, Yasuhito; Fujimoto, Manabu; Matsushita, Takashi; Kaji, Kenzo; Komura, Kazuhiro; Hasegawa, Minoru; Takehara, Kazuhiko] Kanazawa Univ, Dept Dermatol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Kodera, Masanari] Social Insurance Chukyo Hosp, Dept Dermatol, Nagoya, Aichi, Japan; [Muroi, Eiji] Nagasaki Univ, Dept Dermatol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Fujikawa, Keita] Nagasaki Univ, Unit Translat Med, Dept Immunol & Rheumatol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Seishima, Mariko] Ogaki Municipal Hosp, Dept Dermatol, Ogaki, Japan; [Yamada, Hidehiro] St Marianna Univ, Div Rheumatol, Dept Internal Med & Allergy, Kawasaki, Kanagawa, Japan; [Yamada, Ryo] Kyoto Univ, Ctr Genom Med, Grad Sch Med, Kyoto, Japan; [Sato, Shinichi] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan; [Kuwana, Masataka] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan	Kanazawa University; Nagasaki University; Nagasaki University; Ogaki Municipal Hospital; Saint Marianna University; Kyoto University; University of Tokyo; Keio University	Fujimoto, M (corresponding author), Kanazawa Univ, Dept Dermatol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan.	fujimoto-m@umin.ac.jp	Komura, Kazuhiro/AAS-8380-2021; Kuwana, Masataka/L-2918-2013; Matsushita, Takashi/C-4750-2015	Komura, Kazuhiro/0000-0002-4775-7356; Matsushita, Takashi/0000-0002-1617-086X; Hasegawa, Minoru/0000-0003-3738-2682; Fujimoto, Manabu/0000-0002-3062-4872; Yamada, Ryo/0000-0002-1587-630X	Ministry of Health, Labor and Welfare of Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a research grant on intractable diseases from the Ministry of Health, Labor and Welfare of Japan (to Manabu Fujimoto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Bandoh S, 2000, ANN RHEUM DIS, V59, P257, DOI 10.1136/ard.59.4.257; Betteridge Z, 2007, RHEUMATOLOGY, V46, P1005, DOI 10.1093/rheumatology/kem045; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BUNN CC, 1986, J EXP MED, V163, P1281, DOI 10.1084/jem.163.5.1281; Connors GR, 2010, CHEST, V138, P1464, DOI 10.1378/chest.10-0180; Fujimoto M, 2012, ARTHRITIS RHEUM-US, V64, P513, DOI 10.1002/art.33403; Gunawardena H, 2008, RHEUMATOLOGY, V47, P324, DOI 10.1093/rheumatology/kem359; Gunawardena H, 2009, RHEUMATOLOGY, V48, P607, DOI 10.1093/rheumatology/kep078; Hamaguchi Y, 2008, BRIT J DERMATOL, V158, P487, DOI 10.1111/j.1365-2133.2007.08392.x; Hamaguchi Y, 2011, ARCH DERMATOL, V147, P391, DOI 10.1001/archdermatol.2011.52; Hashish L, 2005, ARTHRITIS RHEUM-US, V52, pS312; Hervier B, 2012, AUTOIMMUN REV, V12, P210, DOI 10.1016/j.autrev.2012.06.006; Hirakata M, 2000, CURR OPIN RHEUMATOL, V12, P501, DOI 10.1097/00002281-200011000-00005; HIRAKATA M, 1992, ARTHRITIS RHEUM, V35, P449, DOI 10.1002/art.1780350415; Hirakata M, 1999, J IMMUNOL, V162, P2315; Hirakata M, 2007, ARTHRITIS RHEUM, V56, P1295, DOI 10.1002/art.22506; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; Kaji K, 2007, RHEUMATOLOGY, V46, P25, DOI 10.1093/rheumatology/kel161; Kalluri M, 2009, CHEST, V135, P1550, DOI 10.1378/chest.08-2233; Katzap E, 2011, CURR RHEUMATOL REP, V13, P175, DOI 10.1007/s11926-011-0176-8; Komura K, 2005, J DERMATOL SCI, V40, P215, DOI 10.1016/j.jdermsci.2005.09.004; KUWANA M, 1993, J CLIN INVEST, V91, P1399, DOI 10.1172/JCI116343; LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002; Mammen AL, 2011, NAT REV NEUROL, V7, P343, DOI 10.1038/nrneurol.2011.63; Mammen AL, 2010, ANN NY ACAD SCI, V1184, P134, DOI 10.1111/j.1749-6632.2009.05119.x; MATHEWS MB, 1984, J EXP MED, V160, P420, DOI 10.1084/jem.160.2.420; Matsushita T, 2007, J RHEUMATOL, V34, P1012; Mierau R, 1996, ARTHRITIS RHEUM-US, V39, P868, DOI 10.1002/art.1780390521; Mimori T, 2007, CURR OPIN RHEUMATOL, V19, P523, DOI 10.1097/BOR.0b013e3282f01a8c; MOROI Y, 1980, P NATL ACAD SCI-BIOL, V77, P1627, DOI 10.1073/pnas.77.3.1627; Sato S, 2007, RHEUMATOLOGY, V46, P842, DOI 10.1093/rheumatology/kel435; Sato S, 2005, CLIN EXP RHEUMATOL, V23, P609; Sato S, 2005, ARTHRITIS RHEUM-US, V52, P1571, DOI 10.1002/art.21023; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Studynkova JT, 2007, RHEUMATOLOGY, V46, P1174, DOI 10.1093/rheumatology/kem088; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TARGOFF IN, 1992, ARTHRITIS RHEUM, V35, P821, DOI 10.1002/art.1780350718; TARGOFF IN, 1990, AM J MED, V88, P241, DOI 10.1016/0002-9343(90)90149-8; TARGOFF IN, 1990, J IMMUNOL, V144, P1737; Targoff IN, 2002, RHEUM DIS CLIN N AM, V28, P859, DOI 10.1016/S0889-857X(02)00032-7; TARGOFF IN, 1992, RHEUM DIS CLIN N AM, V18, P455; Targoff IN, 2006, ARTHRITIS RHEUM, V54, P3682, DOI 10.1002/art.22164; Vancsa A, 2010, JOINT BONE SPINE, V77, P125, DOI 10.1016/j.jbspin.2009.08.008; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Watanabe K, 2011, RESP MED, V105, P1238, DOI 10.1016/j.rmed.2011.03.022; Yamasaki Y, 2006, ARTHRITIS RHEUM-US, V54, P2004, DOI 10.1002/art.21883; YOSHIDA S, 1983, ARTHRITIS RHEUM, V26, P604, DOI 10.1002/art.1780260505; Yoshifuji H, 2006, AUTOIMMUNITY, V39, P233, DOI 10.1080/08916930600622884; Zong M, 2011, NAT REV RHEUMATOL, V7, P297, DOI 10.1038/nrrheum.2011.39	51	232	250	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60442	10.1371/journal.pone.0060442	http://dx.doi.org/10.1371/journal.pone.0060442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573256	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100072
J	Hu, YX; Gurev, V; Constantino, J; Bayer, JD; Trayanova, NA				Hu, Yuxuan; Gurev, Viatcheslav; Constantino, Jason; Bayer, Jason D.; Trayanova, Natalia A.			Effects of Mechano-Electric Feedback on Scroll Wave Stability in Human Ventricular Fibrillation	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; ION CHANNELS; STRETCH; MODEL; ARRHYTHMIAS; MECHANISMS; CONDUCTION; RESTITUTION; ALTERNANS; HEART	Recruitment of stretch-activated channels, one of the mechanisms of mechano-electric feedback, has been shown to influence the stability of scroll waves, the waves that underlie reentrant arrhythmias. However, a comprehensive study to examine the effects of recruitment of stretch-activated channels with different reversal potentials and conductances on scroll wave stability has not been undertaken; the mechanisms by which stretch-activated channel opening alters scroll wave stability are also not well understood. The goals of this study were to test the hypothesis that recruitment of stretch-activated channels affects scroll wave stability differently depending on stretch-activated channel reversal potential and channel conductance, and to uncover the relevant mechanisms underlying the observed behaviors. We developed a strongly-coupled model of human ventricular electromechanics that incorporated human ventricular geometry and fiber and sheet orientation reconstructed from MR and diffusion tensor MR images. Since a wide variety of reversal potentials and channel conductances have been reported for stretch-activated channels, two reversal potentials, -60 mV and -10 mV, and a range of channel conductances (0 to 0.07 mS/mu F) were implemented. Opening of stretch-activated channels with a reversal potential of -60 mV diminished scroll wave breakup for all values of conductances by flattening heterogeneously the action potential duration restitution curve. Opening of stretch-activated channels with a reversal potential of -10 mV inhibited partially scroll wave breakup at low conductance values (from 0.02 to 0.04 mS/mu F) by flattening heterogeneously the conduction velocity restitution relation. For large conductance values (>0.05 mS/mu F), recruitment of stretch-activated channels with a reversal potential of -10 mV did not reduce the likelihood of scroll wave breakup because Na channel inactivation in regions of large stretch led to conduction block, which counteracted the increased scroll wave stability due to an overall flatter conduction velocity restitution.	[Hu, Yuxuan; Constantino, Jason; Bayer, Jason D.; Trayanova, Natalia A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Gurev, Viatcheslav] IBM TJ Watson Res Ctr, Yorktown Hts, NY USA	Johns Hopkins University; International Business Machines (IBM)	Trayanova, NA (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	ntrayanova@jhu.edu		Trayanova, Natalia/0000-0002-8661-063X	National Institutes of Health grant [R01-HL103428]; National Science Foundation [CBET-0933029, IOS-1124804]; NIH fellowship [F31-HL103090]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103428, F31HL103090] Funding Source: NIH RePORTER; Direct For Biological Sciences [1124804] Funding Source: National Science Foundation	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by National Institutes of Health grant R01-HL103428, National Science Foundation grants CBET-0933029 and IOS-1124804 and NIH fellowship F31-HL103090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarten CM, 2003, PROG BIOPHYS MOL BIO, V82, P25, DOI 10.1016/S0079-6107(03)00003-8; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; Constantino J, 2012, PROG BIOPHYS MOL BIO; Cytrynbaum E, 2002, CHAOS, V12, P788, DOI 10.1063/1.1503941; Eckardt L, 2000, J CARDIOVASC PHARM, V36, P711, DOI 10.1097/00005344-200012000-00005; FRANZ MR, 1992, CIRCULATION, V86, P968, DOI 10.1161/01.CIR.86.3.968; Girouard SD, 1996, CIRCULATION, V93, P603, DOI 10.1161/01.CIR.93.3.603; Gurev V, 2011, BIOMECH MODEL MECHAN, V10, P295, DOI 10.1007/s10237-010-0235-5; Hu H, 1997, J MOL CELL CARDIOL, V29, P1511, DOI 10.1006/jmcc.1997.0392; Isenberg G, 2003, PROG BIOPHYS MOL BIO, V82, P43, DOI 10.1016/S0079-6107(03)00004-X; Jie X, 2010, CIRC RES, V106, P185, DOI 10.1161/CIRCRESAHA.109.210864; Kawase A, 2003, CIRCULATION, V107, P905, DOI 10.1161/01.CIR.0000050148.72502.3A; Keldermann RH, 2010, AM J PHYSIOL-HEART C, V299, pH134, DOI 10.1152/ajpheart.00862.2009; Klingensmith ME., 2008, WASHINGTON MANUAL SU; Kohl P, 2003, PROG BIOPHYS MOL BIO, V82, P3, DOI 10.1016/S0079-6107(03)00022-1; Kohl P, 1998, CAN J CARDIOL, V14, P111; Kohl P, 1999, PROG BIOPHYS MOL BIO, V71, P91, DOI 10.1016/S0079-6107(98)00038-8; Kuijpers NHL, 2011, HEART RHYTHM, V8, P429, DOI 10.1016/j.hrthm.2010.11.020; Larson C, 2003, ANN BIOMED ENG, V31, P768, DOI 10.1114/1.1581289; Li WH, 2008, PROG BIOPHYS MOL BIO, V97, P461, DOI 10.1016/j.pbiomolbio.2008.02.020; Li WH, 2006, HEART RHYTHM, V3, P179, DOI 10.1016/j.hrthm.2005.10.033; Li WH, 2004, J MOL HISTOL, V35, P679; Link MS, 1999, CIRCULATION, V100, P413, DOI 10.1161/01.CIR.100.4.413; McNary TG, 2008, PROG BIOPHYS MOL BIO, V97, P383, DOI 10.1016/j.pbiomolbio.2008.02.023; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Moreno JD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002588; MORRIS CE, 1990, J MEMBRANE BIOL, V113, P93, DOI 10.1007/BF01872883; Nishimura S, 2006, CARDIOVASC RES, V72, P403, DOI 10.1016/j.cardiores.2006.08.011; Panfilov AV, 2007, P NATL ACAD SCI USA, V104, P7922, DOI 10.1073/pnas.0701895104; Panfilov AV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.258104; Panfilov AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118101; Plank G, 2008, PHILOS T R SOC A, V366, P3381, DOI 10.1098/rsta.2008.0112; PLONSEY R, 1989, BIOELECTRICITY; POLLARD AE, 1993, CIRC RES, V72, P744, DOI 10.1161/01.RES.72.4.744; Prassl AJ, 2009, IEEE T BIO-MED ENG, V56, P1318, DOI 10.1109/TBME.2009.2014243; Provost J, 2011, HEART RHYTHM, V8, P752, DOI 10.1016/j.hrthm.2010.12.034; Qu ZL, 2000, BIOPHYS J, V78, P2761, DOI 10.1016/S0006-3495(00)76821-4; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; SHARMA AD, 1990, J AM COLL CARDIOL, V15, P648, DOI 10.1016/0735-1097(90)90640-B; Sung D, 2003, J CARDIOVASC ELECTR, V14, P739, DOI 10.1046/j.1540-8167.2003.03072.x; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.062902; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Trayanova N, 2004, HEART RHYTHM, V1, P67, DOI 10.1016/j.hrthm.2004.01.002; Vadakkumpadan F, 2010, WIRES SYST BIOL MED, V2, P489, DOI 10.1002/wsbm.76; VANWAGONER DR, 1993, CIRC RES, V72, P973, DOI 10.1161/01.RES.72.5.973; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; WHITE E, 1993, EXP PHYSIOL, V78, P65, DOI 10.1113/expphysiol.1993.sp003671; Wu TJ, 2002, CIRCULATION, V106, P1859, DOI 10.1161/01.CIR.0000031334.49170.FB; Xie LH, 2008, BIOPHYS J, V95, P3100, DOI 10.1529/biophysj.108.130955; Zabel M, 1996, CARDIOVASC RES, V32, P120, DOI 10.1016/0008-6363(96)00089-2; Zeng T, 2000, AM J PHYSIOL-HEART C, V278, pH548, DOI 10.1152/ajpheart.2000.278.2.H548	53	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60287	10.1371/journal.pone.0060287	http://dx.doi.org/10.1371/journal.pone.0060287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573245	gold, Green Submitted, Green Published			2022-12-27	WOS:000318840100059
J	Lin, HX; Qiu, HJ; Zeng, F; Rao, HL; Yang, GF; Kung, HF; Zhu, XF; Zeng, YX; Cai, MY; Xie, D				Lin, Huan-Xin; Qiu, Hui-Juan; Zeng, Fei; Rao, Hui-Lan; Yang, Guo-Fen; Kung, Hsiang-Fu; Zhu, Xiao-Feng; Zeng, Yi-Xin; Cai, Mu-Yan; Xie, Dan			Decreased Expression of Beclin 1 Correlates Closely with Bcl-xL Expression and Poor Prognosis of Ovarian Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; AUTOPHAGY GENE; HEPATOCELLULAR-CARCINOMA; REGULATES AUTOPHAGY; PROTEIN; CANCER; TUMORIGENESIS; PREDICTOR; COMPLEXES; SYSTEM	Background: It has been suggested that autophagy-related Beclin 1 plays a critical role in the regulation of tumor development and/or progression, but its prognostic significance and relationship with Bcl-xL expression in ovarian carcinoma are unclear. Methodology/Principal Findings: In the present study, the methods of Western blotting and immunohistochemistry (IHC) were utilized to investigate the expression status of Beclin 1 and Bcl-xL in fresh ovarian tissues and paraffin-embedded epithelial ovarian tumor tissues. Decreased expression of Beclin 1 was examined by IHC in 8.3% of normal ovaries, in 15.4% of cystadenomas, in 20.0% of borderline tumors, and in 55.6% of ovarian carcinomas, respectively. In ovarian carcinomas, decreased expression of Beclin 1 was correlated closely with ascending histological grade, later pT/pN/pM status and/or advanced clinical stage (P < 0.05). In univariate survival analysis, a highly significant association between low-expressed Beclin 1 and shortened patient survival was evaluated in ovarian carcinoma patients (P < 0.01), and Beclin 1 expression was an independent prognostic factor as evidenced by multivariate analysis (P = 0.013). In addition, decreased expression of Beclin 1 was inversely correlated with altered expression of Bcl-xL in ovarian carcinoma cohort, and combined analysis further showed that the low Beclin 1/high Bcl-xL group had the lowest survival rate. Conclusions/Significance: Our findings suggest that Beclin 1 expression, as examined by IHC, could be served as an additional tool in identifying ovarian carcinoma patients at risk of tumor progression, and predicting patient survival in ovarian carcinomas with increased expression of Bcl-xL.	[Lin, Huan-Xin; Qiu, Hui-Juan; Zeng, Fei; Rao, Hui-Lan; Kung, Hsiang-Fu; Zhu, Xiao-Feng; Zeng, Yi-Xin; Cai, Mu-Yan; Xie, Dan] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Fei] Shantou Univ, Coll Med, Dept Gynecol, Affiliated Hosp 1, Shantou, Peoples R China; [Rao, Hui-Lan; Cai, Mu-Yan; Xie, Dan] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Guo-Fen] Sun Yat Sen Univ, Dept Gynecol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Kung, Hsiang-Fu] Chinese Univ Hong Kong, State Key Lab Oncol South China, Hong Kong, Hong Kong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Shantou University; Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong; State Key Lab Oncology South China	Cai, MY (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	caimuyan@hotmail.com; xiedan@sysucc.org.cn			National Nature Science Foundation of China [81225018]; Ph.D. Programs Foundation of Ministry of Education of China [20110171110078]; 973 Project of China [2010CB529401]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); 973 Project of China(National Basic Research Program of China)	This study was supported by grants from the National Nature Science Foundation of China (No. 81225018), the Ph.D. Programs Foundation of Ministry of Education of China (No. 20110171110078), and the 973 Project of China (2010CB529401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-51; Ahn CH, 2007, APMIS, V115, P1344, DOI 10.1111/j.1600-0463.2007.00858.x; Cai MY, 2011, MOL MED, V17, P12, DOI 10.2119/molmed.2010.00103; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Chen W, 2009, CANCER EPIDEM BIOMAR, V18, P400, DOI 10.1158/1055-9965.EPI-08-0754; Chen YS, 2009, PATHOL ONCOL RES, V15, P487, DOI 10.1007/s12253-008-9143-8; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Huang JJ, 2010, AUTOPHAGY, V6, P777, DOI 10.4161/auto.6.6.12784; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; KOSARY CL, 1994, SEMIN SURG ONCOL, V10, P31, DOI 10.1002/ssu.2980100107; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li BX, 2009, AUTOPHAGY, V5, P303, DOI 10.4161/auto.5.3.7491; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lynch HT, 1998, SEMIN ONCOL, V25, P265; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Miracco C, 2007, INT J ONCOL, V30, P429; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Pimkina J, 2009, J BIOL CHEM, V284, P2803, DOI 10.1074/jbc.M804705200; Pirtoli L, 2009, AUTOPHAGY, V5, P930, DOI 10.4161/auto.5.7.9227; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; RAESIDE DE, 1976, PHYS MED BIOL, V21, P181, DOI 10.1088/0031-9155/21/2/001; Schwartz Peter E, 2002, Cancer Treat Res, V107, P99; Shen Y, 2008, AUTOPHAGY, V4, P1067, DOI 10.4161/auto.6827; Shi YH, 2009, AUTOPHAGY, V5, P380, DOI 10.4161/auto.5.3.7658; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Wan XB, 2010, AUTOPHAGY, V6, P395, DOI 10.4161/auto.6.3.11303; Xie D, 2006, BRIT J CANCER, V94, P108, DOI 10.1038/sj.bjc.6602904; Xue Li-Yan, 2011, Chin J Cancer, V30, P69; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhao LP, 2012, CHIN J CANCER, V31, P476, DOI 10.5732/cjc.012.10029	42	134	141	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60516	10.1371/journal.pone.0060516	http://dx.doi.org/10.1371/journal.pone.0060516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573264	gold, Green Submitted, Green Published			2022-12-27	WOS:000318840100082
J	Panguluri, SK; Tur, J; Chapalamadugu, KC; Katnik, C; Cuevas, J; Tipparaju, SM				Panguluri, Siva K.; Tur, Jared; Chapalamadugu, Kalyan C.; Katnik, Chris; Cuevas, Javier; Tipparaju, Srinivas M.			MicroRNA-301a Mediated Regulation of Kv4.2 in Diabetes: Identification of Key Modulators	PLOS ONE			English	Article							NF-KAPPA-B; TRANSIENT OUTWARD CURRENT; NECROSIS-FACTOR-ALPHA; RAT VENTRICULAR MYOCYTES; K+ CHANNEL GENES; MYOCARDIAL-INFARCTION; HEART-FAILURE; I-TO; CARDIOMYOCYTE HYPERTROPHY; CARDIAC-HYPERTROPHY	Diabetes is a metabolic disorder that ultimately results in major pathophysiological complications in the cardiovascular system. Diabetics are predisposed to higher incidences of sudden cardiac deaths (SCD). Several studies have associated diabetes as a major underlying risk for heart diseases and its complications. The diabetic heart undergoes remodeling to cope up with the underlying changes, however ultimately fails. In the present study we investigated the changes associated with a key ion channel and transcriptional factors in a diabetic heart model. In the mouse db/db model, we identified key transcriptional regulators and mediators that play important roles in the regulation of ion channel expression. Voltage-gated potassium channel (Kv4.2) is modulated in diabetes and is down regulated. We hypothesized that Kv4.2 expression is altered by potassium channel interacting protein-2 (KChIP2) which is regulated upstream by NFkB and miR-301a. We utilized qRT-PCR analysis and identified the genes that are affected in diabetes in a regional specific manner in the heart. At protein level we identified and validated differential expression of Kv4.2 and KChIP2 along with NFkB in both ventricles of diabetic hearts. In addition, we identified up-regulation of miR-301a in diabetic ventricles. We utilized loss and gain of function approaches to identify and validate the role of miR-301a in regulating Kv4.2. Based on in vivo and in vitro studies we conclude that miR-301a may be a central regulator for the expression of Kv4.2 in diabetes. This miR-301 mediated regulation of Kv4.2 is independent of NFkB and Irx5 and modulates Kv4.2 by direct binding on Kv4.2 3'untranslated region (3'-UTR). Therefore targeting miR-301a may offer new potential for developing therapeutic approaches.	[Panguluri, Siva K.; Tur, Jared; Chapalamadugu, Kalyan C.; Tipparaju, Srinivas M.] Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33620 USA; [Katnik, Chris; Cuevas, Javier] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Tur, Jared] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Tipparaju, SM (corresponding author), Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33620 USA.	stippara@health.usf.edu			National Institutes of Health (NIH) NHLBI [R01 HL102171]; USF COP seed grant; USF COP; AHA, Greater Southeastern Affiliate [11GRNT7990120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102171] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); USF COP seed grant; USF COP; AHA, Greater Southeastern Affiliate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) NHLBI R01 HL102171, a USF COP seed grant, a USF COP start-up fund and an AHA Grant-In-Aid, Greater Southeastern Affiliate (11GRNT7990120) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; Bhatnagar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013262; Casis O, 2000, DIABETOLOGIA, V43, P101, DOI 10.1007/s001250050013; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; FEIN FS, 1990, DIABETES CARE, V13, P1169, DOI 10.2337/diacare.13.11.1169; FEIN FS, 1983, J MOL CELL CARDIOL, V15, P769, DOI 10.1016/0022-2828(83)90336-X; Feng BA, 2010, DIABETES-METAB RES, V26, P40, DOI 10.1002/dmrr.1054; Fernandez-Velasco M, 2007, AM J PHYSIOL-HEART C, V293, pH238, DOI 10.1152/ajpheart.01122.2006; GidhJain M, 1996, CIRC RES, V79, P669, DOI 10.1161/01.RES.79.4.669; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Gupta S, 2005, AM J PHYSIOL-HEART C, V289, pH20, DOI 10.1152/ajpheart.00082.2005; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; He W, 2009, CARDIOVASC RES, V81, P64, DOI 10.1093/cvr/cvn259; Heather LC, 2011, J MOL CELL CARDIOL, V50, P598, DOI 10.1016/j.yjmcc.2011.01.007; Higuchi Y, 2002, J MOL CELL CARDIOL, V34, P233, DOI 10.1006/jmcc.2001.1505; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Jia Y, 2003, CARDIOVASC RES, V60, P278, DOI 10.1016/S0008-6363(03)00528-5; Kaprielian R, 1999, J PHYSIOL-LONDON, V517, P229, DOI 10.1111/j.1469-7793.1999.0229z.x; Kawada H, 2006, CIRC J, V70, P605, DOI 10.1253/circj.70.605; Khavandi K, 2009, BEST PRACT RES CL EN, V23, P347, DOI 10.1016/j.beem.2008.10.016; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Li X, 2005, AM J PHYSIOL-HEART C, V288, pH1417, DOI 10.1152/ajpheart.00559.2004; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Lugo JN, 2012, LEARN MEMORY, V19, P182, DOI 10.1101/lm.023614.111; MALHOTRA A, 1981, CIRC RES, V49, P1243, DOI 10.1161/01.RES.49.6.1243; Mariappan N, 2010, CARDIOVASC RES, V85, P473, DOI 10.1093/cvr/cvp305; Milstein ML, 2012, P NATL ACAD SCI; Nishiyama A, 2001, AM J PHYSIOL-HEART C, V281, pH1800, DOI 10.1152/ajpheart.2001.281.4.H1800; Nitabach MN, 2001, P NATL ACAD SCI USA, V98, P705, DOI 10.1073/pnas.031446198; Panama BK, 2011, CIRC RES, V108, P537, DOI 10.1161/CIRCRESAHA.110.229112; Panguluri SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008760; Panguluri SK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-577; Petkova-Kirova PS, 2006, AM J PHYSIOL-HEART C, V290, pH2098, DOI 10.1152/ajpheart.00097.2005; Prasad SVN, 2009, J BIOL CHEM, V284, P27487, DOI 10.1074/jbc.M109.036541; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Qin DY, 2001, BIOCHEM BIOPH RES CO, V283, P549, DOI 10.1006/bbrc.2001.4825; Radicke S, 2006, CARDIOVASC RES, V71, P695, DOI 10.1016/j.cardiores.2006.06.017; Rosati B, 2006, J MOL CELL CARDIOL, V40, P295, DOI 10.1016/j.yjmcc.2005.11.002; Semeniuk LM, 2002, AM J PHYSIOL-HEART C, V283, pH976, DOI 10.1152/ajpheart.00088.2002; Shimoni Y, 2004, J PHYSIOL-LONDON, V555, P345, DOI 10.1113/jphysiol.2003.055590; Shimoni Y, 2003, AM J PHYSIOL-HEART C, V284, pH1168, DOI 10.1152/ajpheart.00748.2002; Tipparaju SM, 2012, PFLUG ARCH EUR J PHY, V463, P799, DOI 10.1007/s00424-012-1093-z; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Veglio M, 2004, J ENDOCRINOL INVEST, V27, P175, DOI 10.1007/BF03346265; Wang YG, 2003, J MOL CELL CARDIOL, V35, P1083, DOI 10.1016/S0022-2828(03)00200-1; Wong SCY, 1998, CIRCULATION, V98, P100, DOI 10.1161/01.CIR.98.2.100; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yeung CY, 2012, DIABETES CARE; Yuan WL, 2005, J NEUROSCI, V25, P9185, DOI 10.1523/JNEUROSCI.2858-05.2005; Yue P, 2007, AM J PHYSIOL-HEART C, V292, pH2106, DOI 10.1152/ajpheart.00856.2006; Zhang HL, 2005, J PHARMACOL EXP THER, V313, P1387, DOI 10.1124/jpet.105.084152; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	58	38	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60545	10.1371/journal.pone.0060545	http://dx.doi.org/10.1371/journal.pone.0060545			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573265	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100083
J	Saino, N; Romano, M; Rubolini, D; Ambrosini, R; Caprioli, M; Milzani, A; Costanzo, A; Colombo, G; Canova, L; Wakamatsu, K				Saino, Nicola; Romano, Maria; Rubolini, Diego; Ambrosini, Roberto; Caprioli, Manuela; Milzani, Aldo; Costanzo, Alessandra; Colombo, Graziano; Canova, Luca; Wakamatsu, Kazumasa			Viability Is Associated with Melanin-Based Coloration in the Barn Swallow (Hirundo rustica)	PLOS ONE			English	Article							SEXUAL SELECTION; PLUMAGE COLOR; CHEMICAL-ANALYSIS; FEMALE ORNAMENT; EVOLUTION; PATERNITY; STRESS; OWLS; CORTICOSTERONE; PHEOMELANIN	Pigmentation of body surface in animals can have multiple determinants and accomplish diverse functions. Eumelanin and pheomelanin are the main animal pigments, being responsible of yellow, brownish-red and black hues, and have partly common biosynthetic pathways. Many populations of vertebrates show individual variation in melanism, putatively with large heritable component. Genes responsible for eu- or pheomelanogenesis have pleiotropic but contrasting effects on life-history traits, explaining the patterns of covariation observed between melanization and physiology (e.g. immunity and stress response), sexual behavior and other characters in diverse taxa. Yet, very few studies in the wild have investigated if eu- and pheomelanization predict major fitness traits like viability or fecundity. In this correlative study, by contrasting adult barn swallows (Hirundo rustica) matched for age, sex, breeding site, and year and date of sampling, we show that males but not females that survived until the next year had paler, relatively more eu- than pheomelanic pigmentation of ventral body feathers. Better performance of individuals that allocate relatively more to eumelanogenesis was expected based on previous evidence on covariation between eumelanic pigmentation and specific traits related to immunity and susceptibility to stress. However, together with the evidence of no covariation between viability and melanization among females, this finding raises the question of the mechanisms that maintain variation in genes for melanogenesis. We discuss the possibility that eu- and pheomelanization are under contrasting viability and sexual selection, as suggested by larger breeding and sperm competition success of darker males from other barn swallow subspecies.	[Saino, Nicola; Romano, Maria; Rubolini, Diego; Caprioli, Manuela; Milzani, Aldo; Costanzo, Alessandra; Colombo, Graziano] Univ Milan, Dept Biosci, Milan, Italy; [Ambrosini, Roberto] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Canova, Luca] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Wakamatsu, Kazumasa] Fujita Hlth Univ, Dept Chem, Sch Hlth Sci, Toyoake, Aichi, Japan	University of Milan; University of Milano-Bicocca; University of Pavia; Fujita Health University	Saino, N (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	nicola.saino@unimi.it	Wakamatsu, Kazumasa/AAZ-5877-2020; Milzani, Aldo/AHE-3364-2022; Rubolini, Diego/F-2851-2011; costanzo, alessandra/AAF-8987-2020; Ambrosini, Roberto/F-3188-2012; Canova, Luca/P-6066-2017	Wakamatsu, Kazumasa/0000-0003-1748-9001; Milzani, Aldo/0000-0002-1496-6872; Rubolini, Diego/0000-0003-2703-5783; costanzo, alessandra/0000-0003-3781-0798; Ambrosini, Roberto/0000-0002-7148-1468; Canova, Luca/0000-0002-5011-7413; Saino, Nicola/0000-0002-0230-3967; COLOMBO, GRAZIANO/0000-0001-8663-735X				Almasi B, 2012, J EVOLUTION BIOL, V25, P1189, DOI 10.1111/j.1420-9101.2012.02508.x; Almasi B, 2010, J EVOLUTION BIOL, V23, P987, DOI 10.1111/j.1420-9101.2010.01969.x; Almasi B, 2008, HORM BEHAV, V54, P217, DOI 10.1016/j.yhbeh.2008.02.021; Bize P, 2006, EVOLUTION, V60, P2370; Cramp S, 1998, COMPLETE BIRDS W PAL; Dreiss A, 2010, OECOLOGIA, V164, P65, DOI 10.1007/s00442-010-1680-7; Dreiss AN, 2010, BIOL J LINN SOC, V101, P689, DOI 10.1111/j.1095-8312.2010.01503.x; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Fargallo JA, 2007, EVOL ECOL, V21, P157, DOI 10.1007/s10682-006-0020-1; Galvan I, 2009, FUNCT ECOL, V23, P302, DOI 10.1111/j.1365-2435.2008.01504.x; Gasparini J, 2009, J ANIM ECOL, V78, P608, DOI 10.1111/j.1365-2656.2008.01521.x; Ginn H. B., 1983, MOULT BIRDS BTO GUID; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; HAASE E, 1992, J HERED, V83, P64, DOI 10.1093/oxfordjournals.jhered.a111160; Hill G. E., 2006, BIRD COLORATION, V2; Hill G. E., 2006, BIRD COLORATION, V1; Ito S, 2000, PIGM CELL RES, V13, P103, DOI 10.1034/j.1600-0749.13.s8.19.x; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Majerus M, 1998, MELANISM EVOLUTION A; McGraw KJ, 2005, FUNCT ECOL, V19, P816, DOI 10.1111/j.1365-2435.2005.01032.x; Moller AP, 2006, EVOLUTION, V60, P856; Moller AP, 1998, AM NAT, V151, P236, DOI 10.1086/286114; Moller AP, 1995, J EVOLUTION BIOL, V8, P671, DOI 10.1046/j.1420-9101.1995.8060671.x; Moller AP., 1994, SEXUAL SELECTION BAR; Piault R, 2012, NATURWISSENSCHAFTEN, V99, P391, DOI 10.1007/s00114-012-0914-4; Piault R, 2009, AM NAT, V174, P548, DOI 10.1086/605374; Prota G., 1992, MELANINS MELANOGENES; Roulin A, 2008, BEHAV ECOL SOCIOBIOL, V62, P507, DOI 10.1007/s00265-007-0475-2; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Roulin A, 2005, J ORNITHOL, V146, P390, DOI 10.1007/s10336-005-0096-3; Roulin A, 2004, OECOLOGIA, V140, P668, DOI 10.1007/s00442-004-1636-x; Roulin A, 2011, J EVOLUTION BIOL, V24, P2241, DOI 10.1111/j.1420-9101.2011.02353.x; Roulin A, 2010, J EVOLUTION BIOL, V23, P2046, DOI 10.1111/j.1420-9101.2010.02086.x; Roulin A, 2007, BEHAV ECOL, V18, P563, DOI 10.1093/beheco/arm015; Roulin A, 2011, EUR J PHARMACOL, V660, P226, DOI 10.1016/j.ejphar.2011.01.036; Roulin A, 2010, ECOL LETT, V13, P616, DOI 10.1111/j.1461-0248.2010.01459.x; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Saino N, 1999, J ANIM ECOL, V68, P999, DOI 10.1046/j.1365-2656.1999.00350.x; Saino N, 1997, EVOLUTION, V51, P562, DOI 10.1111/j.1558-5646.1997.tb02443.x; Saino N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058024; Saino N, 2012, J ANIM ECOL, V81, P1004, DOI 10.1111/j.1365-2656.2012.01989.x; Saino N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019593; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Turner A., 2006, BARN SWALLOW; Vortman Y, 2011, BEHAV ECOL, V22, P1344, DOI 10.1093/beheco/arr139; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x	48	35	37	1	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60426	10.1371/journal.pone.0060426	http://dx.doi.org/10.1371/journal.pone.0060426			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573254	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100069
J	Stuckas, H; Gemel, R; Fritz, U				Stuckas, Heiko; Gemel, Richard; Fritz, Uwe			One Extinct Turtle Species Less: Pelusios seychellensis Is Not Extinct, It Never Existed	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; DNA; MITOCHONDRIAL; COLONIZATION; DISPERSAL; NUCLEAR; INDIA; AGE	Pelusios seychellensis is thought to be a freshwater turtle species endemic to the island of Mahe, Seychelles. There are only three museum specimens from the late 19th century known. The species has been never found again, despite intensive searches on Mahe . Therefore, P. seychellensis has been declared as "Extinct" by the IUCN and is the sole putatively extinct freshwater turtle species. Using DNA sequences of three mitochondrial genes of the historical type specimen and phylogenetic analyses including all other species of the genus, we provide evidence that the description of P. seychellensis was erroneously based on a widely distributed West African species, P. castaneus. Consequently, we synonymize the two species and delete P. seychellensis from the list of extinct chelonian species and from the faunal list of the Seychelles.	[Stuckas, Heiko; Fritz, Uwe] Senckenberg Dresden, Museum Zool, Dresden, Germany; [Gemel, Richard] Nat Hist Museum Vienna, Vienna, Austria	Senckenberg Gesellschaft fur Naturforschung (SGN)	Fritz, U (corresponding author), Senckenberg Dresden, Museum Zool, Dresden, Germany.	uwe.fritz@senckenberg.de	Fritz, Uwe/AAC-4029-2019; Stuckas, Heiko/AFM-0009-2022	Fritz, Uwe/0000-0002-6740-7214; Stuckas, Heiko/0000-0002-5690-0994	Senckenberg	Senckenberg	This work was funded by Senckenberg (www.senckenberg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler K, 1989, CONTRIBUTIONS HERPET, V5, P202; Adler K, 1989, CONTRIBUTIONS HIST H, V1, P202; Auffenberg W., 1963, Journal of the Bombay Natural History Society, V60, P462; Austin JJ, 2001, P ROY SOC B-BIOL SCI, V268, P2515, DOI 10.1098/rspb.2001.1825; Blanc CP, 1971, ANN U MADAGASCAR, V8, P95; BOUR R, 1980, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V2, P895; BOUR R, 1983, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V5, P343; Bour R., 1988, Studia Geologica Salmanticensia Volumen Especial, V2, P23; Bour R., 2008, CHELONIAN RES MONOGR, V5; Bour R, 1985, STUDIA PALAEOCHELONI, V1, P17; BOUR R, 1984, BIOGEOGRAPHY ECOLOGY, P281; Bourret R, 1941, TORTUES INDOCHINE, V235; BRAMBLE DM, 1981, HERPETOLOGICA, V37, P205; Broadley D.G., 1981, OCCASIONAL PAPERS OF THE NATIONAL MUSEUMS AND MONUMENTS OF RHODESIA SERIES B NATURAL SCIENCES, V6, P633; BURLEIGH R, 1986, PROC R SOC SER B-BIO, V227, P137, DOI 10.1098/rspb.1986.0014; Cheke A.S., 2008, LOST LAND DODO ECOLO, P464; Collier JS, 2008, EARTH PLANET SC LETT, V272, P264, DOI 10.1016/j.epsl.2008.04.045; Daniels SR, 2011, MOL PHYLOGENET EVOL, V61, P534, DOI 10.1016/j.ympev.2011.07.015; Ernst CH, 2000, WORLD BIODIVERSITY D; Fritz Uwe, 2007, Vertebrate Zoology, V57, P149; Fritz U, 2013, ORG DIVERS EVOL, V13, P215, DOI 10.1007/s13127-012-0113-3; Fritz U, 2012, J ZOOL SYST EVOL RES, V50, P125, DOI 10.1111/j.1439-0469.2011.00647.x; Fritz U, 2012, AMPHIBIA-REPTILIA, V33, P150, DOI 10.1163/156853812X627204; Fritz U, 2011, ZOOL SCR, V40, P115, DOI 10.1111/j.1463-6409.2010.00464.x; Gaffney Eugene S., 1996, Bulletin of the American Museum of Natural History, V229, P1; Gaffney ES, 2006, B AM MUS NAT HIST, P1; Garrick RC, 2012, CURR BIOL, V22, pR10, DOI 10.1016/j.cub.2011.12.004; Gerlach J, 2001, ORYX, V35, P313, DOI 10.1017/S0030605300032075; Gerlach J, 2008, CHELONIAN RES MONOGR, V5; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hawlitschek O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042970; *IUCN, 2003, IUCN RED LIST THREAT; IUCN, 2012, IUCN RED LIST THREAT; Iverson J. B., 1992, REVISED CHECKLIST DI; Kindler C, 2012, J ZOOL SYST EVOL RES, V50, P192, DOI 10.1111/j.1439-0469.2012.00660.x; Klaus S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-287; Laurent RF, 1965, ANN MUSEE ROYAL CONG, V8, p[135, 1]; LOVERIDGE A, 1947, COPEIA, P120; Mertens R., 1955, Zoologische Jahrbuecher Systematik, V83, P323; Nagy ZT, 2003, P ROY SOC B-BIOL SCI, V270, P2613, DOI 10.1098/rspb.2003.2547; Nicholls H, 2012, NATURE, V487, P279, DOI 10.1038/487279a; Ogilby J. D., 1905, P Soc Queensland, Vxix, P1; Olson Storrs L., 2005, Bulletin of the British Ornithologists' Club, V125, P31; Parham JF, 2004, P ROY SOC B-BIOL SCI, V271, pS391, DOI 10.1098/rsbl.2004.0217; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poulakakis N, 2008, P NATL ACAD SCI USA, V105, P15464, DOI 10.1073/pnas.0805340105; Poulakakis N, 2012, MOL ECOL, V21, P160, DOI 10.1111/j.1365-294X.2011.05370.x; Pritchard PCH, 1996, CHELONIAN RES MONOGR, V1, P85; Rasmussen Pamela C., 2003, Bulletin of the British Ornithologists' Club, V123A, P66; Rendahl H, 1939, ZOOLOGISCHE JB ABTEI, V72, P255; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schleich H.H., 1987, Spixiana Supplement, P1; Siebenrock F, 1906, REISE OSTAFRIKA JAHR, VII; Siebenrock F, 1916, ANN NATURHIST MUS WI, V30, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan H. H., 2000, Bulletin of Zoological Nomenclature, V57, P29; Tiedemann F, 1988, HERPETOZOA, V1, P109; Townsend TM, 2011, BIOL LETTERS, V7, P225, DOI 10.1098/rsbl.2010.0701; van Dijk P. P., 2011, CHELONIAN RES MONOGR, V5; Vanhoffen E, 1918, MITT ZOOL MUS BERLIN, V9, P1; Vargas-Ramirez M, 2010, MOL PHYLOGENET EVOL, V56, P428, DOI 10.1016/j.ympev.2010.03.019; Vasconcelos R, 2013, ORYX, V47, P77, DOI 10.1017/S0030605311001438; Vences M, 2003, P ROY SOC B-BIOL SCI, V270, P2435, DOI 10.1098/rspb.2003.2516; WERMUTH H, 1965, ISRAEL J ZOOL, V14, P277; Wermuth H, 1977, TESTUDINES CROCODYLI, V100, p[i, 1]; White A, 2010, LIBR J, V135, P107; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhou Ting, 2004, Sichuan Journal of Zoology, V23, P325	69	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e57116	10.1371/journal.pone.0057116	http://dx.doi.org/10.1371/journal.pone.0057116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573185	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100004
J	Sundelof, A; Bartolino, V; Ulmestrand, M; Cardinale, M				Sundelof, Andreas; Bartolino, Valerio; Ulmestrand, Mats; Cardinale, Massimiliano			Multi-Annual Fluctuations in Reconstructed Historical Time-Series of a European Lobster (Homarus gammarus) Population Disappear at Increased Exploitation Levels	PLOS ONE			English	Article							DYNAMICS; ECOLOGY; DEPLETION; EVOLUTION; AGE	Through the history of ecology, fluctuations of populations have been a dominating topic, and endogenous causes of fluctuations and oscillations have been recognized and studied for more than 80 years. Here we analyzed an historical dataset, covering more than 130 years, of European lobster (Homarus gammarus) catches. The data shows periodic fluctuations, which are first dampened and then disappear over time. The disappearance of the periodicity coincided with a substantial increase in fishing effort and the oscillations have not reappeared in the time series. The shifting baseline syndrome has changed our perception of not only the status of the stock, but also the regulating pressures. We describe the transition of a naturally regulated lobster population into a heavily exploited fisheries controlled stock. This is shown by the incorporation of environmental and endogenous processes in generalized additive models, autocorrelation functions and periodicity analyses of time-series.	[Sundelof, Andreas; Bartolino, Valerio; Ulmestrand, Mats; Cardinale, Massimiliano] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Marine Res, Lysekil, Sweden; [Bartolino, Valerio] Gothenburg Univ, Dept Earth Sci, Gothenburg, Sweden	Swedish University of Agricultural Sciences; University of Gothenburg	Sundelof, A (corresponding author), Swedish Univ Agr Sci, Dept Aquat Resources, Inst Marine Res, Lysekil, Sweden.	Andreas.Sundelof@slu.se		Bartolino, Valerio/0000-0002-4506-4329	Swedish Environment Protection Agency [Dnr 309-1685-09 Nh]	Swedish Environment Protection Agency	The project "Waking the Deads", of which this study has been a part, was financed by the Swedish Environment Protection Agency (Dnr 309-1685-09 Nh, http://www.naturvardsverket.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HMAP is gratefully thanked for covering the publication fees of this issue.	Allee WC, 1932, J EXP ZOOL, V61, P185, DOI 10.1002/jez.1400610202; Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; [Anonymous], 1955, STROMSTADS TIDNING; Axelsson G, 1944, SVENSKA HUMMERFISKET; Bartolino V, 2012, CAN J FISH AQUAT SCI, V69, P833, DOI 10.1139/F2012-028; Berryman AA, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P3; Bjornstad ON, 1999, P NATL ACAD SCI USA, V96, P5066, DOI 10.1073/pnas.96.9.5066; Cardinale M, 2012, J APPL ICHTHYOL, V28, P200, DOI 10.1111/j.1439-0426.2012.01937.x; Cardinale M, 2011, FISH FISH, V12, P289, DOI 10.1111/j.1467-2979.2010.00393.x; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chatfield C, 1999, ANAL TIME SERIES INT; Cushing DH, 1975, MARINE ECOLOGY FISHE, p[202, 278]; Elton CS, 1924, BR J EXP BIOL, V2, P119; Ernande B, 2004, P ROY SOC B-BIOL SCI, V271, P415, DOI 10.1098/rspb.2003.2519; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hughes JT, 1972, SCIENCE, V4056, P1110; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; LAW R, 1989, EVOL ECOL, V3, P343, DOI 10.1007/BF02285264; Lotka AJ, 1931, J WASHINGTON ACAD SC, V22, P461; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pitcher T.J., 1982, FISHERIES ECOLOGY; Rouyer T, 2012, ECOL LETT, V15, P658, DOI 10.1111/j.1461-0248.2012.01781.x; ROYAMA T, 1981, ECOL MONOGR, V51, P473, DOI 10.2307/2937325; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Sheehy MRJ, 1999, CAN J FISH AQUAT SCI, V56, P1904, DOI 10.1139/cjfas-56-10-1904; Shelton AO, 2011, P NATL ACAD SCI USA, V108, pE1226, DOI 10.1073/pnas.1115765108; Shelton AO, 2011, P NATL ACAD SCI USA, V108, P7075, DOI 10.1073/pnas.1100334108; Smith IP, 2008, ICES J MAR SCI, V65, P1600, DOI 10.1093/icesjms/fsn170; Smith IP, 1999, MAR ECOL PROG SER, V186, P255, DOI 10.3354/meps186255; Solhaug, 1983, NORSKE FISKERIERS HI; Stenseth NC, 2008, NATURE, V452, P825, DOI 10.1038/452825a; Sugihara G, 2011, P NATL ACAD SCI USA, V108, pE1224, DOI 10.1073/pnas.1112033108; TURCHIN P, 1992, ECOLOGY, V73, P289, DOI 10.2307/1938740; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; van der Meeren GI, 2000, CAN J FISH AQUAT SCI, V57, P1794, DOI 10.1139/cjfas-57-9-1794; VOLTERRA V, 1928, J CONS INT EXPLOR ME, V3, P3, DOI DOI 10.1093/ICESJMS/3.1.3; Wahle RA, 2003, FISH RES, V65, P3, DOI 10.1016/j.fishres.2003.09.004; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zhang YY, 2011, FISH RES, V108, P385, DOI 10.1016/j.fishres.2011.01.014	44	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e58160	10.1371/journal.pone.0058160	http://dx.doi.org/10.1371/journal.pone.0058160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573187	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000318840100006
J	Workentine, ML; Sibley, CD; Glezerson, B; Purighalla, S; Norgaard-Gron, JC; Parkins, MD; Rabin, HR; Surette, MG				Workentine, Matthew L.; Sibley, Christopher D.; Glezerson, Bryan; Purighalla, Swathi; Norgaard-Gron, Jens C.; Parkins, Michael D.; Rabin, Harvey R.; Surette, Michael G.			Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; GENETIC ADAPTATION; POLYMICROBIAL NATURE; ADAPTIVE RADIATION; HIGHLY ADHERENT; LUNG INFECTIONS; AIRWAYS; CHILDREN; DISEASE; PATHOGENESIS	The opportunistic pathogen Pseudomonas aeruginosa chronically infects the lower airways of patients with cystic fibrosis. Throughout the course of infection this organism undergoes adaptations that contribute to its long-term persistence in the airways. While P. aeruginosa diversity has been documented, it is less clear to what extent within-patient diversity contributes to the overall population structure as most studies have been limited to the analysis of only a few isolates per patient per time point. To examine P. aeruginosa population structure in more detail we collected multiple isolates from individual sputum samples of a patient chronically colonized with P. aeruginosa. This strain collection, comprised of 169 clonal isolates and representing three pulmonary exacerbations as well as clinically stable periods, was assayed for a wide selection of phenotypes. These phenotypes included colony morphology, motility, quorum sensing, protease activity, auxotrophy, siderophore levels, antibiotic resistance, and growth profiles. Each phenotype displayed significant variation even within isolates of the same colony morphotype from the same sample. Isolates demonstrated a large degree of individuality across phenotypes, despite being part of a single clonal lineage, suggesting that the P. aeruginosa population in the cystic fibrosis airways is being significantly under-sampled.	[Workentine, Matthew L.; Surette, Michael G.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Workentine, Matthew L.; Surette, Michael G.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Surette, Michael G.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Sibley, Christopher D.; Glezerson, Bryan; Purighalla, Swathi; Norgaard-Gron, Jens C.; Parkins, Michael D.; Rabin, Harvey R.; Surette, Michael G.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Parkins, Michael D.; Rabin, Harvey R.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Parkins, Michael D.; Rabin, Harvey R.] Univ Calgary, Adult Cyst Fibrosis Clin, Calgary, AB, Canada	McMaster University; McMaster University; McMaster University; University of Calgary; University of Calgary; University of Calgary	Surette, MG (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada.	surette@mcmaster.ca	Surette, Michael G/AAE-8825-2020; Glezerson, Bryan/AAY-6901-2020	Glezerson, Bryan/0000-0002-8183-7026; Workentine, Matthew/0000-0002-6415-2797	Cystic Fibrosis Canada; Canada Research Chair in Interdisciplinary Microbiome Research; Canada Graduate Scholarship from the Canadian Institutes of Health Research	Cystic Fibrosis Canada; Canada Research Chair in Interdisciplinary Microbiome Research; Canada Graduate Scholarship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from Cystic Fibrosis Canada to M.G.S and to M.D.P. and a postdoctoral fellowship to M.L.W. M.G.S. is also supported as a Canada Research Chair in Interdisciplinary Microbiome Research. C.D.S. was supported by a Canada Graduate Scholarship from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel E, 2010, INFECT IMMUN, V78, P2937, DOI 10.1128/IAI.00144-10; Baynham PJ, 2006, J BACTERIOL, V188, P132, DOI 10.1128/JB.188.1.132-140.2006; Ciofu O, 2010, MICROBIOL-SGM, V156, P1108, DOI 10.1099/mic.0.033993-0; Clinical and Laboratory Standard Institute (CBI), 2009, PERF STAND ANT SUS S; Core R Team, 2012, R LANG ENV STAT COMP; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; Davidson CJ, 2008, ISME J, V2, P293, DOI 10.1038/ismej.2008.4; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Duan K, 2007, J BACTERIOL, V189, P4827, DOI 10.1128/JB.00043-07; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Feliziani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012669; Fothergill JL, 2010, J MED MICROBIOL, V59, P472, DOI 10.1099/jmm.0.015875-0; Foweraker JE, 2005, J ANTIMICROB CHEMOTH, V55, P921, DOI 10.1093/jac/dki146; Foweraker JE, 2009, ANTIMICROB AGENTS CH, V53, P4809, DOI 10.1128/AAC.00269-09; Glezerson BA, 2012, J CYST FIBROS, V11, pS41; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0; HENRY RL, 1992, PEDIATR PULM, V12, P158, DOI 10.1002/ppul.1950120306; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; Kahm M, 2010, J STAT SOFTW, V33, P1; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kassen R, 2009, ANN NY ACAD SCI, V1168, P3, DOI 10.1111/j.1749-6632.2009.04574.x; KEREM E, 1990, J PEDIATR-US, V116, P714, DOI 10.1016/S0022-3476(05)82653-8; Kosorok MR, 2001, PEDIATR PULM, V32, P277, DOI 10.1002/ppul.2009.abs; Lee B, 2005, J CLIN MICROBIOL, V43, P5247, DOI 10.1128/JCM.43.10.5247-5255.2005; Lee SM, 2010, APPL ENVIRON MICROB, V76, P4655, DOI 10.1128/AEM.00358-10; Leone I, 2008, EUR J CLIN MICROBIOL, V27, P1093, DOI 10.1007/s10096-008-0551-1; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Parkins MD, 2008, PEDIATR PULM, V43, P490, DOI 10.1002/ppul.20809; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sibley CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022702; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Sibley CD, 2009, CURR OPIN INVEST DR, V10, P787; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; SMITH HL, 1958, J BACTERIOL, V76, P662, DOI 10.1128/JB.76.6.662-665.1958; SOKOL PA, 1979, J CLIN MICROBIOL, V9, P538; SOKOL PA, 1982, J BACTERIOL, V151, P783, DOI 10.1128/JB.151.2.783-787.1982; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Stressmann FA, 2011, J CLIN MICROBIOL, V49, P281, DOI 10.1128/JCM.01650-10; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; von Gotz F, 2004, J BACTERIOL, V186, P3837, DOI 10.1128/JB.186.12.3837-3847.2004; Wagner T, 2005, CHEST, V128, P912, DOI 10.1378/chest.128.2.912; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	61	129	131	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60225	10.1371/journal.pone.0060225	http://dx.doi.org/10.1371/journal.pone.0060225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573242	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100056
J	Bilodeau, E; Guay, JF; Turgeon, J; Cloutier, C				Bilodeau, Emilie; Guay, Jean-Frederic; Turgeon, Julie; Cloutier, Conrad			Survival to Parasitoids in an Insect Hosting Defensive Symbionts: A Multivariate Approach to Polymorphic Traits Affecting Host Use by Its Natural Enemy	PLOS ONE			English	Article							FITNESS TRADE-OFFS; PEA APHID; ACYRTHOSIPHON-PISUM; HORIZONTAL TRANSFER; GENETIC-VARIATION; EVOLUTION; RESISTANCE; HYMENOPTERA; COEVOLUTION; POPULATIONS	Insect parasitoids and their insect hosts represent a wide range of parasitic trophic relations that can be used to understand the evolution of biotic diversity on earth. Testing theories of coevolution between hosts and parasites is based on factors directly involved in host susceptibility and parasitoid virulence. We used controlled encounters with potential hosts of the Aphidius ervi wasp to elucidate behavioral and other phenotypic traits of host Acyrthosiphon pisum that most contribute to success or failure of parasitism. The host aphid is at an advanced stage of specialization on different crop plants, and exhibits intra-population polymorphism for traits of parasitoid avoidance and resistance based on clonal variation of color morph and anti-parasitoid bacterial symbionts. Randomly selected aphid clones from alfalfa and clover were matched in 5 minute encounters with wasps of two parasitoid lineages deriving from hosts of each plant biotype in a replicated transplant experimental design. In addition to crop plant affiliation (alfalfa, clover), aphid clones were characterized for color morph (green, pink), Hamiltonella defensa and Regiella insecticola symbionts, and frequently used behaviors in encounters with A. ervi wasps. A total of 12 explanatory variables were examined using redundancy analysis (RDA) to predict host survival or failure to A. ervi parasitism. Aphid color was the best univariate predictor, but was poorly predictive in the RDA model. In contrast, aphid host plant and symbionts were not significant univariate predictors, but significant predictors in the multivariate model. Aphid susceptibility to wasp acceptance as reflected in host attacks and oviposition clearly differed from its suitability to parasitism and progeny development. Parasitoid progeny were three times more likely to survive on clover than alfalfa host aphids, which was compensated by behaviorally adjusting eggs invested per host. Strong variation of the predictive power of intrinsic (body color) and extrinsic traits (symbionts, host plant), indicate that host variables considered as key predictors of outcomes strongly interact and cannot be considered in isolation.	[Bilodeau, Emilie; Guay, Jean-Frederic; Turgeon, Julie; Cloutier, Conrad] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada	Laval University	Cloutier, C (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	Conrad.Cloutier@bio.ulaval.ca	Turgeon, Julie/H-5631-2013		Natural Sciences & Engineering Research Council of Canada (NSERC); Discovery Grants	Natural Sciences & Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Discovery Grants	Funding came from Natural Sciences & Engineering Research Council of Canada (NSERC) and Discovery Grants to CC and JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Antolin MF, 2006, ECOL ENTOMOL, V31, P242, DOI 10.1111/j.1365-2311.2006.00769.x; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; Bilodeau E, 2012, EVOL ECOL IN PRESS; Brodeur J, 2004, ANNU REV ENTOMOL, V49, P27, DOI 10.1146/annurev.ento.49.061703.153618; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; Carton Y, 2005, DEV COMP IMMUNOL, V29, P9, DOI 10.1016/j.dci.2004.05.004; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Dion E, 2011, BIOL LETTERS, V7, P743, DOI 10.1098/rsbl.2011.0249; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Ferrari J, 2012, EVOLUTION, V66, P375, DOI 10.1111/j.1558-5646.2011.01436.x; Frank SA, 1994, PHILOS T R SOC B, V346, P283; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; GERLING D, 1990, J INSECT BEHAV, V3, P501, DOI 10.1007/BF01052014; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Godfray HCJ, 2000, PARASITOID POPULATION BIOLOGY, P121; Grbic M, 2003, INT J DEV BIOL, V47, P633; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; Guay JF, 2009, J INSECT PHYSIOL, V55, P919, DOI 10.1016/j.jinsphys.2009.06.006; Hartbauer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010417; Hawkins BA, 1997, ECOLOGY, V78, P2145, DOI 10.1890/0012-9658(1997)078[2145:PPAPAM]2.0.CO;2; Henry LM, 2008, EVOLUTION, V62, P689, DOI 10.1111/j.1558-5646.2007.00316.x; HENTER HJ, 1995, EVOLUTION, V49, P427, DOI [10.1111/j.1558-5646.1995.tb02275.x, 10.2307/2410267]; HENTER HJ, 1995, EVOLUTION, V49, P439, DOI 10.1111/j.1558-5646.1995.tb02276.x; Hufbauer RA, 2001, ECOLOGY, V82, P717, DOI 10.1890/0012-9658(2001)082[0717:PAPIHP]2.0.CO;2; Hufbauer RA, 2004, MOL ECOL, V13, P337, DOI 10.1046/j.1365-294X.2003.02084.x; Hufbauer RA, 1999, EVOLUTION, V53, P1435, DOI 10.1111/j.1558-5646.1999.tb05408.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kraaijeveld Alex R., 2008, P315, DOI 10.1002/9780470696200.ch14; Kraaijeveld AR, 1998, PARASITOLOGY, V116, pS29, DOI 10.1017/S0031182000084924; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; KURIS AM, 1974, Q REV BIOL, V49, P129, DOI 10.1086/408018; Langley SA, 2006, OECOLOGIA, V150, P172, DOI 10.1007/s00442-006-0486-0; Lapchin Laurent, 2005, Front Zool, V2, P4, DOI 10.1186/1742-9994-2-4; Legendre P., 2012, NUMERICAL ECOLOGY; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018563; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; Mackauer M, 1996, CAN ENTOMOL, V128, P959, DOI 10.4039/Ent128959-6; Morris RJ, 2002, BEHAV ECOL SOCIOBIOL, V51, P386, DOI 10.1007/s00265-001-0439-x; Nguyen TTA, 2008, INSECT BIOCHEM MOLEC, V38, P730, DOI 10.1016/j.ibmb.2008.04.005; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Peccoud J, 2008, MOL ECOL, V17, P4608, DOI 10.1111/j.1365-294X.2008.03949.x; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Quicke D. L. J., 1997, PARASITIC WASPS; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Seed, 2001, PARASITISM DIVERSITY; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; Takada H, 2000, ENTOMOL EXP APPL, V97, P11, DOI 10.1023/A:1004044311184; Takemoto H, 2009, APPL ENTOMOL ZOOL, V44, P23, DOI 10.1303/aez.2009.23; Ter Braak C.J.F., 2004, ADV ECOL RES, V34, P235; TERBRAAK CJF, 1990, PSYCHOMETRIKA, V55, P519, DOI 10.1007/BF02294765; Thompson J. N., 2005, INTERSPEC INTERACT; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; VINSON SB, 1980, Q REV BIOL, V55, P143, DOI 10.1086/411731; Wu GM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-19; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	63	6	8	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60708	10.1371/journal.pone.0060708	http://dx.doi.org/10.1371/journal.pone.0060708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565269	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300140
J	Chatterjee, P; Choudhary, GS; Sharma, A; Singh, K; Heston, WD; Ciezki, J; Klein, EA; Almasan, A				Chatterjee, Payel; Choudhary, Gaurav S.; Sharma, Arishya; Singh, Kamini; Heston, Warren D.; Ciezki, Jay; Klein, Eric A.; Almasan, Alexandru			PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer Cells	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE INHIBITOR; HOMOLOGOUS RECOMBINATION; CARCINOMA-CELLS; IONIZING-RADIATION; GENOTOXIC STRESS; LYMPHOMA-CELLS; DNA-DAMAGE; TUMORS; PROGRESSION; AG014699	Exposure to genotoxic agents, such as irradiation produces DNA damage, the toxicity of which is augmented when the DNA repair is impaired. Poly (ADP-ribose) polymerase (PARP) inhibitors were found to be "synthetic lethal" in cells deficient in BRCA1 and BRCA2 that impair homologous recombination. However, since many tumors, including prostate cancer (PCa) rarely have on such mutations, there is considerable interest in finding alternative determinants of PARP inhibitor sensitivity. We evaluated the effectiveness of radiation in combination with the PARP inhibitor, rucaparib in PCa cells. The combination index for clonogenic survival following radiation and rucaparib treatments revealed synergistic interactions in a panel of PCa cell lines, being strongest for LNCaP and VCaP cells that express ETS gene fusion proteins. These findings correlated with synergistic interactions for senescence activation, as indicated by beta-galactosidase staining. Absence of PTEN and presence of ETS gene fusion thus facilitated activation of senescence, which contributed to decreased clonogenic survival. Increased radiosensitivity in the presence of rucaparib was associated with persistent DNA breaks, as determined by chi-H2AX, p53BP1, and Rad51 foci. VCaP cells, which harbor the TMPRSS2-ERG gene fusion and PC3 cells that stably express a similar construct (fusion III) showed enhanced sensitivity towards rucaparib, which, in turn, increased the radiation response to a similar extent as the DNA-PKcs inhibitor NU7441. Rucaparib radiosensitized PCa cells, with a clear benefit of low dose-rate radiation (LDR) administered over a longer period of time that caused enhanced DNA damage. LDR mimicking brachytherapy, which is used successfully in the clinic, was most effective when combined with rucaparib by inducing persistent DNA damage and senescence, leading to decreased clonogenic survival. This combination was most effective in the presence of the TMPRSS2-ERG and in the absence of PTEN, indicating clinical potential for brachytherapy in patients with intermediate and high risk PCa.	[Chatterjee, Payel; Choudhary, Gaurav S.; Sharma, Arishya; Singh, Kamini; Heston, Warren D.; Almasan, Alexandru] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA; [Ciezki, Jay; Almasan, Alexandru] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA; [Klein, Eric A.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Chatterjee, Payel] Kent State Univ, Kent, OH 44242 USA; [Choudhary, Gaurav S.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Sharma, Arishya] Cleveland State Univ, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; University System of Ohio; Cleveland State University	Almasan, A (corresponding author), Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA.	almasaa@ccf.org	Almasan, Alex/C-2715-2008; Sharma, Arishya/L-1449-2019; Choudhary, Gaurav S./C-3673-2019	Almasan, Alex/0000-0002-8916-6650; Choudhary, Gaurav S./0000-0001-5365-6706	Pfizer RDG; National Cancer Institute [CA127264]; United States Department of Defense Post-doctoral Training Award [PC094405]; National Insitutes of Health [P30 CA43703]; NATIONAL CANCER INSTITUTE [R01CA127264, P30CA043703] Funding Source: NIH RePORTER	Pfizer RDG; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Defense Post-doctoral Training Award; National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was primarily supported by Pfizer RDG, with additional support from National Cancer Institute (CA127264 to AA) and United States Department of Defense Post-doctoral Training Award (PC094405 to KS). It was also supported in part by National Insitutes of Health grant P30 CA43703 for use of the Radiation Resources Core Facility, Case Western Reserve University and the CASE Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2007, CLIN CANCER RES, V13, P3033, DOI 10.1158/1078-0432.CCR-06-2872; Ali M, 2011, MOL CANCER THER, V10, P2320, DOI 10.1158/1535-7163.MCT-11-0356; Barreto-Andrade JC, 2011, MOL CANCER THER, V10, P1185, DOI 10.1158/1535-7163.MCT-11-0061; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; Bouchaert P, 2012, INT J RADIAT ONCOL, V84, P1179, DOI 10.1016/j.ijrobp.2012.02.014; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chalmers A, 2004, INT J RADIAT ONCOL, V58, P410, DOI 10.1016/j.ijrobp.2003.09.053; Crosby ME, 2007, ONCOGENE, V26, P1897, DOI 10.1038/sj.onc.1209998; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Drew Y, 2011, JNCI-J NATL CANCER I, V103, P334, DOI 10.1093/jnci/djq509; DuPree EL, 2004, CANCER RES, V64, P4390, DOI 10.1158/0008-5472.CAN-03-3695; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fraser M, 2012, CLIN CANCER RES, V18, P1015, DOI 10.1158/1078-0432.CCR-11-2189; Han S, 2012, CANC DISCOV; Hoglund A, 2011, CELL CYCLE, V10, P3598, DOI 10.4161/cc.10.20.17887; Hunter JE, 2011, ONCOGENE; Javle M, 2011, BRIT J CANCER, V105, P1114, DOI 10.1038/bjc.2011.382; Kunos CA, 2011, INT J RADIAT ONCOL, V80, P1198, DOI 10.1016/j.ijrobp.2011.01.034; Liu SK, 2008, RADIOTHER ONCOL, V88, P258, DOI 10.1016/j.radonc.2008.04.005; Loser DA, 2010, MOL CANCER THER, V9, P1775, DOI 10.1158/1535-7163.MCT-09-1027; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Martinez AA, 2011, PROSTATE; Mazumder S, 2007, MOL CELL BIOL, V27, P3511, DOI 10.1128/MCB.01448-06; Mukhopadhyay A, 2011, BJOG-INT J OBSTET GY, V118, P429, DOI 10.1111/j.1471-0528.2010.02838.x; Nag S, 2000, Semin Urol Oncol, V18, P133; Oplustilova L, 2012, CELL CYCLE, V11, P3837, DOI 10.4161/cc.22026; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Ray S, 2005, APOPTOSIS, V10, P1411, DOI 10.1007/s10495-005-2490-y; Ray S, 2007, MOL CANCER THER, V6, P1368, DOI 10.1158/1535-7163.MCT-05-0414; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schiewer MJ, 2012, CANCER DISCOV, V2, P1134, DOI 10.1158/2159-8290.CD-12-0120; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh K, 2012, AUTOPHAGY, V8, P236, DOI 10.4161/auto.8.2.18600; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Vilar E, 2011, CANCER RES, V71, P2632, DOI 10.1158/0008-5472.CAN-10-1120; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Williamson CT, 2010, MOL CANCER THER, V9, P347, DOI 10.1158/1535-7163.MCT-09-0872; Yin LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021319; Zaremba T, 2011, BIOCHEM J, V436, P671, DOI 10.1042/BJ20101723	47	84	87	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60408	10.1371/journal.pone.0060408	http://dx.doi.org/10.1371/journal.pone.0060408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565244	Green Submitted, gold, Green Published			2022-12-27	WOS:000317717300114
J	Kobayashi, DT; Shi, J; Stephen, L; Ballard, KL; Dewey, R; Mapes, J; Chung, B; McCarthy, K; Swoboda, KJ; Crawford, TO; Li, R; Plasterer, T; Joyce, C; Chung, WK; Kaufmann, P; Darras, BT; Finkel, RS; Sproule, DM; Martens, WB; McDermott, MP; De Vivo, DC; Walker, MG; Chen, KS				Kobayashi, Dione T.; Shi, Jing; Stephen, Laurie; Ballard, Karri L.; Dewey, Ruth; Mapes, James; Chung, Brett; McCarthy, Kathleen; Swoboda, Kathryn J.; Crawford, Thomas O.; Li, Rebecca; Plasterer, Thomas; Joyce, Cynthia; Chung, Wendy K.; Kaufmann, Petra; Darras, Basil T.; Finkel, Richard S.; Sproule, Douglas M.; Martens, William B.; McDermott, Michael P.; De Vivo, Darryl C.; Walker, Michael G.; Chen, Karen S.		Biomarkers Spinal Muscular Atrophy; Pediat Neuromuscular Clinical Res	SMA-MAP: A Plasma Protein Panel for Spinal Muscular Atrophy	PLOS ONE			English	Article							FUNCTIONAL MOTOR SCALE; AMYOTROPHIC-LATERAL-SCLEROSIS; MOUSE MODEL; SKELETAL-MUSCLE; GENE-EXPRESSION; NEURON PROTEIN; SURVIVAL; CHILDREN; METABOLISM; BIOMARKERS	Objectives: Spinal Muscular Atrophy (SMA) presents challenges in (i) monitoring disease activity and predicting progression, (ii) designing trials that allow rapid assessment of candidate therapies, and (iii) understanding molecular causes and consequences of the disease. Validated biomarkers of SMA motor and non-motor function would offer utility in addressing these challenges. Our objectives were (i) to discover additional markers from the Biomarkers for SMA (BforSMA) study using an immunoassay platform, and (ii) to validate the putative biomarkers in an independent cohort of SMA patients collected from a multi-site natural history study (NHS). Methods: BforSMA study plasma samples (N = 129) were analyzed by immunoassay to identify new analytes correlating to SMA motor function. These immunoassays included the strongest candidate biomarkers identified previously by chromatography. We selected 35 biomarkers to validate in an independent cohort SMA type 1, 2, and 3 samples (N = 158) from an SMA NHS. The putative biomarkers were tested for association to multiple motor scales and to pulmonary function, neurophysiology, strength, and quality of life measures. We implemented a Tobit model to predict SMA motor function scores. Results: 12 of the 35 putative SMA biomarkers were significantly associated (p<0.05) with motor function, with a 13th analyte being nearly significant. Several other analytes associated with non-motor SMA outcome measures. From these 35 biomarkers, 27 analytes were selected for inclusion in a commercial panel (SMA-MAP) for association with motor and other functional measures. Conclusions: Discovery and validation using independent cohorts yielded a set of SMA biomarkers significantly associated with motor function and other measures of SMA disease activity. A commercial SMA-MAP biomarker panel was generated for further testing in other SMA collections and interventional trials. Future work includes evaluating the panel in other neuromuscular diseases, for pharmacodynamic responsiveness to experimental SMA therapies, and for predicting functional changes over time in SMA patients.	[Kobayashi, Dione T.; Chung, Brett; McCarthy, Kathleen; Joyce, Cynthia; Chen, Karen S.] Spinal Muscular Atrophy Fdn, New York, NY USA; [Shi, Jing; Walker, Michael G.] Walker Biosci, Carlsbad, CA USA; [Stephen, Laurie; Ballard, Karri L.; Dewey, Ruth; Mapes, James] Myriad RBM, Austin, TX USA; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Crawford, Thomas O.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Crawford, Thomas O.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Li, Rebecca] New England Res Inst, Watertown, MA 02172 USA; [Plasterer, Thomas] BG Med, Waltham, MA USA; [Chung, Wendy K.; Kaufmann, Petra; Darras, Basil T.; Finkel, Richard S.; Sproule, Douglas M.; Martens, William B.; McDermott, Michael P.; De Vivo, Darryl C.] Pediat Neuromuscular Clin Res Network, New York, NY USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Johns Hopkins University; Johns Hopkins University; HealthCore, Inc	Kobayashi, DT (corresponding author), Spinal Muscular Atrophy Fdn, New York, NY USA.	dkobayashi@smafoundation.org	Gooch, Clifton L/M-1874-2016; McDermott, Michael Francis/GZM-5330-2022; SAHIN, MUSTAFA/I-8653-2019	Gooch, Clifton L/0000-0002-2210-2038; SAHIN, MUSTAFA/0000-0001-7044-2953; Nelson, Leslie/0000-0003-3606-5757; kobayashi, dione/0000-0002-5541-7175; Joyce, Cynthia/0000-0002-5063-4859; Swoboda, Kathryn/0000-0002-4593-6342; mathews, katherine/0000-0003-4160-0435; Darras, Basil/0000-0002-1536-8145; Kang, Peter/0000-0002-4270-7325	SMA Foundation; PTC Therapeutics; Santhera Pharmaceuticals; Genzyme Corp.; Merck Pharmaceuticals; Southern Biotechnology Associates; Upstate Pharmaceuticals; Santa Cruz Biotechnology; NIH; Families of SMA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069045, P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054599] Funding Source: NIH RePORTER	SMA Foundation; PTC Therapeutics; Santhera Pharmaceuticals; Genzyme Corp.(Sanofi-AventisGenzyme Corporation); Merck Pharmaceuticals(Merck & Company); Southern Biotechnology Associates; Upstate Pharmaceuticals; Santa Cruz Biotechnology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Families of SMA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The SMA Foundation (www.smafoundation.org) funded all studies and its staff was involved in all aspects of study design, data collection and analysis, the decision to publish, and preparation of the manuscript.; MGW and JS are employees/owners of Walker Biosciences statistical consulting group. LS, KB, RD and JM are employees of Myriad RBM, a for-profit company involved in producing research diagnostics. Myriad RBM sells the SMA-MAP panel. RL is a former employee of NERI, a for-profit clinical research organization. TP is the former employee of BG Medicine, a for-profit company involved in producing research diagnostics. RSF receives commercial research support from PTC Therapeutics, Santhera Pharmaceuticals, and Genzyme Corp., accepted travel stipends as part of grants from PTC Therapeutics, reviewed and prepared a report for Adibi legal proceeding, spends 50% of his professional time carrying out clinical studies, and serves on the medical advisory board of DuchenneConnect and Families of SMA and on the scientific advisory board of PTC Therapeutics. TOC serves on the medical and scientific advisory boards of Families of SMA, the medical board of the Muscular Dystrophy Association, and has served as frequent ad hoc advisor to the Scientific Advisory Board of the SMA Foundation. KJS serves on the scientific advisory boards of Families of SMA, the Pediatric Neurotransmitter Disorders Foundation, California Stem Cell, Inc., and the Alternating Hemiplegia of Childhood Foundation (AHCF). She serves as an ad-hoc reviewer for the Muscular Dystrophy Association (MDA) and National Institutes of Health (NIH). She has accepted research funds for consultation for Biomarin Pharmaceuticals and Shire, Inc. The SMA Foundation has filed a patent application on aspects of this work, International Patent Application No. PCT/US2010/048675, and Ref: SMAF- 005/01WO 304991-2019. A member of RSF's immediate family receives commercial research support from Merck Pharmaceuticals, has received license fee payments from Southern Biotechnology Associates, Upstate Pharmaceuticals, and Santa Cruz Biotechnology, holds 6 patents or pending patents, contributes to other clinical research as a local co-investigator or PI in studies funded by the NIH and the UK, is the editor of Janeway Textbook of Immunology and Arthritis Research and Therapy, and devotes 33% of her professional time to clinical studies in her practice. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.; We are deeply indebted to the generous patients and families in SMA clinics across the United States and Canada who contributed to this effort with their time and blood samples. Use of "Modified Hammersmith Motor Scale (c)" was provided by Families of Spinal Muscular Atrophy. This scale was developed by Kristin J. Krosschell, Jo Anne Maczulski, Thomas O. Crawford, Charles Scott, Kathryn Swoboda and other clinicians of the Project Cure SMA Clinical Trial Network, with funding from Families of SMA. We are grateful to Drs. Kathie Bishop, Christopher Henderson, Katherine Klinger, Bruce Levin, Nanguneri Nirmala, James Rusche, Louise Simard, and James Wang for their discussions on the biomarker development. We also thank Jackie Montes for providing key administrative assistance in coordinating with the PNCRN, and to Sergey Paushkin and Mina Kang of the SMA Foundation for assistance with manuscript preparation.	Barbara Pasanisi M, 2012, EUR J HUM GENET; Bosch-Marce M, 2011, HUM MOL GENET, V20, P1844, DOI 10.1093/hmg/ddr067; Bowerman M, 2012, ANN NEUROL, V72, P256, DOI 10.1002/ana.23582; Bowser R, 2009, MUSCLE NERVE, V40, P753, DOI 10.1002/mus.21488; Bromberg MB, 2002, MUSCLE NERVE, V25, P445, DOI 10.1002/mus.10050; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Chen-Plotkin AS, 2011, ANN NEUROL, V69, P655, DOI 10.1002/ana.22271; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; COOK JD, 1990, MUSCLE NERVE, V13, pS7, DOI 10.1002/mus.880131304; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Crawford TO, 1999, ANN NEUROL, V45, P337, DOI 10.1002/1531-8249(199903)45:3<337::AID-ANA9>3.0.CO;2-U; Demir O, 2011, BBA-MOL BASIS DIS, V1812, P652, DOI 10.1016/j.bbadis.2011.02.012; Dimitriadi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001172; Farooq F, 2011, J CLIN INVEST, V121, P3042, DOI 10.1172/JCI46276; Fernandez-Puente P, 2011, J PROTEOME RES, V10, P5095, DOI 10.1021/pr200695p; Finkel RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035462; Franco SJ, 2011, DEV NEUROBIOL, V71, P889, DOI 10.1002/dneu.20946; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; Heemskerk J, 2012, NEUROPSYCHOPHARMACOL, V37, P287, DOI 10.1038/npp.2011.177; Hensel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031202; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Hubers L, 2011, HUM MOL GENET, V20, P553, DOI 10.1093/hmg/ddq500; Iannaccone ST, 2000, J CHILD NEUROL, V15, P97, DOI 10.1177/088307380001500207; Iannaccone ST, 2009, NEUROMUSCULAR DISORD, V19, P805, DOI 10.1016/j.nmd.2009.09.009; Ilzecka J, 2008, SCAND J CLIN LAB INV, V68, P348, DOI 10.1080/00365510701604628; Kaufmann P, 2011, ARCH NEUROL-CHICAGO, V68, P779, DOI 10.1001/archneurol.2010.373; Kissel JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021296; Kobayashi DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050763; Kobayashi DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024269; Kolarcik C, 2006, MOL DIAGN THER, V10, P281, DOI 10.1007/BF03256203; Krosschell KJ, 2006, NEUROMUSCULAR DISORD, V16, P417, DOI 10.1016/j.nmd.2006.03.015; Lawton KA, 2012, AMYOTROPH LATERAL SC, V13, P110, DOI 10.3109/17482968.2011.619197; Lewelt A, 2010, MUSCLE NERVE, V42, P703, DOI 10.1002/mus.21838; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Locatelli D, 2012, J BIOL CHEM, V287, P25782, DOI 10.1074/jbc.M112.362830; Long JS, 1997, LTD OUTCOME TOBIT MO, P187; Main M, 2003, EUR J PAEDIATR NEURO, V7, P155, DOI 10.1016/S1090-3798(03)00060-6; Makhortova NR, 2011, NAT CHEM BIOL, V7, P544, DOI [10.1038/NCHEMBIO.595, 10.1038/nchembio.595]; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; McDermott MP, 2012, NEUROLOGY; Mercuri E, 2004, NEUROMUSCULAR DISORD, V14, P130, DOI 10.1016/j.nmd.2003.11.006; Miller RG, 2001, J NEUROL SCI, V191, P127, DOI 10.1016/S0022-510X(01)00632-3; Millino C, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-14; Murdocca M, 2012, MOL MED; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; Nardo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025545; Nelson L, 2006, NEUROMUSCULAR DISORD, V16, P374, DOI 10.1016/j.nmd.2006.03.005; Neumiller JJ, 2010, PHARMACOTHERAPY, V30, P463, DOI 10.1592/phco.30.5.463; Nolle A, 2011, HUM MOL GENET, V20, P4865, DOI 10.1093/hmg/ddr425; O'Hagen JM, 2007, NEUROMUSCULAR DISORD, V17, P693, DOI 10.1016/j.nmd.2007.05.009; Ohlendieck K, 2010, EXPERT REV PROTEOMIC, V7, P283, DOI 10.1586/EPR.10.2; Pane M, 2008, NEUROMUSCULAR DISORD, V18, P536, DOI 10.1016/j.nmd.2008.05.004; Paracchini V, 2005, AM J EPIDEMIOL, V162, P101, DOI 10.1093/aje/kwi174; Pegoraro E, 2011, NEUROLOGY, V76, P219, DOI 10.1212/WNL.0b013e318207afeb; Rutkove SB, 2010, MUSCLE NERVE, V42, P915, DOI 10.1002/mus.21784; SAMAHA FJ, 1994, J CHILD NEUROL, V9, P326, DOI 10.1177/088307389400900321; Saris CGJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-405; Schulte T, 2003, J NEURAL TRANSM, V110, P749, DOI 10.1007/s00702-003-0832-x; Shababi M, 2011, HUM GENE THER, V22, P135, DOI 10.1089/hum.2010.114; Shanmugarajan S, 2007, J CHILD NEUROL, V22, P967, DOI 10.1177/0883073807305664; Shanmugarajan S, 2009, J PATHOL, V219, P52, DOI 10.1002/path.2566; Soares H.D., 2012, ARCH NEUROL-CHICAGO, V16, P1; Soares HD, 2009, ANN NY ACAD SCI, V1180, P56, DOI 10.1111/j.1749-6632.2009.05066.x; Sproule DM, 2012, J CHILD NEUROL, V27, P845, DOI 10.1177/0883073811415680; Sproule DM, 2011, J CHILD NEUROL, V26, P309, DOI 10.1177/0883073810380457; Sproule DM, 2010, NEUROMUSCULAR DISORD, V20, P448, DOI 10.1016/j.nmd.2010.05.013; Srivastava T, 2012, NEUROLOGY, V79, P358, DOI 10.1212/WNL.0b013e3182604395; Swoboda KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012140; Swoboda KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005268; Tiziano FD, 2011, INT J MOL SCI, V12, P24, DOI 10.3390/ijms12010024; Tyrberg B, 2011, ISLETS, V3, P327, DOI 10.4161/isl.3.6.17705; Van Meerbeke JP, 2011, DISCOV MED, V12, P291; Wadman R. I., 2012, COCHRANE DB SYST REV, V4; Wadman RI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006282.pub4; Xu GW, 2005, J RHEUMATOL, V32, P410	77	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60113	10.1371/journal.pone.0060113	http://dx.doi.org/10.1371/journal.pone.0060113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565191	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300060
J	Peeters, MW; Van Aken, K; Claessens, AL				Peeters, Maarten W.; Van Aken, Katrijn; Claessens, Albrecht L.			The Left Hand Second to Fourth Digit Ratio (2D:4D) Is Not Related to Any Physical Fitness Component in Adolescent Girls	PLOS ONE			English	Article							SPORTING SUCCESS; FEMALE FENCERS; 2D/4D; STRENGTH; PREDICTS; ELITE; TESTOSTERONE; METAANALYSIS; PERFORMANCE; STUDENTS	Introduction:The second to fourth-digit-ratio (2D:4D), a putative marker of prenatal androgen action and a sexually dimorphic trait, has been suggested to be related with fitness and sports performance, although results are not univocal. Most studies however focus on a single aspect of physical fitness or one sports discipline. Methods: In this study the 2D:4D ratio of 178 adolescent girls (age 13,5-18 y) was measured on X-rays of the left hand. The relation between 2D:4D digit ratio and multiple aspects of physical fitness (balance, speed of limb movement, flexibility, explosive strength, static strength, trunk strength, functional strength, running speed/agility, and endurance) was studied by correlation analyses and stepwise multiple regression. For comparison the relation between these physical fitness components and a selected number of objectively measured anthropometric traits (stature, mass, BMI, somatotype components and the Bayer & Bailey androgyny index) are presented alongside the results of 2D:4D digit ratio. Results: Left hand 2D:4D digit ratio (0.925 +/- 0.019) was not significantly correlated with any of the physical fitness components nor any of the anthropometric variables included in the present study. 2D:4D did not enter the multiple stepwise regression for any of the physical fitness components in which other anthropometric traits explained between 9,2% (flexibility) and 33,9% (static strength) of variance. Conclusion: Unlike other anthropometric traits the 2D:4D digit ratio does not seem to be related to any physical fitness component in adolescent girls and therefore most likely should not be considered in talent detection programs for sporting ability in girls.	[Peeters, Maarten W.; Claessens, Albrecht L.] Katholieke Univ Leuven, Dept Kinesiol, Louvain, Belgium; [Van Aken, Katrijn] Katholieke Univ Leuven, Dept Rehabil Sci, Louvain, Belgium	KU Leuven; KU Leuven	Peeters, MW (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Louvain, Belgium.	Maarten.Peeters@faber.kuleuven.be			Research Foundation-Flanders	Research Foundation-Flanders(FWO)	MWP is supported as a post doctoral fellow by the Research Foundation-Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, EUROFIT HDB EUROFIT; Bayley N, 1946, AM J PHYS ANTHROP-NE, V4, P433, DOI 10.1002/ajpa.1330040406; Bennett M, 2010, J SPORT SCI, V28, P1415, DOI 10.1080/02640414.2010.510143; Bescos R, 2009, J SPORT SCI, V27, P625, DOI 10.1080/02640410802707029; Claessens A. L., 1990, GROWTH FITNESS FLEMI, P21; Claessens AL, 1999, J SPORT MED PHYS FIT, V39, P355; CLAESSENS AL, 2008, PAEDIAT EXERCISE SCI, P23; Fink B, 2006, AM J HUM BIOL, V18, P776, DOI 10.1002/ajhb.20549; Gallup AC, 2007, EVOL HUM BEHAV, V28, P423, DOI 10.1016/j.evolhumbehav.2007.07.001; Giffin NA, 2012, J SPORT SCI, V30, P135, DOI 10.1080/02640414.2011.630744; Halil M, 2013, ARCH GERONTOL GERIAT, V56, P358, DOI 10.1016/j.archger.2012.11.003; Hill R, 2012, J SPORT SCI, V30, P129, DOI 10.1080/02640414.2011.637947; Honekopp J, 2006, HORM BEHAV, V49, P545, DOI 10.1016/j.yhbeh.2005.11.006; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; Landry F, 1978, BIOMECHANICS SPORTS, P403; Longman D, 2011, AM J PHYS ANTHROPOL, V144, P337, DOI 10.1002/ajpa.21407; Malina R.M., 1995, PHYSL ASSESSMENT HUM, P205; Manning JT, 2009, AM J HUM BIOL, V21, P210, DOI 10.1002/ajhb.20855; Manning JT, 2007, AM J HUM BIOL, V19, P416, DOI 10.1002/ajhb.20603; Manning JT., 2002, DIGIT RATIO POINTER; Paul SN, 2006, BRIT J SPORT MED, V40, P981, DOI 10.1136/bjsm.2006.027193; Peeters MW, 2013, J SPORT SCI, V31, P1302, DOI 10.1080/02640414.2013.779741; Peeters MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040270; Pokrywka L, 2005, AM J HUM BIOL, V17, P796, DOI 10.1002/ajhb.20449; SIMONS J, 1990, GROWTH FITNESS FLEMI; Tester N, 2007, J PERS, V75, P663, DOI 10.1111/j.1467-6494.2007.00452.x; van Anders SM, 2007, AM J HUM BIOL, V19, P437, DOI 10.1002/ajhb.20634; Voracek M, 2010, SCAND J MED SCI SPOR, V20, P853, DOI 10.1111/j.1600-0838.2009.01031.x; Zhao DP, 2012, AM J PHYS ANTHROPOL, V149, P266, DOI 10.1002/ajpa.22130	30	12	12	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59766	10.1371/journal.pone.0059766	http://dx.doi.org/10.1371/journal.pone.0059766			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565167	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300036
J	Arooj, M; Sakkiah, S; Cao, GP; Lee, KW				Arooj, Mahreen; Sakkiah, Sugunadevi; Cao, Guang Ping; Lee, Keun Woo			An Innovative Strategy for Dual Inhibitor Design and Its Application in Dual Inhibition of Human Thymidylate Synthase and Dihydrofolate Reductase Enzymes	PLOS ONE			English	Article							DRUG DISCOVERY; DOCKING; TARGET	Due to the diligence of inherent redundancy and robustness in many biological networks and pathways, multitarget inhibitors present a new prospect in the pharmaceutical industry for treatment of complex diseases. Nevertheless, to design multitarget inhibitors is concurrently a great challenge for medicinal chemists. We have developed a novel computational approach by integrating the affinity predictions from structure-based virtual screening with dual ligand-based pharmacophore to discover potential dual inhibitors of human Thymidylate synthase (hTS) and human dihydrofolate reductase (hDHFR). These are the key enzymes in folate metabolic pathway that is necessary for the biosynthesis of RNA, DNA, and protein. Their inhibition has found clinical utility as antitumor, antimicrobial, and antiprotozoal agents. A druglike database was utilized to perform dual-target docking studies. Hits identified through docking experiments were mapped over a dual pharmacophore which was developed from experimentally known dual inhibitors of hTS and hDHFR. Pharmacophore mapping procedure helped us in eliminating the compounds which do not possess basic chemical features necessary for dual inhibition. Finally, three structurally diverse hit compounds that showed key interactions at both active sites, mapped well upon the dual pharmacophore, and exhibited lowest binding energies were regarded as possible dual inhibitors of hTS and hDHFR. Furthermore, optimization studies were performed for final dual hit compound and eight optimized dual hits demonstrating excellent binding features at target systems were also regarded as possible dual inhibitors of hTS and hDHFR. In general, the strategy used in the current study could be a promising computational approach and may be generally applicable to other dual target drug designs.	[Arooj, Mahreen; Sakkiah, Sugunadevi; Cao, Guang Ping; Lee, Keun Woo] GNU, SSAC, RINS, Div Appl Life Sci,Program BK21,PMBBRC, Jinju, South Korea		Lee, KW (corresponding author), GNU, SSAC, RINS, Div Appl Life Sci,Program BK21,PMBBRC, Jinju, South Korea.	kwlee@gnu.ac.kr	Arooj, Mahreen/AAC-7565-2020	Arooj, Mahreen/0000-0003-1975-5289; Sakkiah, Suguna Devi/0000-0002-8337-9348	Basic Science Research Program [2012R1A1A4A01013657]; Pioneer Research Center Program [2009-0081539]; Management of Climate Change Program through the National Research Foundation of Korea (NRF) [2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ008038]	Basic Science Research Program; Pioneer Research Center Program; Management of Climate Change Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea	This research was supported by Basic Science Research Program (2012R1A1A4A01013657), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. This work was also supported by the Next-Generation BioGreen 21 Program (PJ008038) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arooj M, 2011, INT J MOL SCI, V12, P9236, DOI 10.3390/ijms12129236; Bennett BC, 2009, J STRUCT BIOL, V166, P162, DOI 10.1016/j.jsb.2009.01.001; BERMAN EM, 1991, J MED CHEM, V34, P479, DOI 10.1021/jm00106a001; Blakley R.L., 1984, FOLATES PTERINS, V1, P191; Boda K, 2007, J COMPUT AID MOL DES, V21, P311, DOI 10.1007/s10822-006-9099-2; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Brown D, 2003, DRUG DISCOV TODAY, V8, P1067, DOI 10.1016/S1359-6446(03)02902-7; Chan DCM, 2006, CURR MED CHEM, V13, P377, DOI 10.2174/092986706775527938; Cody V, 2005, ACTA CRYSTALLOGR D, V61, P147, DOI 10.1107/S0907444904030422; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Frei E., 1997, HOLLAND FREI CANC ME, V1, P907; Gangjee A, 1996, CURR PHARM DESIGN, V2, P263; Gangjee A, 2007, CURR PHARM DESIGN, V13, P609, DOI 10.2174/138161207780162827; Gangjee A, 2006, J MED CHEM, V49, P1055, DOI 10.1021/jm058276a; Gangjee A, 2008, J MED CHEM, V51, P5789, DOI 10.1021/jm8006933; Gangjee A, 2008, J MED CHEM, V51, P68, DOI 10.1021/jm701052u; Gangjee A, 2010, BIOORGAN MED CHEM, V18, P953, DOI 10.1016/j.bmc.2009.11.029; Gangjee A, 2009, J MED CHEM, V52, P4892, DOI 10.1021/jm900490a; Gmeiner WH, 2005, CURR MED CHEM, V12, P191, DOI 10.2174/0929867053363432; GREER J, 1994, J MED CHEM, V37, P1035, DOI 10.1021/jm00034a001; Hawser S, 2006, BIOCHEM PHARMACOL, V71, P941, DOI 10.1016/j.bcp.2005.10.052; Huang S, 2002, DRUG DISCOV TODAY, V7, pS163, DOI 10.1016/S1359-6446(02)02463-7; Huang SY, 2007, PROTEIN SCI, V16, P43, DOI 10.1110/ps.062501507; JACKMAN AL, 1991, CANCER RES, V51, P5579; Kim SG, 2000, BIOORGAN MED CHEM, V8, P11, DOI 10.1016/S0968-0896(99)00246-1; Kisliuk RL, 1990, FOLIC ACID MATABOLIS, P79; Kisliuk RL, 1985, P 2 WORKSH FOL ANT P, P319; Korcsmaros T, 2007, EXPERT OPIN DRUG DIS, V2, P799, DOI 10.1517/17460441.2.6.799; Ma XH, 2010, PHARM RES-DORDR, V27, P739, DOI 10.1007/s11095-010-0065-2; Morphy R, 2004, DRUG DISCOV TODAY, V9, P641, DOI 10.1016/S1359-6446(04)03163-0; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Peters GJ, 1999, CANC DRUG DISC DEV, P101; Phan J, 2001, BIOCHEMISTRY-US, V40, P1897, DOI 10.1021/bi002413i; Rosowsky A, 1989, Prog Med Chem, V26, P1, DOI 10.1016/S0079-6468(08)70241-8; Smith BJ, 2002, J MED CHEM, V45, P2207, DOI 10.1021/jm010528u; Szuromi P, 2004, SCIENCE, V303, P1795, DOI 10.1126/science.303.5665.1795; Tiwari R, 2009, J CHEM INF MODEL, V49, P1581, DOI 10.1021/ci900031y; Toba S, 2006, J CHEM INF MODEL, V46, P728, DOI 10.1021/ci050410c; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wei DG, 2008, J MED CHEM, V51, P7882, DOI 10.1021/jm8010096; Zaliani A, 2009, J COMPUT AID MOL DES, V23, P593, DOI 10.1007/s10822-009-9291-2; Zhang X, 2011, BIOORGAN MED CHEM, V19, P3585, DOI 10.1016/j.bmc.2011.03.067; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	43	32	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60470	10.1371/journal.pone.0060470	http://dx.doi.org/10.1371/journal.pone.0060470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577115	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800054
J	Grinsztejn, B; Luz, PM; Pacheco, AG; Santos, DVG; Velasque, L; Moreira, RI; Guimaraes, MRC; Nunes, EOP; Lemos, AS; Ribeiro, SR; Campos, DP; Vitoria, MAA; Veloso, VG				Grinsztejn, Beatriz; Luz, Paula M.; Pacheco, Antonio G.; Santos, Desiree V. G.; Velasque, Luciane; Moreira, Ronaldo I.; Guimaraes, Maria Regina C.; Nunes, Esteva O. P.; Lemos, Alberto S.; Ribeiro, Sayonara R.; Campos, Dayse P.; Vitoria, Marco A. A.; Veloso, Valdilea G.			Changing Mortality Profile among HIV-Infected Patients in Rio de Janeiro, Brazil: Shifting from AIDS to Non-AIDS Related Conditions in the HAART Era	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; CLINICAL CARE; IMMUNE STATUS; DEATH; RISK; PEOPLE; CANCER	Introduction: We describe temporal trends in the mortality rates and factors associated with AIDS and non-AIDS related mortality at the Evandro Chagas Clinical Research Institute (IPEC), Oswaldo Cruz Foundation (FIOCRUZ). Methods: Adult patients enrolling from 1986 through 2009 with a minimum follow up of 60 days were included. Vital status was exhaustively checked using patients' medical charts, through active contact with individuals and family members and by linkage with the Rio de Janeiro Mortality database using a previously validated algorithm. The CoDe protocol was used to establish the cause of death. Extended Cox proportional hazards models were used for multivariate modeling. Results: A total of 3530 individuals met the inclusion criteria, out of which 868 (24.6%) deceased; median follow up per patient was 3.9 years (interquartile range 1.7-9.2 years). The dramatic decrease in the overall mortality rates was driven by AIDS-related causes that decreased from 9.19 deaths/100PYs n 1986-1991 to 1.35/100PYs in 2007-2009. Non-AIDS related mortality rates remained stable overtime, at around 1 death/100PYs. Immunodeficiency significantly increased the hazard of both AIDS-related and non-AIDS-related causes of death, while HAART use was strongly associated with a lower hazard of death from either cause. Conclusions: Our results confirm the remarkable decrease in AIDS-related mortality as the HIV epidemic evolved and alerts to the conditions not traditionally related to HIV/AIDS which are now becoming more frequent, needing careful monitoring.	[Grinsztejn, Beatriz; Luz, Paula M.; Santos, Desiree V. G.; Velasque, Luciane; Moreira, Ronaldo I.; Guimaraes, Maria Regina C.; Nunes, Esteva O. P.; Lemos, Alberto S.; Ribeiro, Sayonara R.; Campos, Dayse P.; Veloso, Valdilea G.] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Pacheco, Antonio G.] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil; [Velasque, Luciane] Univ Fed Estado Rio de Janeiro, Dept Matemat & Estat, Rio De Janeiro, Brazil; [Vitoria, Marco A. A.] WHO, HIV Dept, CH-1211 Geneva, Switzerland	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro; World Health Organization	Grinsztejn, B (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.	gbeatriz@ipec.fiocruz.br	Pacheco, Antonio Guilherme/E-6378-2013; de Lemos, Alberto dos Santos/M-4246-2013	Pacheco, Antonio Guilherme/0000-0003-3095-1774; de Lemos, Alberto dos Santos/0000-0003-0138-6577; Luz, Paula/0000-0001-9746-719X	National Council of Technological and Scientific Development (CNPq); Research Funding Agency of the State of Rio de Janeiro (FAPERJ)	National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Funding Agency of the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	B.G. acknowledges funding from the National Council of Technological and Scientific Development (CNPq) and the Research Funding Agency of the State of Rio de Janeiro (FAPERJ). A.G.P. acknowledges funding from the National Council of Technological and Scientific Development (CNPq) and the Research Funding Agency of the State of Rio de Janeiro (FAPERJ). P.M.L. acknowledges funding from the National Council of Technological and Scientific Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Diamond C, 2006, LEUKEMIA LYMPHOMA, V47, P1822, DOI 10.1080/10428190600658688; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Funk MJ, 2011, ARCH INTERN MED, V171, P1560, DOI 10.1001/archinternmed.2011.401; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Grinsztejn B, 2009, AIDS, V23, P2107, DOI 10.1097/QAD.0b013e32832ec494; Grinszten B, 2007, JAIDS-J ACQ IMM DEF, V45, P515, DOI 10.1097/QAI.0b013e3180decb6a; Japiassu AM, 2010, CRIT CARE, V14, DOI 10.1186/cc9221; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kowalska JD, 2012, AIDS, V26, P315, DOI 10.1097/QAD.0b013e32834e8805; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Lang S, 2012, CLIN INFECT DIS, V55, P600, DOI 10.1093/cid/cis489; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Moreira RI, 2011, JAIDS-J ACQ IMM DEF, V57, pS171, DOI 10.1097/QAI.0b013e31821e9d59; Pacheco AG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001531; Pacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5; Pacheco AG, 2008, AM J EPIDEMIOL, V168, P1326, DOI 10.1093/aje/kwn249; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Schramm Joyce Mendes de Andrade, 2004, Ciênc. saúde coletiva, V9, P897, DOI 10.1590/S1413-81232004000400011; Simard EP, 2010, CLIN INFECT DIS, V51, P957, DOI 10.1086/656416; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Triant VA, 2010, J ACQUIRED IMMUNODEF; Weller I, 2009, AIDS, V23, P2029, DOI 10.1097/QAD.0b013e32832e531c; WHO, 2012, WHO POL COLL TB HIV; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918	32	96	99	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59768	10.1371/journal.pone.0059768	http://dx.doi.org/10.1371/journal.pone.0059768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577074	Green Published, gold			2022-12-27	WOS:000319109800018
J	Morroy, G; Wielders, CCH; Kruisbergen, MJB; van der Hoek, W; Marcelis, JH; Wegdam-Blans, MCA; Wijkmans, CJ; Schneeberger, PM				Morroy, Gabriella; Wielders, Cornelia C. H.; Kruisbergen, Mandy J. B.; van der Hoek, Wim; Marcelis, Jan H.; Wegdam-Blans, Marjolijn C. A.; Wijkmans, Clementine J.; Schneeberger, Peter M.			Large Regional Differences in Serological Follow-Up of Q Fever Patients in The Netherlands	PLOS ONE			English	Article							ENDOCARDITIS; IMPLEMENTATION; GUIDELINES	Background: During the Dutch Q fever epidemic more than 4,000 Q fever cases were notified. This provided logistical challenges for the organisation of serological follow-up, which is considered mandatory for early detection of chronic infection. The aim of this study was to investigate the proportion of acute Q fever patients that received serological follow-up, and to identify regional differences in follow-up rates and contributing factors, such as knowledge of medical practitioners. Methods: Serological datasets of Q fever patients diagnosed between 2007 and 2009 (N = 3,198) were obtained from three Laboratories of Medical Microbiology (LMM) in the province of Noord-Brabant. One LMM offered an active follow-up service by approaching patients; the other two only tested on physician's request. The medical microbiologist in charge of each LMM was interviewed. In December 2011, 240 general practices and 112 medical specialists received questionnaires on their knowledge and practices regarding the serological follow-up of Q fever patients. Results: Ninety-five percent (2,226/2,346) of the Q fever patients diagnosed at the LMM with a follow-up service received at least one serological follow-up within 15 months of diagnosis. For those diagnosed at a LMM without this service, this was 25% (218/852) (OR 54, 95% CI 43-67). Although 80% (162/203) of all medical practitioners with Q fever patients reported informing patients of the importance of serological follow-up, 33% (67/203) never requested it. Conclusions: Regional differences in follow-up are substantial and range from 25% to 95%. In areas with a low follow-up rate the proportion of missed chronic Q fever is potentially higher than in areas with a high follow-up rate. Medical practitioners lack knowledge regarding the need, timing and implementation of serological follow-up, which contributes to patients receiving incorrect or no follow-up. Therefore, this information should be incorporated in national guidelines and patient information forms.	[Morroy, Gabriella; Kruisbergen, Mandy J. B.; Wijkmans, Clementine J.] Municipal Hlth Serv Hart Brabant, Dept Infect Dis Control, Shertogenbosch, Netherlands; [Morroy, Gabriella; Wijkmans, Clementine J.] Radboud Univ Nijmegen, Dept Primary & Community Care, Collaborat Ctr AMPHI, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Wielders, Cornelia C. H.; Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Wielders, Cornelia C. H.; van der Hoek, Wim] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Marcelis, Jan H.] St Elizabeth Hosp, Lab Med Microbiol, Tilburg, Netherlands; [Wegdam-Blans, Marjolijn C. A.] Dept Med Microbiol, Lab Pathol & Med Microbiol PAMM, Veldhoven, Netherlands	Radboud University Nijmegen; Jeroen Bosch Ziekenhuis; Netherlands National Institute for Public Health & the Environment; Elisabeth-TweeSteden Ziekenhuis (ETZ)	Morroy, G (corresponding author), Municipal Hlth Serv Hart Brabant, Dept Infect Dis Control, Shertogenbosch, Netherlands.	g.morroy@ggdhvb.nl	Wielders, Cornelia CH/I-1970-2019	Wielders, Cornelia CH/0000-0002-2413-9088				Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Crump JA, 2004, J CLIN MICROBIOL, V42, P881, DOI 10.1128/JCM.42.2.881-883.2004; ECDC, 2010, TECHN REP RISK ASS Q, DOI [10.2900/28860, DOI 10.2900/28860]; Fenollar F, 2001, CLIN INFECT DIS, V33, P312, DOI 10.1086/321889; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Hackert VH, 2012, CLIN INFECT DIS, V55, P1591, DOI 10.1093/cid/cis734; Hall Amanda, 2004, Health Info Libr J, V21, P102, DOI 10.1111/j.1471-1842.2004.00506.x; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Landais C, 2007, CLIN INFECT DIS, V44, P1337, DOI 10.1086/515401; Marrie T. J., 1990, Q fever. Volume 1. The disease., P49; Nabuurs-Franssen M.H., 2008, NED TIJDSCHR MED MIC, V16, P20; Raoult D, 1999, ARCH INTERN MED, V159, P167, DOI 10.1001/archinte.159.2.167; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Schimmer B, 2009, EUROSURVEILLANCE, V14, P14; van der Hoek W, 2012, EURO SURVEILL, V17; van der Hoek W, 2011, CLIN INFECT DIS, V52, P1431, DOI 10.1093/cid/cir234; Wagner-Wiening C, 2006, INT J MED MICROBIOL, V296, P294, DOI 10.1016/j.ijmm.2006.01.045; Wegdam-Blans MCA, 2010, NED TIJDSCHR GENEES, V15, pA2388	19	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60707	10.1371/journal.pone.0060707	http://dx.doi.org/10.1371/journal.pone.0060707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577152	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800094
J	Pueyo, N; Ortega, FJ; Mercader, JM; Moreno-Navarrete, JM; Sabater, M; Bonas, S; Botas, P; Delgado, E; Ricart, W; Martinez-Larrad, MT; Serrano-Rios, M; Torrents, D; Fernandez-Real, JM				Pueyo, Neus; Ortega, Francisco J.; Mercader, Josep M.; Moreno-Navarrete, Jose M.; Sabater, Monica; Bonas, Silvia; Botas, Patricia; Delgado, Elias; Ricart, Wifredo; Martinez-Larrad, Maria T.; Serrano-Rios, Manuel; Torrents, David; Fernandez-Real, Jose M.			Common Genetic Variants of Surfactant Protein-D (SP-D) Are Associated with Type 2 Diabetes	PLOS ONE			English	Article							INNATE IMMUNITY; LUNG-FUNCTION; INSULIN-RESISTANCE; VIRUS-INFECTION; HOST-DEFENSE; GLUCOSE; RISK; POPULATION; DISEASE; POLYMORPHISMS	Context: Surfactant protein-D (SP-D) is a primordial component of the innate immune system intrinsically linked to metabolic pathways. We aimed to study the association of single nucleotide polymorphisms (SNPs) affecting SP-D with insulin resistance and type 2 diabetes (T2D). Research Design and Methods: We evaluated a common genetic variant located in the SP-D coding region (rs721917, Met(31) Thr) in a sample of T2D patients and non-diabetic controls (n = 2,711). In a subset of subjects (n = 1,062), this SNP was analyzed in association with circulating SP-D concentrations, insulin resistance, and T2D. This SNP and others were also screened in the publicly available Genome Wide Association (GWA) database of the Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC). Results: We found the significant association of rs721917 with circulating SP-D, parameters of insulin resistance and T2D. Indeed, G carriers showed decreased circulating SP-D (p = 0.004), decreased fasting glucose (p = 0.0002), glycated hemoglobin (p = 0.0005), and 33% (p = 0.002) lower prevalence of T2D, estimated under a dominant model, especially among women. Interestingly, these differences remained significant after controlling for origin, age, gender, and circulating SP-D. Moreover, this SNP and others within the SP-D genomic region (i.e. rs10887344) were significantly associated with quantitative measures of glucose homeostasis, insulin sensitivity, and T2D, according to GWAS datasets from MAGIC. Conclusions: SP-D gene polymorphisms are associated with insulin resistance and T2D. These associations are independent of circulating SP-D concentrations.	[Pueyo, Neus; Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Sabater, Monica; Ricart, Wifredo; Fernandez-Real, Jose M.] CIBER Fisiopatol Obesidad & Nutr CIBERobn, CB06 03 0010, Serv Diabet Endocrinol & Nutr UDEN, Inst Invest Biomed Girona IdIBGi, Girona, Spain; [Pueyo, Neus; Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Sabater, Monica; Ricart, Wifredo; Fernandez-Real, Jose M.] Inst Salud Carlos III ISCIII, Girona, Spain; [Mercader, Josep M.; Bonas, Silvia; Torrents, David] Barcelona Supercomp Ctr, Joint IRB BSC Program Computat Biol, Barcelona, Spain; [Torrents, David] ICREA, Barcelona, Spain; [Botas, Patricia; Delgado, Elias] Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Spain; [Martinez-Larrad, Maria T.; Serrano-Rios, Manuel] Hosp Clin San Carlos, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Dept Internal Med 2, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); ICREA; Central University Hospital Asturias; University of Oviedo; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Clinico San Carlos	Fernandez-Real, JM (corresponding author), CIBER Fisiopatol Obesidad & Nutr CIBERobn, CB06 03 0010, Serv Diabet Endocrinol & Nutr UDEN, Inst Invest Biomed Girona IdIBGi, Girona, Spain.	jmfreal@idibgi.org	Fernández-Real, Jose Manuel/AGH-3599-2022; Moreno-Navarrete, José María/ABG-5548-2021; Serrano Ríos, Manuel/E-4625-2019; Sabater-Masdeu, Mònica/G-1168-2016; Delgado, Elias/B-2634-2013; Moreno-Navarrete, José María/H-9772-2015; Ortega, Francisco José J/F-3883-2016; Torrents, David/G-5785-2015	Fernández-Real, Jose Manuel/0000-0002-7442-9323; Moreno-Navarrete, José María/0000-0002-2883-511X; Serrano Ríos, Manuel/0000-0002-3214-1444; Sabater-Masdeu, Mònica/0000-0001-9636-0921; Delgado, Elias/0000-0001-6114-9712; Moreno-Navarrete, José María/0000-0002-2883-511X; Ortega, Francisco José J/0000-0003-2111-769X; Ricart, Wifredo/0000-0002-3452-9098; Mercader, Josep M/0000-0001-8494-3660; Torrents, David/0000-0002-6086-9037	Spanish Ministry of Science and Innovation [FIS 2011-0214]; CIBER de la Fisiopatologia de la Obesidad y la Nutricion (CIBERobn); Spanish Ministry of Science and Education [SAF 2005-02073]; Sara Borrell fellowship from the Instituto de Salud Carlos III; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBER de la Fisiopatologia de la Obesidad y la Nutricion (CIBERobn); Spanish Ministry of Science and Education(Spanish Government); Sara Borrell fellowship from the Instituto de Salud Carlos III(Instituto de Salud Carlos III); ICREA(ICREA)	This work was supported by research grants from the Spanish Ministry of Science and Innovation (FIS 2011-0214), CIBER de la Fisiopatologia de la Obesidad y la Nutricion (CIBERobn), and by research grants from the Spanish Ministry of Science and Education (SAF 2005-02073). Dr. Josep M. Mercader was supported by Sara Borrell fellowship from the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We greatly appreciate the technical assistance of Gerard Pardo, Ester Guerra, Adriana Perich, and Oscar Rovira. Dr. Josep M Mercader was supported by Sara Borrell fellowship from the Instituto de Salud Carlos III. Data on glycaemic traits have been contributed by MAGIC investigators and have been downloaded from www.magicinvestigators.org. Disclaimers: The authors have nothing to disclose. All authors of this manuscript have directly participated in the execution, and analysis of the study. All authors are aware of and agree to the content of the manuscript, and all authors have approved the final version submitted and their being listed as an author on the manuscript. The contents of this manuscript have not been copyrighted or published previously. There are no directly related manuscripts or abstracts, published or unpublished, by one or more authors of this manuscript. The contents of this manuscript are not now under consideration for publication elsewhere. The submitted manuscript nor any similar manuscript, in whole or in part, will be neither copyrighted, submitted, or published elsewhere while the Journal is under consideration.	Arora P, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-95; BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Crouch E C, 2000, Respir Res, V1, P93; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Engstrom G, 2003, J INTERN MED, V253, P574, DOI 10.1046/j.1365-2796.2003.01138.x; Engstrom G, 2002, DIABETIC MED, V19, P167, DOI 10.1046/j.1464-5491.2002.00652.x; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fernandez-Real JM, 2012, DIABETOLOGIA, V55, P273, DOI 10.1007/s00125-011-2387-y; Fernandez-Real JM, 2008, TRENDS ENDOCRIN MET, V19, P10, DOI 10.1016/j.tem.2007.10.004; Floros J, 2000, J INFECT DIS, V182, P1473, DOI 10.1086/315866; Ford ES, 2004, DIABETES CARE, V27, P2966, DOI 10.2337/diacare.27.12.2966; Foreman MG, 2011, AM J RESP CELL MOL, V44, P316, DOI 10.1165/rcmb.2009-0360OC; Gubern C, 2006, DIABETES, V55, P216, DOI 10.2337/diabetes.55.1.216; Haagsman HP, 2008, NEONATOLOGY, V93, P288, DOI 10.1159/000121454; Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Lahti M, 2002, PEDIATR RES, V51, P696, DOI [10.1203/00006450-200206000-00006, 10.1023/01.PDR.0000015911.65104.93]; Leth-Larsen R, 2005, J IMMUNOL, V174, P1532, DOI 10.4049/jimmunol.174.3.1532; Lopez-Bermejo A, 2007, ARTERIOSCL THROM VAS, V27, P1166, DOI 10.1161/ATVBAHA.106.138594; Mansego ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031853; Lund MB, 1996, ANN ONCOL, V7, P257; Fernandez-Real JM, 2010, EUR J CLIN INVEST, V40, P600, DOI 10.1111/j.1365-2362.2010.02306.x; Fernandez-Real JM, 2010, DIABETES CARE, V33, P847, DOI 10.2337/dc09-0542; Moreno-Navarrete JM, 2008, CLIN CHEM, V54, P301, DOI 10.1373/clinchem.2007.095943; Moreno-Navarrete JM, 2011, DIABETES CARE, V34, pS335, DOI 10.2337/dc11-s238; Moreno-Navarrete JM, 2010, DIABETES, V59, P200, DOI 10.2337/db09-0700; Muller YL, 2010, DIABETES, V59, P2080, DOI 10.2337/db09-1593; Noreen M, 2012, INFLAMM RES, V61, P177, DOI 10.1007/s00011-011-0427-1; Prescott E, 1997, EUR RESPIR J, V10, P822; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Provost PR, 2009, J ENDOCRINOL, V200, P321, DOI 10.1677/JOE-08-0238; Reading PC, 1998, J VIROL, V72, P6884, DOI 10.1128/JVI.72.8.6884-6887.1998; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Sorensen GL, 2006, AM J PHYSIOL-LUNG C, V290, pL1010, DOI 10.1152/ajplung.00487.2005; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Trotter A, 2009, EARLY HUM DEV, V85, P353, DOI 10.1016/j.earlhumdev.2008.12.013; Valdes S, 2007, DIABETES CARE, V30, P2258, DOI 10.2337/dc06-2461; Wright JR, 2004, BIOL NEONATE, V85, P326, DOI 10.1159/000078172; Yeh HC, 2005, DIABETES CARE, V28, P1472, DOI 10.2337/diacare.28.6.1472; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	43	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60468	10.1371/journal.pone.0060468	http://dx.doi.org/10.1371/journal.pone.0060468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577114	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800053
J	Desmoulin, F; Galinier, M; Trouillet, C; Berry, M; Delmas, C; Turkieh, A; Massabuau, P; Taegtmeyer, H; Smih, F; Rouet, P				Desmoulin, Franck; Galinier, Michel; Trouillet, Charlotte; Berry, Matthieu; Delmas, Clement; Turkieh, Annie; Massabuau, Pierre; Taegtmeyer, Heinrich; Smih, Fatima; Rouet, Philippe			Metabonomics Analysis of Plasma Reveals the Lactate to Cholesterol Ratio as an Independent Prognostic Factor of Short-Term Mortality in Acute Heart Failure	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; IN-HOSPITAL MORTALITY; CARDIAC TRANSCRIPTOME; BACH BIOMARKERS; DIAGNOSIS; SEVERITY; PROGRAM; SYSTEM; SERUM; HYPOCHOLESTEROLEMIA	Objective: Mortality in heart failure (AHF) remains high, especially during the first days of hospitalization. New prognostic biomarkers may help to optimize treatment. The aim of the study was to determine metabolites that have a high prognostic value. Methods: We conducted a prospective study on a training cohort of AHF patients (n = 126) admitted in the cardiac intensive care unit and assessed survival at 30 days. Venous plasmas collected at admission were used for H-1 NMR-based metabonomics analysis. Differences between plasma metabolite profiles allow determination of discriminating metabolites. A cohort of AHF patients was subsequently constituted (n = 74) to validate the findings. Results: Lactate and cholesterol were the major discriminating metabolites predicting 30-day mortality. Mortality was increased in patients with high lactate and low total cholesterol concentrations at admission. Accuracies of lactate, cholesterol concentration and lactate to cholesterol (Lact/Chol) ratio to predict 30-day mortality were evaluated using ROC analysis. The Lact/Chol ratio provided the best accuracy with an AUC of 0.82 (P < 0.0001). The acute physiology and chronic health evaluation (APACHE) II scoring system provided an AUC of 0.76 for predicting 30-day mortality. APACHE II score, Cardiogenic shock (CS) state and Lact/Chol ratio >= 0.4 (cutoff value with 82% sensitivity and 64% specificity) were significant independent predictors of 30-day mortality with hazard ratios (HR) of 1.11, 4.77 and 3.59, respectively. In CS patients, the HR of 30-day mortality risk for plasma Lact/Chol ratio >= 0.4 was 3.26 compared to a Lact/Chol ratio of < 0.4 (P = 0.018). The predictive power of the Lact/Chol ratio for 30-day mortality outcome was confirmed with the independent validation cohort. Conclusion: This study identifies the plasma Lact/Chol ratio as a useful objective and simple parameter to evaluate short term prognostic and could be integrated into quantitative guidance for decision making in heart failure care.	[Desmoulin, Franck; Galinier, Michel; Trouillet, Charlotte; Berry, Matthieu; Delmas, Clement; Turkieh, Annie; Massabuau, Pierre; Smih, Fatima; Rouet, Philippe] Univ UPS, INSERM, I2MC, UMR 1048,Equipe Obesite & Insuffisance Cardiaque, Toulouse, France; [Galinier, Michel; Trouillet, Charlotte; Berry, Matthieu; Delmas, Clement; Massabuau, Pierre; Rouet, Philippe] CHU Rangueil, Serv Cardiol A, F-31054 Toulouse, France; [Taegtmeyer, Heinrich] Univ Texas Houston, Sch Med, Dept Internal Med, Div Cardiol, Houston, TX USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; University of Texas System; University of Texas Health Science Center Houston	Rouet, P (corresponding author), Univ UPS, INSERM, I2MC, UMR 1048,Equipe Obesite & Insuffisance Cardiaque, Toulouse, France.	Philippe.rouet@inserm.fr	desmoulin, franck/AAU-4544-2020; DESMOULIN, Franck/O-1895-2018	desmoulin, franck/0000-0003-0560-6266; DESMOULIN, Franck/0000-0003-0560-6266; GALINIER, Michel/0000-0003-1735-3390; Delmas, Clement/0000-0001-9180-9128; Rouet, Philippe/0000-0001-6204-2079; TURKIEH, Annie/0000-0001-6968-4517	Federation Francaise de Cardiologie/Societe Francaise de Cardiologie grant; US Public Health Service [5R01HL061483]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061483, R01HL073162] Funding Source: NIH RePORTER	Federation Francaise de Cardiologie/Societe Francaise de Cardiologie grant; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Federation Francaise de Cardiologie/Societe Francaise de Cardiologie grant. Dr Taegtmeyer receives support from the US Public Health Service (5R01HL061483). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Adams Kirkwood F Jr, 2008, Congest Heart Fail, V14, P127; Booth FV, 2005, CRIT CARE, V9, pR522, DOI 10.1186/cc3790; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Canver CC, 2001, J CARDIOVASC SURG, V42, P705; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di Somma S, 2010, CRIT CARE, V14, DOI 10.1186/cc9067; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Faggiano P, 2010, INT J CARDIOL, V140, P88, DOI 10.1016/j.ijcard.2008.11.020; Fellahi JL, 2009, ANESTHESIOLOGY, V111, P250, DOI 10.1097/ALN.0b013e3181a1f720; FRANZBLAU A, 1984, J CHRON DIS, V37, P387, DOI 10.1016/0021-9681(84)90105-X; Ham C, 2003, BRIT MED J, V327, P1257, DOI 10.1136/bmj.327.7426.1257; HENNING RJ, 1982, CIRC SHOCK, V9, P307; Horwich TB, 2008, AM HEART J, V156, P1170, DOI 10.1016/j.ahj.2008.07.004; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krishna U, 2009, INDIAN J CRIT CARE M, V13, P66, DOI 10.4103/0972-5229.56051; Krumholz HM, 2000, AM HEART J, V139, P72, DOI 10.1016/S0002-8703(00)90311-9; Lewis GD, 2008, J AM COLL CARDIOL, V52, P117, DOI 10.1016/j.jacc.2008.03.043; Maisel A, 2011, CIRC-HEART FAIL, V4, P613, DOI 10.1161/CIRCHEARTFAILURE.110.960096; Maisel A, 2011, J AM COLL CARDIOL, V58, P1057, DOI 10.1016/j.jacc.2011.06.006; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Makinen VP, 2006, MAGN RESON MATER PHY, V19, P281, DOI 10.1007/s10334-006-0054-y; Noveanu M, 2011, CRIT CARE, V15, DOI 10.1186/cc9398; OSTER P, 1981, KLIN WOCHENSCHR, V59, P857, DOI 10.1007/BF01721056; Park S, 2009, CRIT CARE, V13, DOI 10.1186/cc7878; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Peacock WF, 2009, ANN EMERGENCY MED, V54; Peterson PN, 2010, CIRC-CARDIOVASC QUAL, V3, P25, DOI 10.1161/CIRCOUTCOMES.109.854877; Philip-Couderc P, 2004, FASEB J, V18, P1539, DOI 10.1096/fj.03-1242fje; Philip-Couderc P, 2004, PHYSIOL GENOMICS, V19, P32, DOI 10.1152/physiolgenomics.00001.2004; Philip-Couderc P, 2003, HYPERTENSION, V41, P414, DOI 10.1161/01.HYP.0000057573.32425.95; Richartz BM, 1998, CARDIOLOGY, V89, P184, DOI 10.1159/000006785; Roncalli J, 2007, J MOL CELL CARDIOL, V42, P526, DOI 10.1016/j.yjmcc.2006.11.007; Sassolas A, 1999, ANN BIOL CLIN-PARIS, V57, P555; Smith WR, 2002, CHEST, V121, P1610, DOI 10.1378/chest.121.5.1610; Trocme C, 2009, ANN RHEUM DIS, V68, P1328, DOI 10.1136/ard.2008.093153; Tyagi RK, 1996, MAGN RESON MED, V35, P194, DOI 10.1002/mrm.1910350210; van Kimmenade RRJ, 2006, AM J CARDIOL, V98, P386, DOI 10.1016/j.amjcard.2006.02.043; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Waldo SW, 2008, J AM COLL CARDIOL, V51, P1874, DOI 10.1016/j.jacc.2007.12.051	42	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60737	10.1371/journal.pone.0060737	http://dx.doi.org/10.1371/journal.pone.0060737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573279	gold, Green Submitted, Green Published			2022-12-27	WOS:000318840100099
J	Nemes, K; Sebestyen, A; Mark, A; Hajdu, M; Kenessey, I; Sticz, T; Nagy, E; Barna, G; Varadi, Z; Kovacs, G; Kopper, L; Csoka, M				Nemes, Karolina; Sebestyen, Anna; Mark, Agnes; Hajdu, Melinda; Kenessey, Istvan; Sticz, Tamas; Nagy, Eszter; Barna, Gabor; Varadi, Zsofia; Kovacs, Gabor; Kopper, Laszlo; Csoka, Monika			Mammalian Target of Rapamycin (mTOR) Activity Dependent Phospho-Protein Expression in Childhood Acute Lymphoblastic Leukemia (ALL)	PLOS ONE			English	Article							RAD001 EVEROLIMUS; CELLS; INHIBITION; THERAPY; DRUG; RESISTANCE; APOPTOSIS; PATHWAY; PHOSPHORYLATION; PI3K	Modern treatment strategies have improved the prognosis of childhood ALL; however, treatment still fails in 25-30% of patients. Further improvement of treatment may depend on the development of targeted therapies. mTOR kinase, a central mediator of several signaling pathways, has recently attracted remarkable attention as a potential target in pediatric ALL. However, limited data exists about the activity of mTOR. In the present study, the amount of mTOR activity dependent phospho-proteins was characterized by ELISA in human leukemia cell lines and in lymphoblasts from childhood ALL patients (n = 49). Expression was measured before and during chemotherapy and at relapses. Leukemia cell lines exhibited increased mTOR activity, indicated by phospho-S6 ribosomal protein (p-S6) and phosphorylated eukaryotic initiation factor 4E binding protein (p-4EBP1). Elevated p-4EBP1 protein levels were detected in ALL samples at diagnosis; efficacy of chemotherapy was followed by the decrease of mTOR activity dependent protein phosphorylation. Optical density (OD) for p-4EBP1 (ELISA) was significantly higher in patients with poor prognosis at diagnosis, and in the samples of relapsed patients. Our results suggest that measuring mTOR activity related phospho-proteins such as p-4EBP1 by ELISA may help to identify patients with poor prognosis before treatment, and to detect early relapses. Determining mTOR activity in leukemic cells may also be a useful tool for selecting patients who may benefit from future mTOR inhibitor treatments.	[Nemes, Karolina; Varadi, Zsofia; Kovacs, Gabor] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Nemes, Karolina; Sebestyen, Anna; Mark, Agnes; Hajdu, Melinda; Sticz, Tamas; Barna, Gabor; Varadi, Zsofia; Kopper, Laszlo] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Sebestyen, Anna] Hungarian Acad Sci, Tumor Progress Res Grp, Budapest, Hungary; [Sebestyen, Anna] Semmelweis Univ, H-1085 Budapest, Hungary; [Kenessey, Istvan] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Nagy, Eszter] Natl Inst Rheumatism & Physiotherapy, Budapest, Hungary	Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; National Institute Rheumatology & Physiotherapy		csokam@t-online.hu	Kovács, Gábor/AAM-5883-2020	Csoka, Monika/0000-0003-4202-891X	Hungarian Scientific Research Fund [K68341, K81624, K84262]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund (http://www.otka.hu/) grant numbers K68341, K81624 and K84262. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakanat A, 2007, BIOCHEM BIOPH RES CO, V362, P330, DOI 10.1016/j.bbrc.2007.07.151; Avellino R, 2005, BLOOD, V106, P1400, DOI 10.1182/blood-2005-03-0929; Bertrand FE, 2005, LEUKEMIA, V19, P98, DOI 10.1038/sj.leu.2403560; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brown P, 2009, EXPERT REV HEMATOL, V2, P145, DOI 10.1586/EHM.09.1; Brown VI, 2003, P NATL ACAD SCI USA, V100, P15113, DOI 10.1073/pnas.2436348100; Crazzolara R, 2009, BLOOD, V113, P3297, DOI 10.1182/blood-2008-02-137752; Dekter HE, 2010, ANAL BIOCHEM, V403, P79, DOI 10.1016/j.ab.2010.04.022; DOW LW, 1985, BLOOD, V66, P902; Evangelisti C, 2011, LEUKEMIA, V25, P781, DOI 10.1038/leu.2011.20; Fouladi M, 2007, J CLIN ONCOL, V25, P4806, DOI 10.1200/JCO.2007.11.4017; Gingras AC, 2001, GENE DEV, V15, P2852; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Gu L, 2008, LEUKEMIA, V22, P2091, DOI 10.1038/leu.2008.204; Gu L, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-150; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hess Georg, 2009, Semin Oncol, V36 Suppl 3, pS37, DOI 10.1053/j.seminoncol.2009.10.012; Houghton PJ, 2008, PEDIATR BLOOD CANCER, V50, P799, DOI 10.1002/pbc.21296; Houghton PJ, 2003, CURR TOP MICROBIOL, V279, P339; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Leclerc Gilles M, 2010, J Mol Signal, V5, P15, DOI 10.1186/1750-2187-5-15; Lee-Sherick AB, 2010, BRIT J HAEMATOL, V151, P295, DOI 10.1111/j.1365-2141.2010.08282.x; Mihalik Rudolf, 1996, Pathol Oncol Res, V2, P78; MUTHUKKUMAR S, 1995, TRANSPLANTATION, V60, P264, DOI 10.1097/00007890-199508000-00010; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pulsipher MA, 2009, BRIT J HAEMATOL, V147, P691, DOI 10.1111/j.1365-2141.2009.07889.x; Ringshausen I, 2005, LEUKEMIA LYMPHOMA, V46, P11, DOI 10.1080/10428190400005353; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Saunders P, 2011, HAEMATOL-HEMATOL J, V96, P69, DOI 10.3324/haematol.2010.026997; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sebestyen A, 2012, MODERN PATHOL, V25, P1623, DOI 10.1038/modpathol.2012.141; Staehler M, 2010, ONCOTARGETS THER, V3, P191, DOI 10.2147/OTT.S7657; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Teachey DT, 2008, BLOOD, V112, P2020, DOI 10.1182/blood-2008-02-137141; Teachey DT, 2009, BRIT J HAEMATOL, V145, P569, DOI 10.1111/j.1365-2141.2009.07657.x; Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935; Torok S, 2005, EUR J EPIDEMIOL, V20, P899, DOI 10.1007/s10654-005-2340-9; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Yee KWL, 2006, CLIN CANCER RES, V12, P5165, DOI 10.1158/1078-0432.CCR-06-0764	47	20	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59335	10.1371/journal.pone.0059335	http://dx.doi.org/10.1371/journal.pone.0059335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573198	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000318840100017
J	Ohlsen, G; van Zoest, W; van Vugt, M				Ohlsen, Garian; van Zoest, Wieske; van Vugt, Mark			Gender and Facial Dominance in Gaze Cuing: Emotional Context Matters in the Eyes That We Follow	PLOS ONE			English	Article							GATES SOCIAL ATTENTION; INDIVIDUAL-DIFFERENCES; SPATIAL ATTENTION; PERCEPTION; CUES; DIRECTION; EXPRESSION; LEADERSHIP; EVOLUTION; COGNITION	Gaze following is a socio-cognitive process that provides adaptive information about potential threats and opportunities in the individual's environment. The aim of the present study was to investigate the potential interaction between emotional context and facial dominance in gaze following. We used the gaze cue task to induce attention to or away from the location of a target stimulus. In the experiment, the gaze cue either belonged to a (dominant looking) male face or a (non-dominant looking) female face. Critically, prior to the task, individuals were primed with pictures of threat or no threat to induce either a dangerous or safe environment. Findings revealed that the primed emotional context critically influenced the gaze cuing effect. While a gaze cue of the dominant male face influenced performance in both the threat and no-threat conditions, the gaze cue of the non-dominant female face only influenced performance in the no-threat condition. This research suggests an implicit, context-dependent follower bias, which carries implications for research on visual attention, social cognition, and leadership.	[Ohlsen, Garian; van Vugt, Mark] Vrije Univ Amsterdam, Amsterdam, Netherlands; [van Zoest, Wieske] Univ Trent, Ctr Mind Brain Sci, Trento, Italy; [van Vugt, Mark] Univ Oxford, Oxford, England	Vrije Universiteit Amsterdam; University of Trento; University of Oxford	Ohlsen, G (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	garian_ohlsen@hotmail.com; m.van.vugt@vu.nl	van Zoest, Wieske/L-2166-2019	van Zoest, Wieske/0000-0001-6760-2346				Ando S, 2004, PERCEPTION, V33, P1173, DOI 10.1068/p5297; Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Bayliss AP, 2010, VIS COGN, V18, P1214, DOI 10.1080/13506285.2010.484657; Bayliss AP, 2005, Q J EXP PSYCHOL-A, V58, P631, DOI 10.1080/02724980443000124; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Dalmaso M, 2012, BIOL LETTERS, V8, P450, DOI 10.1098/rsbl.2011.0881; Deaner RO, 2007, BIOL LETTERS, V3, P64, DOI 10.1098/rsbl.2006.0564; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Friesen CK, 2011, COGNITION EMOTION, V25, P73, DOI 10.1080/02699931003672381; Friesen CK, 2004, J EXP PSYCHOL HUMAN, V30, P319, DOI 10.1037/0096-1523.30.2.319; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Galfano G, 2011, SOC NEUROSCI-UK, V6, P257, DOI 10.1080/17470919.2010.515722; Graham R., 2009, VIS COGN, V18, P331, DOI DOI 10.1080/13506280802689281; Hietanen JK, 2003, J EXP PSYCHOL HUMAN, V29, P1228, DOI 10.1037/0096-1523.29.6.1228; HODES RL, 1985, PSYCHOPHYSIOLOGY, V22, P545, DOI 10.1111/j.1469-8986.1985.tb01649.x; Holmes A, 2010, SOC NEUROSCI-UK, V5, P285, DOI 10.1080/17470910903422819; Jones BC, 2010, P ROY SOC B-BIOL SCI, V277, P617, DOI 10.1098/rspb.2009.1575; Kingstone A, 2009, CURR OPIN NEUROBIOL, V19, P52, DOI 10.1016/j.conb.2009.05.004; Kuhn G, 2011, PSYCHON B REV, V18, P89, DOI 10.3758/s13423-010-0033-1; Lang PJ, 2008, INT AFFECTIVE PICTUR; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Liuzza MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025117; Maner JK, 2008, PERS SOC PSYCHOL B, V34, P488, DOI 10.1177/0146167207311910; Olivola CY, 2010, J NONVERBAL BEHAV, V34, P83, DOI 10.1007/s10919-009-0082-1; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Pavan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025608; Pecchinenda A, 2008, EMOTION, V8, P628, DOI 10.1037/a0013437; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Ricciardelli P, 2000, COGNITION, V77, pB1, DOI 10.1016/S0010-0277(00)00092-5; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Singular Inversions, 2006, SING INV VERS 3 1 CO; Sinha P, 2000, PERCEPTION, V29, P1005, DOI 10.1068/p2908no; Spisak BR, 2012, LEADERSHIP QUART, V23, P273, DOI 10.1016/j.leaqua.2011.08.006; Spisak BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030399; Tipples J, 2006, COGNITION EMOTION, V20, P309, DOI 10.1080/02699930500405550; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; Van Vugt M, 2006, PERS SOC PSYCHOL REV, V10, P354, DOI 10.1207/s15327957pspr1004_5; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Zuberbuhler K, 2008, CURR BIOL, V18, pR453, DOI 10.1016/j.cub.2008.03.015	45	40	40	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59471	10.1371/journal.pone.0059471	http://dx.doi.org/10.1371/journal.pone.0059471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23573199	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100018
J	Vorwerg, Y; Petroff, D; Kiess, W; Bluher, S				Vorwerg, Yvonne; Petroff, David; Kiess, Wieland; Blueher, Susann			Physical Activity in 3-6 Year Old Children Measured by SenseWear Pro (R): Direct Accelerometry in the Course of the Week and Relation to Weight Status, Media Consumption, and Socioeconomic Factors	PLOS ONE			English	Article							TOTAL-ENERGY EXPENDITURE; ACTIVITY PATTERNS; METABOLIC RISK; YOUTH; ADOLESCENTS; VALIDATION; CHILDHOOD; MODERATE; PRESCHOOLERS; ASSOCIATIONS	Background: Data on objectively measured physical activity (PA) in preschoolers are controversial. Direct accelerometry was performed in children aged 3-6 years, and differences in PA patterns over the course of the week were evaluated. Data were analyzed with gender, BMI, lifestyle, and socioeconomic parameters as covariates. Methods: PA was measured in 119 children by the SensewearPro (R) accelerometer and analyzed in the 92 (40 girls) that wore it for at least 4 days including one day of the weekend. Median measuring time in this group was 7 consecutive days (median/mean daily measuring time: 23.5 h/d and 21.8 h/d, respectively), corresponding to 834,000 analyzed minutes. PA questionnaires were completed by 103 parents and 87 preschool teachers to collect anthropometric, lifestyle, and socioeconomic data. Results: Median daily PA (MET>3) was 4.3 hours (mean: 4.4 hours). Boys spent an estimated 52 min/week more being very active (MET>6) than girls (95% CI [6, 96] min/week, p = 0.02). PA was lower during the weekend (3.7 h/d) compared to weekdays (4.5 h/d), p = 3 x 10(-6)), where a 95% CI for the difference is [0.5, 1.0] h/d. PA levels did not differ between overweight/obese children (median 4.7 h/d) and normal-weight peers (median 4.2 h/d). Daily media consumption increased with decreasing social class on weekdays (p = 0.05) and during the weekend (p = 0.01), but was not related to the amount of daily PA. A multivariate regression with BMI-SDS as independent variable and gender, age, amount of PA>6 MET, parental BMI, media time and socioeconomic status as explanatory variables revealed that only SES had a significant contribution. Conclusion: The negative impact of obesity-promoting factors in older children is rather low for preschoolers, but there is evidently a gradient in PA between weekdays and weekends already in this age group. Weight status of preschoolers is already considerably influenced by SES, but not physical activity levels.	[Vorwerg, Yvonne; Petroff, David; Blueher, Susann] Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04109 Leipzig, Germany; [Vorwerg, Yvonne; Kiess, Wieland; Blueher, Susann] Univ Hosp Leipzig, Hosp Children & Adolescents, Dept Women & Child Hlth, Leipzig, Germany; [Petroff, David] Univ Leipzig, Clin Trial Ctr, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Bluher, S (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04109 Leipzig, Germany.	susann.blueher@medizin.uni-leipzig.de		Weihrauch-Bluher, Susann/0000-0001-7399-223X	Federal Ministry of Education and Research, Germany (Integrated Research and Treatment Center IFB "AdiposityDiseases") [FKZ: 01E01001]; Roland-Ernst-Stiftung fur Gesundheitsforschung, Dresden, Germany; German National Forum for Diabetes Mellitus (NAFDM); Federal Ministry of Education and Research (BMBF, Kompetenznetz "Adipositas"); German Research Foundation (DFG, "Atherobesity," Bonn, Germany) [KFO 152]; Federal Ministry of Education and Research (BMBF, Konsortium "LARGE")	Federal Ministry of Education and Research, Germany (Integrated Research and Treatment Center IFB "AdiposityDiseases"); Roland-Ernst-Stiftung fur Gesundheitsforschung, Dresden, Germany; German National Forum for Diabetes Mellitus (NAFDM); Federal Ministry of Education and Research (BMBF, Kompetenznetz "Adipositas")(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG, "Atherobesity," Bonn, Germany)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF, Konsortium "LARGE")(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Education and Research, Germany (Integrated Research and Treatment Center IFB "AdiposityDiseases," FKZ: 01E01001, to SB, DP and WK), as well as the Roland-Ernst-Stiftung fur Gesundheitsforschung, Dresden, Germany, and the German National Forum for Diabetes Mellitus (NAFDM) (SB and WK). WK is also being supported by a grant from the Federal Ministry of Education and Research (BMBF, Kompetenznetz "Adipositas," Konsortium "LARGE") and by the German Research Foundation (DFG, KFO 152 "Atherobesity," Bonn, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph AL, 2012, J PHYS ACT HEALTH, V9, P944, DOI 10.1123/jpah.9.7.944; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Arvidsson D, 2009, MED SCI SPORT EXER, V41, P603, DOI 10.1249/MSS.0b013e31818896f4; Beets MW, 2011, PEDIATRICS, V127, P658, DOI 10.1542/peds.2010-2021; Blaes A, 2011, AM J HUM BIOL, V23, P353, DOI 10.1002/ajhb.21142; Bluher S, 2012, CURR DIABETES REP, V12, P147, DOI 10.1007/s11892-012-0255-x; Bluher S, 2011, INT J PEDIATR OBES, V6, pE199, DOI 10.3109/17477166.2010.526305; Bornstein DB, 2011, J SCI MED SPORT, V14, P504, DOI 10.1016/j.jsams.2011.05.007; Bornstein DB, 2011, J SCI MED SPORT, V14, P404, DOI 10.1016/j.jsams.2011.03.013; Byun W, 2011, PEDIATRICS, V128, P937, DOI 10.1542/peds.2011-0748; Calabro MA, 2009, MED SCI SPORT EXER, V41, P1714, DOI 10.1249/MSS.0b013e3181a071cf; Cleland V, 2008, INT J OBESITY, V32, P1685, DOI 10.1038/ijo.2008.171; Vale SMCG, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/479439; Deforche B, 2009, INT J BEHAV NUTR PHY, V14, P6; Dorsey KB, 2011, INT J PEDIATR OBES, V6, pE547, DOI 10.3109/17477166.2010.490586; Dowda M, 2011, ARCH PEDIAT ADOL MED, V165, P939, DOI 10.1001/archpediatrics.2011.84; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Federal office for statistics city of Leipzig, 2011, STAT YB, P114; Fisher A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010110; Goldfield GS, 2012, INT J ENV RES PUB HE, V9, P1326, DOI 10.3390/ijerph9041326; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Hinkley T, 2012, MED SCI SPORT EXER, V44, P2436, DOI 10.1249/MSS.0b013e3182661478; Hinkley T, 2012, AM J PREV MED, V43, P159, DOI 10.1016/j.amepre.2012.04.020; Jackson DM, 2009, AM J CLIN NUTR, V89, P1031, DOI 10.3945/ajcn.2008.26746; Kelly LA, 2006, ARCH DIS CHILD, V91, P35, DOI 10.1136/adc.2005.080275; Kim Y, 2013, J SCI MED SPORT, V16, P129, DOI 10.1016/j.jsams.2012.05.015; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lampert T, 2007, BUNDESGESUNDHEITSBLA, V50, P634, DOI 10.1007/s00103-007-0224-8; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Nyberg GA, 2009, MED SCI SPORT EXER, V41, P1842, DOI 10.1249/MSS.0b013e3181a48ee6; Ojiambo R, 2011, INT J OBESITY, V35, pS98, DOI 10.1038/ijo.2011.40; Pagani LS, 2010, ARCH PEDIAT ADOL MED, V164, P425, DOI 10.1001/archpediatrics.2010.50; Pate RR, 2004, PEDIATRICS, V114, P1258, DOI 10.1542/peds.2003-1088-L; Pate RR, 2006, OBESITY, V14, P2000, DOI 10.1038/oby.2006.234; Pate RR, 2010, MED SCI SPORT EXER, V42, P508, DOI 10.1249/MSS.0b013e3181cea116; Pulsford RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021822; Reilly JJ, 2004, LANCET, V363, P211, DOI 10.1016/S0140-6736(03)15331-7; Rizzo NS, 2007, J PEDIATR-US, V150, P388, DOI 10.1016/j.jpeds.2006.12.039; Shen B, 2012, J PHYS ACT HLTH; Tanaka Chiaki, 2009, Journal of Physiological Anthropology, V28, P283, DOI 10.2114/jpa2.28.283; Team RDC, 2010, R LANG ENV STAT COMP; Telford RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050014; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Verbestel V, 2011, PEDIATR EXERC SCI, V23, P366, DOI 10.1123/pes.23.3.366; Winkler J, 1999, Gesundheitswesen, V61 Spec No, pS178; Yang X, 2006, MED SCI SPORT EXER, V38, P919, DOI 10.1249/01.mss.0000218121.19703.f7	48	27	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60619	10.1371/journal.pone.0060619	http://dx.doi.org/10.1371/journal.pone.0060619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573273	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100092
J	Williams, EJ; Bott, LA; Patrick, J; Lewis, MB				Williams, Emma J.; Bott, Lewis A.; Patrick, John; Lewis, Michael B.			Telling Lies: The Irrepressible Truth?	PLOS ONE			English	Article							PREFRONTAL CORTEX; RESPONSE-TIME; CONCEALED INFORMATION; DECEPTION; CUES; NEUROSCIENCE; KNOWLEDGE; FRAMEWORK; MULTIPLE; VALIDITY	Telling a lie takes longer than telling the truth but precisely why remains uncertain. We investigated two processes suggested to increase response times, namely the decision to lie and the construction of a lie response. In Experiments 1 and 2, participants were directed or chose whether to lie or tell the truth. A colored square was presented and participants had to name either the true color of the square or lie about it by claiming it was a different color. In both experiments we found that there was a greater difference between lying and telling the truth when participants were directed to lie compared to when they chose to lie. In Experiments 3 and 4, we compared response times when participants had only one possible lie option to a choice of two or three possible options. There was a greater lying latency effect when questions involved more than one possible lie response. Experiment 5 examined response choice mechanisms through the manipulation of lie plausibility. Overall, results demonstrate several distinct mechanisms that contribute to additional processing requirements when individuals tell a lie.	[Williams, Emma J.; Bott, Lewis A.; Patrick, John; Lewis, Michael B.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Lewis, MB (corresponding author), Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales.	lewismb@cardiff.ac.uk	Lewis, Michael/D-1488-2009	Lewis, Michael/0000-0002-5735-5318; Bott, Lewis/0000-0002-4926-1231; Williams, Emma/0000-0002-8581-6214	European Aeronautic Defence and Space Foundation Wales [RCPS400]	European Aeronautic Defence and Space Foundation Wales	This work was conducted as part of a PhD study undertaken by the first author. This PhD was funded by the European Aeronautic Defence and Space Foundation Wales (grant number RCPS400): http://eadsfoundation.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2008, CEREB CORTEX, V18, P2811, DOI 10.1093/cercor/bhn037; Abe N, 2007, J COGNITIVE NEUROSCI, V19, P287, DOI 10.1162/jocn.2007.19.2.287; Appelbaum PS, 2007, PSYCHIAT SERV, V58, P460, DOI 10.1176/appi.ps.58.4.460; Ben-Shakhar G, 2002, HDB POLYGRAPH TESTIN, P87; BOAZ TL, 1991, J APPL PSYCHOL, V76, P788, DOI 10.1037/0021-9010.76.6.788; Bond GD, 2005, APPL COGNITIVE PSYCH, V19, P313, DOI 10.1002/acp.1087; Carrion RE, 2010, COGNITION, V114, P105, DOI 10.1016/j.cognition.2009.05.014; Christ SE, 2009, CEREB CORTEX, V19, P1557, DOI 10.1093/cercor/bhn189; Cole T, 2001, J SOC PERS RELAT, V18, P107, DOI 10.1177/0265407501181005; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; DEPAULO BM, 1989, NATO ADV SCI I D-BEH, V47, P51; DePaulo BM, 1998, J PERS SOC PSYCHOL, V74, P63, DOI 10.1037/0022-3514.74.1.63; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; Duran ND, 2010, PSYCHON B REV, V17, P486, DOI 10.3758/PBR.17.4.486; EKMAN P, 1974, J PERS SOC PSYCHOL, V29, P288, DOI 10.1037/h0036006; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Fukuda K, 2001, INT J PSYCHOPHYSIOL, V40, P239, DOI 10.1016/S0167-8760(00)00192-6; Fullam RS, 2009, BRIT J PSYCHIAT, V194, P229, DOI 10.1192/bjp.bp.108.053199; Ganis G, 2011, NEUROIMAGE, V55, P312, DOI 10.1016/j.neuroimage.2010.11.025; Granhag PA, 2002, APPL COGNITIVE PSYCH, V16, P243, DOI 10.1002/acp.784; Grice P., 1989, STUDIES WAY WORDS; Holden RR, 1998, J SOC BEHAV PERS, V13, P387; Inbau F.E., 2011, CRIMINAL INTERROGATI; Johnson R, 2004, NEUROPSYCHOLOGIA, V42, P878, DOI 10.1016/j.neuropsychologia.2003.12.005; Kintsch W, 1998, COMPREHENSION PARADI; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Lee TMC, 2005, NEUROIMAGE, V28, P305, DOI 10.1016/j.neuroimage.2005.06.051; Lui M, 2008, PSYCHOPHYSIOLOGY, V45, P721, DOI 10.1111/j.1469-8986.2008.00683.x; LYKKEN DT, 1959, J APPL PSYCHOL, V43, P385, DOI 10.1037/h0046060; Mameli F, 2010, BEHAV BRAIN RES, V211, P164, DOI 10.1016/j.bbr.2010.03.024; Meibauer J, 2005, J PRAGMATICS, V37, P1373, DOI 10.1016/j.pragma.2004.12.007; PHILIPPOT P, 1993, COGNITION EMOTION, V7, P171, DOI 10.1080/02699939308409183; Porter S, 2008, LEGAL CRIMINOL PSYCH, V13, P27, DOI 10.1348/135532507X186653; Porter S, 2009, LEGAL CRIMINOL PSYCH, V14, P119, DOI 10.1348/135532508X281520; RASKIN DC, 1991, SUGGESTIBILITY OF CHILDRENS RECOLLECTIONS, P153, DOI 10.1037/10097-009; Rosenfeld JP, 2007, BIOL PSYCHOL, V74, P396, DOI 10.1016/j.biopsycho.2006.10.002; Seiter J.S., 2002, WESTERM J COMMUN, V66, P158, DOI [10.1080/10570310209374731, DOI 10.3389/FPSYG.2014.00080, https://doi.org/10.1080/10570310209374731, DOI 10.1080/10570310209374731]; Serota KB, 2010, HUM COMMUN RES, V36, P2, DOI 10.1111/j.1468-2958.2009.01366.x; Seymour TL, 2000, J APPL PSYCHOL, V85, P30, DOI 10.1037/0021-9010.85.1.30; Seymour TL, 2009, APPL PSYCHOPHYS BIOF, V34, P177, DOI 10.1007/s10484-009-9092-3; Spence SA, 2004, PHILOS T R SOC B, V359, P1755, DOI 10.1098/rstb.2004.1555; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Spence SA, 2008, NEUROIMAGE, V40, P1411, DOI 10.1016/j.neuroimage.2008.01.035; Vendemia JMC, 2005, BEHAV NEUROL, V16, P25, DOI 10.1155/2005/804026; Vendemia JMC, 2005, AM J PSYCHOL, V118, P413; Verschuere B, 2008, INT J PSYCHOPHYSIOL, V69, P149, DOI 10.1016/j.ijpsycho.2008.05.366; Verschuere B, 2011, MEMORY DETECTION THE, P128, DOI [10.1017/CBO9780511975196.008, DOI 10.1017/CBO9780511975196.008, 10.1017/CBO9780511975196.004]; Verschuere B, 2010, APPL COGNITIVE PSYCH, V24, P991, DOI 10.1002/acp.1601; Vrij A, 2000, J NONVERBAL BEHAV, V24, P239, DOI 10.1023/A:1006610329284; Vrij A, 2008, LAW HUMAN BEHAV, V32, P253, DOI 10.1007/s10979-007-9103-y; Vrij A, 2007, LAW HUMAN BEHAV, V31, P499, DOI 10.1007/s10979-006-9066-4; Walczyk JJ, 2009, J BUS PSYCHOL, V24, P33, DOI 10.1007/s10869-009-9090-8; Walczyk JJ, 2005, PERS PSYCHOL, V58, P141, DOI 10.1111/j.1744-6570.2005.00484.x; Walczyk JJ, 2003, APPL COGNITIVE PSYCH, V17, P755, DOI 10.1002/acp.914; Wilcox D. T., 2009, USE POLYGRAPH ASSESS, P267; Zuckerman M., 1981, ADV EXP SOC PSYCHOL, V14, P1, DOI DOI 10.1016/S0065-2601(08)60369-X	56	12	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60713	10.1371/journal.pone.0060713	http://dx.doi.org/10.1371/journal.pone.0060713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23573277	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000318840100097
J	Wong, MCS; Hirai, HW; Luk, AKC; Lam, TYT; Ching, JYL; Griffiths, SM; Chan, FKL; Sung, JJY				Wong, Martin C. S.; Hirai, Hoyee W.; Luk, Arthur K. C.; Lam, Thomas Y. T.; Ching, Jessica Y. L.; Griffiths, Sian M.; Chan, Francis K. L.; Sung, Joseph J. Y.			The Knowledge of Colorectal Cancer Symptoms and Risk Factors among 10,078 Screening Participants: Are High Risk Individuals More Knowledgeable?	PLOS ONE			English	Article							FECAL-OCCULT-BLOOD; HEALTH BELIEF MODEL; BARRIERS; ASIA; ATTITUDES; TESTS; RECOMMENDATION; CHINESE	Objectives: We tested the a priori hypothesis that self-perceived and real presences of risks for colorectal cancer (CRC) are associated with better knowledge of the symptoms and risk factors for CRC, respectively. Methods: One territory-wide invitation for free CRC screening between 2008 to 2012 recruited asymptomatic screening participants aged 50-70 years in Hong Kong. They completed survey items on self-perceived and real presences of risks for CRC (advanced age, male gender, positive family history and smoking) as predictors, and knowledge of CRC symptoms and risk factors as outcome measures, respectively. Their associations were evaluated by binary logistic regression analyses. Results: From 10,078 eligible participants (average age 59 years), the mean knowledge scores for symptoms and risk factors were 3.23 and 4.06, respectively (both score range 0-9). Male gender (adjusted odds ratio [AOR] = 1.34, 95% C.I. 1.20-1.50, p<0.01), self-perception as not having any risks for CRC (AOR = 1.12, 95% C.I. 1.01-1.24, p = 0.033) or uncertainty about having risks (AOR = 1.94, 95% C.I. 1.55-2.43, p<0.001), smoking (AOR 1.38, 95% C.I. 1.11-1.72, p = 0.004), and the absence of family history (AOR 0.61 to 0.78 for those with positive family history, p<0.001) were associated with poorer knowledge scores (<= 4) of CRC symptoms. These factors remained significant for knowledge of risk factors. Conclusions: Male and smokers were more likely to have poorer knowledge but family history of CRC was associated with better knowledge. Since screening of these higher risk individuals could lead to greater yield of colorectal neoplasm, educational interventions targeted to male smokers were recommended.	[Wong, Martin C. S.; Hirai, Hoyee W.; Luk, Arthur K. C.; Lam, Thomas Y. T.; Ching, Jessica Y. L.; Chan, Francis K. L.; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Inst Digest Dis, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Martin C. S.; Griffiths, Sian M.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Fac Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Sung, JJY (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Fac Med, Hong Kong, Hong Kong, Peoples R China.	jjysung@cuhk.edu.hk	Wong, Martin/L-4568-2014; Chan, Francis K. L./F-4851-2010; Sung, Joseph J. Y./R-3203-2018	Wong, Martin/0000-0001-7706-9370; Chan, Francis K. L./0000-0001-7388-2436; Sung, Joseph J. Y./0000-0003-3125-5199	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	The Hong Kong Jockey Club Charities Trust provided the full funding of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2011, CANC FACTS FIG 2011; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; Christou A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-528; Dan YY, 2012, CLIN GASTROENTEROL H, V10, P266, DOI 10.1016/j.cgh.2011.11.011; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garcia AZG, 2011, EUR J GASTROEN HEPAT, V23, P1165, DOI 10.1097/MEG.0b013e32834a289e; Gimeno-Garcia AZ, 2009, MED CLIN-BARCELONA, V133, P736, DOI 10.1016/j.medcli.2009.03.041; Harmy MY, 2011, ASIAN PAC J CANCER P, V12, P1957; Javanparast S, 2012, MED J AUSTRALIA, V196, P521, DOI 10.5694/mja11.10701; Koo JH, 2012, GASTROINTEST ENDOSC, V76, P126, DOI 10.1016/j.gie.2012.03.168; Koo JH, 2010, CANCER EPIDEMIOL, V34, P604, DOI 10.1016/j.canep.2010.05.013; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Robinson CM, 2011, J NATL MED ASSOC, V103, P746, DOI 10.1016/S0027-9684(15)30414-4; Salimzadeh H, 2012, INT J PREVENTIVE MED, V3, P29; Sanderson PR, 2011, PREV CHRONIC DIS, V8; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Sung JJY, 2008, AM J GASTROENTEROL, V103, P974, DOI 10.1111/j.1572-0241.2007.01649.x; Tam Tammy K. W., 2011, Hong Kong Medical Journal, V17, P350; Ueland AS, 2006, GASTROENTEROL NURS, V29, P357, DOI 10.1097/00001610-200609000-00002; Walsh JME, 2004, J GEN INTERN MED, V19, P156, DOI 10.1111/j.1525-1497.2004.30263.x; Wong MCS, 2010, ALIMENT PHARM THER, V32, P74, DOI 10.1111/j.1365-2036.2010.04312.x; Wong MCS, 2012, CANCER CAUSE CONTROL, V23, P1541, DOI 10.1007/s10552-012-0031-x; Yeoh KG, 2011, GUT, V60, P1236, DOI 10.1136/gut.2010.221168	27	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60366	10.1371/journal.pone.0060366	http://dx.doi.org/10.1371/journal.pone.0060366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573248	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100063
J	Liu, R; Lin, G; Xu, HP				Liu, Rui; Lin, Gou; Xu, Hanpeng			An Efficient Method for Dorsal Root Ganglia Neurons Purification with a One-Time Anti-Mitotic Reagent Treatment	PLOS ONE			English	Article							ADULT SENSORY NEURONS; SCHWANN-CELLS; PERIPHERAL-NERVE; BASAL LAMINA; CULTURE; MYELINATION; GROWTH; TISSUE; ESTABLISHMENT; REGENERATION	Background: The dorsal root ganglia (DRG) neuron is an invaluable tool in axon growth, growth factor regulation, myelin formation and myelin-relevant researches. The purification of DRG neurons is a key step in these studies. Traditionally, purified DRG neurons were obtained in two weeks after exposure to several rounds of anti-mitotic reagent. Methods and Results: In this report, a novel, simple and efficient method for DRG purification is presented. DRG cultures were treated once with a high-dose anti-mitotic reagent cocktail for 72 hours. Using this new method, DRG neurons were obtained with 99% purification within 1 week. We confirmed that the neurite growth and the viability of the purified DRG neurons have no difference from the DRG neurons purified by traditional method. Furthermore, P0 and MBP expression was observed in myelin by immunocytochemistry in the DRG/SC co-culture system. The formation of mature node of Ranvier in DRG-Schwann cell co-culture system was observed using anti-Nav 1.6 and anti-caspr antibody. Conclusion and Significance: The results indicate that this high dose single treatment did not compromise the capacity of DRG neurons for myelin formation in the DRG/SC co-culture system. In conclusion, a convenient approach for purifying DRG neurons was developed which is time-saving and high-efficiency.	[Liu, Rui] Fourth Mil Med Univ, Dept Geriatr, Tangdu Hosp, Xian 710032, Shaanxi Provinc, Peoples R China; [Lin, Gou] Univ Calif Los Angeles, Dept Neurol, LONI, Los Angeles, CA 90024 USA; [Xu, Hanpeng] Fourth Mil Med Univ, Basic Med Sch, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; University of California System; University of California Los Angeles; Air Force Military Medical University	Liu, R (corresponding author), Fourth Mil Med Univ, Dept Geriatr, Tangdu Hosp, Xian 710032, Shaanxi Provinc, Peoples R China.	liuruishaanxi@gmail.com; hanpxu@gmail.com			National Natural Science Foundation of China [81200966]; Natural Science Fund of Shaanxi province [2010JQ4014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Shaanxi province(Natural Science Foundation of Shaanxi Province)	This work was supported by the National Natural Science Foundation of China (No.81200966) and Natural Science Fund of Shaanxi province (No. 2010JQ4014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; BUNGE MB, 1980, J CELL BIOL, V84, P184, DOI 10.1083/jcb.84.1.184; Bunge RP, 1987, PROG BRAIN RES <D>, V71, P143; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Chan JR, 2007, J CELL BIOL, V177, P953, DOI 10.1083/jcb.200705105; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; DELREE P, 1989, J NEUROSCI RES, V23, P198, DOI 10.1002/jnr.490230210; FUKUDA J, 1985, DEV NEUROSCI-BASEL, V7, P374, DOI 10.1159/000112304; Fukuda J, 1979, ENHANCEMENT CA SPIKE; GOLDENBERG SSS, 1983, J NEUROBIOL, V14, P195, DOI 10.1002/neu.480140304; GROTHE C, 1987, J NEUROSCI RES, V18, P539, DOI 10.1002/jnr.490180406; Kim YE, 2010, NAT PROTOC, V5, P1396, DOI 10.1038/nprot.2010.101; Lei M, 2008, J NEUROSCI METH, V174, P215, DOI 10.1016/j.jneumeth.2008.07.006; Lewallen KA, 2011, J NEUROSCI, V31, P3032, DOI 10.1523/JNEUROSCI.4345-10.2011; Li GN, 2008, TISSUE ENG PART B-RE, V14, P33, DOI 10.1089/teb.2007.0181; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Plant GW, 2002, J NEUROSCI, V22, P6083; Steain M, 2010, CURR TOP MICROBIOL, V342, P211, DOI 10.1007/82_2010_15; UNSICKER K, 1985, DEV BRAIN RES, V17, P304, DOI 10.1016/0165-3806(85)90161-0; WINDEBANK AJ, 1985, J NEUROSCI, V5, P1563; WOOD PM, 1976, BRAIN RES, V115, P361, DOI 10.1016/0006-8993(76)90355-3; Xu H, 2010, J VISUALIZED EXPT JO	24	24	24	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60558	10.1371/journal.pone.0060558	http://dx.doi.org/10.1371/journal.pone.0060558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565257	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300128
J	Liu, TM; Zhu, SY; Fu, LL; Tang, QM; Yu, YT; Chen, P; Luan, MB; Wang, CB; Tang, SW				Liu, Touming; Zhu, Siyuan; Fu, Lili; Tang, Qingming; Yu, Yongting; Chen, Ping; Luan, Mingbao; Wang, Changbiao; Tang, Shouwei			Development and Characterization of 1,827 Expressed Sequence Tag-Derived Simple Sequence Repeat Markers for Ramie (Boehmeria nivea L. Gaud)	PLOS ONE			English	Article							GENIC MICROSATELLITE MARKERS; SSR-MARKERS; EST-SSRS; IDENTIFICATION; PLANT	Ramie (Boehmeria nivea L. Gaud) is one of the most important natural fiber crops, and improvement of fiber yield and quality is the main goal in efforts to breed superior cultivars. However, efforts aimed at enhancing the understanding of ramie genetics and developing more effective breeding strategies have been hampered by the shortage of simple sequence repeat (SSR) markers. In our previous study, we had assembled de novo 43,990 expressed sequence tags (ESTs). In the present study, we searched these previously assembled ESTs for SSRs and identified 1,685 ESTs (3.83%) containing 1,878 SSRs. Next, we designed 1,827 primer pairs complementary to regions flanking these SSRs, and these regions were designated as SSR markers. Among these markers, dinucleotide and trinucleotide repeat motifs were the most abundant types (36.4% and 36.3%, respectively), whereas tetranucleotide, pentanucleotide, and hexanucleotide motifs represented <10% of the markers. The motif AG/CT was the most abundant, accounting for 28.74% of the markers. One hundred EST-SSR markers (97 SSRs located in genes encoding transcription factors and 3 SSRs in genes encoding cellulose synthases) were amplified using polymerase chain reaction for detecting 24 ramie varieties. Of these 100 markers, 98 markers were successfully amplified and 81 markers were polymorphic, with 2-6 alleles among the 24 varieties. Analysis of the genetic diversity of all 24 varieties revealed similarity coefficients that ranged from 0.51 to 0.80. The EST-SSRs developed in this study represent the first large-scale development of SSR markers for ramie. These SSR markers could be used for development of genetic and physical maps, quantitative trait loci mapping, genetic diversity studies, association mapping, and cultivar fingerprinting.	[Liu, Touming; Zhu, Siyuan; Fu, Lili; Tang, Qingming; Yu, Yongting; Chen, Ping; Luan, Mingbao; Tang, Shouwei] Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China; [Liu, Touming; Zhu, Siyuan; Fu, Lili; Tang, Qingming; Yu, Yongting; Chen, Ping; Luan, Mingbao; Tang, Shouwei] Chinese Acad Agr Sci, Ctr Southern Econ Crops, Changsha, Hunan, Peoples R China; [Wang, Changbiao] Shanxi Acad Agr Sci, Biotechnol Res Ctr, Taiyuan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS; Chinese Academy of Agricultural Sciences; Shanxi Agricultural University	Tang, SW (corresponding author), Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China.	csec2012@yahoo.cn	Wang, Changbiao/S-8473-2019	Yu, Yongting/0000-0001-6818-4094	National Natural Science Foundation of China [31101189]; Natural Science Foundation of Hunan Province [10JJ3063]; National Modern Agro-industry Technology Research System [nycytx-19-E16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); National Modern Agro-industry Technology Research System	This work was supported by the National Natural Science Foundation of China (31101189), http://www.nsfc.gov.cn/; Natural Science Foundation of Hunan Province (10JJ3063), http://www.hnst.gov.cn/zxgz/zkjj/; National Modern Agro-industry Technology Research System (nycytx-19-E16), http://119.253.58.231/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; Bozhko M, 2003, MOL ECOL, V12, P3147, DOI 10.1046/j.1365-294X.2003.01983.x; Cardle L, 2000, GENETICS, V156, P847; Chen JH, 2011, AFR J MICROBIOL RES, V5, P3504; Cloutier S, 2009, THEOR APPL GENET, V119, P53, DOI 10.1007/s00122-009-1016-3; Fraser LG, 2004, THEOR APPL GENET, V108, P1010, DOI 10.1007/s00122-003-1517-4; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gong L, 2008, THEOR APPL GENET, V117, P37, DOI 10.1007/s00122-008-0750-2; He Guohao, 2003, BMC Plant Biology, V3, P3, DOI 10.1186/1471-2229-3-3; Jiang YanBo, 2007, Acta Agronomica Sinica, V33, P158; Liao Liang, 2010, Guangxi Zhiwu / Guihaia, V30, P791; Liu TM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-125; [蒙祖庆 Meng Zuqing], 2009, [分子植物育种, Molecular Plant Breeding], V7, P365; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Peng J. H., 2005, Functional & Integrative Genomics, V5, P80, DOI 10.1007/s10142-004-0128-8; Qiu CS, 2011, HUBEI AGR SCI, V50, P1499; Rafalski JA, 1996, ANAL NONMAMMALIAN GE, P75; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rohlf F.J., 2002, NTSYS PC NUMERICAL T; Rozen S, 2000, Methods Mol Biol, V132, P365; Rungis D, 2004, THEOR APPL GENET, V109, P1283, DOI 10.1007/s00122-004-1742-5; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Simbaqueba J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026719; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Varshney RK, 2006, THEOR APPL GENET, V113, P239, DOI 10.1007/s00122-006-0289-z; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; [王长彪 WANG Chang-biao], 2009, [棉花学报, Cotton Science], V21, P243; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; WU KS, 1993, MOL GEN GENET, V241, P225, DOI 10.1007/BF00280220; Xu Y, 2004, GENOME, V47, P1091, DOI [10.1139/g04-058, 10.1139/G04-058]; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94	32	46	61	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60346	10.1371/journal.pone.0060346	http://dx.doi.org/10.1371/journal.pone.0060346			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565230	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300100
J	Zhao, YF; Wang, L; Qiu, JH; Zha, DJ; Sun, Q; Chen, C				Zhao, Yufeng; Wang, Li; Qiu, Jianhua; Zha, Dingjun; Sun, Qiang; Chen, Chen			Linoleic Acid Stimulates [Ca2+]i Increase in Rat Pancreatic Beta-Cells through Both Membrane Receptor- and Intracellular Metabolite-Mediated Pathways	PLOS ONE			English	Article							FREE FATTY-ACIDS; MITOCHONDRIAL PERMEABILITY TRANSITION; ACYL-COA ESTERS; INSULIN-SECRETION; PALMITIC ACID; CA2+; GPR40; DEATH; PORE; RELEASE	The role of the free fatty acid (FFA) receptor and the intracellular metabolites of linoleic acid (LA) in LA-stimulated increase in cytosolic free calcium concentration ([Ca2+]i) was investigated. [Ca2+]i was measured using Fura-2 as indicator in rat pancreatic beta-cells in primary culture. LA (20 mu M for 2 min) stimulated a transient peak increase followed by a minor plateau increase in [Ca2+]i. Elongation of LA stimulation up to 10 min induced a strong and long-lasting elevation in [Ca2+]i. Activation of FFA receptors by the non-metabolic agonist GW9508 (40 mu M for 10 min) resulted in an increase in [Ca2+]i similar to that of 2-min LA treatment. Inhibition of acyl-CoA synthetases by Triacsin C suppressed the strong and long-lasting increase in [Ca2+]i. The increase in [Ca2+]i induced by 2 min LA or GW9508 were fully eliminated by exhaustion of endoplasmic reticulum (ER) Ca2+ stores or by inhibition of phospholipase C (PLC). Removal of extracellular Ca2+ did not influence the transient peak increase in [Ca2+]i stimulated by 2 min LA or GW9508. The strong and long-lasting increase in [Ca2+]i induced by 10 min LA was only partially suppressed by extracellular Ca2+ removal or thapsigargin pretreatment, whereas remaining elevation in [Ca2+]i was eliminated after exhaustion of mitochondrial Ca2+ using triphenyltin. In conclusion, LA stimulates Ca2+ release from ER through activation of the FFA receptor coupled to PLC and mobilizes mitochondrial Ca2+ by intracellular metabolites in b-cells.	[Zhao, Yufeng; Sun, Qiang; Chen, Chen] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Zhao, Yufeng; Qiu, Jianhua; Zha, Dingjun] Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol, Xian 710032, Peoples R China; [Wang, Li] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Xian 710049, Peoples R China	University of Queensland; Air Force Military Medical University; Xi'an Jiaotong University	Zhao, YF (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	zhaoyf@fmmu.edu.cn; chen.chen@uq.edu.au	chen, chen/GRY-7085-2022; CHEN, CHEN/HDM-6657-2022; Chen, Chen/B-4284-2010; zhao, yufeng/AAL-8042-2020	Chen, Chen/0000-0003-2104-534X; Zhao, Yufeng/0000-0002-5296-3568	Australian NHMRC; National Natural Sciences Foundation of China [30971078]	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the grant from Australian NH&MRC and the National Natural Sciences Foundation of China ( NO. 30971078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belosludtsev KN, 2005, BIOCHEMISTRY-MOSCOW+, V70, P815, DOI 10.1007/s10541-005-0189-x; Belosludtsev K, 2006, J BIOENERG BIOMEMBR, V38, P113, DOI 10.1007/s10863-006-9010-9; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; CRESPIN SR, 1973, J CLIN INVEST, V52, P1979, DOI 10.1172/JCI107382; Di Paola M, 2006, FEBS LETT, V580, P775, DOI 10.1016/j.febslet.2005.12.090; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; FULCERI R, 1994, CELL CALCIUM, V15, P109, DOI 10.1016/0143-4160(94)90049-3; GERONDAES P, 1988, BIOCHEM J, V253, P169, DOI 10.1042/bj2530169; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Liu YJ, 1997, CELL CALCIUM, V22, P277, DOI 10.1016/S0143-4160(97)90066-X; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Mason TM, 1999, DIABETES, V48, P524, DOI 10.2337/diabetes.48.3.524; MIYATA H, 1991, AM J PHYSIOL, V261, pH1123, DOI 10.1152/ajpheart.1991.261.4.H1123; Morillas M, 2000, BIOCHEM J, V351, P495, DOI 10.1042/0264-6021:3510495; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; OMURA S, 1986, J ANTIBIOT, V39, P1211, DOI 10.7164/antibiotics.39.1211; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P9558, DOI 10.1073/pnas.95.16.9558; Shin CY, 2003, MOL CELL NEUROSCI, V24, P57, DOI 10.1016/S1044-7431(03)00121-0; Smaili SS, 2000, J BIOENERG BIOMEMBR, V32, P35, DOI 10.1023/A:1005508311495; Sultan A, 2001, ARCH BIOCHEM BIOPHYS, V386, P37, DOI 10.1006/abbi.2000.2194; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Yaney GC, 2000, ENDOCRINOLOGY, V141, P1989, DOI 10.1210/en.141.6.1989; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; ZAZUETA C, 1994, J BIOENERG BIOMEMBR, V26, P457, DOI 10.1007/BF00762786; Zhao YF, 2003, ENDOCRINE, V22, P185, DOI 10.1385/ENDO:22:3:185; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; ZOCCARATO F, 1982, EUR J BIOCHEM, V127, P333, DOI 10.1111/j.1432-1033.1982.tb06875.x	41	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60255	10.1371/journal.pone.0060255	http://dx.doi.org/10.1371/journal.pone.0060255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565210	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300079
J	Behrens, M; Mau-Moeller, A; Wassermann, F; Bruhn, S				Behrens, Martin; Mau-Moeller, Anett; Wassermann, Franziska; Bruhn, Sven			Effect of Fatigue on Hamstring Reflex Responses and Posterior-Anterior Tibial Translation in Men and Women	PLOS ONE			English	Article							MEDICAL-RESEARCH PROGRAM; KNEE-JOINT LAXITY; CRUCIATE LIGAMENT; NEUROMUSCULAR CHARACTERISTICS; MUSCLE STRENGTH; SHORT-LATENCY; INJURIES; RISK; EXERCISE; GENDER	Anterior cruciate ligament (ACL) rupture ranks among the most common injuries in sports. The incidence of ACL injuries is considerablyhigher in females than in males and the underlying mechanisms are still underdebate. Furthermore, it has been suggested that muscle fatigue can be a riskfactor for ACL injuries. We investigated gender differences in hamstring reflex responses and posterior-anterior tibial translation (TT) before andafter fatiguing exercise. We assessed the isolated movement of the tibia relativeto the femur in the sagittal plane as a consequence of mechanically inducedTT in standing subjects. The muscle activity of the hamstrings was evaluated. Furthermore, isometric maximum voluntary torque (iMVT) and rateof torque development (RTD) of the hamstrings (H) andquadriceps (Q) were measured and the MVT H/Q as well as theRTD H/Q ratios were calculated. After fatigue, reflex onset latencies were enhanced in women. A reduction of reflex responses associated with an increased TT was observedin females. Men showed no differences in these parameters. Correlation analysisrevealed no significant associations between parameters for TT and MVT H/Qas well as RTD H/Q. The results of the present study revealed that the fatigue protocolused in this study altered the latency and magnitude of reflex responses ofthe hamstrings as well as TT in women. These changes were not found in men. Based on our results, it is conceivable that the fatigue-induced decreasein neuromuscular function with a corresponding increase in TT probably contributesto the higher incidence of ACL injuries in women.	[Behrens, Martin; Mau-Moeller, Anett; Wassermann, Franziska; Bruhn, Sven] Univ Rostock, Dept Exercise Sci, D-18055 Rostock, Germany	University of Rostock	Behrens, M (corresponding author), Univ Rostock, Dept Exercise Sci, D-18055 Rostock, Germany.	martin.behrens@uni-rostock.de	Bruhn, Sven/C-5141-2009; Behrens, Martin/H-8443-2019	Bruhn, Sven/0000-0001-5282-2071; Behrens, Martin/0000-0003-1980-3260; Mau-Moeller, Anett/0000-0002-3097-1700	German-Austrian-SwissSociety of Orthopaedic Traumatologic Sports Medicine (GOTS); Bundesinstitut fuer Sportwissenschaft (BISp)	German-Austrian-SwissSociety of Orthopaedic Traumatologic Sports Medicine (GOTS); Bundesinstitut fuer Sportwissenschaft (BISp)	This study was supported by the German-Austrian-SwissSociety of Orthopaedic Traumatologic Sports Medicine (GOTS) andthe Bundesinstitut fuer Sportwissenschaft (BISp). The funders hadno role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 1997, INT J SPORTS MED, V18, P521, DOI 10.1055/s-2007-972675; Aagaard P, 1998, AM J SPORT MED, V26, P231, DOI 10.1177/03635465980260021201; BEARD DJ, 1993, J BONE JOINT SURG BR, V75, P311, DOI 10.1302/0301-620X.75B2.8444956; Behrens M, 2012, INT J SPORTS MED, V33, P600, DOI 10.1055/s-0032-1304642; BONGIOVANNI LG, 1990, J PHYSIOL-LONDON, V423, P1; Bruhn S, 1999, ORTHOPADE, V28, P819; Bruhn S, 2011, HUM MOVEMENT SCI, V30, P1079, DOI 10.1016/j.humov.2011.07.015; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Derrick TR, 2002, MED SCI SPORT EXER, V34, P998, DOI 10.1097/00005768-200206000-00015; DUCHATEAU J, 1993, J PHYSIOL-LONDON, V471, P787, DOI 10.1113/jphysiol.1993.sp019928; Duchateau J, 2002, J PHYSIOL-LONDON, V541, P959, DOI 10.1113/jphysiol.2002.016790; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Friemert B, 2005, J NEUROPHYSIOL, V94, P3996, DOI 10.1152/jn.00410.2005; Friemert B, 2005, EXP BRAIN RES, V160, P1, DOI 10.1007/s00221-004-1980-4; Friemert B, 2010, J NEUROPHYSIOL, V103, P616, DOI 10.1152/jn.00172.2009; Gehring D, 2009, CLIN BIOMECH, V24, P82, DOI 10.1016/j.clinbiomech.2008.07.005; Gribble PA, 2004, ARCH PHYS MED REHAB, V85, P589, DOI 10.1016/j.apmr.2003.06.031; Gruber M, 2006, INT J SPORTS MED, V27, P636, DOI 10.1055/s-2005-872904; Hawkins RD, 2001, BRIT J SPORT MED, V35, P43, DOI 10.1136/bjsm.35.1.43; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hughes G, 2006, SPORTS MED, V36, P411, DOI 10.2165/00007256-200636050-00004; Johannsen H V, 1989, Br J Sports Med, V23, P165; JOHANSSON H, 1990, NEUROSCI RES, V8, P54, DOI 10.1016/0168-0102(90)90057-L; KERNELL D, 1982, EXP BRAIN RES, V46, P197; Kirkley A, 2001, AM J SPORT MED, V29, P311, DOI 10.1177/03635465010290031001; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Kvist J, 2006, KNEE, V13, P132, DOI 10.1016/j.knee.2005.12.003; MARKOLF KL, 1990, J BONE JOINT SURG AM, V72A, P557, DOI 10.2106/00004623-199072040-00014; Masci I, 2010, EUR J APPL PHYSIOL, V108, P443, DOI 10.1007/s00421-009-1226-z; McLean SG, 2007, MED SCI SPORT EXER, V39, P502, DOI 10.1249/mss.0b013e3180d47f0; Melnyk M, 2007, KNEE SURG SPORT TR A, V15, P525, DOI 10.1007/s00167-006-0226-3; Miura K, 2004, ARTHROSCOPY, V20, P414, DOI 10.1016/j.arthro.2004.01.007; Moore BD, 2002, J ELECTROMYOGR KINES, V12, P351, DOI 10.1016/S1050-6411(02)00032-9; MORE RC, 1993, AM J SPORT MED, V21, P231, DOI 10.1177/036354659302100212; Nawata K, 1999, ACTA ORTHOP SCAND, V70, P261, DOI 10.3109/17453679908997803; Price RJ, 2004, BRIT J SPORT MED, V38, P466, DOI 10.1136/bjsm.2003.005165; Racinais S, 2007, J NEUROPHYSIOL, V97, P596, DOI 10.1152/jn.00903.2006; Ramesh R, 2005, J BONE JOINT SURG BR, V87B, P800, DOI 10.1302/0301-620X.87B6.15833; ROTTO DM, 1988, J APPL PHYSIOL, V64, P2306, DOI 10.1152/jappl.1988.64.6.2306; Rozzi SL, 1999, J ATHL TRAINING, V34, P106; Rozzi SL, 1999, AM J SPORT MED, V27, P312, DOI 10.1177/03635465990270030801; TAKEDA Y, 1994, ARTHROSCOPY, V10, P140, DOI 10.1016/S0749-8063(05)80081-7; Tillin NA, 2011, MUSCLE NERVE, V43, P375, DOI 10.1002/mus.21885; Tillin NA, 2010, MED SCI SPORT EXER, V42, P781, DOI 10.1249/MSS.0b013e3181be9c7e; Tsai LC, 2009, MED SCI SPORT EXER, V41, P1952, DOI 10.1249/MSS.0b013e3181a4b266; Victor J, 2010, J ORTHOP RES, V28, P419, DOI 10.1002/jor.21019; WEISMAN G, 1980, AM J SPORT MED, V8, P24, DOI 10.1177/036354658000800105; Wojtys EM, 1996, AM J SPORT MED, V24, P615, DOI 10.1177/036354659602400509; Zebis MK, 2011, J STRENGTH COND RES, V25, P1989, DOI 10.1519/JSC.0b013e3181e501a6; Zhang LQ, 2001, J NEUROPHYSIOL, V86, P1086, DOI 10.1152/jn.2001.86.3.1086	51	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56988	10.1371/journal.pone.0056988	http://dx.doi.org/10.1371/journal.pone.0056988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23573178	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000053
J	Suzuki, T; Ikari, K; Yano, K; Inoue, E; Toyama, Y; Taniguchi, A; Yamanaka, H; Momohara, S				Suzuki, Taku; Ikari, Katsunori; Yano, Koichiro; Inoue, Eisuke; Toyama, Yoshiaki; Taniguchi, Atsuo; Yamanaka, Hisashi; Momohara, Shigeki			PADI4 and HLA-DRB1 Are Genetic Risks for Radiographic Progression in RA Patients, Independent of ACPA Status: Results from the IORRA Cohort Study	PLOS ONE			English	Article							CYCLIC CITRULLINATED PEPTIDE; EARLY RHEUMATOID-ARTHRITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISEASE-ACTIVITY; SHARED EPITOPE; JOINT DAMAGE; FUNCTIONAL HAPLOTYPE; CLINICAL-PRACTICE; JAPANESE PATIENTS; DEIMINASE TYPE-4	Introduction: Rheumatoid arthritis (RA) is a systemic, chronic inflammatory disease influenced by both genetic and environmental factors, leading to joint destruction and functional impairment. Recently, a large-scaled GWAS meta-analysis using more than 37,000 Japanese samples were conducted and 13 RA susceptibility loci were identified. However, it is not clear whether these loci have significant impact on joint destruction or not. This is the first study focused on the 13 loci to investigate independent genetic risk factors for radiographic progression in the first five years from onset of RA. Methods: Sharp/van der Heijde score of hands at 5-year disease duration, which represents joint damage, were measured retrospectively and used as an outcome variable in 865 Japanese RA patients. Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2). These putative genetic risk factors were assessed by a stepwise multiple regression analysis adjusted for possible non-genetic risk factors: autoantibody positivity (anti-citrullinated peptide antibody [ACPA] and rheumatoid factor), history of smoking, gender and age at disease onset. Results: The number of SE alleles (P = 0.002) and risk alleles of peptidyl arginine deiminase type IV gene (PADI4, P = 0.04) had significant impact on progressive joint destruction, as well as following non-genetic factors: ACPA positive (P = 0.0006), female sex (P = 0.006) and younger age of onset (P = 0.02). Conclusions: In the present study, we found that PADI4 risk allele and HLA-DRB1 shared epitope are independent genetic risks for radiographic progression in Japanese rheumatoid arthritis patients. The results of this study give important knowledge of the risks on progressive joint damage in RA patients.	[Suzuki, Taku; Ikari, Katsunori; Yano, Koichiro; Inoue, Eisuke; Taniguchi, Atsuo; Yamanaka, Hisashi; Momohara, Shigeki] Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo, Japan; [Suzuki, Taku; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo, Japan	Tokyo Women's Medical University; Keio University	Ikari, K (corresponding author), Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo, Japan.	kikari@ior.twmu.ac.jp	Toyama, Yoshiaki/K-5743-2013		Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health, Labour and Welfare; Japan Science and Technology Agency; Asahikasei Kuraray Medical Co., Ltd.; Abbott Japan Co., Ltd.; Asahikasei Pharma Corporation; Astellas Pharma Inc.; AstraZeneca K. K.; Bristol-Myers Squibb; Chugai Pharmaceutical Co., Ltd.; Daiichi Fine Chemical Co., Ltd.; Daiichi Sankyo Co., Ltd.; Dainippon Sumitomo Pharma Co., Ltd.; Dentsu, Sudler Hennessey Inc.; Eisai Co., Ltd.; GlaxoSmithKline K. K.; Hisamitsu Pharmaceutical Co., Inc.; Janssen Pharmaceutical K. K.; Japan Tobacco Inc.; Kaken Pharmaceutical Co., Ltd.; Kissei Pharmaceutical Co., Ltd.; Kowa Pharmaceutical Co., Ltd.; Mitsubishi Chemical Medience Corporation; Mitsubishi Tanabe Pharma Corporation; Mochida Pharmaceutical Co., Ltd.; MSD K. K.; Mundipharma K. K.; Nippon Chemiphar Co., Ltd.; Nippon Shinyaku Co., Ltd.; Novartis Pharma K. K.; Otsuka Pharmaceutical Co., Ltd.; Pfizer Japan Inc.; Sanofi-Aventis K. K.; Santen Pharmaceutical Co., Ltd.; Sanwa Kagaku Kenkyusho Co., Ltd.; Sekisui Medical Co., Ltd.; Taishotoyama Pharmaceutical Co., Ltd.; Takeda Pharmaceutical Company Limited; Teijin Pharma Limited; Torii Pharmaceutical Co., Ltd.; UCB Japan Co., Ltd.; ZERIA Pharmaceutical Co., Ltd.	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Asahikasei Kuraray Medical Co., Ltd.; Abbott Japan Co., Ltd.(Abbott Laboratories); Asahikasei Pharma Corporation; Astellas Pharma Inc.(Astellas Pharmaceuticals); AstraZeneca K. K.(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Chugai Pharmaceutical Co., Ltd.; Daiichi Fine Chemical Co., Ltd.(Daiichi Sankyo Company Limited); Daiichi Sankyo Co., Ltd.(Daiichi Sankyo Company Limited); Dainippon Sumitomo Pharma Co., Ltd.(Dainippon Sumitomo Pharma Co., Ltd.); Dentsu, Sudler Hennessey Inc.; Eisai Co., Ltd.(Eisai Co Ltd); GlaxoSmithKline K. K.(GlaxoSmithKline); Hisamitsu Pharmaceutical Co., Inc.; Janssen Pharmaceutical K. K.; Japan Tobacco Inc.(Japan Tobacco Inc.); Kaken Pharmaceutical Co., Ltd.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kissei Pharmaceutical Co., Ltd.(Kissei Pharmaceutical Co Ltd); Kowa Pharmaceutical Co., Ltd.; Mitsubishi Chemical Medience Corporation; Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Mochida Pharmaceutical Co., Ltd.; MSD K. K.(Merck & Company); Mundipharma K. K.; Nippon Chemiphar Co., Ltd.; Nippon Shinyaku Co., Ltd.(Nippon Shinyaku Co Ltd); Novartis Pharma K. K.(Novartis); Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); Pfizer Japan Inc.(Pfizer); Sanofi-Aventis K. K.(Sanofi-Aventis); Santen Pharmaceutical Co., Ltd.; Sanwa Kagaku Kenkyusho Co., Ltd.; Sekisui Medical Co., Ltd.; Taishotoyama Pharmaceutical Co., Ltd.; Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd); Teijin Pharma Limited(Teijin Pharma Limited); Torii Pharmaceutical Co., Ltd.; UCB Japan Co., Ltd.(UCB Pharma SA); ZERIA Pharmaceutical Co., Ltd.(Zeria Pharmaceutical Co Ltd)	This work was supported by grants provided by the Japanese Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research (KI), the Japanese Ministry of Health, Labour and Welfare (SM, HY) and the Japan Science and Technology Agency (HY). The IORRA cohort was supported by non-restricted research grants from commercial companies (Asahikasei Kuraray Medical Co., Ltd., Abbott Japan Co., Ltd., Asahikasei Pharma Corporation, Astellas Pharma Inc., AstraZeneca K. K., Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd., Daiichi Fine Chemical Co., Ltd., Daiichi Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Dentsu, Sudler & Hennessey Inc., Eisai Co., Ltd., GlaxoSmithKline K. K., Hisamitsu Pharmaceutical Co., Inc., Janssen Pharmaceutical K. K., Japan Tobacco Inc., Kaken Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., Kowa Pharmaceutical Co., Ltd., Mitsubishi Chemical Medience Corporation, Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., MSD K. K., Mundipharma K. K., Nippon Chemiphar Co., Ltd., Nippon Shinyaku Co., Ltd., Novartis Pharma K. K., Otsuka Pharmaceutical Co., Ltd., Pfizer Japan Inc., Sanofi-Aventis K. K., Santen Pharmaceutical Co., Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Sekisui Medical Co., Ltd., Taishotoyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, Torii Pharmaceutical Co., Ltd., UCB Japan Co., Ltd., ZERIA Pharmaceutical Co., Ltd.). However, these funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aletaha D, 2009, ARTHRITIS RHEUM, V60, P1242, DOI 10.1002/art.24433; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bang SY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3051; Barton A, 2004, ARTHRITIS RHEUM, V50, P1117, DOI 10.1002/art.20169; Berglin E, 2006, ANN RHEUM DIS, V65, P453, DOI 10.1136/ard.2005.041376; Burr ML, 2010, ANN RHEUM DIS, V69, P666, DOI 10.1136/ard.2009.111294; Cha S, 2007, ARTHRITIS RHEUM-US, V56, P1454, DOI 10.1002/art.22570; de Vries-Bouwstra JK, 2008, ARTHRITIS RHEUM-US, V58, P1293, DOI 10.1002/art.23439; Forslind K, 2004, ANN RHEUM DIS, V63, P1090, DOI 10.1136/ard.2003.014233; Gorman JD, 2004, ARTHRITIS RHEUM-US, V50, P400, DOI 10.1002/art.20006; Harris ML, 2008, ARTHRITIS RHEUM-US, V58, P1958, DOI 10.1002/art.23596; Hoppe B, 2009, ANN RHEUM DIS, V68, P898, DOI 10.1136/ard.2008.091983; Ideguchi H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1943; Iwamoto T, 2006, RHEUMATOLOGY, V45, P804, DOI 10.1093/rheumatology/kel023; Kang CP, 2006, ARTHRITIS RHEUM-US, V54, P90, DOI 10.1002/art.21536; KEENE ON, 1995, STAT MED, V14, P811, DOI 10.1002/sim.4780140810; Keystone EC, 2009, J RHEUMATOL, V36, P11, DOI 10.3899/jrheum.090125; Kobayashi S, 2008, ARTHRITIS RHEUM, V58, P1940, DOI 10.1002/art.23494; Kuiper S, 2001, J RHEUMATOL, V28, P1809; Landewe R, 2005, CLIN EXP RHEUMATOL, V23, pS63; Lindqvist E, 2005, ANN RHEUM DIS, V64, P196, DOI 10.1136/ard.2003.019992; Manfredsdottir VF, 2006, RHEUMATOLOGY, V45, P734, DOI 10.1093/rheumatology/kei240; Marotte H, 2006, ANN RHEUM DIS, V65, P905, DOI 10.1136/ard.2005.036913; Martinez A, 2005, RHEUMATOLOGY, V44, P1263, DOI 10.1093/rheumatology/kei008; MCDONALD JH, 2009, HDB BIOL STAT, P160; Nakajima A, 2010, SCAND J RHEUMATOL, V39, P360, DOI 10.3109/03009741003604542; Nakajima A, 2011, MOD RHEUMATOL, V21, P594, DOI 10.1007/s10165-011-0457-0; Nishimoto K, 2010, ANN RHEUM DIS, V69, P368, DOI 10.1136/ard.2008.104315; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Pease CT, 1999, RHEUMATOLOGY, V38, P228, DOI 10.1093/rheumatology/38.3.228; Rojas-Villarraga A, 2009, J AUTOIMMUN, V32, P64, DOI 10.1016/j.jaut.2008.11.004; Shidara K, 2011, RHEUMATOL INT, V31, P617, DOI 10.1007/s00296-009-1336-2; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; Tanaka E, 2008, ANN RHEUM DIS, V67, P1153, DOI 10.1136/ard.2007.072751; Too CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4093; Tsukahara S, 2008, RHEUMATOLOGY, V47, P41, DOI 10.1093/rheumatology/kem312; van der Heijde D, 2000, J RHEUMATOL, V27, P261; VANDERHEIJDE DMFM, 1992, BRIT J RHEUMATOL, V31, P519; VanderHeijde DMFM, 1995, BRIT J RHEUMATOL, V34, P74; VANDERHEIJDE DMFM, 1991, J RHEUMATOL, V18, P1285; Wagner U, 2003, RHEUMATOLOGY, V42, P553, DOI 10.1093/rheumatology/keg190; Welsing PMJ, 2004, ARTHRITIS RHEUM-US, V50, P2082, DOI 10.1002/art.20350; Wolfe F, 2000, J RHEUMATOL, V27, P630; Yamanaka Hisashi, 2006, Mod Rheumatol, V16, P75; Yamanaka Hisashi, 2007, Mod Rheumatol, V17, P283, DOI 10.1007/s10165-007-0587-6; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	51	41	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61045	10.1371/journal.pone.0061045	http://dx.doi.org/10.1371/journal.pone.0061045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577190	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000095
J	de-Torres, JP; Blanco, D; Alcaide, AB; Seijo, LM; Bastarrika, G; Pajares, MJ; Munoz-Barrutia, A; Ortiz-de-Solorzano, C; Pio, R; Campo, A; Montes, U; Segura, V; Pueyo, J; Montuenga, LM; Zulueta, JJ				de-Torres, Juan P.; Blanco, David; Alcaide, Ana B.; Seijo, Luis M.; Bastarrika, Gorka; Jose Pajares, Maria; Munoz-Barrutia, Arrate; Ortiz-de-Solorzano, Carlos; Pio, Ruben; Campo, Arantza; Montes, Usua; Segura, Victor; Pueyo, Jesus; Montuenga, Luis M.; Zulueta, Javier J.			Smokers with CT Detected Emphysema and No Airway Obstruction Have Decreased Plasma Levels of EGF, IL-15, IL-8 and IL-1ra	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; GROWTH-FACTOR RECEPTOR; LUNG-CANCER; COMPUTED-TOMOGRAPHY; PULMONARY-DISEASE; RISK; INFLAMMATION; ASSOCIATION; BURDEN; COPD	Rationale: Low-grade inflammation and emphysema have been shown to be associated with an increased risk of lung cancer. However, the systemic inflammatory response in patients with emphysema is still unknown. Objective: To compare the plasma cytokine profiles in two groups of current or former smokers without airway obstruction: a control group of individuals without computed tomography (CT) detected emphysema vs. a study group of individuals with CT detected emphysema. Methods: Subjects underwent a chest CT, spirometry, and determination of EGF, IL-15, IL-1ra, IL-8, MCP-1, MIP-1 beta, TGF alpha, TNF alpha, and VEGF levels in plasma. Cytokine levels in each group were compared adjusting for confounding factors. Results: 160 current smokers and former smokers without airway obstruction participated in the study: 80 without emphysema and 80 subjects with emphysema. Adjusted group comparisons revealed significant reductions in EGF (-0.317, p = 0.01), IL-15 (-0.21, p = 0.01), IL-8 (-0.180, p = 0.02) and IL-1ra (-0.220, p = 0.03) in subjects with emphysema and normal spirometry. Conclusions: Current or former smokers expressing a well-defined disease characteristic such as emphysema, has a specific plasma cytokine profile. This includes a decrease of cytokines mainly implicated in activation of apoptosis or decrease of immunosurveillance. This information should be taken into account when evaluated patients with tobacco respiratory diseases.	[de-Torres, Juan P.; Alcaide, Ana B.; Seijo, Luis M.; Campo, Arantza; Montes, Usua; Zulueta, Javier J.] Univ Navarra, Univ Navarra Clin, Dept Pulm, E-31080 Pamplona, Spain; [Bastarrika, Gorka; Pueyo, Jesus] Univ Navarra, Univ Navarra Clin, Dept Radiol, E-31080 Pamplona, Spain; [Blanco, David; Jose Pajares, Maria; Munoz-Barrutia, Arrate; Ortiz-de-Solorzano, Carlos; Pio, Ruben; Montes, Usua; Segura, Victor; Montuenga, Luis M.] Univ Navarra, Ctr Appl Med Res, E-31080 Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra	de-Torres, JP (corresponding author), Univ Navarra, Univ Navarra Clin, Dept Pulm, E-31080 Pamplona, Spain.	jupa65@hotmail.com	Zulueta, Javier J/H-5127-2011; Campo, Arantza/F-9487-2017; Montuenga, Luis M/AAF-7783-2020; Ortiz-de-Solorzano, Carlos/G-3278-2010; Pio, Ruben/F-5353-2017; Segura, Victor/E-4531-2010; Zulueta, Javier J/GXZ-5810-2022; Munoz-Barrutia, Arrate/G-1776-2016; /P-5869-2014	Zulueta, Javier J/0000-0003-3182-3555; Campo, Arantza/0000-0001-9700-4355; Montuenga, Luis M/0000-0002-8739-1387; Ortiz-de-Solorzano, Carlos/0000-0001-8720-0205; Pio, Ruben/0000-0002-6831-6111; Segura, Victor/0000-0002-7740-6290; Munoz-Barrutia, Arrate/0000-0002-1573-1661; Seijo, Luis/0000-0001-9344-728X; /0000-0001-7867-0010; de Torres, Juan Pablo/0000-0003-1231-4894; Alcaide Ocana, Ana Belen/0000-0003-0733-3564	ISCIII (Ministry of Health, Government of Spain) [PI070792, RD12/0036/0040, RD12/0036/0062]; FIS [PI10/01652]; UTE project CIMA	ISCIII (Ministry of Health, Government of Spain); FIS(Instituto de Salud Carlos III); UTE project CIMA	Financially supported by ISCIII (Ministry of Health, Government of Spain) research grants noPI070792, RD12/0036/0040, RD12/0036/0062, the FIS research grant noPI10/01652, and "UTE project CIMA". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Bastarrika G, 2005, AM J RESP CRIT CARE, V171, P1378, DOI 10.1164/rccm.200411-1479OC; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Carbo N, 2000, BRIT J CANCER, V83, P526, DOI 10.1054/bjoc.2000.1299; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Chung KF, 2001, EUR RESPIR J, V18, p50S, DOI 10.1183/09031936.01.00229701; DAVID H, 1988, PATHOL RES PRACT, V183, P356, DOI 10.1016/S0344-0338(88)80138-9; Dayer JM, 2002, CLIN EXP RHEUMATOL, V20, pS14; de Torres JP, 2006, EUR RESPIR J, V27, P902, DOI 10.1183/09031936.06.00109605; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Global Initiative for Chronic Obstructive Lung Disease, 2008, GLOB STRAT DIAGN MAN; Hasan SU, 1996, AM J RESP CRIT CARE, V154, P1579, DOI 10.1164/ajrccm.154.5.8912785; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Ishii M, 2008, J GERONTOL A-BIOL, V63, P1289, DOI 10.1093/gerona/63.12.1289; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Kurosaki H, 2009, INTERNAL MED, V48, P41, DOI 10.2169/internalmedicine.48.1102; Lemos-Gonzalez Y, 2007, BRIT J CANCER, V96, P1569, DOI 10.1038/sj.bjc.6603770; Lind H, 2005, LUNG CANCER, V50, P285, DOI 10.1016/j.lungcan.2005.07.003; Madani A, 2006, RADIOLOGY, V238, P1036, DOI 10.1148/radiol.2382042196; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mian MF, 2009, MOL IMMUNOL, V46, P3108, DOI 10.1016/j.molimm.2009.06.009; Papaioannou AI, 2010, RESP MED, V104, P275, DOI 10.1016/j.rmed.2009.09.016; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pinto-Plata V, 2007, THORAX, V62, P595, DOI 10.1136/thx.2006.064428; Roca J, 1998, EUR RESPIR J, V11, P1354, DOI 10.1183/09031936.98.11061354; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sapey E, 2009, J CLIN IMMUNOL, V29, P508, DOI 10.1007/s10875-009-9286-8; Smith BM, 2012, LUNG CANCER, V77, P58, DOI 10.1016/j.lungcan.2012.02.019; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Zeidel A, 2002, ACTA ANAESTH SCAND, V46, P959, DOI 10.1034/j.1399-6576.2002.460806.x	33	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60260	10.1371/journal.pone.0060260	http://dx.doi.org/10.1371/journal.pone.0060260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577098	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800040
J	Goto, T; Sato, A; Shimizu, M; Adachi, S; Satoh, K; Iemura, S; Natsume, T; Shibuya, H				Goto, Toshiyasu; Sato, Atsushi; Shimizu, Masahiro; Adachi, Shungo; Satoh, Kiyotoshi; Iemura, Shun-ichiro; Natsume, Tohru; Shibuya, Hiroshi			IQGAP1 Functions as a Modulator of Dishevelled Nuclear Localization in Wnt Signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BETA-CATENIN; PLANAR POLARITY; XENOPUS-LAEVIS; AXIS FORMATION; CELL ADHESION; SMALL GTPASES; C-JUN; CALMODULIN; PATHWAY	Dishevelled (DVL) is a central factor in the Wnt signaling pathway, which is highly conserved among various organisms. DVL plays important roles in transcriptional activation in the nucleus, but the molecular mechanisms underlying their nuclear localization remain unclear. In the present study, we identified IQGAP1 as a regulator of DVL function. In Xenopus embryos, depletion of IQGAP1 reduced Wnt-induced nuclear accumulation of DVL, and expression of Wnt target genes during early embryogenesis. The domains in DVL and IQGAP1 that mediated their interaction are also required for their nuclear localization. Endogenous expression of Wnt target genes was reduced by depletion of IQGAP1 during early embryogenesis, but notably not by depletion of other IQGAP family genes. Moreover, expression of Wnt target genes caused by depletion of endogenous IQGAP1 could be rescued by expression of wild-type IQGAP1, but not IQGAP1 deleting DVL binding region. These results provide the first evidence that IQGAP1 functions as a modulator in the canonical Wnt signaling pathway.	[Goto, Toshiyasu; Sato, Atsushi; Shimizu, Masahiro; Adachi, Shungo; Satoh, Kiyotoshi; Shibuya, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Bunkyo Ku, Tokyo, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Kohtoh Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); National Institute of Advanced Industrial Science & Technology (AIST)	Shibuya, H (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Bunkyo Ku, Tokyo, Japan.	shibuya.mcb@mri.tmd.ac.jp	Natsume, Tohru/M-7627-2018; Satoh, Kiyotoshi/M-3653-2017	Natsume, Tohru/0000-0002-1510-2582; Satoh, Kiyotoshi/0000-0001-6029-6534	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for scientific research from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Carnac G, 1996, DEVELOPMENT, V122, P3055; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Glinka A, 1996, MECH DEVELOP, V60, P221, DOI 10.1016/S0925-4773(96)00624-7; Gumbiner BM, 1997, CURR BIOL, V7, pR443, DOI 10.1016/S0960-9822(06)00214-4; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Klingensmith J, 1996, MECH DEVELOP, V58, P15, DOI 10.1016/S0925-4773(96)00549-7; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Laurent MN, 1997, DEVELOPMENT, V124, P4905; Lee YN, 2008, CELL SIGNAL, V20, P443, DOI 10.1016/j.cellsig.2007.11.005; Li QW, 2004, BIOCHEM BIOPH RES CO, V317, P787, DOI 10.1016/j.bbrc.2004.03.119; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Moriguchi T, 1999, J BIOL CHEM, V274, P30957, DOI 10.1074/jbc.274.43.30957; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Ohnishi E, 2010, MOL CELL BIOL, V30, P675, DOI 10.1128/MCB.00576-09; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pizzuti A, 1996, HUM MOL GENET, V5, P953, DOI 10.1093/hmg/5.7.953; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055301; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P6791, DOI 10.1073/pnas.96.12.6791; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Song DH, 2000, J BIOL CHEM, V275, P23790, DOI 10.1074/jbc.M909107199; Strovel ET, 2000, J BIOL CHEM, V275, P2399, DOI 10.1074/jbc.275.4.2399; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Weissbach L, 1998, BIOCHEM BIOPH RES CO, V251, P269, DOI 10.1006/bbrc.1998.9371; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamashiro S, 2003, CELL MOTIL CYTOSKEL, V55, P36, DOI 10.1002/cm.10109; Yamashiro S, 2007, DEV BIOL, V308, P485, DOI 10.1016/j.ydbio.2007.06.001	52	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60865	10.1371/journal.pone.0060865	http://dx.doi.org/10.1371/journal.pone.0060865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577172	Green Submitted, gold, Green Published			2022-12-27	WOS:000319109800109
J	Zhao, Y; Han, YS; Zhang, L; Wang, YC; Ma, YS; Zhang, F; Fu, D; Wang, XF				Zhao, Yuan; Han, Yusong; Zhang, Liang; Wang, Yichao; Ma, Yushui; Zhang, Feng; Fu, Da; Wang, Xiaofeng			Quantitative Assessment of the Effect of Cytochrome P450 2C9 Gene Polymorphism and Colorectal Cancer	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CARCINOGEN-METABOLIZING ENZYMES; CIGARETTE-SMOKING; CYP2C9; RISK; ASSOCIATION; MEAT; METAANALYSIS; VARIANTS; UGT1A6	CYP2C9 enzyme activity is involved in the metabolism of substances related to colorectal cancer (CRC), and it is functionally linked to a genetic polymorphism. Two allelic variants of the CYP2C9 gene, namely CYP2C9*2 and CYP2C9*3, differ from wild-type CYP2C9*1 by single amino acid substitutions. These mutated alleles encode enzymes with altered properties that are associated with impaired metabolism. In the past decade, a number of case-control studies have been carried out to investigate the relationship between the CYP2C9 polymorphism and CRC susceptibility, but the results were conflicting. To investigate this inconsistency, we performed a meta-analysis of 13 studies involving a total of 20,879 subjects for CYP2C9*2 and *3 polymorphisms to evaluate the effect of CYP2C9 on genetic susceptibility for CRC. Overall, the summary odds ratio of CRC was 0.94 (95% CI: 0.87-1.03, P = 0.18) and 1.00 (95% CI: 0.86-1.16, P = 0.99) for CYP2C9 *2 and *3 carriers, respectively. No significant results were observed in heterozygous and homozygous when compared with wild genotype for these polymorphisms. In the stratified analyses according to ethnicity, sample size, diagnostic criterion, HWE status and sex, no evidence of any gene-disease association was obtained. Our result suggest that the *2, *3 polymorphisms of CYP2C9 gene are not associated with CRC susceptibility.	[Zhao, Yuan] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Han, Yusong] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China; [Zhang, Liang; Wang, Yichao; Ma, Yushui; Zhang, Feng; Fu, Da; Wang, Xiaofeng] Fudan Univ, Zhongshan Hosp, Dept Orthopaed Surg, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Fu, D (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Orthopaed Surg, Shanghai 200433, Peoples R China.	superdafu@hotmail.com; superwangxf@hotmail.com	Fu, Da/F-1763-2013; ma, yushui/HGC-6206-2022; Fu, Da/GXF-2656-2022		China Postdoctoral Science Foundation [20100480542, 201104227]; National Natural Science Foundation of China [81201535]; Nature Science Foundation of Shanghai [12ZR1436000]; Youth Innovation Promotion Association; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Youth Innovation Promotion Association; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This work was supported by China Postdoctoral Science Foundation Funded Project (20100480542, 201104227), National Natural Science Foundation of China (81201535), Nature Science Foundation of Shanghai (12ZR1436000), Youth Innovation Promotion Association and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron JA, 2000, ANNU REV MED, V51, P511, DOI 10.1146/annurev.med.51.1.511; Bartsch H, 1999, CARCINOGENESIS, V20, P2209, DOI 10.1093/carcin/20.12.2209; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Buyukdogan M, 2009, UHOD-ULUSLAR HEMATOL, V19, P134; Calvert PM, 2002, ANN INTERN MED, V137, P603, DOI 10.7326/0003-4819-137-7-200210010-00012; Chan AT, 2004, CLIN GASTROENTEROL H, V2, P704, DOI 10.1016/S1542-3565(04)00294-0; Cleary SP, 2010, AM J EPIDEMIOL, V172, P1000, DOI 10.1093/aje/kwq245; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cotterchio M, 2008, CANCER EPIDEM BIOMAR, V17, P3098, DOI 10.1158/1055-9965.EPI-08-0341; DEVERDIER MG, 1991, INT J CANCER, V49, P520, DOI 10.1002/ijc.2910490408; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gill HJ, 1999, PHARMACOGENETICS, V9, P43, DOI 10.1097/00008571-199902000-00007; Gooderham NJ, 2001, DRUG METAB DISPOS, V29, P529; Haining RL, 1996, ARCH BIOCHEM BIOPHYS, V333, P447, DOI 10.1006/abbi.1996.0414; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kury S, 2007, CANCER EPIDEM BIOMAR, V16, P1460, DOI 10.1158/1055-9965.EPI-07-0236; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Lee CR, 2004, METHOD FIND EXP CLIN, V26, P463; Liao LH, 2007, CLIN CHIM ACTA, V380, P191, DOI 10.1016/j.cca.2007.02.033; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Martinez C, 2001, CARCINOGENESIS, V22, P1323, DOI 10.1093/carcin/22.8.1323; McGreavey LE, 2005, PHARMACOGENET GENOM, V15, P713, DOI 10.1097/01.fpc.0000174786.85238.63; NAGAO M, 1993, MUTAT RES, V290, P43, DOI 10.1016/0027-5107(93)90031-A; Northwood EL, 2010, PHARMACOGENET GENOM, V20, P315, DOI 10.1097/FPC.0b013e3283395c6a; Oda Y, 2001, MUTAT RES-GEN TOX EN, V492, P81, DOI 10.1016/S1383-5718(01)00154-1; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sainz J, 2011, ENDOCR-RELAT CANCER, V18, P265, DOI 10.1530/ERC-10-0264; Samowitz WS, 2006, CLIN GASTROENTEROL H, V4, P894, DOI 10.1016/j.cgh.2006.04.021; Schwarz UI, 2003, EUR J CLIN INVEST, V33, P23, DOI 10.1046/j.1365-2362.33.s2.6.x; SHOU MG, 1994, MOL CARCINOGEN, V10, P159, DOI 10.1002/mc.2940100307; Sugimura T, 2000, CARCINOGENESIS, V21, P387, DOI 10.1093/carcin/21.3.387; SullivanKlose TH, 1996, PHARMACOGENETICS, V6, P341, DOI 10.1097/00008571-199608000-00007; Takahashi H, 1998, PHARMACOGENETICS, V8, P365, DOI 10.1097/00008571-199810000-00001; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Tranah GJ, 2005, MOL CARCINOGEN, V44, P21, DOI 10.1002/mc.20112	36	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60607	10.1371/journal.pone.0060607	http://dx.doi.org/10.1371/journal.pone.0060607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577132	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800072
J	Pollet, TV; Cobey, KD; van der Meij, L				Pollet, Thomas V.; Cobey, Kelly D.; van der Meij, Leander			Testosterone Levels Are Negatively Associated with Childlessness in Males, but Positively Related to Offspring Count in Fathers	PLOS ONE			English	Article							SALIVARY TESTOSTERONE; REPRODUCTIVE EFFORT; LIFE-HISTORY; CHALLENGE HYPOTHESIS; ANDROGEN LEVELS; HEALTHY-MEN; WOMEN; MODEL; EVOLUTION; MARRIAGE	Variation in testosterone (T) is thought to affect the allocation of effort between reproductive and parenting strategies. Here, using a large sample of elderly American men (n = 754) and women (n = 669) we examined the relationship between T and self-reported parenthood, as well as the relationship between T and number of reported children. Results supported previous findings from the literature, showing that fathers had lower T levels than men who report no children. Furthermore, we found that among fathers T levels were positively associated with the number of children a man reports close to the end of his lifespan. Results were maintained when controlling for a number of relevant factors such as time of T sampling, participant age, educational attainment, BMI, marital status and reported number of sex partners. In contrast, T was not associated with either motherhood or the number of children women had, suggesting that, at least in this sample, T does not influence the allocation of effort between reproductive and parenting strategies among women. Findings from this study contribute to the growing body of literature suggesting that, among men, pair bonding and paternal care are associated with lower T levels, while searching and acquiring sex partners is associated with higher T levels.	[Pollet, Thomas V.; van der Meij, Leander] Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands; [Cobey, Kelly D.] Univ Groningen, Dept Social Psychol, Groningen, Netherlands	Vrije Universiteit Amsterdam; University of Groningen	Pollet, TV (corresponding author), Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands.	t.v.pollet@vu.nl	Pollet, Thomas V/H-3397-2012; Pollet, Thomas/M-6346-2019; van der Meij, Leander/AAC-8945-2019; Cobey, Kelly D/AAA-5463-2020	Pollet, Thomas V/0000-0002-4210-935X; Pollet, Thomas/0000-0002-4210-935X; van der Meij, Leander/0000-0001-6394-3071; Cobey, Kelly D/0000-0003-2797-1686	National Institutes of Health [R01-AG021487, R37-AG030481, R01-AG033903]; National Institute on Aging, Office of Research on Women's Health; Office of AIDS Research; National Opinion Research Centre; NATIONAL INSTITUTE ON AGING [R37AG030481, R01AG021487, R01AG033903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging, Office of Research on Women's Health; Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Opinion Research Centre; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project used data collected as part of the National Social Life, Health, and Aging Project (NSHAP), and the authors are grateful to these researchers for making the data publicly available via www.icpsr.umich.edu. The formal acknowledgement can be found here: http://www.norc.org/Research/Projects/Pages/national-social-life-health-and-aging-project.aspx. NSHAP is supported by the National Institutes of Health (R01-AG021487), (R37-AG030481), and (R01-AG033903) including: National Institute on Aging, Office of Research on Women's Health and the Office of AIDS Research. Additional financial support was provided by National Opinion Research Centre. The views expressed in this paper are those of the authors and not of the ICPSR, NORC or NSHAP team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abma J. C., 1998, FERTILITY FAMILY PLA; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alvergne A, 2009, HORM BEHAV, V56, P491, DOI 10.1016/j.yhbeh.2009.07.013; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Barrett ES, 2013, HORM BEHAV, V63, P72, DOI 10.1016/j.yhbeh.2012.10.012; Berg SJ, 2001, MAYO CLIN PROC, V76, P582; Berk R, 2008, J QUANT CRIMINOL, V24, P269, DOI 10.1007/s10940-008-9048-4; BOGAERT AF, 1995, J SEX RES, V32, P119, DOI 10.1080/00224499509551782; BOOTH A, 1993, SOC FORCES, V72, P463, DOI 10.2307/2579857; BREMNER WJ, 1983, J CLIN ENDOCR METAB, V56, P1278, DOI 10.1210/jcem-56-6-1278; Bribiescas RG, 2001, YEARB PHYS ANTHROPOL, V44, P148, DOI 10.1002/ajpa.10025; Bribiescas RG, 2012, CURR ANTHROPOL, V53, pS424, DOI 10.1086/667538; Bribiescas RG, 2010, ANN NY ACAD SCI, V1204, P54, DOI 10.1111/j.1749-6632.2010.05524.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burnham TC, 2003, HORM BEHAV, V44, P119, DOI 10.1016/S0018-506X(03)00125-9; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; DABBS JM, 1992, PHYSIOL BEHAV, V52, P195, DOI 10.1016/0031-9384(92)90453-9; Davison SL, 2005, J CLIN ENDOCR METAB, V90, P3847, DOI 10.1210/jc.2005-0212; ELLIS L, 1992, STEROIDS, V57, P72, DOI 10.1016/0039-128X(92)90032-5; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Falk RT, 2002, BRIT J CANCER, V87, P54, DOI 10.1038/sj.bjc.6600339; Fleming AS, 2002, HORM BEHAV, V42, P399, DOI 10.1006/hbeh.2002.1840; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Geary DC, 2000, PSYCHOL BULL, V126, P55, DOI 10.1037/0033-2909.126.1.55; Gettler LT, 2011, HORM BEHAV, V60, P599, DOI 10.1016/j.yhbeh.2011.08.009; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; Gettler LT, 2010, AM ANTHROPOL, V112, P7, DOI 10.1111/j.1548-1433.2009.01193.x; Gray PB, 2007, HORM BEHAV, V52, P499, DOI 10.1016/j.yhbeh.2007.07.005; Gray PB, 2006, P ROY SOC B-BIOL SCI, V273, P333, DOI 10.1098/rspb.2005.3311; Gray PB, 2004, HUM NATURE-INT BIOS, V15, P119, DOI 10.1007/s12110-004-1016-6; Gray PB, 2002, EVOL HUM BEHAV, V23, P193, DOI 10.1016/S1090-5138(01)00101-5; Gray Peter B., 2010, FATHERHOOD EVOLUTION; GURAK DT, 1978, SOC SCI QUART, V59, P295; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; HELLHAMMER DH, 1985, PSYCHONEUROENDOCRINO, V10, P77, DOI 10.1016/0306-4530(85)90041-1; Hogan DP, 2000, AM J PUBLIC HEALTH, V90, P1421, DOI 10.2105/AJPH.90.9.1421; Kuzawa CW, 2010, HORM BEHAV, V57, P441, DOI 10.1016/j.yhbeh.2010.01.014; Kuzawa CW, 2009, HORM BEHAV, V56, P429, DOI 10.1016/j.yhbeh.2009.07.010; Mazur A, 1998, SOC FORCES, V77, P315, DOI 10.2307/3006019; McGlothlin JW, 2007, AM NAT, V170, P864, DOI 10.1086/522838; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; Muller MN, 2009, P ROY SOC B-BIOL SCI, V276, P347, DOI 10.1098/rspb.2008.1028; NORC, NAT SOC LIF HLTH AG; Peters M, 2008, ANIM BEHAV, V76, P297, DOI 10.1016/j.anbehav.2008.02.008; Pierik FH, 2000, INT J ANDROL, V23, P340, DOI 10.1046/j.1365-2605.2000.00250.x; Pollard TM, 2006, AM J HUM BIOL, V18, P741, DOI 10.1002/ajhb.20526; Pollet TV, 2011, HORM BEHAV, V60, P72, DOI 10.1016/j.yhbeh.2011.03.005; Raftery AE, 1996, BIOMETRIKA, V83, P251, DOI 10.1093/biomet/83.2.251; Roney JR, 2007, HORM BEHAV, V52, P326, DOI 10.1016/j.yhbeh.2007.05.008; Sakaguchi K, 2006, PERS INDIV DIFFER, V41, P1077, DOI 10.1016/j.paid.2006.04.013; Salimetrics, 2010, SAL TEST ENZ IMM KIT; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stewart TM, 2009, HUM REPROD, V24, P1561, DOI 10.1093/humrep/dep075; Storey AE, 2000, EVOL HUM BEHAV, V21, P79, DOI 10.1016/S1090-5138(99)00042-2; Storey AE, 2011, HORM BEHAV, V60, P353, DOI 10.1016/j.yhbeh.2011.07.001; TENOVER JS, 1988, J GERONTOL, V43, pM163, DOI 10.1093/geronj/43.6.M163; van Anders SM, 2006, PSYCHONEUROENDOCRINO, V31, P715, DOI 10.1016/j.psyneuen.2006.01.008; van Anders SM, 2012, HORM BEHAV, V61, P31, DOI 10.1016/j.yhbeh.2011.09.012; van der Meij L, 2008, HORM BEHAV, V54, P640, DOI 10.1016/j.yhbeh.2008.07.001; van der Meij L, 2012, P ROY SOC B-BIOL SCI, V279, P202, DOI 10.1098/rspb.2011.0764; Waite LJ, 2010, NATL SOCIAL LIFE HLT, P7; Walker William H, 2011, Spermatogenesis, V1, P116; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134	64	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60018	10.1371/journal.pone.0060018	http://dx.doi.org/10.1371/journal.pone.0060018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573228	Green Accepted, gold, Green Published			2022-12-27	WOS:000318840100041
J	Reda, AA; Biadgilign, S; Deribew, A; Gebre, B; Deribe, K				Reda, Ayalu A.; Biadgilign, Sibhatu; Deribew, Amare; Gebre, Betemariam; Deribe, Kebede			Predictors of Change in CD4 Lymphocyte Count and Weight among HIV Infected Patients on Anti-Retroviral Treatment in Ethiopia: A Retrospective Longitudinal Study	PLOS ONE			English	Article							THERAPY; AIDS; MORTALITY; IMPACT; HAART	Background: Antiretroviral treatment (ART) has been introduced in Ethiopia a decade ago and continues to be scaled up. However, there is dearth of literature on the impact of ART on changes in CD4 lymphocyte count and weight among patients on treatment. Objective: To determine the predictors of change in CD4 lymphocyte count and weight among HIV/AIDS infected patients taking antiretroviral treatment in eastern Ethiopia. Methods: A retrospective cohort study was conducted among HIV/AIDS patients taking ART from 2005 to 2010. A sample of 1540 HIV infected adult patients who started antiretroviral therapy in hospitals located in eastern Ethiopia were included in the study. The primary outcomes of interest were changes in CD4 count and weight. Descriptive statistics and multivariable regression analyses were performed to examine the outcomes among the cohort. Results: Both the median CD4 lymphocyte counts and weight showed improvements in the follow up periods. The multivariate analysis shows that the duration of ART was an important predictor of improvements in CD4 lymphocyte count (beta 7.91; 95% CI 7.48-8.34; p 0.000) and weight (beta 0.15; 95% CI 0.13-0.18; p 0.000). Advanced WHO clinical stage, lower baseline CD4 cell count, and baseline hemoglobin levels were factors associated with decline in weight. Actively working patients had higher CD4 lymphocyte count and weight compared to those that were ambulatory (p<0.05). Conclusion: We detected a substantial increment in weight and CD4 lymphocyte count among the patients who were taking ART in eastern Ethiopia. Patients who are of older age, with low initial CD4 lymphocyte count, late stage of the WHO clinical stages and lower hemoglobin level may need special attention. The reasons for the improved findings on CD4 count and weight throughout the five years of follow up merit further investigation.	[Reda, Ayalu A.] Brown Univ, PSTC, Providence, RI 02912 USA; [Biadgilign, Sibhatu; Deribew, Amare] Jimma Univ, Dept Epidemiol & Biostat, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Gebre, Betemariam] Med Emergency Relief Int Merlin, Country Off, Addis Ababa, Ethiopia; [Deribe, Kebede] Brighton & Sussex Med Sch, Brighton, E Sussex, England	Brown University; Jimma University; University of Brighton; University of Sussex	Reda, AA (corresponding author), Brown Univ, PSTC, Providence, RI 02912 USA.	alex_reda@brown.edu	Deribe, Kebede/K-7055-2019; Deribe, Kebede/I-5422-2019	Deribe, Kebede/0000-0002-8526-6996; Deribew, Amare/0000-0003-2031-6080; Biadgilign, Sibhatu/0000-0002-7582-5977	Haramaya University	Haramaya University	Haramaya University funded this study (www.haramaya.edu.et). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 2004, HIV MED, V5, P55, DOI 10.1111/j.1468-1293.2004.00186.x; Biadgilign S, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-15; Grinspoon S, 2003, CLIN INFECT DIS, V36, pS69, DOI 10.1086/367561; [HAPCO MOH Ethiopian HIV/AIDS Prevention and Control Office], 2007, GUID MAN OPP INF ANT; Hirschel B, 1999, AIDS, V13, pS177; Huruy K, 2020, AIDS RES THERAPY, V7; Jacobson Lisa P, 2004, Curr HIV/AIDS Rep, V1, P74, DOI 10.1007/s11904-004-0011-1; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; LEVY JA, 1993, AIDS, V7, P1401, DOI 10.1097/00002030-199311000-00001; Li N, 2012, AIDS, V26, P577, DOI 10.1097/QAD.0b013e32834f9851; Mangili A, 2006, CLIN INFECT DIS, V42, P836, DOI 10.1086/500398; Mariz CD, 2011, CAD SAUDE PUBLICA, V27, P1997; Masaisa F, 2011, AM J TROP MED HYG, V84, P456, DOI 10.4269/ajtmh.2011.10-0519; Modjarrad K, 2010, LANCET INFECT DIS, V10, P455, DOI 10.1016/S1473-3099(10)70093-1; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Oyomopito R, 2010, HIV MED, V11, P519, DOI 10.1111/j.1468-1293.2010.00822.x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rabe-Hasketh S, 2007, MULTIPLE REGRESSION; Resino S, 2002, ARCH DIS CHILD, V86, P119, DOI 10.1136/adc.86.2.119; Siegel K, 2002, AIDS, V16, pS69, DOI 10.1097/00002030-200216004-00010; Silva M, 1998, AIDS, V12, P1645, DOI 10.1097/00002030-199813000-00012; Tafese Zelalem, 2012, Ethiop Med J, V50, P75; UNAIDS, 2010, GLOB REP UNAIDS REP; Verweel G, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e25; Yamashita TE, 2001, AIDS, V15, P735, DOI 10.1097/00002030-200104130-00009	25	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e58595	10.1371/journal.pone.0058595	http://dx.doi.org/10.1371/journal.pone.0058595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573191	gold, Green Submitted, Green Published			2022-12-27	WOS:000318840100010
J	Strain, MC; Lada, SM; Luong, T; Rought, SE; Gianella, S; Terry, VH; Spina, CA; Woelk, CH; Richman, DD				Strain, Matthew C.; Lada, Steven M.; Luong, Tiffany; Rought, Steffney E.; Gianella, Sara; Terry, Valeri H.; Spina, Celsa A.; Woelk, Christopher H.; Richman, Douglas D.			Highly Precise Measurement of HIV DNA by Droplet Digital PCR	PLOS ONE			English	Article							MESSENGER-RNA; COPY NUMBER; TAR RNA; PLASMA; INFECTION; LYMPHOCYTES; BINDING; PROTEIN; ASSAY; AIDS	Deoxyribonucleic acid (DNA) of the human immunodeficiency virus (HIV) provides the most sensitive measurement of residual infection in patients on effective combination antiretroviral therapy (cART). Droplet digital PCR (ddPCR) has recently been shown to provide highly accurate quantification of DNA copy number, but its application to quantification of HIV DNA, or other equally rare targets, has not been reported. This paper demonstrates and analyzes the application of ddPCR to measure the frequency of total HIV DNA (pol copies per million cells), and episomal 2-LTR (long terminal repeat) circles in cells isolated from infected patients. Analysis of over 300 clinical samples, including over 150 clinical samples assayed in triplicate by ddPCR and by real-time PCR (qPCR), demonstrates a significant increase in precision, with an average 5-fold decrease in the coefficient of variation of pol copy numbers and a >20-fold accuracy improvement for 2-LTR circles. Additional benefits of the ddPCR assay over qPCR include absolute quantification without reliance on an external standard and relative insensitivity to mismatches in primer and probe sequences. These features make digital PCR an attractive alternative for measurement of HIV DNA in clinical specimens. The improved sensitivity and precision of measurement of these rare events should facilitate measurements to characterize the latent HIV reservoir and interventions to eradicate it.	[Strain, Matthew C.; Lada, Steven M.; Luong, Tiffany; Rought, Steffney E.; Gianella, Sara; Terry, Valeri H.; Spina, Celsa A.; Woelk, Christopher H.; Richman, Douglas D.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Strain, Matthew C.; Lada, Steven M.; Luong, Tiffany; Rought, Steffney E.; Gianella, Sara; Terry, Valeri H.; Spina, Celsa A.; Woelk, Christopher H.; Richman, Douglas D.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Strain, MC (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	mstrain@ucsd.edu		Luong, Tiffany/0000-0002-5825-9248; Gianella, Sara/0000-0002-9927-0849; Woelk, Christopher/0000-0002-1977-0502; Strain, Matthew/0000-0002-0726-8814	Department of Veterans Affairs; James Pendleton Charitable Trust; National Institutes of Health (NIH) [AI69432, AI043638, MH62512, MH083552, AI077304, AI047745, AI74621, GM093939, AI080353, AI306214, AI096113]; Swiss National Science Foundation [PBZHP3-125533]; Gustav and Ruth Jacob Foundation (Switzerland); National Institute of General Medical Sciences [GM093939]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080353, U19AI096113, R24AI106039, UM1AI069432, P01AI074621, U01AI043638, U01AI069432, R56AI047745, R21AI077304, R21AI047745, R01AI047745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083552, P30MH062512] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); James Pendleton Charitable Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gustav and Ruth Jacob Foundation (Switzerland); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Department of Veterans Affairs, the James Pendleton Charitable Trust, by the National Institutes of Health (NIH) awards AI69432, AI043638, MH62512, MH083552, AI077304, AI047745, AI74621, GM093939 and AI080353, AI306214 (CFAR), AI096113 (Collaboratory for AIDS Research on Eradication [CARE]; Swiss National Science Foundation grant PBZHP3-125533; Gustav and Ruth Jacob Foundation (Switzerland); and the National Institute of General Medical Sciences grant GM093939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CF, 2010, J VIROL METHODS, V165, P151, DOI 10.1016/j.jviromet.2010.01.012; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Caliendo A M, 1995, AIDS Clin Care, V7, P89; Caliendo AM, 1995, AIDS CLIN CARE, V7, P93; Caliendo AM, 1995, AIDS CLIN CARE, V7, P96; DALY TJ, 1995, J MOL BIOL, V253, P243, DOI 10.1006/jmbi.1995.0549; EVERALL IP, 1995, NAT MED, V1, P1174, DOI 10.1038/nm1195-1174; Fan HC, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.03.002; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Kreutz JE, 2011, ANAL CHEM, V83, P8158, DOI 10.1021/ac201658s; Linnet K, 2004, CLIN CHEM, V50, P732, DOI 10.1373/clinchem.2003.029983; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; MENDEL I, 1995, J MED VIROL, V47, P231, DOI 10.1002/jmv.1890470308; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; SAKSELA K, 1995, ANN INTERN MED, V123, P641, DOI 10.7326/0003-4819-123-9-199511010-00001; Sanders R, 2011, ANAL CHEM, V83, P6474, DOI 10.1021/ac103230c; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Tadmor AD, 2011, SCIENCE, V333, P58, DOI 10.1126/science.1200758; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang JH, 1995, ANAL BIOCHEM, V232, P238, DOI 10.1006/abio.1995.0013; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; White RA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-116; White RA, 2012, J VIROL METHODS, V179, P45, DOI 10.1016/j.jviromet.2011.09.017; WUBAER F, 1995, EMBO J, V14, P5995, DOI 10.1002/j.1460-2075.1995.tb00288.x; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622	28	369	392	14	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e55943	10.1371/journal.pone.0055943	http://dx.doi.org/10.1371/journal.pone.0055943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573183	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000318840100002
J	Yoo, SS; Kim, H; Filandrianos, E; Taghados, SJ; Park, S				Yoo, Seung-Schik; Kim, Hyungmin; Filandrianos, Emmanuel; Taghados, Seyed Javid; Park, Shinsuk			Non-Invasive Brain-to-Brain Interface (BBI): Establishing Functional Links between Two Brains	PLOS ONE			English	Article							FOCUSED ULTRASOUND; COMPUTER INTERFACES; REAL-TIME; NAVIGATION; INTENSITY; DEVICE; CORTEX; FMRI	Transcranial focused ultrasound (FUS) is capable of modulating the neural activity of specific brain regions, with a potential role as a non-invasive computer-to-brain interface (CBI). In conjunction with the use of brain-to-computer interface (BCI) techniques that translate brain function to generate computer commands, we investigated the feasibility of using the FUS-based CBI to non-invasively establish a functional link between the brains of different species (i.e. human and Sprague-Dawley rat), thus creating a brain-to-brain interface (BBI). The implementation was aimed to non-invasively translate the human volunteer's intention to stimulate a rat's brain motor area that is responsible for the tail movement. The volunteer initiated the intention by looking at a strobe light flicker on a computer display, and the degree of synchronization in the electroencephalographic steady-state-visual-evoked-potentials (SSVEP) with respect to the strobe frequency was analyzed using a computer. Increased signal amplitude in the SSVEP, indicating the volunteer's intention, triggered the delivery of a burst-mode FUS (350 kHz ultrasound frequency, tone burst duration of 0.5 ms, pulse repetition frequency of 1 kHz, given for 300 msec duration) to excite the motor area of an anesthetized rat transcranially. The successful excitation subsequently elicited the tail movement, which was detected by a motion sensor. The interface was achieved at 94.0 +/- 3.0% accuracy, with a time delay of 1.59 +/- 1.07 sec from the thought-initiation to the creation of the tail movement. Our results demonstrate the feasibility of a computer-mediated BBI that links central neural functions between two biological entities, which may confer unexplored opportunities in the study of neuroscience with potential implications for therapeutic applications.	[Yoo, Seung-Schik; Kim, Hyungmin] Harvard Univ, Brigham & Womens Hosp, Dept Radiol, Sch Med, Boston, MA 02115 USA; [Kim, Hyungmin; Park, Shinsuk] Korea Univ, Dept Mech Engn, Seoul, South Korea; [Filandrianos, Emmanuel; Taghados, Seyed Javid] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Yoo, Seung-Schik] Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan, South Korea; [Yoo, Seung-Schik; Kim, Hyungmin] Korea Inst Sci & Technol, Ctr Bion, Seoul, South Korea	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Korea University; Boston University; Ulsan National Institute of Science & Technology (UNIST); Korea Institute of Science & Technology (KIST)	Yoo, SS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Radiol, Sch Med, Boston, MA 02115 USA.	yoo@bwh.harvard.edu	Kim, Hyungmin/F-8303-2013	Kim, Hyungmin/0000-0001-9527-0609	National Institutes of Health [R21 NS074124]; KIST Institutional Program [2E23031]; UNIST grant; National Research Foundation of Korea (Korean Ministry of Education, Science and Technology) [2010-0027294]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KIST Institutional Program(Korea Institute of Science & Technology (KIST)); UNIST grant; National Research Foundation of Korea (Korean Ministry of Education, Science and Technology); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (R21 NS074124 to SSY), KIST Institutional Program (2E23031 to SSY and HMK), UNIST grant (to SSY), and National Research Foundation of Korea (Korean Ministry of Education, Science and Technology, 2010-0027294 to SSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026007; Allison B, 2010, IEEE T NEUR SYS REH, V18, P107, DOI 10.1109/TNSRE.2009.2039495; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; FRY FJ, 1958, SCIENCE, V127, P83, DOI 10.1126/science.127.3289.83; Galan F, 2008, CLIN NEUROPHYSIOL, V119, P2159, DOI 10.1016/j.clinph.2008.06.001; Guger C, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00169; Haghighi SS, 1998, NEUROL RES, V20, P555; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hoy KE, 2010, NAT REV NEUROL, V6, P267, DOI 10.1038/nrneurol.2010.30; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Lee JH, 2008, HUM BRAIN MAPP, V29, P157, DOI 10.1002/hbm.20377; Liao LD, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-5; Linden RD, 1999, J NEUROSURG, V91, P205, DOI 10.3171/spi.1999.91.2.0205; Martin E, 2009, ANN NEUROL, V66, P858, DOI 10.1002/ana.21801; McDannold N, 2010, NEUROSURGERY, V66, P323, DOI 10.1227/01.NEU.0000360379.95800.2F; Min BK, 2011, INT J IMAG SYST TECH, V21, P232, DOI 10.1002/ima.20284; Min BK, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-23; Min BK, 2010, TRENDS BIOTECHNOL, V28, P552, DOI 10.1016/j.tibtech.2010.08.002; Naor O, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026006; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; O'Doherty JE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.020.2009; Ostrow LW, 2011, BIOCHEM BIOPH RES CO, V410, P81, DOI 10.1016/j.bbrc.2011.05.109; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Presacco A, 2012, IEEE T NEUR SYS REH, V20, P212, DOI 10.1109/TNSRE.2012.2188304; Rossini PM, 2012, EUR J PHYS REHAB MED, V48, P307; Sorger B, 2012, CURR BIOL, V22, P1333, DOI 10.1016/j.cub.2012.05.022; Sorger B, 2009, PROG BRAIN RES, V177, P275, DOI 10.1016/S0079-6123(09)17719-1; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; Yang PS, 2012, NEUROPSYCHOBIOLOGY, V65, P153, DOI 10.1159/000336001; Yoo SS, 2011, NEUROIMAGE, V56, P1267, DOI 10.1016/j.neuroimage.2011.02.058; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe; Zacksenhouse M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000619	43	64	65	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60410	10.1371/journal.pone.0060410	http://dx.doi.org/10.1371/journal.pone.0060410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573251	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100066
J	Datovo, A; Vari, RP				Datovo, Alessio; Vari, Richard P.			The Jaw Adductor Muscle Complex in Teleostean Fishes: Evolution, Homologies and Revised Nomenclature (Osteichthyes: Actinopterygii)	PLOS ONE			English	Article							TREWAVAS 1933 PISCES; PHYLOGENETIC-RELATIONSHIPS; FUNCTIONAL-MORPHOLOGY; CRANIAL MORPHOLOGY; FEEDING MECHANISM; MODULATORY MULTIPLICITY; ANATOMICAL DESCRIPTION; CICHLID FISHES; HEAD-MUSCLES; PERCIFORMES	The infraclass Teleostei is a highly diversified group of bony fishes that encompasses 96% of all species of living fishes and almost half of extant vertebrates. Evolution of various morphological complexes in teleosts, particularly those involving soft anatomy, remains poorly understood. Notable among these problematic complexes is the adductor mandibulae, the muscle that provides the primary force for jaw adduction and mouth closure and whose architecture varies from a simple arrangement of two segments to an intricate complex of up to ten discrete subdivisions. The present study analyzed multiple morphological attributes of the adductor mandibulae in representatives of 53 of the 55 extant teleostean orders, as well as significant information from the literature in order to elucidate the homologies of the main subdivisions of this muscle. The traditional alphanumeric terminology applied to the four main divisions of the adductor mandibulae - A(1), A(2), A(3), and A omega - patently fails to reflect homologous components of that muscle across the expanse of the Teleostei. Some features traditionally used as landmarks for identification of some divisions of the adductor mandibulae proved highly variable across the Teleostei; notably the insertion on the maxilla and the position of muscle components relative to the path of the ramus mandibularis trigeminus nerve. The evolutionary model of gain and loss of sections of the adductor mandibulae most commonly adopted under the alphanumeric system additionally proved ontogenetically incongruent and less parsimonious than a model of subdivision and coalescence of facial muscle sections. Results of the analysis demonstrate the impossibility of adapting the alphanumeric terminology so as to reflect homologous entities across the spectrum of teleosts. A new nomenclatural scheme is proposed in order to achieve congruence between homology and nomenclature of the adductor mandibulae components across the entire Teleostei.	[Datovo, Alessio] Univ Sao Paulo, Museu Zool, Lab Ictiol, Sao Paulo, Brazil; [Datovo, Alessio] Univ Sao Paulo, Lab Ictiol Ribeirao Preto, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil; [Datovo, Alessio] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA; [Vari, Richard P.] Smithsonian Inst, Div Fishes, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Datovo, A (corresponding author), Univ Sao Paulo, Museu Zool, Lab Ictiol, Sao Paulo, Brazil.	adatovo@gmail.com	Datovo, Alessio/K-7133-2016; Datovo, Alessio/ABA-1945-2021	Datovo, Alessio/0000-0001-9117-7343	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/56445-7, 2010/18984-9]; Herbert R. and Evelyn Axelrod Chair in Systematic Ichthyology, Division of Fishes of the National Museum of Natural History, Smithsonian Institution; Office of the Associate Director for Science, National Museum of Natural History, Smithsonian Institution; FAPESP [2004/09219-6, 2009/54931-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Herbert R. and Evelyn Axelrod Chair in Systematic Ichthyology, Division of Fishes of the National Museum of Natural History, Smithsonian Institution; Office of the Associate Director for Science, National Museum of Natural History, Smithsonian Institution; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP #2006/56445-7 and #2010/18984-9); the Herbert R. and Evelyn Axelrod Chair in Systematic Ichthyology, Division of Fishes of the National Museum of Natural History, Smithsonian Institution; and The Office of the Associate Director for Science, National Museum of Natural History, Smithsonian Institution. Equipment used in this study was provided by infrastructural projects from FAPESP (#2004/09219-6 and #2009/54931-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens D, 1996, J MORPHOL, V229, P255, DOI 10.1002/(SICI)1097-4687(199609)229:3<255::AID-JMOR2>3.0.CO;2-Y; Adriaens Dominique, 2010, P337; AERTS P, 1985, J ZOOL, V205, P391; Aguilera O., 1986, Acta Biologica Venezuelica, V12, P13; Alexander R. M., 1964, Journal of the Linnean Society London, V45, P169; ALEXANDER RM, 1967, J ZOOL, V151, P233; ALEXANDER RM, 1967, J ZOOL, V151, P43; Allis EP, 1903, J MORPHOL, V18, P45, DOI 10.1002/jmor.1050180103; Allis EP, 1909, ZOOLOGICA, V57, p[i, 1]; ANKER G C, 1974, Transactions of the Zoological Society of London, V32, P311; ANKER GC, 1978, NETH J ZOOL, V28, P234, DOI 10.1163/002829678X00071; ANKER GC, 1978, NETH J ZOOL, V28, P485; BALLINTI.CM, 1972, J EXP BIOL, V57, P261; Bellwood David R., 1994, Records of the Australian Museum Supplement, V20, P1; Bemis WE, 1998, SOC VERTEBR PALEONTO, V4; Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Britz R, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)418<0001:DOOTFC>2.0.CO;2; Britz Ralf, 1996, American Museum Novitates, V3181, P1; Britzi R, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)383<0001:PLSOOI>2.0.CO;2; Cabuy E, 1999, J MORPHOL, V240, P169, DOI 10.1002/(SICI)1097-4687(199905)240:2<169::AID-JMOR7>3.0.CO;2-3; Cancino Cecilia, 1999, Revista de Biologia Marina y Oceanografia, V34, P155; CHU CT, 1989, J ZOOL, V217, P417, DOI 10.1111/j.1469-7998.1989.tb02499.x; CLEMENTS KD, 1988, AUST J MAR FRESH RES, V39, P87; Cooper WJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-24; Crowley L. E. L. M., 1995, Records of the Western Australian Museum, V17, P325; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Datovo A, 2012, ZOOTAXA, P33; Datovo A, 2012, ZOOLOGY, V115, P84, DOI 10.1016/j.zool.2011.09.008; Datovo A, 2010, NEOTROP ICHTHYOL, V8, P193, DOI 10.1590/S1679-62252010000200001; DEPINNA MCC, 1989, AM MUS NOVIT, P1; Devaere S, 2006, ZOOMORPHOLOGY, V125, P69, DOI 10.1007/s00435-005-0012-7; Devaere S, 2001, J ZOOL, V255, P235, DOI 10.1017/S0952836901001303; Dietz P. A., 1914, Mitteilungen aus der Zoologischen Station zu Neapel, V22; Dietz P. A., 1921, Mitteilungen aus der Zoologischen Station zu Neapel Berlin, V22, P433; Diogo R, 2006, BELG J ZOOL, V136, P15; Diogo R, 2000, J MORPHOL, V243, P193, DOI 10.1002/(SICI)1097-4687(200002)243:2<193::AID-JMOR8>3.0.CO;2-2; DIOGO R, 2004, MORPHOLOGICAL EVOLUT; Diogo R, 2008, ORIGIN HIGHER CLADES; Diogo R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-24; Dobben W. H. van., 1935, Archives Neerlandaises de Zoologie, V2, P1; DRUCKER EG, 1991, J MORPHOL, V210, P267, DOI 10.1002/jmor.1052100306; DUTTA HM, 1980, ZOOMORPHOLOGIE, V94, P185, DOI 10.1007/BF01081933; Dyer BS, 1996, ZOOL J LINN SOC-LOND, V117, P1; Eagderi S, 2010, J MORPHOL, V271, P1053, DOI 10.1002/jmor.10852; Eagderi S, 2010, ZOOLOGY, V113, P148, DOI 10.1016/j.zool.2009.09.004; EATON TH, 1948, J MORPHOL, V83, P181, DOI 10.1002/jmor.1050830203; Eaton TH, 1935, J MORPHOL, V58, P157, DOI 10.1002/jmor.1050580106; Eaton TH, 1943, J MORPHOL, V72, P183, DOI 10.1002/jmor.1050720107; Edgeworth FH, 1929, PHILOS T R SOC LON B, V217, P39, DOI 10.1098/rstb.1929.0002; Edgeworth FH, 1935, CRANIAL MUSCLES VERT; ELSHOUDOLDENHAVE MJW, 1976, J MORPHOL, V150, P399, DOI 10.1002/jmor.1051500210; Endo Hiromitsu, 2002, Memoirs of the Graduate School of Fisheries Sciences Hokkaido University, V49, P75; Engeman JM, 2009, J MORPHOL, V270, P291, DOI 10.1002/jmor.10688; Eschmeyer WN, 2012, SPECIES FISHES FAMIL; Fink W.L., 1982, B MUS COMP ZOOL HARV, V150, P31; Francis AW, 2008, J MORPHOL, V269, P1169, DOI 10.1002/jmor.10631; Freihofer WC, 1978, OCC PAP CAL ACAD SCI, V128; Friel JP, 1997, SYST BIOL, V46, P441, DOI 10.2307/2413691; Fujimura K, 2008, DEV GROWTH DIFFER, V50, P339, DOI [10.1111/j.1440-169x.2008.01032.x, 10.1111/j.1440-169X.2008.01032.x]; Geerinckx T, 2009, ZOOL J LINN SOC-LOND, V155, P76, DOI 10.1111/j.1096-3642.2008.00434.x; GILL AC, 1993, B MAR SCI, V52, P327; GOSLINE WA, 1986, COPEIA, P705, DOI 10.2307/1444953; GOSLINE WA, 1989, J ZOOL, V218, P649, DOI 10.1111/j.1469-7998.1989.tb05007.x; Gosline William A., 1993, Occasional Papers of the Museum of Zoology University of Michigan, V724, P1; Greenwood P.H, 1971, American Mus Novit, VNo. 2473, P1; Greenwood P. H., 1977, Bulletin Br. Mus. nat. Hist. (Zool.), V32, P65; Haas A, 2001, J MORPHOL, V247, P1, DOI 10.1002/1097-4687(200101)247:1<1::AID-JMOR1000>3.0.CO;2-3; Habegger ML, 2011, J ZOOL, V283, P63, DOI 10.1111/j.1469-7998.2010.00745.x; Hernandez LP, 2008, ZOOLOGY, V111, P442, DOI 10.1016/j.zool.2007.12.002; Hernandez LP, 2007, J EXP ZOOL PART B, V308B, P625, DOI 10.1002/jez.b.21166; Hernandez LP, 2009, J MORPHOL, V270, P645, DOI 10.1002/jmor.10711; Hernandez LP, 1997, J ZOOL, V243, P737; Hernandez LP, 2005, ANAT EMBRYOL, V209, P323, DOI 10.1007/s00429-004-0448-4; Herrick CJ, 1899, J COMP NEUROL, V9, P153; Hertwig ST, 2008, ZOOL SCR, V37, P141, DOI 10.1111/j.1463-6409.2007.00314.x; HOESE DF, 1993, B MAR SCI, V52, P415; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; HOWES G J, 1976, Bulletin of the British Museum (Natural History) Zoology, V29, P203; Howes G.J., 1988, Bulletin of the British Museum (Natural History) Zoology, V54, P1; Howes G.J., 1985, Bulletin of the British Museum (Natural History) Zoology, V49, P273; Howes G.J., 1983, Bulletin of the British Museum (Natural History) Zoology, V45, P309; Hu K, 2001, J STRUCT BIOL, V136, P46, DOI 10.1006/jsbi.2001.4417; Huysentruyt F, 2009, J FISH BIOL, V75, P1601, DOI 10.1111/j.1095-8649.2009.02386.x; Huysentruyt F, 2007, ANIM BIOL, V57, P433, DOI 10.1163/157075607782232170; Imamura H, 2003, ICHTHYOL RES, V50, P259, DOI 10.1007/s10228-003-0167-5; Imamura Hisashi, 1996, Species Diversity, V1, P123; Imamura Hisashi, 2002, Bulletin of Fisheries Sciences Hokkaido University, V53, P107; Ishida Minoru, 1994, Bulletin of Nansei National Fisheries Research Institute, V27, P1; Ishii N, 2008, ICHTHYOL RES, V55, P148, DOI 10.1007/s10228-007-0014-1; IUCN, 2012, IUCN RED LIST THREAT; Ivantsoff W, 1987, P LINN SOC N S W, V109, P331; Iwami T, 2004, ANTARCT SCI, V16, P17, DOI 10.1017/S0954102004001762; Johnson G.D., 1980, Bulletin of the Scripps Institution of Oceanography of the University of California, V24, P1; Johnson G. David, 2001, American Museum Novitates, V3312, P1, DOI 10.1206/0003-0082(2001)312<0001:TISOAF>2.0.CO;2; JOHNSON GD, 1989, P ACAD NAT SCI PHILA, V141, P1; JOHNSON GD, 1988, ZOOL J LINN SOC-LOND, V94, P65, DOI 10.1111/j.1096-3642.1988.tb00882.x; Juge M, 1898, REV SUISSE ZOOL, V6, P1; KERSHAW D R, 1976, Transactions of the Zoological Society of London, V33, P173; Konstantinidis P, 2010, J EXP ZOOL PART B, V316B, P10; LAUDER G V, 1983, Bulletin of the Museum of Comparative Zoology, V150, P95; Lauder G.V. Jr, 1980, Perspectives in Vertebrate Science, V1, P365; LAUDER GV, 1981, COPEIA, P154; Liem K.F., 1980, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V35, P299; Liem K. F., 1970, Fieldiana (Zool.), V56, P1; LIEM KF, 1975, AM ZOOL, V15, P427; LIEM KF, 1967, J MORPHOL, V121, P103, DOI 10.1002/jmor.1051210203; LIEM KF, 1979, J ZOOL, V189, P93; LIEM KF, 1967, J MORPHOL, V121, P135, DOI 10.1002/jmor.1051210204; LIEM KF, 1978, J MORPHOL, V158, P323, DOI 10.1002/jmor.1051580305; LIEM KF, 1984, J EXP BIOL, V113, P1; Luther A, 1914, ACTA SOCIET SCI FENN, V44, P1; MACHADO-ALLISON A, 1983, Acta Biologica Venezuelica, V11, P145; MAHAJAN CL, 1971, J ZOOL, V165, P163; Maie T, 2009, J MORPHOL, V270, P976, DOI 10.1002/jmor.10737; MARKLE DF, 1980, B MAR SCI, V30, P45; MARKLE DF, 1985, COPEIA, P345, DOI 10.2307/1444844; MARKLE DF, 1980, J ZOOL, V190, P225; MOTTA PJ, 1982, J MORPHOL, V174, P283, DOI 10.1002/jmor.1051740305; Munshi J. D., 1960, Indian Journal of Zootomy, V1, P59; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Odani Kenji, 2011, Bulletin of Fisheries Sciences Hokkaido University, V61, P49; Osse J. W. M., 1969, Netherlands Journal of Zoology, V19, P289; OTTEN E, 1983, NETH J ZOOL, V33, P55, DOI 10.1163/002829683X00048; OTTEN E, 1981, NETH J ZOOL, V31, P650; Owen R., 1866, ANATOMY VERTEBRATES, V1; Owen R, 1846, LECT COMP ANATOMY PH; PARENTI L R, 1989, Proceedings of the California Academy of Sciences, V46, P243; PARENTI LR, 1986, ZOOL J LINN SOC-LOND, V87, P37, DOI 10.1111/j.1096-3642.1986.tb01329.x; PATTEN JM, 1983, JPN J ICHTHYOL, V29, P329; PATTERSON C, 1975, PHILOS T R SOC B, V269, P275, DOI 10.1098/rstb.1975.0001; PIETSCH TW, 1989, COPEIA, P253, DOI 10.2307/1445425; PIETSCH TW, 1990, COPEIA, P78, DOI 10.2307/1445824; Prokofiev AM, 2007, J ICHTHYOL+, V47, P413, DOI 10.1134/; ROBERTS T R, 1971, Bulletin of the Museum of Comparative Zoology, V142, P393; Rosen D. E., 1964, Bulletin of the American Museum of Natural History, V127, P217; Rosen D.E., 1973, Zoological J Linn Soc, V53, P397; Rosen DE, 1969, B AM MUS NAT HIST, V141, P361; ROSEN DONN ERIC, 1962, AMER MUS NOVITATES, V2109, P1; Sanford CPJ, 2000, SALMONOID FISH OSTEO; Sarmento-Soares LM, 2006, J MORPHOL, V267, P187, DOI 10.1002/jmor.10395; Sasaki K, 1989, MEMORIES FACULTY FIS, V36, P1, DOI DOI 10.1007/BF02905681; Sato T, 2002, ICHTHYOL RES, V49, P25, DOI 10.1007/s102280200004; Schaefer SA, 2008, AM MUS NOVIT, P1, DOI 10.1206/625.1; Sewertzoff A.N., 1928, ACTA ZOOL-STOCKHOLM, V9, P193, DOI [10.1111/j.1463-6395.1928.tb01166.x, DOI 10.1111/J.1463-6395.1928.TB01166.X]; Shinohara G, 2005, ICHTHYOL RES, V52, P64, DOI 10.1007/s10228-004-0256-0; Shinohara Gento, 1994, Memoirs of the Faculty of Fisheries Hokkaido University, V41, P1; Staab KL, 2010, J MORPHOL, V271, P814, DOI 10.1002/jmor.10836; STARKS EC, 1916, SESAMOID ARTICULAR B; Stiassny M.L.J., 1981, Bulletin of the British Museum (Natural History) Zoology, V40, P67; STIASSNY MLJ, 1981, NETH J ZOOL, V31, P275; Stiassny MLJ, 1996, INTERRELATIONSHIPS F, P333; STIASSNY MLJ, 1990, AM MUS NOVIT, P1; Suda Y, 1996, B MAR SCI, V58, P438; Takahashi T, 2002, ICHTHYOL RES, V49, P171, DOI 10.1007/s102280200023; Takahasi N, 1925, J MORPHOL PHYSIOL, V40, P1, DOI 10.1002/jmor.1050400102; TEDMAN RA, 1980, AUST J MAR FRESH RES, V31, P351, DOI 10.1071/MF9800351; Travers R.A., 1984, Bulletin of the British Museum (Natural History) Zoology, V47, P83; Travers R.A., 1984, Bulletin of the British Museum (Natural History) Zoology, V46, P1; Van Tassell JL, 2001, COPEIA, P1073, DOI 10.1643/0045-8511(2001)001[1073:CTGANS]2.0.CO;2; VANDEWALLE P, 1995, J FISH BIOL, V46, P623, DOI 10.1111/j.1095-8649.1995.tb01101.x; VANHASSELT MJFM, 1979, NETH J ZOOL, V29, P52; Vari R.P., 1983, SMITHSON CONTRIB ZOO, V378, P60, DOI 10.5479/si.00810282.378; Vetter B., 1878, JENA Z NATURW, V12, P431; VIAL CI, 1990, REV CHIL HIST NAT, V63, P247; VIAL CI, 1992, REV CHIL HIST NAT, V65, P471; VRBA E S, 1968, Zoologica Africana, V3, P211; WESTNEAT MW, 1989, J MORPHOL, V202, P129, DOI 10.1002/jmor.1052020202; Westneat MW, 2003, J THEOR BIOL, V223, P269, DOI 10.1016/S0022-5193(03)00058-4; WESTNEAT MW, 1990, J MORPHOL, V205, P269, DOI 10.1002/jmor.1052050304; Wiley E.O., 2010, P123; Williams R.R.G., 1987, PHYLOGENETIC RELATIO; Williams Robert R. G., 1997, Records of the Australian Museum, V49, P139, DOI 10.3853/j.0067-1975.49.1997.1263; Winterbottom R., 1974, Smithsonian Contributions to Zoology, VNo. 155, P1; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; WINTERBOTTOM R, 1993, COPEIA, P21; Wu KY, 2004, ZOOL STUD, V43, P712; Yabe M, 1996, B MAR SCI, V58, P494; Yabe M., 2000, P306, DOI 10.1016/B978-044450434-0/50028-7; YABE M, 1985, Memoirs of the Faculty of Fisheries Hokkaido University, V32, P1; Yagishita N, 2003, ICHTHYOL RES, V50, P358, DOI 10.1007/s10228-003-0180-8; [No title captured]	182	56	57	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60846	10.1371/journal.pone.0060846	http://dx.doi.org/10.1371/journal.pone.0060846			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565279	gold, Green Submitted, Green Published			2022-12-27	WOS:000317717300152
J	Delgado-Baquerizo, M; Maestre, FT; Gallardo, A; Quero, JL; Ochoa, V; Garcia-Gomez, M; Escolar, C; Garcia-Palacios, P; Berdugo, M; Valencia, E; Gozalo, B; Noumi, Z; Derak, M; Wallenstein, MD				Delgado-Baquerizo, Manuel; Maestre, Fernando T.; Gallardo, Antonio; Quero, Jose L.; Ochoa, Victoria; Garcia-Gomez, Miguel; Escolar, Cristina; Garcia-Palacios, Pablo; Berdugo, Miguel; Valencia, Enrique; Gozalo, Beatriz; Noumi, Zouhaier; Derak, Mchich; Wallenstein, Matthew D.			Aridity Modulates N Availability in Arid and Semiarid Mediterranean Grasslands	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; PRECIPITATION GRADIENT; NITROGEN DYNAMICS; STIPA-TENACISSIMA; FOREST; NORTH; DESERTIFICATION; MINERALIZATION; TEMPERATURE; ECOSYSTEMS	While much is known about the factors that control each component of the terrestrial nitrogen (N) cycle, it is less clear how these factors affect total N availability, the sum of organic and inorganic forms potentially available to microorganisms and plants. This is particularly true for N-poor ecosystems such as drylands, which are highly sensitive to climate change and desertification processes that can lead to the loss of soil nutrients such as N. We evaluated how different climatic, abiotic, plant and nutrient related factors correlate with N availability in semiarid Stipa tenacissima grasslands along a broad aridity gradient from Spain to Tunisia. Aridity had the strongest relationship with N availability, suggesting the importance of abiotic controls on the N cycle in drylands. Aridity appeared to modulate the effects of pH, plant cover and organic C (OC) on N availability. Our results suggest that N transformation rates, which are largely driven by variations in soil moisture, are not the direct drivers of N availability in the studied grasslands. Rather, the strong relationship between aridity and N availability could be driven by indirect effects that operate over long time scales (decades to millennia), including both biotic (e.g. plant cover) and abiotic (e. g. soil OC and pH). If these factors are in fact more important than short-term effects of precipitation on N transformation rates, then we might expect to observe a lagged decrease in N availability in response to increasing aridity. Nevertheless, our results suggest that the increase in aridity predicted with ongoing climate change will reduce N availability in the Mediterranean basin, impacting plant nutrient uptake and net primary production in semiarid grasslands throughout this region.	[Delgado-Baquerizo, Manuel; Gallardo, Antonio] Univ Pablo de Olavide, Dept Sistemas Fis Quim & Nat, Seville, Spain; [Maestre, Fernando T.; Quero, Jose L.; Ochoa, Victoria; Garcia-Gomez, Miguel; Escolar, Cristina; Berdugo, Miguel; Valencia, Enrique; Gozalo, Beatriz] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Dept Biol & Geol, Escuela Super Ciencias Expt & Tecnol, Mostoles, Spain; [Quero, Jose L.] Univ Cordoba, Dept Ingn, Cordoba, Spain; [Garcia-Palacios, Pablo; Wallenstein, Matthew D.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Garcia-Palacios, Pablo] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Noumi, Zouhaier] Univ Sfax, Dept Sci Vie, Sfax, Tunisia; [Derak, Mchich] Direct Reg Eaux & Forets & Lutte Desertificat Rif, Tetouan, Morocco	Universidad Pablo de Olavide; Universidad Rey Juan Carlos; Universidad de Cordoba; Colorado State University; Colorado State University; Universite de Sfax	Delgado-Baquerizo, M (corresponding author), Univ Pablo de Olavide, Dept Sistemas Fis Quim & Nat, Seville, Spain.	mdelbaq@upo.es	Pérez, Jose Luis Quero/M-1074-2013; García-Palacios, Pablo/K-7567-2014; Maestre, Fernando T./A-6825-2008; Wallenstein, Matthew/C-6441-2008; Quero, Jose Luis JL/A-4202-2011; Wallenstein, Matthew D/S-3512-2016; DELGADO-BAQUERIZO, MANUEL/GLS-0346-2022; Delgado-Baquerizo, Manuel/L-3653-2017; Gallardo, Antonio/L-3941-2017; Valencia, Enrique/AAR-1438-2021; Alvarez, Sergio/H-9727-2015	Pérez, Jose Luis Quero/0000-0001-5553-506X; García-Palacios, Pablo/0000-0002-6367-4761; Maestre, Fernando T./0000-0002-7434-4856; Wallenstein, Matthew/0000-0002-6219-1442; Quero, Jose Luis JL/0000-0001-5553-506X; Wallenstein, Matthew D/0000-0002-6219-1442; DELGADO-BAQUERIZO, MANUEL/0000-0002-6499-576X; Delgado-Baquerizo, Manuel/0000-0002-6499-576X; Gallardo, Antonio/0000-0002-2674-4265; Alvarez, Sergio/0000-0001-7204-502X; Valencia, Enrique/0000-0003-3359-0759; Berdugo, Miguel/0000-0003-1053-8907	European Research Council (ERC) under European Community [242658]; Ministry of Science and Innovation of the Spanish Government [CGL2010-21381]	European Research Council (ERC) under European Community(European Research Council (ERC)); Ministry of Science and Innovation of the Spanish Government(Spanish Government)	This research is supported by the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 242658 (BIOCOM), and by the Ministry of Science and Innovation of the Spanish Government, Grant no CGL2010-21381. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN S E, 1986, P285; Anderson J. M., 1993, TROPICAL SOIL BIOL F; Aranibar JN, 2004, GLOBAL CHANGE BIOL, V10, P359, DOI 10.1111/j.1365-2486.2003.00698.x; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Austin AT, 2002, J VEG SCI, V13, P351, DOI 10.1111/j.1654-1103.2002.tb02059.x; Barrett JE, 2002, ECOL APPL, V12, P878, DOI 10.1890/1051-0761(2002)012[0878:NRISEA]2.0.CO;2; Beier C, 2008, SCI TOTAL ENVIRON, V407, P692, DOI 10.1016/j.scitotenv.2008.10.001; Bennett J, 2005, MICROBIAL COMMUNITY; Boeckx P., 2011, EUROPEAN NITROGEN AS; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cerda A, 1997, J ARID ENVIRON, V36, P37, DOI 10.1006/jare.1995.0198; Cookson WR, 2006, ECOLOGY, V87, P2047, DOI 10.1890/0012-9658(2006)87[2047:NDIAAS]2.0.CO;2; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Delgado-Baquerizo M, 2011, PEDOSPHERE, V21, P309, DOI 10.1016/S1002-0160(11)60131-8; Delgado-Baquerizo M, 2012, PLANT SOIL, DOI 101007/s11104-012-1404-3; Delgado-Baquerizo M, 2011, SOIL BIOL BIOCHEM, V43, P693, DOI 10.1016/j.soilbio.2010.11.030; Delgado-Baquerizo M, 2010, SOIL BIOL BIOCHEM, V42, P376, DOI 10.1016/j.soilbio.2009.11.003; Eldridge DJ, 2010, ECOSYSTEMS, V13, P499, DOI 10.1007/s10021-010-9335-4; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gao XJ, 2008, GLOBAL PLANET CHANGE, V62, P195, DOI 10.1016/j.gloplacha.2008.02.002; Genin D, 2007, ANIM FEED SCI TECH, V136, P1, DOI 10.1016/j.anifeedsci.2006.08.013; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Grace JB., 2015, STRUCTURAL EQUATION; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kettler TA, 2001, SOIL SCI SOC AM J, V65, P849, DOI 10.2136/sssaj2001.653849x; Kooijman AM, 2009, BIOL FERT SOILS, V45, P449, DOI 10.1007/s00374-009-0354-2; Le Houerou HN, 2001, J ARID ENVIRON, V48, P103, DOI 10.1006/jare.2000.0679; Li FR, 2009, PLANT SOIL, V317, P79, DOI 10.1007/s11104-008-9789-8; Luo TX, 2004, GLOBAL ECOL BIOGEOGR, V13, P345, DOI 10.1111/j.1466-822X.2004.00094.x; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Maestre FT, 2009, ECOL LETT, V12, P930, DOI 10.1111/j.1461-0248.2009.01352.x; Maestre FT, 2004, RESTOR ECOL, V12, P494, DOI 10.1111/j.1061-2971.2004.03106.x; Maestre FT, 2003, ECOLOGY, V84, P3186, DOI 10.1890/02-0635; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; McCulley RL, 2009, OECOLOGIA, V159, P571, DOI 10.1007/s00442-008-1229-1; Medina-Roldan E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051193; Nieder R., 2008, P1; Puigdefabregas J, 1999, EARTH-SCI REV, V48, P39, DOI 10.1016/S0012-8252(99)00046-X; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Reynolds JF, 1999, ECOL MONOGR, V69, P69, DOI 10.1890/0012-9615(1999)069[0069:IODODS]2.0.CO;2; Robertson GP, 2007, MICROBIOLOGY BIOCH E; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; SHIPLEY B, 2001, CAUSE CORRELATION BI; SINGH JS, 1989, NATURE, V338, P499, DOI 10.1038/338499a0; Swap RJ, 2004, GLOBAL CHANGE BIOL, V10, P350, DOI 10.1111/j.1365-2486.2003.00702.x; Szukics U, 2010, FEMS MICROBIOL ECOL, V72, P395, DOI 10.1111/j.1574-6941.2010.00853.x; THIAGALINGAM K, 1973, PLANT SOIL, V38, P177, DOI 10.1007/BF00011225; UNEP, 1992, WORLD ATLAS DESERTIF; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zomer R., 2006, CARBON LAND WATER GL; Zornoza R, 2009, ARID LAND RES MANAG, V23, P213, DOI 10.1080/15324980903038727	57	36	36	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59807	10.1371/journal.pone.0059807	http://dx.doi.org/10.1371/journal.pone.0059807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565170	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000317717300039
J	Janosi, L; Ceccarelli, M				Janosi, Lorant; Ceccarelli, Matteo			The Gating Mechanism of the Human Aquaporin 5 Revealed by Molecular Dynamics Simulations	PLOS ONE			English	Article							WATER PERMEATION; FORCE-FIELDS; AQP5; LOCALIZATION; EXPRESSION; TRANSPORT; CHANNELS; PROTEIN; SALIVARY; IMMUNOLOCALIZATION	Aquaporins are protein channels located across the cell membrane with the role of conducting water or other small sugar alcohol molecules (aquaglyceroporins). The high-resolution X-ray structure of the human aquaporin 5 (HsAQP5) shows that HsAQP5, as all the other known aquaporins, exhibits tetrameric structure. By means of molecular dynamics simulations we analyzed the role of spontaneous fluctuations on the structural behavior of the human AQP5. We found that different conformations within the tetramer lead to a distribution of monomeric channel structures, which can be characterized as open or closed. The switch between the two states of a channel is a tap-like mechanism at the cytoplasmic end which regulates the water passage through the pore. The channel is closed by a translation of the His67 residue inside the pore. Moreover, water permeation rate calculations revealed that the selectivity filter, located at the other end of the channel, regulates the flow rate of water molecules when the channel is open, by locally modifying the orientation of His173. Furthermore, the calculated permeation rates of a fully open channel are in good agreement with the reported experimental value.	[Janosi, Lorant; Ceccarelli, Matteo] Univ Cagliari, Dept Phys, Cagliari, Italy	University of Cagliari	Janosi, L (corresponding author), Univ Cagliari, Dept Phys, Cagliari, Italy.	Lorant.Janosi@dsf.unica.it	Janosi, Lorant/C-1074-2012; Ceccarelli, Matteo/C-8557-2018	Janosi, Lorant/0000-0001-8747-1339; Ceccarelli, Matteo/0000-0003-4272-902X	Marie Curie Actions {International Incoming Fellowship} [254470]; Marie Curie Actions - International Incoming Fellowship (IIF) [254470]; Italian Ministry of Education, Universities and Research [PRIN2010CSJX4F]; CINECA supercomputer [HP10CC81L5, HP10BM6N4U]	Marie Curie Actions {International Incoming Fellowship}; Marie Curie Actions - International Incoming Fellowship (IIF); Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR)); CINECA supercomputer(CINECA, Italy)	We thank the Marie Curie Actions - International Incoming Fellowship (IIF), call FP7-PEOPLE-2009-IIF, for the financial support through project number 254470. The work of MC was supported from the Italian Ministry of Education, Universities and Research (PRIN2010CSJX4F). We are grateful for the computer time granted by the University of Cagliari Cybersar Computational Center and by the CINECA supercomputer (time grants numbers HP10CC81L5 and HP10BM6N4U).	AGRE P, 1987, J BIOL CHEM, V262, P17497; Allen TW, 2004, P NATL ACAD SCI USA, V101, P117, DOI 10.1073/pnas.2635314100; BENGA G, 1986, BIOCHEMISTRY-US, V25, P1535, DOI 10.1021/bi00355a011; Benga G, 2009, IUBMB LIFE, V61, P112, DOI 10.1002/iub.156; Berezhkovskii A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.064503; Burghardt B, 2003, GUT, V52, P1008, DOI 10.1136/gut.52.7.1008; Chakrabarti N, 2004, STRUCTURE, V12, P65, DOI 10.1016/j.str.2003.11.017; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Chen YC, 2005, BIOL CELL, V97, P357, DOI 10.1042/BC20040041; de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Forney MW, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051913; Funaki H, 1998, AM J PHYSIOL-CELL PH, V275, pC1151, DOI 10.1152/ajpcell.1998.275.4.C1151; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Hamann S, 1998, AM J PHYSIOL-CELL PH, V274, pC1332, DOI 10.1152/ajpcell.1998.274.5.C1332; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Hub JS, 2008, P NATL ACAD SCI USA, V105, P1198, DOI 10.1073/pnas.0707662104; Hub JS, 2006, BIOPHYS J, V91, P842, DOI 10.1529/biophysj.106.081406; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishida N, 1997, BIOCHEM BIOPH RES CO, V238, P891, DOI 10.1006/bbrc.1997.7396; Ishikawa Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1303, DOI 10.1152/ajpcell.00211.2005; Jensen MO, 2003, BIOPHYS J, V85, P2884, DOI 10.1016/S0006-3495(03)74711-0; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Kumari SS, 2012, MOL VIS, V18, P957; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lucas TR, 2012, BBA-BIOMEMBRANES, V1818, P318, DOI 10.1016/j.bbamem.2011.09.016; Matsuzaki T, 2003, ARCH HISTOL CYTOL, V66, P307, DOI 10.1679/aohc.66.307; Matsuzaki T, 1999, CELL TISSUE RES, V295, P513, DOI 10.1007/s004410051257; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Mhatre AN, 1999, BIOCHEM BIOPH RES CO, V264, P157, DOI 10.1006/bbrc.1999.1323; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nejsum LN, 2002, P NATL ACAD SCI USA, V99, P511, DOI 10.1073/pnas.012588099; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; Parvin MN, 2002, BBA-MOL CELL RES, V1542, P116, DOI 10.1016/S0167-4889(01)00172-0; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; Scorciapino MA, 2009, J AM CHEM SOC, V131, P11825, DOI 10.1021/ja9028473; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Soveral G, 2008, BBA-BIOMEMBRANES, V1778, P2573, DOI 10.1016/j.bbamem.2008.07.018; Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tanghe A, 2006, TRENDS MICROBIOL, V14, P78, DOI 10.1016/j.tim.2005.12.001; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tornroth-Horsefield S, 2010, FEBS LETT, V584, P2580, DOI 10.1016/j.febslet.2010.04.037; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Van Wilder V, 2008, PLANT CELL PHYSIOL, V49, P1364, DOI 10.1093/pcp/pcn112; Verdoucq L, 2008, BIOCHEM J, V415, P409, DOI 10.1042/BJ20080275; Verkman Alan S, 2009, Handb Exp Pharmacol, P359, DOI 10.1007/978-3-540-79885-9_18; Verkman AS, 2003, EXP EYE RES, V76, P137, DOI 10.1016/S0014-4835(02)00303-2; von Bulow J, 2012, J BIOL CHEM, V287, P7487, DOI 10.1074/jbc.M111.329102; Xin L, 2011, BBA-BIOMEMBRANES, V1808, P1581, DOI 10.1016/j.bbamem.2011.02.001; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; Zhu FQ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.224501; Zhu FQ, 2004, BIOPHYS J, V86, P50, DOI 10.1016/S0006-3495(04)74082-5	69	54	54	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59897	10.1371/journal.pone.0059897	http://dx.doi.org/10.1371/journal.pone.0059897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565173	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300042
J	Poivet, E; Gallot, A; Montagne, N; Glaser, N; Legeai, F; Jacquin-Joly, E				Poivet, Erwan; Gallot, Aurore; Montagne, Nicolas; Glaser, Nicolas; Legeai, Fabrice; Jacquin-Joly, Emmanuelle			A Comparison of the Olfactory Gene Repertoires of Adults and Larvae in the Noctuid Moth Spodoptera littoralis	PLOS ONE			English	Article							ODORANT-BINDING-PROTEIN; SEX-PHEROMONE RECEPTOR; MULTIPLE SEQUENCE ALIGNMENT; CHEMOSENSORY PROTEINS; EXPRESSION PATTERN; FUNCTIONAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; EVOLUTIONARY HISTORY; INTERACTIVE TREE; OBP GENES	To better understand the olfactory mechanisms in a lepidopteran pest model species, the cotton leafworm Spodoptera littoralis, we have recently established a partial transcriptome from adult antennae. Here, we completed this transcriptome using next generation sequencing technologies, namely 454 and Illumina, on both adult antennae and larval tissues, including caterpillar antennae and maxillary palps. All sequences were assembled in 77,643 contigs. Their analysis greatly enriched the repertoire of chemosensory genes in this species, with a total of 57 candidate odorant-binding and chemosensory proteins, 47 olfactory receptors, 6 gustatory receptors and 17 ionotropic receptors. Using RT-PCR, we conducted the first exhaustive comparison of olfactory gene expression between larvae and adults in a lepidopteran species. All the 127 candidate olfactory genes were profiled for expression in male and female adult antennae and in caterpillar antennae and maxillary palps. We found that caterpillars expressed a smaller set of olfactory genes than adults, with a large overlap between these two developmental stages. Two binding proteins appeared to be larvae-specific and two others were adult-specific. Interestingly, comparison between caterpillar antennae and maxillary palps revealed numerous organ-specific transcripts, suggesting the complementary involvement of these two organs in larval chemosensory detection. Adult males and females shared the same set of olfactory transcripts, except two male-specific candidate pheromone receptors, two male-specific and two female-specific odorant-binding proteins. This study identified transcripts that may be important for sex-specific or developmental stage-specific chemosensory behaviors.	[Poivet, Erwan; Gallot, Aurore; Glaser, Nicolas; Jacquin-Joly, Emmanuelle] INRA, UMR Physiol Insecte Signalisat & Commun 1272, F-78026 Versailles, France; [Gallot, Aurore; Legeai, Fabrice] IRISA, Equipe GenScale, Rennes, France; [Montagne, Nicolas] Univ Paris 06, UMR Physiol Insecte Signalisat & Commun 1272, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Jacquin-Joly, E (corresponding author), INRA, UMR Physiol Insecte Signalisat & Commun 1272, F-78026 Versailles, France.	emmanuelle.jacquin@versailles.inra.fr		Poivet, Erwan/0000-0001-8988-9384; Jacquin-Joly, Emmanuelle/0000-0002-6904-2036; Legeai, Fabrice/0000-0002-6472-4839; Montagne, Nicolas/0000-0001-8810-3853	INRA AIP Bioressources;  [ANR-09-BLAN-0239-01]	INRA AIP Bioressources; 	This work was supported by INRA AIP Bioressources and ANR-09-BLAN-0239-01 fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Binyameen M, 2012, CHEM SENSES, V37, P613, DOI 10.1093/chemse/bjs043; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Couton L, 2009, CELL TISSUE RES, V337, P491, DOI 10.1007/s00441-009-0831-9; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; d'Alencon E, 2010, P NATL ACAD SCI USA, V107, P7680, DOI 10.1073/pnas.0910413107; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DETHIER VG, 1969, ENTOMOL EXP APPL, V12, P535, DOI 10.1007/BF00297084; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erdelyan CNG, 2012, INSECT MOL BIOL, V21, P119, DOI 10.1111/j.1365-2583.2011.01120.x; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gouzy J, 2009, BIOINFORMATICS, V25, P670, DOI 10.1093/bioinformatics/btp024; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Kaissling KE, 2004, ANIR, V6, P73, DOI DOI 10.1371/journal.pone.0152147; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; KRIEGER J, 1993, INSECT BIOCHEM MOLEC, V23, P449, DOI 10.1016/0965-1748(93)90052-T; Krieger Juergen, 1997, Invertebrate Neuroscience, V3, P137, DOI 10.1007/BF02480368; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laue M, 2000, ARTHROPOD STRUCT DEV, V29, P57, DOI 10.1016/S1467-8039(00)00013-X; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; Martin M, 2011, EMBNETJOURNAL, V17; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Montagne N, 2012, EUR J NEUROSCI, V36, P2588, DOI 10.1111/j.1460-9568.2012.08183.x; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Ozaki K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1548; Ozaki K, 2008, INSECT BIOCHEM MOLEC, V38, P969, DOI 10.1016/j.ibmb.2008.07.010; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Poivet E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2050; Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Roessingh P, 2007, J COMP PHYSIOL A, V193, P635, DOI 10.1007/s00359-007-0218-x; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; SCHOONHOVEN L. M., 1966, ARCH NEER ZOOL, V16, P497; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; STANGE G, 1995, CHEM SENSES, V20, P421; Stocker RF, 2008, ADV EXP MED BIOL, V628, P69, DOI 10.1007/978-0-387-78261-4_5; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; Vogt RG, 2002, J EXP BIOL, V205, P719; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Xiu WM, 2007, J CHEM ECOL, V33, P947, DOI 10.1007/s10886-007-9277-2; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052	89	91	94	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60263	10.1371/journal.pone.0060263	http://dx.doi.org/10.1371/journal.pone.0060263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565215	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300084
J	Cho, J; Kim, L; Li, ZX; Rose, NR; Talor, MV; Njoku, DB				Cho, Joonhee; Kim, Lina; Li, Zhaoxia; Rose, Noel R.; Talor, Monica Vladut; Njoku, Dolores B.			Sex Bias in Experimental Immune-Mediated, Drug-Induced Liver Injury in BALB/c Mice: Suggested Roles for Tregs, Estrogen, and IL-6	PLOS ONE			English	Article							REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; CUTTING EDGE; INDUCED HEPATITIS; B-CELLS; HALOTHANE; ACTIVATION; CANCER; MOUSE	Background and Aims: Immune-mediated, drug-induced liver injury (DILI) triggered by drug haptens is more prevalent in women than in men. However, mechanisms responsible for this sex bias are not clear. Immune regulation by CD4+CD25+FoxP3+ regulatory T-cells (Tregs) and 17 beta-estradiol is crucial in the pathogenesis of sex bias in cancer and autoimmunity. Therefore, we investigated their role in a mouse model of immune-mediated DILI. Methods: To model DILI, we immunized BALB/c, BALB/cBy, IL-6-deficient, and castrated BALB/c mice with trifluoroacetyl chloride-haptenated liver proteins. We then measured degree of hepatitis, cytokines, antibodies, and Treg and splenocyte function. Results: BALB/c females developed more severe hepatitis (p<0.01) and produced more pro-inflammatory hepatic cytokines and antibodies (p<0.05) than did males. Castrated males developed more severe hepatitis than did intact males (p<0.001) and females (p<0.05). Splenocytes cultured from female mice exhibited fewer Tregs (p<0.01) and higher IL-1 beta (p<0.01) and IL-6 (p<0.05) than did those from males. However, Treg function did not differ by sex, as evidenced by absence of sex bias in programmed death receptor-1 and responses to IL-6, anti-IL-10, anti-CD3, and anti-CD28. Diminished hepatitis in IL-6-deficient, anti-IL-6 receptor alpha-treated, ovariectomized, or male mice; undetectable IL-6 levels in splenocyte supernatants from ovariectomized and male mice; elevated splenic IL-6 and serum estrogen levels in castrated male mice, and IL-6 induction by 17 beta-estradiol in splenocytes from naive female mice (p<0.05) suggested that 17 beta-estradiol may enhance sex bias through IL-6 induction, which subsequently discourages Treg survival. Treg transfer from naive female mice to those with DILI reduced hepatitis severity and hepatic IL-6. Conclusions: 17 beta-estradiol and IL-6 may act synergistically to promote sex bias in experimental DILI by reducing Tregs. Modulating Treg numbers may provide a therapeutic approach to DILI.	[Cho, Joonhee; Kim, Lina; Li, Zhaoxia; Njoku, Dolores B.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21218 USA; [Rose, Noel R.; Talor, Monica Vladut; Njoku, Dolores B.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Rose, Noel R.] Johns Hopkins Univ, W Harvey Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Njoku, Dolores B.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Njoku, DB (corresponding author), Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21218 USA.	dnjoku@jhmi.edu	Njoku, Dolores/AAI-7449-2020	Njoku, Dolores/0000-0002-5458-4596	William F. Rienhoff, Jr., MD Scholars Program; American Autoimmune Related Diseases Association; Gail I Zuckerman Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075828, P30DK079637] Funding Source: NIH RePORTER	William F. Rienhoff, Jr., MD Scholars Program; American Autoimmune Related Diseases Association; Gail I Zuckerman Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	DBN is supported by the William F. Rienhoff, Jr., MD Scholars Program. NRR is supported in part by the American Autoimmune Related Diseases Association, Mr. and Mrs. Joseph Scoby and the Gail I Zuckerman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett B, 2005, AM J REPROD IMMUNOL, V54, P369, DOI 10.1111/j.1600-0897.2005.00330.x; Barron AM, 2009, ENDOCRINOLOGY, V150, P3228, DOI 10.1210/en.2008-1252; Bebo BF, 2001, J IMMUNOL, V166, P2080, DOI 10.4049/jimmunol.166.3.2080; Bourdi M, 1996, CHEM RES TOXICOL, V9, P1159, DOI 10.1021/tx960083q; Cao XF, 2010, IMMUNOL RES, V46, P79, DOI 10.1007/s12026-009-8124-7; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Galgani M, 2009, CURR MED CHEM, V16, P4626, DOI 10.2174/092986709789878201; Gregory SA, 2002, AM J MED, V113, P254, DOI 10.1016/S0002-9343(02)01149-X; Grimaldi CM, 2006, J IMMUNOL, V176, P2703, DOI 10.4049/jimmunol.176.5.2703; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Hammerich L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/345803; Hashimoto T, 2005, INT ARCH ALLERGY IMM, V137, P51, DOI 10.1159/000085432; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Ito A, 2001, J IMMUNOL, V167, P542, DOI 10.4049/jimmunol.167.1.542; Jacob JB, 2007, CANCER RES, V67, P7020, DOI 10.1158/0008-5472.CAN-06-4755; Koizumi N, 2007, J IMMUNOL, V178, P1767, DOI 10.4049/jimmunol.178.3.1767; Lau AWT, 2008, J IMMUNOL, V180, P3889, DOI 10.4049/jimmunol.180.6.3889; Lawson JA, 2000, TOXICOL SCI, V54, P509, DOI 10.1093/toxsci/54.2.509; Lengi AJ, 2006, J MOL ENDOCRINOL, V37, P421, DOI 10.1677/jme.1.02122; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Loddenkemper C, 2009, CANCER SCI, V100, P1112, DOI 10.1111/j.1349-7006.2009.01153.x; Longhi MS, 2005, J AUTOIMMUN, V25, P63, DOI 10.1016/j.jaut.2005.05.001; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Ma XJ, 2007, WORLD J GASTROENTERO, V13, P1060, DOI 10.3748/wjg.v13.i7.1060; Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; NEUBERGER J, 1981, BRIT J ANAESTH, V53, P1173, DOI 10.1093/bja/53.11.1173; Njoku D, 1997, ANESTH ANALG, V84, P173, DOI 10.1097/00000539-199701000-00031; Njoku DB, 2006, CLIN VACCINE IMMUNOL, V13, P258, DOI 10.1128/CVI.13.2.258-265.2006; Njoku DB, 2005, EXP MOL PATHOL, V78, P87, DOI 10.1016/j.yexmp.2004.10.004; Njoku DB, 2009, EUR J IMMUNOL, V39, P1652, DOI 10.1002/eji.200838135; Njoku DB, 2009, J AUTOIMMUN, V32, P52, DOI 10.1016/j.jaut.2008.11.003; Njorku DB, 2002, ANESTH ANALG, V94, P243; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; POHL LR, 1990, SEMIN LIVER DIS, V10, P305, DOI 10.1055/s-2008-1040486; Polanczyk MJ, 2004, J IMMUNOL, V173, P2227, DOI 10.4049/jimmunol.173.4.2227; Radziewicz H, 2009, J CLIN INVEST, V119, P450, DOI 10.1172/JCI38661; Ray A, 2010, MUCOSAL IMMUNOL, V3, P216, DOI 10.1038/mi.2010.4; Stonier SW, 2010, IMMUNOL LETT, V127, P85, DOI 10.1016/j.imlet.2009.09.009; Taieb J, 2001, CLIN BIOCHEM, V34, P237, DOI 10.1016/S0009-9120(01)00211-9; Takamoto S, 2003, HEPATOL RES, V27, P221, DOI 10.1016/S1386-6346(03)00263-8; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; Toyoda Y, 2011, TOXICOL LETT, V204, P17, DOI 10.1016/j.toxlet.2011.03.031; Wiegard C, 2005, HEPATOLOGY, V42, P193, DOI 10.1002/hep.20756; Wing JB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00178; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Yasumi Y, 2007, HEPATOL RES, V37, P248, DOI 10.1111/j.1872-034X.2007.00040.x	51	31	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61186	10.1371/journal.pone.0061186	http://dx.doi.org/10.1371/journal.pone.0061186			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577207	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800129
J	Olives, C; Myerson, R; Mokdad, AH; Murray, CJL; Lim, SS				Olives, Casey; Myerson, Rebecca; Mokdad, Ali H.; Murray, Christopher J. L.; Lim, Stephen S.			Prevalence, Awareness, Treatment, and Control of Hypertension in United States Counties, 2001-2009	PLOS ONE			English	Article							BLOOD-PRESSURE; UNCONTROLLED HYPERTENSION; TRENDS; HEALTH; US; DISEASE; STROKE; ADULTS	Hypertension is an important and modifiable risk factor for cardiovascular disease and mortality. Over the last decade, national-levels of controlled hypertension have increased, but little information on hypertension prevalence and trends in hypertension treatment and control exists at the county-level. We estimate trends in prevalence, awareness, treatment, and control of hypertension in US counties using data from the National Health and Nutrition Examination Survey (NHANES) in five two-year waves from 1999-2008 including 26,349 adults aged 30 years and older and from the Behavioral Risk Factor Surveillance System (BRFSS) from 1997-2009 including 1,283,722 adults aged 30 years and older. Hypertension was defined as systolic blood pressure (BP) of at least 140 mm Hg, self-reported use of antihypertensive treatment, or both. Hypertension control was defined as systolic BP less than 140 mm Hg. The median prevalence of total hypertension in 2009 was estimated at 37.6% (range: 26.5 to 54.4%) in men and 40.1% (range: 28.5 to 57.9%) in women. Within-state differences in the county prevalence of uncontrolled hypertension were as high as 7.8 percentage points in 2009. Awareness, treatment, and control was highest in the southeastern US, and increased between 2001 and 2009 on average. The median county-level control in men was 57.7% (range: 43.4 to 65.9%) and in women was 57.1% (range: 43.0 to 65.46%) in 2009, with highest rates in white men and black women. While control of hypertension is on the rise, prevalence of total hypertension continues to increase in the US. Concurrent increases in treatment and control of hypertension are promising, but efforts to decrease the prevalence of hypertension are needed.	[Olives, Casey; Myerson, Rebecca; Mokdad, Ali H.; Murray, Christopher J. L.; Lim, Stephen S.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Olives, Casey] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Myerson, Rebecca] Univ Chicago, Harris Sch Publ Policy, Chicago, IL 60637 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago	Olives, C (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.	colives@uw.edu	Myerson, Rebecca/AAD-4861-2019; Mokdad, Ali H./AAD-1232-2022	Myerson, Rebecca/0000-0001-7567-936X; Mokdad, Ali H./0000-0002-4994-3339	Bill and Melinda Gates Foundation; Biostatistics, Epidemiologic & Bioinformatic Training in Environmental Health Training Grant [ES015459]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES015459] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Biostatistics, Epidemiologic & Bioinformatic Training in Environmental Health Training Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the Bill and Melinda Gates Foundation. Casey Olives received additional support from the Biostatistics, Epidemiologic & Bioinformatic Training in Environmental Health Training Grant (ES015459). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019; BLACK HR, 1995, AM J HYPERTENS, V8, P331; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Danaei Goodarz, 2009, Popul Health Metr, V7, P16, DOI 10.1186/1478-7954-7-16; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Egan BM, 2011, CIRCULATION, V124, P1046, DOI 10.1161/CIRCULATIONAHA.111.030189; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Harel O, 2007, STAT MED, V26, P3057, DOI 10.1002/sim.2787; Howard G, 2006, STROKE, V37, P1171, DOI 10.1161/01.STR.0000217222.09978.ce; Mokdad AH, 2009, ANNU REV PUBL HEALTH, V30, P43, DOI 10.1146/annurev.publhealth.031308.100226; National Health and Nutrition Examination Survey, NAT HLTH NUTR EX SUR, DOI 11-2012/HPVSWR_G.htm; Okonofua EC, 2006, HYPERTENSION, V47, P345, DOI 10.1161/01.HYP.0000200702.76436.4b; Ostchega Yechiam, 2008, NCHS Data Brief, P1; Perry HM, 1998, HYPERTENSION, V31, P771, DOI 10.1161/01.HYP.31.3.771; Remington PL, 2011, J PUBLIC HEALTH MAN, V17, P397, DOI 10.1097/PHH.0b013e318222b897; Remington PL, 1998, APPLIED EPIDEMIOLOGY, P323; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rohan AMK, 2009, J PUBLIC HEALTH MAN, V15, P24, DOI 10.1097/PHH.0b013e3181903bf8; Rubin DB, 2004, MULTIPLE IMPUTATION; Schenker N, 2010, STAT MED, V29, P533, DOI 10.1002/sim.3809; Srebotnjak T, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-26; Team RDC, 2012, R LANG ENV STAT COMP; Victor RG, 2008, ARCH INTERN MED, V168, P1285, DOI 10.1001/archinte.168.12.1285; Wang TJ, 2005, CIRCULATION, V112, P1651, DOI 10.1161/CIRCULATIONAHA.104.490599; Wong ND, 2007, ARCH INTERN MED, V167, P2431, DOI 10.1001/archinte.167.22.2431	28	126	132	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60308	10.1371/journal.pone.0060308	http://dx.doi.org/10.1371/journal.pone.0060308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577099	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800041
J	Pamenter, ME; Perkins, GA; Gu, XQ; Ellisman, MH; Haddad, GG				Pamenter, Matthew E.; Perkins, Guy A.; Gu, Xiang Q.; Ellisman, Mark H.; Haddad, Gabriel G.			DIDS (4,4-Diisothiocyanatostilbenedisulphonic Acid) Induces Apoptotic Cell Death in a Hippocampal Neuronal Cell Line and Is Not Neuroprotective against Ischemic Stress	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CYTOCHROME-C; CHLORIDE CHANNELS; INFARCT RIM; ACTIVATION; EXCHANGE; HYPOXIA; RELEASE; BRAIN; INHIBITION	DIDS is a commonly used anion channel antagonist that is putatively cytoprotective against ischemic insult. However, recent reports indicate potentially deleterious secondary effects of DIDS. To assess the impact of DIDS on cellular viability comprehensively we examined neuronal morphology and function through 24 hours treatment with ACSF +/- DIDS (40 or 400 mu M). Control cells were unchanged, whereas DIDS induced an apoptotic phenotype (chromatin condensation, nuclear fragmentation and cleavage of the nuclear membrane protein lamin A, expression of pro-apoptotic proteins c-Jun N-terminal kinase 3, caspase 3, and cytochrome C, Annexin V staining, RNA degradation, and oligonucleosomal DNA cleavage). These deleterious effects were mediated by DIDS in a dose- and time-dependant manner, such that higher [DIDS] induced apoptosis more rapidly while apoptosis was observed at lower [DIDS] with prolonged exposure. In an apparent paradox, despite a clear overall apoptotic phenotype, certain hallmarks of apoptosis were not present in DIDS treated cells, including mitochondrial fission and loss of plasma membrane integrity. We conclude that DIDS induces apoptosis in cultured hippocampal neurons, in spite of the fact that some common hallmarks of cell death pathways are prevented. These contradictory effects may cause false-positive results in certain assays and future evaluations of DIDS as a neuroprotective agent should incorporate multiple viability assays.	[Pamenter, Matthew E.; Gu, Xiang Q.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Perkins, Guy A.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Perkins, Guy A.; Ellisman, Mark H.] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Ellisman, Mark H.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp San Diego, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Pamenter, ME (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA.	mpamenter@ucsd.edu	Pamenter, Matt/R-9216-2019	Pamenter, Matt/0000-0003-4035-9555; Perkins, Guy/0000-0002-1834-6646	National Institutes of Health (NIH) [5P01HD032573, P41-RR004050, P30-CA23100, P30 NS047101]; NSERC; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants 5P01HD032573 to GGH, P41-RR004050 and P30-CA23100 to MHE, and P30 NS047101 to the UCSD Neurosciences Microscopy Shared Facility, and an NSERC postdoctoral fellowship to MEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2006, CELL BIOL INT, V30, P93, DOI 10.1016/j.cellbi.2005.10.020; Banasiak KJ, 1999, MOL BRAIN RES, V72, P214, DOI 10.1016/S0169-328X(99)00189-8; Beavis AD, 1996, J BIOENERG BIOMEMBR, V28, P207, DOI 10.1007/BF02110652; Bernardes CF, 2000, INT J BIOCHEM CELL B, V32, P519, DOI 10.1016/S1357-2725(00)00002-9; Brecht S, 2005, EUR J NEUROSCI, V21, P363, DOI 10.1111/j.1460-9568.2005.03857.x; Cavelier P, 2005, J PHYSIOL-LONDON, V564, P397, DOI 10.1113/jphysiol.2004.082131; Clark KL, 2012, J NEUROSCI, V32, P10907, DOI 10.1523/JNEUROSCI.1450-12.2012; Delcarlo M, 2006, AM J PHYSIOL-CELL PH, V290, pC802, DOI 10.1152/ajpcell.00214.2005; FADOK VA, 1992, J IMMUNOL, V148, P2207; Ferrer I, 2003, ACTA NEUROPATHOL, V105, P425, DOI 10.1007/s00401-002-0661-2; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Hahn A, 2003, MMW Fortschr Med, V145, P40; Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874; Ishida T, 2009, NUCLEIC ACIDS RES, V37, P3367, DOI 10.1093/nar/gkp200; Ju WK, 2009, MOL VIS, V15, P120; JUNGNICKEL B, 1993, FEBS LETT, V329, P268, DOI 10.1016/0014-5793(93)80235-M; Kang MK, 2008, BIOCHEM BIOPH RES CO, V373, P539, DOI 10.1016/j.bbrc.2008.06.070; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; KOSOWER EM, 1988, FEBS LETT, V231, P5, DOI 10.1016/0014-5793(88)80691-4; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Kumar S, 2007, J CELL MOL MED, V11, P798, DOI 10.1111/j.1582-4934.2007.00053.x; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Liu AH, 2008, CELL PHYSIOL BIOCHEM, V22, P177, DOI 10.1159/000149795; Liu CJ, 2008, MOL CELL BIOCHEM, V308, P117, DOI 10.1007/s11010-007-9619-y; Matsushita K, 1998, NEUROSCIENCE, V83, P439, DOI 10.1016/S0306-4522(97)00391-6; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; Morin D, 2004, BIOCHEM PHARMACOL, V68, P2065, DOI 10.1016/j.bcp.2004.07.006; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; OBERHAMMER F, 1993, J CELL SCI, V104, P317; Obrdlik P, BIOCH J, V427, P151; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Pamenter ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051469; Pamenter ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043995; Pamenter ME, 2012, BRAIN RES, V1452, P165, DOI 10.1016/j.brainres.2012.03.004; Pan XY, 2006, BRIT J HAEMATOL, V134, P491, DOI 10.1111/j.1365-2141.2006.06224.x; Paul SL, 2007, CURR DRUG TARGETS, V8, P786; Ramasamy R, 2001, CARDIOVASC RES, V51, P275, DOI 10.1016/S0008-6363(01)00301-7; Reich CF, 2009, EXP CELL RES, V315, P760, DOI 10.1016/j.yexcr.2008.12.014; Repici M, 2007, NEUROSCIENCE, V150, P40, DOI 10.1016/j.neuroscience.2007.08.021; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Sasaki C, 2000, NEUROL RES, V22, P223, DOI 10.1080/01616412.2000.11741065; Steinback CD, 2008, J APPL PHYSIOL, V104, P482, DOI 10.1152/japplphysiol.00553.2007; Strohl KP, 2003, SLEEP, V26, P333, DOI 10.1093/sleep/26.3.333; Strohle A, 2003, NERVENARZT, V74, P733, DOI 10.1007/s00115-002-1385-1; Sugawara T, 1999, J NEUROSCI, V19, part. no.; Wang XM, 2005, CELL PHYSIOL BIOCHEM, V16, P147, DOI 10.1159/000089840; Wasilewski M, 2009, TRENDS ENDOCRIN MET, V20, P287, DOI 10.1016/j.tem.2009.03.007; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Xia ZL, 2003, NEUROSCI LETT, V340, P53, DOI 10.1016/S0304-3940(03)00075-2; Xue J, 2008, AM J PHYSIOL-REG I, V294, pR451, DOI 10.1152/ajpregu.00528.2007; Yao H, 2007, J NEUROCHEM, V103, P1644, DOI 10.1111/j.1471-4159.2007.04879.x; Yao H, 2007, J NEUROCHEM, V100, P1224, DOI 10.1111/j.1471-4159.2006.04299.x; Yao H, 2009, J NEUROCHEM, V108, P835, DOI 10.1111/j.1471-4159.2008.05838.x; Zalk R, 2006, FEBS LETT, V580, P5894, DOI 10.1016/j.febslet.2006.09.055	57	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60804	10.1371/journal.pone.0060804	http://dx.doi.org/10.1371/journal.pone.0060804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577164	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800102
J	Sherlekar, AL; Janssen, A; Siehr, MS; Koo, PK; Caflisch, L; Boggess, M; Lints, R				Sherlekar, Amrita L.; Janssen, Abbey; Siehr, Meagan S.; Koo, Pamela K.; Caflisch, Laura; Boggess, May; Lints, Robyn			The C. elegans Male Exercises Directional Control during Mating through Cholinergic Regulation of Sex-Shared Command Interneurons	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; ACETYLCHOLINE-RECEPTORS; NEURONAL CONTROL; NERVOUS-SYSTEM; NEURAL CIRCUIT; BEHAVIOR; ENCODES; PATTERN; IDENTIFICATION; ACTIVATION	Background: Mating behaviors in simple invertebrate model organisms represent tractable paradigms for understanding the neural bases of sex-specific behaviors, decision-making and sensorimotor integration. However, there are few examples where such neural circuits have been defined at high resolution or interrogated. Methodology/Principal Findings: Here we exploit the simplicity of the nematode Caenorhabditis elegans to define the neural circuits underlying the male's decision to initiate mating in response to contact with a mate. Mate contact is sensed by male-specific sensilla of the tail, the rays, which subsequently induce and guide a contact-based search of the hermaphrodite's surface for the vulva (the vulva search). Atypically, search locomotion has a backward directional bias so its implementation requires overcoming an intrinsic bias for forward movement, set by activity of the sex-shared locomotory system. Using optogenetics, cell-specific ablation-and mutant behavioral analyses, we show that the male makes this shift by manipulating the activity of command cells within this sex-shared locomotory system. The rays control the command interneurons through the male-specific, decision-making interneuron PVY and its auxiliary cell PVX. Unlike many sex-shared pathways, PVY/PVX regulate the command cells via cholinergic, rather than glutamatergic transmission, a feature that likely contributes to response specificity and coordinates directional movement with other cholinergic-dependent motor behaviors of the mating sequence. PVY/PVX preferentially activate the backward, and not forward, command cells because of a bias in synaptic inputs and the distribution of key cholinergic receptors (encoded by the genes acr-18, acr-16 and unc29) in favor of the backward command cells. Conclusion/Significance: Our interrogation of male neural circuits reveals that a sex-specific response to the opposite sex is conferred by a male-specific pathway that renders subordinate, sex-shared motor programs responsive to mate cues. Circuit modifications of these types may make prominent contributions to natural variations in behavior that ultimately bring about speciation.	[Sherlekar, Amrita L.; Janssen, Abbey; Siehr, Meagan S.; Koo, Pamela K.; Caflisch, Laura; Lints, Robyn] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Boggess, May] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ USA	Texas A&M University System; Texas A&M University College Station; Arizona State University; Arizona State University-Tempe	Lints, R (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	rlints@bio.tamu.edu		Lints, Robyn/0000-0002-1403-2121	National Science Foundation [EF-0436308, 0818595]; Division Of Integrative Organismal Systems [0818595] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	M.S.S., A.J. and L. C. are supported by a National Science Foundation-funded Undergraduate Biology-Mathematics Program grant (Award No: EF-0436308). The research was supported by an NSF grant (Award No.: 0818595) awarded to R. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballivet M, 1996, J MOL BIOL, V258, P261, DOI 10.1006/jmbi.1996.0248; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; BARKER DM, 1994, ANIM BEHAV, V48, P147, DOI 10.1006/anbe.1994.1221; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Barrios A, 2012, NAT NEUROSCI, V15, P1675, DOI 10.1038/nn.3253; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2006, WORMBOOK, DOI 101895/wormbook11611; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Garcia LR, 2001, CELL, V107, P777, DOI 10.1016/S0092-8674(01)00600-6; Garrison JL, 2012, SCIENCE, V338, P540, DOI 10.1126/science.1226201; GRANATO M, 1994, DEVELOPMENT, V120, P3005; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HALL DH, 1991, J NEUROSCI, V11, P1; Hardaker LA, 2003, J NEUROBIOL, V54, P537, DOI 10.1002/neu.1000; Haspel G, 2010, J NEUROSCI, V30, P11151, DOI 10.1523/JNEUROSCI.2244-10.2010; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; HODGKIN J, 1979, GENETICS, V91, P67; Husson SJ, 2012, CURR BIOL, V22, P743, DOI 10.1016/j.cub.2012.02.066; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Jones AK, 2004, BIOESSAYS, V26, P39, DOI 10.1002/bies.10377; Kawano T, 2011, NEURON, V72, P572, DOI 10.1016/j.neuron.2011.09.005; Kleemann GA, 2007, ANIM BEHAV, V74, P1339, DOI 10.1016/j.anbehav.2007.02.031; Koo PK, 2011, J NEUROSCI, V31, P7497, DOI 10.1523/JNEUROSCI.6153-10.2011; Lee KH, 2007, CURR BIOL, V17, P1858, DOI 10.1016/j.cub.2007.10.015; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Liu YS, 2007, J NEUROSCI, V27, P1411, DOI 10.1523/JNEUROSCI.4320-06.2007; Liu YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001326; Mello C, 1995, METHOD CELL BIOL, V48, P451; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Ohnishi N, 2011, EMBO J, V30, P1376, DOI 10.1038/emboj.2011.13; Palikhova TA, 2006, B EXP BIOL MED+, V142, P275, DOI 10.1007/s10517-006-0345-3; Pan YF, 2012, P NATL ACAD SCI USA, V109, P10065, DOI 10.1073/pnas.1207107109; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Siehr MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026811; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; White JQ, 2012, NEURON, V75, P593, DOI 10.1016/j.neuron.2012.03.044; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Whittaker AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-33; Wicks SR, 1996, J NEUROSCI, V16, P4017; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Xu X, 2011, NAT REV GENET, V12, P793, DOI 10.1038/nrg3050; Yono O, 2008, ZOOL SCI, V25, P517, DOI 10.2108/zsj.25.517; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	69	29	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60597	10.1371/journal.pone.0060597	http://dx.doi.org/10.1371/journal.pone.0060597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577128	Green Submitted, gold, Green Published			2022-12-27	WOS:000319109800068
J	Sinha, R; Hussain, S; Mehrotra, R; Kumar, RS; Kumar, K; Pande, P; Doval, DC; Basir, SF; Bharadwaj, M				Sinha, Rupal; Hussain, Showket; Mehrotra, Ravi; Kumar, R. Suresh; Kumar, Kapil; Pande, Pankaj; Doval, Dinesh Chandra; Basir, Seemi Farhat; Bharadwaj, Mausumi			Kras Gene Mutation and RASSF1A, FHIT and MGMT Gene Promoter Hypermethylation: Indicators of Tumor Staging and Metastasis in Adenocarcinomatous Sporadic Colorectal Cancer in Indian Population	PLOS ONE			English	Article							K-RAS MUTATIONS; ALCOHOL-CONSUMPTION; METHYLATION PROFILE; COLON-CANCER; ASSOCIATION; RISK; INACTIVATION; ACETALDEHYDE; EXPRESSION; ETHANOL	Objective: Colorectal cancer (CRC) development involves underlying modifications at genetic/epigenetic level. This study evaluated the role of Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation together/independently in sporadic CRC in Indian population and correlation with clinicopathological variables of the disease. Methods: One hundred and twenty four consecutive surgically resected tissues (62 tumor and equal number of normal adjacent controls) of primary sporadic CRC were included and patient details including demographic characteristics, lifestyle/food or drinking habits, clinical and histopathological profiles were recorded. Polymerase chain reaction - Restriction fragment length polymorphism and direct sequencing for Kras gene mutation and Methylation Specific-PCR for RASSF1A, FHIT and MGMT genes was performed. Results: Kras gene mutation at codon 12 & 13 and methylated RASSF1A, FHIT and MGMT gene was observed in 47%, 19%, 47%, 37% and 47% cases, respectively. Alcohol intake and smoking were significantly associated with presence of Kras mutation (codon 12) and MGMT methylation (p-value <0.049). Tumor stage and metastasis correlated with presence of mutant Kras codon 12 (p-values 0.018, 0.044) and methylated RASSF1A (p-values 0.034, 0.044), FHIT (p-values 0.001, 0.047) and MGMT (p-values 0.018, 0.044) genes. Combinatorial effect of gene mutation/methylation was also observed (p-value <0.025). Overall, tumor stage 3, moderately differentiated tumors, presence of lymphatic invasion and absence of metastasis was more frequently observed in tumors with mutated Kras and/or methylated RASSF1A, FHIT and MGMT genes. Conclusion: Synergistic interrelationship between these genes in sporadic CRC may be used as diagnostic/prognostic markers in assessing the overall pathological status of CRC.	[Sinha, Rupal; Doval, Dinesh Chandra] Rajiv Gandhi Canc Inst & Res Ctr, Dept Res, Delhi, India; [Sinha, Rupal; Hussain, Showket; Kumar, R. Suresh; Bharadwaj, Mausumi] Inst Cytol & Prevent Oncol, Div Mol Genet & Biochem, Noida, India; [Mehrotra, Ravi] Inst Cytol & Prevent Oncol, Div Cytopathol, Noida, India; [Sinha, Rupal; Kumar, Kapil; Pande, Pankaj] Rajiv Gandhi Canc Inst & Res Ctr, Dept Surg Oncol, Delhi, India; [Doval, Dinesh Chandra] Rajiv Gandhi Canc Inst & Res Ctr, Dept Med Oncol, Delhi, India; [Basir, Seemi Farhat] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Jamia Millia Islamia	Bharadwaj, M (corresponding author), Inst Cytol & Prevent Oncol, Div Mol Genet & Biochem, Noida, India.	bharadwajm@icmr.org.in	Mehrotra, Ravi/E-3285-2010; Basir, Seemi Farhat/GOE-4171-2022	Mehrotra, Ravi/0000-0001-9453-1408; 	Indian Council of Medical Research, New Delhi, India; Institute of Cytology & Preventive Oncology (ICMR), India	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Institute of Cytology & Preventive Oncology (ICMR), India	The authors would like to thank all the patients and their relatives for the support and cooperation. In addition we would like to acknowledge Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India for providing the biological samples and clinical information and Indian Council of Medical Research, New Delhi, India and Institute of Cytology & Preventive Oncology (ICMR), India for providing the core infrastructural facilities and institutional funding.	Brink M, 2005, BRIT J CANCER, V92, P1310, DOI 10.1038/sj.bjc.6602491; Brink M, 2004, CARCINOGENESIS, V25, P1619, DOI 10.1093/carcin/bgh177; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Cejas P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008199; Cho YA, 2011, ASIAN PAC J CANCER P, V12, P761; Dammann R, 2003, HISTOL HISTOPATHOL, V18, P665, DOI 10.14670/HH-18.665; De Stefani E, 2011, ASIAN PAC J CANCER P, V12, P753; Dhillon VS, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-33; Dong SM, 2005, MODERN PATHOL, V18, P170, DOI 10.1038/modpathol.3800261; Edge SB, 2010, CANC STAGING HDB AJC; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Giovannucci E, 1996, JNCI-J NATL CANCER I, V88, P1717, DOI 10.1093/jnci/88.23.1717; Hao XP, 2000, CANCER RES, V60, P18; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hibi K, 2006, ANTICANCER RES, V26, P4263; Hinoda Yuji, 2011, Rinsho Byori, V59, P598; Homann N, 2000, INT J CANCER, V86, P169, DOI 10.1002/(SICI)1097-0215(20000415)86:2&lt;169::AID-IJC4&gt;3.0.CO;2-3; Hughes R, 2001, CARCINOGENESIS, V22, P199, DOI 10.1093/carcin/22.1.199; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kampman E, 2000, CARCINOGENESIS, V21, P307, DOI 10.1093/carcin/21.2.307; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kato K, 2008, INT J CANCER, V122, P603, DOI 10.1002/ijc.23143; KUNE GA, 1992, NUTR CANCER, V18, P97, DOI 10.1080/01635589209514210; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Lee S, 2004, LAB INVEST, V84, P884, DOI 10.1038/labinvest.3700108; Lee SH, 2005, RES COMMUN MOL PATH, V117, P153; Li Z, 2012, WORLD J GASTROENTERO, V18, P855, DOI 10.3748/wjg.v18.i8.855; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Mannan A, 2012, APMIS, V120, P459, DOI 10.1111/j.1600-0463.2011.02852.x; Martinez ME, 1999, CANCER RES, V59, P5181; Maruyama R, 2002, CLIN CANCER RES, V8, P514; Matsubara N, 2012, DIS COLON RECTUM, V55, P96, DOI 10.1097/DCR.0b013e318233a1ef; Neyaz MK, 2010, MOL CELL BIOCHEM, V335, P53, DOI 10.1007/s11010-009-0240-0; Notani PN, 2001, CURR SCI INDIA, V81, P465; Paterson T, 2006, P NUTR SOC, V65, P93, DOI 10.1079/PNS2005477; Roa JC, 2008, REV MED CHILE, V136, P451, DOI /S0034-98872008000400005; Sakamoto N, 2004, ONCOGENE, V23, P8900, DOI 10.1038/sj.onc.1207993; Sambrook J, 1989, MOL CLONING LABORATO, V9, P16; Sameer A. S., 2009, Indian Journal of Cancer, V46, P219, DOI 10.4103/0019-509X.52956; SEITZ HK, 1990, GASTROENTEROLOGY, V98, P406, DOI 10.1016/0016-5085(90)90832-L; Shima K, 2011, CANCER CAUSE CONTROL, V22, P301, DOI 10.1007/s10552-010-9698-z; Shin A, 2011, AM J EPIDEMIOL, V174, P552, DOI 10.1093/aje/kwr098; Sidhu S, 2010, GENET ENG BIOTECHNOL, VGEBJ-8, P1; Sultana SA, 2011, INT J CANC RES, V7, P99; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; van Engeland M, 2003, CANCER RES, V63, P3133; van Engeland M, 2002, ONCOGENE, V21, P3792, DOI 10.1038/sj.onc.1205466; Wahab AHA, 2011, TUMOR BIOL, V32, P845, DOI 10.1007/s13277-011-0156-7; Wang SH, 2010, CLIN CANCER RES, V16, P1324, DOI 10.1158/1078-0432.CCR-09-2672; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Xu XL, 2004, WORLD J GASTROENTERO, V10, P3441; Yin DT, 2010, INT J CLIN EXP PATHO, V3, P482	54	46	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60142	10.1371/journal.pone.0060142	http://dx.doi.org/10.1371/journal.pone.0060142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573237	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100049
J	Wallner, B; Vogl, C; Shukla, P; Burgstaller, JP; Druml, T; Brem, G				Wallner, Barbara; Vogl, Claus; Shukla, Priyank; Burgstaller, Joerg P.; Druml, Thomas; Brem, Gottfried			Identification of Genetic Variation on the Horse Y Chromosome and the Tracing of Male Founder Lineages in Modern Breeds	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MUTATION-RATES; DIVERSITY; ORIGINS; DOG; POLYMORPHISMS; EVOLUTION; SEQUENCE; HISTORY; LINES	The paternally inherited Y chromosome displays the population genetic history of males. While modern domestic horses (Equus caballus) exhibit abundant diversity within maternally inherited mitochondrial DNA, no significant Y-chromosomal sequence diversity has been detected. We used high throughput sequencing technology to identify the first polymorphic Y-chromosomal markers useful for tracing paternal lines. The nucleotide variability of the modern horse Y chromosome is extremely low, resulting in six haplotypes (HT), all clearly distinct from the Przewalski horse (E. przewalskii). The most widespread HT1 is ancestral and the other five haplotypes apparently arose on the background of HT1 by mutation or gene conversion after domestication. Two haplotypes (HT2 and HT3) are widely distributed at high frequencies among modern European horse breeds. Using pedigree information, we trace the distribution of Y-haplotype diversity to particular founders. The mutation leading to HT3 occurred in the germline of the famous English Thoroughbred stallion "Eclipse'' or his son or grandson and its prevalence demonstrates the influence of this popular paternal line on modern sport horse breeds. The pervasive introgression of Thoroughbred stallions during the last 200 years to refine autochthonous breeds has strongly affected the distribution of Y-chromosomal variation in modern horse breeds and has led to the replacement of autochthonous Y chromosomes. Only a few northern European breeds bear unique variants at high frequencies or fixed within but not shared among breeds. Our Y-chromosomal data complement the well established mtDNA lineages and document the male side of the genetic history of modern horse breeds and breeding practices.	[Wallner, Barbara; Vogl, Claus; Shukla, Priyank; Burgstaller, Joerg P.; Druml, Thomas; Brem, Gottfried] Univ Vet Med Vienna, Dept Biomed Sci, Inst Anim Breeding & Genet, Vienna, Austria	University of Veterinary Medicine Vienna	Wallner, B (corresponding author), Univ Vet Med Vienna, Dept Biomed Sci, Inst Anim Breeding & Genet, Vienna, Austria.	barbara.wallner@vetmeduni.ac.at		Shukla, Priyank/0000-0002-4985-9305; Druml, Thomas/0000-0002-2777-4669	Austrian Science Fund [SFB-28]	Austrian Science Fund(Austrian Science Fund (FWF))	PS was supported by the Austrian Science Fund (SFB-28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Andrews S., 2010, FASTQC QUALITY CONTR; Bower MA, 2012, ARCHAEOMETRY, V54, P916, DOI 10.1111/j.1475-4754.2012.00666.x; Bower MA, 2011, BIOL LETTERS, V7, P316, DOI 10.1098/rsbl.2010.0800; Brem G., 2011, LIPIZZANER SPIEGEL W, V2nd; Brown SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028496; Buggs RJA, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04469.x; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Cliffe KM, 2010, ANIM GENET, V41, P619, DOI 10.1111/j.1365-2052.2010.02070.x; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cunningham EP, 2001, ANIM GENET, V32, P360, DOI 10.1046/j.1365-2052.2001.00785.x; Ding ZL, 2012, HEREDITY, V108, P507, DOI 10.1038/hdy.2011.114; Druml T, 2009, HORSES ASIA HIST TRA, P9; Edwards CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015922; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; George Stubbs, 1724, ECLIPSE NEW MARKET G; Godard S, 1998, MAMM GENOME, V9, P633, DOI 10.1007/s003359900835; Grilz-Seger G., 2011, LIPIZZANER HENGSTSTA; Hamann H, 2008, J ANIM SCI, V86, P1503, DOI 10.2527/jas.2007-0382; Hendricks Bonnie, 1995, INT ENCY HORSE BREED; Hill EW, 2002, ANIM GENET, V33, P287, DOI 10.1046/j.1365-2052.2002.00870.x; Iwase M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-225; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; Kavar T, 2002, GENET SEL EVOL, V34, P635, DOI [10.1186/1297-9686-34-5-635, 10.1051/gse:2002028]; King TE, 2009, TRENDS GENET, V25, P351, DOI 10.1016/j.tig.2009.06.003; Lenstra JA, 2012, ANIM GENET, V43, P483, DOI 10.1111/j.1365-2052.2011.02309.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgren G, 2004, NAT GENET, V36, P335, DOI 10.1038/ng1326; Ling YH, 2010, J HERED, V101, P639, DOI 10.1093/jhered/esq047; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Lippold S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1447; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; Meadows JRS, 2006, ANIM GENET, V37, P444, DOI 10.1111/j.1365-2052.2006.01496.x; Natanaelsson C, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-45; Nei M., 1987, MOL EVOLUTIONARY GEN; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Paria N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021374; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Ramirez O, 2009, MOL BIOL EVOL, V26, P2061, DOI 10.1093/molbev/msp118; Raudsepp T, 2004, P NATL ACAD SCI USA, V101, P9321, DOI 10.1073/pnas.0403011101; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rosser ZH, 2009, AM J HUM GENET, V85, P130, DOI 10.1016/j.ajhg.2009.06.009; Sundqvist AK, 2006, GENETICS, V172, P1121, DOI 10.1534/genetics.105.042358; Trombetta B, 2010, MOL BIOL EVOL, V27, P714, DOI 10.1093/molbev/msp231; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wallner B, 2003, ANIM GENET, V34, P453, DOI 10.1046/j.0268-9146.2003.01044.x; Wallner B, 2004, J HERED, V95, P158, DOI 10.1093/jhered/esh020; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	53	54	61	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60015	10.1371/journal.pone.0060015	http://dx.doi.org/10.1371/journal.pone.0060015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573227	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100040
J	Bajaj, JS; Heuman, DM; Sanyal, AJ; Hylemon, PB; Sterling, RK; Stravitz, RT; Fuchs, M; Ridlon, JM; Daita, K; Monteith, P; Noble, NA; White, MB; Fisher, A; Sikaroodi, M; Rangwala, H; Gillevet, PM				Bajaj, Jasmohan S.; Heuman, Douglas M.; Sanyal, Arun J.; Hylemon, Phillip B.; Sterling, Richard K.; Stravitz, R. Todd; Fuchs, Michael; Ridlon, Jason M.; Daita, Kalyani; Monteith, Pamela; Noble, Nicole A.; White, Melanie B.; Fisher, Andmorgan; Sikaroodi, Masoumeh; Rangwala, Huzefa; Gillevet, Patrick M.			Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; GUT MICROBIOME; IN-VITRO; DISEASE; LIVER; COMMUNITIES; DIAGNOSIS; OBESITY; MURINE; ENERGY	Hepatic encephalopathy (HE) represents a dysfunctional gut-liver-brain axis in cirrhosis which can negatively impact outcomes. This altered gut-brain relationship has been treated using gut-selective antibiotics such as rifaximin, that improve cognitive function in HE, especially its subclinical form, minimal HE (MHE). However, the precise mechanism of the action of rifaximin in MHE is unclear. We hypothesized that modulation of gut microbiota and their end-products by rifaximin would affect the gut-brain axis and improve cognitive performance in cirrhosis. Aim To perform a systems biology analysis of the microbiome, metabolome and cognitive change after rifaximin in MHE. Methods: Twenty cirrhotics with MHE underwent cognitive testing, endotoxin analysis, urine/serum metabolomics (GC and LC-MS) and fecal microbiome assessment (multi-tagged pyrosequencing) at baseline and 8 weeks post-rifaximin 550 mg BID. Changes in cognition, endotoxin, serum/urine metabolites (and microbiome were analyzed using recommended systems biology techniques. Specifically, correlation networks between microbiota and metabolome were analyzed before and after rifaximin. Results: There was a significant improvement in cognition(six of seven tests improved,p < 0.01) and endotoxemia (0.55 to 0.48 Eu/ml, p = 0.02) after rifaximin. There was a significant increase in serum saturated (myristic, caprylic, palmitic, palmitoleic, oleic and eicosanoic) and unsaturated (linoleic, linolenic, gamma-linolenic and arachnidonic) fatty acids post-rifaximin. No significant microbial change apart from a modest decrease in Veillonellaceae and increase in Eubacteriaceae was observed. Rifaximin resulted in a significant reduction in network connectivity and clustering on the correlation networks. The networks centered on Enterobacteriaceae, Porphyromonadaceae and Bacteroidaceae indicated a shift from pathogenic to beneficial metabolite linkages and better cognition while those centered on autochthonous taxa remained similar. Conclusions: Rifaximin is associated with improved cognitive function and endotoxemia in MHE, which is accompanied by alteration of gut bacterial linkages with metabolites without significant change in microbial abundance. Trial Registration: ClinicalTrials.gov NCT01069133	[Bajaj, Jasmohan S.; Heuman, Douglas M.; Sanyal, Arun J.; Sterling, Richard K.; Stravitz, R. Todd; Fuchs, Michael; Monteith, Pamela; Noble, Nicole A.; White, Melanie B.] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA; [Bajaj, Jasmohan S.; Heuman, Douglas M.; Sanyal, Arun J.; Sterling, Richard K.; Stravitz, R. Todd; Fuchs, Michael; Monteith, Pamela; Noble, Nicole A.; White, Melanie B.] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Hylemon, Phillip B.; Ridlon, Jason M.; Daita, Kalyani] Virginia Commonwealth Univ, Dept Microbiol, Richmond, VA USA; [Fisher, Andmorgan; Sikaroodi, Masoumeh; Gillevet, Patrick M.] George Mason Univ, Microbiome Anal Ctr, Manassas, VA USA; [Rangwala, Huzefa] George Mason Univ, Dept Comp Sci, Manassas, VA USA	Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; George Mason University; George Mason University	Bajaj, JS (corresponding author), Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA.	jsbajaj@vcu.edu	Sterling, Richard/AAV-1598-2020		National Center for Complementary and Alternative Medicine [U01AT004428]; National Institute on Alcohol Abuse and Alcoholism [RO1AA020203]; National Institute of Diabetes and Digestive and Kidney Diseases [RO1DK087913]; McGuire Research Institute; Salix Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U01AT004428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020203] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); McGuire Research Institute; Salix Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was partly supported by grants U01AT004428 from the National Center for Complementary and Alternative Medicine, grant RO1AA020203 from the National Institute on Alcohol Abuse and Alcoholism, grant RO1DK087913 from the National Institute of Diabetes and Digestive and Kidney Diseases, the McGuire Research Institute and an investigator-initiated grant from Salix Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bajaj JS, 2008, AM J GASTROENTEROL, V103, P1707, DOI 10.1111/j.1572-0241.2008.01861.x; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; Bajaj JS, 2011, GASTROENTEROLOGY, V140, P478, DOI 10.1053/j.gastro.2010.08.061; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Brown EL, 2010, ANTIMICROB AGENTS CH, V54, P388, DOI 10.1128/AAC.00691-09; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Daita K, 2012, AM J PHYSL GASTROINT; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fiehn O, 2011, J BIOL CHEM, V286, P23637, DOI 10.1074/jbc.R110.173617; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; Gillevet P, 2010, CHEM BIODIVERS, V7, P1065, DOI 10.1002/cbdv.200900322; Haussinger D, 2008, GUT, V57, P1156, DOI 10.1136/gut.2007.122176; Hamer HM, 2012, AM J PHYSIOL-GASTR L, V302, pG1, DOI 10.1152/ajpgi.00048.2011; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Jiang ZD, 2005, CHEMOTHERAPY, V51, P67, DOI 10.1159/000081991; Jiang ZD, 2010, INT J ANTIMICROB AG, V35, P278, DOI 10.1016/j.ijantimicag.2009.11.013; Kalambokis GN, 2012, HEPATOLOGY, V55, P655, DOI 10.1002/hep.24751; Kappus MR, 2012, CLIN GASTROENTEROL H; Kesarwani M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002192; Lee KJ, 2010, NEUROGASTROENT MOTIL, V22, P493, DOI 10.1111/j.1365-2982.2010.01482.x; Maccaferri S, 2010, J ANTIMICROB CHEMOTH, V65, P2556, DOI 10.1093/jac/dkq345; Ortiz M, 2005, J HEPATOL, V42, pS45, DOI 10.1016/j.jhep.2004.11.028; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Randolph C, 2009, LIVER INT, V29, P629, DOI 10.1111/j.1478-3231.2009.02009.x; Ronnemaa E, 2012, EUR J CLIN NUTR, V66, P885, DOI 10.1038/ejcn.2012.63; Rosberg-Cody E, 2011, MICROBIOL-SGM, V157, P609, DOI 10.1099/mic.0.043406-0; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sidhu SS, 2011, AM J GASTROENTEROL, V106, P307, DOI 10.1038/ajg.2010.455; Smith S, 2011, INVESTIGATING INTEST; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; TARAO K, 1990, GUT, V31, P702, DOI 10.1136/gut.31.6.702; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Wall R, 2012, AM J CLIN NUTR, V95, P1278, DOI 10.3945/ajcn.111.026435; Wall R, 2009, AM J CLIN NUTR, V89, P1393, DOI 10.3945/ajcn.2008.27023; Weckwerth W, 2004, P NATL ACAD SCI USA, V101, P7809, DOI 10.1073/pnas.0303415101; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7	46	264	275	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60042	10.1371/journal.pone.0060042	http://dx.doi.org/10.1371/journal.pone.0060042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565181	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300050
J	Enokida, Y; Shimizu, K; Atsumi, J; Lezhava, A; Tanaka, Y; Kimura, Y; Soma, T; Hanami, T; Kawai, Y; Usui, K; Okano, Y; Kakegawa, S; Ogawa, H; Miyamae, Y; Miyagi, Y; Nakayama, H; Ishikawa, T; Hayashizaki, Y; Takeyoshi, I				Enokida, Yasuaki; Shimizu, Kimihiro; Atsumi, Jun; Lezhava, Alexander; Tanaka, Yuki; Kimura, Yasumasa; Soma, Takahiro; Hanami, Takeshi; Kawai, Yuki; Usui, Kengo; Okano, Yasuko; Kakegawa, Seiichi; Ogawa, Hiroomi; Miyamae, Yohei; Miyagi, Yohei; Nakayama, Haruhiko; Ishikawa, Toshihisa; Hayashizaki, Yoshihide; Takeyoshi, Izumi			Rapid Detection of SNP (c.309T > G) in the MDM2 Gene by the Duplex SmartAmp Method	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; CELL LUNG-CANCER; AMPLIFICATION PROCESS; HEPATOCELLULAR-CARCINOMA; P53 CODON-72; RISK; PROMOTER; SUSCEPTIBILITY; MUTATIONS; PROBE	Background: Genetic polymorphisms in the human MDM2 gene are suggested to be a tumor susceptibility marker and a prognostic factor for cancer. It has been reported that a single nucleotide polymorphism (SNP) c.309T>G in the MDM2 gene attenuates the tumor suppressor activity of p53 and accelerates tumor formation in humans. Methodology: In this study, to detect the SNP c.309T>G in the MDM2 gene, we have developed a new SNP detection method, named "Duplex SmartAmp,'' which enabled us to simultaneously detect both 309T and 309G alleles in one tube. To develop this new method, we introduced new primers i.e., nBP and oBPs, as well as two different fluorescent dyes that separately detect those genetic polymorphisms. Results and Conclusions: By the Duplex SmartAmp method, the genetic polymorphisms of the MDM2 gene were detected directly from a small amount of genomic DNA or blood samples. We used 96 genomic DNA and 24 blood samples to validate the Duplex SmartAmp by comparison with results of the conventional PCR-RFLP method; consequently, the Duplex SmartAmp results agreed totally with those of the PCR-RFLP method. Thus, the new SNP detection method is considered useful for detecting the SNP c.309T>G in the MDM2 gene so as to judge cancer susceptibility against some cellular stress in the clinical setting, and also to handle a large number of samples and enable rapid clinical diagnosis.	[Enokida, Yasuaki; Shimizu, Kimihiro; Atsumi, Jun; Kakegawa, Seiichi; Ogawa, Hiroomi; Miyamae, Yohei; Takeyoshi, Izumi] Gunma Univ, Grad Sch Med, Div Thorac & Visceral Organ Surg, Maebashi, Gunma 371, Japan; [Lezhava, Alexander; Tanaka, Yuki; Kimura, Yasumasa; Soma, Takahiro; Hanami, Takeshi; Kawai, Yuki; Usui, Kengo; Ishikawa, Toshihisa; Hayashizaki, Yoshihide] RIKEN Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Okano, Yasuko] Yokohama City Univ, Grad Sch Med, Dept Clin Oncol, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Miyagi, Yohei] Kanagawa Canc Ctr, Res Inst, Asahi Ku, Yokohama, Kanagawa 2410815, Japan; [Nakayama, Haruhiko] Kanagawa Canc Ctr, Dept Thorac Surg, Asahi Ku, Yokohama, Kanagawa 2410815, Japan	Gunma University; RIKEN; Yokohama City University; Kanagawa Prefectural Cancer Center; Kanagawa Prefectural Cancer Center	Shimizu, K (corresponding author), Gunma Univ, Grad Sch Med, Div Thorac & Visceral Organ Surg, Maebashi, Gunma 371, Japan.	kmshimizu@gmail.com	Hayashizaki, Yoshihide/N-6590-2015; Hanami, Takeshi/C-3653-2017; Usui, Kengo/A-7203-2016; TANAKA, Yuki/AAE-4497-2019; Tanaka, Yuki/F-9506-2013; Kimura, Yasumasa/M-9720-2013	Hanami, Takeshi/0000-0003-1868-1409; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japanese Government; MEXT [22590516]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Research Grant for RIKEN from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japanese Government to Y.H. This research was partially supported by Grant-in-Aid for Scientific Research (B) (22590516) from the MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aomori T, 2009, CLIN CHEM, V55, P804, DOI 10.1373/clinchem.2008.115295; Asomaning K, 2008, CLIN CANCER RES, V14, P4010, DOI 10.1158/1078-0432.CCR-07-4187; Aw W, 2011, CURR PHARM BIOTECHNO, V12, P693, DOI 10.2174/138920111795164011; Bond GL, 2005, CANCER RES, V65, P5481, DOI 10.1158/0008-5472.CAN-05-0825; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Cao XM, 2012, DNA CELL BIOL, V31, P354, DOI 10.1089/dna.2011.1338; Cescon DW, 2009, CLIN CANCER RES, V15, P3103, DOI 10.1158/1078-0432.CCR-08-3120; Dharel N, 2006, CLIN CANCER RES, V12, P4867, DOI 10.1158/1078-0432.CCR-06-0111; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Han JY, 2008, CANCER-AM CANCER SOC, V113, P799, DOI 10.1002/cncr.23668; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hoshi K, 2007, CLIN CANCER RES, V13, P4974, DOI 10.1158/1078-0432.CCR-07-0509; Ikeda S, 2008, BIOCONJUGATE CHEM, V19, P1719, DOI 10.1021/bc800201m; Ikeda S, 2008, CHEM-ASIAN J, V3, P958, DOI 10.1002/asia.200800014; Ishikawa T, 2010, PHARMACOL THERAPEUT, V126, P69, DOI 10.1016/j.pharmthera.2010.01.005; Jin SK, 2001, J CELL SCI, V114, P4139; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kawai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030236; Kimura Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr041; Kohno T, 2011, J THORAC ONCOL, V6, P813, DOI 10.1097/JTO.0b013e3181ee80ef; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lezhava A, 2010, HUM MUTAT, V31, P208, DOI 10.1002/humu.21177; Li GJ, 2006, CARCINOGENESIS, V27, P2028, DOI 10.1093/carcin/bgl047; Lind H, 2006, INT J CANCER, V119, P718, DOI 10.1002/ijc.21872; Liu G, 2012, INT J UROL; Liu G, 2008, INT J CANCER, V122, P915, DOI 10.1002/ijc.23178; Mitani Y, 2007, NAT METHODS, V4, P257, DOI 10.1038/NMETH1007; Mitani Y, 2009, PHARMACOGENOMICS, V10, P1187, DOI [10.2217/pgs.09.39, 10.2217/PGS.09.39]; Park SH, 2006, LUNG CANCER, V54, P19, DOI 10.1016/j.lungcan.2006.06.008; Pine SR, 2006, CANCER EPIDEM BIOMAR, V15, P1559, DOI 10.1158/1055-9965.EPI-06-0217; Sotamaa K, 2005, CLIN CANCER RES, V11, P6840, DOI 10.1158/1078-0432.CCR-05-1139; Tatsumi K, 2008, J MOL DIAGN, V10, P520, DOI 10.2353/jmoldx.2008.080024; Wan Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-208; Wang XY, 2009, HELICOBACTER, V14, P114, DOI 10.1111/j.1523-5378.2009.00712.x; Watanabe J, 2007, BIOTECHNIQUES, V43, P479, DOI 10.2144/000112563; Yoon YJ, 2008, CARCINOGENESIS, V29, P1192, DOI 10.1093/carcin/bgn090; Zhang XM, 2006, HUM MUTAT, V27, P110, DOI 10.1002/humu.20277; Zhao EJ, 2012, MOL BIOL REP, V39, P3471, DOI 10.1007/s11033-011-1119-1; Zimmer V, 2012, ONCOL LETT, V4, P101, DOI 10.3892/ol.2012.680	39	8	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60151	10.1371/journal.pone.0060151	http://dx.doi.org/10.1371/journal.pone.0060151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565197	gold, Green Submitted, Green Published			2022-12-27	WOS:000317717300066
J	Konishi, M; Sugiyama, S; Sugamura, K; Nozaki, T; Ohba, K; Matsubara, J; Sakamoto, K; Nagayoshi, Y; Sumida, H; Akiyama, E; Matsuzawa, Y; Sakamaki, K; Morita, S; Kimura, K; Umemura, S; Ogawa, H				Konishi, Masaaki; Sugiyama, Seigo; Sugamura, Koichi; Nozaki, Toshimitsu; Ohba, Keisuke; Matsubara, Junichi; Sakamoto, Kenji; Nagayoshi, Yasuhiro; Sumida, Hitoshi; Akiyama, Eiichi; Matsuzawa, Yasushi; Sakamaki, Kentaro; Morita, Satoshi; Kimura, Kazuo; Umemura, Satoshi; Ogawa, Hisao			Basal and Ischemia-Induced Transcardiac Troponin Release into the Coronary Circulation in Patients with Suspected Coronary Artery Disease	PLOS ONE			English	Article							CARDIAC TROPONIN; MYOCARDIAL-ISCHEMIA; HEART-FAILURE; DIAGNOSIS; ASSAY; PREVALENCE; INFARCTION; ELEVATION	Background: Cardiac troponin is a specific biomarker for cardiomyocyte necrosis in acute coronary syndromes. Troponin release from the coronary circulation remains to be determined because of the lower sensitivity of the conventional assay. We sought to determine basal and angina-induced troponin release using a highly sensitive troponin assay. Methods and Results: The cardiac troponin T levels in serum sampled from the peripheral vein (PV), the aortic root (AO), and the coronary sinus (CS) were measured in 105 consecutive stable patients with coronary risk factor(s) and suspected coronary artery disease (CAD) and in 33 patients without CAD who underwent an acetylcholine provocation test. At baseline, there was a significant increase in the troponin levels from AO [9.0 (6.4, 13.1) pg/mL for median (25th, 75th percentiles)] to CS [10.3 (7.3, 15.5) pg/mL, p<0.001] in 96 (91.4%) patients and the difference was 1.1 (0.4, 2.1) pg/mL, which reflected basal transcardiac troponin release (TTR). TTR was positively correlated with PV levels (r = 0.22, p = 0.03). Male sex, left ventricular hypertrophy determined by echocardiography, T-wave inversion, and CAD correlated with elevated TTR defined as above: median, 1.1 pg/mL. A significant increase in TTR was noted in 17 patients with coronary spasms [0.6 (0.2, 1.2) pg/mL, p<0.01] but not in 16 patients without spasms [0.0 (-0.5, 0.9) pg/mL, p=0.73] after the acetylcholine provocation. Conclusion: Basal TTR in the coronary circulation was observed in most of the patients with suspected CAD and risk factor(s). This sensitive assay detected myocardial ischemia-induced increases in TTR caused by coronary spasms.	[Konishi, Masaaki; Sugiyama, Seigo; Sugamura, Koichi; Nozaki, Toshimitsu; Ohba, Keisuke; Matsubara, Junichi; Sakamoto, Kenji; Nagayoshi, Yasuhiro; Sumida, Hitoshi; Akiyama, Eiichi; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Konishi, Masaaki; Matsuzawa, Yasushi; Kimura, Kazuo] Yokohama City Univ, Med Ctr, Div Cardiol, Yokohama, Kanagawa 232, Japan; [Sakamaki, Kentaro; Morita, Satoshi] Yokohama City Univ, Dept Biostat & Epidemiol, Med Ctr, Yokohama, Kanagawa 232, Japan; [Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan	Kumamoto University; Yokohama City University; Yokohama City University; Yokohama City University	Sugiyama, S (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Dept Cardiovasc Med, Kumamoto, Japan.	ssugiyam@kumamoto-u.ac.jp			Ministry of Education, Science, and Culture in Japan [C22590786]; Kimura Memorial Heart Foundation-Bayer; Ministry of Education, Science, and Culture in Japan; Grants-in-Aid for Scientific Research [23790865] Funding Source: KAKEN	Ministry of Education, Science, and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kimura Memorial Heart Foundation-Bayer; Ministry of Education, Science, and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a grant-in-aid for scientific research (grant number C22590786 for S. Sugiyama) from the Ministry of Education, Science, and Culture in Japan, and a grant for clinical vascular function (for M. Konishi) from the Kimura Memorial Heart Foundation-Bayer. The Ministry of Education, Science, and Culture in Japan and the Kimura Memorial Heart Foundation-Bayer had no role in the design, implementation, and reporting of the study and drafting of the manuscript (apart from their financial contributions).	[Anonymous], 2010, CIRC J, V74, P1745; Antman EM, 2002, NEW ENGL J MED, V346, P2079, DOI 10.1056/NEJMe020049; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Imai E, 2008, HYPERTENS RES, V31, P1101, DOI 10.1291/hypres.31.1101; Jeremias A, 2005, ANN INTERN MED, V142, P786, DOI 10.7326/0003-4819-142-9-200505030-00015; Kumar A, 2008, CIRCULATION, V118, P2790, DOI 10.1161/CIRCULATIONAHA.108.772541; Kurz K, 2008, CLIN CHEM, V54, P1234, DOI 10.1373/clinchem.2007.097865; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Sabatine MS, 2009, EUR HEART J, V30, P162, DOI 10.1093/eurheartj/ehn504; Shave R, 2010, J AM COLL CARDIOL, V56, P169, DOI 10.1016/j.jacc.2010.03.037; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Turer AT, 2011, J AM COLL CARDIOL, V57, P2398, DOI 10.1016/j.jacc.2010.11.066; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wu AHB, 1999, CLIN CHIM ACTA, V284, P161, DOI 10.1016/S0009-8981(99)00078-9	20	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60163	10.1371/journal.pone.0060163	http://dx.doi.org/10.1371/journal.pone.0060163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565198	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300067
J	Saelee, N; Noonin, C; Nupan, B; Junkunlo, K; Phongdara, A; Lin, XH; Soderhall, K; Soderhall, I				Saelee, Netnapa; Noonin, Chadanat; Nupan, Benjamas; Junkunlo, Kingkamon; Phongdara, Amornrat; Lin, Xionghui; Soderhall, Kenneth; Soderhall, Irene			beta-Thymosins and Hemocyte Homeostasis in a Crustacean	PLOS ONE			English	Article							CANCER CELLS; DOMAIN; PROLIFERATION; ANGIOGENESIS; METASTASIS; APOPTOSIS; BINDING; GENE	Thymosin proteins are well known for their actin-binding activity. Thymosin beta 4 (T beta 4) has been associated with biological activities in tissue repair and cell migration via interaction with ATP-synthase in vertebrates, while the information of similar thymosin functions in invertebrates is limited. We have shown previously that ATP-synthase is present on the surface of crayfish hematopoietic tissue (HPT) cells, and that astakine 1 (Ast1, an invertebrate cytokine) was found to interact with this beta-subunit of ATP synthase. Here, we identified five different beta-thymosins from Pacifastacus leniusculus, designated Pl-beta-thymosin1-5. The two dominant isoforms in brain, HPT and hemocytes, Pl-beta-thymosin1 and 2, were chosen for functional studies. Both isoforms could bind to the b-subunit of ATP-synthase, and Pl-beta-thymosin1, but not Pl-beta-thymosin2, significantly increased extracellular ATP formation. Moreover, Pl-beta-thymosin1 stimulated HPT cell migration in vitro and Ast1 blocked this effect. Pl-beta-thymosin2 increased the circulating hemocyte number at an early stage after injection. Additionally, in vivo injection of Pl-beta-thymosin1 resulted in significant reduction of reactive oxygen species (ROS) production in crayfish HPT whereas Pl-beta-thymosin2 had a similar but transient effect. Both Pl-beta-thymosins induced the expression of Ast1 and superoxide dismutase (SOD) transcripts, while silencing of endogenous Pl-beta-thymosin 1 and 2 by RNAi resulted in significant reduction of the Ast1 and SOD transcripts. The diverse effects exhibited by Pl-beta-thymosin1 and Pl-beta-thymosin2 indicates that these proteins are involved in a complex interaction that regulates the hematopoietic stem cell proliferation and differentiation.	[Saelee, Netnapa; Noonin, Chadanat; Nupan, Benjamas; Junkunlo, Kingkamon; Lin, Xionghui; Soderhall, Kenneth; Soderhall, Irene] Uppsala Univ, Dept Comparat Physiol, Uppsala, Sweden; [Phongdara, Amornrat] Prince Songkla Univ, Fac Sci, Ctr Genom & Bioinformat Res, Hat Yai, Thailand	Uppsala University; Prince of Songkla University	Soderhall, I (corresponding author), Uppsala Univ, Dept Comparat Physiol, Uppsala, Sweden.	Irene.Soderhall@ebc.uu.se	Soderhall, Irene/AAS-5433-2020; Chana, Netnapa/AAP-1819-2021; Noonin, Chadanat/AAD-6269-2022	Lin, Xionghui/0000-0001-7488-1435	Swedish Science Research Council [621-2009-5715, 319-2010-6250, 621-2012-2418]; Swedish Research Council FORMAS [223-2011-606]; Swedish Science Research [621-2011-4797]; Royal Golden Jubilee Graduate Program from the Thailand Research Fund; Prince of Songkla University Fund [PHD/0278/2550]; Program Strategic Scholarships for Frontier Research Network; Office of the Higher Education Commission, Thailand [94/2550]	Swedish Science Research Council; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Science Research; Royal Golden Jubilee Graduate Program from the Thailand Research Fund; Prince of Songkla University Fund; Program Strategic Scholarships for Frontier Research Network; Office of the Higher Education Commission, Thailand	This work was supported by grants from the Swedish Science Research Council to KS (621-2009-5715,319-2010-6250 and 621-2012-2418) and to KS from The Swedish Research Council FORMAS (223-2011-606) and to IS from the Swedish Science Research (621-2011-4797). It was also supported by The Royal Golden Jubilee Graduate Program from the Thailand Research Fund and Prince of Songkla University Fund to NS (PHD/0278/2550), and by a grant from The Program Strategic Scholarships for Frontier Research Network for the joint Ph.D. Program Thai Doctoral degree from the Office of the Higher Education Commission, Thailand (94/2550 to BN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boquet I, 2000, CELL, V102, P797, DOI 10.1016/S0092-8674(00)00068-4; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; Didry D, 2012, EMBO J, V31, P1000, DOI 10.1038/emboj.2011.461; Domanski M, 2004, J BIOL CHEM, V279, P23637, DOI 10.1074/jbc.M311413200; Freeman KW, 2011, FASEB J, V25, P907, DOI 10.1096/fj.10-169417; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Hannappel E, 2010, ANN NY ACAD SCI, V1194, P27, DOI 10.1111/j.1749-6632.2010.05485.x; Hara T, 2011, VITAM HORM, V87, P277, DOI 10.1016/B978-0-12-386015-6.00032-9; Herrmann D, 2005, MECH DEVELOP, V122, P1183, DOI 10.1016/j.mod.2005.07.003; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Kang YJ, 2011, VET PARASITOL, V181, P222, DOI 10.1016/j.vetpar.2011.03.058; Kim A, 2009, EXP CELL RES, V315, P3325, DOI 10.1016/j.yexcr.2009.05.024; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026912; Larsson LI, 2007, HUM PATHOL, V38, P114, DOI 10.1016/j.humpath.2006.06.025; Li XK, 2007, PROTEIN EXPRES PURIF, V56, P229, DOI 10.1016/j.pep.2007.08.011; Lin XH, 2011, J IMMUNOL, V186, P2073, DOI 10.4049/jimmunol.1001229; Lin XH, 2010, J BIOL CHEM, V285, P28577, DOI 10.1074/jbc.M110.138560; Lin XH, 2009, EXP CELL RES, V315, P1171, DOI 10.1016/j.yexcr.2009.01.001; Lin XH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-58; Mannherz HG, 2009, CELL MOTIL CYTOSKEL, V66, P839, DOI 10.1002/cm.20371; Noonin C, 2012, STEM CELLS DEV, V21, P3173, DOI 10.1089/scd.2012.0077; Philp D, 2004, MECH AGEING DEV, V125, P113, DOI 10.1016/j.mad.2003.11.005; Smart Nicola, 2007, Angiogenesis, V10, P229, DOI 10.1007/s10456-007-9077-x; Soderhall I, 2005, J IMMUNOL, V174, P6153, DOI 10.4049/jimmunol.174.10.6153; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Tang MC, 2011, CANCER LETT, V308, P162, DOI 10.1016/j.canlet.2011.05.001; Tapp H, 2009, BIOTECH HISTOCHEM, V84, P287, DOI 10.3109/10520290903116884; Tokura Y, 2011, J BIOCHEM, V149, P43, DOI 10.1093/jb/mvq115; Wang WS, 2003, ONCOGENE, V22, P3297, DOI 10.1038/sj.onc.1206404; Zhang YQ, 2008, CANCER BIOL THER, V7, P419, DOI 10.4161/cbt.7.3.5415	31	23	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60974	10.1371/journal.pone.0060974	http://dx.doi.org/10.1371/journal.pone.0060974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565293	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300166
J	Khan, NZ; Lindquist, E; Aronsson, H				Khan, Nadir Zaman; Lindquist, Emelie; Aronsson, Henrik			New Putative Chloroplast Vesicle Transport Components and Cargo Proteins Revealed Using a Bioinformatics Approach: An Arabidopsis Model	PLOS ONE			English	Article							PREDICTING SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM EXPORT; K+-CHANNEL KAT1; MEMBRANE-PROTEIN; RAB GTPASE; SORTING SIGNALS; P24 PROTEINS; VESICULAR TRANSPORT; DISULFIDE-ISOMERASE; SURFACE EXPRESSION	Proteins and lipids are known to be transported to targeted cytosolic compartments in vesicles. A similar system in chloroplasts is suggested to transfer lipids from the inner envelope to the thylakoids. However, little is known about both possible cargo proteins and the proteins required to build a functional vesicle transport system in chloroplasts. A few components have been suggested, but only one (CPSAR1) has a verified location in chloroplast vesicles. This protein is localized in the donor membrane (envelope) and vesicles, but not in the target membrane (thylakoids) suggesting it plays a similar role to a cytosolic homologue, Sar1, in the secretory pathway. Thus, we hypothesized that there may be more similarities, in addition to lipid transport, between the vesicle transport systems in the cytosol and chloroplast, i.e. similar vesicle transport components, possible cargo proteins and receptors. Therefore, using a bioinformatics approach we searched for putative chloroplast components in the model plant Arabidopsis thaliana, corresponding mainly to components of the cytosolic vesicle transport system that may act in coordination with previously proposed COPII chloroplast homologues. We found several additional possible components, supporting the notion of a fully functional vesicle transport system in chloroplasts. Moreover, we found motifs in thylakoid-located proteins similar to those of COPII vesicle cargo proteins, supporting the hypothesis that chloroplast vesicles may transport thylakoid proteins from the envelope to the thylakoid membrane. Several putative cargo proteins are involved in photosynthesis, thus we propose the existence of a novel thylakoid protein pathway that is important for construction and maintenance of the photosynthetic machinery.	[Khan, Nadir Zaman; Lindquist, Emelie; Aronsson, Henrik] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg	Aronsson, H (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	henrik.aronsson@bioenv.gu.se	Zaman, Nadir/ABE-6560-2020	Zaman, Nadir/0000-0003-0405-2724	Swedish Research Council (VR); Malakand University, Pakistan	Swedish Research Council (VR)(Swedish Research Council); Malakand University, Pakistan	This work was supported by the Swedish Research Council (VR) and the Malakand University, Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah F, 2000, TRENDS PLANT SCI, V5, P141, DOI 10.1016/S1360-1385(00)01574-0; Ajjawi I, 2010, PLANT PHYSIOL, V152, P529, DOI 10.1104/pp.109.148494; Ali BR, 2005, BIOCHEM SOC T, V33, P652, DOI 10.1042/BST0330652; Kamei CLA, 2008, PLANT PHYSIOL, V147, P1735, DOI 10.1104/pp.108.122226; Anantharaman V, 2002, GENOME BIOL, V3; Andersson MX, 2007, J BIOL CHEM, V282, P1170, DOI 10.1074/jbc.M608124200; Andersson MX, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-40; Andersson MX, 2001, PLANT PHYSIOL, V127, P184, DOI 10.1104/pp.127.1.184; Aravind L, 1999, CURR BIOL, V9, pR195, DOI 10.1016/S0960-9822(99)80127-4; Aronsson H., 2009, V13, P89, DOI 10.1007/7089_2008_40; Aseeva E, 2004, J BIOL CHEM, V279, P35535, DOI 10.1074/jbc.M401750200; Aseeva E, 2007, PLANT PHYSIOL BIOCH, V45, P119, DOI 10.1016/j.plaphy.2007.01.005; Bang WY, 2012, PLANT J, V71, P122, DOI 10.1111/j.1365-313X.2012.04976.x; Bang WY, 2009, PLANT MOL BIOL, V71, P379, DOI 10.1007/s11103-009-9529-3; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Bayle V, 2011, PLANT CELL, V23, P1523, DOI 10.1105/tpc.110.081067; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Bock JB, 1999, P NATL ACAD SCI USA, V96, P12227, DOI 10.1073/pnas.96.22.12227; Boden M, 2005, BIOINFORMATICS, V21, P2279, DOI 10.1093/bioinformatics/bti372; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Burri L, 2004, TRAFFIC, V5, P45, DOI 10.1046/j.1600-0854.2003.00151.x; Carney GE, 2004, BIOL CELL, V96, P271, DOI 10.1016/j.biolcel.2004.01.004; Carrie C, 2012, BIOCH BIOPHYSICA ACT; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chigri F, 2009, MOL PLANT, V2, P1373, DOI 10.1093/mp/ssp073; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, J CELL BIOCHEM, V100, P665, DOI 10.1002/jcb.21096; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cleves A, 1991, Trends Cell Biol, V1, P30, DOI 10.1016/0962-8924(91)90067-J; Contreras I, 2004, PLANT CELL PHYSIOL, V45, P1779, DOI 10.1093/pcp/pch200; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Duchene AM, 2005, P NATL ACAD SCI USA, V102, P16484, DOI 10.1073/pnas.0504682102; Dunkel M, 2008, MOL PLANT, V1, P938, DOI 10.1093/mp/ssn064; Ebine K, 2011, NAT CELL BIOL, V13, P853, DOI 10.1038/ncb2270; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; Fujimoto M, 2010, P NATL ACAD SCI USA, V107, P6094, DOI 10.1073/pnas.0913562107; Gao H, 2006, P NATL ACAD SCI USA, V103, P6759, DOI 10.1073/pnas.0507287103; Garcia C, 2010, PLANT J, V63, P73, DOI 10.1111/j.1365-313X.2010.04225.x; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gillingham AK, 2002, MOL BIOL CELL, V13, P3761, DOI 10.1091/mbc.E02-06-0349; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Goncalves S, 2007, MOL GENET GENOMICS, V278, P273, DOI 10.1007/s00438-007-0247-8; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hanton SL, 2005, PLANT CELL, V17, P3081, DOI 10.1105/tpc.105.034900; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Hofmann NR, 2005, TRENDS PLANT SCI, V10, P450, DOI 10.1016/j.tplants.2005.07.009; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Holthuis JCM, 1998, MOL BIOL CELL, V9, P3383, DOI 10.1091/mbc.9.12.3383; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hutin C, 2002, PLANT J, V29, P531, DOI 10.1046/j.0960-7412.2001.01211.x; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Inadome H, 2007, EXP CELL RES, V313, P688, DOI 10.1016/j.yexcr.2006.11.008; Ito J, 2011, J PROTEOME RES, V10, P1571, DOI 10.1021/pr1009433; Iwahashi J, 2003, CELL MOL BIOL, V49, P467; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; Jin YH, 2008, PROTEIN PEPTIDE LETT, V15, P286; Jouhet J, 2009, J BIOL CHEM, V284, P19132, DOI 10.1074/jbc.M109.012831; Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Kelly AA, 2004, CURR OPIN PLANT BIOL, V7, P262, DOI 10.1016/j.pbi.2004.03.009; Keren N, 2005, PLANT CELL, V17, P2768, DOI 10.1105/tpc.105.035048; Kiessling J, 2004, EMBO REP, V5, P889, DOI 10.1038/sj.embor.7400238; Kim YW, 2001, PLANT PHYSIOL, V127, P1243, DOI 10.1104/pp.010450; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kogata N, 1999, FEBS LETT, V447, P329, DOI 10.1016/S0014-5793(99)00305-1; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Langhans M, 2008, TRAFFIC, V9, P770, DOI 10.1111/j.1600-0854.2008.00719.x; Latijnhouwers M, 2005, CURR OPIN PLANT BIOL, V8, P632, DOI 10.1016/j.pbi.2005.09.014; Laurent F, 2000, BIOCHEM BIOPH RES CO, V270, P286, DOI 10.1006/bbrc.2000.2387; Lazar T, 1997, TRENDS BIOCHEM SCI, V22, P468, DOI 10.1016/S0968-0004(97)01150-X; Lee DW, 2008, PLANT CELL, V20, P1603, DOI 10.1105/tpc.108.060541; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Levitan A, 2005, P NATL ACAD SCI USA, V102, P6225, DOI 10.1073/pnas.0500676102; Li SP, 2010, PLANT PHYSIOL, V154, P1819, DOI 10.1104/pp.110.164178; Lipka V, 2007, ANNU REV CELL DEV BI, V23, P147, DOI 10.1146/annurev.cellbio.23.090506.123529; Lo SM, 2012, PLANT J, V71, P656, DOI 10.1111/j.1365-313X.2012.05020.x; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Mano S, 2011, PLANT CELL PHYSIOL, V52, P2157, DOI 10.1093/pcp/pcr147; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mikosch M, 2006, PLANT PHYSIOL, V142, P923, DOI 10.1104/pp.106.087064; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miras S, 2007, J BIOL CHEM, V282, P29482, DOI 10.1074/jbc.M611112200; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; MORRE DJ, 1991, PLANT PHYSIOL, V97, P1558, DOI 10.1104/pp.97.4.1558; Nielsen E, 2008, PLANT PHYSIOL, V147, P1516, DOI 10.1104/pp.108.121798; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Nziengui H, 2009, CELL MOL LIFE SCI, V66, P584, DOI 10.1007/s00018-008-8373-y; Nziengui H, 2007, FEBS LETT, V581, P3356, DOI 10.1016/j.febslet.2007.06.032; Osterrieder A, 2012, J MICROSCOPY; Otte S, 2004, NAT CELL BIOL, V6, P1189, DOI 10.1038/ncb1195; Park JM, 1998, EMBO J, V17, P859, DOI 10.1093/emboj/17.4.859; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Rantfors M, 2000, PHYSIOL PLANTARUM, V110, P262, DOI 10.1034/j.1399-3054.2000.110217.x; Renna L, 2005, PLANT MOL BIOL, V58, P109, DOI 10.1007/s11103-005-4618-4; Ribeiro FM, 2007, NEUROCHEM INT, V50, P356, DOI 10.1016/j.neuint.2006.09.010; Richardson BC, 2009, P NATL ACAD SCI USA, V106, P13329, DOI 10.1073/pnas.0901966106; Robinson C, 2001, TRAFFIC, V2, P245, DOI 10.1034/j.1600-0854.2001.1r010.x; Robinson DG, 2007, CRIT REV PLANT SCI, V26, P199, DOI 10.1080/07352680701495820; Rolland N., 2009, V13, P41, DOI 10.1007/7089_2008_33; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Sanderfoot A, 2007, PLANT PHYSIOL, V144, P6, DOI 10.1104/pp.106.092973; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Schein AI, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e82; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Schoberer J, 2009, TRAFFIC, V10, P101, DOI 10.1111/j.1600-0854.2008.00841.x; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Schwacke R, 2007, MOL GENET GENOMICS, V277, P631, DOI 10.1007/s00438-007-0214-4; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Shimojima M, 1997, P NATL ACAD SCI USA, V94, P333, DOI 10.1073/pnas.94.1.333; Shirakawa M, 2010, PLANT J, V64, P924, DOI 10.1111/j.1365-313X.2010.04394.x; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Sieben C, 2008, PLANT J, V56, P997, DOI 10.1111/j.1365-313X.2008.03658.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Singer S J, 1992, Trends Cell Biol, V2, P69, DOI 10.1016/0962-8924(92)90060-Z; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Steiner P, 2004, J NEUROCHEM, V89, P569, DOI 10.1111/j.1471-4159.2004.02345.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stockklausner C, 2003, J BIOL CHEM, V278, P17000, DOI 10.1074/jbc.M212243200; Struthers MS, 2009, J CELL SCI, V122, P2292, DOI 10.1242/jcs.046441; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Sztul E, 2009, FEBS LETT, V583, P3770, DOI 10.1016/j.febslet.2009.10.083; Tamura T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-466; Tanz SK, 2012, PLANT J, V69, P743, DOI 10.1111/j.1365-313X.2011.04833.x; Teardo E, 2010, CELL PHYSIOL BIOCHEM, V26, P253, DOI 10.1159/000320525; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372, DOI 10.1074/jbc.271.46.29372; Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Uemura T, 2010, PLANT J, V64, P864, DOI 10.1111/j.1365-313X.2010.04372.x; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Voelker C, 2006, PLANT J, V48, P296, DOI 10.1111/j.1365-313X.2006.02868.x; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Wakana Y, 2005, BIOCHEM BIOPH RES CO, V334, P1198, DOI 10.1016/j.bbrc.2005.07.012; Wang Q, 2004, PLANT PHYSIOL, V136, P3594, DOI 10.1104/pp.104.049841; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Wen WY, 2006, MOL BIOL CELL, V17, P4282, DOI 10.1091/mbc.E06-02-0128; Westphal S, 2001, FEBS LETT, V506, P257, DOI 10.1016/S0014-5793(01)02931-3; Woolhead CA, 2001, J BIOL CHEM, V276, P40841, DOI 10.1074/jbc.M106523200; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zanetti M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010118; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XC, 2009, PLANT J, V57, P146, DOI 10.1111/j.1365-313X.2008.03677.x; Zhao JF, 2003, J BIOCHEM, V133, P115, DOI 10.1093/jb/mvg009; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	190	36	36	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59898	10.1371/journal.pone.0059898	http://dx.doi.org/10.1371/journal.pone.0059898			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573218	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900032
J	Wang, ZY; Jin, L; Tan, HR; Irwin, DM				Wang, Zhao Yang; Jin, Ling; Tan, Huanran; Irwin, David M.			Evolution of Hepatic Glucose Metabolism: Liver-Specific Glucokinase Deficiency Explained by Parallel Loss of the Gene for Glucokinase Regulatory Protein (GCKR)	PLOS ONE			English	Article							PHOSPHORYLATING ISOENZYMES; SUBCELLULAR-LOCALIZATION; RAT-LIVER; INSULIN; VERTEBRATES; IDENTIFICATION; EXPRESSION; CLONING; CDNA; FISH	Background: Glucokinase (GCK) plays an important role in the regulation of carbohydrate metabolism. In the liver, phosphorylation of glucose to glucose-6-phosphate by GCK is the first step for both glycolysis and glycogen synthesis. However, some vertebrate species are deficient in GCK activity in the liver, despite containing GCK genes that appear to be compatible with function in their genomes. Glucokinase regulatory protein (GCKR) is the most important post-transcriptional regulator of GCK in the liver; it participates in the modulation of GCK activity and location depending upon changes in glucose levels. In experimental models, loss of GCKR has been shown to associate with reduced hepatic GCK protein levels and activity. Methodology/Principal Findings: GCKR genes and GCKR-like sequences were identified in the genomes of all vertebrate species with available genome sequences. The coding sequences of GCKR and GCKR-like genes were identified and aligned; base changes likely to disrupt coding potential or splicing were also identified. Conclusions/Significance: GCKR genes could not be found in the genomes of 9 vertebrate species, including all birds. In addition, in multiple mammalian genomes, whereas GCKR-like gene sequences could be identified, these genes could not predict a functional protein. Vertebrate species that were previously reported to be deficient in hepatic GCK activity were found to have deleted (birds and lizard) or mutated (mammals) GCKR genes. Our results suggest that mutation of the GCKR gene leads to hepatic GCK deficiency due to the loss of the stabilizing effect of GCKR.	[Wang, Zhao Yang; Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Jin, Ling; Tan, Huanran; Irwin, David M.] Peking Univ, Hlth Sci Ctr, Dept Pharmacol, Beijing 100871, Peoples R China; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada	University of Toronto; Peking University; University of Toronto	Tan, HR (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Pharmacol, Beijing 100871, Peoples R China.	tanlab@bjmu.edu.cn; david.irwin@utoronto.ca		Irwin, David/0000-0001-6131-4933	National Science Foundation of China (NSFC); Canadian Institutes of Health Research (CIHR); China-Canada Joint Health Research Initiative [81061120525]; DMI [CCI-109605]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); China-Canada Joint Health Research Initiative; DMI	This study was supported by a grant from the National Science Foundation of China (NSFC) -Canadian Institutes of Health Research (CIHR) China-Canada Joint Health Research Initiative to HT (81061120525) and DMI (CCI-109605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS L, 1994, BIOCHEM J, V298, P237, DOI 10.1042/bj2980237; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arden C, 2011, DIABETES, V60, P3110, DOI 10.2337/db11-0061; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Brown KS, 1997, DIABETES, V46, P179, DOI 10.2337/diabetes.46.2.179; de la Iglesia N, 1999, FEBS LETT, V456, P332, DOI 10.1016/S0014-5793(99)00971-0; DETHEUX M, 1993, FEBS LETT, V321, P111, DOI 10.1016/0014-5793(93)80089-D; Farrelly D, 1999, P NATL ACAD SCI USA, V96, P14511, DOI 10.1073/pnas.96.25.14511; Grimsby J, 2000, J BIOL CHEM, V275, P7826, DOI 10.1074/jbc.275.11.7826; Hayward BE, 1998, GENOMICS, V49, P137, DOI 10.1006/geno.1997.5195; Hiskett EK, 2009, VET RES COMMUN, V33, P227, DOI 10.1007/s11259-008-9171-6; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Hussain K, 2010, REV ENDOCR METAB DIS, V11, P179, DOI 10.1007/s11154-010-9147-z; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; IYNEDJIAN PB, 1988, J BIOL CHEM, V263, P740; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kurokawa T, 2005, PEPTIDES, V26, P745, DOI 10.1016/j.peptides.2004.12.017; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Malecki MT, 2005, DIABETES RES CLIN PR, V68, pS10, DOI 10.1016/j.diabres.2005.03.003; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; Polakof S, 2009, J COMP PHYSIOL B, V179, P643, DOI 10.1007/s00360-009-0346-4; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Roncero I, 2009, J NEUROENDOCRINOL, V21, P973, DOI 10.1111/j.1365-2826.2009.01919.x; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Shan Yunfeng, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-49; Shiota C, 1999, J BIOL CHEM, V274, P37125, DOI 10.1074/jbc.274.52.37125; Slosberg ED, 2001, DIABETES, V50, P1813, DOI 10.2337/diabetes.50.8.1813; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiedge M, 1999, DIABETES, V48, P514, DOI 10.2337/diabetes.48.3.514; TOYODA Y, 1995, BIOCHEM BIOPH RES CO, V215, P467, DOI 10.1006/bbrc.1995.2488; URETA T, 1981, COMP BIOCHEM PHYS B, V70, P225, DOI 10.1016/0305-0491(81)90038-9; URETA T, 1982, COMP BIOCHEM PHYS B, V71, P549, DOI 10.1016/0305-0491(82)90461-8; URETA T, 1973, COMP BIOCHEM PHYSIOL, V45, P445, DOI 10.1016/0305-0491(73)90076-X; URETA T, 1975, COMP BIOCHEM PHYS B, V50, P515, DOI 10.1016/0305-0491(75)90081-4; URETA T, 1978, ARCH BIOCHEM BIOPHYS, V186, P235, DOI 10.1016/0003-9861(78)90432-0; VANDERCAMMEN A, 1993, BIOCHEM J, V294, P551, DOI 10.1042/bj2940551; VanSchaftingen E, 1997, BIOCHEM SOC T, V25, P136, DOI 10.1042/bst0250136; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; Veiga-da-Cunha M, 2002, J BIOL CHEM, V277, P8466, DOI 10.1074/jbc.M105984200; Veiga-da-Cunha M, 2009, BIOCHEM J, V423, P323, DOI 10.1042/BJ20090986; VEIGADACUNHA M, 1994, EUR J BIOCHEM, V225, P43, DOI 10.1111/j.1432-1033.1994.00043.x; Verbrugghe A, 2012, CRIT REV FOOD SCI, V52, P172, DOI 10.1080/10408398.2010.499763; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045824; WARNER JP, 1995, MAMM GENOME, V6, P532, DOI 10.1007/BF00356171; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Xavier GD, 2000, J BIOL CHEM, V275, P36269, DOI 10.1074/jbc.M006597200	53	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60896	10.1371/journal.pone.0060896	http://dx.doi.org/10.1371/journal.pone.0060896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573289	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900082
J	Yang, XY; Li, SZ; Feldman, MW				Yang, Xueyan; Li, Shuzhuo; Feldman, Marcus W.			Development and Validation of a Gender Ideology Scale for Family Planning Services in Rural China	PLOS ONE			English	Article							ROLE EGALITARIANISM SCALE; REPRODUCTIVE HEALTH; ATTITUDES; KNOWLEDGE; QUALITY; CARE; BEHAVIOR	The objectives of this study are to develop a scale of gender role ideology appropriate for assessing Quality of Care in family planning services for rural China. Literature review, focus-group discussions and in-depth interviews with service providers and clients from two counties in eastern and western China, as well as experts' assessments, were used to develop a scale for family planning services. Psychometric methodologies were applied to samples of 601 service clients and 541 service providers from a survey in a district in central China to validate its internal consistency, reliability, and construct validity with realistic and strategic dimensions. This scale is found to be reliable and valid, and has prospects for application both academically and practically in the field.	[Yang, Xueyan; Li, Shuzhuo] Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian 710049, Shaanxi Provinc, Peoples R China; [Yang, Xueyan; Li, Shuzhuo] Xi An Jiao Tong Univ, Shaanxi Lab Populat & Dev Res, Xian 710049, Shaanxi Provinc, Peoples R China; [Feldman, Marcus W.] Stanford Univ, Morrison Inst Populat & Resource Studies, Stanford, CA 94305 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Stanford University	Yang, XY (corresponding author), Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian 710049, Shaanxi Provinc, Peoples R China.	xueyanyang@mail.xjtu.edu.cn	Yang, Xueyan/I-8553-2015	Yang, Xueyan/0000-0002-5083-1799	Ford Foundation [1035-1098]; 985-3 Project of Xi'an Jiaotong University; Shaanxi Laboratory for Population and Development Research; New Century Excellent Talents in University by Ministry of Education [NCET-12-0460]; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER	Ford Foundation; 985-3 Project of Xi'an Jiaotong University; Shaanxi Laboratory for Population and Development Research; New Century Excellent Talents in University by Ministry of Education; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is jointly supported by grants from the Ford Foundation (Grant number 1035-1098); the 985-3 Project of Xi'an Jiaotong University and Shaanxi Laboratory for Population and Development Research, The new Program for New Century Excellent Talents in University by Ministry of Education (NCET-12-0460). The roles of fundings: Ford Foundation (Grant number 1035-1098): Study design and data collection. The 985-3 Project of Xi'an Jiaotong University and Shaanxi Laboratory for Population and Development Research: Data analysis. The new Program for New Century Excellent Talents in University by Ministry of Education (NCET-12-0460): Preparation of the manuscript and decision to publish.	ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; BEERE CA, 1984, SEX ROLES, V10, P563; Bender SS, 1999, FAM PLANN PERSPECT, V31, P294, DOI 10.2307/2991540; Gibbons JL, 1997, PSYCHOL WOMEN QUART, V21, P151, DOI 10.1111/j.1471-6402.1997.tb00106.x; Gu BC, 1999, INNOVATION, P7; Gu BC, 2002, RESPONDING CAIRO CAS, P58; Hardee K, 2004, INT FAM PLAN PERSPEC, V30, P68, DOI 10.1363/3006804; Holcombe S, 2003, ASSESSMENT REPORT 20, P8; Hvistendahl M, 2009, SCIENCE, V323, P1164, DOI 10.1126/science.323.5918.1164; Jin W., 2010, POPULATION FAMILY PL, V7, P18; KALIN R, 1982, J SOC PSYCHOL, V116, P141, DOI 10.1080/00224545.1982.9924404; Kaufman J., 1992, International Family Planning Perspectives, V18, P18, DOI 10.2307/2133452; Kaufman J, 2006, STUD FAMILY PLANN, V37, P17, DOI 10.1111/j.1728-4465.2006.00080.x; KAUFMAN J, 1992, STUD FAMILY PLANN, V23, P73, DOI 10.2307/1966537; Kaufman J, 2004, BASELINE REPOR UNPUB, P5; Kaufman J, 2005, PILOT PROJECTS POLIC, P3; Kerr PS, 1996, J SOC BEHAV PERS, V11, P3; King LA, 1997, SEX ROLES, V36, P221, DOI 10.1007/BF02766269; Li JH, 2005, RURAL SOCIOL, V70, P229, DOI 10.1526/0036011054776352; Li JH, 2004, SOC SCI MED, V59, P695, DOI 10.1016/j.socscimed.2003.11.041; Liu C, 2010, J CHINA WOMENS U, V5, P27; Liu H. Y., 2003, POPULATION FAMILY PL, V9, P30; Lu L, 2001, J CHINA WOMEN U SHAN, V4, P8; McHugh MC, 1997, PSYCHOL WOMEN QUART, V21, P1, DOI 10.1111/j.1471-6402.1997.tb00097.x; Mogilevkina I, 2001, J AM COLL HEALTH, V49, P269, DOI 10.1080/07448480109596313; Mu GZ, 2000, NEWSPAPER TECHNOLOGY, V12, P26; Penner L, 1986, SOCIAL PSYCHOL CONCE, P352; Psihogios V, 2002, FERTIL STERIL, V77, P119, DOI 10.1016/S0015-0282(01)02933-8; SAWYER SM, 1995, J ADOLESCENT HEALTH, V17, P46, DOI 10.1016/1054-139X(94)00096-W; Simmons R, 1997, STUD FAMILY PLANN, V28, P79, DOI 10.2307/2138111; Simmons R, 2002, STUD FAMILY PLANN, V33, P61, DOI 10.1111/j.1728-4465.2002.00061.x; Smyth I, 1998, GUIDE GENDER ANAL FR, P8; Spence J.T., 1972, JSAS CATALOG SELECTE, V2, P66, DOI DOI 10.1111/J.1471-6402.1997.TB00098.X; Wang CC, 1998, AM J PUBLIC HEALTH, V88, P646, DOI 10.2105/AJPH.88.4.646; Yang XY, 2009, BIODEMOGR SOC BIOL, V55, P82, DOI 10.1080/19485560903054721; Yang XY, 2005, COLLECTION WOMENS ST, V5, P35; Yen FT, 2007, CULT HEALTH SEX, V9, P55, DOI 10.1080/13691050600965653; Zhu CZ, 2004, BASIC TXB GENDER, P18; Zhu CZ, 1997, DUAL EFFECTS FAMILY, P5	39	0	0	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59919	10.1371/journal.pone.0059919	http://dx.doi.org/10.1371/journal.pone.0059919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117CY	23573222	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900035
J	Araujo, KPC; Bonuccelli, G; Duarte, CN; Gaiad, TP; Moreira, DF; Feder, D; Belizario, JE; Miglino, MA; Lisanti, MP; Ambrosio, CE				Araujo, Karla P. C.; Bonuccelli, Gloria; Duarte, Caio N.; Gaiad, Thais P.; Moreira, Dayson F.; Feder, David; Belizario, Jose E.; Miglino, Maria A.; Lisanti, Michael P.; Ambrosio, Carlos E.			Bortezomib (PS-341) Treatment Decreases Inflammation and Partially Rescues the Expression of the Dystrophin-Glycoprotein Complex in GRMD Dogs	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE ATROPHY; FACTOR-KAPPA-B; PROTEASOME INHIBITION; TGF-BETA; PHASE-I; CELLS; FIBROSIS; IDENTIFICATION; LOCALIZATION	Golden retriever muscular dystrophy (GRMD) is a genetic myopathy corresponding to Duchenne muscular dystrophy (DMD) in humans. Muscle atrophy is known to be associated with degradation of the dystrophin-glycoprotein complex (DGC) via the ubiquitin-proteasome pathway. In the present study, we investigated the effect of bortezomib treatment on the muscle fibers of GRMD dogs. Five GRMD dogs were examined; two were treated (TD- Treated dogs) with the proteasome inhibitor bortezomib, and three were control dogs (CD). Dogs were treated with bortezomib using the same treatment regimen used for multiple myeloma. Pharmacodynamics were evaluated by measuring the inhibition of 20S proteasome activity in whole blood after treatment and comparing it to that in CD. We performed immunohistochemical studies on muscle biopsy specimens to evaluate the rescue of dystrophin and dystrophin-associated proteins in the muscles of GRMD dogs treated with bortezomib. Skeletal tissue from TD had lower levels of connective tissue deposition and inflammatory cell infiltration than CD as determined by histology, collagen morphometry and ultrastructural analysis. The CD showed higher expression of phospho-NF kappa B and TGF-beta 1, suggesting a more pronounced activation of anti-apoptotic factors and inflammatory molecules and greater connective tissue deposition, respectively. Immunohistochemical analysis demonstrated that dystrophin was not present in the sarcoplasmic membrane of either group. However, bortezomib-TD showed higher expression of alpha- and beta-dystroglycan, indicating an improved disease histopathology phenotype. Significant inhibition of 20S proteasome activity was observed 1 hour after bortezomib administration in the last cycle when the dose was higher. Proteasome inhibitors may thus improve the appearance of GRMD muscle fibers, lessen connective tissue deposition and reduce the infiltration of inflammatory cells. In addition, proteasome inhibitors may rescue some dystrophin-associated proteins in the muscle fiber membrane.	[Araujo, Karla P. C.; Duarte, Caio N.; Miglino, Maria A.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, Sao Paulo, Brazil; [Bonuccelli, Gloria; Lisanti, Michael P.] Thomas Jefferson Univ, Dept Stem Cell Biol & Regenerat Med & Canc Biol, Philadelphia, PA 19107 USA; [Gaiad, Thais P.] Univ Fed Vales Jequitinhonha & Mucuri, Dept Physiotherapy, Fac Biol Sci & Hlth, Diamantina, MG, Brazil; [Moreira, Dayson F.; Belizario, Jose E.] Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, Sao Paulo, Brazil; [Feder, David] ABC Sch Med, Dept Pharmacol, Santo Andre, SP, Brazil; [Bonuccelli, Gloria] Ist Ortoped Rizzoli, Lab Orthopaed Pathophysiol & Regenerat Med, Bologna, Italy; [Lisanti, Michael P.] Univ Manchester, Breakthrough Breast Canc Res Unit, Inst Canc Sci, Manchester, Lancs, England; [Ambrosio, Carlos E.] Univ Sao Paulo, Dept Vet Med, Fac Anim Sci & Food Engn, Pirassununga, SP, Brazil	Universidade de Sao Paulo; Jefferson University; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade de Sao Paulo; IRCCS Istituto Ortopedico Rizzoli; University of Manchester; Universidade de Sao Paulo	Ambrosio, CE (corresponding author), Univ Sao Paulo, Dept Vet Med, Fac Anim Sci & Food Engn, Pirassununga, SP, Brazil.	ceambrosio@usp.br	Friaca Moreira, Dayson/L-6500-2014; Miglino, Maria Angelica/B-9519-2012; Lisanti, Michael/B-6131-2018; Ambrosio, Carlos Eduardo/F-3402-2010	Friaca Moreira, Dayson/0000-0002-0995-7031; Miglino, Maria Angelica/0000-0003-4979-115X; Lisanti, Michael/0000-0003-2034-1382; Ambrosio, Carlos Eduardo/0000-0002-8224-5022; Bonuccelli, Gloria/0000-0001-7576-5508	FAPESP [2006/59060-9, 2006/61563-9, 2006/53056-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP with financial support provided as a research grant and a scholarship grant (2006/59060-9, 2006/61563-9, and 2006/53056-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Adams J, 1999, CANCER RES, V59, P2615; Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Ambrosio CE, 2009, GENET MOL RES, V8, P389, DOI 10.4238/vol8-2gmr581; ARAHATA K, 1988, ANN NEUROL, V23, P493, DOI 10.1002/ana.410230511; Assereto S, 2006, AM J PHYSIOL-CELL PH, V290, pC577, DOI 10.1152/ajpcell.00434.2005; Bergman RL, 2002, J AM ANIM HOSP ASSOC, V38, P255, DOI 10.5326/0380255; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; Blaney SM, 2004, J CLIN ONCOL, V22, P4804, DOI 10.1200/JCO.2004.12.185; Bonuccelli G, 2003, AM J PATHOL, V163, P1663, DOI 10.1016/S0002-9440(10)63523-7; Bonuccelli G, 2007, CELL CYCLE, V6, P1242, DOI 10.4161/cc.6.10.4182; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Caron AZ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-185; Chen CR, 1999, RESTRAINT PHYS EXAMI; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Childers MK, 2002, ARCH PHYS MED REHAB, V83, P1572, DOI 10.1053/apmr.2002.35109; Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x; Connolly AM, 2002, NEUROMUSCULAR DISORD, V12, P917, DOI 10.1016/S0960-8966(02)00180-3; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; Cullen MJ, 1982, PATHOLOGICAL REACTIO, P88; Duan D, 2011, RES REP BIOL, V2, P31, DOI 10.2147/RRB.S13463; DUANCE VC, 1980, NATURE, V284, P470, DOI 10.1038/284470a0; Elliott PJ, 2001, AM J CLIN PATHOL, V116, P637; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Gaiad TP, 2011, RES VET SCI, V91, P188, DOI 10.1016/j.rvsc.2011.01.007; Gaiad TP, 2012, MUSCULAR DYSTROPHY, P535, DOI [10.5772/30329, DOI 10.5772/30329]; Gastaldello S, 2008, AM J PATHOL, V173, P170, DOI 10.2353/ajpath.2008.071146; Gazzerro E, 2010, AM J PATHOL, V176, P1863, DOI 10.2353/ajpath.2010.090468; GOROSPE JRM, 1994, J NEUROL SCI, V122, P44, DOI 10.1016/0022-510X(94)90050-7; GRIGGS RC, 1993, NEUROLOGY, V43, P520, DOI 10.1212/WNL.43.3_Part_1.520; Hamilton AL, 2005, J CLIN ONCOL, V23, P6107, DOI 10.1200/JCO.2005.01.136; Herrmann J, 2007, CIRC RES, V101, P865, DOI 10.1161/CIRCRESAHA.107.152959; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Kumamoto T, 2000, ACTA NEUROPATHOL, V100, P595, DOI 10.1007/s004010000229; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lightcap ES, 2000, CLIN CHEM, V46, P673; LIPTON BH, 1979, MUSCLE REGENERATION, P31; Messina S, 2006, EXP NEUROL, V198, P234, DOI 10.1016/j.expneurol.2005.11.021; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; Morrison J, 2000, LAB INVEST, V80, P881, DOI 10.1038/labinvest.3780092; Moxley RT, 2005, NEUROLOGY, V64, P13, DOI 10.1212/01.WNL.0000148485.00049.B7; Muntoni F, 2002, NEUROMUSCULAR DISORD, V12, pS162, DOI 10.1016/S0960-8966(02)00101-3; Nguyen F, 2005, NEUROMUSCULAR DISORD, V15, P154, DOI 10.1016/j.nmd.2004.11.002; Nguyen F, 2002, J COMP PATHOL, V126, P100, DOI 10.1053/jcpa.2001.0526; Passerini L, 2002, NEUROMUSCULAR DISORD, V12, P828, DOI 10.1016/S0960-8966(02)00071-8; Sato Y, 2008, NAT BIOTECHNOL, V26, P413; Schwartz Rowena, 2004, Oncology (Williston Park), V18, P14; SHARP NJH, 1989, SEMIN VET MED SURG, V4, P133; Shelton GD, 2001, J VET INTERN MED, V15, P240, DOI 10.1892/0891-6640(2001)015&lt;0240:MDIFD&gt;2.3.CO;2; Sun G, 2008, J NEUROL SCI, V267, P48, DOI 10.1016/j.jns.2007.09.043; Tang Y, 2010, GENE THER, V17, P1476, DOI 10.1038/gt.2010.110; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; VALENTINE BA, 1986, ACTA NEUROPATHOL, V71, P301, DOI 10.1007/BF00688053; VALENTINE BA, 1990, J NEUROL SCI, V97, P1, DOI 10.1016/0022-510X(90)90095-5; VALENTINE BA, 1988, J NEUROL SCI, V88, P69, DOI 10.1016/0022-510X(88)90206-7; Wadosky KM, 2011, MUSCLE NERVE, V44, P553, DOI 10.1002/mus.22125; Yang HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044438	62	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61367	10.1371/journal.pone.0061367	http://dx.doi.org/10.1371/journal.pone.0061367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23579193	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000130
J	Greenlee, JDW; Behroozmand, R; Larson, CR; Jackson, AW; Chen, FX; Hansen, DR; Oya, H; Kawasaki, H; Howard, MA				Greenlee, Jeremy D. W.; Behroozmand, Roozbeh; Larson, Charles R.; Jackson, Adam W.; Chen, Fangxiang; Hansen, Daniel R.; Oya, Hiroyuki; Kawasaki, Hiroto; Howard, Matthew A., III			Sensory-Motor Interactions for Vocal Pitch Monitoring in Non-Primary Human Auditory Cortex	PLOS ONE			English	Article							FIELD POTENTIALS; SPEECH; FEEDBACK; VOCALIZATION; NEURONS; OSCILLATIONS; SUPPRESSION; MODULATION; FREQUENCY; LARYNGEAL	The neural mechanisms underlying processing of auditory feedback during self-vocalization are poorly understood. One technique used to study the role of auditory feedback involves shifting the pitch of the feedback that a speaker receives, known as pitch-shifted feedback. We utilized a pitch shift self-vocalization and playback paradigm to investigate the underlying neural mechanisms of audio-vocal interaction. High-resolution electrocorticography (ECoG) signals were recorded directly from auditory cortex of 10 human subjects while they vocalized and received brief downward (2100 cents) pitch perturbations in their voice auditory feedback (speaking task). ECoG was also recorded when subjects passively listened to playback of their own pitch-shifted vocalizations. Feedback pitch perturbations elicited average evoked potential (AEP) and event-related band power (ERBP) responses, primarily in the high gamma (70-150 Hz) range, in focal areas of non-primary auditory cortex on superior temporal gyrus (STG). The AEPs and high gamma responses were both modulated by speaking compared with playback in a subset of STG contacts. From these contacts, a majority showed significant enhancement of high gamma power and AEP responses during speaking while the remaining contacts showed attenuated response amplitudes. The speaking-induced enhancement effect suggests that engaging the vocal motor system can modulate auditory cortical processing of self-produced sounds in such a way as to increase neural sensitivity for feedback pitch error detection. It is likely that mechanisms such as efference copies may be involved in this process, and modulation of AEP and high gamma responses imply that such modulatory effects may affect different cortical generators within distinctive functional networks that drive voice production and control.	[Greenlee, Jeremy D. W.; Behroozmand, Roozbeh; Jackson, Adam W.; Chen, Fangxiang; Hansen, Daniel R.; Oya, Hiroyuki; Kawasaki, Hiroto; Howard, Matthew A., III] Univ Iowa, Dept Neurosurg, Human Brain Res Lab, Iowa City, IA 52242 USA; [Larson, Charles R.] Northwestern Univ, Dept Commun Sci & Disorders, Speech Physiol Lab, Evanston, IL USA	University of Iowa; Northwestern University	Greenlee, JDW (corresponding author), Univ Iowa, Dept Neurosurg, Human Brain Res Lab, Iowa City, IA 52242 USA.	jeremy-greenlee@uiowa.edu	Oya, Hiroyuki/Q-2989-2018	Oya, Hiroyuki/0000-0002-1733-5478; Howard, Matthew/0000-0003-3935-8889; Kawasaki, Hiroto/0000-0002-7688-9171; Greenlee, Jeremy/0000-0002-8481-8517	National Institute on Deafness and Other Communication Disorders [K23DC009589, R01DC04290, R01DC006243]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004290, K23DC009589, R01DC006243] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders (grant numbers K23DC009589, R01DC04290, R01DC006243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; Behroozmand R, 2012, BRAIN RES, V1448, P89, DOI 10.1016/j.brainres.2012.02.012; Behroozmand R, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-54; Behroozmand R, 2009, CLIN NEUROPHYSIOL, V120, P1303, DOI 10.1016/j.clinph.2009.04.022; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Boersma Paul, 2002, GLOT INT, V5, P341; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chang EF, 2013, P NATL ACAD SCI US; Coude G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026822; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P476, DOI 10.1007/BF00249601; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Davis PJ, 1993, VOCAL FOLD PHYSL FRO, P189; Eliades SJ, 2005, CEREB CORTEX, V15, P1510, DOI 10.1093/cercor/bhi030; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Flinker A, 2010, J NEUROSCI, V30, P16643, DOI 10.1523/JNEUROSCI.1809-10.2010; Greenlee JDW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014744; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Heinks-Maldonado TH, 2005, PSYCHOPHYSIOLOGY, V42, P180, DOI 10.1111/j.1469-8986.2005.00272.x; Heinks-Maldonado TH, 2006, NEUROREPORT, V17, P1375, DOI 10.1097/01.wnr.0000233102.43526.e9; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Houde JF, 2002, J SPEECH LANG HEAR R, V45, P295, DOI 10.1044/1092-4388(2002/023); Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones JA, 2002, J PHONETICS, V30, P303, DOI 10.1006/jpho.2001.0160; Jurgens U, 2008, J VOICE; LARSON CR, 1991, BRAIN RES, V552, P77, DOI 10.1016/0006-8993(91)90662-F; Larson CR, 1998, J COMMUN DISORD, V31, P489, DOI 10.1016/S0021-9924(98)00021-5; Ludlow CL, 2005, RESP PHYSIOL NEUROBI, V147, P205, DOI 10.1016/j.resp.2005.04.015; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; MULLERPREUSS P, 1980, BRAIN RES, V202, P307, DOI 10.1016/0006-8993(80)90143-2; Natke U, 2001, J SPEECH LANG HEAR R, V44, P577, DOI 10.1044/1092-4388(2001/045); Numminen J, 1999, NEUROSCI LETT, V265, P119, DOI 10.1016/S0304-3940(99)00218-9; Parkinson AL, 2012, NEUROIMAGE, V61, P314, DOI 10.1016/j.neuroimage.2012.02.068; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Titze IR, 1994, PRINCIPLES VOICE PRO; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Trainor L, 2008, NATURE, V453, P598, DOI 10.1038/453598a; von Helmholtz H., 1867, HDB PHYSL OPTICS; von Holst E, 1954, BRIT J ANIM BEHAV, V2, P89, DOI DOI 10.1016/S0950-5601(54)80044-X; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1997, J PHYSIOL-LONDON, V501P, pS12; Zarate JM, 2008, NEUROIMAGE, V40, P1871, DOI 10.1016/j.neuroimage.2008.01.026; Zarate JM, 2010, NEUROPSYCHOLOGIA, V48, P607, DOI 10.1016/j.neuropsychologia.2009.10.025; Zatorre RJ, 2005, NATURE, V436, P1093, DOI 10.1038/4361093a; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	57	48	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60783	10.1371/journal.pone.0060783	http://dx.doi.org/10.1371/journal.pone.0060783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577157	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000068
J	Bachok, N; Ishak, A; Pop, I				Bachok, Norfifah; Ishak, Anuar; Pop, Ioan			Mixed Convection Boundary Layer Flow over a Moving Vertical Flat Plate in an External Fluid Flow with Viscous Dissipation Effect	PLOS ONE			English	Article							HEAT-TRANSFER; FREE-STREAM; SURFACE; WALL; MOMENTUM; SHEET	The steady boundary layer flow of a viscous and incompressible fluid over a moving vertical flat plate in an external moving fluid with viscous dissipation is theoretically investigated. Using appropriate similarity variables, the governing system of partial differential equations is transformed into a system of ordinary (similarity) differential equations, which is then solved numerically using a Maple software. Results for the skin friction or shear stress coefficient, local Nusselt number, velocity and temperature profiles are presented for different values of the governing parameters. It is found that the set of the similarity equations has unique solutions, dual solutions or no solutions, depending on the values of the mixed convection parameter, the velocity ratio parameter and the Eckert number. The Eckert number significantly affects the surface shear stress as well as the heat transfer rate at the surface.	[Bachok, Norfifah] Univ Putra Malaysia, Dept Math, Upm Serdang, Selangor, Malaysia; [Bachok, Norfifah] Univ Putra Malaysia, Inst Math Res, Upm Serdang, Selangor, Malaysia; [Ishak, Anuar] Univ Kebangsaan Malaysia, Sch Math Sci, Fac Sci & Technol, Ukm Bangi, Selangor, Malaysia; [Pop, Ioan] Univ Babes Bolyai, Fac Math, R-3400 Cluj Napoca, Romania	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia; Babes Bolyai University from Cluj	Ishak, A (corresponding author), Univ Kebangsaan Malaysia, Sch Math Sci, Fac Sci & Technol, Ukm Bangi, Selangor, Malaysia.	anuar_mi@ukm.my	Ishak, Anuar/AAN-1341-2021; Pop, Ioan/ABE-6678-2020; Ishak, Anuar/F-1093-2010	Ishak, Anuar/0000-0002-2353-5919; Pop, Ioan/0000-0002-0660-6543; Ishak, Anuar/0000-0002-2353-5919; Bachok, Norfifah/0000-0001-9006-7353	Universiti Kebangsaan Malaysia [DIP-2012-31]	Universiti Kebangsaan Malaysia	Universiti Kebangsaan Malaysia Grant number: DIP-2012-31. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JP, 2005, INT J HEAT FLUID FL, V26, P289, DOI 10.1016/j.ijheatfluidflow.2004.08.007; AFZAL N, 1993, INT J HEAT MASS TRAN, V36, P3399, DOI 10.1016/0017-9310(93)90022-X; Afzal N, 2003, INT J ENG SCI, V41, P1197, DOI 10.1016/S0020-7225(03)00002-8; AFZAL N, 1993, INT J HEAT MASS TRAN, V36, P1128, DOI 10.1016/S0017-9310(05)80296-0; AFZAL N, 1984, J HEAT TRANS-T ASME, V106, P240, DOI 10.1115/1.3246644; Aman F, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/453457; [Anonymous], 1970, POLYM SCI ENG SERIES; Bachok Norfifah, 2010, WSEAS Transactions on Heat and Mass Transfer, V5, P73; Bachok N, 2010, INT J THERM SCI, V49, P1663, DOI 10.1016/j.ijthermalsci.2010.01.026; Bataller RC, 2008, J MATER PROCESS TECH, V203, P176, DOI 10.1016/j.jmatprotec.2007.09.055; Bejan A., 1995, CONVECTION HEAT TRAN; Bergman T.L., 2011, FUNDAMENTALS HEAT MA, Vsixth; Chen CH, 2003, J MATER PROCESS TECH, V138, P332, DOI 10.1016/S0924-0136(03)00094-3; DEY J, 1981, WARME STOFFUBERTRAG, V15, P279, DOI 10.1007/BF01003648; Fang T, 2003, ACTA MECH, V163, P183, DOI 10.1007/s00707-002-0979-9; Fang TG, 2005, APPL MATH LETT, V18, P487, DOI 10.1016/j.aml.2004.08.006; Fang TG, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/1/014703; HIEBER CA, 1973, INT J HEAT MASS TRAN, V16, P769, DOI 10.1016/0017-9310(73)90090-2; INGHAM DB, 1986, Z ANGEW MATH PHYS, V37, P559, DOI 10.1007/BF00945430; Ishak A, 2006, ARAB J SCI ENG, V31, P165; Ishak A, 2006, ARCH MECH, V58, P529; Ishak A, 2007, CHINESE PHYS LETT, V24, P2274, DOI 10.1088/0256-307X/24/8/033; Ishak A, 2006, INT J ENG SCI, V44, P1225, DOI 10.1016/j.ijengsci.2006.08.005; Ishak A, 2006, FLUID DYN RES, V38, P489, DOI 10.1016/j.fluiddyn.2006.03.004; Ishak A, 2009, HEAT MASS TRANSFER, V46, P147, DOI 10.1007/s00231-009-0552-3; Ishak A, 2009, HEAT MASS TRANSFER, V45, P563, DOI 10.1007/s00231-008-0462-9; Jaluria Y, 1992, ANN REV HEAT TRANSFE, V4, P187, DOI DOI 10.1615/AnnualRevHeatTransfer.v4.60; KARWE MV, 1988, J HEAT TRANS-T ASME, V110, P655, DOI 10.1115/1.3250542; Kays W.M, 2011, CONVECTIVE HEAT MASS; MERKIN JH, 1986, J ENG MATH, V20, P171, DOI 10.1007/BF00042775; Postelnicu A, 2011, APPL MATH COMPUT, V217, P4359, DOI 10.1016/j.amc.2010.09.037; Rosca AV, 2013, INT J HEAT MASS TRAN, V60, P355, DOI 10.1016/j.ijheatmasstransfer.2012.12.028; SCHNEIDER W, 1979, INT J HEAT MASS TRAN, V22, P1401, DOI 10.1016/0017-9310(79)90202-3; Sparrow EM, 2005, INT J HEAT MASS TRAN, V48, P3047, DOI 10.1016/j.ijheatmasstransfer.2005.02.028; Weidman PD, 2006, INT J ENG SCI, V44, P730, DOI 10.1016/j.ijengsci.2006.04.005; Xu H, 2008, COMMUN NONLINEAR SCI, V13, P350, DOI 10.1016/j.cnsns.2006.04.008	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60766	10.1371/journal.pone.0060766	http://dx.doi.org/10.1371/journal.pone.0060766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577156	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800098
J	Browne, RW; Kantarci, A; LaMonte, MJ; Andrews, CA; Hovey, KM; Falkner, KL; Cekici, A; Stephens, D; Genco, RJ; Scannapieco, FA; Van Dyke, TE; Wactawski-Wende, J				Browne, Richard W.; Kantarci, Alpdogan; LaMonte, Michael J.; Andrews, Christopher A.; Hovey, Kathleen M.; Falkner, Karen L.; Cekici, Ali; Stephens, Danielle; Genco, Robert J.; Scannapieco, Frank A.; Van Dyke, Thomas E.; Wactawski-Wende, Jean			Performance of Multiplex Cytokine Assays in Serum and Saliva among Community-Dwelling Postmenopausal Women	PLOS ONE			English	Article							INTERNAL QUALITY-CONTROL; BIOLOGICAL VARIATION; ELISA; VALIDATION; RULES; IDENTIFICATION; QUANTITATION; INFLAMMATION; IMMUNOASSAYS; TECHNOLOGY	Multiplexing arrays increase the throughput and decrease sample requirements for studies employing multiple biomarkers. The goal of this project was to examine the performance of Multiplex arrays for measuring multiple protein biomarkers in saliva and serum. Specimens from the OsteoPerio ancillary study of the Women's Health Initiative Observational Study were used. Participants required the presence of at least 6 teeth and were excluded based on active cancer and certain bone issues but were not selected on any specific condition. Quality control (QC) samples were created from pooled serum and saliva. Twenty protein markers were measured on five multiplexing array panels. Sample pretreatment conditions were optimized for each panel. Recovery, lower limit of quantification (LLOQ) and imprecision were determined for each analyte. Statistical adjustment at the plate level was used to reduce imprecision estimates and increase the number of usable observations. Sample pre-treatment improved recovery estimates for many analytes. The LLOQ for each analyte agreed with manufacturer specifications except for MMP-1 and MMP-2 which were significantly higher than reported. Following batch adjustment, 17 of 20 biomarkers in serum and 9 of 20 biomarkers in saliva demonstrated acceptable precision, defined as <20% coefficient of variation (<25% at LLOQ). The percentage of cohort samples having levels within the reportable range for each analyte varied from 10% to 100%. The ratio of levels in saliva to serum varied from 1:100 to 28:1. Correlations between saliva and serum were of moderate positive magnitude and significant for CRP, MMP-2, insulin, adiponectin, GM-CSF and IL-5. Multiplex arrays exhibit high levels of analytical imprecision, particularly at the batch level. Careful sample pre-treatment can enhance recovery and reduce imprecision. Following statistical adjustments to reduce batch effects, we identified biomarkers that are of acceptable quality in serum and to a lesser degree in saliva using Multiplex arrays.	[Browne, Richard W.] SUNY Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY 14260 USA; [Kantarci, Alpdogan; Cekici, Ali; Stephens, Danielle; Van Dyke, Thomas E.] Forsyth Inst, Dept Periodontol, Boston, MA USA; [LaMonte, Michael J.; Hovey, Kathleen M.; Falkner, Karen L.; Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, New York, NY USA; [Andrews, Christopher A.] SUNY Buffalo, Dept Biostat, Buffalo, NY 14260 USA; [Genco, Robert J.; Scannapieco, Frank A.] SUNY Buffalo, Dept Oral Biol, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University; Forsyth Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Browne, RW (corresponding author), SUNY Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY 14260 USA.	rwbrowne@buffalo.edu	LaMonte, Mike/AAC-9953-2021; Cekici, Ali/AAU-3750-2020; Wactawski-Wende, Jean/AGH-5457-2022; Scannapieco, Frank A./AAE-1584-2020; Cekici, Ali/AAW-7224-2020	Wactawski-Wende, Jean/0000-0003-3096-9595; Scannapieco, Frank A./0000-0002-8804-6593; Andrews, Chris/0000-0001-5130-6374	NHLBI	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The funder NHLBI had a role in the study design but not in the data collection and analysis, decision to publish, or preparation of the manuscript.	Bole C, 2010, COMMUNITY DENT ORAL, V38, P487, DOI 10.1111/j.1600-0528.2010.00555.x; Brennan RM, 2007, J PERIODONTOL, V78, P1051, DOI 10.1902/jop.2007.060436; Browne RW, 2008, BIOMARKERS, V13, P160, DOI [10.1080/13547500701775563, 10.1080/13547500701775563 ]; Browne RW, 2010, EPIDEMIOLOGY, V21, pS4, DOI 10.1097/EDE.0b013e3181ce9a61; CARROLL SF, 1981, BIOCHEMISTRY-US, V20, P5973, DOI 10.1021/bi00524a008; Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1; Chaturvedi AK, 2011, CANCER EPIDEM BIOMAR, V20, P1902, DOI 10.1158/1055-9965.EPI-11-0221; CISAR LA, 1987, BIOCHIM BIOPHYS ACTA, V927, P305, DOI 10.1016/0167-4889(87)90094-2; DeSilva B, 2003, PHARM RES-DORDR, V20, P1885, DOI 10.1023/B:PHAM.0000003390.51761.3d; Dorn LD, 2007, ANN CLIN BIOCHEM, V44, P281, DOI 10.1258/000456307780480954; Dossus L, 2009, J IMMUNOL METHODS, V350, P125, DOI 10.1016/j.jim.2009.09.001; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Ellington AA, 2009, CLIN CHEM, V55, P1092, DOI 10.1373/clinchem.2008.120717; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Findlay JWA, 2000, J PHARMACEUT BIOMED, V21, P1249, DOI 10.1016/S0731-7085(99)00244-7; Francis JL, 2005, MED SCI SPORT EXER, V37, P571, DOI 10.1249/01.MSS.0000158191.08331.04; FRASER CG, 1989, CRIT REV CL LAB SCI, V27, P409; Gonzalez AG, 1999, TALANTA, V48, P729, DOI 10.1016/S0039-9140(98)00271-9; Hsu HY, 2008, MED ENG PHYS, V30, P976, DOI 10.1016/j.medengphy.2008.01.003; Hu S, 2007, EXPERT REV PROTEOMIC, V4, P531, DOI 10.1586/14789450.4.4.531; Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501; Kofoed K, 2006, CLIN CHEM, V52, P1284, DOI 10.1373/clinchem.2006.067595; LAUHIO A, 1994, ANTIMICROB AGENTS CH, V38, P400, DOI 10.1128/AAC.38.2.400; Leng SX, 2008, J GERONTOL A-BIOL, V63, P879, DOI 10.1093/gerona/63.8.879; Liew M, 2007, BIOTECHNIQUES, V42, P327, DOI 10.2144/000112332; Marigo L, EUROPEAN REV MED PHA, V15, P751; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Palosaari H, 2000, J DENT RES, V79, P77, DOI 10.1177/00220345000790011401; Pang XLL, 2005, J CLIN VIROL, V33, P168, DOI 10.1016/j.jcv.2004.12.014; Ramseier CA, 2009, J PERIODONTOL, V80, P436, DOI [10.1902/jop.2009.080480, 10.1902/jop.2009.080480 ]; Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002; Toedter G, 2008, CLIN VACCINE IMMUNOL, V15, P42, DOI 10.1128/CVI.00211-07; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Wactawski-Wende J, 2005, J PERIODONTOL, V76, P2116, DOI 10.1902/jop.2005.76.11-S.2116; WESTGARD JO, 1979, CLIN CHEM, V25, P394; WESTGARD JO, 1977, CLIN CHEM, V23, P1857; WESTGARD JO, 1994, CLIN CHEM, V40, P499; Zhang GH, 1995, APMIS, V103, P721	38	49	49	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59498	10.1371/journal.pone.0059498	http://dx.doi.org/10.1371/journal.pone.0059498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577067	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800011
J	Denton, SJ; Trenell, MI; Plotz, T; Savory, LA; Bailey, DP; Kerr, CJ				Denton, Sarah J.; Trenell, Michael I.; Ploetz, Thomas; Savory, Louise A.; Bailey, Daniel P.; Kerr, Catherine J.			Cardiorespiratory Fitness Is Associated with Hard and Light Intensity Physical Activity but Not Time Spent Sedentary in 10-14 Year Old Schoolchildren: The HAPPY Study	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR FITNESS; REFERENCE CURVES; RISK-FACTORS; CHILDREN; PATTERNS; YOUTH; FATNESS; ACCELEROMETER; ADIPOSITY	Background: Sedentary behaviour is a major risk factor for developing chronic diseases and is associated with low cardiorespiratory fitness in adults. It remains unclear how sedentary behaviour and different physical activity subcomponents are related to cardiorespiratory fitness in children. The purpose of this study was to assess how sedentary behaviour and different physical activity subcomponents are associated with 10-14 year-old schoolchildren's cardiorespiratory fitness. Methods: 135 schoolchildren (81 girls, 12 +/- 1 year) completed 7-day minute-by-minute habitual physical activity monitoring using triaxial accelerometers and undertook a maximal cardiorespiratory fitness test. Results: After controlling for sex, age, ethnicity, socioeconomic status and total wear time, light physical activity (1.5-2.9 METs) was negatively associated (beta = -.24, p<.01) and hard physical activity (>= 9 METs) positively associated (beta=.45, p<.001) with cardiorespiratory fitness. Vigorous and hard physical activity were associated with cardiorespiratory fitness for boys (F = 5.64, p<.01) whereas light, moderate and hard physical activity were associated with physical fitness for girls (F = 10.23, p<.001). No association was found between sedentary time and cardiorespiratory fitness (r = -.13, p>.05). Sedentary to active transitions revealed little variability between cardiorespiratory fitness tertiles. Conclusions: Hard physical activity (>= 9 METs) holds greater potential for cardiorespiratory fitness compared to physical activity of lower intensities. There was no relationship between sedentary behaviour and cardiorespiratory fitness. These findings suggest that, for children, advice should focus on higher intensity physical activity and not sedentary behaviour as a means to maintain or improve cardiorespiratory fitness. Future research should explore longitudinal relationships between hard physical activity, cardiorespiratory fitness and health parameters.	[Denton, Sarah J.; Savory, Louise A.; Bailey, Daniel P.; Kerr, Catherine J.] Univ Bedfordshire, Inst Sport & Phys Act Res, Bedford, England; [Denton, Sarah J.; Trenell, Michael I.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ploetz, Thomas] Newcastle Univ, Sch Comp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Bedfordshire; Newcastle University - UK; Newcastle University - UK	Denton, SJ (corresponding author), Univ Bedfordshire, Inst Sport & Phys Act Res, Bedford, England.	sarah.denton@ncl.ac.uk	Bailey, Daniel/HDL-7697-2022	Charman, Sarah/0000-0002-3029-7672; Trenell, Michael/0000-0001-8253-5620; Bailey, Daniel/0000-0003-3772-630X	Bedford Charity [166/308]; Medical Research Council [MC_G0802536, G0700718B] Funding Source: researchfish; National Institute for Health Research [SRF-2011-04-017] Funding Source: researchfish; MRC [MC_G0802536] Funding Source: UKRI	Bedford Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The HAPPY study was funded by the Bedford Charity (grant number 166/308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RA, 2004, EUR J CLIN NUTR, V58, P285, DOI 10.1038/sj.ejcn.1601780; Aires L, 2010, J PHYS ACT HEALTH, V7, P54, DOI 10.1123/jpah.7.1.54; Anderssen SA, 2007, EUR J CARDIOV PREV R, V14, P526, DOI 10.1097/HJR.0b013e328011efc1; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Chastin SFM, 2010, GAIT POSTURE, V31, P82, DOI 10.1016/j.gaitpost.2009.09.002; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Dencker M, 2008, SCAND J MED SCI SPOR, V18, P728, DOI 10.1111/j.1600-0838.2007.00741.x; Dencker M, 2006, J PEDIATR-US, V149, P38, DOI 10.1016/j.jpeds.2006.02.002; Department of Health, 2011, START ACT STAY ACT R; Department of Health, 2009, HLTH SURV ENGL 2008; Department of Health, 2004, LEAST 5 WEEK EV IMP; Department of Health Department for Children Schools and Families, 2010, SED BEH OB REV CURR; Ekelund U, 2004, OBES RES, V12, P513, DOI 10.1038/oby.2004.58; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Ferreira I, 2005, ARCH INTERN MED, V165, P42, DOI 10.1001/archinte.165.1.42; Field A, 2013, DISCOVERING STAT USI; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gaya AR, 2009, ANN HUM BIOL, V36, P379, DOI 10.1080/03014460902817976; Gutin B, 2005, AM J CLIN NUTR, V81, P746, DOI 10.1093/ajcn/81.4.746; Gutin B, 2002, AM J CLIN NUTR, V75, P818, DOI 10.1093/ajcn/75.5.818; Harrington DM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-120; Hussey J, 2007, BRIT J SPORT MED, V41, P311, DOI 10.1136/bjsm.2006.032045; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Krasnoff JB, 2008, J PHYS ACT HEALTH, V5, P527, DOI 10.1123/jpah.5.4.527; Lobelo F, 2010, J ADOLESCENT HEALTH, V47, P352, DOI 10.1016/j.jadohealth.2010.04.012; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; MIMAS, 2008, WELC GEOCONVERT; Parikh T, 2011, SPORTS MED, V41, P477, DOI 10.2165/11588750-000000000-00000; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Rowlands AV, 2008, PREV MED, V46, P317, DOI 10.1016/j.ypmed.2007.11.004; Rowlands AV, 2004, MED SCI SPORT EXER, V36, P518, DOI 10.1249/01.MSS.0000117158.14542.E7; Ruiz JR, 2007, PEDIATR RES, V61, P350, DOI 10.1203/pdr.0b013e318030d1bd; Ruiz JR, 2006, AM J CLIN NUTR, V84, P299; Steele RM, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-88; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Vanhelst J, 2010, J SPORT SCI, V28, P381, DOI 10.1080/02640410903508821	40	42	42	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61073	10.1371/journal.pone.0061073	http://dx.doi.org/10.1371/journal.pone.0061073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577192	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800121
J	Kerr, JL; Baldwin, DS; Tobin, MJ; Puskar, L; Kappen, P; Rees, GN; Silvester, E				Kerr, Janice L.; Baldwin, Darren S.; Tobin, Mark J.; Puskar, Ljiljana; Kappen, Peter; Rees, Gavin N.; Silvester, Ewen			High Spatial Resolution Infrared Micro-Spectroscopy Reveals the Mechanism of Leaf Lignin Decomposition by Aquatic Fungi	PLOS ONE			English	Article							MODEL COMPOUNDS; LITTER; CARBON; DYNAMICS; LEAVES; FRESH; DEGRADATION; BREAKDOWN; SPECTRA	Organic carbon is a critical component of aquatic systems, providing energy storage and transfer between organisms. Fungi are a major decomposer group in the aquatic carbon cycle, and are one of few groups thought to be capable of breaking down woody (lignified) tissue. In this work we have used high spatial resolution (synchrotron light source) infrared microspectroscopy to study the interaction between aquatic fungi and lignified leaf vein material (xylem) from River Redgum trees (E. camaldulensis) endemic to the lowland rivers of South-Eastern Australia. The work provides spatially explicit evidence that fungal colonisation of leaf litter involves the oxidative breakdown of lignin immediately adjacent to the fungal tissue and depletion of the lignin-bound cellulose. Cellulose depletion occurs over relatively short length scales (5-15 mu m) and highlights the likely importance of mechanical breakdown in accessing the carbohydrate content of this resource. Low bioavailability compounds (oxidized lignin and polyphenols of plant origin) remain in colonised leaves, even after fungal activity diminishes, and suggests a possible pathway for the sequestration of carbon in wetlands. The work shows that fungi likely have a critical role in the partitioning of lignified material into a biodegradable fraction that can re-enter the aquatic carbon cycle, and a recalcitrant fraction that enters long-term storage in sediments or contribute to the formation of dissolved organic carbon in the water column.	[Kerr, Janice L.; Silvester, Ewen] La Trobe Univ, Dept Environm Management & Ecol, Wodonga, Vic, Australia; [Kerr, Janice L.; Baldwin, Darren S.; Rees, Gavin N.] La Trobe Univ, MDFRC, Wodonga, Vic, Australia; [Kerr, Janice L.; Baldwin, Darren S.; Rees, Gavin N.] La Trobe Univ, CSIRO Land & Water, Wodonga, Vic, Australia; [Tobin, Mark J.; Puskar, Ljiljana] Australian Synchrotron, Clayton, Vic, Australia; [Kappen, Peter] La Trobe Univ, Ctr Mat & Surface Sci, Bundoora, Vic, Australia; [Kappen, Peter] La Trobe Univ, Dept Phys, Bundoora, Vic 3083, Australia	La Trobe University; La Trobe University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); La Trobe University; La Trobe University; La Trobe University	Silvester, E (corresponding author), La Trobe Univ, Dept Environm Management & Ecol, Wodonga, Vic, Australia.	e.silvester@latrobe.edu.au	Baldwin, Darren S/H-2257-2011; Tobin, Mark J/B-8208-2015; Rees, Gavin/E-6869-2011; Rees, Gavin/U-5653-2019	Tobin, Mark J/0000-0003-1862-0649; Rees, Gavin/0000-0002-5270-8559; Rees, Gavin/0000-0002-5270-8559; Puskar, Ljiljana/0000-0002-8191-7472; Silvester, Ewen/0000-0001-8467-7657	e-Water Cooperative Research Centre (CRC); La Trobe University	e-Water Cooperative Research Centre (CRC); La Trobe University	This work was supported by the e-Water Cooperative Research Centre (CRC; www.ewater.com.au) and La Trobe University (post-graduate stipend to JK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Raheem AM, 2004, MYCOPATHOLOGIA, V157, P277, DOI 10.1023/B:MYCO.0000024178.62244.7c; Baldy V, 2002, AQUAT MICROB ECOL, V28, P25, DOI 10.3354/ame028025; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; BRIGGS SV, 1983, AUST J BOT, V31, P307, DOI 10.1071/BT9830307; Cole JJ, 2001, MAR FRESHWATER RES, V52, P101, DOI 10.1071/MF00084; Cooke R.C., 1993, ECOPHYSIOLOGY FUNGI; DANIEL G, 1989, APPL ENVIRON MICROB, V55, P871, DOI 10.1128/AEM.55.4.871-881.1989; DRING DONALD M., 1955, NEW PHYTOL, V54, P277, DOI 10.1111/j.1469-8137.1955.tb06180.x; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; GESSNER MO, 1991, FRESHWATER BIOL, V26, P387, DOI 10.1111/j.1365-2427.1991.tb01406.x; Glazebrook HS, 1999, AUST J ECOL, V24, P625, DOI 10.1046/j.1442-9993.1999.00992.x; Hammer K., 1997, Plant Genetic Resources Newsletter, P33; Heraud P, 2007, NEW PHYTOL, V173, P216, DOI 10.1111/j.1469-8137.2006.01881.x; HERGERT HL, 1960, J ORG CHEM, V25, P405, DOI 10.1021/jo01073a026; HILLIS WE, 1964, BIOCHEM J, V92, P516, DOI 10.1042/bj0920516; Jilkine K, 2008, J INORG BIOCHEM, V102, P540, DOI 10.1016/j.jinorgbio.2007.10.023; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Kayranli B, 2010, WETLANDS, V30, P111, DOI 10.1007/s13157-009-0003-4; Leck A, 1999, Community Eye Health, V12, P24; MARZULLO L, 1995, J BIOL CHEM, V270, P3823, DOI 10.1074/jbc.270.8.3823; McKnight D.M., 1998, AQUATIC HUMIC SUBSTA, P9, DOI DOI 10.1007/978-3-662-03736-2_; MICHELL AJ, 1966, AUST J CHEM, V19, P2285, DOI 10.1071/CH9662285; Nikolcheva LG, 2005, MYCOL RES, V109, P246, DOI 10.1017/S0953756204001698; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; RUSSELL JD, 1980, GEODERMA, V24, P207, DOI 10.1016/0016-7061(80)90024-5; Silverstein R.M., 1974, J CHEM EDUC; Stumm W., 1981, AQUATIC CHEM; SUBERKROPP K, 1976, ECOLOGY, V57, P707, DOI 10.2307/1936184; SUBERKROPP K, 1976, ECOLOGY, V57, P720, DOI 10.2307/1936185; Suter SG, 2011, MAR FRESHWATER RES, V62, P841, DOI 10.1071/MF10268; Szeghalmi A, 2007, ANAL BIOANAL CHEM, V387, P1779, DOI 10.1007/s00216-006-0850-2; ten Have R, 2001, CHEM REV, V101, P3397, DOI 10.1021/cr000115l; WEBSTER JR, 1986, ANNU REV ECOL SYST, V17, P567, DOI 10.1146/annurev.es.17.110186.003031; Wu T, 2005, J AGR FOOD CHEM, V53, P3888, DOI 10.1021/jf048202s	34	18	18	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60857	10.1371/journal.pone.0060857	http://dx.doi.org/10.1371/journal.pone.0060857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577169	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800107
J	Miller, AV; Hicks, MA; Nakajima, W; Richardson, AC; Windle, JJ; Harada, H				Miller, Anna V.; Hicks, Mark A.; Nakajima, Wataru; Richardson, Amanda C.; Windle, Jolene J.; Harada, Hisashi			Paclitaxel-Induced Apoptosis Is BAK-Dependent, but BAX and BIM-Independent in Breast Tumor	PLOS ONE			English	Article							CANCER CELL-LINES; MITOTIC ARREST; NEU ONCOGENE; KEY ROLE; MCL-1; BCL-2; PHOSPHORYLATION; RESISTANCE; SURVIVAL; CYTOTOXICITY	Paclitaxel (Taxol)-induced cell death requires the intrinsic cell death pathway, but the specific participants and the precise mechanisms are poorly understood. Previous studies indicate that a BH3-only protein BIM (BCL-2 Interacting Mediator of cell death) plays a role in paclitaxel-induced apoptosis. We show here that BIM is dispensable in apoptosis with paclitaxel treatment using bim(-/-) MEFs (mouse embryonic fibroblasts), the bim(-/-) mouse breast tumor model, and shRNA-mediated down-regulation of BIM in human breast cancer cells. In contrast, both bak(-/-) MEFs and human breast cancer cells in which BAK was down-regulated by shRNA were more resistant to paclitaxel. However, paclitaxel sensitivity was not affected in bax(-/-) MEFs or in human breast cancer cells in which BAX was down-regulated, suggesting that paclitaxel-induced apoptosis is BAK-dependent, but BAX-independent. In human breast cancer cells, paclitaxel treatment resulted in MCL-1 degradation which was prevented by a proteasome inhibitor, MG132. A Cdk inhibitor, roscovitine, blocked paclitaxel-induced MCL-1 degradation and apoptosis, suggesting that Cdk activation at mitotic arrest could induce subsequent MCL-1 degradation in a proteasome-dependent manner. BAK was associated with MCL-1 in untreated cells and became activated in concert with loss of MCL-1 expression and its release from the complex. Our data suggest that BAK is the mediator of paclitaxel-induced apoptosis and could be an alternative target for overcoming paclitaxel resistance.	[Miller, Anna V.; Hicks, Mark A.; Nakajima, Wataru; Harada, Hisashi] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Dent, Dept Oral & Craniofacial Mol Biol, Richmond, VA 23284 USA; [Richardson, Amanda C.] Virginia Commonwealth Univ, Sch Med, Dept Pathol, Richmond, VA USA; [Windle, Jolene J.] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Human & Mol Genet, Sch Med, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Harada, H (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Sch Dent, Dept Oral & Craniofacial Mol Biol, Richmond, VA 23284 USA.	hharada@vcu.edu	Harada, Hisashi/H-2815-2019	Harada, Hisashi/0000-0001-5993-1289; Windle, Jolene/0000-0001-6690-385X	American Cancer Society Institutional Research Grant [IRG-73-001-34]; Massey Cancer Center Pilot Project Grant; NATIONAL CANCER INSTITUTE [R01CA134473] Funding Source: NIH RePORTER	American Cancer Society Institutional Research Grant(American Cancer Society); Massey Cancer Center Pilot Project Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by American Cancer Society Institutional Research Grant (IRG-73-001-34) and Massey Cancer Center Pilot Project Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearss DJ, 2000, ONCOGENE, V19, P1114, DOI 10.1038/sj.onc.1203275; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chu R, 2012, BIOCHEM PHARMACOL, V83, P199, DOI 10.1016/j.bcp.2011.10.008; Czernick M, 2009, BIOCHEM BIOPH RES CO, V379, P145, DOI 10.1016/j.bbrc.2008.12.025; Du X, 2010, MOL CELL BIOL, V30, P3444, DOI 10.1128/MCB.00813-09; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Fujita T, 2005, INT J CANCER, V117, P670, DOI 10.1002/ijc.21063; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Hernandez-Vargas H, 2007, CELL CYCLE, V6, P2662, DOI 10.4161/cc.6.21.4821; Inuzuka H, 2011, ONCOTARGET, V2, P239; Janssen K, 2007, BLOOD, V110, P3662, DOI 10.1182/blood-2007-02-073213; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Kutuk O, 2010, CELL DEATH DIFFER, V17, P1624, DOI 10.1038/cdd.2010.41; Li R, 2005, CELL DEATH DIFFER, V12, P292, DOI 10.1038/sj.cdd.4401554; Lindenboim L, 2005, CELL DEATH DIFFER, V12, P713, DOI 10.1038/sj.cdd.4401638; Longuet M, 2004, INT J ONCOL, V25, P309; Michels J, 2005, INT J BIOCHEM CELL B, V37, P267, DOI 10.1016/j.biocel.2004.04.007; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Pardo J, 2006, J CELL BIOL, V174, P509, DOI 10.1083/jcb.200604044; Salah-Eldin AE, 2003, INT J CANCER, V103, P53, DOI 10.1002/ijc.10782; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Tan TT, 2005, CANCER CELL, V7, P227, DOI 10.1016/j.ccr.2005.02.008; Upreti M, 2008, MOL CANCER THER, V7, P2224, DOI 10.1158/1535-7163.MCT-07-2299; Urban C, 2008, CELL DEATH DIFFER, V15, P1396, DOI 10.1038/cdd.2008.61; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	38	39	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60685	10.1371/journal.pone.0060685	http://dx.doi.org/10.1371/journal.pone.0060685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577147	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800088
J	Berent, I; Dupuis, A; Brentari, D				Berent, Iris; Dupuis, Amanda; Brentari, Diane			Amodal Aspects of Linguistic Design	PLOS ONE			English	Article							AMERICAN SIGN-LANGUAGE; VISUAL WORD RECOGNITION; PHONOLOGICAL UNIVERSALS; GESTURAL COMMUNICATION; CATEGORICAL PERCEPTION; DEAF-CHILDREN; SYLLABLES; UNITS; CONSTRAINTS; COMPUTATION	All spoken languages encode syllables and constrain their internal structure. But whether these restrictions concern the design of the language system, broadly, or speech, specifically, remains unknown. To address this question, here, we gauge the structure of signed syllables in American Sign Language (ASL). Like spoken languages, signed syllables must exhibit a single sonority/energy peak (i.e., movement). Four experiments examine whether this restriction is enforced by signers and nonsigners. We first show that Deaf ASL signers selectively apply sonority restrictions to syllables (but not morphemes) in novel ASL signs. We next examine whether this principle might further shape the representation of signed syllables by nonsigners. Absent any experience with ASL, nonsigners used movement to define syllable-like units. Moreover, the restriction on syllable structure constrained the capacity of nonsigners to learn from experience. Given brief practice that implicitly paired syllables with sonority peaks (i.e., movement)-a natural phonological constraint attested in every human language-nonsigners rapidly learned to selectively rely on movement to define syllables and they also learned to partly ignore it in the identification of morpheme-like units. Remarkably, nonsigners failed to learn an unnatural rule that defines syllables by handshape, suggesting they were unable to ignore movement in identifying syllables. These findings indicate that signed and spoken syllables are subject to a shared phonological restriction that constrains phonological learning in a new modality. These conclusions suggest the design of the phonological system is partly amodal.	[Berent, Iris; Dupuis, Amanda] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Brentari, Diane] Univ Chicago, Dept Linguist, Chicago, IL 60637 USA	Northeastern University; University of Chicago	Berent, I (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	i.berent@neu.edu			National Institute on Deafness and Other Communication Disorders (NIDCD) grant [R01DC003277]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003277] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD) grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by National Institute on Deafness and Other Communication Disorders (NIDCD) grant R01DC003277 to IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, PHONETICALLY BASED P; Aronoff M, 2005, LANGUAGE, V81, P301, DOI 10.1353/lan.2005.0043; Ashby J, 2004, LANG COGNITIVE PROC, V19, P391, DOI 10.1080/01690960344000233; Baker SA, 2005, MEM COGNITION, V33, P887, DOI 10.3758/BF03193083; Baker SA, 2006, LANG LEARN DEV, V2, P147, DOI 10.1207/s15473341lld0203_1; Berent I, 2005, J MEM LANG, V53, P342, DOI 10.1016/j.jml.2005.05.002; Berent I, 1997, COGNITION, V64, P39, DOI 10.1016/S0010-0277(97)00016-4; Berent I, 2001, COGNITIVE PSYCHOL, V42, P1, DOI 10.1006/cogp.2000.0742; Berent I, 2001, J MEM LANG, V44, P644, DOI 10.1006/jmla.2000.2760; Berent I., 2013, PHONOLOGICAL MIND; Berent I, 2008, P NATL ACAD SCI USA, V105, P5321, DOI 10.1073/pnas.0801469105; Berent I, 2007, COGNITION, V104, P591, DOI 10.1016/j.cognition.2006.05.015; Berent I, 2012, MENT LEX, V7, P275, DOI 10.1075/ml.7.3.02ber; Berent I, 2011, BRILL HANDB LINGUIST, V1, P373; Berent I, 2012, LANG SPEECH, V55, P311, DOI 10.1177/0023830911417804; Berent I, 2011, LANG ACQUIS, V18, P281, DOI 10.1080/10489223.2011.580676; Berent I, 2007, MENT LEX, V2, P129, DOI 10.1075/ml.2.2.03ber; Berent I, 2010, J EXP PSYCHOL GEN, V139, P418, DOI 10.1037/a0020094; Berent I, 2006, MENT LEX, V1, P201, DOI 10.1075/ml.1.2.03ber; Berent I, 2010, J EXP PSYCHOL HUMAN, V36, P212, DOI 10.1037/a0017638; Berent I, 2009, PHONOLOGY, V26, P75, DOI 10.1017/S0952675709001729; BERTONCINI J, 1981, INFANT BEHAV DEV, V4, P247, DOI 10.1016/S0163-6383(81)80027-6; Best CT, 2010, ATTEN PERCEPT PSYCHO, V72, P747, DOI 10.3758/APP.72.3.747; Brentari D, 2012, NATURAL LANGUAGE LIN, V30; Brentari D., 1993, PHONOLOGY, V10, P281, DOI [10.1017/S0952675700000063, DOI 10.1017/S0952675700000063]; Brentari D, 2010, SIGN LANGUAGES; Brentari D, 1994, SIGN LANGUAGE RES, P39; BRENTARI D., 2006, PAPERS LAB PHONOLOGY, P155; Brentari D, 1998, PROSODIC MODEL SIGN, Vxviii; Brentari D, 2011, LANG SPEECH, V54, P49, DOI 10.1177/0023830910388011; CARREIRAS M, 1993, J MEM LANG, V32, P766, DOI 10.1006/jmla.1993.1038; Cholin J, 2011, BRILL HANDB LINGUIST, V1, P225; Clements G.N., 1990, PAPERS LAB PHONOLOGY, P283, DOI [10.1017/CBO9780511627736.017, DOI 10.1017/CBO9780511627736.017]; Coetzee AW, 2011, BRILL HANDB LINGUIST, V1, P295; Conrad M, 2009, J EXP PSYCHOL HUMAN, V35, P461, DOI 10.1037/a0013480; Corina D., 1993, PHONOLOGY, V10, P165, DOI [10.1017/S0952675700000038, DOI 10.1017/S0952675700000038]; Corina D. P., 1990, 26 ANN REG M CHIC LI, V2, P33; Corina DP, 2003, J COGNITIVE NEUROSCI, V15, P718, DOI 10.1162/jocn.2003.15.5.718; Corina DP, 1999, NEUROIMAGE, V10, P570, DOI 10.1006/nimg.1999.0499; De Lacy P, 2006, CAMB STUD LINGUIST, V112, pXI, DOI 10.1017/CBO9780511486388.001; Emmorey K, 2003, LANG COGNITIVE PROC, V18, P21, DOI 10.1080/01690960143000416; Emmorey K., 2002, LANGUAGE COGNITION B; Emmorey K, 2007, NEUROIMAGE, V36, P202, DOI 10.1016/j.neuroimage.2007.02.040; Fitch WT, 2005, COGNITION, V97, P179, DOI 10.1016/j.cognition.2005.02.005; Goldin-Meadow S, 1998, NATURE, V391, P279, DOI 10.1038/34646; Goldin-Meadow S., 2003, RESILIENCE LANGUAGE; GOLDINMEADOW S, 1983, SCIENCE, V221, P372, DOI 10.1126/science.6867713; Hildebrandt U, 2002, LANG COGNITIVE PROC, V17, P593, DOI 10.1080/01690960143000371; HOCKETT CF, 1960, SCI AM, V203, P88, DOI 10.1038/scientificamerican0960-88; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jantunen T., 2010, SIGN LANGUAGES, P312, DOI [10.1017/CBO9780511712203.015, DOI 10.1017/CBO9780511712203.015]; Klima E., 1979, SIGNS LANGUAGE; LANE H, 1976, COGNITIVE PSYCHOL, V8, P263, DOI 10.1016/0010-0285(76)90027-X; LIDDELL SK, 1986, NAT LANG LINGUIST TH, V4, P445, DOI 10.1007/BF00134470; MacNeilage P. F., 2008, ORIGIN SPEECH, pxi; MacSweeney M, 2004, NEUROIMAGE, V22, P1605, DOI 10.1016/j.neuroimage.2004.03.015; MacSweeney M, 2008, NEUROIMAGE, V40, P1369, DOI 10.1016/j.neuroimage.2007.12.047; Mathur G, 2011, DEAF WORLD IMPACT LA, P54; McCarthy JJ., 1998, HDB MORPHOLOGY, P283; Newman AJ, 2010, NEUROIMAGE, V52, P669, DOI 10.1016/j.neuroimage.2010.03.055; Newport E. L, 1982, LANG ACQUIS, P450; Nishimura H, 1999, NATURE, V397, P116, DOI 10.1038/16376; Ohala DK, 1999, J COMMUN DISORD, V32, P397, DOI 10.1016/S0021-9924(99)00018-0; OHALA JJ, 1990, CLS 26, V2, P319; Orfanidou E, 2010, J MEM LANG, V62, P272, DOI 10.1016/j.jml.2009.12.001; Palmer SB, 2012, CHILD DEV, V83, P543, DOI 10.1111/j.1467-8624.2011.01715.x; Parker Stephen, 2002, THESIS U MASSACHUSET; PERLMUTTER DM, 1992, LINGUIST INQ, V23, P407; PERTZ DL, 1975, LANGUAGE, V51, P149, DOI 10.2307/413156; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Petitto LA, 2001, NATURE, V413, P35, DOI 10.1038/35092613; Pfau R., 2012, SIGN LANGUAGE INT HD, DOI [10.1515/9783110261325, DOI 10.1515/9783110261325]; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Pinker S, 1997, NATURE, V387, P547, DOI 10.1038/42347; PINKER S, 1991, SCIENCE, V253, P530, DOI 10.1126/science.1857983; Prince Alan., 2004, OPTIMALITY THEORY CO; Sandler W, 2005, P NATL ACAD SCI USA, V102, P2661, DOI 10.1073/pnas.0405448102; Sandler W, 2006, SIGN LANGUAGE AND LINGUISTIC UNIVERSALS, P1, DOI 10.2277/ 0521483956; Sandler W, 2008, SYLLABLE SPEECH PROD, P379; Sandler W, 2011, NAT LANG LINGUIST TH, V29, P503, DOI 10.1007/s11049-011-9128-2; Senghas A, 2004, SCIENCE, V305, P1779, DOI 10.1126/science.1100199; Singleton JL, 2004, COGNITIVE PSYCHOL, V49, P370, DOI 10.1016/j.cogpsych.2004.05.001; Smolensky Paul, 2006, HARMONIC MIND NEURAL, P27; Steriade D, 1988, PHONOLOGY, V5, P37; Stokoe WC, 2005, J DEAF STUD DEAF EDU, V10, P3, DOI 10.1093/deafed/eni001; Supalla T.R., 1982, THESIS U SAN DIEGO S; TREIMAN R, 1995, J MEM LANG, V34, P132, DOI 10.1006/jmla.1995.1007; Wilbur R, 2012, BLACKWELL COMPANION, P1309; WILBUR RB, 1986, LANG SPEECH, V29, P263, DOI 10.1177/002383098602900306; WILBUR RB, 1991, LANG SPEECH, V34, P27, DOI 10.1177/002383099103400102; Wilbur RB, 1997, LANG SPEECH, V40, P63, DOI 10.1177/002383099704000104; Zec D, 2007, CAMBRIDGE HANDBOOK OF PHONOLOGY, P161	92	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60617	10.1371/journal.pone.0060617	http://dx.doi.org/10.1371/journal.pone.0060617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	143BA	23573272	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100091
J	Ge, DY; Wen, ZX; Xia, L; Zhang, ZQ; Erbajeva, M; Huang, CM; Yang, QS				Ge, Deyan; Wen, Zhixin; Xia, Lin; Zhang, Zhaoqun; Erbajeva, Margarita; Huang, Chengming; Yang, Qisen			Evolutionary History of Lagomorphs in Response to Global Environmental Change	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; HARES LEPUS-EUROPAEUS; LATE MIOCENE; INTROGRESSIVE HYBRIDIZATION; OCHOTONA-CURZONIAE; AMERICAN PIKA; C-4 GRASSES; DIVERSIFICATION; MAMMALS; MITOCHONDRIAL	Although species within Lagomorpha are derived from a common ancestor, the distribution range and body size of its two extant groups, ochotonids and leporids, are quite differentiated. It is unclear what has driven their disparate evolutionary history. In this study, we compile and update all fossil records of Lagomorpha for the first time, to trace the evolutionary processes and infer their evolutionary history using mitochondrial genes, body length and distribution of extant species. We also compare the forage selection of extant species, which offers an insight into their future prospects. The earliest lagomorphs originated in Asia and later diversified in different continents. Within ochotonids, more than 20 genera occupied the period from the early Miocene to middle Miocene, whereas most of them became extinct during the transition from the Miocene to Pliocene. The peak diversity of the leporids occurred during the Miocene to Pliocene transition, while their diversity dramatically decreased in the late Quaternary. Mantel tests identified a positive correlation between body length and phylogenetic distance of lagomorphs. The body length of extant ochotonids shows a normal distribution, while the body length of extant leporids displays a non-normal pattern. We also find that the forage selection of extant pikas features a strong preference for C-3 plants, while for the diet of leporids, more than 16% of plant species are identified as C-4 (31% species are from Poaceae). The ability of several leporid species to consume C-4 plants is likely to result in their size increase and range expansion, most notably in Lepus. Expansion of C-4 plants in the late Miocene, the so-called 'nature's green revolution', induced by global environmental change, is suggested to be one of the major 'ecological opportunities', which probably drove large-scale extinction and range contraction of ochotonids, but inversely promoted diversification and range expansion of leporids.	[Ge, Deyan; Wen, Zhixin; Xia, Lin; Huang, Chengming; Yang, Qisen] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Zhang, Zhaoqun] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [Erbajeva, Margarita] Russian Acad Sci, Inst Geol, Siberian Branch, Ulan Ude, Russia	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Russian Academy of Sciences; Institute of Geology, Siberian Branch of the RAS	Yang, QS (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	yangqs@ioz.ac.cn	Erbajeva, Margarita/P-9404-2015; Erbajeva, Margarita A/J-6624-2018; Ge, Deyan/AAU-7240-2020; 葛, 德燕/ABB-3018-2021	Erbajeva, Margarita A/0000-0001-6408-1987; Wen, Zhixin/0000-0002-8300-4845; Ge, Deyan/0000-0001-8230-8647	Natural Science Foundation of China [31101629, 31272289, 41072004, J1210002]; Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences [Y229YX5105]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences	This research was sponsored by grants from the Natural Science Foundation of China (No: 31101629, 31272289, 41072004 and J1210002) and a grant (Y229YX5105) from the Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 1996, PALAEOGEOGR PALAEOCL, V127, P285, DOI 10.1016/S0031-0182(96)00100-9; Alroy J, 2002, P NATL ACAD SCI USA, V99, P3706, DOI 10.1073/pnas.062691099; Angelone C, 2008, QUATERN INT, V179, P5, DOI 10.1016/j.quaint.2007.08.019; Angermann R., 1990, P7; [Anonymous], [No title captured]; [Anonymous], 1997, ACTA ECOL SIN; Arnason U, 2008, GENE, V421, P37, DOI 10.1016/j.gene.2008.05.024; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Averianov A.O., 1998, Zoosystematica Rossica, V7, P323; Averianov Alexander O., 1994, Acta Palaeontologica Polonica, V39, P393; Badgley C, 2008, P NATL ACAD SCI USA, V105, P12145, DOI 10.1073/pnas.0805592105; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2; Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Bleefeld A R, 1985, AM MUS NOVIT, V2806, P1; Bonett RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005615; Bouchenak-Khelladi Y, 2009, GLOBAL CHANGE BIOL, V15, P2397, DOI 10.1111/j.1365-2486.2009.01860.x; Brandt R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020040; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Caldas F.B., 2011, IUCN RED LIST THREAT, V2011; Cease AJ, 2012, SCIENCE, V335, P467, DOI 10.1126/science.1214433; Cerling TE, 1998, PHILOS T R SOC B, V353, P159, DOI 10.1098/rstb.1998.0198; Cerling TE, 2003, J MAMMAL, V84, P456, DOI 10.1644/1545-1542(2003)084&lt;0456:DOEABB&gt;2.0.CO;2; Chapman J.A., 1990, P1; Chen Guan-Fang, 2009, Vertebrata Palasiatica, V47, P265; Christin PA, 2008, CURR BIOL, V18, P37, DOI 10.1016/j.cub.2007.11.058; Christin PA, 2009, GENOME BIOL EVOL, V1, P221, DOI 10.1093/gbe/evp020; Dawson M.R., 1967, U KANSAS DEP GEOLOGY, V2, P287; Dimitrijevic V., 1988, Geoloshki Anali Balkanskoga Poluostrva, V51, P379; Drummond A, 2007, TRACER V1 5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Erbajeva M. A., 1988, CENOZOIC PIKAS TAXON; Erbajeva Margarita A., 2003, P97; Erbajeva Margarita A., 2001, Lynx (Prague), V32, P55; Erbajeva Margarita A., 2001, Geodiversitas, V23, P395; Erbajeva MA, 2011, PALAEONTOL ELECTRON, V14; Eriksson O, 2000, AM NAT, V156, P47, DOI 10.1086/303367; Eronen JT, 2011, EVOLUTION, V65, P1514, DOI 10.1111/j.1558-5646.2011.01220.x; Evans AR, 2012, P NATL ACAD SCI USA, V109, P4187, DOI 10.1073/pnas.1120774109; Foote M, 2001, PALEOBIOLOGY, V27, P602, DOI 10.1666/0094-8373(2001)027<0602:ITPOPO>2.0.CO;2; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Fostowicz-Frelik L, 2010, NATURWISSENSCHAFTEN, V97, P325, DOI 10.1007/s00114-009-0634-6; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Galbreath KE, 2010, J BIOGEOGR, V37, P344, DOI 10.1111/j.1365-2699.2009.02201.x; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Ge DY, 2012, PALAEOGEOGR PALAEOCL, V326, P160, DOI 10.1016/j.palaeo.2012.02.016; Ge DY, 2012, MAMM BIOL, V77, P113, DOI 10.1016/j.mambio.2011.09.009; Gingerich PD, 2001, GENETICA, V112, P127, DOI 10.1023/A:1013311015886; Grayson DK, 2005, J BIOGEOGR, V32, P2103, DOI 10.1111/j.1365-2699.2005.01341.x; Green J. S., 1980, Journal of Range Management, V33, P136, DOI 10.2307/3898429; Gureev A. A., 1964, Doklady (Proceedings) of the Academy of Sciences of the USSR Biological Sciences Sections, V155, P319; Hoffmann R. S., 2005, MAMMAL SPECIES WORLD; Hordijk K, 2010, THESIS UTRECHT U, P1; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Johnson CN, 2002, P ROY SOC B-BIOL SCI, V269, P2221, DOI 10.1098/rspb.2002.2130; Jones KE, 2009, ECOLOGY, V90, P2648; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; Kitazoe Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000384; Kovar-Eder J, 2001, REV PALAEOBOT PALYNO, V114, P83, DOI 10.1016/S0034-6667(00)00070-1; Kraatz BP, 2010, PLOS ONE, V5, P12831; Krapp M, 2011, CLIMATE DISCUSSIONS, V7, P1935, DOI DOI 10.5194/CPD-7-1935-2011; Lai CH, 2003, BIODIVERS CONSERV, V12, P1901, DOI 10.1023/A:1024161409110; Lalueza-Fox C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-70; Lanier HC, 2009, MOL PHYLOGENET EVOL, V53, P1, DOI 10.1016/j.ympev.2009.05.035; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-223; Lopatin AW, 1998, PALEONTOL ZH, P77; Lopez-Martinez Nieves, 2008, P27, DOI 10.1007/978-3-540-72446-9_3; Lu X, 2003, BIOL J LINN SOC, V78, P343, DOI 10.1046/j.1095-8312.2003.00145.x; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; MacFadden BJ, 2000, ANNU REV ECOL SYST, V31, P33, DOI 10.1146/annurev.ecolsys.31.1.33; MACFADDEN BJ, 1994, TRENDS ECOL EVOL, V9, P481, DOI 10.1016/0169-5347(94)90313-1; Maddison W., 2018, MESQUITE MODULAR SYS; Madin JS, 2006, SCIENCE, V312, P897, DOI 10.1126/science.1123591; Marincovich L, 1999, NATURE, V397, P149, DOI 10.1038/16446; Martin T, 2004, J VERTEBR PALEONTOL, V24, P411, DOI 10.1671/2513; Matthee CA, 2004, SYST BIOL, V53, P433, DOI 10.1080/10635150490445715; Matthew W. D., 1923, American Museum Novitates, VNo. 102, P1; McKenna Malcolm C., 1997, pi; Mead Jim I., 2004, P155; Meng J, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)425<0001:GEGMFT>2.0.CO;2; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; Meng Jin, 2004, Vertebrata Palasiatica, V42, P261; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Metais G, 2001, ZOOL SCR, V30, P231, DOI 10.1046/j.0300-3256.2001.00071.x; Metais G, 2000, CR ACAD SCI II A, V330, P805, DOI 10.1016/S1251-8050(00)00184-1; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Niu YD, 2004, FOLIA ZOOL, V53, P141; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Osborne CP, 2008, J ECOL, V96, P35, DOI 10.1111/j.1365-2745.2007.01323.x; Osborne CP, 2006, PHILOS T R SOC B, V361, P173, DOI 10.1098/rstb.2005.1737; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Phillips MJ, 2009, P NATL ACAD SCI USA, V106, P17089, DOI 10.1073/pnas.0904649106; Pitra C, 2004, MOL PHYLOGENET EVOL, V33, P880, DOI 10.1016/j.ympev.2004.07.013; Qiu Zhuding, 1996, pi; Quintana J, 2011, J VERTEBR PALEONTOL, V31, P231, DOI 10.1080/02724634.2011.550367; Robinson T, 2005, MAMMAL REV, V35; ROHLF F. J., 2009, NTSYSPC NUMERICAL TA; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Rose KD, 2008, P ROY SOC B-BIOL SCI, V275, P1203, DOI 10.1098/rspb.2007.1661; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Sage R., 1999, C4 PLANT BIOL, P551, DOI DOI 10.1016/B978-012614440-6/50017-3; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Sanz M., 2011, Collectanea Botanica (Barcelona), V30, P7, DOI 10.3989/collectbot.2011.v30.001; Segalen L, 2007, J HUM EVOL, V53, P549, DOI 10.1016/j.jhevol.2006.12.010; Shipley LA, 2006, J CHEM ECOL, V32, P2455, DOI 10.1007/s10886-006-9156-2; SMITH A T, 1990, Mammalian Species, P1, DOI 10.2307/3504319; Smith AT, 1999, ANIM CONSERV, V2, P235, DOI 10.1111/j.1469-1795.1999.tb00069.x; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Stott P, 2006, MAMM BIOL, V71, P214, DOI 10.1016/j.mambio.2006.02.009; Stott P, 2003, MAMM BIOL, V68, P317, DOI 10.1078/1616-5047-00099; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Suchentrunk F, 1998, ACTA THERIOL, P35; Tang HP, 1999, ACTA BOT SIN, V41, P420; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torices R, 2010, J SYST EVOL, V48, P271, DOI 10.1111/j.1759-6831.2010.00088.x; Uno KT, 2011, P NATL ACAD SCI USA, V108, P6509, DOI 10.1073/pnas.1018435108; Vidus-Rosin A, 2010, ACTA THERIOL, V55, P139, DOI 10.4098/j.at.0001-7051.029.2010; Vidus-Rosin A, 2009, HYSTRIX, V20, P101; Wang Dehua, 2009, Acta Theriologica Sinica, V20, P343; WANG Y, 1994, PALAEOGEOGR PALAEOCL, V107, P269, DOI 10.1016/0031-0182(94)90099-X; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wei-Dong L, 2005, ORYX, V39, P30, DOI 10.1017/S0030605305000062; Weston ML, 1982, THESIS U BRIT COLUMB; Wildman DE, 2007, P NATL ACAD SCI USA, V104, P14395, DOI 10.1073/pnas.0704342104; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Williams CJ, 2008, PALAEOGEOGR PALAEOCL, V261, P160, DOI 10.1016/j.palaeo.2008.01.014; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Winkler Alisa J., 2010, P305; Wu CH, 2005, MOL PHYLOGENET EVOL, V37, P45, DOI 10.1016/j.ympev.2005.05.006; Wu YH, 2011, MOL PHYLOGENET EVOL, V59, P545, DOI 10.1016/j.ympev.2011.03.027; Wu YH, 2010, CONSERV GENET, V11, P183, DOI 10.1007/s10592-009-0022-y; Yu N, 2000, MOL PHYLOGENET EVOL, V16, P85, DOI 10.1006/mpev.2000.0776; Yu Y., 2011, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang CF, 2009, EARTH PLANET SC LETT, V287, P311, DOI 10.1016/j.epsl.2009.08.025; Zhang ZQ, 1997, TECH PROTEIN CHEM, P1	142	69	77	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59668	10.1371/journal.pone.0059668	http://dx.doi.org/10.1371/journal.pone.0059668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573205	gold, Green Submitted, Green Published			2022-12-27	WOS:000318840100024
J	Baud, J; Varon, C; Chabas, S; Chambonnier, L; Darfeuille, F; Staedel, C				Baud, Jessica; Varon, Christine; Chabas, Sandrine; Chambonnier, Lucie; Darfeuille, Fabien; Staedel, Cathy			Helicobacter pylori Initiates a Mesenchymal Transition through ZEB1 in Gastric Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; E-CADHERIN EXPRESSION; TYROSINE PHOSPHATASE; MIR-200 FAMILY; FEEDBACK LOOP; UP-REGULATION; CAGA; EMT; CONVERSION; POLARITY	Chronic Helicobacter pylori infection provokes an inflammation of the gastric mucosa, at high risk for ulcer and cancer development. The most virulent strains harbor the cag pathogenicity island (cagPAI) encoding a type 4 secretion system, which allows delivery of bacterial effectors into gastric epithelial cells, inducing pro-inflammatory responses and phenotypic alterations reminiscent of an epithelial-to-mesenchymal transition (EMT). This study characterizes EMT features in H. pylori-infected gastric epithelial cells, and investigates their relationship with NF-kappa B activation. Cultured human gastric epithelial cell lines were challenged with a cagPAI+ H. pylori strain or cag isogenic mutants. Morphological changes, epithelial and mesenchymal gene expression and EMT-related microRNAs were studied. H. pylori up-regulates mesenchymal markers, including ZEB1. This transcription factor is prominently involved in the mesenchymal transition of infected cells and its up-regulation depends on cagPAI and NF-kappa B activation. ZEB1 expression and NF-kappa B activation were confirmed by immunohistochemistry in gastric mucosa from cagPAI+ H. pylori-infected patients. Gastric epithelial cell lines express high miR-200 levels, which are linked to ZEB1 in a reciprocal negative feedback loop and maintain their epithelial phenotype in non-infected conditions. However, miR-200b/c were increased upon infection, despite ZEB1 up-regulation and mesenchymal morphology. In the miR-200b-200a-429 cluster promoter, we identified a functional NF-kappa B binding site, recruiting NF-kappa B upon infection and trans-activating the microRNA cluster transcription. In conclusion, in gastric epithelial cells, cagPAI+ H. pylori activates NF-kappa B, which transactivates ZEB1, subsequently promoting mesenchymal transition. The unexpected N-F kappa B-dependent increase of miR-200 levels likely thwarts the irreversible loss of epithelial identity in that critical situation.	[Baud, Jessica; Chabas, Sandrine; Darfeuille, Fabien; Staedel, Cathy] Univ Bordeaux, ARNA Lab, Bordeaux, France; [Baud, Jessica; Chabas, Sandrine; Darfeuille, Fabien; Staedel, Cathy] INSERM, U869, ARNA Lab, Bordeaux, France; [Varon, Christine; Chambonnier, Lucie] Univ Bordeaux, Lab Bacteriol, Bordeaux, France; [Varon, Christine; Chambonnier, Lucie] INSERM, U853, Lab Bacteriol, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Darfeuille, F (corresponding author), Univ Bordeaux, ARNA Lab, Bordeaux, France.	fabien.darfeuille@inserm.fr; cathy.staedel@inserm.fr	STAEDEL, Cathy/M-7284-2014; Darfeuille, Fabien/M-3883-2014	Darfeuille, Fabien/0000-0003-1167-6113; Varon, Christine/0000-0003-4026-2016; Staedel, Cathy/0000-0003-0488-0239	Association de la Recherche contre le Cancer; La Ligue contre le Cancer (Committee of Dordogne, France); French Ministry of Research	Association de la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); La Ligue contre le Cancer (Committee of Dordogne, France); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by grants from Association de la Recherche contre le Cancer and La Ligue contre le Cancer (Committee of Dordogne, France). JB was supported by the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Azuma T, 2004, J INFECT DIS, V189, P820, DOI 10.1086/381782; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Belair Cedric, 2011, Silence, V2, P7, DOI 10.1186/1758-907X-2-7; BLASER MJ, 1995, CANCER RES, V55, P2111; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Farina AR, 1999, CELL GROWTH DIFFER, V10, P353; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Ferrero RL, 2005, MOL IMMUNOL, V42, P879, DOI 10.1016/j.molimm.2004.12.001; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Kong D, 2012, ONCOGENE, V31, P3949, DOI 10.1038/onc.2011.558; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lamb A, 2010, GUT MICROBES, V1, P109, DOI 10.4161/gmic.1.2.11587; LILIENBAUM A, 1993, J BIOL CHEM, V268, P2180; Lu HS, 2009, J BIOL CHEM, V284, P23024, DOI 10.1074/jbc.M109.001008; Matsushima K, 2011, INT J CANCER, V128, P361, DOI 10.1002/ijc.25348; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Okugawa Y, 2012, J SURG ONCOL, V106, P280, DOI 10.1002/jso.22142; Oliveira MJ, 2009, J INFECT DIS, V200, P745, DOI 10.1086/604727; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wu K, 2009, CRIT REV IMMUNOL, V29, P241, DOI 10.1615/CritRevImmunol.v29.i3.40; Yin YF, 2010, GUT, V59, P1037, DOI 10.1136/gut.2009.199794; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357	42	50	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60315	10.1371/journal.pone.0060315	http://dx.doi.org/10.1371/journal.pone.0060315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565224	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300094
J	Bian, S; Sun, XF; Bai, AP; Zhang, CQ; Li, LL; Enjyoji, K; Junger, WG; Robson, SC; Wu, Y				Bian, Shu; Sun, Xiaofeng; Bai, Aiping; Zhang, Chunqing; Li, Linglin; Enjyoji, Keiichi; Junger, Wolfgang G.; Robson, Simon C.; Wu, Yan			P2X7 Integrates PI3K/AKT and AMPK-PRAS40-mTOR Signaling Pathways to Mediate Tumor Cell Death	PLOS ONE			English	Article							REGULATORY T-CELLS; EXTRACELLULAR ATP; NEUTROPHIL CHEMOTAXIS; P2X(7) RECEPTORS; CD39-NULL MICE; PROTEIN-KINASE; CANCER-THERAPY; LYTIC FUNCTION; ADENOSINE; RELEASE	Background: Extracellular adenosine triphosphate (ATP) functions as a novel danger signal that boosts antitumor immunity and can also directly kill tumor cells. We have previously reported that chronic exposure of tumor cells to ATP provokes P2X7-mediated tumor cell death, by as yet incompletely defined molecular mechanisms. Methodology/Principal Findings: Here, we show that acute exposure of tumor cells to ATP results in rapid cytotoxic effects impacting several aspects of cell growth/survival, leading to inhibition of tumor growth in vitro and in vivo. Using agonist and antagonist studies together with generation of P2X7 deficient tumor cell lines by lentiviral shRNA delivery system, we confirm P2X7 to be the central control node transmitting extracellular ATP signals. We identify that downstream intracellular signaling regulatory networks implicate two signaling pathways: the known P2X7-PI3K/AKT axis and remarkably a novel P2X7-AMPK-PRAS40-mTOR axis. When exposed to high levels of extracellular ATP, these two signaling axes perturb the balance between growth and autophagy, thereby promoting tumor cell death. Conclusions: Our study defines novel molecular mechanisms underpinning the antitumor actions of P2X7 and provides a further rationale for purine-based drugs in targeted cancer therapy.	[Bian, Shu; Zhang, Chunqing] Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan 250100, Peoples R China; [Bian, Shu; Sun, Xiaofeng; Bai, Aiping; Enjyoji, Keiichi; Robson, Simon C.; Wu, Yan] Harvard Univ, Sch Med, Dept Med, Transplant Inst, Boston, MA 02115 USA; [Li, Linglin; Junger, Wolfgang G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Surg, Sch Med, Boston, MA 02215 USA	Shandong University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Robson, SC (corresponding author), Harvard Univ, Sch Med, Dept Med, Transplant Inst, Boston, MA 02115 USA.	srobson@bidmc.harvard.edu; ywu@bidmc.harvard.edu	Junger, Wolfgang G/I-1932-2013; Robson, Simon C./AAA-8537-2021	Junger, Wolfgang G/0000-0003-3350-8452; 	National Institutes of Health [NHLBI PO1-HL076540, RO1-HL094400]; China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076540, R01HL094400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by funds from National Institutes of Health (NHLBI PO1-HL076540 and RO1-HL094400). Dr. S. Bian was a recipient of a scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2007, CLIN CANCER RES, V13, P3109, DOI 10.1158/1078-0432.CCR-06-2798; Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Aymeric L, 2010, CANCER RES, V70, P855, DOI 10.1158/0008-5472.CAN-09-3566; Beldi G, 2008, HEPATOLOGY, V48, P841, DOI 10.1002/hep.22401; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bonnefoy N, 2012, ONCOGENE; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Casas-Pruneda G, 2009, J PHYSIOL-LONDON, V587, P2887, DOI 10.1113/jphysiol.2008.167395; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; da Silva CG, 2006, CIRC RES, V98, pE39, DOI 10.1161/01.RES.0000215436.92414.1d; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Di Virgilio F, 2009, CURR OPIN PHARMACOL, V9, P507, DOI 10.1016/j.coph.2009.06.021; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eltzschig HK, 2012, N ENGL J ME IN PRESS; Feng LL, 2011, NEOPLASIA, V13, P206, DOI 10.1593/neo.101332; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Goepfert C, 2001, CIRCULATION, V104, P3109, DOI 10.1161/hc5001.100663; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Jackson SW, 2007, AM J PATHOL, V171, P1395, DOI 10.2353/ajpath.2007.070190; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Koneru M, 2005, J IMMUNOL, V174, P1830, DOI 10.4049/jimmunol.174.4.1830; Levesque SA, 2010, EUR J IMMUNOL, V40, P1473, DOI 10.1002/eji.200939741; Liu X, 2012, GUT; Mandapathil M, 2012, ONCOIMMUNOLOGY, V1, P659, DOI 10.4161/onci.20387; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Michaud M, 2012, ONCOIMMUNOLOGY, V1, P392, DOI 10.4161/onci.19070; Mistafa O, 2010, J BIOL CHEM, V285, P27900, DOI 10.1074/jbc.M110.117093; Monu N, 2007, CANCER RES, V67, P11447, DOI 10.1158/0008-5472.CAN-07-1441; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Schenk U, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001270; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Souza CO, 2012, BBA-GEN SUBJECTS, V1820, P1867, DOI 10.1016/j.bbagen.2012.08.013; Sun X, 2012, HEPATOLOGY; Sun XF, 2013, HEPATOLOGY, V57, P205, DOI 10.1002/hep.25989; Sun XF, 2010, GASTROENTEROLOGY, V139, P1030, DOI 10.1053/j.gastro.2010.05.007; Takenouchi T, 2009, J IMMUNOL, V182, P2051, DOI 10.4049/jimmunol.0802577; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Vazquez-Cintron EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036101; Vitiello L, 2012, BLOOD, V120, P511, DOI 10.1182/blood-2012-01-406496; Volonte C, 2006, PHARMACOL THERAPEUT, V112, P264, DOI 10.1016/j.pharmthera.2005.04.012; Wang QF, 2012, CANCER RES, V72, P4417, DOI 10.1158/0008-5472.CAN-12-1339-T; Weinhold K, 2010, CELL MOL LIFE SCI, V67, P2631, DOI 10.1007/s00018-010-0355-1; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Wu Y, 2006, BIOCHEM J, V396, P23, DOI 10.1042/BJ20051568; Zhang XJ, 2009, ACTA BIOCH BIOPH SIN, V41, P362, DOI 10.1093/abbs/gmp016	61	73	75	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60184	10.1371/journal.pone.0060184	http://dx.doi.org/10.1371/journal.pone.0060184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565201	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300070
J	He, XN; Dziak, R; Yuan, X; Mao, KY; Genco, R; Swihart, M; Sarkar, D; Li, CY; Wang, CD; Lu, L; Andreadis, S; Yang, SY				He, Xiaoning; Dziak, Rosemary; Yuan, Xue; Mao, Keya; Genco, Robert; Swihart, Mark; Sarkar, Debanjan; Li, Chunyi; Wang, Changdong; Lu, Li; Andreadis, Stelios; Yang, Shuying			BMP2 Genetically Engineered MSCs and EPCs Promote Vascularized Bone Regeneration in Rat Critical-Sized Calvarial Bone Defects	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; OPEN TIBIAL FRACTURES; MORPHOGENETIC PROTEIN-2; IN-VITRO; REPAIR; NEOVASCULARIZATION; DIFFERENTIATION; TRANSPLANTATION; IMPLANTATION	Current clinical therapies for critical-sized bone defects (CSBDs) remain far from ideal. Previous studies have demonstrated that engineering bone tissue using mesenchymal stem cells (MSCs) is feasible. However, this approach is not effective for CSBDs due to inadequate vascularization. In our previous study, we have developed an injectable and porous nano calcium sulfate/alginate (nCS/A) scaffold and demonstrated that nCS/A composition is biocompatible and has proper biodegradability for bone regeneration. Here, we hypothesized that the combination of an injectable and porous nCS/A with bone morphogenetic protein 2 (BMP2) gene-modified MSCs and endothelial progenitor cells (EPCs) could significantly enhance vascularized bone regeneration. Our results demonstrated that delivery of MSCs and EPCs with the injectable nCS/A scaffold did not affect cell viability. Moreover, co-culture of BMP2 gene-modified MSCs and EPCs dramatically increased osteoblast differentiation of MSCs and endothelial differentiation of EPCs in vitro. We further tested the multifunctional bone reconstruction system consisting of an injectable and porous nCS/A scaffold (mimicking the nano-calcium matrix of bone) and BMP2 genetically-engineered MSCs and EPCs in a rat critical-sized (8 mm) caviarial bone defect model. Our in vivo results showed that, compared to the groups of nCS/A, nCS/A+MSCs, nCS/A+MSCs+EPCs and nCS/A+BMP2 gene-modified MSCs, the combination of BMP2 gene -modified MSCs and EPCs in nCS/A dramatically increased the new bone and vascular formation. These results demonstrated that EPCs increase new vascular growth, and that BMP2 gene modification for MSCs and EPCs dramatically promotes bone regeneration. This system could ultimately enable clinicians to better reconstruct the craniofacial bone and avoid donor site morbidity for CSBDs.	[He, Xiaoning; Dziak, Rosemary; Yuan, Xue; Genco, Robert; Li, Chunyi; Wang, Changdong; Yang, Shuying] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA; [Andreadis, Stelios; Yang, Shuying] SUNY Buffalo, Dev Genom Grp, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [He, Xiaoning] China Med Univ, Dept Stomatol, Affiliated Hosp 4, Shenyang, Liaoning, Peoples R China; [Swihart, Mark; Andreadis, Stelios] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Sarkar, Debanjan; Andreadis, Stelios] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA; [Mao, Keya] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing, Peoples R China; [Lu, Li] China Med Univ, Dept Oral & Maxillofacial Surg, Sch Stomatol, Shenyang, Liaoning, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; China Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Chinese People's Liberation Army General Hospital; China Medical University	Yang, SY (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA.	sy47@buffalo.edu	lu, lu/HII-7530-2022; Yang, Shuying/G-4599-2011; Sarkar, Debanjan/C-6093-2017; Yuan, Xue/L-8066-2017; Swihart, Mark T/A-3182-2008	Sarkar, Debanjan/0000-0002-6666-3152; Yuan, Xue/0000-0002-8063-9431; Swihart, Mark T/0000-0002-9652-687X	National Institutes of Health [AR055678, AR061052]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR061052, K08AR055678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding provided by National Institutes of Health grant AR055678 (SY) and AR061052 (SY). (http://www.niams.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita S, 2004, WOUND REPAIR REGEN, V12, P252, DOI 10.1111/j.1067-1927.2004.012118.x; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Atesok K, 2010, J ORTHOP RES, V28, P1007, DOI 10.1002/jor.21083; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74; Block Michael S, 2006, Atlas Oral Maxillofac Surg Clin North Am, V14, P99, DOI 10.1016/j.cxom.2005.11.002; BOWERS GM, 1989, J PERIODONTOL, V60, P683, DOI 10.1902/jop.1989.60.12.683; Burkus JK, 2002, SPINE, V27, P2396, DOI 10.1097/00007632-200211010-00015; COLLINOSDOBY P, 1994, J CELL BIOCHEM, V55, P304, DOI 10.1002/jcb.240550306; DECKER B, 1995, ANAT RECORD, V242, P310, DOI 10.1002/ar.1092420304; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd; Eyckmans J, 2006, TISSUE ENG, V12, P2203, DOI 10.1089/ten.2006.12.2203; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x; Gosain AK, 2000, PLAST RECONSTR SURG, V106, P360, DOI 10.1097/00006534-200008000-00018; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Granero-Molto F, 2008, EXPERT OPIN BIOL TH, V8, P255, DOI 10.1517/14712598.8.3.255 ; He X, 2012, TISSUE ENG A; He XN, 2013, TISSUE ENG PT A, V19, P508, DOI [10.1089/ten.tea.2012.0244, 10.1089/ten.TEA.2012.0244]; Holleville N, 2003, DEV BIOL, V257, P177, DOI 10.1016/S0012-1606(03)00059-9; Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014; Jiang M, 2008, J CELL BIOCHEM, V103, P321, DOI 10.1002/jcb.21416; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; Kaigler D, 2006, J DENT RES, V85, P633, DOI 10.1177/154405910608500710; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Laurell L, 1998, J PERIODONTOL, V69, P303, DOI 10.1902/jop.1998.69.3.303; Luttun A, 2002, TRENDS CARDIOVAS MED, V12, P88, DOI 10.1016/S1050-1738(01)00152-9; Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271; Matsubara H, 2012, BONE, V51, P168, DOI 10.1016/j.bone.2012.02.017; McCarty RC, 2009, J CELL PHYSIOL, V219, P324, DOI 10.1002/jcp.21670; Muschler GF, 2005, CLIN ORTHOP RELAT R, P242, DOI 10.1097/01.blo.0000149812.32857.8b; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; Park YB, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055007; Peterson B, 2005, TISSUE ENG, V11, P120, DOI 10.1089/ten.2005.11.120; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Raida M, 2006, INT J MOL MED, V18, P735; Salvadori B, 2006, J COLLOID INTERF SCI, V298, P487, DOI 10.1016/j.jcis.2005.12.016; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Samstein B, 2001, J AM SOC NEPHROL, V12, P182, DOI 10.1681/ASN.V121182; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299, DOI 10.1097/00003086-198604000-00036; Seebach C, 2012, CELL TRANSPLANT, V21, P1667, DOI 10.3727/096368912X638937; Seebach C, 2010, TISSUE ENG PT A, V16, P1961, DOI 10.1089/ten.TEA.2009.0715; Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609; Stein A, 2008, J VASC SURG, V48, P1217, DOI 10.1016/j.jvs.2008.06.018; Stoller MD, 2012, PHYS CHEM CHEM PHYS, V14, P3388, DOI 10.1039/c2cp00017b; STREETEN DHP, 1990, J CLIN INVEST, V86, P1582, DOI 10.1172/JCI114878; Swiontkowski MF, 2006, J BONE JOINT SURG AM, V88A, P1258, DOI 10.2106/JBJS.E.00499; Tai K, 2008, TISSUE ENG PT A, V14, P1709, DOI 10.1089/ten.tea.2007.0241; Tian F, 2009, BLOOD, V113, P5352, DOI 10.1182/blood-2008-08-173773; Tsuda H, 2005, J GENE MED, V7, P1322, DOI 10.1002/jgm.777; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Usami K, 2009, J BIOMED MATER RES A, V90A, P730, DOI 10.1002/jbm.a.32142; Vaccaro AR, 2005, SPINE, V30, P2709, DOI 10.1097/01.brs.0000190812.08447.ba; Walter DH, 2002, HERZ, V27, P579, DOI 10.1007/s00059-002-2427-y; Yang NN, 2011, CYTOTECHNOLOGY, V63, P217, DOI 10.1007/s10616-010-9329-2; Yang S, 2007, GENE DEV, V21, P1803; Yang SY, 2012, BONE, V51, P407, DOI 10.1016/j.bone.2012.06.021; Yang SY, 2007, J BONE MINER RES, V22, P45, DOI 10.1359/JBMR.061007; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Young PP, 2002, P NATL ACAD SCI USA, V99, P11951, DOI 10.1073/pnas.182215799; Young S, 2008, TISSUE ENG PART B-RE, V14, P295, DOI 10.1089/ten.teb.2008.0153	65	77	91	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60473	10.1371/journal.pone.0060473	http://dx.doi.org/10.1371/journal.pone.0060473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565253	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300124
J	Lee, WC; Russell, B; Lau, YL; Fong, MY; Chu, C; Sriprawat, K; Suwanarusk, R; Nosten, F; Renia, L				Lee, Wenn-Chyau; Russell, Bruce; Lau, Yee-Ling; Fong, Mun-Yik; Chu, Cindy; Sriprawat, Kanlaya; Suwanarusk, Rossarin; Nosten, Francois; Renia, Laurent			Giemsa-Stained Wet Mount Based Method for Reticulocyte Quantification: A Viable Alternative in Resource Limited or Malaria Endemic Settings	PLOS ONE			English	Article							ABERRATION; COUNT	The quantity of circulating reticulocytes is an important indicator of erythropoietic activity in response to a wide range of haematological pathologies. While most modern laboratories use flow cytometry to quantify reticulocytes, most field laboratories still rely on 'subvital' staining. The specialist 'subvital' stains, New Methylene Blue (NMB) and Brilliant Cresyl Blue are often difficult to procure, toxic, and show inconsistencies between batches. Here we demonstrate the utility of Giemsa's stain (commonly used microbiology and parasitology) in a 'subvital' manner to provide an accurate method to visualize and count reticulocytes in blood samples from normal and malaria-infected individuals.	[Lee, Wenn-Chyau; Russell, Bruce; Lau, Yee-Ling; Fong, Mun-Yik] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Russell, Bruce] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Natl Univ Hlth Syst, Singapore 117595, Singapore; [Chu, Cindy; Sriprawat, Kanlaya; Nosten, Francois] SMRU, Mae Sot, Tak Province, Thailand; [Suwanarusk, Rossarin; Renia, Laurent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Nosten, Francois] Mahidol Oxford Univ Res Unit, Bangkok, Thailand; [Nosten, Francois] Univ Oxford, Ctr Trop Med, Churchill Hosp, Oxford, England	Universiti Malaya; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Oxford	Russell, B (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	micbmr@nus.edu.sg	LEE, Wenn-Chyau/AAR-4072-2020; Russell, Bruce/A-9240-2011; Suwanarusk, Rossarin/E-2115-2013; Renia, Laurent/E-2117-2011; Chu, Cindy S/E-3135-2014; Lau, Yee Ling/C-6996-2009; FONG, MUN YIK/B-5443-2010; Nosten, Francois/AAC-5509-2019	LEE, Wenn-Chyau/0000-0002-7324-5792; Russell, Bruce/0000-0003-2333-4348; Suwanarusk, Rossarin/0000-0002-7310-245X; Renia, Laurent/0000-0003-0349-1557; Chu, Cindy S/0000-0001-9465-8214; Lau, Yee Ling/0000-0002-2037-2165; Nosten, Francois/0000-0002-7951-0745	University of Malaya, High Impact Research Fund [E000051-20001]; SIgN; Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore); Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University	University of Malaya, High Impact Research Fund; SIgN(Agency for Science Technology & Research (A*STAR)); Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore); Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University	This study received financial support from the following funds: WCL, YLL, and MYF were supported by University of Malaya, High Impact Research Fund (E000051-20001). BR, RS, and LR were supported by funding from SIgN and from the Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore). KS, CC, and FN were sponsored by The Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University. LR is an adjunct professor in the Department of Parasitology, University of Malaya, Kuala Lumpur, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AF, 2010, J PAK MED ASSOC, V60, P892; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BRECHER G, 1949, AM J CLIN PATHOL, V19, P895, DOI 10.1093/ajcp/19.9_ts.895; Breman JG, 2004, AM J TROP MED HYG, V71, P1; England JM, 1998, CLIN LAB HAEMATOL, V20, P77, DOI 10.1046/j.1365-2257.1998.00104.x; GIBSON SF, 1992, J OPT SOC AM A, V9, P154; KOEPKE JF, 1986, CLIN LAB HAEMATOL, V8, P169, DOI 10.1111/j.1365-2257.1986.tb00093.x; National Committee for Clinical Laboratory Standards (NCCLS), 2004, H44A2 NCCLS; NOBES PR, 1990, J CLIN PATHOL, V43, P675, DOI 10.1136/jcp.43.8.675; Nunez R, 2001, Curr Issues Mol Biol, V3, P39; Riley RS, 2001, LAB MED, V32, P599, DOI 10.1309/U0PB-1XCK-FLQ7-V36V; ROWAN RM, 1991, PURE APPL CHEM, V63, P1141, DOI 10.1351/pac199163081141; Vryonis G, 1939, AM J HYG, V30, P41, DOI 10.1093/oxfordjournals.aje.a118587; Wan DS, 2000, J MICROSC-OXFORD, V197, P274, DOI 10.1046/j.1365-2818.2000.00635.x	14	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60303	10.1371/journal.pone.0060303	http://dx.doi.org/10.1371/journal.pone.0060303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565221	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300090
J	Mosca-Boidron, AL; Faivre, L; Aho, S; Marle, N; Truntzer, C; Rousseau, T; Ragon, C; Payet, M; Thauvin-Robinet, C; Thevenon, J; El Chehadeh, S; Huet, F; Sagot, P; Mugneret, F; Callier, P				Mosca-Boidron, Anne-Laure; Faivre, Laurence; Aho, Serge; Marle, Nathalie; Truntzer, Caroline; Rousseau, Thierry; Ragon, Clemence; Payet, Muriel; Thauvin-Robinet, Christelle; Thevenon, Julien; El Chehadeh, Salima; Huet, Frederic; Sagot, Paul; Mugneret, Francine; Callier, Patrick			An Improved Method to Extract DNA from 1 ml of Uncultured Amniotic Fluid from Patients at Less than 16 Weeks' Gestation	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; FREE FETAL DNA; ARRAY-CGH ANALYSIS; PRENATAL-DIAGNOSIS; MICROARRAY ANALYSIS; ABNORMALITIES; FETUSES; PREGNANCIES; IMBALANCES; DELETION	The aim of this study was to develop an improved technique for DNA extraction from 1 ml of uncultured AF from patients with a gestational age less than 16 weeks and to allow the use of array-CGH without DNA amplification. The DNA extraction protocol was tested in a series of 90 samples including 41 of uncultured AF at less than 16 weeks of gestation. Statistical analyses were performed using linear regression. To evaluate the sensitivity and the specificity of array-CGH on 1 ml of uncultured AF, five samples with an abnormal karyotype (three with aneuploidy, two with structural abnormalities) and five with a normal karyotype were studied. This protocol was reproducible and we were able to show a great improvement with higher yield of DNA obtained from all patients, including those with a gestational age less than 16 weeks (p = 0.003). All chromosomal abnormalities were detected and characterized by array-CGH and normal samples showed normal profiles. This new DNA extraction protocol associated with array-CGH analysis could be used in prenatal testing even when gestational age is less than 16 weeks, especially in cases with abnormal ultrasound findings.	[Mosca-Boidron, Anne-Laure; Faivre, Laurence; Marle, Nathalie; Ragon, Clemence; Payet, Muriel; Thauvin-Robinet, Christelle; Thevenon, Julien; El Chehadeh, Salima; Mugneret, Francine; Callier, Patrick] Hop Le Bocage, Dept Genet, Dijon, France; [Aho, Serge] Hop Le Bocage, Serv Epidemiol & Hyg Hosp, Dijon, France; [Truntzer, Caroline] Hop Le Bocage, Plateforme Prote CLIPP, Dijon, France; [Rousseau, Thierry; Sagot, Paul] Hop Le Bocage, Gynecol Serv, Dijon, France; [Huet, Frederic] Hop Enfants, Dijon, France	CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne	Callier, P (corresponding author), Hop Le Bocage, Dept Genet, Dijon, France.	patrick.callier@chu-dijon.fr	AHO, ludwig/AAR-5753-2021; Serge, Aho Glele Ludwig/AAP-8863-2021	Serge, Aho Glele Ludwig/0000-0001-7590-8644; Faivre, Laurence/0000-0001-9770-444X; Thevenon, Julien/0000-0001-9271-3961; Frederic, HUET/0000-0002-4510-7093	University Hospital of Dijon; regional council of Burgundy [AOI 2008]	University Hospital of Dijon; regional council of Burgundy(Region Bourgogne-Franche-Comte)	The project was financial by a grant from the University Hospital of Dijon and from the regional council of Burgundy (AOI 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi WB, 2008, PRENATAL DIAG, V28, P943, DOI 10.1002/pd.2087; Bianchi DW, 2001, CLIN CHEM, V47, P1867; Callier P, 2009, PRENATAL DIAG, V29, P1002, DOI 10.1002/pd.2333; Choe J, 2007, J HUM GENET, V52, P934, DOI 10.1007/s10038-007-0199-1; Coppinger J, 2009, PRENATAL DIAG, V29, P1156, DOI 10.1002/pd.2371; D'Amours G, 2012, CLIN GENET, V81, P128, DOI 10.1111/j.1399-0004.2011.01687.x; Fiorentino F, 2011, PRENATAL DIAG, V31, P1270, DOI 10.1002/pd.2884; Gruchy N, 2012, PRENATAL DIAG, V32, P383, DOI 10.1002/pd.2861; Kleeman L, 2009, PRENATAL DIAG, V29, P1213, DOI 10.1002/pd.2367; Lapaire O, 2007, PRENATAL DIAG, V27, P616, DOI 10.1002/pd.1752; Larrabee PB, 2004, AM J HUM GENET, V75, P485, DOI 10.1086/423288; Le Caignec C, 2005, J MED GENET, V42, P121, DOI 10.1136/jmg.2004.025478; Lee CN, 2012, BJOG-INT J OBSTET GY, V119, P1282, DOI 10.1111/j.1471-0528.2012.03419.x; Masurel-Paulet A, 2009, AM J MED GENET A, V149A, P1504, DOI 10.1002/ajmg.a.32904; Maya I, 2010, PRENATAL DIAG, V30, P1131, DOI 10.1002/pd.2626; Miura S, 2006, J HUM GENET, V51, P412, DOI 10.1007/s10038-006-0376-7; Mochel F, 2008, EUR J MED GENET, V51, P68, DOI 10.1016/j.ejmg.2007.11.002; Park SJ, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-12; REBELLO MT, 1991, PRENATAL DIAG, V11, P41, DOI 10.1002/pd.1970110108; Rickman L, 2006, J MED GENET, V43, P353, DOI 10.1136/jmg.2005.037648; Sahoo T, 2006, GENET MED, V8, P719, DOI 10.1097/01.gim.0000245576.47154.63; Schaeffer AJ, 2004, AM J HUM GENET, V74, P1168, DOI 10.1086/421250; Shaffer LG, 2008, PRENATAL DIAG, V28, P789, DOI 10.1002/pd.2053; Shafter LG, 2007, GENET MED, V9, P654, DOI 10.1097/GIM.0b013e31814ce3d9; Sung PL, 2009, AM J MED GENET A, V149A, P2768, DOI 10.1002/ajmg.a.32878; Tyreman M, 2009, J MED GENET, V46, P531, DOI 10.1136/jmg.2008.065482; Valduga M, 2010, PRENATAL DIAG, V30, P333, DOI 10.1002/pd.2460; Valduga M, 1950, PRENAT DIAGN, V30, P333; Van den Veyver IB, 2009, PRENATAL DIAG, V29, P29, DOI 10.1002/pd.2127	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59956	10.1371/journal.pone.0059956	http://dx.doi.org/10.1371/journal.pone.0059956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565177	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300046
J	Pocchiari, M; Poleggi, A; Puopolo, M; D'Alessandro, M; Tiple, D; Ladogana, A				Pocchiari, Maurizio; Poleggi, Anna; Puopolo, Maria; D'Alessandro, Marco; Tiple, Dorina; Ladogana, Anna			Age at Death of Creutzfeldt-Jakob Disease in Subsequent Family Generation Carrying the E200K Mutation of the Prion Protein Gene	PLOS ONE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; ANTICIPATION; SLOVAKIA; RISK; PRNP; POLYMORPHISM; CODON-200; LIBYAN; JEWS	Background: The E200K mutation of the prion protein gene (PRNP) is the most frequent amino acid substitution in genetic Creutzfeldt-Jakob disease and is the only one responsible for the appearance of clustered cases in the world. In the Israel and Slovakian clusters, age of disease onset was reduced in successive generations but the absence of a clear molecular basis raised the possibility that this event was an observational bias. The aim of the present study was to investigate possible selection biases or confounding factors related to anticipation in E200K CJD patients belonging to a cluster in Southern Italy. Methods: Clinical and demographical data of 41 parent-offspring pairs from 19 pedigrees of the Italian cluster of E200K patients were collected. Age at death of parents was compared with age at death of E200K CJD offspring. Subgroup analyses were performed for controlling possible selection biases, confounding factors, or both. Results: The mean age at death/last follow-up of the parent generation was 71.4 years while that of CJD offspring was 59.3 years with an estimated anticipation of 12.1 years. When the same analysis was performed including only parents with CJD or carrying the E200K mutation (n = 26), the difference between offspring and parents increased to 14.8 years. Conclusions: These results show that early age at death occurs in offspring of families carrying the E200K PRNP mutation and that this event is not linked to observational biases. Although molecular or environmental bases for this occurrence remain unsettled, this information is important for improving the accuracy of information to give to mutated carriers.	[Pocchiari, Maurizio; Poleggi, Anna; Puopolo, Maria; D'Alessandro, Marco; Tiple, Dorina; Ladogana, Anna] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Pocchiari, M (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	maurizio.pocchiari@iss.it	puopolo, maria/K-9907-2018; Ladogana, Anna/K-1415-2016; Poleggi, Anna/M-7950-2017; Pocchiari, Maurizio/J-8443-2018	puopolo, maria/0000-0001-5410-2334; Pocchiari, Maurizio/0000-0002-7269-2486; Poleggi, Anna/0000-0001-7094-7767; tiple, dorina/0000-0001-7155-4957; ladogana, Anna/0000-0002-7504-6906	Istituto Superiore di Sanita (ISS)-NIH; Italian Ministry of Health (CJD Registry)	Istituto Superiore di Sanita (ISS)-NIH; Italian Ministry of Health (CJD Registry)	This study was supported by the Istituto Superiore di Sanita (ISS)-NIH research program "Rare Diseases 2006" and the Italian Ministry of Health (CJD Registry). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIONDI G, 1990, ANN HUM BIOL, V17, P543, DOI 10.1080/03014469000001322; Bishop MT, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-146; Boonstra PS, 2010, GENET EPIDEMIOL, V34, P756, DOI 10.1002/gepi.20534; Bradley M, 2005, NEUROLOGY, V64, P1628, DOI 10.1212/01.WNL.0000160395.43761.AC; Brown P, 2012, EMERG INFECT DIS, V18, P901, DOI 10.3201/eid1806.120116; Canello T, 2012, NEUROBIOL DIS, V45, P1010, DOI 10.1016/j.nbd.2011.12.020; Canello T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000977; D'Alessandro M, 1998, LANCET, V352, P1989, DOI 10.1016/S0140-6736(05)61335-9; Fraser FC, 1997, LANCET, V350, P459, DOI 10.1016/S0140-6736(05)63077-2; Friedman-Levi Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002350; GOLDFARB LG, 1990, LANCET, V336, P514, DOI 10.1016/0140-6736(90)92073-Q; GOLDFARB LG, 1990, LANCET, V336, P637, DOI 10.1016/0140-6736(90)93443-S; Horwitz M, 1996, AM J HUM GENET, V59, P990; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kong Qingzhong, 2004, VVolume 41, P673; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Ladogana A, 2005, NEUROLOGY, V64, P1592, DOI 10.1212/01.WNL.0000160118.26865.11; McInnis MG, 1996, AM J HUM GENET, V59, P973; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mitrova E, 2002, ACTA VIROL, V46, P31; Miyakawa T, 1998, NEUROL RES, V20, P684; PENROSE LS, 1948, ANN EUGENIC, V14, P125; Picco MF, 2001, ANN INTERN MED, V134, P1124, DOI 10.7326/0003-4819-134-12-200106190-00013; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; Puopolo M, 2011, TRANSFUSION, V51, P1556, DOI 10.1111/j.1537-2995.2010.03004.x; Purdey M, 2005, MED HYPOTHESES, V65, P448, DOI 10.1016/j.mehy.2005.03.018; Rosenmann H, 1999, NEUROLOGY, V53, P1328, DOI 10.1212/WNL.53.6.1328; Sanchez-Juan P, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-73; Slivarichova D, 2011, CENT EUR J PUBL HEAL, V19, P158, DOI 10.21101/cejph.a3667; SPUDICH S, 1995, MOL MED, V1, P607, DOI 10.1007/BF03401601; Stelzer M, 2012, PRION, V6, P71; World Health Organization, 2012, CREUTZF JAK DIS CJD	32	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60376	10.1371/journal.pone.0060376	http://dx.doi.org/10.1371/journal.pone.0060376			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565236	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300106
J	Tancioni, L; Russo, T; Cataudella, S; Milana, V; Hett, AK; Corsi, E; Rossi, AR				Tancioni, Lorenzo; Russo, Tommaso; Cataudella, Stefano; Milana, Valentina; Hett, Anne Kathrin; Corsi, Elisa; Rossi, Anna Rita			Testing Species Delimitations in Four Italian Sympatric Leuciscine Fishes in the Tiber River: A Combined Morphological and Molecular Approach	PLOS ONE			English	Article							FRESH-WATER FISHES; INTROGRESSIVE HYBRIDIZATION; EUROPEAN CYPRINIDS; BAYESIAN-INFERENCE; MITOCHONDRIAL-DNA; COMPLEX TELEOSTEI; SYSTEMATICS; EVOLUTIONARY; CEPHALUS; HYBRIDS	Leuciscine fishes represent an important component of freshwater ichthyofauna endemic to northern Mediterranean areas. This lineage shows high intra-specific morphological variability and exhibits high levels of hybridization, two characteristics that contribute to systematic uncertainties, misclassification of taxa and, potentially, the mismanagement of biodiversity. This study focused on brook chub, Squalius lucumonis, an endemic taxon of Central Italy. The taxonomic status of this species has long been questioned, and a hybrid origin from sympatric leusciscines (S. squalus x Rutilus rubilio, or S. squalus x Telestes muticellus) has been hypothesised. A phenotypic (evaluating shape and meristic counts) and genetic (using mitochondrial and nuclear markers) investigation of these four taxa was conducted to test species delimitation in sympatric areas and to evaluate the taxonomic status of S. lucumonis. One hundred and forty-five individuals of all four taxa were collected within streams of the lowest portion of the Tiber River basin and analysed; this region encompasses a large portion of the S. lucumonis distribution. The different morphological and genetic approaches were individually examined, compared, and then combined in a quantitative model to both investigate the limits of each approach and to identify cases of misclassification. The results obtained confirm the cladogenetic non-hybrid origin of S. lucumonis, highlight the need for immediate conservation actions and emphasise the value of an integrated approach in the study of leuciscines evolution.	[Tancioni, Lorenzo; Russo, Tommaso; Cataudella, Stefano; Corsi, Elisa] Univ Roma Tor Vergata, Dept Biol, Expt Ecol & Aquaculture Lab, I-00173 Rome, Italy; [Milana, Valentina; Hett, Anne Kathrin; Rossi, Anna Rita] Univ Roma La Sapienza, Biol & Biotechnol Dept, Rome, Italy	University of Rome Tor Vergata; Sapienza University Rome	Russo, T (corresponding author), Univ Roma Tor Vergata, Dept Biol, Expt Ecol & Aquaculture Lab, I-00173 Rome, Italy.	Tommaso.Russo@Uniroma2.it	Russo, Tommaso/C-6157-2014; Rossi, Anna Rita/P-6294-2015	Russo, Tommaso/0000-0003-4047-959X; Rossi, Anna Rita/0000-0003-4049-1249				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Bianco P.G., 1983, Senckenbergiana Biologica, V64, P81; Bianco PG, 2003, ENVIRON BIOL FISH, V68, P370; BIANCO PG, 1988, J FISH BIOL, V32, P1, DOI 10.1111/j.1095-8649.1988.tb05331.x; BIANCO PG, 1995, BIOL CONSERV, V72, P159, DOI 10.1016/0006-3207(94)00078-5; Bloomquist EW, 2010, SYST BIOL, V59, P27, DOI 10.1093/sysbio/syp076; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Breiman L., 1984, CLASSIFICATION REGRE; Chambers G, 2012, BIOL PHILOS, V27, P755, DOI 10.1007/s10539-012-9314-6; Chen WJ, 2009, MOL PHYLOGENET EVOL, V52, P544, DOI 10.1016/j.ympev.2009.01.006; Copiz R, 2008, HABITAT SPECIE INTER, P225; Coscia I, 2010, J FISH BIOL, V77, P1137, DOI 10.1111/j.1095-8649.2010.02768.x; Costedoat C, 2006, MOL PHYLOGENET EVOL, V41, P127, DOI 10.1016/j.ympev.2006.04.022; Costedoat C, 2004, CYBIUM, V28, P51; Crivelli A.J., 1996, FRESHWATER FISH ENDE; Crivelli AJ, 2006, SQUALIUS LUCUMONIS I; Doadrio I, 2006, CYBIUM, V30, P199; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dubut V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034423; EC, 1998, OFFICIAL J L, V358; EC, 1992, OFFICIAL J L; EC, 1982, OFFICIAL J L; Eschmeyer W. N., 2012, CATALOG FISHES ELECT; Fadda C, 2001, J ZOOL SYST EVOL RES, V39, P235, DOI 10.1046/j.1439-0469.2001.00169.x; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Freyhof J, 2006, MOL PHYLOGENET EVOL, V38, P416, DOI 10.1016/j.ympev.2005.07.024; Freyhof J, 2005, MOL PHYLOGENET EVOL, V37, P347, DOI 10.1016/j.ympev.2005.07.018; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Gandolfi G., 1991, PESCI ACQUE INTERNE; Giannetto D, 2012, N AM J FISH MANAGE, V32, P428, DOI 10.1080/02755947.2012.686006; Gilles A, 1998, MOL PHYLOGENET EVOL, V10, P132, DOI 10.1006/mpev.1997.0480; Gilles A, 2010, ZOOL SCR, V39, P225, DOI 10.1111/j.1463-6409.2010.00417.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hayden B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-169; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Holland BR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-202; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Joly S, 2012, MOL ECOL RESOUR, V12, P179, DOI 10.1111/j.1755-0998.2011.03065.x; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Kassam DD, 2003, J ZOOL, V260, P153, DOI 10.1017/S0952836903003571; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 2007, MORPHOJ; Krysanov, 2000, J ICHTHYOL, V40, P298; LELEK A, 1987, FRESHWATER FISHES EU; Lieckfeldt D, 2006, EUR J WILDLIFE RES, V52, P63, DOI 10.1007/s10344-005-0010-6; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; MALDINI M., 2006, QUADERNI ETP, V34, P63; Manaresi S, 1997, ITAL J ZOOL, V64, P215, DOI 10.1080/11250009709356199; Manaresi S, 2001, AQUAT SCI, V63, P182, DOI 10.1007/PL00001350; Milana V, 2008, J FISH BIOL, V73, P1216, DOI 10.1111/j.1095-8649.2008.01994.x; Minegishi Y, 2005, MOL PHYLOGENET EVOL, V34, P134, DOI 10.1016/j.ympev.2004.09.003; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nylander JAA, 2008, MRMODELTEST V2 3; Perea S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-265; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quenouille B, 2004, MOL PHYLOGENET EVOL, V31, P66, DOI 10.1016/s1055-7903(03)00278-1; Rambaut A., 2008, FIGTREE V1 4 0; Rambaut A, 2009, TRACER V1 5; Reyjol Y, 2007, GLOBAL ECOL BIOGEOGR, V16, P65, DOI 10.1111/j.1466-8238.2006.00264.x; Rohlf F.J., 2006, TPS DIG; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2000, TPSREGR VERSION 1 24; Rohlf FJ, 2006, TPSPLS VER 1 18; Russo T, 2008, J FISH BIOL, V73, P809, DOI 10.1111/j.1095-8649.2008.01964.x; Russo T, 2009, J MORPHOL, V270, P83, DOI 10.1002/jmor.10674; Salducci MD, 2004, CONSERV GENET, V5, P63, DOI 10.1023/B:COGE.0000014054.57397.3f; Sanjur OI, 2003, MOL PHYLOGENET EVOL, V29, P20, DOI 10.1016/S1055-7903(03)00088-5; Scribner KT, 2000, REV FISH BIOL FISHER, V10, P293, DOI 10.1023/A:1016642723238; Sousa-Santos C, 2007, MOL PHYLOGENET EVOL, V45, P981, DOI 10.1016/j.ympev.2007.05.011; Templeton AR, 2000, P ROY SOC LOND B BIO, V267, P1987; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toscano BJ, 2010, BIOL J LINN SOC, V99, P768, DOI 10.1111/j.1095-8312.2010.01383.x; Turner GF, 1999, REV FISH BIOL FISHER, V9, P281, DOI 10.1023/A:1008903228512; Unver B, 2008, TURK J FISH AQUAT SC, V8, P207; Vayssieres MP, 2000, J VEG SCI, V11, P679, DOI 10.2307/3236575; VERSPOOR E, 1991, J FISH BIOL, V39, P309, DOI 10.1111/j.1095-8649.1991.tb05094.x; WHEELER A, 1978, J FISH BIOL, V13, P467, DOI 10.1111/j.1095-8649.1978.tb03456.x; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zerunian S, 2002, CONDANNATI ALLESTINZ	84	20	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60392	10.1371/journal.pone.0060392	http://dx.doi.org/10.1371/journal.pone.0060392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565240	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300110
J	Zhang, HY; Wu, HH; Yu, Q; Wang, ZW; Wei, CZ; Long, M; Kattge, J; Smith, M; Han, XG				Zhang, Haiyang; Wu, Honghui; Yu, Qiang; Wang, Zhengwen; Wei, Cunzheng; Long, Min; Kattge, Jens; Smith, Melinda; Han, Xingguo			Sampling Date, Leaf Age and Root Size: Implications for the Study of Plant C:N:P Stoichiometry	PLOS ONE			English	Article							BIOLOGICAL STOICHIOMETRY; FUNCTIONAL TRAITS; MINERAL-NUTRITION; WILD PLANTS; NITROGEN; PHOSPHORUS; PATTERNS; TERRESTRIAL; CARBON; CONSTRAINTS	Plant carbon : nitrogen : phosphorus (C:N:P) ratios are powerful indicators of diverse ecological processes. During plant development and growth, plant C:N:P stoichiometry responds to environmental conditions and physiological constraints. However, variations caused by effects of sampling (i.e. sampling date, leaf age and root size) often have been neglected in previous studies. We investigated the relative contributions of sampling date, leaf age, root size and species identity to stoichiometric flexibility in a field mesocosm study and a natural grassland in Inner Mongolia. We found that sampling date, leaf age, root size and species identity all significantly affected C:N:P stoichiometry both in the pot study as well as in the field. Overall, C:N and C:P ratios increased significantly over time and with increasing leaf age and root size, while the dynamics of N:P ratios depended on species identity. Our results suggest that attempts to synthesize C:N:P stoichiometry data across studies that span regional to global scales and include many species need to better account for temporal variation.	[Zhang, Haiyang; Wu, Honghui; Yu, Qiang; Wang, Zhengwen; Long, Min; Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Wu, Honghui; Yu, Qiang; Wei, Cunzheng; Han, Xingguo] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Kattge, Jens] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Smith, Melinda] Colorado State Univ, Dept Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Max Planck Society; Colorado State University	Yu, Q (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	yuqiang@iae.ac.cn; xghan@ibcas.ac.cn	Yu, Qiang/E-2097-2011; Wu, Honghui/AAF-5696-2019; Wang, Zhengwen/A-8292-2011; Cunzheng, Wei/A-4360-2009; Han, Xingguo/K-7552-2016; Smith, Melinda D/J-8987-2014; Kattge, Jens/J-8283-2016	Yu, Qiang/0000-0002-5480-0623; Cunzheng, Wei/0000-0001-9309-2722; Han, Xingguo/0000-0002-1836-975X; Kattge, Jens/0000-0002-1022-8469; Zhang, Haiyang/0000-0001-7951-0502	National Natural Science Foundation of China [31270476, 31170434, 30870422]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31270476, 31170434 and 30870422). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Agren GI, 2012, NEW PHYTOL, V194, P944, DOI 10.1111/j.1469-8137.2012.04114.x; Beardall J, 2009, NEW PHYTOL, V181, P295, DOI 10.1111/j.1469-8137.2008.02660.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bremner J. M., 1996, METHODS SOIL ANAL 3, P1085, DOI DOI 10.2136/SSSAB00KSER5.3.C37; CHAPIN FS, 1983, ECOLOGY, V64, P376, DOI 10.2307/1937083; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Cianciaruso MV, 2009, ECOLOGY, V90, P81, DOI 10.1890/07-1864.1; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Dijkstra FA, 2012, NEW PHYTOL, V196, P807, DOI 10.1111/j.1469-8137.2012.04349.x; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Enquist BJ, 2007, GLOBAL CHANGE BIOL, V13, P591, DOI 10.1111/j.1365-2486.2006.01222.x; Frost PC, 2005, OIKOS, V109, P18, DOI 10.1111/j.0030-1299.2005.14049.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; He JS, 2006, OECOLOGIA, V149, P115, DOI 10.1007/s00442-006-0425-0; Hoagland DR., 1950, WATER CULTURE METHOD; Jensen M. H., 1985, Horticultural Reviews, V7, P483, DOI 10.1002/9781118060735.ch10; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; KENNEDY JS, 1950, ANN APPL BIOL, V37, P651, DOI 10.1111/j.1744-7348.1950.tb00989.x; Kuo S., 1996, METHODS SOIL ANAL 3, P869, DOI 10.2136/sssabookser5.3; MARKERT B, 1989, FRESEN Z ANAL CHEM, V335, P562, DOI 10.1007/BF00474249; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; MCJANNET CL, 1995, FUNCT ECOL, V9, P231, DOI 10.2307/2390569; Mendez M, 2005, ECOLOGY, V86, P982, DOI 10.1890/04-0354; Niklas KJ, 2007, P NATL ACAD SCI USA, V104, P8891, DOI 10.1073/pnas.0701135104; Niklas KJ, 2005, ECOL LETT, V8, P636, DOI 10.1111/j.1461-0248.2005.00759.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; REICH PB, 1995, FUNCT ECOL, V9, P65, DOI 10.2307/2390092; Reich PB, 2009, NEW PHYTOL, V183, P153, DOI 10.1111/j.1469-8137.2009.02824.x; Ridley CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024762; Rivas-Ubach A, 2012, P NATL ACAD SCI USA, V109, P4181, DOI 10.1073/pnas.1116092109; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Venterink HO, 2010, FUNCT ECOL, V24, P877, DOI 10.1111/j.1365-2435.2010.01692.x; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Yamawo A, 2012, J ECOL, V100, P802, DOI 10.1111/j.1365-2745.2011.01934.x; Yu QA, 2011, OECOLOGIA, V166, P1, DOI 10.1007/s00442-010-1902-z; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Yuan ZY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1346; Zhang SB, 2012, GLOBAL ECOL BIOGEOGR, V21, P809, DOI 10.1111/j.1466-8238.2011.00729.x	47	42	60	4	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60360	10.1371/journal.pone.0060360	http://dx.doi.org/10.1371/journal.pone.0060360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565234	Green Submitted, gold, Green Published			2022-12-27	WOS:000317717300104
J	Galvao, FC; Rossi, D; Silveira, WD; Valentini, SR; Zanelli, CF				Galvao, Fabio Carrilho; Rossi, Danuza; Silveira, Wagner da Silva; Valentini, Sandro Roberto; Zanelli, Cleslei Fernando			The Deoxyhypusine Synthase Mutant dys1-1 Reveals the Association of eIF5A and Asc1 with Cell Wall Integrity	PLOS ONE			English	Article							INITIATION-FACTOR 5A; HYPUSINE-CONTAINING PROTEIN; TRANSLATION INITIATION; SACCHAROMYCES-CEREVISIAE; SALMONELLA-ENTERICA; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; AMINO-ACID; IN-VIVO; EF-P	The putative eukaryotic translation initiation factor 5A (eIF5A) is a highly conserved protein among archaea and eukaryotes that has recently been implicated in the elongation step of translation. eIF5A undergoes an essential and conserved posttranslational modification at a specific lysine to generate the residue hypusine. The enzymes deoxyhypusine synthase (Dys1) and deoxyhypusine hydroxylase (Lia1) catalyze this two-step modification process. Although several Saccharomyces cerevisiae eIF5A mutants have importantly contributed to the study of eIF5A function, no conditional mutant of Dys1 has been described so far. In this study, we generated and characterized the dys1-1 mutant, which showed a strong depletion of mutated Dys1 protein, resulting in more than 2-fold decrease in hypusine levels relative to the wild type. The dys1-1 mutant demonstrated a defect in total protein synthesis, a defect in polysome profile indicative of a translation elongation defect and a reduced association of eIF5A with polysomes. The growth phenotype of dys1-1 mutant is severe, growing only in the presence of 1 M sorbitol, an osmotic stabilizer. Although this phenotype is characteristic of Pkc1 cell wall integrity mutants, the sorbitol requirement from dys1-1 is not associated with cell lysis. We observed that the dys1-1 genetically interacts with the sole yeast protein kinase C (Pkc1) and Asc1, a component of the 40S ribosomal subunit. The dys1-1 mutant was synthetically lethal in combination with asc1 Delta and overexpression of TIF51A (eIF5A) or DYS1 is toxic for an asc1 Delta strain. Moreover, eIF5A is more associated with translating ribosomes in the absence of Asc1 in the cell. Finally, analysis of the sensitivity to cell wall-perturbing compounds revealed a more similar behavior of the dys1-1 and asc1 Delta mutants in comparison with the pkc1 Delta mutant. These data suggest a correlated role for eIF5A and Asc1 in coordinating the translational control of a subset of mRNAs associated with cell integrity.	[Galvao, Fabio Carrilho; Rossi, Danuza; Silveira, Wagner da Silva; Valentini, Sandro Roberto; Zanelli, Cleslei Fernando] Univ Estadual Paulista UNESP, Dept Biol Sci, Araraquara Sao Paulo, Brazil	Universidade Estadual Paulista	Zanelli, CF (corresponding author), Univ Estadual Paulista UNESP, Dept Biol Sci, Araraquara Sao Paulo, Brazil.	zanellicf@fcfar.unesp.br	Zanelli, Cleslei Fernando/C-1916-2013; Valentini, Sandro R/C-4353-2012; Zanelli, Cleslei Fernando/AAE-1003-2019	Zanelli, Cleslei Fernando/0000-0001-7831-1149; Valentini, Sandro Roberto/0000-0003-4453-5413	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Faculdade de Ciencias Farmaceuticas, UNESP; FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faculdade de Ciencias Farmaceuticas, UNESP; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants to SRV and CFZ from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and PADC from Faculdade de Ciencias Farmaceuticas, UNESP. The authors also thank FAPESP for fellowships awarded to the authors (FCG and DR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Bearson SMD, 2011, FOODBORNE PATHOG DIS, V8, P725, DOI 10.1089/fpd.2010.0796; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; Chantrel Y, 1998, GENETICS, V148, P559; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; DEVER TE, 2012, COLD SPRING HARB PER, V4; Dias CA, 2011, AMINO ACIDS; Dias CAO, 2008, FEBS J, V275, P1874, DOI 10.1111/j.1742-4658.2008.06345.x; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Guthrie C, 1991, GUIDE YEAST GENETICS; Henderson A, 2011, P NATL ACAD SCI USA, V108, P6415, DOI 10.1073/pnas.1008150108; Henderson BR, 1997, J MOL BIOL, V274, P693, DOI 10.1006/jmbi.1997.1420; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; Jao DLE, 2002, J CELL BIOCHEM, V86, P590, DOI 10.1002/jcb.10235; KANG HA, 1993, J BIOL CHEM, V268, P14750; KANG HA, 1994, J BIOL CHEM, V269, P3934; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; Kim KK, 1998, P NATL ACAD SCI USA, V95, P10419, DOI 10.1073/pnas.95.18.10419; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Lorsh J, 2007, YEAST PHENOTYPIC ASS, P105; Melamed D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011389; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; Park MH, 1997, BIOL SIGNAL, V6, P115; Peat TS, 1998, STRUCT FOLD DES, V6, P1207, DOI 10.1016/S0969-2126(98)00120-8; PELTZ SW, 1992, MOL CELL BIOL, V12, P5778, DOI 10.1128/MCB.12.12.5778; Peng WT, 2001, J BACTERIOL, V183, P36, DOI 10.1128/JB.183.1.36-45.2001; Rachfall N, 2013, MOL CELL PROTEOMICS, V12, P87, DOI 10.1074/mcp.M112.017277; Rosorius O, 1999, J CELL SCI, V112, P2369; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Shi XP, 1997, BIOL SIGNAL, V6, P143; Thompson GM, 2003, FEBS LETT, V555, P464, DOI 10.1016/S0014-5793(03)01305-X; Tong YF, 2009, PROTEINS, V75, P1040, DOI 10.1002/prot.22378; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Valentini SR, 2002, GENETICS, V160, P393; Yao M, 2003, J BIOCHEM, V133, P75, DOI 10.1093/jb/mvg011; Yu L, 2006, MOL BIOL CELL, V17, P4736, DOI 10.1091/mbc.E06-04-0368; Zanelli CF, 2005, GENETICS, V171, P1571, DOI 10.1534/genetics.105.048082; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	52	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60140	10.1371/journal.pone.0060140	http://dx.doi.org/10.1371/journal.pone.0060140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573236	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900050
J	Dhillon, SS; Doro, E; Magyary, I; Egginton, S; Sik, A; Muller, F				Dhillon, Sundeep Singh; Doro, Eva; Magyary, Istvan; Egginton, Stuart; Sik, Attila; Mueller, Ferenc			Optimisation of Embryonic and Larval ECG Measurement in Zebrafish for Quantifying the Effect of QT Prolonging Drugs	PLOS ONE			English	Article							INTERVAL PROLONGATION; HERG CHANNEL; VERAPAMIL; HEART; MODEL; ELECTROCARDIOGRAM; TEMPERATURE; PARAMETERS; CROMAKALIM; ARRHYTHMIA	Effective chemical compound toxicity screening is of paramount importance for safe cardiac drug development. Using mammals in preliminary screening for detection of cardiac dysfunction by electrocardiography (ECG) is costly and requires a large number of animals. Alternatively, zebrafish embryos can be used as the ECG waveform is similar to mammals, a minimal amount of chemical is necessary for drug testing, while embryos are abundant, inexpensive and represent replacement in animal research with reduced bioethical concerns. We demonstrate here the utility of pre-feeding stage zebrafish larvae in detection of cardiac dysfunction by electrocardiography. We have optimised an ECG recording system by addressing key parameters such as the form of immobilization, recording temperature, electrode positioning and developmental age. Furthermore, analysis of 3 days post fertilization (dpf) zebrafish embryos treated with known QT prolonging drugs such as terfenadine, verapamil and haloperidol led to reproducible detection of QT prolongation as previously shown for adult zebrafish. In addition, calculation of Z-factor scores revealed that the assay was sensitive and specific enough to detect large drug-induced changes in QTc intervals. Thus, the ECG recording system is a useful drug-screening tool to detect alteration to cardiac cycle components and secondary effects such as heart block and arrhythmias in zebrafish larvae before free feeding stage, and thus provides a suitable replacement for mammalian experimentation.	[Dhillon, Sundeep Singh; Doro, Eva; Egginton, Stuart; Sik, Attila; Mueller, Ferenc] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Dhillon, Sundeep Singh; Magyary, Istvan] Univ Kaposvar, Dept Nat Protect, Kaposvar, Hungary; [Egginton, Stuart] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England	University of Birmingham; Kaposvar University; University of Leeds	Sik, A (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England.	a.sik@bham.ac.uk; f.mueller@bham.ac.uk	Magyary, Istvan/AAB-2343-2019; Muller, Ferenc/C-6426-2009	Egginton, Stuart/0000-0002-3084-9692; mueller, ferenc/0000-0002-0996-774X	British Heart Foundation; British Heart Foundation [NH/12/3/29636] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This study was funded by the Marie Curie ITN programme "BOLD"; ZF Health Integrated project of EC Framework 7 programme; STSM programme of EuFishBioMed COST action grant from the British Heart Foundation to AS, FM and SE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130; Buss RR, 2003, J NEUROPHYSIOL, V89, P657, DOI 10.1152/jn.00324.2002; Chablais F, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-21; Cheng Hsien C., 2006, Journal of Pharmacological and Toxicological Methods, V54, P278, DOI 10.1016/j.vascn.2006.01.002; COLQUHOUN D, 1979, J PHYSIOL-LONDON, V293, P247, DOI 10.1113/jphysiol.1979.sp012888; Crumb W, 1999, PHARM SCI TECHNOL TO, V2, P270, DOI 10.1016/S1461-5347(99)00172-8; Diekmann H, DRUG DISCOVERY TODAY; Duan JJ, 2007, ACTA PHARMACOL SIN, V28, P959, DOI 10.1111/j.1745-7254.2007.00562.x; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; Forouhar AS, 2004, P ANN INT IEEE EMBS, V26, P3615; Gerace E, 2012, FORENSIC SCI INT, V215, P121, DOI 10.1016/j.forsciint.2011.01.038; Goldsmith P, 2004, CURR OPIN PHARMACOL, V4, P504, DOI 10.1016/j.coph.2004.04.005; Hassel D, 2008, CIRCULATION, V117, P866, DOI 10.1161/CIRCULATIONAHA.107.752220; Haverkamp W, 2000, CARDIOVASC RES, V47, P219, DOI 10.1016/S0008-6363(00)00119-X; Hecker L, 2008, ZEBRAFISH, V5, P319, DOI 10.1089/zeb.2008.0550; Jou CJ, 2010, CELL PHYSIOL BIOCHEM, V25, P419, DOI 10.1159/000303046; Katchman AN, 2006, J PHARMACOL EXP THER, V316, P1098, DOI 10.1124/jpet.105.093393; Kojouri GA, 2007, J EQUINE VET SCI, V27, P499, DOI 10.1016/j.jevs.2007.10.007; Langheinrich U, 2003, TOXICOL APPL PHARM, V193, P370, DOI 10.1016/j.taap.2003.07.012; Langheinrich U, 2003, BIOESSAYS, V25, P904, DOI 10.1002/bies.10326; Leong IUS, 2010, ACTA PHYSIOL, V199, P257, DOI 10.1111/j.1748-1716.2010.02111.x; Letamendia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036690; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; MacRae CA, 2010, EXPERT OPIN DRUG DIS, V5, P619, DOI 10.1517/17460441.2010.492826; Maricondi-Massari M, 1998, J THERM BIOL, V23, P283, DOI 10.1016/S0306-4565(98)00019-9; Martin RL, 2004, J CARDIOVASC PHARM, V43, P369, DOI 10.1097/00005344-200403000-00007; Milan DJ, 2006, AM J PHYSIOL-HEART C, V291, pH269, DOI 10.1152/ajpheart.00960.2005; Milan DJ, 2009, CIRCULATION, V120, P553, DOI 10.1161/CIRCULATIONAHA.108.821082; Mittelstadt S. W., 2008, Journal of Pharmacological and Toxicological Methods, V57, P100, DOI 10.1016/j.vascn.2007.10.004; Recanatini M, 2005, MED RES REV, V25, P133, DOI 10.1002/med.20019; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Reyes BA, 2008, J BIOL RHYTHM, V23, P95, DOI 10.1177/0748730407311855; RIPOLL C, 1990, J PHARMACOL EXP THER, V255, P429; Rombough PJ, 2007, COMP BIOCHEM PHYS A, V148, P463, DOI 10.1016/j.cbpa.2007.06.415; Rottbauer W, 2001, DEV CELL, V1, P265, DOI 10.1016/S1534-5807(01)00023-5; Sabeh MK, 2012, PEDIATR CARDIOL, V33, P916, DOI 10.1007/s00246-012-0300-1; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; SOMOGYI A, 1981, BRIT J CLIN PHARMACO, V12, P51, DOI 10.1111/j.1365-2125.1981.tb01854.x; SPINELLI W, 1990, EUR J PHARMACOL, V179, P243, DOI 10.1016/0014-2999(90)90162-Y; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749; Sun P, 2009, ANN BIOMED ENG, V37, P890, DOI 10.1007/s10439-009-9668-3; Tessadori F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047644; Testai L, 2010, J PHARM PHARMACOL, V62, P924, DOI [10.1211/jpp.62.07.0014, 10.1211/jpp.62.06.0014]; Towart Rob, 2009, Journal of Pharmacological and Toxicological Methods, V60, P1, DOI 10.1016/j.vascn.2009.04.197; Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126; Tsai CT, 2011, CLIN CHIM ACTA, V412, P1963, DOI 10.1016/j.cca.2011.07.002; Tsutsui H, 2010, J PHYSIOL-LONDON, V588, P2017, DOI 10.1113/jphysiol.2010.189126; Waldegger S, 1999, CELL PHYSIOL BIOCHEM, V9, P81, DOI 10.1159/000016304; Warren KS, 1998, AM J PHYSIOL-HEART C, V275, pH1, DOI 10.1152/ajpheart.1998.275.1.H1; Warren KS, 2000, PHILOS T R SOC B, V355, P939, DOI 10.1098/rstb.2000.0629; Yoshida M, 2009, ZOOL SCI, V26, P356, DOI 10.2108/zsj.26.356; Yu F, 2012, BIOMED MICRODEVICES, V14, P357, DOI 10.1007/s10544-011-9612-9; Yu F, 2010, ZEBRAFISH, V7, P325, DOI 10.1089/zeb.2010.0658; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	56	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60552	10.1371/journal.pone.0060552	http://dx.doi.org/10.1371/journal.pone.0060552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23579446	Green Published, gold, Green Accepted			2022-12-27	WOS:000317898000038
J	Holm, R; Forsund, M; Nguyen, MT; Nesland, JM; Trope, CG				Holm, Ruth; Forsund, Mette; Nguyen, Mai T.; Nesland, Jahn M.; Trope, Claes G.			Expression of p15(INK4b) and p57(KIP2) and Relationship with Clinicopathological Features and Prognosis in Patients with Vulvar Squamous Cell Carcinoma	PLOS ONE			English	Article							EPITHELIAL OVARIAN-TUMORS; HEPATOCELLULAR-CARCINOMA; P57/KIP2 PROTEIN; BREAST-CANCER; LUNG-CANCER; CYCLIN-E; METHYLATION; P16(INK4A); TISSUES; GENES	Background: The cyclin-dependent kinase inhibitors p15(INK4b) and p57(KIP2) are important regulators of the cell cycle, and their abnormal expression has been detected in various tumors. However, little is known about the role of p15(INK4b) and p57(KIP2) in the pathogenesis of vulvar carcinoma, and the prognostic impact is still unknown. In our current study, we examined the expression of p15(INK4b) and p57(KIP2) in a large series of vulvar squamous cell carcinomas to elucidate the prognostic impact. Methods: Expression of p15(INK4b) and p57(KIP2) were examined in 297 vulvar squamous cell carcinomas using immunohistochemistry. Both uni- and multivariate analysis of prognostic factors were performed, and correlations with clinicopathologic parameters were examined. Results: Compared to the high levels of p15(INK4b) and p57(KIP2) in normal vulvar squamous epithelium, low levels of p15(INK4b) and p57(KIP2) were found in 82% and 44% of vulvar carcinomas, respectively. Low levels of p15(INK4b) and p57(KIP2) correlated significantly with malignant features, including large tumor diameter (p = 0.03 and p = 0.001, respectively) and increased invasiveness (p = 0.003 and p = 0.04, respectively). Although p15(INK4b) and p57(KIP2) levels could not be identified as prognostic markers, combined analysis of p14(ARF)/p15(INK4b)/p16(INK4a) showed that patients whose tumors expressed low levels of two or three of these INK4 proteins had a worse prognosis than those with only low levels of one or no protein (univariate analysis p = 0.02). The independent prognostic significance of these INK4 proteins was confirmed by multivariate analysis (p = 0.008). Conclusions: We show for the first time that p15(INK4b) and p57(KIP2) may be involved in the progression of vulvar carcinomas and the combined p14(ARF)/p15(INK4b)/p16(INK4a) status was a statistically independent prognostic factor.	[Holm, Ruth; Forsund, Mette; Nguyen, Mai T.; Nesland, Jahn M.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Nesland, Jahn M.; Trope, Claes G.] Univ Oslo, Oslo, Norway; [Trope, Claes G.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Obstet & Gynecol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Holm, R (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway.	ruth.holm@oslo-universitetssykehus.no			Norwegian Cancer Society	Norwegian Cancer Society(Norwegian Cancer Society)	This project was supported by grants from The Norwegian Cancer Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozidogan O, 2008, TUMORI J, V94, P556; Chang HSW, 2004, CANCER-AM CANCER SOC, V101, P125, DOI 10.1002/cncr.20323; Coulter J, 2003, BEST PRACT RES CL OB, V17, P663, DOI 10.1016/S1521-6934(03)00050-6; Drexler HG, 1998, LEUKEMIA, V12, P845, DOI 10.1038/sj.leu.2401043; Endo M, 2011, CLIN CANCER RES, V17, P3771, DOI 10.1158/1078-0432.CCR-10-2393; Fan GK, 2006, ORAL ONCOL, V42, P147, DOI 10.1016/j.oraloncology.2005.06.017; Fan GK, 2006, ACTA OTO-LARYNGOL, V126, P301, DOI 10.1080/00016480500388851; GILES GG, 1995, AUST NZ J OBSTET GYN, V35, P71, DOI 10.1111/j.1479-828X.1995.tb01835.x; Hearle N, 2003, INVEST OPHTH VIS SCI, V44, P458, DOI 10.1167/iovs.02-0026; Ito Y, 2001, ONCOLOGY-BASEL, V61, P221, DOI 10.1159/000055378; Ito Y, 2001, PANCREAS, V23, P246, DOI 10.1097/00006676-200110000-00004; Jones RW, 1997, OBSTET GYNECOL, V90, P448, DOI 10.1016/S0029-7844(97)00298-6; Kim JW, 1998, GYNECOL ONCOL, V70, P75, DOI 10.1006/gyno.1998.5041; Kleihues P SL, 2003, WHO TUMOURS, V2003, P316; Knopp S, 2005, GYNECOL ONCOL, V97, P733, DOI 10.1016/j.ygyno.2005.03.025; Knopp S, 2004, GYNECOL ONCOL, V95, P37, DOI 10.1016/j.ygyno.2004.07.026; Knopp S, 2006, AM J CLIN PATHOL, V126, P266, DOI 10.1309/E9E8Y9WG5QE3LK29; Kudoh K, 2002, INT J CANCER, V99, P579, DOI 10.1002/ijc.10331; Larson PS, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-68; Li JQ, 2003, INT J ONCOL, V23, P1537; Liu ZS, 2005, CLIN CANCER RES, V11, P4968, DOI 10.1158/1078-0432.CCR-04-2293; Matsumoto M, 2000, ANTICANCER RES, V20, P1947; MESSING MJ, 1995, OBSTET GYNECOL, V86, P51, DOI 10.1016/0029-7844(95)00101-V; Nan KJ, 2005, WORLD J GASTROENTERO, V11, P1237, DOI 10.3748/wjg.v11.i8.1237; OKAMOTO A, 1995, CANCER RES, V55, P1448; Pateras IS, 2006, INT J CANCER, V119, P2546, DOI 10.1002/ijc.22214; Pateras IS, 2009, MOL CANCER RES, V7, P1902, DOI 10.1158/1541-7786.MCR-09-0317; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Rosenberg E, 2001, HUM PATHOL, V32, P808, DOI 10.1053/hupa.2001.26462; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sui L, 2002, ANTICANCER RES, V22, P3191; Tsihlias J, 1999, ANNU REV MED, V50, P401; Wong YF, 1997, GYNECOL ONCOL, V65, P319, DOI 10.1006/gyno.1997.4669; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4; Yang XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005011	35	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61273	10.1371/journal.pone.0061273	http://dx.doi.org/10.1371/journal.pone.0061273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580324	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000118
J	Singh, T; Katiyar, SK				Singh, Tripti; Katiyar, Santosh K.			Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE(2)-Mediated Activation of beta-Catenin Signaling	PLOS ONE			English	Article							NATURAL-PRODUCT; NITRIC-OXIDE; COX-2 EXPRESSION; CYCLE ARREST; APOPTOSIS; CYCLOOXYGENASE-2; GROWTH; PHOTOCARCINOGENESIS	Lung cancer remains a leading cause of death due to its metastasis to distant organs. We have examined the effect of honokiol, a bioactive constituent from the Magnolia plant, on human non-small cell lung cancer (NSCLC) cell migration and the molecular mechanisms underlying this effect. Using an in vitro cell migration assay, we found that treatment of A549, H1299, H460 and H226 NSCLC cells with honokiol resulted in inhibition of migration of these cells in a dose-dependent manner, which was associated with a reduction in the levels of cyclooxygenase-2 (COX-2) and prostaglandin E-2 (PGE(2)). Celecoxib, a COX-2 inhibitor, also inhibited cell migration. Honokiol inhibited PGE(2)-enhanced migration of NSCLC cells, inhibited the activation of NF-kappa B/p65, an upstream regulator of COX-2, in A549 and H1299 cells, and treatment of cells with caffeic acid phenethyl ester, an inhibitor of NF-kappa B, also inhibited migration of NSCLC cells. PGE(2) has been shown to activate beta-catenin signaling, which contributes to cancer cell migration. Therefore, we checked the effect of honokiol on beta-catenin signaling. It was observed that treatment of NSCLC cells with honokiol degraded cytosolic beta-catenin, reduced nuclear accumulation of beta-catenin and down-regulated matrix metalloproteinase (MMP)-2 and MMP-9, which are the down-stream targets of beta-catenin and play a crucial role in cancer cell metastasis. Honokiol enhanced: (i) the levels of casein kinase-1 alpha, glycogen synthase kinase-3 beta, and (ii) phosphorylation of beta-catenin on critical residues Ser(45), Ser(33/37) and Thr(41). These events play important roles in degradation or inactivation of beta-catenin. Treatment of celecoxib also reduced nuclear accumulation of beta-catenin in NSCLC cells. FH535, an inhibitor of Wnt/beta-catenin pathway, inhibited PGE(2)-enhanced cell migration of A549 and H1299 cells. These results indicate that honokiol inhibits non-small cell lung cancer cells migration by targeting PGE(2)-mediated activation of delta-catenin signaling.	[Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Singh, Tripti; Katiyar, Santosh K.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Katiyar, SK (corresponding author), Birmingham Vet Affairs Med Ctr, Birmingham, AL USA.	skatiyar@uab.edu			Veterans Administration [1I01BX001410-01]	Veterans Administration(US Department of Veterans Affairs)	This research was financially supported by the Veterans Administration Merit Review Award (1I01BX001410-01, S.K.K.). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2009, CANC FACTS FIG 2009; Arora S, 2012, CURR MOL MED, V12, P1244, DOI 10.2174/156652412803833508; Bai XH, 2003, J BIOL CHEM, V278, P35501, DOI 10.1074/jbc.M302967200; Barth AI, 1997, CURR OPIN CELL BIOL, V9, P683, DOI 10.1016/S0955-0674(97)80122-6; Battle TE, 2005, BLOOD, V106, P690, DOI 10.1182/blood-2004-11-4273; Brabletz T, 2000, GESELLSCHAFT PATHOLO, V84, P175; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen F, 2004, WORLD J GASTROENTERO, V10, P3459; Hahm ER, 2008, CLIN CANCER RES, V14, P1248, DOI 10.1158/1078-0432.CCR-07-1926; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hida T, 1998, CANCER RES, V58, P3761; Hida T, 2000, CLIN CANCER RES, V6, P2006; Hlubek F, 2004, INT J CANCER, V108, P321, DOI 10.1002/ijc.11522; Ho MY, 2012, CANC RES; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Hosomi Y, 2000, LUNG CANCER, V30, P73, DOI 10.1016/S0169-5002(00)00132-X; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim J. I., 2010, MOL CANCER RES, V8, P569, DOI DOI 10.1158/1541-7786.MCR-09-0511.PUBMED:20353998; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Li TSC, 2002, CHINESE RELATED N AM; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Maziak DE, 2004, ANN THORAC SURG, V77, P1484, DOI 10.1016/j.athoracsur.2003.07.017; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mukhtar H, 1996, PHOTOCHEM PHOTOBIOL, V63, P355, DOI 10.1111/j.1751-1097.1996.tb03040.x; Park EJ, 2009, CANCER LETT, V277, P133, DOI 10.1016/j.canlet.2008.11.029; Ponnurangam S, 2012, MOL CANCER THER, V11, P963, DOI 10.1158/1535-7163.MCT-11-0999; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Punathil T, 2008, BIOCHEM BIOPH RES CO, V375, P162, DOI 10.1016/j.bbrc.2008.07.157; Punathil T, 2009, MOL CARCINOGEN, V48, P232, DOI 10.1002/mc.20473; Singh T, 2011, CARCINOGENESIS; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027444; Singh T, 2011, INT J ONCOL, V38, P769, DOI 10.3892/ijo.2011.899; Smith KA, 2012, MOL CARCINOGEN, V51, P734, DOI 10.1002/mc.20840; Tuynman JB, 2008, CANCER RES, V68, P1213, DOI 10.1158/0008-5472.CAN-07-5172; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023000; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021539; Vaid M, 2010, CARCINOGENESIS, V31, P2004, DOI 10.1093/carcin/bgq186; Wolff H, 1998, CANCER RES, V58, P4997	40	72	78	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60749	10.1371/journal.pone.0060749	http://dx.doi.org/10.1371/journal.pone.0060749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580348	Green Submitted, gold, Green Published			2022-12-27	WOS:000317898000059
J	Suchankova, P; Jerlhag, E; Jayaram-Lindstrom, N; Nilsson, S; Toren, K; Rosengren, A; Engel, JA; Franck, J				Suchankova, Petra; Jerlhag, Elisabet; Jayaram-Lindstrom, Nitya; Nilsson, Staffan; Toren, Kjell; Rosengren, Annika; Engel, Jorgen A.; Franck, Johan			Genetic Variation of the Ghrelin Signalling System in Individuals with Amphetamine Dependence	PLOS ONE			English	Article							STIMULATES LOCOMOTOR-ACTIVITY; CONDITIONED PLACE PREFERENCE; ALCOHOL DEPENDENCE; NUCLEUS-ACCUMBENS; SUBSTANCE USE; RISK-FACTORS; DOPAMINE; FOOD; RECEPTOR; REWARD	The development of amphetamine dependence largely depends on the effects of amphetamine in the brain reward systems. Ghrelin, an orexigenic peptide, activates the reward systems and is required for reward induced by alcohol, nicotine, cocaine and amphetamine in mice. Human genetic studies have shown that polymorphisms in the pre-proghrelin (GHRL) as well as GHS-R1A (GHSR) genes are associated with high alcohol consumption, increased weight and smoking in males. Since the heritability factor underlying drug dependence is shared between different drugs of abuse, we here examine the association between single nucleotide polymorphisms (SNPs) and haplotypes in the GHRL and GHSR, and amphetamine dependence. GHRL and GHSR SNPs were genotyped in Swedish amphetamine dependent individuals (n = 104) and controls from the general population (n = 310). A case-control analysis was performed and SNPs and haplotypes were additionally tested for association against Addiction Severity Interview (ASI) composite score of drug use. The minor G-allele of the GHSR SNP rs2948694, was more common among amphetamine dependent individuals when compared to controls (p(c) = 0.02). A significant association between the GHRL SNP rs4684677 and ASI composite score of drug use was also reported (p(c) = 0.03). The haplotype analysis did not add to the information given by the individual polymorphisms. Although genetic variability of the ghrelin signalling system is not a diagnostic marker for amphetamine dependence and problem severity of drug use, the present results strengthen the notion that ghrelin and its receptor may be involved in the development of addictive behaviours and may thus serve as suitable targets for new treatments of such disorders.	[Suchankova, Petra; Jerlhag, Elisabet; Engel, Jorgen A.] Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Gothenburg, Sweden; [Jayaram-Lindstrom, Nitya; Franck, Johan] Karolinska Inst, Dept Clin Neurosci, Div Psychiat, Stockholm, Sweden; [Nilsson, Staffan] Chalmers, Dept Math Stat, Inst Math Sci, S-41296 Gothenburg, Sweden; [Toren, Kjell] Univ Gothenburg, Dept Occupat & Environm Med, Sahlgrenska Acad, Gothenburg, Sweden; [Rosengren, Annika] Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; Karolinska Institutet; Chalmers University of Technology; University of Gothenburg; University of Gothenburg	Jerlhag, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Gothenburg, Sweden.	elisabet.jerlhag@pharm.gu.se	Jayaram-Lindström, Nitya/AAQ-4268-2021	Jayaram-Lindström, Nitya/0000-0002-2678-3782; Rosengren, Annika/0000-0002-5409-6605; Nilsson, Staffan/0000-0003-4748-0446	Swedish Research Council [30207123, K2006-21X-04247-33-3, 2009-2782]; Swedish National Drug Policy Coordinator (a government agency); Swedish brain foundation, LUA/ALF [148251]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Drug Policy Coordinator (a government agency); Swedish brain foundation, LUA/ALF	This study was supported by the Swedish Research Council (grant numbers 30207123, K2006-21X-04247-33-3 and 2009-2782), the Swedish National Drug Policy Coordinator (a government agency), and the Stockholm County Council. The Swedish brain foundation, LUA/ALF ( grant no. 148251) from the Sahlgrenska University Hospital, Alcohol research council of the Swedish alcohol retailing monopoly and the foundations of Adlerbertska, Fredrik and Ingrid Thuring, Tore Nilsson, Langmanska, Torsten and Ragnar Soderberg, Wilhelm and Martina Lundgren, Knut and Alice Wallenberg, Magnus Bergvall, Aners, Jeansons, Ake Wiberg, NovoNordisk and the Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; Berg CM, 2008, AM J CLIN NUTR, V88, P289; Berg CM, 2005, EUR J CARDIOV PREV R, V12, P115, DOI 10.1097/00149831-200504000-00005; Bulik CM, 1997, ADDICT BEHAV, V22, P437, DOI 10.1016/S0306-4603(96)00053-6; Cheung WW, 2012, ISRN ENDOCRINOL, V2012, P536905, DOI [DOI 10.5402/2012/536905, 10.5402/2012/536905]; Cummings DE, 2007, ADDICT BIOL, V12, P1, DOI 10.1111/j.1369-1600.2007.00053.x; Davis KW, 2007, REGUL PEPTIDES, V140, P148, DOI 10.1016/j.regpep.2006.12.003; Di Chiara G, 2005, PHYSIOL BEHAV, V86, P9, DOI 10.1016/j.physbeh.2005.06.020; Dickson SL, 2010, NEUROSCIENCE, V171, P1180, DOI 10.1016/j.neuroscience.2010.10.005; Dickson SL, 2011, MOL CELL ENDOCRINOL, V340, P80, DOI 10.1016/j.mce.2011.02.017; Disse E, 2010, PHYSIOL BEHAV, V101, P277, DOI 10.1016/j.physbeh.2010.05.017; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; ENGEL JA, 1988, J NEURAL TRANSM, V74, P181, DOI 10.1007/BF01244784; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Finger BC, 2011, PSYCHOPHARMACOLOGY, V216, P421, DOI 10.1007/s00213-011-2234-3; Haile CN, 2009, PHARMACOGENOMICS, V10, P1883, DOI [10.2217/pgs.09.146, 10.2217/PGS.09.146]; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2011, DRUG ALCOHOL DEPEN, V117, P126, DOI 10.1016/j.drugalcdep.2011.01.010; Jerlhag E, 2011, ALCOHOL, V45, P341, DOI 10.1016/j.alcohol.2010.10.002; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Kaur S, 2010, ALCOHOL CLIN EXP RES, V34, P1525, DOI 10.1111/j.1530-0277.2010.01237.x; Kendler KS, 2006, PSYCHOL MED, V36, P955, DOI 10.1017/S0033291706007720; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Kim DJ, 2005, ALCOHOL ALCOHOLISM, V40, P76, DOI 10.1093/alcalc/agh108; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Landgren S, 2008, ALCOHOL CLIN EXP RES, V32, P2054, DOI 10.1111/j.1530-0277.2008.00793.x; Landgren S, 2011, NEUROPSYCHOBIOLOGY, V64, P38, DOI 10.1159/000324992; Landgren S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018170; Landgren S, 2011, BEHAV BRAIN RES, V221, P182, DOI 10.1016/j.bbr.2011.03.003; Landgren S, 2012, ADDICT BIOL, V17, P86, DOI 10.1111/j.1369-1600.2010.00280.x; Landgren S, 2010, ALCOHOL CLIN EXP RES, V34, P1519, DOI 10.1111/j.1530-0277.2010.01236.x; Leggio L, 2012, ADDICT BIOL, V17, P452, DOI 10.1111/j.1369-1600.2010.00308.x; Leggio L, 2010, DRUG NEWS PERSPECT, V23, P157, DOI 10.1358/dnp.2010.23.3.1429490; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Quarta D, 2009, NEUROCHEM INT, V54, P89, DOI 10.1016/j.neuint.2008.12.006; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; Skibicka KP, 2011, PEPTIDES, V32, P2265, DOI 10.1016/j.peptides.2011.05.016; Tessari M, 2007, ADDICT BIOL, V12, P22, DOI 10.1111/j.1369-1600.2007.00052.x; Thiele TE, 2003, NEUROPEPTIDES, V37, P321, DOI 10.1016/j.npep.2003.10.002; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Volkow ND, 2002, BEHAV PHARMACOL, V13, P355, DOI 10.1097/00008877-200209000-00008; Wellman PJ, 2005, REGUL PEPTIDES, V125, P151, DOI 10.1016/j.regpep.2004.08.013	56	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61242	10.1371/journal.pone.0061242	http://dx.doi.org/10.1371/journal.pone.0061242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23579732	gold, Green Submitted, Green Published			2022-12-27	WOS:000317898000117
J	Peng, QL; Zhao, LY; Hou, YX; Sun, Y; Wang, LY; Luo, HJ; Peng, HM; Liu, MR				Peng, Qiongle; Zhao, Liuyang; Hou, Yixuan; Sun, Yan; Wang, Liyang; Luo, Haojun; Peng, Huimin; Liu, Manran			Biological Characteristics and Genetic Heterogeneity between Carcinoma-Associated Fibroblasts and Their Paired Normal Fibroblasts in Human Breast Cancer	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; STROMAL FIBROBLASTS; OXIDATIVE STRESS; CELL CARCINOMA; GROWTH-FACTOR; EXPRESSION; MYOFIBROBLASTS; METASTASIS; SIGNATURES; PROTEIN	Background: The extensional signals in cross-talk between stromal cells and tumor cells generated from extracellular matrix molecules, soluble factor, and cell-cell adhesion complexes cooperate at the extra- and intracellular level in the tumor microenvironment. CAFs are the primary type of stromal cells in the tumor microenvironment and play a pivotal role in tumorigenesis and development. Hitherto, there is hardly any systematic analysis of the intrinsic relationship between CAFs function and its abnormal signaling pathway. The extreme complexity of CAFs' features and their role in tumor development are needed to be further investigated. Methodology/Principal Findings: We primary cultured CAFs and NFs from early stages of breast cancer tissue and identified them using their biomarker by immunohistochemistry for Fibronectin, alpha-SMA and FAP. Microarray was applied to analyze gene expression profiles of human breast CAFs and the paired NFs. The Up-regulated genes classified by Gene Ontology, signal pathways enriched by DAVID pathway analysis. Abnormal signaling pathways in breast cancer CAFs are involved in cell cycle, cell adhesion, signal transduction and protein transport being reported in CAFs derived from other tumors. Significantly, the altered ATM signaling pathway, a set of cell cycle regulated signaling, and immune associated signaling are identified to be changed in CAFs. Conclusions/Significance: CAFs have the vigorous ability of proliferation and potential of invasion and migration comparing with NFs. CAFs could promote breast cancer cell invasion under co-culture conditions through up-regulated CCL18 and CXCL12. Consistently with its biologic behavior, the gene expression profiling analyzed by microarray shows that some of key signaling pathways, such as cell cycle, cell adhesion, and secreting factors play an important role in CAFs. The altered ATM signaling pathway is abnormally active in the early stage of breast cancer. The set of immune associated signaling may be involved in tumor cell immune evasion.	[Peng, Qiongle; Zhao, Liuyang; Sun, Yan; Wang, Liyang; Liu, Manran] Chongqing Med Univ, Chinese Minist Educ, Key Lab Lab Med Diagnost, Chongqing, Peoples R China; [Peng, Qiongle; Zhao, Liuyang; Sun, Yan; Wang, Liyang; Liu, Manran] Chongqing Med Univ, Chongqing Key Lab, Lab Med Diagnost, Chongqing, Peoples R China; [Peng, Qiongle; Zhao, Liuyang; Wang, Liyang; Peng, Huimin] Chongqing Med Univ, Dept Cell Biol & Genet, Sch Basic Med Sci, Chongqing, Peoples R China; [Hou, Yixuan; Peng, Huimin] Chongqing Med Univ, Expt Teaching Ctr, Chongqing, Peoples R China; [Luo, Haojun] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Liu, MR (corresponding author), Chongqing Med Univ, Chinese Minist Educ, Key Lab Lab Med Diagnost, Chongqing, Peoples R China.	mliu-hncq@hotmail.com		Peng, Qiongle/0000-0001-9035-3093	National Natural Science Foundation of China [NSFC 30940096, NSFC 81072147]; Natural Science Foundation of Chongqing Science and Technology Commission, China [CSTC2010BB5099]; Chinese Ministry of Education [20105503110001]; Major Program Foundation of Chongqing Medical University [XBZD201006]; Scientific Research Foundation for the excellent oversea comeback scholar; Chongqing Medical University [0200101189]; Outstanding Doctoral Fund; Department of Laboratory Medicine [070025000204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing Science and Technology Commission, China(Natural Science Foundation of Chongqing); Chinese Ministry of Education(Ministry of Education, China); Major Program Foundation of Chongqing Medical University; Scientific Research Foundation for the excellent oversea comeback scholar; Chongqing Medical University; Outstanding Doctoral Fund; Department of Laboratory Medicine	This research was supported in part by the National Natural Science Foundation of China (NSFC 30940096 and NSFC 81072147), the Natural Science Foundation of Chongqing Science and Technology Commission, China (CSTC2010BB5099), the Doctoral Fund of Chinese Ministry of Education (20105503110001), the Major Program Foundation of Chongqing Medical University (XBZD201006), the Scientific Research Foundation for the excellent oversea comeback scholar supported by Chongqing Medical University (0200101189), and The Outstanding Doctoral Fund supported by Department of Laboratory Medicine(070025000204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; Bauer M, 2010, ONCOGENE, V29, P1732, DOI 10.1038/onc.2009.463; Bertos NR, 2011, J CLIN INVEST, V121, P3789, DOI 10.1172/JCI57100; Bogdanov K.V., 2008, CELL TISSUE BIOL, V2, P354, DOI [10.1134/S1990519X08040020, DOI 10.1134/S1990519X08040020]; Casbas-Hernandez P, 2011, J BIOMEDICINE BIOTEC, V2011; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Cirri P, 2011, AM J CANCER RES, V1, P482; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fuyuhiro Y, 2012, CANCER SCI, V103, P797, DOI 10.1111/j.1349-7006.2012.02209.x; Gangemi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029989; Giannoni E, 2011, ANTIOXID REDOX SIGN, V14, P2361, DOI 10.1089/ars.2010.3727; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Haubeiss S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-168; Huang C, 2012, CANCER RES, V72, P655, DOI 10.1158/0008-5472.CAN-11-3102; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacob T, 2012, VASC ENDOVASC SURG, V46, P45, DOI 10.1177/1538574411422277; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Koyama H, 2008, AM J PATHOL, V172, P179, DOI 10.2353/ajpath.2008.070360; Li XY, 2011, PANCREAS, V40, P753, DOI 10.1097/MPA.0b013e318213d51b; Lin JW, 2011, TUMOR BIOL, V32, P597, DOI 10.1007/s13277-011-0158-5; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Lok GTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023790; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Micke P, 2005, EXPERT OPIN THER TAR, V9, P1217, DOI 10.1517/14728222.9.6.1217; Micke P, 2007, J INVEST DERMATOL, V127, P1516, DOI 10.1038/sj.jid.5700714; Mora-Santos M, 2011, J BIOL CHEM, V286, P30047, DOI 10.1074/jbc.M111.232330; Moreno-Mateos MA, 2011, MOL BIOL CELL, V22, P4302, DOI 10.1091/mbc.E10-10-0838; Nakagawa H, 2004, ONCOGENE, V23, P7366, DOI 10.1038/sj.onc.1208013; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Sakuishi K, 2011, TRENDS IMMUNOLOGY; Sarkar D, 2008, CANCER RES, V68, P3087, DOI 10.1158/0008-5472.CAN-07-6210; Singer CF, 2008, BREAST CANCER RES TR, V110, P273, DOI 10.1007/s10549-007-9725-2; Toullec A, 2010, EMBO MOL MED, V2, P211, DOI 10.1002/emmm.201000073; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; [王大飞 Wang Dafei], 2012, [西南师范大学学报. 自然科学版, Journal of Southwest China Normal University. Natural Science Edition], V37, P1; Willems L, 2012, CURRENT ONCOLOGY REP, P1; Wu Z., 2004, STOCHASTIC MODELS IN, P98; Xu R, 2011, INTEGR BIOL-UK, V3, P368, DOI 10.1039/c0ib00087f; Yang WS, 2012, J PROTEOME RES; Ng YZ, 2012, CANCER RES, V72, P3522, DOI 10.1158/0008-5472.CAN-11-2996; Zhang CY, 2009, CLIN CANCER RES, V15, P4017, DOI 10.1158/1078-0432.CCR-08-2824	48	68	76	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60321	10.1371/journal.pone.0060321	http://dx.doi.org/10.1371/journal.pone.0060321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577100	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800042
J	Sakaki, H; Tsukimoto, M; Harada, H; Moriyama, Y; Kojima, S				Sakaki, Hayato; Tsukimoto, Mitsutoshi; Harada, Hitoshi; Moriyama, Yoshinori; Kojima, Shuji			Autocrine Regulation of Macrophage Activation via Exocytosis of ATP and Activation of P2Y11 Receptor	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; T-CELL-ACTIVATION; ALTERNATIVE ACTIVATION; IL-1-BETA RELEASE; UNITED-STATES; IDENTIFICATION; MECHANISM; MONOCYTES; SEPSIS; PATHOPHYSIOLOGY	It is important to understand the mechanisms that regulate macrophage activation to establish novel therapies for inflammatory diseases, such as sepsis; a systemic inflammatory response syndrome generally caused by bacterial lipopolysaccharide (LPS). In this study, we investigated the involvement of extracellular ATP-mediated autocrine signaling in LPS-induced macrophage activation. We show here that ATP release via exocytosis, followed by activation of P2Y11 receptor, is a major pathway of the macrophage activation, leading to release of cytokines. Treatment of human monocyte THP-1 cells with LPS induced rapid ATP release from cells, and this release was blocked by knockdown of SLC17A9 (vesicular nucleotide transporter, VNUT), which is responsible for exocytosis of ATP. ATP-enriched vesicles were found in cytosol of THP-1 cells. These data suggest the involvement of vesicular exocytosis in the release of ATP. Knockdown of SLC17A9, the P2Y11 antagonist NF157 or knockdown of P2Y11 receptor significantly suppressed both M1-type polarization and IL-6 production in THP-1 cells, indicating an important role of activation of P2Y11 receptor by released ATP in macrophage activation. Next, the effect of NF157 on LPS-induced immune activation was examined in vivo. Administration of LPS to mice caused increase of serum IL-1 beta, IL-6, IL-12 and TNF-alpha levels at 3-24 h after the administration. Pre-treatment of LPS-treated mice with NF157 suppressed both elevation of proinflammatory cytokines in serum and M1 polarization of peritoneal/spleen macrophages. Moreover, post-treatment with NF157 at 30 min after administration of LPS also suppressed the elevation of serum cytokines levels. We conclude that vesicular exocytosis of ATP and autocrine, positive feedback through P2Y11 receptors is required for the effective activation of macrophages. Consequently, P2Y11 receptor antagonists may be drug candidates for treatment of inflammatory diseases such as sepsis.	[Sakaki, Hayato; Tsukimoto, Mitsutoshi; Kojima, Shuji] Tokyo Univ Sci, Dept Radiat Biosci, Fac Pharmaceut Sci, Noda, Chiba 278, Japan; [Harada, Hitoshi] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan; [Moriyama, Yoshinori] Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Tokyo University of Science; Okayama University	Tsukimoto, M (corresponding author), Tokyo Univ Sci, Dept Radiat Biosci, Fac Pharmaceut Sci, Noda, Chiba 278, Japan.	tsukim@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590125]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Parts of this work were supported by a Grant-in-Aid for Scientific Research (C) (No. 24590125) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Balogh J, 2005, J MOL CELL CARDIOL, V39, P223, DOI 10.1016/j.yjmcc.2005.03.007; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Ben Yebdri F, 2009, EUR J IMMUNOL, V39, P2885, DOI 10.1002/eji.200939347; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Burnstock G, 2009, BRAZ J MED BIOL RES, V42, P3, DOI 10.1590/S0100-879X2008005000037; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Glauser MP, 1996, DRUGS, V52, P9, DOI 10.2165/00003495-199600522-00004; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Hara S, 2011, TOXICOLOGY, V288, P49, DOI 10.1016/j.tox.2011.07.001; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Into T, 2002, INFECT IMMUN, V70, P3586, DOI 10.1128/IAI.70.7.3586-3591.2002; Iwatsuki K, 2009, BIOCHEM BIOPH RES CO, V388, P1, DOI 10.1016/j.bbrc.2009.07.069; KILBOURN RG, 1993, NEW ENGL J MED, V329, P1427; Lopez-Bojorquez L, 2004, ARCH MED RES, V35, P465, DOI 10.1016/j.arcmed.2004.07.006; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mehta A, 2004, SHOCK, V22, P423, DOI 10.1097/01.shk.0000142184.49976.0c; Meis S, 2010, J PHARMACOL EXP THER, V332, P238, DOI 10.1124/jpet.109.157750; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Sathe MN, 2011, J BIOL CHEM, V286, P25363, DOI 10.1074/jbc.M111.232868; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Spellberg B, 2001, CLIN INFECT DIS, V32, P76, DOI 10.1086/317537; Sperlagh B, 1998, NEUROCHEM INT, V33, P209, DOI 10.1016/S0197-0186(98)00025-4; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takai E, 2012, J CELL SCI; Talasila A, 2009, BRIT J PHARMACOL, V158, P339, DOI 10.1111/j.1476-5381.2009.00172.x; Tokunaga A, 2010, J BIOL CHEM, V285, P17406, DOI 10.1074/jbc.M110.112417; Tsukimoto M, 2009, BIOCHEM BIOPH RES CO, V384, P512, DOI 10.1016/j.bbrc.2009.05.011; von Kugelgen I, 2011, ADV PHARMACOL, V61, P373, DOI 10.1016/B978-0-12-385526-8.00012-6; Wilkin F, 2001, J IMMUNOL, V166, P7172, DOI 10.4049/jimmunol.166.12.7172; Yu J, 2009, AM J PHYSIOL-GASTR L, V296, pG563, DOI 10.1152/ajpgi.90502.2008; ZHANG XK, 1993, J EXP MED, V177, P511, DOI 10.1084/jem.177.2.511	41	89	91	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59778	10.1371/journal.pone.0059778	http://dx.doi.org/10.1371/journal.pone.0059778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577075	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800019
J	Sanchez-Ripoll, Y; Bone, HK; Owen, T; Guedes, AMV; Abranches, E; Kumpfmueller, B; Spriggs, RV; Henrique, D; Welham, MJ				Sanchez-Ripoll, Yolanda; Bone, Heather K.; Owen, Tom; Guedes, Ana M. V.; Abranches, Elsa; Kumpfmueller, Benjamin; Spriggs, Ruth V.; Henrique, Domingos; Welham, Melanie J.			Glycogen Synthase Kinase-3 Inhibition Enhances Translation of Pluripotency-Associated Transcription Factors to Contribute to Maintenance of Mouse Embryonic Stem Cell Self-Renewal	PLOS ONE			English	Article							ES CELLS; BETA-CATENIN; PREVENT DIFFERENTIATION; SIGNALING PATHWAYS; NANOG; WNT; STAT3; ACTIVATION; EXPRESSION; GENE	Maintenance of embryonic stem cell (ESC) self-renewal and pluripotency are controlled by extrinsic factors, molecular signaling pathways and transcriptional regulators. While many of the key players have been studied in depth, how the molecular signals interact with transcription factors of the pluripotency network to regulate their action remains less well understood. Inhibition of glycogen synthase kinase 3 (Gsk-3) has been implicated in the maintenance of mouse ESC pluripotency, although there is contradictory data on its role, with enhancement of cell survival and metabolism, stabilisation of c-Myc and activation of Wnt signalling proposed as potential mechanisms. We have discovered that suppression of Gsk-3 activity leads to enhanced protein levels of key transcriptional regulators of the pluripotency network, notably Nanog, Tbx3 and c-Myc. Protein stability was unchanged following Gsk-3 inhibition, although interestingly, Nanog and Tbx3 proteins were found to have half-lives of 1-3 h, while that of Oct4 protein was longer, at 6 h. We demonstrate that the effects on protein levels seen following inhibition of Gsk-3 are due to both enhanced de novo synthesis of Nanog protein and increases in the proportion of Nanog and Tbx3 RNAs bound to polysomes, findings consistent with Gsk-3 regulating translation of these factors. These effects were not due to changes in regulators of general translation initiation machinery nor mediated via the 5' or 3' UTR sequences of Nanog alone. The data we present provide both new conceptual insight into the mechanisms regulated by Gsk-3 that may contribute to ESC self-renewal and, importantly, establish control of protein translation as an additional mechanism involved in modulation of ESC pluripotency.	[Sanchez-Ripoll, Yolanda; Bone, Heather K.; Owen, Tom; Kumpfmueller, Benjamin; Welham, Melanie J.] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Sanchez-Ripoll, Yolanda; Bone, Heather K.; Owen, Tom; Kumpfmueller, Benjamin; Welham, Melanie J.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Spriggs, Ruth V.] Univ Leicester, Med Res Ctr, Toxicol Unit, Leicester, Leics, England; [Guedes, Ana M. V.; Abranches, Elsa; Henrique, Domingos] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Guedes, Ana M. V.; Abranches, Elsa; Henrique, Domingos] Univ Lisbon, Fac Med, Inst Histol & Biol Desenvolvimento, P-1699 Lisbon, Portugal	University of Bath; University of Bath; University of Leicester; Universidade de Lisboa; Universidade de Lisboa	Welham, MJ (corresponding author), Biotechnol & Biol Sci Res Council, Polaris House, Swindon, Wilts, England.	M.J.Welham@bath.ac.uk	Henrique, Domingos M/E-5460-2010; Abranches, Elsa/D-4324-2012	Henrique, Domingos M/0000-0001-8869-1894; Abranches, Elsa/0000-0003-4493-6065	MRC; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/78313/2011, SFRH/BD/80191/2011, PTDC/SAUOBD/100664/2008]; Biotechnology and Biological Sciences Research Council [BB/C516528/1] Funding Source: researchfish; Medical Research Council [G0801108] Funding Source: researchfish; MRC [G0801108] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an MRC capacity-building studentship, MRC project grant support, Fundacao para a Ciencia e Tecnologia, Portugal(SFRH/BPD/78313/2011 to EA, SFRH/BD/80191/2011 to AG and PTDC/SAUOBD/100664/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2013, PLOS ONE UNPUB; Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Boeuf H, 2001, J BIOL CHEM, V276, P46204, DOI 10.1074/jbc.M106718200; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Coldwell MJ, 2001, ONCOGENE, V20, P4095, DOI 10.1038/sj.onc.1204547; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Day DA, 1998, J ENDOCRINOL, V157, P361, DOI 10.1677/joe.0.1570361; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; GOSS DJ, 1984, J BIOL CHEM, V259, P7374; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kirby LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039329; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Mathews M.B., 2000, ORIGINS PRINCIPLES T; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Singla DK, 2006, BIOCHEM BIOPH RES CO, V345, P789, DOI 10.1016/j.bbrc.2006.04.125; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; WELHAM MJ, 1994, J BIOL CHEM, V269, P21165; Welsh GI, 1997, ANAL BIOCHEM, V244, P16, DOI 10.1006/abio.1996.9838; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035892; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	59	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60148	10.1371/journal.pone.0060148	http://dx.doi.org/10.1371/journal.pone.0060148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577087	Green Submitted, gold, Green Published			2022-12-27	WOS:000319109800030
J	Tabchy, A; Eltonsy, N; Housman, DE; Mills, GB				Tabchy, Adel; Eltonsy, Nevine; Housman, David E.; Mills, Gordon B.			Systematic Identification of Combinatorial Drivers and Targets in Cancer Cell Lines	PLOS ONE			English	Article							LUNG-CANCER; KINASE INHIBITORS; DRUG-SENSITIVITY; BREAST-CANCER; TUMOR-GROWTH; MUTATION; RESISTANCE; BRAF; RAS; EXPRESSION	There is an urgent need to elicit and validate highly efficacious targets for combinatorial intervention from large scale ongoing molecular characterization efforts of tumors. We established an in silico bioinformatic platform in concert with a high throughput screening platform evaluating 37 novel targeted agents in 669 extensively characterized cancer cell lines reflecting the genomic and tissue-type diversity of human cancers, to systematically identify combinatorial biomarkers of response and co-actionable targets in cancer. Genomic biomarkers discovered in a 141 cell line training set were validated in an independent 359 cell line test set. We identified co-occurring and mutually exclusive genomic events that represent potential drivers and combinatorial targets in cancer. We demonstrate multiple cooperating genomic events that predict sensitivity to drug intervention independent of tumor lineage. The coupling of scalable in silico and biologic high throughput cancer cell line platforms for the identification of co-events in cancer delivers rational combinatorial targets for synthetic lethal approaches with a high potential to pre-empt the emergence of resistance.	[Tabchy, Adel; Eltonsy, Nevine; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Tabchy, Adel; Eltonsy, Nevine; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Kleberg Ctr Mol Markers, Houston, TX 77030 USA; [Tabchy, Adel; Eltonsy, Nevine; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Sheikh Zayed Bin Sultan Al Nahyan Inst Personaliz, Houston, TX 77030 USA; [Housman, David E.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Housman, David E.] MIT, Dept Biol, Cambridge, MA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Tabchy, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	atabchy@gmail.com			National Institutes of Health (NIH) [U54 CA112970]; Komen Promise grant [KG08109903]; Komen Proteomics Discovery grant [FAS0703849]; Entertainment Industry Foundation [SU2C-AACR-DT0209 01]; GSK; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, U54CA112970] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Promise grant(Susan G. Komen Breast Cancer Foundation); Komen Proteomics Discovery grant; Entertainment Industry Foundation; GSK(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) U54 CA112970 to GBM (http://www.nih.gov/), a Komen Promise grant (KG08109903) to GBM and Komen Proteomics Discovery grant (FAS0703849) to AT and GBM (http://ww5.komen.org/), a Program of the Entertainment Industry Foundation SU2C-AACR-DT0209 01 grant to GBM (http://www.standup2cancer.org/), and support from GSK to GBM (http://www.gsk.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gerber DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/j.ccr.2010.11.033; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kim N, 2012, INT J CANCER, V000, P1; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Migliardi G, 2012, CLIN CANCER RES, V18, P2515, DOI 10.1158/1078-0432.CCR-11-2683; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60339	10.1371/journal.pone.0060339	http://dx.doi.org/10.1371/journal.pone.0060339			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577104	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800045
J	Vokurkova, J; Petruskova, T; Reifova, R; Kozman, A; Morkovsky, L; Kipper, S; Weiss, M; Reif, J; Dolata, PT; Petrusek, A				Vokurkova, Jana; Petruskova, Tereza; Reifova, Radka; Kozman, Alexandra; Morkovsky, Libor; Kipper, Silke; Weiss, Michael; Reif, Jiri; Dolata, Pawel T.; Petrusek, Adam			The Causes and Evolutionary Consequences of Mixed Singing in Two Hybridizing Songbird Species (Luscinia spp.)	PLOS ONE			English	Article							ECOLOGICAL CHARACTER DISPLACEMENT; COLLARED FLYCATCHERS; HABITAT SELECTION; SEXUAL SELECTION; BEAK MORPHOLOGY; Z-CHROMOSOME; CONVERGENCE; MEGARHYNCHOS; VOCALIZATIONS; NIGHTINGALE	Bird song plays an important role in the establishment and maintenance of prezygotic reproductive barriers. When two closely related species come into secondary contact, song convergence caused by acquisition of heterospecific songs into the birds' repertoires is often observed. The proximate mechanisms responsible for such mixed singing, and its effect on the speciation process, are poorly understood. We used a combination of genetic and bioacoustic analyses to test whether mixed singing observed in the secondary contact zone of two passerine birds, the Thrush Nightingale (Luscinia luscinia) and the Common Nightingale (L. megarhynchos), is caused by introgressive hybridization. We analysed song recordings of both species from allopatric and sympatric populations together with genotype data from one mitochondrial and seven nuclear loci. Semi-automated comparisons of our recordings with an extensive catalogue of Common Nightingale song types confirmed that most of the analysed sympatric Thrush Nightingale males were 'mixed singers' that use heterospecific song types in their repertoires. None of these 'mixed singers' possessed any alleles introgressed from the Common Nightingale, suggesting that they were not backcross hybrids. We also analysed songs of five individuals with intermediate phenotype, which were identified as F-1 hybrids between the Thrush Nightingale female and the Common Nightingale male by genetic analysis. Songs of three of these hybrids corresponded to the paternal species (Common Nightingale) but the remaining two sung a mixed song. Our results suggest that although hybridization might increase the tendency for learning songs from both parental species, interspecific cultural transmission is the major proximate mechanism explaining the occurrence of mixed singers among the sympatric Thrush Nightingales. We also provide evidence that mixed singing does not substantially increase the rate of interspecific hybridization and discuss the possible adaptive value of this phenomenon in nightingales.	[Vokurkova, Jana; Petruskova, Tereza; Petrusek, Adam] Charles Univ Prague, Dept Ecol, Fac Sci, Prague, Czech Republic; [Reifova, Radka; Kozman, Alexandra; Morkovsky, Libor] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Kipper, Silke; Weiss, Michael] Free Univ Berlin, Inst Biol, Anim Behav Grp, Berlin, Germany; [Reif, Jiri] Charles Univ Prague, Inst Environm Studies, Fac Sci, Prague, Czech Republic; [Dolata, Pawel T.] Polish Soc Protect Birds, South Wielkopolska Grp, Ostrow Wielkopolski, Poland	Charles University Prague; Charles University Prague; Free University of Berlin; Charles University Prague	Petrusek, A (corresponding author), Charles Univ Prague, Dept Ecol, Fac Sci, Prague, Czech Republic.	petrusek@natur.cuni.cz	Reif, Jiri/I-9168-2017; Petrusková, Tereza/M-1801-2017; Petrusek, Adam/A-3510-2008; Reifova, Radka/D-2137-2011	Reif, Jiri/0000-0003-2553-7333; Petrusková, Tereza/0000-0002-8046-1581; Petrusek, Adam/0000-0001-5150-4370; Reifova, Radka/0000-0001-5852-5174	Czech Science Foundation [P506/10/1155]; Grant Agency of the Charles University [632712]; Charles University [SVV 267201, 267204]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Charles University; Charles University	The research was supported by grants provided by the Czech Science Foundation (P506/10/1155) to RR, the Grant Agency of the Charles University (632712) to LM, and other funding sources of the Charles University (SVV 267201 and 267204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1990, J EVOLUTION BIOL, V3, P375, DOI 10.1046/j.1420-9101.1990.3050375.x; Anderson EC, 2002, GENETICS, V160, P1217; Backstrom N, 2006, GENETICS, V174, P377, DOI 10.1534/genetics.106.058917; Badyaev AV, 1997, AUK, V114, P40, DOI 10.2307/4089063; Baker MC, 1999, CONDOR, V101, P493, DOI 10.2307/1370179; Becker Joachim, 2007, Vogelwarte, V45, P15; Borge T, 2005, GENETICS, V171, P1861, DOI 10.1534/genetics.105.045120; CODY ML, 1969, CONDOR, V71, P223, DOI 10.2307/1366300; Collins SA, 2002, P ROY SOC B-BIOL SCI, V269, P111, DOI 10.1098/rspb.2001.1864; Cramp S., 2000, BIRDS W PALEARCTIC C; de Kort SR, 2002, J AVIAN BIOL, V33, P150, DOI 10.1034/j.1600-048X.2002.330205.x; Derryberry EP, 2009, AM NAT, V174, P24, DOI 10.1086/599298; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Garamszegi LZ, 2007, BEHAV ECOL, V18, P1001, DOI 10.1093/beheco/arm069; Grant BR, 2008, PHILOS T R SOC B, V363, P2821, DOI 10.1098/rstb.2008.0051; Grant BR, 1996, EVOLUTION, V50, P2471, DOI 10.1111/j.1558-5646.1996.tb03633.x; Grant BR, 1998, ENDLESS FORMS, P404; GRANT BR, 1993, P ROY SOC B-BIOL SCI, V251, P111, DOI 10.1098/rspb.1993.0016; Grant BR, 1996, ECOLOGY, V77, P500, DOI 10.2307/2265625; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; Grant PR, 1997, BIOL J LINN SOC, V60, P317; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant PR, 1997, P NATL ACAD SCI USA, V94, P7768, DOI 10.1073/pnas.94.15.7768; Grant PR, 1997, AM NAT, V149, P1, DOI 10.1086/285976; Grether GF, 2009, BIOL REV, V84, P617, DOI 10.1111/j.1469-185X.2009.00089.x; Griessmann B, 2002, ETHOLOGY, V108, P377, DOI 10.1046/j.1439-0310.2002.00781.x; Haavie J, 2004, J EVOLUTION BIOL, V17, P227, DOI 10.1111/j.1420-9101.2003.00682.x; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; HELB HW, 1985, Z TIERPSYCHOL, V69, P27; Hoese WJ, 2000, J EXP BIOL, V203, P1845; Huber SK, 2006, BIOL J LINN SOC, V88, P489, DOI 10.1111/j.1095-8312.2006.00638.x; HULTSCH H, 1981, BEHAV ECOL SOCIOBIOL, V8, P183, DOI 10.1007/BF00299828; HULTSCH H, 1993, NETH J ZOOL, V43, P155, DOI 10.1163/156854293X00278; Hultsch H, 2008, NEUROSCIENCE BIRDSON, P204; Pigozzi MI, 2008, CHROMOSOME RES, V16, P839, DOI 10.1007/s10577-008-1243-5; Kiefer S, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-29; Kipper S, 2004, BEHAVIOUR, V141, P371, DOI 10.1163/156853904322981914; Kirschel ANG, 2009, P NATL ACAD SCI USA, V106, P8256, DOI 10.1073/pnas.0810124106; Kverek Pavel, 2008, Sylvia, V44, P17; Lachlan RF, 2004, EVOLUTION, V58, P2049; Laiolo P, 2012, J ANIM ECOL, V81, P594, DOI 10.1111/j.1365-2656.2011.01946.x; Leary CJ, 2001, ANIM BEHAV, V61, P431, DOI 10.1006/anbe.2000.1597; LEMAIRE F, 1977, BEHAVIOUR, V63, P215, DOI 10.1163/156853977X00423; LILLE R, 1988, J ORNITHOL, V129, P133, DOI 10.1007/BF01647285; Marler P, 1997, J NEUROBIOL, V33, P501; Mundry R, 2000, THESIS FREE U BERLIN; Nicolakakis N, 2003, ANIM BEHAV, V65, P445, DOI 10.1006/anbe.2003.2085; Parker KA, 2012, ECOL LETT, V15, P778, DOI 10.1111/j.1461-0248.2012.01797.x; Patten MA, 2004, EVOLUTION, V58, P2144; Podos J, 1997, EVOLUTION, V51, P537, DOI 10.1111/j.1558-5646.1997.tb02441.x; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Price T, 2007, SPECIATION BIRDS; Qvarnstrom A, 2006, J EVOLUTION BIOL, V19, P1202, DOI 10.1111/j.1420-9101.2006.01140.x; R Core Team, 2020, R LANG ENV STAT COMP; Ranoszek Ewald, 2001, Ptaki Slaska, V13, P19; Reifova R, 2011, J ORNITHOL, V152, P1063, DOI 10.1007/s10336-011-0700-7; Reifova R, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-138; ROBINSON SK, 1995, J ANIM ECOL, V64, P1, DOI 10.2307/5822; ROCHE JC, 1995, VOGELSTIMMEN EUROPAS; Rowell JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035257; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; SCHMIDT E, 1973, Tiscia (Szeged), V8, P79; Secondi J, 2003, BIOL J LINN SOC, V80, P507, DOI 10.1046/j.1095-8312.2003.00248.x; Secondi J, 2011, EVOL BIOL, V38, P441, DOI 10.1007/s11692-011-9133-8; Seddon N, 2005, EVOLUTION, V59, P200; Slabbekoorn H, 2002, CONDOR, V104, P564, DOI 10.1650/0010-5422(2002)104[0564:BASTTB]2.0.CO;2; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Smith JW, 2007, AM NAT, V169, P455, DOI 10.1086/511961; SORJONEN J, 1986, ORNIS SCAND, V17, P53, DOI 10.2307/3676753; SORJONEN J, 1986, BEHAVIOUR, V98, P274, DOI 10.1163/156853986X01008; Specht R, 2007, AVISOFT SASLAB PRO V; Sprau P, 2010, ANIM BEHAV, V80, P427, DOI 10.1016/j.anbehav.2010.05.028; Stadie C, 1983, VOLIERE, V6, P87; Storchova R, 2010, EVOLUTION, V64, P456, DOI 10.1111/j.1558-5646.2009.00841.x; Svensson L., 1992, IDENTIFICATION GUIDE; ten Cate C, 1999, ADV STUD BEHAV, V28, P1; THIELCKE G, 1972, Journal fuer Ornithologie, V113, P287, DOI 10.1007/BF01647509; Tyack PL, 2008, J COMP PSYCHOL, V122, P319, DOI 10.1037/a0013087; VADAS RL, 1990, OIKOS, V58, P123, DOI 10.2307/3565369; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Verzijden MN, 2012, TRENDS ECOL EVOL, V27, P511, DOI 10.1016/j.tree.2012.05.007	81	29	30	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60172	10.1371/journal.pone.0060172	http://dx.doi.org/10.1371/journal.pone.0060172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577089	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800031
J	Castano-Rodriguez, N; Kaakoush, NO; Goh, KL; Fock, KM; Mitchell, HM				Castano-Rodriguez, Natalia; Kaakoush, Nadeem O.; Goh, Khean-Lee; Fock, Kwong Ming; Mitchell, Hazel M.			The Role of TLR2, TLR4 and CD14 Genetic Polymorphisms in Gastric Carcinogenesis: A Case-Control Study and Meta-Analysis	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; SINGLE-NUCLEOTIDE POLYMORPHISM; PROSTATE-CANCER RISK; TOLL-LIKE RECEPTOR-4; NF-KAPPA-B; THR399ILE POLYMORPHISMS; PROMOTER POLYMORPHISMS; BORDETELLA-PERTUSSIS; SOLUBLE CD14; ASSOCIATION	Background: In addition to Helicobacter pylori infection, host genetic factors contribute to gastric cancer (GC). Recognition of H. pylori is known to involve Toll-like receptors (TLR), which subsequently leads to activation of NF-kappa B. Thus, the overall aim of this study was to estimate for the first time the pooled effect size of polymorphisms in TLR2, TLR4 and CD14 on GC development through a meta-analysis. Methods: A case-control study comprising 284 ethnic Chinese individuals (70 non-cardia GC cases and 214 functional dyspepsia controls) was conducted for the genotyping of TLR2 -196 to -174del, CD14 -260 C/T and TLR4 rs11536889 using PCR, RT-PCR and mass spectrometry. Case-control studies of TLR2, TLR4 and CD14 polymorphisms and GC were searched up to June 2012. Pooled odds ratios and 95% confidence intervals were obtained by means of the random effects model. Results: In our ethnic Chinese case-control study, the TLR4 rs11536889 C allele increased the risk of GC (OR: 1.89, 95% CI: 1.23-2.92) while the CD14 -260 T allele was protective (OR: 0.62, 95% CI: 0.42-0.91). TLR2 -196 to -174 increased the risk of GC only in H. pylori-infected individuals (OR: 3.10, 95% CI: 1.27-7.60). In the meta-analysis, TLR4 Asp299Gly showed borderline results in the general analysis (pooled OR: 1.58, 95% CI: 0.98-2.60), nevertheless, stratified analysis by ethnicity showed that the mutant allele was a definitive risk factor for GC in Western populations (pooled OR: 1.87, 95% CI: 1.31-2.65). There was a potential association between the TLR2 -196 to -174 deletion allele and GC in Japanese (pooled OR: 1.18, 95% CI: 0.96-1.45). TLR4 Thr399Ile did not provide significant results. Conclusions: TLR4 rs11536889 and CD14 -260 C/T are associated with non-cardia GC in Chinese. Based on our meta-analysis, the TLR signalling pathway is involved in gastric carcinogenesis, TLR4 Asp299Gly and TLR2 -196 to -174del showing associations with GC in an ethnic-specific manner.	[Castano-Rodriguez, Natalia; Kaakoush, Nadeem O.; Mitchell, Hazel M.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Goh, Khean-Lee] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Fock, Kwong Ming] Changi Gen Hosp, Dept Med, Div Gastroenterol, Singapore, Singapore	University of New South Wales Sydney; Universiti Malaya; Changi General Hospital	Mitchell, HM (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	h.mitchell@unsw.edu.au	Goh, Khean-Lee/B-6404-2009; Kaakoush, Nadeem/ABG-9499-2020	Goh, Khean-Lee/0000-0002-9965-1561; Kaakoush, Nadeem Omar/0000-0003-4017-1077; Castano-Rodriguez, Natalia/0000-0001-8819-8872	Cancer Council of New South Wales, Australia [66/04]; Early Career fellowship from the National Health and Medical Research, Australia [APP1012413]	Cancer Council of New South Wales, Australia(Cancer Council New South Wales); Early Career fellowship from the National Health and Medical Research, Australia	This work was supported in part by The Cancer Council of New South Wales, Australia (Grant no. 66/04) (http://www.cancercouncil.com.au/). NOK is supported by an Early Career fellowship from the National Health and Medical Research, Australia (APP1012413) (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2010, CELL MOL IMMUNOL, Vseventh, P109; Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Castano-Rodriguez N, 2012, ANTICANCER RES, V32, P3715; Chan WF, 2009, J MICROBIOL METH, V77, P326, DOI 10.1016/j.mimet.2009.03.007; Chochi K, 2008, CLIN CANCER RES, V14, P2909, DOI 10.1158/1078-0432.CCR-07-4467; CORREA P, 1988, CANCER RES, V48, P3554; CROWE SE, 1995, GASTROENTEROLOGY, V108, P65, DOI 10.1016/0016-5085(95)90009-8; de Oliveira JG, 2012, WORLD J GASTROENTERO, V18, P1235, DOI 10.3748/wjg.v18.i11.1235; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Fukusaki T, 2007, J PERIODONTAL RES, V42, P541, DOI 10.1111/j.1600-0765.2007.00979.x; Garza-Gonzalez E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-70; Gianfagna F, 2008, CURR GENOMICS, V9, P361, DOI 10.2174/138920208785699544; Goh KL, 2007, AM J GASTROENTEROL, V102, P40, DOI 10.1111/j.1572-0241.2006.00885.x; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Guo QS, 2006, J GASTROEN HEPATOL, V21, P92, DOI 10.1111/j.1440-1746.2005.04156.x; Hazbon MH, 2004, J CLIN MICROBIOL, V42, P1236, DOI 10.1128/JCM.42.3.1236-1242.2004; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Hishida A, 2009, HELICOBACTER, V14, P47, DOI 10.1111/j.1523-5378.2009.00659.x; Hishida A, 2010, GASTRIC CANCER, V13, P251, DOI 10.1007/s10120-010-0567-y; Hold GL, 2007, GASTROENTEROLOGY, V132, P905, DOI 10.1053/j.gastro.2006.12.026; Hold GL, 2009, EUR J CANCER PREV, V18, P117, DOI 10.1097/CEJ.0b013e3283101292; Hubacek JA, 1999, CIRCULATION, V99, P3218, DOI 10.1161/01.CIR.99.25.3218; Ishihara S, 2004, J IMMUNOL, V173, P1406, DOI 10.4049/jimmunol.173.2.1406; Jing JJ, 2012, GENE, V499, P237, DOI 10.1016/j.gene.2012.03.045; Junpee A, 2010, PARASITOL RES, V107, P807, DOI 10.1007/s00436-010-1932-9; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Karhukorpi J, 2002, CLIN EXP IMMUNOL, V128, P326, DOI 10.1046/j.1365-2249.2002.01837.x; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Kiechl S, 2003, ANN MED, V35, P164, DOI 10.1080/07853890310008215; Kim KD, 2011, WORLD J UROL; Kupcinskas J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-112; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; Li Hanchen, 2003, Curr Gastroenterol Rep, V5, P459, DOI 10.1007/s11894-003-0034-6; Liang XH, 2006, PHARMACOGENET GENOM, V16, P229; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Lochhead P, 2007, BEST PRACT RES CL GA, V21, P281, DOI 10.1016/j.bpg.2007.02.002; Loh M, 2009, EUR J CANCER, V45, P2562, DOI 10.1016/j.ejca.2009.03.017; Mandal RK, 2012, MOL BIOL REP, V39, P7263, DOI 10.1007/s11033-012-1556-5; Merchant JL, 2005, GASTROENTEROLOGY, V129, P1079, DOI 10.1053/j.gastro.2005.07.038; Mitchell H, 2008, ALIMENT PHARM THER, V28, P903, DOI 10.1111/j.1365-2036.2008.03792.x; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Noguchi E, 2004, CLIN EXP ALLERGY, V34, P177, DOI 10.1111/j.1365-2222.2004.01839.x; Oeth PB M, 2005, IPLEX ASSAY INCREASE, P12; Pandey S, 2009, GYNECOL ONCOL, V114, P501, DOI 10.1016/j.ygyno.2009.05.032; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rigoli L, 2010, ANTICANCER RES, V30, P513; Santini D, 2008, CLIN EXP IMMUNOL, V154, P360, DOI 10.1111/j.1365-2249.2008.03776.x; Schmidt HMA, 2011, J GASTROEN HEPATOL, V26, P1725, DOI 10.1111/j.1440-1746.2011.06799.x; Singh V, 2012, ARCH MED RES; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Smith SM, 2011, J IMMUNOL, V186, P2462, DOI 10.4049/jimmunol.1000864; Srivastava K, 2010, LIVER INT, V30, P1067, DOI 10.1111/j.1478-3231.2010.02268.x; Su B, 2003, INFECT IMMUN, V71, P3496, DOI 10.1128/IAI.71.6.3496-3502.2003; Tahara T., 2007, Inflammopharmacology, V15, P124, DOI 10.1007/s10787-006-1567-8; Tahara T, 2007, CANCER SCI, V98, P1790, DOI 10.1111/j.1349-7006.2007.00590.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Talley NJ, 1999, GUT, V45, P37; Thomas CJ, 2002, FEBS LETT, V531, P184, DOI 10.1016/S0014-5793(02)03499-3; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Wu MS, 2006, HEPATO-GASTROENTEROL, V53, P807; Yokota S, 2010, INFECT IMMUN, V78, P468, DOI 10.1128/IAI.00903-09; Yuan M, 2010, INT J NEUROSCI, V120, P415, DOI 10.3109/00207451003778736; Zeng HM, 2011, CANCER EPIDEM BIOMAR, V20, P2594, DOI 10.1158/1055-9965.EPI-11-0702; Zhang K, 2012, EUR J CANC; Zhao D, 2007, CLIN CANCER RES, V13, P2362, DOI 10.1158/1078-0432.CCR-06-2612; Zheng SL, 2004, CANCER RES, V64, P2918, DOI 10.1158/0008-5472.CAN-03-3280	70	65	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60327	10.1371/journal.pone.0060327	http://dx.doi.org/10.1371/journal.pone.0060327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565226	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300096
J	Chen, QL; Li, L; Liao, WT; Zhang, HW; Wang, JH; Sheng, B; Zhang, HQ; Huang, XJ; Ding, YY; Zhang, T; Cao, J; Wu, H; Pan, W				Chen, Qiuli; Li, Lan; Liao, Wenting; Zhang, Hongwei; Wang, Jinhong; Sheng, Bo; Zhang, Huaqun; Huang, Xiaojie; Ding, Yingying; Zhang, Tong; Cao, Jie; Wu, Hao; Pan, Wei			Characterization of Tat Antibody Responses in Chinese Individuals Infected with HIV-1	PLOS ONE			English	Article							IV CD26; PROTEIN; IMMUNODEFICIENCY; BINDING; TRANSACTIVATION; INHIBITION; UGANDANS; VACCINE; CLADE; AIDS	HIV-1 Tat is an important regulatory protein involved in AIDS pathogenesis. However, the immunoprofiles of anti-Tat responses remain unclear. We analysed the immunoprofiles of the anti-Tat antibody responses and the neutralizing activities. Out of 326 HIV-1-seropositive individuals, 12.9% were positive for anti-Tat antibodies. We found six different immunological profiles of anti-Tat antibody responses: full-potential response, combined response, N-specific response, C-specific response, full-length Tat-specific response and Tat-related response. These responses represent two types of anti-Tat responses: the major complete response and the alternative C-prone response. A Tat-neutralizing activity is significantly higher in anti-Tat-seropositive samples than anti-Tat-negative or healthy blood-donor samples, and significantly correlates with the anti-Tat reactivities. The data here could contribute to a better understanding of the significance of anti-Tat responses in preventing HIV pathogenesis and could be useful for designing more effective vaccines in the future.	[Chen, Qiuli; Liao, Wenting; Wang, Jinhong; Zhang, Huaqun; Ding, Yingying; Cao, Jie; Pan, Wei] Second Mil Med Univ, Dept Microbiol, Shanghai, Peoples R China; [Li, Lan; Zhang, Hongwei; Sheng, Bo; Huang, Xiaojie; Zhang, Tong; Wu, Hao] Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China; [Liao, Wenting] Third Mil Med Univ, Coll High Altitude Mil Med, Chongqing, Peoples R China	Naval Medical University; Capital Medical University; Army Medical University	Wu, H (corresponding author), Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China.	haow99@gmail.com; pwpanwei@yahoo.com.cn	ding, yy/HHS-9589-2022; Zhang, Tong/HGC-1090-2022		National Natural Science Foundation of China (NSFC) [30972632, 30872405]; Shanghai Committee of Science and Technology [08JC1405200]; Chinese National Key Special Project for the Prevention and Control of Major Infectious Diseases [2009ZX10104-105]; Chinese National Key Special Project for Major New Drug Discovery [2011ZX09506-001]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Chinese National Key Special Project for the Prevention and Control of Major Infectious Diseases; Chinese National Key Special Project for Major New Drug Discovery	This work was funded by the National Natural Science Foundation of China (NSFC) [Grant numbers 30972632 and 30872405], the Shanghai Committee of Science and Technology [08JC1405200], the Chinese National Key Special Project for the Prevention and Control of Major Infectious Diseases [2009ZX10104-105] and the Chinese National Key Special Project for Major New Drug Discovery [2011ZX09506-001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2008, NAT STRUCT MOL BIOL, V15, P1287, DOI 10.1038/nsmb.1513; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Butto S, 2003, J INFECT DIS, V188, P1171, DOI 10.1086/378412; Cafaro A, 2009, ADV EXP MED BIOL, V655, P189, DOI 10.1007/978-1-4419-1132-2_14; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Cao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018477; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Demirhan I, 2000, J HUMAN VIROL, V3, P137; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2009, VACCINE, V28, P371, DOI 10.1016/j.vaccine.2009.10.038; Gallo RC, 1999, P NATL ACAD SCI USA, V96, P8324, DOI 10.1073/pnas.96.15.8324; GUTHEIL WG, 1994, P NATL ACAD SCI USA, V91, P6594, DOI 10.1073/pnas.91.14.6594; Jiang SHH, 2008, DNA CELL BIOL, V27, P423, DOI 10.1089/dna.2007.0708; Kashi VP, 2009, VACCINE, V27, P6739, DOI 10.1016/j.vaccine.2009.08.078; KRONE WJA, 1988, J MED VIROL, V26, P261, DOI 10.1002/jmv.1890260306; Liao WT, 2012, VACCINE, V30, P2453, DOI 10.1016/j.vaccine.2012.01.055; Lorey S, 2003, EUR J BIOCHEM, V270, P2147, DOI 10.1046/j.1432-1033.2003.03568.x; Mediouni S, 2012, J BIOL CHEM, V287, P11942, DOI 10.1074/jbc.M111.319863; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; Re MC, 2001, MICROBIOLOGICA, V24, P207; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; RUBEN S, 1989, J VIROL, V63, P1; Senkaali D, 2008, AIDS RES HUM RETROV, V24, P587, DOI 10.1089/aid.2007.0171; Serriere J, 2011, J MOL BIOL, V405, P33, DOI 10.1016/j.jmb.2010.10.033; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; Siddappa NB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-53; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Watkins JD, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-83; WIELAND U, 1990, MED MICROBIOL IMMUN, V179, P1, DOI 10.1007/BF00190145; Wrenger S, 2000, J BIOL CHEM, V275, P22180, DOI 10.1074/jbc.M002338200; Zagury J F, 1998, J Hum Virol, V1, P282	32	2	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60825	10.1371/journal.pone.0060825	http://dx.doi.org/10.1371/journal.pone.0060825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565278	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300150
J	Enns, CA; Ahmed, R; Wang, JH; Ueno, A; Worthen, C; Tsukamoto, H; Zhang, AS				Enns, Caroline A.; Ahmed, Riffat; Wang, Jiaohong; Ueno, Akiko; Worthen, Christal; Tsukamoto, Hidekazu; Zhang, An-Sheng			Increased Iron Loading Induces Bmp6 Expression in the Non-Parenchymal Cells of the Liver Independent of the BMP-Signaling Pathway	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN 6; ANTIMICROBIAL PEPTIDE HEPCIDIN; TRANSFERRIN RECEPTOR 2; MOUSE-LIVER; HFE; OVERLOAD; FERRITIN; SERUM; GENE	Bone morphogenetic protein 6 (BMP6) is an essential cytokine for the expression of hepcidin, an iron regulatory hormone secreted predominantly by hepatocytes. Bmp6 expression is upregulated by increased iron-levels in the liver. Both hepatocytes and non-parenchymal liver cells have detectable Bmp6 mRNA. Here we showed that induction of hepcidin expression in hepatocytes by dietary iron is associated with an elevation of Bmp6 mRNA in the non-parenchymal cells of the liver. Consistently, incubation with iron-saturated transferrin induces Bmp6 mRNA expression in isolated hepatic stellate cells, but not in hepatocytes. These observations suggest an important role of the non-parenchymal liver cells in regulating iron-homeostasis by acting as a source of Bmp6.	[Enns, Caroline A.; Ahmed, Riffat; Worthen, Christal; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; [Wang, Jiaohong; Ueno, Akiko; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Tsukamoto, Hidekazu] Greater Los Angeles Healthcare Syst, Dept Vet Affairs, Los Angeles, CA USA	Oregon Health & Science University; University of Southern California	Enns, CA (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA.	ennsca@ohsu.edu; zhanga@ohsu.edu		Worthen, Christal/0000-0003-2107-1898	National Institutes of Health (NIH) [DK080765, NIH P50AA11199, NIH R24AA12885, NIH DK054488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054488, R37DK054488, R01DK072166, R01DK080765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health (NIH) DK080765 (ASZ), NIH P50AA11199 (HT), NIH R24AA12885 (HT), and NIH DK054488 (CAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Babitt JL, 2011, SEMIN LIVER DIS, V31, P280, DOI 10.1055/s-0031-1286059; Bartnikas TB, 2011, BLOOD, V117, P630, DOI 10.1182/blood-2010-05-287359; Camaschella C, 2002, SEMIN HEMATOL, V39, P242, DOI 10.1053/shem.2002.35635; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Corradini E, 2011, HEPATOLOGY, V54, P273, DOI 10.1002/hep.24359; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; De Gobbi M, 2002, BRIT J HAEMATOL, V117, P973, DOI 10.1046/j.1365-2141.2002.03509.x; Feng Q, 2012, AM J PHYSIOL-GASTR L, V302, pG1397, DOI 10.1152/ajpgi.00020.2012; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; Frazer DM, 2012, BRIT J HAEMATOL, V157, P615, DOI 10.1111/j.1365-2141.2012.09104.x; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Knittel T, 1997, EXP CELL RES, V232, P263, DOI 10.1006/excr.1997.3504; Mabuchi Ayako, 2004, Comp Hepatol, V3 Suppl 1, pS29, DOI 10.1186/1476-5926-2-S1-S29; Malik R, 2002, SEMIN CELL DEV BIOL, V13, P425, DOI 10.1016/S1084952102001301; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Otsuka F, 2010, ENDOCR J, V57, P3, DOI 10.1507/endocrj.K09E-310; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Ruschke K, 2012, CELL TISSUE RES, V347, P521, DOI 10.1007/s00441-011-1283-6; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xiong S, 2008, AM J PHYSIOL-GASTR L, V295, pG512, DOI 10.1152/ajpgi.90327.2008; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhu NL, 2012, J BIOL CHEM, V287, P10355, DOI 10.1074/jbc.M111.312751	42	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60534	10.1371/journal.pone.0060534	http://dx.doi.org/10.1371/journal.pone.0060534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565256	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300127
J	Piralla, A; Daleno, C; Scala, A; Greenberg, D; Usonis, V; Principi, N; Baldanti, F; Esposito, S				Piralla, Antonio; Daleno, Cristina; Scala, Alessia; Greenberg, David; Usonis, Vytautas; Principi, Nicola; Baldanti, Fausto; Esposito, Susanna		CAP-PRI Study Grp	Genome Characterisation of Enteroviruses 117 and 118: A New Group within Human Enterovirus Species C	PLOS ONE			English	Article							RESPIRATORY ENTEROVIRUS; STRUCTURE PREDICTION; RNA REPLICATION; RECOMBINATION; INFECTION; IDENTIFICATION; EMERGENCE; EVOLUTION; CHILDREN; SEQUENCE	The more than 120 genotypes of human enteroviruses (HEVs) reflect a wide range of evolutionary divergence, and there are 23 currently classified as human enterovirus C species (HEV-C). Two new HEV-C (EV-C117 and EV-C118) were identified in the Community-Acquired Pneumonia Pediatric Research Initiative (CAP-PRI) study, and the present paper describes the characterisation of the complete genome of one EV-C117 strain (LIT22) and two EV-C118 (ISR38 and ISR10) strains. The EV-C117 and EV-C118 5'UTR sequences were related to those of EV-C104, EV-C105 and EV-C109, and were slightly shorter than those of other HEV A-D species. Similarity plot analyses showed that EV-C117 and EV-C118 have a P1 region that is highly divergent from that of the other HEV-C, and phylogenetic analyses highly supported a monophyletic group consisting of EV-C117, EV-C118, EV-C104, EV-C105 and EV-C109 strains. Phylogenetic, Simplot and Bootscan analyses indicated that recombination was not the main mechanism of EV-C117 and EV-C118 evolution, thus strengthening the hypothesis of the monophyletic origin of the coding regions, as in the case of other HEV-C. Phylogenetic analysis also revealed the emergence of a new group within HEV-C that is divided into two subgroups. Nucleotide and amino acid identity in VP1 sequences have been established as useful criteria for assigning new HEV types, but analysis of the complete P1 region improves resolution.	[Piralla, Antonio; Baldanti, Fausto] Policlin San Matteo, Mol Virol Unit, Fdn Ist Ricovero & Cura Carattere Sci, I-27100 Pavia, Italy; [Daleno, Cristina; Scala, Alessia; Principi, Nicola; Esposito, Susanna] Univ Milan, Fdn Ist Ricovero & Cura Carattere Sci, Ca Granda Osped Maggiore Policlin, Pediat Clin 1, Milan, Italy; [Greenberg, David] Soroka Univ Med Ctr, Pediat Infect Dis Unit, Beer Sheva, Israel; [Usonis, Vytautas] Vilnius Univ, Vilnius Univ Clin Childrens Dis, Vilnius, Lithuania	IRCCS Fondazione San Matteo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Ben Gurion University; Soroka Medical Center; Vilnius University	Esposito, S (corresponding author), Univ Milan, Fdn Ist Ricovero & Cura Carattere Sci, Ca Granda Osped Maggiore Policlin, Pediat Clin 1, Milan, Italy.	susanna.esposito@unimi.it	Usonis, Vytautas/R-6471-2019; Esposito, Susanna/K-3475-2016; Piralla, Antonio/K-4756-2018; Baldanti, Fausto/J-4924-2018	Esposito, Susanna/0000-0003-4103-2837; Piralla, Antonio/0000-0002-6062-2579; Baldanti, Fausto/0000-0002-3358-8969	Italian Ministry of Health (Bando Giovani Ricercatori); Ricerca Corrente (Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy) [80622]; Amici del Bambino Malato Onlus	Italian Ministry of Health (Bando Giovani Ricercatori)(Ministry of Health, Italy); Ricerca Corrente (Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy); Amici del Bambino Malato Onlus	This study was supported by grants from the Italian Ministry of Health (Bando Giovani Ricercatori 2007), Ricerca Corrente (Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy: grant 80622) and Amici del Bambino Malato Onlus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly JL, 2009, INFECT GENET EVOL, V9, P699, DOI 10.1016/j.meegid.2008.04.009; Brown B, 2003, J VIROL, V77, P8973, DOI 10.1128/JVI.77.16.8973-8984.2003; Brown BA, 2009, J GEN VIROL, V90, P1713, DOI 10.1099/vir.0.008540-0; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Daleno C, 2013, J CLIN VIROL, V56, P159, DOI 10.1016/j.jcv.2012.10.013; Daleno C, 2012, EMERG INFECT DIS, V18, P1913, DOI 10.3201/eid1811.120321; Daleno C, 2012, J VIROL, V86, P10888, DOI 10.1128/JVI.01721-12; Debiaggi M, 2012, VIROL J, V9, DOI [10.1186/1743-422X-9-183, 10.1186/1743-422X-9-247]; Goodfellow I, 2000, J VIROL, V74, P4590, DOI 10.1128/JVI.74.10.4590-4600.2000; Grard G, 2010, EURO SURVEILL, V15; Greenberg D, 2013, GENOME ANNOUNC, V1; Hofacker Ivo L., 2007, V395, P527; Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x; Kaida A, 2012, EMERG INFECT DIS, V18, P882, DOI 10.3201/eid1805.111890; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2012, J GEN VIROL, V93, P2357, DOI 10.1099/vir.0.043216-0; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Mulders MN, 2000, J GEN VIROL, V81, P803, DOI 10.1099/0022-1317-81-3-803; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Pallansch M., 2007, FIELDS VIROL, P839; Pankovics P, 2012, ACTA MICROBIOL IMM H, V59, P285, DOI 10.1556/AMicr.59.2012.2.13; Pfister T, 2000, J VIROL, V74, P334, DOI 10.1128/JVI.74.1.334-343.2000; Piralla A, 2012, DIAGN MICR INFEC DIS, V73, P162, DOI 10.1016/j.diagmicrobio.2012.02.019; Piralla A, 2010, EMERG INFECT DIS, V16, P1018, DOI 10.3201/eid1606.091533; Poyry T, 1996, J GEN VIROL, V77, P1699, DOI 10.1099/0022-1317-77-8-1699; Racaniello VR, 2007, FIELDS VIROLOGY, P795; ROHLL JB, 1994, J VIROL, V68, P4384, DOI 10.1128/JVI.68.7.4384-4391.1994; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Tokarz R, 2012, J GEN VIROL; Tokarz R, 2012, J GEN VIROL, V93, P1952, DOI 10.1099/vir.0.043935-0; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	38	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60641	10.1371/journal.pone.0060641	http://dx.doi.org/10.1371/journal.pone.0060641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565264	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300135
J	Graham, BS; Enama, ME; Nason, MC; Gordon, IJ; Peel, SA; Ledgerwood, JE; Plummer, SA; Mascola, JR; Bailer, RT; Roederer, M; Koup, RA; Nabel, GJ				Graham, Barney S.; Enama, Mary E.; Nason, Martha C.; Gordon, Ingelise J.; Peel, Sheila A.; Ledgerwood, Julie E.; Plummer, Sarah A.; Mascola, John R.; Bailer, Robert T.; Roederer, Mario; Koup, Richard A.; Nabel, Gary J.		VRC 008 Study Team	DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial	PLOS ONE			English	Article							HEPATITIS-A VACCINE; T-CELL RESPONSES; NEUTRALIZING ANTIBODY; CANDIDATE VACCINE; HEALTHY-ADULTS; IMMUNOGENICITY EVALUATION; PHASE-1 SAFETY; JET INJECTION; PLASMID DNA; HIV-1	Background: DNA vaccine immunogenicity has been limited by inefficient delivery. Needle-free delivery of DNA using a CO2-powered Biojector (R) device was compared to delivery by needle and syringe and evaluated for safety and immunogenicity. Methods: Forty adults, 18-50 years, were randomly assigned to intramuscular (IM) vaccinations with DNA vaccine, VRC-HIVDNA016-00-VP, (weeks 0, 4, 8) by Biojector (R) 2000 (TM) or needle and syringe (N/S) and boosted IM at week 24 with VRC-HIVADV014-00-VP (rAd5) with N/S at 10(10) or 10(11) particle units (PU). Equal numbers per assigned schedule had low (<= 500) or high (>500) reciprocal titers of preexisting Ad5 neutralizing antibody. Results: 120 DNA and 39 rAd5 injections were given; 36 subjects completed follow-up research sample collections. IFN-gamma ELISpot response rates were 17/19 (89%) for Biojector (R) and 13/17 (76%) for N/S delivery at Week 28 (4 weeks post rAd5 boost). The magnitude of ELISpot response was about 3-fold higher in Biojector (R) compared to N/S groups. Similar effects on response rates and magnitude were observed for CD8+, but not CD4+ T-cell responses by ICS. Env-specific antibody responses were about 10-fold higher in Biojector-primed subjects. Conclusions: DNA vaccination by Biojector (R) was well-tolerated and compared to needle injection, primed for greater IFN-gamma ELISpot, CD8+ T-cell, and antibody responses after rAd5 boosting. Trial Registration: ClinicalTrials.gov NCT00109629	[Graham, Barney S.; Enama, Mary E.; Gordon, Ingelise J.; Ledgerwood, Julie E.; Plummer, Sarah A.; Mascola, John R.; Bailer, Robert T.; Roederer, Mario; Koup, Richard A.; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Peel, Sheila A.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nih.gov	Graham, Barney S./AAC-5898-2019; Roederer, Mario/G-1887-2011; Mascola, John/AAI-7193-2021	Graham, Barney S./0000-0001-8112-0853; 	National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005021, ZICAI005123, ZIAAI005035] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the conduct of this clinical trial was provided by the National Institute of Allergy and Infectious Diseases (NIAID) intramural research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar JC, 2001, VACCINE, V20, P275, DOI 10.1016/S0264-410X(01)00273-0; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; Cooper CJ, 2010, JAMA-J AM MED ASSOC, V304, P275, DOI 10.1001/jama.2010.926; De Rosa SC, 2011, J IMMUNOL, V187, P3391, DOI 10.4049/jimmunol.1101421; Epstein JE, 2002, HUM GENE THER, V13, P1551, DOI 10.1089/10430340260201644; Fisch A, 1996, VACCINE, V14, P1132, DOI 10.1016/0264-410X(96)00044-8; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Jackson LA, 2001, VACCINE, V19, P4703, DOI 10.1016/S0264-410X(01)00225-0; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Khurana S, 2006, JAIDS-J ACQ IMM DEF, V43, P304, DOI 10.1097/01.qai.0000242465.50947.5f; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054; Ledgerwood JE, 2009, HUM VACCINES, V5, P623, DOI 10.4161/hv.8627; Levine MM, 2003, NAT MED, V9, P99, DOI 10.1038/nm0103-99; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Manam S, 2000, INTERVIROLOGY, V43, P273, DOI 10.1159/000053994; Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; Mathei C, 1997, VACCINE, V15, P402, DOI 10.1016/S0264-410X(96)00196-X; Moodie Z, 2006, J IMMUNOL METHODS, V315, P121, DOI 10.1016/j.jim.2006.07.015; Mumper RJ, 2003, METHODS, V31, P255, DOI 10.1016/S1046-2023(03)00138-5; Peiperl L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013579; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Shu Y, 2007, VACCINE, V25, P1398, DOI 10.1016/j.vaccine.2006.10.046; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Tavel JA, 2007, JAIDS-J ACQ IMM DEF, V44, P601, DOI 10.1097/QAI.0b013e3180417cb6; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252; Williams J, 2000, VACCINE, V18, P1939, DOI 10.1016/S0264-410X(99)00446-6	34	54	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e59340	10.1371/journal.pone.0059340	http://dx.doi.org/10.1371/journal.pone.0059340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577062	gold, Green Submitted, Green Published			2022-12-27	WOS:000317898000011
J	Ifflaender, S; Rudiger, M; Koch, A; Burkhardt, W				Ifflaender, Sascha; Ruediger, Mario; Koch, Arite; Burkhardt, Wolfram			Three-Dimensional Digital Capture of Head Size in Neonates - A Method Evaluation	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; PRETERM INFANTS; GROWTH; BRAIN; CIRCUMFERENCE; AGE; ULTRASOUND; OUTCOMES	Introduction: The quality of neonatal care is mainly determined by long-term neurodevelopmental outcome. The neurodevelopment of preterm infants is related to postnatal head growth and depends on medical interventions such as nutritional support. Head circumference (HC) is currently used as a two-dimensional measure of head growth. Since head deformities are frequently found in preterm infants, HC may not always adequately reflect head growth. Laser aided head shape digitizers offer semiautomatic acquisition of HC and cranial volume (CrV) and could thus be useful in describing head size more precisely. Aims: 1) To evaluate reproducibility of a 3D digital capture system in newborns. 2) To compare manual and digital HC measurements in a neonatal cohort. 3) To determine correlation of HC and CrV and predictive value of HC. Methods: Within a twelve-month period data of head scans with a laser shape digitizer were analysed. Repeated measures were used for method evaluation. Manually and digitally acquired HC was compared. Regression analysis of HC and CrV was performed. Results: Interobserver reliability was excellent for HC (bias-0.005%, 95% Limits of Agreement (LoA) -0.39-0.39%) and CrV (bias1.5%, 95% LoA-0.8-3.6%). Method comparison data was acquired from 282 infants. It revealed interchangeability of the methods (bias-0.45%; 95% LoA-4.55-3.65%) and no significant systematic or proportional differences. HC and CrV correlated (r(2) = 0.859, p<0.001), performance of HC predicting CrV was poor (RSD +/- 24 ml). Correlation was worse in infants with lower postmenstrual age (r(2) = 0.745) compared to older infants (r(2) = 0.843). Discussion: The current practice of measuring HC for describing head growth in preterm infants could be misleading since it does not represent a 3D approach. CrV can vary substantially in infants of equal HC. The 3D laser scanner represents a new and promising method to provide reproducible data of CrV and HC. Since it does not provide data on cerebral structures, additional imaging is required.	[Ifflaender, Sascha; Ruediger, Mario; Koch, Arite; Burkhardt, Wolfram] Univ Hosp Carl Gustav Carus, Dept Neonatol & Paediat Intens Care, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Rudiger, M (corresponding author), Univ Hosp Carl Gustav Carus, Dept Neonatol & Paediat Intens Care, Dresden, Germany.	mario.ruediger@uniklinikum-dresden.de		Ifflaender, Sascha/0000-0002-9450-0502	Else Kroner-Fresenius Trust; German Research Foundation; Open Access Publication Funds of the TU Dresden	Else Kroner-Fresenius Trust; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	This work was supported by the Else Kroner-Fresenius Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Sven Reese for his helpful statistical advice and Ben Paarmann and Sandro Koch for proofreading the manuscript. We also acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden.	BHUSHAN V, 1991, J CLIN EPIDEMIOL, V44, P1027, DOI 10.1016/0895-4356(91)90004-S; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671; Collett BR, 2013, PEDIATRICS, V131, pE109, DOI 10.1542/peds.2012-1779; Colvin M, 2004, BRIT MED J, V329, P1390, DOI 10.1136/bmj.329.7479.1390; Dewitte K, 2002, CLIN CHEM, V48, P799; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Embleton NE, 2001, PEDIATRICS, V107, P270, DOI 10.1542/peds.107.2.270; Geil MDS, 2008, J PROSTHET ORTHOT, V20, P35, DOI DOI 10.1097/JPO.0B013E318169C439; GEORGIEFF MK, 1985, J PEDIATR-US, V107, P581, DOI 10.1016/S0022-3476(85)80028-7; HACK M, 1986, PEDIATRICS, V77, P196; HACK M, 1991, NEW ENGL J MED, V325, P231, DOI 10.1056/NEJM199107253250403; Hay WW, 1999, PEDIATRICS, V104, P1360, DOI 10.1542/peds.104.6.1360; Kane AA, 1996, PEDIATRICS, V97, P877; KROUWER JS, 1995, EUR J CLIN CHEM CLIN, V33, P525; Latal-Hajnal B, 2003, J PEDIATR-US, V143, P163, DOI 10.1067/S0022-3476(03)00243-9; Leijser LM, 2007, PEDIATR RADIOL, V37, P640, DOI 10.1007/s00247-007-0485-2; Lindley AA, 1999, EARLY HUM DEV, V56, P17, DOI 10.1016/S0378-3782(99)00033-X; Maunu J, 2009, PEDIATRICS, V123, P617, DOI 10.1542/peds.2007-3264; Mewes AUJ, 2006, PEDIATRICS, V118, P23, DOI 10.1542/peds.2005-2675; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Plank LH, 2006, J CRANIOFAC SURG, V17, P1084, DOI 10.1097/01.scs.0000244920.07383.85; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Zacharia A, 2006, AM J NEURORADIOL, V27, P972	24	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61274	10.1371/journal.pone.0061274	http://dx.doi.org/10.1371/journal.pone.0061274			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580107	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000119
J	Richez, C; Richards, RJ; Duffau, P; Weitzner, Z; Andry, CD; Rifkin, IR; Aprahamian, T				Richez, Christophe; Richards, Rocco J.; Duffau, Pierre; Weitzner, Zachary; Andry, Christopher D.; Rifkin, Ian R.; Aprahamian, Tamar			The Effect of Mycophenolate Mofetil on Disease Development in the gld.apoE(-/-) Mouse Model of Accelerated Atherosclerosis and Systemic Lupus Erythematosus	PLOS ONE			English	Article							INTRAVENOUS CYCLOPHOSPHAMIDE; CONTROLLED-TRIAL; NEPHRITIS; ACID; MECHANISMS; THERAPY; INHIBITION; EFFICACY; EVENTS; CELLS	Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that is characterized by autoantibody production and inflammatory disease involving multiple organs. Premature atherosclerosis is a common complication of SLE and results in substantial morbidity and mortality from cardiovascular disease (CVD). The reasons for the premature atherosclerosis in SLE are incompletely understood, although chronic inflammation is thought to play an important role. There is currently no known preventative treatment of premature atherosclerosis in SLE. Mycophenolate mofetil (MMF) is an immunosuppressive agent that is commonly used for treatment of patients with SLE. In order to study the impact of this drug on murine lupus disease including premature atherosclerosis development, we treated gld.apoE(-/-) mice, a model of SLE and accelerated atherosclerosis, with MMF. We maintained seven-week old gld.apoE(-/-) mice on a high cholesterol Western diet with or without MMF. After 12 weeks on diet, mice receiving MMF showed decreased atherosclerotic lesion area compared to the control group. MMF treatment also improved the lupus phenotype, indicated by a significant decrease circulating autoantibody levels and ameliorating lupus nephritis associated with this model. This data suggests that the effects of MMF on the immune system may not only be beneficial for lupus, but also for inflammation driving lupus-associated atherosclerosis.	[Richez, Christophe] CHU Bordeaux, Hop Pellegrin, Serv Rhumatol, Bordeaux, France; [Richez, Christophe; Duffau, Pierre] Univ Bordeaux 2, CNRS, UMR 5164, F-33076 Bordeaux, France; [Richez, Christophe; Richards, Rocco J.; Weitzner, Zachary; Rifkin, Ian R.; Aprahamian, Tamar] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA; [Duffau, Pierre] CHU Bordeaux, Hop St Andre, Serv Med Interne, Bordeaux, France; [Andry, Christopher D.] Boston Univ, Sch Med, Dept Med Pathol, Boston, MA 02118 USA	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Boston University; CHU Bordeaux; Boston University	Aprahamian, T (corresponding author), Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA.	aprahami@bu.edu		Rifkin, Ian/0000-0002-2674-3991; Aprahamian, Tamar/0000-0001-9295-5995	Aspreva Pharmaceuticals; NIAMS/NIH [K01 AR055965-02]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR055965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007053] Funding Source: NIH RePORTER	Aspreva Pharmaceuticals; NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a research grant from Aspreva Pharmaceuticals to I.R.; and by grant: K01 AR055965-02 from NIAMS/NIH to T.A. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAMS or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1993, IMMUNOL REV, V136, P5, DOI 10.1111/j.1600-065X.1993.tb00652.x; Appel GB, 2009, J AM SOC NEPHROL, V20, P1103, DOI 10.1681/ASN.2008101028; Aprahamian T, 2004, J EXP MED, V199, P1121, DOI 10.1084/jem.20031557; Chan TM, 2000, NEW ENGL J MED, V343, P1156, DOI 10.1056/NEJM200010193431604; Dooley MA, 2011, NEW ENGL J MED, V365, P1886, DOI 10.1056/NEJMoa1014460; EPINETTE WW, 1987, J AM ACAD DERMATOL, V17, P962, DOI 10.1016/S0190-9622(87)70285-0; Ferreira GA, 2007, RHEUMATOLOGY, V46, P1560, DOI 10.1093/rheumatology/kem186; FRANKLIN TJ, 1969, BIOCHEM J, V113, P515, DOI 10.1042/bj1130515; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gibson WT, 2007, ANN NY ACAD SCI, V1110, P209, DOI 10.1196/annals.1423.023; Ginzler EM, 2005, NEW ENGL J MED, V353, P2219, DOI 10.1056/NEJMoa043731; Huang HD, 2002, ACTA PHARMACOL SIN, V23, P649; Jung HJ, 2010, ARTHRITIS RHEUM-US, V62, P863, DOI 10.1002/art.27289; KELLEY VE, 1985, CLIN IMMUNOL IMMUNOP, V37, P220, DOI 10.1016/0090-1229(85)90153-9; Komori H, 2006, J IMMUNOL, V176, P395, DOI 10.4049/jimmunol.176.1.395; Lockshin MD, 2001, ARTHRITIS RHEUM-US, V44, P2215, DOI 10.1002/1529-0131(200110)44:10<2215::AID-ART381>3.3.CO;2-F; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Ng R, 2004, DRUGS DISCOVERY APPR, P107; Ong LM, 2005, NEPHROLOGY, V10, P504, DOI 10.1111/j.1440-1797.2005.00444.x; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Raisanen-Sokolowski A, 1995, Transpl Immunol, V3, P342, DOI 10.1016/0966-3274(95)80021-2; Riboldi P, 2002, CLIN REV ALLERG IMMU, V23, P247, DOI 10.1385/CRIAI:23:3:247; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sedgwick C, 1988, P AM ANIM HOSP ASS, P156; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Urowitz MB, 2010, ARTHRIT CARE RES, V62, P881, DOI 10.1002/acr.20122; van Bruggen MCJ, 1998, J AM SOC NEPHROL, V9, P1407; van Leuven SI, 2012, ANN RHEUM DIS, V71, P408, DOI 10.1136/annrheumdis-2011-200071; van Leuven SI, 2010, ATHEROSCLEROSIS, V211, P231, DOI 10.1016/j.atherosclerosis.2010.01.043; van Leuven SI, 2006, CARDIOVASC RES, V69, P341, DOI 10.1016/j.cardiores.2005.09.018; Westerweel PE, 2007, ARTHRITIS RHEUM-US, V56, P1384, DOI 10.1002/art.22568	31	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61042	10.1371/journal.pone.0061042	http://dx.doi.org/10.1371/journal.pone.0061042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577189	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000094
J	Haapa-Paananen, S; Chen, P; Hellstrom, K; Kohonen, P; Hautaniemi, S; Kallioniemi, O; Perala, M				Haapa-Paananen, Saija; Chen, Ping; Hellstrom, Kirsi; Kohonen, Pekka; Hautaniemi, Sampsa; Kallioniemi, Olli; Perala, Merja			Functional Profiling of Precursor MicroRNAs Identifies MicroRNAs Essential for Glioma Proliferation	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; DRUG-SENSITIVITY; GLIOBLASTOMA; CANCER; CELLS; HSA-MIR-181B; PATHWAYS; MIR-155; GROWTH; TM4	Cancer initiation and progression involve microRNAs that can function like tumor suppressors and oncogenes. The functional significance of most miRNAs is currently unknown. To determine systematically which microRNAs are essential for glioma growth, we screened a precursor microRNA library in three human glioblastoma and one astroglial cell line model systems. The most prominent and consistent cell proliferation-reducing hits were validated in secondary screening with an additional apoptosis endpoint. The functional screening data were integrated in the miRNA expression data to find underexpressed true functional tumor suppressor miRNAs. In addition, we used miRNA-target gene predictions and combined siRNA functional screening data to find the most probable miRNA-target gene pairs with a similar functional effect on proliferation. Nine novel functional miRNAs (hsa-miR-129, -136, -145, -155, -181b, -342-5p, -342-3p, -376a/b) in GBM cell lines were validated for their importance in glioma cell growth, and similar effects for six target genes (ROCK1, RHOA, MET, CSF1R, EIF2AK1, FGF7) of these miRNAs were shown functionally. The clinical significance of the functional hits was validated in miRNA expression data from the TCGA glioblastoma multiforme (GBM) tumor cohort. Five tumor suppressor miRNAs (hsa-miR-136, -145, -342, -129, -376a) showed significant underexpression in clinical GBM tumor samples from the TCGA GBM cohort further supporting the role of these miRNAs in vivo. Most importantly, higher hsa-miR-145 expression in GBM tumors yielded significantly better survival (p<0.005) in a subset of patients thus validating it as a genuine tumor suppressor miRNA. This systematic functional profiling provides important new knowledge about functionally relevant miRNAs in GBM biology and may offer new targets for treating glioma.	[Haapa-Paananen, Saija; Hellstrom, Kirsi; Kohonen, Pekka; Kallioniemi, Olli; Perala, Merja] VTT Tech Res Ctr Finland, Turku, Finland; [Chen, Ping; Hautaniemi, Sampsa] Univ Helsinki, Computat Syst Biol Lab, Inst Biomed, Helsinki, Finland; [Chen, Ping; Hautaniemi, Sampsa] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland; [Kallioniemi, Olli] Univ Helsinki, FIMM Inst Mol Med Finland, Helsinki, Finland	VTT Technical Research Center Finland; University of Helsinki; University of Helsinki; University of Helsinki	Haapa-Paananen, S (corresponding author), VTT Tech Res Ctr Finland, Turku, Finland.	saija.haapa-paananen@vtt.fi	Hautaniemi, Sampsa/CAG-0362-2022; Hautaniemi, Sampsa/A-3122-2009; Kallioniemi, Olli P/H-5111-2011; Kohonen, Pekka/F-9596-2011; Chen, Ping/AAL-8264-2020	Hautaniemi, Sampsa/0000-0002-7749-2694; Hautaniemi, Sampsa/0000-0002-7749-2694; Kallioniemi, Olli P/0000-0002-3231-0332; Kohonen, Pekka/0000-0002-7845-3611; Chen, Ping/0000-0002-8068-1891	Academy of Finland (Translational Genome-Scale Biology Center of Excellence); Academy of Finland (Center of Excellence in Cancer Genetics Research); Finnish Cancer Organisations; Sigrid Juselius foundation; EU-FP6 project RIGHT [LSHB-CT-2004-005276]; Finnish Graduate School in Computational Sciences	Academy of Finland (Translational Genome-Scale Biology Center of Excellence)(Academy of Finland); Academy of Finland (Center of Excellence in Cancer Genetics Research); Finnish Cancer Organisations; Sigrid Juselius foundation(Sigrid Juselius Foundation); EU-FP6 project RIGHT; Finnish Graduate School in Computational Sciences	This work was supported by the Academy of Finland (Translational Genome-Scale Biology Center of Excellence and Center of Excellence in Cancer Genetics Research), Finnish Cancer Organisations, the Sigrid Juselius foundation, EU-FP6 project RIGHT (LSHB-CT-2004-005276), and Finnish Graduate School in Computational Sciences (PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Chen P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr513; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Cittelly DM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-317; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; D'Urso PI, 2012, INT J ONCOL, V41, P228, DOI 10.3892/ijo.2012.1420; Davis F G, 2001, Expert Rev Anticancer Ther, V1, P395, DOI 10.1586/14737140.1.3.395; DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gibcus JH, 2009, NEOPLASIA, V11, P167, DOI 10.1593/neo.08980; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kulkarni AP, 2009, FREE RADICAL RES, V43, P1090, DOI 10.1080/10715760903179673; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	34	40	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60930	10.1371/journal.pone.0060930	http://dx.doi.org/10.1371/journal.pone.0060930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577178	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800113
J	Meng, FJ; Li, H; Shi, HJ; Yang, QX; Zhang, FF; Yang, Y; Kang, LL; Zhen, TT; Dai, SJ; Dong, Y; Han, AJ				Meng, Fengjiao; Li, Hui; Shi, Huijuan; Yang, Qingxu; Zhang, Fenfen; Yang, Yang; Kang, Lili; Zhen, Tiantian; Dai, Sujuan; Dong, Yu; Han, Anjia			MACC1 Down-Regulation Inhibits Proliferation and Tumourigenicity of Nasopharyngeal Carcinoma Cells through Akt/beta-Catenin Signaling Pathway	PLOS ONE			English	Article							COLORECTAL-CANCER; HEPATOCELLULAR-CARCINOMA; MET; MARKER; METASTASIS; EXPRESSION; RECEPTOR; RNA; SUPPRESSION; SURVIVAL	The present study was aimed at investigating the expression of metastasis-associated in colon cancer 1 (MACC1) in nasopharyngeal carcinoma (NPC), its relationship with beta-catenin, Met expression and the clinicopathological features of NPC, and its roles in carcinogenesis of NPC. Our results showed that MACC1 expression was higher in NPC cells and tissues than that in normal nasopharyngeal cells and chronic inflammation of the nasopharynx tissues, respectively. MACC1 expression was closely related to the clinical stage (p = 0.005) and the N classification (p<0.05) of NPC. Significant correlations between MACC1 expression and Met expression (p = 0.003), MACC1 expression and beta-catenin abnormal expression (p = 0.033) were found in NPC tissues. MACC1 knockdown dramatically inhibited cellular proliferation, migration, invasion, and colony formation, but induced apoptosis in NPC cells compared with the control group. Furthermore, MACC1 down-regulation inhibited phosphorylated-Akt (Ser473) and beta-catenin expression in NPC cells, but phosphorylated-Erk1/2 expression was not altered. Further study showed that phosphotidylinsitol-3-kinase inhibitor downregulated beta-catenin and Met expression in NPC cells. There was a significant relationship between MACC1 expression and phosphorylated-Akt expression (p = 0.03), beta-catenin abnormal expression and phosphorylated-Akt expression (p = 0.012) in NPC tissue, respectively. In addition, Epstein Barr virus-encoded oncogene latent membrane protein 1 upregulated MACC1 expression in NPC cells. Our results firstly suggest that MACC1 plays an important role in carcinogenesis of NPC through Akt/beta-catenin signaling pathway. Targeting MACC1 may be a novel therapeutic strategy for NPC.	[Meng, Fengjiao; Li, Hui; Shi, Huijuan; Zhang, Fenfen; Yang, Yang; Kang, Lili; Zhen, Tiantian; Dai, Sujuan; Dong, Yu; Han, Anjia] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Meng, Fengjiao; Li, Hui; Shi, Huijuan; Zhang, Fenfen; Yang, Yang; Kang, Lili; Zhen, Tiantian; Dai, Sujuan; Dong, Yu; Han, Anjia] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Qingxu] Huizhou Municipal Cent Hosp, Dept Pathol, Huizhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Han, AJ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China.	hananjia@mail.sysu.edu.cn			National Natural Science Foundation of China [81272636, 81201582]; Guangdong Province Natural Science Foundation [8151008901000125, S2011010004853]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by National Natural Science Foundation of China (81272636; 81201582) and Guangdong Province Natural Science Foundation (8151008901000125; S2011010004853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Barnes L, 2005, WHO CLASSIFICATION T, P81; Boon EMJ, 2002, CANCER RES, V62, P5126; Dawson CW, 2012, SEMIN CANCER BIOL, V22, P144, DOI 10.1016/j.semcancer.2012.01.004; Edge SB, 2010, AJCC CANC STAGING HD, P63; Gu CD, 2011, ANTICANCER RES, V31, P1141; Hildesheim A, 2012, SEMIN CANCER BIOL, V22, P107, DOI 10.1016/j.semcancer.2012.01.007; Kokoszynska K, 2009, ACTA BIOCHIM POL, V56, P317; Lau PC, 2012, PATHOL ONCOL RES, V18, P357, DOI 10.1007/s12253-011-9452-1; Li YC, 2011, TUMOR BIOL, V32, P1217, DOI 10.1007/s13277-011-0225-y; Maruyama K, 2000, ONCOLOGY-BASEL, V59, P302, DOI 10.1159/000012187; Parkin DM, 2002, IARC SCI PUBLICATION, VVIII; Qian CN, 2002, CANCER RES, V62, P589; Qiu JL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-166; Rasola A, 2007, ONCOGENE, V26, P1078, DOI 10.1038/sj.onc.1209859; Shimokawa H, 2011, J THORAC CARDIOV SUR, V141, P895, DOI 10.1016/j.jtcvs.2010.09.044; Shirahata A, 2011, ANTICANCER RES, V31, P777; Shirahata A, 2010, ANTICANCER RES, V30, P3441; Shirahata A, 2010, ANTICANCER RES, V30, P2689; Song YL, 2012, CANCER EPIDEMIOL, V36, pE116, DOI 10.1016/j.canep.2011.11.002; Stein U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049249; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; YOU S, 2011, TUMOUR BIOL; Zhang FF, 2011, EUR J CANCER, V47, P2060, DOI 10.1016/j.ejca.2011.04.010; Zhang RT, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-83	25	41	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60821	10.1371/journal.pone.0060821	http://dx.doi.org/10.1371/journal.pone.0060821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573286	gold, Green Submitted, Green Published			2022-12-27	WOS:000318840100106
J	Reid, T; Hindell, M; Lavers, JL; Wilcox, C				Reid, Tim; Hindell, Mark; Lavers, Jennifer L.; Wilcox, Chris			Re-Examining Mortality Sources and Population Trends in a Declining Seabird: Using Bayesian Methods to Incorporate Existing Information and New Data	PLOS ONE			English	Article							FLESH-FOOTED SHEARWATERS; PUFFINUS-CARNEIPES; LONGLINE FISHERY; BYCATCH; ISLAND; IMPACT; TUNA	The population of flesh-footed shearwaters (Puffinus carneipes) breeding on Lord Howe Island was shown to be declining from the 1970's to the early 2000's. This was attributed to destruction of breeding habitat and fisheries mortality in the Australian Eastern Tuna and Billfish Fishery. Recent evidence suggests these impacts have ceased; presumably leading to population recovery. We used Bayesian statistical methods to combine data from the literature with more recent, but incomplete, field data to estimate population parameters and trends. This approach easily accounts for sources of variation and uncertainty while formally incorporating data and variation from different sources into the estimate. There is a 70% probability that the flesh-footed shearwater population on Lord Howe continued to decline during 2003-2009, and a number of possible reasons for this are suggested. During the breeding season, road-based mortality of adults on Lord Howe Island is likely to result in reduced adult survival and there is evidence that breeding success is negatively impacted by marine debris. Interactions with fisheries on flesh-footed shearwater winter grounds should be further investigated.	[Reid, Tim; Hindell, Mark; Lavers, Jennifer L.] Univ Tasmania, Inst Marine & Antarctic Studies, Sandy Bay, Tas, Australia; [Reid, Tim; Lavers, Jennifer L.; Wilcox, Chris] Commonwealth Sci & Ind Res Org Marine & Atmospher, Wealth Oceans Natl Flagship, Hobart, Tas, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Reid, T (corresponding author), Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, ZA-7700 Rondebosch, South Africa.	treid@utas.edu.au	Lavers, Jennifer/O-4831-2017; Fennell, Hannah/AAI-1408-2019; Hindell, Mark A/K-1131-2013	Lavers, Jennifer/0000-0001-7596-6588; Hindell, Mark/0000-0002-7823-7185	Australian Government Postgraduates Award; University of Tasmania; CSIRO; Commonwealth Environment Research Facilities Programme; Government of Australia Endeavour Research Fellowship; Gould League of NSW Centenary Cayley Memorial Scholarship; Department of Environment, Water, Heritage and Arts	Australian Government Postgraduates Award(Australian Government); University of Tasmania; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Commonwealth Environment Research Facilities Programme; Government of Australia Endeavour Research Fellowship(Australian GovernmentDepartment of Industry, Innovation and Science); Gould League of NSW Centenary Cayley Memorial Scholarship; Department of Environment, Water, Heritage and Arts	This work was funded by Australian Government Postgraduates Award and a joint University of Tasmania and CSIRO scholarship. Funding for J.L.L. was provided by the Commonwealth Environment Research Facilities Programme, Government of Australia Endeavour Research Fellowship, and a Gould League of NSW Centenary 2010 Cayley Memorial Scholarship. CSIRO and the Department of Environment, Water, Heritage and Arts supplied additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1990, J ANIM ECOL, V59, P1063, DOI 10.2307/5031; Baker G.B., 2010, 2008 NATL ASSESSMENT; Baker GB, 2005, BIOL CONSERV, V126, P306, DOI 10.1016/j.biocon.2005.06.001; Birdlife International, 2008, STAT WORLDS BIRDS; Brooke M, 2004, ALBATROSSES PETRELS; Clover C., 2004, END LINE OVERFISHING; Cochran WG., 1963, SAMPLING TECHNIQUES; Croxall J.P., 1991, Oxford Ornithology Series, P272; Croxall JP, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P46; DECC (Department of Environment Climate Change and Water), 2009, FLESH FOOT SHEARW VU; DEGANGE AR, 1991, CONDOR, V93, P251, DOI 10.2307/1368940; Durham CA, 2004, J AGR RESOUR ECON, V29, P112; Dyer PK, 2001, CORELLA, V26, P38; Gales R, 1998, BIOL CONSERV, V86, P37, DOI 10.1016/S0006-3207(98)00011-1; GOCHFELD M, 1980, AUK, V97, P191; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P117, DOI 10.3354/meps08282; Greig J. C., 1996, P NAT SEAB WORKSH CA; Hamilton S, 1998, NEW ZEAL J ZOOL, V25, P443, DOI 10.1080/03014223.1998.9518167; HAY RB, 1992, J BIOGEOGR, V19, P67, DOI 10.2307/2845621; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Hilborn Ray, 1997, V28; Hutton Ian, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P67; Ito Shin, 2002, Ornithological Science, V1, P159, DOI 10.2326/osj.1.159; Lele SR, 2006, ENVIRONMETRICS, V17, P683, DOI 10.1002/env.786; Lewison RL, 2005, CONSERV BIOL, V21, P79; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; Ogi H, 2008, J DISASTER RES, V3, P187, DOI 10.20965/jdr.2008.p0187; Oka Nariko, 1994, Journal of the Yamashina Institute for Ornithology, V26, P81; Parsons ECM, 2010, J INT WILDLIFE LAW P, V13, P1; Pickard J, 1983, CUNNINGHAMIA, V1, P133; Powell Christopher D. L., 2009, Marine Ornithology, V37, P115; Priddel D, 2006, BIOL CONSERV, V128, P412, DOI 10.1016/j.biocon.2005.10.007; R Foundation for Statistical Computing, 2009, R PROJ STAT COMP; Recher HF, 1974, SURVEY LORD HOWE ISL; Reid TA, 2012, MAR ECOL PROG SER, V447, P231, DOI 10.3354/meps09449; Royle J. A., 2008, HIERARCHICAL MODELIN; Shuntov VP, 1972, SEABIRDS RUSSIAN FAR, P83; Trebilco R, 2010, AQUAT CONSERV, V20, P531, DOI 10.1002/aqc.1115; Tuck GN, 2008, ASSESSING POTENTIAL; WAHL TR, 1989, MAR BIOL, V103, P1, DOI 10.1007/BF00391059; Wanless RM, 2009, BIOL CONSERV, V142, P1710, DOI 10.1016/j.biocon.2009.03.008; Waugh S. M., 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P45; Wilcox C, 2007, FRONT ECOL ENVIRON, V5, P325, DOI 10.1890/1540-9295(2007)5[325:CMAAST]2.0.CO;2	45	23	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e58230	10.1371/journal.pone.0058230	http://dx.doi.org/10.1371/journal.pone.0058230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573188	Green Published, gold, Green Accepted			2022-12-27	WOS:000318840100008
J	Sala, E; Costello, C; Dougherty, D; Heal, G; Kelleher, K; Murray, JH; Rosenberg, AA; Sumaila, R				Sala, Enric; Costello, Christopher; Dougherty, Dawn; Heal, Geoffrey; Kelleher, Kieran; Murray, Jason H.; Rosenberg, Andrew A.; Sumaila, Rashid			A General Business Model for Marine Reserves	PLOS ONE			English	Article							PROTECTED AREAS; REEF FISH; FISHERIES; MANAGEMENT; ADJACENT; BENEFITS; CATCH; IMPACTS	Marine reserves are an effective tool for protecting biodiversity locally, with potential economic benefits including enhancement of local fisheries, increased tourism, and maintenance of ecosystem services. However, fishing communities often fear short-term income losses associated with closures, and thus may oppose marine reserves. Here we review empirical data and develop bioeconomic models to show that the value of marine reserves (enhanced adjacent fishing + tourism) may often exceed the pre-reserve value, and that economic benefits can offset the costs in as little as five years. These results suggest the need for a new business model for creating and managing reserves, which could pay for themselves and turn a profit for stakeholder groups. Our model could be expanded to include ecosystem services and other benefits, and it provides a general framework to estimate costs and benefits of reserves and to develop such business models.	[Sala, Enric] Natl Geog Soc, Washington, DC USA; [Sala, Enric] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain; [Costello, Christopher; Dougherty, Dawn] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Heal, Geoffrey] Columbia Univ, Columbia Business Sch, New York, NY USA; [Kelleher, Kieran] World Bank, Washington, DC 20433 USA; [Murray, Jason H.] Univ S Carolina, Sch Environm, Columbia, SC 29208 USA; [Rosenberg, Andrew A.] Union Concerned Scientists, Cambridge, MA USA; [Sumaila, Rashid] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	National Geographic Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of California System; University of California Santa Barbara; Columbia University; The World Bank; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of British Columbia	Sala, E (corresponding author), Natl Geog Soc, Washington, DC USA.	esala@ngs.org	Sumaila, U. Rashid/ABE-6475-2020		National Geographic Society; Waitt Foundation	National Geographic Society(National Geographic Society); Waitt Foundation	This research was funded by the National Geographic Society and the Waitt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; [Anonymous], [No title captured]; Badalamenti F, 2000, ENVIRON CONSERV, V27, P110, DOI 10.1017/S0376892900000163; Ballesteros E, 2008, MONITORING MARINE PR; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2007, ECON POLICY, P178, DOI 10.1111/j.1468-0327.2007.00174.x; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Buchan K, 1997, 262 CANARI; Burke L., 2004, REEFS RISK CARIBBEAN; Cooke SJ, 2006, OCEAN COAST MANAGE, V49, P342, DOI 10.1016/j.ocecoaman.2006.03.003; Costello C, 2010, AUST J AGR RESOUR EC, V54, P321, DOI 10.1111/j.1467-8489.2010.00495.x; Craig R, 2007, J LAND USE ENV LAW, V22; Dayton PK, 2000, B MAR SCI, V66, P617; FROESE R., 2012, FISHBASE; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Galal N, 2002, MAR FRESHWATER RES, V53, P199, DOI 10.1071/MF01158; Garrabou J, 1998, CONSERV BIOL, V12, P302, DOI 10.1046/j.1523-1739.1998.96417.x; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Goni R., 2011, MARINE PROTECTED ARE, P72; Goni R, 2010, MAR ECOL PROG SER, V400, P233, DOI 10.3354/meps08419; Green E, 2003, AMBIO, V32, P140, DOI 10.1639/0044-7447(2003)032[0140:RSDICM]2.0.CO;2; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hicks CC, 2009, ECOL SOC, V14; Jones PJS, 2008, MAR POLICY, V32, P749, DOI 10.1016/j.marpol.2007.12.009; Kelleher G., 1999, GUIDELINES MARINE PR; Laffoley D., 2009, MANAGEMENT NATURAL C; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Merino G, 2009, ICES J MAR SCI, V66, P147, DOI 10.1093/icesjms/fsn200; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Murray BC, 2011, R1104 NI; NMFS, 2009, SEDAR19DW06 NMFS; Paddack MJ, 2000, ECOL APPL, V10, P855, DOI 10.2307/2641050; Quinn T.J., 1999, BIOL RES MANAG SER; Rassweilier A, 2012, P NATL ACAD IN PRESS; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Sacanell M., 2012, STUDY RECREATIONAL F; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; Sala E, 2001, FISHERIES, V26, P23, DOI 10.1577/1548-8446(2001)026<0023:RDONGS>2.0.CO;2; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; Smith MD, 2006, CAN J FISH AQUAT SCI, V63, P153, DOI 10.1139/F05-205; Sumaila UR, 2006, LAND ECON, V82, P321, DOI 10.3368/le.82.3.321; Tawake A., 2001, CONSERV PRACT, V2, P32, DOI [10.1111/j.1526-4629.2001.tb00020.x, DOI 10.1111/J.1526-4629.2001.TB00020.X]; White C, 2011, ECOL APPL, V21, P350, DOI 10.1890/09-1188.1; Wielgus J, 2009, J ENVIRON MANAGE, V90, P3401, DOI 10.1016/j.jenvman.2009.05.010; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	55	93	94	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e58799	10.1371/journal.pone.0058799	http://dx.doi.org/10.1371/journal.pone.0058799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23573192	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100011
J	Van der Walt, M; Lancaster, J; Odendaal, R; Davis, JG; Shean, K; Farley, J				Van der Walt, Martha; Lancaster, Johanna; Odendaal, Ronel; Davis, Jeanne Garcia; Shean, Karen; Farley, Jason			Serious Treatment Related Adverse Drug Reactions amongst Anti-Retroviral Naive MDR-TB Patients	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; SOUTH-AFRICA; EVENTS	Background: Globally treatment outcomes for multidrug-resistant Mycobacterium tuberculosis (MDR-TB) remain poor and this is compounded by high drug toxicity. Little is known about the influence of adverse drug reactions (ADRs) on treatment outcomes in South Africa. Methods: We evaluated the impact of severe ADRs among a prospective cohort of MDR-TB patients in South Africa (2000-2004). The HIV-infected study participants were anti-retroviral naive. Results: Of 2,079 patients enrolled, 1,390 (66.8%) were included in this analysis based on known HIV test results (39.1% HIV-infected). At least one severe ADR was reported in 83 (6.9%) patients with ototoxicity being the most frequent ADR experienced (38.9%). Conclusions: We found that being HIV-infected but antiretroviral naive did not increase occurrence of SADRs in patients on second-line anti-tuberculosis drugs. Early screening and proactive management of ADRs in this patient population is essential, especially given the rollout of decentralized care and the potential for overlapping toxicity of concomitant MDR-TB and HIV treatment.	[Van der Walt, Martha; Lancaster, Johanna; Odendaal, Ronel; Shean, Karen] South African Med Res Council, TB Epidemiol & Intervent Res Unit, Pretoria, South Africa; [Davis, Jeanne Garcia; Farley, Jason] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA	South African Medical Research Council; Johns Hopkins University	Van der Walt, M (corresponding author), South African Med Res Council, TB Epidemiol & Intervent Res Unit, Pretoria, South Africa.	vdwalt@mrc.ac.za		Farley, Jason/0000-0002-6896-0134	TB directorate, Department of Health in South Africa	TB directorate, Department of Health in South Africa	National pilot, DOTS-Plus project supported by the TB directorate, Department of Health in South Africa. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GUID PROGR MAN DRUG; Bloss E, 2010, INT J TUBERC LUNG D, V14, P275; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; National Department of Health SA, 2010, S AFR ANT TREATM GUI; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Sagwa E, 2012, SO MED REV, V5; Scano F, 2008, INT J TUBERC LUNG D, V12, P1370; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Shin SS, 2007, INT J TUBERC LUNG D, V11, P1314; South African Medical Research Council and the DOTS-plus Study Group of South Africa, 2000, DOTS PLUS MULT RES T; Sterling TR, 2010, CLIN INFECT DIS, V50, pS223, DOI 10.1086/651495; Torun T, 2005, INT J TUBERC LUNG D, V9, P1373; Weyer K, 2007, SAMJ S AFR MED J, V97, P1120; WHO, 2010, GLOB TUB CONTR REP	15	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e58817	10.1371/journal.pone.0058817	http://dx.doi.org/10.1371/journal.pone.0058817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573193	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100012
J	Yen, YM				Yen, Yu-Min			Testing Jumps via False Discovery Rate Control	PLOS ONE			English	Article							DISCRETELY OBSERVED PROCESS; REALIZED VOLATILITY; QUADRATIC VARIATION; FINANCIAL-MARKETS; DEPENDENCE; BOOTSTRAP; VARIANCE	Many recently developed nonparametric jump tests can be viewed as multiple hypothesis testing problems. For such multiple hypothesis tests, it is well known that controlling type I error often makes a large proportion of erroneous rejections, and such situation becomes even worse when the jump occurrence is a rare event. To obtain more reliable results, we aim to control the false discovery rate (FDR), an efficient compound error measure for erroneous rejections in multiple testing problems. We perform the test via the Barndorff-Nielsen and Shephard (BNS) test statistic, and control the FDR with the Benjamini and Hochberg (BH) procedure. We provide asymptotic results for the FDR control. From simulations, we examine relevant theoretical results and demonstrate the advantages of controlling the FDR. The hybrid approach is then applied to empirical analysis on two benchmark stock indices with high frequency data.	Acad Sinica, Inst Econ, Taipei 115, Taiwan	Academia Sinica - Taiwan	Yen, YM (corresponding author), Acad Sinica, Inst Econ, Taipei 115, Taiwan.	YMYEN@econ.sinica.edu.tw						Ait-Sahalia Y, 2009, ANN STAT, V37, P184, DOI 10.1214/07-AOS568; Andersen TG, 2007, REV ECON STAT, V89, P701, DOI 10.1162/rest.89.4.701; Bajgrowicz P, 2011, 1136 SWISS FIN I; Barndorff-Nielsen O. E., 2004, J FINANC ECONOMET, V1, P1, DOI [10.1093/jjfinec/nbh001, DOI 10.1093/JJFINEC/NBH001]; Barndorff-Nielsen O.E., 2006, J FINANC ECONOMET, V4, P1, DOI DOI 10.1093/JJFINEC/NBI022; Barndorff-Nielsen OE, 2002, J APPL ECONOM, V17, P457, DOI 10.1002/jae.691; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bollerslev T, 2008, J ECONOMETRICS, V144, P234, DOI 10.1016/j.jeconom.2008.01.006; Clarke S, 2009, ANN STAT, V37, P332, DOI 10.1214/07-AOS557; Fan JQ, 2007, J AM STAT ASSOC, V102, P1282, DOI 10.1198/016214507000000969; Fan YY, 2011, J ECONOMETRICS, V164, P331, DOI 10.1016/j.jeconom.2011.06.014; Goncalves S, 2011, J ECONOMETRICS, V160, P129, DOI 10.1016/j.jeconom.2010.03.026; Goncalves S, 2009, ECONOMETRICA, V77, P283, DOI 10.3982/ECTA5971; HALL P., 1992, SPRINGER SERIES STAT; Huang X., 2005, J FINANCIAL ECONOMET, V3, P456, DOI [10.1093/jjfinec/nbi025, DOI 10.1093/jjfinec/nbi025, DOI 10.1093/JJFINEC/NBI025]; Jacod J, 2009, ANN STAT, V37, P1792, DOI 10.1214/08-AOS624; Jiang GJ, 2008, J ECONOMETRICS, V144, P352, DOI 10.1016/j.jeconom.2008.04.009; Karatzas I., 2012, BROWNIAN MOTION STOC; Kosorok MR, 2007, ANN STAT, V35, P1456, DOI 10.1214/009053606000001433; Lee SS, 2008, REV FINANC STUD, V21, P2535, DOI 10.1093/rfs/hhm056; Romano JP, 2008, TEST-SPAIN, V17, P417, DOI 10.1007/s11749-008-0126-6; Sarkar SK, 1998, ANN STAT, V26, P494; Sarkar SK, 2002, ANN STAT, V30, P239, DOI 10.1214/aos/1015362192; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tauchen G, 2011, J ECONOMETRICS, V160, P102, DOI 10.1016/j.jeconom.2010.03.023; Veraart AED, 2010, ECONOMET THEOR, V26, P331, DOI 10.1017/S0266466609100014	27	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e58365	10.1371/journal.pone.0058365	http://dx.doi.org/10.1371/journal.pone.0058365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573190	Green Published, gold			2022-12-27	WOS:000318840100009
J	Zhi, XL; Xu, C; Zhang, H; Tian, D; Li, XB; Ning, YX; Yin, LH				Zhi, Xiuling; Xu, Chen; Zhang, Hao; Tian, Dai; Li, Xiaobo; Ning, Yanxia; Yin, Lianhua			Tryptase Promotes Atherosclerotic Plaque Haemorrhage in ApoE-/- Mice	PLOS ONE			English	Article							MAST-CELL TRYPTASE; PLASMINOGEN-ACTIVATOR INHIBITOR-1; HUMAN CAROTID ARTERIES; ENDOTHELIAL-CELLS; INTRAPLAQUE HEMORRHAGE; ANGIOGENESIS; CANCER; GROWTH; CHOLESTEROL; PROGRESSION	Tryptase, the most abundant mast cell (MC) granule protein, plays an important role in atherosclerosis plaque development. To test the hypothesis that tryptase participates directly in atherosclerosis plaque haemorrhage, the gene sequence and siRNA for tryptase were cloned into a lentivirus carrier and atherosclerosis plaque haemorrhage models in ApoE-/- mice were constructed. After a cuffing-cervical artery operation, the mice were randomly divided into 6 groups. Hematoxylin and eosin(HE) staining showed that the cervical artery plaque area was much larger in the tryptase overexpression group compared to the other groups, and there was greater artery stenosis. The artery stenosis from the cuff-side in all groups was more than 90%, except the siRNA group. Tryptase promotes plaque haemorrhage distinctively because 50% of the mice in the tryptase overexpression group had plaque haemorrhage, while only 10% in the siRNA group did. The immunohistochemistry of the cervical artery plaque showed that plasminogen activator inhibitor-1 (PAI-1) expression was the lowest while tissue plasminogen activator (tPA), CD31, CD34 and VEGF was the highest in the tryptase overexpression groups. This observation was completely contrary to what was observed in the siRNA group. Tryptase promoted bEnd.3 cell growth, migration and capillary-like tube formation, which suggests that tryptase can promote microvessel angiogenesis. PAI-1 expression was inhibited, while tPA expression was increased by tryptase in bEnd.3 cells. Our in vivo and in vitro studies suggest that trypase can promote atherosclerotic plaque haemorrhage by promoting angiogenesis and regulating the balance of PAI-1 and tPA. Thus, regulating tryptase expression in MCs may provide a potential target for atherosclerosis treatment.	[Zhi, Xiuling] Fudan Univ, Shanghai Med Coll, Teaching Ctr Expt Med, Lab Med Mol Biol, Shanghai 200433, Peoples R China; [Xu, Chen] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Zhang, Hao; Tian, Dai; Li, Xiaobo; Ning, Yanxia; Yin, Lianhua] Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Yin, LH (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China.	lhyin@shmu.edu.cn	Zhi, Xiuling/P-6492-2019; Ning, Yanxia/F-3262-2014	Zhi, Xiuling/0000-0002-8248-4090; 	National Natural Science Foundation of China [NSFC 30871021, NSFC 81001170, NSFC 81270497, NSFC 81270490, NSFC 81170253]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC 30871021, NSFC 81001170, NSFC 81270497, NSFC 81270490, and NSFC 81170253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELCHER JD, 1991, J LIPID RES, V32, P359; Blair RJ, 1997, J CLIN INVEST, V99, P2691, DOI 10.1172/JCI119458; Bot I, 2011, THROMB HAEMOSTASIS, V106, P820, DOI 10.1160/TH11-05-0291; Compton SJ, 2000, CLIN EXP IMMUNOL, V121, P31, DOI 10.1046/j.1365-2249.2000.01271.x; Conway EM, 2003, PATHOPHYSIOL HAEMO T, V33, P241, DOI 10.1159/000083809; Folsom AR, 2001, ARTERIOSCL THROM VAS, V21, P611, DOI 10.1161/01.ATV.21.4.611; Horrevoets AJG, 2004, BRIT J HAEMATOL, V125, P12, DOI 10.1111/j.1365-2141.2004.04844.x; Ibaraki T, 2005, EUR J CARDIO-THORAC, V28, P617, DOI 10.1016/j.ejcts.2005.06.020; Itoh Y, 2005, J PHARMACOL SCI, V97, P14, DOI 10.1254/jphs.FMJ04005X3; Jeziorska M, 1997, J PATHOL, V182, P115, DOI 10.1002/(SICI)1096-9896(199705)182:1<115::AID-PATH806>3.0.CO;2-9; Jeziorska M, 1999, J PATHOL, V188, P189; Johnson JL, 1998, ARTERIOSCL THROM VAS, V18, P1707, DOI 10.1161/01.ATV.18.11.1707; Kinoshita M, 2005, ARTERIOSCL THROM VAS, V25, P1858, DOI 10.1161/01.ATV.0000174797.71708.97; Kockx MM, 2003, ARTERIOSCL THROM VAS, V23, P440, DOI 10.1161/01.ATV.0000057807.28754.7F; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Kovanen PT, 2007, IMMUNOL REV, V217, P105, DOI 10.1111/j.1600-065X.2007.00515.x; Lappalainen H, 2004, ARTERIOSCL THROM VAS, V24, P1880, DOI 10.1161/01.ATV.0000140820.51174.8d; Lee M, 2002, ARTERIOSCL THROM VAS, V22, P2086, DOI 10.1161/01.ATV.0000041405.07367.B5; Luttun A, 2002, ARTERIOSCL THROM VAS, V22, P499, DOI 10.1161/hq0302.104529; Ma YJ, 2006, BBA-MOL CELL RES, V1763, P313, DOI 10.1016/j.bbamcr.2006.02.002; Malamud V, 2003, J NEUROIMMUNOL, V138, P115, DOI 10.1016/S0165-5728(03)00090-0; McEachron TA, 2011, BLOOD COAGUL FIBRIN, V22, P576, DOI 10.1097/MBC.0b013e3283497647; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moulton K S, 2001, Curr Atheroscler Rep, V3, P225, DOI 10.1007/s11883-001-0065-0; Ranieri G, 2009, INT J ONCOL, V35, P115, DOI 10.3892/ijo_00000319; Ribatti D, 2003, LEUKEMIA, V17, P1428, DOI 10.1038/sj.leu.2402970; Ribatti D, 2008, ANN MED, V40, P606, DOI 10.1080/07853890802186913; Sendo T, 2003, CELL SIGNAL, V15, P773, DOI 10.1016/S0898-6568(03)00014-7; Sobel BE, 2003, ARTERIOSCL THROM VAS, V23, P1979, DOI 10.1161/01.ATV.0000091250.53231.4D; Tang YL, 2009, CHINESE MED J-PEKING, V122, P319, DOI 10.3760/cma.j.issn.0366-6999.2009.03.016; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Yeong PS, 2010, BBA-MOL CELL BIOL L, V1801, P567, DOI 10.1016/j.bbalip.2010.01.011; Zhi XL, 2007, CLIN EXP METASTAS, V24, P439, DOI 10.1007/s10585-007-9081-y	34	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60960	10.1371/journal.pone.0060960	http://dx.doi.org/10.1371/journal.pone.0060960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573292	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100110
J	Bidelman, GM; Hutka, S; Moreno, S				Bidelman, Gavin M.; Hutka, Stefanie; Moreno, Sylvain			Tone Language Speakers and Musicians Share Enhanced Perceptual and Cognitive Abilities for Musical Pitch: Evidence for Bidirectionality between the Domains of Language and Music	PLOS ONE			English	Article							BRAIN-STEM; LINGUISTIC EXPERIENCE; TRAINING INFLUENCES; FOREIGN-LANGUAGE; ABSOLUTE PITCH; WORKING-MEMORY; LEXICAL TONES; SPEECH; MANDARIN; SKILLS	Psychophysiological evidence suggests that music and language are intimately coupled such that experience/training in one domain can influence processing required in the other domain. While the influence of music on language processing is now well-documented, evidence of language-to-music effects have yet to be firmly established. Here, using a cross-sectional design, we compared the performance of musicians to that of tone-language (Cantonese) speakers on tasks of auditory pitch acuity, music perception, and general cognitive ability (e. g., fluid intelligence, working memory). While musicians demonstrated superior performance on all auditory measures, comparable perceptual enhancements were observed for Cantonese participants, relative to English-speaking nonmusicians. These results provide evidence that tone-language background is associated with higher auditory perceptual performance for music listening. Musicians and Cantonese speakers also showed superior working memory capacity relative to nonmusician controls, suggesting that in addition to basic perceptual enhancements, tone-language background and music training might also be associated with enhanced general cognitive abilities. Our findings support the notion that tone language speakers and musically trained individuals have higher performance than English-speaking listeners for the perceptual-cognitive processing necessary for basic auditory as well as complex music perception. These results illustrate bidirectional influences between the domains of music and language.	[Bidelman, Gavin M.] Univ Memphis, Inst Intelligent Syst, Memphis, TN 38152 USA; [Bidelman, Gavin M.] Univ Memphis, Sch Commun Sci & Disorders, Memphis, TN 38152 USA; [Hutka, Stefanie] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Hutka, Stefanie; Moreno, Sylvain] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada	University of Memphis; University of Memphis; University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest	Bidelman, GM (corresponding author), Univ Memphis, Inst Intelligent Syst, Memphis, TN 38152 USA.	g.bidelman@memphis.edu	Bidelman, Gavin M/D-9998-2016	Bidelman, Gavin M/0000-0002-1821-3261	GRAMMY Foundation(R)	GRAMMY Foundation(R)	This research was supported by a grant from the GRAMMY Foundation (R) awarded to GMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2000, FRONT BIOSCI-LANDMRK, V5, pD202, DOI 10.2741/Alain; Aldwell Edward, 2011, HARMONY VOICE LEADIN; Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bent T, 2006, J EXP PSYCHOL HUMAN, V32, P97, DOI 10.1037/0096-1523.32.1.97; Bhagat SP, 2004, HEARING RES, V193, P51, DOI 10.1016/j.heares.2004.04.005; Bialystok E, 2009, J EXP PSYCHOL HUMAN, V35, P565, DOI 10.1037/a0012735; Bidebnan GM, 2010, BRAIN RES, V1355, P112, DOI 10.1016/j.brainres.2010.07.100; Bidelman GM, 2011, BRAIN COGNITION, V77, P1, DOI 10.1016/j.bandc.2011.07.006; Bidelman GM, 2011, EUR J NEUROSCI, V33, P530, DOI 10.1111/j.1460-9568.2010.07527.x; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRADLEY JV, 1958, J AM STAT ASSOC, V53, P525, DOI 10.2307/2281872; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Chandrasekaran B, 2009, BRAIN LANG, V108, P1, DOI 10.1016/j.bandl.2008.02.001; COOK RD, 1979, J AM STAT ASSOC, V74, P169, DOI 10.2307/2286747; Cooper A, 2012, J ACOUST SOC AM, V131, P4756, DOI 10.1121/1.4714355; Corsi PM, 1972, DEP PSYCHOL; DEARY IJ, 1995, DEV PSYCHOL, V31, P237, DOI 10.1037/0012-1649.31.2.237; Delogu F, 2010, EUR J COGN PSYCHOL, V22, P46, DOI 10.1080/09541440802708136; Delogu Franco, 2006, Cogn Process, V7, P203, DOI 10.1007/s10339-006-0146-7; Deutsch D, 2006, J ACOUST SOC AM, V119, P719, DOI 10.1121/1.2151799; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Ellis RJ, 2012, NEUROIMAGE, V60, P1902, DOI 10.1016/j.neuroimage.2012.01.138; Francis AL, 2008, J PHONETICS, V36, P268, DOI 10.1016/j.wocn.2007.06.005; Franklin MS, 2008, PSYCHOL MUSIC, V36, P353, DOI 10.1177/0305735607086044; GANDOUR J, 1981, J CHINESE LINGUIST, V9, P20; George EM, 2011, NEUROPSYCHOLOGIA, V49, P1083, DOI 10.1016/j.neuropsychologia.2011.02.001; Giuliano RJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00146; Hansen M, 2013, PSYCHOL MUSIC, V41, P779, DOI 10.1177/0305735612452186; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Jesteadt W, 2005, PERCEPT PSYCHOPHYS, V67, P72, DOI 10.3758/BF03195013; Johnson RA., 2007, APPL MULTIVARIATE ST; Khouw E, 2007, J PHONETICS, V35, P104, DOI 10.1016/j.wocn.2005.10.003; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krizman J, 2012, P NATL ACAD SCI USA, V109, P7877, DOI 10.1073/pnas.1201575109; Lee CY, 2008, J ACOUST SOC AM, V124, P3235, DOI 10.1121/1.2990713; Lee CY, 2010, J ACOUST SOC AM, V127, P481, DOI 10.1121/1.3266683; Levitin DJ, 2005, TRENDS COGN SCI, V9, P26, DOI 10.1016/j.tics.2004.11.007; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li P, 2006, BEHAV RES METHODS, V38, P202, DOI 10.3758/BF03192770; Macmillan NA, 2005, DETECTION THEORY USE; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Marie C, 2011, J COGNITIVE NEUROSCI, V23, P2701, DOI 10.1162/jocn.2010.21585; Marie C, 2011, J COGNITIVE NEUROSCI, V23, P294, DOI 10.1162/jocn.2010.21413; Marques C, 2007, J COGNITIVE NEUROSCI, V19, P1453, DOI 10.1162/jocn.2007.19.9.1453; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Milovanov R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00321; Milovanov R, 2009, NEUROSCI LETT, V460, P161, DOI 10.1016/j.neulet.2009.05.063; Moreno S, 2011, MUSIC PERCEPT, V29, P165, DOI 10.1525/MP.2011.29.2.165; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Moreno S, 2010, J NEUROLINGUIST, V23, P564, DOI 10.1016/j.jneuroling.2010.05.002; Moreno S, 2009, CONTEMP MUSIC REV, V28, P329, DOI 10.1080/07494460903404410; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Musacchia G, 2008, HEARING RES, V241, P34, DOI 10.1016/j.heares.2008.04.013; Nan Y, 2010, BRAIN, V133, P2635, DOI 10.1093/brain/awq178; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; Peng G, 2006, J CHINESE LINGUIST, V34, P134; Pfordresher PQ, 2009, ATTEN PERCEPT PSYCHO, V71, P1385, DOI 10.3758/APP.71.6.1385; Raven J., 1998, ADV PROGR MATRICES; Russo FA, 2012, EAR HEARING, V33, P177, DOI 10.1097/AUD.0b013e318233acee; Schellenberg EG, 2008, TRENDS COGN SCI, V12, P45, DOI 10.1016/j.tics.2007.11.005; Schellenberg EG, 2008, MUSIC PERCEPT, V25, P241, DOI 10.1525/MP.2008.25.3.241; Schellenberg EG, 2010, PSYCHOL MUSIC, V38, P209, DOI 10.1177/0305735609339473; Schellenberg EG, 2004, PSYCHOL SCI, V15, P511, DOI 10.1111/j.0956-7976.2004.00711.x; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Schulze K, 2012, ANN NY ACAD SCI, V1252, P229, DOI 10.1111/j.1749-6632.2012.06447.x; Schulze K, 2012, MUSIC PERCEPT, V29, P255, DOI 10.1525/MP.2012.29.3.255; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Slevc LR, 2009, PSYCHON B REV, V16, P374, DOI 10.3758/16.2.374; STAGRAY JR, 1993, J CHINESE LINGUIST, V21, P143; Steinke WR, 1997, CAN J EXP PSYCHOL, V51, P316, DOI 10.1037/1196-1961.51.4.316; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; Thompson WF, 2004, EMOTION, V4, P46, DOI 10.1037/1528-3542.4.1.46; Vuust P, 2006, NEUROIMAGE, V31, P832, DOI 10.1016/j.neuroimage.2005.12.037; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wong PCM, 2007, APPL PSYCHOLINGUIST, V28, P565, DOI 10.1017/S0142716407070312; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Wong PCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033424; Zatorre RJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001372	90	167	170	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60676	10.1371/journal.pone.0060676	http://dx.doi.org/10.1371/journal.pone.0060676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	127RY	23565267	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300138
J	Narlik-Grassow, M; Blanco-Aparicio, C; Cecilia, Y; Perez, M; Munoz-Galvan, S; Canamero, M; Carnero, A				Narlik-Grassow, Maja; Blanco-Aparicio, Carmen; Cecilia, Yolanda; Perez, Marco; Munoz-Galvan, Sandra; Canamero, Marta; Carnero, Amancio			Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; C-MYC; PROTEIN-KINASE; SERINE/THREONINE KINASES; PANCREATIC-CANCER; LYMPHOID TUMORS; HIGH-FREQUENCY; UP-REGULATION; N-MYC; ANDROGEN	The Pim proteins are a family of highly homologous protein serine/threonine kinases that have been found to be overexpressed in cancer. Elevated levels of Pim1 kinase were first discovered in human leukemia and lymphomas. However, more recently Pim1 was found to be increased in solid tumors, including pancreatic and prostate cancers, and has been proposed as a prognostic marker. Although the Pim kinases have been identified as oncogenes in transgenic models, they have weak transforming abilities on their own. However, they have been shown to greatly enhance the ability of other genes or chemical carcinogens to induce tumors. To explore the role of Pim1 in prostate cancer, we generated conditional Pim1 transgenic mice, expressed Pim1 in prostate epithelium, and analyzed the contribution of PIM1 to neoplastic initiation and progression. Accordingly, we explored the effect of PIM1 overexpression in 3 different settings: upon hormone treatment, during aging, and in combination with the absence of one Pten allele. We have found that Pim1 overexpression increased the severity of mouse prostate intraepithelial neoplasias (mPIN) moderately in all three settings. Furthermore, Pim1 overexpression, in combination with the hormone treatment, increased inflammation surrounding target tissues leading to pyelonephritis in transgenic animals. Analysis of senescence induced in these prostatic lesions showed that the lesions induced in the presence of inflammation exhibited different behavior than those induced in the absence of inflammation. While high grade prostate preneoplastic lesions, mPIN grades III and IV, in the presence of inflammation did not show any senescence markers and demonstrated high levels of Ki67 staining, untreated animals without inflammation showed senescence markers and had low levels of Ki67 staining in similar high grade lesions. Our data suggest that Pim1 might contribute to progression rather than initiation in prostate neoplasia.	[Narlik-Grassow, Maja; Blanco-Aparicio, Carmen; Cecilia, Yolanda] Spanish Natl Canc Res Ctr, Expt Therapeut Programme, Madrid, Spain; [Canamero, Marta] Spanish Natl Canc Res Ctr, Biotechnol Programme, Madrid, Spain; [Perez, Marco; Munoz-Galvan, Sandra; Carnero, Amancio] Univ Seville, Consejo Super Invest Cient, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Carnero, A (corresponding author), Univ Seville, Consejo Super Invest Cient, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain.	acarnero-ibis@us.es	Blanco-Aparicio, Carmen/I-3162-2015; Muñoz-Galván, Sandra/K-5827-2015; /AAI-3238-2021; Renner, Oliver/M-7002-2015; IBIS, CANCER/P-3323-2015	Blanco-Aparicio, Carmen/0000-0002-3249-6595; Renner, Oliver/0000-0002-4046-0517; Perez, Marco/0000-0001-6997-9593; Carnero, Amancio/0000-0003-4357-3979; Munoz-Galvan, Sandra/0000-0003-0579-325X	Spanish Ministry of Science and Innovation [SAF2009-08605]; Consejeria de Ciencia e Innovacion and Consejeria de Salud of the Junta de Andalucia [CTS-6844, PI-0142]; Fundacion Oncologica FERO; Fundacio Josep Botet; Spanish Ministry of Science and Innovation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Ciencia e Innovacion and Consejeria de Salud of the Junta de Andalucia(Junta de Andalucia); Fundacion Oncologica FERO; Fundacio Josep Botet; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the Spanish Ministry of Science and Innovation and Feder Funds (SAF2009-08605), Consejeria de Ciencia e Innovacion and Consejeria de Salud of the Junta de Andalucia (CTS-6844 and PI-0142). AC's laboratory is also funded by a fellowship from the Fundacion Oncologica FERO, supported by the Fundacio Josep Botet. MN-G was funded by a fellowship from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho TL, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-21; Aho TLT, 2005, IMMUNOLOGY, V116, P82, DOI 10.1111/j.1365-2567.2005.02201.x; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Allen JD, 1996, SEMIN CANCER BIOL, V7, P299, DOI 10.1006/scbi.1996.0038; Allen JD, 1997, ONCOGENE, V15, P1133, DOI 10.1038/sj.onc.1201288; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Block KM, 2012, PANCREAS, V41, P773, DOI 10.1097/MPA.0b013e31823cdd10; Bostwick DG, 2003, PROSTATE, V55, P187, DOI 10.1002/pros.10224; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; BREUER M, 1989, NATURE, V340, P61, DOI 10.1038/340061a0; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen J, 2009, ONCOGENE, V28, P2581, DOI 10.1038/onc.2009.124; Chen J, 2009, AM J PATHOL, V175, P400, DOI 10.2353/ajpath.2009.080972; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cibull TL, 2006, J CLIN PATHOL, V59, P285, DOI 10.1136/jcp.2005.027672; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; CUYPERS HT, 1986, HUM GENET, V72, P262, DOI 10.1007/BF00291892; Dai H, 2005, PROSTATE, V65, P276, DOI 10.1002/pros.20294; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Eichmann A, 2000, ONCOGENE, V19, P1215, DOI 10.1038/sj.onc.1203355; Evans KR, 2007, CANCER LETT, V249, P1, DOI 10.1016/j.canlet.2006.12.033; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Freeman KW, 2003, CANCER RES, V63, P8256; Gerald WL, 2012, ONCOGENE; Gu JJ, 2009, ONCOGENE, V28, P4261, DOI 10.1038/onc.2009.276; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Hogan C, 2008, J BIOL CHEM, V283, P18012, DOI 10.1074/jbc.M709695200; Hoover DS, 1997, CELL GROWTH DIFFER, V8, P1371; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Ishibashi Y, 2001, FEBS LETT, V506, P33, DOI 10.1016/S0014-5793(01)02881-2; Jackson LJ, 2012, CELL IMMUNOL, V272, P200, DOI 10.1016/j.cellimm.2011.10.011; Kim J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-248; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Lamont KR, 2010, ADV CANCER RES, V107, P137, DOI 10.1016/S0065-230X(10)07005-3; Li YY, 2011, CANC SCI; Li Z, 2006, CARCINOGENESIS, V27, P1054, DOI 10.1093/carcin/bgi324; Linn DE, 2012, J BIOL CHEM, V287, P22959, DOI 10.1074/jbc.M111.338350; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mizuno K, 2001, BIOCHEM BIOPH RES CO, V281, P663, DOI 10.1006/bbrc.2001.4405; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; MOROY T, 1991, ONCOGENE, V6, P1941; Mumenthaler SM, 2009, MOL CANCER THER, V8, P2882, DOI 10.1158/1535-7163.MCT-09-0293; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Nga ME, 2010, INT J EXP PATHOL, V91, P34, DOI 10.1111/j.1365-2613.2009.00673.x; Nihira K, 2010, CELL DEATH DIFFER, V17, P689, DOI 10.1038/cdd.2009.174; Owaki T, 2008, J IMMUNOL, V180, P2903, DOI 10.4049/jimmunol.180.5.2903; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Peltola KJ, 2004, BLOOD, V103, P3744, DOI 10.1182/blood-2003-09-3126; Peregrina S, 2012, CARCINOGENESIS; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; Roy-Burman P, 2004, ENDOCR-RELAT CANCER, V11, P225, DOI 10.1677/erc.0.0110225; Scherl A, 2004, PROSTATE, V59, P448, DOI 10.1002/pros.20020; SELTEN G, 1986, CELL, V46, P603, DOI 10.1016/0092-8674(86)90886-X; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Shay KP, 2005, MOL CANCER RES, V3, P170; STORER RD, 1995, CARCINOGENESIS, V16, P285, DOI 10.1093/carcin/16.2.285; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; THEYER G, 1992, LAB INVEST, V66, P96; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Valdman A, 2004, PROSTATE, V60, P367, DOI 10.1002/pros.20064; Valkenburg KC, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/895238; van der Poel HG, 2010, UROL INT, V84, P212, DOI 10.1159/000277601; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Wang J, 2012, ONCOGENE, V31, P1794, DOI 10.1038/onc.2011.371; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang Z, 2001, J Vet Sci, V2, P167; Wang ZP, 2005, NUCLEIC ACIDS RES, V33, P2248, DOI 10.1093/nar/gki523; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; White E, 2003, GENE DEV, V17, P1813, DOI 10.1101/gad.1123103; WINGETT D, 1995, CELL IMMUNOL, V162, P123, DOI 10.1006/cimm.1995.1059; Winn LM, 2003, CELL CYCLE, V2, P258, DOI 10.4161/cc.2.3.383; Wu Y, 2010, ONCOGENE, V29, P2228, DOI 10.1038/onc.2009.504; Xu Y, 2005, J SURG ONCOL, V92, P326, DOI 10.1002/jso.20325; Yadav N, 2012, MINERVA UROL NEFROL, V64, P35; Yatkin E, 2009, INT J ANDROL, V32, P399, DOI 10.1111/j.1365-2605.2008.00930.x; Zemskova M, 2010, MOL CANCER RES, V8, P1126, DOI 10.1158/1541-7786.MCR-10-0174; Zhang F, 2009, CANCER BIOL THER, V8, P846, DOI 10.4161/cbt.8.9.8210; Zhang T, 2010, J SURG ONCOL, V101, P513, DOI 10.1002/jso.21524; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhao Y, 2008, ONCOGENE, V27, P1, DOI 10.1038/sj.onc.1210625	91	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60277	10.1371/journal.pone.0060277	http://dx.doi.org/10.1371/journal.pone.0060277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565217	gold, Green Submitted, Green Published			2022-12-27	WOS:000317717300086
J	Seibert, AM; Koblitz, JC; Denzinger, A; Schnitzler, HU				Seibert, Anna-Maria; Koblitz, Jens C.; Denzinger, Annette; Schnitzler, Hans-Ulrich			Scanning Behavior in Echolocating Common Pipistrelle Bats (Pipistrellus pipistrellus)	PLOS ONE			English	Article							BIG BROWN BATS; SONAR BEAM PATTERN; EYE-MOVEMENTS; PREY CAPTURE; FLIGHT; PLASTICITY; SIGNALS; FIELD	Echolocating bats construct an auditory world sequentially by analyzing successive pulse-echo pairs. Many other mammals rely upon a visual world, acquired by sequential foveal fixations connected by visual gaze saccades. We investigated the scanning behavior of bats and compared it to visual scanning. We assumed that each pulse-echo pair evaluation corresponds to a foveal fixation and that sonar beam movements between pulses can be seen as acoustic gaze saccades. We used a two-dimensional 16 microphone array to determine the sonar beam direction of succeeding pulses and to characterize the three dimensional scanning behavior in the common pipistrelle bat (Pipistrellus pipistrellus) flying in the field. We also used variations of signal amplitude of single microphone recordings as indicator for scanning behavior in open space. We analyzed 33 flight sequences containing more than 700 echolocation calls to determine bat positions, source levels, and beam aiming. When searching for prey and orienting in space, bats moved their sonar beam in all directions, often alternately back and forth. They also produced sequences with irregular or no scanning movements. When approaching the array, the scanning movements were much smaller and the beam was moved over the array in small steps. Differences in the scanning pattern at various recording sites indicated that the scanning behavior depended on the echolocation task that was being performed. The scanning angles varied over a wide range and were often larger than the maximum angle measurable by our array. We found that echolocating bats use a "saccade and fixate" strategy similar to vision. Through the use of scanning movements, bats are capable of finding and exploring targets in a wide search cone centered along flight direction.	[Seibert, Anna-Maria; Koblitz, Jens C.; Denzinger, Annette; Schnitzler, Hans-Ulrich] Univ Tubingen, Inst Neurobiol, Tubingen, Germany	Eberhard Karls University of Tubingen	Seibert, AM (corresponding author), Univ Tubingen, Inst Neurobiol, Tubingen, Germany.	anni.seibert@googlemail.com			Werner Reichardt-Centre for Integrated Neuroscience at the University of Tubingen [S.51.40001.2]; Deutsche Forschungsgemeinschaft [SFB 550, Schn 138/27-1]	Werner Reichardt-Centre for Integrated Neuroscience at the University of Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Werner Reichardt-Centre for Integrated Neuroscience at the University of Tubingen (S.51.40001.2; www.cin.uni-tuebingen.de) and by the Deutsche Forschungsgemeinschaft (SFB 550 and Schn 138/27-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS RA, 1988, J EXP PSYCHOL HUMAN, V14, P428, DOI 10.1037/0096-1523.14.3.428; Brinklov S, 2010, BEHAV ECOL SOCIOBIOL, V64, P1867, DOI 10.1007/s00265-010-0998-9; Chiu C, 2010, J EXP BIOL, V213, P3348, DOI 10.1242/jeb.044818; Denzinger A, 2001, J COMP PHYSIOL A, V187, P521, DOI 10.1007/s003590100223; Ghose K, 2006, J NEUROSCI, V26, P1704, DOI 10.1523/JNEUROSCI.4315-05.2006; Ghose K, 2003, J ACOUST SOC AM, V114, P1120, DOI 10.1121/1.1589754; Ghose K, 2007, J ACOUST SOC AM, V122, P3717, DOI 10.1121/1.2799491; Goldberg M. E, 2000, PRINCIPLES NEURAL SC, P782; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Hardiess G, 2008, J VISION, V8, DOI 10.1167/8.1.7; HARTLEY DJ, 1989, J ACOUST SOC AM, V86, P8, DOI 10.1121/1.398225; Hiryu S, 2007, J ACOUST SOC AM, V121, P1749, DOI 10.1121/1.2431337; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Jakobsen L, 2013, NATURE, V493, P93, DOI 10.1038/nature11664; Jensen ME, 1999, BEHAV ECOL SOCIOBIOL, V47, P60, DOI 10.1007/s002650050650; KALKO EKV, 1995, ANIM BEHAV, V50, P861, DOI 10.1016/0003-3472(95)80090-5; KALKO EKV, 1993, BEHAV ECOL SOCIOBIOL, V33, P415; Koblitz JC, 2009, WORKSH 5 AN SON S KY; Koblitz JC, 2011, J ACOUST SOC AM, V130, P3090, DOI 10.1121/1.3628345; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; Land MF, 2004, EXP BRAIN RES, V159, P151, DOI 10.1007/s00221-004-1951-9; Madsen PT, 2007, DEEP-SEA RES PT I, V54, P1421, DOI 10.1016/j.dsr.2007.04.020; MASTERS WM, 1985, SCIENCE, V228, P1331, DOI 10.1126/science.4001947; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1992, CAN J PSYCHOL, V46, P342, DOI 10.1037/h0084328; Schaub A, 2007, BEHAV ECOL SOCIOBIOL, V61, P513, DOI 10.1007/s00265-006-0279-9; SCHNITZLER HU, 1987, J COMP PHYSIOL A, V161, P267, DOI 10.1007/BF00615246; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Siemers BM, 2001, BEHAV ECOL SOCIOBIOL, V50, P317, DOI 10.1007/s002650100379; Stilz P, 2006, J ACOUST SOC AM, V120, P3324; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Surlykke A, 2008, P ROYAL SOC B, V276, P853; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620; Webster FA, 1965, 65172 US AIR FORC	35	38	38	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60752	10.1371/journal.pone.0060752	http://dx.doi.org/10.1371/journal.pone.0060752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580164	Green Published, gold			2022-12-27	WOS:000317898000060
J	Wu, W; Liang, XL; Zhao, HY; Xu, TT; Liu, XD				Wu, Wei; Liang, Xin Li; Zhao, Hai Yang; Xu, Ting Ting; Liu, Xiang Dong			Special Plant Species Determines Diet Breadth of Phytophagous Insects: A Study on Host Plant Expansion of the Host-Specialized Aphis gossypii Glover	PLOS ONE			English	Article							ENEMY-FREE SPACE; COTTON APHID; DIVERSITY; EVOLUTION; SPECIFICITY; RANGE; MELON; CUCURBITACINS	Host specialization is a ubiquitous character of phytophagous insects. The polyphagous population is usually composed of some subpopulations that can use only a few closely related plants. Cotton-melon aphids, Aphis gossypii Glover exhibited strong host specialization, and the cotton-and cucurbits-specialized biotypes had been clearly identified. However, the experimental work that addressed the roles of plant species in determining diet breadth of phytophagous insects is rare. In the present study, we took the artificial host transfer method to assess the role of two special plants, zucchini Cucurbita zucchini L. and cowpea Vigna unguiculata (Linn.) Walp, in regulating diet breadth of cotton-and cucurbits-specialized A. gossypii collected from cotton and cucumber fields and reared separately on the native host plant for ten years. The results showed that the cotton-specialized aphids did not directly use cucumber whereas the cucurbits-specialized did not use cotton regardless of the coexistence or separation of cotton and cucumber plants. Neither of the cotton-and cucurbits-specialized aphids could use capsicum Capsicum annuum, eggplant Solanum melongenahttp://en.wikipedia.org/wiki/Carolus_Linnaeus, tomato Solanum lycopersicum, maize Zea mayshttp://en.wikipedia.org/wiki/Carl_Linnaeus, and radish Raphanus sativus, however, both of them could use zucchini and cowpea. Moreover, the feeding experience on zucchini led the cotton-specialized aphids to use cucumber well and finally to be transformed into the cucurbits-specialized biotype. The short-term feeding experience on cowpea resulted in the diet breadth expansion of the cucurbits-specialized aphids to use cotton. On the other hand, the diet breadth expansion of the cucurbits- and cotton-specialized aphids was only realized by different species of plant. It concluded that the special host plant did induce the conversion of feeding habits in the cotton- and cucurbits-specialized aphids, and consequently broke the host specialization. The plant species is an underlying factor to determine the diet breadth of phytophagous insects.	[Wu, Wei; Liang, Xin Li; Zhao, Hai Yang; Xu, Ting Ting; Liu, Xiang Dong] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, XD (corresponding author), Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	liuxd@njau.edu.cn			National Natural Science Foundation of China [31070377]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant no. 31070377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P500, DOI 10.1890/0012-9658(2000)081[0500:HREAAT]2.0.CO;2; Barrett LG, 2012, TRENDS PLANT SCI, V17, P282, DOI 10.1016/j.tplants.2012.02.009; Becerra JX, 1999, P NATL ACAD SCI USA, V96, P12626, DOI 10.1073/pnas.96.22.12626; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; Bennett GM, 2012, MOL PHYLOGENET EVOL, V65, P705, DOI 10.1016/j.ympev.2012.07.024; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bernays EA, 1999, P ROY SOC B-BIOL SCI, V266, P151, DOI 10.1098/rspb.1999.0615; BERNAYS EA, 1989, EVOL ECOL, V3, P299, DOI 10.1007/BF02285261; Blackman RL, 2000, APHIS WORLDS CROPS I; Brevault T, 2008, AGR FOREST ENTOMOL, V10, P215, DOI 10.1111/j.1461-9563.2008.00377.x; Charaabi K, 2008, B ENTOMOL RES, V98, P333, DOI 10.1017/S0007485307005585; Chen JQ, 1999, PHYTOCHEMISTRY, V50, P1117, DOI 10.1016/S0031-9422(98)00686-4; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; DETHIER VG, 1954, EVOLUTION, V8, P33, DOI 10.2307/2405664; Ding Jin-Hua, 1995, Entomological Knowledge, V32, P141; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Forister ML, 2012, ECOLOGY, V93, P981, DOI 10.1890/11-0650.1; FOX LR, 1981, SCIENCE, V211, P887, DOI 10.1126/science.211.4485.887; Fuller SJ, 1999, MOL ECOL, V8, P1867, DOI 10.1046/j.1365-294x.1999.00782.x; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Futuyma DJ, 1997, EVOULTIONARY BIOL; Gao Xue, 2008, Acta Entomologica Sinica, V51, P40; Gratton C, 1999, ECOLOGY, V80, P773, DOI 10.1890/0012-9658(1999)080[0773:DEFSEE]2.0.CO;2; GULDEMOND JA, 1994, ENVIRON ENTOMOL, V23, P1235, DOI 10.1093/ee/23.5.1235; INAIZUMI M, 1981, Kontyu, V49, P219; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Janz N, 1997, P ROY SOC B-BIOL SCI, V264, P701, DOI 10.1098/rspb.1997.0100; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Koizumi T, 1999, ENTOMOL EXP APPL, V93, P165, DOI 10.1023/A:1003819426067; KRING JAMES B., 1959, ANN ENT SOC AMER, V52, P284, DOI 10.1093/aesa/52.3.284; Liu XD, 2010, ENVIRON ENTOMOL, V39, P1878, DOI 10.1603/EN09210; Liu XD, 2008, ECOL RES, V23, P919, DOI 10.1007/s11284-007-0458-9; Liu Xiang-dong, 2003, Scientia Agricultura Sinica, V36, P54; Liu Xiang-Dong, 2004, Acta Entomologica Sinica, V47, P768; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; MIRO M, 1995, PHYTOTHER RES, V9, P159, DOI 10.1002/ptr.2650090302; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Murphy SM, 2004, P NATL ACAD SCI USA, V101, P18048, DOI 10.1073/pnas.0406490102; Nosil P, 2002, EVOLUTION, V56, P1701, DOI 10.1111/j.0014-3820.2002.tb01482.x; Rehm S., 1957, J SCIENCE FOOD AGRIC, V8, P679, DOI DOI 10.1002/JSFA.2740081203; Singer MS, 2004, ECOLOGY, V85, P2747, DOI 10.1890/03-0827; Tallamy DW, 1997, ENVIRON ENTOMOL, V26, P678, DOI 10.1093/ee/26.3.678; Thompson JD., 1994, COEVOLUTIONARY PROCE; Vanlerberghe-Masutti F, 1999, MOL ECOL, V8, P693, DOI 10.1046/j.1365-294x.1999.00876.x; Wiklund C, 2008, OECOLOGIA, V157, P287, DOI 10.1007/s00442-008-1077-z; Zhang Fan, 2012, Nanjing Nongye Daxue Xuebao, V35, P65; ZHANG GX, 1982, SINOZOOLOGIA, V2, P7	48	13	15	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60832	10.1371/journal.pone.0060832	http://dx.doi.org/10.1371/journal.pone.0060832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580128	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000075
J	Correia, M; Michel, V; Osorio, H; El Ghachi, M; Bonis, M; Boneca, IG; De Reuse, H; Matos, AA; Lenormand, P; Seruca, R; Figueiredo, C; Machado, JC; Touati, E				Correia, Marta; Michel, Valerie; Osorio, Hugo; El Ghachi, Meriem; Bonis, Mathilde; Boneca, Ivo G.; De Reuse, Hilde; Matos, Antonio A.; Lenormand, Pascal; Seruca, Raquel; Figueiredo, Ceu; Machado, Jose Carlos; Touati, Eliette			Crosstalk between Helicobacter pylori and Gastric Epithelial Cells Is Impaired by Docosahexaenoic Acid	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSPEPTIDASE; FATTY-ACIDS; GASTROINTESTINAL-TRACT; MESSENGER-RNA; AGS CELLS; EXPRESSION; CANCER; INFECTION; RESPONSES; METABOLISM	H. pylori colonizes half of the world's population leading to gastritis, ulcers and gastric cancer. H. pylori strains resistant to antibiotics are increasing which raises the need for alternative therapeutic approaches. Docosahexaenoic acid (DHA) has been shown to decrease H. pylori growth and its associated-inflammation through mechanisms poorly characterized. We aimed to explore DHA action on H. pylori-mediated inflammation and adhesion to gastric epithelial cells (AGS) and also to identify bacterial structures affected by DHA. H. pylori growth and metabolism was assessed in liquid cultures. Bacterial adhesion to AGS cells was visualized by transmission electron microscopy and quantified by an Enzyme Linked Immunosorbent Assay. Inflammatory proteins were assessed by immunoblotting in infected AGS cells, previously treated with DHA. Bacterial total and outer membrane protein composition was analyzed by 2-dimensional gel electrophoresis. Concentrations of 100 mu M of DHA decreased H. pylori growth, whereas concentrations higher than 250 mu M irreversibly inhibited bacteria survival. DHA reduced ATP production and adhesion to AGS cells. AGS cells infected with DHA pre-treated H. pylori showed a 3-fold reduction in Interleukin-8 (IL-8) production and a decrease of COX2 and iNOS. 2D electrophoresis analysis revealed that DHA changed the expression of H. pylori outer membrane proteins associated with stress response and metabolism and modified bacterial lipopolysaccharide phenotype. As conclusions our results show that DHA anti-H. pylori effects are associated with changes of bacteria morphology and metabolism, and with alteration of outer membrane proteins composition, that ultimately reduce the adhesion of bacteria and the burden of H. pylori-related inflammation.	[Correia, Marta; Osorio, Hugo; Seruca, Raquel; Figueiredo, Ceu; Machado, Jose Carlos] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Correia, Marta; Osorio, Hugo; Seruca, Raquel; Figueiredo, Ceu; Machado, Jose Carlos] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Correia, Marta; Michel, Valerie; De Reuse, Hilde; Touati, Eliette] Inst Pasteur, Unite Pathogenese Helicobacter, Paris, France; [El Ghachi, Meriem; Bonis, Mathilde; Boneca, Ivo G.] Inst Pasteur, Biol & Genet Paroi Bacterienne G5, Paris, France; [El Ghachi, Meriem; Bonis, Mathilde; Boneca, Ivo G.] INSERM, Grp AVENIR, F-75724 Paris, France; [Matos, Antonio A.] Ctr Hosp Lisboa Cent, Lisbon, Portugal; [Matos, Antonio A.] Univ Lisbon, Fac Ciencias, Ctr Estudos Ambiente & Mar CESAM FCUL, Lisbon, Portugal; [Matos, Antonio A.] Ctr Invest Interdisciplinar Egas Moniz CiiEM Camp, Lisbon, Portugal; [Lenormand, Pascal] Inst Pasteur, Paris, France	Universidade do Porto; Universidade do Porto; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior de Ciencias da Saude Egas Moniz; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Touati, E (corresponding author), Inst Pasteur, Unite Pathogenese Helicobacter, Paris, France.	etouati@pasteur.fr	Boneca, Ivo G/H-1677-2014; Machado, Jose Carlos/C-5907-2009; Figueiredo, Ceu/B-8776-2008; Osorio, Hugo/A-7847-2012; Matos, Antonio P. A./A-4539-2013; seruca, raquel/F-8187-2011	Boneca, Ivo G/0000-0001-8122-509X; Machado, Jose Carlos/0000-0003-4741-8415; Figueiredo, Ceu/0000-0001-5247-840X; Osorio, Hugo/0000-0002-6362-8255; Matos, Antonio P. A./0000-0001-9386-0349; DE REUSE, Hilde/0000-0002-0100-4826; Touati, Eliette/0000-0002-3450-1773; Correia, Maria Marta/0000-0001-5040-735X; Seruca, Raquel/0000-0002-8851-4166	ERA-NET Pathogenomics [ERA-PTG/0001/2010]; Portuguese Foundation for Science and Technology [FCT - PTDC/SAU-SAP/120024/2010]; FCT fellowship [BD/36689/2007]; The Accoes integradas Luso-Francesas (CRUP-PAULIF) Portugal [AF-8/09]; The Accoes integradas Luso-Francesas (CRUP-PAULIF) France [AF-8/09]; Ministere de l'Enseignement Superieur et de la Recherche, France; ERC starting grant (PGNfromSHAPE) [202283]	ERA-NET Pathogenomics; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FCT fellowship(Portuguese Foundation for Science and Technology); The Accoes integradas Luso-Francesas (CRUP-PAULIF) Portugal; The Accoes integradas Luso-Francesas (CRUP-PAULIF) France; Ministere de l'Enseignement Superieur et de la Recherche, France; ERC starting grant (PGNfromSHAPE)	This study was supported by the ERA-NET Pathogenomics (ERA-PTG/0001/2010) and by the Portuguese Foundation for Science and Technology (FCT - PTDC/SAU-SAP/120024/2010). MC is supported by an FCT fellowship BD/36689/2007. The Accoes integradas Luso-Francesas (CRUP-PAULIF) Portugal and France also provided financial support (AF-8/09). Mathilde Bonis was supported by a PhD fellowship (Ministere de l'Enseignement Superieur et de la Recherche, France). This study was also supported by the ERC starting grant (PGNfromSHAPEtoVIR number 202283) to Ivo G. Boneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires V, 2003, BRIT J PHARMACOL, V140, P1217, DOI 10.1038/sj.bjp.0705563; Ambs S, 1998, CANCER RES, V58, P334; Amedei A, 2006, J CLIN INVEST, V116, P1092, DOI 10.1172/JCI27177; Barber MD, 2005, NUTRITION, V21, P588, DOI 10.1016/j.nut.2004.09.017; Boonyanugomol W, 2012, DIG DIS SCI; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Correia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035072; de Bernard M, 2010, TOXICON, V56, P1186, DOI 10.1016/j.toxicon.2009.09.020; Edwards NJ, 2000, MOL MICROBIOL, V35, P1530, DOI 10.1046/j.1365-2958.2000.01823.x; El Ghachi M, 2011, MOL MICROBIOL, V82, P68, DOI 10.1111/j.1365-2958.2011.07791.x; Erah PO, 1997, J ANTIMICROB CHEMOTH, V39, P5, DOI 10.1093/jac/39.1.5; Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25; Fuccio L, 2009, ANN INTERN MED, V151, P121, DOI 10.7326/0003-4819-151-2-200907210-00009; Gancz H, 2011, J MICROBIOL, V49, P294, DOI 10.1007/s12275-011-0396-7; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Hwang SW, 2012, PROSTAG LEUKOTR ESS, V86, P225, DOI 10.1016/j.plefa.2012.04.002; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Jung HC, 1997, J GASTROEN HEPATOL, V12, P473, DOI 10.1111/j.1440-1746.1997.tb00469.x; Kim JS, 2000, DIGEST DIS SCI, V45, P83, DOI 10.1023/A:1005461427250; Kim KM, 2007, BIOCHEM BIOPH RES CO, V355, P562, DOI 10.1016/j.bbrc.2007.02.021; Kim KM, 2010, J MICROBIOL, V48, P372, DOI 10.1007/s12275-010-9293-8; Kuriki K, 2007, CANCER EPIDEM BIOMAR, V16, P2406, DOI 10.1158/1055-9965.EPI-07-0655; Leduc D, 2010, INFECT IMMUN, V78, P2782, DOI 10.1128/IAI.00149-10; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lee JY, 2006, MOL CELLS, V21, P174; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; McLean MH, 2011, RECENT RESULTS CANC, V185, P173, DOI 10.1007/978-3-642-03503-6_11; Megraud F., 2012, GUT; Moran AP, 1996, ALIMENT PHARM THER, V10, P39, DOI 10.1046/j.1365-2036.1996.22164004.x; Nakachi N, 2000, FEMS IMMUNOL MED MIC, V29, P23, DOI 10.1111/j.1574-695X.2000.tb01500.x; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Persson C, 2011, AM J EPIDEMIOL, V173, P259, DOI 10.1093/aje/kwq370; Petschow BW, 1996, ANTIMICROB AGENTS CH, V40, P302, DOI 10.1128/AAC.40.2.302; Pflock M, 2007, J BACTERIOL, V189, P2339, DOI 10.1128/JB.01827-06; Pinho SS, 2009, BIOCHEM BIOPH RES CO, V379, P1091, DOI 10.1016/j.bbrc.2009.01.024; Schauer K, 2007, MOL MICROBIOL, V63, P1054, DOI 10.1111/j.1365-2958.2006.05578.x; Seo JY, 2009, J PHYSIOL PHARMACOL, V60, P101; Shibayama K, 2007, MOL MICROBIOL, V64, P396, DOI 10.1111/j.1365-2958.2007.05661.x; Shimada T, 1998, J GASTROENTEROL, V33, P613, DOI 10.1007/s005350050146; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Spencer L, 2009, EUR J CANCER, V45, P2077, DOI 10.1016/j.ejca.2009.04.026; Stingl K, 2008, MOL CELL PROTEOMICS, V7, P2429, DOI 10.1074/mcp.M800160-MCP200; Sun CQ, 2003, FEMS IMMUNOL MED MIC, V36, P9, DOI 10.1016/S0928-8244(03)00008-7; THOMPSON L, 1994, GUT, V35, P1557, DOI 10.1136/gut.35.11.1557; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Tulassay Z, 2010, SCAND J GASTROENTERO, V45, P1048, DOI 10.3109/00365520903575737; Waidner B, 2002, INFECT IMMUN, V70, P3923, DOI 10.1128/IAI.70.7.3923-3929.2002; Waidner B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000669; Wang J, 2011, DIGESTION, V83, P253, DOI 10.1159/000280318	51	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60657	10.1371/journal.pone.0060657	http://dx.doi.org/10.1371/journal.pone.0060657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577140	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800081
J	Liu, Z; Lv, D; Liu, S; Gong, JB; Wang, D; Xiong, M; Chen, XN; Xiang, R; Tan, XY				Liu, Ze; Lv, Dan; Liu, Shu; Gong, Junbo; Wang, Da; Xiong, Min; Chen, Xiaoniao; Xiang, Rong; Tan, Xiaoyue			Alginic Acid-Coated Chitosan Nanoparticles Loaded with Legumain DNA Vaccine: Effect against Breast Cancer in Mice	PLOS ONE			English	Article							ORAL DELIVERY; TUMOR MICROENVIRONMENT; PROTECTIVE IMMUNITY; GROWTH; DRUG; SYSTEM; MODEL	Legumain-based DNA vaccines have potential to protect against breast cancer. However, the lack of a safe and efficient oral delivery system restricts its clinical application. Here, we constructed alginic acid-coated chitosan nanoparticles (A.C.NPs) as an oral delivery carrier for a legumain DNA vaccine. First, we tested its characteristic in acidic environments in vitro. DNA agarose electrophoresis data show that A.C.NPs protected DNA better from degradation in acidic solution (pH 1.5) than did chitosan nanoparticles (C.NPs). Furthermore, size distribution analysis showed that A.C.NPs tended to aggregate and form micrometer scale complexes in pH < 2.7, while dispersing into nanoparticles with an increase in pH. Mice were intragastrically administrated A.C.NPs carrying EGFP plasmids and EGFP expression was detected in the intestinal Peyer's patches. Full-length legumain plasmids were loaded into different delivery carriers, including C.NPs, attenuated Salmonella typhimurium and A.C.NPs. A.C.NPs loaded with empty plasmids served as a control. Oral vaccination was performed in the murine orthotopic 4T1 breast cancer model. Our data indicate that tumor volume was significantly smaller in groups using A.C.NPs or attenuated Salmonella typhimurium as carriers. Furthermore, splenocytes co-cultured them with 4T1 cells pre-stimulated with CoCl2, which influenced the translocation of legumain from cytoplasm to plasma membrane, showed a 4.7 and 2.3 folds increase in active cytotoxic T lymphocytes (CD3(+)/CD8(+)/CD25(+)) when treated with A.C.NPs carriers compared with PBS C.NPs. Our study suggests that C.NPs coated with alginic acid may be a safe and efficient tool for oral delivery of a DNA vaccine. Moreover, a legumain DNA vaccine delivered orally with A.C.NPs can effectively improve autoimmune response and protect against breast cancer in mice.	[Liu, Ze; Lv, Dan; Liu, Shu; Xiong, Min; Chen, Xiaoniao; Xiang, Rong; Tan, Xiaoyue] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Lv, Dan] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Gong, Junbo] Tianjin Univ, Tianjin Key Lab Modern Drug Delivery & High Effic, Tianjin 300072, Peoples R China; [Wang, Da] Nankai Univ, Minist Educ, Key Lab Funct Polymer Mat, Tianjin 300071, Peoples R China	Nankai University; University of California System; University of California San Diego; Tianjin University; Nankai University	Tan, XY (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.	xiaoyuetan@nankai.edu.cn	Gong, Junbo/J-7798-2012; Wang, Da/ACO-3036-2022; Liu, Ze/GLS-9466-2022	Gong, Junbo/0000-0002-3376-3296; Wang, Da/0000-0001-7115-5067; Liu, Ze/0000-0002-1635-5573; Xiong, Min/0000-0001-9926-3836	National Basic Research Program of China (973 Program) [2013CB967201]; National Natural Science Foundation of China [81273331, 81270774]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) number 2013CB967201, National Natural Science Foundation of China 81273331 (to R. Xiang) and National Natural Science Foundation of China 81270774 (to X. Tan). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer H, 2005, GENE THER, V12, P364, DOI 10.1038/sj.gt.3302423; Bharali DJ, 2007, ADV EXP MED BIOL, V601, P415; Bhowmik T, 2012, J DRUG TARGET, V20, P364, DOI 10.3109/1061186X.2012.662686; Borges O, 2006, J CONTROL RELEASE, V114, P348, DOI 10.1016/j.jconrel.2006.06.011; Borges O, 2008, INT IMMUNOPHARMACOL, V8, P1773, DOI 10.1016/j.intimp.2008.08.013; Bowman K, 2006, INT J NANOMED, V1, P117, DOI 10.2147/nano.2006.1.2.117; Boyle JS, 1998, NATURE, V392, P408, DOI 10.1038/32932; Doroud D, 2011, J CONTROL RELEASE, V153, P154, DOI 10.1016/j.jconrel.2011.04.011; Fourcade J, 2012, CANCER RES, V72, P887, DOI 10.1158/0008-5472.CAN-11-2637; Fu J, 2012, VACCINE, V30, P2187, DOI 10.1016/j.vaccine.2012.01.002; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Handgretinger R, 2002, NEW ENGL J MED, V347, P613; Holmgren J, 2005, IMMUNOL LETT, V97, P181, DOI 10.1016/j.imlet.2004.11.009; Iqbal M, 2003, VACCINE, V21, P1478, DOI 10.1016/S0264-410X(02)00662-X; Jones DH, 1998, DEV BIOL STAND, V92, P149; Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7; Lee SJ, 2011, J CONTROL RELEASE, V152, P21, DOI 10.1016/j.jconrel.2011.03.027; Lewen S, 2008, CANCER IMMUNOL IMMUN, V57, P507, DOI 10.1007/s00262-007-0389-x; Liao D, 2011, NANOMED-NANOTECHNOL, V7, P665, DOI 10.1016/j.nano.2011.03.001; Liao D, 2011, CANCER RES, V71, P5688, DOI 10.1158/0008-5472.CAN-11-1264; Lin SJ, 2006, BIOMATERIALS, V27, P1462, DOI 10.1016/j.biomaterials.2005.08.031; Luo YP, 2005, CANCER RES, V65, P3419, DOI 10.1158/0008-5472.CAN-04-3120; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mathiowitz E, 1997, NATURE, V386, P410, DOI 10.1038/386410a0; Minigo G, 2007, VACCINE, V25, P1316, DOI 10.1016/j.vaccine.2006.09.086; Niethammer AG, 2002, NAT MED, V8, P1369, DOI 10.1038/nm794; Roy K, 1999, NAT MED, V5, P387, DOI 10.1038/7385; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; Sonaje K, 2010, BIOMATERIALS, V31, P6849, DOI 10.1016/j.biomaterials.2010.05.042; Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075; Xiang R, 2008, IMMUNOL REV, V222, P117, DOI 10.1111/j.1600-065X.2008.00613.x; Xu QM, 2012, BIOMATERIALS, V33, P3909, DOI 10.1016/j.biomaterials.2012.02.014; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; Yin LC, 2009, BIOMATERIALS, V30, P5691, DOI 10.1016/j.biomaterials.2009.06.055; Yoo MK, 2010, BIOMATERIALS, V31, P7738, DOI 10.1016/j.biomaterials.2010.06.059; Zhou XF, 2008, BIOMATERIALS, V29, P111, DOI 10.1016/j.biomaterials.2007.09.007	37	28	31	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60190	10.1371/journal.pone.0060190	http://dx.doi.org/10.1371/journal.pone.0060190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577091	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800033
J	Rogers, LA; Peacock, SJ; McKenzie, P; DeDominicis, S; Jones, SRM; Chandler, P; Foreman, MGG; Revie, CW; Krkosek, M				Rogers, Luke A.; Peacock, Stephanie J.; McKenzie, Peter; DeDominicis, Sharon; Jones, Simon R. M.; Chandler, Peter; Foreman, Michael G. G.; Revie, Crawford W.; Krkosek, Martin			Modeling Parasite Dynamics on Farmed Salmon for Precautionary Conservation Management of Wild Salmon	PLOS ONE			English	Article							LICE LEPEOPHTHEIRUS-SALMONIS; ADULT PACIFIC SALMON; JUVENILE PINK SALMON; SEA LICE; ATLANTIC SALMON; EMAMECTIN BENZOATE; BRITISH-COLUMBIA; ONCORHYNCHUS-GORBUSCHA; BROUGHTON ARCHIPELAGO; COASTAL WATERS	Conservation management of wild fish may include fish health management in sympatric populations of domesticated fish in aquaculture. We developed a mathematical model for the population dynamics of parasitic sea lice (Lepeophtheirus salmonis) on domesticated populations of Atlantic salmon (Salmo salar) in the Broughton Archipelago region of British Columbia. The model was fit to a seven-year dataset of monthly sea louse counts on farms in the area to estimate population growth rates in relation to abiotic factors (temperature and salinity), local host density (measured as cohort surface area), and the use of a parasiticide, emamectin benzoate, on farms. We then used the model to evaluate management scenarios in relation to policy guidelines that seek to keep motile louse abundance below an average three per farmed salmon during the March-June juvenile wild Pacific salmon (Oncorhynchus spp.) migration. Abiotic factors mediated the duration of effectiveness of parasiticide treatments, and results suggest treatment of farmed salmon conducted in January or early February minimized average louse abundance per farmed salmon during the juvenile wild salmon migration. Adapting the management of parasites on farmed salmon according to migrations of wild salmon may therefore provide a precautionary approach to conserving wild salmon populations in salmon farming regions.	[Rogers, Luke A.; Krkosek, Martin] Univ Otago, Dept Zool, Dunedin, Otago, New Zealand; [Peacock, Stephanie J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [McKenzie, Peter] Mainstream Canada, Campbell River, BC, Canada; [DeDominicis, Sharon] Marine Harvest Canada, Campbell River, BC, Canada; [Jones, Simon R. M.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9R 5K6, Canada; [Chandler, Peter; Foreman, Michael G. G.] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada; [Revie, Crawford W.] Univ PEI, Atlantic Vet Coll, Charlottetown, PE, Canada; [Krkosek, Martin] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Otago; University of Alberta; Fisheries & Oceans Canada; Fisheries & Oceans Canada; University of Prince Edward Island; University of Toronto	Rogers, LA (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, Otago, New Zealand.	luke.allister.rogers@gmail.com	Jones, Simon/C-2485-2012; Revie, Crawford/B-5002-2011	Jones, Simon/0000-0002-8800-9653; Revie, Crawford/0000-0002-5018-0340; Rogers, Luke/0000-0003-3843-064X	Fisheries and Oceans Canada; Coastal Alliance for Aquaculture Reform; Marine Harvest Canada; Mainstream Canada; Grieg Seafood; University of Otago; NSERC; Alberta Innovates	Fisheries and Oceans Canada; Coastal Alliance for Aquaculture Reform; Marine Harvest Canada; Mainstream Canada; Grieg Seafood; University of Otago; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates	This research is a product of the Broughton Archipelago Monitoring Program (www.bamp.ca), which is sponsored by Fisheries and Oceans Canada, Coastal Alliance for Aquaculture Reform, Marine Harvest Canada, Mainstream Canada, and Grieg Seafood. The work was also partially supported by funding from a University of Otago Research Grant to MK, and NSERC and Alberta Innovates graduate student scholarships to SJP. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Amundrud TL, 2009, J FISH DIS, V32, P27, DOI 10.1111/j.1365-2761.2008.00980.x; ANDERSON R M, 1991; AUSTRENG E, 1987, AQUACULTURE, V60, P157, DOI 10.1016/0044-8486(87)90307-3; BAMP, 2011, BROUGHT ARCH MON PRO; Barton K., 2012, MUMIN MULTIMODEL INF; Bates D., 2011, PACKAGE LME4 LINEAR; Beamish RJ, 2007, FISH RES, V85, P332, DOI 10.1016/j.fishres.2007.01.005; Beamish RJ, 2005, FISH RES, V76, P198, DOI 10.1016/j.fishres.2005.06.007; Berg AGT, 2009, AQUACULTURE, V288, P22, DOI 10.1016/j.aquaculture.2008.11.008; Brooks KM, 2009, J FISH DIS, V32, P59, DOI 10.1111/j.1365-2761.2008.01013.x; Brooks KM, 2008, REV FISH SCI, V16, P403, DOI 10.1080/10641260801937131; Brooks KM, 2005, REV FISH SCI, V13, P177, DOI 10.1080/10641260500207109; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Connors BM, 2010, J APPL ECOL, V47, P1365, DOI 10.1111/j.1365-2664.2010.01887.x; Connors BM, 2010, J APPL ECOL, V47, P1372, DOI 10.1111/j.1365-2664.2010.01889.x; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Costello MJ, 2003, CHECKLIST BEST PRACT; Delgado C. L., 2003, FISH 2020 SUPPLY DEM; Food and Agricultural Organization of the United Nations, 2012, STAT WORLD FISH AQ; Food and Agriculture Organization of the United Nations Fisheries Department, 2002, STAT WORLD FISH AQ; Foreman MGG, 2009, OCEAN MODEL, V30, P29, DOI 10.1016/j.ocemod.2009.05.009; Frazer LN, 2007, FISH RES, V85, P328, DOI 10.1016/j.fishres.2006.10.010; Frazer LN, 2012, P ROY SOC B-BIOL SCI, V279, P1950, DOI 10.1098/rspb.2011.2210; Frazer LN, 2009, CONSERV BIOL, V23, P599, DOI 10.1111/j.1523-1739.2008.01128.x; Gustafson L, 2006, J FISH DIS, V29, P621, DOI 10.1111/j.1365-2761.2006.00761.x; Horsberg T., 2006, SEA LICE RESISTANCE; Igboeli OO, 2012, AQUACULTURE, V344, P40, DOI 10.1016/j.aquaculture.2012.03.026; Ikonomou MG, 2012, INT J ENVIRON AN CH, P1; Jansen PA, 2012, P ROY SOC B-BIOL SCI, V279, P2330, DOI 10.1098/rspb.2012.0084; JOHNSON SC, 1991, J MAR BIOL ASSOC UK, V71, P425, DOI 10.1017/S0025315400051687; Jones S, 2008, J FISH DIS, V31, P591, DOI 10.1111/j.1365-2761.2008.00933.x; Jones S, 2006, J FISH DIS, V29, P489, DOI 10.1111/j.1365-2761.2006.00742.x; Jones SRM, 2007, DIS AQUAT ORGAN, V75, P229, DOI 10.3354/dao075229; Jones SRM, 2009, DIS AQUAT ORGAN, V84, P131, DOI 10.3354/dao02043; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Krkosek M, 2006, P NATL ACAD SCI USA, V103, P15506, DOI 10.1073/pnas.0603525103; Krkosek M, 2011, P NATL ACAD SCI USA, V108, P14700, DOI 10.1073/pnas.1101845108; Krkosek M, 2011, ECOL APPL, V21, P897, DOI 10.1890/09-1861.1; Krkosek M, 2011, CAN J FISH AQUAT SCI, V68, P17, DOI 10.1139/F10-137; Krkosek M, 2010, AQUACULT ENV INTERAC, V1, P137, DOI 10.3354/aei00014; Krkosek M, 2010, FRONT ECOL ENVIRON, V8, P201, DOI 10.1890/080097; Lees F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001549; Marty GD, 2010, P NATL ACAD SCI USA, V107, P22599, DOI 10.1073/pnas.1009573108; Morton A, 2005, N AM J FISH MANAGE, V25, P811, DOI 10.1577/M04-149.1; Morton A, 2004, CAN J FISH AQUAT SCI, V61, P147, DOI 10.1139/F04-016; Morton A, 2011, ICES J MAR SCI, V68, P144, DOI 10.1093/icesjms/fsq146; Murray AG, 2006, MAR POLLUT BULL, V53, P128, DOI 10.1016/j.marpolbul.2005.09.013; Murray AG, 2005, PREV VET MED, V67, P223, DOI 10.1016/j.prevetmed.2004.10.012; O'Shea B, 2006, J FISH DIS, V29, P437, DOI 10.1111/j.1365-2761.2006.00728.x; Peacock SJ, ECOL APPL IN PRESS; R Development Core Team, 2011, R LANG ENV STAT COMP; Ramstad A, 2002, DIS AQUAT ORGAN, V50, P29, DOI 10.3354/dao050029; Revie CW, 2003, DIS AQUAT ORGAN, V57, P85, DOI 10.3354/dao057085; Revie CW, 2002, PEST MANAG SCI, V58, P576, DOI 10.1002/ps.476; Roy WJ, 2006, AQUACULTURE, V259, P6, DOI 10.1016/j.aquaculture.2006.02.069; Saksida SM, 2012, J FISH DIS, V35, P137, DOI 10.1111/j.1365-2761.2011.01330.x; Saksida SM, 2010, J FISH DIS, V33, P913, DOI 10.1111/j.1365-2761.2010.01192.x; Saksida SM, 2012, J FISH DIS, DOI 101111/jfd12018; Saksida S, 2007, AQUAC RES, V38, P219, DOI 10.1111/j.1365-2109.2007.01651.x; Saksida SM, 2011, SALMON LICE: AN INTEGRATED APPROACH TO UNDERSTANDING PARASITE ABUNDANCE AND DISTRIBUTION, P235; Stien A, 2005, MAR ECOL PROG SER, V290, P263, DOI 10.3354/meps290263; Stone J, 2000, DIS AQUAT ORGAN, V41, P141, DOI 10.3354/dao041141; Stucchi DJ, 2011, SALMON LICE: AN INTEGRATED APPROACH TO UNDERSTANDING PARASITE ABUNDANCE AND DISTRIBUTION, P117; Sutherland BJG, 2011, COMP BIOCHEM PHYS D, V6, P213, DOI 10.1016/j.cbd.2011.04.001; The SLICE&REG;sustainability project, 2010, SLICE SUST PROJ INT, P1; Tucker CS, 2000, J FISH DIS, V23, P309, DOI 10.1046/j.1365-2761.2000.00219.x; Tucker CS, 2002, DIS AQUAT ORGAN, V49, P145, DOI 10.3354/dao049145; United Nations Department of Economic and Social Affairs Population Division, 2011, STESASERA313 UN DEP, VI; Veldhoen N, 2012, AQUAT TOXICOL, V108, P94, DOI 10.1016/j.aquatox.2011.10.015; Westcott JD, 2010, SEA LIC 2010 8 INT S	73	31	31	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60096	10.1371/journal.pone.0060096	http://dx.doi.org/10.1371/journal.pone.0060096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577082	Green Published, Green Accepted, gold			2022-12-27	WOS:000319109800025
J	Song, HF; Janosko, K; Johnson, RF; Qin, J; Josleyn, N; Jett, C; Byrum, R; St Claire, M; Dyall, J; Blaney, JE; Jennings, G; Jahrling, PB				Song, Haifeng; Janosko, Krisztina; Johnson, Reed F.; Qin, Jing; Josleyn, Nicole; Jett, Catherine; Byrum, Russell; St Claire, Marisa; Dyall, Julie; Blaney, Joseph E.; Jennings, Gerald; Jahrling, Peter B.			Poxvirus Antigen Staining of Immune Cells as a Biomarker to Predict Disease Outcome in Monkeypox and Cowpox Virus Infection in Non-Human Primates	PLOS ONE			English	Article							SMALLPOX VACCINATION; VACCINIA VIRUS; PROTECTION; MODEL; PROGRESSION; CHALLENGE; MACAQUES	Infection of non-human primates (NHPs) such as rhesus and cynomolgus macaques with monkeypox virus (MPXV) or cowpox virus (CPXV) serve as models to study poxvirus pathogenesis and to evaluate vaccines and anti-orthopox therapeutics. Intravenous inoculation of macaques with high dose of MPXV (>1-2 x 10(7) PFU) or CPXV (>10(2) PFU) results in 80% to 100% mortality and 66 to 100% mortality respectively. Here we report that NHPs with positive detection of poxvirus antigens in immune cells by flow cytometric staining, especially in monocytes and granulocytes succumbed to virus infection and that early positive pox staining is a strong predictor for lethality. Samples from four independent studies were analyzed. Eighteen NHPs from three different experiments were inoculated with two different MPXV strains at lethal doses. Ten NHPs displayed positive pox-staining and all 10 NHPs reached moribund endpoint. In contrast, none of the three NHPs that survived anticipated lethal virus dose showed apparent virus staining in the monocytes and granulocytes. In addition, three NHPs that were challenged with a lethal dose of MPXV and received cidofovir treatment were pox-antigen negative and all three NHPs survived. Furthermore, data from a CPXV study also demonstrated that 6/9 NHPs were pox-antigen staining positive and all 6 NHPs reached euthanasia endpoint, while the three survivors were pox-antigen staining negative. Thus, we conclude that monitoring pox-antigen staining in immune cells can be used as a biomarker to predict the prognosis of virus infection. Future studies should focus on the mechanisms and implications of the pox-infection of immune cells and the correlation between pox-antigen detection in immune cells and disease progression in human poxviral infection.	[Song, Haifeng; Janosko, Krisztina; Josleyn, Nicole; Jett, Catherine; Byrum, Russell; Dyall, Julie; Jennings, Gerald; Jahrling, Peter B.] NIAID, Integrated Res Facil, NIH, Frederick, MD USA; [Johnson, Reed F.; St Claire, Marisa; Blaney, Joseph E.; Jahrling, Peter B.] NIAID, Emerging Viral Pathogens Sect, NIH, Bethesda, MD 20892 USA; [Qin, Jing] NIAID, Biostat Res Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Song, HF (corresponding author), NIAID, Integrated Res Facil, NIH, Frederick, MD USA.	songhai@mail.nih.gov			NIAID (National Institute of Allergy and Infectious Diseases, National Institutes of Health) [HHSN272200200016I]; NIAID Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001025, ZIDAI009006] Funding Source: NIH RePORTER	NIAID (National Institute of Allergy and Infectious Diseases, National Institutes of Health); NIAID Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was performed under Battelle Memorial contract with NIAID (National Institute of Allergy and Infectious Diseases, National Institutes of Health)(contract HHSN272200200016I). This study was funded, in part, by the NIAID Division of Intramural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman JL, 2010, VET PATHOL, V47, P852, DOI 10.1177/0300985810378649; Dyall J, 2011, J INFECT DIS, V204, P1902, DOI 10.1093/infdis/jir663; Earl PL, 2008, P NATL ACAD SCI USA, V105, P10889, DOI 10.1073/pnas.0804985105; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Frey SE, 2004, NEW ENGL J MED, V350, P324, DOI 10.1056/NEJMp038208; Goff AJ, 2011, J VIROL, V85, P4898, DOI 10.1128/JVI.02525-10; Hooper JW, 2004, J VIROL, V78, P4433, DOI 10.1128/JVI.78.9.4433-4443.2004; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Ibrahim MS, 2003, J CLIN MICROBIOL, V41, P3835, DOI 10.1128/JCM.41.8.3835-3839.2003; Johnson RF, 2011, VIROLOGY, V418, P102, DOI 10.1016/j.virol.2011.07.013; Johnson RF, 2011, J VIROL, V85, P2112, DOI 10.1128/JVI.01931-10; Nalca A, 2005, CLIN INFECT DIS, V41, P1765, DOI 10.1086/498155; Nalca A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012880; Parker S, 2008, ANTIVIR THER, V13, P863; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Sanchez-Puig JM, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-10; Stittelaar KJ, 2006, NATURE, V439, P745, DOI 10.1038/nature04295; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373; Zielinski RJ, 2010, VACCINE, V28, P7081, DOI 10.1016/j.vaccine.2010.08.008	22	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60533	10.1371/journal.pone.0060533	http://dx.doi.org/10.1371/journal.pone.0060533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577120	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800060
J	Drew, J; Philipp, C; Westneat, MW				Drew, Joshua; Philipp, Christopher; Westneat, Mark W.			Shark Tooth Weapons from the 19th Century Reflect Shifting Baselines in Central Pacific Predator Assemblies	PLOS ONE			English	Article							MARINE FISHES; CONSERVATION; ISLANDS; ATOLLS	The reefs surrounding the Gilbert Islands (Republic of Kiribati, Central Pacific), like many throughout the world, have undergone a period of rapid and intensive environmental perturbation over the past 100 years. A byproduct of this perturbation has been a reduction of the number of shark species present in their waters, even though sharks play an important in the economy and culture of the Gilbertese. Here we examine how shark communities changed over time periods that predate the written record in order to understand the magnitude of ecosystem changes in the Central Pacific. Using a novel data source, the shark tooth weapons of the Gilbertese Islanders housed in natural history museums, we show that two species of shark, the Spot-tail (Carcharhinus sorrah) and the Dusky (C. obscurus), were present in the islands during the last half of the 19th century but not reported in any historical literature or contemporary ichthyological surveys of the region. Given the importance of these species to the ecology of the Gilbert Island reefs and to the culture of the Gilbertese people, documenting these shifts in baseline fauna represents an important step toward restoring the vivid splendor of both ecological and cultural diversity.	[Drew, Joshua; Westneat, Mark W.] Field Museum Nat Hist, Div Fishes, Chicago, IL 60605 USA; [Drew, Joshua; Westneat, Mark W.] Field Museum Nat Hist, Biodivers Synth Ctr, Chicago, IL 60605 USA; [Drew, Joshua] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Philipp, Christopher] Field Museum Nat Hist, Dept Anthropol, Chicago, IL 60605 USA	Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago); Columbia University; Field Museum of Natural History (Chicago)	Drew, J (corresponding author), Field Museum Nat Hist, Div Fishes, Chicago, IL 60605 USA.	jd2977@columbia.edu		Drew, Joshua/0000-0001-9072-0885				Ainsworth CH, 2008, BIOL CONSERV, V141, P848, DOI 10.1016/j.biocon.2008.01.006; Barrett JH, 2004, P ROY SOC B-BIOL SCI, V271, P2417, DOI 10.1098/rspb.2004.2885; Barrett JH, 1999, J ARCHAEOL SCI, V26, P353, DOI 10.1006/jasc.1998.0336; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Camhi MD., 2009, SHARKS OPEN OCEAN BI; Catala R.L.A., 1957, ATOLL RES B, V59; Clarke S, 2004, FISH FISH, V5, P53, DOI 10.1111/j.1467-2960.2004.00137.x; Compagno LJV, 1984, CARCHARHINIFORMES FA, V4; Compagno LJV, 2001, SHARKS WORLD ANNOT; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Drew JA, 2012, ECOLOGY EVO IN PRESS; Drew J, 2011, CONSERV BIOL, V25, P1250, DOI 10.1111/j.1523-1739.2011.01725.x; Drew JA, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-15; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Grimble Arthur, 1921, J ROYAL ANTHR I GREA, V51, P25; Gudger EW, 1923, WOODEN HOOKS USED CA, P199; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Luiz OJ, 2011, BIOL CONSERV, V144, P2873, DOI 10.1016/j.biocon.2011.08.004; LUOMALA K, 1980, ANTHROPOS, V75, P523; LUOMALA K, 1974, J POLYNESIAN SOC, V83, P14; Luomala K., 1984, FISHING CULTURE WORL, P1203; MAUDE HC, 1981, J POLYNESIAN SOC, V90, P307; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; Murdoch G.M., 1923, J POLYNESIAN SOC, V32, P174; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Newell J.E., 1895, J POLYNESIAN SOC, V4, P231; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Robertson DR, 2008, DIVERS DISTRIB, V14, P891, DOI 10.1111/j.1472-4642.2008.00519.x; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; Wilkes C., 1844, NARRATIVE US EXPLORI; Woodford Charles Morris, 1895, GEOGR J, V6, P325	35	28	30	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59855	10.1371/journal.pone.0059855	http://dx.doi.org/10.1371/journal.pone.0059855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573214	Green Published, gold			2022-12-27	WOS:000318840100030
J	Balti, EV; Kengne, AP; Fokouo, JVF; Nouthe, BE; Sobngwi, E				Balti, Eric Vounsia; Kengne, Andre Pascal; Fokouo, Jean Valentin Fogha; Nouthe, Brice Enid; Sobngwi, Eugene			Metabolic Syndrome and Fatal Outcomes in the Post-Stroke Event: A 5-Year Cohort Study in Cameroon	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR MORTALITY; ALL-CAUSE; STROKE; RISK; DEATH; CHOLESTEROL; COMPONENTS; BURDEN	Background and Purpose: Determinants of post-acute stroke outcomes in Africa have been less investigated. We assessed the association of metabolic syndrome (MetS) and insulin resistance with post-stroke mortality in patients with first-ever-in-lifetime stroke in the capital city of Cameroon (sub-Saharan Africa). Methods: Patients with an acute first-stroke event (n = 57) were recruited between May and October 2006, and followed for 5 years for mortality outcome. MetS definition was based on the Joint Interim Statement 2009, insulin sensitivity/resistance assessed via glucose-to-insulin ratio, quantitative insulin sensitivity check index and homeostatic model assessment. Results: Overall, 24 (42%) patients deceased during follow-up. The prevalence of MetS was higher in patients who died after 28 days, 1 year and 5 years from any cause or cardiovascular-related causes (all p <= 0.040). MetS was associated with an increased overall mortality both after 1 year (39% vs. 9%) and 5 years of follow-up (55% vs. 26%, p = 0.022). Similarly, fatal events due to cardiovascular-related conditions were more frequent in the presence of MetS both 1 year (37% vs. 9%) and 5 years after the first-ever-in-lifetime stroke (43% vs. 13%, p = 0.017). Unlike biochemical measures of insulin sensitivity and resistance (non-significant), in age-and sex-adjusted Cox models, MetS was associated with hazard ratio (95% CI) of 2.63 (1.03-6.73) and 3.54 (1.00-12.56) respectively for all-cause and cardiovascular mortality 5 years after stroke onset. Conclusion: The Joint Interim Statement 2009 definition of MetS may aid the identification of a subgroup of black African stroke patients who may benefit from intensification of risk factor management.	[Balti, Eric Vounsia] Free Univ Brussels, Fac Med & Pharm, Diabet Res Ctr, Brussels, Belgium; [Balti, Eric Vounsia; Kengne, Andre Pascal; Fokouo, Jean Valentin Fogha; Nouthe, Brice Enid; Sobngwi, Eugene] Univ Yaounde I, Yaounde Cent Hosp, Natl Obes Ctr, Yaounde, Cameroon; [Balti, Eric Vounsia; Kengne, Andre Pascal; Fokouo, Jean Valentin Fogha; Nouthe, Brice Enid; Sobngwi, Eugene] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Kengne, Andre Pascal] South African Med Res Council, NCRP Cardiovasc & Metab Dis, Cape Town, South Africa; [Kengne, Andre Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Nouthe, Brice Enid] McGill Univ, Dept Med, Montreal, PQ, Canada; [Sobngwi, Eugene] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Yaounde I; University of Yaounde I; South African Medical Research Council; University of Cape Town; McGill University; Newcastle University - UK	Sobngwi, E (corresponding author), Univ Yaounde I, Yaounde Cent Hosp, Natl Obes Ctr, Yaounde, Cameroon.	eugene.sobngwi@newcastle.ac.uk	Kengne, Andre Pascal/ABB-3696-2020; Balti, Eric/H-5630-2019	Balti, Eric/0000-0003-4445-308X; Kengne, Andre Pascal/0000-0002-5183-131X				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bruno G, 2004, DIABETES CARE, V27, P2689, DOI 10.2337/diacare.27.11.2689; Callahan A, 2011, ARCH NEUROL-CHICAGO, V68, P1245, DOI 10.1001/archneurol.2011.146; Connor MD, 2007, AM J PREV MED, V33, P172, DOI 10.1016/j.amepre.2007.04.006; Fezeu L, 2007, ATHEROSCLEROSIS, V193, P70, DOI 10.1016/j.atherosclerosis.2006.08.037; Gaillard T, 2009, ETHNIC DIS, V19, pS1; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Gupta AK, 2010, DIABETES CARE, V33, P1647, DOI 10.2337/dc09-2208; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kengne AP, 2006, INT J STROKE, V1, P180, DOI 10.1111/j.1747-4949.2006.00064.x; Kengne AP, 2012, CARDIOVASC J AFR, V23, P105, DOI 10.5830/CVJA-2011-042; Kolo PM, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/960546; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Motala AA, 2009, ETHNIC DIS, V19, pS8; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Okafor Christian I, 2012, Indian J Endocrinol Metab, V16, P56, DOI 10.4103/2230-8210.91191; Setel PW, 2005, B WORLD HEALTH ORGAN, V83, P611; Sobngwi E, 2012, J STROKE CEREBROVASC, V21, P639, DOI 10.1016/j.jstrokecerebrovasdis.2011.02.009; Tillin T, 2006, DIABETES CARE, V29, P2127, DOI 10.2337/dc06-0779; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; WARNICK GR, 1990, CLIN CHEM, V36, P15	26	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60117	10.1371/journal.pone.0060117	http://dx.doi.org/10.1371/journal.pone.0060117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565192	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300061
J	Chen, J; Cai, Y; Clark, M; Yu, Y				Chen, Jie; Cai, Yun; Clark, Malcolm; Yu, Yan			Equilibrium and Kinetic Studies of Phosphate Removal from Solution onto a Hydrothermally Modified Oyster Shell Material	PLOS ONE			English	Article							AQUEOUS-SOLUTION; WASTE-WATER; FLY-ASH; ADSORPTION CHARACTERISTICS; PHOSPHORUS REMOVAL; METHYLENE-BLUE; BIOSORPTION; COPPER; IONS; RED	Phosphate removal to a hydrothermally modified fumed silica and pulverized oyster shell material for use in wastewater treatments were made. Sorption data modeling (pH's 3-11, P concentrations of 3, 5, 10, 15, 20, & 25 mg/L, and at an ambient temperature of 23 degrees C) indicate that an optimal removal of P occurs at pH 11. Three kinetic models were also applied (a pseudo-first-order Lagergren kinetic model, a pseudo-second-order (PSO) kinetic and Elovich) and indicate that a PSO model best describes P-removal. In addition, an application of the Weber and Morris intra-particle diffusion model indicates that external mass transfer and intra-particle diffusion were both involved in the rate-determining step. Langmuir, Freundlich modeling of the sorption data also indicate that the heterogeneous Freundlich sorption site model best describes the data although Langmuir data also fit with data tailing suggesting data are not linear. The data collected indicates that the hydrothermally modified fumed silica and pulverized oyster shell material is suitable for use in wastewater treatment, with P-removal to the solids being preferential and spontaneous.	[Chen, Jie; Cai, Yun; Yu, Yan] Fuzhou Univ, Coll Mat Sci & Engn, Fuzhou, Fujian, Peoples R China; [Clark, Malcolm] So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia	Fuzhou University; Southern Cross University	Yu, Y (corresponding author), Fuzhou Univ, Coll Mat Sci & Engn, Fuzhou, Fujian, Peoples R China.	yuyan_1972@126.com	Yu, Yan/GYV-4514-2022; Clark, M W/Q-4875-2017	Clark, Malcolm/0000-0003-1012-7411	National Natural Science Fund Project of China [51102047]; Key Project of Fujian Provincial Science and Technology Department [2011Y0037]; Fujian Provincial Natural Science Fund for Distinguished Young Scholars [2012J06011]	National Natural Science Fund Project of China(National Natural Science Foundation of China (NSFC)); Key Project of Fujian Provincial Science and Technology Department; Fujian Provincial Natural Science Fund for Distinguished Young Scholars	This work was supported by National Natural Science Fund Project of China (No. 51102047), Key Project of Fujian Provincial Science and Technology Department (2011Y0037) and Fujian Provincial Natural Science Fund for Distinguished Young Scholars (2012J06011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst DJ, 2006, ENVIRON CHEM, V3, P65, DOI 10.1071/EN05038; Akkaya G, 2005, PROCESS BIOCHEM, V40, P3559, DOI 10.1016/j.procbio.2005.03.048; BERNHART DN, 1955, ANAL CHEM, V27, P440, DOI 10.1021/ac60099a035; Chen HC, 2010, INTEGR SER INFORM SY, V21, P177, DOI 10.1007/978-1-4419-1278-7_13; Cheng ZH, 2010, J HAZARD MATER, V182, P408, DOI 10.1016/j.jhazmat.2010.06.048; Clark MW, 2011, J ENVIRON QUAL, V40, P1835, DOI 10.2134/jeq2011.0090; Clark MW, 2011, J COLLOID INTERF SCI, V356, P699, DOI 10.1016/j.jcis.2011.01.068; Despland LM, 2011, ENVIRON SCI TECHNOL, V45, P5746, DOI 10.1021/es200934y; Fytianos K, 1998, ENVIRON POLLUT, V101, P123, DOI 10.1016/S0269-7491(98)00007-4; Gok O, 2008, COLLOID SURFACE A, V317, P174, DOI 10.1016/j.colsurfa.2007.10.009; Haghseresht F, 2009, APPL CLAY SCI, V46, P369, DOI 10.1016/j.clay.2009.09.009; Hashim MA, 2004, CHEM ENG J, V97, P249, DOI 10.1016/S1385-8947(03)00216-X; Ho YS, 1996, ENVIRON TECHNOL, V17, P71, DOI 10.1080/09593331708616362; Ho YS, 2000, SEPAR PURIF METHOD, V29, P189, DOI 10.1081/SPM-100100009; Hsu TC, 2009, J HAZARD MATER, V171, P995, DOI 10.1016/j.jhazmat.2009.06.105; Huang WW, 2008, J HAZARD MATER, V158, P35, DOI 10.1016/j.jhazmat.2008.01.061; Juang RS, 1997, ENVIRON TECHNOL, V18, P525, DOI 10.1080/09593331808616568; Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0; Karaca S, 2006, J HAZARD MATER, V128, P273, DOI 10.1016/j.jhazmat.2005.08.003; KOUTSOUKOS P, 1980, J AM CHEM SOC, V102, P1553, DOI 10.1021/ja00525a015; Lin JW, 2011, COLLOID SURFACE A, V384, P9, DOI 10.1016/j.colsurfa.2011.02.044; Mall ID, 2005, CHEMOSPHERE, V61, P492, DOI 10.1016/j.chemosphere.2005.03.065; Mohan SV, 1997, ENVIRON POLLUT, V97, P183, DOI 10.1016/S0269-7491(97)00025-0; Namasivayam C, 2005, J CHEM TECHNOL BIOT, V80, P356, DOI 10.1002/jctb.1175; Ozer A, 2005, CHEM ENG J, V112, P181, DOI 10.1016/j.cej.2005.07.007; Park WH, 2008, J ENVIRON SCI HEAL A, V43, P511, DOI 10.1080/10934520701796440; Rengaraj S, 2004, J COLLOID INTERF SCI, V273, P14, DOI 10.1016/j.jcis.2004.01.007; Ugurlu A, 1998, ENVIRON INT, V24, P911, DOI 10.1016/S0160-4120(98)00079-8; Wang SB, 2006, J HAZARD MATER, V133, P243, DOI 10.1016/j.jhazmat.2005.10.034; Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6; Wu DY, 2006, J COLLOID INTERF SCI, V304, P300, DOI 10.1016/j.jcis.2006.09.011; Yu Y, 2010, J COLLOID INTERF SCI, V350, P538, DOI 10.1016/j.jcis.2010.06.033	32	26	26	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60243	10.1371/journal.pone.0060243	http://dx.doi.org/10.1371/journal.pone.0060243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565207	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300076
J	Dhurandhar, EJ; Allison, DB; van Groen, T; Kadish, I				Dhurandhar, Emily J.; Allison, David B.; van Groen, Thomas; Kadish, Inga			Hunger in the Absence of Caloric Restriction Improves Cognition and Attenuates Alzheimer's Disease Pathology in a Mouse Model	PLOS ONE			English	Article							WEIGHT-LOSS; CHOLESTEROL LEVEL; TRANSGENIC MICE; STATIN USE; LIFE-SPAN; GHRELIN; RISK; INFLAMMATION; DYSFUNCTION; PREVENTION	It has been shown that caloric restriction (CR) delays aging and possibly delays the development of Alzheimer's disease (AD). We conjecture that the mechanism may involve interoceptive cues, rather than reduced energy intake per se. We determined that hunger alone, induced by a ghrelin agonist, reduces AD pathology and improves cognition in the APP-SwDI mouse model of AD. Long-term treatment with a ghrelin agonist was sufficient to improve the performance in the water maze. The treatment also reduced levels of amyloid beta (Ab) and inflammation (microglial activation) at 6 months of age compared to the control group, similar to the effect of CR. Thus, a hunger-inducing drug attenuates AD pathology, in the absence of CR, and the neuroendocrine aspects of hunger also prevent age-related cognitive decline.	[Dhurandhar, Emily J.; Allison, David B.] Univ Alabama Birmingham, Sch Publ Hlth, Off Energet, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [van Groen, Thomas; Kadish, Inga] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Nutr Obes Res Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kadish, I (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Nutr Obes Res Ctr, Birmingham, AL USA.	ikadisha@uab.edu		Allison, David/0000-0003-3566-9399	Alzheimer's of Central Alabama; National Institutes of Health [P30 NS47466, T32DK062710]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062710, P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466] Funding Source: NIH RePORTER	Alzheimer's of Central Alabama; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by Alzheimer's of Central Alabama, and part of the work was supported by National Institutes of Health P30 NS47466 and T32DK062710. In addition, the ghrelin agonist was donated for the study by Eli Lilly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arab L, 2010, J ALZHEIMERS DIS, V20, P785, DOI 10.3233/JAD-2010-091573; Aziz NA, 2008, J NEUROL, V255, P1872, DOI 10.1007/s00415-009-0062-8; Bales KR, 2010, NEUROPHARMACOLOGY, V59, P295, DOI 10.1016/j.neuropharm.2010.01.005; Bonda DJ, 2011, LANCET NEUROL, V10, P275, DOI 10.1016/S1474-4422(11)70013-8; Bulgarelli I, 2009, J NEUROSCI RES, V87, P2718, DOI 10.1002/jnr.22088; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Davidson TL, 2005, PEPTIDES, V26, P1602, DOI 10.1016/j.peptides.2005.02.014; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; FURST A, 1987, HEALTH PHYS, V52, P527, DOI 10.1097/00004032-198705000-00001; Furuya TK, 2012, NEUROCHEM INT; Giddings M, 2008, OB SOC ANN M OB PHOE, pS108; Gillette-Guyonnet S, 2007, J NUTR HEALTH AGING, V11, P38; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Hambly C, 2007, REJUV RES, V10, P533, DOI 10.1089/rej.2007.0555; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Inelmen EM, 2010, AGING CLIN EXP RES, V22, P192, DOI [10.3275/6677, 10.1007/BF03324796]; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Lugar CW, 2004, BIOORG MED CHEM LETT, V14, P5873, DOI 10.1016/j.bmcl.2004.09.027; Minor RK, 2009, MOL CELL ENDOCRINOL, V299, P79, DOI 10.1016/j.mce.2008.10.044; Moon M, 2011, J ALZHEIMERS DIS, V23, P147, DOI 10.3233/JAD-2010-101263; Rattan SIS, 2004, J GERONTOL A-BIOL, V59, P705; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; Seneff S, 2011, EUR J INTERN MED, V22, P134, DOI 10.1016/j.ejim.2010.12.017; Shepardson NE, 2011, ARCH NEUROL-CHICAGO, V68, P1385, DOI 10.1001/archneurol.2011.242; Shepardson NE, 2011, ARCH NEUROL-CHICAGO, V68, P1239, DOI 10.1001/archneurol.2011.203; Stalder M, 2001, NEUROBIOL AGING, V22, P427, DOI 10.1016/S0197-4580(01)00209-3; Tamura Bruce K., 2007, Journal of Nutrition for the Elderly, V26, P21, DOI 10.1300/J052v26n03_02; Tezapsidis N, 2009, J ALZHEIMERS DIS, V16, P731, DOI 10.3233/JAD-2009-1021; van Groen T, 2005, BRAIN RES REV, V48, P370, DOI 10.1016/j.brainresrev.2004.12.026; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Wang J, 2010, BBA-PROTEINS PROTEOM, V1804, P1690, DOI 10.1016/j.bbapap.2009.11.015; Weih M, 2007, J NEURAL TRANSM, V114, P1187, DOI 10.1007/s00702-007-0704-x; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0	40	46	51	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60437	10.1371/journal.pone.0060437	http://dx.doi.org/10.1371/journal.pone.0060437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565247	Green Published, gold			2022-12-27	WOS:000317717300117
J	Pape, E; Jones, DOB; Manini, E; Bezerra, TN; Vanreusel, A				Pape, Ellen; Jones, Daniel O. B.; Manini, Elena; Bezerra, Tania Nara; Vanreusel, Ann			Benthic-Pelagic Coupling: Effects on Nematode Communities along Southern European Continental Margins	PLOS ONE			English	Article							SEDIMENTARY ORGANIC-MATTER; EASTERN MEDITERRANEAN SEA; ABYSSAL NE ATLANTIC; DEEP ARABIAN SEA; METAZOAN MEIOFAUNA; PHYTODETRITUS DEPOSITION; EQUATORIAL PACIFIC; NORTHEAST ATLANTIC; STANDING STOCK; SHELF BREAK	Along a west-to-east axis spanning the Galicia Bank region (Iberian margin) and the Mediterranean basin, a reduction in surface primary productivity and in seafloor flux of particulate organic carbon was mirrored in the in situ organic matter quantity and quality within the underlying deep-sea sediments at different water depths (1200, 1900 and 3000 m). Nematode standing stock (abundance and biomass) and genus and trophic composition were investigated to evaluate downward benthic-pelagic coupling. The longitudinal decline in seafloor particulate organic carbon flux was reflected by a reduction in benthic phytopigment concentrations and nematode standing stock. An exception was the station sampled at the Galicia Bank seamount, where despite the maximal particulate organic carbon flux estimate, we observed reduced pigment levels and nematode standing stock. The strong hydrodynamic forcing at this station was believed to be the main cause of the local decoupling between pelagic and benthic processes. Besides a longitudinal cline in nematode standing stock, we noticed a west-to-east gradient in nematode genus and feeding type composition (owing to an increasing importance of predatory/scavenging nematodes with longitude) governed by potential proxies for food availability (percentage of nitrogen, organic carbon, and total organic matter). Within-station variability in generic composition was elevated in sediments with lower phytopigment concentrations. Standing stock appeared to be regulated by sedimentation rates and benthic environmental variables, whereas genus composition covaried only with benthic environmental variables. The coupling between deep-sea nematode assemblages and surface water processes evidenced in the present study suggests that it is likely that climate change will affect the composition and function of deep-sea nematodes.	[Pape, Ellen; Bezerra, Tania Nara; Vanreusel, Ann] Univ Ghent, Marine Biol Res Grp, B-9000 Ghent, Belgium; [Jones, Daniel O. B.] Natl Oceanog Ctr, Southampton, Hants, England; [Manini, Elena] CNR, Inst Marine Sci, Ancona, Italy	Ghent University; NERC National Oceanography Centre; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Pape, E (corresponding author), Univ Ghent, Marine Biol Res Grp, B-9000 Ghent, Belgium.	Ellen.Pape@Ugent.be	Bezerra, Tania Nara/F-3070-2011; Manini, Elena/C-2032-2015; pape, ellen/A-9594-2011; Jones, Daniel/A-3412-2009; CNR, Ismar/P-1247-2014	Manini, Elena/0000-0002-8990-2929; Jones, Daniel/0000-0001-5218-1649; Pape, Ellen/0000-0003-2881-8341; CNR, Ismar/0000-0001-5351-1486	ESF-EuroDEEP BIOFUN project (FWO) [3G067007]; European Commission's Seventh Framework Programme HERMIONE project [226354]; FWO [G083512W]; NERC [noc010004, noc010011, noc010009] Funding Source: UKRI; Natural Environment Research Council [noc010004, noc010011, noc010009] Funding Source: researchfish	ESF-EuroDEEP BIOFUN project (FWO)(FWO); European Commission's Seventh Framework Programme HERMIONE project; FWO(FWO); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded through the ESF-EuroDEEP BIOFUN project (FWO project number 3G067007), the European Commission's Seventh Framework Programme HERMIONE project (grant number 226354) and FWO project nr G083512W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2003, MAR ECOL PROG SER, V251, P37, DOI 10.3354/meps251037; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bergamasco A., 2010, ADV OCEANOGR LIMNOL, V1, P11, DOI DOI 10.1080/19475721.2010.491656; BETT BJ, 1994, MAR ECOL PROG SER, V104, P197, DOI 10.3354/meps104197; Bianchelli S, 2010, DEEP-SEA RES PT I, V57, P420, DOI 10.1016/j.dsr.2009.12.001; Boon AR, 1996, J SEA RES, V35, P279, DOI 10.1016/S1385-1101(96)90755-8; Bosc E, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002034; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; Campbell J, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001444; Carr ME, 2006, DEEP-SEA RES PT II, V53, P741, DOI 10.1016/j.dsr2.2006.01.028; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Claustre H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014056; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; Danovaro R, 1999, PROG OCEANOGR, V44, P287, DOI 10.1016/S0079-6611(99)00030-0; Danovaro R, 1999, J SEA RES, V42, P117, DOI 10.1016/S1385-1101(99)00024-6; Danovaro R, 2008, ECOGRAPHY, V31, P231, DOI 10.1111/j.0906-7590.2008.5484.x; Danovaro R, 1995, PROG OCEANOGR, V36, P329, DOI 10.1016/0079-6611(96)00002-X; De La Rocha CL, 2007, DEEP-SEA RES PT II, V54, P639, DOI 10.1016/j.dsr2.2007.01.004; Ducklow Hugh W., 2001, Oceanography, V14, P50; Duineveld GCA, 2004, MAR ECOL PROG SER, V277, P13, DOI 10.3354/meps277013; Duineveld GCA, 2000, PROG OCEANOGR, V46, P457, DOI 10.1016/S0079-6611(00)00029-X; Estrada M, 1996, SCI MAR, V60, P55; Flach E, 2002, PROG OCEANOGR, V52, P433, DOI 10.1016/S0079-6611(02)00018-6; Fonseca G, 2009, POLAR BIOL, V32, P1345, DOI 10.1007/s00300-009-0631-4; Gage JD, 2003, ECOSY WORLD, V28, P313; Galeron J, 2001, PROG OCEANOGR, V50, P303, DOI 10.1016/S0079-6611(01)00059-3; Galeron J, 2000, MAR ECOL PROG SER, V197, P121, DOI 10.3354/meps197121; Gambi C., 2010, ADV OCEANOGR LIMNOL, V1, P167, DOI [10.4081/aiol.2010.5299, DOI 10.4081/AIOL.2010.5299]; Gambi C, 2006, DEEP-SEA RES PT I, V53, P1117, DOI 10.1016/j.dsr.2006.05.003; Gardner W.D., 2000, CHANGING OCEAN CARBO, P240; Gooday AJ, 1996, J MAR BIOL ASSOC UK, V76, P297, DOI 10.1017/S0025315400030563; Gorley C.K., 2006, GETTING STARTED PRIM; Gorsky G, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001064; Gorsky G, 2002, J MARINE SYST, V33, P289, DOI 10.1016/S0924-7963(02)00063-5; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Ingels J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020094; Ingels J, 2010, MAR ECOL PROG SER, V406, P121, DOI 10.3354/meps08535; Ingels J, 2009, DEEP-SEA RES PT I, V56, P1521, DOI 10.1016/j.dsr.2009.04.010; Jeffreys RM, 2011, DEEP-SEA RES PT I, V58, P415, DOI 10.1016/j.dsr.2011.02.002; Joint I, 2002, J MARINE SYST, V32, P219, DOI 10.1016/S0924-7963(02)00037-4; Kerherve P, 1999, PROG OCEANOGR, V44, P651, DOI 10.1016/S0079-6611(99)00040-3; Kim S, 2011, PPCOR PARTIAL SEMIPA; Lampadariou N, 2006, PROG OCEANOGR, V69, P19, DOI 10.1016/j.pocean.2006.02.013; Lampadariou N, 2009, SCI MAR, V73, P337, DOI 10.3989/scimar.2009.73n2337; Legendre L, 2002, MAR ECOL PROG SER, V242, P95, DOI 10.3354/meps242095; Lorenzen C.J., 1980, UNESCO TECHNICAL PAP, V35, P1, DOI DOI 10.4319/LO.1967.12.2.0343; Lutz M, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001383; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; MAYER LM, 1994, CHEM GEOL, V114, P347, DOI 10.1016/0009-2541(94)90063-9; MCCLAIN CR, 1986, J GEOPHYS RES-OCEANS, V91, P8470, DOI 10.1029/JC091iC07p08470; Mokievskii VO, 2007, OCEANOLOGY+, V47, P797, DOI 10.1134/S0001437007060057; Moutin T, 2002, J MARINE SYST, V33, P273, DOI 10.1016/S0924-7963(02)00062-3; Neira C, 2001, DEEP-SEA RES PT I, V48, P2453, DOI 10.1016/S0967-0637(01)00018-8; PFANNKUCHE O, 1993, DEEP-SEA RES PT II, V40, P135, DOI 10.1016/0967-0645(93)90010-K; Pfannkuche O, 2000, DEEP-SEA RES PT II, V47, P2805, DOI 10.1016/S0967-0645(00)00050-3; Pfannkuche O, 1999, DEEP-SEA RES PT I, V46, P573, DOI 10.1016/S0967-0637(98)00081-8; Pusceddu A, 2010, DEEP-SEA RES PT I, V57, P441, DOI 10.1016/j.dsr.2009.11.008; Pusceddu A, 2009, DEEP-SEA RES PT II, V56, P755, DOI 10.1016/j.dsr2.2008.10.012; R Core Team, 2012, R LANG ENV STAT COMP; Relexans JC, 1996, DEEP-SEA RES PT I, V43, P1343, DOI 10.1016/0967-0637(96)00062-3; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Shimanaga M, 2007, DEEP-SEA RES PT II, V54, P131, DOI 10.1016/j.dsr2.2006.11.003; SIBUET M, 1993, ANN I OCEANOGR PARIS, V69, P21; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Smith KL, 2001, LIMNOL OCEANOGR, V46, P543, DOI 10.4319/lo.2001.46.3.0543; SOETAERT K, 1995, MAR ECOL PROG SER, V125, P171, DOI 10.3354/meps125171; Soetaert K, 1997, DEEP-SEA RES PT I, V44, P1671, DOI 10.1016/S0967-0637(97)00043-5; Soetaert K, 2009, MAR ECOL PROG SER, V392, P123, DOI 10.3354/meps08202; Soltwedel T, 2000, PROG OCEANOGR, V46, P59, DOI 10.1016/S0079-6611(00)00030-6; Sommer S, 2000, DEEP-SEA RES PT II, V47, P2957, DOI 10.1016/S0967-0645(00)00054-0; Stephens MP, 1997, GEOCHIM COSMOCHIM AC, V61, P4605, DOI 10.1016/S0016-7037(97)00358-X; Tecchio S, 2011, MAR ECOL PROG SER, V439, P181, DOI 10.3354/meps09333; Thistle D, 1998, DEEP-SEA RES PT I, V45, P625, DOI 10.1016/S0967-0637(97)00101-5; TIETJEN JH, 1984, DEEP-SEA RES, V31, P119, DOI 10.1016/0198-0149(84)90019-0; Tselepides A, 2004, DEEP-SEA RES PT I, V51, P833; Tselepides A, 2004, SCI MAR, V68, P39, DOI 10.3989/scimar.2004.68s339; Turley CM, 2000, MAR ECOL PROG SER, V193, P11, DOI 10.3354/meps193011; Tyler PA, 2003, ECOSY WORLD, V28, P261; Udalov AA, 2005, PROG OCEANOGR, V67, P1, DOI 10.1016/j.pocean.2005.02.020; Van Gansbeke D, PROG OCEANO IN PRESS; van Weering TCE, 2002, PROG OCEANOGR, V52, P349, DOI 10.1016/S0079-6611(02)00015-0; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; WIESER W., 1953, ARKIV ZOOL, V4, P439; Witbaard R, 2000, J SEA RES, V43, P15, DOI 10.1016/S1385-1101(99)00040-4; Witte U, 2003, NATURE, V424, P763, DOI 10.1038/nature01799; Witte U, 2003, MAR ECOL PROG SER, V251, P27, DOI 10.3354/meps251027; Zuniga D, 2007, DEEP-SEA RES PT I, V54, P1530, DOI 10.1016/j.dsr.2007.06.001	95	24	24	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59954	10.1371/journal.pone.0059954	http://dx.doi.org/10.1371/journal.pone.0059954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565176	Green Accepted, Green Published, gold			2022-12-27	WOS:000317717300045
J	Shi, HX; Lin, C; Lin, BB; Wang, ZG; Zhang, HY; Wu, FZ; Cheng, Y; Xiang, LJ; Guo, DJ; Luo, X; Zhang, GY; Fu, XB; Bellusci, S; Li, XK; Xiao, J				Shi, Hong-Xue; Lin, Cai; Lin, Bei-Bei; Wang, Zhou-Guang; Zhang, Hong-Yu; Wu, Fen-Zan; Cheng, Yi; Xiang, Li-Jun; Guo, Di-Jiong; Luo, Xu; Zhang, Guo-You; Fu, Xiao-Bing; Bellusci, Saverio; Li, Xiao-Kun; Xiao, Jian			The Anti-Scar Effects of Basic Fibroblast Growth Factor on the Wound Repair In Vitro and In Vivo	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; RABBIT EAR MODEL; HYPERTROPHIC SCARS; FACTOR-BETA; TEMPORAL EXPRESSION; DERMAL FIBROBLASTS; APOPTOSIS; TISSUE; MECHANISMS; BIOLOGY	Hypertrophic scars (HTS) and keloids are challenging problems. Their pathogenesis results from an overproduction of fibroblasts and excessive deposition of collagen. Studies suggest a possible anti-scarring effect of basic fibroblast growth factor (bFGF) during wound healing, but the precise mechanisms of bFGF are still unclear. In view of this, we investigated the therapeutic effects of bFGF on HTS animal model as well as human scar fibroblasts (HSF) model. We show that bFGF promoted wound healing and reduced the area of flattened non-pathological scars in rat skin wounds and HTS in the rabbit ear. We provide evidence of a new therapeutic strategy: bFGF administration for the treatment of HTS. The scar elevation index (SEI) and epidermal thickness index (ETI) was also significantly reduced. Histological reveal that bFGF exhibited significant amelioration of the collagen tissue. bFGF regulated extracellular matrix (ECM) synthesis and degradation via interference in the collagen distribution, the alpha-smooth muscle actin (alpha-SMA) and transforming growth factor-1 (TGF-beta 1) expression. In addition, bFGF reduced scarring and promoted wound healing by inhibiting TGF beta 1/SMAD-dependent pathway. The levels of fibronectin (FN), tissue inhibitor of metalloproteinase-1 (TIMP-1) collagen I, and collagen III were evidently decreased, and matrix metalloproteinase-1 (MMP-1) and apoptosis cells were markedly increased. These results suggest that bFGF possesses favorable therapeutic effects on hypertrophic scars in vitro and in vivo, which may be an effective cure for human hypertrophic scars.	[Shi, Hong-Xue; Lin, Bei-Bei; Wang, Zhou-Guang; Zhang, Hong-Yu; Wu, Fen-Zan; Cheng, Yi; Xiang, Li-Jun; Li, Xiao-Kun; Xiao, Jian] Wenzhou Med Coll, Sch Pharm, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou, Peoples R China; [Lin, Cai; Luo, Xu] Wenzhou Med Coll, Dept Burns, Affiliated Hosp 1, Wenzhou, Peoples R China; [Guo, Di-Jiong] Wenzhou Med Coll, Cixi Hosp, Dept Gen Surg, Ningbo, Zhejiang, Peoples R China; [Zhang, Guo-You] Wenzhou Med Coll, Dept Orthopaed, Affiliated Hosp 2, Wenzhou, Peoples R China; [Fu, Xiao-Bing] Chinese Peoples Liberat Army Gen Hosp, Inst Basic Med Sci, Wound Healing & Cell Biol Lab, Beijing, Peoples R China; [Bellusci, Saverio] Univ Giessen, German Ctr Lung Res, D-35390 Giessen, Hessen, Germany	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Chinese People's Liberation Army General Hospital; Justus Liebig University Giessen	Li, XK (corresponding author), Wenzhou Med Coll, Sch Pharm, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou, Peoples R China.	xiaokunli@163.net; xfxj2000@126.com	Wang, Zhouguang/F-7918-2017; Shi, Hongxue/AAM-4965-2020	Wang, Zhouguang/0000-0001-9903-0362; Shi, Hongxue/0000-0001-9877-0369	Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; State Key Basic Research Development Program [2012CB518105]; Zhejiang Provincial Project of Key Group [2010R50042]; Ninbo City Natural Science Foundation [R2090550]; Zhejiang Natural Science Foundation [Z2080985]	Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; State Key Basic Research Development Program; Zhejiang Provincial Project of Key Group; Ninbo City Natural Science Foundation; Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents (to J.X.), State Key Basic Research Development Program (2012CB518105), Zhejiang Provincial Project of Key Group (2010R50042), Ninbo City Natural Science Foundation (R2090550), and Zhejiang Natural Science Foundation (Z2080985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; Akita S, 2008, WOUND REPAIR REGEN, V16, P635, DOI 10.1111/j.1524-475X.2008.00414.x; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bloemen MCT, 2009, BURNS, V35, P463, DOI 10.1016/j.burns.2008.07.016; Chalmers RL, 2011, INT WOUND J, V8, P218, DOI 10.1111/j.1742-481X.2011.00771.x; Colwell AS, 2005, PLAST RECONSTR SURG, V116, P1387, DOI 10.1097/01.prs.0000182343.99694.28; Dabiri G, 2006, J INVEST DERMATOL, V126, P963, DOI 10.1038/sj.jid.5700187; El Kahi CG, 2009, INT WOUND J, V6, P214, DOI 10.1111/j.1742-481X.2009.00597.x; Eto H, 2012, LAB INVEST, V92, P214, DOI 10.1038/labinvest.2011.127; Fu XB, 1998, LANCET, V352, P1661, DOI 10.1016/S0140-6736(98)01260-4; Funato N, 1997, BIOCHEM BIOPH RES CO, V240, P21, DOI 10.1006/bbrc.1997.7588; Grieb G, 2011, INT REV CEL MOL BIO, V291, P1, DOI 10.1016/B978-0-12-386035-4.00001-X; Haines P, 2011, J DERMATOL SCI, V64, P210, DOI 10.1016/j.jdermsci.2011.08.005; Honardoust D, 2012, J BURN CARE RES, V33, P668, DOI 10.1097/BCR.0b013e31824088e3; Imaizumi R, 2009, HISTOPATHOLOGY, V54, P722, DOI 10.1111/j.1365-2559.2009.03287.x; Kryger ZB, 2007, J AM COLL SURGEONS, V205, P78, DOI 10.1016/j.jamcollsurg.2007.03.001; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Nedelec B, 2001, SURGERY, V130, P798, DOI 10.1067/msy.2001.116453; Niessen FB, 1998, PLAST RECONSTR SURG, V102, P1962, DOI 10.1097/00006534-199811000-00023; Oliveira GV, 2009, INT WOUND J, V6, P445, DOI 10.1111/j.1742-481X.2009.00638.x; Ono I, 2007, WOUND REPAIR REGEN, V15, P617, DOI 10.1111/j.1524-475X.2007.00293.x; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; Satish L, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-113; Shi F, 2011, J CELL SCI, V124, P4039, DOI 10.1242/jcs.087858; Sidgwick GP, 2012, J EUR ACAD DERMATOL, V26, P141, DOI 10.1111/j.1468-3083.2011.04200.x; Singh P, 2004, J INVEST DERMATOL, V123, P1176, DOI 10.1111/j.0022-202X.2004.23485.x; Spyrou GE, 2002, BRIT J PLAST SURG, V55, P275, DOI 10.1054/bjps.2002.3831; Tan Y, 2008, J HEALTH SCI, V54, P432, DOI 10.1248/jhs.54.432; van der Veer WM, 2010, ANN PLAS SURG, V65, P321, DOI 10.1097/SAP.0b013e3181c60f88; Verhaegen PD, 2012, WOUND REPAIR REGEN, V20, P658, DOI 10.1111/j.1524-475X.2012.00827.x; Verhaegen PDHM, 2012, J MICROSC-OXFORD, V245, P82, DOI 10.1111/j.1365-2818.2011.03547.x; Wang W, 2008, LIFE SCI, V82, P190, DOI 10.1016/j.lfs.2007.11.009; WARD R S, 1991, Journal of Burn Care and Rehabilitation, V12, P257, DOI 10.1097/00004630-199105000-00011; Wu FZ, 2012, CNS NEUROSCI THER; Xiang Q, 2011, BURNS, V37, P886, DOI 10.1016/j.burns.2011.01.018; Xiao J, 2010, BIOL PHARM BULL, V33, P444, DOI 10.1248/bpb.33.444; Xie JL, 2008, WOUND REPAIR REGEN, V16, P576, DOI 10.1111/j.1524-475X.2008.00405.x	38	132	144	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59966	10.1371/journal.pone.0059966	http://dx.doi.org/10.1371/journal.pone.0059966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565178	gold, Green Submitted, Green Published			2022-12-27	WOS:000317717300047
J	van Blitterswijk, M; Wang, ET; Friedman, BA; Keagle, PJ; Lowe, P; Leclerc, AL; van den Berg, LH; Housman, DE; Veldink, JH; Landers, JE				van Blitterswijk, Marka; Wang, Eric T.; Friedman, Brad A.; Keagle, Pamela J.; Lowe, Patrick; Leclerc, Ashley Lyn; van den Berg, Leonard H.; Housman, David E.; Veldink, Jan H.; Landers, John E.			Characterization of FUS Mutations in Amyotrophic Lateral Sclerosis Using RNA-Seq	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT; BINDING PROTEIN; TLS/FUS; TDP-43; GENE; TLS; FUS/TLS; TARGETS; IDENTIFICATION; ACCUMULATION	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease resulting in severe muscle weakness and eventual death by respiratory failure. Although little is known about its pathogenesis, mutations in fused in sarcoma/translated in liposarcoma (FUS) are causative for familial ALS. FUS is a multifunctional protein that is involved in many aspects of RNA processing. To elucidate the role of FUS in ALS, we overexpressed wild-type and two mutant forms of FUS in HEK-293T cells, as well as knocked-down FUS expression. This was followed by RNA-Seq to identify genes which displayed differential expression or altered splicing patterns. Pathway analysis revealed that overexpression of wild-type FUS regulates ribosomal genes, whereas knock-down of FUS additionally affects expression of spliceosome related genes. Furthermore, cells expressing mutant FUS displayed global transcription patterns more similar to cells overexpressing wild-type FUS than to the knock-down condition. This observation suggests that FUS mutants do not contribute to the pathogenesis of ALS through a loss-of-function. Finally, our results demonstrate that the R521G and R522G mutations display differences in their influence on transcription and splicing. Taken together, these results provide additional insights into the function of FUS and how mutations contribute to the development of ALS.	[van Blitterswijk, Marka; van den Berg, Leonard H.; Veldink, Jan H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [van Blitterswijk, Marka; Keagle, Pamela J.; Lowe, Patrick; Leclerc, Ashley Lyn; Landers, John E.] Univ Massachusetts, Med Ctr, Dept Neurol, Worcester, MA 01655 USA; [Wang, Eric T.] MIT, Dept Biol, Cambridge, MA USA; [Wang, Eric T.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA; [Friedman, Brad A.; Housman, David E.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Friedman, Brad A.; Housman, David E.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Utrecht University; Utrecht University Medical Center; University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts Institute of Technology (MIT)	Landers, JE (corresponding author), Univ Massachusetts, Med Ctr, Dept Neurol, Worcester, MA 01655 USA.	john.landers@umassmed.edu	van Blitterswijk, Marka/H-7274-2012; van Blitterswijk, Marka/AAL-4126-2021	van Blitterswijk, Marka/0000-0002-3054-7053; van Blitterswijk, Marka/0000-0002-3054-7053; Friedman, Brad/0000-0002-5864-5253; Veldink, Jan/0000-0001-5572-9657; Landers, John/0000-0001-8084-5043	Netherlands ALS Foundation; Adessium Foundation; European Community's Health Seventh Framework Program [259867]; Thierry Latran Foundation; National Institutes of Health/National Institute of Neurological Disorders and Stroke [1R01NS065847, 1R01NS073873]; University of Massachusetts Clinical and Translational Science Award Pilot Program [UL1RR031982]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000161] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073873, R01NS065847] Funding Source: NIH RePORTER	Netherlands ALS Foundation; Adessium Foundation; European Community's Health Seventh Framework Program; Thierry Latran Foundation; National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Massachusetts Clinical and Translational Science Award Pilot Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by The Netherlands ALS Foundation; J.R. van Dijk; the Adessium Foundation; the European Community's Health Seventh Framework Program [grant number 259867]; the Thierry Latran Foundation; the National Institutes of Health/National Institute of Neurological Disorders and Stroke [grant numbers 1R01NS065847, 1R01NS073873]; and the University of Massachusetts Clinical and Translational Science Award Pilot Program [grant number UL1RR031982]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Belly A, 2005, NEUROSCI LETT, V379, P152, DOI 10.1016/j.neulet.2004.12.071; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; CALVIO C, 1995, RNA, V1, P724; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Friedman BA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r69; Fushimi K, 2011, PROTEIN CELL, V2, P141, DOI 10.1007/s13238-011-1014-5; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; Goransson M, 2009, ONCOGENE, V28, P270, DOI 10.1038/onc.2008.378; Halliday G, 2012, ACTA NEUROPATHOL, V124, P373, DOI 10.1007/s00401-012-1030-4; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Kryndushkin D, 2011, PROTEIN CELL, V2, P223, DOI 10.1007/s13238-011-1525-0; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2012, NAT NEUROSCI; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lanson NA, 2011, HUM MOL GENET, V20, P2510, DOI 10.1093/hmg/ddr150; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Meissner M, 2003, EXP CELL RES, V283, P184, DOI 10.1016/S0014-4827(02)00046-0; Mitchell JC, 2012, ACTA NEUROPATHOL; Murakami T, 2012, HUM MOL GENET, V21, P1, DOI 10.1093/hmg/ddr417; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Pokrishevsky E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035050; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sasayama H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039483; Selamat W, 2009, NEUROSCI LETT, V450, P163, DOI 10.1016/j.neulet.2008.12.014; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Shelkovnikova TA, 2011, DOKL BIOCHEM BIOPHYS, V438, P123, DOI 10.1134/S1607672911030045; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Tan AY, 2010, MOL CELL BIOL, V30, P186, DOI 10.1128/MCB.00884-09; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Vaccaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042117; Vaccaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031321; van Blitterswijk M, 2012, HUM MOL GENET, V21, P3776, DOI 10.1093/hmg/dds199; van Blitterswijk M, 2010, NEUROGENETICS, V11, P275, DOI 10.1007/s10048-010-0239-4; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang JW, 2011, J CLIN INVEST, V121, P4118, DOI 10.1172/JCI57883; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513; Zinszner H, 1997, J CELL SCI, V110, P1741	51	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60788	10.1371/journal.pone.0060788	http://dx.doi.org/10.1371/journal.pone.0060788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577159	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000070
J	Chong, WP; Ling, MT; Liu, YP; Caspi, RR; Wong, WM; Wu, WT; Tu, WW; Lau, YL				Chong, Wai Po; Ling, Man To; Liu, Yinping; Caspi, Rachel R.; Wong, Wai Man; Wu, Wutian; Tu, Wenwei; Lau, Yu Lung			Essential Role of NK Cells in IgG Therapy for Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; REGULATORY T-CELLS; FC-GAMMA-RECEPTORS; INTRAVENOUS IMMUNOGLOBULIN; DENDRITIC CELLS; IN-VIVO; DISEASE; RESPONSES; IL-2; ACTIVATION	Intravenous immunoglobulin has long been used in treating autoimmune diseases, although mechanisms remain uncertain. Activating Fc gamma receptors are receptors of IgG and reported to be essential in intravenous immunoglobulin (IVIG) therapy. Therefore, we hypothesized natural killer (NK) cells, which express abundant activating Fc gamma receptors, are the potential cellular target. In experimental autoimmune encephalomyelitis (EAE), we demonstrated that IgG suppressed disease development in intact, but not in NK cell depleted mice. Adoptive transfer of IgG-treated NK cell could protect mice against EAE, and suppressed interferon c and interleukin 17 production. The percentage of CD4(+)Foxp3(+) regulatory T cells was significantly increased. The increase of regulatory T cells was also observed in IgG-treated EAE mice but not in NK cell depleted mice. In vitro experiments confirmed that IgG-treated NK cells enhanced regulatory T cell induction from naive CD4(+) T cells. Interestingly, cells from draining lymph nodes produced more interleukin 2 after the adoptive transfer of IgG-treated NK cells. We neutralized interleukin 2 and the induction of CD4(+)Foxp3(+) T cells by IgG-treated NK cells was significantly reduced. To our knowledge, we identified for the first time the critical role of NK cells in the mechanism of IgG-induced induction of Treg cells in treatment of autoimmunity.	[Chong, Wai Po; Ling, Man To; Liu, Yinping; Tu, Wenwei; Lau, Yu Lung] Univ Hong Kong, Dept Paediat & Adolescent Med, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Chong, Wai Po; Caspi, Rachel R.] NEI, Immunol Lab, Bethesda, MD 20892 USA; [Wong, Wai Man; Wu, Wutian] Univ Hong Kong, Dept Anat, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Hong Kong	Lau, YL (corresponding author), Univ Hong Kong, Dept Paediat & Adolescent Med, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.	lauylung@hkucc.hku.hk	Chong, Wai Po/HCI-1030-2022; Lau, Yu Lung/C-4322-2009; Tu, Wenwei/C-4429-2009	Chong, Wai Po/0000-0001-9640-199X; Lau, Yu Lung/0000-0002-4780-0289; Tu, Wenwei/0000-0002-6801-8798; Caspi, Rachel/0000-0002-7140-7671	Area of Excellence Scheme of the University Grants Committee, Hong Kong SAR, China [A0E/M-12/06]; Edward Sai-Kim Hotung Paediatric Education and Research Fund; Chung Ko Lee and Cheung Yuen Kan Education and Research Fund in Paediatric Immunology; Shun Tak District Min Yuen Tong; Wong Ching Yee Memorial Postgraduate Scholarship; Mary Sun Medical Scholarship; NATIONAL EYE INSTITUTE [ZIAEY000184, ZICEY000457] Funding Source: NIH RePORTER	Area of Excellence Scheme of the University Grants Committee, Hong Kong SAR, China; Edward Sai-Kim Hotung Paediatric Education and Research Fund; Chung Ko Lee and Cheung Yuen Kan Education and Research Fund in Paediatric Immunology; Shun Tak District Min Yuen Tong; Wong Ching Yee Memorial Postgraduate Scholarship; Mary Sun Medical Scholarship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The study was partially supported by the Area of Excellence Scheme of the University Grants Committee, Hong Kong SAR, China (Grant A0E/M-12/06; YLL and WT), Edward Sai-Kim Hotung Paediatric Education and Research Fund (WPC and YLL), Chung Ko Lee and Cheung Yuen Kan Education and Research Fund in Paediatric Immunology (YLL), The Shun Tak District Min Yuen Tong (YLL), Wong Ching Yee Memorial Postgraduate Scholarship (WPC) and Mary Sun Medical Scholarship (WPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHIRON A, 1994, J CLIN INVEST, V93, P600, DOI 10.1172/JCI117012; Araujo LM, 2011, J IMMUNOL, V186, P3289, DOI 10.4049/jimmunol.1003076; Aubin E, 2010, BLOOD, V115, P1727, DOI 10.1182/blood-2009-06-225417; Bao Y, 2011, EUR J IMMUNOL, V41, P657, DOI 10.1002/eji.201040840; Bergmann C, 2011, EUR J IMMUNOL, V41, P3564, DOI 10.1002/eji.201141532; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bohn AB, 2011, EUR J NEUROL, V18, P919, DOI 10.1111/j.1468-1331.2010.03333.x; Brillard E, 2007, EXP HEMATOL, V35, P416, DOI 10.1016/j.exphem.2006.12.004; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Griseri T, 2010, J EXP MED, V207, P699, DOI 10.1084/jem.20091618; Hanna J, 2004, J CLIN INVEST, V114, P1612, DOI 10.1172/JCI200422787; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Horwitz DA, 2003, J LEUKOCYTE BIOL, V74, P471, DOI 10.1189/jlb.0503228; Inoue Y, 2007, J IMMUNOL, V179, P764, DOI 10.4049/jimmunol.179.2.764; Jacobi C, 2009, CLIN IMMUNOL, V133, P393, DOI 10.1016/j.clim.2009.09.006; Jorgensen SH, 2005, NEUROL RES, V27, P591, DOI 10.1179/016164105X48798; Kessel A, 2007, J IMMUNOL, V179, P5571, DOI 10.4049/jimmunol.179.8.5571; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Meazza R, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/861920; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; 't Hart BA, 2011, TRENDS MOL MED, V17, P119, DOI 10.1016/j.molmed.2010.11.006; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Tha-In T, 2007, BLOOD, V110, P3253, DOI 10.1182/blood-2007-03-077057; Winkler-Pickett R, 2008, J IMMUNOL, V180, P4495, DOI 10.4049/jimmunol.180.7.4495; Xu W, 2005, J NEUROIMMUNOL, V163, P24, DOI 10.1016/j.jneuroim.2005.02.011; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677; Zingoni A, 2004, J IMMUNOL, V173, P3716, DOI 10.4049/jimmunol.173.6.3716	40	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60862	10.1371/journal.pone.0060862	http://dx.doi.org/10.1371/journal.pone.0060862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577171	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800108
J	Moertl, MG; Lackner, HK; Papousek, I; Roessler, A; Hinghofer-Szalkay, H; Lang, U; Kolovetsiou-Kreiner, V; Schlembach, D				Moertl, Manfred Georg; Lackner, Helmut Karl; Papousek, Ilona; Roessler, Andreas; Hinghofer-Szalkay, Helmut; Lang, Uwe; Kolovetsiou-Kreiner, Vassiliki; Schlembach, Dietmar			Phase Synchronization of Hemodynamic Variables at Rest and after Deep Breathing Measured during the Course of Pregnancy	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RESPIRATORY SINUS ARRHYTHMIA; SYSTOLIC ARTERIAL-PRESSURE; BLOOD-PRESSURE; BAROREFLEX SENSITIVITY; CARDIOVASCULAR-SYSTEM; SPECTRAL-ANALYSIS; RR INTERVAL; TIME-SERIES; OSCILLATIONS	Background: The autonomic nervous system plays a central role in the functioning of systems critical for the homeostasis maintenance. However, its role in the cardiovascular adaptation to pregnancy-related demands is poorly understood. We explored the maternal cardiovascular systems throughout pregnancy to quantify pregnancy-related autonomic nervous system adaptations. Methodology: Continuous monitoring of heart rate (R-R interval; derived from the 3-lead electrocardiography), blood pressure, and thoracic impedance was carried out in thirty-six women at six time-points throughout pregnancy. In order to quantify in addition to the longitudinal effects on baseline levels throughout gestation the immediate adaptive heart rate and blood pressure changes at each time point, a simple reflex test, deep breathing, was applied. Consequently, heart rate variability and blood pressure variability in the low (LF) and high (HF) frequency range, respiration and baroreceptor sensitivity were analyzed in resting conditions and after deep breathing. The adjustment of the rhythms of the R-R interval, blood pressure and respiration partitioned for the sympathetic and the parasympathetic branch of the autonomic nervous system were quantified by the phase synchronization index gamma, which has been adopted from the analysis of weakly coupled chaotic oscillators. Results: Heart rate and LF/HF ratio increased throughout pregnancy and these effects were accompanied by a continuous loss of baroreceptor sensitivity. The increases in heart rate and LF/HF ratio levels were associated with an increasing decline in the ability to flexibly respond to additional demands (i.e., diminished adaptive responses to deep breathing). The phase synchronization index gamma showed that the observed effects could be explained by a decreased coupling of respiration and the cardiovascular system (HF components of heart rate and blood pressure). Conclusions/Significance: The findings suggest that during the course of pregnancy the individual systems become increasingly independent to meet the increasing demands placed on the maternal cardiovascular and respiratory system.	[Moertl, Manfred Georg; Lang, Uwe; Kolovetsiou-Kreiner, Vassiliki; Schlembach, Dietmar] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Moertl, Manfred Georg] Ctr Clin, Dept Obstet & Gynecol, Klagenfurt, Austria; [Lackner, Helmut Karl; Roessler, Andreas; Hinghofer-Szalkay, Helmut] Med Univ Graz, Dept Physiol, Graz, Austria; [Lackner, Helmut Karl] Graz Univ Technol, Dept Med Engn, A-8010 Graz, Austria; [Papousek, Ilona] Karl Franzens Univ Graz, Dept Psychol, Biol Psychol Unit, Graz, Austria; [Schlembach, Dietmar] Univ Jena, Univ Clin Jena, Dept Obstet & Gynecol, Jena, Germany	Medical University of Graz; Medical University of Graz; Graz University of Technology; University of Graz; Friedrich Schiller University of Jena	Lackner, HK (corresponding author), Med Univ Graz, Dept Physiol, Graz, Austria.	helmut.lackner@pro.medunigraz.at	Papousek, Ilona/H-3043-2019; Schlembach, Dietmar/AAJ-4433-2020; Roessler, Andreas/A-5751-2008	Papousek, Ilona/0000-0002-6620-0318; Schlembach, Dietmar/0000-0003-3641-5278; Roessler, Andreas/0000-0001-9543-8870; Lackner, Helmut/0000-0002-0159-3720				Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Badra LJ, 2001, AM J PHYSIOL-HEART C, V280, pH2674, DOI 10.1152/ajpheart.2001.280.6.H2674; Baumert M, 2012, COMPUT BIOL MED, V42, P347, DOI 10.1016/j.compbiomed.2011.03.019; BERNTSON GG, 1993, PSYCHOPHYSIOLOGY, V30, P183, DOI 10.1111/j.1469-8986.1993.tb01731.x; Blake MJ, 2000, CLIN SCI, V98, P259, DOI 10.1042/CS19990270; Camm AJ, 1996, CIRCULATION, V93, P1043; Carlin A, 2008, BEST PRACT RES CL OB, V22, P801, DOI 10.1016/j.bpobgyn.2008.06.005; Chamchad D, 2007, INT J OBSTET ANESTH, V16, P106, DOI 10.1016/j.ijoa.2006.08.008; CLAPP JF, 1988, AM J OBSTET GYNECOL, V159, P1456, DOI 10.1016/0002-9378(88)90574-1; Cysarz D, 2004, AM J PHYSIOL-HEART C, V287, pH579, DOI 10.1152/ajpheart.01131.2003; Di Rienzo M, 2001, AM J PHYSIOL-REG I, V280, pR744, DOI 10.1152/ajpregu.2001.280.3.R744; Diehl RR, 1997, CLIN AUTON RES, V7, P131, DOI 10.1007/BF02308840; Duvekot J J, 1994, Obstet Gynecol Surv, V49, pS1, DOI 10.1097/00006254-199412011-00001; Eckberg DL, 2009, J APPL PHYSIOL, V106, P1740, DOI 10.1152/japplphysiol.91107.2008; Ekholm E M, 1994, Clin Auton Res, V4, P161, DOI 10.1007/BF01826181; EKHOLM EMK, 1993, BRIT J OBSTET GYNAEC, V100, P177, DOI 10.1111/j.1471-0528.1993.tb15217.x; Ekholm EMK, 1996, EUR J OBSTET GYN R B, V64, P29, DOI 10.1016/0301-2115(95)02255-4; Fortin J, 2006, COMPUT BIOL MED, V36, P941, DOI 10.1016/j.compbiomed.2005.04.003; Fu Q, 2009, SEMIN REPROD MED, V27, P330, DOI 10.1055/s-0029-1225261; Heiskanen N, 2008, CLIN PHYSIOL FUNCT I, V28, P384, DOI 10.1111/j.1475-097X.2008.00818.x; Heusser K, 2010, HYPERTENSION, V55, P619, DOI 10.1161/HYPERTENSIONAHA.109.140665; Hinghofer-Szalkay H, 2004, AVIAT SPACE ENVIR MD, V75, P947; Hoyer D, 1997, IEEE ENG MED BIOL, V16, P31, DOI 10.1109/51.566150; JULIUS S, 1988, J HYPERTENS, V6, P177, DOI 10.1097/00004872-198803000-00001; Karemaker JM, 2009, J APPL PHYSIOL, V106, P1742, DOI 10.1152/japplphysiol.91107.2008a; Kevin D, 2007, AM J PHYSIOL-REG I, V293, pR3; Kreuz T, 2007, PHYSICA D, V225, P29, DOI 10.1016/j.physd.2006.09.039; Kuo CD, 2000, BRIT J ANAESTH, V84, P323, DOI 10.1093/oxfordjournals.bja.a013433; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; La Rovere MT, 2001, CIRCULATION, V103, P2072; Lackner HK, 2011, INT J PSYCHOPHYSIOL, V79, P401, DOI 10.1016/j.ijpsycho.2011.01.001; Lucini D, 1999, J HYPERTENS, V17, P1899, DOI 10.1097/00004872-199917121-00019; Magness RR, 1998, CONT ENDOCRINOL, V9, P507; Malberg H, 2007, CHAOS, V17, DOI 10.1063/1.2711660; Moertl MG, 2012, PHYSIOL MEAS, V33, P1015, DOI 10.1088/0967-3334/33/6/1015; Moertl MG, 2009, EUR J OBSTET GYN R B, V144, pS179, DOI 10.1016/j.ejogrb.2009.02.037; Niizeki K, 2012, AM J PHYSIOL-HEART C, V302, pH359, DOI 10.1152/ajpheart.00746.2011; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; PARATI G, 1988, HYPERTENSION, V12, P214, DOI 10.1161/01.HYP.12.2.214; PARMER RJ, 1992, CIRCULATION, V85, P497, DOI 10.1161/01.CIR.85.2.497; Pena MA, 2011, AUTON NEUROSCI-BASIC, V159, P117, DOI 10.1016/j.autneu.2010.09.006; PHIPPARD AF, 1986, J HYPERTENS, V4, P773, DOI 10.1097/00004872-198612000-00013; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Pitzalis MV, 1998, CARDIOVASC RES, V38, P332, DOI 10.1016/S0008-6363(98)00029-7; Ponomarenko VI, 2005, CHAOS SOLITON FRACT, V23, P1429, DOI 10.1016/j.chaos.2004.06.041; Porta A, 2012, COMPUT BIOL MED, V42, P298, DOI 10.1016/j.compbiomed.2011.04.019; Porta A, 2011, AM J PHYSIOL-REG I, V300, pR378, DOI 10.1152/ajpregu.00553.2010; Rang S, 2004, J HYPERTENS, V22, P369, DOI 10.1097/00004872-200402000-00022; Reyes Del Paso Gustavo A., 1996, International Journal of Psychophysiology, V22, P163, DOI 10.1016/0167-8760(96)00020-7; Riedl M, 2010, PHILOS T R SOC A, V368, P2237, DOI 10.1098/rsta.2010.0029; ROBSON SC, 1989, AM J PHYSIOL, V256, pH1060, DOI 10.1152/ajpheart.1989.256.4.H1060; Rosenblum M., 1998, NONLINEAR ANAL PHYSL, P91, DOI 10.1007/978-3-642-71949-3_6; Rosenblum MG, 2004, FLUCT NOISE LETT, V4, pL53, DOI 10.1142/S0219477504001653; Rudas L, 1999, AM J PHYSIOL-HEART C, V276, pH1691, DOI 10.1152/ajpheart.1999.276.5.H1691; Schafer C, 1999, PHYS REV E, V60, P857, DOI 10.1103/PhysRevE.60.857; Schlembach D, 2012, HEART RATE VARIABILI, P137; Seeck A, 2011, PHYSIOL MEAS, V32, P1611, DOI 10.1088/0967-3334/32/10/009; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; Silversides CK, 2007, HEART DISEASE IN PREGNANCY, 2ND EDITION, P6, DOI 10.1002/9780470994955.ch2; Stevens JP, 1999, INTERMEDIATE STAT MO; Taylor JA, 1996, CIRCULATION, V93, P1527, DOI 10.1161/01.CIR.93.8.1527; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Voss A, 2000, AM J HYPERTENS, V13, P1218, DOI 10.1016/S0895-7061(00)01199-7; Walther T, 2005, HYPERTENS RES, V28, P113, DOI 10.1291/hypres.28.113; White MD, 2006, J APPL PHYSIOL, V101, P655, DOI 10.1152/japplphysiol.00210.2006; Yang CCH, 2000, AM J PHYSIOL-HEART C, V278, pH1269, DOI 10.1152/ajpheart.2000.278.4.H1269; Yasuma F, 2004, CHEST, V125, P683, DOI 10.1378/chest.125.2.683; [No title captured], DOI DOI 10.1097/HJH.0B013E3283588189	68	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60675	10.1371/journal.pone.0060675	http://dx.doi.org/10.1371/journal.pone.0060675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577144	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800085
J	Quick, ML; Wong, L; Mukherjee, S; Done, JD; Schaeffer, AJ; Thumbikat, P				Quick, Marsha L.; Wong, Larry; Mukherjee, Soumi; Done, Joseph D.; Schaeffer, Anthony J.; Thumbikat, Praveen			Th1-Th17 Cells Contribute to the Development of Uropathogenic Escherichia coli-Induced Chronic Pelvic Pain	PLOS ONE			English	Article							CD8(+) T-CELLS; AUTOIMMUNE PROSTATITIS; BACTERIAL PROSTATITIS; CHEMOATTRACTANT PROTEIN-1; MOUSE MODEL; IFN-GAMMA; EXPRESSION; ANTIGEN; HYPERPLASIA; PLAYS	The etiology of chronic prostatitis/chronic pelvic pain syndrome in men is unknown but may involve microbes and autoimmune mechanisms. We developed an infection model of chronic pelvic pain in NOD/ShiLtJ (NOD) mice with a clinical Escherichia coli isolate (CP-1) from a patient with chronic pelvic pain. We investigated pain mechanisms in NOD mice and compared it to C57BL/6 (B6) mice, a strain resistant to CP-1-induced pain. Adoptive transfer of CD4+ T cells, but not serum, from CP-1-infected NOD mice was sufficient to induce chronic pelvic pain. CD4+ T cells in CP-1-infected NOD mice expressed IFN-gamma and IL-17A but not IL-4, consistent with a Th1/Th17 immune signature. Adoptive transfer of ex-vivo expanded IFN-gamma or IL-17A-expressing cells was sufficient to induce pelvic pain in naive NOD recipients. Pelvic pain was not abolished in NOD-IFN-gamma-KO mice but was associated with an enhanced IL-17A immune response to CP1 infection. These findings demonstrate a novel role for Th1 and Th17-mediated adaptive immune mechanisms in chronic pelvic pain.	[Quick, Marsha L.; Wong, Larry; Mukherjee, Soumi; Done, Joseph D.; Schaeffer, Anthony J.; Thumbikat, Praveen] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Thumbikat, Praveen] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Thumbikat, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	thumbikat@northwestern.edu	Thumbikat, Praveen/AAQ-1782-2021; Mukherjee, Soumi/CAA-1074-2022	Thumbikat, Praveen/0000-0002-5454-4172; Mukherjee, Soumi/0000-0001-7010-3564	National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIDDK/NIH) [K01DK079019, R01DK083609]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083609, K01DK079019, R01DK094898] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIDDK/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (NIDDK/NIH) under Award number K01DK079019 and R01DK083609. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 1997, UROLOGY, V50, P893, DOI 10.1016/S0090-4295(97)00456-1; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Boehm BJ, 2011, PROSTATE; BOZIC CR, 1995, J IMMUNOL, V154, P6048; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Collins MM, 1998, J UROLOGY, V159, P1224, DOI 10.1016/S0022-5347(01)63564-X; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Desireddi NV, 2008, J UROLOGY, V179, P1857, DOI 10.1016/j.juro.2008.01.028; Desireddi NV, 2008, J UROLOGY, V179, P1861; Elkahwaji JE, 2005, UROLOGY, V66, P883, DOI 10.1016/j.urology.2005.04.013; Elkahwaji JE, 2007, PROSTATE, V67, P14, DOI 10.1002/pros.20445; Giamberardino MA, 2010, PAIN, V151, P307, DOI 10.1016/j.pain.2010.06.023; Hochreiter WW, 2000, J UROLOGY, V163, P127, DOI 10.1016/S0022-5347(05)67987-6; Hou YF, 2009, J CLIN INVEST, V119, P2031, DOI 10.1172/JCI38332; Hua VN, 2004, MED CLIN N AM, V88, P483, DOI 10.1016/S0025-7125(03)00169-X; Jarrell J., 2011, PAIN RES TREAT, V2011, DOI [10.1155/2011/692102, DOI 10.1155/2011/692102]; Jarrell J, 2009, J VIS EXP; John H, 2003, ANDROLOGIA, V35, P294, DOI 10.1046/j.1439-0272.2003.00573.x; Johnson JR, 2001, J INFECT DIS, V184, P1556, DOI 10.1086/323891; Khalili M, 2010, AM J PATHOL, V176, P2259, DOI 10.2353/ajpath.2010.080747; Kim CF, 2011, J PAIN, V12, P370, DOI 10.1016/j.jpain.2010.08.003; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Krieger JN, 2002, J UROLOGY, V167, P2574, DOI 10.1016/S0022-5347(05)65041-0; Krieger JN, 1996, J CLIN MICROBIOL, V34, P3120, DOI 10.1128/JCM.34.12.3120-3128.1996; Leskinen MJ, 2003, PROSTATE, V55, P105, DOI 10.1002/pros.10218; MEARES EM, 1968, INVEST UROL, V5, P492; Motrich RD, 2005, CLIN IMMUNOL, V116, P149, DOI 10.1016/j.clim.2005.03.011; Nickel JC, 2003, J UROLOGY, V170, P818, DOI 10.1097/01.ju.0000082252.49374.e9; Pinto LG, 2010, PAIN, V148, P247, DOI 10.1016/j.pain.2009.11.006; Ponniah S, 2000, PROSTATE, V44, P49; Richter F, 2012, ARTHRITIS RHEUM-US, V64, P4125, DOI 10.1002/art.37695; Rivero V, 2002, CLIN IMMUNOL, V105, P176, DOI 10.1006/clim.2002.5281; Rivero VE, 1998, J AUTOIMMUN, V11, P603, DOI 10.1006/jaut.1998.0248; Rudick CN, 2008, AM J PHYSIOL-REG I, V294, pR1268, DOI 10.1152/ajpregu.00836.2007; Rudick CN, 2011, INFECT IMMUN, V79, P628, DOI 10.1128/IAI.00910-10; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; SHIZURU JA, 1988, SCIENCE, V240, P659, DOI 10.1126/science.2966437; Sivick KE, 2010, J IMMUNOL, V184, P2065, DOI 10.4049/jimmunol.0902386; Thumbikat P, 2006, J IMMUNOL, V176, P3080, DOI 10.4049/jimmunol.176.5.3080; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Verri WA, 2006, P NATL ACAD SCI USA, V103, P9721, DOI 10.1073/pnas.0603286103; von Banchet GS, 2013, MOL CELL NEUROSCI, V52, P152, DOI 10.1016/j.mcn.2012.11.006; Wang B, 2000, J IMMUNOL, V164, P1216, DOI 10.4049/jimmunol.164.3.1216; Wang B, 2001, J IMMUNOL, V167, P1283, DOI 10.4049/jimmunol.167.3.1283; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Wu Q, 2007, J ENDOCRINOL, V195, P89, DOI 10.1677/JOE-06-0181; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]	49	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60987	10.1371/journal.pone.0060987	http://dx.doi.org/10.1371/journal.pone.0060987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577183	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800118
J	Taylor, SD; Sanders, ME; Tullos, NA; Stray, SJ; Norcross, EW; McDaniel, LS; Marquart, ME				Taylor, Sidney D.; Sanders, Melissa E.; Tullos, Nathan A.; Stray, Stephen J.; Norcross, Erin W.; McDaniel, Larry S.; Marquart, Mary E.			The Cholesterol-Dependent Cytolysin Pneumolysin from Streptococcus pneumoniae Binds to Lipid Raft Microdomains in Human Corneal Epithelial Cells	PLOS ONE			English	Article							TRANSMEMBRANE BETA-HAIRPINS; IN-SITU KERATOMILEUSIS; PNEUMOCOCCAL KERATITIS; PERFRINGOLYSIN-O; ACTIVATED CYTOLYSINS; MICROBIAL KERATITIS; THETA-TOXIN; MEMBRANE; PREPORE; IMMUNIZATION	Streptococcus pneumoniae (pneumococcus) is an opportunistic bacterial pathogen responsible for causing several human diseases including pneumonia, meningitis, and otitis media. Pneumococcus is also a major cause of human ocular infections and is commonly isolated in cases of bacterial keratitis, an infection of the cornea. The ocular pathology that occurs during pneumococcal keratitis is partly due to the actions of pneumolysin (Ply), a cholesterol-dependent cytolysin produced by pneumococcus. The lytic mechanism of Ply is a three step process beginning with surface binding to cholesterol. Multiple Ply monomers then oligomerize to form a prepore. The prepore then undergoes a conformational change that creates a large pore in the host cell membrane, resulting in cell lysis. We engineered a collection of single amino acid substitution mutants at residues (A370, A406, W433, and L460) that are crucial to the progression of the lytic mechanism and determined the effects that these mutations had on lytic function. Both Ply(WT) and the mutant Ply molecules (Ply(A370G), Ply(A370E), Ply(A406G), Ply(A406E), Ply(W433G), Ply(W433E), Ply(W433F), Ply(L460G), and Ply(L460E)) were able to bind to the surface of human corneal epithelial cells (HCECs) with similar efficiency. Additionally, Ply(WT) localized to cholesterol-rich microdomains on the HCEC surface, however, only one mutant (Ply(A370G)) was able to duplicate this behavior. Four of the 9 mutant Ply molecules (Ply(A370E), Ply(W433G), Ply(W433E), and Ply(L460E)) were deficient in oligomer formation. Lastly, all of the mutant Ply molecules, except Ply(A370G), exhibited significantly impaired lytic activity on HCECs. The other 8 mutants all experienced a reduction in lytic activity, but 4 of the 8 retained the ability to oligomerize. A thorough understanding of the molecular interactions that occur between Ply and the target cell, could lead to targeted treatments aimed to reduce the pathology observed during pneumococcal keratitis.	[Taylor, Sidney D.; Sanders, Melissa E.; Tullos, Nathan A.; Stray, Stephen J.; Norcross, Erin W.; McDaniel, Larry S.; Marquart, Mary E.] Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Marquart, ME (corresponding author), Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA.	mmarquart@umc.edu	McDaniel, Larry/AAC-8459-2020	McDaniel, Larry/0000-0002-1649-7563	Public Health Services, National Eye Institute, National Institutes of Health [R01EY016195]; NATIONAL EYE INSTITUTE [R01EY016195] Funding Source: NIH RePORTER	Public Health Services, National Eye Institute, National Institutes of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Public Health Services Grant R01EY016195 (MEM), National Eye Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern JW, 2009, SOUTH MED J, V102, P1189, DOI 10.1097/SMJ.0b013e3181b9b137; Alexander JE, 1998, MICROB PATHOGENESIS, V24, P167, DOI 10.1006/mpat.1997.0185; ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683, DOI 10.1128/IAI.62.12.5683-5688.1994; Antao VC, 2009, ADV EXP MED BIOL, V634, P19, DOI 10.1007/978-0-387-79838-7_2; Berry AM, 1999, INFECT IMMUN, V67, P981, DOI 10.1128/IAI.67.2.981-985.1999; BERRY AM, 1995, INFECT IMMUN, V63, P1969, DOI 10.1128/IAI.63.5.1969-1974.1995; Bhave P, 2008, J HOSP MED, V3, P353, DOI 10.1002/jhm.306; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Cid M, 1997, AM J OPHTHALMOL, V123, P133, DOI 10.1016/S0002-9394(14)71009-8; Crum NF, 2004, CLIN INFECT DIS, V39, P1148, DOI 10.1086/424522; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Dada T, 2000, J CATARACT REFR SURG, V26, P460, DOI 10.1016/S0886-3350(99)00349-1; Dang TX, 2005, J STRUCT BIOL, V150, P100, DOI 10.1016/j.jsb.2005.02.003; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gekara NO, 2005, CELL MICROBIOL, V7, P1345, DOI 10.1111/j.1462-5822.2005.00561.x; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Hirst RA, 2004, CLIN EXP IMMUNOL, V138, P195, DOI 10.1111/j.1365-2249.2004.02611.x; Hotze EM, 2011, BIOCH BIOPHYS ACTA; Jacobs T, 1999, FEBS LETT, V459, P463, DOI 10.1016/S0014-5793(99)01297-1; JOHNSON MK, 1980, INFECT IMMUN, V27, P97, DOI 10.1128/IAI.27.1.97-101.1980; Kakazu A, 2008, INVEST OPHTH VIS SCI, V49, P2927, DOI 10.1167/iovs.07-0709; Kisakye A, 2009, CLIN INFECT DIS, V48, pS153, DOI 10.1086/596495; Kunimoto DY, 1998, OPHTHALMOLOGY, V105, P252, DOI 10.1016/S0161-6420(98)92899-8; Lifshitz T, 2005, J REFRACT SURG, V21, P498; Marquart ME, 2007, INVEST OPHTH VIS SCI, V48, P2661, DOI 10.1167/iovs.07-0017; McMahon KA, 2006, PROTEOMICS, V6, P143, DOI 10.1002/pmic.200500208; Norcross EW, 2011, INVEST OPHTH VIS SCI, V52, P9232, DOI 10.1167/iovs.10-6968; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Parmar P, 2003, CLIN EXP OPHTHALMOL, V31, P44, DOI 10.1046/j.1442-9071.2003.00598.x; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Ramirez M, 2002, J CATARACT REFR SURG, V28, P550, DOI 10.1016/S0886-3350(01)01000-8; Sanders ME, 2010, CURR EYE RES, V35, P1142, DOI 10.3109/02713683.2010.512114; SekinoSuzuki N, 1996, EUR J BIOCHEM, V241, P941, DOI 10.1111/j.1432-1033.1996.00941.x; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; Soriano F, 2006, CLIN MICROBIOL INFEC, V12, P519, DOI 10.1111/j.1469-0691.2006.01418.x; Sprenger RR, 2004, ELECTROPHORESIS, V25, P156, DOI 10.1002/elps.200305675; Thornton J, 2005, INFECT IMMUN, V73, P6493, DOI 10.1128/IAI.73.10.6493-6498.2005; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; TWETEN RK, 1988, INFECT IMMUN, V56, P3235, DOI 10.1128/IAI.56.12.3235-3240.1988; Yoshioka CRM, 2011, J PEDIAT-BRAZIL, V87, P70, DOI [10.1590/S0021-75572011000100012, 10.2223/JPED.2063]; Zegans ME, 2009, CORNEA, V28, P503, DOI 10.1097/ICO.0b013e3181909362	49	25	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61300	10.1371/journal.pone.0061300	http://dx.doi.org/10.1371/journal.pone.0061300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577214	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800137
J	Zhou, MN; Zhang, ZQ; Wu, JL; Lin, FQ; Fu, LF; Wang, SQ; Guan, CP; Wang, HL; Xu, A				Zhou, Miao-ni; Zhang, Zhi-qing; Wu, Ji-long; Lin, Fu-quan; Fu, Li-fang; Wang, Sui-quan; Guan, Cui-ping; Wang, Hong-lin; Xu, Aie			Dermal Mesenchymal Stem Cells (DMSCs) Inhibit Skin-Homing CD8+T Cell Activity, a Determining Factor of Vitiligo Patients' Autologous Melanocytes Transplantation Efficiency	PLOS ONE			English	Article							MARROW STROMAL CELLS; CD8(+) T-CELLS; GENERALIZED VITILIGO; PROLIFERATION; DESTRUCTION; DIFFERENTIATION; ANTIOXIDANTS; INFLAMMATION; SUPPRESSION; EXPANSION	We here investigated the efficiency of autologous melanocyte transplantation of 23 vitiligo patients by focusing on perilesional skin homing CD8+ T lymphocytes, and studied the potential effect of dermal mesenchymal stem cells (DMSCs) on CD8+ T cell activities in vitro. Out of 23 patients with the autologous melanocyte transplantation, 12 patients (52.17%) had an excellent re-pigmentation, 6 patients (26.09%) had a good re-pigmentation, 5 patients (21.74%) had a fair or poor re-pigmentation. CD8+ T cells infiltrating was observed in the perilesional vitiligo area of all patients. Importantly, the efficiency of the transplantation was closely associated with skin-homing CD8+ T cell activities. The patients with high number of perilesional CD8+ T cells or high level of cytokines/chemokines were associated with poor re-pigmentation efficiency. For in-vitro experiments, we successfully isolated and characterized human DMSCs and skin-homing CD8+ T cells. We established DMSCs and CD8+ T cell co-culture system, where DMSCs possessed significant inhibitory effects against skin homing CD8+ T lymphocytes. DMSCs inhibited CD8+ T cells proliferation, induced them apoptosis and regulated their cytokines/chemokines production. Our results suggest that vitiligo patients' autologous melanocytes transplantation efficiency might be predicted by perilesional skin-homing CD8+ T cell activities, and DMSCs might be used as auxiliary agent to improve transplantation efficacy.	[Zhou, Miao-ni; Wu, Ji-long; Lin, Fu-quan; Fu, Li-fang; Wang, Sui-quan; Guan, Cui-ping; Xu, Aie] Third Peoples Hosp Hangzhou, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Zhi-qing] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Wang, Hong-lin] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China	Soochow University - China; Chinese Academy of Sciences; Shanghai Jiao Tong University	Xu, A (corresponding author), Third Peoples Hosp Hangzhou, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China.	xuaiehz@msn.com	WANG, Honglin/AAJ-2708-2020	WANG, Honglin/0000-0001-6302-6927; guan, cuiping/0000-0001-9084-5418	National Natural Science Foundation of China [81071294, 81271758]; Natural Science Foundation of Zhejiang, China [Z2100973, LY12H11009]; National key clinical specialty construction project of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang, China(Natural Science Foundation of Zhejiang Province); National key clinical specialty construction project of China	This study was supported in part by the National Natural Science Foundation of China (Grant NO: 81071294 and 81271758), the Natural Science Foundation of Zhejiang, China (Grant NO: Z2100973, LY12H11009) and the National key clinical specialty construction project of China. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; ALBADRI AMT, 1993, J PATHOL, V170, P149, DOI 10.1002/path.1711700209; Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337; Comite P, 2011, CELL MOL BIOL, V57, P1600, DOI 10.1170/185; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; CUI J, 1995, ARCH DERMATOL, V131, P314, DOI 10.1001/archderm.131.3.314; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Glassman SJ, 2011, CLIN SCI, V120, P99, DOI 10.1042/CS20090603; Grimes PE, 2005, JAMA-J AM MED ASSOC, V293, P730, DOI 10.1001/jama.293.6.730; Groux H, 1998, J IMMUNOL, V160, P3188; Guerra L, 2010, CURR DRUG METAB, V11, P451, DOI 10.2174/138920010791526105; Hong WS, 2011, BRIT J DERMATOL, V165, P520, DOI 10.1111/j.1365-2133.2011.10398.x; Hong WS, 2011, J EUR ACAD DERMATOL, V25, P538, DOI 10.1111/j.1468-3083.2010.03824.x; Ines D, 2006, ARCH DERMATOL RES, V298, P147, DOI 10.1007/s00403-006-0680-2; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jones EA, 2006, CYTOM PART B-CLIN CY, V70B, P391, DOI 10.1002/cyto.b.20118; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Miyahara N, 2004, J IMMUNOL, V172, P2549, DOI 10.4049/jimmunol.172.4.2549; Musette P, 1999, J IMMUNOL, V162, P1789; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Njoo MD, 1998, ARCH DERMATOL, V134, P1543, DOI 10.1001/archderm.134.12.1543; Ogg GS, 1998, J EXP MED, V188, P1203, DOI 10.1084/jem.188.6.1203; Ongenae K, 2003, PIGM CELL RES, V16, P90, DOI 10.1034/j.1600-0749.2003.00023.x; Oyarbide-Valencia K, 2006, AUTOIMMUN REV, V5, P486, DOI 10.1016/j.autrev.2006.03.012; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Rao A, 2012, BRIT J DERMATOL, V166, P1230, DOI 10.1111/j.1365-2133.2012.10886.x; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Siepe M, 2009, TISSUE ENG PT A, V15, P1787, DOI 10.1089/ten.tea.2008.0356; Steitz J, 2004, EUR J CELL BIOL, V83, P797, DOI 10.1078/0171-9335-00423; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; van den Boorn JG, 2009, J INVEST DERMATOL, V129, P2220, DOI 10.1038/jid.2009.32; van den Wijngaard R, 2000, LAB INVEST, V80, P1299, DOI 10.1038/labinvest.3780138; Wankowicz-Kalinska A, 2003, LAB INVEST, V83, P683, DOI 10.1097/01.LAB.0000069521.42488.1B; Watkins LR, 1995, PAIN, V63, P289, DOI 10.1016/0304-3959(95)00186-7; Wu J, 2012, MOL MED REPORT; Yildirim M, 2004, J EUR ACAD DERMATOL, V18, P683, DOI 10.1111/j.1468-3083.2004.01080.x; Yildirim M, 2003, J DERMATOL, V30, P104, DOI 10.1111/j.1346-8138.2003.tb00356.x; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345	44	26	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60254	10.1371/journal.pone.0060254	http://dx.doi.org/10.1371/journal.pone.0060254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577097	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800039
J	Neff, JJ; Laniado, D; Kappler, KE; Volkovich, Y; Aragon, P; Kaltenbrunner, A				Neff, Jessica J.; Laniado, David; Kappler, Karolin E.; Volkovich, Yana; Aragon, Pablo; Kaltenbrunner, Andreas			Jointly They Edit: Examining the Impact of Community Identification on Political Interaction in Wikipedia	PLOS ONE			English	Article							SOCIAL IDENTITY THEORY; ONLINE; SENSE; SELF	Background: In their 2005 study, Adamic and Glance coined the memorable phrase 'divided they blog', referring to a trend of cyberbalkanization in the political blogosphere, with liberal and conservative blogs tending to link to other blogs with a similar political slant, and not to one another. As political discussion and activity increasingly moves online, the power of framing political discourses is shifting from mass media to social media. Methodology/Principal Findings: Continued examination of political interactions online is critical, and we extend this line of research by examining the activities of political users within the Wikipedia community. First, we examined how users in Wikipedia choose to display their political affiliation. Next, we analyzed the patterns of cross-party interaction and community participation among those users proclaiming a political affiliation. In contrast to previous analyses of other social media, we did not find strong trends indicating a preference to interact with members of the same political party within the Wikipedia community. Conclusions/Significance: Our results indicate that users who proclaim their political affiliation within the community tend to proclaim their identity as a 'Wikipedian' even more loudly. It seems that the shared identity of 'being Wikipedian' may be strong enough to triumph over other potentially divisive facets of personal identity, such as political affiliation.	[Neff, Jessica J.] Univ So Calif, Annenberg Sch Commun & Journalism, Los Angeles, CA USA; [Laniado, David; Kappler, Karolin E.; Volkovich, Yana; Aragon, Pablo; Kaltenbrunner, Andreas] Barcelona Media Innovat Ctr, Barcelona, Spain	University of Southern California	Laniado, D (corresponding author), Barcelona Media Innovat Ctr, Barcelona, Spain.	david.laniado@barcelonamedia.org	Kaltenbrunner, Andreas/A-7301-2016; Laniado, David/G-7552-2016	Kaltenbrunner, Andreas/0000-0002-2271-3066; Laniado, David/0000-0003-4574-0881; Aragon, Pablo/0000-0002-6017-4577				Ackland, 2005, BLOGTALK 2005 UNPUB; Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Alexa. com, 2012, TOP SIT; [Anonymous], 2012, WIK HIGHL; [Anonymous], 2012, WIK US; Aragon P, 2013, POLICY INTE IN PRESS; Blanchard A. L., 2004, Data Base for Advances in Information Systems, V35, P65; Brown AR, 2011, PS-POLIT SCI POLIT, V44, P339, DOI 10.1017/S1049096511000199; Bryant SL, 2005, GROUP 05 P 2005 INT; Conover MD, 2011, ICWSM 11 P 5 INT AAA; DEAUX K, 1995, J PERS SOC PSYCHOL, V68, P280, DOI 10.1037/0022-3514.68.2.280; Feller A, 2011, ICWSM 11 P 5 INT AAA; Fitzpatrick A, 2012, IS RACE WHITE HOUSE; Foster JG, 2010, P NATL ACAD SCI USA, V107, P10815, DOI 10.1073/pnas.0912671107; Fowler JH, 2007, J POLIT, V69, P813, DOI 10.1111/j.1468-2508.2007.00577.x; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Greene S, 1999, POLIT PSYCHOL, V20, P393, DOI 10.1111/0162-895X.00150; Greene S, 2004, SOC SCI QUART, V85, P136, DOI 10.1111/j.0038-4941.2004.08501010.x; Hargittai E, 2008, PUBLIC CHOICE, V134, P67, DOI 10.1007/s11127-007-9201-x; Hogg MA, 2001, PERS SOC PSYCHOL REV, V5, P184, DOI 10.1207/S15327957PSPR0503_1; Holsti O. R., 1969, CONTENT ANAL SOCIAL; Kaltenbrunner A, 2012, WIKISYM 12 P 8 INT S; Kelly J. W., 2006, P 2006 INT C DIG GOV; Laniado D, 2012, WIKISYM 12 P 8 INT S; Laniado D, 2011, ICWSM 11 P 5 INT AAA; Lawrence E, 2010, PERSPECT POLIT, V8, P141, DOI 10.1017/S1537592709992714; McMillan DW, 1996, J COMMUNITY PSYCHOL, V24, P315, DOI 10.1002/(SICI)1520-6629(199610)24:4<315::AID-JCOP2>3.0.CO;2-T; MCMILLAN DW, 1986, J COMMUNITY PSYCHOL, V14, P6, DOI 10.1002/1520-6629(198601)14:1<6::AID-JCOP2290140103>3.0.CO;2-I; Mitzenmacher M., 2004, INTERNET MATH, V1, P305, DOI DOI 10.1080/15427951.2004.10129092; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; NPOV, 2012, NPOV; Rafaeli S, 2008, PSYCHOLOGICAL ASPECTS OF CYBERSPACE: THEORY, RESEARCH, APPLICATIONS, P243; Ren YQ, 2007, ORGAN STUD, V28, P377, DOI 10.1177/0170840607076007; Rice A, 2004, CAMPAIGNS ONLINE PRO; Silverwood S, 2012, WIKIPEDIA PAGE ONE G; Smith A., 2011, 22 ONLINE AM USED SO; SPEARS R, 1994, COMMUN RES, V21, P427, DOI 10.1177/009365094021004001; Tajfel H, 1986, PSYCHOL INTERGROUP R; Turner J.C., 1987, REDISCOVERING SOCIAL; Wikipedia Statistics-English, 2012, WIK STAT ENGL; Wojcieszak ME, 2009, J COMMUN, V59, P40, DOI 10.1111/j.1460-2466.2008.01403.x	41	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60584	10.1371/journal.pone.0060584	http://dx.doi.org/10.1371/journal.pone.0060584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23573269	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100088
J	Petit, GH; Berkovich, E; Hickery, M; Kallunki, P; Fog, K; Fitzer-Attas, C; Brundin, P				Petit, Geraldine H.; Berkovich, Elijahu; Hickery, Mark; Kallunki, Pekka; Fog, Karina; Fitzer-Attas, Cheryl; Brundin, Patrik			Rasagiline Ameliorates Olfactory Deficits in an Alpha-Synuclein Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							ODOR DISCRIMINATION; RECEPTOR ACTIVATION; DOUBLE-BLIND; DYSFUNCTION; NEUROPROTECTION; SURVIVAL; THERAPY	Impaired olfaction is an early pre-motor symptom of Parkinson's disease. The neuropathology underlying olfactory dysfunction in Parkinson's disease is unknown, however alpha-synuclein accumulation/aggregation and altered neurogenesis might play a role. We characterized olfactory deficits in a transgenic mouse model of Parkinson's disease expressing human wild-type alpha-synuclein under the control of the mouse alpha-synuclein promoter. Preliminary clinical observations suggest that rasagiline, a monoamine oxidase-B inhibitor, improves olfaction in Parkinson's disease. We therefore examined whether rasagiline ameliorates olfactory deficits in this Parkinson's disease model and investigated the role of olfactory bulb neurogenesis. alpha-Synuclein mice were progressively impaired in their ability to detect odors, to discriminate between odors, and exhibited alterations in short-term olfactory memory. Rasagiline treatment rescued odor detection and odor discrimination abilities. However, rasagiline did not affect short-term olfactory memory. Finally, olfactory changes were not coupled to alterations in olfactory bulb neurogenesis. We conclude that rasagiline reverses select olfactory deficits in a transgenic mouse model of Parkinson's disease. The findings correlate with preliminary clinical observations suggesting that rasagiline ameliorates olfactory deficits in Parkinson's disease.	[Petit, Geraldine H.; Brundin, Patrik] Lund Univ, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Neuronal Survival Unit, Lund, Sweden; [Berkovich, Elijahu; Fitzer-Attas, Cheryl] Teva Pharmaceut Ind Ltd, Global Innovat Prod, Petah Tiqwa, Israel; [Hickery, Mark] H Lundbeck & Co AS, Copenhagen, Denmark; [Kallunki, Pekka; Fog, Karina] H Lundbeck & Co AS, Neurodegenerat 1, Copenhagen, Denmark; [Brundin, Patrik] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI USA	Lund University; Teva Pharmaceutical Industries; Lundbeck Corporation; Lundbeck Corporation; Van Andel Institute	Petit, GH (corresponding author), Lund Univ, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Neuronal Survival Unit, BMC B11, Lund, Sweden.	geraldine.petit@med.lu.se		Fitzer-Attas, Cheryl/0000-0002-8709-1384	Swedish Research Council [K2010-61X-11286-16-3, 315-2004-6629]; Swedish Parkinson Foundation [253/08]; Swedish Brain Power; H. Lundbeck A/S; TEVA Pharmaceutical Industries Ltd	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Parkinson Foundation; Swedish Brain Power; H. Lundbeck A/S; TEVA Pharmaceutical Industries Ltd(Teva Pharmaceutical Industries)	This work was supported by the Swedish Research Council [K2010-61X-11286-16-3, 315-2004-6629] (www.vr.se), the Swedish Parkinson Foundation [253/08] (www.parkinsonfonden.se), Swedish Brain Power (www.swedishbrainpower.se), H. Lundbeck A/S (www.lundbeck.com) and TEVA Pharmaceutical Industries Ltd (www.tevapharm.com). The authors EB, CFA (TEVA Pharmaceutical Industries Ltd) and MH, PK and KF (H. Lundbeck A/S) participated in the study design, the manuscript preparation and they approved the manuscript to be published. The other funders (the Swedish Research Council, the Swedish Parkinson Foundation and Swedish Brain Power) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Teva Pharmaceutical Industries Ltd and H.Lundbeck A/S, which market rasagiline, contributed to the funding of this study. The authors EB and CFA work for Teva Pharmaceutical Industries Ltd. The authors MH, PK and KF work for H. Lundbeck A/S. PB has received speaking honoraria from and provided consulting services to Teva Pharmaceutical Industries Ltd and H.Lundbeck A/S. Teva Pharmaceutical Industries Ltd. covered the costs of GHP to attend the MDS congress (Toronto 2011). The use of rasagiline for the treatment of olfactory dysfunction is covered by patent number US 2012/0029087 A1. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Alvarez M, 2011, 10 INT C ALZH PARK D, V8, P927; Alvarez MV, 2010, MOVEMENT DISORD, V25, pS255; ANSARI KA, 1975, J CHRON DIS, V28, P493, DOI 10.1016/0021-9681(75)90058-2; Banerjee K, 2010, FEBS LETT, V584, P1571, DOI 10.1016/j.febslet.2010.03.012; Blandini F, 2004, EXP NEUROL, V187, P455, DOI 10.1016/j.expneurol.2004.03.005; Boesveldt S, 2008, MOVEMENT DISORD, V23, P1984, DOI 10.1002/mds.22155; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Buyukozturk A, 1995, EUR NEUROPSYCHOPHARM, V5, P527; Chaudhuri KR, 2008, J NEUROL, V255, P33, DOI 10.1007/s00415-008-5006-1; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; DOTY RL, 1992, J NEUROL NEUROSUR PS, V55, P138, DOI 10.1136/jnnp.55.2.138; Eliash S, 2001, J NEURAL TRANSM, V108, P909, DOI 10.1007/s007020170012; Eliash S, 2009, BRAIN RES, V1256, P138, DOI 10.1016/j.brainres.2008.11.097; Escanilla O, 2009, BEHAV NEUROSCI, V123, P828, DOI 10.1037/a0015855; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Guay David R P, 2006, Am J Geriatr Pharmacother, V4, P330, DOI 10.1016/j.amjopharm.2006.12.001; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Haehner A, 2010, EUR NEUROL REV, V5, P26; Hashizume C, 2003, J VET MED SCI, V65, P893, DOI 10.1292/jvms.65.893; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Kranick SM, 2008, NEUROSIGNALS, V16, P35, DOI 10.1159/000109757; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Marxreiter F, 2009, EUR J NEUROSCI, V29, P879, DOI 10.1111/j.1460-9568.2009.06641.x; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Meusel T, 2010, NEUROSCI LETT, V486, P166, DOI 10.1016/j.neulet.2010.09.044; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Naoi M, 2002, J NEURAL TRANSM, V109, P607, DOI 10.1007/s007020200050; Oksman M, 2007, 8 INT C ALZH PARK DI, V4, pS234; Olanow CW, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/WNL.66.10_suppl_4.S69; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Rascol O, 2005, LANCET, V365, P947, DOI 10.1016/S0140-6736(05)71083-7; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Schapira AHV, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/159160; Schwid SR, 2005, ARCH NEUROL-CHICAGO, V62, P241; Siderowf A, 2002, ARCH NEUROL-CHICAGO, V59, P1937; Speiser Z, 2007, J NEURAL TRANSM, V114, P595, DOI 10.1007/s00702-006-0612-5; Stefanova N, 2008, EXP NEUROL, V210, P421, DOI 10.1016/j.expneurol.2007.11.022; Stocchi F, 2006, INT J CLIN PRACT, V60, P215, DOI 10.1111/j.1742-1241.2006.00806.x; Tillerson JL, 2006, BEHAV BRAIN RES, V172, P97, DOI 10.1016/j.bbr.2006.04.025; Ubeda-Banon I, 2010, ACTA NEUROPATHOL, V119, P723, DOI 10.1007/s00401-010-0687-9; Wei CJ, 2006, BEHAV NEUROSCI, V120, P393, DOI 10.1037/0735-7044.120.2.393; Wesson DW, 2011, NEUROSCI BIOBEHAV R, V35, P655, DOI 10.1016/j.neubiorev.2010.08.004; Westerlund M, 2008, MOL CELL NEUROSCI, V39, P586, DOI 10.1016/j.mcn.2008.08.001; WILLIAMS RW, 1988, J COMP NEUROL, V278, P344, DOI 10.1002/cne.902780305; Winner B, 2004, J NEUROPATH EXP NEUR, V63, P1155, DOI 10.1093/jnen/63.11.1155; Winner B, 2008, NEUROBIOL AGING, V29, P913, DOI 10.1016/j.neurobiolaging.2006.12.016; Youdim MBH, 2005, J NEUROSCI RES, V79, P172, DOI 10.1002/jnr.20350; Youdim MBH, 2003, BIOCHEM PHARMACOL, V66, P1635, DOI 10.1016/S0006-2952(03)00535-5; Yue EL, 2004, BEHAV NEUROSCI, V118, P184, DOI 10.1037/0735-7044.118.1.184	53	29	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60691	10.1371/journal.pone.0060691	http://dx.doi.org/10.1371/journal.pone.0060691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573275	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100095
J	Torres, CM; Laugesen, A; Helin, K				Torres, Cristina Morales; Laugesen, Anne; Helin, Kristian			Utx Is Required for Proper Induction of Ectoderm and Mesoderm during Differentiation of Embryonic Stem Cells	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; RNA-POLYMERASE-II; PROGENITOR CELLS; ANTERIOR NEUROECTODERM; MOUSE DEVELOPMENT; DEMETHYLASE UTX; ROSTRAL BRAIN; GENE; MICE; CHROMATIN	Embryonic development requires chromatin remodeling for dynamic regulation of gene expression patterns to ensure silencing of pluripotent transcription factors and activation of developmental regulators. Demethylation of H3K27me3 by the histone demethylases Utx and Jmjd3 is important for the activation of lineage choice genes in response to developmental signals. To further understand the function of Utx in pluripotency and differentiation we generated Utx knockout embryonic stem cells (ESCs). Here we show that Utx is not required for the proliferation of ESCs, however, Utx contributes to the establishment of ectoderm and mesoderm in vitro. Interestingly, this contribution is independent of the catalytic activity of Utx. Furthermore, we provide data showing that the Utx homologue, Uty, which is devoid of detectable demethylase activity, and Jmjd3 partly compensate for the loss of Utx. Taken together our results show that Utx is required for proper formation of ectoderm and mesoderm in vitro, and that Utx, similar to its C. elegans homologue, has demethylase dependent and independent functions.	[Torres, Cristina Morales; Laugesen, Anne; Helin, Kristian] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Torres, Cristina Morales; Laugesen, Anne; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Helin, K (corresponding author), Univ Copenhagen, BRIC, Copenhagen, Denmark.	kristian.helin@bric.ku.dk	Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022; Laugesen, Anne/AAB-2519-2019	Helin, Kristian/0000-0003-1975-6097; Laugesen, Anne/0000-0003-1115-8201	Danish National Research Foundation; Danish Cancer Society; Danish Medical Research Council; Excellence Programme of the University of Copenhagen	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Excellence Programme of the University of Copenhagen	This work was supported by the Danish National Research Foundation, the Danish Cancer Society, the Danish Medical Research Council, and the Excellence Programme of the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Ang SL, 1996, DEVELOPMENT, V122, P243; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen Y, 2006, AM J PHYSIOL-HEART C, V291, pH1653, DOI 10.1152/ajpheart.00363.2005; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; FAUST C, 1995, DEVELOPMENT, V121, P273; Good P, 1998, GENOMICS, V52, P382, DOI 10.1006/geno.1998.5456; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Grindley JC, 1997, MECH DEVELOP, V64, P111, DOI 10.1016/S0925-4773(97)00055-5; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hofemeister H, 2011, METHODS, V53, P437, DOI 10.1016/j.ymeth.2010.12.026; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jiang W, 2013, CELL RES, V23, P122, DOI 10.1038/cr.2012.119; Kan LX, 2007, DEV BIOL, V310, P85, DOI 10.1016/j.ydbio.2007.07.026; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kavka AI, 1997, BBA-REV CANCER, V1333, pF73, DOI 10.1016/S0304-419X(97)00016-4; King T, 1998, MECH DEVELOP, V79, P29, DOI 10.1016/S0925-4773(98)00166-X; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Liu JN, 2012, EXP HEMATOL, V40, P487, DOI 10.1016/j.exphem.2012.01.017; Lugus JJ, 2009, BLOOD, V113, P563, DOI 10.1182/blood-2008-06-162750; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Malas S, 2003, NEUROSCIENCE, V119, P421, DOI 10.1016/S0306-4522(03)00158-1; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mastick GS, 1997, DEVELOPMENT, V124, P1985; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Okano H, 2002, J CELL SCI, V115, P1355; Osumi N, 1997, DEVELOPMENT, V124, P2961; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shibata S, 2012, BRAIN RES, V1462, P162, DOI 10.1016/j.brainres.2012.01.068; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Smith ER, 2008, MOL CELL BIOL, V28, P1041, DOI 10.1128/MCB.01504-07; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Vandamme J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002647; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Warren N, 1997, DEVELOPMENT, V124, P1573; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	82	71	74	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60020	10.1371/journal.pone.0060020	http://dx.doi.org/10.1371/journal.pone.0060020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573229	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100042
J	Wu, YN; Tao, Z; Song, C; Jia, QS; Bai, J; Zhi, KK; Qu, LF				Wu, Yina; Tao, Zhen; Song, Chao; Jia, Qingshuai; Bai, Jun; Zhi, Kangkang; Qu, Lefeng			Overexpression of YKL-40 Predicts Plaque Instability in Carotid Atherosclerosis with CagA-Positive Helicobacter Pylori Infection	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CHITINASE FAMILY; STRAINS; PROTEIN; STROKE; CLASSIFICATION; BIOMARKERS; RISK	Objectives: YKL-40 has been demonstrated to be related to atherosclerosis, but its role in predicting plaque status and the outcome of carotid atherosclerosis (CAS) caused by CagA-positive helicobacter pylori remains unclear. This study was aimed to investigate the role of YKL-40 in predicting the outcome of carotid atherosclerosis with CagA-positive Helicobacter pylori infection. Methods: The serum concentrations of YKL-40, C-reaction protein in 310 patients undergoing color Duplex assessment of carotid atherosclerosis were recorded and divided into 3 groups according to the infectious statuses of helicobacter pylori. We also examined serum YKL-40, C-reaction protein and the plaque morphology in animal model of carotid atherosclerosis with different types of helicobacter pylori infection. Results: Overexpression of YKL-40 was only found in carotid atherosclerosis group with CagA-positive helicobacter pylori infection; C-reaction protein failed to distinguish different infectious statuses of helicobacter pylori infection. In patients with CagA-positive helicobacter pylori infection, elevated YKL-40 expression was accompanied by more severe clinical symptoms. We also confirmed similar findings in rabbit model of carotid atherosclerosis with CagA-positive helicobacter pylori infection. We found that in 7 rabbits treated with anti-helicobacter pylori therapy, the serum YKL-40 level decreased and the plaque became more stable. Conclusion: Our findings suggested that increased serum YKL-40 level indicates plaque instability and more severe clinical symptoms of carotid atherosclerosis with CagA-positive helicobacter pylori infection. Compared with C-reaction protein, YKL-40 seems to be a more specific predictor of plaque status and outcome of carotid atherosclerosis with CagA-positive helicobacter pylori infection.	[Wu, Yina] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Tao, Zhen] Jinan Mil Command, Dept Neurol, Gen Hosp, Jinan, Shandong, Peoples R China; [Song, Chao] Second Mil Med Univ, Changhai Hosp, Dept Vasc Surg, Shanghai, Peoples R China; [Jia, Qingshuai] Jinan Mil Command, Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Bai, Jun; Zhi, Kangkang; Qu, Lefeng] Second Mil Med Univ, Changzheng Hosp, Dept Vasc & Endovasc Surg, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Chinese Center for Disease Control & Prevention; Naval Medical University	Qu, LF (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Vasc & Endovasc Surg, Shanghai, Peoples R China.	qulefeng@163.com			Shanghai Rising-Star Program [11QH1403000]; Key Basic Research Project from Science and Technology Commission of Shanghai Municipality [12JC1411202]	Shanghai Rising-Star Program; Key Basic Research Project from Science and Technology Commission of Shanghai Municipality	This work was supported by Shanghai Rising-Star Program (11QH1403000); and Key Basic Research Project from Science and Technology Commission of Shanghai Municipality (12JC1411202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Biasillo G, 2010, INTERN EMERG MED, V5, P225, DOI 10.1007/s11739-010-0361-1; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Gabrielli M, 2004, EUR HEART J, V25, P64, DOI 10.1016/j.ehj.2003.10.004; Ge S, 2009, ATHEROSCLEROSIS, V205, P74, DOI 10.1016/j.atherosclerosis.2008.11.012; Kastrup J, 2009, EUR HEART J, V30, P1066, DOI 10.1093/eurheartj/ehp049; Kucur M, 2007, CORONARY ARTERY DIS, V18, P391, DOI 10.1097/MCA.0b013e328241d991; Mayr M, 2003, STROKE, V34, P610, DOI 10.1161/01.STR.0000058481.82639.EF; MILLIS AJT, 1985, J BIOL CHEM, V260, P3754; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Olsen MH, 2010, CURR VASC PHARMACOL, V8, P134, DOI 10.2174/157016110790226633; Pietroiusti A, 2002, CIRCULATION, V106, P580, DOI 10.1161/01.CIR.0000023894.10871.2F; Rathcke CN, 2006, INFLAMM RES, V55, P221, DOI 10.1007/s00011-006-0076-y; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Wang YZ, 2008, SCAND CARDIOVASC J, V42, P295, DOI 10.1080/14017430802220567; Yiqi XG DU, 1999, CHINESE J DIGESTION, V19; Zheng JL, 2010, ATHEROSCLEROSIS, V210, P590, DOI 10.1016/j.atherosclerosis.2009.12.016	18	16	21	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59996	10.1371/journal.pone.0059996	http://dx.doi.org/10.1371/journal.pone.0059996			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573226	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100039
J	Diaz-Gallo, LM; Sanchez, E; Ortego-Centeno, N; Sabio, JM; Garcia-Hernandez, FJ; de Ramon, E; Gonzalez-Gay, MA; Witte, T; Anders, HJ; Gonzalez-Escribano, MF; Martin, J				Diaz-Gallo, Lina-Marcela; Sanchez, Elena; Ortego-Centeno, Norberto; Mario Sabio, Jose; Garcia-Hernandez, Francisco J.; de Ramon, Enrique; Gonzalez-Gay, Miguel A.; Witte, Torsten; Anders, Hans-Joachim; Gonzalez-Escribano, Maria F.; Martin, Javier			Evidence of New Risk Genetic Factor to Systemic Lupus Erythematosus: The UBASH3A Gene	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; LOCI	The ubiquitin associated and Src-homology 3 (SH3) domain containing A (UBASH3a) is a suppressor of T-cell receptor signaling, underscoring antigen presentation to T-cells as a critical shared mechanism of diseases pathogenesis. The aim of the present study was to determine whether the UBASH3a gene influence the susceptibility to systemic lupus erythematosus (SLE) in Caucasian populations. We evaluated five UBASH3a polymorphisms (rs2277798, rs2277800, rs9976767, rs13048049 and rs17114930), using TaqMan (R) allelic discrimination assays, in a discovery cohort that included 906 SLE patients and 1165 healthy controls from Spain. The SNPs that exhibit statistical significance difference were evaluated in a German replication cohort of 360 SLE patients and 379 healthy controls. The case-control analysis in the Spanish population showed a significant association between the rs9976767 and SLE (Pc = 9.9E-03 OR = 1.21 95% CI = 1.07-1.37) and a trend of association for the rs2277798 analysis (P = 0.09 OR = 0.9 95% CI = 0.79-1.02). The replication in a German cohort and the meta-analysis confirmed that the rs9976767 (Pc = 0.02; Pc = 2.4E-04, for German cohort and meta-analysis, respectively) and rs2277798 (Pc = 0.013; Pc = 4.7E-03, for German cohort and meta-analysis, respectively) UBASH3a variants are susceptibility factors for SLE. Finally, a conditional regression analysis suggested that the most likely genetic variation responsible for the association was the rs9976767 polymorphism. Our results suggest that UBASH3a gene plays a role in the susceptibility to SLE. Moreover, our study indicates that UBASH3a can be considered as a common genetic factor in autoimmune diseases.	[Diaz-Gallo, Lina-Marcela; Sanchez, Elena; Martin, Javier] CSIC, IPBLN, Cellular Biol & Immunol Dept, Granada, Spain; [Ortego-Centeno, Norberto] Hosp Clin San Cecilio, Dept Internal Med, Granada, Spain; [Mario Sabio, Jose] Hosp Virgen de las Nieves, Dept Internal Med, Granada, Spain; [Garcia-Hernandez, Francisco J.] Hosp Virgen del Rocio, Dept Internal Med, Seville, Spain; [de Ramon, Enrique] Hosp Carlos Haya, Dept Internal Med, Malaga, Spain; [Gonzalez-Gay, Miguel A.] Hosp Univ Marques de Valdecilla, Inst Formac & Invest Marques de Valdecilla, Dept Rheumatol, Santander, Spain; [Witte, Torsten] Hannover Med Sch, Dept Clin Immunol & Rheumatol, Hannover, Germany; [Anders, Hans-Joachim] Klinikum Univ, Dept Med, Munich, Germany; [Anders, Hans-Joachim] Klinikum Univ, Policlin 4, Munich, Germany; [Gonzalez-Escribano, Maria F.] Hosp Virgen del Rocio, Dept Immunol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario San Cecilio; Hospital Universitario Virgen de las Nieves; Virgen del Rocio University Hospital; Hospital Carlos Haya; Hospital Universitario Marques de Valdecilla (HUMV); Hannover Medical School; University of Munich; University of Munich; Virgen del Rocio University Hospital	Diaz-Gallo, LM (corresponding author), CSIC, IPBLN, Cellular Biol & Immunol Dept, Granada, Spain.	lina.diaz@ipb.csic.es	IBIS, EPIDEMIOLOGIA/O-8791-2015; Sanchez, Elena/B-4140-2017; Martín, Javier/AAV-5209-2021; Sanchez, Elena/AAC-1985-2021; González-Gay, Miguel A./B-2306-2008; Centeno, Norberto Ortego/C-4793-2019; Anders, Hans-Joachim/ABD-6247-2021; Martín, María/HDL-9512-2022; Witte, Torsten/B-5783-2016; González-Escribano, María Francisca/X-5554-2019; Martin, Javier/B-8141-2008; Diaz-Gallo, Lina Marcela/F-1181-2018	Sanchez, Elena/0000-0002-7041-5485; González-Gay, Miguel A./0000-0002-7924-7406; Centeno, Norberto Ortego/0000-0003-2325-0937; Martin, Javier/0000-0002-2202-0622; Diaz-Gallo, Lina Marcela/0000-0002-5688-0102; Anders, Hans-Joachim/0000-0003-2434-2956; Garcia-Hernandez, Francisco Jose/0000-0002-2600-0485	RETICS Program from Instituto de Salud Carlos III [RD08/0075 (RIER), VI PN de I+D+i 2008-2011 (FEDER)]; Ayudas Predoctorales de Formacion en Investigacion en Salud from the "Instituto de Salud Carlos III" [KFO 250, TP 03, WI 1031/6-1 LMDG, PFIS - FI09/00544]	RETICS Program from Instituto de Salud Carlos III; Ayudas Predoctorales de Formacion en Investigacion en Salud from the "Instituto de Salud Carlos III"	This work was partially supported by RETICS Program, RD08/0075 (RIER) from Instituto de Salud Carlos III, within the VI PN de I+D+i 2008-2011 (FEDER) and grant KFO 250, TP 03, WI 1031/6-1 LMDG was supported by the "Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS - FI09/00544)" from the "Instituto de Salud Carlos III". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Collingwood TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/jbc.M706870200; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Diaz-Gallo LM, 2012, EXPERT REV CLIN IMMU, V8, P107, DOI [10.1586/ECI.11.90, 10.1586/eci.11.90]; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Grant SFA, 2009, DIABETES, V58, P290, DOI 10.2337/db08-1022; Guerra SG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3844; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tsygankov AY, 2009, CELL MOL LIFE SCI, V66, P2949, DOI 10.1007/s00018-009-0071-x; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Zenewicz LA, 2010, CELL, V140, P791, DOI 10.1016/j.cell.2010.03.003; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	22	20	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60646	10.1371/journal.pone.0060646	http://dx.doi.org/10.1371/journal.pone.0060646			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565265	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300136
J	Hlawatsch, J; Karlstetter, M; Aslanidis, A; Luckoff, A; Walczak, Y; Plank, M; Bock, J; Langmann, T				Hlawatsch, Julia; Karlstetter, Marcus; Aslanidis, Alexander; Lueckoff, Anika; Walczak, Yana; Plank, Michael; Boeck, Julia; Langmann, Thomas			Sterile Alpha Motif Containing 7 (Samd7) Is a Novel Crx-Regulated Transcriptional Repressor in the Retina	PLOS ONE			English	Article							ROD PHOTORECEPTOR DEVELOPMENT; RETINOSCHISIS RS1 GENE; KINASE PHOSPHORYLATION; DOMAIN PROTEIN; HOMEOBOX GENE; CELL FATE; EXPRESSION; DIFFERENTIATION; RECEPTOR; DISEASE	Inherited retinal diseases are mainly caused by mutations in genes that are highly expressed in photoreceptors of the retina. The majority of these genes is under the control of the transcription factor Cone rod homeobox (Crx), that acts as a master transcription factor in photoreceptors. Using a genome-wide chromatin immunoprecipitation dataset that highlights all potential in vivo targets of Crx, we have identified a novel sterile alpha motif (SAM) domain containing protein, Samd7. mRNA Expression of Samd7 was confined to the late postnatal and adult mouse retina as well as the pineal gland. Using immunohistochemistry and Western blot, we could detect Samd7 protein in the outer nuclear layer of adult mouse retina. Ectopic over-expression in HEK293 cells demonstrated that Samd7 resides in the cytoplasm as well as the nucleus. In vitro electroporation of fluorescent reporters into living mouse retinal cultures revealed that transcription of the Samd7 gene depends on evolutionary conserved Crx motifs located in the first intron enhancer. Moreover, Crx knock-down with shRNA strongly reduced Samd7 reporter activity and endogenous Samd7 protein, indicating that Crx is required for retinal expression of Samd7. Finally, using co-transfections in luciferase reporter assays we found that Samd7 interferes with Crx-dependent transcription. Samd7 suppressed luciferase activity from a reporter plasmid with five Crx consensus repeats in a dose dependent manner and reduced Crx-mediated transactivation of regulatory sequences in the retinoschisin gene and the Samd7 gene itself. Taken together, we have identified a novel retinal SAM domain protein, Samd7, which could act as a transcriptional repressor involved in fine-tuning of Crx-regulated gene expression.	[Hlawatsch, Julia; Karlstetter, Marcus; Aslanidis, Alexander; Walczak, Yana; Plank, Michael; Boeck, Julia; Langmann, Thomas] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Karlstetter, Marcus; Aslanidis, Alexander; Lueckoff, Anika; Walczak, Yana; Langmann, Thomas] Univ Cologne, Dept Ophthalmol, D-50931 Cologne, Germany	University of Regensburg; University of Cologne	Langmann, T (corresponding author), Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany.	thomas.langmann@uk-koeln.de	Langmann, Thomas/HHZ-9814-2022	Langmann, Thomas/0000-0001-6826-529X	Deutsche Forschungsgemeinschaft [LA1203/6-2, LA1203/8-1]; Pro Retina Stiftung; Hans und Marlies Stock-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Pro Retina Stiftung; Hans und Marlies Stock-Stiftung	Funds were provided by the Deutsche Forschungsgemeinschaft (LA1203/6-2, LA1203/8-1), the Pro Retina Stiftung and the Hans und Marlies Stock-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldiri I, 2012, DEV BIOL, V367, P91, DOI 10.1016/j.ydbio.2012.04.030; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Baker DA, 2001, NATURE, V411, P330, DOI 10.1038/35077122; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Blackshaw S, 1997, J NEUROSCI, V17, P8074; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gehrig A, 2007, INVEST OPHTH VIS SCI, V48, P891, DOI 10.1167/iovs.06-0641; Green JB, 2003, MOL CELL, V11, P1537, DOI 10.1016/S1097-2765(03)00178-3; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Inoue T, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-15; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; Kraus D, 2011, BBA-GENE REGUL MECH, V1809, P245, DOI 10.1016/j.bbagrm.2011.03.001; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; Langmann T, 2008, NUCLEIC ACIDS RES, V36, P6523, DOI 10.1093/nar/gkn737; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Meruelo AD, 2009, PROTEINS, V74, P1, DOI 10.1002/prot.22232; Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099; Montana CL, 2011, J BIOL CHEM, V286, P36921, DOI 10.1074/jbc.M111.279026; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Omori Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019685; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Robinson AK, 2012, J BIOL CHEM, V287, P8702, DOI 10.1074/jbc.M111.336115; Sanuki R, 2010, FEBS LETT, V584, P753, DOI 10.1016/j.febslet.2009.12.030; Slupsky CM, 1998, P NATL ACAD SCI USA, V95, P12129, DOI 10.1073/pnas.95.21.12129; Tu H, 1997, MOL CELL BIOL, V17, P5876, DOI 10.1128/MCB.17.10.5876; Tummala P, 2010, MOL VIS, V16, P252; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160	40	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60633	10.1371/journal.pone.0060633	http://dx.doi.org/10.1371/journal.pone.0060633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565263	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300134
J	Yuan, W; Zhao, MD; Yuan, FL; Che, W; Duan, PG; Liu, Y; Dong, J				Yuan, Wei; Zhao, Ming-Dong; Yuan, Feng-Lai; Che, Wu; Duan, Ping-Guo; Liu, Yi; Dong, Jian			Association of Endothelin-1 Expression and Cartilaginous Endplate Degeneration in Humans	PLOS ONE			English	Article							INTERVERTEBRAL DISC DEGENERATION; NITRIC-OXIDE; MATRIX METALLOPROTEINASES; ARTICULAR CHONDROCYTES; GROWTH-FACTORS; RAT; CYTOKINES; DEGRADATION; CELLS; LOCALIZATION	Background: Inflammatory cytokines are involved in intervertebral disc (IVD) degeneration. Endothelin-1 (ET-1), a 21-amino-acid cytokine implicated with cartilage degradation, is secreted by vascular endothelial cells and also by many other cell types. The expression of ET-1 in human IVD cartilage endplate (CEP) and its role in disc degeneration have not been explored. Methods and Findings: The expression of ET-1 in degenerated CEP was analyzed by immunohistochemical staining and Western blotting; ET-1 was demonstrated in cartilaginous endplate cells (CECs) by immunofluorescent staining. The ET-1 mRNA expression and protein production by CECs stimulated by tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory cytokine, were determined by real-time PCR analysis and Western blotting, respectively. The matrix metalloprotease-1 (MMP-1), MMP-13 and tissue inhibitor of metalloproteases-1 (TIMP-1) levels in the supernatant of cultured CECs treated with ET-1 were determined using enzyme-linked immunosorbent assays. Nitric oxide (NO) release and nitric oxide synthase (NOS) activity were measured using a spectrophotometric assay. The apoptosis of CECs by ET-1 was measured by an Annexin V-FITC detection assay. The production of ET-1 in degenerated cartilage endplate was significantly higher than normal CEP. The results showed that ET-1 was expressed by CECs and modulated by TNF-alpha in a dose-dependent manner. ET-1 increased production of MMP-1 and MMP-13, decreased TIMP-1 production, and induced NO and NOS release by cultured CECs. The direct stimulation of CECs by ET-1 did not promote cell apoptosis. Conclusion: The study results suggest that ET-1 played a pivotal role in human CEP degeneration, and may be a new target for development of therapies for this condition.	[Yuan, Wei; Zhao, Ming-Dong; Yuan, Feng-Lai; Che, Wu; Duan, Ping-Guo; Liu, Yi; Dong, Jian] Fudan Univ, Zhongshan Hosp, Dept Orthoped Surg, Shanghai 200433, Peoples R China; [Zhao, Ming-Dong] Fudan Univ, Dept Orthoped Surg, Jinshan Hosp, Shanghai 200433, Peoples R China; [Yuan, Feng-Lai] Nantong Univ, Hosp 3, Wuxi, Peoples R China; [Duan, Ping-Guo] Nanchang Univ, Affiliated Hosp 1, Dept Orthoped Surg, Nanchang, Peoples R China; [Liu, Yi] Fudan Univ, Huadong Hosp, Dept Orthoped Surg, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Nantong University; Nanchang University; Fudan University	Dong, J (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Orthoped Surg, Shanghai 200433, Peoples R China.	dong.jian@zs-hospital.sh.cn			Natural Science Foundation of China [31170925, 30970718]; Shanghai Science and Technology Commission [12411951300, 12JC1402600]; Shanghai International Science and Technology Partnership Program [11540702700]; Shanghai Municipal Health Bureau Research Youth Foundation [2012-138]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai International Science and Technology Partnership Program; Shanghai Municipal Health Bureau Research Youth Foundation	This work was supported by Natural Science Foundation of China (31170925, 30970718), Key Project of Shanghai Science and Technology Commission (12411951300, 12JC1402600), Shanghai International Science and Technology Partnership Program(11540702700) and Shanghai Municipal Health Bureau Research Youth Foundation (2012-138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D Greg, 2005, Spine J, V5, p260S, DOI 10.1016/j.spinee.2005.02.010; Anderson DG, 2002, SPINE, V27, P1291, DOI 10.1097/00007632-200206150-00009; Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511; Grava ALD, 2012, EUR SPINE J, V21, P537, DOI 10.1007/s00586-011-2027-8; Feletou M, 2012, ANN MED, V44, P694, DOI 10.3109/07853890.2011.585658; Grange L, 2001, JOINT BONE SPINE, V68, P547, DOI 10.1016/S1297-319X(01)00324-4; Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0; Guiot BH, 2000, NEUROSURGERY, V47, P1034, DOI 10.1097/00006123-200011000-00003; He X, 2012, SPINE, V37, pE1068, DOI 10.1097/BRS.0b013e31825640eb; Hee HT, 2011, SPINE, V36, P505, DOI 10.1097/BRS.0b013e3181d32410; Hoogendoorn R, 2008, SPINE, V33, P1714, DOI 10.1097/BRS.0b013e31817d2468; KANG JD, 1995, SPINE, V20, P2373, DOI 10.1097/00007632-199511001-00001; Kang JD, 1997, SPINE, V22, P1065, DOI 10.1097/00007632-199705150-00003; Kawakami M, 1997, SPINE, V22, P1074, DOI 10.1097/00007632-199705150-00004; Khatib AM, 1997, CYTOKINE, V9, P556, DOI 10.1006/cyto.1997.0201; Kirkby NS, 2008, BRIT J PHARMACOL, V153, P1105, DOI 10.1038/sj.bjp.0707516; Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; Liu GZ, 2001, SPINE, V26, P134, DOI 10.1097/00007632-200101150-00005; Magini A, 1996, J CLIN ENDOCR METAB, V81, P1428, DOI 10.1210/jc.81.4.1428; Manacu CA, 2005, ARTHRITIS RES THER, V7, pR324, DOI 10.1186/ar1489; Melrose J, 2012, SPINE, V37, P18, DOI 10.1097/BRS.0b013e31820cd8d5; Messai H, 2000, MECH AGEING DEV, V114, P37, DOI 10.1016/S0047-6374(99)00117-7; Messai H, 2001, MECH AGEING DEV, V122, P519, DOI 10.1016/S0047-6374(01)00231-7; Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007; Roberts S, 1996, SPINE, V21, P415, DOI 10.1097/00007632-199602150-00003; Roy-Beaudry M, 2003, ARTHRITIS RHEUM, V48, P2855, DOI 10.1002/art.11247; SASAKI T, 1993, ANAT REC, V237, P332, DOI 10.1002/ar.1092370306; SIMONSON MS, 1989, J CLIN INVEST, V83, P708, DOI 10.1172/JCI113935; Sweazea KL, 2011, HORM METAB RES, V43, P470, DOI 10.1055/s-0031-1273763; Takahashi H, 1996, SPINE, V21, P218, DOI 10.1097/00007632-199601150-00011; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; Wang F, 2011, INJURY, V42, P790, DOI 10.1016/j.injury.2011.01.034; Wang Y, 2012, SPINE, V37, P1490, DOI 10.1097/BRS.0b013e3182608ac4; Wang Y, 2011, BONE, V48, P804, DOI 10.1016/j.bone.2010.12.005; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Weiler C, 2002, EUR SPINE J, V11, P308, DOI 10.1007/s00586-002-0472-0; Zigouris A, 2011, J NEUROSURG-SPINE, V14, P268, DOI 10.3171/2010.9.SPINE09935	38	12	15	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60062	10.1371/journal.pone.0060062	http://dx.doi.org/10.1371/journal.pone.0060062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565184	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300053
J	Lauper, JM; Krause, A; Vaughan, TL; Monnat, RJ				Lauper, Julia M.; Krause, Alison; Vaughan, Thomas L.; Monnat, Raymond J., Jr.			Spectrum and Risk of Neoplasia in Werner Syndrome: A Systematic Review	PLOS ONE			English	Review							SHWACHMAN-DIAMOND SYNDROME; SYNDROME ADULT PROGERIA; FANCONI-ANEMIA; CANCER; MUTATIONS; HETEROZYGOTES; INSTABILITY; FREQUENCY; LEUKEMIA; GENOTYPE	Background: Werner syndrome (WS) is an autosomal recessive genetic instability and progeroid ('premature aging') syndrome which is associated with an elevated risk of cancer. Objectives: Our study objectives were to characterize the spectrum of neoplasia in WS using a well-documented study population, and to estimate the type-specific risk of neoplasia in WS relative to the general population. Methods: We obtained case reports of neoplasms in WS patients through examining previous case series and reviews of WS, as well as through database searching in PubMed, Google Scholar, and J-EAST, a search engine for articles from Japan. We defined the spectrum (types and sites) of neoplasia in WS using all case reports, and were able to determine neoplasm type-specific risk in Japan WS patients by calculating standardized incidence and proportionate incidence ratios (SIR and SPIR, respectively) relative to Osaka Japan prefecture incidence rates. Results: We used a newly assembled study population of 189 WS patients with 248 neoplasms to define the spectrum of neoplasia in WS. The most frequent neoplasms in WS patients, representing 2/3 of all reports, were thyroid neoplasms, malignant melanoma, meningioma, soft tissue sarcomas, leukemia and pre-leukemic conditions of the bone marrow, and primary bone neoplasms. Cancer risk defined by SIRs was significantly elevated in Japan-resident WS patients for the six most frequent neoplasms except leukemia, ranging from 53.5-fold for melanoma of the skin (95% CI: 24.5, 101.6) to 8.9 (95% CI: 4.9, 15.0) for thyroid neoplasms. Cancer risk as defined by SPIR was also significantly elevated for the most common malignancies except leukemia. Conclusions: WS confers a strong predisposition to several specific types of neoplasia. These results serve as a guide for WS clinical care, and for additional analyses to define the mechanistic basis for cancer in WS and the general population.	[Lauper, Julia M.; Vaughan, Thomas L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lauper, Julia M.; Monnat, Raymond J., Jr.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Krause, Alison] Univ Washington, Dept Sch Med, Seattle, WA 98195 USA; [Vaughan, Thomas L.] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Monnat, Raymond J., Jr.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Monnat, RJ (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	monnat@u.washington.edu			Northern California Scholarship Foundation; National Cancer Institute (NCI) [K05CA124911, CA077852];  [T32CA08-0416]; NATIONAL CANCER INSTITUTE [K05CA124911, P01CA077852, T32CA080416] Funding Source: NIH RePORTER	Northern California Scholarship Foundation; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work supported by a pre-doctoral training award to J.M.L. (T32CA08-0416); a Northern California Scholarship Foundation award to J.M.L.; a National Cancer Institute (NCI) Career Award to T. L. V. (K05CA124911); and a NCI Program Award to R.J.M., Jr. (CA077852). Statistical software was provided through the Center for Studies in Demography and Ecology (CSDE) and the Student Technology Fee at the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Alter BP, 2003, CANCER-AM CANCER SOC, V97, P425, DOI 10.1002/cncr.11046; Birch JM, 1998, ONCOGENE, V17, P1061, DOI 10.1038/sj.onc.1202033; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; De Vos M, 2006, JNCI-J NATL CANCER I, V98, P358, DOI 10.1093/jnci/djj073; Dror Yigal, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000938; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; FEINBERG AP, 1982, CANCER RES, V42, P3252; Ferlay J, 2010, CANC INCIDENCE 5 CON; Fritz A, 2000, INT CLASSIFICATION D; FUKUCHI K, 1990, HUM GENET, V84, P249; German J, 1997, CANCER GENET CYTOGEN, V93, P100, DOI 10.1016/S0165-4608(96)00336-6; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Goto M, 1997, MECH AGEING DEV, V98, P239, DOI 10.1016/S0047-6374(97)00111-5; Howlader N, 2012, SEER CANC STAT REV 1; Huang JN, 2011, CURR OPIN HEMATOL, V18, P30, DOI 10.1097/MOH.0b013e32834114a5; Huang SR, 2006, HUM MUTAT, V27, P558, DOI 10.1002/humu.20337; Ishikawa Y, 2000, JPN J CANCER RES, V91, P1345, DOI 10.1111/j.1349-7006.2000.tb00924.x; Kyoizumi S, 1998, HUM GENET, V103, P405, DOI 10.1007/s004390050841; Monnat Jr RJ, 2002, WHO IARC MONOGRAPH P, P273; Monnat Jr RJ, 2006, HDB MODELS HUMAN AGI, P961; Monnat RJ, 2010, SEMIN CANCER BIOL, V20, P329, DOI 10.1016/j.semcancer.2010.10.002; Monnat RJ, 1999, CANCER, V86, P728, DOI 10.1002/(SICI)1097-0142(19990815)86:4<728::AID-CNCR23>3.3.CO;2-2; Monnat RJ, 2001, GANN MONOGR CANC RES, P83; Moser MJ, 2000, CANCER RES, V60, P2492; Parkin D., 2002, IARC PUBL, V8; Parkin DM, 1997, CANC INCIDENCE 5 CON, VVII; Rosenberg PS, 2003, BLOOD, V101, P822, DOI 10.1182/blood-2002-05-1498; Satoh M, 1999, LANCET, V353, P1766, DOI 10.1016/S0140-6736(98)05869-3; Schellenberg G.D., 2001, ONLINE METABOLIC MOL, P1; Seiter K, 2005, LEUKEMIA LYMPHOMA, V46, P1091, DOI 10.1080/10428190500102688; Siitonen HA, 2009, EUR J HUM GENET, V17, P151, DOI 10.1038/ejhg.2008.154; Vlachos A, 2012, BLOOD, V119, P3815, DOI 10.1182/blood-2011-08-375972; Wang LL, 2003, J NATL CANCER I, V95, P669, DOI 10.1093/jnci/95.9.669	35	124	127	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59709	10.1371/journal.pone.0059709	http://dx.doi.org/10.1371/journal.pone.0059709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573208	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900025
J	Brum, JR; Culley, AI; Steward, GF				Brum, Jennifer R.; Culley, Alexander I.; Steward, Grieg F.			Assembly of a Marine Viral Metagenome after Physical Fractionation	PLOS ONE			English	Article							GENOMIC ANALYSIS; VIRUSES; DIVERSITY; RECONSTRUCTION; BAY	Metagenomic analyses of marine viruses generate an overview of viral genes present in a sample, but the percentage of the resulting sequence fragments that can be reassembled is low and the phenotype of the virus from which a given sequence derives is usually unknown. In this study, we employed physical fractionation to characterize the morphological and genomic traits of a subset of uncultivated viruses from a natural marine assemblage. Viruses from Kane'ohe Bay, Hawai'i were fractionated by equilibrium buoyant density centrifugation in a cesium chloride (CsCl) gradient, and one fraction from the CsCl gradient was then further fractionated by strong anion-exchange chromatography. One of the fractions resulting from this two-dimensional separation appeared to be dominated by only a few virus types based on genome sizes and morphology. Sequences generated from a shotgun clone library of the viruses in this fraction were assembled into significantly more numerous contigs than have been generated with previous metagenomic investigations of whole DNA viral assemblages with comparable sequencing effort. Analysis of the longer contigs (up to 6.5 kb) assembled from our metagenome allowed us to assess gene arrangement in this subset of marine viruses. Our results demonstrate the potential for physical fractionation to facilitate sequence assembly from viral metagenomes and permit linking of morphological and genomic data for uncultivated viruses.	[Brum, Jennifer R.; Culley, Alexander I.; Steward, Grieg F.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Steward, GF (corresponding author), Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA.	grieg@hawaii.edu	Steward, Grieg F./D-9768-2011	Steward, Grieg F./0000-0001-5988-0522	National Science Foundation [OCE 04-42664, OCE 08-26650, EF 04-24599]	National Science Foundation(National Science Foundation (NSF))	This research was supported by National Science Foundation grants to Grieg Steward (OCE 04-42664, OCE 08-26650) and the National Science Foundation-supported Center for Microbial Oceanography Research and Education (EF 04-24599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017722; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; Bergeron A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000830; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Brum JR, 2011, LIMNOL OCEANOGR-METH, V9, P150, DOI 10.4319/lom.2011.9.150; Brum JR, 2005, AQUAT MICROB ECOL, V41, P103, DOI 10.3354/ame041103; Castberg T, 2002, J PHYCOL, V38, P767, DOI 10.1046/j.1529-8817.2002.02015.x; Chen K, 2005, PLOS COMPUT BIOL, V1, P106, DOI 10.1371/journal.pcbi.0010024; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Duhaime MB, 2012, ENVIRON MICROBIOL, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Hugenholtz P, 2002, GENOME BIOL, V3; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11; Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002; Legault BA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-171; Lohr JE, 2005, APPL ENVIRON MICROB, V71, P1598, DOI 10.1128/AEM.71.3.1598-1609.2005; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mizuno CM, 2013, APPL ENVIRON MICROB, V79, P688, DOI 10.1128/AEM.02742-12; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Steward GF, 2000, LIMNOL OCEANOGR, V45, P1697, DOI 10.4319/lo.2000.45.8.1697; Steward GF, 2001, METHOD MICROBIOL, V30, P85, DOI 10.1016/S0580-9517(01)30041-7; Steward GF, 2007, ISME J, V1, P100, DOI 10.1038/ismej.2007.25; Steward GF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-287; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943	44	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60604	10.1371/journal.pone.0060604	http://dx.doi.org/10.1371/journal.pone.0060604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580170	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000042
J	Rivera, FP; Medina, AM; Bezada, S; Valencia, R; Bernal, M; Meza, R; Maves, RC; Ochoa, TJ				Rivera, Fulton P.; Medina, Anicia M.; Bezada, Sandra; Valencia, Roberto; Bernal, Maria; Meza, Rina; Maves, Ryan C.; Ochoa, Theresa J.			Bovine Lactoferrin Decreases Cholera-Toxin-Induced Intestinal Fluid Accumulation in Mice by Ganglioside Interaction	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; HEAT-LABILE ENTEROTOXIN; FREE SECRETORY COMPONENT; HUMAN-MILK; ANTIBACTERIAL ACTIVITY; BINDING; DIARRHEA; CELLS; ANTAGONISTS; INHIBITION	Secretory diarrhea caused by cholera toxin (CT) is initiated by binding of CT's B subunit (CTB) to GM1-ganglioside on the surface of intestinal cells. Lactoferrin, a breast milk glycoprotein, has shown protective effect against several enteropathogens. The aims of this study were to determine the effect of bovine-lactoferrin (bLF) on CT-induced intestinal fluid accumulation in mice, and the interaction between bLF and CT/CTB with the GM1-ganglioside receptor. Fluid accumulation induced by CT was evaluated in the mouse ileal loop model using 56 BALB/c mice, with and without bLF added before, after or at the same time of CT administration. The effect of bLF in the interaction of CT and CTB with GM1-ganglioside was evaluated by a GM1-enzyme-linked immunosorbent assay. bLF decreased CT-induced fluid accumulation in the ileal loop of mice. The greatest effect was when bLF was added before CT (median, 0.066 vs. 0.166 g/cm, with and without bLF respectively, p<0.01). We conclude that bLF decreases binding of CT and CTB to GM1-ganglioside, suggesting that bLF suppresses CT-induced fluid accumulation by blocking the binding of CTB to GM1-ganglioside. bLF may be effective as adjunctive therapy for treatment of cholera diarrhea.	[Rivera, Fulton P.; Medina, Anicia M.; Ochoa, Theresa J.] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Rivera, Fulton P.] Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, RA-1425 Buenos Aires, DF, Argentina; [Bezada, Sandra] Univ Nacl Mayor San Marcos, Fac Farm & Bioquim, Farmacol Lab, Lima 14, Peru; [Valencia, Roberto] Univ Peruana Cayetano Heredia, Fac Vet & Zootecnia, Lima, Peru; [Bernal, Maria; Meza, Rina; Maves, Ryan C.] US Naval Med Res Unit SIX, Dept Bacteriol, Lima, Peru; [Maves, Ryan C.] USN, San Diego Med Ctr, Div Infect Dis, San Diego, CA 92152 USA; [Ochoa, Theresa J.] Univ Texas Houston, Sch Publ Hlth, Ctr Infect Dis, Houston, TX USA	Universidad Peruana Cayetano Heredia; University of Buenos Aires; Universidad Nacional Mayor de San Marcos; Universidad Peruana Cayetano Heredia; United States Department of Defense; United States Navy; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Rivera, FP (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.	Fulton.Rivera@upch.pe	Maves, Ryan C/AGG-3988-2022	Maves, Ryan C/0000-0001-6234-6160; Ochoa, Theresa/0000-0002-3227-3906; BEZADA, SANDRA/0000-0001-9516-0805; Rivera, Fulton/0000-0002-3676-389X; Medina, Anicia/0000-0002-5905-4711	Institutional Research Fund (Fondo Concursable) of Universidad Peruana Cayetano Heredia; United States Military Infectious Disease Research Program (MIDRP) [60000.000.0.B0017]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067694] Funding Source: NIH RePORTER	Institutional Research Fund (Fondo Concursable) of Universidad Peruana Cayetano Heredia; United States Military Infectious Disease Research Program (MIDRP); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work has been funded by the Institutional Research Fund (Fondo Concursable) of Universidad Peruana Cayetano Heredia (F.P.R) and by the United States Military Infectious Disease Research Program (MIDRP) (work unit number 60000.000.0.B0017). The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, the U.S. Government, nor that of the National Institutes of Health or other funding institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajello M, 2002, BIOCHEM CELL BIOL, V80, P119, DOI 10.1139/o01-211; APPELMELK BJ, 1994, INFECT IMMUN, V62, P2628, DOI 10.1128/IAI.62.6.2628-2632.1994; BRINES RD, 1983, BIOCHIM BIOPHYS ACTA, V759, P229, DOI 10.1016/0304-4165(83)90317-3; BROCK JH, 1983, INFECT IMMUN, V40, P453, DOI 10.1128/IAI.40.2.453-459.1983; Chen JC, 2007, J AGR FOOD CHEM, V55, P8390, DOI 10.1021/jf071460f; de Oliveira IR, 2007, BRAZ J MICROBIOL, V38, P86, DOI 10.1590/S1517-83822007000100018; de Oliveira IR, 2001, FEMS MICROBIOL LETT, V203, P29, DOI 10.1016/S0378-1097(01)00332-9; DIONYSIUS DA, 1993, J DAIRY SCI, V76, P2597, DOI 10.3168/jds.S0022-0302(93)77594-3; Drescher K, 1999, J NUTR, V129, P1026, DOI 10.1093/jn/129.5.1026; Farmer P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001145; Farnaud S, 2003, MOL IMMUNOL, V40, P395, DOI 10.1016/S0161-5890(03)00152-4; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Garg P, 2000, EPIDEMIOL INFECT, V124, P393, DOI 10.1017/S0950268899003957; GIUGLIANO LG, 1995, J MED MICROBIOL, V42, P3, DOI 10.1099/00222615-42-1-3; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kawasaki Y, 2000, BIOSCI BIOTECH BIOCH, V64, P348, DOI 10.1271/bbb.64.348; KAWASAKI Y, 1992, BIOSCI BIOTECH BIOCH, V56, P195, DOI 10.1271/bbb.56.195; MERRITT EA, 1995, CURR OPIN STRUC BIOL, V5, P165, DOI 10.1016/0959-440X(95)80071-9; Mitchell DD, 2004, BIOORGAN MED CHEM, V12, P907, DOI 10.1016/j.bmc.2003.12.019; Morrow Ardythe L, 2004, Semin Pediatr Infect Dis, V15, P221, DOI 10.1053/j.spid.2004.07.002; Ochoa TJ, 2012, BIOCHEM CELL BIOL, V90, P457, DOI [10.1139/o11-087, 10.1139/O11-087]; Ochoa TJ, 2009, BIOCHIMIE, V91, P30, DOI 10.1016/j.biochi.2008.04.006; Pickens JC, 2002, CHEM BIOL, V9, P215, DOI 10.1016/S1074-5521(02)00097-2; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; SAMSON RR, 1980, ACTA PAEDIATR SCAND, V69, P517, DOI 10.1111/j.1651-2227.1980.tb07124.x; Sanchez J, 2005, CURR OPIN IMMUNOL, V17, P388, DOI 10.1016/j.coi.2005.06.007; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Svennerholm AM, 2004, BEST PRACT RES CL GA, V18, P421, DOI 10.1016/j.bpg.2003.11.004; SVENNERHOLM AM, 1983, J CLIN MICROBIOL, V17, P596, DOI 10.1128/JCM.17.4.596-600.1983; Troost FJ, 2001, J NUTR, V131, P2101, DOI 10.1093/jn/131.8.2101; Valenti P, 2005, CELL MOL LIFE SCI, V62, P2576, DOI 10.1007/s00018-005-5372-0; VISCA P, 1990, MED MICROBIOL IMMUN, V179, P323; YAMAUCHI K, 1993, INFECT IMMUN, V61, P719, DOI 10.1128/IAI.61.2.719-728.1993; Zavaleta N, 2007, J PEDIATR GASTR NUTR, V44, P258, DOI 10.1097/MPG.0b013e31802c41b7	35	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e59253	10.1371/journal.pone.0059253	http://dx.doi.org/10.1371/journal.pone.0059253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580005	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000009
J	Rodriguez, FB; Huerta, R; Aylwin, MDL				Rodriguez, Francisco B.; Huerta, Ramon; de la Luz Aylwin, Maria			Neural Sensitivity to Odorants in Deprived and Normal Olfactory Bulbs	PLOS ONE			English	Article							DEPRIVATION; NEURONS; SYSTEM; REPRESENTATIONS; MOUSE; RAT; DISCRIMINATION; INTERNEURONS; STIMULATION; INHIBITION	Early olfactory deprivation in rodents is accompanied by an homeostatic regulation of the synaptic connectivity in the olfactory bulb (OB). However, its consequences in the neural sensitivity and discrimination have not been elucidated. We compared the odorant sensitivity and discrimination in early sensory deprived and normal OBs in anesthetized rats. We show that the deprived OB exhibits an increased sensitivity to different odorants when compared to the normal OB. Our results indicate that early olfactory stimulation enhances discriminability of the olfactory stimuli. We found that deprived olfactory bulbs adjusts the overall excitatory and inhibitory mitral cells (MCs) responses to odorants but the receptive fields become wider than in the normal olfactory bulbs. Taken together, these results suggest that an early natural sensory stimulation sharpens the receptor fields resulting in a larger discrimination capability. These results are consistent with previous evidence that a varied experience with odorants modulates the OB's synaptic connections and increases MCs selectivity.	[Rodriguez, Francisco B.] Univ Autonoma Madrid, Escuela Politecn Super, Dpto Ingn Informat, Grp Neurocomp Biol, Madrid, Spain; [Huerta, Ramon] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [de la Luz Aylwin, Maria] Univ Chile, Fac Med, Programa Fisiol & Biofis, Santiago 7, Chile	Autonomous University of Madrid; University of California System; University of California San Diego; Universidad de Chile	Rodriguez, FB (corresponding author), Univ Autonoma Madrid, Escuela Politecn Super, Dpto Ingn Informat, Grp Neurocomp Biol, Madrid, Spain.	f.rodriguez@uam.es	Huerta, Ramon/C-9296-2013; de Borja Rodriguez, Francisco/F-7812-2013; Huerta, Ramon/J-4316-2012	Huerta, Ramon/0000-0003-3925-5169; de Borja Rodriguez, Francisco/0000-0003-4053-099X; Huerta, Ramon/0000-0003-3925-5169	MINECO [TIN2010-19607]; Iniciativa Cientifica Milenio ICM [P04-068-F]; Fundacion Puelma; Programa de movilidad para profesores de la Universidad Autonoma de Madrid;  [NIDCD-R01DC011422-01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011422] Funding Source: NIH RePORTER	MINECO(Spanish Government); Iniciativa Cientifica Milenio ICM; Fundacion Puelma; Programa de movilidad para profesores de la Universidad Autonoma de Madrid; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported MINECO TIN2010-19607 to FBR and RH and Iniciativa Cientifica Milenio ICM P04-068-F and Fundacion Puelma to MLA. FBR acknowledges partial support from Programa de movilidad para profesores de la Universidad Autonoma de Madrid. RH acknowledges partial support from NIDCD-R01DC011422-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angely CJ, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-26; Aylwin ML, 2009, NEUROSCIENCE, V162, P1265, DOI 10.1016/j.neuroscience.2009.05.051; Aylwin MDL, 2005, BIOL RES, V38, P13, DOI 10.4067/S0716-97602005000100003; Bastien-Dionne PO, 2010, J COMP NEUROL, V518, P1847, DOI 10.1002/cne.22307; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bazhenov M., 2009, ENCY NEURO SCI, P87, DOI [10.1016/B978-008045046-9.01424-8, DOI 10.1016/B978-008045046-9.01424-8]; Cleland TA, 2007, P NATL ACAD SCI USA, V104, P1953, DOI 10.1073/pnas.0608564104; Coppola DM, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/351752; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cummings DM, 1997, EXP NEUROL, V148, P360, DOI 10.1006/exnr.1997.6660; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Dempster AP, 1997, STAT COMPUT, V7, P247, DOI 10.1023/A:1018598421607; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Fonollosa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037809; FRAZIER LL, 1988, J COMP NEUROL, V269, P355, DOI 10.1002/cne.902690304; FRAZIERCIERPIAL L, 1989, J COMP NEUROL, V289, P481, DOI 10.1002/cne.902890312; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Garcia-Sanchez M, 2003, J COMPUT NEUROSCI, V15, P5, DOI 10.1023/A:1024460700856; GUTHRIE KM, 1990, J NEUROSCI, V10, P3402; Huerta R, 2004, NEURAL COMPUT, V16, P1601, DOI 10.1162/089976604774201613; Jun Shao DT, 1995, SPRINGER SERIES STAT; Lagier S, 2004, J NEUROSCI, V24, P4382, DOI 10.1523/JNEUROSCI.5570-03.2004; Lehmkuhle MJ, 2006, J NEUROPHYSIOL, V95, P1369, DOI 10.1152/jn.01334.2004; Locatelli FF, 2013, EUR J NEUROSCI, V37, P63, DOI 10.1111/ejn.12021; Maher BJ, 2009, P NATL ACAD SCI USA, V106, P16865, DOI 10.1073/pnas.0808946106; Maldonado PE, 1996, VISUAL NEUROSCI, V13, P509, DOI 10.1017/S095252380000818X; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rodriguez FB, 2004, NEURAL NETWORKS, V17, P963, DOI 10.1016/j.neunet.2003.12.003; Rodriguez FB, 2009, BIOL CYBERN, V100, P289, DOI 10.1007/s00422-009-0297-6; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Saghatelyan A, 2005, NEURON, V46, P103, DOI 10.1016/j.neuron.2005.02.016; Schaefer AT, 2007, TRENDS NEUROSCI, V30, P92, DOI 10.1016/j.tins.2007.01.001; Scott JW, 2006, CHEM SENSES, V31, P119, DOI 10.1093/chemse/bjj013; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vlachos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032883; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Waggener CT, 2007, NEUROSCI LETT, V427, P112, DOI 10.1016/j.neulet.2007.09.013; Wehr M, 1999, J NEUROSCI, V19, P381, DOI 10.1523/JNEUROSCI.19-01-00381.1999; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; WILSON DA, 1992, NEUROSCIENCE, V49, P183, DOI 10.1016/0306-4522(92)90086-H; WILSON DA, 1990, NEUROSCI LETT, V116, P250, DOI 10.1016/0304-3940(90)90082-K; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yaksi E, 2007, PLOS BIOL, V5, P1453, DOI 10.1371/journal.pbio.0050178	51	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60745	10.1371/journal.pone.0060745	http://dx.doi.org/10.1371/journal.pone.0060745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580211	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000058
J	Shen, WP; Chen, X; Cormier, O; Cheng, DCP; Reed, B; Harden, N				Shen, Weiping; Chen, Xi; Cormier, Olga; Cheng, David Chung-Pei; Reed, Bruce; Harden, Nicholas			Modulation of Morphogenesis by Egfr during Dorsal Closure in Drosophila	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; AMINO-TERMINAL KINASE; DISTINCT ROLES; CELL FATES; DOWN-REGULATION; DPP PATHWAYS; THICK VEINS; MESOTHORAX SPECIFICATION; DECAPENTAPLEGIC SIGNAL; DORSOVENTRAL PATTERN	During Drosophila embryogenesis the process of dorsal closure (DC) results in continuity of the embryonic epidermis, and DC is well recognized as a model system for the analysis of epithelial morphogenesis as well as wound healing. During DC the flanking lateral epidermal sheets stretch, align, and fuse along the dorsal midline, thereby sealing a hole in the epidermis occupied by an extra-embryonic tissue known as the amnioserosa (AS). Successful DC requires the regulation of cell shape change via actomyosin contractility in both the epidermis and the AS, and this involves bidirectional communication between these two tissues. We previously demonstrated that transcriptional regulation of myosin from the zipper (zip) locus in both the epidermis and the AS involves the expression of Ack family tyrosine kinases in the AS in conjunction with Dpp secreted from the epidermis. A major function of Ack in other species, however, involves the negative regulation of Egfr. We have, therefore, asked what role Egfr might play in the regulation of DC. Our studies demonstrate that Egfr is required to negatively regulate epidermal expression of dpp during DC. Interestingly, we also find that Egfr signaling in the AS is required to repress zip expression in both the AS and the epidermis, and this may be generally restrictive to the progression of morphogenesis in these tissues. Consistent with this theme of restricting morphogenesis, it has previously been shown that programmed cell death of the AS is essential for proper DC, and we show that Egfr signaling also functions to inhibit or delay AS programmed cell death. Finally, we present evidence that Ack regulates zip expression by promoting the endocytosis of Egfr in the AS. We propose that the general role of Egfr signaling during DC is that of a braking mechanism on the overall progression of DC.	[Shen, Weiping; Chen, Xi; Cheng, David Chung-Pei; Harden, Nicholas] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cormier, Olga; Reed, Bruce] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	Simon Fraser University; University of Waterloo	Harden, N (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	nharden@sfu.ca		Cormier, Olga/0000-0002-1414-5652	Canadian Institutes of Health Research [MOP 74513]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by Canadian Institutes of Health Research grant no. MOP 74513 to NH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFOLTER M, 1994, DEVELOPMENT, V120, P3105; Arquier N, 2001, DEVELOPMENT, V128, P2209; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bardet PL, 2008, P NATL ACAD SCI USA, V105, P13901, DOI 10.1073/pnas.0806983105; BRAND AH, 1993, DEVELOPMENT, V118, P401; Byars CL, 1999, DEVELOPMENT, V126, P4913; Campos I, 2010, GENETICS, V184, P129, DOI 10.1534/genetics.109.110288; Carmena A, 1998, GENE DEV, V12, P3910, DOI 10.1101/gad.12.24.3910; Carneiro K, 2006, DEV BIOL, V296, P203, DOI 10.1016/j.ydbio.2006.04.453; Chang T, 2003, DEV BIOL, V263, P103, DOI 10.1016/S0012-1606(03)00448-2; Chen CK, 1998, DEVELOPMENT, V125, P4959; Chen Y, 2006, MECH DEVELOP, V123, P395, DOI 10.1016/j.mod.2006.03.007; CHILDS SR, 1993, P NATL ACAD SCI USA, V90, P9475, DOI 10.1073/pnas.90.20.9475; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; CLIFFORD R, 1992, DEVELOPMENT, V115, P853; CLIFFORD RJ, 1989, GENETICS, V123, P771; Conder R, 2004, DEV BIOL, V276, P378, DOI 10.1016/j.ydbio.2004.08.044; Cormier O, 2012, AUTOPHAGY, V8, P252, DOI 10.4161/auto.8.2.18618; Crozatier M, 2002, DEVELOPMENT, V129, P4261; Dahmann C, 2007, DROSOPHILA METHODS P; de Navascues J, 2007, DEVELOPMENT, V134, P1779, DOI 10.1242/dev.02844; deCelis JF, 1997, DEVELOPMENT, V124, P1007; Deng WM, 1997, DEVELOPMENT, V124, P4639; Dequier E, 2001, MECH DEVELOP, V106, P47, DOI 10.1016/S0925-4773(01)00418-X; Dobens LL, 2000, DEVELOPMENT, V127, P745; Dumstrei K, 1998, DEVELOPMENT, V125, P3417; Dumstrei K, 2002, DEVELOPMENT, V129, P3983; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Fernandez BG, 2007, MECH DEVELOP, V124, P884, DOI 10.1016/j.mod.2007.09.002; Frank LH, 1996, DEVELOPMENT, V122, P1343; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gabay L, 1997, DEVELOPMENT, V124, P3535; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Geiger JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028349; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; Goentoro LA, 2006, DEV CELL, V11, P263, DOI 10.1016/j.devcel.2006.07.004; GoldmanLevi R, 1996, INT J DEV BIOL, V40, P1043; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Harden N, 1996, MOL CELL BIOL, V16, P1896; Harden N, 1999, J CELL SCI, V112, P273; Heisenberg CP, 2009, BIOESSAYS, V31, P1284, DOI 10.1002/bies.200900109; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Hou XS, 1997, GENE DEV, V11, P1728, DOI 10.1101/gad.11.13.1728; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; JACKSON PD, 1994, DEV DYNAM, V199, P28, DOI 10.1002/aja.1001990104; Jordan KC, 2000, NAT GENET, V24, P429, DOI 10.1038/74294; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kim SY, 2008, MOL CELLS, V26, P576; Kopp A, 1999, DEVELOPMENT, V126, P3495; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kubota K, 2000, DEVELOPMENT, V127, P3769; Kumar JP, 2001, DEVELOPMENT, V128, P2689; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lada K, 2012, BIOL OPEN, V1, P353, DOI 10.1242/bio.2012497; Lamka ML, 1999, DEV BIOL, V214, P102, DOI 10.1006/dbio.1999.9409; Lee T, 1996, DEVELOPMENT, V122, P409; Letizia A, 2007, DEVELOPMENT, V134, P1337, DOI 10.1242/dev.02823; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; Lin Q, 2002, J BIOL CHEM, V277, P10134, DOI 10.1074/jbc.M110329200; Lin Q, 2010, MOL CELL BIOL, V30, P1541, DOI 10.1128/MCB.00013-10; Liu M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000740; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Martin-Blanco E, 1999, DEVELOPMENT, V126, P5739; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mateus AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018729; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Mohseni N, 2009, AUTOPHAGY, V5, P329, DOI 10.4161/auto.5.3.7444; Morel V, 2004, DEVELOPMENT, V131, P3273, DOI 10.1242/dev.01217; Motola S, 2004, DEV DYNAM, V230, P535, DOI 10.1002/dvdy.20066; Nagaraj R, 2009, EMBO J, V28, P337, DOI 10.1038/emboj.2008.286; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; O'Keefe DD, 2007, DEV BIOL, V311, P25, DOI 10.1016/j.ydbio.2007.08.003; Oda H, 2001, J CELL SCI, V114, P493; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Peri F, 2000, DEVELOPMENT, V127, P841; Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285; Radke K, 2001, GENETICS, V159, P1031; Reed BH, 2001, CURR BIOL, V11, P1098, DOI 10.1016/S0960-9822(01)00318-9; Reed BH, 2004, CURR BIOL, V14, P372, DOI 10.1016/j.cub.2004.02.029; Reed BH, 2009, J VIS EXP; Ricos MG, 1999, J CELL SCI, V112, P1225; RiesgoEscovar JR, 1997, GENE DEV, V11, P1717, DOI 10.1101/gad.11.13.1717; RiesgoEscovar JR, 1997, SCIENCE, V278, P669, DOI 10.1126/science.278.5338.669; Royzman I, 1997, GENE DEV, V11, P1999, DOI 10.1101/gad.11.15.1999; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Schoenherr JA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002725; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Scuderi A, 2005, DEV DYNAM, V232, P791, DOI 10.1002/dvdy.20306; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; Sem KP, 2002, MOL CELL BIOL, V22, P3685, DOI 10.1128/MCB.22.11.3685-3697.2002; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Shirai T, 2003, BIOCHEM BIOPH RES CO, V311, P473, DOI 10.1016/j.bbrc.2003.10.017; Shravage BV, 2007, DEVELOPMENT, V134, P2261, DOI 10.1242/dev.02856; Sluss HK, 1997, J CELL BIOCHEM, V67, P1; Sotillos S, 2005, DEV DYNAM, V232, P738, DOI 10.1002/dvdy.20270; STJOHNSTON RD, 1987, EMBO J, V6, P2785, DOI 10.1002/j.1460-2075.1987.tb02574.x; Stronach BE, 2001, DEVELOPMENT, V128, P2905; Szuts D, 2000, MECH DEVELOP, V98, P71, DOI 10.1016/S0925-4773(00)00455-X; Szuts D, 1998, GENE DEV, V12, P2022, DOI 10.1101/gad.12.13.2022; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; Van Vactor D, 1999, ADV MOLEC BIOL, P490; VanHook A, 2008, DEV DYNAM, V237, P28, DOI 10.1002/dvdy.21405; Von Ohlen T, 2000, DEV BIOL, V224, P362, DOI 10.1006/dbio.2000.9789; Wada A, 2007, DEV BIOL, V301, P340, DOI 10.1016/j.ydbio.2006.09.020; Wahlstrom G, 2006, MECH DEVELOP, V123, P801, DOI 10.1016/j.mod.2006.08.004; Wappner P, 1997, DEVELOPMENT, V124, P4707; Wei HC, 2003, CURR BIOL, V13, P1882, DOI 10.1016/j.cub.2003.09.056; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Yagi Y, 1997, GENES CELLS, V2, P41, DOI 10.1046/j.1365-2443.1997.d01-282.x; Yakoby N, 2008, DEVELOPMENT, V135, P343, DOI 10.1242/dev.008920; Yan SJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.35; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; Zahedi B, 2008, DEV DYNAM, V237, P2936, DOI 10.1002/dvdy.21722; Zeitlinger J, 1997, EMBO J, V16, P7393, DOI 10.1093/emboj/16.24.7393	121	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60180	10.1371/journal.pone.0060180	http://dx.doi.org/10.1371/journal.pone.0060180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23579691	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000023
J	Shiu, TY; Huang, SM; Shih, YL; Chu, HC; Chang, WK; Hsieh, TY				Shiu, Tzu-Yue; Huang, Shih-Ming; Shih, Yu-Lueng; Chu, Heng-Cheng; Chang, Wei-Kuo; Hsieh, Tsai-Yuan			Hepatitis C Virus Core Protein Down-Regulates p21(Waf1/Cip1) and Inhibits Curcumin-Induced Apoptosis through MicroRNA-345 Targeting in Human Hepatoma Cells	PLOS ONE			English	Article							HEPATOCELLULAR CARCINOMAS; SUBCELLULAR-LOCALIZATION; CELLULAR-TRANSFORMATION; EXPRESSION LEVELS; CANCER; CYCLE; P21; HEPATOCARCINOGENESIS; IDENTIFICATION; DEGRADATION	Background: Hepatitis C virus (HCV) has been reported to regulate cellular microRNAs. The HCV core protein is considered to be a potential oncoprotein in HCV-related hepatocellular carcinoma, but HCV core-modulated cellular microRNAs are unknown. The HCV core protein regulates p21(Waf1/Cip1) expression. However, the mechanism of HCV core-associated p21(Waf1/Cip1) regulation remains to be further clarified. Therefore, we attempted to determine whether HCV core modulated cellular microRNAs play an important role in regulating p21(Waf1/Cip1) expression in human hepatoma cells. Methods: Cellular microRNA profiling was investigated in core-overexpressing hepatoma cells using TaqMan low density array. Array data were further confirmed by TaqMan real-time qPCR for single microRNA in core-overexpressing and full-length HCV replicon-expressing cells. The target gene of microRNA was examined by reporter assay. The gene expression was determined by real-time qPCR and Western blotting. Apoptosis was examined by annexin V-FITC apoptosis assay. Cell cycle analysis was performed by propidium iodide staining. Cell proliferation was analyzed by MTT assay. Results: HCV core protein up- or down-regulated some cellular microRNAs in Huh7 cells. HCV core-induced microRNA-345 suppressed p21(Waf1/Cip1) gene expression through targeting its 3' untranslated region in human hepatoma cells. Moreover, the core protein inhibited curcumin-induced apoptosis through p21(Waf1/Cip1)-targeting microRNA-345 in Huh7 cells. Conclusion and Significance: HCV core protein enhances the expression of microRNA-345 which then down-regulates p21(Waf1/Cip1) expression. It is the first time that HCV core protein has ever been shown to suppress p21(Waf1/Cip1) gene expression through miR-345 targeting.	[Shiu, Tzu-Yue; Hsieh, Tsai-Yuan] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Shiu, Tzu-Yue; Shih, Yu-Lueng; Chu, Heng-Cheng; Chang, Wei-Kuo; Hsieh, Tsai-Yuan] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Huang, Shih-Ming] Natl Def Med Ctr, Grad Inst Biochem, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Hsieh, TY (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	tyh1216@ms46.hinet.net			Foundation for Medical Research of Tri-Service General Hospital; National Defense Medical Center [TSGH-C98-47, TSGH-C101-066, DOD-100-I-27]	Foundation for Medical Research of Tri-Service General Hospital; National Defense Medical Center	This study was supported in part by Grants from the Foundation for Medical Research of Tri-Service General Hospital and National Defense Medical Center (TSGH-C98-47, TSGH-C101-066 and DOD-100-I-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Beard MR, 1999, HEPATOLOGY, V30, P316, DOI 10.1002/hep.510300137; Braconi C, 2010, CLIN CANCER RES, V16, P957, DOI 10.1158/1078-0432.CCR-09-2123; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Castello G, 2010, CLIN IMMUNOL, V134, P237, DOI 10.1016/j.clim.2009.10.007; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; CHEN PJ, 1992, VIROLOGY, V188, P102, DOI 10.1016/0042-6822(92)90739-C; Chen WX, 2008, VIRUS RES, V133, P250, DOI 10.1016/j.virusres.2008.01.011; Darvesh AS, 2012, CURR PHARM BIOTECHNO, V13, P218; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Falcon V, 2003, BIOCHEM BIOPH RES CO, V310, P54, DOI 10.1016/j.bbrc.2003.08.118; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jin DY, 2000, EMBO J, V19, P729, DOI 10.1093/emboj/19.4.729; Koike K, 2007, J GASTROEN HEPATOL, V22, pS108, DOI 10.1111/j.1440-1746.2006.04669.x; Lee MN, 2002, J GEN VIROL, V83, P2145, DOI 10.1099/0022-1317-83-9-2145; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu QY, 1997, J VIROL, V71, P657, DOI 10.1128/JVI.71.1.657-662.1997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LO SY, 1995, VIROLOGY, V213, P455, DOI 10.1006/viro.1995.0018; Marquez RT, 2010, LAB INVEST, V90, P1727, DOI 10.1038/labinvest.2010.126; Moriishi K, 2003, J VIROL, V77, P10237, DOI 10.1128/JVI.77.19.10237-10249.2003; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nguyen H, 2003, VIROLOGY, V312, P245, DOI 10.1016/S0042-6822(03)00209-5; Ohkawa K, 2004, J BIOL CHEM, V279, P11719, DOI 10.1074/jbc.M308560200; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Srivastava RK, 2007, CELL CYCLE, V6, P2953, DOI 10.4161/cc.6.23.4951; Suzuki R, 2001, VIROLOGY, V280, P301, DOI 10.1006/viro.2000.0785; Tang JT, 2011, CARCINOGENESIS, V32, P1207, DOI 10.1093/carcin/bgr114; Tsutsumi T, 2002, HEPATOLOGY, V35, P937, DOI 10.1053/jhep.2002.32470; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang WZ, 2008, FEBS LETT, V582, P2689, DOI 10.1016/j.febslet.2008.06.048; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Yamaguchi R, 2004, INT J MOL MED, V14, P1097; Yamanaka T, 2002, BIOCHEM BIOPH RES CO, V294, P521, DOI 10.1016/S0006-291X(02)00507-7; Yoshida T, 2002, J EXP MED, V196, P641, DOI 10.1084/jem.20012127; You LR, 1999, J VIROL, V73, P2841	43	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61089	10.1371/journal.pone.0061089	http://dx.doi.org/10.1371/journal.pone.0061089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577194	Green Submitted, gold, Green Published			2022-12-27	WOS:000317898000099
J	Burrell, JR; Hornberger, M; Villemagne, VL; Rowe, CC; Hodges, JR				Burrell, James R.; Hornberger, Michael; Villemagne, Victor L.; Rowe, Christopher C.; Hodges, John R.			Clinical Profile of PiB-Positive Corticobasal Syndrome	PLOS ONE			English	Article							PRIMARY-PROGRESSIVE-APHASIA; ADDENBROOKES COGNITIVE EXAMINATION; PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; DEGENERATION SYNDROME; SUPRANUCLEAR PALSY; 3 VARIANTS; A-BETA; PATHOLOGY	Background: Corticobasal syndrome (CBS) is a multifaceted neurodegenerative disorder characterized by a combination of motor and cognitive deficits. Several different pathological entities, including Alzheimer's pathology, have been described in association with CBS. The present study aimed to establish clinical, neuropsychological, and neuroimaging features that could be useful in the distinction of CBS due to AD pathology from other CBS cases in life based on [C-11] Pittsburgh Compound B positron emission tomography (PiB-PET) status. Methods: Patients with CBS were prospectively recruited from a specialized cognitive disorders clinic. All patients underwent detailed clinical and neuropsychological assessment, with structural imaging using voxel-based analysis of magnetic resonance imaging. Alzheimer's pathology was detected using PiB-PET imaging, and PiB-positive and PiB-negative groups were compared. Results: Fourteen CBS patients meeting defined criteria were included (7 male, 7 female; mean age 66.1+/-6.9 years; median symptom duration was 35.5+/-22.6 months) and compared to 20 matched control subjects. Of the 14 patients, 4 were PiB-positive and 10 PiB-negative. There were no significant differences between PiB-positive and PiB-negative CBS patients in age, gender, education, symptom duration, or motor features. PiB-positive patients had greater visuospatial deficits, a higher rate of sentence repetition impairment, and more functional decline. Voxel-based morphometry analyses demonstrated extensive peri-insular and post-central atrophy in both groups, but PiB-positive patients had atrophy that extended to include the posterior part of the left superior temporal gyrus. Conclusions: Visuospatial function, aspects of language, and the pattern of cerebral atrophy may be useful in distinguishing patients with CBS due to underlying AD pathology.	[Burrell, James R.; Hornberger, Michael; Hodges, John R.] Neurosci Res Australia, Sydney, NSW, Australia; [Burrell, James R.] Prince Wales Clin Sch, Sydney, NSW, Australia; [Burrell, James R.; Hornberger, Michael; Hodges, John R.] Univ New S Wales, Sydney, NSW, Australia; [Villemagne, Victor L.] Austin Hlth, Dept Nucl Med, Melbourne, Vic, Australia; [Villemagne, Victor L.] Austin Hlth, Ctr PET, Melbourne, Vic, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Univ Melbourne, Austin Hlth, Dept Med, Melbourne, Vic, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Hodges, JR (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	j.hodges@neura.edu.au	Rowe, Christopher/AAX-8748-2021; Villemagne, Victor/AAC-5406-2019; Hornberger, Michael/C-9610-2011	Villemagne, Victor/0000-0002-5832-9875; Hornberger, Michael/0000-0002-2214-3788; Burrell, James/0000-0001-9638-2768	National Health and Medical Research Council of Australia; Motor Neuron Disease Research Institute of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Motor Neuron Disease Research Institute of Australia; Australian Research Council(Australian Research Council)	This study was funded by the National Health and Medical Research Council of Australia. In addition, JRB gratefully acknowledges funding support from the Motor Neuron Disease Research Institute of Australia, JRH is supported by Australian Research Council Federation Fellowships, and MH is supported by an Australian Research Council grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacskai BJ, 2007, ARCH NEUROL-CHICAGO, V64, P431, DOI 10.1001/archneur.64.3.431; Boeve BF, 1999, NEUROLOGY, V53, P795, DOI 10.1212/WNL.53.4.795; Boxer AL, 2006, ARCH NEUROL-CHICAGO, V63, P81, DOI 10.1001/archneur.63.1.81; Bozeat S, 2000, J NEUROL NEUROSUR PS, V69, P178, DOI 10.1136/jnnp.69.2.178; Company, 1994, DOORS PEOPLE TEST VI; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gorno-Tempini ML, 2008, NEUROLOGY, V71, P1227, DOI 10.1212/01.wnl.0000320506.79811.da; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Gorno-Tempini ML, 2004, ANN NEUROL, V55, P335, DOI 10.1002/ana.10825; Graham NL, 2003, NEUROLOGY, V61, P493, DOI 10.1212/01.WNL.0000081230.09863.ED; Graham NL, 2003, MOVEMENT DISORD, V18, P1224, DOI 10.1002/mds.10536; Hodges JR, 2007, COGNITIVE ASSESSMENT; Hu WT, 2009, MOVEMENT DISORD, V24, P1375, DOI 10.1002/mds.22574; Ikonomovic MD, 2008, BRAIN, V131, P1630, DOI 10.1093/brain/awn016; Josephs KA, 2010, MOVEMENT DISORD, V25, P1246, DOI 10.1002/mds.23062; Kertesz A, 2000, NEUROLOGY, V55, P1368, DOI 10.1212/WNL.55.9.1368; Kertesz A, 2010, J NEUROL SCI, V289, P138, DOI 10.1016/j.jns.2009.08.036; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lee SE, 2011, ANN NEUROL, V70, P327, DOI 10.1002/ana.22424; Leyton CE, 2011, BRAIN, V134, P3030, DOI 10.1093/brain/awr216; Ling HL, 2010, BRAIN, V133, P2045, DOI 10.1093/brain/awq123; Mathew R, 2012, J NEUROL NEUROSUR PS, V83, P405, DOI 10.1136/jnnp-2011-300875; Mathew R, 2011, DEMENT GERIATR COGN, V31, P254, DOI 10.1159/000327169; Mesulam M, 2008, ANN NEUROL, V63, P709, DOI 10.1002/ana.21388; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Rabinovici GD, 2008, ANN NEUROL, V64, P388, DOI 10.1002/ana.21451; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RINNE JO, 1994, BRAIN, V117, P1183, DOI 10.1093/brain/117.5.1183; Rogalski E, 2011, J NEUROSCI, V31, P3344, DOI 10.1523/JNEUROSCI.5544-10.2011; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Shelley BP, 2009, MOVEMENT DISORD, V24, P1593, DOI 10.1002/mds.22558; Soliveri P, 2005, NEUROLOGY, V64, P448, DOI 10.1212/01.WNL.0000150732.92567.BA; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Warrington EK., 1991, VISUAL OBJECT SPACE; Wedderburn C, 2008, J NEUROL NEUROSUR PS, V79, P500, DOI 10.1136/jnnp.2007.122028; Whitwell JL, 2010, NEUROLOGY, V75, P1879, DOI 10.1212/WNL.0b013e3181feb2e8; Whitwell JL, 2011, NEUROBIOL AGING, V32, P1531, DOI 10.1016/j.neurobiolaging.2009.10.012	37	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61025	10.1371/journal.pone.0061025	http://dx.doi.org/10.1371/journal.pone.0061025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577184	Green Published, gold			2022-12-27	WOS:000319109800119
J	Garassino, MC; Piva, S; La Verde, N; Spagnoletti, I; Iorno, V; Carbone, C; Febbraro, A; Bianchi, A; Bramati, A; Moretti, A; Ganzinelli, M; Marabese, M; Gentili, M; Torri, V; Farina, G				Garassino, Marina Chiara; Piva, Sheila; La Verde, Nicla; Spagnoletti, Ilaria; Iorno, Vittorio; Carbone, Claudia; Febbraro, Antonio; Bianchi, Anna; Bramati, Annalisa; Moretti, Anna; Ganzinelli, Monica; Marabese, Mirko; Gentili, Marta; Torri, Valter; Farina, Gabriella			Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients	PLOS ONE			English	Article							CONTROLLED-RELEASE OXYCODONE; NONCANCER PAIN; ASSOCIATION; MORPHINE; METAANALYSIS; EFFICACY; SAFETY; GENE	Purpose: Neuropathic pain is commonly associated with cancer. Current treatments include combination opioid and adjuvant therapies, but no guidelines are available for dose escalation strategies. This phase II study compared the efficacy and tolerability of two dose escalation strategies for oxycodone and pregabalin combination therapy. Methods: Patients (N = 75) with oncological neuropathic pain, previously untreated with pregabalin, were recruited in 5 Italian institutions between 2007 and 2010. Patients were randomised to two different dose escalation strategies (arm A; N = 38) oxycodone at a fixed dose with increasing pregabalin doses; (arm B; N = 37) pregabalin at a fixed dose with increasing oxycodone doses. Patients were evaluated from daily diaries and follow-ups at 3, 7, 10, and 14 days after beginning treatment with a numerical rating scale (NRS), neuropathic pain scale (SDN), and well-being scale (ESAS). The primary endpoint was a >= 1/3 reduction in pain (NRS); secondary endpoints included the time to analgesia and adverse effects. The study had a 90% probability of detecting the best strategy for a true difference of at least 15%. Results: More patients in arm A (76%) than arm B (64%) achieved >= 1/3 overall pain reduction even after controlling for baseline factors (gender, baseline pain). Group A reported fewer side effects than group B; constipation 52.8% vs. 66.7%; nausea: 27.8% vs. 44.4%; drowsiness: 44.4% vs. 55.6%; confusion: 16.7% vs. 27.8%; itching: 8.3% vs. 19.4%. Conclusions: Both strategies effectively controlled neuropathic pain, but according to the adopted selection design arm A is preferable to arm B for pain control.	[Garassino, Marina Chiara] Fdn IRCCS Ist Nazl Tumori, Med Oncol Unit 1, Milan, Italy; [Piva, Sheila; La Verde, Nicla; Bramati, Annalisa; Moretti, Anna; Gentili, Marta; Farina, Gabriella] AO Fatebenefratelli & Oftalm 23, Dept Oncol, Milan, Italy; [Spagnoletti, Ilaria; Febbraro, Antonio] AO Sacro Cuore Gesu, Fatebenefratelli, Benevento, Italy; [Iorno, Vittorio] Policlin Maggiore, Milan, Italy; [Carbone, Claudia] Osped Serbelloni, Dept Oncol, Gorgonzola, Italy; [Bianchi, Anna] Dept Neurol Ao St Antonio Abate, Gallarate, Italy; [Ganzinelli, Monica; Marabese, Mirko; Torri, Valter] Dept Oncol Mario Negri Inst, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Piva, S (corresponding author), AO Fatebenefratelli & Oftalm 23, Dept Oncol, Milan, Italy.	sheila.piva@fbf.milano.it	Torri, Valter/H-7550-2015; la verde, nicla/AAW-9398-2020; Ganzinelli, Monica/K-4548-2016; Marabese, Mirko/AAA-6876-2019; Garassino, Marina C/D-7128-2017	Torri, Valter/0000-0001-9541-9354; la verde, nicla/0000-0002-2884-1632; Ganzinelli, Monica/0000-0002-0526-0835; Marabese, Mirko/0000-0001-9379-0301; Garassino, Marina C/0000-0002-3821-5598; , Anna/0000-0002-6518-5734	UMAN.A project, a recognised non-profit social assistance organisation (Onlus)	UMAN.A project, a recognised non-profit social assistance organisation (Onlus)	Funding was received from the UMAN.A project, a recognised non-profit social assistance organisation (Onlus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blommel ML, 2007, AM J HEALTH-SYST PH, V64, P1475, DOI 10.2146/ajhp060371; Bruera E, 1998, J CLIN ONCOL, V16, P3222, DOI 10.1200/JCO.1998.16.10.3222; Bruera E, 1991, J Palliat Care, V7, P6; Campa D, 2008, CLIN PHARMACOL THER, V83, P559, DOI 10.1038/sj.clpt.6100385; Caraceni A, 2004, J CLIN ONCOL, V22, P2909, DOI 10.1200/jco.2004.08.141; Caraceni A, 2002, J PAIN SYMPTOM MANAG, V23, P239, DOI 10.1016/S0885-3924(01)00409-2; Eisenberg E, 2005, JAMA-J AM MED ASSOC, V293, P3043, DOI 10.1001/jama.293.24.3043; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; Fukuda Ken-ichi, 2010, Anesth Prog, V57, P145, DOI 10.2344/0003-3006-57.4.145; Fukuda K, 2009, PAIN, V147, P194, DOI 10.1016/j.pain.2009.09.004; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Gatti A, 2011, EUR NEUROL, V65, P317, DOI 10.1159/000323424; Gatti A, 2009, EUR NEUROL, V61, P129, DOI 10.1159/000186502; Gordon Jason, 2012, J Med Econ, V15, P207, DOI 10.3111/13696998.2011.632797; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Irving GA, 2005, NEUROLOGY, V64, pS21, DOI 10.1212/WNL.64.12_suppl_3.S21; Klepstad P, 2004, ACTA ANAESTH SCAND, V48, P1232, DOI 10.1111/j.1399-6576.2004.00517.x; Negri E, 2002, Minerva Anestesiol, V68, P95; PORTENOY RK, 1998, OXFORD TXB PALLIATIV, P361; SIMON R, 1985, CANCER TREAT REP, V69, P1375; Stamer UM, 2007, CURR OPIN ANESTHESIO, V20, P478, DOI 10.1097/ACO.0b013e3282ef6b2c	21	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59981	10.1371/journal.pone.0059981	http://dx.doi.org/10.1371/journal.pone.0059981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577077	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800020
J	Lenormand, C; Spiegelhalter, C; Cinquin, B; Bardin, S; Bausinger, H; Angenieux, C; Eckly, A; Proamer, F; Wall, D; Lich, B; Tourne, S; Hanau, D; Schwab, Y; Salamero, J; de la Salle, H				Lenormand, Cedric; Spiegelhalter, Coralie; Cinquin, Bertrand; Bardin, Sabine; Bausinger, Huguette; Angenieux, Catherine; Eckly, Anita; Proamer, Fabienne; Wall, David; Lich, Ben; Tourne, Sylvie; Hanau, Daniel; Schwab, Yannick; Salamero, Jean; de la Salle, Henri			Birbeck Granule-Like "Organized Smooth Endoplasmic Reticulum" Resulting from the Expression of a Cytoplasmic YFP-Tagged Langerin	PLOS ONE			English	Article							CELL-MEMBRANE ORGANIZATION; GREEN-FLUORESCENT PROTEIN; CUBIC MEMBRANES; T-CELLS; MECHANISM; CISTERNAE; AEQUOREA; ANTIGENS; RECEPTOR; VIRUS	Langerin is required for the biogenesis of Birbeck granules (BGs), the characteristic organelles of Langerhans cells. We previously used a Langerin-YFP fusion protein having a C-terminal luminal YFP tag to dynamically decipher the molecular and cellular processes which accompany the traffic of Langerin. In order to elucidate the interactions of Langerin with its trafficking effectors and their structural impact on the biogenesis of BGs, we generated a YFP-Langerin chimera with an N-terminal, cytosolic YFP tag. This latter fusion protein induced the formation of YFP-positive large puncta. Live cell imaging coupled to a fluorescence recovery after photobleaching approach showed that this coalescence of proteins in newly formed compartments was static. In contrast, the YFP-positive structures present in the pericentriolar region of cells expressing Langerin-YFP chimera, displayed fluorescent recovery characteristics compatible with active membrane exchanges. Using correlative light-electron microscopy we showed that the coalescent structures represented highly organized stacks of membranes with a pentalaminar architecture typical of BGs. Continuities between these organelles and the rough endoplasmic reticulum allowed us to identify the stacks of membranes as a form of "Organized Smooth Endoplasmic Reticulum" (OSER), with distinct molecular and physiological properties. The involvement of homotypic interactions between cytoplasmic YFP molecules was demonstrated using an A206K variant of YFP, which restored most of the Langerin traffic and BG characteristics observed in Langerhans cells. Mutation of the carbohydrate recognition domain also blocked the formation of OSER. Hence, a "double-lock" mechanism governs the behavior of YFP-Langerin, where asymmetric homodimerization of the YFP tag and homotypic interactions between the lectin domains of Langerin molecules participate in its retention and the subsequent formation of BG-like OSER. These observations confirm that BG-like structures appear wherever Langerin accumulates and confirm that membrane trafficking effectors dictate their physiology and, illustrate the importance of molecular interactions in the architecture of intracellular membranes.	[Lenormand, Cedric; Bausinger, Huguette; Angenieux, Catherine; Eckly, Anita; Proamer, Fabienne; Hanau, Daniel; de la Salle, Henri] Inst Natl Sante & Rech Med, Unite Mixte Rech Sante 725, Strasbourg, France; [Lenormand, Cedric; Bausinger, Huguette; Angenieux, Catherine; Eckly, Anita; Proamer, Fabienne; Hanau, Daniel; de la Salle, Henri] Univ Strasbourg, Strasbourg, France; [Lenormand, Cedric; Bausinger, Huguette; Angenieux, Catherine; Proamer, Fabienne; Tourne, Sylvie; Hanau, Daniel; de la Salle, Henri] Etab Francais Sang Alsace, Histocompatibil Lab, Strasbourg, France; [Spiegelhalter, Coralie; Schwab, Yannick] Inst Genet & Biol Mol & Cellulaire, Imaging Ctr, Illkirch Graffenstaden, France; [Cinquin, Bertrand; Bardin, Sabine; Salamero, Jean] Inst Curie, Mol Mech Intracellular Transport Lab, Unite Mixte Rech 144, Ctr Natl Rech Sci, Paris, France; [Cinquin, Bertrand; Salamero, Jean] BioImaging Cell Inst Curie, Cell & Tissue Imaging Facil, Paris, France; [Cinquin, Bertrand; Salamero, Jean] Inst Curie, Tissue Core Facil, Paris, France; [Cinquin, Bertrand; Salamero, Jean] Inst Curie, Nikon Imaging Ctr, Unite Mixte Rech 144, Ctr Natl Rech Sci, Paris, France; [Cinquin, Bertrand] Soleil Synchrotron, Gif Sur Yvette, France; [Eckly, Anita] Inst Natl Sante & Rech Med, Unite Mixte Rech Sante 949, Strasbourg, France; [Wall, David; Lich, Ben] FEI Co, Eindhoven, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Sorbonne Universite; SOLEIL Synchrotron; Institut National de la Sante et de la Recherche Medicale (Inserm); Thermo Fisher Scientific; FEI Company	de la Salle, H (corresponding author), Inst Natl Sante & Rech Med, Unite Mixte Rech Sante 725, Strasbourg, France.	henri.delasalle@efs-alsace.fr	De La Salle, Henri/H-9353-2016	De La Salle, Henri/0000-0001-5136-0776; Schwab, Yannick/0000-0001-8027-1836; Spiegelhalter, Coralie/0000-0001-6372-1647; salamero, jean/0000-0002-2610-5826; Lenormand, Cedric/0000-0003-0501-5212; Eckly, Anita/0000-0001-9620-4961	EFS-Alsace; ARMESA (Association de Recherche et de Developpement en Medecine et Sante Publique); Canceropole de la region ile de France; Synchrotron Soleil grant; Nikon S.A.; Roper Scientific S.A.S	EFS-Alsace; ARMESA (Association de Recherche et de Developpement en Medecine et Sante Publique); Canceropole de la region ile de France(Region Ile-de-France); Synchrotron Soleil grant; Nikon S.A.; Roper Scientific S.A.S	This work was supported by EFS-Alsace and grants from ARMESA (Association de Recherche et de Developpement en Medecine et Sante Publique) to (C.L.). This work was partly funded by the "Canceropole de la region ile de France" (www.canceropole-idf.fr). B.C. was a recipient of a Synchrotron Soleil grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Ben Lich and David Wall are employed by FEI; own shares in the company and FEI holds patents where Ben Lich is one of the inventors. J. Salamero is heading the 9th Nikon Imaging Center on the behalf of his own academic institution (Roper Scientific S.A.S is a corporate partner of the NIC). While the authors constantly receive support from private companies Nikon S.A. and Roper Scientific S.A.S, this does not concern any activities such as employment, consultancy, patents, products in development etc. The authors simply acknowledge these companies who make it possible to use their microscopes for free in an open core facility, for academic research teams. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Almsherqi ZA, 2006, J CELL BIOL, V173, P839, DOI 10.1083/jcb.200603055; Almsherqi ZA, 2009, INT REV CEL MOL BIO, V274, P275, DOI 10.1016/S1937-6448(08)02006-6; BIRBECK MS, 1961, J INVEST DERMATOL, V37, P51, DOI 10.1038/jid.1961.80; Boulanger J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013190; Fasana E, 2010, FASEB J, V24, P1419, DOI 10.1096/fj.09-147850; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; Gidon A, 2012, TRAFFIC, V13, P815, DOI 10.1111/j.1600-0854.2012.01354.x; HANAU D, 1988, J INVEST DERMATOL, V90, P298, DOI 10.1111/1523-1747.ep12456083; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Korkhov VM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-59; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lingwood D, 2009, J BIOL CHEM, V284, P12041, DOI 10.1074/jbc.M900220200; MACKENSEN A, 1993, CANCER RES, V53, P3569; Mc Dermott R, 2002, MOL BIOL CELL, V13, P317, DOI 10.1091/mbc.01-06-0300; McDermott R, 2004, J INVEST DERMATOL, V123, P72, DOI 10.1111/j.0022-202X.2004.22728.x; Mullin NP, 1997, J BIOL CHEM, V272, P5668, DOI 10.1074/jbc.272.9.5668; PARRISH ML, 1995, MOL BIOL CELL, V6, P1535, DOI 10.1091/mbc.6.11.1535; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Snapp EL, 2009, TRENDS CELL BIOL, V19, P649, DOI 10.1016/j.tcb.2009.08.002; Spiegelhalter C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009014; Thepaut M, 2009, BIOCHEMISTRY-US, V48, P2684, DOI 10.1021/bi802151w; Uzan-Gafsou S, 2007, MOL BIOL CELL, V18, P3169, DOI 10.1091/mbc.E06-09-0779; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; van der Vlist M, 2011, EUR J IMMUNOL, V41, P2619, DOI 10.1002/eji.201041305; Verdijk P, 2005, J INVEST DERMATOL, V124, P714, DOI 10.1111/j.0022-202X.2005.23645.x; Volkova EG, 2012, BIOL OPEN, V1, P802, DOI 10.1242/bio.20121537; Windsor M, 2012, TRAFFIC, V13, P30, DOI 10.1111/j.1600-0854.2011.01293.x; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	31	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60813	10.1371/journal.pone.0060813	http://dx.doi.org/10.1371/journal.pone.0060813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577166	Green Published, gold			2022-12-27	WOS:000319109800104
J	Miyanishi, T; Sumiyoshi, T; Higuchi, Y; Seo, T; Suzuki, M				Miyanishi, Tomohiro; Sumiyoshi, Tomiki; Higuchi, Yuko; Seo, Tomonori; Suzuki, Michio			LORETA Current Source Density for Duration Mismatch Negativity and Neuropsychological Assessment in Early Schizophrenia	PLOS ONE			English	Article							VERBAL MEMORY; GRAY-MATTER; DEFICITS; 1ST-EPISODE; PSYCHOSIS; SYMPTOMS; MRI; MMN; COGNITION; VOLUME	Introduction: Patients with schizophrenia elicit cognitive decline from the early phase of the illness. Mismatch negativity (MMN) has been shown to be associated with cognitive function. We investigated the current source density of duration mismatch negativity (dMMN), by using low-resolution brain electromagnetic tomography (LORETA), and neuropsychological performance in subjects with early schizophrenia. Methods: Data were obtained from 20 patients meeting DSM-IV criteria for schizophrenia or schizophreniform disorder, and 20 healthy control (HC) subjects. An auditory odd-ball paradigm was used to measure dMMN. Neuropsychological performance was evaluated by the brief assessment of cognition in schizophrenia Japanese version (BACS-J). Results: Patients showed smaller dMMN amplitudes than those in the HC subjects. LORETA current density for dMMN was significantly lower in patients compared to HC subjects, especially in the temporal lobes. dMMN current density in the frontal lobe was positively correlated with working memory performance in patients. Conclusions: This is the first study to identify brain regions showing smaller dMMN current density in early schizophrenia. Further, poor working memory was associated with decreased dMMN current density in patients. These results are likely to help understand the neural basis for cognitive impairment of schizophrenia.	[Miyanishi, Tomohiro; Sumiyoshi, Tomiki; Higuchi, Yuko; Seo, Tomonori; Suzuki, Michio] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neuropsychiat, Toyama 930, Japan	University of Toyama	Sumiyoshi, T (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neuropsychiat, Toyama 930, Japan.	tomikisumiyoshi840@hotmail.com	Sumiyoshi, Tomiki/K-4507-2019		Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare, Japan; SENSHIN Medical Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	This work was supported by grants-in-aid for Scientific Research from Japan Society for the Promotion of Science, grants-in-aid from the Ministry of Health, Labour and Welfare, Japan, and SENSHIN Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Andreasen N C, 1990, Mod Probl Pharmacopsychiatry, V24, P73; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Fujiwara H, 2007, NEUROIMAGE, V36, P1236, DOI 10.1016/j.neuroimage.2007.03.068; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hermens DF, 2010, PROG NEURO-PSYCHOPH, V34, P822, DOI 10.1016/j.pnpbp.2010.03.019; Higuchi Y, 2008, SCHIZOPHR RES, V101, P320, DOI 10.1016/j.schres.2008.01.020; Higuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054080; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Itoh T, 2011, NEUROSCI RES, V70, P442, DOI 10.1016/j.neures.2011.05.003; Kaneda Y, 2007, PSYCHIAT CLIN NEUROS, V61, P602, DOI 10.1111/j.1440-1819.2007.01725.x; Kawasaki Y, 2007, SCHIZOPHR RES, V94, P164, DOI 10.1016/j.schres.2007.04.015; Keefe RSE, 2006, SCHIZOPHR RES, V88, P26, DOI 10.1016/j.schres.2006.06.041; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Kircher TTJ, 2004, AM J PSYCHIAT, V161, P294, DOI 10.1176/appi.ajp.161.2.294; Krabbendam L, 2000, J NEUROPSYCH CLIN N, V12, P251, DOI 10.1176/appi.neuropsych.12.2.251; Kuroki N, 2006, AM J PSYCHIAT, V163, P2103, DOI 10.1176/appi.ajp.163.12.2103; Leung S, 2007, PSYCHOPHARMACOLOGY, V194, P443, DOI 10.1007/s00213-007-0865-1; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Lin YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034454; Mechelli A, 2011, ARCH GEN PSYCHIAT, V68, P489, DOI 10.1001/archgenpsychiatry.2011.42; Mondragon-Maya A, 2011, ACTAS ESP PSIQUIATRI, V39, P363; Naatanen R, 2011, BRAIN, V134, P3432, DOI 10.1093/brain/awr064; Nestor PG, 2007, SCHIZOPHR RES, V91, P103, DOI 10.1016/j.schres.2006.11.025; Park HJ, 2002, HUM BRAIN MAPP, V17, P168, DOI 10.1002/hbm.10059; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; Rasser PE, 2011, SCHIZOPHRENIA BULL, V37, P131, DOI 10.1093/schbul/sbp060; Rissling AJ, 2012, CLIN NEUROPHYSIOL, V123, P1942, DOI 10.1016/j.clinph.2012.02.079; SHELLEY AM, 1991, BIOL PSYCHIAT, V30, P1059, DOI 10.1016/0006-3223(91)90126-7; Shin KS, 2009, BIOL PSYCHIAT, V65, P1071, DOI 10.1016/j.biopsych.2008.12.024; Sumiyoshi T, 2006, PROG NEURO-PSYCHOPH, V30, P733, DOI 10.1016/j.pnpbp.2005.11.031; Sumiyoshi T, 2004, NEUROSCI LETT, V364, P124, DOI 10.1016/j.neulet.2004.04.027; Sumiyoshi T, 2006, PROG NEURO-PSYCHOPH, V30, P1299, DOI 10.1016/j.pnpbp.2006.04.028; Sumiyoshi T, 2009, PSYCHIAT RES-NEUROIM, V172, P180, DOI 10.1016/j.pscychresns.2008.07.005; Suzuki M, 2005, BRAIN, V128, P2109, DOI 10.1093/brain/awh554; Szeszko PR, 2002, AM J PSYCHIAT, V159, P217, DOI 10.1176/appi.ajp.159.2.217; Takahashi H, 2013, NEUROIMAGE, V66, P594, DOI 10.1016/j.neuroimage.2012.09.074; Talairach J., 1988, COPLANAR STEREOTAXIC; TOWLE VL, 1993, ELECTROEN CLIN NEURO, V86, P1, DOI 10.1016/0013-4694(93)90061-Y; Toyomaki A, 2008, PROG NEURO-PSYCHOPH, V32, P95, DOI 10.1016/j.pnpbp.2007.07.020; Wynn JK, 2010, BIOL PSYCHIAT, V67, P940, DOI 10.1016/j.biopsych.2009.11.024	45	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61152	10.1371/journal.pone.0061152	http://dx.doi.org/10.1371/journal.pone.0061152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577204	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800127
J	Liu, JY; Zhang, MX; Niu, C; Luo, ZX; Dai, JH; Wang, LJ; Liu, EM; Fu, Z				Liu, Jingyue; Zhang, Mingxiang; Niu, Chao; Luo, Zhengxiu; Dai, Jihong; Wang, Lijia; Liu, Enmei; Fu, Zhou			Dexamethasone Inhibits Repair of Human Airway Epithelial Cells Mediated by Glucocorticoid-Induced Leucine Zipper (GILZ)	PLOS ONE			English	Article							APOPTOSIS; PATHWAYS; RECEPTOR; BINDING; GENE	Background: Glucocorticoids (GCs) are a first-line treatment for asthma for their anti-inflammatory effects, but they also hinder the repair of airway epithelial injury. The anti-inflammatory protein GC-induced leucine zipper (GILZ) is reported to inhibit the activation of the mitogen-activated protein kinase (MAPK)-extracellular-signal-regulated kinase (ERK) signaling pathway, which promotes the repair of airway epithelial cells around the damaged areas. We investigated whether the inhibition of airway epithelial repair imposed by the GC dexamethasone (DEX) is mediated by GILZ. Methods: We tested the effect of DEX on the expressions of GILZ mRNA and GILZ protein and the MAPK-ERK signaling pathway in human airway epithelial cells, via RT-PCR and Western blot. We further evaluated the role of GILZ in mediating the effect of DEX on the MAPK-ERK signaling pathway and in airway epithelium repair by utilizing small-interfering RNAs, MTT, CFSE labeling, wound-healing and cell migration assays. Results: DEX increased GILZ mRNA and GILZ protein levels in a human airway epithelial cell line. Furthermore, DEX inhibited the phosphorylation of Raf-1, Mek1/2, Erk1/2 (components of the MAPK-ERK signaling pathway), proliferation and migration. However, the inhibitory effect of DEX was mitigated in cells when the GILZ gene was silenced. Conclusions: The inhibition of epithelial injury repair by DEX is mediated in part by activation of GILZ, which suppressed activation of the MAPK-ERK signaling pathway, proliferation and migration. Our study implicates the involvement of DEX in this process, and furthers our understanding of the dual role of GCs.	[Liu, Jingyue; Zhang, Mingxiang; Niu, Chao; Luo, Zhengxiu; Dai, Jihong; Liu, Enmei; Fu, Zhou] Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China; [Liu, Jingyue; Niu, Chao; Luo, Zhengxiu; Dai, Jihong; Wang, Lijia; Liu, Enmei; Fu, Zhou] Chongqing Med Univ, Childrens Hosp, Key Lab Child Dev & Disorders, Minist Educ,Resp Res Lab, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Fu, Z (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China.	fu_zhou79@yahoo.com.cn			National Natural Science Foundation of China [81070014]; Chongqing Municipal Health Bureau [2010-1-46]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Municipal Health Bureau	This work was supported by grants from the National Natural Science Foundation of China (number 81070014) and Chongqing Municipal Health Bureau (number 2010-1-46). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barbato A, 2006, AM J RESP CRIT CARE, V174, P975, DOI 10.1164/rccm.200602-189OC; Barnes PJ, 2003, ANN INTERN MED, V139, P359, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00012; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Dorscheid DR, 2006, AM J PHYSIOL-LUNG C, V291, pL794, DOI 10.1152/ajplung.00322.2005; Dorscheid DR, 2001, AM J RESP CRIT CARE, V164, P1939, DOI 10.1164/ajrccm.164.10.2103013; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; ELIAS JA, 1994, J BIOL CHEM, V269, P22261; Freishtat RJ, 2011, AM J RESP CELL MOL, V44, P863, DOI 10.1165/rcmb.2010-0029OC; Godot V, 2006, ALLERGY, V61, P886, DOI 10.1111/j.1398-9995.2006.01065.x; Gomez M, 2010, J IMMUNOL, V184, P5715, DOI 10.4049/jimmunol.0903521; Grugan KD, 2008, J STEROID BIOCHEM, V110, P244, DOI 10.1016/j.jsbmb.2007.11.003; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Kardos Zsuzsanna, 2012, Acta Pharm Hung, V82, P33; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Koberle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040730; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Spangler Dennis L, 2012, Am J Manag Care, V18, pS35; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; van der Laan S, 2008, J NEUROCHEM, V106, P2515, DOI 10.1111/j.1471-4159.2008.05575.x; Wadsworth SJ, 2006, J CLIN IMMUNOL, V26, P376, DOI 10.1007/s10875-006-9029-z; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200	32	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60705	10.1371/journal.pone.0060705	http://dx.doi.org/10.1371/journal.pone.0060705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573276	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100096
J	Wong, GKC; Lam, SW; Wong, A; Ngai, K; Poon, WS; Mok, V				Wong, George Kwok Chu; Lam, Sandy Wai; Wong, Adrian; Ngai, Karine; Poon, Wai Sang; Mok, Vincent			Comparison of Montreal Cognitive Assessment and Mini-Mental State Examination in Evaluating Cognitive Domain Deficit Following Aneurysmal Subarachnoid Haemorrhage	PLOS ONE			English	Article							NEUROPSYCHOLOGICAL OUTCOMES; IMPAIRMENT; STROKE; DYSFUNCTION; PREVALENCE; TESTS	Objective: Cognitive deficits are common after aneurysmal subarachnoid haemorrhage (aSAH), and clinical evaluation is important for their management. Our hypothesis was that the Montreal Cognitive Assessment (MoCa) is superior to the Mini-Mental State Examination (MMSE) in screening for cognitive domain deficit in aSAH patients. Methods: We carried out a prospective observational and diagnostic accuracy study on Hong Kong aSAH patients aged 21 to 75 years who had been admitted within 96 hours of ictus. The domain-specific neuropsychological assessment battery, the MoCA and MMSE were administered 2-4 weeks and 1 year after ictus. A cognitive domain deficit was defined as a cognitive domain z score <-1.65 (below the fifth percentile). Cognitive impairment was defined as two or more cognitive domain deficits. The study is registered at ClinicalTrials.gov of the US National Institutes of Health (NCT01038193). Results: Both the MoCA and the MMSE were successful in differentiating between patients with and without cognitive domain deficits and cognitive impairment at both assessment periods. At 1 year post-ictus, the MoCA produced higher area under the curve scores for cognitive impairment than the MMSE (MoCA, 0.92; 95% CI, 0.83 to 0.97 versus MMSE, 0.77; 95% CI, 0.66 to 0.83, p = 0.009). Interpretation: Cognitive domain deficits and cognitive impairment in patients with aSAH can be screened with the MoCA in both the subacute and chronic phases.	[Wong, George Kwok Chu; Lam, Sandy Wai; Ngai, Karine; Poon, Wai Sang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China; [Mok, Vincent] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Div Neurol, Hong Kong, Hong Kong, Peoples R China; [Wong, Adrian] Hong Kong Inst Educ, Dept Psychol Studies, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Education University of Hong Kong (EdUHK)	Wong, GKC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China.	georgewong@surgery.cuhk.edu.hk	Poon, Wai S/HGD-3084-2022; Mok, Vincent/N-6421-2015; Wong, George Kwok Chu/L-4344-2016; Wong, George KC/A-6378-2011; Poon, Wai Sang/F-1558-2011; Wong, Adrian/K-4859-2014	Mok, Vincent/0000-0002-8102-8835; Wong, George KC/0000-0002-6078-2548; Wong, Adrian/0000-0002-7859-3956				Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Chan A, 2002, EUR NEUROL, V47, P37, DOI 10.1159/000047945; Chan A.S., 1999, HONG KONG LIST LEARN; Chau PH, 2011, CEREBROVASC DIS, V31, P138, DOI 10.1159/000321734; Chiu H., 1994, HONG KONG J PSYCH S2, V4, P25; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Cumming TB, 2011, STROKE, V42, P2642, DOI 10.1161/STROKEAHA.111.619486; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dong YH, 2012, J NEUROL NEUROSUR PS, V83, P580, DOI 10.1136/jnnp-2011-302070; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Hua M., 2005, WECHSLER MEMORY SCAL, V3; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P529, DOI 10.1076/1380-3395(200008)22:4;1-0;FT529; Mayer SA, 2002, NEUROLOGY, V59, P1750, DOI 10.1212/01.WNL.0000035748.91128.C2; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Passier PECA, 2012, NEUROREHABILITATION, V30, P137, DOI 10.3233/NRE-2012-0737; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Schweizer TA, 2012, J NEUROL SCI, V316, P137, DOI 10.1016/j.jns.2012.01.003; Scott RB, 2010, STROKE, V41, P1743, DOI 10.1161/STROKEAHA.110.585240; Scott RB, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-13; Smith A., 1982, SYMBOL DIGIT MODALIT; Tasi C. H., 2011, INT S QUAL EL DES IS, P1; Tham W, 2002, J NEUROL SCI, V203, P49, DOI 10.1016/S0022-510X(02)00260-5; Wong GKC, 2009, ACTA NEUROCHIR, V151, P1601, DOI 10.1007/s00701-009-0425-z; Wong GKC, 2012, J NEUROL NEUROSUR PS, V83, P1112, DOI 10.1136/jnnp-2012-302217; Wong GKC, 2012, ACTA NEUROCHIR, V154, P105, DOI 10.1007/s00701-011-1198-8; Wong GKC, 2011, HONG KONG J OCCUP TH, V21, P27, DOI 10.1016/j.hkjot.2011.05.004; Wong GKC, 2010, J NEUROL SCI, V299, P5, DOI 10.1016/j.jns.2010.08.059; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zadikoff C, 2008, MOVEMENT DISORD, V23, P297, DOI 10.1002/mds.21837	32	48	51	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59946	10.1371/journal.pone.0059946	http://dx.doi.org/10.1371/journal.pone.0059946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23573223	Green Submitted, gold, Green Published			2022-12-27	WOS:000318840100035
J	Burke, C; Liu, M; Britton, W; Triccas, JA; Thomas, T; Smith, AL; Allen, S; Salomon, R; Harry, E				Burke, Catherine; Liu, Michael; Britton, Warwick; Triccas, James A.; Thomas, Torsten; Smith, Adrian L.; Allen, Steven; Salomon, Robert; Harry, Elizabeth			Harnessing Single Cell Sorting to Identify Cell Division Genes and Regulators in Bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHROMOSOME SEGREGATION; ELEMENT E14; FTSZ; PROTEIN; FILAMENTATION; INHIBITION; EXPRESSION; SYSTEM; SITE	Cell division is an essential cellular process that requires an array of known and unknown proteins for its spatial and temporal regulation. Here we develop a novel, high-throughput screening method for the identification of bacterial cell division genes and regulators. The method combines the over-expression of a shotgun genomic expression library to perturb the cell division process with high-throughput flow cytometry sorting to screen many thousands of clones. Using this approach, we recovered clones with a filamentous morphology for the model bacterium, Escherichia coli. Genetic analysis revealed that our screen identified both known cell division genes, and genes that have not previously been identified to be involved in cell division. This novel screening strategy is applicable to a wide range of organisms, including pathogenic bacteria, where cell division genes and regulators are attractive drug targets for antibiotic development.	[Burke, Catherine; Liu, Michael; Harry, Elizabeth] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Britton, Warwick; Triccas, James A.; Smith, Adrian L.; Allen, Steven; Salomon, Robert] Univ Sydney, Centenary Inst Canc Med & Cell Biol, Sydney, NSW 2006, Australia; [Britton, Warwick; Triccas, James A.; Smith, Adrian L.; Allen, Steven; Salomon, Robert] Univ Sydney, Dept Infect Dis & Immunol, Sydney, NSW 2006, Australia; [Thomas, Torsten] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Thomas, Torsten] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia	University of Technology Sydney; University of Sydney; Centenary Institute; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Burke, C (corresponding author), Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia.	Catherine.Burke@uts.edu.au	Harry, Liz/AAT-9396-2020; Harry, Elizabeth/G-8123-2017; Burke, Catherine/C-5664-2014; Salomon, Robert/K-8448-2019; Triccas, Jamie/AAD-7629-2020	Britton, Warwick/0000-0001-6721-9646; Burke, Catherine/0000-0002-8917-0019; Smith, Adrian/0000-0002-0505-0344; Triccas, James/0000-0003-3730-2339; Harry, Elizabeth/0000-0003-0858-9473	Australian Research Council [DP1026388]	Australian Research Council(Australian Research Council)	This work was funded by the Australian Research Council (www.arc.gov.au), discovery grant DP1026388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Ammendola A, 1998, FEMS MICROBIOL LETT, V164, P69, DOI 10.1016/S0378-1097(98)00197-9; Arends SJR, 2010, J BACTERIOL, V192, P242, DOI 10.1128/JB.01244-09; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becton DaC, 2003, BD FACSARIA US GUID; BELAS MR, 1982, J BACTERIOL, V150, P956, DOI 10.1128/JB.150.2.956-959.1982; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Chen K, 2005, ANTIMICROB AGENTS CH, V49, P1002, DOI 10.1128/AAC.49.3.1002-1009.2005; Chien AC, 2012, CURR BIOL, V22, pR340, DOI 10.1016/j.cub.2012.02.032; Corno G, 2006, APPL ENVIRON MICROB, V72, P78, DOI 10.1128/AEM.72.1.78-86.2006; DAI K, 1991, J BACTERIOL, V173, P3500, DOI 10.1128/jb.173.11.3500-3506.1991; DAI K, 1992, J BACTERIOL, V174, P6145, DOI 10.1128/JB.174.19.6145-6151.1992; Datta P, 2010, PLOS ONE, V5; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; Draper GC, 1998, J BACTERIOL, V180, P4621, DOI 10.1128/JB.180.17.4621-4627.1998; England K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-79; de Oliveira IFF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012048; FRANDSEN N, 1993, MOL GEN GENET, V240, P348, DOI 10.1007/BF00280385; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Harms A, 2012, MOL MICROBIOL; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; Hoffman R.A., 2009, CURR PROTOC CYTOM; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Khlebnikov A, 2000, J BACTERIOL, V182, P7029, DOI 10.1128/JB.182.24.7029-7034.2000; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; LAUDER SD, 1993, J MOL BIOL, V234, P72, DOI 10.1006/jmbi.1993.1564; Li ZR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001411; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Lopez-Garrido J, 2010, GUT MICROBES, V1, P285, DOI 10.4161/gmic.1.4.12079; Lutkenhaus J, 1998, CURR OPIN MICROBIOL, V1, P210, DOI 10.1016/S1369-5274(98)80013-1; LYNGSTADAAS A, 1995, MOL GEN GENET, V247, P546, DOI 10.1007/BF00290345; Ma S, 2012, CHEMMEDCHEM, V7, P1161, DOI 10.1002/cmdc.201200156; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Mellies JL, 2007, J BACTERIOL, V189, P2863, DOI 10.1128/JB.01859-06; Modell JW, 2011, GENE DEV, V25, P1328, DOI 10.1101/gad.2038911; Pearson MM, 2010, INFECT IMMUN, V78, P2834, DOI 10.1128/IAI.01222-09; PLASTERK RHA, 1985, EMBO J, V4, P237, DOI 10.1002/j.1460-2075.1985.tb02341.x; Pogliano J, 1997, P NATL ACAD SCI USA, V94, P559, DOI 10.1073/pnas.94.2.559; Resina-Pelfort O, 2001, SYST APPL MICROBIOL, V24, P31, DOI 10.1078/0723-2020-00003; Rodrigues CDA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002561; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Sambrook J., 2001, MOL CLONING LAB MANU; Saville SP, 2006, ANTIMICROB AGENTS CH, V50, P3312, DOI 10.1128/AAC.00628-06; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Stokes NR, 2012, ANTIMICROB AGENTS CH; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Uehara T, 2011, CURR OPIN MICROBIOL, V14, P698, DOI 10.1016/j.mib.2011.10.003; van Dijk MA, 2010, CYTOM PART A, V77A, P911, DOI 10.1002/cyto.a.20946; VANDEPUTTE P, 1964, MUTAT RES, V1, P121, DOI 10.1016/0027-5107(64)90014-4; WARD JE, 1985, CELL, V42, P941, DOI 10.1016/0092-8674(85)90290-9; Willemse J, 2011, GENE DEV, V25, P89, DOI 10.1101/gad.600211; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Wyckoff TJ, 2012, TRENDS MICROBIOL, V20, P540, DOI 10.1016/j.tim.2012.08.003; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105	64	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60964	10.1371/journal.pone.0060964	http://dx.doi.org/10.1371/journal.pone.0060964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565292	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300165
J	Cavallini, C; Lovato, O; Bertolaso, A; Pacelli, L; Zoratti, E; Zanolin, E; Krampera, M; Zamo, A; Tecchio, C; Cassatella, MA; Pizzolo, G; Scupoli, MT				Cavallini, Chiara; Lovato, Ornella; Bertolaso, Anna; Pacelli, Luciano; Zoratti, Elisa; Zanolin, Elisabetta; Krampera, Mauro; Zamo, Alberto; Tecchio, Cristina; Cassatella, Marco A.; Pizzolo, Giovanni; Scupoli, Maria T.			The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells	PLOS ONE			English	Article							DOMAIN-CONTAINING RECEPTOR; ALLERGIC LUNG INFLAMMATION; T-CELL; DEATH-DOMAIN; RHEUMATOID-ARTHRITIS; GAMMA PRODUCTION; DR3; LIGAND; EXPRESSION; APOPTOSIS	Death receptor (DR3) 3 is a member of the TNFR superfamily. Its ligand is TNF-like ligand 1A (TL1A), a member of the TNF superfamily. TL1A/DR3 interactions have been reported to modulate the functions of T cells, NK, and NKT cells and play a crucial role in driving inflammatory processes in several T-cell-dependent autoimmune diseases. However, TL1A expression and effects on B cells remain largely unknown. In this study, we described for the first time that B cells from human blood express significant amounts of DR3 in response to B cell receptor polyclonal stimulation. The relevance of these results has been confirmed by immunofluorescence analysis in tonsil and spleen tissue specimens, which showed the in situ expression of DR3 in antigen-stimulated B cells in vivo. Remarkably, we demonstrated that TL1A reduces B-cell proliferation induced by anti-IgM-antibodies and IL-2 but did not affect B-cell survival, suggesting that TL1A inhibits the signal(s) important for B-cell proliferation. These results revealed a novel function of TL1A in modulating B-cell proliferation in vitro and suggest that TL1A may contribute to homeostasis of effector B-cell functions in immune response and host defense, thus supporting the role of the TL1A/DR3 functional axis in modulating the adaptive immune response.	[Cavallini, Chiara; Lovato, Ornella; Pacelli, Luciano; Zoratti, Elisa; Krampera, Mauro; Tecchio, Cristina; Pizzolo, Giovanni; Scupoli, Maria T.] Univ Verona, Dept Med, Sect Hematol, I-37100 Verona, Italy; [Cavallini, Chiara; Lovato, Ornella; Scupoli, Maria T.] Univ Verona, Interdept Lab Med Res LURM, I-37100 Verona, Italy; [Bertolaso, Anna; Zamo, Alberto] Univ Verona, Dept Pathol & Diagnost, Sect Pathol Anat, I-37100 Verona, Italy; [Zoratti, Elisa; Scupoli, Maria T.] Univ Verona, Appl Res Canc Network ARC NET, I-37100 Verona, Italy; [Zanolin, Elisabetta] Univ Verona, Dept Med & Publ Hlth, Sect Epidemiol & Med Stat, I-37100 Verona, Italy; [Cassatella, Marco A.] Univ Verona, Dept Pathol & Diagnost, Sect Gen Pathol, I-37100 Verona, Italy	University of Verona; University of Verona; University of Verona; University of Verona; University of Verona; University of Verona	Scupoli, MT (corresponding author), Univ Verona, Dept Med, Sect Hematol, I-37100 Verona, Italy.	mariateresa.scupoli@univr.it	Cassatella, M A/B-8037-2013; SCUPOLI, Maria/AAX-9712-2021; KRAMPERA, MAURO/K-5596-2018; Zamò, Alberto/ABF-4436-2020; tecchio, cristina/GRX-9586-2022	Cassatella, M A/0000-0001-7824-1806; SCUPOLI, Maria/0000-0002-3352-7859; Zamo, Alberto/0000-0001-6203-7966; KRAMPERA, Mauro/0000-0002-7280-2040; Cavallini, Chiara/0000-0002-2470-0162	Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno e Ancona; Associazione Italiana Ricerca sul Cancro (AIRC) [6599]; Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno, e Ancona [2008.14.44]	Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno e Ancona(Fondazione Cariverona); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno, e Ancona(Fondazione Cariverona)	This study was granted by Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno e Ancona and Associazione Italiana Ricerca sul Cancro (AIRC) (grant #6599) and Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno, e Ancona (grant #2008.14.44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Buchan SL, 2012, EUR J IMMUNOL, V42, P580, DOI 10.1002/eji.201041950; Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Gout S, 2006, CANCER RES, V66, P9117, DOI 10.1158/0008-5472.CAN-05-4605; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Heidemann SC, 2010, J CLIN IMMUNOL, V30, P531, DOI 10.1007/s10875-010-9382-9; Jin T, 2007, BIOCHEM BIOPH RES CO, V364, P1, DOI 10.1016/j.bbrc.2007.09.097; Jones GW, 2011, FASEB J, V25, P409, DOI 10.1096/fj.10-166843; Kamada N, 2010, INFLAMM BOWEL DIS, V16, P568, DOI 10.1002/ibd.21124; Kim S, 2005, J IMMUNOL METHODS, V298, P1, DOI 10.1016/j.jim.2004.12.019; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Mainiero F, 1998, J EXP MED, V188, P1267, DOI 10.1084/jem.188.7.1267; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Meylan F, 2011, MUCOSAL IMMUNOL, V4, P172, DOI 10.1038/mi.2010.67; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Meylan F, 2011, IMMUNOL REV, V244, P188, DOI 10.1111/j.1600-065X.2011.01068.x; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; Schreiber TH, 2010, J CLIN INVEST, V120, P3629, DOI 10.1172/JCI42933; Screaton GR, 1997, P NATL ACAD SCI USA, V94, P4615, DOI 10.1073/pnas.94.9.4615; Tan KB, 1997, GENE, V204, P35, DOI 10.1016/S0378-1119(97)00509-X; Taraban VY, 2011, MUCOSAL IMMUNOL, V4, P186, DOI 10.1038/mi.2010.70; Tian F, 2007, J IMMUNOL, V179, P3742, DOI 10.4049/jimmunol.179.6.3742; Twohig JP, 2012, FASEB J, V26, P3575, DOI 10.1096/fj.11-200618; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645	35	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60136	10.1371/journal.pone.0060136	http://dx.doi.org/10.1371/journal.pone.0060136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565196	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300065
J	Jacobson-Pick, S; Audet, MC; McQuaid, RJ; Kalvapalle, R; Anisman, H				Jacobson-Pick, Shlomit; Audet, Marie-Claude; McQuaid, Robyn Jane; Kalvapalle, Rahul; Anisman, Hymie			Social Agonistic Distress in Male and Female Mice: Changes of Behavior and Brain Monoamine Functioning in Relation to Acute and Chronic Challenges	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MESSENGER-RNA EXPRESSION; SEX-DIFFERENCES; DEFEAT STRESS; LEARNED HELPLESSNESS; UNPREDICTABLE STRESS; RESTRAINT STRESS; ANIMAL-MODELS; RAT-BRAIN; SWIM TASK	Stressful events promote several neuroendocrine and neurotransmitter changes that might contribute to the provocation of psychological and physical pathologies. Perhaps, because of its apparent ecological validity and its simple application, there has been increasing use of social defeat (resident-intruder) paradigms as a stressor. The frequency of stress-related psychopathology is much greater in females than in males, but the typical resident-intruder paradigm is less useful in assessing stressor effects in females. An alternative, but infrequently used procedure in females involves exposing a mouse to a lactating dam, resulting in threatening gestures being expressed by the resident. In the present investigation we demonstrated the utility of this paradigm, showing that the standard resident-intruder paradigm in males and the modified version in females promoted elevated anxiety in a plus-maze test. The behavioral effects that reflected anxiety were more pronounced 2 weeks after the stressor treatment than they were 2 hr afterward, possibly reflecting the abatement of the stress-related of hyper-arousal. These treatments, like a stressor comprising physical restraint, increased plasma corticosterone and elicited variations of norepinephrine and serotonin levels and turnover within the prefrontal cortex, hippocampus and central amygdala. Moreover, the stressor effects were exaggerated among mice that had been exposed to a chronic or subchronic-intermittent regimen of unpredictable stressors. Indeed, some of the monoamine changes were more pronounced in females than in males, although it is less certain whether this represented compensatory changes to deal with chronic stressors that could result in excessive strain on biological systems (allostatic overload).	[Jacobson-Pick, Shlomit; Audet, Marie-Claude; McQuaid, Robyn Jane; Kalvapalle, Rahul; Anisman, Hymie] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada	Carleton University	Jacobson-Pick, S (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada.	shulamit76@gmail.com	McQuaid, Robyn/ABB-4143-2021		Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The research was supported by the Natural Sciences and Engineering Research Council of Canada. HA holds a Canada Research Chair in Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, STRESS, V13, P356, DOI 10.3109/10253891003667862; Anisman H, 2001, BEHAV NEUROSCI, V115, P443, DOI 10.1037/0735-7044.115.2.443; Anisman H, 2008, PSYCHOPHARMACOLOGY, V199, P231, DOI 10.1007/s00213-008-1166-z; Audet MC, 2010, INT J NEUROPSYCHOPH, V13, P361, DOI 10.1017/S1461145709990174; Barnum CJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-9; Beck KD, 2002, PHYSIOL BEHAV, V75, P661, DOI 10.1016/S0031-9384(02)00670-4; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Berton O, 1998, NEUROSCIENCE, V82, P147; BolanosJimenez F, 1995, EUR J PHARMACOL, V294, P531, DOI 10.1016/0014-2999(95)00590-0; Bowman RE, 2009, PHYSIOL BEHAV, V97, P21, DOI 10.1016/j.physbeh.2009.01.012; Bowman RE, 2005, J NEUROENDOCRINOL, V17, P526, DOI 10.1111/j.1365-2826.2005.01335.x; Buwalda B, 2010, PHYSIOL BEHAV, V101, P719, DOI 10.1016/j.physbeh.2010.08.010; Caramaschi D, 2008, BEHAV BRAIN RES, V189, P263, DOI 10.1016/j.bbr.2008.01.003; Clarke M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044073; Cohen H, 2011, DIS MARKERS, V30, P141, DOI [10.1155/2011/734372, 10.3233/DMA-2011-0778]; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Czeh B, 2010, HIPPOCAMPUS, V20, P174, DOI 10.1002/hipo.20599; Dalla C, 2010, BASIC CLIN PHARMACOL, V106, P226, DOI 10.1111/j.1742-7843.2009.00516.x; Dwivedi Y, 2005, NEUROPHARMACOLOGY, V48, P204, DOI 10.1016/j.neuropharm.2004.10.004; Franklin KB., 1997, STEREOTAXIC ATLAS MO; Galea LAM, 1997, NEUROSCIENCE, V81, P689, DOI 10.1016/S0306-4522(97)00233-9; Gibb J, 2013, BRAIN BEHAV IMMUN, V28, P149, DOI 10.1016/j.bbi.2012.11.004; Goel N, 2010, ENDOCRINOLOGY, V151, P1784, DOI 10.1210/en.2009-1180; Hammack SE, 2012, NEUROPHARMACOLOGY, V62, P565, DOI 10.1016/j.neuropharm.2011.02.024; Hammamieh R, 2012, BEHAV BRAIN RES, V235, P55, DOI 10.1016/j.bbr.2012.07.022; HANEY M, 1993, J COMP PSYCHOL, V107, P373, DOI 10.1037/0735-7036.107.4.373; Harkin A, 2002, J PSYCHOPHARMACOL, V16, P115, DOI 10.1177/026988110201600201; Hayley S, 1999, J NEUROSCI, V19, P5654; HEINRICHS SC, 1992, BRAIN RES, V581, P190, DOI 10.1016/0006-8993(92)90708-H; Holly EN, 2012, PSYCHOPHARMACOLOGY, V224, P179, DOI 10.1007/s00213-012-2846-2; HUHMAN KL, 1991, HORM BEHAV, V25, P206, DOI 10.1016/0018-506X(91)90051-I; Jacobson-Pick S, 2012, NEUROSCIENCE, V215, P114, DOI 10.1016/j.neuroscience.2012.04.038; Jacobson-Pick S, 2011, BEHAV BRAIN RES, V216, P365, DOI 10.1016/j.bbr.2010.08.016; Jacobson-Pick S, 2010, BEHAV BRAIN RES, V214, P268, DOI 10.1016/j.bbr.2010.05.036; Keeney A, 2006, J NEUROENDOCRINOL, V18, P330, DOI 10.1111/j.1365-2826.2006.01422.x; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Koolhaas JM, 1997, ACTA PHYSIOL SCAND, V161, P69; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Luine VN, 2007, J NEUROENDOCRINOL, V19, P743, DOI 10.1111/j.1365-2826.2007.01594.x; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; McQuaid RJ, 2012, INT J NEUROPSYCHOPH, V1, P1; Merali Z, 2004, EUR J NEUROSCI, V20, P229, DOI 10.1111/j.1460-9568.2004.03468.x; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Mitsushima D, 2006, EUR J NEUROSCI, V24, P3245, DOI 10.1111/j.1460-9568.2006.05214.x; Nocjar C, 2012, NEUROSCIENCE, V218, P138, DOI 10.1016/j.neuroscience.2012.05.033; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Ossowska G, 2001, J NEURAL TRANSM, V108, P311, DOI 10.1007/s007020170077; Pitychoutis PM, 2012, NEUROSCIENCE, V210, P152, DOI 10.1016/j.neuroscience.2012.03.003; PRINCE CR, 1986, PHARMACOL BIOCHEM BE, V24, P323, DOI 10.1016/0091-3057(86)90359-X; PRINCE CR, 1984, BEHAV NEURAL BIOL, V42, P99, DOI 10.1016/S0163-1047(84)90942-7; Pulliam JVK, 2010, J PSYCHIATR RES, V44, P106, DOI 10.1016/j.jpsychires.2009.05.005; RODGERS RJ, 1993, PHYSIOL BEHAV, V53, P383, DOI 10.1016/0031-9384(93)90222-2; Rouge-Pont F, 1998, EUR J NEUROSCI, V10, P3903, DOI 10.1046/j.1460-9568.1998.00438.x; SAAL FSV, 1995, PHYSIOL BEHAV, V58, P669, DOI 10.1016/0031-9384(95)00121-X; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; SGOIFO A, 1995, AGGRESSIVE BEHAV, V21, P79, DOI 10.1002/1098-2337(1995)21:1<79::AID-AB2480210110>3.0.CO;2-M; STONE EA, 1987, EUR J PHARMACOL, V141, P347, DOI 10.1016/0014-2999(87)90551-6; Takahashi A., 2012, CURR TOP BEHAV NEURO; Tannenbaum B, 2003, BIOL PSYCHIAT, V53, P292, DOI 10.1016/S0006-3223(02)01487-7; THURMOND JB, 1975, PHYSIOL BEHAV, V14, P879, DOI 10.1016/0031-9384(75)90086-4; Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Wann BP, 2010, HORM BEHAV, V58, P907, DOI 10.1016/j.yhbeh.2010.09.001; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; ZACHARKO RM, 1983, BEHAV BRAIN RES, V9, P129, DOI 10.1016/0166-4328(83)90123-7	68	44	45	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60133	10.1371/journal.pone.0060133	http://dx.doi.org/10.1371/journal.pone.0060133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565195	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300064
J	Patassini, C; Garolla, A; Bottacin, A; Menegazzo, M; Speltra, E; Foresta, C; Ferlin, A				Patassini, Cristina; Garolla, Andrea; Bottacin, Alberto; Menegazzo, Massimo; Speltra, Elena; Foresta, Carlo; Ferlin, Alberto			Molecular Karyotyping of Human Single Sperm by Array-Comparative Genomic Hybridization	PLOS ONE			English	Article							HUMAN SPERMATOZOA; CHROMOSOMAL-ABNORMALITIES; ANEUPLOIDY; CGH	No valid method is currently available to analyze the entire genome of sperm, including aneuploidies and structural chromosomal alterations. Here we describe the optimization and application of array-Comparative Genomic Hybridization (aCGH) on single human sperm. The aCGH procedure involves screening of the entire chromosome complement by DNA microarray allowing having a molecular karyotype, and it is currently used in research and in diagnostic clinical practice (prenatal diagnosis, pre-implantation genetic diagnosis), but it has never been applied on sperm. DNA from single human sperm isolated by micromanipulator was extracted, decondensed and amplified by whole-genome amplification (WGA) and then labeled, hybridized to BAC array, and scanned by microarray scanner. Application of this protocol to 129 single sperm from normozoospermic donors identified 7.8% of sperm with different genetic anomalies, including aneuploidies and gains and losses in different chromosomes (unbalanced sperm). On the contrary, of 130 single sperm from men affected by Hodgkin lymphoma at the end of three months of chemotherapy cycles 23.8% were unbalanced. Validation of the method also included analysis of 43 sperm from a man with a balanced translocation [46, XY, t(2; 12)(p11.2; q24.31)], which showed gains and losses corresponding to the regions involved in the translocation in 18.6% of sperm and alterations in other chromosomes in 16.3% of sperm. Future application of this method might give important information on the biology and pathophysiology of spermatogenesis and sperm chromosome aberrations in normal subjects and in patients at higher risk of producing unbalanced sperm, such as infertile men, carriers of karyotype anomalies, men with advanced age, subjects treated with chemotherapy, and partners of couples with repeated miscarriage and repeated failure during assisted reproduction techniques.	[Ferlin, Alberto] Univ Padua, Dept Mol Med, Sect Clin Pathol, Padua, Italy; Univ Padua, Ctr Human Reprod Pathol, Padua, Italy	University of Padua; University of Padua	Ferlin, A (corresponding author), Univ Padua, Dept Mol Med, Sect Clin Pathol, Padua, Italy.	alberto.ferlin@unipd.it	Ferlin, Alberto/AAO-3541-2020; menegazzo, massimo/AAD-2548-2022; Garolla, Andrea/AAC-4607-2022; Garolla, Andrea/AFS-1388-2022	Ferlin, Alberto/0000-0001-5817-8141; Garolla, Andrea/0000-0003-4736-9051; Garolla, Andrea/0000-0003-4736-9051				Carrell DT, 2003, OBSTET GYNECOL, V101, P1229, DOI 10.1016/S0029-7844(03)00339-9; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Ferlin A, 2005, CYTOGENET GENOME RES, V111, P310, DOI 10.1159/000086905; Ferlin A, 2007, J CLIN ENDOCR METAB, V92, P762, DOI 10.1210/jc.2006-1981; Fiorentino F, 2011, HUM REPROD, V26, P1925, DOI 10.1093/humrep/der082; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold TJ, 1998, CURR TOP DEV BIOL, V37, P383; Jacobs P A, 1992, Oxf Rev Reprod Biol, V14, P47; Roux C, 2005, CYTOGENET GENOME RES, V111, P291, DOI 10.1159/000086902; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Shinawi M, 2008, DRUG DISCOV TODAY, V13, P760, DOI 10.1016/j.drudis.2008.06.007; Templado C, 2005, CYTOGENET GENOME RES, V111, P199, DOI 10.1159/000086890; Templado C, 2011, CYTOGENET GENOME RES, V133, P91, DOI 10.1159/000323795; Templado C, 2011, EUR J HUM GENET, V19, P145, DOI 10.1038/ejhg.2010.166; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_	16	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60922	10.1371/journal.pone.0060922	http://dx.doi.org/10.1371/journal.pone.0060922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565289	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300162
J	Sharma-Kuinkel, BK; Zhang, YR; Yan, Q; Ahn, SH; Fowler, VG				Sharma-Kuinkel, Batu K.; Zhang, Yurong; Yan, Qin; Ahn, Sun Hee; Fowler, Vance G., Jr.			Host Gene Expression Profiling and In Vivo Cytokine Studies to Characterize the Role of Linezolid and Vancomycin in Methicillin-Resistant Staphylococcus aureus (MRSA) Murine Sepsis Model	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; TOXIC-SHOCK-SYNDROME; SUBINHIBITORY CONCENTRATIONS; VIRULENCE DETERMINANT; MEDICAL PROGRESS; MOUSE MODELS; KAPPA-B; INFLAMMATION; CLINDAMYCIN; ANTIBIOTICS	Linezolid (L), a potent antibiotic for Methicillin Resistant Staphylococcus aureus (MRSA), inhibits bacterial protein synthesis. By contrast, vancomycin (V) is a cell wall active agent. Here, we used a murine sepsis model to test the hypothesis that L treatment is associated with differences in bacterial and host characteristics as compared to V. Mice were injected with S. aureus USA300, and then intravenously treated with 25 mg/kg of either L or V at 2 hours post infection (hpi). In vivo alphahemolysin production was reduced in both L and V-treated mice compared to untreated mice but the reduction did not reach the statistical significance [P = 0.12 for L; P = 0.70 for V). PVL was significantly reduced in L-treated mice compared to untreated mice (P = 0.02). However the reduction of in vivo PVL did not reach the statistical significance in V-treated mice compared to untreated mice (P = 0.27). Both antibiotics significantly reduced IL-1 beta production [P = 0.001 for L; P = 0.006 for V]. IL-6 was significantly reduced with L but not V antibiotic treatment [P, 0.001 for L; P = 0.11 for V]. Neither treatment significantly reduced production of TNF-alpha. Whole-blood gene expression profiling showed no significant effect of L and V on uninfected mice. In S. aureus-infected mice, L altered the expression of a greater number of genes than V (95 vs. 42; P = 0.001). Pathway analysis for the differentially expressed genes identified toll-like receptor signaling pathway to be common to each S. aureus-infected comparison. Expression of immunomodulatory genes like Cxcl9, Cxcl10, Il1r2, Cd14 and Nfkbia was different among the treatment groups. Glycerolipid metabolism pathway was uniquely associated with L treatment in S. aureus infection. This study demonstrates that, as compared to V, treatment with L is associated with reduced levels of toxin production, differences in host inflammatory response, and distinct host gene expression characteristics in MRSA sepsis.	[Sharma-Kuinkel, Batu K.; Zhang, Yurong; Yan, Qin; Ahn, Sun Hee; Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA; [Fowler, Vance G., Jr.] Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University	Sharma-Kuinkel, BK (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA.	batu.sharma@duke.edu; sunhee.ahn@duke.edu	Yan, Qin/K-3539-2013; Fowler, Vance/AAW-2017-2021	Yan, Qin/0000-0002-6344-6398; 	Pfizer Inc. [WS499060]; United States National Institutes of Health [K24 AI093969]; Astellas Pharma, Inc.; Cubist Pharmaceuticals; Merck Co., Inc.; Theravance, Inc.; MedImmune; Cerexa, Inc.; Pfizer; Advanced Liquid Logic; United States National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI093969] Funding Source: NIH RePORTER	Pfizer Inc.(Pfizer); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Astellas Pharma, Inc.(Astellas Pharmaceuticals); Cubist Pharmaceuticals; Merck Co., Inc.(Merck & Company); Theravance, Inc.; MedImmune(AstraZenecaMedimmune); Cerexa, Inc.; Pfizer(Pfizer); Advanced Liquid Logic; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported primarily by a grant from Pfizer Inc., WS499060 to S. H. A. V. G. F. was supported in part by K24 AI093969 from the United States National Institutes of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. V. G. F. has received grants or research support from Astellas Pharma, Inc., Cubist Pharmaceuticals, Merck & Co., Inc., Theravance, Inc., MedImmune, Cerexa, Inc., Pfizer, Advanced Liquid Logic, MedImmune and the United States National Institutes of Health. He is a consultant for Astellas Pharma, Inc., Biosynexus, Novartis, Cubist Pharmaceuticals, Inimex, Merck & Co., Inc., Galderma, Johnson & Johnson, Medicines Company, Novartis and is on the speaker's bureau and advisory committee for Cubist Pharmaceuticals. He has received honoraria from Achaogen, Arpida, Astellas Pharma, Inc., Cubist Pharmaceuticals, Durata, Inhibitex, Leo Pharma, Merck & Co., Inc., Pfizer, Targanta, Theravance, Inc., and Ortho-McNeil. This study uses Linezolid, a product produced by Pfizer, Inc. The co-author V. G. F. is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. B. K. S. K, Y.Z., Q. Y. and S. H. A. have no competing interests to declare.	Ahn SH, 2005, INFECT IMMUN, V73, P722, DOI 10.1128/IAI.73.2.722-729.2005; Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Bernardo K, 2004, ANTIMICROB AGENTS CH, V48, P546, DOI 10.1128/AAC.48.2.546-555.2004; BRISSETTE JL, 1986, J BIOL CHEM, V261, P6338; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Coyle EA, 2003, ANTIMICROB AGENTS CH, V47, P1752, DOI 10.1128/AAC.47.5.1752-1755.2003; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Dalhoff A, 2003, LANCET INFECT DIS, V3, P359, DOI 10.1016/S1473-3099(03)00658-3; Danin J, 2003, ORAL SURG ORAL MED O, V96, P492, DOI 10.1016/S1079-2104(03)00059-3; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; De Gascun C, 2006, J ANTIMICROB CHEMOTH, V57, P150, DOI 10.1093/jac/dki394; Desaki M, 2004, ANTIMICROB AGENTS CH, V48, P1581, DOI 10.1128/AAC.48.5.1581-1585.2004; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; DOSS SA, 1993, J APPL BACTERIOL, V75, P123, DOI 10.1111/j.1365-2672.1993.tb02756.x; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Dumitrescu O, 2007, ANTIMICROB AGENTS CH, V51, P1515, DOI 10.1128/AAC.01201-06; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Garcia-Roca P, 2006, ARCH MED RES, V37, P31, DOI 10.1016/j.arcmed.2005.05.022; Gemmell CG, 2002, J ANTIMICROB CHEMOTH, V50, P665, DOI 10.1093/jac/dkf192; Giamarellos-Bourboulis EJ, 2008, INT J ANTIMICROB AG, V31, P12, DOI 10.1016/j.ijantimicag.2007.08.001; Gill CJ, 2007, ANTIMICROB AGENTS CH, V51, P3434, DOI 10.1128/AAC.01567-06; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Gould IM, 2012, INT J ANTIMICROB AG, V39, P96, DOI 10.1016/j.ijantimicag.2011.09.028; Hardison JL, 2006, INFECT IMMUN, V74, P125, DOI 10.1128/IAI.74.1.125-134.2006; HAYNES MP, 1994, ANTIMICROB AGENTS CH, V38, P1523, DOI 10.1128/AAC.38.7.1523; He M, 2010, CLIN CANCER RES, V16, P249, DOI 10.1158/1078-0432.CCR-09-1602; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KERNODLE DS, 1995, J INFECT DIS, V172, P410, DOI 10.1093/infdis/172.2.410; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kobayashi SD, 2009, CURR OPIN PHARMACOL, V9, P545, DOI 10.1016/j.coph.2009.07.009; Krehmeier Ulrich, 2002, Journal of Infection and Chemotherapy, V8, P194, DOI 10.1007/s101560200036; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Laborada G, 2005, CHEMOTHERAPY, V51, P363, DOI 10.1159/000088963; LaBreche HG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-61; LaPlante KL, 2008, ANTIMICROB AGENTS CH, V52, P2156, DOI 10.1128/AAC.01046-07; Libert N, 2009, REV MED INTERNE, V30, P907, DOI 10.1016/j.revmed.2008.11.014; Lin YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007499; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Ma XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034970; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Miyazaki S, 2002, J ANTIMICROB CHEMOTH, V50, P971, DOI 10.1093/jac/dkf245; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Ohlsen K, 1998, ANTIMICROB AGENTS CH, V42, P2817, DOI 10.1128/AAC.42.11.2817; Olsen RJ, 2010, AM J PATHOL, V176, P1346, DOI 10.2353/ajpath.2010.090960; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Patel R, 2000, ANTIMICROB AGENTS CH, V44, P3438, DOI 10.1128/AAC.44.12.3438-3440.2000; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Pultz NJ, 2005, ANTIMICROB AGENTS CH, V49, P3513, DOI 10.1128/AAC.49.8.3513-3516.2005; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Rose WE, 2012, J INFECT DIS, V206, P1604, DOI 10.1093/infdis/jis552; Shinkai M, 2008, PHARMACOL THERAPEUT, V117, P393, DOI 10.1016/j.pharmthera.2007.11.001; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; STEVENS DL, 1987, J INFECT DIS, V155, P220, DOI 10.1093/infdis/155.2.220; Stevens DL, 2006, CLIN INFECT DIS, V42, P729, DOI 10.1086/500265; STEVENS DL, 1988, J INFECT DIS, V158, P23, DOI 10.1093/infdis/158.1.23; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Takahashi G, 2010, J INFECT CHEMOTHER, V16, P94, DOI 10.1007/s10156-009-0012-5; Tateda K, 2000, J Infect Chemother, V6, P1, DOI 10.1007/s101560050042; Thakker M, 1998, INFECT IMMUN, V66, P5183, DOI 10.1128/IAI.66.11.5183-5189.1998; Thorgersen EB, 2010, FASEB J, V24, P712, DOI 10.1096/fj.09-140798; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; VED HS, 1984, J BIOL CHEM, V259, P8115; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yoshizawa S, 2012, ANTIMICROB AGENTS CH, V56, P1744, DOI 10.1128/AAC.05430-11; Yu SL, 2004, AM J RESP CRIT CARE, V169, P1135, DOI 10.1164/rccm.200211-1278OC; Zimbelman J, 1999, PEDIATR INFECT DIS J, V18, P1096, DOI 10.1097/00006454-199912000-00014	79	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60463	10.1371/journal.pone.0060463	http://dx.doi.org/10.1371/journal.pone.0060463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565251	Green Submitted, gold, Green Published			2022-12-27	WOS:000317717300122
J	Watanabe, S; Kumazawa, Y; Inoue, J				Watanabe, Sachiko; Kumazawa, Yoshio; Inoue, Joe			Liposomal Lipopolysaccharide Initiates TRIF-Dependent Signaling Pathway Independent of CD14	PLOS ONE			English	Article							MYD88-DEFICIENT DENDRITIC CELLS; TOLL-LIKE RECEPTORS; TAPE-STRIPPED SKIN; IMMUNE-RESPONSES; CPG-OLIGODEOXYNUCLEOTIDE; NC/NGA MICE; ENDOTOXIN; LPS; ANTIGEN; TLR4	Lipopolysaccharide (LPS) is recognized by CD14 with Toll-like receptor 4 (TLR4), and initiates 2 major pathways of TLR4 signaling, the MyD88-dependent and TRIF-dependent signaling pathways. The MyD88-dependent pathway induces inflammatory responses such as the production of TNF-alpha, IL-6, and IL-12 via the activation of NF kappa B and MAPK. The TRIF-dependent pathway induces the production of type-I IFN, and RANTES via the activation of IRF-3 and NF kappa B, and is also important for the induction of adaptive immune responses. CD14 plays a critical role in initiating the TRIF-dependent signaling pathway response to LPS, to support the internalization of LPS via endocytosis. Here, we clearly demonstrate that intracellular delivery of LPS by LPS-formulated liposomes (LPS-liposomes) initiate only TRIF-dependent signaling via clathrin-mediated endocytosis, independent of CD14. In fact, LPS-liposomes do not induce the production of TNF-alpha and IL-6 but induce RANTES production in peritoneal macrophages. Additionally, LPS-liposomes could induce adaptive immune responses effectively in CD14-deficient mice. Collectively, our results strongly suggest that LPS-liposomes are useful as a TRIF-dependent signaling-based immune adjuvant without inducing unnecessary inflammation.	[Watanabe, Sachiko; Kumazawa, Yoshio; Inoue, Joe] Kitasato Univ, Dept Biosci, Sch Sci, Sagamihara, Kanagawa 228, Japan; [Watanabe, Sachiko; Kumazawa, Yoshio; Inoue, Joe] Kitasato Univ, Grad Sch Sci, Sagamihara, Kanagawa 228, Japan; [Inoue, Joe] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan	Kitasato University; Kitasato University; Kyoto University	Inoue, J (corresponding author), Kitasato Univ, Dept Biosci, Sch Sci, Sagamihara, Kanagawa 228, Japan.	inoue@imm.med.kyoto-u.ac.jp	sachiko, watanabe/AAM-8862-2021; Watanabe, Sachiko/GRE-6723-2022	sachiko, watanabe/0000-0002-6110-9603; Watanabe, Sachiko/0000-0002-6110-9603	MEXT KAKENHI [19790326]; Kitasato University	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kitasato University	This project was supported by MEXT KAKENHI Grant Number 19790326 (to JI) and a grant-in aid from Kitasato University Research Grant for Young Researchers (to JI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler B, 2002, CURR TOP MICROBIOL, V270, P109; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Felgner P L, 1991, Methods Mol Biol, V7, P81, DOI 10.1385/0-89603-178-0:81; FERRERO E, 1993, P NATL ACAD SCI USA, V90, P2380, DOI 10.1073/pnas.90.6.2380; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gangloff SC, 2005, J IMMUNOL, V175, P3940, DOI 10.4049/jimmunol.175.6.3940; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Inoue J, 2006, BIOL PHARM BULL, V29, P385, DOI 10.1248/bpb.29.385; Inoue J, 2005, J CONTROL RELEASE, V108, P294, DOI 10.1016/j.jconrel.2005.08.014; Inoue J, 2005, PHARM RES-DORDR, V22, P1627, DOI 10.1007/s11095-005-6834-7; Inoue J, 2007, J INVEST DERMATOL, V127, P614, DOI 10.1038/sj.jid.5700656; Inoue J, 2007, VACCINE, V25, P1007, DOI 10.1016/j.vaccine.2006.09.075; Inoue J, 2007, J IMMUNOL, V178, P584, DOI 10.4049/jimmunol.178.1.584; Inoue J, 2009, J CONTROL RELEASE, V133, P18, DOI 10.1016/j.jconrel.2008.09.078; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kitchens RL, 1998, J IMMUNOL, V161, P5534; LEGENDRE JY, 1992, PHARMACEUT RES, V9, P1235, DOI 10.1023/A:1015836829670; Leturcq DJ, 1996, J CLIN INVEST, V98, P1533, DOI 10.1172/JCI118945; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; MORGAN JR, 1980, ANTIMICROB AGENTS CH, V17, P544, DOI 10.1128/AAC.17.4.544; Poussin C, 1998, J BIOL CHEM, V273, P20285, DOI 10.1074/jbc.273.32.20285; Puneet P, 2011, NAT IMMUNOL, V12, P344, DOI 10.1038/ni.2004; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yamamoto M, 2009, ADV EXP MED BIOL, V667, P59, DOI 10.1007/978-1-4419-1603-7_6; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	38	33	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60078	10.1371/journal.pone.0060078	http://dx.doi.org/10.1371/journal.pone.0060078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565187	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300056
J	Wells, CJ; Alano, A				Wells, Christopher J.; Alano, Abraham			Prophylactic Procurement of University Students in Southern Ethiopia: Stigma and the Value of Condom Machines on Campus	PLOS ONE			English	Article								Introduction: Risky sexual behavior among Ethiopian university students, especially females, is a major contributor to young adult morbidity and mortality. Ambaw et al. found that female university students in Ethiopia may fear the humiliation associated with procuring condoms. A study in Thailand suggests condom machines may provide comfortable condom procurement, but the relevance to a high-risk African context is unknown. The objective of this study was to examine if the installation of condom machines in Ethiopia predicts changes in student condom uptake and use, as well as changes in procurement related stigma. Methods: Students at a large urban university in Southern Ethiopia completed self reported surveys in 2010 (N = 2,155 surveys) and again in 2011 (N = 2,000), six months after the installation of condom machines. Mann-Whitney and Chi-square tests were conducted to evaluate significant changes in student sexual behavior, as well as condom procurement and associated stigma over the subsequent one year period. Results: After installing condom machines, the average number of trips made to procure condoms on-campus significantly increased 101% for sexually active females and significantly decreased 36% for sexually active males. Additionally, reports of condom use during last sexual intercourse showed a non-significant 4.3% increase for females and a significant 9.0% increase for males. During this time, comfort procuring condoms and ability to convince sexual partners to use condoms were significantly higher for sexually active male students. There was no evidence that the condom machines led to an increase in promiscuity. Conclusions: The results suggest that condom machines may be associated with more condom procurement among vulnerable female students in Ethiopia and could be an important component of a comprehensive university health policy.	[Wells, Christopher J.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Dev, New Orleans, LA 70118 USA; [Alano, Abraham] Hawassa Univ, Coll Med & Hlth Sci, Hawassa, Ethiopia	Tulane University; Hawassa University	Wells, CJ (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Dev, New Orleans, LA 70118 USA.	cwells@tulane.edu	Ali, Abraham/L-9433-2019		United States Peace Corps in Ethiopia	United States Peace Corps in Ethiopia	The limited funding for the study came from the researchers and the United States Peace Corps in Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambaw F., 2010, ETHIOP J HEALTH SCI, V20, P169, DOI 10.4314%2Fejhs.v20i3.69446; Chetty D, 2000, I RESPONSE HIV AIDS; EPSTEIN H, 2007, INVISIBLE CURE AFRIC; Fetene G., 2009, THESIS STATE U NEW Y; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Guest G, 2005, J FAM PLAN REPROD H, V31, P285, DOI 10.1783/jfp.31.2.285; Holmes K, 2004, B WHO; Kaba M, 2008, 19 ANN C ETH PUBL HL; Kidd R, 2003, UNDERSTANDING CHALLE; Maharaj P., 2005, Development Southern Africa, V22, P187, DOI 10.1080/03768350500163097; Masvawure T, 2010, CULT HEALTH SEX, V12, P857, DOI 10.1080/13691050903471441; Meekers D, 2001, AIDS CARE, V13, P297, DOI 10.1080/09540120120043946; Ministry of Health, 2009, GUID COORD IMPL HIV; Nesidai K., 2011, AFRICAN HLTH SCI J, V19, P41; Otaala B, 2003, REG TRAIN C IMPR TER; Pattman R., 2002, AGENDA, V53, P33; Saint W, 2004, CRAFTING I RESPONSES; Sandoy IF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-10; Sarkar NN, 2008, EUR J CONTRACEP REPR, V13, P114, DOI 10.1080/13625180802011302; Sayegh MA, 2006, J ADOLESCENT HEALTH, V39, P388, DOI 10.1016/j.jadohealth.2005.12.027; SEARS DO, 1983, J PERS SOC PSYCHOL, V44, P233, DOI 10.1037/0022-3514.44.2.233; Singh S, 2003, A B C UGANDA ROLES A; Tagoe Michael, 2009, J Health Hum Serv Adm, V32, P51; U.S. President's Emergency Plan for AIDS Relief, 2012, PARTN FIGHT HIV AIDS; UN Joint Programme on HIV / AIDS, 2012, WORLD AIDS DAY REP R; UN Joint Programme on HIV / AIDS, 2012, REP GLOB AIDS EP; UN Joint Programme on HIV/AIDS, 2004, REP GLOB AIDS EP; UN Joint Programme on HIV/AIDS, 2012, UNAIDS COR EP SLID G; UNAIDS, 2012, COUNTR PROGR REP HIV; UNESCO, 2008, TRAIN TEACH HIV AIDS; UNFPA, 2011, PREV HIV UNW PREGN; UNFPA, 2011, HIV PREV GAINS MOM S; US President's Emergency Plan for AIDS Relief, 2008, PEPFAR OP PLAN; USAID, 2011, ETH DEM HLTH SURV; USAID-Ethiopia, 2012, MULU PREV PROGR MOST; Weinberg C, 1998, CANADIAN J PUBLIC HL, V89, P367; WHO UNFPA UNAIDS, 2009, POS STAT COND HIV PR; Yuntadilok N., 2004, INT C AIDS JUL 15 20; Zewdie Z., 2005, THESIS ADDIS ABABA U	39	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60725	10.1371/journal.pone.0060725	http://dx.doi.org/10.1371/journal.pone.0060725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565272	Green Submitted, gold, Green Published			2022-12-27	WOS:000317717300143
J	Li, XN; He, HS; Wu, ZW; Liang, Y; Schneiderman, JE				Li, Xiaona; He, Hong S.; Wu, Zhiwei; Liang, Yu; Schneiderman, Jeffrey E.			Comparing Effects of Climate Warming, Fire, and Timber Harvesting on a Boreal Forest Landscape in Northeastern China	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; SPATIALLY EXPLICIT; GLOBAL CHANGE; MODEL; SIMULATION; PATTERNS; MANAGEMENT; UNCERTAINTY; DISTURBANCE; INCREASES	Forest management under a changing climate requires assessing the effects of climate warming and disturbance on the composition, age structure, and spatial patterns of tree species. We investigated these effects on a boreal forest in northeastern China using a factorial experimental design and simulation modeling. We used a spatially explicit forest landscape model (LANDIS) to evaluate the effects of three independent variables: climate (current and expected future), fire regime (current and increased fire), and timber harvesting (no harvest and legal harvest). Simulations indicate that this forested landscape would be significantly impacted under a changing climate. Climate warming would significantly increase the abundance of most trees, especially broadleaf species (aspen, poplar, and willow). However, climate warming would have less impact on the abundance of conifers, diversity of forest age structure, and variation in spatial landscape structure than burning and harvesting. Burning was the predominant influence in the abundance of conifers except larch and the abundance of trees in mid-stage. Harvesting impacts were greatest for the abundance of larch and birch, and the abundance of trees during establishment stage (1-40 years), early stage (41-80 years) and old-growth stage (>180 years). Disturbance by timber harvesting and burning may significantly alter forest ecosystem dynamics by increasing forest fragmentation and decreasing forest diversity. Results from the simulations provide insight into the long term management of this boreal forest.	[Li, Xiaona; He, Hong S.; Wu, Zhiwei; Liang, Yu] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [He, Hong S.; Schneiderman, Jeffrey E.] Univ Missouri, Sch Nat Resources, Columbia, MO USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Missouri System; University of Missouri Columbia	He, HS (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	HeH@missouri.edu	Wu, Zhiwei/AHC-9115-2022; Yu, Liang/AFO-1361-2022	He, Hong S./0000-0002-3983-2512	Knowledge Innovation Project of Chinese Academy of Sciences (CAS) [KZCX2-YW-444]; Natural Science Foundation of China (NSFC) [41071120, 2011CB403206]	Knowledge Innovation Project of Chinese Academy of Sciences (CAS); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research is funded by the Knowledge Innovation Project of Chinese Academy of Sciences (CAS; Grant No. KZCX2-YW-444) and the Natural Science Foundation of China (NSFC; Grant Nos. 41071120 and 2011CB403206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang Y, 2007, INT J WILDLAND FIRE, V16, P34, DOI 10.1071/WF05093; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Euskirchen ES, 2006, GLOBAL CHANGE BIOL, V12, P731, DOI 10.1111/j.1365-2486.2006.01113.x; Fang JY, 2006, J BIOGEOGR, V33, P1804, DOI 10.1111/j.1365-2699.2006.01533.x; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Flannigan MD, 2000, SCI TOTAL ENVIRON, V262, P221, DOI 10.1016/S0048-9697(00)00524-6; Flannigan M, 2009, GLOBAL CHANGE BIOL, V15, P549, DOI 10.1111/j.1365-2486.2008.01660.x; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; Gustafson EJ, 2000, CAN J FOREST RES, V30, P32, DOI 10.1139/cjfr-30-1-32; Gustafson EJ, 2010, ECOL APPL, V20, P700, DOI 10.1890/08-1693.1; Hansen AJ, 2001, BIOSCIENCE, V51, P765, DOI 10.1641/0006-3568(2001)051[0765:GCIFRO]2.0.CO;2; He HS, 1999, ECOL MODEL, V119, P1, DOI 10.1016/S0304-3800(99)00041-1; He HS, 1999, ECOL MODEL, V114, P213, DOI 10.1016/S0304-3800(98)00147-1; He HS, 2005, J BIOGEOGR, V32, P2043, DOI 10.1111/j.1365-2699.2005.01353.x; He HS, 1999, ECOLOGY, V80, P81, DOI 10.1890/0012-9658(1999)080[0081:SEASSO]2.0.CO;2; He HS, 2002, FOREST ECOL MANAG, V155, P257, DOI 10.1016/S0378-1127(01)00563-1; He HS, 2000, LANDSCAPE ECOL, V15, P591, DOI 10.1023/A:1008102521322; IPCC, 2007, SUMM POL SYNTH REP I; Johnson EA, 1998, J VEG SCI, V9, P603, DOI 10.2307/3237276; Johnstone JF, 2010, CAN J FOREST RES, V40, P1302, DOI 10.1139/X10-061; Johnstone JF, 2010, GLOBAL CHANGE BIOL, V16, P1281, DOI 10.1111/j.1365-2486.2009.02051.x; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Krawchuk MA, 2009, CLIMATIC CHANGE, V92, P83, DOI 10.1007/s10584-008-9460-7; Kurz WA, 2008, PHILOS T R SOC B, V363, P2261, DOI 10.1098/rstb.2007.2198; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Liu ZH, 2012, GLOBAL CHANGE BIOL, V18, P2041, DOI 10.1111/j.1365-2486.2012.02649.x; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; MacDonald GM, 2008, PHILOS T R SOC B, V363, P2285, DOI 10.1098/rstb.2007.2200; McGarigal K., 1995, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Pan Y, 2006, ECOL APPL, V16, P125, DOI 10.1890/05-0247; Peng CH, 1999, ECOL MODEL, V122, P175, DOI 10.1016/S0304-3800(99)00137-4; Post WM, 1996, CLIMATIC CHANGE, V34, P253, DOI 10.1007/BF00224636; Ruckstuhl KE, 2008, PHILOS T R SOC B, V363, P2245, DOI 10.1098/rstb.2007.2196; Scheller RM, 2005, GLOBAL CHANGE BIOL, V11, P307, DOI 10.1111/j.1365-2486.2005.00906.x; Schumacher S, 2006, GLOBAL CHANGE BIOL, V12, P1435, DOI 10.1111/j.1365-2486.2006.01188.x; Shifley SR, 2000, COMPUT ELECTRON AGR, V27, P7, DOI 10.1016/S0168-1699(00)00087-9; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Stocks BJ, 1998, CLIMATIC CHANGE, V38, P1, DOI 10.1023/A:1005306001055; Stueve KM, 2011, ECOLOGY, V92, P496, DOI 10.1890/09-1725.1; Wang XG, 2006, FOREST ECOL MANAG, V225, P82, DOI 10.1016/j.foreco.2005.12.029; Wang XC, 2009, TREES-STRUCT FUNCT, V23, P875, DOI 10.1007/s00468-009-0329-9; Weber M. G., 1997, Environmental Reviews, V5, P145, DOI 10.1139/a97-008; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wotton BM, 2010, INT J WILDLAND FIRE, V19, P253, DOI 10.1071/WF09002; Xu CG, 2005, ECOL MODEL, V185, P255, DOI 10.1016/j.ecolmodel.2004.12.009; Xu CG, 2004, ECOL MODEL, V180, P57, DOI 10.1016/j.ecolmodel.2004.01.018; Xu CG, 2007, GLOBAL CHANGE BIOL, V13, P1469, DOI 10.1111/j.1365-2486.2007.01387.x; Xu HC, 1998, FOREST GREAT XINGAN; Yang J, 2004, ECOL MODEL, V180, P119, DOI 10.1016/j.ecolmodel.2004.03.017; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590; Zheng H. N., 1986, Journal of North-East Forestry University, China, V14, P1; Zhou YL, 1991, VEGETATION GREAT XIA	55	31	32	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59747	10.1371/journal.pone.0059747	http://dx.doi.org/10.1371/journal.pone.0059747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573209	Green Published, gold			2022-12-27	WOS:000316930900026
J	Colaneri, AC; Jones, AM				Colaneri, Alejandro C.; Jones, Alan M.			Genome-Wide Quantitative Identification of DNA Differentially Methylated Sites in Arabidopsis Seedlings Growing at Different Water Potential	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; TRANSCRIPTIONAL REGULATION; OSMOTIC ADJUSTMENT; DROUGHT TOLERANCE; PLANT; SALINITY; ACCUMULATION; MAINTENANCE; ACTIVATION; RESPONSES	Background: In eukaryotes, the combinatorial usage of cis-regulatory elements enables the assembly of composite genetic switches to integrate multifarious, convergent signals within a single promoter. Plants as sessile organisms, incapable of seeking for optimal conditions, rely on the use of this resource to adapt to changing environments. Emerging evidence suggests that the transcriptional responses of plants to stress are associated with epigenetic processes that govern chromatin accessibility. However, the extent at which specific chromatin modifications contribute to gene regulation has not been assessed. Methodology/Principal Findings: In the present work, we combined methyl-sensitive-cut counting and RNA-seq to follow the transcriptional and epigenetic response of plants to simulated drought. Comprehensive genome wide evidence supports the notion that the methylome is widely reactive to water potential. The predominant changes in methylomes were loci in the promoters of genes encoding for proteins suited to cope with the environmental challenge. Conclusion/Significance: These selective changes in the methylome with corresponding changes in gene transcription suggest drought sets in motion an instructive mechanism guiding epigenetic machinery toward specific effectors genes.	[Colaneri, Alejandro C.; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu			National Institute of General Medical Science [R01GM065989]; National Science Foundation [MCB-0723515, MCB-1158054]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-05er15671]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of General Medical Science (R01GM065989) and National Science Foundation (MCB-0723515 and MCB-1158054) to AMJ. The Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through the grant DE-FG02-05er15671 to AMJ funded sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Alexandersson E, 2010, PLANT J, V61, P650, DOI 10.1111/j.1365-313X.2009.04087.x; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barth O, 2009, PLANT MOL BIOL, V69, P213, DOI 10.1007/s11103-008-9419-0; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Colaneri A, 2011, P NATL ACAD SCI USA, V108, P9715, DOI 10.1073/pnas.1105713108; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1732; Eaves HL, 2009, BIOINFORMATICS, V25, P969, DOI 10.1093/bioinformatics/btp092; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Jung C, 2010, MOL CELLS, V29, P71, DOI 10.1007/s10059-010-0009-z; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Raj S, 2011, P NATL ACAD SCI USA, V108, P12521, DOI 10.1073/pnas.1103341108; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reinders J, 2009, EPIGENETICS-US, V4, P557, DOI 10.4161/epi.4.8.10347; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Scheid OM, 1998, P NATL ACAD SCI USA, V95, P632, DOI 10.1073/pnas.95.2.632; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Sharma S, 2010, PLANT CELL ENVIRON, V33, P1838, DOI 10.1111/j.1365-3040.2010.02188.x; Sharp RE, 2004, J EXP BOT, V55, P2343, DOI 10.1093/jxb/erh276; Shibuya K, 2009, P NATL ACAD SCI USA, V106, P1660, DOI 10.1073/pnas.0809294106; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Suzuki M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r36; Tan MP, 2010, PLANT PHYSIOL BIOCH, V48, P21, DOI 10.1016/j.plaphy.2009.10.005; van der Weele CM, 2000, J EXP BOT, V51, P1555, DOI 10.1093/jexbot/51.350.1555; Verslues PE, 2010, METHODS MOL BIOL, V639, P301, DOI 10.1007/978-1-60761-702-0_19; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Verslues PE, 2004, PLANT PHYSIOL, V136, P2831, DOI 10.1104/pp.104.045856; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Xiao WY, 2006, PLANT CELL, V18, P805, DOI 10.1105/tpc.105.038836; Xiong LM, 2002, J BIOL CHEM, V277, P8588, DOI 10.1074/jbc.M109275200; Yaish MW, 2011, J EXP BOT, V62, P3727, DOI 10.1093/jxb/err177; Zhang X, 2006, COLD SPRING HARB SYM, V71, P439, DOI 10.1101/sqb.2006.71.047; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	46	44	47	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e59878	10.1371/journal.pone.0059878	http://dx.doi.org/10.1371/journal.pone.0059878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577076	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000016
J	Do, PT; Degenkolbe, T; Erban, A; Heyer, AG; Kopka, J; Kohl, KI; Hincha, DK; Zuther, E				Do, Phuc Thi; Degenkolbe, Thomas; Erban, Alexander; Heyer, Arnd G.; Kopka, Joachim; Koehl, Karin I.; Hincha, Dirk K.; Zuther, Ellen			Dissecting Rice Polyamine Metabolism under Controlled Long-Term Drought Stress	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; RAPE LEAF DISCS; SALT-STRESS; ARGININE DECARBOXYLASE; PROLINE ACCUMULATION; OSMOTIC ADJUSTMENT; WATER DEFICITS; UPLAND RICE; GENE-EXPRESSION; ABIOTIC STRESS	A selection of 21 rice cultivars (Oryza sativa L. ssp. indica and japonica) was characterized under moderate long-term drought stress by comprehensive physiological analyses and determination of the contents of polyamines and selected metabolites directly related to polyamine metabolism. To investigate the potential regulation of polyamine biosynthesis at the transcriptional level, the expression of 21 genes encoding enzymes involved in these pathways were analyzed by qRT-PCR. Analysis of the genomic loci revealed that 11 of these genes were located in drought-related QTL regions, in agreement with a proposed role of polyamine metabolism in rice drought tolerance. The cultivars differed widely in their drought tolerance and parameters such as biomass and photosynthetic quantum yield were significantly affected by drought treatment. Under optimal irrigation free putrescine was the predominant polyamine followed by free spermidine and spermine. When exposed to drought putrescine levels decreased markedly and spermine became predominant in all cultivars. There were no correlations between polyamine contents and drought tolerance. GC-MS analysis revealed drought-induced changes of the levels of ornithine/arginine (substrate), substrates of polyamine synthesis, proline, product of a competing pathway and GABA, a potential degradation product. Gene expression analysis indicated that ADC-dependent polyamine biosynthesis responded much more strongly to drought than the ODC-dependent pathway. Nevertheless the fold change in transcript abundance of ODC1 under drought stress was linearly correlated with the drought tolerance of the cultivars. Combining metabolite and gene expression data, we propose a model of the coordinate adjustment of polyamine biosynthesis for the accumulation of spermine under drought conditions.	[Do, Phuc Thi; Degenkolbe, Thomas; Erban, Alexander; Kopka, Joachim; Koehl, Karin I.; Hincha, Dirk K.; Zuther, Ellen] Max Planck Inst Mol Pflanzenphysiol, Potsdam, Germany; [Heyer, Arnd G.] Univ Stuttgart, Inst Biol, Abt Bot, D-70174 Stuttgart, Germany	Max Planck Society; University of Stuttgart	Zuther, E (corresponding author), Max Planck Inst Mol Pflanzenphysiol, Potsdam, Germany.	zuther@mpimp-golm.mpg.de	Heyer, Arnd G./O-9828-2015; Zuther, Ellen/H-9814-2019; Do, Phuc Thi/A-2318-2014	Heyer, Arnd G./0000-0003-2074-3234; Do, Phuc Thi/0000-0002-2893-8223; Kopka, Joachim/0000-0001-9675-4883; Zuther, Ellen/0000-0002-7446-0515	German Ministry of Education and Science (BMBF) [0312854]; Vietnamese government; German Academic Exchange Council; Max Planck Institute for Molecular Plant Physiology	German Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Vietnamese government; German Academic Exchange Council; Max Planck Institute for Molecular Plant Physiology	This work was supported by a grant of the German Ministry of Education and Science (BMBF grant: 0312854). Phuc Thi Do was supported by fellowships from the Vietnamese government, the German Academic Exchange Council, and the Max Planck Institute for Molecular Plant Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; Alcazar R, 2006, PHYSIOL PLANTARUM, V128, P448, DOI 10.1111/j.1399-3054.2006.00780.x; Alcazar R, 2011, PLANT SIGNAL BEHAV, V6, P243, DOI 10.4161/psb.6.2.14317; Alcazar R, 2010, PLANT PHYSIOL BIOCH, V48, P547, DOI 10.1016/j.plaphy.2010.02.002; Alcazar R, 2010, PLANTA, V231, P1237, DOI 10.1007/s00425-010-1130-0; Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; Ashraf M, 2010, Biotechnol Adv, V28, P169, DOI 10.1016/j.biotechadv.2009.11.005; Aziz A, 1997, PLANT GROWTH REGUL, V21, P153, DOI 10.1023/A:1005730509433; Aziz A, 1995, PLANT SCI, V112, P175, DOI 10.1016/0168-9452(95)04264-4; Babu RC, 2003, CROP SCI, V43, P1457, DOI 10.2135/cropsci2003.1457; Bagni N, 2001, AMINO ACIDS, V20, P301, DOI 10.1007/s007260170046; Bernier J, 2008, J SCI FOOD AGR, V88, P927, DOI 10.1002/jsfa.3153; BIRECKA H, 1985, PLANT PHYSIOL, V79, P509, DOI 10.1104/pp.79.2.509; Bitrian M, 2012, METABOLITES, V2, P516, DOI 10.3390/metabo2030516; Bouchereau A, 1999, PLANT SCI, V140, P103, DOI 10.1016/S0168-9452(98)00218-0; BROWN DH, 1966, PHYTOCHEMISTRY, V5, P887, DOI 10.1016/S0031-9422(00)82785-5; Cabuslay GS, 2002, PLANT SCI, V163, P815, DOI 10.1016/S0168-9452(02)00217-0; Capell T, 2004, P NATL ACAD SCI USA, V101, P9909, DOI 10.1073/pnas.0306974101; Coffman WR, 1987, AGRONOMY MONOGRAPH, V28, P101, DOI DOI 10.2134/AGR0NM0N0GR28.C5; Cornic G, 2000, TRENDS PLANT SCI, V5, P187, DOI 10.1016/S1360-1385(00)01625-3; Courtois B, 2000, MOL BREEDING, V6, P55, DOI 10.1023/A:1009652326121; Degenkolbe T, 2009, PLANT MOL BIOL, V69, P133, DOI 10.1007/s11103-008-9412-7; Erdei L, 1996, J PLANT PHYSIOL, V147, P599, DOI 10.1016/S0176-1617(96)80052-6; ERDEI L, 1990, J PLANT PHYSIOL, V137, P165, DOI 10.1016/S0176-1617(11)80075-1; EVANS PT, 1989, ANNU REV PLANT PHYS, V40, P235, DOI 10.1146/annurev.pp.40.060189.001315; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; FLORES HE, 1982, SCIENCE, V217, P1259, DOI 10.1126/science.217.4566.1259; FLORES HE, 1984, PLANT PHYSIOL, V75, P102, DOI 10.1104/pp.75.1.102; FUKAI S, 1995, FIELD CROP RES, V40, P67, DOI 10.1016/0378-4290(94)00096-U; GALIBA G, 1993, PLANT SCI, V92, P203, DOI 10.1016/0168-9452(93)90207-G; GALSTON AW, 1983, BIOSCIENCE, V33, P382, DOI 10.2307/1309107; Galston AW, 1997, BOT ACTA, V110, P197, DOI 10.1111/j.1438-8677.1997.tb00629.x; GALSTON AW, 1990, PLANT PHYSIOL, V94, P406, DOI 10.1104/pp.94.2.406; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; Goicoechea N, 1998, J PLANT PHYSIOL, V153, P706, DOI 10.1016/S0176-1617(98)80224-1; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; Hao YJ, 2005, J EXP BOT, V56, P1105, DOI 10.1093/jxb/eri102; He LX, 2002, PLANT CELL PHYSIOL, V43, P196, DOI 10.1093/pcp/pcf021; Hemamalini GS, 2000, EUPHYTICA, V112, P69, DOI 10.1023/A:1003854224905; HERVIEU F, 1995, PLANT CELL ENVIRON, V18, P205, DOI 10.1111/j.1365-3040.1995.tb00354.x; Hsu SY, 2003, BIOL PLANTARUM, V46, P73, DOI 10.1023/A:1022362117395; Hummel J, 2010, METABOLOMICS, V6, P322, DOI 10.1007/s11306-010-0198-7; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; INGRAM KT, 1990, EUPHYTICA, V48, P253, DOI 10.1007/BF00023658; INTHAPAN P, 1988, AUST J EXP AGR, V28, P243, DOI 10.1071/EA9880243; Jacobs M., 2003, Advances in rice genetics, Los Banos, Laguna, Philippines, 22-27 October 2000, P582; Jongdee B, 2002, FIELD CROP RES, V76, P153, DOI 10.1016/S0378-4290(02)00036-9; Jongdee B, 1998, P 9 AUSTR AGR C WAGG, P403; Kakkar RK, 2002, PHYSIOL PLANTARUM, V116, P281, DOI 10.1034/j.1399-3054.2002.1160302.x; Kamoshita A, 2004, PLANT PROD SCI, V7, P406, DOI 10.1626/pps.7.406; Kamoshita A, 2008, FIELD CROP RES, V109, P1, DOI 10.1016/j.fcr.2008.06.010; Kasukabe Y, 2004, PLANT CELL PHYSIOL, V45, P712, DOI 10.1093/pcp/pch083; Kaur-Sawhney Ravindar, 2003, Journal of Cell and Molecular Biology, V2, P1; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; KRISHNAMURTHY R, 1989, PLANT PHYSIOL, V91, P500, DOI 10.1104/pp.91.2.500; Kuehn GD, 2005, CRIT REV PLANT SCI, V24, P123, DOI 10.1080/07352680590953161; Kwak SH, 2001, PLANT CELL PHYSIOL, V42, P314, DOI 10.1093/pcp/pce040; Lafitte HR, 2007, J EXP BOT, V58, P169, DOI 10.1093/jxb/erl101; Lafitte HR, 2004, THEOR APPL GENET, V109, P1237, DOI 10.1007/s00122-004-1731-8; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Lee TM, 1997, PLANT SCI, V126, P1, DOI 10.1016/S0168-9452(97)00076-9; Lefevre I, 2001, PLANT SCI, V161, P943, DOI 10.1016/S0168-9452(01)00485-X; Legocka J, 2005, J PLANT PHYSIOL, V162, P662, DOI 10.1016/j.jplph.2004.08.009; Leung H, 2008, CURR OPIN PLANT BIOL, V11, P201, DOI 10.1016/j.pbi.2007.12.005; Li ZY, 2000, THEOR APPL GENET, V100, P782, DOI 10.1007/s001220051352; Li ZY, 2000, J PLANT PHYSIOL, V156, P386, DOI 10.1016/S0176-1617(00)80078-4; Lilley JM, 1996, J EXP BOT, V47, P1427, DOI 10.1093/jxb/47.9.1427; Liu HP, 2004, PLANT SCI, V166, P1261, DOI 10.1016/j.plantsci.2003.12.039; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Ma R, 2005, J ARID ENVIRON, V63, P177, DOI 10.1016/j.jaridenv.2005.01.021; Maiale S, 2004, J PLANT PHYSIOL, V161, P35, DOI 10.1078/0176-1617-01167; Marco F, 2012, POLYAMINES DEV STRES, P623; Martin-Tanguy J, 2001, PLANT GROWTH REGUL, V34, P135, DOI 10.1023/A:1013343106574; MartinTanguy J, 1997, PHYSIOL PLANTARUM, V100, P675, DOI 10.1034/j.1399-3054.1997.1000331.x; Mitchell JH, 1998, FIELD CROP RES, V55, P129, DOI 10.1016/S0378-4290(97)00074-9; Mo H, 2002, PHYSIOL PLANTARUM, V114, P439, DOI 10.1034/j.1399-3054.2002.1140314.x; Ndayiragije A, 2006, PLANT GROWTH REGUL, V48, P51, DOI 10.1007/s10725-005-4825-7; OTOOLE JC, 1982, CROP SCI, V22, P1144, DOI 10.2135/cropsci1982.0011183X002200060014x; OTOOLE JC, 1980, PLANT PHYSIOL, V65, P428, DOI 10.1104/pp.65.3.428; OTOOLE JC, 1981, FIELD CROP RES, V4, P247, DOI 10.1016/0378-4290(81)90076-9; OTOOLE JC, 2004, 1 INT C RIC FUT, P1; PANAGIOTIDIS CA, 1995, NUCLEIC ACIDS RES, V23, P1800, DOI 10.1093/nar/23.10.1800; Peremarti A, 2010, TRANSGENIC RES, V19, P785, DOI 10.1007/s11248-009-9354-0; Peremarti A, 2009, PLANT MOL BIOL, V70, P253, DOI 10.1007/s11103-009-9470-5; Price AH, 2002, PLANT MOL BIOL, V48, P683, DOI 10.1023/A:1014805625790; Price AH, 1997, NEW PHYTOL, V137, P83, DOI 10.1046/j.1469-8137.1997.00818.x; PUCKRIDGE DW, 1981, FIELD CROP RES, V3, P303; Quinet M, 2010, J EXP BOT, V61, P2719, DOI 10.1093/jxb/erq118; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; RAJAM MV, 1993, CURR SCI INDIA, V65, P461; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Robin S, 2003, THEOR APPL GENET, V107, P1288, DOI 10.1007/s00122-003-1360-7; Rodriguez-Kessler M, 2006, PLANT GROWTH REGUL, V48, P175, DOI 10.1007/s10725-005-5990-4; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; Sanchez DH, 2005, PLANT SCI, V168, P541, DOI 10.1016/j.plantsci.2004.09.025; SantaCruz A, 1997, PHYSIOL PLANTARUM, V101, P341, DOI 10.1034/j.1399-3054.1997.1010213.x; Sebela M, 2001, PLANT SCI, V160, P197, DOI 10.1016/S0168-9452(00)00380-0; Shiozaki N, 2005, THEOR APPL GENET, V110, P1177, DOI 10.1007/s00122-005-1931-x; Siahpoosh MR, 2012, PLANT SCI, V182, P101, DOI 10.1016/j.plantsci.2011.01.001; Siopongco JDLC, 2006, PLANT PROD SCI, V9, P141, DOI 10.1626/pps.9.141; SMITH MA, 1985, PLANT PHYSIOL, V78, P89, DOI 10.1104/pp.78.1.89; Soyka S, 1999, FEBS LETT, V458, P219, DOI 10.1016/S0014-5793(99)01125-4; Tiburcio AF, 1997, PHYSIOL PLANTARUM, V100, P664, DOI 10.1034/j.1399-3054.1997.1000330.x; TIBURCIO AF, 1986, PLANT PHYSIOL, V82, P375, DOI 10.1104/pp.82.2.375; TURNER LB, 1986, J EXP BOT, V37, P170, DOI 10.1093/jxb/37.2.170; TURNER NC, 1986, FIELD CROP RES, V13, P257, DOI 10.1016/0378-4290(86)90027-4; Turner NC, 1986, ADV AGRON, V39, P1, DOI 10.1016/S0065-2113(08)60464-2; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Urano K, 2003, PLANT CELL ENVIRON, V26, P1917, DOI 10.1046/j.1365-3040.2003.01108.x; Urano K, 2009, PLANT J, V57, P1065, DOI 10.1111/j.1365-313X.2008.03748.x; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3; Witcombe JR, 2008, PHILOS T R SOC B, V363, P703, DOI 10.1098/rstb.2007.2179; Wopereis MCS, 1996, SOIL USE MANAGE, V12, P158, DOI 10.1111/j.1475-2743.1996.tb00537.x; Yamaguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P486, DOI 10.1016/j.bbrc.2006.11.041; Yang CW, 1999, PLANT GROWTH REGUL, V27, P189; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yang JC, 2007, J EXP BOT, V58, P1545, DOI 10.1093/jxb/erm032	121	83	86	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60325	10.1371/journal.pone.0060325	http://dx.doi.org/10.1371/journal.pone.0060325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577102	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000027
J	Ma, ZY; Qi, J; Fu, ZJ; Ling, MY; Li, L; Zhang, Y				Ma, Zhiyong; Qi, Jia; Fu, Zhijie; Ling, Mingying; Li, Li; Zhang, Yun			Protective Role of Acidic pH-Activated Chloride Channel in Severe Acidosis-Induced Contraction from the Aorta of Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ARTERY SMOOTH-MUSCLE; EXTRACELLULAR PH; CL-CHANNELS; CELLS; TEMPERATURE; MECHANISM; MYOCYTES; CURRENTS; IMPACT	Severe acidic pH-activated chloride channel (I-Cl,I- acid) has been found in various mammalian cells. In the present study, we investigate whether this channel participates in reactions of the thoracic aorta to severe acidosis and whether it plays a role in hypertension. We measured isometric contraction in thoracic aorta rings from spontaneously hypertensive rats (SHRs) and normotensive Wistar rats. Severe acidosis induced contractions of both endothelium-intact and -denuded thoracic aorta rings. In Wistar rats, contractions did not differ at pH 6.4, 5.4 and 4.4. However, in SHRs, contractions were higher at pH 5.4 or 4.4 than pH 6.4, with no difference between contractions at pH 5.4 and 4.4. Nifedipine, I-Cl,I- acid blockers 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) and 4,4'-diisothiocyanatostilbene-2, 2'-disulfonic acid (DIDS) inhibited severe acidosis-induced contraction of aortas at different pH levels. When blocking I-Cl,I- acid, the remnant contraction was greater at pH 4.4 than pH 5.4 and 6.4 for both SHRs and Wistar rats. With nifedipine, the remnant contraction was greatly reduced at pH 4.4 as compared with at pH 6.4 and 5.4. With NPPB or DIDS, the ratio of remnant contractions at pH 4.4 and 5.4 (R-4.4/5.4) was lower for SHRs than Wistar rats (all <1). However, with nifedipine, the R-4.4/5.4 was higher for SHRs than Wistar rats (both >1). Furthermore, patch clamp recordings of I-Cl,I- acid and intracellular Ca2+ measurements in smooth muscle cells confirmed these findings. I-Cl,I- acid may protect arteries against excess vasoconstriction under extremely acidic extracellular conditions. This protective effect may be decreased in hypertension.	[Ma, Zhiyong; Qi, Jia; Ling, Mingying; Li, Li; Zhang, Yun] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Peoples R China; [Ma, Zhiyong; Qi, Jia; Ling, Mingying; Li, Li; Zhang, Yun] Shandong Univ, Chinese Minist Publ Hlth, Dept Cardiol, Qilu Hosp, Jinan 250100, Peoples R China; [Fu, Zhijie] Shandong Univ, Clin Med Coll, Shandong Prov Qianfoshan Hosp, Dept Otorhinolaryngol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Zhang, Y (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Peoples R China.	sdqlzhangyun@163.com	ling, mingying/GZB-1112-2022		National 973 Basic Research Program of China [2011CB503906, 2012CB518603]; National High-tech Research and Development Program of China [2012AA02A510]; Program of Introducing Talents of Discipline to Universities [B07035]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]; National Natural Science Foundation of China [30800468, 81100207, 81173251, 81100102, 81270350, 81000126, 81000127]	National 973 Basic Research Program of China(National Basic Research Program of China); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 973 Basic Research Program of China (No. 2011CB503906, No. 2012CB518603), the National High-tech Research and Development Program of China (No. 2012AA02A510), the Program of Introducing Talents of Discipline to Universities (No. B07035), the State Program of National Natural Science Foundation of China for Innovative Research Group (No. 81021001), and the grants of the National Natural Science Foundation of China (No. 30800468, 81100207, 81173251, 81100102, 81270350, 81000126, 81000127,). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennetts B, 2001, J PHYSIOL-LONDON, V535, P83, DOI 10.1111/j.1469-7793.2001.t01-1-00083.x; Celotto AC, 2011, EUR J PHARMACOL, V656, P88, DOI 10.1016/j.ejphar.2011.01.053; de Morais HA, 2008, VET CLIN N AM-SMALL, V38, P559, DOI 10.1016/j.cvsm.2008.02.003; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Furukawa KI, 1996, BRIT J PHARMACOL, V118, P485, DOI 10.1111/j.1476-5381.1996.tb15429.x; Gourdin MJ, 2009, EUR J ANAESTH, V26, P537, DOI 10.1097/EJA.0b013e328324b7c2; Grahnert A, 2009, PURINERG SIGNAL, V5, P309, DOI 10.1007/s11302-009-9144-4; Ives SJ, 2013, EXP PHYSIOL, V98, P256, DOI 10.1113/expphysiol.2012.066613; Jeong EM, 2012, J MOL CELL CARDIOL, V52, P454, DOI 10.1016/j.yjmcc.2011.09.018; Kellum JA, 2000, CRIT CARE, V4, P6, DOI 10.1186/cc644; Kluess HA, 2005, AM J PHYSIOL-HEART C, V288, pH129, DOI 10.1152/ajpheart.00574.2004; Lambert S, 2005, J PHYSIOL-LONDON, V567, P191, DOI 10.1113/jphysiol.2005.089888; Li J, 2008, CIRC RES, V103, pE97, DOI 10.1161/CIRCRESAHA.108.182931; Liang WB, 2009, HYPERTENSION, V54, P286, DOI 10.1161/HYPERTENSIONAHA.109.130138; Ma ZY, 2008, BIOCHEM BIOPH RES CO, V371, P437, DOI 10.1016/j.bbrc.2008.04.090; Mancarella S, 2011, J BIOL CHEM, V286, P44788, DOI 10.1074/jbc.M111.303081; Mattiazzi A, 2007, CARDIOVASC RES, V73, P648, DOI 10.1016/j.cardiores.2006.12.002; NAGESETTY R, 1994, CIRC RES, V75, P990, DOI 10.1161/01.RES.75.6.990; Overgaard J, 2007, J EXP BIOL, V210, P1687, DOI 10.1242/jeb.001925; PACAUD P, 1991, BRIT J PHARMACOL, V104, P1000, DOI 10.1111/j.1476-5381.1991.tb12540.x; Park SJ, 2008, KOREAN J PHYSIOL PHA, V12, P177, DOI 10.4196/kjpp.2008.12.4.177; Ren Z, 2008, CARDIOVASC RES, V77, P73, DOI 10.1093/cvr/cvm031; Rohra DK, 2002, EUR J PHARMACOL, V453, P279, DOI 10.1016/S0014-2999(02)02432-9; Schafer FQ, 2000, FREE RADICAL BIO MED, V28, P1175, DOI 10.1016/S0891-5849(00)00319-1; Shi CY, 2009, INT IMMUNOPHARMACOL, V9, P247, DOI 10.1016/j.intimp.2008.11.011; Smith G, 1998, SIGHT SOUND, V8, P38; Tang XH, 2012, CANCER RES, V72, P491, DOI 10.1158/0008-5472.CAN-11-2076; Woo YC, 2004, ANESTHESIOLOGY, V101, P468, DOI 10.1097/00000542-200408000-00029; Yamamoto S, 2006, AM J PHYSIOL-HEART C, V290, pH1905, DOI 10.1152/ajpheart.00965.2005; Yeo JL, 2010, EUR J PHARMACOL, V642, P99, DOI 10.1016/j.ejphar.2010.05.040	30	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61018	10.1371/journal.pone.0061018	http://dx.doi.org/10.1371/journal.pone.0061018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580361	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000090
J	Shih, KS; Lin, CC; Hung, HF; Yang, YC; Wang, CA; Jeng, KC; Fu, HW				Shih, Kuo-Shun; Lin, Chih-Chang; Hung, Hsiao-Fang; Yang, Yu-Chi; Wang, Chung-An; Jeng, Kee-Ching; Fu, Hua-Wen			One-Step Chromatographic Purification of Helicobacter pylori Neutrophil-Activating Protein Expressed in Bacillus subtilis	PLOS ONE			English	Article							ION-EXCHANGE CHROMATOGRAPHY; HP-NAP; INFLAMMATION; IMMUNOGENICITY; EPIDEMIOLOGY; ANTIBODIES; RETENTION; RESPONSES; ANTIGEN; SAFETY	Helicobacter pylori neutrophil-activating protein (HP-NAP), a major virulence factor of Helicobacter pylori (H. pylori), is capable of activating human neutrophils to produce reactive oxygen species (ROS) and secrete inammatory mediators. HP-NAP is a vaccine candidate, a possible drug target, and a potential in vitro diagnostic marker for H. pylori infection. HP-NAP has also been shown to be a novel therapeutic agent for the treatment of allergic asthma and bladder cancer. Hence, an efficient way to obtain pure HP-NAP needs to be developed. In this study, one-step anion-exchange chromatography in negative mode was applied to purify the recombinant HP-NAP expressed in Bacillus subtilis (B. subtilis). This purification technique was based on the binding of host cell proteins and/or impurities other than HP-NAP to DEAE Sephadex resins. At pH 8.0, almost no other proteins except HP-NAP passed through the DEAE Sephadex column. More than 60% of the total HP-NAP with purity higher than 91% was recovered in the flow-through fraction from this single-step DEAE Sephadex chromatography. The purified recombinant HP-NAP was further demonstrated to be a multimeric protein with a secondary structure of a-helix and capable of activating human neutrophils to stimulate ROS production. Thus, this one-step negative chromatography using DEAE Sephadex resin can efficiently yield functional HP-NAP from B. subtilis in its native form with high purity. HP-NAP purified by this method could be further utilized for the development of new drugs, vaccines, and diagnostics for H. pylori infection.	[Shih, Kuo-Shun; Lin, Chih-Chang; Hung, Hsiao-Fang; Yang, Yu-Chi; Wang, Chung-An; Fu, Hua-Wen] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Hung, Hsiao-Fang] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Jeng, Kee-Ching] Taichung Vet Gen Hosp, Dept Res, Taichung, Taiwan; [Fu, Hua-Wen] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Tsing Hua University; Taichung Veterans General Hospital; National Tsing Hua University	Fu, HW (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	hwfu@life.nthu.edu.tw		Fu, Hua-Wen/0000-0002-6346-2785	National Research Program for Genomic Medicine, National Science Council, Taiwan [NSC95-3112-B-007-003, NSC96-3112-B-007-003]; National Science Council of Taiwan [NSC98-2311-B-007-006-MY3, NSC101-2311-B-007-007]; National Tsing Hua University [100N7727E1, 101N2727E1]; Mackay Memorial Hospital [100N7727E1, 101N2727E1]	National Research Program for Genomic Medicine, National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University; Mackay Memorial Hospital	This work was supported by grants from the National Research Program for Genomic Medicine, National Science Council, Taiwan (NSC95-3112-B-007-003 and NSC96-3112-B-007-003) and partially supported by grants from the National Science Council of Taiwan (NSC98-2311-B-007-006-MY3 and NSC101-2311-B-007-007) and the Joint Research Program of National Tsing Hua University and Mackay Memorial Hospital (100N7727E1 and 101N2727E1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedei A, 2006, J CLIN INVEST, V116, P1092, DOI 10.1172/JCI27177; Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040; Ceci P, 2007, NUCLEIC ACIDS RES, V35, P2247, DOI 10.1093/nar/gkm077; Choli-Papadopoulou T, 2011, WORLD J GASTROENTERO, V17, P2585, DOI 10.3748/wjg.v17.i21.2585; Codolo G, 2008, CELL MICROBIOL, V10, P2355, DOI 10.1111/j.1462-5822.2008.01217.x; Codolo G, 2012, CANCER IMMUNOL IMMUN, V61, P31, DOI 10.1007/s00262-011-1087-2; Del Prete G, 2008, J ALLERGY CLIN IMMUN, V122, P908, DOI 10.1016/j.jaci.2008.08.016; EVANS DJ, 1995, INFECT IMMUN, V63, P2213, DOI 10.1128/IAI.63.6.2213-2220.1995; FIOCCA R, 1994, SCAND J GASTROENTERO, V29, P11, DOI 10.3109/00365529409091404; Go MF, 2002, ALIMENT PHARM THER, V16, P3, DOI 10.1046/j.1365-2036.2002.0160s1003.x; Grandi G, 2006, United States patent application, Patent No. [US 7038012 B1, 7038012]; Hallgren E, 2000, J CHROMATOGR A, V877, P13, DOI 10.1016/S0021-9673(00)00190-4; Heit B, 2006, J IMMUNOL, V177, P6405, DOI 10.4049/jimmunol.177.9.6405; Iankov ID, 2011, VACCINE, V29, P1710, DOI 10.1016/j.vaccine.2010.12.020; Kang QZ, 2005, WORLD J GASTROENTERO, V11, P454, DOI 10.3748/wjg.v11.i3.454; KAWAMURA F, 1984, J BACTERIOL, V160, P442, DOI 10.1128/JB.160.1.442-444.1984; KOPACIEWICZ W, 1983, J CHROMATOGR, V266, P3, DOI 10.1016/S0021-9673(01)90875-1; Kottakis F, 2008, FEBS J, V275, P302, DOI 10.1111/j.1742-4658.2007.06201.x; Li W, 2009, MULT SCLER J, V15, P1411, DOI 10.1177/1352458509348961; Long M, 2009, WORLD J GASTROENTERO, V15, P2381, DOI 10.3748/wjg.15.2381; Malfertheiner P, 2008, GASTROENTEROLOGY, V135, P787, DOI 10.1053/j.gastro.2008.05.054; MARSHALL BJ, 1984, LANCET, V1, P1311; Montemurro P, 2001, J INFECT DIS, V183, P1055, DOI 10.1086/319280; Polenghi A, 2007, J IMMUNOL, V178, P1312, DOI 10.4049/jimmunol.178.3.1312; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; Rossi G, 2004, INFECT IMMUN, V72, P3252, DOI 10.1128/IAI.72.6.3252-3259.2004; Satin B, 2000, J EXP MED, V191, P1467, DOI 10.1084/jem.191.9.1467; Tang RX, 2008, WORLD J GASTROENTERO, V14, P4816, DOI 10.3748/wjg.14.4816; Thoreson ACE, 2000, J CLIN MICROBIOL, V38, P3436, DOI 10.1128/JCM.38.9.3436-3441.2000; Tonello F, 1999, MOL MICROBIOL, V34, P238, DOI 10.1046/j.1365-2958.1999.01584.x; Wang CA, 2008, BIOCHEM BIOPH RES CO, V377, P52, DOI 10.1016/j.bbrc.2008.09.072; Xu WS, 1998, J CHROMATOGR A, V828, P357, DOI 10.1016/S0021-9673(98)00641-4; Yeh CM, 2007, FOOD BIOTECHNOL, V21, P105, DOI 10.1080/08905430701410506; Yeh Chuan-Mei, 2005, Taiwanese Journal of Agricultural Chemistry and Food Science, V43, P368; Zanotti G, 2002, J MOL BIOL, V323, P125, DOI 10.1016/S0022-2836(02)00879-3	35	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60786	10.1371/journal.pone.0060786	http://dx.doi.org/10.1371/journal.pone.0060786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577158	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000069
J	Boulkedid, R; Sibony, O; Goffinet, F; Fauconnier, A; Branger, B; Alberti, C				Boulkedid, Rym; Sibony, Olivier; Goffinet, Francois; Fauconnier, Arnaud; Branger, Bernard; Alberti, Corinne			Quality Indicators for Continuous Monitoring to Improve Maternal and Infant Health in Maternity Departments: A Modified Delphi Survey of an International Multidisciplinary Panel	PLOS ONE			English	Article							PERFORMANCE INDICATORS; PRIMARY-CARE; APGAR SCORE; CONSENSUS METHODS; GENERAL-PRACTICE; DISEASE; CHILDHOOD; MORTALITY; MEDICINE; SERVICES	Objective: Measuring the quality of inpatient obstetrical care using quality indicators is becoming increasingly important for both patients and healthcare providers. However, there is no consensus about which measures are optimal. We describe a modified Delphi method to identify a set of indicators for continuously monitoring the quality of maternity care by healthcare professionals. Methodology and Main Findings: An international French-speaking multidisciplinary panel comprising 22 obstetricians-gynaecologists, 12 midwives, and 1 paediatrician assessed potential indicators extracted from a medical literature search, using a two-round Delphi procedure followed by a physical meeting. Each panellist rated each indicator based on validity and feasibility. In the first round, 35 panellists from 5 countries and 20 maternity units evaluated 26 indicators including 15 related to the management of the overall population of pregnant women, 3 to the management of women followed from the first trimester of pregnancy, 2 to the management of low-risk pregnant women, and 6 to the management of neonates. 25 quality indicators were kept for next step. In the second round, 27 (27/35: 77%) panellists selected 17 indicators; the remaining 8 indicators were discussed during a physical meeting. The final set comprised 18 indicators. Conclusion: A multidisciplinary panel selected indicators that reflect the quality of obstetrical care. This set of indicators could be used to assess and monitor obstetrical care, with the goal of improving the quality of care in maternity units.	[Boulkedid, Rym; Alberti, Corinne] Hop Robert Debre, AP HP, Unite Epidemiol Clin, F-75019 Paris, France; [Boulkedid, Rym; Alberti, Corinne] INSERM, CIE 5, Paris, France; [Sibony, Olivier] Hop Robert Debre, AP HP, Hosp Gynecol Obstet, F-75019 Paris, France; [Sibony, Olivier; Alberti, Corinne] Univ Paris Diderot, Paris, France; [Goffinet, Francois; Fauconnier, Arnaud] UPMC, INSERM, Unite Rech Epidemiol Sante Perinatale & Sante Fem, U953, Paris, France; [Goffinet, Francois] Hop Cochin Broca, AP HP, Hotel Dieu, Paris, France; [Goffinet, Francois] Univ Paris 05, Paris, France; [Fauconnier, Arnaud] CHI Poissy St Germain Laye, Serv Gynecol Obstet, Poissy, France; [Branger, Bernard] Ruseau Secur Naissance Naitre Ensemble, Nantes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Chi of Poissy Saint Germain	Boulkedid, R (corresponding author), Hop Robert Debre, AP HP, Unite Epidemiol Clin, F-75019 Paris, France.	rym.boulkedid@rdb.aphp.fr		GOFFINET, Francois/0000-0001-9643-0299	Reseau Mere-Enfant de la Francophonie	Reseau Mere-Enfant de la Francophonie	This work was supported by the Reseau Mere-Enfant de la Francophonie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelsen NK, 2001, ARCH DIS CHILD, V85, P183, DOI 10.1136/adc.85.3.183; [Anonymous], 2003, QUAL IMPR EM OBST CA; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Bailit JL, 2007, OBSTET GYNECOL SURV, V62, P207, DOI 10.1097/01.ogx.0000256800.21193.ce; BANTEL KA, 1993, PSYCHOL REP, V73, P35, DOI 10.2466/pr0.1993.73.1.35; Baud O, 2008, J GYNECOL OBST BIO R, V37, pS260, DOI 10.1016/S0368-2315(08)74763-X; Beattie E, 2004, EMERG MED J, V21, P47, DOI 10.1136/emj.2003.001123; Boulkedid R, 2010, BJOG-INT J OBSTET GY, V117, P1225, DOI 10.1111/j.1471-0528.2010.02632.x; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Campbell SM, 2001, J CLIN PHARM THER, V26, P5, DOI 10.1046/j.1365-2710.2001.00331.x; Campbell SM, 2000, BRIT MED J, V321, P425, DOI 10.1136/bmj.321.7258.425; CATLIN EA, 1986, J PEDIATR-US, V109, P865, DOI 10.1016/S0022-3476(86)80715-6; Clark SL, 2008, OBSTET GYNECOL, V112, P1279, DOI 10.1097/AOG.0b013e31818da2c7; COULTER I, 1995, HEALTH SERV RES, V30, P577; Draycott T, 2010, BJOG-INT J OBSTET GY, V117, P1571, DOI 10.1111/j.1471-0528.2010.02734.x; Esmaily HM, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-33; Florea A, 2010, J OBSTET GYNAECOL CA, V32, P657, DOI 10.1016/S1701-2163(16)34569-8; Gagliardi AR, 2005, GYNECOL ONCOL, V97, P446, DOI 10.1016/j.ygyno.2004.12.059; Gdalevich M, 2001, J AM ACAD DERMATOL, V45, P520, DOI 10.1067/mjd.2001.114741; Gibberd R, 2004, INT J QUAL HEALTH C, V16, pI37, DOI 10.1093/intqhc/mzh019; Grol R, 2001, MED CARE, V39, pII46; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hegyi T, 1998, PEDIATRICS, V101, P77, DOI 10.1542/peds.101.1.77; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Hong CS, 2010, JAMA-J AM MED ASSOC, V304, P1107, DOI 10.1001/jama.2010.1287; Jacob S, 1998, OBSTET GYNECOL, V91, P187, DOI 10.1016/S0029-7844(97)00664-9; Jairath N, 1994, Can J Nurs Adm, V7, P29; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Lindsay P, 2002, ACAD EMERG MED, V9, P1131, DOI 10.1197/aemj.9.11.1131; MAJEED FA, 1995, BRIT MED J, V311, P209, DOI 10.1136/bmj.311.6999.209; Mann S, 2006, JT COMM J QUAL PATIE, V32, P497, DOI 10.1016/S1553-7250(06)32065-X; Mullen Penelope M, 2004, Health Serv Manage Res, V17, P217, DOI 10.1258/0951484042317723; Normand SLT, 1998, INT J QUAL HEALTH C, V10, P247, DOI 10.1093/intqhc/10.3.247; Pollak VE, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-38; ROLAND M, 1998, QUALITY ASSESSMENT G; Rudiger M, 2009, ACTA PAEDIATR, V98, P1433, DOI 10.1111/j.1651-2227.2009.01347.x; Shield T, 2003, QUAL SAF HEALTH CARE, V12, P100, DOI 10.1136/qhc.12.2.100; Smith LFP, 2001, QUAL HEALTH CARE, V10, P17, DOI 10.1136/qhc.10.1.17; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Walker A, 1996, BR J THER REHABIL, V3, P677, DOI 10.12968/bjtr.1996.3.12.14731; Wang CJ, 2006, PEDIATRICS, V117, P2080, DOI 10.1542/peds.2005-1904; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; Weerasekera D S, 2002, J Obstet Gynaecol, V22, P344; Wensing M, 2002, QUAL SAF HEALTH CARE, V11, P153, DOI 10.1136/qhc.11.2.153	46	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60663	10.1371/journal.pone.0060663	http://dx.doi.org/10.1371/journal.pone.0060663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RZ	23577143	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800084
J	Carassou, L; Leopold, M; Guillemot, N; Wantiez, L; Kulbicki, M				Carassou, Laure; Leopold, Marc; Guillemot, Nicolas; Wantiez, Laurent; Kulbicki, Michel			Does Herbivorous Fish Protection Really Improve Coral Reef Resilience? A Case Study from New Caledonia (South Pacific)	PLOS ONE			English	Article							ALGAL PHASE-SHIFTS; GREAT-BARRIER-REEF; CLIMATE-CHANGE; MARINE RESERVES; PHYTOPLANKTON COMMUNITIES; STOCK ASSESSMENT; CARIBBEAN REEFS; FLORIDA-KEYS; LONG-TERM; RECOVERY	Parts of coral reefs from New Caledonia (South Pacific) were registered at the UNESCO World Heritage list in 2008. Management strategies aiming at preserving the exceptional ecological value of these reefs in the context of climate change are currently being considered. This study evaluates the appropriateness of an exclusive fishing ban of herbivorous fish as a strategy to enhance coral reef resilience to hurricanes and bleaching in the UNESCO-registered areas of New Caledonia. A two-phase approach was developed: 1) coral, macroalgal, and herbivorous fish communities were examined in four biotopes from 14 reefs submitted to different fishing pressures in New Caledonia, and 2) results from these analyses were challenged in the context of a global synthesis of the relationship between herbivorous fish protection, coral recovery and relative macroalgal development after hurricanes and bleaching. Analyses of New Caledonia data indicated that 1) current fishing pressure only slightly affected herbivorous fish communities in the country, and 2) coral and macroalgal covers remained unrelated, and macroalgal cover was not related to the biomass, density or diversity of macroalgae feeders, whatever the biotope or level of fishing pressure considered. At a global scale, we found no relationship between reef protection status, coral recovery and relative macroalgal development after major climatic events. These results suggest that an exclusive protection of herbivorous fish in New Caledonia is unlikely to improve coral reef resilience to large-scale climatic disturbances, especially in the lightly fished UNESCO-registered areas. More efforts towards the survey and regulation of major chronic stress factors such as mining are rather recommended. In the most heavily fished areas of the country, carnivorous fish and large targeted herbivores may however be monitored as part of a precautionary approach.	[Carassou, Laure; Guillemot, Nicolas] IRD, Res Unit Coreus 227, Noumea, New Caledonia; [Leopold, Marc] IRD, Vanuatu Fisheries Dept, Res Unit Coreus 227, Port Vila, Vanuatu; [Wantiez, Laurent] Univ New Caledonia, Res Unit LIVE EA4243, Noumea, New Caledonia; [Wantiez, Laurent] Aquarium Lagons, Noumea, New Caledonia; [Kulbicki, Michel] IRD, Lab Arago, Res Unit Coreus 227, Banyuls Sur Mer, France	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Universite Nouvelle Caledonie; Institut de Recherche pour le Developpement (IRD)	Carassou, L (corresponding author), IRD, Res Unit Coreus 227, Noumea, New Caledonia.	l.carassou@ru.ac.za	Wantiez, Laurent/L-3343-2013; Carassou, Laure/L-3425-2013	Wantiez, Laurent/0000-0001-5024-2057; Carassou, Laure/0000-0001-8024-8038; Kulbicki, Michel/0000-0003-1258-5061	French Initiative for Coral Reefs (IFRECOR) in New Caledonia; World Wildlife Fund (WWF); Zoneco program	French Initiative for Coral Reefs (IFRECOR) in New Caledonia; World Wildlife Fund (WWF); Zoneco program	This study has been funded by the French Initiative for Coral Reefs (IFRECOR) in New Caledonia. Data collection in the Unesco World Heritage sites was funded by the Northern, Southern and Loyalty Provinces authorities from new Caledonia and the World Wildlife Fund (WWF). Data collection in Kone area involved the Aquaculture and Fisheries Department of the Northern Province of New Caledonia, Koniambo Nickel SAS, the Secretariat of the Pacific Community, and the IRD. The Zoneco program funded data collection in Moindou, Thio, Canala and Lifou sites. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Andrefouet S, 2010, MAR POLLUT BULL, V61, P612, DOI 10.1016/j.marpolbul.2010.06.031; Andrefouet S, 2009, CORAL REEFS, V28, P691, DOI 10.1007/s00338-009-0503-y; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burke L., 2011, REEF RISK REVISITED; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Burt J, 2008, MAR BIOL, V154, P27, DOI 10.1007/s00227-007-0892-9; Bythell JC, 2000, MAR ECOL PROG SER, V204, P93, DOI 10.3354/meps204093; CAMERON AM, 1991, MAR ECOL PROG SER, V75, P251, DOI 10.3354/meps075251; Chabanet P, 2010, MAR POLLUT BULL, V61, P598, DOI 10.1016/j.marpolbul.2010.06.032; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Choat J. Howard, 2002, P57; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; Coles SL, 2007, CORAL REEFS, V26, P705, DOI 10.1007/s00338-007-0257-3; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; David G, 2010, MAR POLLUT BULL, V61, P323, DOI 10.1016/j.marpolbul.2010.06.020; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; DOLLAR SJ, 1993, CORAL REEFS, V12, P223, DOI 10.1007/BF00334481; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; Fenner Douglas, 2012, Diversity, V4, P105, DOI 10.3390/d4010105; Floeter SR, 2005, MAR BIOL, V147, P1435, DOI 10.1007/s00227-005-0027-0; Fricke Ronald, 2011, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V4, P341; FROESE R., 2012, FISHBASE; Fung T, 2011, ECOLOGY, V92, P967, DOI 10.1890/10-0378.1; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Guillemot N, 2010, CORAL REEFS, V29, P445, DOI 10.1007/s00338-010-0587-4; Guillemot N, 2009, FISH RES, V98, P51, DOI 10.1016/j.fishres.2009.03.013; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Hawkins JP, 2006, BIOL CONSERV, V127, P487, DOI 10.1016/j.biocon.2005.09.008; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2005, LIMNOL OCEANOGR, V50, P265, DOI 10.4319/lo.2005.50.1.0265; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoey AS, 2010, MAR BIOL, V157, P189, DOI 10.1007/s00227-009-1309-8; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; Iltis J, 1984, NRTS25UNUP505; Jacquet S, 2006, MAR ECOL PROG SER, V320, P65, DOI 10.3354/meps320065; Jameson SC, 2002, MAR POLLUT BULL, V44, P1177, DOI 10.1016/S0025-326X(02)00258-8; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jollit I, 2010, MAR POLLUT BULL, V61, P585, DOI 10.1016/j.marpolbul.2010.06.033; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Keller BD, 2009, ENVIRON MANAGE, V44, P1069, DOI 10.1007/s00267-009-9346-0; Knowlton N, 1990, SMITHSON CONTR MAR S, V31, P1, DOI DOI 10.5479/SI.01960768.31.1; Kramer KL, 2007, MAR ECOL PROG SER, V349, P111, DOI 10.3354/meps07083; Kulbicki M, 2005, CYBIUM, V29, P235; Kulbicki M, 2006, THESIS ECOLE PRATIQU; Kulbicki M, 2007, J EXP MAR BIOL ECOL, V353, P145, DOI 10.1016/j.jembe.2007.02.021; Kulbicki Michel, 1997, Cybium, V21, P47; Labrosse P, 2000, AQUAT LIVING RESOUR, V13, P91, DOI 10.1016/S0990-7440(00)00143-1; Lasagna R, 2008, CHEM ECOL, V24, P67, DOI 10.1080/02757540801966454; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Leopold M, 2004, AQUAT LIVING RESOUR, V17, P119, DOI 10.1051/alr:2004020; Letourneur Y, 2000, AQUAT LIVING RESOUR, V13, P65, DOI 10.1016/S0990-7440(00)00145-5; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McClanahan T, 2002, AMBIO, V31, P543, DOI 10.1639/0044-7447(2002)031[0543:EOTCME]2.0.CO;2; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2000, MAR POLLUT BULL, V40, P587, DOI 10.1016/S0025-326X(00)00064-3; McClanahan TR, 1997, J EXP MAR BIOL ECOL, V218, P77, DOI 10.1016/S0022-0981(97)00069-5; McClanahan TR, 1997, J EXP MAR BIOL ECOL, V209, P103, DOI 10.1016/S0022-0981(96)02663-9; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; McManus JW, 2000, ICES J MAR SCI, V57, P572, DOI 10.1006/jmsc.2000.0720; Mellin C, 2007, ESTUAR COAST SHELF S, V75, P481, DOI 10.1016/j.ecss.2007.05.026; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Pascal M, 2008, CONSERV BIOL, V22, P498, DOI 10.1111/j.1523-1739.2008.00889.x; Payri CE, 2006, DOCUMENTS SCI TECHNI, VII7, P93; Pichon M., 2006, COMPENDIUM MARINE SP, V7, P147; Rasher DB, 2012, OECOLOGIA, V169, P187, DOI 10.1007/s00442-011-2174-y; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; Richer de Forges B, 1998, THESIS MUSEUM NATL H; Riegl B, 2002, MAR BIOL, V140, P29, DOI 10.1007/s002270100676; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; ROGERS CS, 1991, MAR ECOL PROG SER, V78, P189, DOI 10.3354/meps078189; Rossier O, 2000, CYBIUM, V24, P3; Sale P. F., 2002, CORAL REEF FISHES DY; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Shulman MJ, 1996, CORAL REEFS, V15, P231, DOI 10.1007/s003380050048; Smith LD, 2008, CORAL REEFS, V27, P197, DOI 10.1007/s00338-007-0311-1; Somerfield PJ, 2008, CORAL REEFS, V27, P951, DOI 10.1007/s00338-008-0390-7; Steneck RS, 2009, CORAL REEFS, V28, P367, DOI 10.1007/s00338-009-0470-3; Tenorio MMB, 2005, ESTUAR COAST SHELF S, V64, P531, DOI 10.1016/j.ecss.2005.02.030; Verges A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045543; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wantiez L, 2006, J MAR BIOL ASSOC UK, V86, P1229, DOI 10.1017/S0025315406014238; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilkinson C, 2008, STATUS CARIBBEAN COR; Williams ID, 2001, MAR ECOL PROG SER, V222, P187, DOI 10.3354/meps222187; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121	108	31	31	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60564	10.1371/journal.pone.0060564	http://dx.doi.org/10.1371/journal.pone.0060564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577123	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800063
J	Gannoun-Zaki, L; Alibaud, L; Carrere-Kremer, S; Kremer, L; Blanc-Potard, AB				Gannoun-Zaki, Laila; Alibaud, Laeticia; Carrere-Kremer, Severine; Kremer, Laurent; Blanc-Potard, Anne-Beatrice			Overexpression of the KdpF Membrane Peptide in Mycobacterium bovis BCG Results in Reduced Intramacrophage Growth and Altered Cording Morphology	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTISENSE RNA; TUBERCULOSIS; VIRULENCE; PROTEINS; COMPLEX; EXPRESSION; IDENTIFICATION; SURVIVAL; BIOLOGY	Membrane peptides appear as an emerging class of regulatory molecules in bacteria, which can interact with membrane proteins, such as sensor kinases. To date, regulatory membrane peptides have been completely overlooked in mycobacteria. The 30 amino-acid-long KdpF peptide, which is co-transcribed with kdpABC genes and regulated by the KdpDE two-component system, is supposed to stabilize the KdpABC potassium transporter complex but may also exhibit unsuspected regulatory function(s) towards the KdpD sensor kinase. Herein, we showed by quantitative RT-PCR that the Mycobacterium bovis BCG kdpAB and kdpDE genes clusters are differentially induced in potassium-deprived broth medium or within infected macrophages. We have overexpressed the kdpF gene in M. bovis BCG to investigate its possible regulatory role and effect on mycobacterial virulence. Our results indicate that KdpF does not play a critical regulatory role on kdp genes expression despite the fact that KdpF interacts with the KdpD sensor kinase in a bacterial two-hybrid assay. However, overexpression of kdpF results in a significant reduction of M. bovis BCG growth in both murine and human primary macrophages, and is associated with a strong alteration of colonial morphology and impaired cording formation. To identify novel KdpF interactants, a mycobacterial library was screened using KdpF as bait in the bacterial two-hybrid system. This allowed us to identify members of the MmpL family of membrane proteins, known to participate in the biosynthesis/transport of various cell wall lipids, thus highlighting a possible link between KdpF and cell wall lipid metabolism. Taken together, these data suggest that KdpF overexpression reduces intramacrophage growth which may result from alteration of the mycobacterial cell wall.	[Gannoun-Zaki, Laila; Alibaud, Laeticia; Carrere-Kremer, Severine; Kremer, Laurent; Blanc-Potard, Anne-Beatrice] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR5235, Montpellier, France; [Gannoun-Zaki, Laila; Alibaud, Laeticia; Carrere-Kremer, Severine; Kremer, Laurent; Blanc-Potard, Anne-Beatrice] Univ Montpellier I, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR5235, Montpellier, France; [Kremer, Laurent] CNRS, INSERM, UMR5235, DIMNP, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Blanc-Potard, AB (corresponding author), Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR5235, Montpellier, France.	anne.blanc-potard@univ-montp2.fr	Kremer, Laurent/M-4935-2017; Blanc-Potard, Anne/AAI-9542-2021	Kremer, Laurent/0000-0002-6604-4458; Blanc-Potard, Anne/0000-0001-9963-6786; Gannoun, Laila/0000-0002-9644-1083	French Research Agency [ANR-10-MIDI-010, ANR-06-MIME-027-01]	French Research Agency(French National Research Agency (ANR))	This work was supported by the French Research Agency (ANR-10-MIDI-010 to LA and ANR-06-MIME-027-01 to SCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix E, 2008, EMBO J, V27, P546, DOI 10.1038/sj.emboj.7601983; Alix E, 2009, MOL MICROBIOL, V72, P5, DOI 10.1111/j.1365-2958.2009.06626.x; Bessoles S, 2009, EUR J IMMUNOL, V39, P1025, DOI 10.1002/eji.200838929; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; de Chastellier C, 2009, CELL MICROBIOL, V11, P1190, DOI 10.1111/j.1462-5822.2009.01324.x; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Eguchi Y, 2007, P NATL ACAD SCI USA, V104, P18712, DOI 10.1073/pnas.0705768104; Eguchi Y, 2012, MOL MICROBIOL, V85, P299, DOI 10.1111/j.1365-2958.2012.08114.x; Gassel M, 1999, J BIOL CHEM, V274, P37901, DOI 10.1074/jbc.274.53.37901; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Greie JC, 2007, J BIOENERG BIOMEMBR, V39, P397, DOI 10.1007/s10863-007-9111-0; Greie JC, 2011, EUR J CELL BIOL, V90, P705, DOI 10.1016/j.ejcb.2011.04.011; Hamann K, 2008, J BACTERIOL, V190, P2360, DOI 10.1128/JB.01635-07; Haydel SE, 2004, FEMS MICROBIOL LETT, V236, P341, DOI 10.1016/j.femsle.2004.06.010; Hemm MR, 2010, J BACTERIOL, V192, P46, DOI 10.1128/JB.00872-09; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Hobbs EC, 2011, CURR OPIN MICROBIOL, V14, P167, DOI 10.1016/j.mib.2011.01.007; Hu J, 2007, PROTEIN SCI, V16, P2153, DOI 10.1110/ps.072996707; Julian E, 2010, J BACTERIOL, V192, P1751, DOI 10.1128/JB.01485-09; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawano M, 2002, MOL MICROBIOL, V45, P333, DOI 10.1046/j.1365-2958.2002.03042.x; Klepp LI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-3; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; Lippa AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000788; LORIAN V, 1969, APPL MICROBIOL, V17, P559, DOI 10.1128/AEM.17.4.559-562.1969; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Shin SJ, 2006, INFECT IMMUN, V74, P3825, DOI 10.1128/IAI.01742-05; Steyn AJC, 2003, MOL MICROBIOL, V47, P1074, DOI 10.1046/j.1365-2958.2003.03356.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Veyron-Churlet R, 2011, TUBERCULOSIS, V91, P544, DOI 10.1016/j.tube.2011.06.008; Wagner D, 2005, MICROBIOL-SGM, V151, P323, DOI 10.1099/mic.0.27213-0	39	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60379	10.1371/journal.pone.0060379	http://dx.doi.org/10.1371/journal.pone.0060379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577107	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800047
J	Gou, SJ; Xu, PC; Chen, M; Zhao, MH				Gou, Shen-Ju; Xu, Peng-Cheng; Chen, Min; Zhao, Ming-Hui			Epitope Analysis of Anti-Myeloperoxidase Antibodies in Patients with ANCA-Associated Vasculitis	PLOS ONE			English	Article							WEGENERS-GRANULOMATOSIS; CHINESE PATIENTS; MPO-ANCA; MICROSCOPIC POLYANGIITIS; SYSTEMIC VASCULITIDES; MYELOPEROXIDASE; AUTOANTIBODIES; DISEASE; SERA; GLOMERULONEPHRITIS	Objective: Increasing evidences have suggested the pathogenic role of anti-neutrophil cytoplasmic antibodies (ANCA) directing myeloperoxidase (MPO) in ANCA-associated vasculitis (AAV). The current study aimed to analyze the association between the linear epitopes of MPO-ANCA and clinicopathological features of patients with AAV. Methods: Six recombinant linear fragments, covering the whole length amino acid sequence of a single chain of MPO, were produced from E. coli. Sera from 77 patients with AAV were collected at presentation. 13 out of the 77 patients had coexistence of serum anti-GBM antibodies. Ten patients also had sequential sera during follow up. The epitope specificities were detected by enzyme-linked immunosorbent assay using the recombinant fragments as solid phase ligands. Results: Sera from 45 of the 77 (58.4%) patients with AAV showed a positive reaction to one or more linear fragments of the MPO chain. The Birmingham Vasculitis Activity Scores and the sera creatinine were significantly higher in patients with positive binding to the light chain fragment than that in patients without the binding. The epitopes recognized by MPO-ANCA from patients with co-existence of serum anti-GBM antibodies were mainly located in the N-terminus of the heavy chain. In 5 out of the 6 patients, whose sera in relapse recognize linear fragments, the reactivity to linear fragments in relapse was similar to that of initial onset. Conclusion: The epitope specificities of MPO-ANCA were associated with disease activity and some clinicopathological features in patients with ANCA-associated vasculitis.	[Gou, Shen-Ju; Xu, Peng-Cheng; Chen, Min; Zhao, Ming-Hui] Peking Univ, Hosp 1,Dept Med,Minist Educ, Inst Nephrol,Minist Hlth China,Key Lab Renal Dis, Key Lab Chron Kidney Dis Prevent & Treatment,Rena, Beijing 100871, Peoples R China	Peking University	Chen, M (corresponding author), Peking Univ, Hosp 1,Dept Med,Minist Educ, Inst Nephrol,Minist Hlth China,Key Lab Renal Dis, Key Lab Chron Kidney Dis Prevent & Treatment,Rena, Beijing 100871, Peoples R China.	leimeng@public3.bta.net.cn	Xu, Pengcheng/J-1429-2012	Xu, Pengcheng/0000-0001-8651-208X	Chinese 973 project [2012CB517702]; Research Fund for the Doctoral Program of Higher Education of China [20120001110018]; "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China [2011BAI10B04]; National Natural Science Fund [81021004]	Chinese 973 project(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China; National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This study is supported by a grant of Chinese 973 project (No. 2012CB517702), the Research Fund for the Doctoral Program of Higher Education of China (No. 20120001110018), "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China (No. 2011BAI10B04) and a grant of the National Natural Science Fund (No. 81021004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIMURA Y, 1993, CLIN NEPHROL, V40, P256; Bansal PJ, 2004, ANN ALLERG ASTHMA IM, V93, P398, DOI 10.1016/S1081-1206(10)61400-7; Birck R, 2006, AM J KIDNEY DIS, V47, P15, DOI 10.1053/j.ajkd.2005.09.022; Bruner BF, 2011, CLIN EXP IMMUNOL, V164, P330, DOI 10.1111/j.1365-2249.2011.04372.x; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; Chen M, 2005, POSTGRAD MED J, V81, P723, DOI 10.1136/pgmj.2005.034215; Chen M, 2005, KIDNEY INT, V68, P2225, DOI 10.1111/j.1523-1755.2005.00679.x; Chen M, 2008, MEDICINE, V87, P203, DOI 10.1097/MD.0b013e31817c744b; Chen M, 2007, NEPHROL DIAL TRANSPL, V22, P139, DOI 10.1093/ndt/gfl509; Chen M, 2010, NEPHROL DIAL TRANSPL, V25, P2062, DOI 10.1093/ndt/gfq134; Cui Z, 2005, NEPHRON CLIN PRACT, V99, pC49, DOI 10.1159/000083133; Erdbrugger U, 2006, KIDNEY INT, V69, P1799, DOI 10.1038/sj.ki.5000354; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Falk RJ, 1997, J AM SOC NEPHROL, V8, P314; Fujieda M, 2005, CLIN NEPHROL, V63, P437; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; Hellmark T, 1997, J AM SOC NEPHROL, V8, P376; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; Holland M, 2004, CLIN EXP IMMUNOL, V138, P183, DOI 10.1111/j.1365-2249.2004.02566.x; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; KOKOLINA E, 1994, KIDNEY INT, V46, P177, DOI 10.1038/ki.1994.257; LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807; Lin W, 2009, AUTOIMMUNITY, V42, P198, DOI 10.1080/08916930802668594; Liu LJ, 2008, NEPHROLOGY, V13, P629, DOI 10.1111/j.1440-1797.2008.00976.x; Locke IC, 1999, CLIN EXP IMMUNOL, V115, P369, DOI 10.1046/j.1365-2249.1999.00809.x; Pankhurst T, 2011, CLIN EXP IMMUNOL, V164, P218, DOI 10.1111/j.1365-2249.2011.04367.x; SHORT AK, 1995, AM J KIDNEY DIS, V26, P439, DOI 10.1016/0272-6386(95)90489-1; Suzuki K, 2007, MICROBIOL IMMUNOL, V51, P1215, DOI 10.1111/j.1348-0421.2007.tb04017.x; Tomizawa K, 1998, J CLIN IMMUNOL, V18, P142, DOI 10.1023/A:1023251001261; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Ye H, 2004, CLIN EXP IMMUNOL, V138, P179, DOI 10.1111/j.1365-2249.2004.02557.x; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5; Zhao MH, 1996, J IMMUNOL METHODS, V197, P121, DOI 10.1016/0022-1759(96)00123-8	33	18	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60530	10.1371/journal.pone.0060530	http://dx.doi.org/10.1371/journal.pone.0060530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577119	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800058
J	Jin, RJ; Sterling, JA; Edwards, JR; DeGraff, DJ; Lee, C; Park, SI; Matusik, RJ				Jin, Renjie; Sterling, Julie A.; Edwards, James R.; DeGraff, David J.; Lee, Changki; Park, Serk In; Matusik, Robert J.			Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in Bone	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; RECEPTOR ACTIVATOR; NUCLEAR-LOCALIZATION; METASTASIS; MECHANISMS; PROGRESSION; OSTEOCLASTOGENESIS; EXPRESSION; DISEASE; OSTEOPROTEGERIN	Patients with advanced prostate cancer almost invariably develop osseous metastasis. Although many studies indicate that the activation of NF-kappa B signaling appears to be correlated with advanced cancer and promotes tumor metastasis by influencing tumor cell migration and angiogenesis, the influence of altered NF-kappa B signaling in prostate cancer cells within boney metastatic lesions is not clearly understood. While C4-2B and PC3 prostate cancer cells grow well in the bone, LNCaP cells are difficult to grow in murine bone following intraskeletal injection. Our studies show that when compared to LNCaP, NF-kappa B activity is significantly higher in C4-2B and PC3, and that the activation of NF-kappa B signaling in prostate cancer cells resulted in the increased expression of the osteoclast inducing genes PTHrP and RANKL. Further, conditioned medium derived from NF-kappa B activated LNCaP cells induce osteoclast differentiation. In addition, inactivation of NF-kappa B signaling in prostate cancer cells inhibited tumor formation in the bone, both in the osteolytic PC3 and osteoblastic/osteoclastic mixed C4-2B cells; while the activation of NF-kappa B signaling in LNCaP cells promoted tumor establishment and proliferation in the bone. The activation of NF-kappa B in LNCaP cells resulted in the formation of an osteoblastic/osteoclastic mixed tumor with increased osteoclasts surrounding the new formed bone, similar to metastases commonly seen in patients with prostate cancer. These results indicate that osteoclastic reaction is required even in the osteoblastic cancer cells and the activation of NF-kappa B signaling in prostate cancer cells increases osteoclastogenesis by up-regulating osteoclastogenic genes, thereby contributing to bone metastatic formation.	[Jin, Renjie; DeGraff, David J.; Matusik, Robert J.] Vanderbilt Univ, Med Ctr, Vanderbilt Prostate Canc Ctr, Nashville, TN 37235 USA; [Jin, Renjie; DeGraff, David J.; Matusik, Robert J.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN USA; [Sterling, Julie A.; Lee, Changki; Park, Serk In] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Bone Biol, Nashville, TN USA; [Sterling, Julie A.] Tennessee Valley Healthcare Syst Nashville, Dept Vet Affairs, Nashville, TN USA; [Edwards, James R.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of Oxford	Jin, RJ (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Prostate Canc Ctr, Nashville, TN 37235 USA.	renjie.jin@vanderbilt.edu	Park, Serk In/D-2840-2011	Park, Serk In/0000-0001-8643-5096; Matusik, Robert/0000-0003-2057-9892	Department of Defense (DOD) Prostate Cancer Research Program (PCRP) [W81XWH-10-1-0236]; TMEN [5U54 CA 126505]; Vanderbilt University Bone Center PPG [5P01 CA40035]; Department of Veterans Affairs Career Development Award; National Cancer Institute [4R01 CA076142-14]; Frances Preston Laboratories of the T.J. Martell Foundation; NATIONAL CANCER INSTITUTE [T32CA119925, P01CA040035, U54CA126505, R01CA076142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007563] Funding Source: NIH RePORTER	Department of Defense (DOD) Prostate Cancer Research Program (PCRP); TMEN; Vanderbilt University Bone Center PPG; Department of Veterans Affairs Career Development Award(US Department of Veterans Affairs); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Frances Preston Laboratories of the T.J. Martell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported to RJ by the Department of Defense (DOD) Prostate Cancer Research Program (PCRP) (W81XWH-10-1-0236); to JAS by the TMEN (5U54 CA 126505), the Vanderbilt University Bone Center PPG (5P01 CA40035) and Department of Veterans Affairs Career Development Award; to RJM by the National Cancer Institute (4R01 CA076142-14) and the Frances Preston Laboratories of the T.J. Martell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Ayesha, 2010, J Ayub Med Coll Abbottabad, V22, P218; Bradley DA, 2007, J UROLOGY, V178, pS42, DOI 10.1016/j.juro.2007.04.035; Bussard KM, 2008, CANCER METAST REV, V27, P41, DOI 10.1007/s10555-007-9109-4; Chen CL, 2000, J IMMUNOL, V165, P5418, DOI 10.4049/jimmunol.165.10.5418; Chen CL, 2000, J INVEST DERMATOL, V115, P1124, DOI 10.1046/j.1523-1747.2000.00162.x; Cheville JC, 2002, CANCER-AM CANCER SOC, V95, P1028, DOI 10.1002/cncr.10788; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Domingo-Domenech J, 2005, BRIT J CANCER, V93, P1285, DOI 10.1038/sj.bjc.6602851; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; Garnero P, 2000, BRIT J CANCER, V82, P858, DOI 10.1054/bjoc.1999.1012; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hildreth BE, 2010, J SURG RES, V162, pE9, DOI 10.1016/j.jss.2010.02.023; Hofbauer LC, 2001, CANCER-AM CANCER SOC, V92, P460, DOI 10.1002/1097-0142(20010801)92:3<460::AID-CNCR1344>3.0.CO;2-D; Inoue H, 2005, CANCER LETT, V223, P121, DOI 10.1016/j.canlet.2004.09.053; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Ismail H, 2004, PROSTATE, V58, P308, DOI 10.1002/pros.10335; Jiang JH, 2012, CLIN EXP METASTAS, V29, P165, DOI 10.1007/s10585-011-9439-z; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Johnson LC, 2011, BONE, V48, P141, DOI 10.1016/j.bone.2010.05.033; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Keller ET, 2002, DRUG TODAY, V38, P91, DOI 10.1358/dot.2002.38.2.820105; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Kitazawa S, 2002, J PATHOL, V198, P228, DOI 10.1002/path.1199; Lee CH, 2007, BIOFACTORS, V29, P19, DOI 10.1002/biof.5520290103; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Lessard L, 2006, CLIN CANCER RES, V12, P5741, DOI 10.1158/1078-0432.CCR-06-0330; Leverkus M, 2003, J INVEST DERMATOL, V121, P149, DOI 10.1046/j.1523-1747.2003.12332.x; Liao JH, 2008, INT J CANCER, V123, P2267, DOI 10.1002/ijc.23602; Liao JH, 2006, CANCER METAST REV, V25, P559, DOI 10.1007/s10555-006-9033-z; Lin DL, 2001, PROSTATE, V47, P212, DOI 10.1002/pros.1065; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Mori K, 2007, BONE, V40, P981, DOI 10.1016/j.bone.2006.11.006; Msaouel P, 2008, BEST PRACT RES CL EN, V22, P341, DOI 10.1016/j.beem.2008.01.011; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Pacifico F, 2006, BIOCHEM PHARMACOL, V72, P1142, DOI 10.1016/j.bcp.2006.07.032; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Roodman GD, 2001, J CLIN ONCOL, V19, P3562, DOI 10.1200/JCO.2001.19.15.3562; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Setlur SR, 2007, CANCER RES, V67, P10296, DOI 10.1158/0008-5472.CAN-07-2173; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Weischenfeldt J, 2008, CSH PROTOC, V2008; Whang PG, 2005, J ORTHOP RES, V23, P1475, DOI 10.1016/j.orthres.2005.05.004; Yonou H, 2004, PROSTATE, V58, P406, DOI 10.1002/pros.10349; Zhang J, 2003, CANCER RES, V63, P7883; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685; Zhau Haiyen E., 2000, Cancer, V88, P2995, DOI 10.1002/1097-0142(20000615)88:12+<2995::AID-CNCR15>3.0.CO;2-Y	55	57	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60983	10.1371/journal.pone.0060983	http://dx.doi.org/10.1371/journal.pone.0060983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577181	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800116
J	Liu, XR; Tang, M; Zhang, T; Hu, YY; Zhang, SS; Kong, L; Xue, YY				Liu, Xiaorun; Tang, Meng; Zhang, Ting; Hu, Yuanyuan; Zhang, Shanshan; Kong, Lu; Xue, Yuying			Determination of a Threshold Dose to Reduce or Eliminate CdTe-Induced Toxicity in L929 Cells by Controlling the Exposure Dose	PLOS ONE			English	Article							CDSE QUANTUM DOTS; IN-VITRO; APOPTOSIS; CYTOTOXICITY; FLUORESCENT; PHOTOLUMINESCENCE; NANOPARTICLES; MITOCHONDRIA; MODULATION; RELEASE	With the widespread use of quantum dots (QDs), the likelihood of exposure to quantum dots has increased substantially. The application of quantum dots in numerous biomedical areas requires detailed studies on their toxicity. In this study, we aimed to determine the threshold dose which reduced or eliminated CdTe-induced toxicity in L929 cells by controlling the exposure dose. We established a cellular model of acute exposure to CdTe QDs. Cells were exposed to different concentrations of CdTe QDs (2.2 nm and 3.5 nm) followed by illustrative cytotoxicity analysis. The results showed that low concentrations of CdTe QDs (under 10 mu g/mL) promoted cell viability, caused no obvious effect on the rate of cell apoptosis, intracellular calcium levels and changes in mitochondrial membrane potential, while high concentrations significantly inhibited cell viability. In addition, reactive oxygen species in the 10 mu g/mL-treated group was significantly reduced compared with the control group. In summary, the cytotoxicity of CdTe QDs on L929 cell is dose-dependent, time-dependent and size-dependent. Low concentrations of CdTe QDs (below 10 mu g/mL) may be nontoxic and safe in L929 cells, whereas high concentrations (above 10 mu g/mL) may be toxic resulting in inhibition of proliferation and induction of apoptosis in L929 cells.	[Liu, Xiaorun; Tang, Meng; Zhang, Ting; Hu, Yuanyuan; Zhang, Shanshan; Kong, Lu; Xue, Yuying] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med & Engn, Nanjing, Jiangsu, Peoples R China; [Liu, Xiaorun; Tang, Meng; Zhang, Ting; Hu, Yuanyuan; Zhang, Shanshan; Kong, Lu; Xue, Yuying] Southeast Univ, Jiangsu Key Lab Biomat & Devices, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Tang, M (corresponding author), Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med & Engn, Nanjing, Jiangsu, Peoples R China.	tm@seu.edu.cn	Kong, Lu/E-5974-2016					Aboulaich A, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/33/335101; Biju V, 2008, ANAL BIOANAL CHEM, V391, P2469, DOI 10.1007/s00216-008-2185-7; Borchert H, 2003, J PHYS CHEM B, V107, P9662, DOI 10.1021/jp0352884; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Brunetti V, 2013, NANOSCALE, V5, P307, DOI 10.1039/c2nr33024e; Calabrese EJ, 2011, J CELL COMMUN SIGNAL, V5, P25, DOI 10.1007/s12079-011-0119-1; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P249, DOI 10.1177/0960327109363973; Chan WH, 2006, TOXICOL LETT, V167, P191, DOI 10.1016/j.toxlet.2006.09.007; Cho SJ, 2007, LANGMUIR, V23, P1974, DOI 10.1021/la060093j; Choi AO, 2008, J MOL MED-JMM, V86, P291, DOI 10.1007/s00109-007-0274-2; Clarke SJ, 2006, NAT MATER, V5, P409, DOI 10.1038/nmat1631; Dahlem YA, 2006, CELL CALCIUM, V39, P387, DOI 10.1016/j.ceca.2006.01.001; de Farias PMA, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1993257; De M, 2008, ADV MATER, V20, P4225, DOI 10.1002/adma.200703183; Deng XK, 2006, TOXICOL SCI, V91, P59, DOI 10.1093/toxsci/kfj114; Dumas E, 2010, ENVIRON SCI TECHNOL, V44, P1464, DOI 10.1021/es902898d; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guo GN, 2007, MATER LETT, V61, P1641, DOI 10.1016/j.matlet.2006.07.105; Hardman R, 2006, ENVIRON HEALTH PERSP, V114, P165, DOI 10.1289/ehp.8284; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Hoshino A, 2004, BIOCHEM BIOPH RES CO, V314, P46, DOI 10.1016/j.bbrc.2003.11.185; Hsiang-Yu Lu, 2006, Journal of Medical and Biological Engineering, V26, P89; Jackson JG, 2006, J NEUROPHYSIOL, V96, P1093, DOI 10.1152/jn.00283.2006; Jia SJ, 2006, VASC PHARMACOL, V44, P143, DOI 10.1016/j.vph.2005.09.005; Katunuma N, 2004, ADV ENZYME REGUL, V44, P1, DOI 10.1016/j.advenzreg.2003.11.016; Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m; Li KG, 2009, TOXICOL IN VITRO, V23, P1007, DOI 10.1016/j.tiv.2009.06.020; Lim Yong Taik, 2003, Mol Imaging, V2, P50, DOI 10.1162/153535003765276282; Liu JW, 2009, CHINESE CHEM LETT, V20, P977, DOI 10.1016/j.cclet.2009.03.036; Lovric J, 2005, CHEM BIOL, V12, P1227, DOI 10.1016/j.chembiol.2005.09.008; Lu X, 2011, INT J NANOMED, V6, P1889, DOI 10.2147/IJN.S24005; Macrez N, 2004, CURR MOL MED, V4, P263, DOI 10.2174/1566524043360762; Mahto SK, 2010, TOXICOL IN VITRO, V24, P1070, DOI 10.1016/j.tiv.2010.03.017; Mahto SK, 2009, BIOMED MICRODEVICES, V11, P401, DOI 10.1007/s10544-008-9246-8; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Mundy WR, 2000, NEUROTOXICOLOGY, V21, P1135; Oberdorster C, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-8; Pu YM, 2002, BIOCHEM BIOPH RES CO, V299, P762, DOI 10.1016/S0006-291X(02)02722-5; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3; Sako Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100100; Santos Ana R., 2010, Journal of Nanobiotechnology, V8, P24, DOI 10.1186/1477-3155-8-24; Tokumasu F, 2005, J CELL SCI, V118, P1091, DOI 10.1242/jcs.01662; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; van Vlerken Lilian E, 2006, Expert Opin Drug Deliv, V3, P205, DOI 10.1517/17425247.3.2.205; Walkey Carl, 2009, Hematology Am Soc Hematol Educ Program, P701, DOI 10.1182/asheducation-2009.1.701; Wang H, 2000, FREE RADICAL BIO MED, V28, P1222, DOI 10.1016/S0891-5849(00)00241-0; Wu CH, 2010, CHEM RES TOXICOL, V23, P82, DOI 10.1021/tx900291c; Ye JL, 2007, ENVIRON TOXICOL PHAR, V24, P45, DOI 10.1016/j.etap.2007.01.007; Zhang G, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-418; Zhang HL, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3291999; Zhang TT, 2006, NANO LETT, V6, P800, DOI 10.1021/nl0603350; Zhelev Z, 2006, J AM CHEM SOC, V128, P6324, DOI 10.1021/ja061137d	56	29	33	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59359	10.1371/journal.pone.0059359	http://dx.doi.org/10.1371/journal.pone.0059359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577063	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800007
J	Sherwood, LJ; Hayhurst, A				Sherwood, Laura J.; Hayhurst, Andrew			Ebolavirus Nucleoprotein C-Termini Potently Attract Single Domain Antibodies Enabling Monoclonal Affinity Reagent Sandwich Assay (MARSA) Formulation	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; MARBURG VIRUS NUCLEOPROTEIN; HEMORRHAGIC-FEVER; MOLECULAR CHARACTERIZATION; VARIABLE DOMAINS; INACTIVATION; EPITOPES; ANTIGEN; PROTEIN; FILOVIRUSES	Background: Antigen detection assays can play an important part in environmental surveillance and diagnostics for emerging threats. We are interested in accelerating assay formulation; targeting the agents themselves to bypass requirements for a priori genome information or surrogates. Previously, using in vitro affinity reagent selection on Marburg virus we rapidly established monoclonal affinity reagent sandwich assay (MARSA) where one recombinant antibody clone was both captor and tracer for polyvalent nucleoprotein (NP). Hypothesizing that the closely related Ebolavirus genus may share the same Achilles' heel, we redirected the scheme to see whether similar assays could be delivered and began to explore their mechanism. Methods and Findings: In parallel we selected panels of llama single domain antibodies (sdAb) from a semi-synthetic library against Zaire, Sudan, Ivory Coast, and Reston Ebola viruses. Each could perform as both captor and tracer in the same antigen sandwich capture assay thereby forming MARSAs. All sdAb were specific for NP and those tested required the C-terminal domain for recognition. Several clones were cross-reactive, indicating epitope conservation across the Ebolavirus genus. Analysis of two immune shark sdAb revealed they also targeted the C-terminal domain, and could be similarly employed, yet were less sensitive than a comparable llama sdAb despite stemming from immune selections. Conclusions: The C-terminal domain of Ebolavirus NP is a strong attractant for antibodies and enables sensitive sandwich immunoassays to be rapidly generated using a single antibody clone. The polyvalent nature of nucleocapsid borne NP and display of the C-terminal region likely serves as a bountiful affinity sink during selections, and a highly avid target for subsequent immunoassay capture. Combined with the high degree of amino acid conservation through 37 years and across wide geographies, this domain makes an ideal handle for monoclonal affinity reagent driven antigen sandwich assays for the Ebolavirus genus.	[Sherwood, Laura J.; Hayhurst, Andrew] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX USA	Texas Biomedical Research Institute	Hayhurst, A (corresponding author), Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX USA.	ahayhurst@TxBiomed.org		Hayhurst, Andrew/0000-0003-4612-8707	National Institutes of Health (NIH) [R21 AI73394-2, C06 RR12087]; Defense Threat Reduction Agency Basic Science Program/Office of Naval Research [N00173-08-1-G003]; Texas Biomedical Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073394] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency Basic Science Program/Office of Naval Research; Texas Biomedical Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health (NIH) award R21 AI73394-2, Defense Threat Reduction Agency Basic Science Program/ Office of Naval Research award N00173-08-1-G003, NIH construction grant C06 RR12087, and the Texas Biomedical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130; ALKAISSI EN, 1982, J VIROL METHODS, V4, P353, DOI 10.1016/0166-0934(82)90060-X; Amanna IJ, 2012, NAT MED, V18, P974, DOI 10.1038/nm.2763; BACHMANN MF, 1994, MED MICROBIOL IMMUN, V183, P95, DOI 10.1007/BF00277160; Beniac DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029608; Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109; Bharat TAM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001196; Bidinosti M, 2012, J BIOL CHEM, V287, P33691, DOI 10.1074/jbc.M112.379792; BLACKBURN NK, 1991, J VIROL METHODS, V33, P367, DOI 10.1016/0166-0934(91)90036-Y; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Bray M, 2003, ANTIVIR RES, V57, P53, DOI 10.1016/S0166-3542(02)00200-0; Butler John E, 2004, Methods Mol Med, V94, P333; COLLINS FH, 1988, AM J TROP MED HYG, V38, P283, DOI 10.4269/ajtmh.1988.38.283; Conway JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008818; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Edwards BM, 2003, J MOL BIOL, V334, P103, DOI 10.1016/j.jmb.2003.09.054; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; ELLIOTT LH, 1985, VIROLOGY, V147, P169, DOI 10.1016/0042-6822(85)90236-3; ELLIOTT LH, 1982, J CLIN MICROBIOL, V16, P704, DOI 10.1128/JCM.16.4.704-708.1982; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Feldmann H, 1999, CURR TOP MICROBIOL, V235, P1; Feng K, 2011, APPL ENVIRON MICROB, V77, P3507, DOI 10.1128/AEM.00081-11; Ferrara F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049535; Fujita N., 2009, Morbidity and Mortality Weekly Report, V58, P1377; Furuya Y, 2012, IMMUNOL CELL BIOL, V90, P571, DOI 10.1038/icb.2011.70; Gaidamakova EK, 2012, CELL HOST MICROBE, V12, P117, DOI 10.1016/j.chom.2012.05.011; Geisbert TW, 1995, VIRUS RES, V39, P129, DOI 10.1016/0168-1702(95)00080-1; Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053; Gonzalez JP, 2007, CURR TOP MICROBIOL, V315, P363; Goodchild SA, 2011, MOL IMMUNOL, V48, P2027, DOI 10.1016/j.molimm.2011.06.437; GRIFFITHS AD, 1993, EMBO J, V12, P725, DOI 10.1002/j.1460-2075.1993.tb05706.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; Hayman DTS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011978; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Huang Y, 2002, MOL CELL, V10, P307, DOI 10.1016/S1097-2765(02)00588-9; Ikegami T, 2003, CLIN DIAGN LAB IMMUN, V10, P552, DOI 10.1128/CDLI.10.4.552-557.2003; Iwasa A, 2011, J INFECT DIS, V204, pS897, DOI 10.1093/infdis/jir313; Jonges M, 2010, J CLIN MICROBIOL, V48, P928, DOI 10.1128/JCM.02045-09; Kachko A. V., 2001, Molekulyarnaya Biologiya (Moscow), V35, P492; Kasai T, 2012, BIOCHEM BIOPH RES CO, V422, P375, DOI 10.1016/j.bbrc.2012.04.146; KILEY MP, 1988, J GEN VIROL, V69, P1957, DOI 10.1099/0022-1317-69-8-1957; Kolesnikova L, 2000, J VIROL, V74, P3899, DOI 10.1128/JVI.74.8.3899-3904.2000; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Legastelois I, 2011, J VIROL METHODS, V178, P129, DOI 10.1016/j.jviromet.2011.08.027; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Licata JM, 2004, J VIROL, V78, P7344, DOI 10.1128/JVI.78.14.7344-7351.2004; Lucht A, 2004, MED MICROBIOL IMMUN, V193, P181, DOI 10.1007/s00430-003-0204-z; Lucht A, 2003, J VIROL METHODS, V111, P21, DOI 10.1016/S0166-0934(03)00131-9; MacNeil A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001546; Martina BEE, 2009, EMBO MOL MED, V1, P10, DOI 10.1002/emmm.200900005; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Mateo M, 2011, J INFECT DIS, V204, pS1011, DOI 10.1093/infdis/jir338; McConnell AD, 2013, PROTEIN ENG DES SEL, V26, P151, DOI 10.1093/protein/gzs090; Mehan MR, 2013, ADV EXP MED BIOL, V735, P283, DOI 10.1007/978-1-4614-4118-2_20; Meissner F, 2002, VIROLOGY, V300, P236, DOI 10.1006/viro.2002.1533; MITCHELL SW, 1984, J CLIN MICROBIOL, V20, P486, DOI 10.1128/JCM.20.3.486-489.1984; Neffleship Joanne E., 2009, V498, P245, DOI 10.1007/978-1-59745-196-3_16; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Nidom CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040740; Niikura M, 2003, CLIN DIAGN LAB IMMUN, V10, P83, DOI 10.1128/CDLI.10.1.83-87.2003; Niikura M, 2001, J CLIN MICROBIOL, V39, P3267, DOI 10.1128/JCM.39.9.3267-3271.2001; Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099; Noda T, 2010, J GEN VIROL, V91, P1478, DOI 10.1099/vir.0.019794-0; Ogawa H, 2011, J VIROL METHODS, V171, P310, DOI 10.1016/j.jviromet.2010.11.010; Olson Sarah H, 2012, Emerg Health Threats J, V5, DOI 10.3402/ehtj.v5i0.9134; Pan T, 2005, J VIROL, V79, P12355, DOI 10.1128/JVI.79.19.12355-12364.2005; Panning M, 2007, J INFECT DIS, V196, pS199, DOI 10.1086/520600; Perchiacca JM, 2012, ANNU REV CHEM BIOMOL, V3, P263, DOI 10.1146/annurev-chembioeng-062011-081052; Peters CJ, 2000, EMERGING INFECTIONS 4, P201; Ponsel D, 2011, MOLECULES, V16, P3675, DOI 10.3390/molecules16053675; Prasad BVV, 2012, ADV EXP MED BIOL, V726, P17, DOI 10.1007/978-1-4614-0980-9_3; Prassler J, 2011, J MOL BIOL, V413, P261, DOI 10.1016/j.jmb.2011.08.012; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; Saerens D, 2005, ANAL CHEM, V77, P7547, DOI 10.1021/ac051092j; Saijo M, 2005, J MED VIROL, V76, P111, DOI 10.1002/jmv.20332; Sanchez A, 1999, J INFECT DIS, V179, pS164, DOI 10.1086/514282; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Schirrmann T, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P387, DOI 10.1007/978-3-642-01147-4_30; Sherwood L, 2009, 7 ASM BIOD EM DIS RE, P37; Sherwood LJ, 2007, J INFECT DIS, V196, pS213, DOI 10.1086/520586; Sherwood LJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00807; Shi W, 2008, J VIROL, V82, P6190, DOI 10.1128/JVI.02731-07; Shurtleff AC, 2012, VIRUSES-BASEL, V4, P3511, DOI 10.3390/v4123511; Slenczka WG, 1999, CURR TOP MICROBIOL, V235, P49; Spurgers KB, 2010, MOL CELL PROTEOMICS, V9, P2690, DOI 10.1074/mcp.M110.003418; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Taniguchi S, 2011, EMERG INFECT DIS, V17, P1559, DOI 10.3201/eid1708.101693; Tereshko V, 2008, PROTEIN SCI, V17, P1175, DOI 10.1110/ps.034892.108; Timen A, 2009, EMERG INFECT DIS, V15, P1171, DOI [10.3201/eid1508.090015, 10.3201/eid1508.090051]; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Uittenbogaard JP, 2011, J BIOL CHEM, V286, P36198, DOI 10.1074/jbc.M111.279232; VANDERGROEN G, 1982, ANN SOC BELG MED TR, V62, P49; Vanlandschoot P, 2011, ANTIVIR RES, V92, P389, DOI 10.1016/j.antiviral.2011.09.002; Vercruysse T, 2010, J BIOL CHEM, V285, P21768, DOI 10.1074/jbc.M110.112490; Volchkov VE, 2000, VIROLOGY, V277, P147, DOI 10.1006/viro.2000.0572; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; Warfield KL, 2007, J INFECT DIS, V196, pS276, DOI 10.1086/520605; Watanabe S, 2006, J VIROL, V80, P3743, DOI 10.1128/JVI.80.8.3743-3751.2006; Weidmann M, 2004, J CLIN VIROL, V30, P94, DOI 10.1016/j.jcv.2003.09.004; Weidmann M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-81; Weingartl HM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00811; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104; Wu MT, 2011, J STRUCT BIOL, V174, P124, DOI 10.1016/j.jsb.2010.10.007; Yuan JF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-236; Zhou YH, 2007, IMMUNOL CELL BIOL, V85, P73, DOI 10.1038/sj.icb.7100004	117	28	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61232	10.1371/journal.pone.0061232	http://dx.doi.org/10.1371/journal.pone.0061232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577211	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800133
J	Siglin, AE; Sun, SJ; Moore, JK; Tan, S; Poenie, M; Lear, JD; Polenova, T; Cooper, JA; Williams, JC				Siglin, Amanda E.; Sun, Shangjin; Moore, Jeffrey K.; Tan, Sarah; Poenie, Martin; Lear, James D.; Polenova, Tatyana; Cooper, John A.; Williams, John C.			Dynein and Dynactin Leverage Their Bivalent Character to Form a High-Affinity Interaction	PLOS ONE			English	Article							CYTOPLASMIC DYNEIN; INTERMEDIATE CHAIN; LIGHT-CHAIN; INTRACELLULAR-TRANSPORT; RETROGRADE TRANSPORT; IN-VIVO; BINDING; PROTEIN; MOTOR; COMPLEX	Cytoplasmic dynein and dynactin participate in retrograde transport of organelles, checkpoint signaling and cell division. The principal subunits that mediate this interaction are the dynein intermediate chain (IC) and the dynactin p150(Glued); however, the interface and mechanism that regulates this interaction remains poorly defined. Herein, we use multiple methods to show the N-terminus of mammalian dynein IC, residues 10-44, is sufficient for binding p150(Glued). Consistent with this mapping, monoclonal antibodies that antagonize the dynein-dynactin interaction also bind to this region of the IC. Furthermore, double and triple alanine point mutations spanning residues 6 to 19 in the yeast IC homolog, Pac11, produce significant defects in spindle positioning. Using the same methods we show residues 381 to 530 of p150(Glued) form a minimal fragment that binds to the dynein IC. Sedimentation equilibrium experiments indicate that these individual fragments are predominantly monomeric, but admixtures of the IC and p150(Glued) fragments produce a 2:2 complex. This tetrameric complex is sensitive to salt, temperature and pH, suggesting that the binding is dominated by electrostatic interactions. Finally, circular dichroism (CD) experiments indicate that the N-terminus of the IC is disordered and becomes ordered upon binding p150(Glued). Taken together, the data indicate that the dynein-dynactin interaction proceeds through a disorder-to-order transition, leveraging its bivalent-bivalent character to form a high affinity, but readily reversible interaction.	[Siglin, Amanda E.; Williams, John C.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Sun, Shangjin; Polenova, Tatyana] Univ Delaware, Dept Chem & Biochem, Newark, DC USA; [Moore, Jeffrey K.; Cooper, John A.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO USA; [Tan, Sarah; Poenie, Martin] Univ Texas Austin, Dept Cell & Mol Biol, Austin, TX 78712 USA; [Lear, James D.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Williams, John C.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA USA	Jefferson University; University of Delaware; Washington University (WUSTL); University of Texas System; University of Texas Austin; University of Pennsylvania; City of Hope; Beckman Research Institute of City of Hope	Williams, JC (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	jwilliams@coh.org	; Cooper, John/D-4448-2014	Poenie, Martin/0000-0003-2524-4039; Cooper, John/0000-0002-0933-4571	National Institutes of Health [R21NS071166, R01GM085306]; NCRR [SRR022316A, GM 47337, 5P20RR017716-07, 5-T32-DK07705]; American Heart Association [0715196U]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047337, R01GM085306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health R21NS071166 (J.C.W.), R01GM085306 (J.C.W. & T.P.), NCRR SRR022316A (J.C.W.), GM 47337 (J.A.C.), NCRR 5P20RR017716-07 (T.P.), 5-T32-DK07705 (A.E.S) and The American Heart Association 0715196U (A.E.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin M, 2001, ANAL BIOCHEM, V299, P98, DOI 10.1006/abio.2001.5396; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Brunet S, 2001, EMBO REP, V2, P669, DOI 10.1093/emb0-reports/kve158; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; CORTHESYTHEULAZ I, 1992, J CELL BIOL, V118, P1333, DOI 10.1083/jcb.118.6.1333; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Efimov VP, 1998, GENETICS, V149, P101; GANS PJ, 1991, BIOPOLYMERS, V31, P1605, DOI 10.1002/bip.360311315; Guy J, 2007, J AM CHEM SOC, V129, P11969, DOI 10.1021/ja0738125; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Imai H, 2006, J MOL BIOL, V359, P833, DOI 10.1016/j.jmb.2006.03.071; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Luedtke NW, 2007, NAT CHEM BIOL, V3, P779, DOI 10.1038/nchembio.2007.49; Maier KC, 2008, TRAFFIC, V9, P481, DOI 10.1111/j.1600-0854.2008.00702.x; MAMMEN M, 1995, ANAL CHEM, V67, P3526, DOI 10.1021/ac00115a023; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Moore JK, 2009, P NATL ACAD SCI USA, V106, P5147, DOI 10.1073/pnas.0810828106; Morgan JL, 2011, J BIOL CHEM, V286, P39349, DOI 10.1074/jbc.M111.296277; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nyarko A, 2012, J BIOL CHEM, V287, P24884, DOI 10.1074/jbc.M112.376038; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Pfister KK, 1996, J BIOL CHEM, V271, P1687, DOI 10.1074/jbc.271.3.1687; Rao JH, 1998, SCIENCE, V280, P708, DOI 10.1126/science.280.5364.708; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; Stuchell-Brereton MD, 2011, MOL BIOL CELL, V22, P2690, DOI 10.1091/mbc.E11-01-0075; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Towns WL, 2009, CELL MOTIL CYTOSKEL, V66, P80, DOI 10.1002/cm.20327; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2000, BBA-MOL CELL RES, V1496, P89, DOI 10.1016/S0167-4889(00)00011-2; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Varma D, 2010, P NATL ACAD SCI USA, V107, P3493, DOI 10.1073/pnas.0908959107; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104	55	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59453	10.1371/journal.pone.0059453	http://dx.doi.org/10.1371/journal.pone.0059453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577064	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800008
J	Sun, L; Yang, XW; Chen, FF; Li, RP; Li, XS; Liu, ZX; Gu, YY; Gong, XY; Liu, ZH; Wei, H; Huang, Y; Yuan, S				Sun, Lei; Yang, Xiaowei; Chen, Feifei; Li, Rongpeng; Li, Xuesong; Liu, Zhenxing; Gu, Yuyu; Gong, Xiaoyan; Liu, Zhonghua; Wei, Hua; Huang, Ying; Yuan, Sheng			Paralogous Ribosomal Protein L32-1 and L32-2 in Fission Yeast May Function Distinctively in Cellular Proliferation and Quiescence by Changing the Ratio of Rpl32 Paralogs	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; SCHIZOSACCHAROMYCES-POMBE; EXTRARIBOSOMAL FUNCTIONS; STATIONARY-PHASE; STRUCTURAL BASIS; DIVISION CYCLE; GENOME; PCR; TRANSCRIPTION	Fission yeast cells express Rpl32-2 highly while Rpl32-1 lowly in log phase; in contrast, expression of Rpl32-1 raises and reaches a peak level while Rpl32-2 is downregulated to a low basic level when cells enter into stationary phase. Overexpression of Rpl32-1 inhibits cell growth while overexpression of Rpl32-2 does not. Deleting rpl32-2 impairs cell growth more severely than deleting rpl32-1 does. Cell growth impaired by deleting either paralog can be rescued completely by reintroducing rpl32-2, but only partly by rpl32-1. Overexpression of Rpl32-1 inhibits cell division, yielding 4c DNA and multiple septa, while overexpressed Rpl32-2 promotes it. Transcriptomics analysis proved that Rpl32 paralogs regulate expression of a subset of genes related with cell division and stress response in a distinctive way. This functional difference of the two paralogs is due to their difference of 95th amino acid residue. The significance of a competitive inhibition between Rpl32 paralogs on their expression is discussed.	[Sun, Lei; Yang, Xiaowei; Chen, Feifei; Li, Rongpeng; Li, Xuesong; Liu, Zhenxing; Gu, Yuyu; Gong, Xiaoyan; Liu, Zhonghua; Wei, Hua; Huang, Ying; Yuan, Sheng] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Microbes & Funct Genom, Jiangsu Engn & Technol Res Ctr Industrializat Mic, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Yuan, S (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Microbes & Funct Genom, Jiangsu Engn & Technol Res Ctr Industrializat Mic, Nanjing, Jiangsu, Peoples R China.	yuansheng@njnu.edu.cn			National Natural Science Fundation of China [30670025, 31070060]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research is supported by the National Natural Science Fundation of China Grants (#30670025 and #31070060) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Nunez ML, 2005, MOL BIOL CELL, V16, P2003, DOI 10.1091/mbc.E04-06-0442; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bhavsar Rital B., 2010, Human Genomics, V4, P327; DABEVA MD, 1987, J BIOL CHEM, V262, P16055; DABEVA MD, 1993, J BIOL CHEM, V268, P19669; Degenhardt RF, 2008, PLANT PHYSIOL, V147, P128, DOI 10.1104/pp.107.111799; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; FANKHAUSER C, 1993, EMBO J, V12, P2697, DOI 10.1002/j.1460-2075.1993.tb05931.x; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Haarer B, 2007, GENE DEV, V21, P148, DOI 10.1101/gad.1477507; Jang YJ, 1997, J BIOL CHEM, V272, P19993, DOI 10.1074/jbc.272.32.19993; Jing W, 2006, FEBS LETT, V580, P1827, DOI 10.1016/j.febslet.2006.02.040; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; KEENEY JB, 1994, GENETICS, V136, P849; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kerres A, 2006, MOL BIOL CELL, V17, P4167, DOI 10.1091/mbc.E06-04-0264; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Lemieux C, 2011, MOL CELL, V44, P108, DOI 10.1016/j.molcel.2011.06.035; Li RP, 2013, EUKARYOT CELL, V12, P450, DOI 10.1128/EC.00321-12; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Martinez MJ, 2004, MOL BIOL CELL, V15, P5295, DOI 10.1091/mbc.E03-11-0856; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; MINET M, 1979, J BACTERIOL, V137, P440, DOI 10.1128/JB.137.1.440-446.1979; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; Ohno S., 1970, EVOLUTION GENE DUPLI; Parenteau J, 2011, CELL, V147, P320, DOI 10.1016/j.cell.2011.08.044; Paul SK, 2009, BIOSCI BIOTECH BIOCH, V73, P1339, DOI 10.1271/bbb.90005; Petit CS, 2005, J CELL SCI, V118, P5731, DOI 10.1242/jcs.02687; Qian WF, 2010, TRENDS GENET, V26, P425, DOI 10.1016/j.tig.2010.07.002; Ray S, 2010, J CELL BIOL, V190, P793, DOI 10.1083/jcb.201002055; ROTENBERG MO, 1988, GENE DEV, V2, P160, DOI 10.1101/gad.2.2.160; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sajiki K, 2009, J CELL SCI, V122, P1418, DOI 10.1242/jcs.046466; SAZER S, 1990, J CELL SCI, V97, P509; Su SSY, 1996, J CELL SCI, V109, P1347; Szklarczyk R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-337; Vilardell J, 2000, MOL CELL, V5, P761, DOI 10.1016/S1097-2765(00)80255-5; Vilardell J, 1997, MOL CELL BIOL, V17, P1959, DOI 10.1128/MCB.17.4.1959; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Weisberg RA, 2008, MOL CELL, V32, P747, DOI 10.1016/j.molcel.2008.12.010; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Wu J, 2004, P NATL ACAD SCI USA, V101, P3148, DOI 10.1073/pnas.0308321100; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Zhao Z, 2009, BIOCHEM J, V422, P483, DOI 10.1042/BJ20090743	55	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60689	10.1371/journal.pone.0060689	http://dx.doi.org/10.1371/journal.pone.0060689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577148	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800089
J	Wang, Y; Cong, YS; Li, J; Li, XT; Li, B; Qi, SH				Wang, Ying; Cong, Yushuang; Li, Jun; Li, Xueting; Li, Bing; Qi, Sihua			Comparison of Invasive Blood Pressure Measurements from the Caudal Ventral Artery and the Femoral Artery in Male Adult SD and Wistar Rats	PLOS ONE			English	Article							TAIL-ARTERY; MODEL; CUFF; AGREEMENT	Background and Purpose: Studies have suggested that the caudal ventral artery is a potential site for continuous arterial blood pressure monitoring in rats. However, the agreement of mean arterial pressure values between the femoral artery and the caudal ventral artery has not been investigated. This study was performed to identify whether the caudal ventral artery could be safely used for continuous blood pressure monitoring as an alternative site to the femoral artery. Methods: Rats were randomized into four groups: Sprague Dawley rats under normothermia; Wistar rats under normothermia; Sprague Dawley rats under hypothermia; Wistar rats under hypothermia. Each rat underwent simultaneous monitoring of blood pressure using femoral artery and caudal ventral artery catheterization during a stable hemodynamic state and three periods of acute severe hemodynamic changes. The effects of rat strain, rectal temperature, experimental time course and hemodynamic factors on pressure gradients, the concordance of mean arterial pressure values between the femoral artery and the caudal ventral artery, and the rates of distal ischemia after surgery were determined. Results: There was a significant difference in the rate of distal ischemia between femoral and caudal ventral arteries after catheterization (25% vs 5%, P<0.05). The overall mean gradient and the mean gradient under a steady hemodynamic state were 4.9+/-3.7 mm Hg and 5.5+/-2.5 mm Hg, respectively. The limits of agreement (bias+/-1.96 SD) were (22.5 mm Hg, 12.3 mm Hg) and (-0.5 mm Hg, 10.5 mm Hg), respectively. Although the concordance decreased during the first 30 sec of each period of severe hemodynamic changes, the degree of agreement was acceptable regardless of the effects of rat strain and rectal temperature. Conclusions: Based on the degree of agreement and the safety of catheterization, the caudal ventral artery may be a preferred site for continuous arterial blood pressure monitoring without acute severe hemodynamic changes.	[Wang, Ying; Cong, Yushuang; Li, Jun; Li, Xueting; Qi, Sihua] Harbin Med Univ, Affiliated Hosp 4, Dept Anesthesiol, Harbin, Peoples R China; [Li, Bing] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Qi, SH (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Anesthesiol, Harbin, Peoples R China.	sihuaqi2012@163.com			National Basic Research Program of China 973 Program [2012CB517602, 2012CB517803]; National Natural Science Foundation of China [81271456]; Natural Science Foundation of Heilongjiang Province [ZD201017]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This study was supported by research grants from the National Basic Research Program of China 973 Program (No. 2012CB517602 and No. 2012CB517803), the National Natural Science Foundation of China (No. 81271456), and the Natural Science Foundation of Heilongjiang Province (ZD201017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara B, 1998, J RECONSTR MICROSURG, V14, P359, DOI 10.1055/s-2007-1000191; BAO JYS, 1995, MICROSURG, V16, P122, DOI 10.1002/micr.1920160216; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; CHIUEH CC, 1978, AM J PHYSIOL, V234, pH690, DOI 10.1152/ajpheart.1978.234.6.H690; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Dorman T, 1998, CRIT CARE MED, V26, P1646, DOI 10.1097/00003246-199810000-00014; FEJESTOTH G, 1984, HYPERTENSION, V6, P926, DOI 10.1161/01.HYP.6.6.926; Franca AS, 1997, BRAZ J MED BIOL RES, V30, P891, DOI 10.1590/S0100-879X1997000700012; Galluccio ST, 2009, CRIT CARE RESUSC, V11, P34; GUIGNARD JP, 1970, CIRC RES, V27, P505, DOI 10.1161/01.RES.27.4.505; HAGMULLER K, 1992, J PHARMACOL TOXICOL, V28, P79, DOI 10.1016/1056-8719(92)90051-2; Ibrahim J, 2006, CLIN EXP HYPERTENS, V28, P57, DOI 10.1080/10641960500386817; IKEDA K, 1991, LAB ANIM-UK, V25, P26, DOI 10.1258/002367791780808176; Jamieson MJ, 1997, AM J HYPERTENS, V10, P209, DOI 10.1016/S0895-7061(96)00321-4; Johnson C, 2007, J PHYSIOL-LONDON, V584, P221, DOI 10.1113/jphysiol.2007.139360; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; KVETNANSKY R, 1979, J PHARMACOL EXP THER, V209, P287; Lin T, 2008, KIDNEY INT, V74, P528, DOI 10.1038/ki.2008.207; Manecke GR, 2004, J CARDIOTHOR VASC AN, V18, P175, DOI 10.1053/j.jvca.2004.01.023; Marko SB, 2008, AM J PHYSIOL-HEART C, V294, pH2646, DOI 10.1152/ajpheart.00291.2008; McCarty R, 1996, HYPERTENSION, V27, P1115, DOI 10.1161/01.HYP.27.5.1115; Mignini MA, 2006, CRIT CARE, V10, DOI 10.1186/cc4852; Souza FM, 2008, BRAZ J MED BIOL RES, V41, P416, DOI 10.1590/S0100-879X2008005000018; Staszyk C, 2003, LAB ANIM-UK, V37, P121, DOI 10.1258/00236770360563750; Westvik TS, 2009, J VASC SURG, V49, P464, DOI 10.1016/j.jvs.2008.08.077; WU YL, 1995, PHYS MED BIOL, V40, P789, DOI 10.1088/0031-9155/40/5/006; YOUNG AA, 1982, CAN J PHYSIOL PHARM, V60, P392, DOI 10.1139/y82-057	28	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60625	10.1371/journal.pone.0060625	http://dx.doi.org/10.1371/journal.pone.0060625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577136	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800076
J	Black, SA; Fellous, A; Yamaguchi, N; Roberts, DL				Black, Simon A.; Fellous, Amina; Yamaguchi, Nobuyuki; Roberts, David L.			Examining the Extinction of the Barbary Lion and Its Implications for Felid Conservation	PLOS ONE			English	Article							PANTHERA-LEO; CARNIVORE; WEST; DISTRIBUTIONS; DIVERSITY; CONFLICT; ORIGIN	Estimations of species extinction dates are rarely definitive, yet declarations of extinction or extirpation are important as they define when conservation efforts may cease. Erroneous declarations of extinctions not only destabilize conservation efforts but also corrode local community support. Mismatches in perceptions by the scientific and local communities risk undermining sensitive, but important partnerships. We examine observations relating to the decline and extinction of Barbary lions in North Africa. Whilst the extinction predates the era of the scientific conservation movement, the decline is relatively well documented in historical records. Recently unearthed accounts suggest Barbary lions survived later than previously assumed. We use probabilistic methods to estimate a more recent extinction date for the subspecies. The evidence presented for a much later persistence of lions in North Africa, including generations when sightings were nil, suggests caution when considering felid populations as extinct in the wild. The case raises the possibility that captive animals descended from the Moroccan royal collection are closer contemporaries to wild Barbary lions. Furthermore, our results highlight the vulnerability of very small lion populations and the significance of continued conservation of remnant lion populations in Central and West Africa.	[Black, Simon A.; Roberts, David L.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Fellous, Amina] Agence Natl Conservat Nat, Algiers, Algeria; [Yamaguchi, Nobuyuki] Univ Qatar, Dept Biol & Environm Sci, Doha, Qatar	University of Kent; Qatar University	Black, SA (corresponding author), Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.	S.Black@kent.ac.uk	Yamaguchi, Nobuyuki/AAN-4884-2020	Yamaguchi, Nobuyuki/0000-0002-6492-6588; Roberts, David/0000-0001-6788-2691				Agencia EFE, 2010, HALLAN POBLACION LEO; [Anonymous], 1860, HUNTING GROUNDS OLD; [Anonymous], 1860, J CHASSEURS, V24, P239; [Anonymous], 1845, J HARAS CHASSES COUR, VIII; [Anonymous], 1893, RUBRIQUE ANNONCE; [Anonymous], 1936, REV CHASSE PECHE NOR, P7; [Anonymous], 1898, REV HEBDOMADAIRE; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Barnett R, 2008, CONTRIB ZOOL, V77, P7, DOI 10.1163/18759866-07701002; Barnett R, 2007, CONTRIB ZOOL, V76, P87, DOI 10.1163/18759866-07602002; Barnett R, 2006, P ROY SOC B-BIOL SCI, V273, P2119, DOI 10.1098/rspb.2006.3555; Baroli M, 1967, VIE QUOTIDIENNE FRAN; Bartosiewicz L., 2009, ACTA ARCHAEOL-HUNG, V60, P275, DOI [10.1556/AArch.59.2008.2.28, DOI 10.1556/AARCH.59.2008.2.28]; Bauer H, 2008, PANTHERA LEO; Bauer H, 2010, MAMMALIA, V74, P363, DOI 10.1515/MAMM.2010.048; Berard V, 1867, ALGER TYPO BASTIDE; Bernard A, 1906, EVOLUTION NOMADISME; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Black S, 2009, FELID TAG M COP DENM; Black S, 2008, THESIS U KENT; Black S, 2010, EUR J WILDLIFE RES, V56, P21, DOI 10.1007/s10344-009-0280-5; Blakesley JW, 1859, MONTHS ALGERIA VISIT; Bloch A, 2002, MILIANA TEXTES; Bombonnel CL, 1893, BOMBONNEL TUEUR PANT; Bourde P, 1880, TRAVERS ALGERIE SOUV; Bowkett AE, 2009, CONSERV BIOL, V23, P773, DOI 10.1111/j.1523-1739.2008.01157.x; Breitenmoser U, 2008, IUCN 2012 IUCN RED L; Burton AC, 2011, BIOL CONSERV, V144, P2344, DOI 10.1016/j.biocon.2011.06.014; Cabrera A, 1932, SERIA ZOOLOGICA TRAB; Can OE, 2004, CONV CONS EUR WILDL; Carette E, 1844, EXPLORATION SCI ALGE, VII, P355; Carteron C, 1866, VOYAGE ALGERIE; Celesia GG, 2010, AFR J ECOL, V48, P58, DOI 10.1111/j.1365-2028.2009.01082.x; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Cuzin F, 2003, THESIS U MONTPELLIER; D'Esschavannes MJ, 1852, REV ORIENT ALGERIE C, VXII, P221; Daumas E, 1845, SAHARA ALGERIEN; Daumas E, 1855, MOEURS COUNTUMES ALG; Davies R. E. G., 1964, HIST WORLDS AIRLINES; de Planhol X, 2004, PAYSASGE ANIMAL HOMM; De Smet K, 1982, B FOREST CONSERV NAT, V1, P23; Desparmet J, 1939, COUTUMES I CROYANCES, VI; Dobson M, 1998, MAMMAL REV, V28, P77, DOI 10.1046/j.1365-2907.1998.00027.x; Drummond-Hay JH, 1861, MOROCCO MOORS W ITS; Dubach J, 2005, CONSERV GENET, V6, P15, DOI 10.1007/s10592-004-7729-6; Dufour L, 1856, NOTICE LION TUE ALGE; Dunant JH, 1858, NOTICE REGENCE TUNIS; Emmanuel J, 2003, MAUPASSANT GUY CHEMI; Fenech EV, 1867, RECITS CHASSES ALGRI; Gastineau B, 1863, CHASESS LION PANTHER; Gerard J, 1892, TUEUR LIONS; Gerard J, 1864, CHASSE LION; Gerard J, 1859, CHASSE LION; Gharaibeh BM, 1997, THESIS TEXAS TU LUBB; Gippoliti S, 2012, BIODIVERS CONSERV, V21, P1359, DOI 10.1007/s10531-012-0256-8; Grzimek B, 1975, GRZIMEKS ANIMAL LIFE, V12, P353; Guerin Victor, 1862, VOYAGE ARCHEOLOGIQUE; Guggisberg CAW, 1963, SIMBA LIFE LION; Haddadou MA, 1994, ALGERIE MYSTERIEUSE; Hanoteau A, 1893, KABYLIE COUTUMES KAB, VI; Hemmer H., 1978, 1 INT S MAN BREED TI, P65; Henschel P., 2008, IUCN 2010 IUCN RED L; Henschel Philipp, 2010, Cat News, V52, P34; Hunter LTB, 2013, ORYX, V47, P19, DOI 10.1017/S0030605312000695; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; IUCN, 2012, IUCN RED LIST THREAT; Jackson P., 1996, BIOL CONSERVATION; Jhala YV, 2009, BIODIVERS CONSERV, V18, P3383, DOI 10.1007/s10531-009-9648-9; Johnston HH, 1911, TUNISIA ENCY BRITANN, V27; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Kennedy JC, 1846, ALGERIA TUNIS 1845, VI; Kennedy JC, 1846, ALGERIA TUNIS 1845, VII; Kissui BM, 2010, POPUL ECOL, V52, P103, DOI 10.1007/s10144-009-0176-y; Lataste F., 1885, ACTES SOC LINN BORD, V39, P129; Lavauden L, 1932, CHENE SOC FORESTIERE, P208; Lavauden L., 1926, VERTEBRES SAHARA; Lestiboudois T, 1853, VOYAGE ALGERIE ETUDE; Loche, 1867, EXPLORATION SCI ALGE, P123; Margueritte A, 1869, CHASSES ALGERIE NOTE; Martin JP, 2006, BELEZMA FORGERON BAT; Masseti M, 2010, J ARID ENVIRON, V74, P794, DOI 10.1016/j.jaridenv.2009.07.008; Mazak JH, 2010, J ZOOL, V281, P194, DOI 10.1111/j.1469-7998.2010.00694.x; Mogensen NL, 2011, AFR ZOOL, V46, P78, DOI 10.3377/004.046.0120; Ormsby J, 1864, AUTUMN RAMBLES N AFR; Ossendowski FA, 1927, BREATH DESERT ACCOUN; Packer C, 2001, SCIENCE, V293, P690, DOI 10.1126/science.1062320; Palisser G, 1982, ALGERIANISTE; Panouse JB, 1957, TRAV I SCI CHERIF Z; Patterson BD, 2007, EVOL BIOL, V34, P55, DOI 10.1007/s11692-007-9003-6; Playfair R.L., 1877, TRAVELS FOOTSTEPS BR; Robert G, 1891, VOYAGE TRAVERS ALGER; Roches L, 1904, DIX ANS TRAVERS ISLA; Saint Arnaud AJL, 1864, LETT MARECHAL SAINT; Saint Marie C, 1846, ALGERIA 1845 VISIT F; Schnitzler AE, 2011, MAMMAL REV, V41, P220, DOI 10.1111/j.1365-2907.2010.00181.x; Scott KC, 1842, J RESIDENCE ESMAILLA; Seurat LG, 1924, ZOOLOGIE FORESTIERE; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Simmonds P. L., 1877, ANIMAL PRODUCTS THEI; Solow AR, 2005, MATH BIOSCI, V195, P47, DOI 10.1016/j.mbs.2005.02.001; Sunquist ME, 2002, WILD CATS WORLD; Thierry-Mieg Charles, 1861, 6 SEMAINES AFRIQUE S, P294; Tounsi G, 1998, J JEUNE INDEPENDANT; Tumenta PN, 2010, AFR J ECOL, V48, P888, DOI 10.1111/j.1365-2028.2009.01181.x; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; Visser HD, 2009, J ZOOL, V300, P131; Vogel RM, 2009, B MATH BIOL, V71, P701, DOI 10.1007/s11538-008-9377-3; Windham WG, 1862, NOTES N AFRICA GUIDE; Yadav PR, 2004, VANISHING ENDANGERED; Yamaguchi N, 2004, J ZOOL, V263, P329, DOI 10.1017/S0952836904005242; Yamaguchi N, 2002, INT ZOO NEWS, V49, P321; Zoo-Olomouc, 2010, PRIR 6 8 2010 LEV BE	112	9	10	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60174	10.1371/journal.pone.0060174	http://dx.doi.org/10.1371/journal.pone.0060174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573239	Green Submitted, gold, Green Published			2022-12-27	WOS:000318840100051
J	Fukuishi, N; Igawa, Y; Kunimi, T; Hamano, H; Toyota, M; Takahashi, H; Kenmoku, H; Yagi, Y; Matsui, N; Akagi, M				Fukuishi, Nobuyuki; Igawa, Yuusuke; Kunimi, Tomoyo; Hamano, Hirofumi; Toyota, Masao; Takahashi, Hironobu; Kenmoku, Hiromichi; Yagi, Yasuyuki; Matsui, Nobuaki; Akagi, Masaaki			Generation of Mast Cells from Mouse Fetus: Analysis of Differentiation and Functionality, and Transcriptome Profiling Using Next Generation Sequencer	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; IN-VITRO; HOMOLOGOUS RECOMBINATION; HIGHLY PROFICIENT; MAMMALIAN-CELLS; LINE NALM-6; EXPRESSION; RELEASE; IGE; RECEPTOR	While gene knockout technology can reveal the roles of proteins in cellular functions, including in mast cells, fetal death due to gene manipulation frequently interrupts experimental analysis. We generated mast cells from mouse fetal liver (FLMC), and compared the fundamental functions of FLMC with those of bone marrow-derived mouse mast cells (BMMC). Under electron microscopy, numerous small and electron-dense granules were observed in FLMC. In FLMC, the expression levels of a subunit of the Fc epsilon RI receptor and degranulation by IgE cross-linking were comparable with BMMC. By flow cytometry we observed surface expression of c-Kit prior to that of Fc epsilon RI on FLMC, although on BMMC the expression of c-Kit came after Fc epsilon RI. The surface expression levels of Sca-1 and c-Kit, a marker of putative mast cell precursors, were slightly different between bone marrow cells and fetal liver cells, suggesting that differentiation stage or cell type are not necessarily equivalent between both lineages. Moreover, this indicates that phenotypically similar mast cells may not have undergone an identical process of differentiation. By comprehensive analysis using the next generation sequencer, the same frequency of gene expression was observed for 98.6% of all transcripts in both cell types. These results indicate that FLMC could represent a new and useful tool for exploring mast cell differentiation, and may help to elucidate the roles of individual proteins in the function of mast cells where gene manipulation can induce embryonic lethality in the mid to late stages of pregnancy.	[Fukuishi, Nobuyuki; Igawa, Yuusuke; Kunimi, Tomoyo; Hamano, Hirofumi; Matsui, Nobuaki; Akagi, Masaaki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Pharmacol, Tokushima 770, Japan; [Toyota, Masao; Takahashi, Hironobu; Kenmoku, Hiromichi; Yagi, Yasuyuki] Tokushima Bunri Univ, Inst Pharmacognosy, Tokushima, Japan	Tokushima Bunri University; Tokushima Bunri University	Fukuishi, N (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Pharmacol, Yamashiro Cho, Tokushima 770, Japan.	nobuf@ph.bunri-u.ac.jp		Takahashi, Hironobu/0000-0003-0045-7716; Hamano, Hirofumi/0000-0002-2231-0179	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Senryaku Research from the Ministry of Education, Culture, Sports, Science and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2006, DNA CELL BIOL, V25, P19, DOI 10.1089/dna.2006.25.19; Adachi Noritaka, 2008, V435, P17, DOI 10.1007/978-1-59745-232-8_2; Akagi M, 2001, PHARMACOLOGY, V63, P203, DOI 10.1159/000056135; AKAGI M, 1983, J ELECTRON MICROSC, V32, P207; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Arinobu Yojiro, 2009, Allergology International, V58, P21, DOI 10.2332/allergolint.08-RAI-0067; Ashmole I, 2012, J ALLERGY CLIN IMMUN, V129, P1628, DOI 10.1016/j.jaci.2012.01.070; Cerrato S, 2010, VET IMMUNOL IMMUNOP, V133, P9, DOI 10.1016/j.vetimm.2009.06.011; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Falanga YT, 2012, J IMMUNOL, V188, P4360, DOI 10.4049/jimmunol.1003223; Franco CB, 2010, CELL STEM CELL, V6, P361, DOI 10.1016/j.stem.2010.02.013; Fukuishi N, 2004, J WORLD ALLEFGY ORG, V16, P70; Fureder W, 1997, J LEUKOCYTE BIOL, V61, P592; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gomi K, 2000, J IMMUNOL, V165, P6545, DOI 10.4049/jimmunol.165.11.6545; Good-Jacobson KL, 2012, J IMMUNOL, V188, P4217, DOI 10.4049/jimmunol.1102885; Heinzmann A, 2002, INT ARCH ALLERGY IMM, V127, P170, DOI 10.1159/000053861; Hu P, 2012, J BIOL CHEM, V287, P20258, DOI 10.1074/jbc.M112.358119; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Kashiwakura J, 2008, J LEUKOCYTE BIOL, V84, P357, DOI 10.1189/jlb.1207841; Kashiwakura JI, 2011, ADV EXP MED BIOL, V716, P29, DOI 10.1007/978-1-4419-9533-9_3; Koodie L, 2010, AM J PATHOL, V177, P984, DOI 10.2353/ajpath.2010.090621; Kubo Y, 2007, INFLAMM RES, V56, P70, DOI 10.1007/s00011-006-6064-4; Kuehn HS, 2011, J BIOL CHEM, V286, P391, DOI 10.1074/jbc.M110.164772; Kulka M, 2009, CURR TOP MED CHEM, V9, P1611, DOI 10.2174/156802609789941898; Kwon JS, 2011, J MOL CELL CARDIOL, V50, P814, DOI 10.1016/j.yjmcc.2011.01.019; Lam V, 2003, BLOOD, V102, P1405, DOI 10.1182/blood-2002-10-3176; MacNeil AJ, 2011, J IMMUNOL, V187, P3374, DOI 10.4049/jimmunol.1003126; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Manikandan J, 2012, CELL MOL LIFE SCI, V69, P1917, DOI 10.1007/s00018-011-0886-0; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Moffatt JD, 2005, PHARMACOL THERAPEUT, V107, P343, DOI 10.1016/j.pharmthera.2005.03.007; Moon TC, 2012, J LEUKOCYTE BIOL, V91, P581, DOI 10.1189/jlb.0811436; NAKAHATA T, 1982, BLOOD, V60, P352; Nakajima T, 2002, BLOOD, V100, P3861, DOI 10.1182/blood-2002-02-0602; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Papadopoulos EJ, 2000, EUR J IMMUNOL, V30, P2355, DOI 10.1002/1521-4141(2000)30:8<2355::AID-IMMU2355>3.0.CO;2-#; Radinger M, 2011, J IMMUNOL, V187, P5587, DOI 10.4049/jimmunol.1101257; RAZIN E, 1981, P NATL ACAD SCI-BIOL, V78, P2559, DOI 10.1073/pnas.78.4.2559; Sasaki T, 2001, J EXP MED, V194, P757, DOI 10.1084/jem.194.6.757; Shea-Donohue T, 2011, CURR GASTROENTEROL R, V12, P349; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Tanaka S, 2005, EUR J IMMUNOL, V35, P460, DOI 10.1002/eji.200425622; TAS J, 1977, HISTOCHEM J, V9, P205, DOI 10.1007/BF01003632; Theoharides TC, 2006, STEM CELL REV, V2, P143; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; Traum D, 2012, J LEUKOCYTE BIOL, V91, P427, DOI 10.1189/jlb.0411209; Yamazoe M, 2004, DNA REPAIR, V3, P1175, DOI 10.1016/j.dnarep.2004.03.039; Yoshioka M, 2007, J ALLERGY CLIN IMMUN, V120, P452, DOI 10.1016/j.jaci.2007.03.027; Zhang HY, 2007, IMMUNOL CELL BIOL, V85, P558, DOI 10.1038/sj.icb.7100085; Zuberbier T, 2001, BRIT J DERMATOL, V145, P661, DOI 10.1046/j.1365-2133.2001.04435.x	52	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60837	10.1371/journal.pone.0060837	http://dx.doi.org/10.1371/journal.pone.0060837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573287	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100107
J	Hu, FL; Li, DD; Wang, YBN; Yao, XP; Zhang, WC; Liang, J; Lin, CQ; Ren, JJ; Zhu, L; Wu, ZW; Li, SY; Li, Y; Zhao, XJ; Cui, BB; Dong, XS; Tian, SL; Zhao, YS				Hu, Fulan; Li, Dandan; Wang, Yibaina; Yao, Xiaoping; Zhang, Wencui; Liang, Jing; Lin, Chunqing; Ren, Jiaojiao; Zhu, Lin; Wu, Zhiwei; Li, Shuying; Li, Ye; Zhao, Xiaojuan; Cui, Binbin; Dong, Xinshu; Tian, Suli; Zhao, Yashuang			Novel DNA Variants and Mutation Frequencies of hMLH1 and hMSH2 Genes in Colorectal Cancer in the Northeast China Population	PLOS ONE			English	Article							MISMATCH-REPAIR GENES; NONPOLYPOSIS COLON-CANCER; GERM-LINE MUTATIONS; MICROSATELLITE INSTABILITY; LYNCH SYNDROME; MISSENSE MUTATIONS; MLH1; MSH2; IDENTIFICATION; POLYMORPHISMS	Research on hMLH1 and hMSH2 mutations tend to focus on Lynch syndrome (LS) and LS-like colorectal cancer (CRC). No studies to date have assessed the role of hMLH1 and hMSH2 genes in mass sporadic CRC (without preselection by MSI or early age of onset). We aimed to identify novel hMLH1 and hMSH2 DNA variants, to determine the mutation frequencies and sites in both sporadic and LS CRC and their relationships with clinicopathological characteristics of CRC in Northeast of China. 452 sporadic and 21 LS CRC patients were screened for germline and somatic mutations in hMLH1 and hMSH2 genes with PCR-SSCP sequencing. We identified 11 hMLH1 and seven hMSH2 DNA variants in our study cohort. Six of them were novel: four in hMLH1 gene (IVS8-16 A>T, c.644 GAT>GTT, c.1529 CAG>CGG and c.1831 ATT>TTT) and two in hMSH2 gene (-39 C>T, insertion AACAACA at c.1127 and deletion AAG at c.1129). In sporadic CRC, germline and somatic mutation frequencies of hMLH1/hMSH2 gene were 15.59% and 17.54%, respectively (p = 0.52). Germline mutations present in hMLH1 and hMSH2 genes were 5.28% and 10.78%, respectively (p<0.01). Somatic mutations in hMLH1 and hMSH2 genes were 6.73% and 11.70%, respectively (p = 0.02). In LS CRC, both germline and somatic mutation frequencies of hMLH1/hMSH2 gene were 28.57%. The most prevalent germline mutation site in hMSH2 gene was c.1168 CTT>TTT (3.90%), a polymorphism. Somatic mutation frequency of hMLH1/hMSH2 gene was significantly different in proximal, distal colon and rectal cancer (p = 0.03). Our findings elucidate the mutation spectrum and frequency of hMLH1 and hMSH2 genes in sporadic and LS CRC, and their relationships with clinicopathological characteristics of CRC.	[Hu, Fulan; Li, Dandan; Wang, Yibaina; Yao, Xiaoping; Zhang, Wencui; Liang, Jing; Lin, Chunqing; Ren, Jiaojiao; Zhu, Lin; Wu, Zhiwei; Li, Shuying; Li, Ye; Zhao, Xiaojuan; Zhao, Yashuang] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Peoples R China; [Cui, Binbin] Harbin Med Univ, Dept Colorectal Surg, Canc Hosp, Harbin, Peoples R China; [Dong, Xinshu; Tian, Suli] Harbin Med Univ, Affiliated Hosp 4, Dept Surg, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhao, YS (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Peoples R China.	zhao_yashuang@263.net	Lin, Chunqing/ABF-2894-2020; Zhao, Yashuang/I-6145-2019		National Natural Science Foundation of China [30671801, 30371243]; Foundation for the Returned Scholars of Harbin [2005AFLXJ017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Returned Scholars of Harbin	This work was supported by the grants of National Natural Science Foundation of China (No. 30671801 and 30371243) and the Foundation for the Returned Scholars of Harbin (No. 2005AFLXJ017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1994, ANTICANCER RES, V14, P1657; Abe Y, 2000, J SURG ONCOL, V74, P249, DOI 10.1002/1096-9098(200008)74:4<249::AID-JSO2>3.0.CO;2-S; Akiyama Y, 1996, CANCER-AM CANCER SOC, V78, P2478, DOI 10.1002/(SICI)1097-0142(19961215)78:12<2478::AID-CNCR5>3.0.CO;2-G; Bai YQ, 1999, INT J CANCER, V82, P512, DOI 10.1002/(SICI)1097-0215(19990812)82:4<512::AID-IJC7>3.0.CO;2-8; Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; BUERSTEDDE JM, 1995, J MED GENET, V32, P909, DOI 10.1136/jmg.32.11.909; Chaksangchaichot P, 2007, J CANCER RES CLIN, V133, P65, DOI 10.1007/s00432-006-0147-z; Chao EC, 2008, HUM MUTAT, V29, P852, DOI 10.1002/humu.20735; Christensen LL, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-52; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; Cui BB, 2007, WORLD CHINESE J DIGE, V15, P2442; Fan Y, 2007, CLIN CANCER RES, V13, P7515, DOI 10.1158/1078-0432.CCR-07-1028; Fan YM, 2006, CANCER GENET CYTOGEN, V170, P121, DOI 10.1016/j.cancergencyto.2006.05.010; Farrington SM, 1998, AM J HUM GENET, V63, P749, DOI 10.1086/301996; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fredriksson H, 2006, EUR J CANCER, V42, P2802, DOI 10.1016/j.ejca.2006.04.024; Huang YQ, 2010, J ZHEJIANG UNIV-SC B, V11, P647, DOI 10.1631/jzus.B1000198; Isidro G, 2003, Hum Mutat, V22, P419, DOI 10.1002/humu.9192; Jacob S, 2002, BIOCHIMIE, V84, P27, DOI 10.1016/S0300-9084(01)01362-1; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Jeong SY, 2003, DIS COLON RECTUM, V46, P1069, DOI 10.1007/s10350-004-7282-x; Jin HY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-44; Joshi AD, 2009, CARCINOGENESIS, V30, P472, DOI 10.1093/carcin/bgn260; Kim Jin C, 2004, Fam Cancer, V3, P129; Konishi M, 1996, GASTROENTEROLOGY, V111, P307, DOI 10.1053/gast.1996.v111.pm8690195; Kowalski LD, 1997, GENE CHROMOSOME CANC, V18, P219, DOI 10.1002/(SICI)1098-2264(199703)18:3<219::AID-GCC8>3.0.CO;2-4; Lu SL, 1996, JPN J CANCER RES, V87, P279, DOI 10.1111/j.1349-7006.1996.tb00218.x; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; MIYAKI M, 1995, J MOL MED-JMM, V73, P515; MIYAKI M, 1990, CANCER RES, V50, P7166; Nakahara M, 1997, CANCER EPIDEM BIOMAR, V6, P1057; Nilbert M, 2009, FAM CANCER, V8, P75, DOI 10.1007/s10689-008-9199-3; Nomura S, 2000, BIOCHEM BIOPH RES CO, V271, P120, DOI 10.1006/bbrc.2000.2547; Raevaara TE, 2005, GASTROENTEROLOGY, V129, P537, DOI 10.1053/j.gastro.2005.06.005; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Raptis S, 2007, JNCI-J NATL CANCER I, V99, P463, DOI 10.1093/jnci/djk095; Rubio-Del-Campo A, 2008, BJU INT, V102, P504, DOI 10.1111/j.1464-410X.2008.07581.x; Senba S, 1998, CANCER, V82, P279, DOI 10.1002/(SICI)1097-0142(19980115)82:2<279::AID-CNCR6>3.3.CO;2-D; Seton-Rogers S, 2012, NAT REV CANCER, V12, P1, DOI 10.1038/nrc3190; Sheng J Q, 2008, Cytogenet Genome Res, V122, P22, DOI 10.1159/000151312; Shitoh K, 2000, J CLIN PATHOL, V53, P841, DOI 10.1136/jcp.53.11.841; Tinat J, 2008, FAM CANCER, V7, P339, DOI 10.1007/s10689-008-9196-6; Wei WQ, 2010, J BIOINFORM COMPUT B, V8, P111, DOI 10.1142/S0219720010005154; Yamada K, 2003, ONCOL REP, V10, P859; Yan HL, 2008, CANCER SCI, V99, P770, DOI 10.1111/j.1349-7006.2008.00737.x; Yap HL, 2009, FAM CANCER, V8, P85, DOI 10.1007/s10689-008-9209-5; Yu JH, 2006, AM J GASTROENTEROL, V101, P1313, DOI 10.1111/j.1572-0241.2006.00551.x; Yuen ST, 2002, ONCOGENE, V21, P7585, DOI 10.1038/sj.onc.1205968	51	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60233	10.1371/journal.pone.0060233	http://dx.doi.org/10.1371/journal.pone.0060233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573243	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100057
J	Boehme, S; Duenges, B; Klein, KU; Hartwich, V; Mayr, B; Consiglio, J; Baumgardner, JE; Markstaller, K; Basciani, R; Vogt, A				Boehme, Stefan; Duenges, Bastian; Klein, Klaus U.; Hartwich, Volker; Mayr, Beate; Consiglio, Jolanda; Baumgardner, James E.; Markstaller, Klaus; Basciani, Reto; Vogt, Andreas			Multi Frequency Phase Fluorimetry (MFPF) for Oxygen Partial Pressure Measurement: Ex Vivo Validation by Polarographic Clark-Type Electrode	PLOS ONE			English	Article							BRAIN-TISSUE OXYGEN; END-EXPIRATORY PRESSURE; BLOOD-GAS ANALYSIS; IN-VITRO ACCURACY; RESPIRATORY RATE; ARTERIAL-BLOOD; TEMPERATURE; LICOX; OSCILLATIONS; AGREEMENT	Background: Measurement of partial pressure of oxygen (P-O2) at high temporal resolution remains a technological challenge. This study introduces a novel P-O2 sensing technology based on Multi-Frequency Phase Fluorimetry (MFPF). The aim was to validate MFPF against polarographic Clark-type electrode (CTE) P-O2 measurements. Methodology/Principal Findings: MFPF technology was first investigated in N = 8 anaesthetised pigs at F-IO2 of 0.21, 0.4, 0.6, 0.8 and 1.0. At each F-IO2 level, blood samples were withdrawn and P-O2 was measured in vitro with MFPF using two FOXY-AL300 probes immediately followed by CTE measurement. Secondly, MFPF-P-O2 readings were compared to CTE in an artificial circulatory setup (human packed red blood cells, haematocrit of 30%). The impacts of temperature (20, 30, 40 degrees C) and blood flow (0.8, 1.6, 2.4, 3.2, 4.0 L min(-1)) on MFPF-P-O2 measurements were assessed. MFPF response time in the gas- and blood-phase was determined. Porcine MFPF-P-O2 ranged from 63 to 749 mmHg; the corresponding CTE samples from 43 to 712 mmHg. Linear regression: CTE = 15.59+1.18*MFPF (R-2 = 0.93; P < 0.0001). Bland Altman analysis: mean(diff) 69.2 mmHg, range(diff) -50.1/215.6 mmHg, 1.96-SD limits -56.3/194.8 mmHg. In artificial circulatory setup, MFPF-P-O2 ranged from 20 to 567 mmHg and CTE samples from 11 to 575 mmHg. Linear regression: CTE = 28.73+1.05*MFPF (R-2 = 0.99; P < 0.0001). Bland-Altman analysis: mean(diff) 6.6 mmHg, range(diff) -9.7/20.5 mmHg, 1.96-SD limits -12.7/25.8 mmHg. Differences between MFPF and CTE-P-O2 due to variations of temperature were less than 6 mmHg (range 0-140 mmHg) and less than 35 mmHg (range 140-750 mmHg); differences due to variations in blood flow were less than 15 mmHg (all P-values>0.05). MFPF response-time (monoexponential) was 1.48+/-0.26 s for the gas-phase and 1.51+/-0.20 s for the blood-phase. Conclusions/Significance: MFPF-derived P-O2 readings were reproducible and showed excellent correlation and good agreement with Clark-type electrode-based P-O2 measurements. There was no relevant impact of temperature and blood flow upon MFPF-P-O2 measurements. The response time of the MFPF FOXY-AL300 probe was adequate for real-time sensing in the blood phase.	[Boehme, Stefan; Klein, Klaus U.; Markstaller, Klaus] Med Univ Vienna, Dept Anaesthesia Gen Intens Care & Pain Managemen, Vienna, Austria; [Boehme, Stefan; Duenges, Bastian; Klein, Klaus U.; Markstaller, Klaus] Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Med Ctr, D-55122 Mainz, Germany; [Baumgardner, James E.] Oscillogy, Folsom, PA USA; [Hartwich, Volker; Basciani, Reto; Vogt, Andreas] Univ Hosp Bern, Dept Anesthesiol & Pain Therapy, Inselspital, CH-3010 Bern, Switzerland; [Hartwich, Volker; Basciani, Reto; Vogt, Andreas] Univ Bern, Bern, Switzerland; [Mayr, Beate; Consiglio, Jolanda] Univ Hosp Bern, Dept Cardiovasc Surg, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland	Medical University of Vienna; Johannes Gutenberg University of Mainz; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Boehme, S (corresponding author), Med Univ Vienna, Dept Anaesthesia Gen Intens Care & Pain Managemen, Vienna, Austria.	stefan_boehme@web.de		Vogt, Andreas/0000-0002-3676-7188; Klein, Klaus Ulrich/0000-0001-7446-0542	German Research Council [DFG PAK 415/7-1, Ma 2398-3]; Swiss National Foundation [SNF POIB 117065/1]; Research Department of Anesthesiology and Pain Therapy, Inselspital, Bern, Switzerland; Covidien Europe	German Research Council(German Research Foundation (DFG)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Research Department of Anesthesiology and Pain Therapy, Inselspital, Bern, Switzerland; Covidien Europe	The study was supported by research grants of the German Research Council (DFG PAK 415/7-1, Ma 2398-3) and Swiss National Foundation (SNF POIB 117065/1), and by an institutional grant of the Research Department of Anesthesiology and Pain Therapy, Inselspital, Bern, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JEB is President of Fa. Oscillogy. RB received lecture honoraria from Medtronic Switzerland for lectures in the field of anesthetic management for transcatheter aortic valve implantation. RB received lecture honoraria and a travel grant from Covidien Europe for speaking at the meeting of the European Association of Cardiothoracic Anaesthesiologists (EACTA) in the field of near-infrared spectroscopy for cerebral tissue oximetry in thoracic aortic surgery. In the authors' opinion, these conflicts are in no way related to being competitive in the field of our manuscript: these conflicts do not interfere with, or could be perceived as interfering with, the complete and objective presentation, peer review, editorial decision-making, or publication of the manuscript. There are no conflicts related to being competative researchers in this field. Overall, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baumgardner JE, 2002, AM J RESP CRIT CARE, V166, P1556, DOI 10.1164/rccm.200207-717OC; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Burkhardt H, 2008, SCAND J CLIN LAB INV, V68, P171, DOI 10.1080/00365510701601665; Citerio G, 2004, ACTA NEUROCHIR, V146, P1221, DOI 10.1007/s00701-004-0351-z; CLARK LC, 1953, J APPL PHYSIOL, V6, P189, DOI 10.1152/jappl.1953.6.3.189; Ganter M, 2003, BRIT J ANAESTH, V91, P397, DOI 10.1093/bja/aeg176; GRUNDMANN A, 1992, ADV EXP MED BIOL, V317, P213; Hahn CEW, 1998, ANALYST, V123, p57R; Haitsma I, 2008, ACTA NEUROCHIR SUPPL, V102, P197, DOI 10.1007/978-3-211-85578-2_39; Hartmann EK, 2012, CRIT CARE, V16, DOI 10.1186/cc11147; Herweling A, 2005, RESUSCITATION, V65, P71, DOI 10.1016/j.resuscitation.2004.04.017; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Huschak G, 2009, J NEUROSURG ANESTH, V21, P155, DOI 10.1097/ANA.0b013e31818f2eac; Jaeger M, 2005, ACTA NEUROCHIR SUPPL, V95, P79; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kimmich H P, 1976, Adv Exp Med Biol, V75, P33; Klein KU, 2011, J NEUROSURG ANESTH, V23, P341, DOI 10.1097/ANA.0b013e31822cf893; Lakowicz J.R., 2008, J BIOMED OPT, V13; MADIEDO G, 1980, J CLIN PATHOL, V33, P864, DOI 10.1136/jcp.33.9.864; MAHUTTE CK, 1994, INTENS CARE MED, V20, P85, DOI 10.1007/BF01707657; Orakcioglu B, 2010, NEUROSURGERY, V67, P1716, DOI 10.1227/NEU.0b013e3181f9bb5b; Picandet V, 2007, J VET INTERN MED, V21, P476, DOI 10.1892/0891-6640(2007)21[476:EOSTAS]2.0.CO;2; PURVES MJ, 1966, RESP PHYSIOL, V1, P281, DOI 10.1016/0034-5687(66)90047-8; Sakowitz OW, 2011, NEUROSURGERY, V67, P1722; Severinghaus JW, 2002, ANESTHESIOLOGY, V97, P253, DOI 10.1097/00000542-200207000-00031; Stewart C, 2008, NEUROSURGERY, V63, P1159, DOI 10.1227/01.NEU.0000333265.19131.7C; Urbaniak G. C., 2010, RES RANDOMIZER VERSI; Williams EM, 2000, BRIT J ANAESTH, V85, P456, DOI 10.1093/bja/85.3.456; Zaugg M, 1998, ANESTH ANALG, V87, P647, DOI 10.1097/00000539-199809000-00030	30	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60591	10.1371/journal.pone.0060591	http://dx.doi.org/10.1371/journal.pone.0060591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565259	gold, Green Published			2022-12-27	WOS:000317717300130
J	Jing, F; Mogi, M; Min, LJ; Ohshima, K; Nakaoka, H; Tsukuda, K; Wang, XL; Iwanami, J; Horiuchi, M				Jing, Fei; Mogi, Masaki; Min, Li-Juan; Ohshima, Kousei; Nakaoka, Hirotomo; Tsukuda, Kana; Wang, Xiaoli; Iwanami, Jun; Horiuchi, Masatsugu			Effect of Angiotensin II Type 2 Receptor-Interacting Protein on Adipose Tissue Function via Modulation of Macrophage Polarization	PLOS ONE			English	Article							REGULATORY FACTOR-I; INSULIN-RESISTANCE; AT2 RECEPTOR; BLOOD MONOCYTES; CELL-DIFFERENTIATION; GLUCOSE-UPTAKE; PPAR-GAMMA; INFLAMMATION; OBESITY; EXPRESSION	We demonstrated that angiotensin II type 2 (AT(2)) receptor-interacting protein (ATIP) 1 ameliorates inflammation-mediated vascular remodeling independent of the AT(2) receptor, leading us to explore the possibility of whether ATIP1 could exert anti-inflammatory effects and play a role in other pathophysiological conditions. We examined the possible anti-inflammatory effects of ATIP1 in adipose tissue associated with amelioration of insulin resistance. In mice fed a high-cholesterol diet, adipose tissue macrophage (ATM) infiltration and M1-to-M2 ratio were decreased in ATIP1 transgenic mice (ATIP1-Tg) compared with wild-type mice (WT), with decreased expression of inflammatory cytokines such as tumor necrosis factor-alpha and monocyte chemoattractant protein-1 in white adipose tissue (WAT), but an increase in interleukin-10, an anti-inflammatory cytokine. Moreover, 2-[H-3]deoxy-d-glucose (2-[H-3]DG) uptake was significantly increased in ATIP1-Tg compared with WT. Next, we examined the roles of ATIP1 in BM-derived hematopoietic cells, employing chimeric mice produced by BM transplantation into irradiated type 2 diabetic mice with obesity, KKAy, as recipients. ATM infiltration and M1-to-M2 ratio were decreased in ATIP1 chimera (ATIP1-tg as BM donor), with improvement of insulin-mediated 2-[H-3] DG uptake and amelioration of inflammation in WAT. Moreover, serum adiponectin concentration in ATIP1 chimera was significantly higher than that in WT chimera (WT as BM donor) and KKAy chimera (KKAy as BM donor). These results indicate that ATIP1 could exert anti-inflammatory effects in adipose tissue via macrophage polarization associated with improvement of insulin resistance, and ATIP1 in hematopoietic cells may contribute to these beneficial effects on adipose tissue functions in type 2 diabetes.	[Jing, Fei; Mogi, Masaki; Min, Li-Juan; Ohshima, Kousei; Nakaoka, Hirotomo; Tsukuda, Kana; Wang, Xiaoli; Iwanami, Jun; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Matsuyama, Ehime 790, Japan	Ehime University	Horiuchi, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Matsuyama, Ehime 790, Japan.	horiuchi@m.ehime-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan; Novartis Foundation for Gerontological Research	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Novartis Foundation for Gerontological Research(Novartis Foundation for Gerontological Research)	This study was supported by the Ministry of Education, Science, Sports, and Culture of Japan to MH and MM, and the Novartis Foundation for Gerontological Research to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Aparicio-Vergara M, 2010, ATHEROSCLEROSIS, V213, P335, DOI 10.1016/j.atherosclerosis.2010.05.030; Bie JH, 2010, J BIOL CHEM, V285, P13630, DOI 10.1074/jbc.M109.069781; Charo IF, 2007, CELL METAB, V6, P96, DOI 10.1016/j.cmet.2007.07.006; Cudejko C, 2011, BLOOD, V118, P2556, DOI 10.1182/blood-2010-10-313106; Dawson J, 2003, EXPERT OPIN THER TAR, V7, P35; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Di Benedetto M, 2006, GENE, V380, P127, DOI 10.1016/j.gene.2006.05.021; Di Benedetto M, 2006, MOL CELL ENDOCRINOL, V252, P207, DOI 10.1016/j.mce.2006.03.014; Frank B, 2007, CARCINOGENESIS, V28, P1442, DOI 10.1093/carcin/bgm033; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Fujita T, 2009, HYPERTENSION, V53, P688, DOI 10.1161/HYPERTENSIONAHA.108.128140; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Horiuchi M, 1997, J BIOL CHEM, V272, P11952, DOI 10.1074/jbc.272.18.11952; HORIUCHI M, 1995, J BIOL CHEM, V270, P20225, DOI 10.1074/jbc.270.34.20225; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Iwanami J, 2011, HYPERTENSION, V58, P404, DOI 10.1161/HYPERTENSIONAHA.111.177873; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kullo IJ, 2002, AM J CARDIOL, V89, P1441, DOI 10.1016/S0002-9149(02)02366-4; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Li JM, 2007, MOL ENDOCRINOL, V21, P499, DOI 10.1210/me.2006-0005; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Nouet S, 2004, J BIOL CHEM, V279, P28989, DOI 10.1074/jbc.M403880200; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Ohshima K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048387; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212; Rodrigues-Ferreira S, 2010, TRENDS ENDOCRIN MET, V21, P684, DOI 10.1016/j.tem.2010.08.009; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schaefer KL, 2007, INT J CANCER, V120, P702, DOI 10.1002/ijc.22361; Schaefer KL, 2008, PPAR RES, V2008, DOI 10.1155/2008/785405; Seibold S, 2003, FASEB J, V17, P1180, DOI 10.1096/fj.02-0934fje; Shiuchi T, 2001, ENDOCRINOLOGY, V142, P608, DOI 10.1210/en.142.2.608; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soukas A, 2000, GENE DEV, V14, P963; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; SUDO M, 1991, AM J PHYSIOL, V261, pE298, DOI 10.1152/ajpendo.1991.261.3.E298; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wruck CJ, 2005, ARTERIOSCL THROM VAS, V25, P57, DOI 10.1161/01.ATV.0000150662.51436.14; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamada H, 1999, HYPERTENSION, V33, P1414, DOI 10.1161/01.HYP.33.6.1414; Zaynagetdinov R, 2011, J IMMUNOL, V187, P5703, DOI 10.4049/jimmunol.1100558	60	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60067	10.1371/journal.pone.0060067	http://dx.doi.org/10.1371/journal.pone.0060067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565185	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300054
J	Lin, WC; Schmidt, JW; Creamer, BA; Triplett, AA; Wagner, KU				Lin, Wan-chi; Schmidt, Jeffrey W.; Creamer, Bradley A.; Triplett, Aleata A.; Wagner, Kay-Uwe			Gain-of-Function of Stat5 Leads to Excessive Granulopoiesis and Lethal Extravasation of Granulocytes to the Lung	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TYROSINE KINASE JAK2; TRANSCRIPTION FACTORS; LYMPHOID DEVELOPMENT; MAMMARY-GLAND; MOUSE MODEL; GROWTH; GENE; ACTIVATION; EXPRESSION	The Signal Transducer and Activator of Transcription 5 (Stat5) plays a significant role in normal hematopoiesis and a variety of hematopoietic malignancies. Deficiency in Stat5 causes impaired cytokine-mediated proliferation and survival of progenitors and their differentiated descendants along major hematopoietic lineages such as erythroid, lymphoid, and myeloid cells. Overexpression and persistent activation of Stat5 are sufficient for neoplastic transformation and development of multi-lineage leukemia in a transplant model. Little is known, however, whether a continuous activation of this signal transducer is essential for the maintenance of hematopoietic malignancies. To address this issue, we developed transgenic mice that express a hyperactive mutant of Stat5 in hematopoietic progenitors and derived lineages in a ligand-controlled manner. In contrast to the transplant model, expression of mutant Stat5 did not adversely affect normal hematopoiesis in the presence of endogenous wildtype Stat5 alleles. However, the gain-of-function of this signal transducer in mice that carry Stat5a/b hypomorphic alleles resulted in abnormally high numbers of circulating granulocytes that caused severe airway obstruction. Downregulation of hyperactive Stat5 in diseased animals restored normal granulopoiesis, which also resulted in a swift clearance of granulocytes from the lung. Moreover, we demonstrate that Stat5 promotes the initiation and maintenance of severe granulophilia in a cell autonomous manner. The results of this study show that the gain-of-function of Stat5 causes excessive granulopoiesis and prolonged survival of granulocytes in circulation. Collectively, our findings underline the critical importance of Stat5 in maintaining a normal balance between myeloid and lymphoid cells during hematopoiesis, and we provide direct evidence for a function of Stat5 in granulophilia-associated pulmonary dysfunction.	[Lin, Wan-chi; Schmidt, Jeffrey W.; Creamer, Bradley A.; Triplett, Aleata A.; Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Wagner, KU (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	kuwagner@unmc.edu		Creamer, Bradley/0000-0002-0822-3001; Wagner, Kay-Uwe/0000-0002-5081-0226	Public Health Service [CA117930]; Nebraska Cancer and Smoking Disease Research Program [NE DHHS LB506 2012-44]; UNMC Graduate Studies Office; UNMC Cancer Research Training Program [CA009476]; Breast Cancer Predoctoral Traineeship Award from the Department of Defense Congressionally Directed Medical Research Program [BC100147]; NATIONAL CANCER INSTITUTE [T32CA009476, R01CA117930] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Nebraska Cancer and Smoking Disease Research Program; UNMC Graduate Studies Office; UNMC Cancer Research Training Program; Breast Cancer Predoctoral Traineeship Award from the Department of Defense Congressionally Directed Medical Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the Public Health Service grants CA117930 (KUW) Additional financial support provided to KUW by the Nebraska Cancer and Smoking Disease Research Program (NE DHHS LB506 2012-44) was imperative to finance the maintenance of the Stat5 transgenic mice. WcL and BAC were supported through a research assistantship from the UNMC Graduate Studies Office. JWS received a graduate fellowship through the UNMC Cancer Research Training Program (CA009476), a Program of Excellence Graduate Assistantship from the UNMC Graduate Studies Office as well as a Breast Cancer Predoctoral Traineeship Award from the Department of Defense Congressionally Directed Medical Research Program (BC100147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bernasconi A, 2006, PEDIATRICS, V118, pE1584, DOI 10.1542/peds.2005-2882; Brizzi MF, 1999, J BIOL CHEM, V274, P16965, DOI 10.1074/jbc.274.24.16965; Buettner R, 2002, CLIN CANCER RES, V8, P945; Creamer BA, 2009, GENESIS, V47, P234, DOI 10.1002/dvg.20480; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Dai XZ, 2007, J IMMUNOL, V179, P1068, DOI 10.4049/jimmunol.179.2.1068; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fievez L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000727; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Hennighausen L, 1995, J CELL BIOCHEM, V59, P463, DOI 10.1002/jcb.240590407; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Hwa V, 2005, J CLIN ENDOCR METAB, V90, P4260, DOI 10.1210/jc.2005-0515; Iavnilovitch E, 2004, INT J CANCER, V112, P607, DOI 10.1002/ijc.20484; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Joliot V, 2006, ONCOGENE, V25, P4573, DOI 10.1038/sj.onc.1209480; Kalaitzidis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003776; Kieslinger M, 2000, GENE DEV, V14, P232; Kimura A, 2010, J BIOL CHEM, V285, P32704, DOI 10.1074/jbc.M110.141804; Kimura A, 2009, BLOOD, V114, P4721, DOI 10.1182/blood-2009-04-216390; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Liu G, 2007, EXP HEMATOL, V35, P1684, DOI 10.1016/j.exphem.2007.08.026; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Mizuki M, 2003, BLOOD, V101, P3164, DOI 10.1182/blood-2002-06-1677; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nadeau K, 2011, J PEDIATR-US, V158, P701, DOI 10.1016/j.jpeds.2010.12.042; Nishida S, 2006, BLOOD, V107, P3303, DOI 10.1182/blood-2005-04-1656; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Sakamoto K, 2007, MOL ENDOCRINOL, V21, P1877, DOI 10.1210/me.2006-0316; Sakamoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043778; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Taketani T, 2004, BLOOD, V103, P1085, DOI 10.1182/blood-2003-02-0418; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Turlej RK, 2001, THORAX, V56, P696, DOI 10.1136/thorax.56.9.696; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Valentino L, 2006, BIOCHEM PHARMACOL, V71, P713, DOI 10.1016/j.bcp.2005.12.017; Wagner KU, 2008, J MAMMARY GLAND BIOL, V13, P93, DOI 10.1007/s10911-008-9062-z; Wagner KU, 2012, ACTIVATION JANUS KIN, P259; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zhang Q, 2010, TRANSGENIC RES, V19, P499, DOI 10.1007/s11248-009-9329-1; Zhang Y, 2007, BLOOD, V110, P116, DOI 10.1182/blood-2006-11-060707	55	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60902	10.1371/journal.pone.0060902	http://dx.doi.org/10.1371/journal.pone.0060902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565285	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300158
J	Searle, CL; Xie, GY; Blaustein, AR				Searle, Catherine L.; Xie, Gisselle Yang; Blaustein, Andrew R.			Development and Infectious Disease in Hosts with Complex Life Cycles	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; AMPHIBIAN CHYTRID FUNGUS; FOOD LEVEL; PATHOGEN; DENSITY; METAMORPHOSIS; CHYTRIDIOMYCOSIS; RESISTANCE; GROWTH; TRANSMISSION	Metamorphosis is often characterized by profound changes in morphology and physiology that can affect the dynamics of species interactions. For example, the interaction between a pathogen and its host may differ depending on the life stage of the host or pathogen. One pathogen that infects hosts with complex life cycles is the emerging fungal pathogen of amphibians, Batrachochytrium dendrobatidis (Bd). We sought to determine how conditions at the larval stage can affect variation in development and patterns of Bd infection across amphibian life stages. We used outdoor experimental mesocosms to simulate natural pond habitats and manipulated the presence of Bd, the larval density, and the number of host species in larvae of two co-occurring amphibian species (Rana cascadae and Pseudacris regilla). We found that infection differed between species throughout development; P. regilla consistently had higher infection severity compared to R. cascadae. Additionally, while up to 100% of larvae were infected, only 18.2% of R. cascadae and 81.5% of P. regilla were infected after metamorphosis. This indicates that amphibians have the ability to recover from Bd infection as they undergo metamorphosis. Higher larval densities in P. regilla led to a shorter larval period, and individuals with a shorter larval period had lower infection severity. This led to a trend where P. regilla larvae reared at high densities tended to have lower infection prevalence after metamorphosis. We also found that exposure to Bd increased larval mortality and prolonged the larval period in P. regilla, indicating that P. regilla are susceptible to the negative effects of Bd as larvae. This study demonstrates that host density, species composition, and pathogen exposure may all interact to influence development and infection in hosts with complex life cycles.	[Searle, Catherine L.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Searle, Catherine L.; Xie, Gisselle Yang; Blaustein, Andrew R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Blaustein, Andrew R.] Oregon State Univ, Environm Sci Grad Program, Corvallis, OR 97331 USA	University of Michigan System; University of Michigan; Oregon State University; Oregon State University	Searle, CL (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	searlec@umich.edu		Searle, Catherine/0000-0002-6607-2299	Society of Wetland Scientists; Oregon Zoo Foundation Future for Wildlife Grant Program; Graduate Women in Sciences Sigma Delta Epsilon Fellowship	Society of Wetland Scientists; Oregon Zoo Foundation Future for Wildlife Grant Program; Graduate Women in Sciences Sigma Delta Epsilon Fellowship	This project was funded by the Society of Wetland Scientists, the Oregon Zoo Foundation Future for Wildlife Grant Program, and a Graduate Women in Sciences Sigma Delta Epsilon Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre SE, 2008, J WILDLIFE DIS, V44, P716, DOI 10.7589/0090-3558-44.3.716; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; BERVEN KA, 1988, OECOLOGIA, V75, P67, DOI 10.1007/BF00378815; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Brunner JL, 2004, ECOLOGY, V85, P560, DOI 10.1890/02-0374; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Fellers GM, 2011, HERPETOL CONSERV BIO, V6, P383; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Gervasi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054490; Gosner K. L., 1960, Herpetologica, V16, P183; Han BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016675; Hokit DG, 1997, ECOLOGY, V78, P1722; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kiesecker JM, 1999, ECOLOGY, V80, P2442, DOI 10.1890/0012-9658(1999)080[2442:PRCBLA]2.0.CO;2; Koprivnikar J, 2008, OECOLOGIA, V155, P641, DOI 10.1007/s00442-007-0937-2; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Luijckx P, 2011, ECOL LETT, V14, P125, DOI 10.1111/j.1461-0248.2010.01561.x; Marantelli Gerry, 2004, Pacific Conservation Biology, V10, P173; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; NEWMAN RA, 1994, ECOLOGY, V75, P1085, DOI 10.2307/1939432; Nussbaum RA., 1983, AMPHIBIANS REPTILES; Padgett-Flohr GE, 2009, DIS AQUAT ORGAN, V83, P1, DOI 10.3354/dao02003; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Pearl CA, 2009, ECOHEALTH, V6, P209, DOI 10.1007/s10393-009-0237-x; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; R Development Core Team, 2012, R LANG ENV STAT COMP; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Relyea RA, 2003, OECOLOGIA, V134, P596, DOI 10.1007/s00442-002-1161-8; Retallick RWR, 2007, DIS AQUAT ORGAN, V75, P201, DOI 10.3354/dao075201; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Richter J, 2009, J HERPETOL, V43, P551, DOI 10.1670/08-060R1.1; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Ryce EKN, 2005, DIS AQUAT ORGAN, V63, P69, DOI 10.3354/dao063069; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; SEMLITSCH RD, 1982, ECOLOGY, V63, P905, DOI 10.2307/1937230; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Thomas AM, 2010, ECOL ENTOMOL, V35, P200, DOI 10.1111/j.1365-2311.2009.01169.x; Venesky MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024991; Venesky MD, 2009, ECOHEALTH, V6, P565, DOI 10.1007/s10393-009-0272-7; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; WILBUR HM, 1977, ECOLOGY, V58, P196, DOI 10.2307/1935122; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; WOODWARD BD, 1982, OECOLOGIA, V54, P96, DOI 10.1007/BF00541115	58	10	10	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60920	10.1371/journal.pone.0060920	http://dx.doi.org/10.1371/journal.pone.0060920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565288	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300161
J	van der Velde, M; See, L; You, LZ; Balkovic, J; Fritz, S; Khabarov, N; Obersteiner, M; Wood, S				van der Velde, Marijn; See, Linda; You, Liangzhi; Balkovic, Juraj; Fritz, Steffen; Khabarov, Nikolay; Obersteiner, Michael; Wood, Stanley			Affordable Nutrient Solutions for Improved Food Security as Evidenced by Crop Trials	PLOS ONE			English	Article							YIELD GAPS; SOIL	The continuing depletion of nutrients from agricultural soils in Sub-Saharan African is accompanied by a lack of substantial progress in crop yield improvement. In this paper we investigate yield gaps for corn under two scenarios: a micro-dosing scenario with marginal increases in nitrogen (N) and phosphorus (P) of 10 kg ha(-1) and a larger yet still conservative scenario with proposed N and P applications of 80 and 20 kg ha(-1) respectively. The yield gaps are calculated from a database of historical FAO crop fertilizer trials at 1358 locations for Sub-Saharan Africa and South America. Our approach allows connecting experimental field scale data with continental policy recommendations. Two critical findings emerged from the analysis. The first is the degree to which P limits increases in corn yields. For example, under a micro-dosing scenario, in Africa, the addition of small amounts of N alone resulted in mean yield increases of 8% while the addition of only P increased mean yields by 26%, with implications for designing better balanced fertilizer distribution schemes. The second finding was the relatively large amount of yield increase possible for a small, yet affordable amount of fertilizer application. Using African and South American fertilizer prices we show that the level of investment needed to achieve these results is considerably less than 1% of Agricultural GDP for both a micro-dosing scenario and for the scenario involving higher yet still conservative fertilizer application rates. In the latter scenario realistic mean yield increases ranged between 28 to 85% in South America and 71 to 190% in Africa (mean plus one standard deviation). External investment in this low technology solution has the potential to kick start development and could complement other interventions such as better crop varieties and improved economic instruments to support farmers.	[van der Velde, Marijn; See, Linda; Balkovic, Juraj; Fritz, Steffen; Khabarov, Nikolay; Obersteiner, Michael] IIASA, Ecosyst Serv & Management Program, Laxenburg, Austria; [You, Liangzhi] IFPRI, Washington, DC USA; [You, Liangzhi] Huazhong Agr Univ, Coll Econ & Management, Wuhan, Peoples R China; [Wood, Stanley] Bill & Melinda Gates Fdn, Global Dev Program, Seattle, WA USA	International Institute for Applied Systems Analysis (IIASA); CGIAR; International Food Policy Research Institute (IFPRI); Huazhong Agricultural University; Bill & Melinda Gates Foundation	van der Velde, M (corresponding author), IIASA, Ecosyst Serv & Management Program, Laxenburg, Austria.	velde@iiasa.ac.at	van der Velde, Marijn/B-3305-2009	van der Velde, Marijn/0000-0002-9103-7081; , Steffen/0000-0003-0420-8549; Balkovic, Juraj/0000-0003-2955-4931	Austrian Research Funding Agency (FFG) [833421]	Austrian Research Funding Agency (FFG)(Austrian Science Fund (FWF))	The Austrian Research Funding Agency (FFG) funded projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was supported by the Austrian Research Funding Agency (FFG) for the Project FarmSupport (No. 833421).	Baker LA, 2011, CHEMOSPHERE, V84, P779, DOI 10.1016/j.chemosphere.2011.03.026; Bindraban PS, 2012, CURR OPIN ENV SUST, V4, P478, DOI 10.1016/j.cosust.2012.09.015; Bumb B., 2011, 01084 IFPRI; Buresh R.J., 1997, SSSA SPECIAL PUBLICA, P111, DOI DOI 10.2136/SSSASPECPUB51.C6; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Ejeta G, 2010, SCIENCE, V327, P831, DOI 10.1126/science.1187152; FAO, 2011, STAT WORLDS LAND WAT; *FAO, 1989, FERT FOOD PROD SUMM; FAO, 2009, FEED WORLD 2050; Finger R., 2008, The Open Agriculture Journal, V2, P90, DOI 10.2174/1874331500802010090; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; FRANK MD, 1990, AM J AGR ECON, V72, P597, DOI 10.2307/1243029; Fritz S, 2012, ENVIRON MODELL SOFTW, V31, P110, DOI 10.1016/j.envsoft.2011.11.015; Gilbert N, 2012, NATURE, V483, P525, DOI 10.1038/483525a; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; IFA IFDC IPI PPI FAO, 2002, FERT US CROP; IFPRI, 2012, GLOB SUBN CROP DAT; Kilman S, 2009, ENOUGH WHY WORLDS PO; Lal R, 2010, J PLANT NUTR SOIL SC, V173, P4, DOI 10.1002/jpln.200900290; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lobell DB, 2011, NAT CLIM CHANG, DOI [10.1038/NCLIMATE1043.Dafadf, DOI 10.1038/NCLIMATE1043.DAFADF]; Maitima J. M., 2009, African Journal of Environmental Science and Technology, V3, P310; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Nelson G.C., 2010, FOOD SECURITY FARMIN; Nin-Pratt A., 2011, IFPRI RES MONOGRAPH, DOI [10.2499/9780896291829, DOI 10.2499/9780896291829]; Pingali P.L., 2001, CIMMYT 1999 2000 WOR; Potter P, 2010, EARTH INTERACT, V14, DOI 10.1175/2009EI288.1; Pronyk P, 2012, COSTS BENEFITS MILLE; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; SANCHEZ PA, 1981, ADV AGRON, V34, P279, DOI 10.1016/S0065-2113(08)60889-5; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Sanchez PA, 2009, SCIENCE, V325, P680, DOI 10.1126/science.1175084; Sattari SZ, 2012, P NATL ACAD SCI USA, V109, P6348, DOI 10.1073/pnas.1113675109; The World Bank, 2007, AFR FERT POL TOOLK P; Tittonell P, 2008, PLANT SOIL, V313, P19, DOI 10.1007/s11104-008-9676-3; Twomlow S, 2010, NUTR CYCL AGROECOSYS, V88, P3, DOI 10.1007/s10705-008-9200-4; UBOS, 2002, UG NAT HOUS SURV 199, P4; Van Averbeke W, 1997, USING KRAAL MANURE F; van der Velde M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024022; van der Velde M, 2012, NATURE, V484, P318, DOI 10.1038/484318c; World Bank, 2011, DAT	42	23	23	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60075	10.1371/journal.pone.0060075	http://dx.doi.org/10.1371/journal.pone.0060075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565186	Green Submitted, gold, Green Published			2022-12-27	WOS:000317717300055
J	Grabowski, LM; Bryson, DM; Dyer, FC; Pennock, RT; Ofria, C				Grabowski, Laura M.; Bryson, David M.; Dyer, Fred C.; Pennock, Robert T.; Ofria, Charles			A Case Study of the De Novo Evolution of a Complex Odometric Behavior in Digital Organisms	PLOS ONE			English	Article							MODEL; ANTS	Investigating the evolution of animal behavior is difficult. The fossil record leaves few clues that would allow us to recapitulate the path that evolution took to build a complex behavior, and the large population sizes and long time scales required prevent us from re-evolving such behaviors in a laboratory setting. We present results of a study in which digital organisms-self-replicating computer programs that are subject to mutations and selection-evolved in different environments that required information about past experience for fitness-enhancing behavioral decisions. One population evolved a mechanism for step-counting, a surprisingly complex odometric behavior that was only indirectly related to enhancing fitness. We examine in detail the operation of the evolved mechanism and the evolutionary transitions that produced this striking example of a complex behavior.	[Grabowski, Laura M.] Univ Texas Pan Amer, Dept Comp Sci, Edinburg, TX 78541 USA; [Bryson, David M.; Dyer, Fred C.; Pennock, Robert T.; Ofria, Charles] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA	University of Texas System; University of Texas Rio Grande Valley; Michigan State University	Grabowski, LM (corresponding author), Univ Texas Pan Amer, Dept Comp Sci, Edinburg, TX 78541 USA.	grabowskilm@utpa.edu	Bryson, David/I-4388-2013	Bryson, David/0000-0001-8614-3157; Ofria, Charles/0000-0003-2924-1732	National Science Foundation, NSF [CCF-0643952, DBI-0939454]; Cambridge Templeton Consortium	National Science Foundation, NSF(National Science Foundation (NSF)); Cambridge Templeton Consortium	Funding was provided by the National Science Foundation, http://www.nsf.gov/, NSF grants CCF-0643952 and DBI-0939454; and the Cambridge Templeton Consortium, http://www.cambridge-templetonconsortium.org/, "Emerging Intelligence: Contingency, Convergence and Constraints in the Evolution of Intelligent Behavior." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2000, P NATL ACAD SCI USA, V97, P4463, DOI 10.1073/pnas.97.9.4463; [Anonymous], ALIFE; Clune J, 2011, P ROY SOC B-BIOL SCI, V278, P666, DOI 10.1098/rspb.2010.1557; Clune J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000187; COLLETT TS, 1992, PHILOS T R SOC B, V337, P295, DOI 10.1098/rstb.1992.0107; Dale K, 2001, CURR BIOL, V11, P1305, DOI 10.1016/S0960-9822(01)00418-3; Goldsby HJ, 2012, ARTIF LIFE, V13, P178, DOI DOI 10.7551/978-0-262-31050-5-ch025; Goldstein R, 2009, SEMINAIRE POINCARE, P75; Grabowski LM, 2011, PROCEEDINGS OF THE E; Haferlach T, 2007, ADAPT BEHAV, V15, P273, DOI 10.1177/1059712307082080; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Misevic D, 2006, P ROY SOC B-BIOL SCI, V273, P457, DOI 10.1098/rspb.2005.3338; Ofria C, 2005, ARTIFICIAL LIFE MODELS IN SOFTWARE, P3, DOI 10.1007/1-84628-214-4_1; Ofria C, 2002, IEEE T EVOLUTIONARY, V17, P528; Vickerstaff RJ, 2005, J EXP BIOL, V208, P3349, DOI 10.1242/jeb.01772; Wehner R, 1997, EXS, V84, P145; WEHNER R, 1986, MONIT ZOOL ITAL, V20, P309; Wilke CO, 2001, NATURE, V423, P139; Wittlinger M, 2006, SCIENCE, V312, P1965, DOI 10.1126/science.1126912; Wolf H, 2011, J EXP BIOL, V214, P274; Zhang SW, 1996, NEUROBIOL LEARN MEM, V66, P267, DOI 10.1006/nlme.1996.0069	21	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60466	10.1371/journal.pone.0060466	http://dx.doi.org/10.1371/journal.pone.0060466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577113	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000034
J	Li, L; Nie, W; Li, WF; Yuan, WF; Huang, WJ				Li, Li; Nie, Wei; Li, Weifeng; Yuan, Weifeng; Huang, Wenjie			Associations between TNF-alpha Polymorphisms and Pneumonia: A Meta-Analysis	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CYTOKINE EXPRESSION; SEPSIS MORTALITY; SEPTIC SHOCK; IN-VITRO; PROMOTER; SUSCEPTIBILITY; RISK	Background: Several studies evaluated the associations of tumor necrosis factor-alpha (TNF-alpha) polymorphisms with pneumonia in different populations. However, the results were conflicting and controversial. Methods: Databases including PubMed, Embase, Web of Science, and China National Knowledge Infrastructure (CNKI) were searched to find relevant studies. Data were extracted independently by two investigators. Crude odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were estimated. Results: Twelve case-control studies and one cohort study were included. Overall, no association between TNF-alpha -308A/G polymorphism and pneumonia risk was observed for AA +AG vs. GG (OR = 1.13; 95% CI 0.99-1.30; P = 0.07). In addition, TNF-alpha -308A/G polymorphism was not associated with pneumonia mortality (OR = 1.96; 95% CI 0.94-4.09; P = 0.07). Furthermore, there was no association of TNF-alpha -238A/G polymorphism with the risk of pneumonia (OR = 1.38; 95% CI 0.84-2.28; P = 0.20). Conclusions: TNF-alpha -308A/G, -238A/G polymorphisms were not associated with pneumonia risk. Moreover, TNF-alpha -308A/G polymorphism did not play a role in the pneumonia mortality risk.	[Li, Li; Li, Weifeng; Yuan, Weifeng; Huang, Wenjie] Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Nie, Wei] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Resp Med, Shanghai, Peoples R China	Southern Theater Command General Hospital; Naval Medical University	Huang, WJ (corresponding author), Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	huangyelu1029@vip.163.com			National Natural Science Foundation of China [81070003]; Natural Science Foundation of Guangdong province [10151001002000005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This study was supported by National Natural Science Foundation of China (NO. 81070003) and Natural Science Foundation of Guangdong province (NO. 10151001002000005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulou A, 2012, INT J INFECT DIS, V16, pE204, DOI 10.1016/j.ijid.2011.11.012; Bauer TT, 2000, THORAX, V55, P46, DOI 10.1136/thorax.55.1.46; Cipriano C, 2005, INT J IMMUNOGENET, V32, P13, DOI 10.1111/j.1744-313X.2005.00490.x; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; Confalonieri M, 2011, LANCET, V377, P1982, DOI 10.1016/S0140-6736(11)60777-0; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Endeman H, 2011, EUR RESPIR J, V37, P1431, DOI 10.1183/09031936.00074410; Hedberg CL, 2004, PEDIATR INFECT DIS J, V23, P424, DOI 10.1097/01.inf.0000122607.73324.20; Hellmig S, 2005, AM J GASTROENTEROL, V100, P2644, DOI 10.1111/j.1572-0241.2005.00338.x; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hildebrandt GC, 2004, BLOOD, V104, P586, DOI 10.1182/blood-2003-12-4259; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huizinga TWJ, 1997, J NEUROIMMUNOL, V72, P149, DOI 10.1016/S0165-5728(96)00182-8; Kaluza W, 2000, J INVEST DERMATOL, V114, P1180, DOI 10.1046/j.1523-1747.2000.00001.x; Kinder BW, 2007, ARTHRITIS RHEUM, V56, P2679, DOI 10.1002/art.22804; Kotsaki A, 2012, CYTOKINE, V59, P358, DOI 10.1016/j.cyto.2012.04.040; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Lee JH, 2003, AM J RESP CRIT CARE, V168, P1462, DOI 10.1164/rccm.200302-303OC; Lindholm E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002546; Mason CM, 1997, J INFECT DIS, V176, P1293, DOI 10.1086/514125; Monton C, 1999, CRIT CARE MED, V27, P1745, DOI 10.1097/00003246-199909000-00008; Pappachan JV, 2009, IMMUNOGENETICS, V61, P657, DOI 10.1007/s00251-009-0395-6; PUREN AJ, 1995, CHEST, V107, P1342, DOI 10.1378/chest.107.5.1342; Salnikova LE, 2012, GENE IN PRESS; Schaaf BM, 2003, AM J RESP CRIT CARE, V168, P476, DOI 10.1164/rccm.200210-1164OC; Sole-Violan J, 2010, RESP MED, V104, P440, DOI 10.1016/j.rmed.2009.10.009; Song ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046113; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Teuffel O, 2010, CRIT CARE MED, V38, P276, DOI 10.1097/CCM.0b013e3181b42af0; Waterer GW, 2012, SEMIN RESP CRIT CARE, V33, P257, DOI 10.1055/s-0032-1315637; Waterer Grant W, 2010, Expert Rev Respir Med, V4, P229, DOI 10.1586/ers.10.13; Waterer GW, 2001, AM J RESP CRIT CARE, V163, P1599, DOI 10.1164/ajrccm.163.7.2011088; WHITE JC, 1986, J INFECT DIS, V153, P202, DOI 10.1093/infdis/153.2.202; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Wright TW, 2004, J IMMUNOL, V172, P2511, DOI 10.4049/jimmunol.172.4.2511; Yende S, 2005, AM J RESP CRIT CARE, V172, P1440, DOI 10.1164/rccm.200506-888OC; [袁伟锋 YUAN Weifeng], 2008, [中国病理生理杂志, Chinese Journal of Pathophysiology], V24, P2391; Zhang DeZhong, 2010, Chinese Journal of Nosocomiology, V20, P929	38	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61039	10.1371/journal.pone.0061039	http://dx.doi.org/10.1371/journal.pone.0061039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577187	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000093
J	Park, AW; Magori, K; White, BA; Stallknecht, DE				Park, Andrew W.; Magori, Krisztian; White, Brad A.; Stallknecht, David E.			When More Transmission Equals Less Disease: Reconciling the Disconnect between Disease Hotspots and Parasite Transmission	PLOS ONE			English	Article							WHITE-TAILED DEER; EPIZOOTIC HEMORRHAGIC-DISEASE; ENZOOTIC STABILITY; BLUETONGUE; ANTIBODIES; DYNAMICS; VIRUSES; EPIDEMIOLOGY; POPULATION	The assumed straightforward connection between transmission intensity and disease occurrence impacts surveillance and control efforts along with statistical methodology, including parameter inference and niche modeling. Many infectious disease systems have the potential for this connection to be more complicated-although demonstrating this in any given disease system has remained elusive. Hemorrhagic disease (HD) is one of the most important diseases of white-tailed deer and is caused by viruses in the Orbivirus genus. Like many infectious diseases, the probability or severity of disease increases with age (after loss of maternal antibodies) and the probability of disease is lower upon re-infection compared to first infection (based on cross-immunity between virus strains). These broad criteria generate a prediction that disease occurrence is maximized at intermediate levels of transmission intensity. Using published US field data, we first fit a statistical model to predict disease occurrence as a function of seroprevalence (a proxy for transmission intensity), demonstrating that states with intermediate seroprevalence have the highest level of case reporting. We subsequently introduce an independently parameterized mechanistic model supporting the theory that high case reporting should come from areas with intermediate levels of transmission. This is the first rigorous demonstration of this phenomenon and illustrates that variation in transmission rate (e. g. along an ecologically-controlled transmission gradient) can create cryptic refuges for infectious diseases.	[Park, Andrew W.; Magori, Krisztian; White, Brad A.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Park, Andrew W.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Stallknecht, David E.] Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Park, AW (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	awpark@uga.edu	Magori, Krisztian/H-9516-2019	Magori, Krisztian/0000-0002-2288-835X	McDonnell [220020193]	McDonnell	This work was partly supported by a McDonnell grant (#220020193) to AWP. No additional external funding was received for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2398; Bruce D, 1910, P R SOC LOND B-CONTA, V82, P256, DOI 10.1098/rspb.1910.0016; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Coleman PG, 2001, LANCET, V357, P1284, DOI 10.1016/S0140-6736(00)04410-X; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; Flacke GL, 2004, J WILDLIFE DIS, V40, P288, DOI 10.7589/0090-3558-40.2.288; Gaydos JK, 2002, J WILDLIFE DIS, V38, P713, DOI 10.7589/0090-3558-38.4.713; Gaydos JK, 2002, J WILDLIFE DIS, V38, P720, DOI 10.7589/0090-3558-38.4.720; Gaydos JK, 2002, J WILDLIFE DIS, V38, P253, DOI 10.7589/0090-3558-38.2.253; Gehlke CE, 1934, J AM STAT ASSOC, V29, P169, DOI 10.2307/2277827; Gibbs EPJ, 1989, ARBOVIRUSES EPIDEMIO, V2, P30; Hewitt DG, 2011, Biology and Management of White-Tailed Deer, P1; Howerth EW, 2008, BLUETONGUE EPIZOOTIC, P77; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; KOCAN AA, 1987, AM J VET RES, V48, P1048; Mettam R. W. M., 1936, Parasitology Cambridge, V28, P254, DOI 10.1017/S0031182000022447; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; NETTLES VF, 1992, T N AM WILDL NAT RES, V57, P499; Openshaw S., 1983, MODIFIABLE AREAL UNI; Perry BD, 1995, PREV VET MED, V25, P107, DOI 10.1016/0167-5877(95)00546-3; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Quist CF, 1997, J WILDLIFE DIS, V33, P584, DOI 10.7589/0090-3558-33.3.584; ROY P, 2000, ORBIVIRUSES THEIR RE; Simard MA, 2010, J WILDLIFE MANAGE, V74, P1671, DOI 10.2193/2009-258; STALLKNECHT DE, 1991, J WILDLIFE DIS, V27, P238, DOI 10.7589/0090-3558-27.2.238; Stallknecht DE, 1996, J WILDLIFE DIS, V32, P695, DOI 10.7589/0090-3558-32.4.695; STALLKNECHT DE, 1991, J WILDLIFE DIS, V27, P668, DOI 10.7589/0090-3558-27.4.668; THOMAS F C, 1974, Journal of Wildlife Diseases, V10, P187; WILKENING AJ, 1985, FLA ENTOMOL, V68, P511, DOI 10.2307/3494854; Xu B, 2012, VET REC, V170, P288, DOI 10.1136/vr.100000	31	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61501	10.1371/journal.pone.0061501	http://dx.doi.org/10.1371/journal.pone.0061501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23579922	Green Submitted, gold, Green Published			2022-12-27	WOS:000317898000134
J	Chavez, JC; de la Vega-Beltran, JL; Escoffier, J; Visconti, PE; Trevino, CL; Darszon, A; Salkoff, L; Santi, CM				Chavez, Julio C.; de la Vega-Beltran, Jose L.; Escoffier, Jessica; Visconti, Pablo E.; Trevino, Claudia L.; Darszon, Alberto; Salkoff, Lawrence; Santi, Celia M.			Ion Permeabilities in Mouse Sperm Reveal an External Trigger for SLO3-Dependent Hyperpolarization	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; SLO3 K+ CHANNELS; PH; CAPACITATION; SPERMATOZOA; CAMP; INVOLVEMENT; BICARBONATE; ENVIRONMENT; EXPRESSION	Unlike most cells of the body which function in an ionic environment controlled within narrow limits, spermatozoa must function in a less controlled external environment. In order to better understand how sperm control their membrane potential in different ionic conditions, we measured mouse sperm membrane potentials under a variety of conditions and at different external K+ concentrations, both before and after capacitation. Experiments were undertaken using both wild-type, and mutant mouse sperm from the knock-out strain of the sperm-specific, pH-sensitive, SLO3 K+ channel. Membrane voltage data were fit to the Goldman-Hodgkin-Katz equation. Our study revealed a significant membrane permeability to both K+ and Cl- before capacitation, as well as Na+. The permeability to both K+ and Cl- has the effect of preventing large changes in membrane potential when the extracellular concentration of either ion is changed. Such a mechanism may protect against undesired shifts in membrane potential in changing ionic environments. We found that a significant portion of resting membrane potassium permeability in wild-type sperm was contributed by SLO3 K+ channels. We also found that further activation of SLO3 channels was the essential mechanism producing membrane hyperpolarization under two separate conditions, 1) elevation of external pH prior to capacitation and 2) capacitating conditions. Both conditions produced a significant membrane hyperpolarization in wild-type which was absent in SLO3 mutant sperm. Hyperpolarization in both conditions may result from activation of SLO3 channels by raising intracellular pH; however, demonstrating that SLO3-dependent hyperpolarization is achieved by an alkaline environment alone shows that SLO3 channel activation might occur independently of other events associated with capacitation. For example sperm may undergo stages of membrane hyperpolarization when reaching alkaline regions of the female genital tract. Significantly, other events associated with sperm capacitation, occur in SLO3 mutant sperm and thus proceed independently of hyperpolarization.	[Chavez, Julio C.; de la Vega-Beltran, Jose L.; Trevino, Claudia L.; Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62191, Morelos, Mexico; [Chavez, Julio C.; Salkoff, Lawrence; Santi, Celia M.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Salkoff, Lawrence] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Escoffier, Jessica; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	Universidad Nacional Autonoma de Mexico; Washington University (WUSTL); Washington University (WUSTL); University of Massachusetts System; University of Massachusetts Amherst	Santi, CM (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	santic@pcg.wustl.edu	Escoffier, jessica/E-9498-2017; Escoffier, jessica/T-9857-2019	Escoffier, jessica/0000-0001-8166-5845; Chavez, Julio/0000-0002-7375-9531; Trevino, Claudia L/0000-0002-7281-0534; Darszon, Alberto/0000-0002-2502-0505	National Institutes of Health [R01HD069631, R01NS0661871-01, R01 HD44044, HD038082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038082, R01HD069631, R01HD044044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by National Institutes of Health: R01HD069631 to CS, R01NS0661871-01 to LS, R01 HD44044 and HD038082 to PEV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; BABCOCK DF, 1983, J BIOL CHEM, V258, P6380; BALDI E, 1991, J ANDROL, V12, P323; Chavez JC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094037; Chen CH, 2009, J PHYSIOL-LONDON, V587, P1727, DOI 10.1113/jphysiol.2008.166918; Colas C, 2008, REPROD FERT DEVELOP, V20, P649, DOI 10.1071/RD08023; DASGUPTA S, 1993, J REPROD FERTIL, V99, P135; De la Vega-Beltran JL, 2012, J BIOL CHEM; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; EGGERTKRUSE W, 1993, FERTIL STERIL, V59, P617; Escoffier J, 2012, J CELL SCI, V125, P473, DOI 10.1242/jcs.093344; ESPINOSA F, 1995, FEBS LETT, V372, P119, DOI 10.1016/0014-5793(95)00962-9; Hamamah S, 1998, HUM REPROD, V13, P20, DOI 10.1093/humrep/13.suppl_4.20; Henkel Ralf R, 2003, Reprod Biol Endocrinol, V1, P108, DOI 10.1186/1477-7827-1-108; Hernandez-Gonzalez EO, 2007, J BIOL CHEM, V282, P24397, DOI 10.1074/jbc.M701603200; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Leonetti MD, 2012, P NATL ACAD SCI US; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Martinez-Lopez P, 2009, BIOCHEM BIOPH RES CO, V381, P204, DOI 10.1016/j.bbrc.2009.02.008; Munoz-Garay C, 2001, DEV BIOL, V234, P261, DOI 10.1006/dbio.2001.0196; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Neill JD, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1; PLASEK J, 1994, BBA-BIOMEMBRANES, V1196, P181, DOI 10.1016/0005-2736(94)00209-6; RINK TJ, 1980, BIOCHIM BIOPHYS ACTA, V595, P15, DOI 10.1016/0005-2736(80)90243-6; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; STRICKHOLM A, 1981, BIOPHYS J, V35, P677, DOI 10.1016/S0006-3495(81)84820-5; Tang QY, 2010, CHANNELS, V4, P22, DOI 10.4161/chan.4.1.10481; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Visconti PE, 1999, BIOL REPROD, V61, P76, DOI 10.1095/biolreprod61.1.76; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304; Zhang X, 2006, J GEN PHYSIOL, V128, P317, DOI 10.1085/jgp.200609552	37	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60578	10.1371/journal.pone.0060578	http://dx.doi.org/10.1371/journal.pone.0060578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577126	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800066
J	Haimov, I; Shatil, E				Haimov, Iris; Shatil, Evelyn			Cognitive Training Improves Sleep Quality and Cognitive Function among Older Adults with Insomnia	PLOS ONE			English	Article							DECLARATIVE MEMORY CONSOLIDATION; AGE-RELATED-CHANGES; EYE-MOVEMENT SLEEP; SLOW-WAVE SLEEP; REM-SLEEP; CIRCADIAN-RHYTHMS; DEPENDENT CHANGES; ELDERLY-PEOPLE; BRAIN ACTIVITY; STAGE-2 SLEEP	Study Objectives: To investigate the effect of an eight-week, home-based, personalized, computerized cognitive training program on sleep quality and cognitive performance among older adults with insomnia. Design: Participants (n = 51) were randomly allocated to a cognitive training group (n = 34) or to an active control group (n = 17). The participants in the cognitive training group completed an eight-week, home-based, personalized, computerized cognitive training program, while the participants in the active control group completed an eight-week, home-based program involving computerized tasks that do not engage high-level cognitive functioning. Before and after training, all participants' sleep was monitored for one week by an actigraph and their cognitive performance was evaluated. Setting: Community setting: residential sleep/performance testing facility. Participants: Fifty-one older adults with insomnia (aged 65-85). Interventions: Eight weeks of computerized cognitive training for older adults with insomnia. Results: Mixed models for repeated measures analysis showed between-group improvements for the cognitive training group on both sleep quality (sleep onset latency and sleep efficiency) and cognitive performance (avoiding distractions, working memory, visual memory, general memory and naming). Hierarchical linear regressions analysis in the cognitive training group indicated that improved visual scanning is associated with earlier advent of sleep, while improved naming is associated with the reduction in wake after sleep onset and with the reduction in number of awakenings. Likewise the results indicate that improved "avoiding distractions" is associated with an increase in the duration of sleep. Moreover, the results indicate that in the active control group cognitive decline observed in working memory is associated with an increase in the time required to fall asleep. Conclusions: New learning is instrumental in promoting initiation and maintenance of sleep in older adults with insomnia. Lasting and personalized cognitive training is particularly indicated to generate the type of learning necessary for combined cognitive and sleep enhancements in this population.	[Haimov, Iris; Shatil, Evelyn] Yezreel Acad Coll, Dept Psychol, Emek Yezreel, Israel; [Haimov, Iris; Shatil, Evelyn] Yezreel Acad Coll, Ctr Psychobiol Res, Emek Yezreel, Israel; [Shatil, Evelyn] CogniFit Inc, New York, NY USA		Haimov, I (corresponding author), Yezreel Acad Coll, Dept Psychol, Emek Yezreel, Israel.	i_haimov@yvc.ac.il						American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Ancoli-Israel S, 2005, J AM GERIATR SOC, V53, pS264, DOI 10.1111/j.1532-5415.2005.53392.x; Ancoli-Israel S, 2004, GERIATRICS, V59, P37; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Ancoli-Israel S, 2000, SLEEP, V23, pS23; Ancoli-Israel S, 2008, HARVARD REV PSYCHIAT, V16, P279, DOI 10.1080/10673220802432210; APA, 1994, DIAGN STAT MAN MENT; Backhaus J, 2006, BIOL PSYCHIAT, V60, P1324, DOI 10.1016/j.biopsych.2006.03.051; BARRETT TR, 1972, J EXP PSYCHOL, V96, P321, DOI 10.1037/h0033625; Bassuk SS, 2000, AM J EPIDEMIOL, V151, P676; Benington JH, 2003, PROG NEUROBIOL, V69, P71, DOI 10.1016/S0301-0082(03)00018-2; BENINGTON JH, 1995, BRAIN RES, V681, P141, DOI 10.1016/0006-8993(95)00305-A; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; Blackwell T, 2011, SLEEP, V34, P1347, DOI 10.5665/SLEEP.1276; BROOKS JO, 1993, SLEEP, V16, P151, DOI 10.1093/sleep/16.2.151; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Carney Colleen E, 2006, Behav Sleep Med, V4, P13, DOI 10.1207/s15402010bsm0401_2; Cervilla JA, 2000, J NEUROL NEUROSUR PS, V68, P622, DOI 10.1136/jnnp.68.5.622; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; Crowley K, 2002, CLIN NEUROPHYSIOL, V113, P1615, DOI 10.1016/S1388-2457(02)00237-7; DEKONINCK J, 1989, INT J PSYCHOPHYSIOL, V8, P43, DOI 10.1016/0167-8760(89)90018-4; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Espiritu JRD, 2008, CLIN GERIATR MED, V24, P1, DOI 10.1016/j.cger.2007.08.007; Ficca G, 1999, NEUROSCI LETT, V275, P219, DOI 10.1016/S0304-3940(99)00765-X; Floyd JA, 2000, RES NURS HEALTH, V23, P106, DOI 10.1002/(SICI)1098-240X(200004)23:2<106::AID-NUR3>3.0.CO;2-A; Fogel SM, 2006, J SLEEP RES, V15, P250, DOI 10.1111/j.1365-2869.2006.00522.x; Foley DJ, 1999, SLEEP, V22, pS366; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; Gais S, 2002, J NEUROSCI, V22, P6830; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Haimov I, 2006, CLIN NEUROPHYSIOLOGI, P145; Haimov Iris, 2006, Eur J Ageing, V3, P107, DOI 10.1007/s10433-006-0026-0; Haimov I, 2008, BEHAV SLEEP MED, V6, P32, DOI 10.1080/15402000701796080; Harvey AG, 2002, BEHAV RES THER, V40, P267, DOI 10.1016/S0005-7967(01)00012-2; HAURI PJ, 1992, SLEEP, V15, P293, DOI 10.1093/sleep/15.4.293; HAYNES SN, 1981, J ABNORM PSYCHOL, V90, P601, DOI 10.1037/0021-843X.90.6.601; Hoekert M, 2006, AM J GERIAT PSYCHIAT, V14, P104, DOI 10.1097/01.JGP.0000192481.27931.c5; Hornung OP, 2005, EXP GERONTOL, V40, P279, DOI 10.1016/j.exger.2005.02.001; Horowitz-Kraus T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007141; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; JOLLES J, 1995, DRUG AGING, V7, P459, DOI 10.2165/00002512-199507060-00006; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Kryger M, 2004, GERIATRICS-US, V59, P24; Landolt HP, 2001, CLIN NEUROPHYSIOL, V112, P369, DOI 10.1016/S1388-2457(00)00542-3; Lichstein K, 2003, TREATING SLEEP DISOR, P286; Lichstein KL, 2006, SLEEP, V29, P232; Lichstein KL, 2003, BEHAV RES THER, V41, P427, DOI 10.1016/S0005-7967(02)00023-2; Lichstein KL, 2004, EPIDEMIOLOGY SLEEP A; Manber R, 2005, J PSYCHIATR RES, V39, P481, DOI 10.1016/j.jpsychires.2004.12.003; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; Martin JL, 2006, AM J GERIAT PSYCHIAT, V14, P121, DOI 10.1097/01.JGP.0000192483.35555.a3; McCrae CS, 2001, SLEEP MED REV, V5, P47, DOI 10.1053/smrv.2000.0146; Melzer D, 1999, BRIT MED J, V318, P1108; MULLANEY DJ, 1980, SLEEP, V3, P83, DOI 10.1093/sleep/3.1.83; Nau SD, 2005, CLINICAL SLEEP DISORDERS, P157; Nau SD, 2005, CLIN PSYCHOL REV, V25, P645, DOI 10.1016/j.cpr.2005.04.008; Nissen C, 2006, SLEEP, V29, P1068, DOI 10.1093/sleep/29.8.1068; Nissen C, 2011, J SLEEP RES, V20, P129, DOI 10.1111/j.1365-2869.2010.00872.x; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ostbye T, 1999, J AM GERIATR SOC, V47, P1249, DOI 10.1111/j.1532-5415.1999.tb05207.x; Papp KV, 2009, ALZHEIMERS DEMENT, V5, P50, DOI 10.1016/j.jalz.2008.10.008; Park D. C., 2000, COGNITIVE AGING PRIM, V11, P3; Peretz C, 2011, NEUROEPIDEMIOLOGY, V36, P91, DOI 10.1159/000323950; Perlis Michael L, 2006, Behav Sleep Med, V4, P104, DOI 10.1207/s15402010bsm0402_3; Persson J, 2006, PROG BRAIN RES, V157, P45, DOI 10.1016/S0079-6123(06)57004-9; Peters KR, 2008, J SLEEP RES, V17, P23, DOI 10.1111/j.1365-2869.2008.00634.x; Peters KR, 2007, J COGNITIVE NEUROSCI, V19, P817, DOI 10.1162/jocn.2007.19.5.817; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Preiss M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00108; Rosnow RL, 2000, PSYCHOL SCI, V11, P446, DOI 10.1111/1467-9280.00287; Sadeh A, 2002, CHILD DEV, V73, P405, DOI 10.1111/1467-8624.00414; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; SADEH A, 1995, SLEEP, V18, P288, DOI 10.1093/sleep/18.4.288; Sadeh A., 1989, J AMBUL MONITOR, V2, P209; Schabus M, 2006, EUR J NEUROSCI, V23, P1738, DOI 10.1111/j.1460-9568.2006.04694.x; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Shatil E, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00008; Shatil E, 2010, NEUROREHABILITATION, V26, P143, DOI 10.3233/NRE-2010-0546; Silber MH, 2005, NEW ENGL J MED, V353, P803, DOI 10.1056/NEJMcp043762; Sinoff G, 1999, INT J GERIATR PSYCH, V14, P1062, DOI 10.1002/(SICI)1099-1166(199912)14:12<1062::AID-GPS67>3.0.CO;2-Q; Sivertsen B, 2006, SLEEP, V29, P1353, DOI 10.1093/sleep/29.10.1353; Smith CT, 2004, LEARN MEMORY, V11, P714, DOI 10.1101/lm.74904; SPSS, 2008, SPSS WINDOWS; Taylor Daniel J, 2003, Behav Sleep Med, V1, P227, DOI 10.1207/S15402010BSM0104_5; Twamley EW, 2003, SCHIZOPHRENIA BULL, V29, P359, DOI 10.1093/oxfordjournals.schbul.a007011; Vallieres A, 2003, SLEEP, V26, P902, DOI 10.1093/sleep/26.7.902; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; Vegni C, 2001, NEUROSCI LETT, V297, P58, DOI 10.1016/S0304-3940(00)01636-0; Verghese J, 2010, J GERONTOL A-BIOL, P1; Verghese J, 2010, J GERONTOL A-BIOL, V65, P1338, DOI 10.1093/gerona/glq127; Vertes RP, 2004, NEURON, V44, P135, DOI 10.1016/j.neuron.2004.08.034; Voyer P, 2010, CAN J AGING, V29, P205, DOI 10.1017/S0714980810000115; Wagner U, 2008, STRESS, V11, P28, DOI 10.1080/10253890701408822; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Yoo SS, 2007, NAT NEUROSCI, V10, P385, DOI 10.1038/nn1851; Zhdanova IV, 2001, J CLIN ENDOCR METAB, V86, P4727, DOI 10.1210/jc.86.10.4727; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	106	62	63	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61390	10.1371/journal.pone.0061390	http://dx.doi.org/10.1371/journal.pone.0061390			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RZ	23577218	gold, Green Published			2022-12-27	WOS:000319109800138
J	Lisowska, KA; Frackowiak, JE; Mikosik, A; Witkowski, JM				Lisowska, Katarzyna A.; Frackowiak, Joanna E.; Mikosik, Anna; Witkowski, Jacek M.			Changes in the Expression of Transcription Factors Involved in Modulating the Expression of EPO-R in Activated Human CD4-Positive Lymphocytes	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; BLOOD CELL-CULTURES; RECEPTOR GENE; GATA-1; DIFFERENTIATION; PROLIFERATION; BINDING; ALPHA	We have recently described the presence of the erythropoietin receptor (EPO-R) on CD4(+) lymphocytes and demonstrated that its expression increases during their activation, reaching a level reported to be typical for erythroid progenitors. This observation suggests that EPO-R expression is modulated during lymphocyte activation, which may be important for the cells' function. Here we investigated whether the expression of GATA1, GATA3 and Sp1 transcription factors is correlated with the expression of EPO-R in human CD4(+) lymphocytes stimulated with monoclonal anti-CD3 antibody. The expression of GATA1, GATA3 and Sp1 transcription factors in CD4(+) cells was estimated before and after stimulation with anti-CD3 antibody by Western Blot and flow cytometry. The expression of EPO-R was measured using real-time PCR and flow cytometry. There was no change in the expression of GATA1 and GATA3 in CD4(+) lymphocytes after stimulation with anti-CD3 antibody. However, stimulation resulted in the significantly increased expression of the Sp1 factor. CD4(+) lymphocytes stimulated with anti-CD3 antibody exhibited an increase in both the expression level of EPOR gene and the number of EPOR molecules on the cells' surface, the latter being significantly correlated with the increased expression of Sp1. Sp1 is noted to be the single transcription factor among the ones studied whose level changes as a result of CD4(+) lymphocyte stimulation. It seems that Sp1 may significantly affect the number of EPO-R molecules present on the surface of activated CD4(+) lymphocytes.	[Lisowska, Katarzyna A.; Frackowiak, Joanna E.; Mikosik, Anna; Witkowski, Jacek M.] Med Univ Gdansk, Dept Pathophysiol, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk	Lisowska, KA (corresponding author), Med Univ Gdansk, Dept Pathophysiol, Gdansk, Poland.	katlis@gumed.edu.pl	Witkowski, Jacek M./B-8488-2013; Lisowska, Katarzyna/B-6774-2013	Witkowski, Jacek M./0000-0003-2906-1109; Lisowska, Katarzyna/0000-0002-6086-0024; Frackowiak, Joanna/0000-0002-7924-4221; Mikosik-Roczynska, Anna/0000-0002-7211-1514	project Iuventus Plus [IP2010 022770]	project Iuventus Plus	This work was supported by the project Iuventus Plus IP2010 022770. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; Bryl E, 1999, ARTIF ORGANS, V23, P809, DOI 10.1046/j.1525-1594.1999.06177.x; Bryl E, 1998, ARTIF ORGANS, V22, P177, DOI 10.1046/j.1525-1594.1998.06002.x; CHIN K, 1995, NUCLEIC ACIDS RES, V23, P3041, DOI 10.1093/nar/23.15.3041; Ho IC, 2007, CELL MOL IMMUNOL, V4, P15; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Lacroix I, 2002, J BIOL CHEM, V277, P9598, DOI 10.1074/jbc.M111444200; Lisowska KA, 2013, J CLIN IMMUNOL, V33, P661, DOI 10.1007/s10875-012-9835-4; Lisowska KA, 2011, J RECEPT SIG TRANSD, V31, P241, DOI 10.3109/10799893.2011.578646; Lisowska KA, 2010, ARTIF ORGANS, V34, P654, DOI 10.1111/j.1525-1594.2009.00948.x; Lisowska KA, 2010, ARTIF ORGANS, V34, pE77, DOI 10.1111/j.1525-1594.2009.00942.x; MAYEUX P, 1987, J BIOL CHEM, V262, P13985; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Sela S, 2001, NEPHRON, V88, P205, DOI 10.1159/000045991; Stachura DL, 2006, BLOOD, V107, P87, DOI 10.1182/blood-2005-07-2740; Sundrud MS, 2005, BLOOD, V106, P3440, DOI 10.1182/blood-2005-03-0857; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; Trzonkowski P, 2002, NEPHROL DIAL TRANSPL, V17, P1070, DOI 10.1093/ndt/17.6.1070; von Salisch S, 2011, J CELL MOL MED, V15, P1963, DOI 10.1111/j.1582-4934.2010.01193.x; Wallach I, 2009, PEDIATR RES, V65, P619, DOI 10.1203/PDR.0b013e31819ea3b8; WICKREMA A, 1992, BLOOD, V80, P1940, DOI 10.1182/blood.V80.8.1940.1940; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10638, DOI 10.1073/pnas.88.23.10638	24	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60326	10.1371/journal.pone.0060326	http://dx.doi.org/10.1371/journal.pone.0060326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577103	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800044
J	Sun, YX; Moore, MJ; Meng, AP; Soltis, PS; Soltis, DE; Li, JQ; Wang, HC				Sun, Yan-xia; Moore, Michael J.; Meng, Ai-ping; Soltis, Pamela S.; Soltis, Douglas E.; Li, Jian-qiang; Wang, Heng-chang			Complete Plastid Genome Sequencing of Trochodendraceae Reveals a Significant Expansion of the Inverted Repeat and Suggests a Paleogene Divergence between the Two Extant Species	PLOS ONE			English	Article							COMPLETE CHLOROPLAST GENOME; ANGIOSPERM PHYLOGENY; BASAL EUDICOTS; REPRODUCTIVE STRUCTURES; WASHINGTON-STATE; POTOMAC GROUP; DNA; DIVERSIFICATION; DIVERSITY; GENES	The early-diverging eudicot order Trochodendrales contains only two monospecific genera, Tetracentron and Trochodendron. Although an extensive fossil record indicates that the clade is perhaps 100 million years old and was widespread throughout the Northern Hemisphere during the Paleogene and Neogene, the two extant genera are both narrowly distributed in eastern Asia. Recent phylogenetic analyses strongly support a clade of Trochodendrales, Buxales, and Gunneridae (core eudicots), but complete plastome analyses do not resolve the relationships among these groups with strong support. However, plastid phylogenomic analyses have not included data for Tetracentron. To better resolve basal eudicot relationships and to clarify when the two extant genera of Trochodendrales diverged, we sequenced the complete plastid genome of Tetracentron sinense using Illumina technology. The Tetracentron and Trochodendron plastomes possess the typical gene content and arrangement that characterize most angiosperm plastid genomes, but both genomes have the same unusual similar to 4 kb expansion of the inverted repeat region to include five genes (rpl22, rps3, rpl16, rpl14, and rps8) that are normally found in the large single-copy region. Maximum likelihood analyses of an 83-gene, 88 taxon angiosperm data set yield an identical tree topology as previous plastid-based trees, and moderately support the sister relationship between Buxaceae and Gunneridae. Molecular dating analyses suggest that Tetracentron and Trochodendron diverged between 44-30 million years ago, which is congruent with the fossil record of Trochodendrales and with previous estimates of the divergence time of these two taxa. We also characterize 154 simple sequence repeat loci from the Tetracentron sinense and Trochodendron aralioides plastomes that will be useful in future studies of population genetic structure for these relict species, both of which are of conservation concern.	[Sun, Yan-xia; Meng, Ai-ping; Li, Jian-qiang; Wang, Heng-chang] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Hubei, Peoples R China; [Sun, Yan-xia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Moore, Michael J.] Oberlin Coll, Dept Biol, Oberlin, OH 44074 USA; [Soltis, Pamela S.; Soltis, Douglas E.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Soltis, Douglas E.] Univ Florida, Dept Biol, Gainesville, FL USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Oberlin College; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Li, JQ (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Hubei, Peoples R China.	lijq@wbgcas.cn; hcwang@wbgcas.cn	Soltis, Pamela S/L-5184-2015; Soltis, Douglas/L-5957-2015; Soltis, Pamela S/GNH-5557-2022	Soltis, Pamela S/0000-0001-9310-8659; Moore, Michael/0000-0003-2222-8332	Knowledge Innovation Project of Chinese Academy of Sciences [KSCX2-EW-J-20]; National Natural Science Foundation of China [31070191]; U.S. National Science Foundation [ER-0431266]	Knowledge Innovation Project of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Science Foundation(National Science Foundation (NSF))	This research was supported by Knowledge Innovation Project of Chinese Academy of Sciences (KSCX2-EW-J-20), National Natural Science Foundation of China grant (31070191) and U.S. National Science Foundation grant (ER-0431266). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; [Anonymous], 1991, POLLEN SPORES PATTER; Barniske AM, 2012, J SYST EVOL, V50, P85, DOI 10.1111/j.1759-6831.2012.00181.x; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Brenner Gilbert J., 1996, P91, DOI 10.1007/978-0-585-23095-5_5; Cantino PD, 2007, TAXON, V56, P822, DOI 10.2307/25065865; CHELEBAEVA A I, 1988, Botanicheskii Zhurnal (St. Petersburg), V73, P315; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Cosner ME, 1997, CURR GENET, V31, P419, DOI 10.1007/s002940050225; Crane P.R., 1990, FIELDIANA GEOLOGY, V20, P1, DOI [10.5962/bhl.title.100826, DOI 10.5962/BHL.TITLE.100826]; CRANE PR, 1991, AM J BOT, V78, P1311, DOI 10.2307/2445271; CRANE PR, 1993, SYST BOT, V18, P328, DOI 10.2307/2419407; CRANE PR, 1989, PLANT SYST EVOL, V162, P165, DOI 10.1007/BF00936916; Cronquist A, 1981, INTEGRATED SYSTEM CL; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diekmann K, 2009, DNA RES, V16, P165, DOI 10.1093/dnares/dsp008; Doweld AB, 1998, ANN BOT-LONDON, V82, P413, DOI 10.1006/anbo.1998.0679; Downie S, 1992, MOL SYSTEMATICS PLAN, P14, DOI DOI 10.1007/978-1-4615-3276-7_2; DOYLE JA, 1992, CRETACEOUS RES, V13, P337, DOI 10.1016/0195-6671(92)90039-S; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ebert D, 2009, MOL ECOL RESOUR, V9, P673, DOI 10.1111/j.1755-0998.2008.02319.x; Endress PK, 1999, BOT J LINN SOC, V130, P305, DOI 10.1111/j.1095-8339.1999.tb00528.x; ENDRESS PK, 1986, PLANT SYST EVOL, V152, P1, DOI 10.1007/BF00985348; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fields P.F., 1996, THESIS MICHIGAN STAT; Fields Patrick F., 1996, American Journal of Botany, V83, P110; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Friis EM, 1999, ANN MO BOT GARD, V86, P259, DOI 10.2307/2666179; FRIIS EM, 1994, INT J PLANT SCI, V155, P772, DOI 10.1086/297217; Fu L.G., 1992, CHINA PLANT RED DATA, V1; Grassi F, 2002, VITIS, V41, P157; Grimsson F, 2008, GRANA, V47, P1, DOI 10.1080/00173130701873081; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hoot SB, 1999, ANN MO BOT GARD, V86, P1, DOI 10.2307/2666215; Hughes NF., 1994, ENIGMA ANGIOSPERM OR; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kim YK, 2009, MOL CELLS, V27, P365, DOI 10.1007/s10059-009-0047-6; Knox EB, 1999, PLANT SYST EVOL, V214, P49, DOI 10.1007/BF00985731; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Li HF, 2011, FLORA, V206, P595, DOI 10.1016/j.flora.2010.11.018; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Mabberley DJ, 1987, PLANT BOOK; Magallon S, 1999, ANN MO BOT GARD, V86, P297, DOI 10.2307/2666180; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; MANCHESTER SR, 1991, BOT GAZ, V152, P357, DOI 10.1086/337898; Manchester SR, 2006, INT J PLANT SCI, V167, P601, DOI 10.1086/503206; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; McCauley DE, 1996, AM J BOT, V83, P727, DOI 10.2307/2445849; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Moore MJ, 2011, INT J PLANT SCI, V172, P541, DOI 10.1086/658923; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; OZAKI K, 1987, Transactions and Proceedings of the Palaeontological Society of Japan New Series, P77; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Pigg KB, 2007, INT J PLANT SCI, V168, P521, DOI 10.1086/512104; Pigg KB, 2001, INT J PLANT SCI, V162, P1187, DOI 10.1086/321927; Plunkett GM, 2000, SYST BOT, V25, P648, DOI 10.2307/2666726; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Qiu YL, 2006, TAXON, V55, P837, DOI 10.2307/25065680; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Qiu YL, 2005, INT J PLANT SCI, V166, P815, DOI 10.1086/431800; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Smith A. C., 1945, JOUR ARNOLD ARBORETUM, V26, P123; Soltis D, 2005, PHYLOGENY EVOLUTION; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Soltis DE, 2010, ANN MO BOT GARD, V97, P514, DOI 10.3417/2009136; Steele PR, 2012, AM J BOT, V99, P330, DOI 10.3732/ajb.1100491; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Stull GW, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200497; SUZUKI M, 1991, BOT MAG TOKYO, V104, P37, DOI 10.1007/BF02493402; THURSTON MI, 2005, MSATFINDER DETECTION; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Watson L., 2006, FAMILIES FLOWERING P; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Worberg A, 2007, ORG DIVERS EVOL, V7, P55, DOI 10.1016/j.ode.2006.08.001; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang ZY, 2012, AM J BOT, V99, pE320, DOI 10.3732/ajb.1200012; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zwickl D. J, 2006, GENETIC ALGORITHM AP	89	43	45	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60429	10.1371/journal.pone.0060429	http://dx.doi.org/10.1371/journal.pone.0060429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577110	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800050
J	Turpin, W; Humblot, C; Noordine, ML; Wrzosek, L; Tomas, J; Mayeur, C; Cherbuy, C; Guyot, JP; Thomas, M				Turpin, Williams; Humblot, Christele; Noordine, Marie-Louise; Wrzosek, Laura; Tomas, Julie; Mayeur, Camille; Cherbuy, Claire; Guyot, Jean-Pierre; Thomas, Muriel			Behavior of Lactobacilli Isolated from Fermented Slurry (ben-saalga) in Gnotobiotic Rats	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; NUCLEAR ANTIGEN PCNA; ESCHERICHIA-COLI; IN-VITRO; ADHESION; EXPRESSION; PROBIOTICS; MUCIN; PLANTARUM; LACTATE	Most bacterial strains, which have been studied so far for their probiotic functions, are extensively used by manufacturers in developed countries. In our work, we sought to study a mix (called BSL) comprising three strains belonging to Lactobacillus fermentum, L. paraplantarum and L. salivarius, that were isolated from a traditional African pearl millet based fermented slurry. Our objective was to study this BSL cocktail in gnotobiotic rats, to evaluate their survival and their behavior in the digestive tract conditions. After a single oral inoculation of germfree rats with BSL, the species established stably in the digestive tract with the following hierarchy of abundance: L. salivarius> L. plantarum> L. fermentum. BSL cocktail was metabolically active since it produced 50 mM lactate and it expressed genes involved in binding mechanism in the caecum. Furthermore, the global morphology of the colon epithelium was not disturbed by the BSL cocktail. BSL cocktail did not modify mucus content and host mucus-related genes (MUC1, MUC2, MUC3 or resistin-like molecule beta). The cocktail of lactobacilli enhanced the proliferating cell nuclear antigen (PCNA) at a level comparable to what was observed in conventional rats. PCNA was involved in proliferation and DNA repair, but the presence of the cocktail did not provoke proliferative events (with Ki67 as indicator), so we suppose BSL may help gut preservation. This work is the first step towards the selection of strains that are derived from traditional fermented food to formulate new probiotic mixture.	[Turpin, Williams; Humblot, Christele; Guyot, Jean-Pierre] IRD Montpellier2 Montpellier1, IRD, UMR NUTRIPASS, Montpellier, France; [Noordine, Marie-Louise; Wrzosek, Laura; Tomas, Julie; Mayeur, Camille; Cherbuy, Claire; Thomas, Muriel] INRA, Micalis UMR1319, Commensal & Probiot Host Interact Lab, Jouy En Josas, France; [Noordine, Marie-Louise; Wrzosek, Laura; Tomas, Julie; Mayeur, Camille; Cherbuy, Claire; Thomas, Muriel] AgroParisTech, UMR Micalis, Commensal & Probiot Host Interact Lab, Jouy En Josas, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Turpin, W (corresponding author), IRD Montpellier2 Montpellier1, IRD, UMR NUTRIPASS, Montpellier, France.	williams.turpin@utoronto.ca	Humblot, Christèle/A-7932-2008; Williams, Turpin/H-3255-2019; TOMAS, Julie/AAC-9819-2022; thomas, muriel/HDO-3887-2022	Humblot, Christèle/0000-0002-9797-1625; Williams, Turpin/0000-0001-9364-5868; 	French Ministry of Education and Research; French Institute of Agricultural Research	French Ministry of Education and Research; French Institute of Agricultural Research	Laura Wrzosek and Williams Turpin acknowledge a PhD grant from the French Ministry of Education and Research. Julie Tomas acknowledges a PhD grant from the French Institute of Agricultural Research. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; ALAM M, 1994, SCAND J GASTROENTERO, V29, P445, DOI 10.3109/00365529409096836; Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Bambirra FHS, 2007, LETT APPL MICROBIOL, V45, P663, DOI 10.1111/j.1472-765X.2007.02250.x; ben Omar N, 2000, APPL ENVIRON MICROB, V66, P3664, DOI 10.1128/AEM.66.9.3664-3673.2000; Ben-Yahia L, 2012, BENEF MICROBES, V3, P211, DOI 10.3920/BM2012.0012; Bezirtzoglou E, 2011, ANAEROBE, V17, P369, DOI 10.1016/j.anaerobe.2011.03.010; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; BONGAERTS G, 1995, CLIN CHEM, V41, P107; Bourriaud C, 2005, J APPL MICROBIOL, V99, P201, DOI 10.1111/j.1365-2672.2005.02605.x; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; BUSTOS D, 1994, DIGEST DIS SCI, V39, P2315, DOI 10.1007/BF02087644; Caballero-Franco C, 2007, AM J PHYSIOL-GASTR L, V292, pG315, DOI 10.1152/ajpgi.00265.2006; Chagnaud P, 2001, J MICROBIOL METH, V44, P139, DOI 10.1016/S0167-7012(00)00244-X; CHERBUY C, 1995, GASTROENTEROLOGY, V109, P1890, DOI 10.1016/0016-5085(95)90756-4; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; Chiaramonte F, 2009, APPL ENVIRON MICROB, V75, P4498, DOI 10.1128/AEM.02868-08; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Collado MC, 2007, J DAIRY SCI, V90, P2710, DOI 10.3168/jds.2006-456; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Dharmani P, 2011, INFECT IMMUN, V79, P2597, DOI 10.1128/IAI.05118-11; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Dykstra NS, 2011, PEDIATR RES, V69, P206, DOI 10.1203/PDR.0b013e3182096ff0; Eaton KA, 2011, INFECT IMMUN, V79, P185, DOI 10.1128/IAI.00880-10; Ehrmann MA, 2002, J APPL MICROBIOL, V92, P966, DOI 10.1046/j.1365-2672.2002.01608.x; Ewaschuk JB, 2005, J NUTR, V135, P1619, DOI 10.1093/jn/135.7.1619; FAO/WHO, 2001, EV HLTH NUTR PROP PO; Fouhy F, 2012, GUT MICROBES, V3, P203, DOI 10.4161/gmic.20169; Gionchetti P, 2005, GASTROENTEROL CLIN N, V34, P499, DOI 10.1016/j.gtc.2005.05.003; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Howarth Gordon S., 2001, Current Opinion in Pharmacology, V1, P568, DOI 10.1016/S1471-4892(01)00098-4; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; Jiang HY, 2011, J NUTR, V141, P1239, DOI 10.3945/jn.110.137414; KERNEIS S, 1994, GUT, V35, P1449, DOI 10.1136/gut.35.10.1449; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kim Y, 2008, J MICROBIOL BIOTECHN, V18, P1278; Kravtsov EG, 2008, B EXP BIOL MED+, V145, P232, DOI 10.1007/s10517-008-0058-x; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Laparra JM, 2009, LETT APPL MICROBIOL, V49, P695, DOI 10.1111/j.1472-765X.2009.02729.x; Lardy H, 2006, DIGEST DIS SCI, V51, P326, DOI 10.1007/s10620-006-3133-z; Lebeer S, 2010, BENEF MICROBES, V1, P335, DOI 10.3920/BM2010.0032; LESHER S, 1964, NATURE, V202, P884, DOI 10.1038/202884a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Mare L, 2006, J APPL MICROBIOL, V100, P838, DOI 10.1111/j.1365-2672.2006.02835.x; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Molin G, 2001, AM J CLIN NUTR, V73, p380S, DOI 10.1093/ajcn/73.2.380s; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NATARAJAN AT, 1988, MUTAT RES, V206, P47, DOI 10.1016/0165-1218(88)90140-1; Neu J, 2007, EARLY HUM DEV, V83, P767, DOI 10.1016/j.earlhumdev.2007.09.009; Ohashi Y, 2009, ANIM SCI J, V80, P361, DOI 10.1111/j.1740-0929.2009.00645.x; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Patel RM, 2011, GUT MICROBES, V1, P186; Podolsky Daniel K., 2000, Journal of Gastroenterology, V35, P69; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Ramiah K, 2007, INT J FOOD MICROBIOL, V116, P405, DOI 10.1016/j.ijfoodmicro.2007.02.011; Rendueles O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002815; Rul F, 2011, J BIOL CHEM, V286, P10288, DOI 10.1074/jbc.M110.168666; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; Songre-Ouattara LT, 2008, INT J FOOD MICROBIOL, V128, P395, DOI 10.1016/j.ijfoodmicro.2008.09.004; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Thim L, 2005, CELL MOL LIFE SCI, V62, P2956, DOI 10.1007/s00018-005-5484-6; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028789; Tomas J, 2012, FASEB J; Tou EH, 2006, INT J FOOD MICROBIOL, V106, P52, DOI 10.1016/j.ijfoodmicro.2005.05.010; Turpin W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038034; Turpin W, 2011, APPL ENVIRON MICROB, V77, P8722, DOI 10.1128/AEM.05988-11; Turpin W, 2010, INT J FOOD MICROBIOL, V143, P87, DOI 10.1016/j.ijfoodmicro.2010.07.032; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Uribarri J, 1998, MEDICINE, V77, P73, DOI 10.1097/00005792-199803000-00001; van der Wielen PWJJ, 2000, APPL ENVIRON MICROB, V66, P2536, DOI 10.1128/AEM.66.6.2536-2540.2000; VANKLINKEN BJW, 1995, AM J PHYSIOL-GASTR L, V269, pG613, DOI 10.1152/ajpgi.1995.269.5.G613; Wagner RD, 2008, ADV EXP MED BIOL, V635, P41, DOI 10.1007/978-0-387-09550-9_4; WEIRICHSCHWAIGER H, 1995, ARZNEIMITTEL-FORSCH, V45-1, P342; Wilks M, 2007, EARLY HUM DEV, V83, P165, DOI 10.1016/j.earlhumdev.2007.01.007; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yuan J, 2008, J PROTEOME RES, V7, P375, DOI 10.1021/pr0704940	78	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e57711	10.1371/journal.pone.0057711	http://dx.doi.org/10.1371/journal.pone.0057711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577056	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800003
J	Vesth, T; Lagesen, K; Acar, O; Ussery, D				Vesth, Tammi; Lagesen, Karin; Acar, Oncel; Ussery, David			CMG-Biotools, a Free Workbench for Basic Comparative Microbial Genomics	PLOS ONE			English	Article							STRANDS; DNA	Background: Today, there are more than a hundred times as many sequenced prokaryotic genomes than were present in the year 2000. The economical sequencing of genomic DNA has facilitated a whole new approach to microbial genomics. The real power of genomics is manifested through comparative genomics that can reveal strain specific characteristics, diversity within species and many other aspects. However, comparative genomics is a field not easily entered into by scientists with few computational skills. The CMG-biotools package is designed for microbiologists with limited knowledge of computational analysis and can be used to perform a number of analyses and comparisons of genomic data. Results: The CMG-biotools system presents a stand-alone interface for comparative microbial genomics. The package is a customized operating system, based on Xubuntu 10.10, available through the open source Ubuntu project. The system can be installed on a virtual computer, allowing the user to run the system alongside any other operating system. Source codes for all programs are provided under GNU license, which makes it possible to transfer the programs to other systems if so desired. We here demonstrate the package by comparing and analyzing the diversity within the class Negativicutes, represented by 31 genomes including 10 genera. The analyses include 16S rRNA phylogeny, basic DNA and codon statistics, proteome comparisons using BLAST and graphical analyses of DNA structures. Conclusion: This paper shows the strength and diverse use of the CMG-biotools system. The system can be installed on a vide range of host operating systems and utilizes as much of the host computer as desired. It allows the user to compare multiple genomes, from various sources using standardized data formats and intuitive visualizations of results. The examples presented here clearly shows that users with limited computational experience can perform complicated analysis without much training.	[Vesth, Tammi; Ussery, David] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Lagesen, Karin] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Acar, Oncel] Tech Univ Denmark, Dept Elect Engn, DK-2800 Lyngby, Denmark	Technical University of Denmark; University of Oslo; Technical University of Denmark	Ussery, D (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	dave@cbs.dtu.dk	Ussery, David/J-2026-2019	Ussery, David/0000-0003-3632-5512; Lagesen, Karin/0000-0003-1329-9032; Vesth, Tammi Camilla/0000-0003-4182-1764	Danish Research Council; Technical University of Denmark	Danish Research Council(Det Frie Forskningsrad (DFF)); Technical University of Denmark	This work was supported in part by grants from the Danish Research Council, and from The Technical University of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Binnewies TT, 2005, MICROBIOL-SGM, V151, P1, DOI 10.1099/mic.0.27760-0; BOLSHOY A, 1991, P NATL ACAD SCI USA, V88, P2312, DOI 10.1073/pnas.88.6.2312; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Friis C, 2000, GENETICA, V108, P47, DOI 10.1023/A:1004091626474; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jensen LJ, 2000, BIOINFORMATICS, V16, P326; Jensen LJ, 1999, RES MICROBIOL, V150, P773, DOI 10.1016/S0923-2508(99)00116-3; Klockgether J, 2008, GENOME DIVERSITY PSE; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Marin A, 2008, J THEOR BIOL, V253, P508, DOI 10.1016/j.jtbi.2008.04.004; ORNSTEIN RL, 1978, BIOPOLYMERS, V17, P2341, DOI 10.1002/bip.1978.360171005; Pedersen AG, 2000, J MOL BIOL, V299, P907, DOI 10.1006/jmbi.2000.3787; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Pilo P, 2011, INFECT GENET EVOL, V11, P1218, DOI 10.1016/j.meegid.2011.05.013; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; SHPIGELMAN ES, 1993, COMPUT APPL BIOSCI, V9, P435; Snipen L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-385; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Vesth T, 2010, MICROB ECOL, V59, P1, DOI 10.1007/s00248-009-9596-7; Willenbrock H, 2006, J BACTERIOL, V188, P7713, DOI 10.1128/JB.01043-06; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Worning P, 2006, ENVIRON MICROBIOL, V8, P353, DOI 10.1111/j.1462-2920.2005.00917.x	31	81	81	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60120	10.1371/journal.pone.0060120	http://dx.doi.org/10.1371/journal.pone.0060120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577086	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800029
J	Villa-Vialaneix, N; Liaubet, L; Laurent, T; Cherel, P; Gamot, A; SanCristobal, M				Villa-Vialaneix, Nathalie; Liaubet, Laurence; Laurent, Thibault; Cherel, Pierre; Gamot, Adrien; SanCristobal, Magali			The Structure of a Gene Co-Expression Network Reveals Biological Functions Underlying eQTLs	PLOS ONE			English	Article							SKELETAL-MUSCLE; ASSOCIATION; EXPRESSION; FRAMEWORK; QUALITY; TRAIT; GRAPH; EZH2	What are the commonalities between genes, whose expression level is partially controlled by eQTL, especially with regard to biological functions? Moreover, how are these genes related to a phenotype of interest? These issues are particularly difficult to address when the genome annotation is incomplete, as is the case for mammalian species. Moreover, the direct link between gene expression and a phenotype of interest may be weak, and thus difficult to handle. In this framework, the use of a co-expression network has proven useful: it is a robust approach for modeling a complex system of genetic regulations, and to infer knowledge for yet unknown genes. In this article, a case study was conducted with a mammalian species. It showed that the use of a co-expression network based on partial correlation, combined with a relevant clustering of nodes, leads to an enrichment of biological functions of around 83%. Moreover, the use of a spatial statistics approach allowed us to superimpose additional information related to a phenotype; this lead to highlighting specific genes or gene clusters that are related to the network structure and the phenotype. Three main results are worth noting: first, key genes were highlighted as a potential focus for forthcoming biological experiments; second, a set of biological functions, which support a list of genes under partial eQTL control, was set up by an overview of the global structure of the gene expression network; third, pH was found correlated with gene clusters, and then with related biological functions, as a result of a spatial analysis of the network topology.	[Villa-Vialaneix, Nathalie] INRA, UR875, UBIA, F-31326 Castanet Tolosan, France; [Liaubet, Laurence; Gamot, Adrien; SanCristobal, Magali] INRA, Lab Genet Cellulaire UMR444, F-31326 Castanet Tolosan, France; [Laurent, Thibault] Univ Toulouse 1, Toulouse Sch Econ, Toulouse, France; [Cherel, Pierre] Hendrix Genet RTC, St Jean En Braye, France	INRAE; INRAE; Universite de Toulouse; Universite Toulouse 1 Capitole; Toulouse School of Economics	Villa-Vialaneix, N (corresponding author), INRA, UR875, UBIA, F-31326 Castanet Tolosan, France.	nathalie.villa@toulouse.inra.fr		Liaubet, Laurence/0000-0003-0201-0264	French Ministry of Research; Eadgene network of Excellence	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Eadgene network of Excellence	This project received financial support from the French Ministry of Research in the framework of the PG-ASG program. This work was partly supported by the Eadgene network of Excellence (http://www.eadgene.info). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bonnet Agnes, 2009, BMC Proc, V3 Suppl 4, pS11, DOI 10.1186/1753-6561-3-S4-S11; Bordbar A, 2012, J INTERN MED, V271, P131, DOI 10.1111/j.1365-2796.2011.02494.x; Boulet R, 2008, NEUROCOMPUTING, V71, P1257, DOI 10.1016/j.neucom.2007.12.026; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Butte A J, 2000, Pac Symp Biocomput, P418; Butte AJ, 1999, J AM MED INFORM ASSN, P711; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Cook R, 1982, RESIDUALS INUENCE RE; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Dunn R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-39; Edwards D, 1995, INTRO GRAPHICAL MODE; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fouss F, 2007, IEEE T KNOWL DATA EN, V19, P355, DOI 10.1109/TKDE.2007.46; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hedegaard Jakob, 2009, BMC Proc, V3 Suppl 4, pS5; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Hwang W, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-24; Inoue K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012623; Jordan I, 2008, BMC SYSTEMS BIOL, V13, P2; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kondor R. I., 2002, PROC 19 INT C MACH L, P315; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Laurent T, 2011, INFORM INTERACTION I, V11; Lee SH, 2010, MEAT SCI, V86, P166, DOI 10.1016/j.meatsci.2010.04.040; Lengerken G. von, 2002, Veterinarija ir Zootechnika, P82; Li HD, 2010, J ANIM SCI, V88, P2904, DOI 10.2527/jas.2009-2590; Liaubet L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-548; Lobjois V, 2008, ANIM GENET, V39, P147, DOI 10.1111/j.1365-2052.2007.01695.x; Lord LD, 2011, NEUROIMAGE, V56, P1531, DOI 10.1016/j.neuroimage.2011.02.012; Ma HS, 2011, BIOINFORMATICS, V27, P1290, DOI 10.1093/bioinformatics/btr136; Ma XT, 2007, BIOINFORMATICS, V23, P215, DOI 10.1093/bioinformatics/btl569; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ngapo TM, 2008, CRIT REV FOOD SCI, V48, P599, DOI 10.1080/10408390701558126; Noack Andreas, 2007, Journal of Graph Algorithms and Applications, V11, P453, DOI 10.7155/jgaa.00154; Park WR, 2005, CANCER RES, V65, P1197, DOI 10.1158/0008-5472.CAN-04-3339; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; PEARL J, 1998, PROBABILISTIC REASON; Pearl J, 2002, BAYESIAN NETWORKS; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rodriguez A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-379; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Scholkopf B., 2004, KERNEL METHODS COMPU; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Tolstonog GV, 2010, P NATL ACAD SCI USA, V107, P13193, DOI 10.1073/pnas.1007945107; Verhave G, 2010, NETH J MED, V68, P113; Villers F, 2008, STAT APPL GENET MOL, V7; VONMERING C, 2003, J MOL BIOL, V327, P919; Wei QO, 2011, P NATL ACAD SCI USA, V108, P7004, DOI 10.1073/pnas.1013012108; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	66	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60045	10.1371/journal.pone.0060045	http://dx.doi.org/10.1371/journal.pone.0060045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577081	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800024
J	Whitehouse, IJ; Miners, JS; Glennon, EBC; Kehoe, PG; Love, S; Kellett, KAB; Hooper, NM				Whitehouse, Isobel J.; Miners, J. Scott; Glennon, Elizabeth B. C.; Kehoe, Patrick G.; Love, Seth; Kellett, Katherine A. B.; Hooper, Nigel M.			Prion Protein Is Decreased in Alzheimer's Brain and Inversely Correlates with BACE1 Activity, Amyloid-beta Levels and Braak Stage	PLOS ONE			English	Article							INSULIN-DEGRADING ENZYME; A-BETA; PRECURSOR PROTEIN; SECRETASE ACTIVITY; CELLULAR PRION; SYNAPTIC ZINC; DISEASE; ACCUMULATION; NEPRILYSIN; CONTACTIN	The cellular prion protein (PrPC) has been implicated in the development of Alzheimer's disease (AD). PrPC decreases amyloid-beta (A beta) production, which is involved in AD pathogenesis, by inhibiting beta-secretase (BACE1) activity. Contactin 5 (CNTN5) has also been implicated in the development of AD by a genome-wide association study. Here we measured PrPC and CNTN5 in frontal cortex samples from 24 sporadic AD and 24 age-matched control brains and correlated the expression of these proteins with markers of AD. PrPC was decreased in sporadic AD compared to controls (by 49%, p = 0.014) but there was no difference in CNTN5 between sporadic AD and controls (p = 0.217). PrPC significantly inversely correlated with BACE1 activity (r(s) = -0.358, p = 0.006), A beta load (r(s) = -0.456, p = 0.001), soluble A beta (r(s) = -0.283, p = 0.026) and insoluble A beta (r(s) = -0.353, p = 0.007) and PrPC also significantly inversely correlated with the stage of disease, as indicated by Braak tangle stage (r(s) = -0.377, p = 0.007). CNTN5 did not correlate with A beta load (r(s) = 0.040, p = 0.393), soluble A beta (r(s) = 0.113, p = 0.223) or insoluble A beta (r(s) = 0.169, p = 0.125). PrPC was also measured in frontal cortex samples from 9 Down's syndrome (DS) and 8 age-matched control brains. In contrast to sporadic AD, there was no difference in PrPC in the DS brains compared to controls (p = 0.625). These data are consistent with a role for PrPC in regulating Ab production and indicate that brain PrPC level may be important in influencing the onset and progression of sporadic AD.	[Whitehouse, Isobel J.; Glennon, Elizabeth B. C.; Kellett, Katherine A. B.; Hooper, Nigel M.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Miners, J. Scott; Kehoe, Patrick G.; Love, Seth] Univ Bristol, Inst Clin Neurosci, Sch Clin Sci, Dementia Res Grp, Bristol, Avon, England	University of Leeds; University of Bristol	Kellett, KAB (corresponding author), Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.	k.a.b.kellett@leeds.ac.uk; n.m.hooper@leeds.ac.uk	Kehoe, Patrick/P-8760-2018	Kehoe, Patrick/0000-0002-7542-1139; Miners, James/0000-0001-8594-1640; Love, Seth/0000-0001-8683-3625; Hooper, Nigel/0000-0002-5811-3484; Glennon, Elizabeth/0000-0002-2499-1246; Kellett, Katherine/0000-0002-2802-0615	Medical Research Council of Great Britain [G0802189]; Alzheimer's Research UK [PG2008-2, PhD2009-1]; BRACE (Bristol Research into Ageing and Care of the Elderly) [BRACE(8120)]; MRC [G0802189] Funding Source: UKRI; Alzheimers Research UK [ART-EG2005B-1] Funding Source: researchfish; Medical Research Council [G0802189] Funding Source: researchfish	Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); BRACE (Bristol Research into Ageing and Care of the Elderly); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge the financial support of the Medical Research Council of Great Britain, www.mrc.ac.uk, (G0802189), Alzheimer's Research UK, www.alzheimersresearchuk.org, (PG2008-2 and PhD2009-1) and BRACE (Bristol Research into Ageing and Care of the Elderly, www.alzheimers-brace.org, (BRACE(8120)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Ballard CG, 2007, NEUROLOGY, V68, P1726, DOI 10.1212/01.wnl.0000261920.03297.64; Beyer N, 2012, J ALZHEIMERS DIS, V29, P863, DOI 10.3233/JAD-2012-112105; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b158; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Chalmers K, 2003, NEUROPATH APPL NEURO, V29, P231, DOI 10.1046/j.1365-2990.2003.00457.x; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; CRAS P, 1995, ACTA NEUROPATHOL, V89, P291; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hooper NM, 2008, TRENDS BIOCHEM SCI, V33, P151, DOI 10.1016/j.tibs.2008.01.004; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lewis V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031754; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; Matthews FE, 2007, INT J GERIATR PSYCH, V22, P627, DOI 10.1002/gps.1720; Menendez M, 2005, BRAIN DEV-JPN, V27, P246, DOI 10.1016/j.braindev.2004.07.008; Miners JS, 2010, BRAIN PATHOL, V20, P794, DOI 10.1111/j.1750-3639.2010.00375.x; Miners JS, 2011, J ALZHEIMERS DIS, V23, P101, DOI 10.3233/JAD-2010-101395; Miners JS, 2009, J NEUROPATH EXP NEUR, V68, P902, DOI 10.1097/NEN.0b013e3181afe475; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mount C, 2006, NAT MED, V12, P780, DOI 10.1038/nm0706-780; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; Saijo E, 2011, PRION, V5, P110, DOI 10.4161/pri.5.2.16355; Stimson E, 1999, BIOCHEMISTRY-US, V38, P4885, DOI 10.1021/bi982330q; van Helmond Z, 2010, BRAIN PATHOL, V20, P787, DOI 10.1111/j.1750-3639.2010.00374.x; van Helmond Z, 2010, BRAIN PATHOL, V20, P468, DOI 10.1111/j.1750-3639.2009.00321.x; Vincent B, 2009, J NEUROSCI, V29, P6752, DOI 10.1523/JNEUROSCI.0789-09.2009; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Whitehouse IJ, 2010, J ALZHEIMERS DIS, V22, P1023, DOI 10.3233/JAD-2010-101071	41	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59554	10.1371/journal.pone.0059554	http://dx.doi.org/10.1371/journal.pone.0059554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577068	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800012
J	Muirhead, CR; Cheetham, TD; Court, S; Begon, M; McNally, RJQ				Muirhead, Colin R.; Cheetham, Timothy D.; Court, Simon; Begon, Michael; McNally, Richard J. Q.			How Do Childhood Diagnoses of Type 1 Diabetes Cluster in Time?	PLOS ONE			English	Article							POPULATION-DENSITY; SEASONAL-VARIATION; VIRAL-INFECTIONS; NORTHERN-IRELAND; MELLITUS; CHILDREN; TRENDS; RISK; EPIDEMIOLOGY; EUROPE	Background: Previous studies have indicated that type 1 diabetes may have an infectious origin. The presence of temporal clustering-an irregular temporal distribution of cases-would provide additional evidence that occurrence may be linked with an agent that displays epidemicity. We tested for the presence and form of temporal clustering using population-based data from northeast England. Materials and Methods: The study analysed data on children aged 0-14 years diagnosed with type 1 diabetes during the period 1990-2007 and resident in a defined geographical region of northeast England (Northumberland, Newcastle upon Tyne, and North Tyneside). Tests for temporal clustering by time of diagnosis were applied using a modified version of the Potthoff-Whittinghill method. Results: The study analysed 468 cases of children diagnosed with type 1 diabetes. There was highly statistically significant evidence of temporal clustering over periods of a few months and over longer time intervals (p<0.001). The clustering within years did not show a consistent seasonal pattern. Conclusions: The study adds to the growing body of literature that supports the involvement of infectious agents in the aetiology of type 1 diabetes in children. Specifically it suggests that the precipitating agent or agents involved might be an infection that occurs in "mini-epidemics".	[Muirhead, Colin R.; Court, Simon; McNally, Richard J. Q.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Cheetham, Timothy D.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Begon, Michael] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	Newcastle University - UK; Newcastle University - UK; University of Liverpool	Muirhead, CR (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Colin.Muirhead@Newcastle.ac.uk		Begon, Mike/0000-0003-1715-5327; Muirhead, Colin/0000-0001-5394-1267; McNally, Richard/0000-0001-6685-6467	UK Joint Environment and Human Health Programme - the National Environment Research Council; Environment Agency; Department of the Environment and Rural Affairs; Ministry of Defence; Medical Research Council; Wellcome Trust; Economic & Social Research Council; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Health Protection Agency; NERC [NE/E008011/1, NE/E008038/1] Funding Source: UKRI; Natural Environment Research Council [NE/E008011/1, NE/E008038/1] Funding Source: researchfish	UK Joint Environment and Human Health Programme - the National Environment Research Council; Environment Agency; Department of the Environment and Rural Affairs; Ministry of Defence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic & Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Health Protection Agency; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the UK Joint Environment and Human Health Programme - the National Environment Research Council, Environment Agency, Department of the Environment and Rural Affairs, Ministry of Defence, Medical Research Council, Wellcome Trust, Economic & Social Research Council, Biotechnology and Biological Sciences Research Council, Engineering and Physical Sciences Research Council and Health Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begon M, 2009, P ROY SOC B-BIOL SCI, V276, P1603, DOI 10.1098/rspb.2008.1732; Borchers AT, 2010, AUTOIMMUN REV, V9, pA355, DOI 10.1016/j.autrev.2009.12.003; Bruno G, 2009, DIABETOLOGIA, V52, P2531, DOI 10.1007/s00125-009-1538-x; Cardwell CR, 2008, DIABETIC MED, V25, P261, DOI 10.1111/j.1464-5491.2007.02351.x; Cardwell CR, 2007, DIABETIC MED, V24, P289, DOI 10.1111/j.1464-5491.2007.02080.x; Cardwell CR, 2006, DIABETOLOGIA, V49, P2074, DOI 10.1007/s00125-006-0342-0; Cardwell CR, 2012, DIABETES, V61, P702, DOI 10.2337/db11-1000; Cardwell CR, 2011, INT J EPIDEMIOL, V40, P363, DOI 10.1093/ije/dyq207; Chong JW, 2007, PEDIATR DIABETES, V8, P67, DOI 10.1111/j.1399-5448.2007.00229.x; Christen U, 2004, J CLIN INVEST, V113, P74, DOI 10.1172/JCI200417005; Davis S, 2005, VECTOR-BORNE ZOONOT, V5, P305, DOI 10.1089/vbz.2005.5.305; Filippi C, 2005, CELL IMMUNOL, V233, P125, DOI 10.1016/j.cellimm.2005.04.009; Forlenza GP, 2011, CURR OPIN ENDOCRINOL, V18, P248, DOI 10.1097/MED.0b013e32834872ce; Gale EAM, 2002, DIABETOLOGIA, V45, P588, DOI 10.1007/s00125-002-0801-1; Gibbon C, 1997, ARCH DIS CHILD, V77, P384, DOI 10.1136/adc.77.5.384; Goldberg E, 2009, AUTOIMMUN REV, V8, P682, DOI 10.1016/j.autrev.2009.02.017; Graham KL, 2008, J VIROL, V82, P6139, DOI 10.1128/JVI.00597-08; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Hober D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7072; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Holmqvist BM, 2008, DIABETIC MED, V25, P255, DOI 10.1111/j.1464-5491.2007.02342.x; Hunsberger S, 2002, BIOSTATISTICS, V3, P289, DOI 10.1093/biostatistics/3.2.289; Imkampe AK, 2011, DIABETIC MED, V28, P811, DOI 10.1111/j.1464-5491.2011.03288.x; JONES RH, 1988, BIOMETRICS, V44, P1131, DOI 10.2307/2531741; Kaila B, 2001, DIABETES CARE, V24, P1353, DOI 10.2337/diacare.24.8.1353; Kallio ER, 2010, P ROY SOC B-BIOL SCI, V277, P3783, DOI 10.1098/rspb.2010.1022; Kyambi S., 2005, BLACK WHITE MAPPING; Lambin X, 2000, J ANIM ECOL, V69, P106, DOI 10.1046/j.1365-2656.2000.00380.x; McKinney PA, 1999, DIABETES CARE, V22, P928, DOI 10.2337/diacare.22.6.928; McNally RJQ, 2010, EPIDEMIOLOGY, V21, P914, DOI 10.1097/EDE.0b013e3181f38f3f; McNally RJQ, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S14; Moltchanova EV, 2009, DIABETIC MED, V26, P673, DOI 10.1111/j.1464-5491.2009.02743.x; Mooney JA, 2004, ARCH DIS CHILD, V89, P970, DOI 10.1136/adc.2003.040865; Muirhead C R, 1996, IARC Sci Publ, P40; Muirhead CR, 2006, STAT METHODS MED RES, V15, P363, DOI 10.1191/0962280206sm457oa; Niklasson B, 1998, EMERG INFECT DIS, V4, P187, DOI 10.3201/eid0402.980206; Niklasson B, 2006, OECOLOGIA, V150, P1, DOI 10.1007/s00442-006-0493-1; Niklasson Bo, 2003, Int J Exp Diabesity Res, V4, P35; Parslow RC, 2001, INT J EPIDEMIOL, V30, P533, DOI 10.1093/ije/30.3.533; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Patterson CC, 1996, DIABETOLOGIA, V39, P1063, DOI 10.1007/BF00400655; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pless-Mulloli T, 2000, OCCUP ENVIRON MED, V57, P145, DOI 10.1136/oem.57.3.145; Pless-Mulloli T, 2001, INT J EPIDEMIOL, V30, P556, DOI 10.1093/ije/30.3.556; POTTHOFF RF, 1966, BIOMETRIKA, V53, P183, DOI 10.2307/2334063; POTTHOFF RF, 1966, BIOMETRIKA, V53, P167, DOI 10.2307/2334062; Pundziunte-Lycka A, 2000, DIABETOLOGIA, V43, P1229, DOI 10.1007/s001250051517; Ramondetti F, 2012, DIABETIC MED, V29, P761, DOI 10.1111/j.1464-5491.2011.03529.x; Rewers M, 2004, ADV EXP MED BIOL, V552, P219; Rook GAW, 2012, CLIN REV ALLERG IMMU, V42, P5, DOI 10.1007/s12016-011-8285-8; Soltesz G, 2007, PEDIATR DIABETES, V8, P6, DOI 10.1111/j.1399-5448.2007.00280.x; Staines A, 1997, INT J EPIDEMIOL, V26, P1307, DOI 10.1093/ije/26.6.1307; Svensson J, 2009, PEDIATR DIABETES, V10, P248, DOI 10.1111/j.1399-5448.2008.00483.x; Tracy S, 2011, DIABETES-METAB RES, V27, P820, DOI 10.1002/dmrr.1255; Wilkin TJ, 2008, PEDIATR DIABETES, V9, P23, DOI 10.1111/j.1399-5448.2007.00343.x; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35; Zipris D, 2009, CLIN IMMUNOL, V131, P11, DOI 10.1016/j.clim.2008.12.011	57	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60489	10.1371/journal.pone.0060489	http://dx.doi.org/10.1371/journal.pone.0060489			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573261	gold, Green Submitted, Green Published			2022-12-27	WOS:000318840100078
J	Ost, J; Blank, H; Davies, J; Jones, G; Lambert, K; Salmon, K				Ost, James; Blank, Hartmut; Davies, Joanna; Jones, Georgina; Lambert, Katie; Salmon, Kelly			False Memory not equal False Memory: DRM Errors Are Unrelated to the Misinformation Effect	PLOS ONE			English	Article							DEVELOPMENTAL REVERSALS; INDIVIDUAL-DIFFERENCES; REMEMBERING WORDS; TRUE; RECOGNITION; LISTS; DISTORTION; BRAINERD; REYNA	The DRM method has proved to be a popular and powerful, if controversial, way to study 'false memories'. One reason for the controversy is that the extent to which the DRM effect generalises to other kinds of memory error has been neither satisfactorily established nor subject to much empirical attention. In the present paper we contribute data to this ongoing debate. One hundred and twenty participants took part in a standard misinformation effect experiment, in which they watched some CCTV footage, were exposed to misleading post-event information about events depicted in the footage, and then completed free recall and recognition tests. Participants also completed a DRM test as an ostensibly unrelated filler task. Despite obtaining robust misinformation and DRM effects, there were no correlations between a broad range of misinformation and DRM effect measures (mean r = -.01). This was not due to reliability issues with our measures or a lack of power. Thus DRM 'false memories' and misinformation effect 'false memories' do not appear to be equivalent.	[Ost, James; Blank, Hartmut; Davies, Joanna; Jones, Georgina; Lambert, Katie; Salmon, Kelly] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England	University of Portsmouth	Ost, J (corresponding author), Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England.	james.ost@port.ac.uk		Blank, Hartmut/0000-0002-8647-6522; Ost, James/0000-0002-6992-8160				[Anonymous], 2008, SOURCE MONITORING J; Baym CL, 2010, COGN AFFECT BEHAV NE, V10, P339, DOI 10.3758/CABN.10.3.339; Belli RF., 1996, PLIABILITY AUTOBIOGR, P157, DOI [10.1017/CBO9780511527913.006, DOI 10.1017/CBO9780511527913.006]; Brainerd CJ, 2008, PSYCHOL BULL, V134, P773, DOI 10.1037/0033-2909.134.5.773; Brainerd CJ, 2008, PSYCHOL BULL, V134, P343, DOI 10.1037/0033-2909.134.3.343; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Clancy SA, 2002, J ABNORM PSYCHOL, V111, P455, DOI 10.1037//0021-843X.111.3.455; DePrince AP, 2004, ETHICS BEHAV, V14, P201, DOI 10.1207/s15327019eb1403_1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; French CC, 2008, CORTEX, V44, P1387, DOI 10.1016/j.cortex.2007.11.011; Freyd JJ, 1996, J EXP PSYCHOL LEARN, V22, P811, DOI 10.1037/0278-7393.22.3.811; Gallo DA, 2010, MEM COGNITION, V38, P833, DOI 10.3758/MC.38.7.833; Ghetti S, 2008, PSYCHOL BULL, V134, P764, DOI 10.1037/0033-2909.134.5.764; Higham PA, 1998, BRIT J PSYCHOL, V89, P265, DOI 10.1111/j.2044-8295.1998.tb02684.x; Howe ML, 2008, PSYCHOL BULL, V134, P768, DOI 10.1037/0033-2909.134.5.768; Hyman IE, 1998, MEMORY, V6, P1, DOI 10.1080/741941598; Hyman IE, 1999, EMORY S COG, P229; Loftus EF, 2005, LEARN MEMORY, V12, P1, DOI 10.1101/lm.90805; Mazzoni G, 2002, EUR PSYCHOL, V7, P17, DOI 10.1027//1016-9040.7.1.17; MCCLOSKEY M, 1985, J EXP PSYCHOL GEN, V114, P1, DOI 10.1037/0096-3445.114.1.1; McNally RJ, 2009, PERSPECT PSYCHOL SCI, V4, P126, DOI 10.1111/j.1745-6924.2009.01112.x; Meyersburg CA, 2009, J ABNORM PSYCHOL, V118, P399, DOI 10.1037/a0015371; Okado Y, 2003, COGN AFFECT BEHAV NE, V3, P323, DOI 10.3758/CABN.3.4.323; Ost J, 2008, MEMORY, V16, P76, DOI 10.1080/09658210701723323; Otgaar H, 2011, PSYCHOL CRIME LAW, V17, P513, DOI 10.1080/10683160903373392; Pansky A, 2011, J MEM LANG, V64, P270, DOI 10.1016/j.jml.2010.12.003; Pezdek K, 2007, CONSCIOUS COGN, V16, P2, DOI 10.1016/j.concog.2005.06.006; Qin JJ, 2008, J EXP PSYCHOL-APPL, V14, P373, DOI 10.1037/a0014309; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Roediger HL, 1996, J EXP PSYCHOL LEARN, V22, P814; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stadler MA, 1999, MEM COGNITION, V27, P494, DOI 10.3758/BF03211543; Stark CEL, 2010, LEARN MEMORY, V17, P485, DOI 10.1101/lm.1845710; Wade KA, 2007, CONSCIOUS COGN, V16, P18, DOI 10.1016/j.concog.2006.07.001; Wilkinson C, 1998, APPL COGNITIVE PSYCH, V12, pS29, DOI 10.1002/(SICI)1099-0720(199812)12:7<S29::AID-ACP596>3.0.CO;2-R; YouTube, JEW STOR ROBB; Zaragoza MS, 2006, DO JUSTICE LET SKY F, P35	39	55	55	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e57939	10.1371/journal.pone.0057939	http://dx.doi.org/10.1371/journal.pone.0057939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23573186	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100005
J	Talukdar, PK; Rahman, M; Rahman, M; Nabi, A; Islam, Z; Hoque, MM; Endtz, HP; Islam, MA				Talukdar, Prabhat Kumar; Rahman, Mizanur; Rahman, Mahdia; Nabi, Ashikun; Islam, Zhahirul; Hoque, M. Mahfuzul; Endtz, Hubert P.; Islam, Mohammad Aminul			Antimicrobial Resistance, Virulence Factors and Genetic Diversity of Escherichia coli Isolates from Household Water Supply in Dhaka, Bangladesh	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; LACTAMASE-PRODUCING ENTEROBACTERIACEAE; KLEBSIELLA-PNEUMONIAE; CHANGING EPIDEMIOLOGY; SURFACE-WATER; SHIGELLA; PREVALENCE; BACTERIA; DIARRHEA; ANIMALS	Background: Unsafe water supplies continue to raise public health concerns, especially in urban areas in low resource countries. To understand the extent of public health risk attributed to supply water in Dhaka city, Bangladesh, Escherichia coli isolated from tap water samples collected from different locations of the city were characterized for their antibiotic resistance, pathogenic properties and genetic diversity. Methodology/Principal Findings: A total of 233 E. coli isolates obtained from 175 tap water samples were analysed for susceptibility to 16 different antibiotics and for the presence of genes associated with virulence and antibiotic resistance. Nearly 36% (n = 84) of the isolates were multi-drug(>= 3 classes of antibiotics) resistant (MDR) and 26% (n = 22) of these were positive for extended spectrum beta-lactamase (ESBL). Of the 22 ESBL-producers, 20 were positive for bla(CTX-M-15), 7 for bla(OXA-1-group) (all had bla(OXA-47)) and 2 for bla(CMY-2). Quinolone resistance genes, qnrS and qnrB were detected in 6 and 2 isolates, respectively. Around 7% (n = 16) of the isolates carried virulence gene(s) characteristic of pathogenic E. coli; 11 of these contained lt and/or st and thus belonged to enterotoxigenic E. coli and 5 contained bfp and eae and thus belonged to enteropathogenic E. coli. All MDR isolates carried multiple plasmids (2 to 8) of varying sizes ranging from 1.2 to >120 MDa. Ampicillin and ceftriaxone resistance were co-transferred in conjugative plasmids of 70 to 100 MDa in size, while ampicillin, trimethoprim-sulfamethoxazole and tetracycline resistance were co-transferred in conjugative plasmids of 50 to 90 MDa. Pulsed-field gel electrophoresis analysis revealed diverse genetic fingerprints of pathogenic isolates. Significance: Multi-drug resistant E. coli are wide spread in public water supply in Dhaka city, Bangladesh. Transmission of resistant bacteria and plasmids through supply water pose serious threats to public health in urban areas.	[Talukdar, Prabhat Kumar; Rahman, Mizanur; Rahman, Mahdia; Nabi, Ashikun; Islam, Zhahirul; Endtz, Hubert P.; Islam, Mohammad Aminul] Icddr B, Ctr Food & Waterborne Dis, Food Safety Res Grp, Dhaka, Bangladesh; [Talukdar, Prabhat Kumar; Hoque, M. Mahfuzul] Univ Dhaka, Dept Microbiol, Dhaka 1000, Bangladesh; [Endtz, Hubert P.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	International Centre for Diarrhoeal Disease Research (ICDDR); University of Dhaka; Erasmus University Rotterdam; Erasmus MC	Islam, MA (corresponding author), Icddr B, Ctr Food & Waterborne Dis, Food Safety Res Grp, Dhaka, Bangladesh.	maislam@icddrb.org	Talukdar, Prabhat Kumar/AAD-5762-2020; Nabi, Ambreen/AED-3676-2022	Nabi, Ambreen/0000-0003-1899-363X; Talukdar, Prabhat/0000-0002-7796-7696; Islam, Dr. Zhahirul/0000-0003-0935-8079	icddr,b; Australian Agency for International Development (AusAID); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	icddr,b; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This research study was funded by icddr,b and its donors which provide unrestricted support to icddr,b for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The authors gratefully acknowledge these donors for their support and commitment to icddr,b 's research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 1998, APMIS, V106, P745, DOI 10.1111/j.1699-0463.1998.tb00222.x; Ahmed D, 2013, J APPL MICROBIOL, V114, P1223, DOI 10.1111/jam.12109; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Begum YA, 2005, J CLIN MICROBIOL, V43, P3582, DOI 10.1128/JCM.43.7.3582-3583.2005; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; Clinical and Laboratory Standards Institute (CLSI), 2009, PERF STAND ANT DISK, V10th; Coleman BL, 2012, EPIDEMIOL INFECT, V140, P633, DOI 10.1017/S0950268811001038; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Henriques IS, 2006, RES MICROBIOL, V157, P938, DOI 10.1016/j.resmic.2006.09.003; Higgins JA, 2005, APPL ENVIRON MICROB, V71, P2511, DOI 10.1128/AEM.71.5.2511-2519.2005; Hiroi M, 2011, JPN J INFECT DIS, V64, P153; Honma Y, 2003, INT J ANTIMICROB AG, V21, P262, DOI 10.1016/S0924-8579(02)00270-4; Hu JY, 2008, ENVIRON SCI TECHNOL, V42, P3415, DOI 10.1021/es7026746; Huda TMN, 2012, SOC SCI MED, V75, P604, DOI 10.1016/j.socscimed.2011.10.042; Islam MA, 2012, EUR J CLIN MICROBIOL, V31, P2593, DOI 10.1007/s10096-012-1601-2; Islam MA, 2007, J MED MICROBIOL, V56, P380, DOI 10.1099/jmm.0.46916-0; Islam S., 2010, BANGLADESH J MED MIC, V4, P9, DOI [10. 3329/bjmm.v4i1.8462, DOI 10.3329/BJMM.V4I1.8462]; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Lothigius A, 2008, J APPL MICROBIOL, V104, P1128, DOI 10.1111/j.1365-2672.2007.03628.x; Lynch JP, 2013, EXPERT OPIN PHARMACO, V14, P199, DOI 10.1517/14656566.2013.763030; Ma JY, 2009, ANTIMICROB AGENTS CH, V53, P519, DOI 10.1128/AAC.00886-08; MACRINA FL, 1978, PLASMID, V1, P417, DOI 10.1016/0147-619X(78)90056-2; Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Murray BE, 1997, ADV INTERNAL MED, V42, P339; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320, DOI 10.1097/QCO.0b013e3283398dc1; Pathak SP, 2008, J TOXICOL ENV HEAL A, V71, P427, DOI 10.1080/15287390701838796; Pico RC, 2008, J ANTIMICROB CHEMOTH, V62, P948, DOI 10.1093/jac/dkn341; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Poirel L, 2008, CLIN MICROBIOL INFEC, V14, P295, DOI 10.1111/j.1469-0691.2007.01930.x; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Rahman MM, 2004, INT J ANTIMICROB AG, V24, P508, DOI 10.1016/j.ijantimicag.2004.05.007; Ram S, 2008, J APPL MICROBIOL, V105, P1899, DOI 10.1111/j.1365-2672.2008.03879.x; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Shin JH, 2008, MICROB DRUG RESIST, V14, P221, DOI 10.1089/mdr.2008.0834; Takasu H, 2011, MICROBES ENVIRON, V26, P135, DOI 10.1264/jsme2.ME10204; Talukder KA, 2003, J CLIN MICROBIOL, V41, P5053, DOI 10.1128/JCM.41.11.5053-5058.2003; Talukder KA, 2002, J CLIN MICROBIOL, V40, P2490, DOI 10.1128/JCM.40.7.2490-2497.2002; Talukder KA, 2006, J MED MICROBIOL, V55, P1257, DOI 10.1099/jmm.0.46641-0; Teo JWP, 2009, INT J ANTIMICROB AG, V33, P177, DOI 10.1016/j.ijantimicag.2008.08.019; Thong KL, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-8; Turner SM, 2006, FEMS MICROBIOL LETT, V263, P10, DOI 10.1111/j.1574-6968.2006.00401.x; van den Bogaard AE, 2000, INT J ANTIMICROB AG, V14, P327, DOI 10.1016/S0924-8579(00)00145-X; van den Bogaard AEJM, 2000, J ANTIMICROB CHEMOTH, V45, P663, DOI 10.1093/jac/45.5.663; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; WHO, 2012, FACTS FIG WAT SAN HY; Yue L, 2008, VET MICROBIOL, V132, P414, DOI 10.1016/j.vetmic.2008.05.009	50	107	109	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e61090	10.1371/journal.pone.0061090	http://dx.doi.org/10.1371/journal.pone.0061090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573295	Green Published, gold			2022-12-27	WOS:000318840100113
J	Agudelo-Romero, P; Erban, A; Sousa, L; Pais, MS; Kopka, J; Fortes, AM				Agudelo-Romero, Patricia; Erban, Alexander; Sousa, Lisete; Pais, Maria Salome; Kopka, Joachim; Fortes, Ana Margarida			Search for Transcriptional and Metabolic Markers of Grape Pre-Ripening and Ripening and Insights into Specific Aroma Development in Three Portuguese Cultivars	PLOS ONE			English	Article							CABERNET-SAUVIGNON GRAPES; GENE-EXPRESSION; GAS-CHROMATOGRAPHY; VOLATILE COMPOUNDS; FLAVOR PRECURSORS; TOMATO FRUIT; BERRY; BIOSYNTHESIS; IDENTIFICATION; FERMENTATION	Background: Grapes (Vitis species) are economically the most important fruit crop worldwide. However, the complexity of molecular and biochemical events that lead to ripening of berries as well as how aroma is developed are not fully understood. Methodology/Principal Findings: In an attempt to identify the common mechanisms associated with the onset of ripening independently of the cultivar, grapes of Portuguese elite cultivars, Trincadeira, Aragones, and Touriga Nacional, were studied. The mRNA expression profiles corresponding to veraison (EL35) and mature berries (EL36) were compared. Across the three varieties, 9,8% (2255) probesets corresponding to 1915 unigenes were robustly differentially expressed at EL 36 compared to EL 35. Eleven functional categories were represented in this differential gene set. Information on gene expression related to primary and secondary metabolism was verified by RT-qPCR analysis of selected candidate genes at four developmental stages (EL32, EL35, EL36 and EL 38). Gene expression data were integrated with metabolic profiling data from GC-EI-TOF/MS and headspace GC-EI-MS platforms. Conclusions/Significance: Putative molecular and metabolic markers of grape pre-ripening and ripening related to primary and secondary metabolism were established and revealed a substantial developmental reprogramming of cellular metabolism. Altogether the results provide valuable new information on the main metabolic events leading to grape ripening. Furthermore, we provide first hints about how the development of a cultivar specific aroma is controlled at transcriptional level.	[Agudelo-Romero, Patricia; Pais, Maria Salome; Fortes, Ana Margarida] Univ Lisbon, Fac Ciencias Lisboa, Ctr Biodivers Funct & Integrat Genom, P-1699 Lisbon, Portugal; [Erban, Alexander; Kopka, Joachim] Max Planck Inst Mol Pflanzenphysiol, D-14476 Golm, Germany; [Sousa, Lisete] Fac Ciencias Lisboa, Dept Stat & Operat Res, Ctr Estat & Aplicacoes UL, Lisbon, Portugal	Universidade de Lisboa; Max Planck Society; Universidade de Lisboa	Fortes, AM (corresponding author), Univ Lisbon, Fac Ciencias Lisboa, Ctr Biodivers Funct & Integrat Genom, P-1699 Lisbon, Portugal.	amfortes@fc.ul.pt	Fortes, Ana Margarida/F-4148-2012; Agudelo-Romero, Patricia/K-4625-2015; Sousa, Lisete M R/M-1842-2015	Agudelo-Romero, Patricia/0000-0002-3703-4111; Sousa, Lisete M R/0000-0002-2114-720X; Fortes, Ana Margarida/0000-0001-7552-0164; Kopka, Joachim/0000-0001-9675-4883; Pais, Maria Salome/0000-0002-3068-5851	Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/72070/2010]; Auxiliar Researcher contract Cie project [PTDC/AGR-GPL/100919/2008]; ERA-PG under the project Genomic Research-Assisted breeding for Sustainable Production of Quality GRAPEs and WINE [FCT ERA-PG/0004/2006]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Auxiliar Researcher contract Cie project; ERA-PG under the project Genomic Research-Assisted breeding for Sustainable Production of Quality GRAPEs and WINE	Funding was provided by the Portuguese Foundation for Science and Technology (FCT) through a Post-doctoral fellowship to Patricia Agudelo-Romero (SFRH/BPD/72070/2010) and Auxiliar Researcher contract Cie project PTDC/AGR-GPL/100919/2008, and ERA-PG (FCT ERA-PG/0004/2006) under the project Genomic Research-Assisted breeding for Sustainable Production of Quality GRAPEs and WINE (http://urgi.versailles.inra.fr/projects/GRASP/). This work was developed within the BioFig Center with reference PEst-OE/BIA/UI4046/2011 with participation of CEAUL (PEst-OE/MAT/UI0006/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2002, J EXP BOT, V53, P2073, DOI 10.1093/jxb/erf026; Ali K, 2011, FOOD CHEM, V124, P1760, DOI 10.1016/j.foodchem.2010.08.015; Ali K, 2010, PHYTOCHEM REV, V9, P357, DOI 10.1007/s11101-009-9158-0; Ali MB, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-7; Allwood JW, 2009, METABOLOMICS, V5, P479, DOI 10.1007/s11306-009-0169-z; Arisz SA, 2009, BBA-MOL CELL BIOL L, V1791, P869, DOI 10.1016/j.bbalip.2009.04.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIANCHI G, 1992, PHYTOCHEMISTRY, V31, P3503, DOI 10.1016/0031-9422(92)83716-C; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Byfield GE, 2007, CROP SCI, V47, P1698, DOI 10.2135/cropsci2006.04.0213; CAMARA B, 1981, PLANTA, V151, P359, DOI 10.1007/BF00393291; CHOW ETS, 1978, J FOOD SCI, V43, P1424, DOI 10.1111/j.1365-2621.1978.tb02510.x; Commenil P, 1997, J EXP BOT, V48, P1599, DOI 10.1093/jexbot/48.313.1599; Conde C, 2008, J PLANT PHYSIOL, V165, P1545, DOI 10.1016/j.jplph.2008.04.018; Coombe B. G., 2000, Australian Journal of Grape and Wine Research, V6, P131, DOI 10.1111/j.1755-0238.2000.tb00171.x; Coombe B. G., 1995, Australian Journal of Grape and Wine Research, V1, P104, DOI 10.1111/j.1755-0238.1995.tb00086.x; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Croft KD, 1998, ANN NY ACAD SCI, V854, P435, DOI 10.1111/j.1749-6632.1998.tb09922.x; D'Auria JC, 2002, PLANT PHYSIOL, V130, P466, DOI 10.1104/pp.006460; Davies C, 1999, PLANT SCI, V147, P93, DOI 10.1016/S0168-9452(99)00059-X; de Pinho PG, 2007, J FOOD SCI, V72, pS396, DOI 10.1111/j.1750-3841.2007.00405.x; Delrot S, 2013, J EXP BOT; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Downey MO, 2003, AUST J GRAPE WINE R, V9, P110, DOI 10.1111/j.1755-0238.2003.tb00261.x; Dubourdieu D, 2006, AM J ENOL VITICULT, V57, P81; Effmert U, 2005, PHYTOCHEMISTRY, V66, P1211, DOI 10.1016/j.phytochem.2005.03.031; Erban Alexander, 2007, V358, P19, DOI 10.1007/978-1-59745-244-1_2; Flamini R, 2005, J MASS SPECTROM, V40, P705, DOI 10.1002/jms.887; Fortes AM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-149; Franco M, 2004, J AGR FOOD CHEM, V52, P3905, DOI 10.1021/jf0354949; Franks TK, 2005, PHYTOCHEMISTRY, V66, P165, DOI 10.1016/j.phytochem.2004.11.017; Gao HY, 2008, J INTEGR PLANT BIOL, V50, P991, DOI 10.1111/j.1744-7909.2008.00685.x; Grant TN, 2009, CAN J PLANT SCI, V89, P961, DOI 10.4141/CJPS08188; Grimplet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008365; GRNCAREVIC M, 1971, AM J ENOL VITICULT, V22, P80; Harbertson JF, 2002, AM J ENOL VITICULT, V53, P54; Havkin-Frenkel D., 1999, PLANT CELL TISSUE CU, P35; HELSPER JP, 1982, PLANT PHYSIOL, V69, P1365, DOI 10.1104/pp.69.6.1365; Hummel J, 2010, METABOLOMICS, V6, P322, DOI 10.1007/s11306-010-0198-7; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson R.S., 2000, WINE SCI PRINCIPLES, P375, DOI [10.1016/B978-0-12-373646-8.50004-4, DOI 10.1016/B978-0-12-373646-8.50004-4]; Janssen BJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-16; Jones MG, 2004, J EXP BOT, V55, P1903, DOI 10.1093/jxb/erh138; Martinez-Esteso MJ, 2011, J EXP BOT, V62, P2521, DOI 10.1093/jxb/erq434; Kalua CM, 2009, J AGR FOOD CHEM, V57, P3818, DOI 10.1021/jf803471n; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Katiyar SK, 2001, CARCINOGENESIS, V22, P287, DOI 10.1093/carcin/22.2.287; Kita M, 2000, FEBS LETT, V469, P173, DOI 10.1016/S0014-5793(00)01275-8; Kobayashi H, 2011, J EXP BOT, V62, P1325, DOI 10.1093/jxb/erq376; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Korthout H, 2012, METABOLOMICS; Kotseridis Y, 2000, J AGR FOOD CHEM, V48, P400, DOI 10.1021/jf990565i; Liu ZJ, 2009, RUSS J PLANT PHYSL+, V56, P709, DOI 10.1134/S1021443709050185; Livio T, 2007, CARYOLOGIA, V60, P156, DOI 10.1080/00087114.2007.10589565; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; LONGHURST TJ, 1990, J FOOD BIOCHEM, V14, P421, DOI 10.1111/j.1745-4514.1990.tb00804.x; Lucker J, 2004, PHYTOCHEMISTRY, V65, P2649, DOI 10.1016/j.phytochem.2004.08.017; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Mellema S, 2002, PLANT J, V30, P329, DOI 10.1046/j.1365-313X.2002.01293.x; Millan C, 1992, J WINE RES, V3; Negri AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-378; Okuda T, 1999, AM J ENOL VITICULT, V50, P264; Oliveira C, 2003, J AGR FOOD CHEM, V51, P5967, DOI 10.1021/jf034275k; Ong PKC, 1998, J AGR FOOD CHEM, V46, P611, DOI 10.1021/jf970665t; Pais MS, 2013, PLANT PHYSL IN PRESS; Pereira DM, 2009, MOLECULES, V14, P2202, DOI 10.3390/molecules14062202; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Pilati S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-428; Pripis-Nicolau L, 2000, J AGR FOOD CHEM, V48, P3761, DOI 10.1021/jf991024w; Saber M, 2010, J CHEM SOC PAKISTAN, V32, P662; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Strehmel N, 2008, J CHROMATOGR B, V871, P182, DOI 10.1016/j.jchromb.2008.04.042; Sweetman C, 2009, PHYTOCHEMISTRY, V70, P1329, DOI 10.1016/j.phytochem.2009.08.006; Symons GM, 2006, PLANT PHYSIOL, V140, P150, DOI 10.1104/pp.105.070706; Takashima Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2308, DOI 10.1271/bbb.70215; Terrier N, 2005, PLANTA, V222, P832, DOI 10.1007/s00425-005-0017-y; Toffali K, 2011, METABOLOMICS, V7, P424, DOI 10.1007/s11306-010-0259-y; van Damme M, 2009, PLANT CELL, V21, P2179, DOI 10.1105/tpc.109.066811; Vetter J, 2000, TOXICON, V38, P11, DOI 10.1016/S0041-0101(99)00128-2; Vignault C, 2005, J EXP BOT, V56, P1409, DOI 10.1093/jxb/eri142; Vogel JT, 2008, J BIOL CHEM, V283, P11364, DOI 10.1074/jbc.M710106200; Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3; Wang J, 2005, PLANT J, V44, P606, DOI 10.1111/j.1365-313X.2005.02552.x; Whitaker BD, 2008, J AGR FOOD CHEM, V56, P3828, DOI 10.1021/jf7037983; WILLS RBH, 1984, J AGR FOOD CHEM, V32, P836, DOI 10.1021/jf00124a035; Yadav M, 2009, J MED FOOD, V12, P473, DOI 10.1089/jmf.2008.0096; Zamboni A, 2008, J EXP BOT, V59, P4145, DOI 10.1093/jxb/ern256; Zamboni A, 2010, PLANT PHYSIOL, V154, P1439, DOI 10.1104/pp.110.160275; Zhang JJ, 2011, J EXP BOT, V62, P1103, DOI 10.1093/jxb/erq343; Zhang XY, 2006, PLANT PHYSIOL, V142, P220, DOI 10.1104/pp.106.081430; Zheng Hong-Qiang, 2003, Ai Zheng, V22, P363	93	46	49	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60422	10.1371/journal.pone.0060422	http://dx.doi.org/10.1371/journal.pone.0060422			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565246	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300116
J	Fukuyama, Y; Tokuhara, D; Sekine, S; Aso, K; Kataoka, K; Davydova, J; Yamamoto, M; Gilbert, RS; Tokuhara, Y; Fujihashi, K; Kunisawa, J; Yuki, Y; Kiyono, H; McGhee, JR; Fujihashi, K				Fukuyama, Yoshiko; Tokuhara, Daisuke; Sekine, Shinichi; Aso, Kazuyoshi; Kataoka, Kosuke; Davydova, Julia; Yamamoto, Masato; Gilbert, Rebekah S.; Tokuhara, Yuka; Fujihashi, Keiko; Kunisawa, Jun; Yuki, Yoshikazu; Kiyono, Hiroshi; McGhee, Jerry R.; Fujihashi, Kohtaro			Potential Roles of CCR5(+) CCR6(+) Dendritic Cells Induced by Nasal Ovalbumin plus Flt3 Ligand Expressing Adenovirus for Mucosal IgA Responses	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR6; MESENTERIC LYMPH-NODES; T-CELLS; LYMPHORETICULAR TISSUE; IMMUNE-RESPONSE; PEYERS-PATCHES; GUT; MIGRATION; MICE; LOCALIZATION	We assessed the role of CCR5(+)/CCR6(+)/CD11b(+)/CD11c(+) dendritic cells (DCs) for induction of ovalbumin (OVA)-specific antibody (Ab) responses following mucosal immunization. Mice given nasal OVA plus an adenovirus expressing Flt3 ligand (Ad-FL) showed early expansion of CCR5(+)/CCR6(+)/CD11b(+)/CD11c(+) DCs in nasopharyngeal-associated lymphoid tissue (NALT) and cervical lymph nodes (CLNs). Subsequently, this DC subset became resident in submandibular glands (SMGs) and nasal passages (NPs) in response to high levels of CCR-ligands produced in these tissues. CD11b(+)/CD11c(+) DCs were markedly decreased in both CCR5(-/-) and CCR6(-/-) mice. Chimera mice reconstituted with bone marrow cells from CD11c-diphtheria toxin receptor (CD11c-DTR) and CCR5(-/-) or CD11c-DTR and CCR6(-/-) mice given nasal OVA plus Ad-FL had elevated plasma IgG, but reduced IgA as well as low anti-OVA secretory IgA (SIgA) Ab responses in saliva and nasal washes. These results suggest that CCR5(+) CCR6(+) DCs play an important role in the induction of Ag-specific SIgA Ab responses.	[Fukuyama, Yoshiko; Tokuhara, Daisuke; Aso, Kazuyoshi; Gilbert, Rebekah S.; Tokuhara, Yuka; Fujihashi, Keiko; McGhee, Jerry R.; Fujihashi, Kohtaro] Univ Alabama Birmingham, Dept Pediat Dent, Immunobiol Vaccine Ctr, Inst Oral Hlth Res, Birmingham, AL USA; [Fukuyama, Yoshiko; Tokuhara, Daisuke; Aso, Kazuyoshi; Gilbert, Rebekah S.; Tokuhara, Yuka; Fujihashi, Keiko; McGhee, Jerry R.; Fujihashi, Kohtaro] Univ Alabama Birmingham, Dept Microbiol, Immunobiol Vaccine Ctr, Inst Oral Hlth Res, Birmingham, AL 35294 USA; [Fukuyama, Yoshiko; Tokuhara, Daisuke; Kunisawa, Jun; Yuki, Yoshikazu; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Tokyo, Japan; [Sekine, Shinichi] Osaka Univ, Dept Prevent Dent, Grad Sch Dent, Osaka, Japan; [Kataoka, Kosuke] Univ Tokushima, Dept Prevent Dent, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Davydova, Julia; Yamamoto, Masato] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Kunisawa, Jun] Natl Inst Biomed Innovat, Lab Vaccine Mat, Osaka, Japan	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Tokyo; Osaka University; Tokushima University; University of Minnesota System; University of Minnesota Twin Cities; National Institute of Health Sciences - Japan	Fujihashi, K (corresponding author), Univ Alabama Birmingham, Dept Pediat Dent, Immunobiol Vaccine Ctr, Inst Oral Hlth Res, Birmingham, AL USA.	kohtarof@uab.edu	Kiyono, Hiroshi/AAC-6735-2022; KATAOKA, KOSUKE/AAD-7003-2022; Tokuhara, Daisuke/AAY-2554-2021; Sekine, Shinichi/AGT-1514-2022	Sekine, Shinichi/0000-0003-4160-5578; Tokuhara, Daisuke/0000-0002-2441-5062	National Institutes of Health [DE012242, AG025873]; Japan Society of the Promotion of Science; Global Center of Excellence Program "Center of Education and Research for the Advanced Genome - Based Medicine - For personalized medicine, the control of worldwide infectious diseases - "MEXT" Japan; Japan Foundation for Pediatric Research; Houjinkai fellowship award of the Department of Pediatrics at Osaka City University Graduate School of Medicine; Mochida Memorial Foundation for Medical and Pharmaceutical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012242, R29DE012242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence Program "Center of Education and Research for the Advanced Genome - Based Medicine - For personalized medicine, the control of worldwide infectious diseases - "MEXT" Japan; Japan Foundation for Pediatric Research; Houjinkai fellowship award of the Department of Pediatrics at Osaka City University Graduate School of Medicine; Mochida Memorial Foundation for Medical and Pharmaceutical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by National Institutes of Health grants DE012242 and AG025873 (http://www.nih.gov/) as well as the Japan Society of the Promotion of Science program entitled "Young Researcher Overseas Visits Program for Vitalizing Brain Circulation"(http://www.jsps.go.jp/english/e-zunoujunkan2/index.html), Global Center of Excellence Program "Center of Education and Research for the Advanced Genome - Based Medicine - For personalized medicine, the control of worldwide infectious diseases - "MEXT" Japan (http://www.jsps.go.jp/english/e-globalcoe/index.html). In addition, a part of studies is supported by the Japan Foundation for Pediatric Research and Houjinkai fellowship award of the Department of Pediatrics at Osaka City University Graduate School of Medicine and The Mochida Memorial Foundation for Medical and Pharmaceutical Research (http://www.mochida.co.jp/zaidan/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Brandtzaeg P, 2011, AM J RESP CRIT CARE, V183, P1595, DOI 10.1164/rccm.201011-1783OC; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Caux C, 2000, SPRINGER SEMIN IMMUN, V22, P345, DOI 10.1007/s002810000053; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chiu BC, 2004, AM J PATHOL, V165, P1199, DOI 10.1016/S0002-9440(10)63380-9; Coates PTH, 2004, KIDNEY INT, V66, P1907, DOI 10.1111/j.1523-1755.2004.00965.x; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Fujihashi K, 2001, P NATL ACAD SCI USA, V98, P3310, DOI 10.1073/pnas.061412598; Fukuiwa T, 2008, VACCINE, V26, P4849, DOI 10.1016/j.vaccine.2008.06.091; Fukuyama Y, 2011, J IMMUNOL, V186, P2454, DOI 10.4049/jimmunol.1002837; Fukuyama Y, 2010, J IMMUNOL, V185, P1755, DOI 10.4049/jimmunol.1000831; Hagiwara Y, 2003, J IMMUNOL, V170, P1754, DOI 10.4049/jimmunol.170.4.1754; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jahnsen FL, 2006, J IMMUNOL, V177, P5861, DOI 10.4049/jimmunol.177.9.5861; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Kataoka K, 2004, J IMMUNOL, V172, P3612, DOI 10.4049/jimmunol.172.6.3612; Kataoka K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025396; Kataoka K, 2011, INFECT IMMUN, V79, P2819, DOI 10.1128/IAI.01360-10; Kim DY, 2011, J IMMUNOL, V186, P4253, DOI 10.4049/jimmunol.0903794; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kobayashi H, 2004, J LEUKOCYTE BIOL, V75, P434, DOI 10.1189/jlb.0603250; Kucharzik T, 2002, EUR J IMMUNOL, V32, P104, DOI 10.1002/1521-4141(200201)32:1<104::AID-IMMU104>3.0.CO;2-C; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Lillard JW, 2003, BLOOD, V101, P807, DOI 10.1182/blood-2002-07-2305; Lukacs NW, 2001, J EXP MED, V194, P551, DOI 10.1084/jem.194.4.551; Martinoli C, 2007, IMMUNITY, V27, P975, DOI 10.1016/j.immuni.2007.10.011; McGhee JR, 2007, TRENDS IMMUNOL, V28, P150, DOI 10.1016/j.it.2007.02.001; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Sekine S, 2008, J IMMUNOL, V180, P8126, DOI 10.4049/jimmunol.180.12.8126; Song JH, 2009, J IMMUNOL, V182, P6851, DOI 10.4049/jimmunol.0803568; Sozzani S, 1997, J IMMUNOL, V159, P1993; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Teitelbaum R, 1999, IMMUNITY, V10, P641, DOI 10.1016/S1074-7613(00)80063-1; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Wen HT, 2007, EUR J IMMUNOL, V37, P2487, DOI 10.1002/eji.200737370; Williams IR, 2004, IMMUNOL RES, V29, P283, DOI 10.1385/IR:29:1-3:283; Zhao XY, 2003, J IMMUNOL, V171, P2797, DOI 10.4049/jimmunol.171.6.2797	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60453	10.1371/journal.pone.0060453	http://dx.doi.org/10.1371/journal.pone.0060453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565250	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300120
J	Geuze, J; van Gerven, MAJ; Farquhar, J; Desain, P				Geuze, Jeroen; van Gerven, Marcel A. J.; Farquhar, Jason; Desain, Peter			Detecting Semantic Priming at the Single-Trial Level	PLOS ONE			English	Article							WORDS; N400; POTENTIALS	Semantic priming is usually studied by examining ERPs over many trials and subjects. This article aims at detecting semantic priming at the single-trial level. By using machine learning techniques it is possible to analyse and classify short traces of brain activity, which could, for example, be used to build a Brain Computer Interface (BCI). This article describes an experiment where subjects were presented with word pairs and asked to decide whether the words were related or not. A classifier was trained to determine whether the subjects judged words as related or unrelated based on one second of EEG data. The results show that the classifier accuracy when training per subject varies between 54% and 67%, and is significantly above chance level for all subjects (N = 12) and the accuracy when training over subjects varies between 51% and 63%, and is significantly above chance level for 11 subjects, pointing to a general effect.	[Geuze, Jeroen; van Gerven, Marcel A. J.; Farquhar, Jason; Desain, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Geuze, J (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	j.geuze@donders.ru.nl	van Gerven, Marcel A. J./D-7800-2012	van Gerven, Marcel A. J./0000-0002-2206-9098	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	This research was funded by the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen R. H, 1995, CELEX LEXICAL DATABA; BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; Bishop C. M, 2006, PATTERN RECOGNITION; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROWN C, 1993, J COGNITIVE NEUROSCI, V5, P34, DOI 10.1162/jocn.1993.5.1.34; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Dal Seno Bernardo, 2010, Computational Intelligence & Neuroscience, DOI 10.1155/2010/307254; De Deyne S, 2008, BEHAV RES METHODS, V40, P198, DOI 10.3758/BRM.40.1.198; Farquhar JRD, 2012, NEUROINFORMATICS, P1; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Ferrez PW, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P1413; Field A., 2012, DISCOVERING STAT USI; Geuze J, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/1/016009; Hohne J, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045003; Kiefer M, 2002, COGNITIVE BRAIN RES, V13, P27, DOI 10.1016/S0926-6410(01)00085-4; Kleiner M, 2007, PERCEPTION, V36, P14; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KUTAS M, 1993, LANG COGNITIVE PROC, V8, P533, DOI 10.1080/01690969308407587; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M., 1988, ADV PSYCHOPHYSIOLOGY, VVol. 3, P139; Lau E, 2009, BRAIN LANG, V111, P161, DOI 10.1016/j.bandl.2009.08.007; Li K, 2012, INT J E-HEALTH MED C, V3, P31, DOI 10.4018/jehmc.2012100103; Li K, 2009, IEEE ENG MED BIO, P4035, DOI 10.1109/IEMBS.2009.5333745; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RATCLIFF R, 1988, PSYCHOL REV, V95, P385, DOI 10.1037/0033-295X.95.3.385; RUGG MD, 1985, PSYCHOPHYSIOLOGY, V22, P642, DOI 10.1111/j.1469-8986.1985.tb01661.x; Schreuder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009813; Small SI, 1988, LEXICAL AMBIGUITY RE; Tzovara A, 2013, BRAIN, V136, P81, DOI 10.1093/brain/aws264; van Casteren M, 2007, BEHAV RES METHODS, V39, P973, DOI 10.3758/BF03192992; van der Waal M, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045002; van Vliet M, 2010, LECT NOTES ARTIF INT, V6334, P180, DOI 10.1007/978-3-642-15314-3_17; Wolpaw J R, 1998, IEEE Trans Rehabil Eng, V6, P326, DOI 10.1109/86.712231; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	37	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60377	10.1371/journal.pone.0060377	http://dx.doi.org/10.1371/journal.pone.0060377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565237	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300107
J	Mistry, BV; Zhao, YQ; Chang, TC; Yasue, H; Chiba, M; Oatley, J; Diaz, F; Liu, WS				Mistry, Bhavesh V.; Zhao, Yaqi; Chang, Ti-Cheng; Yasue, Hiroshi; Chiba, Mitsuru; Oatley, Jon; Diaz, Francisco; Liu, Wan-Sheng			Differential Expression of PRAMEL1, a Cancer/Testis Antigen, during Spermatogenesis in the Mouse	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; CANCER-TESTIS ANTIGENS; ACROSOME BIOGENESIS; GENE-EXPRESSION; SPERM FLAGELLA; PROTEIN; BINDING; CELLS; IDENTIFICATION; GAMETOGENESIS	PRAME belongs to a group of cancer/testis antigens (CTAs) that are characterized by their restricted expression in normal gametogenic tissues and a variety of tumors. The PRAME family is one of the most amplified gene families in the mouse and other mammalian genomes. Members of the PRAME gene family encode leucine-rich repeat (LRR) proteins functioning as transcription regulators in cancer cells. However, the role of PRAME in normal gonads is unknown. The objective of this study is to characterize the temporal and spatial expression of the mouse Pramel1 gene, and to determine the cellular localization of the PRAMEL1 protein during the mouse spermatogenesis. Our results indicated that the mouse Pramel1 was expressed in testis only. The mRNA and protein expression level was low in the newborn testes, and gradually increased from 1- to 3-week-old testes, and then remained constant after three weeks of age. Immunofluorescent staining on testis sections with the mouse PRAMEL1 antibody revealed that PRAMEL1 was localized in the cytoplasm of spermatocytes and the acrosomal region of round, elongating and elongated spermatids. Further analyses on the testis squash preparation and spermatozoa at a subcellular level indicated that the protein localization patterns of PRAMEL1 were coordinated with morphological alterations during acrosome formation in spermatids, and were significantly different in connecting piece, middle piece and principal piece of the flagellum between testicular and epididymal spermatozoa. Collectively, our results suggest that PRAMEL1 may play a role in acrosome biogenesis and sperm motility.	[Mistry, Bhavesh V.; Zhao, Yaqi; Chang, Ti-Cheng; Oatley, Jon; Diaz, Francisco; Liu, Wan-Sheng] Penn State Univ, Dept Anim Sci, Coll Agr Sci, Ctr Reprod Biol & Hlth, University Pk, PA 16802 USA; [Yasue, Hiroshi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Chiba, Mitsuru] Hirosaki Univ, Grad Sch Hlth Sci, Dept Biomed Sci, Div Med Life Sci, Hirosaki, Aomori, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institute of Agrobiological Sciences - Japan; Hirosaki University	Liu, WS (corresponding author), Penn State Univ, Dept Anim Sci, Coll Agr Sci, Ctr Reprod Biol & Hlth, University Pk, PA 16802 USA.	wul12@psu.edu	Chang, Ti-Cheng/N-3252-2018; Chang, Ti-Cheng/HHS-7370-2022; Chiba, Mitsuru/F-4882-2013	Chiba, Mitsuru/0000-0002-4514-7124; Mistry, Bhavesh/0000-0002-4272-7713	USDA-NIFA [2010-65205-20362]; Pennsylvania State University	USDA-NIFA(United States Department of Agriculture (USDA)); Pennsylvania State University	This work was supported by USDA-NIFA (grant no. 2010-65205-20362) and start-up funds from the Pennsylvania State University to W-SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Haila A, 2000, ARCH BIOCHEM BIOPHYS, V379, P173, DOI 10.1006/abbi.2000.1880; Birtle Zoe, 2005, BMC Genomics, V6, P120, DOI 10.1186/1471-2164-6-120; Bouma GJ, 2007, GENE EXPR PATTERNS, V7, P113, DOI 10.1016/j.modgep.2006.05.011; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Buffone MG, 2008, INT J DEV BIOL, V52, P511, DOI 10.1387/ijdb.072532mb; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Ceulemans H, 2002, J BIOL CHEM, V277, P47331, DOI 10.1074/jbc.M206838200; Chang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016867; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Costessi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042822; Costessi A, 2011, EMBO J, V30, P3786, DOI 10.1038/emboj.2011.262; Desjardins C, 1993, CELL MOL BIOL TESTIS; Epping MT, 2008, BRIT J CANCER, V99, P398, DOI 10.1038/sj.bjc.6604494; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Fardilha M, 2011, MOL HUM REPROD, V17, P466, DOI 10.1093/molehr/gar004; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Ghafouri-Fard S, 2009, ARCH IRAN MED, V12, P395; HECHT NB, 1995, DEV GENET, V16, P95, DOI 10.1002/dvg.1020160202; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P279, DOI 10.1002/jemt.20787; Huang ZH, 2002, BIOL REPROD, V67, P1936, DOI 10.1095/biolreprod.102.004093; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Inaba K, 2003, ZOOL SCI, V20, P1043, DOI 10.2108/zsj.20.1043; Inaba K, 2011, MOL HUM REPROD, V17, P524, DOI 10.1093/molehr/gar034; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KONG M, 1995, BIOL REPROD, V53, P579, DOI 10.1095/biolreprod53.3.579; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Mathieu MG, 2009, J BUON, V14, pS97; Matsushita M, 2003, LEUKEMIA LYMPHOMA, V44, P439, DOI 10.1080/1042819021000035725; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Mirandola L, 2011, INT REV IMMUNOL, V30, P127, DOI 10.3109/08830185.2011.572504; Mishra S, 2003, BIOL REPROD, V69, P1572, DOI 10.1095/biolreprod.103.018739; Moreno RD, 2000, BIOL REPROD, V63, P89, DOI 10.1095/biolreprod63.1.89; Oberthuer A, 2004, CLIN CANCER RES, V10, P4307, DOI 10.1158/1078-0432.CCR-03-0813; Saburi S, 2001, J BIOL CHEM, V276, P49378, DOI 10.1074/jbc.M108584200; Satie AP, 2002, LAB INVEST, V82, P775, DOI 10.1097/01.LAB.0000017169.26718.5F; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; SOTOMAYOR RE, 1986, BIOL REPROD, V34, P171, DOI 10.1095/biolreprod34.1.171; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Wadelin F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-226; Wang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021767; Wang R, 2010, BIOL CELL, V102, P173, DOI 10.1042/BC20090091; Wang R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-9; Yang WX, 2003, BIOL REPROD, V69, P1719, DOI 10.1095/biolreprod.102.014878; Zendman AJW, 2003, J CELL PHYSIOL, V194, P272, DOI 10.1002/jcp.10215	53	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60611	10.1371/journal.pone.0060611	http://dx.doi.org/10.1371/journal.pone.0060611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565261	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300132
J	Salgado-Delgado, RC; Saderi, N; Basualdo, MD; Guerrero-Vargas, NN; Escobar, C; Buijs, RM				Salgado-Delgado, Roberto C.; Saderi, Nadia; del Carmen Basualdo, Maria; Guerrero-Vargas, Natali N.; Escobar, Carolina; Buijs, Ruud M.			Shift Work or Food Intake during the Rest Phase Promotes Metabolic Disruption and Desynchrony of Liver Genes in Male Rats	PLOS ONE			English	Article							CIRCADIAN CLOCK; NIGHT; EXPRESSION; LIGHT; COORDINATION; ASSOCIATION; OBESITY; HEALTH; BRAIN; MODEL	In the liver, clock genes are proposed to drive metabolic rhythms. These gene rhythms are driven by the suprachiasmatic nucleus (SCN) mainly by food intake and via autonomic and hormonal pathways. Forced activity during the normal rest phase, induces also food intake, thus neglecting the signals of the SCN, leading to conflicting time signals to target tissues of the SCN. The present study explored in a rodent model of night-work the influence of food during the normal sleep period on the synchrony of gene expression between clock genes and metabolic genes in the liver. Male Wistar rats were exposed to forced activity for 8 h either during the rest phase (day) or during the active phase (night) by using a slow rotating wheel. In this shift work model food intake shifts spontaneously to the forced activity period, therefore the influence of food alone without induced activity was tested in other groups of animals that were fed ad libitum, or fed during their rest or active phase. Rats forced to be active and/or eating during their rest phase, inverted their daily peak of Per1, Bmal1 and Clock and lost the rhythm of Per2 in the liver, moreover NAMPT and metabolic genes such as Ppar alpha lost their rhythm and thus their synchrony with clock genes. We conclude that shift work or food intake in the rest phase leads to desynchronization within the liver, characterized by misaligned temporal patterns of clock genes and metabolic genes. This may be the cause of the development of the metabolic syndrome and obesity in individuals engaged in shift work.	[Salgado-Delgado, Roberto C.; Saderi, Nadia; del Carmen Basualdo, Maria; Guerrero-Vargas, Natali N.; Buijs, Ruud M.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico; [Salgado-Delgado, Roberto C.; Saderi, Nadia] Univ Autonoma San Luis Potosi, Fac Ciencias, Dept Biol Celular, San Luis Potosi, Mexico; [Escobar, Carolina] Univ Nacl Autonoma Mexico, Fac Med, Dept Anat, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma de San Luis Potosi; Universidad Nacional Autonoma de Mexico	Buijs, RM (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico.	ruudbuijs@gmail.com	Buijs, Rudolf/AAD-5707-2020; Escobar, Carolina/AAX-2354-2020	Escobar, Carolina/0000-0002-2974-7875; Guerrero-Vargas, Natali N/0000-0002-6048-7047	CONACyT [M-79797 M-82462, B-183078]; DGAPA-PAPIIT-UNAM [IN-209711]; PROMEP [103.5/12/3953]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); PROMEP	Financial support was obtained by CONACyT, M-79797 M-82462, and B-183078; DGAPA-PAPIIT-UNAM IN-209711, and PROMEP 103.5/12/3953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Barclay JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037150; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Colak Y, 2011, MED SCI MONITOR, V17, pHY5, DOI 10.12659/MSM.881749; Colles SL, 2007, INT J OBESITY, V31, P1722, DOI 10.1038/sj.ijo.0803664; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Duguay D, 2009, CHRONOBIOL INT, V26, P1479, DOI 10.3109/07420520903497575; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Glad CAM, 2011, ENDOCRINOLOGY, V152, P869, DOI 10.1210/en.2010-0713; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Kreier F, 2002, J CLIN INVEST, V110, P1243, DOI 10.1172/JCI200215736; Kumar V, 2010, CELL, V142, P841, DOI 10.1016/j.cell.2010.08.037; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Marcheva B, 2009, J APPL PHYSIOL, V107, P1638, DOI 10.1152/japplphysiol.00698.2009; Mazzoccoli G, 2012, CHRONOBIOL INT, V29, P227, DOI 10.3109/07420528.2012.658127; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Poirier P, 2008, CAN J CARDIOL, V24, P13; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Salgado-Delgado R, 2008, NEUROSCIENCE, V154, P922, DOI 10.1016/j.neuroscience.2008.03.066; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Schernhammer ES, 2011, OCCUP ENVIRON MED, V68, P310, DOI 10.1136/oem.2010.058222; Schmutz I, 2012, MOL CELL ENDOCRINOL, V349, P38, DOI 10.1016/j.mce.2011.05.007; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; TAKAHASHI JS, 1992, SCIENCE, V258, P238, DOI 10.1126/science.1384127; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Wu T, 2010, PHYSIOL RES, V59, P581, DOI 10.33549/physiolres.931818; Wu T, 2008, GENE, V419, P27, DOI 10.1016/j.gene.2008.04.010; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhao I, 2012, J OCCUP ENVIRON MED, V54, P834, DOI 10.1097/JOM.0b013e31824e1058	47	106	110	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60052	10.1371/journal.pone.0060052	http://dx.doi.org/10.1371/journal.pone.0060052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565183	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300052
J	Leray, M; Agudelo, N; Mills, SC; Meyer, CP				Leray, Matthieu; Agudelo, Natalia; Mills, Suzanne C.; Meyer, Christopher P.			Effectiveness of Annealing Blocking Primers versus Restriction Enzymes for Characterization of Generalist Diets: Unexpected Prey Revealed in the Gut Contents of Two Coral Reef Fish Species	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SECONDARY PREDATION; ANTARCTIC KRILL; DNA-SEQUENCES; PCR; AMPLIFICATION; IDENTIFICATION; DIVERSITY; IDENTIFY; TRACKING	Characterization of predator-prey interactions is challenging as researchers have to rely on indirect methods that can be costly, biased and too imprecise to elucidate the complexity of food webs. DNA amplification and sequencing techniques of gut and fecal contents are promising approaches, but their success largely depends on the ability to amplify the taxonomic array of prey consumed and then match prey amplicons with reference sequences. When little a priori information on diet is available or a generalist predator is targeted, versatile primer sets (also referred to as universal or general primers) as opposed to group- or species-specific primer sets are the most powerful to unveil the full range of prey consumed. However, versatile primers are likely to preferentially amplify the predominant, less degraded predator DNA if no manipulation is performed to exclude this confounding DNA template. In this study we compare two approaches that eliminate the confounding predator template: restriction digestion and the use of annealing blocking primers. First, we use a preliminary DNA barcode library provided by the Moorea BIOCODE project to 1) evaluate the cutting frequency of commercially available restriction enzymes and 2) design predator specific annealing blocking primers. We then compare the performance of the two predator removal strategies for the detection of prey templates using two versatile primer sets from the gut contents of two generalist coral reef fish species sampled in Moorea. Our study demonstrates that blocking primers should be preferentially used over restriction digestion for predator DNA removal as they recover greater prey diversity. We also emphasize that a combination of versatile primers may be required to best represent the breadth of a generalist's diet.	[Leray, Matthieu; Mills, Suzanne C.] Univ Perpignan, CBETM, USR CRIOBE CNRS EPHE 3278, Lab Excellence Corail, F-66025 Perpignan, France; [Leray, Matthieu; Agudelo, Natalia; Meyer, Christopher P.] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA	Universite Perpignan Via Domitia; Smithsonian Institution; Smithsonian National Museum of Natural History	Leray, M (corresponding author), Univ Perpignan, CBETM, USR CRIOBE CNRS EPHE 3278, Lab Excellence Corail, F-66025 Perpignan, France.	leray.upmc@gmail.com	Mills, Suzanne/K-5538-2012	Mills, Suzanne/0000-0001-8948-3384; Meyer, Christopher/0000-0003-2501-7952; Leray, Matthieu/0000-0002-7327-1878	Gordon and Betty Moore Foundation; Smithsonian Institution Fellowship Program; France American Cultural Exchange program (FACE - puf)	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Smithsonian Institution Fellowship Program(Smithsonian InstitutionSmithsonian National Museum of Natural History); France American Cultural Exchange program (FACE - puf)	This work was funded by the Gordon and Betty Moore Foundation, Smithsonian Institution Fellowship Program and France American Cultural Exchange program (FACE - puf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admassu B, 2006, SOIL BIOL BIOCHEM, V38, P1308, DOI 10.1016/j.soilbio.2005.08.019; Altschul SF, 1997, NUCLEIC ACIDS RES, V12, P102; Bachet P, 2007, GUIDE POISSONS TAHIT; Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Braley M, 2010, MOL ECOL RESOUR, V10, P466, DOI 10.1111/j.1755-0998.2009.02767.x; Budarf AC, 2011, J FISH BIOL, V79, P112, DOI 10.1111/j.1095-8649.2011.02999.x; Carreon-Martinez L, 2010, MOL ECOL, V19, P25, DOI 10.1111/j.1365-294X.2009.04412.x; Check E, 2006, NATURE, V439, P378, DOI 10.1038/439378a; Clare EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/j.1365-294X.2011.05040.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Deagle BE, 2005, J HERED, V96, P417, DOI 10.1093/jhered/esi036; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Drummond A., 2011, GENEIOUS V5 5; Dunn MR, 2010, DEEP-SEA RES PT I, V57, P923, DOI 10.1016/j.dsr.2010.02.006; Dunshea G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005252; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GLYNN PW, 1987, SYMBIOSIS, V4, P301; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Harwood JD, 2007, MOL ECOL, V16, P4390, DOI 10.1111/j.1365-294X.2007.03482.x; Harwood JD, 2009, BIOL INVASIONS, V11, P895, DOI 10.1007/s10530-008-9302-6; Harwood JD, 2001, MOL ECOL, V10, P2049, DOI 10.1046/j.0962-1083.2001.01349.x; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoareau TB, 2010, MOL ECOL RESOUR, V10, P960, DOI 10.1111/j.1755-0998.2010.02848.x; Hoogendoorn M, 2001, MOL ECOL, V10, P2059, DOI 10.1046/j.1365-294X.2001.01316.x; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jarman SN, 2006, MOL ECOL NOTES, V6, P268, DOI 10.1111/j.1471-8286.2005.01172.x; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; Kane C, 2009, ENVIRON BIOL FISH, V84, P1, DOI 10.1007/s10641-008-9377-z; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leray M, 2012, CORAL REEFS, V31, P383, DOI 10.1007/s00338-011-0845-0; Machida RJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-438; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Nejstgaard JC, 2008, MAR BIOL, V153, P565, DOI 10.1007/s00227-007-0830-x; O'Rorke R, 2012, MOL ECOL RESOUR, V12, P5, DOI 10.1111/j.1755-0998.2011.03091.x; Odinetz MO, 1983, THESIS U PIERRE M CU; Passmore AJ, 2006, MAR BIOTECHNOL, V8, P686, DOI 10.1007/s10126-005-6088-8; PIERCE GJ, 1991, OCEANOGR MAR BIOL, V29, P409; Plaisance L, 2009, CORAL REEFS, V28, P977, DOI 10.1007/s00338-009-0543-3; Plaisance Laetitia, 2011, Diversity, V3, P581; Plaisance L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025026; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Randall J. E., 2005, REEF SHORE FISHES S; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Sheppard SK, 2005, MOL ECOL, V14, P4461, DOI 10.1111/j.1365-294X.2005.02742.x; Stewart HL, 2006, CORAL REEFS, V25, P609, DOI 10.1007/s00338-006-0132-7; Stier AC, 2010, CORAL REEFS, V29, P1019, DOI 10.1007/s00338-010-0663-9; Stier AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032079; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vestheim H, 2011, METHODS MOL BIOL, V687, P265, DOI 10.1007/978-1-60761-944-4_19; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; WAGNER A, 1994, SYST BIOL, V43, P250, DOI 10.2307/2413465; WU DY, 1991, DNA CELL BIOL, V10, P233, DOI 10.1089/dna.1991.10.233; Zaidi RH, 1999, MOL ECOL, V8, P2081, DOI 10.1046/j.1365-294x.1999.00823.x	69	48	50	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e58076	10.1371/journal.pone.0058076	http://dx.doi.org/10.1371/journal.pone.0058076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23579925	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000002
J	Matsuoka, K; Shitara, H; Taya, C; Kohno, K; Kikkawa, Y; Yonekawa, H				Matsuoka, Kunie; Shitara, Hiroshi; Taya, Choji; Kohno, Kenji; Kikkawa, Yoshiaki; Yonekawa, Hiromichi			Novel Basophil- or Eosinophil-Depleted Mouse Models for Functional Analyses of Allergic Inflammation	PLOS ONE			English	Article							MAST-CELLS; ANTIBODY 97A6; KEY ROLE; IN-VIVO; IGE; ROLES; ACTIVATION; EXPRESSION; RECEPTOR; MARKER	Basophils and eosinophils play important roles in various host defense mechanisms but also act as harmful effectors in allergic disorders. We generated novel basophil- and eosinophil-depletion mouse models by introducing the human diphtheria toxin (DT) receptor gene under the control of the mouse CD203c and the eosinophil peroxidase promoter, respectively, to study the critical roles of these cells in the immunological response. These mice exhibited selective depletion of the target cells upon DT administration. In the basophil-depletion model, DT administration attenuated a drop in body temperature in IgG-mediated systemic anaphylaxis in a dose-dependent manner and almost completely abolished the development of ear swelling in IgE-mediated chronic allergic inflammation (IgE-CAI), a typical skin swelling reaction with massive eosinophil infiltration. In contrast, in the eosinophil-depletion model, DT administration ameliorated the ear swelling in IgE-CAI whether DT was administered before, simultaneously, or after, antigen challenge, with significantly lower numbers of eosinophils infiltrating into the swelling site. These results confirm that basophils and eosinophils act as the initiator and the effector, respectively, in IgE-CAI. In addition, antibody array analysis suggested that eotaxin-2 is a principal chemokine that attracts proinflammatory cells, leading to chronic allergic inflammation. Thus, the two mouse models established in this study are potentially useful and powerful tools for studying the in vivo roles of basophils and eosinophils. The combination of basophil- and eosinophil-depletion mouse models provides a new approach to understanding the complicated mechanism of allergic inflammation in conditions such as atopic dermatitis and asthma.	[Matsuoka, Kunie; Kikkawa, Yoshiaki] Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Tokyo 113, Japan; [Shitara, Hiroshi; Taya, Choji; Yonekawa, Hiromichi] Tokyo Metropolitan Inst Med Sci, Lab Transgen Technol, Tokyo 113, Japan; [Kohno, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Nara Institute of Science & Technology	Matsuoka, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Bunkyo Ku, Tokyo 113, Japan.	matsuoka-kn@igakuken.or.jp	Kohno, Kenji/AAZ-6573-2020; Kikkawa, Yoshiaki/AAI-7229-2020	Kohno, Kenji/0000-0002-3503-6551; Kikkawa, Yoshiaki/0000-0001-8859-4998	JSPS KAKENHI [19500374]; Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by JSPS KAKENHI Grant Number 19500374 to KM and the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) to HY and KK, and Takeda Science Foundation research grant to HY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar K, 2007, CURR OPIN PULM MED, V13, P414, DOI 10.1097/MCP.0b013e328224b90b; BROWN SJ, 1982, J IMMUNOL, V129, P790; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Buhring HJ, 2004, INT ARCH ALLERGY IMM, V133, P317, DOI 10.1159/000077351; Buhring HJ, 2001, BLOOD, V97, P3303, DOI 10.1182/blood.V97.10.3303; Buhring HJ, 1999, BLOOD, V94, P2343; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Grimbaldeston MA, 2006, CURR OPIN IMMUNOL, V18, P751, DOI 10.1016/j.coi.2006.09.011; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Karasuyama H, 2011, ALLERGY, V66, P1133, DOI 10.1111/j.1398-9995.2011.02613.x; Kita H, 2011, IMMUNOL REV, V242, P161, DOI 10.1111/j.1600-065X.2011.01026.x; KITAMURA Y, 1978, BLOOD, V52, P447; Kojima T, 2007, J IMMUNOL, V179, P7093, DOI 10.4049/jimmunol.179.10.7093; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Martin LB, 1996, INT ARCH ALLERGY IMM, V109, P207, DOI 10.1159/000237239; Matsuwaki Y, 2009, J IMMUNOL, V183, P6708, DOI 10.4049/jimmunol.0901220; Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Oettgen HC, 1999, J CLIN INVEST, V104, P829, DOI 10.1172/JCI8205; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Prussin Calman, 2003, Journal of Allergy and Clinical Immunology, V111, pS486; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Sato S, 2010, INT ARCH ALLERGY IMM, V152, P54, DOI 10.1159/000312126; Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Shen T, 2008, INT IMMUNOL, V20, P1201, DOI 10.1093/intimm/dxn077; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; WERSHIL BK, 1992, J EXP MED, V175, P245, DOI 10.1084/jem.175.1.245; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656	39	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60958	10.1371/journal.pone.0060958	http://dx.doi.org/10.1371/journal.pone.0060958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577180	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000085
J	Selemidis, S; Seow, HJ; Broughton, BRS; Vinh, A; Bozinovski, S; Sobey, CG; Drummond, GR; Vlahos, R				Selemidis, Stavros; Seow, Huei Jiunn; Broughton, Brad R. S.; Vinh, Antony; Bozinovski, Steven; Sobey, Christopher G.; Drummond, Grant R.; Vlahos, Ross			Nox1 Oxidase Suppresses Influenza A Virus-Induced Lung Inflammation and Oxidative Stress	PLOS ONE			English	Article							CIGARETTE-SMOKE EXPOSURE; NITRIC-OXIDE; SUPEROXIDE-PRODUCTION; NADPH OXIDASES; PATHOGENESIS; DISEASE	Influenza A virus infection is an ongoing clinical problem and thus, there is an urgent need to understand the mechanisms that regulate the lung inflammation in order to unravel novel generic pharmacological strategies. Evidence indicates that the Nox2-containing NADPH oxidase enzyme promotes influenza A virus-induced lung oxidative stress, inflammation and dysfunction via ROS generation. In addition, lung epithelial and endothelial cells express the Nox1 isoform of NADPH oxidase, placing this enzyme at key sites to regulate influenza A virus-induced lung inflammation. The aim of this study was to investigate whether Nox1 oxidase regulates the inflammatory response and the oxidative stress to influenza infection in vivo in mice. Male WT and Nox1-deficient (Nox1(-/y)) mice were infected with the moderately pathogenic HkX-31 (H3N2, 1x10(4) PFU) influenza A virus for analysis of bodyweight, airways inflammation, oxidative stress, viral titre, lung histopathology, and cytokine/chemokine expression at 3 and 7 days post infection. HkX-31 virus infection of Nox1(-/y) mice resulted in significantly greater: loss of bodyweight (Day 3); BALF neutrophilia, peri-bronchial, peri-vascular and alveolar inflammation; Nox2-dependent inflammatory cell ROS production and peri-bronchial, epithelial and endothelial oxidative stress. The expression of pro-inflammatory cytokines including CCL2, CCL3, CXCL2, IL-1 beta, IL-6, GM-CSF and TNF-alpha was higher in Nox1(-/y) lungs compared to WT mice at Day 3, however, the expression of CCL2, CCL3, CXCL2, IFN-gamma and the anti-inflammatory cytokine IL-10 were lower in lungs of Nox1(-/y) mice vs. WT mice at Day 7. Lung viral titre, and airways infiltration of active CD8(+) and CD4(+) T lymphocytes, and of Tregs were similar between WT and Nox1(-/y) mice. In conclusion, Nox1 oxidase suppresses influenza A virus induced lung inflammation and oxidative stress in mice particularly at the early phases of the infection. Nox1 and Nox2 oxidases appear to have opposing roles in the regulation of inflammation caused by influenza A viruses.	[Selemidis, Stavros; Broughton, Brad R. S.; Vinh, Antony; Sobey, Christopher G.; Drummond, Grant R.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; [Seow, Huei Jiunn; Bozinovski, Steven; Vlahos, Ross] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia	Monash University; University of Melbourne	Selemidis, S (corresponding author), Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia.	stavros.selemidis@monash.edu; rossv@unimelb.edu.au	Vlahos, Ross/AAM-3837-2020; Sobey, Christopher G/A-2786-2008; Vinh, Antony/I-1563-2014	Vlahos, Ross/0000-0001-8443-7071; Sobey, Christopher G/0000-0001-6525-9097; /0000-0001-8844-974X; Drummond, Grant/0000-0001-8556-9738; Seow, Huei/0000-0002-4790-4811; Vinh, Antony/0000-0001-8367-6134; Bozinovski, Steven/0000-0001-6533-8641; Selemidis, Stavros/0000-0002-3989-7615	National Health and Medical Research Council of Australia (NHMRC) [606472, 1006017, 545942, 570861, 606488, 1010984, 509226]; Australian Research Council [FT120100876]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council of Australia (NHMRC; nhmrc.gov.au) for Fellowship and Project Grant Support (I.D. 606472, 1006017, 545942, 570861, 606488, 1010984 and 509226) and the Australian Research Council (arc.gov.au) for Fellowship support (I.D. FT120100876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Carnesecchi S, 2009, AM J RESP CRIT CARE, V180, P972, DOI 10.1164/rccm.200902-0296OC; Chen H, 2007, AM J PHYSIOL-ENDOC M, V293, pE1564, DOI 10.1152/ajpendo.00442.2007; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Harrison CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048326; Harrison CB, 2010, CLIN EXP PHARMACOL P, V37, P429, DOI 10.1111/j.1440-1681.2009.05317.x; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Malec V, 2010, FREE RADICAL BIO MED, V48, P1626, DOI 10.1016/j.freeradbiomed.2010.03.008; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Newall AT, 2007, EC REPORT COST INFLU, P1; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070; Peshavariya H, 2009, N-S ARCH PHARMACOL, V380, P193, DOI 10.1007/s00210-009-0413-0; Prause O, 2009, PULM PHARMACOL THER, V22, P199, DOI 10.1016/j.pupt.2008.12.005; Selemidis S, 2007, CARDIOVASC RES, V75, P349, DOI 10.1016/j.cardiores.2007.03.030; Selemidis S, 2008, PHARMACOL THERAPEUT, V120, P254, DOI 10.1016/j.pharmthera.2008.08.005; Snelgrove RJ, 2006, EUR J IMMUNOL, V36, P1364, DOI 10.1002/eji.200635977; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; TANNOCK GA, 1984, INFECT IMMUN, V43, P457, DOI 10.1128/IAI.43.2.457-462.1984; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Vlahos R, 2012, TRENDS PHARMACOL SCI, V33, P3, DOI 10.1016/j.tips.2011.09.001; Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; Yatmaz S, 2012, AM J RESP CELL MOL B	35	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60792	10.1371/journal.pone.0060792	http://dx.doi.org/10.1371/journal.pone.0060792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577160	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000071
J	Srivastava, A; Mishra, A; Singh, R; Rai, R; Srivastava, N; Mittal, B				Srivastava, Anshika; Mishra, Avshesh; Singh, Rajan; Rai, Rajani; Srivastava, Neena; Mittal, Balraj			Multi-Analytic Approach Elucidates Significant Role of Hormonal and Hepatocanalicular Transporter Genetic Variants in Gallstone Disease in North Indian Population	PLOS ONE			English	Article							BILIARY-TRACT CANCERS; TRP64ARG POLYMORPHISM; GALLBLADDER-DISEASE; ESTROGEN-RECEPTORS; RISK; CHOLESTEROL; ABCG8; ASSOCIATION; PREVALENCE; SUSCEPTIBILITY	Objective: Cholesterol gallstone disease (CGD) is a multifactorial and multistep disease. Apart from female gender and increasing age being the documented non-modifiable risk factor for gallstones the pathobiological mechanisms underlying the phenotypic expression of CGD appear to be rather complex, and one or more variations in genes could play critical roles in the diverse pathways further progressing to cholesterol crystal formation. In the present study we performed genotyping score, Multifactor dimensionality reduction (MDR) and Classification and Regression Tree analysis (CART) to identify combinations of alleles among the hormonal, hepatocanalicular transporter and adipogenesis differentiation pathway genes in modifying the risk for CGD. Design: The present case-control study recruited total of 450 subjects, including 230 CGD patients and 220 controls. We analyzed common ESR1, ESR2, PGR, ADRB3, ADRA2A, ABCG8, SLCO1B1, PPAR gamma 2, and SREBP2 gene polymorphisms to find out combinations of genetic variants contributing to CGD risk, using multi-analytical approaches (G-score, MDR, and CART). Results: Single locus analysis by logistic regression showed association of ESR1 IVS1-397C>T (rs2234693), IVS1-351A>G (rs9340799) PGR ins/del (rs1042838) ADRB3-190 T>C (rs4994) ABCG8 D19H (rs11887534), SLCO1B1 Exon4 C>A (rs11045819) and SREBP2 1784G>C (rs2228314) with CGD risk. However, the MDR and CART analysis revealed ESR1 IVS1-397C>T (rs2234693) ADRB3-190 T>C (rs4994) and ABCG8 D19H (rs11887534) polymorphisms as the best polymorphic signature for discriminating between cases and controls. The overall odds ratio for the applied multi-analytical approaches ranged from 4.33 to 10.05 showing an incremental risk for cholesterol crystal formation. In conclusion, our muti-analytical approach suggests that, ESR1, ADRB3, in addition to ABCG8 genetic variants confer significant risk for cholesterol gallstone disease.	[Srivastava, Anshika; Mishra, Avshesh; Singh, Rajan; Rai, Rajani; Mittal, Balraj] SGPGIMS Lucknow, Dept Genet, Lucknow, Uttar Pradesh, India; [Srivastava, Neena] KGMU Lucknow, Dept Physiol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; King George's Medical University	Mittal, B (corresponding author), SGPGIMS Lucknow, Dept Genet, Lucknow, Uttar Pradesh, India.	bml_pgi@yahoo.com			ICMR; DBT; DST	ICMR(Indian Council of Medical Research (ICMR)); DBT(Department of Biotechnology (DBT) India); DST(Department of Science & Technology (India))	The study was supported by research and fellowship grants from ICMR, DBT and DST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro D, 2002, MOL CELL ENDOCRINOL, V193, P105, DOI 10.1016/S0303-7207(02)00103-X; Alvaro D, 2000, GASTROENTEROLOGY, V119, P1681, DOI 10.1053/gast.2000.20184; Anthony A, 1998, ALIMENT PHARM THERAP, V12, P519; BARBARA L, 1987, HEPATOLOGY, V7, P913, DOI 10.1002/hep.1840070520; Baturin A. K., 2012, Voprosy Pitaniya, V81, P23; Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101; Buch S, 2010, GASTROENTEROLOGY, V139, P1942, DOI 10.1053/j.gastro.2010.09.003; CHEN A, 1991, MED HYPOTHESES, V36, P259, DOI 10.1016/0306-9877(91)90145-O; de Haan HG, 2012, BLOOD, V120, P656, DOI 10.1182/blood-2011-12-397752; de Luis DA, 2012, EUR REV MED PHARMACO, V16, P610; DEPONTI F, 1995, PHARMACOLOGY, V51, P288, DOI 10.1159/000139338; DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Fumino S, 2005, J PEDIATR SURG, V40, P1716, DOI 10.1016/j.jpedsurg.2005.07.030; JENSEN KH, 1991, GASTROENTEROLOGY, V100, P790, DOI 10.1016/0016-5085(91)80027-7; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; Katsika D, 2010, J INTERN MED, V268, P279, DOI 10.1111/j.1365-2796.2010.02249.x; KHUROO MS, 1989, GUT, V30, P201, DOI 10.1136/gut.30.2.201; Kimura K, 2000, HORM METAB RES, V32, P91, DOI 10.1055/s-2007-978597; Krawczyk M, 2011, SEMIN LIVER DIS, V31, P157, DOI 10.1055/s-0031-1276645; Liu XL, 2010, ATHEROSCLEROSIS, V208, P421, DOI 10.1016/j.atherosclerosis.2009.08.011; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; MACDONALD FR, 1981, GASTROINTEST RADIOL, V6, P39, DOI 10.1007/BF01890219; McLean RC, 2011, CARDIOVASC DRUG THER, V25, P251, DOI 10.1007/s10557-011-6307-7; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Park SK, 2009, CARCINOGENESIS, V30, P606, DOI 10.1093/carcin/bgp024; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Siddapuram SP, 2010, J GASTROEN HEPATOL, V25, P1093, DOI 10.1111/j.1440-1746.2010.06309.x; Srivastava A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040162; Srivastava A, 2011, HEPATOL RES, V41, P71, DOI 10.1111/j.1872-034X.2010.00736.x; Srivastava A, 2010, J GASTROEN HEPATOL, V25, P1758, DOI 10.1111/j.1440-1746.2010.06349.x; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; Wang HH, 2008, FRONT BIOSCI-LANDMRK, V13, P401, DOI 10.2741/2688; Xu HL, 2011, CARCINOGENESIS, V32, P58, DOI 10.1093/carcin/bgq194; Yoshihara R, 2009, J ATHEROSCLER THROMB, V16, P250, DOI 10.5551/jat.E471	37	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e59173	10.1371/journal.pone.0059173	http://dx.doi.org/10.1371/journal.pone.0059173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577061	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000008
J	Debono, M; Chadarevian, R; Eastell, R; Ross, RJ; Newell-Price, J				Debono, Miguel; Chadarevian, Rita; Eastell, Richard; Ross, Richard J.; Newell-Price, John			Mifepristone Reduces Insulin Resistance in Patient Volunteers with Adrenal Incidentalomas That Secrete Low Levels of Cortisol: A Pilot Study	PLOS ONE			English	Article							SUBCLINICAL CUSHINGS-SYNDROME; CORONARY-HEART-DISEASE; INDUCED HYPERTENSION; DIAGNOSIS; GLUCOSE; RISK; HYPERCORTISOLISM; SENSITIVITY; MANAGEMENT; STATEMENT	Background: Incidental adrenal masses are commonly detected during imaging for other pathologies. 10% of the elderly population has an 'adrenal incidentaloma', up to 20% of these show low-grade autonomous cortisol secretion and 60% of patients with autonomous cortisol secretion have insulin resistance. Cortisol excess is known to cause insulin resistance, an independent cardiovascular risk marker, however in patients with adrenal incidentalomas it is unknown whether their insulin resistance is secondary to the excess cortisol and therefore potentially reversible. In a proof of concept study we examined the short-term effects of glucocorticoid receptor (GR) antagonism in patients with an adrenal incidentaloma to determine whether their insulin resistance was reversible. Methodology/Principal Findings: In a prospective open-label pilot study, six individuals with adrenal incidentalomas and autonomous cortisol secretion were treated with mifepristone (a GR antagonist) 200 mg twice daily and studied for 4 weeks on a Clinical Research Facility. Insulin resistance at four weeks was assessed by insulin resistance indices, lnHOMA-IR and lnMatsuda, and AUC insulin during a 2-hour glucose tolerance test. Biochemical evidence of GR blockade was shown in all individuals and across the group there was a significant reduction in insulin resistance: lnHOMA-IR (1.0vs0.6; p = 0.03), lnHOMA-% beta (4.8vs4.3; p = 0.03) and lnMatsuda (1.2vs1.6; p = 0.03). Five out of six individuals showed a reduction in insulin AUC >7237 pmol/l.min, and in two patients this showed a clinically significant cardiovascular benefit (as defined by the Helsinki heart study). Conclusions: Short-term GR antagonism is sufficient to reduce insulin resistance in some individuals with adrenal incidentalomas and mild cortisol excess. Further assessment is required to assess if the responses may be used to stratify therapy as adrenal incidentalomas may be a common remediable cause of increased cardiovascular risk.	[Debono, Miguel; Ross, Richard J.; Newell-Price, John] Univ Sheffield, Dept Human Metab, Acad Unit Diabet Endocrinol & Reprod, Sheffield, S Yorkshire, England; [Eastell, Richard] Univ Sheffield, Dept Human Metab, Acad Unit Bone Metab, Sheffield, S Yorkshire, England; [Chadarevian, Rita] HRA Pharma, Paris, France	University of Sheffield; University of Sheffield	Newell-Price, J (corresponding author), Univ Sheffield, Dept Human Metab, Acad Unit Diabet Endocrinol & Reprod, Sheffield, S Yorkshire, England.	j.newellprice@sheffield.ac.uk	Debono, Miguel/G-2148-2010; Debono, Miguel/AAF-5135-2021; Eastell, Richard/G-5851-2011	Debono, Miguel/0000-0002-1059-9702; Eastell, Richard/0000-0002-0323-3366	HRA Pharma [R/123263]; MRC [MR/K006312/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1] Funding Source: researchfish	HRA Pharma; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded in part by HRA Pharma grant number: R/123263. The funder had no role in data collection, analysis and decision to publish. The study design, and all ethical applications and associated administration, were conceived and written by JN-P and MD. The funder contributed to study design and the preparation of the manuscript.	Chiodini I, 2011, J CLIN ENDOCR METAB, V96, P1223, DOI 10.1210/jc.2010-2722; Chiodini I, 2010, J CLIN ENDOCR METAB, V95, P2736, DOI 10.1210/jc.2009-2387; Davani B, 2000, J BIOL CHEM, V275, P34841, DOI 10.1074/jbc.C000600200; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Di Dalmazi G, 2012, EUR J ENDOCRINOL, V166, P669, DOI 10.1530/EJE-11-1039; Elamin MB, 2008, J CLIN ENDOCR METAB, V93, P1553, DOI 10.1210/jc.2008-0139; Fleseriu M, 2012, J CLIN ENDOCRINOL ME; FRIEDMAN JE, 1993, J BIOL CHEM, V268, P12952; Gordon BA, 2011, DIABETES RES CLIN PR, V94, pE78, DOI 10.1016/j.diabres.2011.08.025; HEBERT PR, 1993, ARCH INTERN MED, V153, P578, DOI 10.1001/archinte.153.5.578; Heikinheimo O, 1997, CLIN PHARMACOKINET, V33, P7, DOI 10.2165/00003088-199733010-00002; KAWAI S, 1987, J PHARMACOL EXP THER, V241, P401; Kumai T, 2000, LIFE SCI, V67, P1993, DOI 10.1016/S0024-3205(00)00787-6; Lawes CMM, 2004, STROKE, V35, P1024, DOI 10.1161/01.STR.0000126208.14181.DD; Mansmann G, 2004, ENDOCR REV, V25, P309, DOI 10.1210/er.2002-0031; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Midorikawa S, 2001, CLIN ENDOCRINOL, V54, P797, DOI 10.1046/j.1365-2265.2001.01274.x; Morelli V, 2010, CLIN ENDOCRINOL, V73, P161, DOI 10.1111/j.1365-2265.2010.03794.x; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Newell-Price J, 1998, ENDOCR REV, V19, P647, DOI 10.1210/er.19.5.647; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; NOSADINI R, 1983, J CLIN ENDOCR METAB, V57, P529, DOI 10.1210/jcem-57-3-529; Page ST, 2012, J CLIN ENDOCR METAB, V97, P1598, DOI 10.1210/jc.2011-2813; Perogamvros I, 2009, J CHROMATOGR B, V877, P3771, DOI 10.1016/j.jchromb.2009.09.014; Pyorala M, 2000, ARTERIOSCL THROM VAS, V20, P538, DOI 10.1161/01.ATV.20.2.538; Qi D, 2007, AM J PHYSIOL-ENDOC M, V292, pE654, DOI 10.1152/ajpendo.00453.2006; Reimondo G, 2011, J ENDOCRINOL INVEST, V34, pE1, DOI [10.1007/BF03346701, 10.3275/7167]; Rossi R, 2000, J CLIN ENDOCR METAB, V85, P1440, DOI 10.1210/jc.85.4.1440; Stewart PM, 2010, J CLIN ENDOCR METAB, V95, P2618, DOI 10.1210/jc.2010-0633; Tauchmanova L, 2002, J CLIN ENDOCR METAB, V87, P4872, DOI 10.1210/jc.2001-011766; Terzolo M, 2011, EUR J ENDOCRINOL, V164, P851, DOI 10.1530/EJE-10-1147; Terzolo M, 2002, J CLIN ENDOCR METAB, V87, P998, DOI 10.1210/jc.87.3.998; Toniato A, 2009, ANN SURG, V249, P388, DOI 10.1097/SLA.0b013e31819a47d2; Tsagarakis S, 1998, CLIN ENDOCRINOL, V49, P165, DOI 10.1046/j.1365-2265.1998.00509.x; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; WHITWORTH JA, 1995, STEROIDS, V60, P76, DOI 10.1016/0039-128X(94)00033-9; Young WF, 2007, NEW ENGL J MED, V356, P601, DOI 10.1056/NEJMcp065470	39	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60984	10.1371/journal.pone.0060984	http://dx.doi.org/10.1371/journal.pone.0060984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577182	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000319109800117
J	Decherchi, S; Rocchia, W				Decherchi, Sergio; Rocchia, Walter			A general and Robust Ray-Casting-Based Algorithm for Triangulating Surfaces at the Nanoscale	PLOS ONE			English	Article							MOLECULAR-SURFACE; VISUALIZATION; SHAPE; EFFICIENT; AREAS	We present a general, robust, and efficient ray-casting-based approach to triangulating complex manifold surfaces arising in the nano-bioscience field. This feature is inserted in a more extended framework that: i) builds the molecular surface of nanometric systems according to several existing definitions, ii) can import external meshes, iii) performs accurate surface area estimation, iv) performs volume estimation, cavity detection, and conditional volume filling, and v) can color the points of a grid according to their locations with respect to the given surface. We implemented our methods in the publicly available NanoShaper software suite (www.electrostaticszone.eu). Robustness is achieved using the CGAL library and an ad hoc ray-casting technique. Our approach can deal with any manifold surface (including nonmolecular ones). Those explicitly treated here are the Connolly-Richards (SES), the Skin, and the Gaussian surfaces. Test results indicate that it is robust to rotation, scale, and atom displacement. This last aspect is evidenced by cavity detection of the highly symmetric structure of fullerene, which fails when attempted by MSMS and has problems in EDTSurf. In terms of timings, NanoShaper builds the Skin surface three times faster than the single threaded version in Lindow et al. on a 100,000 atoms protein and triangulates it at least ten times more rapidly than the Kruithof algorithm. NanoShaper was integrated with the DelPhi Poisson-Boltzmann equation solver. Its SES grid coloring outperformed the DelPhi counterpart. To test the viability of our method on large systems, we chose one of the biggest molecular structures in the Protein Data Bank, namely the 1VSZ entry, which corresponds to the human adenovirus (180,000 atoms after Hydrogen addition). We were able to triangulate the corresponding SES and Skin surfaces (6.2 and 7.0 million triangles, respectively, at a scale of 2 grids per angstrom) on a middle-range workstation.	[Decherchi, Sergio; Rocchia, Walter] Ist Italiano Tecnol, Dept Drug Discovery & Dev, Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Rocchia, W (corresponding author), Ist Italiano Tecnol, Dept Drug Discovery & Dev, Genoa, Italy.	walter.rocchia@iit.it	Rocchia, Walter/H-3784-2012	Rocchia, Walter/0000-0003-2480-7151; Decherchi, Sergio/0000-0001-8371-2270	NIGMS, NIH [1R01GM093937-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093937] Funding Source: NIH RePORTER	NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, NIH, grant number 1R01GM093937-01. The Authors also gratefully acknowledge the IIT platform "Computation''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiraju N, 1996, DISCRETE APPL MATH, V71, P5, DOI 10.1016/S0166-218X(96)00054-6; [Anonymous], 2012, PASSMARK CPU BENCHMA; Bates PW, 2008, J COMPUT CHEM, V29, P380, DOI 10.1002/jcc.20796; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blinn J. F., 1982, Computer Graphics, V16, DOI 10.1145/965145.801290; Boissonnat JD, 2002, COMP GEOM-THEOR APPL, V22, P5, DOI 10.1016/S0925-7721(01)00054-2; Can T, 2006, J MOL GRAPH MODEL, V25, P442, DOI 10.1016/j.jmgm.2006.02.012; Case DA, 2012, AMBER 12; Chavent M, 2008, J MOL GRAPH MODEL, V27, P209, DOI 10.1016/j.jmgm.2008.04.007; Chen WY, 2010, COMPUT AIDED DESIGN, V42, P267, DOI 10.1016/j.cad.2009.10.003; Cheng HL, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P399; Cheng HL, 2001, DISCRETE COMPUT GEOM, V25, P525, DOI 10.1007/s00454-001-0007-1; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; D'Agostino D, 2012, LECT NOTES COMPUT SC, V7203, P347, DOI 10.1007/978-3-642-31464-3_35; Decherchi S, 2013, COMMUN COMPUT PHYS, V13, P61, DOI 10.4208/cicp.050711.111111s; Edelsbrunner H, 1999, DISCRETE COMPUT GEOM, V21, P87, DOI 10.1007/PL00009412; GRANT JA, 1995, J PHYS CHEM-US, V99, P3503, DOI 10.1021/j100011a016; Hook D, 1990, USING STURM SEQUENCE, P416; Juba D, 2008, J MOL GRAPH MODEL, V27, P82, DOI 10.1016/j.jmgm.2008.03.001; Kim B, 2012, APPL MATH INFORM SCI, V6, P185; Krone M., 2011, 2011 IEEE Symposium on Biological Data Visualization, P17, DOI 10.1109/BioVis.2011.6094043; Krone M, 2011, COMPUT GRAPH FORUM, V30, P673, DOI 10.1111/j.1467-8659.2011.01916.x; Krone M., 2012, EUROVIS SHORT PAPERS, P67, DOI [10.2312/PE/EuroVisShort/, DOI 10.2312/PE/EUROVISSHORT/EUROVISSHORT2012/067-071, 10.2312/pe/eurovisshort/eurovisshort2012/067-071]; Krone M, 2009, IEEE T VIS COMPUT GR, V15, P1391, DOI 10.1109/TVCG.2009.157; Kruithof NGH, 2007, COMPUTATIONAL GEOMET, V36; Liang J, 1998, PROTEINS, V33, P1; Lindow N, 2010, COMPUT GRAPH FORUM, V29, P943, DOI 10.1111/j.1467-8659.2009.01693.x; Lorensen W. E., 1987, COMPUTER GRAPHICS, V21; Lu Q, 2003, J CHEM PHYS, V119, P11035, DOI 10.1063/1.1622376; Moller T., 1997, J GRAPH TOOL, V2, P21, DOI [DOI 10.1080/10867651.1997.10487468, 10.1080/10867651.1997.10487468]; Philippe M., 2010, PROC WORLD GEOTH C, P1, DOI DOI 10.1109/IPDPSW.2010.5470898; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; SRIDHARAN S, 1995, J COMPUT CHEM, V16, P1038, DOI 10.1002/jcc.540160810; Xu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008140; YOU T, 1995, J COMPUT CHEM, V16, P743, DOI 10.1002/jcc.540160610; Yu ZY, 2008, J MOL GRAPH MODEL, V26, P1370, DOI 10.1016/j.jmgm.2008.01.007	40	66	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59744	10.1371/journal.pone.0059744	http://dx.doi.org/10.1371/journal.pone.0059744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577073	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800017
J	Shen, H; Li, J; Zhang, JG; Xu, C; Jiang, Y; Wu, ZK; Zhao, FP; Liao, L; Chen, J; Lin, Y; Tian, Q; Papasian, CJ; Deng, HW				Shen, Hui; Li, Jian; Zhang, Jigang; Xu, Chao; Jiang, Yan; Wu, Zikai; Zhao, Fuping; Liao, Li; Chen, Jun; Lin, Yong; Tian, Qing; Papasian, Christopher J.; Deng, Hong-Wen			Comprehensive Characterization of Human Genome Variation by High Coverage Whole-Genome Sequencing of Forty Four Caucasians	PLOS ONE			English	Article							MASSIVELY-PARALLEL DNA; COPY NUMBER VARIATION; OF-FUNCTION VARIANTS; MISSING HERITABILITY	Whole genome sequencing studies are essential to obtain a comprehensive understanding of the vast pattern of human genomic variations. Here we report the results of a high-coverage whole genome sequencing study for 44 unrelated healthy Caucasian adults, each sequenced to over 50-fold coverage (averaging 65.8x). We identified approximately 11 million single nucleotide polymorphisms (SNPs), 2.8 million short insertions and deletions, and over 500,000 block substitutions. We showed that, although previous studies, including the 1000 Genomes Project Phase 1 study, have catalogued the vast majority of common SNPs, many of the low-frequency and rare variants remain undiscovered. For instance, approximately 1.4 million SNPs and 1.3 million short indels that we found were novel to both the dbSNP and the 1000 Genomes Project Phase 1 data sets, and the majority of which (similar to 96%) have a minor allele frequency less than 5%. On average, each individual genome carried similar to 3.3 million SNPs and similar to 492,000 indels/block substitutions, including approximately 179 variants that were predicted to cause loss of function of the gene products. Moreover, each individual genome carried an average of 44 such loss-of-function variants in a homozygous state, which would completely "knock out" the corresponding genes. Across all the 44 genomes, a total of 182 genes were "knocked-out" in at least one individual genome, among which 46 genes were "knocked out" in over 30% of our samples, suggesting that a number of genes are commonly "knocked-out" in general populations. Gene ontology analysis suggested that these commonly "knocked-out" genes are enriched in biological process related to antigen processing and immune response. Our results contribute towards a comprehensive characterization of human genomic variation, especially for less-common and rare variants, and provide an invaluable resource for future genetic studies of human variation and diseases.	[Shen, Hui; Li, Jian; Zhang, Jigang; Xu, Chao; Jiang, Yan; Wu, Zikai; Zhao, Fuping; Liao, Li; Chen, Jun; Tian, Qing; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, Ctr Bioinformat & Genom, New Orleans, LA 70118 USA; [Shen, Hui; Li, Jian; Zhang, Jigang; Xu, Chao; Jiang, Yan; Wu, Zikai; Zhao, Fuping; Liao, Li; Tian, Qing; Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Xu, Chao; Jiang, Yan; Wu, Zikai; Lin, Yong; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China	Tulane University; University of Missouri System; University of Missouri Kansas City; University of Shanghai for Science & Technology	Deng, HW (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, Ctr Bioinformat & Genom, New Orleans, LA 70118 USA.	hdeng2@tulane.edu	Li, Jian/G-4445-2015; Xu, Chao/AAN-6427-2020; Xu, Chao/J-2717-2015	Xu, Chao/0000-0002-3821-6187; Xu, Chao/0000-0002-3821-6187; Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [P50AR055081, R01AG026564, R01AR050496, R01AR057049, R03TW008221]; Franklin D. Dickson/Missouri Endowment from University of Missouri-Kansas City; Edward G. Schlieder Endowment from Tulane University; Shanghai Leading Academic Discipline Project [S30501]; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081, R01AR059781, R01AR057049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin D. Dickson/Missouri Endowment from University of Missouri-Kansas City; Edward G. Schlieder Endowment from Tulane University; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The investigators of this work were partially supported by grants from the National Institutes of Health (P50AR055081, R01AG026564, R01AR050496, R01AR057049, and R03TW008221), the Franklin D. Dickson/Missouri Endowment from University of Missouri-Kansas City, and the Edward G. Schlieder Endowment from Tulane University. The work was also benefited by Shanghai Leading Academic Discipline Project (S30501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Habegger L, 2012, BIOINFORMATICS, V28, P2267, DOI 10.1093/bioinformatics/bts368; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Kingsley CB, 2011, METHODS MOL BIOL, V700, P37, DOI 10.1007/978-1-61737-954-3_3; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rosenfeld JA, 2010, NUCLEIC ACIDS RES, V38, P6102, DOI 10.1093/nar/gkq408; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	41	37	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59494	10.1371/journal.pone.0059494	http://dx.doi.org/10.1371/journal.pone.0059494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577066	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800010
J	Shen, W; Yang, YM; Yu, MB; Li, J; Wei, T; Li, X; Li, JJ; Su, XD; Zhong, H; Yuan, YS				Shen, Wei; Yang, Yongming; Yu, Minbin; Li, Jun; Wei, Tao; Li, Xun; Li, Juanjuan; Su, Xiaodan; Zhong, Hua; Yuan, Yuansheng			Prevalence and Outcomes of Cataract Surgery in Adult Rural Chinese Populations of the Bai Nationality in Dali: The Yunnan Minority Eye Study	PLOS ONE			English	Article							VISUAL IMPAIRMENT SURVEY; SELF-REPORTED BARRIERS; SURGICAL COVERAGE; RAPID ASSESSMENT; AVOIDABLE BLINDNESS; LATIN-AMERICA; SERVICES; PAKISTAN; COUNTY; INDIA	Purpose: To investigate the prevalence and visual acuity (VA) outcomes of cataract surgery in adults of the Bai Nationality populations in rural China. Methods: We conducted a population-based cross-sectional survey (from randomly selected block groups) of Chinese Bai Nationality aged >= 50 years in southwestern China. Presenting visual acuity (PVA), best corrected visual acuity (BCVA) were recorded and a detailed eye examination was carried out. For all aphakic and pseudophakic subjects identified, information on the date, setting, type, and complications of cataract surgery were recorded. In eyes with VA <20/63, the principal cause of visual impairment was identified. Results: Of 2133 (77.8% of 2742) subjects, 99 people (129 eyes) had undergone cataract surgery. The prevalence of cataract surgery was 4.6%. Surgical coverage among those with PVA <20/200 in both eyes because of cataract was 52.8%. Unoperated cataract was associated with older age. The main barrier to cataract surgery was lack of awareness and knowledge, cost, and fear. Among the 129 cataract-operated eyes, 22.5% had PVA of >= 20/32, 25.6% had PVA of 20/40 to 20/63, 23.3% had PVA <20/63 to 20/200, and 28.7% had PVA <20/200. With BCVA, the percentages were 42.6%, 23.3%, 10.9%, and 23.3%, respectively. Aphakia (odds ratio [OR], 8.49; P < 0.001) and no education (OR, 10.18; P = 0.001) or less education (OR, 6.49; P = 0.014) were significantly associated with postoperative visual impairment defined by PVA, while aphakia (OR, 8.49; P < 0.001) and female gender (OR, 4.19; P = 0.004) were significantly associated with postoperative visual impairment by BCVA. The main causes of postoperative visual impairment were refractive error, retinal disorders and glaucoma. Conclusions: Half of those with bilateral visual impairment or blindness because of cataract remain in need of cataract surgery in Bai population. Surgical uptake and visual outcomes should be further improved in the future.	[Shen, Wei; Yang, Yongming; Li, Juanjuan; Su, Xiaodan; Zhong, Hua; Yuan, Yuansheng] Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China; [Shen, Wei; Li, Jun] Yunnan Red Cross Hosp, Kunming, Peoples R China; [Yu, Minbin] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wei, Tao; Li, Xun] Kunming Med Univ, Kunming, Peoples R China	Kunming Medical University; Sun Yat Sen University; Kunming Medical University	Zhong, H (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China.	zhoculist@163.com; 1119abcd@163.com	tao, wei/GXN-4445-2022		National Natural Science Foundation of China [30860309, 81160121]; Yunnan Province Science and Technology Project [2009CA007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province Science and Technology Project	Supported by the National Natural Science Foundation of China under grant No. 30860309, No. 81160121 and Yunnan Province Science and Technology Project under grant No. 2009CA007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiov PA, 2008, CLIN EXP OPHTHALMOL, V36, P521, DOI 10.1111/j.1442-9071.2008.01829.x; Athanasiov PA, 2009, CLIN EXP OPHTHALMOL, V37, P780, DOI 10.1111/j.1442-9071.2009.02152.x; Bassett KL, 2005, BRIT J OPHTHALMOL, V89, P5, DOI 10.1136/bjo.2004.048744; Bourne R, 2007, BRIT J OPHTHALMOL, V91, P420, DOI 10.1136/bjo.2006.106724; China Disabled Person's Federation (CDPF), 2005, STAT YB UND PEOPL DI; Dandona L, 1999, AM J OPHTHALMOL, V127, P650, DOI 10.1016/S0002-9394(99)00044-6; Hsu WM, 2004, OPHTHALMOLOGY, V111, P62, DOI 10.1016/j.ophtha.2003.05.011; Huang WY, 2011, INVEST OPHTH VIS SCI, V52, P16, DOI 10.1167/iovs.10-5382; Jadoon Z, 2007, BRIT J OPHTHALMOL, V91, P1269, DOI 10.1136/bjo.2006.106914; Johnson GJ, 2000, LANCET, V355, P158, DOI 10.1016/S0140-6736(99)00404-3; Lau J, 2002, BRIT J OPHTHALMOL, V86, P12, DOI 10.1136/bjo.86.1.12; Li J, 2012, INVEST OPHTH VIS SCI, V53, P4498, DOI 10.1167/iovs.12-9429; Li SZ, 1999, OPHTHALMOLOGY, V106, P1602, DOI 10.1016/S0161-6420(99)90459-1; Li ZJ, 2009, OPHTHAL EPIDEMIOL, V16, P78, DOI 10.1080/09286580802573193; Limburg H, 2008, BRIT J OPHTHALMOL, V92, P315, DOI 10.1136/bjo.2007.125906; Limburg H, 2009, REV PANAM SALUD PUBL, V25, P449, DOI 10.1590/S1020-49892009000500011; Liu B, 2009, OPHTHALMOLOGY, V116, P1322, DOI 10.1016/j.ophtha.2009.01.030; Murthy GVS, 2009, OPHTHAL EPIDEMIOL, V16, P400, DOI 10.3109/09286580903315809; Rabiu MM, 2008, OPHTHAL EPIDEMIOL, V15, P359, DOI 10.1080/09286580802399078; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Salomao SR, 2009, AM J OPHTHALMOL, V148, P199, DOI 10.1016/j.ajo.2009.02.019; Sapkota Y D, 2004, Kathmandu Univ Med J (KUMJ), V2, P103; Sherchan A, 2010, BRIT J OPHTHALMOL, V94, P161, DOI 10.1136/bjo.2008.155408; Wadud Z, 2006, BRIT J OPHTHALMOL, V90, P1225, DOI 10.1136/bjo.2006.101287; World Health Organization, 1988, GUID HLTH HOUS; Wu M, 2008, OPHTHALMOLOGY, V115, P969, DOI 10.1016/j.ophtha.2007.08.002; Zhao JL, 2010, OPHTHALMOLOGY, V117, P2120, DOI 10.1016/j.ophtha.2010.03.005; Zhao JL, 1998, AM J OPHTHALMOL, V126, P506, DOI 10.1016/S0002-9394(98)00275-X; Zhong H, 2012, INVEST OPHTH VIS SCI, V53, P3221, DOI 10.1167/iovs.11-9306	29	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60236	10.1371/journal.pone.0060236	http://dx.doi.org/10.1371/journal.pone.0060236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577095	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800037
J	Zhang, GQ; Liu, KW; Chen, LJ; Xiao, XJ; Zhai, JW; Li, LQ; Cai, J; Hsiao, YY; Rao, WH; Huang, J; Ma, XY; Chung, SW; Huang, LQ; Tsai, WC; Liu, ZJ				Zhang, Guo-Qiang; Liu, Ke-Wei; Chen, Li-Jun; Xiao, Xin-Ju; Zhai, Jun-Wen; Li, Li-Qiang; Cai, Jing; Hsiao, Yu-Yun; Rao, Wen-Hui; Huang, Jie; Ma, Xue-Yong; Chung, Shih-Wen; Huang, Lai-Qiang; Tsai, Wen-Chieh; Liu, Zhong-Jian			A New Molecular Phylogeny and a New Genus, Pendulorchis, of the Aerides-Vanda Alliance (Orchidaceae: Epidendroideae)	PLOS ONE			English	Article							NONCODING REGIONS; HOLCOGLOSSUM ORCHIDACEAE; UNIVERSAL PRIMERS; CHLOROPLAST DNA; EVOLUTION; AMPLIFICATION; BIOGEOGRAPHY; POLLINATION; NUCLEAR; SYSTEM	Background: The Aerides-Vanda alliance is a complex group in the subtribe Aeridinae (subfamily Epidendroideae, Orchidaceae). Some phylogenetic systems of this alliance have been previously proposed based on molecular and morphological analyses. However, several taxonomic problems within this alliance as well as between it and its allies remain unsolved. Methodology/Principal Findings: We utilized ITS and five plastid DNA regions in this phylogenetic analysis. Consensus trees strongly indicate that the Aerides-Vanda alliance is monophyletic, and the 14 genera of this alliance can be grouped into the following clades with 14 subclades: 1. Aerides, comprising two subclades: Rhynchostylis and Aerides; 2. Ascocentropsis; 3. Papilionanthe; 4. Vanda, comprising five subclades: Neofinetia, Christensonia, Seidenfadenia, Ascocentrum, and Vanda-Trudelia, in which Vanda and Trudelia form a subclade; 5. Tsiorchis, comprising three subclades: Chenorchis, Tsiorchis, and two species of Ascocentrum; 6. Paraholcoglossum; and 7. Holcoglossum. Among the 14 genera, only Ascocentrum is triphyletic: two species of the Ascocentrum subclade, an independent subclade Ascocentrum subclade in the Tsiorchis clade; the Ascocentrum subclade in the Vanda clade; and one species in the Holcoglossum clade. The Vanda and Trudelia species belong to the same subclade. The molecular conclusion is consistent with their morphological characteristics. Conclusions: We elucidate the relationship among the 14 genera of the Aerides-Vanda alliance. Our phylogenetic results reveal that the Aerides-Vanda alliance is monophyletic, but it can be divided into 14 genera. The data prove that Ascocentrum is triphyletic. Plants with elongate-terete leaves and small flowers should be treated as a new genus, Pendulorchis. Saccolabium himalaicum (Ascocentrum himalaicum) should be transferred to Pendulorchis. Ascocentrum pumilum, endemic to Taiwan, should be transferred to Holcoglossum. A new combination, Holcoglossum pumilum, was also established. Trudelia should not be recognized as an independent genus. Two new species, Pendulorchis gaoligongensis and Holcoglossum singchianum, were described as well.	[Zhang, Guo-Qiang; Liu, Ke-Wei; Chen, Li-Jun; Xiao, Xin-Ju; Zhai, Jun-Wen; Li, Li-Qiang; Cai, Jing; Rao, Wen-Hui; Huang, Jie; Ma, Xue-Yong; Liu, Zhong-Jian] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Zhang, Guo-Qiang; Liu, Ke-Wei; Chen, Li-Jun; Xiao, Xin-Ju; Zhai, Jun-Wen; Li, Li-Qiang; Cai, Jing; Rao, Wen-Hui; Huang, Jie; Ma, Xue-Yong; Liu, Zhong-Jian] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Liu, Ke-Wei; Huang, Lai-Qiang; Liu, Zhong-Jian] Tsinghua Univ, Grad Sch Shenzhen, Ctr Biotechnol & BioMed, Shenzhen 518057, Peoples R China; [Zhai, Jun-Wen] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Zhai, Jun-Wen] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Hsiao, Yu-Yun] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Chung, Shih-Wen] Taiwan Forestry Res Inst, Dept Bot, Taipei, Taiwan; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 70101, Taiwan; [Liu, Zhong-Jian] South China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China; [Liu, Zhong-Jian] Fujian Agr & Forestry Univ, Landscape Coll, Fuzhou, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Cheng Kung University; National Cheng Kung University; South China Agricultural University; Fujian Agriculture & Forestry University	Tsai, WC (corresponding author), Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 70101, Taiwan.	tsaiwc@mail.ncku.edu.tw; liuzj@sinicaorchid.org	Zhang, Guo-Qiang/AAG-6817-2019	Zhang, Guo-Qiang/0000-0001-6439-019X; Liu, Zhong-Jian/0000-0003-4390-3878; Cai, Jing/0000-0002-2496-4731	State Forestry Administration, China [2011-4-53]; Science and Technology Project of Shenzhen, China [SYF200646408, SY200806270123A]	State Forestry Administration, China; Science and Technology Project of Shenzhen, China	This work was supported by the 948 Program of the State Forestry Administration, China. (no. 2011-4-53) and the Science and Technology Project of Shenzhen, China (grant nos. SYF200646408 and SY200806270123A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlsward BS, 2006, AM J BOT, V93, P770, DOI 10.3732/ajb.93.5.770; CHRISTENSON E A, 1987, Notes from the Royal Botanic Garden Edinburgh, V44, P249; Christenson EA, 1994, P 14 WORLD ORCH C, P206; Christenson EA, 1987, P 12 WORLD ORCH C WO, V12, P35; CHRISTENSON EA, 1998, ORCHID DIGEST, V62, P152; Christenson EA, 2001, LANKESTERIANA, V2, P19; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Fan J, 2009, TAXON, V58, P849, DOI 10.1002/tax.583013; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; GARAY L A, 1972, BOT MUS LEAFL HARV UNIV, V23, P149; Garay LA, 1986, ORCH DIG         MAR, P73; Hidayat T, 2005, J PLANT RES, V118, P271, DOI 10.1007/s10265-005-0217-3; Jin XH, 2005, BOT J LINN SOC, V149, P465, DOI 10.1111/j.1095-8339.2005.00463.x; Jin XH, 2005, PLANT SYST EVOL, V254, P31, DOI 10.1007/s00606-005-0310-z; Jin XH, 2003, THESIS CHINESE ACAD; Jin XH, 2009, FLORA CHINA, V25, P499; Jin XH, 2007, BOT J LINN SOC, V154, P283, DOI 10.1111/j.1095-8339.2007.00654.x; Jin Xiao-Hua, 2008, Acta Botanica Yunnanica, V30, P531, DOI 10.3724/SP.J.1143.2008.07325; Kocyan A, 2008, MOL PHYLOGENET EVOL, V48, P422, DOI 10.1016/j.ympev.2008.02.017; Liu KW, 2006, NATURE, V441, P945, DOI 10.1038/441945a; [刘仲健 LIU ZhongJian], 2008, [生态学报, Acta Ecologica Sinica], V28, P2433; Liu ZJ, 2011, PLOS ONE, DOI [10.1371/journal.-pone.0024864, DOI 10.1371/J0URNAL.-P0NE.0024864]; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Seidenfaden G., 1988, OPERA BOT, V95, P304; Senghas K., 2000, J ORCHIDEENFREUND, V7, P287; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiv M, 1999, PLANT SYST EVOL, V218, P299, DOI 10.1007/BF01089233; Tsi Z.H., 1982, ACTA PHYTOTAX SINICA, V20, P439; Wu Z.Y., 2009, FLORA CHINA, V25	37	33	37	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60097	10.1371/journal.pone.0060097	http://dx.doi.org/10.1371/journal.pone.0060097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577083	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800026
J	Gaertner, C; Creux, C; Espinasse-Berrod, MA; Orssaud, C; Dufier, JL; Kapoula, Z				Gaertner, Chrystal; Creux, Charlotte; Espinasse-Berrod, Marie-Andree; Orssaud, Christophe; Dufier, Jean-Louis; Kapoula, Zoi			Benefit of Bi-Ocular Visual Stimulation for Postural Control in Children with Strabismus	PLOS ONE			English	Article							BINOCULAR COORDINATION; PERIPHERAL-VISION; EQUILIBRIUM; STABILITY; DISTANCE; BALANCE; HUMANS; MOTION; SWAY; ATTENTION	Vision is important for postural control as is shown by the Romberg quotient (RQ): with eyes closed, postural instability increases relative to eyes open (RQ = 2). Yet while fixating at far distance, postural stability is similar with eyes open and eyes closed (RQ = 1). Postural stability can be better with both eyes viewing than one eye, but such effect is not consistent among healthy subjects. The first goal of the study is to test the RQ as a function of distance for children with convergent versus divergent strabismus. The second goal is to test whether vision from two eyes relative to vision from one eye provides better postural stability. Thirteen children with divergent strabismus and eleven with convergent strabismus participated in this study. Posturtography was done with the Techno concept device. Experiment 1, four conditions: fixation at 40 cm and at 200 cm both with eyes open and eyes covered (evaluation of RQ). Experiment 2, six conditions: fixation at 40 cm and at 200 cm, with both eyes viewing or under monocular vision (dominant and non-dominant eye). For convergent strabismus, the groups mean value of RQ was 1.3 at near and 0.94 at far distance; for divergent, it was 1.06 at near and 1.68 at far. For all children, the surface of body sway was significantly smaller under both eyes viewing than monocular viewing (either eye). Increased RQ value at near for convergent and at far for divergent strabismus is attributed to the influence of the default strabismus angle and to better use of ocular motor signals. Vision with the two eyes improves postural control for both viewing distances and for both types of strabismus. Such benefit can be due to complementary mechanisms: larger visual field, better quality of fixation and vergence angle due to the use of visual inputs from both eyes.	[Gaertner, Chrystal; Kapoula, Zoi] Univ Paris 05, CNRS, UMR8194, Ctr Etud SensoriMotrices,IRIS Grp, Paris, France; [Creux, Charlotte; Espinasse-Berrod, Marie-Andree; Orssaud, Christophe; Dufier, Jean-Louis] Hop Enfants Necker, Serv Ophtalmol, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Gaertner, C (corresponding author), Univ Paris 05, CNRS, UMR8194, Ctr Etud SensoriMotrices,IRIS Grp, Paris, France.	chrystal.gaertner@gmail.com; zoi.kapoula@egp.aphp.fr	Orssaud, Christophe/ACM-6549-2022					AMBLARD B, 1980, PERCEPT MOTOR SKILL, V51, P903, DOI 10.2466/pms.1980.51.3.903; ANDREDESHAYS C, 1988, EXP BRAIN RES, V69, P399; ANDREDESHAYS C, 1991, EXP BRAIN RES, V84, P359; ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; Berencsi A, 2005, HUM MOVEMENT SCI, V24, P689, DOI 10.1016/j.humov.2005.10.014; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; Brandt T, 1999, VISUAL VERTIGO ITS M; Bucci MP, 2009, INVEST OPHTH VIS SCI, V50, P4678, DOI 10.1167/iovs.09-3537; Bucci MP, 1999, NEURO-OPHTHALMOLOGY, V22, P115, DOI 10.1076/noph.22.2.115.3736; EDWARDS AS, 1946, J EXP PSYCHOL, V36, P526, DOI 10.1037/h0059909; FOX CR, 1990, PERCEPT PSYCHOPHYS, V47, P409, DOI 10.3758/BF03208174; GENTAZ R, 1991, Agressologie, V32, P187; GENTAZ R, 1988, Agressologie, V29, P685; Han Y, 1998, ACTA OPHTHALMOL SCAN, V76, P283, DOI 10.1034/j.1600-0420.1998.760306.x; Henriksson NG, 1967, ACTA OTO-LARYNGOL, V63, P272, DOI [10.3109/00016486709123592, DOI 10.3109/00016486709123592]; Isotalo E, 2004, AURIS NASUS LARYNX, V31, P11, DOI 10.1016/j.anl.2003.10.001; Kapoula Z, 2006, EXP BRAIN RES, V173, P438, DOI 10.1007/s00221-006-0382-1; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Le TT, 2008, GAIT POSTURE, V27, P493, DOI 10.1016/j.gaitpost.2007.06.003; Le TT, 2006, VISION RES, V46, P3586, DOI 10.1016/j.visres.2006.06.018; Legrand A, 2011, NEUROSCI LETT, V501, P96, DOI 10.1016/j.neulet.2011.06.056; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; ODENRICK P, 1984, DEV MED CHILD NEUROL, V26, P495; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Ramat S, 2005, ANN NY ACAD SCI, V1039, P36, DOI 10.1196/annals.1325.005; SNYDER LH, 1992, J NEUROPHYSIOL, V67, P861, DOI 10.1152/jn.1992.67.4.861; TRAVIS RC, 1945, J EXP PSYCHOL, V35, P216, DOI 10.1037/h0059788; Von Noorden G. K., 2002, BINOCULAR VISION OCU, V6th; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9	30	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60341	10.1371/journal.pone.0060341	http://dx.doi.org/10.1371/journal.pone.0060341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565228	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300098
J	Said, MA; Johnson, HL; Nonyane, BAS; Deloria-Knoll, M; OBrien, KL				Said, Maria A.; Johnson, Hope L.; Nonyane, Bareng A. S.; Deloria-Knoll, Maria; OBrien, Katherine L.		AGEDD Adult Pneumococcal Burden	Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques	PLOS ONE			English	Review							COMMUNITY-ACQUIRED PNEUMONIA; URINARY ANTIGEN TEST; STREPTOCOCCUS-PNEUMONIAE; HOSPITALIZED-PATIENTS; ETIOLOGIC DIAGNOSIS; PREDICTION RULE; RISK PATIENTS; MANAGEMENT; ASSAY; BINAX	Background: Pneumococcal pneumonia causes significant morbidity and mortality among adults. Given limitations of diagnostic tests for non-bacteremic pneumococcal pneumonia, most studies report the incidence of bacteremic or invasive pneumococcal disease (IPD), and thus, grossly underestimate the pneumococcal pneumonia burden. We aimed to develop a conceptual and quantitative strategy to estimate the non-bacteremic disease burden among adults with community-acquired pneumonia (CAP) using systematic study methods and the availability of a urine antigen assay. Methods and Findings: We performed a systematic literature review of studies providing information on the relative yield of various diagnostic assays (BinaxNOW (R) S. pneumoniae urine antigen test (UAT) with blood and/or sputum culture) in diagnosing pneumococcal pneumonia. We estimated the proportion of pneumococcal pneumonia that is bacteremic, the proportion of CAP attributable to pneumococcus, and the additional contribution of the Binax UAT beyond conventional diagnostic techniques, using random effects meta-analytic methods and bootstrapping. We included 35 studies in the analysis, predominantly from developed countries. The estimated proportion of pneumococcal pneumonia that is bacteremic was 24.8% (95% CI: 21.3%, 28.9%). The estimated proportion of CAP attributable to pneumococcus was 27.3% (95% CI: 23.9%, 31.1%). The Binax UAT diagnosed an additional 11.4% (95% CI: 9.6, 13.6%) of CAP beyond conventional techniques. We were limited by the fact that not all patients underwent all diagnostic tests and by the sensitivity and specificity of the diagnostic tests themselves. We address these resulting biases and provide a range of plausible values in order to estimate the burden of pneumococcal pneumonia among adults. Conclusions: Estimating the adult burden of pneumococcal disease from bacteremic pneumococcal pneumonia data alone significantly underestimates the true burden of disease in adults. For every case of bacteremic pneumococcal pneumonia, we estimate that there are at least 3 additional cases of non-bacteremic pneumococcal pneumonia.	[Said, Maria A.] Johns Hopkins Sch Med, Div Infect Dis, Dept Med, Baltimore, MD USA; [Johnson, Hope L.; Nonyane, Bareng A. S.; Deloria-Knoll, Maria; OBrien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Said, MA (corresponding author), Johns Hopkins Sch Med, Div Infect Dis, Dept Med, Baltimore, MD USA.	said.maria@gmail.com	Hernes, Susanne/H-7653-2019; Masiá, Mar/U-7510-2017; van der Eerden, Menno M./P-8383-2018; Nonyane, Bareng A.S./AAC-8118-2020; Carratala, Jordi/AAC-2639-2020; Murdoch, David/A-2012-2009; Andreo, Felipe/G-8472-2013; Carratalà, Jordi/B-8410-2011; Guchev, Igor/P-8348-2014	Hernes, Susanne/0000-0001-6018-652X; Masiá, Mar/0000-0001-9878-2458; Nonyane, Bareng A.S./0000-0001-5633-7487; Carratala, Jordi/0000-0003-3209-2563; Carratalà, Jordi/0000-0003-3209-2563; van der Eerden, Menno/0000-0002-8407-2524; Falco, Vicenc/0000-0001-9626-0023; Vila-Corcoles, Angel/0000-0002-1644-0188; Deloria Knoll, Maria/0000-0001-9041-2671; Garcia-Vidal, Carolina/0000-0002-8915-0683; Guchev, Igor/0000-0002-8958-5767; O'Brien, Katherine/0000-0002-0164-4030	Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI073192] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2010, JAMA-J AM MED ASSOC, V304, P1326, DOI 10.1001/jama.2010.1339; Andreo F, 2006, RESP MED, V100, P884, DOI 10.1016/j.rmed.2005.08.020; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; Bartlett JG, 2004, CLIN INFECT DIS, V39, P170, DOI 10.1086/421498; Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953; Beovic B, 2003, EUR J CLIN MICROBIOL, V22, P584, DOI 10.1007/s10096-003-0997-0; Butler JC, 2003, J INFECT DIS, V187, P1416, DOI 10.1086/374623; Charles PGP, 2008, CLIN INFECT DIS, V46, P1513, DOI 10.1086/586749; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz A, 2007, CHEST, V131, P779, DOI 10.1378/chest.06-1800; Dominguez J, 2001, CHEST, V119, P243, DOI 10.1378/chest.119.1.243; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Ehara N, 2008, J MED MICROBIOL, V57, P820, DOI 10.1099/jmm.0.47793-0; Endeman H, 2008, SCAND J INFECT DIS, V40, P715, DOI 10.1080/00365540802014864; Falguera M, 2010, THORAX, V65, P101, DOI 10.1136/thx.2009.118588; Falguera M, 2009, CLIN INFECT DIS, V49, P409, DOI 10.1086/600291; Feldman C, 1999, CHEST, V116, P107, DOI 10.1378/chest.116.1.107; Fernandez-Sabe N, 2003, MEDICINE, V82, P159, DOI 10.1097/00005792-200305000-00002; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Guchev IA, 2005, CLIN INFECT DIS, V40, P1608, DOI 10.1086/429919; Gutierrez F, 2003, CLIN INFECT DIS, V36, P286, DOI 10.1086/345852; Heffron R, 1939, PNEUMONIA SPECIAL RE; Hernes SS, 2010, CLIN MICROBIOL INFEC, V16, P909, DOI 10.1111/j.1469-0691.2009.03000.x; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Hohenthal U, 2008, SCAND J INFECT DIS, V40, P131, DOI 10.1080/00365540701534525; Ishida T, 1998, CHEST, V114, P1588, DOI 10.1378/chest.114.6.1588; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Jokinen J, 2010, EPIDEMIOLOGY, V21, P719, DOI 10.1097/EDE.0b013e3181e4c4d5; Khalil A, 2005, AM THOR SOC INT C SA; Kobashi Y, 2007, RESPIRATION, V74, P387, DOI 10.1159/000092547; Krcova M., 2008, Studia Pneumologica et Phthiseologica, V68, P151; Lasocki S, 2006, INTENS CARE MED, V32, P1766, DOI 10.1007/s00134-006-0329-9; Lauderdale TL, 2005, RESP MED, V99, P1079, DOI 10.1016/j.rmed.2005.02.026; LEVY M, 1988, CHEST, V93, P43, DOI 10.1378/chest.93.1.43; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marcos MA, 2003, EUR RESPIR J, V21, P209, DOI 10.1183/09031936.03.00058802; Marekovic I, 2008, SCAND J INFECT DIS, V40, P843, DOI 10.1080/00365540802029581; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Matute AJ, 2006, INT J ANTIMICROB AG, V28, P423, DOI 10.1016/j.ijantimicag.2006.07.016; MUFSON MA, 1981, JAMA-J AM MED ASSOC, V246, P1942, DOI 10.1001/jama.246.17.1942; Murdoch DR, 2001, J CLIN MICROBIOL, V39, P3495, DOI 10.1128/JCM.39.10.3495-3498.2001; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ortega L, 2005, SCAND J INFECT DIS, V37, P657, DOI 10.1080/00365540510027174; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Roson B, 2004, CLIN INFECT DIS, V38, P222, DOI 10.1086/380639; Ruiz-Gonzalez A, 1999, AM J MED, V106, P385, DOI 10.1016/S0002-9343(99)00050-9; Sanchez M, 2010, EUR J EMERG MED; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Smith MD, 2003, J CLIN MICROBIOL, V41, P2810, DOI 10.1128/JCM.41.7.2810-2813.2003; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC; Sorde R, 2011, ARCH INTERN MED, V171, P166, DOI 10.1001/archinternmed.2010.347; StataCorp, 2021, STATA STAT SOFTWARE; Stralin K, 2004, J CLIN MICROBIOL, V42, P3620, DOI 10.1128/jcm.42.8.3620-3625.2004; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tilghman RC, 1937, ARCH INTERN MED, V59, P602, DOI 10.1001/archinte.1937.00170200044004; van der Eerden MM, 2005, EUR J CLIN MICROBIOL, V24, P241, DOI 10.1007/s10096-005-1316-8; Vidal J, 2006, J CHEMOTHERAPY, V18, P562, DOI 10.1179/joc.2006.18.5.562; Waterer GW, 2001, RESP MED, V95, P78, DOI 10.1053/rmed.2000.0977; Watt J., 2010, EPIDEMIOLOGY INFECT, P1; Weatherall C, 2008, EMERG MED J, V25, P144, DOI 10.1136/emj.2007.050179	68	266	275	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60273	10.1371/journal.pone.0060273	http://dx.doi.org/10.1371/journal.pone.0060273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565216	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300085
J	Shen, XJ; Ou, LM; Chen, XJ; Zhang, X; Tan, XR				Shen, Xuejun; Ou, Limin; Chen, Xiaojun; Zhang, Xin; Tan, Xuerui			The Application of the Grey Disaster Model to Forecast Epidemic Peaks of Typhoid and Paratyphoid Fever in China	PLOS ONE			English	Article							PREDICTION MODEL; SALMONELLA; PREVALENCE; OUTBREAK; DISTRICT; VACCINE	Objective: The objectives of this study were to forecast epidemic peaks of typhoid and paratyphoid fever in China using the grey disaster model, to evaluate its feasibility of predicting the epidemic tendency of notifiable diseases. Methods: According to epidemiological features, the GM(1,1) model and DGM model were used to build the grey disaster model based on the incidence data of typhoid and paratyphoid fever collected from the China Health Statistical Yearbook. Model fitting accuracy test was used to evaluate the performance of these two models. Then, the next catastrophe date was predicted by the better model. Results: The simulation results showed that DGM model was better than GM(1,1) model in our data set. Using the DGM model, we predicted the next epidemic peak time will occur between 2023 to 2025. Conclusion: The grey disaster model can predict the typhoid and paratyphoid fever epidemic time precisely, which may provide valuable information for disease prevention and control.	[Shen, Xuejun; Chen, Xiaojun; Tan, Xuerui] Shantou Univ Med Coll, Affiliated Hosp 1, Dept Cardiol, Shantou, Guangdong, Peoples R China; [Ou, Limin] Shantou Univ Med Coll, Affiliated Hosp 1, Dept Neurol, Shantou, Guangdong, Peoples R China; [Zhang, Xin] Shantou Univ Med Coll, Affiliated Hosp 1, Mol Cardiol Lab, Shantou, Guangdong, Peoples R China; [Shen, Xuejun] Shantou Univ Med Coll, Shantou, Guangdong, Peoples R China		Tan, XR (corresponding author), Shantou Univ Med Coll, Affiliated Hosp 1, Dept Cardiol, Shantou, Guangdong, Peoples R China.	tanxuerui@vip.sina.com			National Natural Science Foundation of China [81172776]; Project for High-level Talents in Guangdong Higher Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for High-level Talents in Guangdong Higher Education	This work was supported by the National Natural Science Foundation of China1/4No. 81172776, www.nsfc.gov.cn1/4 parts per thousand and Project for High-level Talents in Guangdong Higher Education (www.gdhed.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barat S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002966; Basnyat B, 2005, CLIN INFECT DIS, V41, P1467, DOI 10.1086/497136; Beeching NJ, 2011, LANCET INFECT DIS, V11, P419, DOI 10.1016/S1473-3099(11)70119-0; Blackstock Sarah J, 2012, N S W Public Health Bull, V23, P148, DOI 10.1071/NB11041; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; CAPASSO V, 1980, Annali Sclavo, V22, P189; Chen X, 2007, J HEALTH POPUL NUTR, V25, P469; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Deng JL, 2002, ELEMENTS GREY THEORY; Deng Julong, 1989, Journal of Grey Systems, V1, P1; Ding F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027295; Ding F, 2011, INFECT GENET EVOL, V11, P222, DOI 10.1016/j.meegid.2010.09.015; Dongol S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047342; Hsu CC, 2003, ENERG CONVERS MANAGE, V44, P2241, DOI 10.1016/S0196-8904(02)00248-0; Hsu LC, 2003, TECHNOL FORECAST SOC, V70, P563, DOI 10.1016/S0040-1625(02)00195-6; Kayacan E, 2010, EXPERT SYST APPL, V37, P1784, DOI 10.1016/j.eswa.2009.07.064; Khan MI, 2012, VACCINE, V30, P5389, DOI 10.1016/j.vaccine.2012.06.015; Kobayashi A, 2012, SE ASIAN J TROP MED, V43, P423; Koirala KD, 2012, ANTIMICROB AGENTS CH, V56, P2761, DOI 10.1128/AAC.06414-11; Li J, 2006, PETROL SCI, V3, P89; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Liu SF, 2010, UNDERST COMPLEX SYST, P1; Lu P, 2003, NAT HAZARDS, V30, P383, DOI 10.1023/B:NHAZ.0000007168.00673.27; Lunguya O, 2012, T ROY SOC TROP MED H, V106, P348, DOI 10.1016/j.trstmh.2012.03.006; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; Ministry of Health of the People's Republic of China, 2011, CHIN HLTH STAT YB 20; Neil KP, 2012, CLIN INFECT DIS, V54, P1091, DOI 10.1093/cid/cis025; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Palombi L, 2012, CLIN INFECT DIS, V55, P268, DOI 10.1093/cid/cis380; Porta M, 2008, DICT EPIDEMIOLOGY; Ren YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042055; Rios M, 1996, MED CLIN-BARCELONA, V106, P686; Thomson MC, 2006, TROP MED INT HEALTH, V11, P781, DOI 10.1111/j.1365-3156.2006.01630.x; Wahid R, 2012, CLIN VACCINE IMMUNOL, V19, P825, DOI 10.1128/CVI.00058-12; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Watkins RE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-263; Whitaker JA, 2009, J TRAVEL MED, V16, P46, DOI 10.1111/j.1708-8305.2008.00273.x; Xie NM, 2009, APPL MATH MODEL, V33, P1173, DOI 10.1016/j.apm.2008.01.011; Yan M., 2005, DIS SURVEILLANCE, V20, P401; Yang Wei-Zhong, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1240	41	28	34	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60601	10.1371/journal.pone.0060601	http://dx.doi.org/10.1371/journal.pone.0060601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565260	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300131
J	Bogaty, P; Dagenais, GR; Joseph, L; Boyer, L; Leblanc, A; Belisle, P; Brophy, JM				Bogaty, Peter; Dagenais, Gilles R.; Joseph, Lawrence; Boyer, Luce; Leblanc, Anne; Belisle, Patrick; Brophy, James M.			Time Variability of C-Reactive Protein: Implications for Clinical Risk Stratification	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INFLAMMATORY MARKERS; CARDIOVASCULAR-DISEASE; HEALTHY; ANGINA; ATHEROSCLEROSIS; PREDICTION; GUIDELINES; UTILITY; EVENTS	Background: C-reactive protein (CRP) is proposed as a screening test for predicting risk and guiding preventive approaches in coronary artery disease (CAD). However, the stability of repeated CRP measurements over time in subjects with and without CAD is not well defined. We sought to determine the stability of serial CRP measurements in stable subjects with distinct CAD manifestations and a group without CAD while carefully controlling for known confounders. Methods: We prospectively studied 4 groups of 25 stable subjects each 1) a history of recurrent acute coronary events; 2) a single myocardial infarction >= 7 years ago; 3) longstanding CAD (>= 7 years) that had never been unstable; 4) no CAD. Fifteen measurements of CRP were obtained to cover 21 time-points: 3 times during one day; 5 consecutive days; 4 consecutive weeks; 4 consecutive months; and every 3 months over the year. CRP risk threshold was set at 2.0 mg/L. We estimated variance across time-points using standard descriptive statistics and Bayesian hierarchical models. Results: Median CRP values of the 4 groups and their pattern of variability did not differ substantially so all subjects were analyzed together. The median individual standard deviation (SD) CRP values within-day, within-week, between-weeks and between-months were 0.07, 0.19, 0.36 and 0.63 mg/L, respectively. Forty-six percent of subjects changed CRP risk category at least once and 21% had >= 4 weekly and monthly CRP values in both low and high-risk categories. Conclusions: Considering its large intra-individual variability, it may be problematic to rely on CRP values for CAD risk prediction and therapeutic decision-making in individual subjects.	[Bogaty, Peter; Dagenais, Gilles R.; Boyer, Luce; Leblanc, Anne] Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Joseph, Lawrence; Belisle, Patrick; Brophy, James M.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada	Laval University; Quebec Heart & Lung Institute; McGill University	Bogaty, P (corresponding author), Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ, Canada.	peter.bogaty@fmed.ulaval.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875	Canadian Institutes of Health research	Canadian Institutes of Health research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health research (http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belalcazar LM, 2010, DIABETES CARE, V33, P2297, DOI 10.2337/dc10-0728; Bogaty P, 2005, ARCH INTERN MED, V165, P221, DOI 10.1001/archinte.165.2.221; Bogaty P, 2004, CIRCULATION, V110, P934, DOI 10.1161/01.CIR.0000139338.12464.5F; Bogaty P, 2001, CIRCULATION, V103, P3062, DOI 10.1161/01.CIR.103.25.3062; Bogaty P, 2008, J AM COLL CARDIOL, V51, P2339, DOI 10.1016/j.jacc.2008.03.019; Campbell B, 2002, ANN CLIN BIOCHEM, V39, P85, DOI 10.1258/0004563021901757; CLARK GH, 1993, ANN CLIN BIOCHEM, V30, P373, DOI 10.1177/000456329303000404; Cristell N, 2011, J AM COLL CARDIOL, V58, P2654, DOI 10.1016/j.jacc.2011.08.055; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; deMaat MPM, 1996, ARTERIOSCL THROM VAS, V16, P1156, DOI 10.1161/01.ATV.16.9.1156; Emberson J, 2011, J GERONTOL B-PSYCHOL, V377, P469; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Glynn RJ, 2009, CLIN CHEM, V55, P305, DOI 10.1373/clinchem.2008.120642; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Macy EM, 1997, CLIN CHEM, V43, P52; Ockene IS, 2001, CLIN CHEM, V47, P444; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sakkinen PA, 1999, AM J EPIDEMIOL, V149, P261; Sever PS, 2012, EUR HEART J, V33, P486, DOI 10.1093/eurheartj/ehr262; Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217; Woloshin S, 2005, NEW ENGL J MED, V352, P1611, DOI 10.1056/NEJM200504143521525	29	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60759	10.1371/journal.pone.0060759	http://dx.doi.org/10.1371/journal.pone.0060759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23579782	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000062
J	Chu, IM; Lai, WC; Aprelikova, O; El Touny, LH; Kouros-Mehr, H; Green, JE				Chu, Isabel M.; Lai, Wei-Chu; Aprelikova, Olga; El Touny, Lara H.; Kouros-Mehr, Hosein; Green, Jeffrey E.			Expression of GATA3 in MDA-MB-231 Triple-negative Breast Cancer Cells Induces a Growth Inhibitory Response to TGF beta	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; MAMMARY-GLAND; METASTASIS; DIFFERENTIATION; PROLIFERATION; TUMORIGENESIS; PROGRESSION; MIGRATION; LINES	Transforming growth factor (beta 1TGF beta 1) can promote proliferation in late stage cancers but acts as a tumor suppressor in normal epithelial cells and in early stage cancers. Although, the TGF beta pathway has been shown to play a key role in tumorigenesis and metastasis, only a limited number of models have been developed to understand this process. Here, we present a novel model system to discern this paradoxical role of TGF beta 1 using the MDA-MB-231 (MB-231) cell line. The MB-231 triple-negative breast cancer cell line has been extensively characterized and has been shown to continue to proliferate and undergo epithelial-to-mesenchymal transition (EMT) upon TGF beta 1 stimulation. We have previously shown by microarray analysis that expression of GATA3 in MB-231 cells results in reprogramming of these cells from a basal to a luminal subtype associated with a reduction of metastasis and tumorigenesis when implanted as xenografts. We now demonstrate that GATA3 overexpression in these cells results in a reduction of TGF beta 1 response, reversal of EMT, and most importantly, restoration of sensitivity to the inhibitory effects on proliferation of TGF beta 1. Microarray analysis revealed that TGF beta 1 treatment resulted in reduction of several cell cycle effectors in 231-GATA3 cells but not in control cells. Furthermore, our microarray analysis revealed a significant increase of BMP5 in 231-GATA3 cells. We demonstrate that combined treatment of MB-231 control cells with TGF beta 1 and BMP5 results in a significant reduction of cellular proliferation. Thus, this model offers a means to further investigate potentially novel mechanisms involved in the switch in response to TGF beta 1 from tumor promoter to tumor suppressor through the reprogramming of a triple-negative breast cancer cell line by the GATA3 transcription factor.	[Chu, Isabel M.; Lai, Wei-Chu; Aprelikova, Olga; El Touny, Lara H.; Kouros-Mehr, Hosein; Green, Jeffrey E.] NCI, Transgen Oncogenesis & Genom Sect, Lab Canc Biol & Genet, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Green, JE (corresponding author), NCI, Transgen Oncogenesis & Genom Sect, Lab Canc Biol & Genet, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	jegreen@nih.gov			Intramural program of the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC005740] Funding Source: NIH RePORTER	Intramural program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural program of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarmo EL, 2009, CANCER LETT, V275, P35, DOI 10.1016/j.canlet.2008.09.028; Andarawewa KL, 2007, CANCER RES, V67, P8662, DOI 10.1158/0008-5472.CAN-07-1294; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bramlage CP, 2011, J NEPHROL, V24, P647, DOI 10.5301/JN.2011.6330; Buijs JT, 2007, CANCER RES, V67, P8742, DOI 10.1158/0008-5472.CAN-06-2490; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Chu IM, 2012, ONCOGENE, V31, P2017, DOI 10.1038/onc.2011.382; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; Ghosh-Choudhury N, 2000, BIOCHEM BIOPH RES CO, V272, P705, DOI 10.1006/bbrc.2000.2844; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Romagnoli M, 2012, CANCER RES, V72, P6268, DOI 10.1158/0008-5472.CAN-12-2270; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Serra Rosa, 2003, Breast Dis, V18, P61; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Tamura G, 2000, J NATL CANCER I, V92, P569, DOI 10.1093/jnci/92.7.569; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian F, 2003, CANCER RES, V63, P8284; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Virtanen S, 2011, EXP CELL RES, V317, P2136, DOI 10.1016/j.yexcr.2011.06.001; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang K, 2011, J CANCER RES CLIN, V137, P1687, DOI 10.1007/s00432-011-1047-4; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yan W, 2010, J BIOL CHEM; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoon NK, 2010, HUM PATHOL, V41, P1794, DOI 10.1016/j.humpath.2010.06.010; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhou M, 2003, IMMUNOL RES, V28, P25, DOI 10.1385/IR:28:1:25	46	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61125	10.1371/journal.pone.0061125	http://dx.doi.org/10.1371/journal.pone.0061125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577196	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000102
J	Dang, HY; Zhou, HX; Zhang, ZN; Yu, ZS; Hua, E; Liu, XS; Jiao, NZ				Dang, Hongyue; Zhou, Haixia; Zhang, Zhinan; Yu, Zishan; Hua, Er; Liu, Xiaoshou; Jiao, Nianzhi			Molecular Detection of Candidatus Scalindua pacifica and Environmental Responses of Sediment Anammox Bacterial Community in the Bohai Sea, China	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; OXYGEN-MINIMUM-ZONE; RIBOSOMAL-RNA GENES; OXIDIZING BACTERIA; MARINE-SEDIMENTS; WIDESPREAD OCCURRENCE; SPATIAL-DISTRIBUTION; UNITED-KINGDOM; NITROGEN LOSS; NORTH CHINA	The Bohai Sea is a large semi-enclosed shallow water basin, which receives extensive river discharges of various terrestrial and anthropogenic materials such as sediments, nutrients and contaminants. How these terrigenous inputs may influence the diversity, community structure, biogeographical distribution, abundance and ecophysiology of the sediment anaerobic ammonium oxidation (anammox) bacteria was unknown. To answer this question, an investigation employing both 16S rRNA and hzo gene biomarkers was carried out. Ca. Scalindua bacteria were predominant in the surface sediments of the Bohai Sea, while non-Scalindua anammox bacteria were also detected in the Yellow River estuary and inner part of Liaodong Bay that received strong riverine and anthropogenic impacts. A novel 16S rRNA gene sequence clade was identified, putatively representing an anammox bacterial new candidate species tentatively named "Ca. Scalindua pacifica". Several groups of environmental factors, usually with distinct physicochemical or biogeochemical natures, including general marine and estuarine physicochemical properties, availability of anammox substrates (inorganic N compounds), alternative reductants and oxidants, environmental variations caused by river discharges and associated contaminants such as heavy metals, were identified to likely play important roles in influencing the ecology and biogeochemical functioning of the sediment anammox bacteria. In addition to inorganic N compounds that might play a key role in shaping the anammox microbiota, organic carbon, organic nitrogen, sulfate, sulfide and metals all showed the potentials to participate in the anammox process, releasing the strict dependence of the anammox bacteria upon the direct availability of inorganic N nutrients that might be limiting in certain areas of the Bohai Sea. The importance of inorganic N nutrients and certain other environmental factors to the sediment anammox microbiota suggests that these bacteria were active for the in situ N transforming process and maintained a versatile life style well adapted to the varying environmental conditions of the studied coastal ocean.	[Dang, Hongyue; Zhou, Haixia] China Univ Petr East China, State Key Lab Heavy Oil Proc, Key Lab Bioengn & Biotechnol Univ Shandong, Ctr Bioengn & Biotechnol, Qingdao, Peoples R China; [Dang, Hongyue; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Zhang, Zhinan; Yu, Zishan; Hua, Er; Liu, Xiaoshou] Ocean Univ China, Coll Life Sci & Technol, Qingdao, Peoples R China	China University of Petroleum; Xiamen University; Ocean University of China	Dang, HY (corresponding author), China Univ Petr East China, State Key Lab Heavy Oil Proc, Key Lab Bioengn & Biotechnol Univ Shandong, Ctr Bioengn & Biotechnol, Qingdao, Peoples R China.	DangHY20042000@yahoo.com.cn	Liu, Xiaoshou/B-3741-2008; Dang, Hongyue/H-6577-2019; Liu, Xiaoshou/I-3001-2019; HUA, Er/AAF-3504-2020	Liu, Xiaoshou/0000-0002-0017-7186; 	China NSFC [41076091, 91028011, 91028001, 40730847]; National Key Basic Research Program of China [2013CB955700]; China SOA [201105021]	China NSFC(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); China SOA	This work was supported by China NSFC (http://www.nsfc.gov.cn/Portal0/default166.htm) grants 41076091, 91028011, 91028001 and 40730847, National Key Basic Research Program of China (http://www.973.gov.cn/English/Index.aspx) grant 2013CB955700, and China SOA (http://www.soa.gov.cn/soa/index.htm) grant 201105021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amano T, 2007, MICROBES ENVIRON, V22, P232, DOI 10.1264/jsme2.22.232; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Brandsma J, 2011, ENV MICROBIOL REP, V3, P360, DOI 10.1111/j.1758-2229.2010.00233.x; Byrne N, 2009, ISME J, V3, P117, DOI 10.1038/ismej.2008.72; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Dai MX, 2009, B ENVIRON CONTAM TOX, V83, P907, DOI 10.1007/s00128-009-9842-1; Dale OR, 2009, ENVIRON MICROBIOL, V11, P1194, DOI 10.1111/j.1462-2920.2008.01850.x; Dalsgaard T, 2005, RES MICROBIOL, V156, P457, DOI 10.1016/j.resmic.2005.01.011; Dang HY, 2008, MICROBIOL-SGM, V154, P2084, DOI 10.1099/mic.0.2007/013581-0; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Dang HY, 2013, APPL ENVIRON MICROB, V79, P121, DOI 10.1128/AEM.01889-12; Dang HY, 2011, ENVIRON MICROBIOL, V13, P3059, DOI 10.1111/j.1462-2920.2011.02583.x; Dang HY, 2010, APPL ENVIRON MICROB, V76, P7036, DOI 10.1128/AEM.01264-10; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; Danovaro R., 2009, METHODS STUDY DEEP S; Dell'Anno A, 2000, MAR ECOL PROG SER, V196, P15, DOI 10.3354/meps196015; den Camp HJMO, 2006, BIOCHEM SOC T, V34, P174, DOI 10.1042/BST0340174; Dong LF, 2009, APPL ENVIRON MICROB, V75, P3171, DOI 10.1128/AEM.02511-08; Durbin AM, 2011, ENVIRON MICROBIOL, V13, P3219, DOI 10.1111/j.1462-2920.2011.02544.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fussel J, 2012, ISME J, V6, P1200, DOI 10.1038/ismej.2011.178; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China Standardization Administration of the People's Republic of China, 2008, 1737852007 GB; Gong J, 2012, 2 S DEPP SEA RES EAR; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Hannig M, 2007, LIMNOL OCEANOGR, V52, P1336, DOI 10.4319/lo.2007.52.4.1336; Harhangi HR, 2012, APPL ENVIRON MICROB, V78, P752, DOI 10.1128/AEM.07113-11; Hirsch MD, 2011, MICROB ECOL, V61, P264, DOI 10.1007/s00248-010-9743-1; Hogslund S, 2009, ISME J, V3, P647, DOI 10.1038/ismej.2009.17; Hong YG, 2011, MICROB ECOL, V62, P36, DOI 10.1007/s00248-011-9849-0; Hu BL, 2011, BIOCHEM SOC T, V39, P1811, DOI 10.1042/BST20110711; Hu LM, 2009, MAR CHEM, V113, P197, DOI 10.1016/j.marchem.2009.02.001; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Humbert S, 2010, ISME J, V4, P450, DOI 10.1038/ismej.2009.125; Jaeschke A, 2010, LIMNOL OCEANOGR, V55, P365, DOI 10.4319/lo.2010.55.1.0365; Jensen MM, 2011, ISME J, V5, P1660, DOI 10.1038/ismej.2011.44; Jetten MSM, 2009, CRIT REV BIOCHEM MOL, V44, P65, DOI 10.1080/10409230902722783; Jetten MSM, 1998, FEMS MICROBIOL REV, V22, P421, DOI 10.1016/S0168-6445(98)00023-0; Kalvelage T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029299; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Kim G, 2005, EARTH PLANET SC LETT, V237, P156, DOI 10.1016/j.epsl.2005.06.011; Kindaichi T, 2011, MICROBES ENVIRON, V26, P67, DOI 10.1264/jsme2.ME10158; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li LN, 1999, BIODIVERS CONSERV, V8, P659, DOI 10.1023/A:1008848203739; Li M, 2011, MICROBES ENVIRON, V26, P15, DOI 10.1264/jsme2.ME10131; Li M, 2010, APPL MICROBIOL BIOT, V86, P781, DOI 10.1007/s00253-009-2361-5; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039690; Liu ST, 2008, BIORESOURCE TECHNOL, V99, P6817, DOI 10.1016/j.biortech.2008.01.054; Liu WX, 2006, ENVIRON POLLUT, V140, P4, DOI 10.1016/j.envpol.2005.08.074; Liu XS, 2007, ESTUAR COAST SHELF S, V71, P616, DOI 10.1016/j.ecss.2006.09.013; Meyer RL, 2005, APPL ENVIRON MICROB, V71, P6142, DOI 10.1128/AEM.71.10.6142-6149.2005; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1016/0168-6496(94)00081-7; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; Nakajima J, 2008, BIOSCI BIOTECH BIOCH, V72, P2195, DOI 10.1271/bbb.80117; Nicholls JC, 2009, AQUAT MICROB ECOL, V55, P105, DOI 10.3354/ame01285; Penton CR, 2006, APPL ENVIRON MICROB, V72, P6829, DOI 10.1128/AEM.01254-06; Qin YW, 2011, MAR POLLUT BULL, V62, P371, DOI 10.1016/j.marpolbul.2010.09.028; Quan ZX, 2008, ENVIRON MICROBIOL, V10, P3130, DOI 10.1111/j.1462-2920.2008.01642.x; REDFIELD AC, 1958, AM SCI, V46, P205; Rooks C, 2012, FEMS MICROBIOL ECOL, V80, P19, DOI 10.1111/j.1574-6941.2011.01266.x; Rysgaard S, 2004, LIMNOL OCEANOGR, V49, P1493, DOI 10.4319/lo.2004.49.5.1493; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmid M, 2003, SYST APPL MICROBIOL, V26, P529, DOI 10.1078/072320203770865837; Schmid MC, 2008, ENVIRON MICROBIOL, V10, P3140, DOI 10.1111/j.1462-2920.2008.01732.x; Schmid MC, 2007, ENVIRON MICROBIOL, V9, P1476, DOI 10.1111/j.1462-2920.2007.01266.x; Schmid MC, 2005, APPL ENVIRON MICROB, V71, P1677, DOI 10.1128/AEM.71.4.1677-1684.2005; Shih R, 2011, J ENVIRON QUAL, V40, P1586, DOI 10.2134/jeq2011.0072; Shimamura M, 2007, APPL ENVIRON MICROB, V73, P1065, DOI 10.1128/AEM.01978-06; Shu QL, 2008, MAR ECOL-EVOL PERSP, V29, P413, DOI 10.1111/j.1439-0485.2008.00251.x; Simpson SL, 2005, HDB SEDIMENT QUALITY; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Strous M, 2004, ANNU REV MICROBIOL, V58, P99, DOI 10.1146/annurev.micro.58.030603.123605; Tang DL, 2006, ADV SPACE RES-SERIES, V37, P681, DOI 10.1016/j.asr.2005.04.045; Teske A, 2010, SCIENCE, V330, P1326, DOI 10.1126/science.1198400; Trimmer M, 2005, APPL ENVIRON MICROB, V71, P1923, DOI 10.1128/AEM.71.4.1923-1930.2005; Trimmer M, 2003, APPL ENVIRON MICROB, V69, P6447, DOI 10.1128/AEM.69.11.6447-6454.2003; US EPA, 2001, 823B01002 US EPA; van de Vossenberg J, 2008, ENVIRON MICROBIOL, V10, P3120, DOI 10.1111/j.1462-2920.2008.01643.x; van de Vossenberg J, 2013, ENVIRON MICROBIOL, V15, P1275, DOI 10.1111/j.1462-2920.2012.02774.x; van Niftrik L, 2012, MICROBIOL MOL BIOL R, V76, P585, DOI 10.1128/MMBR.05025-11; VANDEGRAAF AA, 1995, APPL ENVIRON MICROB, V61, P1246, DOI 10.1128/AEM.61.4.1246-1251.1995; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; Wan L, 2008, B ENVIRON CONTAM TOX, V80, P311, DOI 10.1007/s00128-008-9376-y; Wang BD, 2011, INT J OCEANOGR, V2011, DOI DOI 10.1155/2011/731828; Wang CY, 2007, J ENVIRON SCI, V19, P1061, DOI 10.1016/S1001-0742(07)60173-9; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Webster G, 2003, J MICROBIOL METH, V55, P155, DOI 10.1016/S0167-7012(03)00140-4; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Woebken D, 2008, ENVIRON MICROBIOL, V10, P3106, DOI 10.1111/j.1462-2920.2008.01640.x; Xu SS, 2011, J ENVIRON SCI-CHINA, V23, P553, DOI 10.1016/S1001-0742(10)60447-0; Zhang P, 2009, ENVIRON INT, V35, P632, DOI 10.1016/j.envint.2008.09.014; Zhang ZH, 2004, ENV RISK ASSESSMENT	99	61	67	5	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61330	10.1371/journal.pone.0061330	http://dx.doi.org/10.1371/journal.pone.0061330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577216	Green Published, gold			2022-12-27	WOS:000317898000125
J	Lyons, RA; Kendrick, D; Towner, EML; Coupland, C; Hayes, M; Christie, N; Sleney, J; Jones, S; Kimberlee, R; Rodgers, SE; Turner, S; Brussoni, M; Vinogradova, Y; Sarvotham, T; Macey, S				Lyons, Ronan A.; Kendrick, Denise; Towner, Elizabeth M. L.; Coupland, Carol; Hayes, Mike; Christie, Nicola; Sleney, Judith; Jones, Sarah; Kimberlee, Richard; Rodgers, Sarah E.; Turner, Samantha; Brussoni, Mariana; Vinogradova, Yana; Sarvotham, Tinnu; Macey, Steven			The Advocacy for Pedestrian Safety Study: Cluster Randomised Trial Evaluating a Political Advocacy Approach to Reduce Pedestrian Injuries in Deprived Communities	PLOS ONE			English	Article							CHILD; INEQUALITIES; POLICY	Objective: To determine whether advocacy targeted at local politicians leads to action to reduce the risk of pedestrian injury in deprived areas. Design: Cluster randomised controlled trial. Setting: 239 electoral wards in 57 local authorities in England and Wales. Participants: 617 elected local politicians. Interventions: Intervention group politicians were provided with tailored information packs, including maps of casualty sites, numbers injured and a synopsis of effective interventions. Main outcome measures: 25-30 months post intervention, primary outcomes included: electoral ward level: percentage of road traffic calmed; proportion with new interventions; school level: percentage with 20 mph zones, Safe Routes to School, pedestrian training or road safety education; politician level: percentage lobbying for safety measures. Secondary outcomes included politicians' interest and involvement in injury prevention, and facilitators and barriers to implementation. Results: Primary outcomes did not significantly differ: % difference in traffic calming (0.07, 95% CI: -0.07 to 0.20); proportion of schools with 20 mph zones (RR 1.47, 95% CI: 0.93 to 2.32), Safe Routes to School (RR 1.34, 95% CI: 0.83 to 2.17), pedestrian training (RR 1.23, 95% CI: 0.95 to 1.61) or other safety education (RR 1.16, 95% CI: 0.97 to 1.39). Intervention group politicians reported greater interest in child injury prevention (RR 1.09, 95% CI 1.03 to 1.16), belief in potential to help prevent injuries (RR 1.36, 95% CI 1.16 to 1.61), particularly pedestrian safety (RR 1.55, 95% CI 1.19 to 2.03). 63% of intervention politicians reported supporting new pedestrian safety schemes. The majority found the advocacy information surprising, interesting, effectively presented, and could identify suitable local interventions. Conclusions: This study demonstrates the feasibility of an innovative approach to translational public health by targeting local politicians in a randomised controlled trial. The intervention package was positively viewed and raised interest but changes in interventions were not statistically significance. Longer term supported advocacy may be needed. Trial Registration: Current Controlled Trials ISRCTN91381117.	[Lyons, Ronan A.; Jones, Sarah; Rodgers, Sarah E.; Turner, Samantha; Macey, Steven] Swansea Univ, Swansea, W Glam, Wales; [Kendrick, Denise; Coupland, Carol; Vinogradova, Yana] Univ Nottingham, Nottingham NG7 2RD, England; [Towner, Elizabeth M. L.; Kimberlee, Richard] Univ W England, Bristol BS16 1QY, Avon, England; [Hayes, Mike] Child Accid Prevent Trust, London, England; [Christie, Nicola] UCL, London, England; [Sleney, Judith] Univ Surrey, Surrey, England; [Jones, Sarah; Sarvotham, Tinnu] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales; [Brussoni, Mariana] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	Swansea University; University of Nottingham; University of West England; University of London; University College London; University of Surrey; Cardiff University; University of British Columbia	Lyons, RA (corresponding author), Swansea Univ, Swansea, W Glam, Wales.	r.a.lyons@swansea.ac.uk	Brussoni, Mariana/U-9404-2018	Brussoni, Mariana/0000-0002-1495-816X; Lyons, Ronan/0000-0001-5225-000X; Coupland, Carol/0000-0002-2327-3306; Christie, Nicola/0000-0001-7152-5240; Kendrick, Denise/0000-0003-3603-6542; Rodgers, Sarah/0000-0002-4483-0845; Hayes, Mike/0000-0002-7738-9451	Department of Health Policy Relevant Research Programme, Moving from Observation to Intervention to reduce inequalities in injury (MOI) grant [001-0009]; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [MR/K006525/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [MR/K006525/1] Funding Source: researchfish	Department of Health Policy Relevant Research Programme, Moving from Observation to Intervention to reduce inequalities in injury (MOI) grant; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Department of Health Policy Relevant Research Programme as part of the Moving from Observation to Intervention to reduce inequalities in injury (MOI) grant, reference 001-0009. The views expressed by the independent researchers in this paper are their own and do not necessarily reflect the views of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audit Commission, 2007, CHANG LAN EV ROL ROA; Audit Commission, 2005, QUAL LIF IND; Bergman AB, 2002, INJ PREV, V8, P264, DOI 10.1136/ip.8.4.264; Carlisle S, 2000, HEALTH PROMOT INT, V15, P369, DOI 10.1093/heapro/15.4.369; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coupland C, 2003, BRIT MED J, V327, P593, DOI 10.1136/bmj.327.7415.593; Department for Transport, 2009, SAF WAY CONS MAK BRI; Department of Health (DoH), 2011, HLTH LIV HLTH PEOPL; Edwards P, 2006, BMJ-BRIT MED J, V333, P119, DOI 10.1136/bmj.38875.757488.4F; Elvick R, 2004, HDB ROAD SAFETY MEAS; Engel U, 1982, SEM SHORT TERM AR WI, P251; FAWCETT SB, 1987, J SOC ISSUES, V43, P133, DOI 10.1111/j.1540-4560.1987.tb01300.x; Gielen ACE., 2006, INJURY VIOLENCE PREV; Graham D, 2005, ACCIDENT ANAL PREV, V37, P125, DOI 10.1016/j.aap.2004.07.002; Grundy C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4469; Gulliford MC, 1999, AM J EPIDEMIOL, V149, P876; House of Commons Public Accounts Committee, 2009, 49 HOUS COMM PUBL AC; JASON LA, 1984, AM J COMMUN PSYCHOL, V12, P485, DOI 10.1007/BF00896507; Jones SJ, 2005, INJURY PREV, V11, P152, DOI 10.1136/ip.2004.007252; Lyons RA, 2008, INJURY PREV, V14, DOI 10.1136/ip.2007.017632; Lyons RA, 2006, INJURY PREV, V12, P312, DOI 10.1136/ip.2006.011916; McCubbin M, 2001, ADVOCACY HLTH PUBLIC; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Milward L, 2003, PUBLIC HLTH INTERVEN; Ogilvie D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-116; Ordnance Survey, 2007, OS MASTERMAP INT TRA; Peden M., 2008, World report on child injury prevention; Peden M, 2002, INJURY LEADING CAUSE; Peden M., 2004, WORLD REPORT ROAD TR; Phillimore P., 1987, HLTH DEPRIVATION INE; Poulos R, 2007, INJURY PREV, V13, P322, DOI 10.1136/ip.2007.015693; RIVARA FP, 1985, PEDIATRICS, V76, P375; Rodgers SE, 2010, INJURY PREV, V16, P7, DOI 10.1136/ip.2009.022426; RUNYAN CW, 1985, AM J PUBLIC HEALTH, V75, P354, DOI 10.2105/AJPH.75.4.354; SCHELP L, 1988, SOC SCI MED, V26, P1087, DOI 10.1016/0277-9536(88)90183-9; Towner E, 2001, WHAT WORKS PREVENTIN; Ward H, 2007, TOMORROWS ROADS SAFE; Webster D, 1996, 215 TRL; WHO, 1986, 1 INT C HLTH PROM OT, DOI DOI 10.1093/HEAPRO/1.4.405; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	41	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60158	10.1371/journal.pone.0060158	http://dx.doi.org/10.1371/journal.pone.0060158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130FG	23577088	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000022
J	Chen, P; Gan, Y; Han, N; Fang, W; Li, JF; Zhao, F; Hu, KH; Rayner, S				Chen, Ping; Gan, Yun; Han, Na; Fang, Wei; Li, Jiafu; Zhao, Fei; Hu, Kanghong; Rayner, Simon			Computational Evolutionary Analysis of the Overlapped Surface (S) and Polymerase (P) Region in Hepatitis B Virus Indicates the Spacer Domain in P Is Crucial for Survival	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; C-VIRUS; REVERSE-TRANSCRIPTASE; IMMUNE-RESPONSE; STRUCTURE PREDICTION; READING FRAMES; RNA-BINDING; T-CELLS; ANTIGEN; SELECTION	Introduction: The Hepatitis B Virus (HBV) genome contains four ORFs, S (surface), P (polymerase), C (core) and X. S is completely overlapped by P and as a consequence the overlapping region is subject to distinctive evolutionary constraints compared to the remainder of the genome. Specifically, a non-synonymous substitution in one coding frame may produce a synonymous substitution in the alternative frame, suggesting a possible conflict between requirements for diversifying and purifying forces. To examine how these contrasting requirements are balanced within this region, we investigated the relationship amongst positive selection sites, conserved regions, epitopes and elements of protein structure to consider how HBV balances the contrasting evolutionary pressures. Methodology/Results: 323 HBV genotype D genome sequences were collected and analyzed to identify sites under positive selection and highly conserved regions. Epitopes sequences were retrieved from previously published experimental studies stored in the Immune Epitope Database. Predicted secondary structures were used to investigate the association between structure and conservation. Entropy was used as a measure of conservation and bivariate logistic regression was used to investigate the relationship between positive selection/conserved sites and epitope/secondary structure regions. Our results indicate: (i) conservation in S is primarily dictated by alpha-helix elements in the protein structure, (ii) variable residues are mainly located in PreS, the major hydrophilic region (MHR) and the C-terminus, (iii) epitopes in S, which are directly targeted by the host immune system, are significantly associated with sites under positive selection. Conclusions: The highly variable spacer domain in P, which corresponds to PreS in S, appears to act as a harbor for the accumulation of mutations that can provide flexibility for conformational changes and responding to immune pressure.	[Chen, Ping; Han, Na; Fang, Wei; Rayner, Simon] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China; [Chen, Ping; Gan, Yun; Zhao, Fei; Hu, Kanghong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Li, Jiafu] Wuhan Univ, Zhongnan Hosp, Dept Obstet & Gynecol, Wuhan 430072, Peoples R China; [Hu, Kanghong] Hubei Univ Technol, Biomed Ctr, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Wuhan University; Hubei University of Technology	Hu, KH (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	hukgh@wh.iov.cn; s.raynere@wh.iov.cn	rayner, simon/N-7715-2013; Hu, Kanghong/AAL-3011-2020	rayner, simon/0000-0001-8703-9140; 	National Major Science and Technology Special Projects for Infectious Diseases of China [2012ZX10004503-008, 2012ZX10001006-002, 2012ZX10002006-002]; National Basic Research Program of China [2012CB721100]	National Major Science and Technology Special Projects for Infectious Diseases of China; National Basic Research Program of China(National Basic Research Program of China)	The work was supported by grants from the National Major Science and Technology Special Projects for Infectious Diseases of China (2012ZX10004503-008, 2012ZX10001006-002, 2012ZX10002006-002) and the National Basic Research Program of China (2012CB721100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badtke MP, 2009, VIROLOGY, V390, P130, DOI 10.1016/j.virol.2009.04.023; Bertoletti A, 2010, ANTIVIR THER, V15, P15, DOI 10.3851/IMP1620; Bettella F, 2012, J CHEM INF MODEL, V52, P545, DOI 10.1021/ci200321u; Blanchet M, 2007, J VIROL, V81, P5841, DOI 10.1128/JVI.00096-07; Bruss V, 1997, J VIROL, V71, P9350, DOI 10.1128/JVI.71.12.9350-9357.1997; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; Chang JJ, 2007, IMMUNOL CELL BIOL, V85, P16, DOI 10.1038/sj.icb.7100009; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; Cheng Jianlin, 2008, IEEE Rev Biomed Eng, V1, P41, DOI 10.1109/RBME.2008.2008239; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Coleman PF, 2006, EMERG INFECT DIS, V12, P198, DOI 10.3201/eid1203.050038; Daga PR, 2010, PROTEIN SCI, V19, P796, DOI 10.1002/pro.359; Depla E, 2008, J VIROL, V82, P435, DOI 10.1128/JVI.01505-07; Doherty P C, 1993, Trends Microbiol, V1, P207, DOI 10.1016/0966-842X(93)90133-C; Donlin MJ, 2012, J VIROL, V86, P3050, DOI 10.1128/JVI.06857-11; Durantel D, 2010, ANTIVIR THER, V15, P521, DOI 10.3851/IMP1551; Feng Hui, 2009, Virologica Sinica, V24, P509, DOI 10.1007/s12250-009-3076-6; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Guyader S, 2002, J GEN VIROL, V83, P1799, DOI 10.1099/0022-1317-83-7-1799; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hu JM, 2006, J VIROL, V80, P2141, DOI 10.1128/JVI.80.5.2141-2150.2006; Hu JM, 2004, J VIROL, V78, P13122, DOI 10.1128/JVI.78.23.13122-13131.2004; Hu JM, 2002, J VIROL, V76, P269, DOI 10.1128/JVI.76.1.269-279.2002; Hu ZY, 1999, J VIROL, V73, P7231, DOI 10.1128/JVI.73.9.7231-7240.1999; Huang CF, 2006, CELL MOL IMMUNOL, V3, P97; Hughes AL, 2001, J VIROL, V75, P7966, DOI 10.1128/JVI.75.17.7966-7972.2001; JUNG MC, 1994, EUR J CLIN INVEST, V24, P641, DOI 10.1111/j.1365-2362.1994.tb01055.x; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kakimi K, 2002, J VIROL, V76, P8609, DOI 10.1128/JVI.76.17.8609-8620.2002; Lai Ming-Wei, 2010, J Med Case Rep, V4, P190, DOI 10.1186/1752-1947-4-190; Le Seyec J, 1999, J VIROL, V73, P2052, DOI 10.1128/JVI.73.3.2052-2057.1999; Mikulska M, 2012, J MED VIROL, V84, P1340, DOI 10.1002/jmv.23338; MILICH DR, 1990, P NATL ACAD SCI USA, V87, P6599, DOI 10.1073/pnas.87.17.6599; Mizokami M, 1997, J MOL EVOL, V44, pS83, DOI 10.1007/PL00000061; Mizukoshi E, 2004, J IMMUNOL, V173, P5863, DOI 10.4049/jimmunol.173.9.5863; Myers R, 2006, J GEN VIROL, V87, P1459, DOI 10.1099/vir.0.81734-0; Narechania A, 2005, J GEN VIROL, V86, P1307, DOI 10.1099/vir.0.80747-0; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Ni Y, 2010, J VIROL, V84, P3879, DOI 10.1128/JVI.02528-09; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Ogura Y, 1999, J INFECT DIS, V180, P1444, DOI 10.1086/315094; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirovano W, 2010, METHODS MOL BIOL, V609, P327, DOI 10.1007/978-1-60327-241-4_19; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; PRANGE R, 1995, EMBO J, V14, P247, DOI 10.1002/j.1460-2075.1995.tb06998.x; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; RADZIWILL G, 1990, J VIROL, V64, P613, DOI 10.1128/JVI.64.2.613-620.1990; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Salemi M, 2002, J MOL EVOL, V54, P62, DOI 10.1007/s00239-001-0018-9; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schewe K, 2010, VIRUSES-BASEL, V2, P1564, DOI 10.3390/v2081564; Snoeck J, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-87; Sobao Y, 2001, J HEPATOL, V34, P922, DOI 10.1016/S0168-8278(01)00048-4; Stahl M, 2007, NUCLEIC ACIDS RES, V35, P6124, DOI 10.1093/nar/gkm628; STIRK HJ, 1992, INTERVIROLOGY, V33, P148, DOI 10.1159/000150244; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Strait BJ, 1996, BIOPHYS J, V71, P148, DOI 10.1016/S0006-3495(96)79210-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099; van de Klundert MAA, 2012, J VIRAL HEPATITIS, V19, pE34, DOI 10.1111/j.1365-2893.2011.01506.x; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Wang XT, 2002, J BIOL CHEM, V277, P24361, DOI 10.1074/jbc.M202198200; Wang ZY, 2011, PROTEOMICS, V11, P3786, DOI 10.1002/pmic.201100196; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yewdell JW, 1999, ANNU REV CELL DEV BI, V15, P579, DOI 10.1146/annurev.cellbio.15.1.579; Zaaijer HL, 2007, J GEN VIROL, V88, P2137, DOI 10.1099/vir.0.82906-0; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	73	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60098	10.1371/journal.pone.0060098	http://dx.doi.org/10.1371/journal.pone.0060098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577084	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800027
J	Christie, AF; Dent, C; McIntyre, P; Wilson, L; Studdert, DM				Christie, Andrew F.; Dent, Chris; McIntyre, Peter; Wilson, Lachlan; Studdert, David M.			Patents Associated with High-Cost Drugs in Australia	PLOS ONE			English	Article							INNOVATION	Australia, like most countries, faces high and rapidly-rising drug costs. There are longstanding concerns about pharmaceutical companies inappropriately extending their monopoly position by "evergreening" blockbuster drugs, through misuse of the patent system. There is, however, very little empirical information about this behaviour. We fill the gap by analysing all of the patents associated with 15 of the costliest drugs in Australia over the last 20 years. Specifically, we search the patent register to identify all the granted patents that cover the active pharmaceutical ingredient of the high-cost drugs. Then, we classify the patents by type, and identify their owners. We find a mean of 49 patents associated with each drug. Three-quarters of these patents are owned by companies other than the drug's originator. Surprisingly, the majority of all patents are owned by companies that do not have a record of developing top-selling drugs. Our findings show that a multitude of players seek monopoly control over innovations to blockbuster drugs. Consequently, attempts to control drug costs by mitigating misuse of the patent system are likely to miss the mark if they focus only on the patenting activities of originators.	[Christie, Andrew F.; Dent, Chris; Studdert, David M.] Univ Melbourne, Melbourne Law Sch, Melbourne, Vic, Australia; [McIntyre, Peter] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia; [Wilson, Lachlan] Univ Melbourne, UoM Commercial Ltd, Melbourne, Vic, Australia; [Studdert, David M.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia	University of Melbourne; Royal Melbourne Institute of Technology (RMIT); University of Melbourne; University of Melbourne	Christie, AF (corresponding author), Univ Melbourne, Melbourne Law Sch, Melbourne, Vic, Australia.	a.christie@unimelb.edu.au	Studdert, David/AAF-3116-2021; Dent, Chris/R-1155-2019; Mcintyre, Peter/N-4109-2013	Studdert, David/0000-0003-0585-5537; Dent, Chris/0000-0002-1801-713X; Wilson, Lachlan/0000-0003-4534-2365; McIntyre, Peter/0000-0001-9506-5998	Australian Research Council [DP0987570]	Australian Research Council(Australian Research Council)	This research was funded by the Australian Research Council (http://www.arc.gov.au/), as Discovery Project DP0987570, Chief Investigators: AF Christie, DM Studdert, P McIntyre, C Dent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken M, 2009, HEALTH AFFAIR, V28, pW151, DOI 10.1377/hlthaff.28.1.w151; Amin T, 2012, HEALTH AFFAIR, V31, P2286, DOI 10.1377/hlthaff.2012.0107; Australian Institute of Health and Welfare, 2011, HLTH WELFARE EXPENDI, V46; Bouchard R, 2010, NW J TECHNOLOGY INTE, V8, P174; Chalmers Robert, 2006, MELB UNIV LAW REV, V30, P29; Chesmond R, 2006, FLINDERS J L REF, V9, P51; Department of Health Housing and Community Services, 1992, AUSTR STAT MED; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Engelberg AB, 2009, NEW ENGL J MED, V361, P1917, DOI 10.1056/NEJMp0908496; European Commission Competition DG, 2009, PHARM SECT INQ FIN 1; European Patent Office, EXT INPADOC PAT FAM; European Patent Office, WORLDW PAT STAT DAT; Faunce T, 2007, AUST NZ HLTH POLICY, V4; Food and Drug Administration, OR BOOK APPR DRUG PR; Gladwell M, 2004, NEW YORKER; Glasgow Lara J., 2001, IDEA, V41, P227; Hemphill CS, 2012, J HEALTH ECON, V31, P327, DOI 10.1016/j.jhealeco.2012.01.004; Jackevicius CA, 2012, NEW ENGL J MED, V366, P201, DOI 10.1056/NEJMp1113112; Mergent Online, AB MERG ONL; O'Neil MJ, 2010, MERCK INDEX ENCY CHE; Ouellette Lisa Larrimore, 2010, MICH TELECOMM TECH L, V17, P300; Parker Scott, 2007, J COMMERCIAL BIOTECH, V13, P235, DOI DOI 10.1057/PALGRAVE.JCB.3050066; Westlaw, DERW WORLD PAT LEG L; WHO Collaborating Centre for Drug Statistics Methodology, ATC STRUCT PRINC; World Health Organization, INT NONPR NAM	25	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60812	10.1371/journal.pone.0060812	http://dx.doi.org/10.1371/journal.pone.0060812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RZ	23577165	Green Published, gold			2022-12-27	WOS:000319109800103
J	Laird, A; O'Mahony, FC; Nanda, J; Riddick, ACP; O'Donnell, M; Harrison, DJ; Stewart, GD				Laird, Alexander; O'Mahony, Fiach C.; Nanda, Jyoti; Riddick, Antony C. P.; O'Donnell, Marie; Harrison, David J.; Stewart, Grant D.			Differential Expression of Prognostic Proteomic Markers in Primary Tumour, Venous Tumour Thrombus and Metastatic Renal Cell Cancer Tissue and Correlation with Patient Outcome	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESSENGER-RNA EXPRESSION; P53 PROTEIN EXPRESSION; CLEAR-CELL; PATHOLOGICAL FEATURES; COLORECTAL-CANCER; INTERFERON-ALPHA; CARCINOMA; SURVIVAL; GENE	Renal cell carcinoma (RCC) is the most deadly of urological malignancies. Metastatic disease affects one third of patients at diagnosis with a further third developing metastatic disease after extirpative surgery. Heterogeneity in the clinical course ensures predicting metastasis is notoriously difficult, despite the routine use of prognostic clinico-pathological parameters in risk stratification. With greater understanding of pathways involved in disease pathogenesis, a number of biomarkers have been shown to have prognostic significance, including Ki67, p53, vascular endothelial growth factor receptor 1 (VEGFR1) and ligand D (VEGFD), SNAIL and SLUG. Previous pathway analysis has been from study of the primary tumour, with little attention to the metastatic tumours which are the focus of targeted molecular therapies. As such, in this study a tissue microarray from 177 patients with primary renal tumour, renal vein tumour thrombus and/or RCC metastasis has been created and used with Automated Quantitative Analysis (AQUA) of immunofluorescence to study the prognostic significance of these markers in locally advanced and metastatic disease. Furthermore, this has allowed assessment of differential protein expression between the primary tumours, renal vein tumour thrombi and metastases. The results demonstrate that clinico-pathological parameters remain the most significant predictors of cancer specific survival; however, high VEGFR1 or VEGFD can predict poor cancer specific survival on univariate analysis for locally advanced and metastatic disease. There was significantly greater expression of Ki67, p53, VEGFR1, SLUG and SNAIL in the metastases compared with the primary tumours and renal vein tumour thrombi. With the exception of p53, these differences in protein expression have not been shown previously in RCC. This confirms the importance of proliferation, angiogenesis and epithelial to mesenchymal transition in the pathogenesis and metastasis of RCC. Importantly, this work highlights the need for further pathway analysis of metastatic tumours for overcoming drug resistance and developing new therapies.	[Laird, Alexander] Univ Edinburgh, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Laird, Alexander; O'Mahony, Fiach C.; Nanda, Jyoti; Riddick, Antony C. P.; Harrison, David J.; Stewart, Grant D.] Univ Edinburgh, Edinburgh Urol Canc Grp, Edinburgh, Midlothian, Scotland; [O'Donnell, Marie] Western Gen Hosp, Dept Pathol, Edinburgh EH4 2XU, Midlothian, Scotland; [Harrison, David J.] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of St Andrews	Laird, A (corresponding author), Univ Edinburgh, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.	alex.laird@ed.ac.uk		Stewart, Grant D./0000-0003-3188-9140; harrison, david/0000-0001-9041-9988	Royal College of Surgeons of Edinburgh Robertson's Trust; Melville Trust for the care and cure of cancer; Medical Research Council Scottish Clinical Pharmacology and Pathology Programme; Chief Scientist Office [ETM37]; Cancer Research UK Experimental Cancer Medicine Centre; MRC [G1000419] Funding Source: UKRI; Medical Research Council [G1000419] Funding Source: researchfish; Chief Scientist Office [ETM/37] Funding Source: researchfish	Royal College of Surgeons of Edinburgh Robertson's Trust; Melville Trust for the care and cure of cancer; Medical Research Council Scottish Clinical Pharmacology and Pathology Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office; Cancer Research UK Experimental Cancer Medicine Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The work of the author AL is funded by The Royal College of Surgeons of Edinburgh Robertson's Trust, The Melville Trust for the care and cure of cancer and The Medical Research Council Scottish Clinical Pharmacology and Pathology Programme. The work of authors FCO, JN, ACPR, DJH and GDS mentioned above is funded by the Chief Scientist Office, grant number ETM37, and supported by Chief Scientist Funded Health Sciences Scotland and the Cancer Research UK Experimental Cancer Medicine Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agui T, 2002, ANTICANCER RES, V22, P1769; Anjomshoaa A, 2009, BRIT J CANCER, V101, P822, DOI 10.1038/sj.bjc.6605229; Backus HHJ, 2002, J CLIN PATHOL, V55, P206, DOI 10.1136/jcp.55.3.206; BLATH RA, 1976, J UROLOGY, V115, P514, DOI 10.1016/S0022-5347(17)59263-0; Blute ML, 2004, J UROLOGY, V172, P465, DOI 10.1097/01.ju.0000129815.91927.85; BOT FJ, 1994, INT J CANCER, V57, P634; Brannon A Rose, 2010, Genes Cancer, V1, P152; Calascibetta A, 2006, NUCLEOS NUCLEOT NUCL, V25, P1193, DOI 10.1080/15257770600894527; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Capitanio U, 2009, BJU INT, V103, P33, DOI 10.1111/j.1464-410X.2008.08014.x; Cheville JC, 2002, CANCER, V94, P2180, DOI 10.1002/cncr.10433; D'Andrea MR, 2007, BREAST CANCER RES TR, V101, P279, DOI 10.1007/s10549-006-9300-2; Delahunt B, 1999, PATHOLOGY, V31, P185, DOI 10.1080/003130299104945; Delahunt B, 2002, CANCER-AM CANCER SOC, V94, P658, DOI 10.1002/cncr.10255; Delahunt B, 2009, MODERN PATHOL, V22, pS24, DOI 10.1038/modpathol.2008.183; Dirim A, 2008, INT UROL NEPHROL, V40, P861, DOI 10.1007/s11255-008-9362-7; Ficarra V, 2001, UROL INT, V67, P130, DOI 10.1159/000050968; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Ganepola GAP, 2010, CLIN EXP METASTAS, V27, P1, DOI 10.1007/s10585-009-9295-2; Gelb AB, 1997, CANCER-AM CANCER SOC, V80, P1768, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1768::AID-CNCR11>3.0.CO;2-3; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Green FL, 2002, AJCC CANC STAGING MA, P323; Haitel A, 2000, CLIN CANCER RES, V6, P1840; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hofmockel G, 1996, J UROLOGY, V156, P18, DOI 10.1016/S0022-5347(01)65926-3; Jacobsen J, 2004, BJU INT, V93, P297, DOI 10.1111/j.1464-410X.2004.04605.x; Janzen NK, 2003, UROL CLIN N AM, V30, P843, DOI 10.1016/S0094-0143(03)00056-9; Kawasaki T, 1999, ONCOL REP, V6, P329; Kikuchi H, 2006, CANCER SCI, V97, P127, DOI 10.1111/j.1349-7006.2006.00154.x; Kim HL, 2005, J UROLOGY, V173, P1496, DOI 10.1097/01.ju.0000154351.37249.f0; Klatte T, 2009, CANCER EPIDEM BIOMAR, V18, P894, DOI 10.1158/1055-9965.EPI-08-0786; Kobayashi H, 2008, ANN SURG ONCOL, V15, P1232, DOI 10.1245/s10434-008-9811-7; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lam JS, 2005, WORLD J UROL, V23, P202, DOI 10.1007/s00345-004-0466-0; Lau WK, 2002, UROLOGY, V59, P532, DOI 10.1016/S0090-4295(01)01589-8; Lee CT, 2003, UROL ONCOL-SEMIN ORI, V21, P179, DOI 10.1016/S1078-1439(02)00236-3; Lee JL, 2012, ANN ONCOL, V23, P2108, DOI 10.1093/annonc/mdr586; Lee JS, 2001, J SURG ONCOL, V77, P55, DOI 10.1002/jso.1066; LIPPONEN P, 1994, INT J CANCER, V57, P275, DOI 10.1002/ijc.2910570224; Ljungberg BJ, 2006, BJU INT, V98, P661, DOI 10.1111/j.1464-410X.2006.06387.x; Lughezzani G, 2009, CANCER-AM CANCER SOC, V115, P5680, DOI 10.1002/cncr.24682; Malmstrom PU, 2002, J UROLOGY, V168, P2240, DOI 10.1016/S0022-5347(05)64363-7; Mian BM, 2002, J UROLOGY, V167, P65, DOI 10.1016/S0022-5347(05)65384-0; Mikami S, 2011, LAB INVEST, V91, P1443, DOI 10.1038/labinvest.2011.111; Minervini R, 2000, BJU INT, V86, P199, DOI 10.1046/j.1464-410x.2000.00826.x; Moch H, 2000, CANCER, V89, P604, DOI 10.1002/1097-0142(20000801)89:3<604::AID-CNCR16>3.3.CO;2-H; Moch H, 1997, UROL RES, V25, pS25, DOI 10.1007/BF00942044; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; O'Mahony FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031557; Rioux-Leclercq N, 2000, UROLOGY, V55, P501, DOI 10.1016/S0090-4295(99)00550-6; Schultz L, 2011, AM J SURG PATHOL, V35, P1549, DOI 10.1097/PAS.0b013e31822895e5; Stewart GD, 2011, NAT REV UROL, V8, P255, DOI 10.1038/nrurol.2011.43; Sun M, 2011, EUR UROL, V60, P644, DOI 10.1016/j.eururo.2011.06.041; Tunuguntla HSGR, 2008, J UROLOGY, V179, P2096, DOI 10.1016/j.juro.2008.01.083; Turner KJ, 2002, CANCER RES, V62, P2957; UHLMAN DL, 1994, J NATL CANCER I, V86, P1470, DOI 10.1093/jnci/86.19.1470; Wiesener MS, 2001, CANCER RES, V61, P5215; Zhao HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006039; Zigeuner R, 2004, UROLOGY, V63, P651, DOI 10.1016/j.urology.2003.11.011; Zisman A, 2002, J CLIN ONCOL, V20, P1368, DOI 10.1200/JCO.20.5.1368; Zisman A, 2001, J CLIN ONCOL, V19, P1649, DOI 10.1200/JCO.2001.19.6.1649	65	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60483	10.1371/journal.pone.0060483	http://dx.doi.org/10.1371/journal.pone.0060483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577117	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800056
J	Micheli, F; Levin, N; Giakoumi, S; Katsanevakis, S; Abdulla, A; Coll, M; Fraschetti, S; Kark, S; Koutsoubas, D; Mackelworth, P; Maiorano, L; Possingham, HP				Micheli, Fiorenza; Levin, Noam; Giakoumi, Sylvaine; Katsanevakis, Stelios; Abdulla, Ameer; Coll, Marta; Fraschetti, Simonetta; Kark, Salit; Koutsoubas, Drosos; Mackelworth, Peter; Maiorano, Luigi; Possingham, Hugh P.			Setting Priorities for Regional Conservation Planning in the Mediterranean Sea	PLOS ONE			English	Article							MARINE CONSERVATION; SPECIES DISTRIBUTION; MANAGEMENT; BIODIVERSITY; HABITATS; COASTAL; COSTS; INITIATIVES; EFFICIENCY; FRAMEWORK	Spatial prioritization in conservation is required to direct limited resources to where actions are most urgently needed and most likely to produce effective conservation outcomes. In an effort to advance the protection of a highly threatened hotspot of marine biodiversity, the Mediterranean Sea, multiple spatial conservation plans have been developed in recent years. Here, we review and integrate these different plans with the goal of identifying priority conservation areas that represent the current consensus among the different initiatives. A review of six existing and twelve proposed conservation initiatives highlights gaps in conservation and management planning, particularly within the southern and eastern regions of the Mediterranean and for offshore and deep sea habitats. The eighteen initiatives vary substantially in their extent (covering 0.1-58.5% of the Mediterranean Sea) and in the location of additional proposed conservation and management areas. Differences in the criteria, approaches and data used explain such variation. Despite the diversity among proposals, our analyses identified ten areas, encompassing 10% of the Mediterranean Sea, that are consistently identified among the existing proposals, with an additional 10% selected by at least five proposals. These areas represent top priorities for immediate conservation action. Despite the plethora of initiatives, major challenges face Mediterranean biodiversity and conservation. These include the need for spatial prioritization within a comprehensive framework for regional conservation planning, the acquisition of additional information from data-poor areas, species or habitats, and addressing the challenges of establishing transboundary governance and collaboration in socially, culturally and politically complex conditions. Collective prioritised action, not new conservation plans, is needed for the north, western, and high seas of the Mediterranean, while developing initial information-based plans for the south and eastern Mediterranean is an urgent requirement for true regional conservation planning.	[Micheli, Fiorenza] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Levin, Noam] Hebrew Univ Jerusalem, Dept Geog, Jerusalem, Israel; [Giakoumi, Sylvaine] Hellen Ctr Marine Res, Inst Marine Biol Resources, Ag Kosmas, Greece; [Giakoumi, Sylvaine; Abdulla, Ameer; Kark, Salit; Possingham, Hugh P.] Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Katsanevakis, Stelios] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Water Resources Unit, Ispra, Italy; [Abdulla, Ameer] UNEP World Conservat Monitoring Ctr, Cambridge, England; [Coll, Marta] Inst Marine Sci, Marine Renewal Resources Dept ICM CSIC, Barcelona, Spain; [Fraschetti, Simonetta] Univ Salento, Marine Biol Lab, CoNISMa, Lecce, Italy; [Kark, Salit] Hebrew Univ Jerusalem, Biodivers Res Grp, Dept Ecol Evolut & Behav, Jerusalem, Israel; [Koutsoubas, Drosos] Univ Aegean, Sch Environm, Dept Marine Sci, Mitilini, Greece; [Koutsoubas, Drosos] Natl Marine Pk Zakynthos, Zakynthos, Greece; [Mackelworth, Peter] Blue World Inst Marine Res & Conservat, Dept Conservat, Veli Losinj, Croatia; [Maiorano, Luigi] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy	Stanford University; Hebrew University of Jerusalem; Hellenic Centre for Marine Research; University of Queensland; European Commission Joint Research Centre; EC JRC ISPRA Site; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); CoNISMa; University of Salento; Hebrew University of Jerusalem; University of Aegean; Sapienza University Rome	Micheli, F (corresponding author), Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	micheli@stanford.edu	Katsanevakis, Stelios/AGR-7012-2022; Possingham, Hugh/B-1337-2008; Levin, Noam/D-2180-2013; Kark, Salit/I-7123-2013; Maiorano, Luigi/A-8637-2008; Fraschetti, Simonetta/R-8716-2019; Giakoumi, Sylvaine/I-2702-2014; Kark, Salit/C-6795-2016; POSSINGHAM, HUGH/R-8310-2019; Katsanevakis, Stelios/AAD-8289-2020; Coll, Marta/A-9488-2012	Katsanevakis, Stelios/0000-0002-5137-7540; Possingham, Hugh/0000-0001-7755-996X; Levin, Noam/0000-0002-9434-7501; Kark, Salit/0000-0002-7183-3988; Maiorano, Luigi/0000-0002-2957-8979; Fraschetti, Simonetta/0000-0002-1780-1651; Kark, Salit/0000-0002-7183-3988; POSSINGHAM, HUGH/0000-0001-7755-996X; Micheli, Fiorenza/0000-0002-6865-1438; Giakoumi, Sylvaine/0000-0002-3301-5538; Mackelworth, Peter/0000-0003-2135-1208; Coll, Marta/0000-0001-6235-5868	Australian Research Council Centre of Excellence for Environmental Decisions; Pew Marine Trust; Oak Foundation; NETMED; European Union; Greek State; Ramon y Cajal fellowship program of the Spanish Government; MedPAN Network; European Community's 7th Framework Programme (FP7) [287844]	Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council); Pew Marine Trust; Oak Foundation; NETMED; European Union(European Commission); Greek State; Ramon y Cajal fellowship program of the Spanish Government; MedPAN Network; European Community's 7th Framework Programme (FP7)	The workshop in which this work was initiated was funded by The Australian Research Council Centre of Excellence for Environmental Decisions (www.ceed.edu.au). The Greek television channel SKAI (www.skai.gr/tv/) covered workshop participants' accommodation. The Biodiversity Research Group provided the workshop with consumables. FM acknowledges the support of the Pew Marine Trust and the Oak Foundation. SG was supported by the project "NETMED" co-financed by the European Union and the Greek State. MC was funded through the Ramon y Cajal fellowship program of the Spanish Government. DK was funded through the MedPAN Network (www.medpan.org). SF was also supported by the European Community's 7th Framework Programme (FP7/2007-2013) under Grant Agreement No. 287844 for the project 'Towards COast to Coast NETworks of marine protected areas (from the shore to the high and deep sea), coupled with sea-based wind energy potential (COCONET)'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Malak D., 2011, OVERVIEW CONSERVATIO; Abdulla A., 2008, STATUS MARINE PROTEC; Abdulla A, 2009, ICES J MAR SCI, V66, P22, DOI 10.1093/icesjms/fsn164; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; [Anonymous], 2005, EC HUM WELL BEING SY; Bensted-Smith R., 2010, COMP APPROACHES MANA; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Council of Europe, 2011, PA07E2011DOC COUNC E; de Juan S, 2010, OCEAN COAST MANAGE, V53, P717, DOI 10.1016/j.ocecoaman.2010.10.005; de Juan S, 2012, OCEAN COAST MANAGE, V65, P51, DOI 10.1016/j.ocecoaman.2012.04.024; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Fraschetti S, 2009, MAR ECOL PROG SER, V375, P13, DOI 10.3354/meps07781; Fraschetti S, 2008, J EXP MAR BIOL ECOL, V366, P109, DOI 10.1016/j.jembe.2008.07.015; Giakoumi S, 2012, AQUAT CONSERV, V22, P762, DOI 10.1002/aqc.2273; Giakoumi S, 2012, REV FISH BIOL FISHER, V22, P943, DOI 10.1007/s11160-012-9272-8; Giakoumi S, 2011, BIOL CONSERV, V144, P753, DOI 10.1016/j.biocon.2010.11.006; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Jensen JR., 2005, INTRO DIGITAL IMAGE; Johannes RE, 1998, TRENDS ECOL EVOL, V13, P243, DOI 10.1016/S0169-5347(98)01384-6; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Katsanevakis S, 2011, OCEAN COAST MANAGE, V54, P807, DOI 10.1016/j.ocecoaman.2011.09.002; Khadduri W, 2012, MEDITERR POLIT, V17, P111, DOI 10.1080/13629395.2012.655049; Klein CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012431; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; Mace GM, 2000, NATURE, V405, P393, DOI 10.1038/35013247; Mackelworth P, 2011, CIESM WORKSHOP MONOG, V41, P27; Mackelworth P, 2012, CONSERV LETT, V5, P90, DOI 10.1111/j.1755-263X.2012.00223.x; Maiorano L, 2009, ICES J MAR SCI, V66, P137, DOI 10.1093/icesjms/fsn148; Maiorano L, 2011, PHILOS T R SOC B, V366, P2681, DOI 10.1098/rstb.2011.0121; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marshall N, 2009, J ENVIRON PLANN MAN, V52, P901, DOI 10.1080/09640560903180982; Maxwell DL, 2009, J SEA RES, V61, P258, DOI 10.1016/j.seares.2008.11.008; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Micheli F, 2011, MAP CUMULATIVE HUMAN; Moilanen A, 2009, SPATIAL CONSERVATION; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Notarbartolo diSciara G, 2010, OVERVIEW SCI FINDING; Notarbartolo-Di-Sciara G, 2008, AQUAT CONSERV, V18, P367, DOI 10.1002/aqc.855; Piha H, 2011, 18319424 I ENV SUST; Portman ME, 2012, AMBIO, V41, P670, DOI 10.1007/s13280-012-0298-x; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500; Ray GC, 2004, AQUAT CONSERV, V14, P211, DOI 10.1002/aqc.621; Reiss H, 2011, MAR ECOL PROG SER, V442, P71, DOI 10.3354/meps09391; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Salomidi M, 2012, MEDITERR MAR SCI, V13, P49, DOI 10.12681/mms.23; Shaffer B, 2011, ENERG POLICY, V39, P5379, DOI 10.1016/j.enpol.2011.05.026; Shine C, 2007, 2 M ADV COMM STRAT A; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Westing AH, 1998, ENVIRON CONSERV, V25, P91, DOI 10.1017/S0376892998000137; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87	63	90	91	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59038	10.1371/journal.pone.0059038	http://dx.doi.org/10.1371/journal.pone.0059038			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577060	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800006
J	Nakaoka, H; Mitsunaga, S; Hosomichi, K; Shyh-Yuh, L; Sawamoto, T; Fujiwara, T; Tsutsui, N; Suematsu, K; Shinagawa, A; Inoko, H; Inoue, I				Nakaoka, Hirofumi; Mitsunaga, Shigeki; Hosomichi, Kazuyoshi; Shyh-Yuh, Liou; Sawamoto, Taiji; Fujiwara, Tsutomu; Tsutsui, Naohisa; Suematsu, Koji; Shinagawa, Akira; Inoko, Hidetoshi; Inoue, Ituro			Detection of Ancestry Informative HLA Alleles Confirms the Admixed Origins of Japanese Population	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II; LINKAGE-DISEQUILIBRIUM; GENETIC ASSOCIATION; SOUTHWEST CHINA; Y-CHROMOSOMES; HUMAN GENOME; EAST-ASIA; HAPLOTYPES; DIVERSITY	The polymorphisms in the human leukocyte antigen (HLA) region are powerful tool for studying human evolutionary processes. We investigated genetic structure of Japanese by using five-locus HLA genotypes (HLA-A, -B, -C, -DRB1, and -DPB1) of 2,005 individuals from 10 regions of Japan. We found a significant level of population substructure in Japanese; particularly the differentiation between Okinawa Island and mainland Japanese. By using a plot of the principal component scores, we identified ancestry informative alleles associated with the underlying population substructure. We examined extent of linkage disequilibrium (LD) between pairs of HLA alleles on the haplotypes that were differentiated among regions. The LDs were strong and weak for pairs of HLA alleles characterized by low and high frequencies in Okinawa Island, respectively. The five-locus haplotypes whose alleles exhibit strong LD were unique to Japanese and South Korean, suggesting that these haplotypes had been recently derived from the Korean Peninsula. The alleles characterized by high frequency in Japanese compared to South Korean formed segmented three-locus haplotype that was commonly found in Aleuts, Eskimos, and North- and Meso-Americans but not observed in Korean and Chinese. The serologically equivalent haplotype was found in Orchid Island in Taiwan, Mongol, Siberia, and Arctic regions. It suggests that early Japanese who existed prior to the migration wave from the Korean Peninsula shared ancestry with northern Asian who moved to the New World via the Bering Strait land bridge. These results may support the admixture model for peopling of Japanese Archipelago.	[Nakaoka, Hirofumi; Hosomichi, Kazuyoshi; Inoue, Ituro] Natl Inst Genet, Div Human Genet, Dept Integrated Genet, Mishima, Shizuoka 411, Japan; [Mitsunaga, Shigeki; Inoko, Hidetoshi; Inoue, Ituro] Tokai Univ, Sch Med, Div Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Mitsunaga, Shigeki; Inoko, Hidetoshi] GenoDive Pharma Inc, Isehara, Kanagawa, Japan; [Shyh-Yuh, Liou] Japan Takeda Pharmaceut Co Ltd, Clin Pharmacol, Clin Data Sci Dept, Takeda Dev Ctr,Chuo Ku, Osaka, Japan; [Sawamoto, Taiji] Astellas Pharma Inc, Astellas Pharma Global Dev, Clin Pharmacol, Itabashi Ku, Tokyo, Japan; [Fujiwara, Tsutomu] Otsuka Pharmaceut Co Ltd, PGx Off, Dept Clin Res & Dev, Chuo Ku, Osaka, Japan; [Tsutsui, Naohisa] Mitsubishi Tanabe Pharma Corp, Dept Clin Pharmacol, Dev Div, Yodogawa Ku, Osaka, Japan; [Suematsu, Koji] Taisho Pharmaceut Co Ltd, PGx, Clin Res, Toshima Ku, Tokyo, Japan; [Shinagawa, Akira] Daiichi Sankyo Co Ltd, Translat Med & Clin Pharmacol Dept, R&D Div, Shinagawa Ku, Tokyo, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tokai University; Astellas Pharmaceuticals; Otsuka Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Taisho Pharmaceutical Holdings Co Ltd; Daiichi Sankyo Company Limited	Inoue, I (corresponding author), Natl Inst Genet, Div Human Genet, Dept Integrated Genet, Mishima, Shizuoka 411, Japan.	itinoue@nig.ac.jp	Hosomichi, Kazuyoshi/K-9477-2015	Hosomichi, Kazuyoshi/0000-0003-2712-1825; Nakaoka, Hirofumi/0000-0002-8454-1159	 [23133507]; Grants-in-Aid for Scientific Research [23133507, 22510213, 25860257] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas Grant Number 23133507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Bannai M, 2000, TISSUE ANTIGENS, V55, P128, DOI 10.1034/j.1399-0039.2000.550204.x; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chen SW, 2007, HUM IMMUNOL, V68, P550, DOI 10.1016/j.humimm.2007.02.006; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Di D, 2011, AM J PHYS ANTHROPOL, V145, P81, DOI 10.1002/ajpa.21470; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fry AE, 2006, AM J HUM GENET, V78, P1053, DOI 10.1086/504160; Garcia-Ortiz JE, 2006, TISSUE ANTIGENS, V68, P135, DOI 10.1111/j.1399-0039.2006.00636.x; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Hatta Y, 1999, HUM BIOL, V71, P353; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Hoa BK, 2008, TISSUE ANTIGENS, V71, P127, DOI 10.1111/j.1399-0039.2007.00982.x; Hollenbach JA, 2001, HUM IMMUNOL, V62, P378, DOI 10.1016/S0198-8859(01)00212-9; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Lee KW, 2005, TISSUE ANTIGENS, V65, P437, DOI 10.1111/j.1399-0039.2005.00386.x; Leffell MS, 2002, HUM IMMUNOL, V63, P614, DOI 10.1016/S0198-8859(02)00415-9; LEWONTIN RC, 1964, GENETICS, V49, P49; Lin M, 2000, TISSUE ANTIGENS, V55, P1, DOI 10.1034/j.1399-0039.2000.550101.x; Loo JH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-21; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Moscoso J, 2008, MOL IMMUNOL, V45, P1018, DOI 10.1016/j.molimm.2007.07.024; Nakaoka H, 2009, J HUM GENET, V54, P615, DOI 10.1038/jhg.2009.95; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Omoto K, 1997, AM J PHYS ANTHROPOL, V102, P437; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Sagoo GS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000028; Saito S, 2000, TISSUE ANTIGENS, V56, P522, DOI 10.1034/j.1399-0039.2000.560606.x; Shi L, 2010, TISSUE ANTIGENS, V75, P159, DOI 10.1111/j.1399-0039.2009.01407.x; Shi L, 2008, HUM IMMUNOL, V69, P58, DOI 10.1016/j.humimm.2007.11.007; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Song EY, 2002, TISSUE ANTIGENS, V59, P475, DOI 10.1034/j.1399-0039.2002.590604.x; Tajima A, 2004, J HUM GENET, V49, P187, DOI 10.1007/s10038-004-0131-x; Tajima A, 2002, HUM GENET, V110, P80, DOI 10.1007/s00439-001-0651-9; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Tohkin M, 2011, PHARMACOGENOMICS J, DOI [10.1038/tpj.2011.41, DOI 10.1038/TPJ.2011.41;10.1038/TPJ.2011.41]; Tokunaga K, 2001, HUM IMMUNOL, V62, P1001, DOI 10.1016/S0198-8859(01)00301-9; Tokunaga K, 1997, IMMUNOGENETICS, V46, P199, DOI 10.1007/s002510050262; TOKUNAGA K, 1996, PREHISTORIC MONGOLOI; Vina MAF, 2012, PHILOS T R SOC B, V367, P820, DOI 10.1098/rstb.2011.0320; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yamaguchi-Kabata Y, 2012, J HUM GENET, V57, P326, DOI 10.1038/jhg.2012.26; Yang KL, 2009, HUM IMMUNOL, V70, P269, DOI 10.1016/j.humimm.2009.01.015; Yao Y, 2009, TISSUE ANTIGENS, V73, P561, DOI 10.1111/j.1399-0039.2009.01237.x; [No title captured]	61	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60793	10.1371/journal.pone.0060793	http://dx.doi.org/10.1371/journal.pone.0060793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577161	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800099
J	Prevot, V; Jordaens, K; Sonet, G; Backeljau, T				Prevot, Vanya; Jordaens, Kurt; Sonet, Gontran; Backeljau, Thierry			Exploring Species Level Taxonomy and Species Delimitation Methods in the Facultatively Self-Fertilizing Land Snail Genus Rumina (Gastropoda: Pulmonata)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; HELIX-ASPERSA; POPULATION-STRUCTURE; MOLECULAR SYSTEMATICS; ACCELERATED EVOLUTION; CORNU-ASPERSUM; HISTORY; COALESCENT; MOLLUSCA; COMPLEX	Delimiting species in facultatively selfing taxa is a challenging problem of which the terrestrial pulmonate snail genus Rumina is a good example. These snails have a mixed breeding system and show a high degree of shell and color variation. Three nominal species (R. decollata, R. saharica and R. paivae) and two color morphs within R. decollata (dark and light) are currently recognized. The present study aims at evaluating to what extent these entities reflect evolutionary diverging taxonomic units, rather than fixed polymorphisms due to sustained selfing. Therefore, a phylogenetic analysis of nuclear (ITS1, ITS2) and mitochondrial DNA (COI, CytB, 12S rDNA, 16S rDNA) sequences was performed. Putative species in Rumina, inferred from the mitochondrial DNA phylogeny, were compared with those proposed on the basis of the COI gene by (1) DNA barcoding gap analysis, (2) Automatic Barcode Gap Discovery, (3) the species delimitation plug-in of the Geneious software, (4) the Genealogical Sorting Index, and (5) the General Mixed Yule Coalescent model. It is shown that these methods produce a variety of different species hypotheses and as such one may wonder to what extent species delimitation methods are really useful. With respect to Rumina, the data suggest at least seven species, one corresponding to R. saharica and six that are currently grouped under the name R. decollata. The species-level status of R. paivae is rejected.	[Prevot, Vanya; Jordaens, Kurt; Sonet, Gontran; Backeljau, Thierry] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Prevot, Vanya] Univ Libre Bruxelles, Lab Evolut Biol & Ecol, Brussels, Belgium; [Jordaens, Kurt; Backeljau, Thierry] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Jordaens, Kurt; Sonet, Gontran; Backeljau, Thierry] Royal Museum Cent Africa, JEMU, Tervuren, Belgium	Royal Belgian Institute of Natural Sciences; Universite Libre de Bruxelles; University of Antwerp; Royal Museum for Central Africa	Backeljau, T (corresponding author), Royal Belgian Inst Nat Sci, Brussels, Belgium.	Thierry.Backeljau@naturalsciences.be			FNRS (Fonds National de la Recherche Scientifique, Belgique); "Fonds David et Alice Van Buuren", Belgium; BELSPO [MO/36/017]	FNRS (Fonds National de la Recherche Scientifique, Belgique)(Fonds de la Recherche Scientifique - FNRS); "Fonds David et Alice Van Buuren", Belgium; BELSPO(Belgian Federal Science Policy Office)	This work was made with the support of the FNRS (Fonds National de la Recherche Scientifique, Belgique) that conceded a FRIA (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture) PhD grant to VP, who also received financial support from the "Fonds David et Alice Van Buuren", Belgium. This work was done in the context of BELSPO grant MO/36/017 to TB and of the Joint Experimental Molecular Unit (JEMU) at RBINS and RMCA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Armbruster Georg F.J., 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V76, P11; Astrin JJ, 2006, ZOOL SCR, V35, P441, DOI 10.1111/j.1463-6409.2006.00239.x; Avise JC, 1997, P NATL ACAD SCI USA, V94, P7748, DOI 10.1073/pnas.94.15.7748; Backeljau T, 1996, BCPC SYMP SER, P21; Bank R. A., 1993, Zoologische Mededelingen (Leiden), V67, P525; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; BATTS JEANNE HINES, 1957, SOUTHWESTERN NAT, V2, P74, DOI 10.2307/3669494; Baum DA, 2009, SYST BIOL, V58, P74, DOI 10.1093/sysbio/syp011; Bininda-Emonds ORP, 2011, ORG DIVERS EVOL, V11, P1, DOI 10.1007/s13127-011-0040-8; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Bleakney M. M., 1989, Monograph - British Crop Protection Council, P319; Brooks TM, 2010, NATURE, V467, P540, DOI 10.1038/467540a; Carr R, 2002, J CONCHOL, V37, P569; Chiba S, 1999, EVOLUTION, V53, P460, DOI 10.1111/j.1558-5646.1999.tb03781.x; Chueca L. J., 2011, MALACOLOGIST, V56, P5; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Corrins C, 1918, SITZBER K PREUSS AKA, P221; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Davison A, 2000, P ROY SOC B-BIOL SCI, V267, P1399, DOI 10.1098/rspb.2000.1156; Davison A, 2009, MOL ECOL RESOUR, V9, P1092, DOI 10.1111/j.1755-0998.2009.02559.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Queiroz K, 1999, SPECIES, P49; de Queiroz K, 1998, ENDLESS FORMS, P57; Douris V, 1998, EVOLUTION, V52, P116, DOI 10.1111/j.1558-5646.1998.tb05144.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DUNDEE DS, 1986, NAUTILUS, V100, P32; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fregin S, 2012, MOL PHYLOGENET EVOL, V62, P319, DOI 10.1016/j.ympev.2011.10.003; Geenen S, 2006, BIOL J LINN SOC, V89, P589, DOI 10.1111/j.1095-8312.2006.00693.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gittenberger E, 2004, MOL PHYLOGENET EVOL, V30, P64, DOI 10.1016/S1055-7903(03)00182-9; Giusti F, 1995, NONMARINE MOLLUSCS M; Goodacre SL, 2002, MOL ECOL, V11, P55, DOI 10.1046/j.0962-1083.2001.01422.x; Guiller A, 2001, MOL ECOL, V10, P81, DOI 10.1046/j.1365-294X.2001.01145.x; GUILLER A, 1994, J MOLLUS STUD, V60, P205, DOI 10.1093/mollus/60.3.205; Guiller A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-18; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haase M, 2003, J EVOLUTION BIOL, V16, P415, DOI 10.1046/j.1420-9101.2003.00542.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haszprunar G, 2011, ORG DIVERS EVOL, V11, P249, DOI 10.1007/s13127-011-0047-1; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Hayashi M, 2000, BIOL J LINN SOC, V70, P391, DOI 10.1111/j.1095-8312.2000.tb01230.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2001, TRENDS ECOL EVOL, V16, P326, DOI 10.1016/S0169-5347(01)02145-0; Hey Jody, 2001, GENES CATEGORIES SPE; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Jordaens K, 2000, HEREDITY, V85, P571, DOI 10.1046/j.1365-2540.2000.00793.x; Jordaens K, 2010, ZOOL SCR, V39, P343, DOI 10.1111/j.1463-6409.2010.00425.x; KALTENBACH HERBERT, 1951, ARCH MOLLUSKENK, V80, P27; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kubatko LS, 2011, SYST BIOL, V60, P393, DOI 10.1093/sysbio/syr011; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Maddison WP, 2009, MESQUITE MODULAR SYS; MADEC L, 1993, J MOLLUS STUD, V59, P455, DOI 10.1093/mollus/59.4.455; Madec L, 2003, HEREDITY, V91, P224, DOI 10.1038/sj.hdy.6800301; MADEC L, 1991, CR ACAD SCI III-VIE, V313, P339; MADEC L, 1993, MALACOLOGIA, V35, P99; Madec L, 1989, THESIS U RENNES FRAN; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Matsukuma Akihiko, 2009, Bulletin of the Kyushu University Museum, V7, P35; Mayden R. L., 1997, V54, P381; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Merritt TJS, 1998, MOL MAR BIOL BIOTECH, V7, P7; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mienis Henk K., 2008, MalaCo, V5, P229; Mienis Henk K., 2002, Triton (Rehovot), V5, P33; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nylander J.A.A, 2004, MRMODELTEST V2; Palumbi SR, 1996, NUCL ACIDS 2 POLYM C; Papadopoulou A, 2009, SYST BIOL, V58, P442, DOI 10.1093/sysbio/syp038; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Pfenninger M, 2010, MOL PHYLOGENET EVOL, V54, P427, DOI 10.1016/j.ympev.2009.09.024; Pilsbry HA, 1905, P ACAD NAT SCI PHILA, V57, P211; Pinceel J, 2005, J EVOLUTION BIOL, V18, P1264, DOI 10.1111/j.1420-9101.2005.00932.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rambaut A., 2007, TRACER V1 4; Reise H, 1997, J ZOOL, V241, P103, DOI 10.1111/j.1469-7998.1997.tb05502.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richards AR, 2010, SPECIES PROBLEM PHIL; Rodrigo A, 2008, PHILOS T R SOC B, V363, P3893, DOI 10.1098/rstb.2008.0173; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; SELANDER R K, 1974, Veliger, V16, P265; SELANDER RK, 1973, P NATL ACAD SCI USA, V70, P1186, DOI 10.1073/pnas.70.4.1186; SELANDER RK, 1976, AM NAT, V110, P695, DOI 10.1086/283098; SELANDER RK, 1983, ISOZYMES-CURR T BIOL, V10, P93; Singer BS, 1993, LEVANTINA, V76, P5; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomaz D, 1996, P ROY SOC B-BIOL SCI, V263, P363, DOI 10.1098/rspb.1996.0056; Van Riel P, 2005, MOL PHYLOGENET EVOL, V37, P132, DOI 10.1016/j.ympev.2005.03.019; Viard F, 1997, P ROY SOC B-BIOL SCI, V264, P39, DOI 10.1098/rspb.1997.0006; Wade CM, 2006, BIOL J LINN SOC, V87, P593, DOI 10.1111/j.1095-8312.2006.00596.x; Watanabe Y, 2001, MOL ECOL, V10, P2635, DOI 10.1046/j.0962-1083.2001.01388.x; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Williams S, 2011, EVOLUTION, V65, P1752, DOI 10.1111/j.1558-5646.2011.01255.x; WILSON E O, 1992; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	114	45	51	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60736	10.1371/journal.pone.0060736	http://dx.doi.org/10.1371/journal.pone.0060736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577154	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800096
J	Almomani, B; Hawwa, AF; Millership, JS; Heaney, L; Douglas, I; McElnay, JC; Shields, MD				Almomani, Basima; Hawwa, Ahmed F.; Millership, Jeffrey S.; Heaney, Liam; Douglas, Isabella; McElnay, James C.; Shields, Michael D.			Can Certain Genotypes Predispose to Poor Asthma Control in Children? A Pharmacogenetic Study of 9 Candidate Genes in Children with Difficult Asthma	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PROMOTER POLYMORPHISM; INTERLEUKIN-13 GENE; ASSOCIATION; HAPLOTYPE; EXACERBATIONS; FORMOTEROL; ATOPY; BUDESONIDE; REGION	Objective: We tested the hypothesis that patients with difficult asthma have an increased frequency of certain genotypes that predispose them to asthma exacerbations and poor asthma control. Methods: A total of 180 Caucasian children with confirmed asthma diagnosis were selected from two phenotypic groups; difficult (n = 112) versus mild/moderate asthma (n = 68) groups. All patients were screened for 19 polymorphisms in 9 candidate genes to evaluate their association with difficult asthma. Key Results: The results indicated that LTA4H A-9188>G, TNF alpha G-308>A and IL-4R alpha A1727>G polymorphisms were significantly associated with the development of difficult asthma in paediatric patients (p<0.001, p = 0.019 and p = 0.037, respectively). Haplotype analysis also revealed two haplotypes (ATA haplotype of IL-4R alpha A1199>C, IL-4R alpha T1570>C and IL-4R alpha A1727>G and CA haplotype of TNF alpha C-863>A and TNF alpha G-308>A polymorphisms) which were significantly associated with difficult asthma in children (p = 0.04 and p = 0.018, respectively). Conclusions and Clinical Relevance: The study revealed multiple SNPs and haplotypes in LTA4H, TNF alpha and IL4-R alpha genes which constitute risk factors for the development of difficult asthma in children. Of particular interest is the LTA4H A-9188>G polymorphism which has been reported, for the first time, to have strong association with severe asthma in children. Our results suggest that screening for patients with this genetic marker could help characterise the heterogeneity of responses to leukotriene-modifying medications and, hence, facilitate targeting these therapies to the subset of patients who are most likely to gain benefit.	[Almomani, Basima; Hawwa, Ahmed F.; Millership, Jeffrey S.; McElnay, James C.] Queens Univ Belfast, Sch Pharm, Clin & Practice Res Grp, Belfast, Antrim, North Ireland; [Heaney, Liam; Shields, Michael D.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Douglas, Isabella; Shields, Michael D.] Belfast Hlth & Social Care Trust, Royal Belfast Hosp Sick Children, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	McElnay, JC (corresponding author), Queens Univ Belfast, Sch Pharm, Clin & Practice Res Grp, Belfast, Antrim, North Ireland.	j.mcelnay@qub.ac.uk; m.shields@qub.ac.uk		Hawwa, Ahmed/0000-0003-0547-7361				Barnes PJ, 1999, PROG INFLAM RES, P33; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bilolikar H, 2005, EUR RESPIR J, V26, P637, DOI 10.1183/09031936.05.00071104; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2009, THORAX S4, V63, P1; Burchard EG, 1999, AM J RESP CRIT CARE, V160, P919, DOI 10.1164/ajrccm.160.3.9812024; Bush A, 2011, EUR RESP MONOGRAPH, V51, P58; Busse WW, 2011, EUR RESPIR MONOGR, P1, DOI 10.1183/1025448x.10000510; Chung LP, 2011, CLIN EXP ALLERGY, V41, P312, DOI 10.1111/j.1365-2222.2011.03696.x; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Erzurum SC, 2006, NEW ENGL J MED, V354, P754, DOI 10.1056/NEJMe058266; Evans BK, 2003, CLIN PHARMACOL THER, P163; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Holloway JW, 2008, ALLERGY, V63, P1046, DOI 10.1111/j.1398-9995.2008.01667.x; Howard TD, 2001, AM J RESP CELL MOL, V25, P377, DOI 10.1165/ajrcmb.25.3.4483; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Isidoro-Garcia Maria, 2005, Clin Mol Allergy, V3, P15, DOI 10.1186/1476-7961-3-15; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kruse S, 1999, IMMUNOLOGY, V96, P365; Lee DKC, 2004, BRIT J CLIN PHARMACO, V57, P68, DOI 10.1046/j.1365-2125.2003.01955.x; Leung TF, 2001, CLIN EXP ALLERGY, V31, P1515, DOI 10.1046/j.1365-2222.2001.01212.x; Li YF, 2006, AM J RESP CRIT CARE, V173, P970, DOI 10.1164/rccm.200508-1256OC; Liggett SB, 2001, NAT MED, V7, P281, DOI 10.1038/85411; Lima JJ, 2006, AM J RESP CRIT CARE, V173, P379, DOI 10.1164/rccm.200509-1412OC; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Migita O, 2005, CLIN EXP ALLERGY, V35, P790, DOI 10.1111/j.1365-2222.2005.02265.x; Noguchi E, 2002, AM J RESP CRIT CARE, V166, P43, DOI 10.1164/rccm.2110052; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; Palmer CNA, 2006, THORAX, V61, P940, DOI 10.1136/thx.2006.059386; Paltiel AD, 2001, J ALLERGY CLIN IMMUN, V108, P39, DOI 10.1067/mai.2001.116289; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pearce N, 1997, CHEST, V112, P1148, DOI 10.1378/chest.112.4.1148-b; Qidwai T, 2011, SCAND J IMMUNOL, V74, P522, DOI 10.1111/j.1365-3083.2011.02602.x; Raby BA, 2001, CURR OPIN MOL THER, V3, P554; Randolph AG, 2005, AM J RESP CRIT CARE, V172, P687, DOI 10.1164/rccm.200501-122OC; Rosa-Rosa L, 1999, J ALLERGY CLIN IMMUN, V104, P1008, DOI 10.1016/S0091-6749(99)70082-5; Rubio-Padilla M, 2009, ALERGIA, V56, P115; Sandford AJ, 2000, J ALLERGY CLIN IMMUN, V106, P135, DOI 10.1067/mai.2000.107926; Sayers I, 2003, THORAX, V58, P417, DOI 10.1136/thorax.58.5.417; Shin HD, 2004, HUM MOL GENET, V13, P397, DOI 10.1093/hmg/ddh036; Tantisira KG, 2004, HUM MOL GENET, V13, P1353, DOI 10.1093/hmg/ddh149; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; Thomas PS, 1996, CLIN EXP ALLERGY, V26, P710, DOI 10.1111/j.1365-2222.1996.tb00598.x; Tse SM, 2011, PHARMACOGENOMICS J, V11, P383, DOI 10.1038/tpj.2011.46; Wa TCLK, 1999, CLIN EXP ALLERGY, V29, P1204; Weiss ST, 2006, PHARMACOGENOMICS J, V6, P311, DOI 10.1038/sj.tpj.6500387	48	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60592	10.1371/journal.pone.0060592	http://dx.doi.org/10.1371/journal.pone.0060592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573270	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000318840100089
J	Deng, J; Han, YL; Sun, MY; Tao, J; Yan, CH; Kang, J; Li, SH				Deng, Jie; Han, Yaling; Sun, Mingyu; Tao, Jie; Yan, Chenghui; Kang, Jian; Li, Shaohua			Nanoporous CREG-Eluting Stent Attenuates In-Stent Neointimal Formation in Porcine Coronary Arteries	PLOS ONE			English	Article							E1A-STIMULATED GENES; CELLULAR REPRESSOR; ACTIVATION; THROMBOSIS; APOPTOSIS; GROWTH; HYPERSENSITIVITY; PROLIFERATION; FIBROBLASTS; PATHWAY	Background: The goal of this study was to evaluate the efficacy of a nanoporous CREG-eluting stent (CREGES) in inhibiting neointimal formation in a porcine coronary model. Methods: In vitro proliferation assays were performed using isolated human endothelial and smooth muscle cells to investigate the cell-specific pharmacokinetic effects of CREG and sirolimus. We implanted CREGES, control sirolimus-eluting stents (SES) or bare metal stents (BMS) into pig coronary arteries. Histology and immunohistochemistry were performed to assess the efficacy of CREGES in inhibiting neointimal formation. Results: CREG and sirolimus inhibited in vitro vascular smooth muscle cell proliferation to a similar degree. Interestingly, human endothelial cell proliferation was only significantly inhibited by sirolimus and was increased by CREG. CREGES attenuated neointimal formation after 4 weeks in porcine coronary model compared with BMS. No differences were found in the injury and inflammation scores among the groups. Scanning electron microscopy and CD31 staining by immunohistochemistry demonstrated an accelerated reendothelialization in the CREGES group compared with the SES or BMS control groups. Conclusions: The current study suggests that CREGES reduces neointimal formation, promotes reendothelialization in porcine coronary stent model.	[Deng, Jie; Han, Yaling; Sun, Mingyu; Tao, Jie; Yan, Chenghui; Kang, Jian] Shenyang Northern Hosp, Peoples Liberat Army, Inst Cardiovasc Res, Dept Cardiol, Shenyang, Liaoning, Peoples R China; [Li, Shaohua] Robert Wood Johnson Med Sch UMDNJ, Dept Surg, Div Vasc Surg, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Han, YL (corresponding author), Shenyang Northern Hosp, Peoples Liberat Army, Inst Cardiovasc Res, Dept Cardiol, Shenyang, Liaoning, Peoples R China.	hanyaling53@gmail.com			National Young Science Foundation of China [30800465]; National Natural Science Foundation of China [30770793, 30971218, 81070097]	National Young Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Young Science Foundation of China (30800465 to JD) and the National Natural Science Foundation of China (30770793 and 30971218 to YH, 81070097 to CY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia V, 2003, J Postgrad Med, V49, P291; BOONKITTICHAROEN V, 1990, NUCL MED COMMUN, V11, P295, DOI 10.1097/00006231-199004000-00007; Farb A, 2002, CIRCULATION, V106, P2379, DOI 10.1161/01.CIR.0000033973.06059.04; Finn AV, 2005, CIRCULATION, V112, P270, DOI 10.1161/CIRCULATIONAHA.104.508937; Hamilos MI, 2008, J AM COLL CARDIOL, V51, P2123, DOI 10.1016/j.jacc.2007.12.059; Han Ya-Ling, 2006, Shengli Xuebao, V58, P324; Han YL, 2008, GENES CELLS, V13, P977, DOI 10.1111/j.1365-2443.2008.01221.x; Han Ya-Ling, 2005, Zhonghua Yi Xue Za Zhi, V85, P49; Han YL, 2008, J VASC SURG, V48, P201, DOI 10.1016/j.jvs.2008.01.061; Han YL, 2008, CARDIOVASC RES, V78, P597, DOI 10.1093/cvr/cvn036; Han YL, 2011, J MOL CELL CARDIOL, V50, P723, DOI 10.1016/j.yjmcc.2010.12.013; Han YL, 2010, J MOL CELL CARDIOL, V48, P1225, DOI 10.1016/j.yjmcc.2009.12.018; Han YL, 2009, EXP CELL RES, V315, P3301, DOI 10.1016/j.yexcr.2009.09.013; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; LI Y, 2012, CURR MOL MED; Li Y, 2012, ATHEROSCLEROSIS, V225, P304, DOI 10.1016/j.atherosclerosis.2012.08.015; Masuda S, 2011, J ATHEROSCLER THROMB, V18, P1043, DOI 10.5551/jat.8730; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Miyauchi K, 2008, CIRC J, V72, P832, DOI 10.1253/circj.72.832; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Nakatani M, 2003, CARDIOVASC PATHOL, V12, P40, DOI 10.1016/S1054-8807(02)00135-7; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; Ong ATL, 2005, ARCH MAL COEUR VAISS, V98, P123; Sacher M, 2005, P NATL ACAD SCI USA, V102, P18326, DOI 10.1073/pnas.0505071102; Schwartz RS, 2002, CIRCULATION, V106, P1867, DOI 10.1161/01.CIR.0000033485.20594.6F; Seabra-Gomes R, 2006, HEART, V92, P410, DOI 10.1136/hrt.2005.062992; Sousa JE, 2001, CIRCULATION, V104, P2007, DOI 10.1161/hc4201.098056; Veal E, 1998, MOL CELL BIOL, V18, P5032, DOI 10.1128/MCB.18.9.5032; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Wang N, 2011, ATHEROSCLEROSIS, V218, P543, DOI 10.1016/j.atherosclerosis.2011.08.002; Yang GT, 2011, MOL BIOL REP, V38, P2133, DOI 10.1007/s11033-010-0340-7; Zhang HM, 2011, EXP CELL RES, V317, P2904, DOI 10.1016/j.yexcr.2011.08.012	33	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60735	10.1371/journal.pone.0060735	http://dx.doi.org/10.1371/journal.pone.0060735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573278	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100098
J	Grainger, TN; Turkington, R				Grainger, Tess Nahanni; Turkington, Roy			Mechanisms for Success after Long-term Nutrient Enrichment in a Boreal Forest Understory	PLOS ONE			English	Article							NITROGEN DEPOSITION; PLANT TRAITS; DIVERSITY LOSS; LAND-USE; FERTILIZATION; LIGHT; BIODIVERSITY; COMPETITION; PLASTICITY; ALLOCATION	Global levels of reactive nitrogen are predicted to rise in the coming decades as a result of increased deposition from the burning of fossil fuels and the large-scale conversion of nitrogen into a useable form for agriculture. Many plant communities respond strongly to increases in soil nitrogen, particularly in northern ecosystems where nitrogen levels are naturally very low. An experiment in northern Canada that was initiated in 1990 has been investigating the effects of long-term nutrient enrichment (fertilizer added annually) on a boreal forest understory community. We used this experiment to investigate why some species increase in abundance under nutrient enrichment whereas others decline. We focused on four species that differed in their responses to fertilization: Mertensia paniculata and Epilobium angustifolium increased in abundance, Achillea millefolium remained relatively constant and Festuca altaica declined. We hypothesized that the two species that were successful in the new high-nutrient, light-limited environment would be taller, have higher specific leaf area, change phenology by growing earlier in the season and be more morphologically plastic than their less successful counterparts. We compared plant height, specific leaf area, growth spurt date and allocation to leaves in plants grown in control and fertilized plots. We demonstrated that each of the two species that came to dominate fertilized plots has a different combination of traits and responses that likely gave them a competitive advantage; M. paniculata has the highest specific leaf area of the four species whereas E. angustifolium is tallest and exhibits morphological plasticity when fertilized by increasing biomass allocation to leaves. These results indicate that rather than one strategy determining success when nutrients become available, a variety of traits and responses may contribute to a species' ability to persist in a nutrient-enriched boreal forest understory.	[Grainger, Tess Nahanni] Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Grainger, TN (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada.	tessng@interchange.ubc.ca			Discovery Grant from Natural Sciences and Engineering Research Council of Canada; Alexander Graham Bell Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada; Association of Canadian Universities for Northern Studies; Northern Scientific Training Program	Discovery Grant from Natural Sciences and Engineering Research Council of Canada; Alexander Graham Bell Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada; Association of Canadian Universities for Northern Studies; Northern Scientific Training Program	Funding for this work was provided by a Discovery Grant (RT) and an Alexander Graham Bell Canada Graduate Scholarship (TNG) from Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). A W. Garfield Weston Award for Northern Research from the Association of Canadian Universities for Northern Studies (TNG) (www.acuns.ca) and a grant from the Northern Scientific Training Program (TNG) (www.aadnc-aandc.gc.ca) also helped to make this work possible. The funders had no role in the study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Aerts R, 2006, PLANT ECOL, V182, P65, DOI 10.1007/s11258-005-9031-1; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Bazzaz F. A., 1996, PLANTS CHANGING ENV; Binkley D, 1989, ADV SOIL SCI, V10, P116; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bret-Harte MS, 2001, ECOLOGY, V82, P18, DOI 10.1890/0012-9658(2001)082[0018:DPABNT]2.0.CO;2; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; COLEMAN JS, 1994, TRENDS ECOL EVOL, V9, P187, DOI 10.1016/0169-5347(94)90087-6; DeKoning PK, 2011, CONSEQUENCES RECOVER; Diekmann M, 2002, J ECOL, V90, P108, DOI 10.1046/j.0022-0477.2001.00639.x; Dormann CF, 2002, FUNCT ECOL, V16, P4, DOI 10.1046/j.0269-8463.2001.00596.x; Environment Canada, 2012, CAN CLIM NORM 1971 2; Exley D, 2008, WEED RES, V32, P175; Firn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035870; Fremlin KM, 2011, ARCT ANTARCT ALP RES, V43, P389, DOI 10.1657/1938-4246-43.3.389; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Gilliam FS, 2006, J ECOL, V94, P1176, DOI 10.1111/j.1365-2745.2006.01155.x; Gough L, 2002, ARCT ANTARCT ALP RES, V34, P211, DOI 10.2307/1552473; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Gough L, 2012, OECOLOGIA, P1; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; HARPER JL, 1967, J ANIM ECOL, V36, P495, DOI 10.2307/2808; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Huang YX, 2010, BOTANY, V88, P13, DOI 10.1139/B09-095; JOHN E, 1995, J ECOL, V83, P581, DOI 10.2307/2261626; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; KELLNER O, 1993, J APPL ECOL, V30, P563, DOI 10.2307/2404195; Klady RA, 2011, GLOBAL CHANGE BIOL, V17, P1611, DOI 10.1111/j.1365-2486.2010.02319.x; Krebs CJ, 2012, COMMUNITY ECOLOGICAL; Laliberte E, 2012, J ECOL; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Manninen OH, 2009, J VEG SCI, V20, P311, DOI 10.1111/j.1654-1103.2009.05529.x; McIntyre S, 2008, AGR ECOSYST ENVIRON, V128, P251, DOI 10.1016/j.agee.2008.06.015; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; NAMS VO, 1993, CAN J BOT, V71, P93, DOI 10.1139/b93-011; Niu KC, 2008, BASIC APPL ECOL, V9, P485, DOI 10.1016/j.baae.2007.06.015; Nordin A, 2005, AMBIO, V34, P20, DOI 10.1639/0044-7447(2005)034[0020:NDATBO]2.0.CO;2; Pan QM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020078; Poorter H, 1999, NEW PHYTOL, V143, P163, DOI 10.1046/j.1469-8137.1999.00428.x; Quetier F, 2007, ECOL MONOGR, V77, P33, DOI 10.1890/06-0054; Rasband WS, 1997, IMAGEJ; SAMSON DA, 1986, AM NAT, V127, P667, DOI 10.1086/284512; Seccombe-Hett P, 2008, OIKOS, V117, P1874, DOI 10.1111/j.1600-0706.2008.16773.x; SHAVER GR, 1986, ARCTIC ALPINE RES, V18, P261, DOI 10.2307/1550883; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; SPSS Statistics, 2008, SPSS 17 0; Strengbom J, 2004, CAN J BOT, V82, P430, DOI [10.1139/B04-017, 10.1139/b04-017]; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; Turkington R, 2002, J ECOL, V90, P325, DOI 10.1046/j.1365-2745.2001.00666.x; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Xu ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039762	56	6	6	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e61229	10.1371/journal.pone.0061229	http://dx.doi.org/10.1371/journal.pone.0061229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573298	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100119
J	Brudner, M; Karpel, M; Lear, C; Chen, L; Yantosca, LM; Scully, C; Sarraju, A; Sokolovska, A; Zariffard, MR; Eisen, DP; Mungall, BA; Kotton, DN; Omari, A; Huang, IC; Farzan, M; Takahashi, K; Stuart, L; Stahl, GL; Ezekowitz, AB; Spear, GT; Olinger, GG; Schmidt, EV; Michelow, IC				Brudner, Matthew; Karpel, Marshall; Lear, Calli; Chen, Li; Yantosca, L. Michael; Scully, Corinne; Sarraju, Ashish; Sokolovska, Anna; Zariffard, M. Reza; Eisen, Damon P.; Mungall, Bruce A.; Kotton, Darrell N.; Omari, Amel; Huang, I-Chueh; Farzan, Michael; Takahashi, Kazue; Stuart, Lynda; Stahl, Gregory L.; Ezekowitz, Alan B.; Spear, Gregory T.; Olinger, Gene G.; Schmidt, Emmett V.; Michelow, Ian C.			Lectin-Dependent Enhancement of Ebola Virus Infection via Soluble and Transmembrane C-type Lectin Receptors	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; RP-C4-CYP21-TNX RCCX MODULES; POLYMERASE-CHAIN-REACTION; COPY-NUMBER VARIATIONS; WEST NILE VIRUS; ENVELOPE GLYCOPROTEINS; INFLAMMATORY RESPONSE; SURFACE GLYCOPROTEIN; FALCIPARUM-MALARIA; SERINE PROTEASE-2	Mannose-binding lectin (MBL) is a key soluble effector of the innate immune system that recognizes pathogen-specific surface glycans. Surprisingly, low-producing MBL genetic variants that may predispose children and immunocompromised individuals to infectious diseases are more common than would be expected in human populations. Since certain immune defense molecules, such as immunoglobulins, can be exploited by invasive pathogens, we hypothesized that MBL might also enhance infections in some circumstances. Consequently, the low and intermediate MBL levels commonly found in human populations might be the result of balancing selection. Using model infection systems with pseudotyped and authentic glycosylated viruses, we demonstrated that MBL indeed enhances infection of Ebola, Hendra, Nipah and West Nile viruses in low complement conditions. Mechanistic studies with Ebola virus (EBOV) glycoprotein pseudotyped lentiviruses confirmed that MBL binds to N-linked glycan epitopes on viral surfaces in a specific manner via the MBL carbohydrate recognition domain, which is necessary for enhanced infection. MBL mediates lipid-raft-dependent macropinocytosis of EBOV via a pathway that appears to require less actin or early endosomal processing compared with the filovirus canonical endocytic pathway. Using a validated RNA interference screen, we identified C1QBP (gC1qR) as a candidate surface receptor that mediates MBL-dependent enhancement of EBOV infection. We also identified dectin-2 (CLEC6A) as a potentially novel candidate attachment factor for EBOV. Our findings support the concept of an innate immune haplotype that represents critical interactions between MBL and complement component C4 genes and that may modify susceptibility or resistance to certain glycosylated pathogens. Therefore, higher levels of native or exogenous MBL could be deleterious in the setting of relative hypocomplementemia which can occur genetically or because of immunodepletion during active infections. Our findings confirm our hypothesis that the pressure of infectious diseases may have contributed in part to evolutionary selection of MBL mutant haplotypes.	[Brudner, Matthew; Karpel, Marshall; Chen, Li; Yantosca, L. Michael; Sarraju, Ashish; Sokolovska, Anna; Takahashi, Kazue; Stuart, Lynda; Ezekowitz, Alan B.; Schmidt, Emmett V.; Michelow, Ian C.] Massachusetts Gen Hosp, Dept Pediat, Programs Dev Immunol, Boston, MA 02114 USA; [Lear, Calli; Scully, Corinne; Olinger, Gene G.] USA, Div Virol, Med Res Inst Infect Dis, Frederick, MD USA; [Zariffard, M. Reza] Rush Univ, Dept Immunol & Microbiol, Med Ctr, Chicago, IL 60612 USA; [Eisen, Damon P.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia; [Mungall, Bruce A.] Commonwealth Sci & Ind Res Org CSIRO Livestock In, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Kotton, Darrell N.; Omari, Amel] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Huang, I-Chueh; Farzan, Michael] New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Stahl, Gregory L.] Brigham & Womens Hosp, CETRI, Boston, MA 02115 USA; [Huang, I-Chueh; Farzan, Michael; Takahashi, Kazue; Stuart, Lynda; Stahl, Gregory L.; Schmidt, Emmett V.; Michelow, Ian C.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Rush University; Royal Melbourne Hospital; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schmidt, EV (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Programs Dev Immunol, Boston, MA 02114 USA.	eschmidt@partners.org; ian_michelow@brown.edu	eisen, damon/AAC-7433-2019; Michelow, Ian C./AAH-2373-2020	Michelow, Ian C./0000-0002-8399-480X; Mungall, Bruce/0000-0002-6772-1633; Stahl, Gregory/0000-0002-4805-8119; Eisen, Damon/0000-0002-8987-4358; Farzan, Michael/0000-0002-2990-5319; Kotton, Darrell/0000-0002-9604-8476; Chen, Li/0000-0001-9303-4047; Olinger, Gene/0000-0001-7338-0292; Sarraju, Ashish/0000-0003-1649-2110	National Institutes of Health [U01 AI070330]; United States Department of Defense, Defense Threat Reduction Agency Biological Therapeutics Program [4.10006, 4.10007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI093679, U01AI070330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense, Defense Threat Reduction Agency Biological Therapeutics Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant U01 AI070330 (to EVS) and by United States Department of Defense, Defense Threat Reduction Agency Biological Therapeutics Program Grants 4.10006 and 4.10007 (to GGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Barrientos LG, 2004, J INFECT DIS, V189, P1440, DOI 10.1086/382658; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Bernig T, 2004, GENES IMMUN, V5, P461, DOI 10.1038/sj.gene.6364116; Bhattacharyya S, 2010, VIROLOGY, V401, P18, DOI 10.1016/j.virol.2010.02.015; Blanchong CA, 2000, J EXP MED, V191, P2183, DOI 10.1084/jem.191.12.2183; Boldt ABW, 2006, GENES IMMUN, V7, P393, DOI 10.1038/sj.gene.6364312; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brown GD, 2011, TRENDS IMMUNOL; Casanova JL, 2004, J EXP MED, V199, P1295, DOI 10.1084/jem.20040537; Catano G, 2008, J INFECT DIS, V198, P72, DOI 10.1086/588712; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; de Messias-Reason IJ, 2007, J INFECT DIS, V196, P1379, DOI 10.1086/521627; Denholm JT, 2010, CLIN EXP IMMUNOL, V162, P84, DOI 10.1111/j.1365-2249.2010.04221.x; Dolnik O, 2008, CELL MOL LIFE SCI, V65, P756, DOI 10.1007/s00018-007-7406-2; Dong MD, 2007, J IMMUNOL, V178, P3016, DOI 10.4049/jimmunol.178.5.3016; Dube D, 2008, J VIROL, V82, P7238, DOI 10.1128/JVI.00425-08; Dube D, 2010, P NATL ACAD SCI USA, V107, P16637, DOI 10.1073/pnas.1008509107; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; FELDMANN H, 1994, VIROLOGY, V199, P469, DOI 10.1006/viro.1994.1147; Feldmann H, 2001, J GEN VIROL, V82, P2839, DOI 10.1099/0022-1317-82-12-2839; Francica JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001098; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; GARRED P, 1994, EUR J IMMUNOGENET, V21, P125, DOI 10.1111/j.1744-313X.1994.tb00183.x; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Gunn BM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002586; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; HAWKES RA, 1964, AUST J EXP BIOL MED, V42, P465, DOI 10.1038/icb.1964.44; Hood CL, 2010, J VIROL, V84, P2972, DOI 10.1128/JVI.02151-09; Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Hyatt AD, 1996, VIRUS RES, V43, P1, DOI 10.1016/0168-1702(96)01307-X; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Jack DL, 2001, J INFECT DIS, V184, P1152, DOI 10.1086/323803; Ji X, 2005, J GEN VIROL, V86, P2535, DOI 10.1099/vir.0.81199-0; Kainulainen L, 2012, HUM IMMUNOL, V73, P498, DOI 10.1016/j.humimm.2012.02.015; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Klein NJ, 2005, MOL IMMUNOL, V42, P919, DOI 10.1016/j.molimm.2004.12.006; Kondratowicz AS, 2011, P NATL ACAD SCI US; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Li K, 2007, MOL IMMUNOL, V44, P3866, DOI 10.1016/j.molimm.2007.06.006; Ling MT, 2012, J INFECT DIS, V205, P44, DOI 10.1093/infdis/jir691; Madsen HO, 1998, J IMMUNOL, V161, P3169; Maginnis MS, 2010, J VIROL, V84, P9677, DOI 10.1128/JVI.00978-10; Matei E, 2010, J BIOL CHEM, V285, P13057, DOI 10.1074/jbc.M109.094938; McGreal E, 2002, BIOCHEM SOC T, V30, P1010, DOI 10.1042/BST0301010; Medina MF, 2003, MOL THER, V8, P777, DOI 10.1016/S1525-0016(03)00266-1; Mehlhop E, 2009, CELL HOST MICROBE, V6, P381, DOI 10.1016/j.chom.2009.09.003; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Michelow IC, 2011, J INFECT DIS, V203, P175, DOI 10.1093/infdis/jiq025; Michelow IC, 2010, J BIOL CHEM, V285, P24729, DOI 10.1074/jbc.M110.106260; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Nepomuceno RR, 1999, J IMMUNOL, V162, P3583; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Pagh R, 2008, FEBS J, V275, P515, DOI 10.1111/j.1742-4658.2007.06218.x; PHANUPHAK P, 1985, CLIN EXP IMMUNOL, V59, P571; Pickering M C, 2000, Adv Immunol, V76, P227; POWELL LD, 2001, CURR PROTOC IMMUNOL, pCH8; Powlesland AS, 2008, J BIOL CHEM, V283, P593, DOI 10.1074/jbc.M706292200; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Quinn K, 2009, J VIROL, V83, P10176, DOI 10.1128/JVI.00422-09; Reynard O, 2009, J VIROL, V83, P9596, DOI 10.1128/JVI.00784-09; Rojek JM, 2008, J VIROL, V82, P7677, DOI 10.1128/JVI.00560-08; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Sanchez A, 2007, J INFECT DIS, V196, pS251, DOI 10.1086/520597; Saxena K, 2009, MOL IMMUNOL, V46, P1289, DOI 10.1016/j.molimm.2008.11.018; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Seyfarth J, 2005, HUM MOL GENET, V14, P2859, DOI 10.1093/hmg/ddi318; Seyfarth J, 2006, MOL IMMUNOL, V43, P962, DOI 10.1016/j.molimm.2005.06.033; Shiell BJ, 2003, VIRUS RES, V92, P55, DOI 10.1016/S0168-1702(02)00313-1; Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06; Spiropoulou CF, 2009, VIROLOGY, V392, P11, DOI 10.1016/j.virol.2009.06.032; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; SUPER M, 1989, LANCET, V2, P1236; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Takada A, 2003, REV MED VIROL, V13, P387, DOI 10.1002/rmv.405; Takada A, 2007, J INFECT DIS, V196, pS347, DOI 10.1086/520581; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Thiel S, 2007, GENES IMMUN, V8, P154, DOI 10.1038/sj.gene.6364373; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Thiel S, 2009, J IMMUNOL, V182, P2939, DOI 10.4049/jimmunol.0802053; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Vorup-Jensen T, 2001, INT IMMUNOPHARMACOL, V1, P677, DOI 10.1016/S1567-5769(00)00052-7; WILLIAMSON WA, 1978, T ROY SOC TROP MED H, V72, P676, DOI 10.1016/0035-9203(78)90042-1; Wu YL, 2007, J IMMUNOL, V179, P3012, DOI 10.4049/jimmunol.179.5.3012; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yang Y, 2003, J IMMUNOL, V171, P2734, DOI 10.4049/jimmunol.171.5.2734; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005; Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519; Zhang H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r73	102	52	53	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60838	10.1371/journal.pone.0060838	http://dx.doi.org/10.1371/journal.pone.0060838			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23573288	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000317717300151
J	Chodzynski, KJ; Conotte, S; Vanhamme, L; Van Antwerpen, P; Kerkhofs, M; Legros, JL; Vanhaeverbeek, M; Van Meerhaeghe, A; Coussement, G; Boudjeltia, KZ; Legrand, A				Chodzynski, Kamil J.; Conotte, Stephanie; Vanhamme, Luc; Van Antwerpen, Pierre; Kerkhofs, Myriam; Legros, J. L.; Vanhaeverbeek, Michel; Van Meerhaeghe, Alain; Coussement, Gregory; Boudjeltia, Karim Zouaoui; Legrand, Alexandre			A New Device to Mimic Intermittent Hypoxia in Mice	PLOS ONE			English	Article							EPISODIC HYPOXIA; BLOOD-PRESSURE	Intermittent hypoxia (hypoxia-reoxygenation) is often associated with cardiovascular morbidity and mortality. We describe a new device which can be used to submit cohorts of mice to controlled and standardised hypoxia-normoxia cycles at an individual level. Mice were placed in individual compartments to which similar gas flow parameters were provided using an open loop strategy. Evaluations made using computational fluid dynamics were confirmed by studying changes in haemoglobin oxygen saturation in vivo. We also modified the parameters of the system and demonstrated its ability to generate different severities of cyclic hypoxemia very precisely, even with very high frequency cycles of hypoxia-reoxygenation. The importance of the parameters on reoxygenation was shown. This device will allow investigators to assess the effects of hypoxia-reoxygenation on different pathological conditions, such as obstructive sleep apnoea or chronic obstructive pulmonary disease.	[Chodzynski, Kamil J.; Coussement, Gregory] Univ Mons, Fluid Machines Dept, B-7000 Mons, Belgium; [Conotte, Stephanie; Legrand, Alexandre] Univ Mons, Dept Physiol & Pharmacol, B-7000 Mons, Belgium; [Vanhamme, Luc] Univ Libre Brussels, Mol Parasitol Lab, IBMM, Brussels, Belgium; [Van Antwerpen, Pierre] Univ Libre Brussels, Fac Pharm, Lab Therapeut Chem, Brussels, Belgium; [Legros, J. L.] ISAT, EPHEC, Brussels, Belgium; [Kerkhofs, Myriam; Van Meerhaeghe, Alain] CHU Charleroi, Sleep Lab, Montignies le Tilleul, Belgium; [Kerkhofs, Myriam; Vanhaeverbeek, Michel; Boudjeltia, Karim Zouaoui] CHU Charleroi, Expt Med Lab, ULB Unit 222, Montignies le Tilleul, Belgium	University of Mons; University of Mons; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Chodzynski, KJ (corresponding author), Univ Mons, Fluid Machines Dept, B-7000 Mons, Belgium.	kamil.chodzynski@umons.ac.be; stephanie.conotte@umons.ac.be		Van Antwerpen, Pierre/0000-0002-4934-8863	ISPPC (Intercommunale de Sante Publique du Pays de Charleroi)	ISPPC (Intercommunale de Sante Publique du Pays de Charleroi)	LV is director of Research at the Belgian National Fund for Scientific Research. This work was supported by a scientific grant from ISPPC ((Intercommunale de Sante Publique du Pays de Charleroi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beguin PC, 2005, J APPL PHYSIOL, V99, P1064, DOI 10.1152/japplphysiol.00056.2005; Chiang AA, 2006, CHINESE J PHYSIOL, V49, P234; Cour M, 2011, EUR HEART J, V32, P226, DOI 10.1093/eurheartj/ehq112; Fletcher EC, 2000, RESP PHYSIOL, V119, P189, DOI 10.1016/S0034-5687(99)00114-0; Fletcher EC, 2001, J APPL PHYSIOL, V90, P1600, DOI 10.1152/jappl.2001.90.4.1600; Ishii M, 2010, ADV EXP MED BIOL, V662, P121, DOI 10.1007/978-1-4419-1241-1_17; LAUNOISROLLINAT S, 2006, REV MAL RESPIR, V23; Levy P, 2008, EUR RESPIR J, V32, P1082, DOI 10.1183/09031936.00013308; McGuire M, 2002, CHEST, V122, P1012, DOI 10.1378/chest.122.3.1012; Tauman R, 2007, SLEEP BREATH, V11, P77, DOI 10.1007/s11325-006-0085-7; Young T, 2008, SLEEP, V31, P1071	11	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59973	10.1371/journal.pone.0059973	http://dx.doi.org/10.1371/journal.pone.0059973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565179	Green Submitted, gold, Green Published			2022-12-27	WOS:000317717300048
J	Jhun, BS; Lee, H; Jin, ZG; Yoon, Y				Jhun, Bong Sook; Lee, Hakjoo; Jin, Zheng-Gen; Yoon, Yisang			Glucose Stimulation Induces Dynamic Change of Mitochondrial Morphology to Promote Insulin Secretion in the Insulinoma Cell Line INS-1E	PLOS ONE			English	Article							DOMINANT OPTIC ATROPHY; PANCREATIC BETA-CELLS; MAMMALIAN-CELLS; PROTEIN DLP1; RAT ISLETS; COMPLEX-I; FISSION; RELEASE; FUSION; OPA1	Fission and fusion of mitochondrial tubules are the major processes regulating mitochondrial morphology. However, the physiological significance of mitochondrial shape change is poorly understood. Glucose-stimulated insulin secretion (GSIS) in pancreatic beta-cells requires mitochondrial ATP production which evokes Ca2+ influx through plasma membrane depolarization, triggering insulin vesicle exocytosis. Therefore, GSIS reflects mitochondrial function and can be used for evaluating functional changes associated with morphological alterations of mitochondria. Using the insulin-secreting cell line INS-1E, we found that glucose stimulation induced rapid mitochondrial shortening and recovery. Inhibition of mitochondrial fission through expression of the dominant-negative mutant DLP1-K38A eliminated this dynamic mitochondrial shape change and, importantly, blocked GSIS. We found that abolishing mitochondrial morphology change in glucose stimulation increased the mitochondrial inner membrane proton leak, and thus significantly diminished the mitochondrial ATP producing capacity in response to glucose stimulation. These results demonstrate that dynamic change of mitochondrial morphology is a previously unrecognized component for metabolism-secretion coupling of pancreatic beta-cells by participating in efficient ATP production in response to elevated glucose levels.	[Lee, Hakjoo; Yoon, Yisang] Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA USA; [Jhun, Bong Sook] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA; [Jin, Zheng-Gen] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Jin, Zheng-Gen] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY USA	University System of Georgia; Augusta University; Jefferson University; University of Rochester; University of Rochester	Yoon, Y (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA USA.	yyoon@gru.edu	Yoon, Yisang/AAJ-7910-2020	Yoon, Yisang/0000-0002-1618-5439; Jhun, Bong Sook/0000-0001-9916-9962	National Institutes of Health [DK078618, DK061991, HL080611]; American Diabetes Association [1-06-CD-13]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061991, R01DK078618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants DK078618 and DK061991 to YY and National Institutes of Health grant HL080611 and Thomas R. Lee Award 1-06-CD-13 from the American Diabetes Association to Z-GJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Benard G, 2008, ANTIOXID REDOX SIGN, V10, P1313, DOI 10.1089/ars.2007.2000; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Dlaskova A, 2010, BIOCH BIOPHYS ACTA; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; MACDONALD MJ, 1990, ARCH BIOCHEM BIOPHYS, V279, P104, DOI 10.1016/0003-9861(90)90468-E; Maechler P, 1998, BIOFACTORS, V8, P255, DOI 10.1002/biof.5520080313; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; MCCORMACK JG, 1990, BIOCHEM J, V267, P527, DOI 10.1042/bj2670527; Men XL, 2009, INT J BIOCHEM CELL B, V41, P879, DOI 10.1016/j.biocel.2008.08.031; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; MORGAN NG, 1985, BIOCHEM J, V231, P629, DOI 10.1042/bj2310629; Nesher R, 2002, DIABETES, V51, pS53, DOI 10.2337/diabetes.51.2007.S53; Park KS, 2008, J BIOL CHEM, V283, P33347, DOI 10.1074/jbc.M806251200; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Plecita-Hlavata L, 2008, BBA-BIOENERGETICS, V1777, P834, DOI 10.1016/j.bbabio.2008.04.002; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Santel A, 2001, J CELL SCI, V114, P867; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; SOMERS G, 1979, ACTA DIABETOL LAT, V16, P9, DOI 10.1007/BF02590758; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Zhang ZY, 2011, MOL BIOL CELL, V22, P2235, DOI 10.1091/mbc.E10-12-0933; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	46	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60810	10.1371/journal.pone.0060810	http://dx.doi.org/10.1371/journal.pone.0060810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565276	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300148
J	Liao, Y; Wang, B; Huang, ZL; Shi, M; Yu, XJ; Zheng, LM; Li, SP; Li, L				Liao, Yuan; Wang, Bo; Huang, Zhi-Liang; Shi, Ming; Yu, Xing-Juan; Zheng, Limin; Li, Shengping; Li, Lian			Increased Circulating Th17 Cells after Transarterial Chemoembolization Correlate with Improved Survival in Stage III Hepatocellular Carcinoma: A Prospective Study	PLOS ONE			English	Article							REGULATORY T-CELLS; ACTIVATED MONOCYTES; PERITUMORAL STROMA; CANCER; ENVIRONMENT; RECURRENCE; PHENOTYPE; SIGNATURE; CD4(+); BETA	Transarterial chemoembolization (TACE) has therapeutic effects in patients with unresectable hepatocellular carcinoma (HCC), but its impact on the cellular immune response during disease progression is largely unknown. Here we conducted a prospective study to evaluate the effect of TACE on immune status and to identify prognostic immune markers governing treatment success. In this study, 51 stage III HCC patients, 28 stage I HCC patients (TNM classification) and 20 healthy donors were enrolled. Flow cytometry and cytometric bead array were used to evaluate the circulating immune cell subsets, including CD4(+)T cells (Th1, Th17 and Treg cells), CD8(+)T cells, NK cells, and NKT cells, and plasma cytokines before TACE and 30 days after TACE. Interestingly, among those immune parameters, the frequency of circulating Th17 cells was higher in stage III HCC patients than in stage I HCC patients (P = 0.015) and healthy donors (P<0.001). Moreover, an increased frequency of circulating Th17 cells was observed 30 days after TACE (Th17(D30)) compared with the baseline level (P = 0.036). Kaplan-Meier analysis demonstrated that Th17(D30) was positively associated with overall survival (OS; P = 0.007) and time to progression (TTP; P = 0.009). Multivariate Cox analysis revealed that Th17(D30) was an independent prognostic factor for OS (HR = 0.317, P = 0.032) and TTP (HR = 0.304, P = 0.010). These results provide a potential prognostic marker for stage III HCC patients undergoing TACE and may be useful for identifying patients who can benefit from adjuvant immunotherapies.	[Liao, Yuan; Yu, Xing-Juan; Zheng, Limin; Li, Shengping] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Bo; Zheng, Limin; Li, Lian] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Zhi-Liang; Shi, Ming; Li, Shengping] Sun Yat Sen Univ, Dept Hepatobiliary Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, SP (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	lishp@sysucc.org.cn; lilian-75@163.com	zheng, limin/HGB-2510-2022	Shi, Ming/0000-0002-4051-4474; Zheng, Limin/0000-0002-8281-1450	Ministry of Health of China [2012ZX10002-011]; National Natural Science Foundation of China [30901355, 91029737, 30872372]; Fundamental Research Funds for the Central Universities [11lgpy57]; Natural Science Foundation of Guangdong Province [S2011010001393]	Ministry of Health of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the Ministry of Health of China (2012ZX10002-011), the National Natural Science Foundation of China (30901355, 91029737 and 30872372), the Fundamental Research Funds for the Central Universities (11lgpy57) and the Natural Science Foundation of Guangdong Province (S2011010001393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breous E, 2011, J HEPATOL, V54, P830, DOI 10.1016/j.jhep.2010.10.013; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Cariani E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032493; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Fu YX, 2012, CELL MOL IMMUNOL, V9, P1, DOI 10.1038/cmi.2011.54; Hao Ming-Zhi, 2010, Chin J Cancer, V29, P172; Hoffmann K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-349; Huang ZL, 2011, J VASC INTERV RADIOL, V22, P702, DOI 10.1016/j.jvir.2010.12.041; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung MC, 2002, LANCET INFECT DIS, V2, P43, DOI 10.1016/S1473-3099(01)00172-4; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Koyama K, 2008, CLIN CANCER RES, V14, P6770, DOI 10.1158/1078-0432.CCR-08-1156; Kryczek I, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002949; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lao XM, 2013, LIVER INT, V33, P595, DOI 10.1111/liv.12112; Lencioni R, 2010, ONCOLOGIST, V15, P42, DOI 10.1634/theoncologist.2010-S4-42; Luo J, 2011, ANN SURG ONCOL, V18, P413, DOI 10.1245/s10434-010-1321-8; Maniati E, 2010, ONCOGENE, V29, P5653, DOI 10.1038/onc.2010.367; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Mizukoshi E, 2010, INT J CANCER, V126, P2164, DOI 10.1002/ijc.24882; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Pang XH, 2011, HEPATO-GASTROENTEROL, V58, P1687, DOI 10.5754/hge10799; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park JW, 2012, J HEPATOL, V56, P1336, DOI 10.1016/j.jhep.2012.01.006; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Shirabe K, 2010, INT J CLIN ONCOL, V15, P552, DOI 10.1007/s10147-010-0131-0; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Viaud S, 2011, CANCER RES, V71, P661, DOI 10.1158/0008-5472.CAN-10-1259; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Xu J, 2012, J HEPATOL, V57, P313, DOI 10.1016/j.jhep.2012.03.027; Yamashita F, 1997, ONCOLOGY, V54, P28; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	41	41	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60444	10.1371/journal.pone.0060444	http://dx.doi.org/10.1371/journal.pone.0060444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565248	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300118
J	Lacle, MM; van der Pol, C; Witkamp, A; van der Wall, E; van Diest, PJ				Lacle, Miangela M.; van der Pol, Carmen; Witkamp, Arjen; van der Wall, Elsken; van Diest, Paul J.			Prognostic Value of Mitotic Index and Bcl2 Expression in Male Breast Cancer	PLOS ONE			English	Article							MAMMARY-CARCINOMA PROJECT; MARKER; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; REPRODUCIBILITY; GRADE; P53	The incidence of male breast cancer (MBC) is rising. Current treatment regimens for MBC are extrapolated from female breast cancer (FBC), based on the assumption that FBC prognostic features and therapeutic targets can be extrapolated to MBC. However, there is yet little evidence that prognostic features that have been developed and established in FBC are applicable to MBC as well. In a recent study on FBC, a combination of mitotic index and Bcl2 expression proved to be of strong prognostic value. Previous papers on Bcl2 expression in MBC were equivocal, and the prognostic value of Bcl2 combined with mitotic index has not been studied in MBC. The aim of the present study was therefore to investigate the prognostic value of Bcl2 in combination with mitotic index in MBC. Immunohistochemical staining for Bcl2 was performed on tissue microarrays of a total of 151 male breast cancer cases. Mitotic index was scored. The prognostic value of Bcl2 expression and Bcl2/mitotic index combinations was evaluated studying their correlations with clinicopathologic features and their prediction of survival. The vast majority of MBC (94%) showed Bcl2 expression, more frequently than previously described for FBC. Bcl2 expression had no significant associations with clinicopathologic features such as tumor size, mitotic count and grade. In univariate survival analysis, Bcl2 had no prognostic value, and showed no additional prognostic value to tumor size and histological grade in Cox regression. In addition, the Bcl2/mitotic index combination as opposed to FBC did not predict survival in MBC. In conclusion, Bcl2 expression is common in MBC, but is not associated with major clinicopathologic features and, in contrast to FBC, does not seem to have prognostic value, also when combined with mitotic index.	[Lacle, Miangela M.; van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van der Pol, Carmen; Witkamp, Arjen] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [van der Wall, Elsken] Univ Med Ctr Utrecht, Div Internal Med & Dermatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Diest, PJ (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	p.j.vandiest@umcutrecht.nl		Lacle, Miangela/0000-0003-3466-3569				Abdel-Fatah TMA, 2010, J PATHOL, V222, P388, DOI 10.1002/path.2775; Baak JPA, 2005, J CLIN ONCOL, V23, P5993, DOI 10.1200/JCO.2005.05.511; BAAK JPA, 1989, PATHOL RES PRACT, V185, P664, DOI 10.1016/S0344-0338(89)80213-4; BHARGAVA V, 1994, AM J PATHOL, V145, P535; Callagy GM, 2006, CLIN CANCER RES, V12, P2468, DOI 10.1158/1078-0432.CCR-05-2719; Callagy GM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-153; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; DOGLIONI C, 1994, VIRCHOWS ARCH, V424, P47; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Hwang KT, 2012, INT J CANCER, V131, pE1109, DOI 10.1002/ijc.27539; Jalava PJ, 2000, ANTICANCER RES, V20, P1213; Kornegoor R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3220; Kornegoor R, 2012, HISTOPATHOLOGY, V61, P1145, DOI 10.1111/j.1365-2559.2012.04330.x; Kornegoor R, 2012, MODERN PATHOL, V25, P1397, DOI 10.1038/modpathol.2012.101; Kornegoor R, 2012, BREAST CANCER RES TR, V135, P49, DOI 10.1007/s10549-012-2051-3; Kornegoor R, 2012, MODERN PATHOL, V25, P398, DOI 10.1038/modpathol.2011.174; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; Pich A, 1998, VIRCHOWS ARCH, V433, P229, DOI 10.1007/s004280050241; PICH A, 1994, AM J PATHOL, V145, P481; PIETENPOL JA, 1994, CANCER RES, V54, P3714; Rayson D, 1998, CANCER, V83, P1947, DOI 10.1002/(SICI)1097-0142(19981101)83:9<1947::AID-CNCR10>3.0.CO;2-J; Shaaban AM, 2012, BREAST CANCER RES TR, V133, P949, DOI 10.1007/s10549-011-1856-9; SILVESTRINI R, 1994, J NATL CANCER I, V86, P499, DOI 10.1093/jnci/86.7.499; Speirs V, 2009, BREAST CANCER RES TR, V115, P429, DOI 10.1007/s10549-008-0053-y; Tavassoli FA, 2003, PATHOLOGY GENETICS T, P9; Temmim L, 2001, BREAST, V10, P166, DOI 10.1054/brst.2000.0223; Trere D, 2007, ANN ONCOL, V18, P1004, DOI 10.1093/annonc/mdm074; van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; Wang-Rodriguez J, 2002, MODERN PATHOL, V15, P853, DOI 10.1097/01.MP.0000022251.61944.1D; WeberChappuis K, 1996, EUR J CANCER, V32A, P1686, DOI 10.1016/0959-8049(96)00154-2; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	33	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60138	10.1371/journal.pone.0060138	http://dx.doi.org/10.1371/journal.pone.0060138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573235	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900049
J	Chi, A; Ma, P; Fu, GS; Hobbs, G; Welsh, JS; Nguyen, NP; Jang, SY; Dai, JR; Jin, J; Komaki, R				Chi, Alexander; Ma, Pan; Fu, Guishan; Hobbs, Gerry; Welsh, James S.; Nguyen, Nam P.; Jang, Si Young; Dai, Jinrong; Jin, Jing; Komaki, Ritsuko			Critical Structure Sparing in Stereotactic Ablative Radiotherapy for Central Lung Lesions: Helical Tomotherapy vs. Volumetric Modulated Arc Therapy	PLOS ONE			English	Article							BODY RADIATION-THERAPY; ESOPHAGEAL CANCER; PHASE-II; TOXICITY; IMRT; FEASIBILITY; PNEUMONITIS; TUMORS	Background: Helical tomotherapy (HT) and volumetric modulated arc therapy (VMAT) are both advanced techniques of delivering intensity-modulated radiotherapy (IMRT). Here, we conduct a study to compare HT and partial-arc VMAT in their ability to spare organs at risk (OARs) when stereotactic ablative radiotherapy (SABR) is delivered to treat centrally located early stage non-small-cell lung cancer or lung metastases. Methods: 12 patients with centrally located lung lesions were randomly chosen. HT, 2 & 8 arc (Smart Arc, Pinnacle v9.0) plans were generated to deliver 70 Gy in 10 fractions to the planning target volume (PTV). Target and OAR dose parameters were compared. Each technique's ability to meet dose constraints was further investigated. Results: HT and VMAT plans generated essentially equivalent PTV coverage and dose conformality indices, while a trend for improved dose homogeneity by increasing from 2 to 8 arcs was observed with VMAT. Increasing the number of arcs with VMAT also led to some improvement in OAR sparing. After normalizing to OAR dose constraints, HT was found to be superior to 2 or 8-arc VMAT for optimal OAR sparing (meeting all the dose constraints) (p = 0.0004). All dose constraints were met in HT plans. Increasing from 2 to 8 arcs could not help achieve optimal OAR sparing for 4 patients. 2/4 of them had 3 immediately adjacent structures. Conclusion: HT appears to be superior to VMAT in OAR sparing mainly in cases which require conformal dose avoidance of multiple immediately adjacent OARs. For such cases, increasing the number of arcs in VMAT cannot significantly improve OAR sparing.	[Chi, Alexander] W Virginia Univ, Dept Radiat Oncol, Morgantown, WV 26506 USA; [Ma, Pan; Fu, Guishan; Dai, Jinrong; Jin, Jing] Peking Union Med Coll, Canc Hosp & Inst, Dept Radiat Oncol, Beijing 100021, Peoples R China; [Ma, Pan; Fu, Guishan; Dai, Jinrong; Jin, Jing] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Hobbs, Gerry] W Virginia Univ, Dept Biostat, Morgantown, WV 26506 USA; [Welsh, James S.] Fermilab Natl Accelerator Lab, NIU Fast Neutron Radiat Therapy Facil, Batavia, IL 60510 USA; [Nguyen, Nam P.; Jang, Si Young] Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA; [Komaki, Ritsuko] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	West Virginia University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; West Virginia University; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; University of Arizona; University of Texas System; UTMD Anderson Cancer Center	Chi, A (corresponding author), W Virginia Univ, Dept Radiat Oncol, Morgantown, WV 26506 USA.	achiaz2010@gmail.com						Bzdusek K, 2009, MED PHYS, V36, P2328, DOI 10.1118/1.3132234; Cattaneo GM, 2008, RADIOTHER ONCOL, V88, P310, DOI 10.1016/j.radonc.2008.06.006; Chen AM, 2012, BR J RADIOL IN PRESS; Chen YJ, 2007, MED DOSIM, V32, P166, DOI 10.1016/j.meddos.2006.12.003; Chi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035809; Chi A, 2011, INT J RADIAT ONCOL, V81, P856, DOI 10.1016/j.ijrobp.2010.11.051; Chi A, 2010, RADIOTHER ONCOL, V94, P1, DOI 10.1016/j.radonc.2009.12.008; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Fenwick JD, 2006, SEMIN RADIAT ONCOL, V16, P199, DOI 10.1016/j.semradonc.2006.04.002; Guckenberger M, 2009, RADIOTHER ONCOL, V93, P259, DOI 10.1016/j.radonc.2009.08.015; Gutierrez AN, 2011, MED DOSIM, V36, P126, DOI 10.1016/j.meddos.2010.02.003; Holt A, 2011, INT J RADIAT ONCOL, V81, P1560, DOI 10.1016/j.ijrobp.2010.09.014; Jiang XQ, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-140; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Lagerwaard FJ, 2009, INT J RADIAT ONCOL, V75, P253, DOI 10.1016/j.ijrobp.2009.03.029; Lee N, 2007, HEAD NECK-J SCI SPEC, V29, P387, DOI 10.1002/hed.20332; Liao ZXX, 2010, INT J RADIAT ONCOL, V76, P775, DOI 10.1016/j.ijrobp.2009.02.032; Lu SH, 2010, RADIOTHER O IN PRESS; McGrath SD, 2010, RADIOTHER ONCOL, V95, P153, DOI 10.1016/j.radonc.2009.12.039; Nagata Y, 2011, INT J RADIAT ONCOL, V79, P660, DOI 10.1016/j.ijrobp.2010.10.004; Nguyen NP, 2011, RADIOTHER ONCOL, V101, P438, DOI 10.1016/j.radonc.2011.07.015; Onimaru R, 2003, INT J RADIAT ONCOL, V56, P126, DOI 10.1016/S0360-3016(03)00095-6; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34; Onishi H, 2011, INT J RADIAT ONCOL, V81, P1352, DOI 10.1016/j.ijrobp.2009.07.1751; Oshiro Y, 2010, STRAHLENTHER ONKOL, V186, P274, DOI 10.1007/s00066-010-2072-y; Otto K, 2008, MED PHYS, V35, P310, DOI 10.1118/1.2818738; Palma DA, 2011, INT J RADIAT ONCOL, V80, P506, DOI 10.1016/j.ijrobp.2010.02.032; Ricardi U, 2012, LUNG CANCER, V75, P77, DOI 10.1016/j.lungcan.2011.04.021; Rong Y, 2011, INT J RADIAT ONCOL, V81, P284, DOI 10.1016/j.ijrobp.2010.10.059; Stauder MC, 2011, RADIOTHER ONCOL, V99, P166, DOI 10.1016/j.radonc.2011.04.002; Sterzing F, 2010, INT J RADIAT ONCOL, V76, P1266, DOI 10.1016/j.ijrobp.2009.07.1686; Takahashi W, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-20; Timmerman R, 2006, J CLIN ONCOL, V24, P4833, DOI 10.1200/JCO.2006.07.5937; Tomita N, 2010, TECHNOL CANCER RES T, V9, P407, DOI 10.1177/153303461000900410; Xia TY, 2006, INT J RADIAT ONCOL, V66, P117, DOI 10.1016/j.ijrobp.2006.04.013; Yorke ED, 2005, INT J RADIAT ONCOL, V63, P672, DOI 10.1016/j.ijrobp.2005.03.026; Zhang GG, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-152	37	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59729	10.1371/journal.pone.0059729	http://dx.doi.org/10.1371/journal.pone.0059729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577071	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800015
J	Jungers, JM; Fargione, JE; Sheaffer, CC; Wyse, DL; Lehman, C				Jungers, Jacob M.; Fargione, Joseph E.; Sheaffer, Craig C.; Wyse, Donald L.; Lehman, Clarence			Energy Potential of Biomass from Conservation Grasslands in Minnesota, USA	PLOS ONE			English	Article							RESERVE PROGRAM LAND; BIOENERGY PRODUCTION; HARVEST MANAGEMENT; SOUTH-DAKOTA; SOIL CARBON; SWITCHGRASS; DIVERSITY; NITROGEN; YIELDS; FERTILIZATION	Perennial biomass from grasslands managed for conservation of soil and biodiversity can be harvested for bioenergy. Until now, the quantity and quality of harvestable biomass from conservation grasslands in Minnesota, USA, was not known, and the factors that affect bioenergy potential from these systems have not been identified. We measured biomass yield, theoretical ethanol conversion efficiency, and plant tissue nitrogen (N) as metrics of bioenergy potential from mixed-species conservation grasslands harvested with commercial-scale equipment. With three years of data, we used mixed-effects models to determine factors that influence bioenergy potential. Sixty conservation grassland plots, each about 8 ha in size, were distributed among three locations in Minnesota. Harvest treatments were applied annually in autumn as a completely randomized block design. Biomass yield ranged from 0.5 to 5.7 Mg ha(-1). May precipitation increased biomass yield while precipitation in all other growing season months showed no affect. Averaged across all locations and years, theoretical ethanol conversion efficiency was 450 l Mg-1 and the concentration of plant N was 7.1 g kg(-1), both similar to dedicated herbaceous bioenergy crops such as switchgrass. Biomass yield did not decline in the second or third year of harvest. Across years, biomass yields fluctuated 23% around the average. Surprisingly, forb cover was a better predictor of biomass yield than warm-season grass with a positive correlation with biomass yield in the south and a negative correlation at other locations. Variation in land ethanol yield was almost exclusively due to variation in biomass yield rather than biomass quality; therefore, efforts to increase biomass yield might be more economical than altering biomass composition when managing conservation grasslands for ethanol production. Our measurements of bioenergy potential, and the factors that control it, can serve as parameters for assessing the economic viability of harvesting conservation grasslands for bioenergy.	[Jungers, Jacob M.] Univ Minnesota, Conservat Biol Grad Program, St Paul, MN 55108 USA; [Fargione, Joseph E.] Nature Conservancy, Minneapolis, MN USA; [Sheaffer, Craig C.; Wyse, Donald L.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Lehman, Clarence] Univ Minnesota, Coll Biol Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; Nature Conservancy; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jungers, JM (corresponding author), Univ Minnesota, Conservat Biol Grad Program, St Paul, MN 55108 USA.	junge037@umn.edu	Jungers, Jacob/ABC-1942-2020	Jungers, Jacob/0000-0001-8954-7325; Fargione, Joseph/0000-0002-0636-5380	University of Minnesota; Minnesota Environment and Natural Resources Trust Fund	University of Minnesota(University of Minnesota System); Minnesota Environment and Natural Resources Trust Fund	This study was supported by the University of Minnesota and the Minnesota Environment and Natural Resources Trust Fund as recommended by the Legislative-Citizen Commission on Minnesota Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2006, AGRON J, V98, P1518, DOI 10.2134/agronj2005.0351; Adler PR, 2009, ECOL APPL, V19, P2202, DOI 10.1890/07-2094.1; [Anonymous], 2010, R LANG ENV STAT COMP; Baxter LL, 1998, FUEL PROCESS TECHNOL, V54, P47, DOI 10.1016/S0378-3820(97)00060-X; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cai XM, 2011, ENVIRON SCI TECHNOL, V45, P334, DOI 10.1021/es103338e; Collins SL, 1998, SCIENCE, V280, P745, DOI 10.1126/science.280.5364.745; David K, 2010, ENERG ENVIRON SCI, V3, P1182, DOI 10.1039/b926617h; Di Virgilio N, 2007, FIELD CROP RES, V101, P232, DOI 10.1016/j.fcr.2006.11.009; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Florine SE, 2006, BIOMASS BIOENERG, V30, P522, DOI 10.1016/j.biombioe.2005.12.007; Fornara DA, 2008, J ECOL, V96, P314, DOI 10.1111/j.1365-2745.2007.01345.x; Gardiner MA, 2010, BIOENERG RES, V3, P6, DOI 10.1007/s12155-009-9065-7; Gelfand I, 2011, P NATL ACAD SCI USA, V108, P13864, DOI 10.1073/pnas.1017277108; Gillitzer PA, 2013, BIOENERG RES, V6, P131, DOI 10.1007/s12155-012-9233-z; Glover JD, 2010, AGR ECOSYST ENVIRON, V137, P3, DOI 10.1016/j.agee.2009.11.001; Guretzky JA, 2011, PLANT SOIL, V339, P69, DOI 10.1007/s11104-010-0376-4; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Jarchow ME, 2013, GCB BIOENERGY, V5, P281, DOI 10.1111/j.1757-1707.2012.01186.x; Jarchow ME, 2012, GCB BIOENERGY, V4, P671, DOI 10.1111/j.1757-1707.2012.01184.x; Jefferson PG, 1999, CAN J ANIM SCI, V79, P485, DOI 10.4141/A98-123; JENKINSON DS, 1994, J AGR SCI-CAMBRIDGE, V122, P365, DOI 10.1017/S0021859600067290; Johnson MVV, 2010, BIOENERG RES, V3, P353, DOI 10.1007/s12155-010-9094-2; Jungers JM, 2011, P 22 N AM PRAIR C, P168; Ledgard SF, 2001, PLANT SOIL, V228, P43, DOI 10.1023/A:1004810620983; Lee D, 2007, COMPOSITION HERBACEO; Lee DK, 2007, AGRON J, V99, P462, DOI 10.2134/agronj2006.0152; Lee D, 2013, GCB BIOENERGY, V5, P6, DOI 10.1111/j.1757-1707.2012.01177.x; Malhi SS, 2010, NUTR CYCL AGROECOSYS, V86, P425, DOI 10.1007/s10705-009-9306-3; Mangan ME, 2011, AGRON J, V103, P509, DOI 10.2134/agronj2010.0360; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; Monti A, 2009, BIOMASS BIOENERG, V33, P841, DOI 10.1016/j.biombioe.2009.01.006; Mulkey VR, 2008, BIORESOURCE TECHNOL, V99, P609, DOI 10.1016/j.biortech.2006.12.035; Mulkey VR, 2006, CROP SCI, V46, P712, DOI 10.2135/cropsci2005.04-0007; Nippert JB, 2006, PLANT ECOL, V184, P65, DOI 10.1007/s11258-005-9052-9; Nussbaumer T, 2003, ENERG FUEL, V17, P1510, DOI 10.1021/ef030031q; Ogden CA, 2010, FUEL PROCESS TECHNOL, V91, P266, DOI 10.1016/j.fuproc.2009.10.007; Olson D, 2007, SUSTAINABLE BIOMASS; Robertson BA, 2011, GCB BIOENERGY, V3, P235, DOI 10.1111/j.1757-1707.2010.01080.x; Robertson GP, 2011, ECOL APPL, V21, P1055, DOI 10.1890/09-0456.1; Russelle MP, 2007, SCIENCE, V316, DOI 10.1126/science.1139388; Sanderson MA, 1999, AGRON J, V91, P5, DOI 10.2134/agronj1999.00021962009100010002x; Schmer MR, 2012, AGRON J, V104, P54, DOI 10.2134/agronj2011.0195; Schmer MR, 2010, BIOENERG RES, V3, P159, DOI 10.1007/s12155-009-9045-y; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Venuto BC, 2010, CROP SCI, V50, P737, DOI 10.2135/cropsci2008.11.0641; Waramit N, 2011, AGRON J, V103, P655, DOI 10.2134/agronj2010.0374; West B. T., 2007, LINEAR MIXED MODELS; Wiens J, 2011, ECOL APPL, V21, P1085, DOI 10.1890/09-0673.1; Zuur Alain F., 2009, P1	53	37	38	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61209	10.1371/journal.pone.0061209	http://dx.doi.org/10.1371/journal.pone.0061209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577208	Green Published, gold			2022-12-27	WOS:000319109800130
J	May, M; Batkai, S; Zoerner, AA; Tsikas, D; Jordan, J; Engeli, S				May, Marcus; Batkai, Sandor; Zoerner, Alexander A.; Tsikas, Dimitrios; Jordan, Jens; Engeli, Stefan			Enhanced Human Tissue Microdialysis Using Hydroxypropyl-beta-Cyclodextrin as Molecular Carrier	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; BLOOD-FLOW; MITOCHONDRIAL TOXICITY; SKELETAL-MUSCLE; TOPICAL DRUG; METABOLITES; CALIBRATION; ISCHEMIA; RECOVERY; SKIN	Microdialysis sampling of lipophilic molecules in human tissues is challenging because protein binding and adhesion to the membrane limit recovery. Hydroxypropyl-beta-cyclodextrin (HP-beta-CD) forms complexes with hydrophobic molecules thereby improving microdialysis recovery of lipophilic molecules in vitro and in rodents. We tested the approach in human subjects. First, we determined HP-beta-CD influences on metabolite stability, delivery, and recovery in vitro. Then, we evaluated HP-beta-CD as microdialysis perfusion fluid supplement in 20 healthy volunteers. We placed 20 kDa microdialysis catheters in subcutaneous abdominal adipose tissue and in the vastus lateralis muscle. We perfused catheters with lactate free Ringer solution with or without 10% HP-beta-CD at flow rates of 0.3-2.0 mu l/min. We assessed tissue metabolites, ultrafiltration effects, and blood flow. In both tissues, metabolite concentrations with Ringer+HP-beta-CD perfusate were equal or higher compared to Ringer alone. Addition of HP-beta-CD increased dialysate volume by 10%. Adverse local or systemic reactions to HP-beta-CD did not occur and analytical methods were not disturbed. HP-beta-CD addition allowed to measure interstitial anandamide concentrations, a highly lipophilic endogenous molecule. Our findings suggest that HP-beta-CD is a suitable supplement in clinical microdialysis to enhance recovery of lipophilic molecules from human interstitial fluid.	[May, Marcus; Zoerner, Alexander A.; Tsikas, Dimitrios; Jordan, Jens; Engeli, Stefan] Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany; [Batkai, Sandor] Hannover Med Sch, Inst Mol & Translat, Hannover, Germany	Hannover Medical School; Hannover Medical School	Engeli, S (corresponding author), Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany.	engeli.stefan@mh-hannover.de	May, Marcus/A-1456-2017; Batkai, Sandor/H-7983-2014	May, Marcus/0000-0002-7513-4244; 	German Obesity Network of Competence [01 Gl0830, 01 Gl1122D]; Commission of the European Communities (Collaborative Project ADAPT) [HEALTH-F2-2008-201100]; Deutsche Forschungsgemeinschaft	German Obesity Network of Competence; Commission of the European Communities (Collaborative Project ADAPT); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the German Obesity Network of Competence (projects 01 Gl0830 and 01 Gl1122D) and the Commission of the European Communities (Collaborative Project ADAPT, Contract No. HEALTH-F2-2008-201100. Publication costs are funded by the support Program 'open access publication' of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson P, 2011, CLIN PHYSIOL FUNCT I, V31, P175, DOI 10.1111/j.1475-097X.2010.00995.x; Adams F, 2005, HORM METAB RES, V37, P68, DOI 10.1055/s-2005-861156; Bodenlenz M, 2012, EUR J PHARM BIOPHARM, V81, P635, DOI 10.1016/j.ejpb.2012.04.009; Chaurasia CS, 2007, J CLIN PHARMACOL, V47, P589, DOI 10.1177/0091270006299091; Clausen Trine Schnedler, 2009, Journal of Pharmacological and Toxicological Methods, V60, P281, DOI 10.1016/j.vascn.2009.03.001; Clough GF, 2005, AAPS J, V7, pE686, DOI 10.1208/aapsj070369; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Ekberg NR, 2005, CLIN CHIM ACTA, V359, P53, DOI 10.1016/j.cccn.2005.03.033; ENOKSSON S, 1995, INT J OBESITY, V19, P350; Farnebo S, 2011, MICROCIRCULATION, V18, P198, DOI 10.1111/j.1549-8719.2010.00077.x; FDA, 2001, AG RESP LETT GRAS NO; Fellander G, 1996, INT J OBESITY, V20, P220; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Groth L, 1996, ACTA DERM-VENEREOL, V76, P1; Hamrin K, 2002, J APPL PHYSIOL, V92, P385, DOI 10.1152/jappl.2002.92.1.385; Henriksson J, 1999, P NUTR SOC, V58, P919, DOI 10.1017/S0029665199001226; Herkenne C, 2008, PHARM RES-DORDR, V25, P87, DOI 10.1007/s11095-007-9429-7; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Homola A, 2006, NEUROSCI LETT, V404, P137, DOI 10.1016/j.neulet.2006.05.028; Keller AK, 2008, J UROLOGY, V179, P371, DOI 10.1016/j.juro.2007.08.088; Lange ECM, 2013, MICRODIALYSIS DRUG D, P13; Li YJ, 2006, AAPS J, V8, pE222; Magkos F, 2005, CURR OPIN CLIN NUTR, V8, P501, DOI 10.1097/01.mco.0000170756.71114.78; Maurer MH, 2008, PROTEOM CLIN APPL, V2, P437, DOI 10.1002/prca.200780044; Pereira CV, 2009, CURR DRUG SAF, V4, P34, DOI 10.2174/157488609787354440; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; Strindberg L, 2000, SCAND J CLIN LAB INV, V60, P205, DOI 10.1080/003655100750044857; Sun L, 2003, J PHARMACEUT BIOMED, V33, P1059, DOI 10.1016/S0731-7085(03)00363-7; Sun L, 2007, J CHROMATOGR A, V1161, P261, DOI 10.1016/j.chroma.2007.05.104; Tholance Y, 2011, CLIN CHIM ACTA, V412, P647, DOI 10.1016/j.cca.2010.12.025; Trickler W, 2003, J PHARM SCI-US, V92, P1419, DOI 10.1002/jps.10410; Walker JM, 1999, P NATL ACAD SCI USA, V96, P12198, DOI 10.1073/pnas.96.21.12198; Whitaker G, 2010, J PHARMACEUT BIOMED, V53, P490, DOI 10.1016/j.jpba.2010.05.023; Zoerner AA, 2012, ANAL BIOANAL CHEM, V402, P2727, DOI 10.1007/s00216-012-5729-9; Zoerner AA, 2012, J CHROMATOGR B, V883, P161, DOI 10.1016/j.jchromb.2011.06.025	38	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60628	10.1371/journal.pone.0060628	http://dx.doi.org/10.1371/journal.pone.0060628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577137	Green Submitted, gold, Green Published			2022-12-27	WOS:000319109800077
J	Niederer, S				Niederer, Steven			Regulation of Ion Gradients across Myocardial Ischemic Border Zones: A Biophysical Modelling Analysis	PLOS ONE			English	Article							INTRACELLULAR CHLORIDE ACTIVITY; HEART PURKINJE-FIBERS; SODIUM-CALCIUM EXCHANGE; ACUTE GLOBAL-ISCHEMIA; EXTRACELLULAR POTASSIUM CONCENTRATION; CORONARY-ARTERY OCCLUSION; RAT VENTRICULAR MYOCYTES; RETICULUM CA2+ LEAK; NA+-H+ EXCHANGE; IN-VITRO MODEL	The myocardial ischemic border zone is associated with the initiation and sustenance of arrhythmias. The profile of ionic concentrations across the border zone play a significant role in determining cellular electrophysiology and conductivity, yet their spatial-temporal evolution and regulation are not well understood. To investigate the changes in ion concentrations that regulate cellular electrophysiology, a mathematical model of ion movement in the intra and extracellular space in the presence of ionic, potential and material property heterogeneities was developed. The model simulates the spatial and temporal evolution of concentrations of potassium, sodium, chloride, calcium, hydrogen and bicarbonate ions and carbon dioxide across an ischemic border zone. Ischemia was simulated by sodium-potassium pump inhibition, potassium channel activation and respiratory and metabolic acidosis. The model predicted significant disparities in the width of the border zone for each ionic species, with intracellular sodium and extracellular potassium having discordant gradients, facilitating multiple gradients in cellular properties across the border zone. Extracellular potassium was found to have the largest border zone and this was attributed to the voltage dependence of the potassium channels. The model also predicted the efflux of K+ from the ischemic region due to electrogenic drift and diffusion within the intra and extracellular space, respectively, which contributed to K+ depletion in the ischemic region.	Kings Coll London, London WC2R 2LS, England	University of London; King's College London	Niederer, S (corresponding author), Kings Coll London, London WC2R 2LS, England.	steven.niederer@kcl.ac.uk		Niederer, Steven/0000-0002-4612-6982	UK Engineering and Physical Sciences Research Council [EP/F043929/1]; British Heart Foundation [PG/11/101/29212]; Boston Scientific; Engineering and Physical Sciences Research Council [EP/F043929/2] Funding Source: researchfish; EPSRC [EP/F043929/2] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation(British Heart Foundation); Boston Scientific(Boston Scientific); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported by UK Engineering and Physical Sciences Research Council EP/F043929/1, British Heart Foundation (PG/11/101/29212) and Boston Scientific. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABETE P, 1992, EUR J PHARMACOL, V211, P399, DOI 10.1016/0014-2999(92)90398-N; ABETE P, 1988, J PHYSIOL-LONDON, V404, P275, DOI 10.1113/jphysiol.1988.sp017290; ALLEN DG, 1983, J PHYSIOL-LONDON, V335, P555, DOI 10.1113/jphysiol.1983.sp014550; ALLEN DG, 1984, J PHYSIOL-LONDON, V350, P615, DOI 10.1113/jphysiol.1984.sp015221; AUSTIN WH, 1963, J APPL PHYSIOL, V18, P301, DOI 10.1152/jappl.1963.18.2.301; Baartscheer A, 2008, BRIT J PHARMACOL, V154, P1266, DOI 10.1038/bjp.2008.189; Baartscheer A, 2003, CARDIOVASC RES, V58, P99, DOI 10.1016/S0008-6363(02)00854-4; Baartscheer A, 1997, J MOL CELL CARDIOL, V29, P3375, DOI 10.1006/jmcc.1997.0567; BACKX PH, 1989, J GEN PHYSIOL, V93, P963, DOI 10.1085/jgp.93.5.963; Baetz D, 2003, MOL CELL BIOCHEM, V242, P115, DOI 10.1023/A:1021197930694; BALKE CW, 1994, J PHYSIOL-LONDON, V474, P447, DOI 10.1113/jphysiol.1994.sp020036; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; BASSANI JWM, 1995, BIOPHYS J, V68, P1453, DOI 10.1016/S0006-3495(95)80318-8; BASSANI RA, 1995, BIOPHYS J, V68, P2015, DOI 10.1016/S0006-3495(95)80378-4; BAUMGARTEN CM, 1981, AM J PHYSIOL, V241, pC121, DOI 10.1152/ajpcell.1981.241.3.C121; Bennett DL, 1999, PFLUG ARCH EUR J PHY, V437, P731, DOI 10.1007/s004240050839; BERLIN JR, 1994, BIOPHYS J, V67, P1775, DOI 10.1016/S0006-3495(94)80652-6; BERS DM, 1982, PFLUG ARCH EUR J PHY, V393, P171, DOI 10.1007/BF00582941; BERS DM, 1981, AM J PHYSIOL, V240, pH576, DOI 10.1152/ajpheart.1981.240.4.H576; Bers DM, 2001, EXCITATION CONTRACTI; BLANCHARD EM, 1984, CIRC RES, V55, P382, DOI 10.1161/01.RES.55.3.382; Bollensdorff C, 2004, AM J PHYSIOL-HEART C, V286, pH283, DOI 10.1152/ajpheart.00232.2003; BOLTON TB, 1977, J PHYSIOL-LONDON, V270, P801, DOI 10.1113/jphysiol.1977.sp011983; Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516; BOUNTRA C, 1990, J PHYSIOL-LONDON, V424, P343, DOI 10.1113/jphysiol.1990.sp018071; BOUNTRA C, 1989, J PHYSIOL-LONDON, V418, P163, DOI 10.1113/jphysiol.1989.sp017833; Boyer PK, 1940, AM HEART J, V20, P586, DOI 10.1016/S0002-8703(40)90936-X; CAILLE JP, 1981, AM J PHYSIOL, V240, pC183, DOI 10.1152/ajpcell.1981.240.5.C183; CARMELIET E, 1977, J PHYSIOL-LONDON, V265, P193, DOI 10.1113/jphysiol.1977.sp011712; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Carmeliet Edward, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS2, DOI 10.1111/j.1540-8167.2006.00378.x; Cascio WE, 2001, J CARDIOVASC ELECTR, V12, P726, DOI 10.1046/j.1540-8167.2001.00726.x; CASCIO WE, 1992, CIRC RES, V70, P409, DOI 10.1161/01.RES.70.2.409; CHAPMAN RA, 1986, J PHYSIOL-LONDON, V373, P163, DOI 10.1113/jphysiol.1986.sp016040; CHEUNG JY, 1982, AM J PHYSIOL, V243, pC184, DOI 10.1152/ajpcell.1982.243.3.C184; Chopra N, 2007, CIRC RES, V101, P617, DOI 10.1161/CIRCRESAHA.107.157552; COHEN CJ, 1982, CIRC RES, V50, P651, DOI 10.1161/01.RES.50.5.651; COLE WC, 1991, CIRC RES, V69, P571, DOI 10.1161/01.RES.69.3.571; CONWAY RS, 1985, CARDIOVASC RES, V19, P160, DOI 10.1093/cvr/19.3.160; Cordeiro JM, 2001, J PHYSIOL-LONDON, V531, P301, DOI 10.1111/j.1469-7793.2001.0301i.x; CORONEL R, 1991, CIRC RES, V68, P1241, DOI 10.1161/01.RES.68.5.1241; CORONEL R, 1995, J MOL CELL CARDIOL, V27, P2069, DOI 10.1016/0022-2828(95)90028-4; CORONEL R, 1988, CIRCULATION, V77, P1125, DOI 10.1161/01.CIR.77.5.1125; Crampin EJ, 2006, BIOPHYS J, V90, P3074, DOI 10.1529/biophysj.105.070557; CUMMINGS JR, 1960, CIRC RES, V8, P865, DOI 10.1161/01.RES.8.4.865; CYRAN SE, 1993, J PEDIATR-US, V122, pS77, DOI 10.1016/S0022-3476(09)90048-8; DEITMER JW, 1980, J PHYSIOL-LONDON, V300, P269, DOI 10.1113/jphysiol.1980.sp013161; DEITMER JW, 1978, J PHYSIOL-LONDON, V277, P437, DOI 10.1113/jphysiol.1978.sp012283; DEITMER JW, 1980, J PHYSIOL-LONDON, V304, P471, DOI 10.1113/jphysiol.1980.sp013337; Delbridge LMD, 1997, AM J PHYSIOL-HEART C, V272, pH2425, DOI 10.1152/ajpheart.1997.272.5.H2425; DENNIS SC, 1991, J MOL CELL CARDIOL, V23, P1077, DOI 10.1016/0022-2828(91)91642-5; Despa S, 2003, BIOPHYS J, V84, P4157, DOI 10.1016/S0006-3495(03)75140-6; Despa S, 2002, J PHYSIOL-LONDON, V539, P133, DOI 10.1113/jphysiol.2001.012940; Diaz ME, 2001, BIOPHYS J, V80, P1915, DOI 10.1016/S0006-3495(01)76161-9; Ducroq J, 2005, EUR J PHARMACOL, V518, P165, DOI 10.1016/j.ejphar.2005.06.014; Eigel BN, 1999, AM J PHYSIOL-HEART C, V277, pH1817, DOI 10.1152/ajpheart.1999.277.5.H1817; El Banani H, 2000, CARDIOVASC RES, V47, P688, DOI 10.1016/S0008-6363(00)00136-X; ELLIOTT AC, 1992, J PHYSIOL-LONDON, V454, P467, DOI 10.1113/jphysiol.1992.sp019274; ELLIS D, 1977, J PHYSIOL-LONDON, V273, P211, DOI 10.1113/jphysiol.1977.sp012090; ELLIS D, 1985, J PHYSIOL-LONDON, V359, P81, DOI 10.1113/jphysiol.1985.sp015576; ERDMANN E, 1971, ARCH BIOCHEM BIOPHYS, V145, P121, DOI 10.1016/0003-9861(71)90017-8; Faber GM, 2000, BIOPHYS J, V78, P2392, DOI 10.1016/S0006-3495(00)76783-X; Fink M, 2011, PROG BIOPHYS MOL BIO, V104, P2, DOI 10.1016/j.pbiomolbio.2010.03.002; FOZZARD HA, 1976, J PHYSIOL-LONDON, V256, P663, DOI 10.1113/jphysiol.1976.sp011345; GAMBASSI G, 1993, J GEN PHYSIOL, V102, P575, DOI 10.1085/jgp.102.3.575; GASSER RNA, 1990, J PHYSIOL-LONDON, V431, P713, DOI 10.1113/jphysiol.1990.sp018356; GAYESKI TEJ, 1991, AM J PHYSIOL, V260, pH522, DOI 10.1152/ajpheart.1991.260.2.H522; Gottlieb RA, 1996, J CLIN INVEST, V97, P2391, DOI 10.1172/JCI118683; HAK JB, 1993, AM J PHYSIOL, V265, pH2081, DOI 10.1152/ajpheart.1993.265.6.H2081; HAN S, 1994, J PHYSIOL-LONDON, V480, P411, DOI 10.1113/jphysiol.1994.sp020371; Hand PE, 2010, B MATH BIOL, V72, P1408, DOI 10.1007/s11538-009-9499-2; HARKEN AH, 1978, AM J CARDIOL, V42, P954, DOI 10.1016/0002-9149(78)90681-1; Hartmann M, 1999, J MOL CELL CARDIOL, V31, P1985, DOI 10.1006/jmcc.1999.1029; HEARSE DJ, 1981, AM J CARDIOL, V47, P1321, DOI 10.1016/0002-9149(81)90266-6; HILL JL, 1980, CIRCULATION, V61, P768, DOI 10.1161/01.CIR.61.4.768; HILLIS LD, 1979, J CLIN INVEST, V63, P99, DOI 10.1172/JCI109284; Hobai IA, 2001, CIRCULATION, V103, P1577; HORACEK T, 1984, BASIC RES CARDIOL, V79, P649, DOI 10.1007/BF01908383; HOVEMADSEN L, 1993, CIRC RES, V73, P820, DOI 10.1161/01.RES.73.5.820; Imahashi K, 1999, CIRC RES, V84, P1401; Imahashi K, 2001, CIRC RES, V88, P1176, DOI 10.1161/hh1101.092139; JANSE MJ, 1979, CIRC RES, V44, P576, DOI 10.1161/01.RES.44.4.576; KAILA K, 1987, J PHYSIOL-LONDON, V390, P93, DOI 10.1113/jphysiol.1987.sp016688; Kanda A, 1997, CIRCULATION, V95, P1937; KANTOR PF, 1990, CIRC RES, V66, P478, DOI 10.1161/01.RES.66.2.478; KAPLINSKY E, 1979, CIRCULATION, V60, P397, DOI 10.1161/01.CIR.60.2.397; KATZUNG BG, 1975, CIRC RES, V37, P118, DOI 10.1161/01.RES.37.1.118; KHURI SF, 1975, CIRC RES, V37, P455, DOI 10.1161/01.RES.37.4.455; KIMURA J, 1987, J PHYSIOL-LONDON, V384, P199, DOI 10.1113/jphysiol.1987.sp016450; KIMURA S, 1986, CIRCULATION, V74, P401, DOI 10.1161/01.CIR.74.2.401; KIMURA S, 1986, CIRC RES, V58, P202, DOI 10.1161/01.RES.58.2.202; KITAZAWA T, 1984, J PHYSIOL-LONDON, V355, P635, DOI 10.1113/jphysiol.1984.sp015443; KLEBER AG, 1984, J MOL CELL CARDIOL, V16, P389, DOI 10.1016/S0022-2828(84)80610-0; KLEBER AG, 1983, CIRC RES, V52, P442, DOI 10.1161/01.RES.52.4.442; KLEBER AG, 1978, CIRC RES, V42, P603, DOI 10.1161/01.RES.42.5.603; Komukai K, 2002, AM J PHYSIOL-HEART C, V283, pH412, DOI 10.1152/ajpheart.01042.2001; KUNZE DL, 1977, CIRC RES, V41, P122, DOI 10.1161/01.RES.41.1.122; KUSUOKA H, 1993, J AM COLL CARDIOL, V21, P240, DOI 10.1016/0735-1097(93)90743-K; LAGADICGOSSMANN D, 1992, J PHYSIOL-LONDON, V458, P361, DOI 10.1113/jphysiol.1992.sp019422; Lai ZF, 1998, AM J PHYSIOL-HEART C, V275, pH1613, DOI 10.1152/ajpheart.1998.275.5.H1613; LEE CO, 1975, J GEN PHYSIOL, V65, P695, DOI 10.1085/jgp.65.6.695; Leem CH, 1998, J PHYSIOL-LONDON, V509, P487, DOI 10.1111/j.1469-7793.1998.487bn.x; Leem CH, 1999, J PHYSIOL-LONDON, V517, P159, DOI 10.1111/j.1469-7793.1999.0159z.x; Li L, 2010, AM J PHYSIOL-HEART C, V299, pH1045, DOI 10.1152/ajpheart.00219.2010; MATTIAZZI A, 1994, AM J PHYSIOL, V267, pH812, DOI 10.1152/ajpheart.1994.267.2.H812; MITANI A, 1992, AM J PHYSIOL, V263, pH333, DOI 10.1152/ajpheart.1992.263.2.H333; MITANI A, 1991, AM J PHYSIOL, V261, pH1864, DOI 10.1152/ajpheart.1991.261.6.H1864; MIURA DS, 1977, J GEN PHYSIOL, V69, P463, DOI 10.1085/jgp.69.4.463; MIURA DS, 1978, CIRC RES, V42, P333, DOI 10.1161/01.RES.42.3.333; MONNEREA.H, 1969, CR SOC BIOL, V163, P1419; MOORE E W, 1970, Journal of Clinical Investigation, V49, P318, DOI 10.1172/JCI106241; Mori Y, 2008, P NATL ACAD SCI USA, V105, P6463, DOI 10.1073/pnas.0801089105; Muzikant AL, 1998, PROG BIOPHYS MOL BIO, V69, P205, DOI 10.1016/S0079-6107(98)00008-X; NAKANISHI T, 1990, CIRC RES, V67, P111, DOI 10.1161/01.RES.67.1.111; Niederer SA, 2008, BIOPHYS J, V94, P2385, DOI 10.1529/biophysj.107.118885; Niederer SA, 2007, BIOPHYS J, V92, P4030, DOI 10.1529/biophysj.106.095463; Nygren A, 1999, J THEOR BIOL, V199, P329, DOI 10.1006/jtbi.1999.0962; ORCHARD CH, 1990, AM J PHYSIOL, V258, pC967, DOI 10.1152/ajpcell.1990.258.6.C967; PAGE E, 1978, AM J PHYSIOL, V235, pC147, DOI 10.1152/ajpcell.1978.235.5.C147; PAGE E, 1979, CIRC RES, V45, P260, DOI 10.1161/01.RES.45.2.260; Park CO, 1999, AM J PHYSIOL-HEART C, V276, pH1581, DOI 10.1152/ajpheart.1999.276.5.H1581; PIKE MM, 1993, AM J PHYSIOL, V265, pH2017, DOI 10.1152/ajpheart.1993.265.6.H2017; POLIMENI PI, 1975, CIRC RES, V37, P725, DOI 10.1161/01.RES.37.6.725; POLIMENI PI, 1974, AM J PHYSIOL, V227, P676, DOI 10.1152/ajplegacy.1974.227.3.676; POLIMENI PI, 1974, J MOL CELL CARDIOL, V6, P531, DOI 10.1016/0022-2828(74)90034-0; POOLEWILSON PA, 1975, AM J PHYSIOL, V229, P1299, DOI 10.1152/ajplegacy.1975.229.5.1299; POST JA, 1992, J MEMBRANE BIOL, V129, P49; Potse M, 2007, MED BIOL ENG COMPUT, V45, P1187, DOI 10.1007/s11517-007-0276-9; Potse M, 2007, HEART RHYTHM, V4, P200, DOI 10.1016/j.hrthm.2006.10.022; POWELL T, 1980, J PHYSIOL-LONDON, V302, P131; PRASAD K, 1979, CARDIOVASC RES, V13, P95, DOI 10.1093/cvr/13.2.95; PRINZEN FW, 1989, PFLUG ARCH EUR J PHY, V415, P220, DOI 10.1007/BF00370596; Richardson G, 2009, MATH MED BIOL; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; Rodriguez B, 2004, AM J PHYSIOL-HEART C, V286, pH2078, DOI 10.1152/ajpheart.01175.2003; Roth BJ, 1997, BIOMEDICAL ENG IEEE, V44, P326; Rouet R, 2000, CIRCULATION, V101, P86, DOI 10.1161/01.CIR.101.1.86; RUMSEY WL, 1994, AM J PHYSIOL, V266, pH1676, DOI 10.1152/ajpheart.1994.266.4.H1676; Saito T, 2005, AM J PHYSIOL-HEART C, V288, pH352, DOI 10.1152/ajpheart.00695.2004; SASYNIUK BI, 1984, J PHARMACOL EXP THER, V231, P387; SCHAAPHERDER AFM, 1990, BASIC RES CARDIOL, V85, P33, DOI 10.1007/BF01907012; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; SHEU SS, 1980, CIRC RES, V47, P692, DOI 10.1161/01.RES.47.5.692; Sidorov VY, 2011, AM J PHYSIOL-HEART C, V301, pH209, DOI 10.1152/ajpheart.01141.2010; SINGH S, 1981, CIRC RES, V49, P434, DOI 10.1161/01.RES.49.2.434; SIRI FM, 1991, AM J PHYSIOL, V261, pH514, DOI 10.1152/ajpheart.1991.261.2.H514; Smith NP, 2004, PROG BIOPHYS MOL BIO, V85, P387, DOI 10.1016/j.pbiomolbio.2004.01.010; Sossalla S, 2008, J MOL CELL CARDIOL, V45, P32, DOI 10.1016/j.yjmcc.2008.03.006; SPITZER KW, 1980, AM J PHYSIOL, V238, pH487, DOI 10.1152/ajpheart.1980.238.4.H487; Swietach P, 2003, PROG BIOPHYS MOL BIO, V83, P69, DOI 10.1016/S0079-6107(03)00027-0; Swietach P, 2007, CIRC RES, V100, P1045, DOI 10.1161/01.RES.0000264071.11619.47; Ten Hove M, 2005, AM J PHYSIOL-HEART C, V288, pH287, DOI 10.1152/ajpheart.01102.2003; Terkildsen JR, 2007, AM J PHYSIOL-HEART C, V293, pH3036, DOI 10.1152/ajpheart.00771.2007; Terracciano CMN, 1997, BIOPHYS J, V72, P1319, DOI 10.1016/S0006-3495(97)78778-2; Tice BM, 2007, EUROPACE, V9, P46, DOI 10.1093/europace/eum204; Trafford AW, 1999, PFLUG ARCH EUR J PHY, V437, P501, DOI 10.1007/s004240050808; Trenor B, 2005, ANN BIOMED ENG, V33, P897, DOI 10.1007/s10439-005-3554-4; Van Emous JG, 2001, AM J PHYSIOL-HEART C, V280, pH2189, DOI 10.1152/ajpheart.2001.280.5.H2189; VANECHTELD CJA, 1991, J MOL CELL CARDIOL, V23, P297, DOI 10.1016/0022-2828(91)90066-U; VANHEEL B, 1992, CARDIOVASC RES, V26, P1030, DOI 10.1093/cvr/26.11.1030; VARRO A, 1993, PFLUG ARCH EUR J PHY, V423, P158, DOI 10.1007/BF00374975; Vaughan-Jones RD, 2009, J MOL CELL CARDIOL, V46, P318, DOI 10.1016/j.yjmcc.2008.10.024; VAUGHANJONES RD, 1979, J PHYSIOL-LONDON, V295, P111, DOI 10.1113/jphysiol.1979.sp012957; VAUGHANJONES RD, 1979, J PHYSIOL-LONDON, V295, P83, DOI 10.1113/jphysiol.1979.sp012956; VAUGHANJONES RD, 1990, J PHYSIOL-LONDON, V428, P441, DOI 10.1113/jphysiol.1990.sp018221; VAUGHANJONES RD, 1986, J PHYSIOL-LONDON, V379, P377, DOI 10.1113/jphysiol.1986.sp016259; Vigmond EJ, 2002, IEEE T BIO-MED ENG, V49, P1260, DOI 10.1109/TBME.2002.804597; Vinnakota KC, 2011, BIOPHYS J, V100, P369, DOI 10.1016/j.bpj.2010.11.079; Walden AP, 2009, J MOL CELL CARDIOL, V46, P463, DOI 10.1016/j.yjmcc.2008.11.003; WANG YP, 1994, AM J PHYSIOL, V266, pC1077, DOI 10.1152/ajpcell.1994.266.4.C1077; Weber CR, 2002, CIRC RES, V90, P182, DOI 10.1161/hh0202.103940; Weiss JN, 2000, CIRC RES, V87, P1103, DOI 10.1161/01.RES.87.12.1103; WIEGAND V, 1979, CARDIOVASC RES, V13, P297, DOI 10.1093/cvr/13.5.297; Wikswo JP, 1995, BIOPHYS J, V69, P2195, DOI 10.1016/S0006-3495(95)80115-3; WILDE AAM, 1995, CARDIOVASC RES, V29, P1; WILDE AAM, 1990, CIRC RES, V67, P835, DOI 10.1161/01.RES.67.4.835; WILENSKY RL, 1986, CIRCULATION, V74, P1137, DOI 10.1161/01.CIR.74.5.1137; Wu ML, 1997, J MOL CELL CARDIOL, V29, P1131, DOI 10.1006/jmcc.1996.0338; WU ML, 1994, CIRC RES, V75, P123, DOI 10.1161/01.RES.75.1.123; Xiao XH, 1999, CIRC RES, V85, P723, DOI 10.1161/01.RES.85.8.723; Yan GX, 2004, CIRCULATION, V110, P1036, DOI 10.1161/01.CIR.0000140258.09964.19; YAN GX, 1992, CIRC RES, V71, P460, DOI 10.1161/01.RES.71.2.460; Yan GX, 1996, J PHYSIOL-LONDON, V490, P215, DOI 10.1113/jphysiol.1996.sp021137; YELLON DM, 1981, AM J CARDIOL, V47, P1233, DOI 10.1016/0002-9149(81)90252-6; Yvon A, 2002, BRIT J ANAESTH, V89, P888, DOI 10.1093/bja/aef283; Zaitsev AV, 2003, CIRC RES, V92, P546, DOI 10.1161/01.RES.0000061917.23107.F7; Zaniboni M, 2003, CIRC RES, V93, P726, DOI 10.1161/01.RES.0000093986.47383.CE; Zaniboni M, 2003, AM J PHYSIOL-HEART C, V285, pH1236, DOI 10.1152/ajpheart.00277.2003; Zima AV, 2010, J PHYSIOL-LONDON, V588, P4743, DOI 10.1113/jphysiol.2010.197913	189	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60323	10.1371/journal.pone.0060323	http://dx.doi.org/10.1371/journal.pone.0060323			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577101	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800043
J	Petrini, I; Rajan, A; Pham, T; Voeller, D; Davis, S; Gao, J; Wang, YS; Giaccone, G				Petrini, Iacopo; Rajan, Arun; Trung Pham; Voeller, Donna; Davis, Sean; Gao, James; Wang, Yisong; Giaccone, Giuseppe			Whole Genome and Transcriptome Sequencing of a B3 Thymoma	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; SOMATIC MUTATIONS; TUMOR-SUPPRESSOR; BCOR; CANCER; CARCINOMA; PROTEINS; GENES	Molecular pathology of thymomas is poorly understood. Genomic aberrations are frequently identified in tumors but no extensive sequencing has been reported in thymomas. Here we present the first comprehensive view of a B3 thymoma at whole genome and transcriptome levels. A 55-year-old Caucasian female underwent complete resection of a stage IVA B3 thymoma. RNA and DNA were extracted from a snap frozen tumor sample with a fraction of cancer cells over 80%. We performed array comparative genomic hybridization using Agilent platform, transcriptome sequencing using HiSeq 2000 (Illumina) and whole genome sequencing using Complete Genomics Inc platform. Whole genome sequencing determined, in tumor and normal, the sequence of both alleles in more than 95% of the reference genome (NCBI Build 37). Copy number (CN) aberrations were comparable with those previously described for B3 thymomas, with CN gain of chromosome 1q, 5, 7 and X and CN loss of 3p, 6, 11q42.2-qter and q13. One translocation t(11;X) was identified by whole genome sequencing and confirmed by PCR and Sanger sequencing. Ten single nucleotide variations (SNVs) and 2 insertion/deletions (INDELs) were identified; these mutations resulted in non-synonymous amino acid changes or affected splicing sites. The lack of common cancer-associated mutations in this patient suggests that thymomas may evolve through mechanisms distinctive from other tumor types, and supports the rationale for additional high-throughput sequencing screens to better understand the somatic genetic architecture of thymoma.	[Petrini, Iacopo; Rajan, Arun; Trung Pham; Voeller, Donna; Gao, James; Wang, Yisong; Giaccone, Giuseppe] NCI, Med Oncol Branch, Bethesda, MD 20892 USA; [Davis, Sean] NCI, Genet Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giaccone, G (corresponding author), NCI, Med Oncol Branch, Bethesda, MD 20892 USA.	giacconeg@mail.nih.gov	Davis, Sean/AAD-1801-2021; Petrini, Iacopo/P-9318-2019; Petrini, Iacopo/K-7316-2016; Giaccone, Giuseppe/E-8297-2017	Davis, Sean/0000-0002-8991-6458; Petrini, Iacopo/0000-0002-7752-6866; Petrini, Iacopo/0000-0002-7752-6866; Giaccone, Giuseppe/0000-0002-5023-7562	National Cancer Institute intramural program; NATIONAL CANCER INSTITUTE [ZIDBC011540] Funding Source: NIH RePORTER	National Cancer Institute intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute intramural program funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; Girard N, 2009, CLIN CANCER RES, V15, P6790, DOI 10.1158/1078-0432.CCR-09-0644; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Kelly RJ, 2011, J CLIN ONCOL, V29, P4820, DOI 10.1200/JCO.2011.36.0487; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kondo K, 2003, ANN THORAC SURG, V76, P878, DOI 10.1016/S0003-4975(03)00555-1; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ng D, 2004, NAT GENET, V36, P411, DOI 10.1038/ng1321; Petrini I, 2012, CELL DEATH IN PRESS; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Travis WD., 2004, TRAVIS WB WHO CLASSI; Vinatzer U, 2008, CLIN CANCER RES, V14, P6426, DOI 10.1158/1078-0432.CCR-08-0702; Wamstad JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002814; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Zettl A, 2000, AM J PATHOL, V157, P257, DOI 10.1016/S0002-9440(10)64536-1; Zhou MI, 2005, P NATL ACAD SCI USA, V102, P11035, DOI 10.1073/pnas.0500757102	42	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60572	10.1371/journal.pone.0060572	http://dx.doi.org/10.1371/journal.pone.0060572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577124	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800064
J	Aziz, NA; Rozing, MP				Aziz, Nasir Ahmad; Rozing, Maarten Pieter			Profit (p)-Index: The Degree to Which Authors Profit from Co-Authors	PLOS ONE			English	Article							H-INDEX; SCIENTIFIC-RESEARCH; PUBLICATION; CREDIT	Current metrics for estimating a scientist's academic performance treat the author's publications as if these were solely attributable to the author. However, this approach ignores the substantive contributions of co-authors, leading to misjudgments about the individual's own scientific merits and consequently to misallocation of funding resources and academic positions. This problem is becoming the more urgent in the biomedical field where the number of collaborations is growing rapidly, making it increasingly harder to support the best scientists. Therefore, here we introduce a simple harmonic weighing algorithm for correcting citations and citation-based metrics such as the h-index for co-authorships. This weighing algorithm can account for both the nvumber of co-authors and the sequence of authors on a paper. We then derive a measure called the 'profit (p)-index', which estimates the contribution of co-authors to the work of a given author. By using samples of researchers from a renowned Dutch University hospital, Spinoza Prize laureates (the most prestigious Dutch science award), and Nobel Prize laureates in Physiology or Medicine, we show that the contribution of co-authors to the work of a particular author is generally substantial (i.e., about 80%) and that researchers' relative rankings change materially when adjusted for the contributions of co-authors. Interestingly, although the top University hospital researchers had the highest h-indices, this appeared to be due to their significantly higher p-indices. Importantly, the ranking completely reversed when using the profit adjusted h-indices, with the Nobel laureates having the highest, the Spinoza Prize laureates having an intermediate, and the top University hospital researchers having the lowest profit adjusted h-indices, respectively, suggesting that exceptional researchers are characterized by a relatively high degree of scientific independency/ originality. The concepts and methods introduced here may thus provide a more fair impression of a scientist's autonomous academic performance.	[Aziz, Nasir Ahmad] Leiden Univ Med Ctr, Dept Neurol, Leiden, Netherlands; [Rozing, Maarten Pieter] GGZinGeest Geestgronden, Inst Mental Hlth Care, Amstelveen, Netherlands	Leiden University; Leiden University Medical Center (LUMC)	Aziz, NA (corresponding author), Leiden Univ Med Ctr, Dept Neurol, Leiden, Netherlands.	N.A.Aziz@lumc.nl	Rozing, Maarten/AHC-7454-2022; Aziz, Ahmad/AAQ-3744-2021					Abbas AM, 2011, SCIENTOMETRICS, V88, P107, DOI 10.1007/s11192-011-0389-7; Abbott A, 2010, NATURE, V465, P860, DOI 10.1038/465860a; Acuna DE, 2012, NATURE, V489, P201, DOI 10.1038/489201a; Baerlocher MO, 2007, J INVEST MED, V55, P174, DOI 10.2310/6650.2007.06044; Batista PD, 2006, SCIENTOMETRICS, V68, P179, DOI 10.1007/s11192-006-0090-4; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P830, DOI 10.1002/asi.20806; Bras-Amoros M, 2011, J INFORMETR, V5, P248, DOI 10.1016/j.joi.2010.11.001; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Greene M, 2007, NATURE, V450, P1165, DOI 10.1038/4501165a; Hagen NT, 2010, SCIENTOMETRICS, V84, P785, DOI 10.1007/s11192-009-0129-4; Hagen NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004021; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Imperial J, 2007, SCIENTOMETRICS, V71, P271, DOI 10.1007/s11192-007-1665-4; Schreiber M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/040201; Sekercioglu CH, 2008, SCIENCE, V322, P371, DOI 10.1126/science.322.5900.371a; Tol RSJ, 2011, SCIENTOMETRICS, V89, P291, DOI 10.1007/s11192-011-0451-5; Wallace ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033339; Zhang CT, 2009, EMBO REP, V10, P416, DOI 10.1038/embor.2009.74; Zhang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005429	19	29	30	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59814	10.1371/journal.pone.0059814	http://dx.doi.org/10.1371/journal.pone.0059814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23573211	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100028
J	Cao, XY; Jiang, XL; Li, XL; Lo, MCJH; Li, R				Cao, Xiaoyi; Jiang, Xiaolian; Li, Xiaolin; Lo, Man-chun Jenny Hui; Li, Rong			Family Functioning and Its Predictors among Disaster Bereaved Individuals in China: Eighteen Months after the Wenchuan Earthquake	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH RISK; ANHUI RURAL AREA; LONELINESS; APGAR; ADOLESCENTS; SURVIVORS; SYMPTOMS; CONTEXT; SUPPORT	Background: The 2008 Wenchuan earthquake in China resulted in great loss of life and property, and previous studies have focused on psychopathological symptoms in survivors after disasters. This study examined perceived family functioning and its predictors in disaster bereaved individuals eighteen months after the 2008 Wenchuan earthquake. Methodology/Findings: This was a cross-sectional study of a convenience sample of 264 bereaved individuals. The instruments used in the study included Family APGAR Index, Family Adaptability and Cohesion Evaluation ScaleaA, Emotional and Social Loneliness Scale, and a range of items eliciting demographic characteristics and disaster-related variables. The results indicated that the rates of moderate family dysfunction and severe family dysfunction in bereaved individuals were 37.1% and 12.9%, respectively. Less financial loss during the earthquake was a significant predictor for positive family function. Better self-rated health status after the earthquake was significantly related to positive family function, cohesion, and adaptability. Scores on family cohesion and adaptability in bereaved individuals from extended or nuclear families were significantly higher than those from single-parent families. The ability to give birth to another baby of bereaved parents was a significant predictor for positive family function and cohesion. Poorer family function, cohesion and adaptability were significantly related to greater loneliness. Conclusions/Significance: This study found a high prevalence of family dysfunction in bereaved individuals eighteen months after the 2008 Wenchuan earthquake. Strategies can be designed to facilitate post-disaster recovery, particularly for the bereaved at high risk for family dysfunction. The study provides useful information for post-disaster rebuilding and relief work.	[Cao, Xiaoyi; Jiang, Xiaolian; Li, Xiaolin; Li, Rong] Sichuan Univ, Dept Nursing, West China Hosp, West China Sch Med, Chengdu 610064, Sichuan Provinc, Peoples R China; [Lo, Man-chun Jenny Hui] Hong Kong Polytech Univ, Sch Social Sci, Hong Kong, Hong Kong, Peoples R China	Sichuan University; Hong Kong Polytechnic University	Jiang, XL (corresponding author), Sichuan Univ, Dept Nursing, West China Hosp, West China Sch Med, Chengdu 610064, Sichuan Provinc, Peoples R China.	jiang_xiaoliannurs@126.com	Cao, XiaoYi/H-1548-2017		Sichuan University [004020541501]	Sichuan University(Sichuan University)	This study was supported by Sichuan University (004020541501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellon Saameno J A, 1996, Aten Primaria, V18, P289; Cano Annmarie, 2003, Prim Care Companion J Clin Psychiatry, V5, P111; Central People's Government of the People's Republic of China, 2008, JUP 9 THER WER 69 14; Chan CLW, 2012, J ANXIETY DISORD, V26, P673, DOI 10.1016/j.janxdis.2012.05.002; Chung Y S, 1990, Kanho Hakhoe Chi, V20, P5; Coffman S, 1996, Issues Ment Health Nurs, V17, P353; DiTommaso E, 2003, PERS INDIV DIFFER, V35, P303, DOI 10.1016/S0191-8869(02)00190-3; Drabek TE, 1984, HUMAN RESPONSES SYST; Dykstra PA, 2005, RES AGING, V27, P725, DOI 10.1177/0164027505279712; Dyregrov A, 2007, FAMILY RECOVERY TERR, DOI Family recovery from terror grief and trauma; Gardner W, 2001, J FAM PRACTICE, V50, P19; Hasson Dan, 2006, Popul Health Metr, V4, P8, DOI 10.1186/1478-7954-4-8; HILL R, 1958, SOC CASEWORK-JCSW, V39, P139, DOI 10.1177/1044389458039002-318; Kluck Annette S, 2008, Eat Behav, V9, P471, DOI 10.1016/j.eatbeh.2008.07.006; Kristensen P, 2009, DEPRESS ANXIETY, V26, P1127, DOI 10.1002/da.20625; Lopez-Navas A, 2011, TRANSPL P, V43, P701, DOI 10.1016/j.transproceed.2011.01.095; McDermott BM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-55; McDermott BM, 2010, AUST NZ J PSYCHIAT, V44, P384, DOI 10.3109/00048670903489916; Ministry of Civil Affairs of the People's Republic of China, 2008, EM ASS WAS PROV CENT; Nojima S, 1994, Nihon Kango Kagakkaishi, V14, P28; NORRIS FH, 1993, J APPL SOC PSYCHOL, V23, P1263, DOI 10.1111/j.1559-1816.1993.tb01032.x; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Olson D. H., 1982, FAMILY INVENTORIES I, P5; Olson DH, 1992, FAMILY INVENTORIES I, P12; Olson DH, 2000, J FAM THER, V22, P121; Panganiban-Corales Avegeille T, 2011, Asia Pac Fam Med, V10, P14, DOI 10.1186/1447-056X-10-14; POLLOCK GH, 1986, PEDIATR ANN, V15, P851, DOI 10.3928/0090-4481-19861201-06; Robinson J.P., 1991, MEASURES PERSONALITY; Rodriguez-Sanchez E, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-19; Rowe CL, 2010, J CONSULT CLIN PSYCH, V78, P806, DOI 10.1037/a0020808; RUSSELL D, 1984, J PERS SOC PSYCHOL, V46, P1313, DOI 10.1037/0022-3514.46.6.1313; Schnittker J, 2007, J AGING HEALTH, V19, P659, DOI 10.1177/0898264307301178; Scholasticus K, 2011, NUCL FAMILY VS JOINT; SELIG AL, 1976, FAM COORD, V25, P291, DOI 10.2307/582345; SMILKSTEIN G, 1982, J FAM PRACTICE, V15, P303; SMILKSTEIN G, 1978, J FAM PRACTICE, V6, P1231; Sun YH, 2009, INT J STD AIDS, V20, P255, DOI 10.1258/ijsa.2008.008348; Tang TC, 2009, SUICIDE LIFE-THREAT, V39, P91, DOI 10.1521/suli.2009.39.1.91; Vigil JM, 2008, J FAM PSYCHOL, V22, P176, DOI 10.1037/0893-3200.22.1.176; Weiss R. S, 1973, LONELINESS EXPERIENC; Wickrama KAS, 2008, SOC SCI MED, V66, P994, DOI 10.1016/j.socscimed.2007.11.012; Wickrama KAS, 2007, SOC SCI MED, V64, P713, DOI 10.1016/j.socscimed.2006.09.031; Wittenberg M, 1986, THESIS U ROCHESTER; Wu ZQ, 2010, AGING MENT HEALTH, V14, P108, DOI 10.1080/13607860903228796; Yao X, 2012, 13 WORLD C PUBL HLTH; Youngblut JM, 2006, J PEDIATR PSYCHOL, V31, P608, DOI 10.1093/jpepsy/jsj066; ZHANG MY, 1990, ANN NEUROL, V27, P428, DOI 10.1002/ana.410270412	47	31	31	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60738	10.1371/journal.pone.0060738	http://dx.doi.org/10.1371/journal.pone.0060738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23573280	Green Published, gold			2022-12-27	WOS:000318840100100
J	George, AM; Jones, PM				George, Anthony M.; Jones, Peter M.			An Asymmetric Post-Hydrolysis State of the ABC Transporter ATPase Dimer	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; MOLECULAR-DYNAMICS SIMULATIONS; MULTIDRUG EFFLUX PUMPS; CYSTIC-FIBROSIS; P-GLYCOPROTEIN; ACTIVE-SITE; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; CONSTANT CONTACT; CATALYTIC CYCLE	ABC transporters are a superfamily of enzyme pumps that hydrolyse ATP in exchange for translocation of substrates across cellular membranes. Architecturally, ABC transporters are a dimer of transmembrane domains coupled to a dimer of nucleotide binding domains (NBDs): the NBD dimer contains two ATP-binding sites at the intersubunit interface. A current controversy is whether the protomers of the NBD dimer separate during ATP hydrolysis cycling, or remain in constant contact. In order to investigate the ABC ATPase catalytic mechanism, MD simulations using the recent structure of the ADP+Pi-bound MJ0796 isolated NBD dimer were performed. In three independent simulations of the ADP+Pi/apo state, comprising a total of >0.5 mu s, significant opening of the apo (empty) active site was observed; occurring by way of intrasubunit rotations between the core and helical subdomains within both NBD monomers. In contrast, in three equivalent simulations of the ATP/apo state, the NBD dimer remained close to the crystal structure, and no opening of either active site occurred. The results thus showed allosteric coupling between the active sites, mediated by intrasubunit conformational changes. Opening of the apo site is exquisitely tuned to the nature of the ligand, and thus to the stage of the reaction cycle, in the opposite site. In addition to this, in also showing how one active site can open, sufficient to bind nucleotide, while the opposite site remains occluded and bound to the hydrolysis products ADP+Pi, the results are consistent with a Constant Contact Model. Conversely, they show how there may be no requirement for the NBD protomers to separate to complete the catalytic cycle.	[George, Anthony M.; Jones, Peter M.] Univ Technol Sydney, Sch Med & Mol Biosci, Broadway, NSW, Australia	University of Technology Sydney	George, AM (corresponding author), Univ Technol Sydney, Sch Med & Mol Biosci, Broadway, NSW, Australia.	tony.george@uts.edu.au		George, Anthony/0000-0003-4691-8960	Australian National Computational Infrastructure (NCI); i Visualization and Electronic Computing (iVEC); Barossa high performance computing networks	Australian National Computational Infrastructure (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); i Visualization and Electronic Computing (iVEC); Barossa high performance computing networks	Funding was provided as timeshare on the Australian National Computational Infrastructure (NCI), i Visualization and Electronic Computing (iVEC) and Barossa high performance computing networks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell JD, 2004, BIOPHYS J, V87, P3703, DOI 10.1529/biophysj.104.046870; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Ernst R, 2010, FEBS J, V277, P540, DOI 10.1111/j.1742-4658.2009.07485.x; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; George AM, 2012, PROG BIOPHYS MOL BIO, V109, P95, DOI 10.1016/j.pbiomolbio.2012.06.003; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2007, J BIOL CHEM, V282, P22793, DOI 10.1074/jbc.M700809200; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Jones PM, 2012, J PHYS CHEM A, V116, P3004, DOI 10.1021/jp211139s; Jones PM, 2011, BIOPHYS J, V100, P3025, DOI 10.1016/j.bpj.2011.05.028; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Jones PM, 2002, P NATL ACAD SCI USA, V99, P12639, DOI 10.1073/pnas.152439599; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Kerr ID, 2010, FEBS J, V277, P550, DOI 10.1111/j.1742-4658.2009.07486.x; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mezei M, 1997, J COMPUT CHEM, V18, P812, DOI 10.1002/(SICI)1096-987X(19970430)18:6<812::AID-JCC6>3.0.CO;2-V; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oliveira ASF, 2010, J PHYS CHEM B, V114, P5486, DOI 10.1021/jp905735y; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; RIORDAN JR, 1989, SCIENCE, V245, P1066; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wriggers W, 1997, PROTEINS, V29, P1; Wriggers W, 1997, BIOPHYS J, V73, P624, DOI 10.1016/S0006-3495(97)78098-6; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zoghbi ME, 2012, J BIOL CHEM, V287, P4157, DOI 10.1074/jbc.M111.318378	53	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59854	10.1371/journal.pone.0059854	http://dx.doi.org/10.1371/journal.pone.0059854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573213	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100029
J	Yan, H; Potu, R; Lu, H; de Almeida, VV; Stewart, T; Ragland, D; Armstrong, A; Adeola, O; Nakatsu, CH; Ajuwon, KM				Yan, Hui; Potu, Ramesh; Lu, Hang; de Almeida, Vivian Vezzoni; Stewart, Terry; Ragland, Darryl; Armstrong, Arthur; Adeola, Olayiwola; Nakatsu, Cindy H.; Ajuwon, Kolapo M.			Dietary Fat Content and Fiber Type Modulate Hind Gut Microbial Community and Metabolic Markers in the Pig	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1C; HUMAN COLONIC MICROBIOTA; GEN. NOV.; OBESITY; BUTYRATE; FERMENTATION; INULIN; ACIDS; QUANTIFICATION; POPULATIONS	Obesity leads to changes in the gut microbial community which contribute to the metabolic dysregulation in obesity. Dietary fat and fiber affect the caloric density of foods. The impact of dietary fat content and fiber type on the microbial community in the hind gut is unknown. Effect of dietary fat level and fiber type on hindgut microbiota and volatile fatty acid (VFA) profiles was investigated. Expression of metabolic marker genes in the gut, adipose tissue and liver was determined. A 2x2 experiment was conducted in pigs fed at two dietary fat levels (5% or 17.5% swine grease) and two fiber types (4% inulin, fermentable fructo-oligosaccharide or 4% solka floc, non-fermentable cellulose). High fat diets (HFD) resulted in a higher (P<0.05) total body weight gain, feed efficiency and back fat accumulation than the low fat diet. Feeding of inulin, but not solka floc, attenuated (P<0.05) the HFD-induced higher body weight gain and fat mass accumulation. Inulin feeding tended to lead to higher total VFA production in the cecum and resulted in a higher (P<0.05) expression of acyl coA oxidase (ACO), a marker of peroxisomal beta-oxidation. Inulin feeding also resulted in lower expression of sterol regulatory element binding protein 1c (SREBP-1c), a marker of lipid anabolism. Bacteria community structure characterized by DGGE analysis of PCR amplified 16S rRNA gene fragments showed that inulin feeding resulted in greater bacterial population richness than solka floc feeding. Cluster analysis of pairwise Dice similarity comparisons of the DGGE profiles showed grouping by fiber type but not the level of dietary fat. Canonical correspondence analysis (CCA) of PCR- DGGE profiles showed that inulin feeding negatively correlated with back fat thickness. This study suggests a strong interplay between dietary fat level and fiber type in determining susceptibility to obesity.	[Yan, Hui; Potu, Ramesh; Lu, Hang; Stewart, Terry; Adeola, Olayiwola; Ajuwon, Kolapo M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [de Almeida, Vivian Vezzoni] Univ Sao Paulo, ESALQ, Piracicaba, SP, Brazil; [Ragland, Darryl] Purdue Univ, Sch Vet Med, W Lafayette, IN 47907 USA; [Armstrong, Arthur; Nakatsu, Cindy H.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universidade de Sao Paulo; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ajuwon, KM (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	kajuwon@purdue.edu	ALMEIDA, V.V./D-7768-2012; Potu, Ramesh Babu/AAV-2795-2021	ALMEIDA, V.V./0000-0002-2574-3893; 	Purdue University College of Agriculture	Purdue University College of Agriculture	The study was funded by internal grant support from Purdue University College of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, PC ORD MULTIVARIATE; Ariefdjohan MW, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-23; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; de Munter JSL, 2007, PLOS MED, V4, P1385, DOI 10.1371/journal.pmed.0040261; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Duplus E, 2002, BIOCHEM PHARMACOL, V64, P893, DOI 10.1016/S0006-2952(02)01157-7; Falony G, 2009, APPL ENVIRON MICROB, V75, P5884, DOI 10.1128/AEM.00876-09; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Fromin N, 2002, ENVIRON MICROBIOL, V4, P634, DOI 10.1046/j.1462-2920.2002.00358.x; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Howarth NC, 2001, NUTR REV, V59, P129, DOI 10.1111/j.1753-4887.2001.tb07001.x; Isken F, 2010, J NUTR BIOCHEM, V21, P278, DOI 10.1016/j.jnutbio.2008.12.012; Jenkins DJA, 2000, CURR OPIN LIPIDOL, V11, P49, DOI 10.1097/00041433-200002000-00008; Kageyama A, 2000, INT J SYST EVOL MICR, V50, P1595, DOI 10.1099/00207713-50-4-1595; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu CX, 2008, INT J SYST EVOL MICR, V58, P1896, DOI 10.1099/ijs.0.65208-0; Liu HY, 2012, APPL ENVIRON MICROB, V78, P4102, DOI 10.1128/AEM.07702-11; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakatsu CH, 2007, SOIL SCI SOC AM J, V71, P562, DOI 10.2136/sssaj2006.0080; Nakatsu CH, 2000, SOIL SCI SOC AM J, V64, P1382, DOI 10.2136/sssaj2000.6441382x; Ott SJ, 2004, J CLIN MICROBIOL, V42, P2566, DOI 10.1128/JCM.42.6.2566-2572.2004; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PLAYNE MJ, 1985, J SCI FOOD AGR, V36, P638, DOI 10.1002/jsfa.2740360803; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005; Scheppach W, 2004, CURR OPIN CLIN NUTR, V7, P563, DOI 10.1097/00075197-200409000-00009; Scott KP, 2011, P NATL ACAD SCI USA, V108, P4672, DOI 10.1073/pnas.1000091107; Slavin JL, 2005, NUTRITION, V21, P411, DOI 10.1016/j.nut.2004.08.018; Tennyson CA, 2008, CURR OPIN ENDOCRINOL, V15, P422, DOI 10.1097/MED.0b013e328308dbfb; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Vaughan E E, 2000, Curr Issues Intest Microbiol, V1, P1; Weickert MO, 2008, J NUTR, V138, P439, DOI 10.1093/jn/138.3.439; West DB, 1998, AM J CLIN NUTR, V67, p505S, DOI 10.1093/ajcn/67.3.505S; Wilbur JD, 2002, BIOMETRICS, V58, P378, DOI 10.1111/j.0006-341X.2002.00378.x; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	51	70	76	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59581	10.1371/journal.pone.0059581	http://dx.doi.org/10.1371/journal.pone.0059581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573202	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100021
J	Lin, SQ; Huo, X; Zhang, QY; Fan, XJ; Du, L; Xu, XJ; Qiu, SS; Zhang, YL; Wang, Y; Gu, J				Lin, Shuiqin; Huo, Xia; Zhang, Qingying; Fan, Xiaojuan; Du, Li; Xu, Xijin; Qiu, Shaoshan; Zhang, Yuling; Wang, Yun; Gu, Jiang			Short Placental Telomere was Associated with Cadmium Pollution in an Electronic Waste Recycling Town in China	PLOS ONE			English	Article							DNA-DAMAGE-RESPONSE; SUPEROXIDE-DISMUTASE; IN-VITRO; LENGTH; LEAD; ANTIOXIDANT; GUIYU; ZINC; FIBROBLASTS; MECHANISMS	In Guiyu, an electronic waste recycling site near Shantou, Guangdong province, China, primitive ways of e-waste processing have caused severe cadmium and lead pollution to the local residents. However, the possible effects of cadmium or lead pollution to genomic integrity of the local residents have not been investigated. We examined the possible relationship between cadmium and lead concentrations in placenta and placental telomere length in Guiyu and compared the data with that of a non-polluted town. Graphite furnace atomic absorption spectrometry and real-time PCR were used to determine placental cadmium and lead concentrations, and placental telomere length. We found that placental cadmium concentration was negatively correlated with placental telomere length (r = 20.138, p = 0.013). We also found that placental cadmium concentration of 0.0294 mg/g might be a critical point at which attrition of placental telomere commenced. No significant correlation between placental lead concentration and placental telomere length was detected (r = 0.027, p = 0.639). Our data suggest that exposure to cadmium pollution during pregnancy may be a risk factor for shortened placental telomere length that is known to be related to cancer development and aging. Furthermore, grave consequence on the offspring from pregnancies in e-waste polluted area is indicated.	[Lin, Shuiqin; Fan, Xiaojuan; Du, Li; Wang, Yun; Gu, Jiang] Shantou Univ Med Coll, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Peoples R China; [Gu, Jiang] Peking Univ, Sch Basic Med Sci, Dept Pathol, Beijing 100871, Peoples R China; [Huo, Xia; Xu, Xijin; Qiu, Shaoshan; Zhang, Yuling] Shantou Univ Med Coll, Analyt Cytol Lab, Shantou, Peoples R China; [Zhang, Qingying] Shantou Univ Med Coll, Dept Prevent Med, Shantou, Peoples R China	Peking University	Gu, J (corresponding author), Shantou Univ Med Coll, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Peoples R China.	jguemailbox@gmail.com		Gu, Jiang/0000-0002-0706-8329; Huo, Xia/0000-0002-2102-4840	National Natural Science Foundation of China [81030033, 30971150, 81110108018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by grants (81030033, 30971150 to JG and 81110108018 to XH) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON DJA, 1992, CANCER GENET CYTOGEN, V61, P204, DOI 10.1016/0165-4608(92)90088-P; Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; Akkad A, 2006, BJOG-INT J OBSTET GY, V113, P318, DOI 10.1111/j.1471-0528.2005.00839.x; Allsopp R, 2007, PLACENTA, V28, P324, DOI 10.1016/j.placenta.2006.04.003; Arita A, 2009, METALLOMICS, V1, P222, DOI 10.1039/b903049b; Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P1454, DOI 10.1289/ehp.10207; Biron-Shental T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.036; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; BLUMENTHAL NC, 1995, CALCIFIED TISSUE INT, V56, P316, DOI 10.1007/BF00318053; Brigden K., 2005, RECYCLING ELECT WAST, P55; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Carbone R, 1998, Ann Ist Super Sanita, V34, P117; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cheung KC, 2008, THESIS HONG KONG BAP; Durska G, 2001, Ann Acad Med Stetin, V47, P49; Durska Grazyna, 2002, Ginekol Pol, V73, P43; Falcon M, 2003, TOXICOLOGY, V185, P59, DOI 10.1016/S0300-483X(02)00589-9; Filipic M, 2006, HUM EXP TOXICOL, V25, P67, DOI 10.1191/0960327106ht590oa; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Guo YY, 2012, SCI TOTAL ENVIRON, V427, P35, DOI 10.1016/j.scitotenv.2012.04.007; Guo YY, 2010, SCI TOTAL ENVIRON, V408, P3113, DOI 10.1016/j.scitotenv.2010.04.018; Hartmann U, 2005, HAEMATOLOGICA, V90, P307; HARTSFIELD JK, 1992, BIOCHEM MED METAB B, V48, P159, DOI 10.1016/0885-4505(92)90061-3; Hartwig A, 2002, FOOD CHEM TOXICOL, V40, P1179, DOI 10.1016/S0278-6915(02)00043-1; Hartwig A, 1998, TOXICOL LETT, V103, P235, DOI 10.1016/S0378-4274(98)00312-9; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Huang CS, 2001, MOL CELL BIOCHEM, V222, P141, DOI 10.1023/A:1017953927347; Huang J, 2010, FREE RADICAL BIO MED, V48, P1663, DOI 10.1016/j.freeradbiomed.2010.03.026; Huo X, 2007, ENV HLTH PERSPECT, V115, P1663; Huppertz B, 2011, THROMB RES, V127, pS96, DOI 10.1016/S0049-3848(11)70026-3; HUSSAIN T, 1987, PHARMACOL TOXICOL, V60, P355, DOI 10.1111/j.1600-0773.1987.tb01526.x; Jarup L, 2000, OCCUP ENVIRON MED, V57, P668, DOI 10.1136/oem.57.10.668; Kurenova EV, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1242; Lagerkvist B J, 1992, IARC Sci Publ, P287; LAUWERYS R, 1978, ENVIRON RES, V15, P278, DOI 10.1016/0013-9351(78)90104-4; Leung A., 2006, J MATER CYCLES WASTE, V8, P21, DOI DOI 10.1007/S10163-3005-0141-6; Liu JX, 2011, NEUROTOXICOLOGY, V32, P458, DOI 10.1016/j.neuro.2011.03.012; Liu Q, 2004, BIOL TRACE ELEM RES, V100, P215, DOI 10.1385/BTER:100:3:215; Llanos MN, 2009, REPROD TOXICOL, V27, P88, DOI 10.1016/j.reprotox.2008.11.057; Lorenz M, 2001, FREE RADICAL BIO MED, V31, P824, DOI 10.1016/S0891-5849(01)00664-5; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; Osman K, 2000, CLIN BIOCHEM, V33, P131, DOI 10.1016/S0009-9120(00)00052-7; Pavanello S, 2010, CARCINOGENESIS, V31, P216, DOI 10.1093/carcin/bgp278; Piekoszewski Wojciech, 2005, Przegl Lek, V62, P1062; Qiu B, 2004, P INT C EL WAST EXT, P79; Raghunath R, 2000, SCI TOTAL ENVIRON, V250, P135, DOI 10.1016/S0048-9697(00)00372-7; Serra V, 2003, J BIOL CHEM, V278, P6824, DOI 10.1074/jbc.M207939200; Shen J, 2007, CANCER RES, V67, P5538, DOI 10.1158/0008-5472.CAN-06-3490; Sorkun HC, 2007, TOXICOLOGY, V238, P15, DOI 10.1016/j.tox.2007.05.020; Takiguchi M, 2003, EXP CELL RES, V286, P355, DOI 10.1016/S0014-4827(03)00062-4; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Waalkes MP, 2003, MUTAT RES-FUND MOL M, V533, P107, DOI 10.1016/j.mrfmmm.2003.07.011; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wu KS, 2011, ECOTOX ENVIRON SAFE, V74, P2141, DOI 10.1016/j.ecoenv.2011.07.038; Xu XJ, 2012, REPROD TOXICOL, V33, P94, DOI 10.1016/j.reprotox.2011.12.006	58	37	40	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60815	10.1371/journal.pone.0060815	http://dx.doi.org/10.1371/journal.pone.0060815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565277	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300149
J	Merdad, L; Hill, K; Graham, W				Merdad, Leena; Hill, Kenneth; Graham, Wendy			Improving the Measurement of Maternal Mortality: The Sisterhood Method Revisited	PLOS ONE			English	Article							HEALTH; DEATH; STATISTICS; COUNTS; HIV	Background: Over the past several decades the efforts to improve maternal survival and the consequent demand for accurate estimates of maternal mortality have increased. However, measuring maternal mortality remains a difficult task especially in developing countries with weak information systems. Sibling histories included in household surveys (most notably the Demographic and Health Surveys (DHS)) have emerged as an important source of maternal mortality data. Data have been mainly collected from women and have not been widely collected from men due to concerns about data quality. We assess data quality of histories obtained from men and the potential to improve the efficiency of surveys measuring maternal mortality by collecting such data. Methods and Findings: We used data from 10 Demographic and Health Surveys (DHS) that have included a full sibling history in both their women's and men's questionnaires. We estimated adult and maternal mortality indicators from histories obtained from men and women. We assessed the completeness and accuracy of these histories using several indicators of data quality. Our study finds that mortality estimates based on sibling histories obtained from men do not systematically or significantly differ from those obtained from women. Quality indicators were similar when comparing data from men and women. Pooling data obtained from men and women produced narrower confidence intervals. Conclusion: From experience across nine developing countries, sibling history data obtained from men appear to be a reliable source of information on adult and maternal mortality. Given that there are no significant differences between mortality estimates based on data obtained from men and women, data can be pooled to increase efficiency. This finding improves the feasibility for countries to generate robust empirical estimates of adult and maternal mortality from surveys. Further we recommend that male sibling histories be collected from all sample households rather than from a subsample.	[Merdad, Leena] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Hill, Kenneth] Harvard Ctr Populat & Dev Studies, Cambridge, MA USA; [Graham, Wendy] Univ Aberdeen, Sch Med & Dent, Inst Appl Hlth Sci, Aberdeen, Scotland; [Merdad, Leena] King Abdulaziz Univ, Fac Dent, Dept Prevent Dent Sci, Jeddah 21413, Saudi Arabia	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Aberdeen; King Abdulaziz University	Merdad, L (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	lam641@mail.harvard.edu	Merdad, Leena/P-7659-2014	Merdad, Leena/0000-0002-3270-0736; Graham, Wendy/0000-0003-1473-5342	King Abdulaziz University; Harvard Center for Population and Development Studies; University of Aberdeen	King Abdulaziz University; Harvard Center for Population and Development Studies; University of Aberdeen	No direct funding was received for this study. The authors were personally salaried by their institutions during the period of writing (though no specific salary was set aside or given for the writing of this paper). LM participated in this study as part of her doctoral studies at the Harvard School of Public Health and received support from King Abdulaziz University. KH received support from the Harvard Center for Population and Development Studies. WG received support from the University of Aberdeen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Deneux-Tharaux C, 2005, OBSTET GYNECOL, V106, P684, DOI 10.1097/01.AOG.0000174580.24281.e6; Fatusic Z, 2005, J MATERN-FETAL NEO M, V18, P259, DOI 10.1080/147670500198501; Gakidou E, 2006, DEMOGRAPHY, V43, P569, DOI 10.1353/dem.2006.0024; GRAHAM W, 1989, STUD FAMILY PLANN, V20, P125, DOI 10.2307/1966567; Graham WJ, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-12; Graham WJ, 2008, BEST PRACT RES CL OB, V22, P425, DOI 10.1016/j.bpobgyn.2007.12.001; Graham WJ, 2002, LANCET, V359, P701, DOI 10.1016/S0140-6736(02)07817-0; Hallett TB, 2010, B WORLD HEALTH ORGAN, V88, P761, DOI 10.2471/BLT.09.071779; Hansen M.H., 1953, SAMPLE SURVEY METHOD; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; ICF International, 2012, 2 MEASURE DHS ICF IN; Kelly J T, 2011, Confl Health, V5, P25, DOI 10.1186/1752-1505-5-25; Macro International Inc, 1996, 3 MACR INC, V6; Masquelier B, 2013, DEMOGRAPHY, V50, P207, DOI 10.1007/s13524-012-0149-1; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; O'Hare BAM, 2007, J ROY SOC MED, V100, P564, DOI 10.1258/jrsm.100.12.564; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Pedersen J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001289; Preston S., 2000, DEMOGRAPHY MEASURING; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; RUTENBERG N, 1991, DEM HLTH SURV WORLD, V3, P1669; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; SHAHIDULLAH M, 1995, STUD FAMILY PLANN, V26, P101, DOI 10.2307/2137935; Soladay Shryock H., 1973, MAT METHODS DEMOGRAP, V1, P201; Stanton C., 1997, DHS MATERNAL MORTALI; TRUSSELL J, 1990, STUD FAMILY PLANN, V21, P344, DOI 10.2307/1966923; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43	31	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59834	10.1371/journal.pone.0059834	http://dx.doi.org/10.1371/journal.pone.0059834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565171	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300040
J	D'Avanzo, N; McCusker, EC; Powl, AM; Miles, AJ; Nichols, CG; Wallace, BA				D'Avanzo, Nazzareno; McCusker, Emily C.; Powl, Andrew M.; Miles, Andrew J.; Nichols, Colin G.; Wallace, B. A.			Differential Lipid Dependence of the Function of Bacterial Sodium Channels	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTROSCOPY; MULTIPLE SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; MEMBRANE-LIPIDS; MECHANOSENSITIVE CHANNEL; PHOSPHOLIPID-COMPOSITION; CHEMOTAXIS; STABILITY; MOTILITY	The lipid bilayer is important for maintaining the integrity of cellular compartments and plays a vital role in providing the hydrophobic and charged interactions necessary for membrane protein structure, conformational flexibility and function. To directly assess the lipid dependence of activity for voltage-gated sodium channels, we compared the activity of three bacterial sodium channel homologues (NaChBac, NavMs, and NavSp) by cumulative Na-22(+) uptake into proteoliposomes containing a 3:1 ratio of 1-palmitoyl 2-oleoyl phosphatidylethanolamine and different "guest" glycerophospholipids. We observed a unique lipid profile for each channel tested. NavMs and NavSp showed strong preference for different negatively-charged lipids (phosphatidylinositol and phosphatidylglycerol, respectively), whilst NaChBac exhibited a more modest variation with lipid type. To investigate the molecular bases of these differences we used synchrotron radiation circular dichroism spectroscopy to compare structures in liposomes of different composition, and molecular modeling and electrostatics calculations to rationalize the functional differences seen. We then examined pore-only constructs (with voltage sensor subdomains removed) and found that in these channels the lipid specificity was drastically reduced, suggesting that the specific lipid influences on voltage-gated sodium channels arise primarily from their abilities to interact with the voltage-sensing subdomains.	[D'Avanzo, Nazzareno] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [D'Avanzo, Nazzareno] Univ Montreal, GEPROM Grp Etud Prot Membranaires, Montreal, PQ H3C 3J7, Canada; [McCusker, Emily C.; Powl, Andrew M.; Miles, Andrew J.; Wallace, B. A.] Univ London, Dept Biol Sci, London, England; [McCusker, Emily C.; Powl, Andrew M.; Miles, Andrew J.; Wallace, B. A.] Univ London, Inst Struct & Mol Biol, Birkbeck Coll, London, England; [D'Avanzo, Nazzareno; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [D'Avanzo, Nazzareno; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA	Universite de Montreal; Universite de Montreal; University of London; University of London; Birkbeck University London; Washington University (WUSTL); Washington University (WUSTL)	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	cnichols@wustl.edu; b.wallace@mail.cryst.bbk.ac.uk	Powl, Andrew/C-4443-2008; Wallace, B A/C-3753-2008	Powl, Andrew/0000-0003-3397-2837; Wallace, B A/0000-0001-9649-5092	UK Biotechnology and Biological Science Research Council (BBSRC); UK Engineering and Physical Sciences Research Council (EPSRC); BBSRC SPORT programme; National Institutes of Health [HL54171, K99 HL112300-01]; ISA (Denmark); Soleil (France); ANKA (Germany); Biotechnology and Biological Sciences Research Council [BB/H01070X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H043888/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL112300, R01HL054171] Funding Source: NIH RePORTER; BBSRC [BB/H01070X/1] Funding Source: UKRI; EPSRC [EP/H043888/1] Funding Source: UKRI	UK Biotechnology and Biological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC SPORT programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISA (Denmark); Soleil (France); ANKA (Germany); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by project grants from the UK Biotechnology and Biological Science Research Council (BBSRC) and the UK Engineering and Physical Sciences Research Council (EPSRC) to BW, a BBSRC SPORT programme grant to the Membrane Protein Structure Initiative Consortium (N. Isaacs, P. I.) and grants from the National Institutes of Health (HL54171 to CN; K99 HL112300-01 to ND). SRCD studies were enabled by beamtime grants (to BW) from the following synchrotrons: ISA (Denmark), Soleil, (France) and ANKA (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Cheng WWL, 2011, BIOPHYS J, V100, P620, DOI 10.1016/j.bpj.2010.12.3724; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; D'Avanzo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019393; D'Avanzo N, 2010, J BIOL CHEM, V285, P37129, DOI 10.1074/jbc.C110.186692; DeLano W.L., 2002, PYMOL MOL VIEWER; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Fujinami S, 2009, FUTURE MICROBIOL, V4, P1137, DOI 10.2217/FMB.09.76; GALLOWAY JH, 1987, J LIPID RES, V28, P279; GOLDFINE H, 1984, J LIPID RES, V25, P1501; Hamplova B, 2004, PHYSIOL RES, V53, P557; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Irie K, 2010, J BIOL CHEM, V285, P3685, DOI 10.1074/jbc.M109.057455; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; JURADO AS, 1991, ARCH BIOCHEM BIOPHYS, V289, P167, DOI 10.1016/0003-9861(91)90457-T; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; McCusker EC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.C111.228122; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Nurani G, 2008, BIOCHEMISTRY-US, V47, P8114, DOI 10.1021/bi800645w; O'Malley MA, 2011, BIOPHYS J, V100, pL11, DOI 10.1016/j.bpj.2010.12.3698; O'Reilly AO, 2008, MOL MEMBR BIOL, V25, P670, DOI 10.1080/09687680802508754; Palygin OA, 2008, AM J PHYSIOL-HEART C, V294, pH1693, DOI 10.1152/ajpheart.01337.2007; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Paynter JJ, 2010, J BIOL CHEM, V285, P40754, DOI 10.1074/jbc.M110.175687; POST JA, 1995, J MOL CELL CARDIOL, V27, P749, DOI 10.1016/0022-2828(95)90080-2; Powl AM, 2008, BIOCHEMISTRY-US, V47, P12175, DOI 10.1021/bi801352a; Powl AM, 2008, BIOCHEMISTRY-US, V47, P4317, DOI 10.1021/bi702409t; Powl AM, 2010, P NATL ACAD SCI USA, V107, P14064, DOI 10.1073/pnas.1001793107; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Shaya D, 2011, P NATL ACAD SCI USA, V108, P12313, DOI 10.1073/pnas.1106811108; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; SINGH EJ, 1972, LIPIDS, V7, P26, DOI 10.1007/BF02531265; Sohlenkamp C, 2003, PROG LIPID RES, V42, P115, DOI 10.1016/S0163-7827(02)00050-4; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; SVENNERHOLM L, 1992, BIOCHIM BIOPHYS ACTA, V1128, P1, DOI 10.1016/0005-2760(92)90250-Y; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wallace BA, 2009, Q REV BIOPHYS, V42, P317, DOI 10.1017/S003358351000003X; Wang SZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1625; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WU CC, 1995, J MOL CELL CARDIOL, V27, P1263, DOI 10.1016/S0022-2828(05)82388-0; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Yarbrough TL, 2002, CIRC RES, V90, P443, DOI 10.1161/hh0402.105177; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	59	17	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61216	10.1371/journal.pone.0061216	http://dx.doi.org/10.1371/journal.pone.0061216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23579615	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000317898000114
J	Liska, F; Gosele, C; Popova, E; Chylikova, B; Krenova, D; Kren, V; Bader, M; Tres, LL; Hubner, N; Kierszenbaum, AL				Liska, Frantisek; Gosele, Claudia; Popova, Elena; Chylikova, Blanka; Krenova, Drahomira; Kren, Vladimir; Bader, Michael; Tres, Laura L.; Hubner, Norbert; Kierszenbaum, Abraham L.			Overexpression of Full-Length Centrobin Rescues Limb Malformation but Not Male Fertility of the Hypodactylous (hd) Rats	PLOS ONE			English	Article							SPERM HEAD; ACROSOME FORMATION; SPERMATOZOA; INFERTILITY; PROTEIN; METHYLATION; EXPRESSION; DEFECT; GENE; MILI	Rat hypodactyly (hd) mutation is characterized by abnormal spermatogenesis and sperm decapitation, limb malformation (missing digits II and III) and growth retardation. We have previously reported centrobin (centrosome BRCA2-interacting protein) truncation at the C-terminus in the hd mutant. Here, we report data from a transgenic rescue experiment carried out to determine a role of centrobin in pathogenesis of hd. The transgenic construct, consisting of full-length-coding cDNA linked to a ubiquitous strong promoter/enhancer combination, was inserted to chromosome 16 into a LINE repeat. No known gene is present in the vicinity of the insertion site. Transgenic centrobin was expressed in all tissues tested, including testis. Transgenic animals show normal body weight and limb morphology as well as average weight of testis and epididymis. Yet, abnormal spermatogenesis and sperm decapitation persisted in the transgenic animals. Western blotting showed the coexistence of full-length and truncated or partially degraded centrobin in sperm of the rescued transgenic animals. Immunocytochemistry showed a buildup of centrobin and ODF2 (outer dense fiber 2) at the sperm decapitation site in the hd mutant and rescued transgenic rats. Additional findings included bulge-like formations and thread-like focal dissociations along the sperm flagellum and the organization of multiple whorls of truncated sperm flagella in the epididymal lumen. We conclude that centrobin is essential for normal patterning of the limb autopod. Centrobin may be required for stabilizing the attachment of the sperm head to flagellum and for maintaining the structural integrity of the sperm flagellum. We postulate that the presence of truncated centrobin, coexisting with full-length centrobin, together with incorrect timing of transgenic centrobin expression may hamper the rescue of fertility in hd male rats.	[Liska, Frantisek; Chylikova, Blanka; Krenova, Drahomira; Kren, Vladimir] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Gosele, Claudia; Popova, Elena; Bader, Michael; Hubner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany; [Tres, Laura L.; Kierszenbaum, Abraham L.] CUNY, Sophie Davis Sch Biomed Educ, Dept Pathobiol, New York, NY 10021 USA	Charles University Prague; Helmholtz Association; Max Delbruck Center for Molecular Medicine; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education	Liska, F (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic.	frantisek.liska@lf1.cuni.cz	Bader, Michael/K-2124-2013; Liska, Frantisek/N-9192-2017; Chylikova, Blanka/D-2976-2017	Liska, Frantisek/0000-0002-9588-806X; Chylikova, Blanka/0000-0002-3439-1850; Bader, Michael/0000-0003-4780-4164; Popova, Elena/0000-0002-3043-9650	Ministry of Education Youth and Sports of the Czech Republic [ME10034]; Ministry of Health of the Czech Republic [NT/12269-5]; USPHS [HD36477, HD37282]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037282, R01HD036477] Funding Source: NIH RePORTER	Ministry of Education Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was partially supported by Ministry of Education Youth and Sports of the Czech Republic (www.msmt.cz) grant No. ME10034 to FL; by Ministry of Health of the Czech Republic (http://www.mzcr.cz/) grant No. NT/12269-5 to FL; USPHS HD36477 to LLT and HD37282 to ALK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccetti B, 2001, HUM REPROD, V16, P1365, DOI 10.1093/humrep/16.7.1365; Bao JQ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095463; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chemes HE, 1999, HUM REPROD, V14, P1811, DOI 10.1093/humrep/14.7.1811; Emery BR, 2004, FERTIL STERIL, V81, P686, DOI 10.1016/j.fertnstert.2003.07.025; Gudi R, 2011, J CELL BIOL, V193, P711, DOI 10.1083/jcb.201006135; Jeffery JM, 2010, ONCOGENE, V29, P2649, DOI 10.1038/onc.2010.37; Kamal A, 1999, HUM REPROD, V14, P2791, DOI 10.1093/humrep/14.11.2791; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Liska F, 2003, FOLIA BIOL-PRAGUE, V49, P129; Liska F, 2010, FOLIA BIOL-PRAGUE, V56, P58; Liska F, 2009, BIOL REPROD, V81, P1196, DOI 10.1095/biolreprod.109.078980; Manandhar G, 2000, CURR TOP DEV BIOL, V49, P343; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; PEROTTI ME, 1981, J REPROD FERTIL, V63, P543; Popova E, 2008, TRANSGENIC RES, V17, P955, DOI 10.1007/s11248-008-9189-0; Rivkin E, 2008, MOL REPROD DEV, V75, P1591, DOI 10.1002/mrd.20911; Tokuhiro K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000712; Toyama Y, 2000, INT J ANDROL, V23, P109, DOI 10.1046/j.1365-2605.2000.t01-1-00217.x; Wang YM, 2010, GENOME RES, V20, P19, DOI 10.1101/gr.100073.109; WOOLLEY DM, 1973, ANAT RECORD, V177, P289, DOI 10.1002/ar.1091770209; Yang KF, 2012, MOL CELL BIOL, V32, P216, DOI 10.1128/MCB.06158-11; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; YOUNG RJ, 1983, J REPROD FERTIL, V69, P1, DOI 10.1530/jrf.0.0690001; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	33	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60859	10.1371/journal.pone.0060859	http://dx.doi.org/10.1371/journal.pone.0060859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577170	Green Published, gold, Green Accepted			2022-12-27	WOS:000317898000078
J	Michel, KD; Uhmann, A; Dressel, R; van den Brandt, J; Hahn, H; Reichardt, HM				Michel, Kai D.; Uhmann, Anja; Dressel, Ralf; van den Brandt, Jens; Hahn, Heidi; Reichardt, Holger M.			The Hedgehog Receptor Patched1 in T Cells Is Dispensable for Adaptive Immunity in Mice	PLOS ONE			English	Article							THYMOCYTE DEVELOPMENT; POSITIVE THYMOCYTE; PRIMARY CILIUM; ACTIVATION; MECHANISMS; DIFFERENTIATION; PROLIFERATION; SELECTION; PATHWAY; THYMUS	Hedgehog (Hh) signaling modulates T cell development and function but its exact role remains a matter of debate. To further address this issue we made use of conditional knock-out mice in which the Hh receptor Patched1 (Ptch) is inactivated in the T cell lineage. Thymocyte development was moderately compromised by the deletion of Ptch as characterized by reduced numbers of CD4 and CD8 single-positive cells. In contrast, peripheral T cells were not affected. Proliferation and IFN gamma secretion by Ptch-deficient T cells were indistinguishable from controls irrespectively of whether we used strong or suboptimal conditions for stimulation. Analysis of CTL and T-reg cell functions did not reveal any differences between both genotypes, and T cell apoptosis induced by glucocorticoids or gamma-irradiation was also similar. Surprisingly, absence of Ptch did not lead to an activation of canonic Hh signaling in peripheral T cells as indicated by unaltered expression levels of Gli1 and Gli2. To test whether we could uncover any role of Ptch in T cells in vivo we subjected the mutant mice to three different disease models, namely allogeneic bone marrow transplantation mimicking graft-versus-host disease, allergic airway inflammation as a model of asthma and growth of adoptively transferred melanoma cells as a means to test tumor surveillance by the immune system. Nonetheless, we were neither able to demonstrate any difference in the disease courses nor in any pathogenic parameter in these three models of adaptive immunity. We therefore conclude that the Hh receptor Ptch is dispensable for T cell function in vitro as well as in vivo.	[Michel, Kai D.; Dressel, Ralf; van den Brandt, Jens; Reichardt, Holger M.] Univ Gottingen, Sch Med, Inst Cellular & Mol Immunol, D-37073 Gottingen, Germany; [Uhmann, Anja; Hahn, Heidi] Univ Gottingen, Sch Med, Inst Human Genet, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Reichardt, HM (corresponding author), Univ Gottingen, Sch Med, Inst Cellular & Mol Immunol, D-37073 Gottingen, Germany.	hreichardt@med.uni-goettingen.de	Dressel, Ralf/R-7065-2016; Reichardt, Holger/AAF-3048-2020	Dressel, Ralf/0000-0002-1651-1214; Reichardt, Holger/0000-0003-4647-057X	Deutsche Forschungsgemeinschaft [RE1631/8-1, HA2197/6-1]; Deutsche Krebshilfe [108713]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (RE1631/8-1 and HA2197/6-1) and Deutsche Krebshilfe (108713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan VSF, 2006, INT IMMUNOL, V18, P1627, DOI 10.1093/intimm/dxl096; Drakopoulou E, 2010, CELL CYCLE, V9, P4144, DOI 10.4161/cc.9.20.13453; Dressel R, 2000, J IMMUNOL, V164, P2362, DOI 10.4049/jimmunol.164.5.2362; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; El Abdaloussi E, 2006, NAT IMMUNOL, V7, P418, DOI 10.1038/ni1313; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Furmanski AL, 2012, EUR J IMMUNOL, V42, P489, DOI 10.1002/eji.201141758; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hager-Theodorides AL, 2009, J IMMUNOL, V183, P3023, DOI 10.4049/jimmunol.0900152; Hwang PH, 2001, CANCER LETT, V172, P83, DOI 10.1016/S0304-3835(01)00632-2; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Lowrey JA, 2002, J IMMUNOL, V169, P1869, DOI 10.4049/jimmunol.169.4.1869; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Rahnama F, 2004, BIOCHEM J, V378, P325, DOI 10.1042/BJ20031200; Rowbotham NJ, 2008, CELL CYCLE, V7, P904, DOI 10.4161/cc.7.7.5628; Rowbotham NJ, 2007, CELL CYCLE, V6, P2138, DOI 10.4161/cc.6.17.4644; Rowbotham NJ, 2007, BLOOD, V109, P3757, DOI 10.1182/blood-2006-07-037655; Sbiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024345; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Shah DK, 2004, J IMMUNOL, V172, P2296, DOI 10.4049/jimmunol.172.4.2296; Siggins SL, 2009, BLOOD, V114, P995, DOI 10.1182/blood-2009-03-208330; Stewart GA, 2002, J IMMUNOL, V169, P5451, DOI 10.4049/jimmunol.169.10.5451; Tischner D, 2011, J IMMUNOL, V187, P4509, DOI 10.4049/jimmunol.1100911; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Uhmann A, 2011, J IMMUNOL, V186, P3383, DOI 10.4049/jimmunol.1001939; Voigt H, 2006, CLIN EXP IMMUNOL, V143, P93, DOI 10.1111/j.1365-2249.2005.02972.x; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Wust S, 2008, J IMMUNOL, V180, P8434, DOI 10.4049/jimmunol.180.12.8434	30	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61034	10.1371/journal.pone.0061034	http://dx.doi.org/10.1371/journal.pone.0061034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577186	Green Submitted, gold, Green Published			2022-12-27	WOS:000317898000092
J	Talma, H; Schonbeck, Y; van Dommelen, P; Bakker, B; van Buuren, S; HiraSing, RA				Talma, Henk; Schonbeck, Yvonne; van Dommelen, Paula; Bakker, Boudewijn; van Buuren, Stef; HiraSing, Remy A.			Trends in Menarcheal Age between 1955 and 2009 in the Netherlands	PLOS ONE			English	Article							BODY-MASS INDEX; NATIONALLY REPRESENTATIVE SURVEYS; PUBERTAL DEVELOPMENT; SECULAR TREND; SCHOOL-CHILDREN; RECENT DECLINE; UNITED-STATES; AVERAGE AGE; GIRLS; WEIGHT	Aim: To assess and compare the secular trend in age at menarche in Dutch girls (1955-2009) and girls from Turkish and Moroccan descent living in the Netherlands (1997-2009). Methods: Data on growth and maturation were collected in 20,867 children of Dutch, Turkish and Moroccan descent in 2009 by trained health care professionals. Girls, 9 years and older, of Dutch (n = 2138), Turkish (n = 282), and Moroccan (n = 295) descent were asked whether they had experienced their first period. We compared median menarcheal age in 2009 with data from the previous Dutch Nationwide Growth Studies in 1955, 1965, 1980 and 1997. Age specific body mass index (BMI) z-scores were calculated to assess differences in BMI between pre- and postmenarcheal girls in different age groups. Results: Median age at menarche in Dutch girls, decreased significantly from 13.66 years in 1955 to 13.15 years in 1997 and 13.05 years in 2009. Compared to Dutch girls there is a larger decrease in median age of menarche in girls of Turkish and Moroccan descent between 1997 and 2009. In Turkish girls age at menarche decreased from 12.80 to 12.50 years and in Moroccan girls from 12.90 to 12.60 years. Thirty-three percent of Turkish girls younger than 12 years start menstruating in primary school. BMI-SDS is significantly higher in postmenarcheal girls than in premenarcheal girls irrespective of age. Conclusion: There is a continuing secular trend in earlier age at menarche in Dutch girls. An even faster decrease in age at menarche is observed in girls of Turkish and Moroccan descent in the Netherlands.	[Talma, Henk; HiraSing, Remy A.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Schonbeck, Yvonne] Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands; [van Dommelen, Paula; van Buuren, Stef] Netherlands Org Appl Sci Res TNO, Dept Stat, Leiden, Netherlands; [Bakker, Boudewijn] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; [van Buuren, Stef] Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University	Talma, H (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.	h.talma@vumc.nl	Bakker, Boudewijn/F-5830-2011	van Buuren, Stef/0000-0003-1098-2119; Bakker, Boudewijn/0000-0003-0229-1123; Schonbeck, Yvonne/0000-0002-4998-5117	Dutch Ministry of Health, Welfare and Sport [310434, 312617, 315319]	Dutch Ministry of Health, Welfare and Sport	The study was financially supported by the Dutch Ministry of Health, Welfare and Sport (grant numbers 310434/312617/315319). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008450; Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Anderson SE, 2005, J PEDIATR-US, V147, P753, DOI 10.1016/j.jpeds.2005.07.016; Anderson SE, 2003, PEDIATRICS, V111, P844, DOI 10.1542/peds.111.4.844; Atay Z, 2011, PEDIATRICS, V128, pE40, DOI 10.1542/peds.2010-2267; Bau AM, 2009, EUR J ENDOCRINOL, V160, P107, DOI 10.1530/EJE-08-0594; Biro FM, 2010, PEDIATRICS, V126, pE583, DOI 10.1542/peds.2009-3079; Braithwaite D, 2009, CANCER CAUSE CONTROL, V20, P713, DOI 10.1007/s10552-008-9284-9; BRUNDTLAND GH, 1980, ANN HUM BIOL, V7, P307, DOI 10.1080/03014468000004381; Bundak Ruveyde, 2008, J Clin Res Pediatr Endocrinol, V1, P8, DOI 10.4008/jcrpe.v1i1.16; Cabanes A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-449; Cakir M, 2007, PEDIATR INT, V49, P938, DOI 10.1111/j.1442-200X.2007.02489.x; Cho GJ, 2010, EUR J PEDIATR, V169, P89, DOI 10.1007/s00431-009-0993-1; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Danker-Hopfe H, 1990, Anthropol Anz, V48, P1; DATTA B, 1981, ANN HUM BIOL, V8, P351, DOI 10.1080/03014468100005151; Demerath EW, 2004, AM J HUM BIOL, V16, P453, DOI 10.1002/ajhb.20039; Ekerbicer HC, 2007, EUR J CONTRACEP REPR, V12, P289, DOI 10.1080/13625180701447854; Ersoy B, 2004, EARLY HUM DEV, V76, P115, DOI 10.1016/j.earlhumdev.2003.11.001; Feng Y, 2008, ATHEROSCLEROSIS, V196, P590, DOI 10.1016/j.atherosclerosis.2007.06.016; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Fredriks AM, 2004, ACTA PAEDIATR, V93, P817, DOI 10.1111/j.1651-2227.2004.tb03024.x; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Fredriks AM, 2003, EUR J PEDIATR, V162, P788, DOI 10.1007/s00431-003-1292-x; Freedman DS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e43; Freedman DS, 2000, ARCH PEDIAT ADOL MED, V154, P155, DOI 10.1001/archpedi.154.2.155; Gaudineau A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-175; Gluckman PD, 2006, MOL CELL ENDOCRINOL, V254, P26, DOI 10.1016/j.mce.2006.04.005; Gohlke B, 2009, DTSCH ARZTEBL INT, V106, P377, DOI 10.3238/arztebl.2009.0377; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Herman-Giddens ME, 2007, J ADOLESCENT HEALTH, V40, P201, DOI 10.1016/j.jadohealth.2006.12.019; Herman-Giddens ME, 2006, INT J ANDROL, V29, P241, DOI 10.1111/j.1365-2605.2005.00575.x; Himes JH, 2006, MOL CELL ENDOCRINOL, V254, P13, DOI 10.1016/j.mce.2006.04.013; HiraSing RA, 1987, THESIS; Hughes IA, 2006, MOL CELL ENDOCRINOL, V254, P1, DOI 10.1016/j.mce.2006.04.014; Joinson C, 2011, BRIT J PSYCHIAT, V198, P17, DOI 10.1192/bjp.bp.110.080861; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; Keij I, 2000, STANDARD DEFINITION; KELSEY JL, 1990, EPIDEMIOL REV, V12, P228, DOI 10.1093/oxfordjournals.epirev.a036056; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; LIESTOL K, 1995, ANN HUM BIOL, V22, P199, DOI 10.1080/03014469500003862; LINDGREN GW, 1991, ACTA PAEDIATR SCAND, V80, P953, DOI 10.1111/j.1651-2227.1991.tb11758.x; McDowell MA, 2007, J ADOLESCENT HEALTH, V40, P227, DOI 10.1016/j.jadohealth.2006.10.002; Mul D, 2001, PEDIATR RES, V50, P479, DOI 10.1203/00006450-200110000-00010; Must A, 2005, PEDIATRICS, V116, P620, DOI 10.1542/peds.2004-1604; NEYZI O, 1975, ANN HUM BIOL, V2, P49, DOI 10.1080/03014467500000561; ODEA J, 1995, LANCET, V345, P657, DOI 10.1016/S0140-6736(95)90563-4; Pierce MB, 2005, AM J CLIN NUTR, V82, P733, DOI 10.1093/ajcn/82.4.733; REES M, 1993, LANCET, V342, P1375, DOI 10.1016/0140-6736(93)92746-G; ROEDE MJ, 1985, TIJDSCHR SOC GEZON S, V63, P1, DOI DOI 10.1007/978-1-4471-1721-6_10; Salsberry PJ, 2009, NURS RES, V58, P382, DOI 10.1097/NNR.0b013e3181b4b921; Schonbeck Y, 2012, PEDIAT RES; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Semiz S, 2008, J PEDIATR ENDOCR MET, V21, P951; STONE PG, 1994, LANCET, V343, P423; ULIJASZEK SJ, 1991, ANN HUM BIOL, V18, P167, DOI 10.1080/03014469100001502; Verweij A., 2008, VOLKSGEZONDHEID TOEK; Vicdan K, 1996, J ADOLESCENT HEALTH, V18, P54, DOI 10.1016/1054-139X(95)00127-E; Wieringen van JC, 1968, GROWTH DIAGRAMS NETH, P1; Wijn de JF, 1960, LECT GROWTH DIAGRAMS, P1	61	78	80	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60056	10.1371/journal.pone.0060056	http://dx.doi.org/10.1371/journal.pone.0060056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130FG	23579990	Green Published, gold			2022-12-27	WOS:000317898000019
J	Cao, DS; Liang, YZ; Deng, Z; Hu, QN; He, M; Xu, QS; Zhou, GH; Zhang, LX; Deng, ZX; Liu, S				Cao, Dong-Sheng; Liang, Yi-Zeng; Deng, Zhe; Hu, Qian-Nan; He, Min; Xu, Qing-Song; Zhou, Guang-Hua; Zhang, Liu-Xia; Deng, Zi-xin; Liu, Shao			Genome-Scale Screening of Drug-Target Associations Relevant to K-i Using a Chemogenomics Approach	PLOS ONE			English	Article							RANDOM FOREST; INTERACTION NETWORKS; CONNECTIVITY MAP; PREDICTION; CLASSIFICATION; DISCOVERY; BINDING; CONSTRUCTION; PHARMACOLOGY; MOLECULES	The identification of interactions between drugs and target proteins plays a key role in genomic drug discovery. In the present study, the quantitative binding affinities of drug-target pairs are differentiated as a measurement to define whether a drug interacts with a protein or not, and then a chemogenomics framework using an unbiased set of general integrated features and random forest (RF) is employed to construct a predictive model which can accurately classify drug-target pairs. The predictability of the model is further investigated and validated by several independent validation sets. The built model is used to predict drug-target associations, some of which were confirmed by comparing experimental data from public biological resources. A drug-target interaction network with high confidence drug-target pairs was also reconstructed. This network provides further insight for the action of drugs and targets. Finally, a web-based server called PreDPI-K-i was developed to predict drug-target interactions for drug discovery. In addition to providing a high-confidence list of drug-target associations for subsequent experimental investigation guidance, these results also contribute to the understanding of drug-target interactions. We can also see that quantitative information of drug-target associations could greatly promote the development of more accurate models. The PreDPI-K-i server is freely available via: http://sdd.whu.edu.cn/dpiki.	[Cao, Dong-Sheng; Liang, Yi-Zeng; He, Min] Cent South Univ, Res Ctr Modernizat Tradit Chinese Med, Changsha, Hunan, Peoples R China; [Deng, Zhe; Hu, Qian-Nan; Deng, Zi-xin] Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, Wuhan 430072, Peoples R China; [Deng, Zhe; Hu, Qian-Nan; Deng, Zi-xin] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430072, Peoples R China; [Zhou, Guang-Hua; Zhang, Liu-Xia] Chinese Peoples Liberat Army, Hosp 163, Changsha, Hunan, Peoples R China; [Xu, Qing-Song] Cent South Univ, Sch Math & Stat, Changsha, Hunan, Peoples R China; [Liu, Shao] Cent South Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China	Central South University; Wuhan University; Wuhan University; Central South University; Central South University	Liang, YZ (corresponding author), Cent South Univ, Res Ctr Modernizat Tradit Chinese Med, Changsha, Hunan, Peoples R China.	yizeng_liang@263.net; qnhu@whu.edu.cn	Hu, Qian/GWZ-7617-2022; Xu, Qingsong/G-6562-2012	Liang, Yizeng/0000-0001-8692-3030	National Nature Foundation Committee of P.R. China [21075138, 21275164, 11271374]	National Nature Foundation Committee of P.R. China	This work is financially supported by the National Nature Foundation Committee of P.R. China (Grants No. 21075138, No. 21275164, and No. 11271374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Block P, 2006, NUCLEIC ACIDS RES, V34, pD522, DOI 10.1093/nar/gkj039; Boulesteix AL, 2012, BRIEF BIOINFORM, V13, P292, DOI 10.1093/bib/bbr053; Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Carlson HA, 2011, J CHEM INF MODEL, V51, P2025, DOI 10.1021/ci200398g; CHEN JC, 1993, LIFE SCI, V52, P389, DOI 10.1016/0024-3205(93)90152-S; Chen XW, 2005, BIOINFORMATICS, V21, P4394, DOI 10.1093/bioinformatics/bti721; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; DIVE C, 1991, BRIT J CANCER, V64, P192, DOI 10.1038/bjc.1991.269; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Dunkel M, 2008, NUCLEIC ACIDS RES, V36, pW55, DOI 10.1093/nar/gkn307; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Goudie AJ, 2003, NEUROPSYCHOPHARMACOL, V28, P2209, DOI 10.1038/sj.npp.1300291; Harris CJ, 2006, DRUG DISCOV TODAY, V11, P880, DOI 10.1016/j.drudis.2006.08.013; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Jacob L, 2008, BIOINFORMATICS, V24, P2149, DOI 10.1093/bioinformatics/btn409; Jacob L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-363; Jahnke W, 2006, FRAGMENT BASED APPRO; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Klabunde T, 2007, BRIT J PHARMACOL, V152, P5, DOI 10.1038/sj.bjp.0707308; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; KRISTENSEN K, 1994, LIFE SCI, V56, pPL45; Kuhn M, 2008, FEBS LETT, V582, P1283, DOI 10.1016/j.febslet.2008.02.024; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li X, 2004, NUCLEIC ACIDS RES, V32, P2685, DOI 10.1093/nar/gkh563; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Luo H, 2011, NUCLEIC ACIDS RES, V39, pW492, DOI 10.1093/nar/gkr299; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; Mestres J, 2004, CURR OPIN DRUG DISC, V7, P304; Mestres J, 2009, MOL BIOSYST, V5, P1051, DOI 10.1039/b905821b; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Nunez S, 2012, DRUG DISCOV TODAY, V17, P10, DOI 10.1016/j.drudis.2011.06.013; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Pittman J, 2002, J CHEM INF COMP SCI, V42, P729, DOI 10.1021/ci0103828; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Rognan D, 2007, BRIT J PHARMACOL, V152, P38, DOI 10.1038/sj.bjp.0707307; Roth BL, 2003, CLIN NEUROSCI RES, V3, P108, DOI 10.1016/S1566-2772(03)00021-5; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Sanseau P, 2011, BRIEF BIOINFORM, V12, P301, DOI 10.1093/bib/bbr047; Shi T, 2005, MODERN PATHOL, V18, P547, DOI 10.1038/modpathol.3800322; Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; van Westen GJP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027518; Wang F, 2011, J CHEM INF MODEL, V51, P2821, DOI 10.1021/ci200264h; Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Xia Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S6; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yao LX, 2010, TRENDS BIOTECHNOL, V28, P161, DOI [10.1016/j.tibtech.2009.06.003, 10.1016/j.tibtech.2010.01.004]; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yu WM, 2011, DRUG DEVELOP RES, V72, P219, DOI 10.1002/ddr.20418; Zhang HP, 2003, P NATL ACAD SCI USA, V100, P4168, DOI 10.1073/pnas.0230559100	72	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e57680	10.1371/journal.pone.0057680	http://dx.doi.org/10.1371/journal.pone.0057680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577055	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800002
J	Martins, C; Natal-da-Luz, T; Sousa, JP; Goncalves, MJ; Salgueiro, L; Canhoto, C				Martins, Carla; Natal-da-Luz, Tiago; Sousa, Jose Paulo; Goncalves, Maria Jose; Salgueiro, Ligia; Canhoto, Cristina			Effects of Essential Oils from Eucalyptus globulus Leaves on Soil Organisms Involved in Leaf Degradation	PLOS ONE			English	Article							PORCELLIO-DILATATUS CRUSTACEA; ANTIFUNGAL ACTIVITY; FEEDING PREFERENCES; WATER-REPELLENCY; FOOD QUALITY; LITTER; COLLEMBOLA; FUNGI; CANDIDA; GROWTH	The replacement of native Portuguese forests by Eucalyptus globulus is often associated with deleterious effects on terrestrial and aquatic communities. Several studies have suggested that such a phenomenon is linked with the leaf essential oils released into the environment during the Eucalyptus leaf degradation process. However, to date, the way these compounds affect leaf degradation in terrestrial systems i.e. by direct toxic effects to soil invertebrates or indirectly by affecting food of soil fauna, is still unknown. In order to explore this question, the effect of essential oils extracted from E. globulus leaves on terrestrial systems was investigated. Fungal growth tests with species known as leaf colonizers (Mucor hiemalis, Alternaria alternata, Penicillium sp., Penicillium glabrum and Fusarium roseum) were performed to evaluate the antifungal effect of essential oils. In addition, a reproduction test with the collembolans Folsomia candida was done using a gradient of eucalyptus essential oils in artificial soil. The influence of essential oils on feeding behaviour of F. candida and the isopods Porcellio dilatatus was also investigated through food avoidance and consumption tests. Eucalyptus essential oils were lethal at concentrations between 2.5-20 mu L/mL and inhibited growth of all fungal species between 1.25-5 mu L/mL. The collembolan reproduction EC50 value was 35.0 (28.6-41.2) mg/kg and both collembola and isopods preferred leaves without oils. Results suggested that the effect of essential oils in leaf processing is related to direct toxic effects on fungi and soil fauna and to indirect effects on the quality and availability of food to soil invertebrates.	[Martins, Carla; Natal-da-Luz, Tiago; Sousa, Jose Paulo; Canhoto, Cristina] Univ Coimbra, Dept Life Sci, Inst Marine Res IMAR CMA, Coimbra, Portugal; [Goncalves, Maria Jose; Salgueiro, Ligia] Univ Coimbra, Fac Pharm, Ctr Pharmaceut Studies CEF, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Canhoto, C (corresponding author), Univ Coimbra, Dept Life Sci, Inst Marine Res IMAR CMA, Coimbra, Portugal.	ccanhoto@ci.uc.pt	Canhoto, Cristina/M-4211-2014; Sousa, Jose Paulo FA/H-5407-2011; Salgueiro, Ligia/T-4759-2017	Canhoto, Cristina/0000-0003-3343-8757; Sousa, Jose Paulo FA/0000-0001-8045-4296; Salgueiro, Ligia/0000-0003-0948-821X; /0000-0003-4852-8982; Natal da Luz, Tiago/0000-0002-1628-5894	Instituto do Mar's (IMAR)	Instituto do Mar's (IMAR)	The work was supported by Instituto do Mar's (IMAR) own funds and facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A'Bear AD, 2012, GLOBAL CHANGE BIOL, V18, P1823, DOI 10.1111/j.1365-2486.2012.02637.x; Adolphson H, 2008, PEDOBIOLOGIA, V51, P427, DOI 10.1016/j.pedobi.2008.01.003; Akpor O. B., 2006, Journal of Biological Sciences, V6, P768; Ashagrie Y, 2005, AGR ECOSYST ENVIRON, V106, P89, DOI 10.1016/j.agee.2004.07.015; Barrocas H. M., 1998, Miscellania Zoologica (Barcelona), V21, P9; Behera N, 2003, FOREST ECOL MANAG, V174, P1, DOI 10.1016/S0378-1127(02)00057-9; Bernhard-Reversat F, 2003, APPL SOIL ECOL, V23, P273, DOI 10.1016/S0929-1393(03)00061-1; BERNHARDREVERSAT F, 1993, ACTA OECOL, V14, P179; Bollmann J, 2010, PEDOBIOLOGIA, V53, P107, DOI 10.1016/j.pedobi.2009.06.003; Canhoto C, 2006, CAN J ZOOL, V84, P1087, DOI 10.1139/Z06-092; Canhoto C, 2002, ARCH HYDROBIOL, V154, P121; Canhoto C, 1999, MICROBIAL ECOL, V37, P163, DOI 10.1007/s002489900140; Canhoto C, 2007, INT REV HYDROBIOL, V92, P173, DOI 10.1002/iroh.200510956; Caseiro I, 2000, ECOTOX ENVIRON SAFE, V47, P285, DOI 10.1006/eesa.2000.1982; CELPA, 2010, B EST IND PAP PORT; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; Council of Europe, 2007, EUROPEAN PHARMACOPOE, V6th; DGRF, 2007, REL FIN 5 INV FLOR N; Doerr SH, 2000, J HYDROL, V231, P134, DOI 10.1016/S0022-1694(00)00190-6; Engenheiro EL, 2005, ENVIRON TOXICOL CHEM, V24, P603, DOI 10.1897/04-131R.1; Environmental Canada, 2004, REP EPS, VEPS 1/RM/47; Ernst EJ, 2005, METHODS MOL MED ANTI; Ferreira AJD, 2000, J HYDROL, V231, P165, DOI 10.1016/S0022-1694(00)00192-X; Fountain MT, 2005, ANNU REV ENTOMOL, V50, P201, DOI 10.1146/annurev.ento.50.071803.130331; Gange A, 2000, TRENDS ECOL EVOL, V15, P369, DOI 10.1016/S0169-5347(00)01940-6; Graca Manuel A. S., 1993, Limnologica, V23, P107; Graca MAS, 2001, FRESHWATER BIOL, V46, P947, DOI 10.1046/j.1365-2427.2001.00729.x; Hassal M, 1987, OECOLOGIA, V27, P1; Inderjit, 1997, FOREST ECOL MANAG, V92, P11, DOI 10.1016/S0378-1127(96)03957-6; ISO, 2010, 175122 ISO; ISO, 1999, 11267 ISO; Jorgensen HB, 2005, BIOL LETTERS, V1, P243, DOI 10.1098/rsbl.2004.0286; Jorgensen HB, 2003, BIOL FERT SOILS, V39, P9, DOI 10.1007/s00374-003-0674-6; Kayang H, 1996, EUR J SOIL BIOL, V32, P35; Lee BH, 2001, CROP PROT, V20, P317, DOI 10.1016/S0261-2194(00)00158-7; Lee Young-Haeng, 2002, Journal of Asia-Pacific Entomology, V5, P131, DOI 10.1016/S1226-8615(08)60142-9; Loureiro S, 2005, ENVIRON POLLUT, V138, P121, DOI 10.1016/j.envpol.2005.02.013; Louzada JNC, 1997, FOREST ECOL MANAG, V94, P31, DOI 10.1016/S0378-1127(96)03986-2; Luanga-Reyrel F., 1999, EUR J SOIL BIOL, V35, P177; Maraun M, 2003, EUR J SOIL BIOL, V39, P85, DOI 10.1016/S1164-5563(03)00006-2; Maxia A, 2012, MYCOPATHOLOGIA, V174, P61, DOI 10.1007/s11046-011-9519-2; MOLINA A, 1991, J CHEM ECOL, V17, P147, DOI 10.1007/BF00994428; Naeem S, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P3; Natal-da-luz T, 2009, CHEMOSPHERE, V77, P1526, DOI 10.1016/j.chemosphere.2009.09.056; POINSOTBALAGUER N, 1993, EUR J SOIL BIOL, V29, P13; REGNAULTROGER C, 1994, STORED PRODUCT PROTECTION, VOLS 1 AND 2, P837; REGNAULTROGER C, 2005, BIOPESTICIDES PLANT; Sadaka-Laulan N, 1998, EUR J SOIL BIOL, V34, P179, DOI 10.1016/S1164-5563(00)86660-1; Salgueiro LR, 2006, FLAVOUR FRAG J, V21, P749, DOI 10.1002/ffj.1610; Sasikumar K, 2004, J TROP FOR SCI, V16, P419; Scheu S, 2004, OECOLOGIA, V139, P347, DOI 10.1007/s00442-004-1513-7; Shaalan EAS, 2005, ENVIRON INT, V31, P1149, DOI 10.1016/j.envint.2005.03.003; Shakesby RA, 2000, J HYDROL, V231, P178, DOI 10.1016/S0022-1694(00)00193-1; Sousa J.P., 2003, Acta Entomologica Iberica e Macaronesica, V1, P1; Sousa J. P., 2000, Belgian Journal of Entomology, V2, P187; Sousa JP, 2006, PEDOBIOLOGIA, V50, P147, DOI 10.1016/j.pedobi.2005.10.005; Sousa JP, 1998, APPL SOIL ECOL, V9, P399, DOI 10.1016/S0929-1393(98)00096-1; SOUSA JP, 1994, EUR J SOIL BIOL, V30, P71; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; STORK NE, 1993, OIKOS, V67, P483, DOI 10.2307/3545360; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Tordoff GM, 2008, SOIL BIOL BIOCHEM, V40, P434, DOI 10.1016/j.soilbio.2007.09.006; Vale-Silva LA, 2010, PLANTA MED, V76, P882, DOI 10.1055/s-0029-1240799; Vermeulen E, 2012, EUROSURVEILLANCE, V17, P11; Wang JJ, 2001, J ECON ENTOMOL, V94, P1296, DOI 10.1603/0022-0493-94.5.1296; Zar JH, 1999, BIOSTATISTICAL ANAL; Zimmer M, 2003, EUR J SOIL BIOL, V39, P209, DOI 10.1016/j.ejsobi.2003.07.001; Zuzarte M, 2012, FOOD CHEM, V135, P1505, DOI 10.1016/j.foodchem.2012.05.090	68	32	33	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61233	10.1371/journal.pone.0061233	http://dx.doi.org/10.1371/journal.pone.0061233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577212	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800134
J	Mizoguchi, A; Ohsumi, S; Kobayashi, K; Okamoto, N; Yamada, N; Tateishi, K; Fujimoto, Y; Kataoka, H				Mizoguchi, Akira; Ohsumi, Shintaro; Kobayashi, Katuji; Okamoto, Naoki; Yamada, Nobuto; Tateishi, Ken; Fujimoto, Yoshinori; Kataoka, Hiroshi			Prothoracicotropic Hormone Acts as a Neuroendocrine Switch between Pupal Diapause and Adult Development	PLOS ONE			English	Article							LAST-LARVAL INSTAR; MOLECULAR CHARACTERIZATION; HELIOTHIS-VIRESCENS; MAMESTRA-BRASSICAE; BOMBYX-MORI; IN-VITRO; GLANDS; SILKWORM; BRAIN; SENSITIVITY	Diapause is a programmed developmental arrest that has evolved in a wide variety of organisms and allows them survive unfavorable seasons. This developmental state is particularly common in insects. Based on circumstantial evidence, pupal diapause has been hypothesized to result from a cessation of prothoracicotropic hormone (PTTH) secretion from the brain. Here, we provide direct evidence for this classical hypothesis by determining both the PTTH titer in the hemolymph and the PTTH content in the brain of diapause pupae in the cabbage army moth Mamestra brassicae. For this purpose, we cloned the PTTH gene, produced PTTH-specific antibodies, and developed a highly sensitive immunoassay for PTTH. While the hemolymph PTTH titer in non-diapause pupae was maintained at high levels after pupation, the titer in diapause pupae dropped to an undetectable level. In contrast, the PTTH content of the post-pupation brain was higher in diapause animals than in non-diapause animals. These results clearly demonstrate that diapause pupae have sufficient PTTH in their brain, but they do not release it into the hemolymph. Injecting PTTH into diapause pupae immediately after pupation induced adult development, showing that a lack of PTTH is a necessary and sufficient condition for inducing pupal diapause. Most interestingly, in diapause-destined larvae, lower hemolymph titers of PTTH and reduced PTTH gene expression were observed for 4 and 2 days, respectively, prior to pupation. This discovery demonstrates that the diapause program is already manifested in the PTTH neurons as early as the mid final instar stage.	[Mizoguchi, Akira; Ohsumi, Shintaro; Okamoto, Naoki; Yamada, Nobuto] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Kobayashi, Katuji; Kataoka, Hiroshi] Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Tateishi, Ken] Natl Inst Agrobiol Sci, Safety Management Sect, Tsukuba, Ibaraki, Japan; [Fujimoto, Yoshinori] Tokyo Inst Technol, Dept Chem & Mat Sci, Tokyo 152, Japan	Nagoya University; University of Tokyo; National Institute of Agrobiological Sciences - Japan; Tokyo Institute of Technology	Mizoguchi, A (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648601, Japan.	mizoguch@bio.nagoya-u.ac.jp; kataoka@k.u-tokyo.ac.jp			Asahi Glass Foundation; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; RIKEN	Asahi Glass Foundation; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; RIKEN	This work was supported by the Asahi Glass Foundation 2007 (http://www.af-info.or.jp/en/index.html) and the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (http://www.naro.affrc.go.jp/brain/inv_up/index.html). N.O. is supported by a RIKEN Special Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLLENBACHER WE, 1979, P NATL ACAD SCI USA, V76, P5148, DOI 10.1073/pnas.76.10.5148; BOWEN MF, 1984, J EXP BIOL, V108, P9; BRADFIELD JY, 1980, GEN COMP ENDOCR, V41, P101, DOI 10.1016/0016-6480(80)90038-6; DAI JD, 1991, DEV BIOL, V144, P309, DOI 10.1016/0012-1606(91)90424-2; Dai JD, 1997, INSECT BIOCHEM MOLEC, V27, P69, DOI 10.1016/S0965-1748(96)00068-9; Denlinger D.L., 2005, P615; Denlinger D.L., 1985, P353; Endo K, 1997, ZOOL SCI, V14, P127, DOI 10.2108/zsj.14.127; KATAOKA H, 1987, AGR BIOL CHEM TOKYO, V51, P1067, DOI 10.1080/00021369.1987.10868149; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; Kopec S, 1922, BIOL BULL-US, V42, P323, DOI 10.2307/1536759; LOEB MJ, 1982, J INSECT PHYSIOL, V28, P667, DOI 10.1016/0022-1910(82)90144-5; Maibeche-Coisne M, 2004, CHEM SENSES, V29, P381, DOI 10.1093/chemse/bjh039; MEOLA RW, 1977, J INSECT PHYSIOL, V23, P683, DOI 10.1016/0022-1910(77)90084-1; Mizoguchi A, 2005, J INSECT PHYSIOL, V51, P871, DOI 10.1016/j.jinsphys.2005.04.002; Mizoguchi A, 2001, INSECT BIOCHEM MOLEC, V31, P349, DOI 10.1016/S0965-1748(00)00127-2; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; OKUDA M, 1985, J INSECT PHYSIOL, V31, P455, DOI 10.1016/0022-1910(85)90092-7; RICHARD DS, 1987, J INSECT PHYSIOL, V33, P385, DOI 10.1016/0022-1910(87)90016-3; Rybczynski R., 2005, P61; Sauman I, 1996, DEV BIOL, V178, P418, DOI 10.1006/dbio.1996.0228; Saunders David S., 2010, P218; Shionoya M, 2003, INSECT BIOCHEM MOLEC, V33, P795, DOI 10.1016/S0965-1748(03)00078-X; Warren J.T., 1988, P181; Wei ZJ, 2005, J INSECT PHYSIOL, V51, P691, DOI 10.1016/j.jinsphys.2005.03.005; WILLIAMS CM, 1952, BIOL BULL, V103, P120, DOI 10.2307/1538411; WILLIAMS CM, 1968, BIOL BULL, V134, P344, DOI 10.2307/1539610; WILLIAMS CM, 1946, BIOL BULL, V90, P234, DOI 10.2307/1538121; WILLIAMS CM, 1947, BIOL BULL, V93, P89, DOI 10.2307/1538279; Xu WH, 2003, INSECT MOL BIOL, V12, P509, DOI 10.1046/j.1365-2583.2003.00437.x; Yamanaka N, 2005, J BIOL CHEM, V280, P14684, DOI 10.1074/jbc.M500308200	31	26	29	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60824	10.1371/journal.pone.0060824	http://dx.doi.org/10.1371/journal.pone.0060824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577167	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800105
J	Nilsson, A; Johansson, E; Ekstrom, L; Bjorck, I				Nilsson, Anne; Johansson, Elin; Ekstrom, Linda; Bjorck, Inger			Effects of a Brown Beans Evening Meal on Metabolic Risk Markers and Appetite Regulating Hormones at a Subsequent Standardized Breakfast: A Randomized Cross-Over Study	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; CHAIN FATTY-ACIDS; IN-VITRO; GLUCOSE-TOLERANCE; HEALTHY-SUBJECTS; ANTIOXIDANT CAPACITY; ADIPOSE-TISSUE; PROPIONIC-ACID; DIETARY FIBER; FOOD-INTAKE	Background: Dietary prevention strategies are increasingly recognized as essential to combat the current epidemic of obesity and related metabolic disorders. The purpose of the present study was to evaluate the potential prebiotic effects of indigestible carbohydrates in Swedish brown beans (Phaseolus vulgaris var. nanus) in relation to cardiometabolic risk markers and appetite regulating hormones. Methods: Brown beans, or white wheat bread (WWB, reference product) were provided as evening meals to 16 healthy young adults in a randomised crossover design. Glucose, insulin, appetite regulatory hormones, GLP-1, GLP-2, appetite sensations, and markers of inflammation were measured at a following standardised breakfast, that is at 11 to 14 h post the evening meals. Additionally, colonic fermentation activity was estimated from measurement of plasma short chain fatty acids (SCFA, including also branched chain fatty acids) and breath hydrogen (H-2) excretion. Results: An evening meal of brown beans, in comparison with WWB, lowered blood glucose (-15%, p < 0.01)- and insulin (-16%, p < 0.05) responses, increased satiety hormones (PYY 51%, p < 0.001), suppressed hunger hormones (ghrelin -14%, p < 0.05), and hunger sensations (-15%, p = 0.05), increased GLP-2 concentrations (8.4%, p < 0.05) and suppressed inflammatory markers (IL-6 -35%, and IL-18 -8.3%, p < 0.05) at a subsequent standardised breakfast. Breath H-2 (141%, p < 0.01), propionate (16%, p < 0.05), and isobutyrate (18%, P < 0.001) were significantly increased after brown beans compared to after WWB, indicating a higher colonic fermentative activity after brown beans. Conclusions: An evening meal with brown beans beneficially affected important measures of cardiometabolic risk and appetite regulatory hormones, within a time frame of 11-14 h, in comparison to a WWB evening meal. Concentrations of plasma SCFA and H2 were increased, indicating involvement of colonic fermentation. Indigestible colonic substrates from brown beans may provide a preventive tool in relation to obesity and the metabolic syndrome.	[Nilsson, Anne; Johansson, Elin; Ekstrom, Linda; Bjorck, Inger] Lund Univ, Dept Food Technol Engn & Nutr, Div Appl Nutr & Food Chem, S-22100 Lund, Sweden	Lund University	Nilsson, A (corresponding author), Lund Univ, Dept Food Technol Engn & Nutr, Div Appl Nutr & Food Chem, S-22100 Lund, Sweden.	anne.nilsson@appliednutrition.lth.se		Nilsson, Anne/0000-0002-9780-7876; Ekstrom, Linda/0000-0003-3671-0146	Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University	Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University	This study was supported by the Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren Bo, 2007, Curr Diab Rep, V7, P340, DOI 10.1007/s11892-007-0056-9; Akerberg A, 1998, J CEREAL SCI, V28, P71, DOI 10.1006/jcrs.1997.0173; Akerberg AKE, 1998, J NUTR, V128, P651; Al-Lahham S, 2012, EUR J CLIN INVEST, V42, P357, DOI 10.1111/j.1365-2362.2011.02590.x; Al-Lahham SH, 2010, EUR J CLIN INVEST, V40, P401, DOI 10.1111/j.1365-2362.2010.02278.x; ASP NG, 1983, J AGR FOOD CHEM, V31, P476, DOI 10.1021/jf00117a003; Baggio LL, 2004, GASTROENTEROLOGY, V127, P546, DOI 10.1053/j.gastro.2004.04.063; BJORCK IME, 1992, J SCI FOOD AGR, V58, P541, DOI 10.1002/jsfa.2740580414; Brighenti F., 1998, FUNCTIONAL PROPERTIE, P150; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Dalvi PS, 2012, ENDOCRINOLOGY, V153, P2385, DOI 10.1210/en.2011-2089; Feldeisen SE, 2007, APPL PHYSIOL NUTR ME, V32, P46, DOI [10.1139/H06-101, 10.1139/h06-101]; Henningsson AM, 2001, BRIT J NUTR, V86, P379, DOI 10.1079/BJN2001423; Hernandez-Salazar M, 2010, J SCI FOOD AGR, V90, P1417, DOI 10.1002/jsfa.3954; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howlett JF, 2010, FOOD NUTR RES, P54; Jenkins DJA, 2002, AM J CLIN NUTR, V76, p266S, DOI 10.1093/ajcn/76.1.266S; McKeown NM, 2002, AM J CLIN NUTR, V76, P390, DOI 10.1093/ajcn/76.2.390; Micallef MA, 2009, ATHEROSCLEROSIS, V204, P476, DOI 10.1016/j.atherosclerosis.2008.09.020; MORTENSEN PB, 1992, JPEN-PARENTER ENTER, V16, P433, DOI 10.1177/0148607192016005433; Musch MW, 2001, AM J PHYSIOL-GASTR L, V280, pG687, DOI 10.1152/ajpgi.2001.280.4.G687; Nilsson A, 2008, EUR J CLIN NUTR, V62, P712, DOI 10.1038/sj.ejcn.1602784; Nilsson A, 2006, EUR J CLIN NUTR, V60, P1092, DOI 10.1038/sj.ejcn.1602423; Nilsson AC, 2008, J NUTR, V138, P732, DOI 10.1093/jn/138.4.732; Nilsson AC, 2010, J NUTR, V140, P1932, DOI 10.3945/jn.110.123604; Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d; Papanikolaou Y, 2008, J AM COLL NUTR, V27, P569, DOI 10.1080/07315724.2008.10719740; Parkar SG, 2008, INT J FOOD MICROBIOL, V124, P295, DOI 10.1016/j.ijfoodmicro.2008.03.017; Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6; Sievenpiper JL, 2009, DIABETOLOGIA, V52, P1479, DOI 10.1007/s00125-009-1395-7; Smiricky-Tjardes MR, 2003, J ANIM SCI, V81, P2535; Stanley S, 2004, AM J PHYSIOL-GASTR L, V286, pG693, DOI 10.1152/ajpgi.00536.2003; THORBURN A, 1993, METABOLISM, V42, P780, DOI 10.1016/0026-0495(93)90249-N; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; TOVAR J, 1992, J AGR FOOD CHEM, V40, P1846, DOI 10.1021/jf00022a024; Tovar J, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-29; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wong CL, 2009, J AM COLL NUTR, V28, P543, DOI 10.1080/07315724.2009.10719786; Xu BJ, 2007, J FOOD SCI, V72, pS167, DOI 10.1111/j.1750-3841.2006.00261.x; Zhong J, 2000, AM J CLIN NUTR, V72, P1503; Zhong Y, 2009, CLIN NUTR, V28, P575, DOI 10.1016/j.clnu.2009.04.026; Zhou J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1160, DOI 10.1152/ajpendo.90637.2008	45	88	92	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59985	10.1371/journal.pone.0059985	http://dx.doi.org/10.1371/journal.pone.0059985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577078	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800021
J	Wakui, E; Juttner, M; Petters, D; Kaur, S; Hummel, JE; Davidoff, J				Wakui, Elley; Juettner, Martin; Petters, Dean; Kaur, Surinder; Hummel, John E.; Davidoff, Jules			Earlier Development of Analytical than Holistic Object Recognition in Adolescence	PLOS ONE			English	Article							PERCEPTUAL ORGANIZATION; FACE RECOGNITION; YOUNG-CHILDREN; ATTENTION; PARTS; SHAPE; INFANTS; REPRESENTATIONS; FAMILIARITY; CATEGORIES	Background: Previous research has shown that object recognition may develop well into late childhood and adolescence. The present study extends that research and reveals novel differences in holistic and analytic recognition performance in 7-12 year olds compared to that seen in adults. We interpret our data within a hybrid model of object recognition that proposes two parallel routes for recognition (analytic vs. holistic) modulated by attention. Methodology/Principal Findings: Using a repetition-priming paradigm, we found in Experiment 1 that children showed no holistic priming, but only analytic priming. Given that holistic priming might be thought to be more 'primitive', we confirmed in Experiment 2 that our surprising finding was not because children's analytic recognition was merely a result of name repetition. Conclusions/Significance: Our results suggest a developmental primacy of analytic object recognition. By contrast, holistic object recognition skills appear to emerge with a much more protracted trajectory extending into late adolescence.	[Wakui, Elley; Davidoff, Jules] Univ London, Dept Psychol, London, England; [Wakui, Elley] Univ E London, Sch Psychol, London E15 4LZ, England; [Juettner, Martin; Petters, Dean; Kaur, Surinder] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Hummel, John E.] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA	University of London; University of East London; Aston University; University of Illinois System; University of Illinois Urbana-Champaign	Juttner, M (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	m.juttner@aston.ac.uk		Juttner, Martin W/0000-0003-3486-7975	Economic and Social Research Council [RES-062-0167]; Heidehof Stiftung [50302.01/4.10]; Economic and Social Research Council [ES/E003699/1] Funding Source: researchfish; ESRC [ES/E003699/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Heidehof Stiftung; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was supported by the Economic and Social Research Council (grant RES-062-0167) and by the Heidehof Stiftung (grant 50302.01/4.10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis M, 2001, J EXP CHILD PSYCHOL, V78, P213, DOI 10.1006/jecp.2000.2573; AKHTAR N, 1989, J EXP CHILD PSYCHOL, V48, P315, DOI 10.1016/0022-0965(89)90008-8; BARTRAM DJ, 1976, MEM COGNITION, V4, P593, DOI 10.3758/BF03213223; BIEDERMAN I, 1991, PERCEPTION, V20, P585, DOI 10.1068/p200585; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; CAREY S, 1977, SCIENCE, V195, P312, DOI 10.1126/science.831281; Carey S., 1994, VIS COGN, V1, P253, DOI [DOI 10.1080/13506289408402302, 10.1080/13506289408402302]; Davidoff J, 2002, J EXP CHILD PSYCHOL, V81, P217, DOI 10.1006/jecp.2002.2659; DAY MC, 1978, J EXP CHILD PSYCHOL, V25, P1, DOI 10.1016/0022-0965(78)90034-6; EIMAS PD, 1994, CHILD DEV, V65, P903; ELLIS HD, 1975, BRIT J PSYCHOL, V66, P409, DOI 10.1111/j.2044-8295.1975.tb01477.x; ELLIS R, 1989, Q J EXP PSYCHOL-A, V41, P775, DOI 10.1080/14640748908402393; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Haaf RA, 2003, J EXP CHILD PSYCHOL, V86, P108, DOI 10.1016/S0022-0965(03)00108-5; Hummel J. E., 1996, ATTENTION PERFORM, P93; HUMMEL JE, 1992, PSYCHOL REV, V99, P480, DOI 10.1037/0033-295X.99.3.480; Hummel JE, 2001, VIS COGN, V8, P489, DOI 10.1080/13506280143000214; Intraub H, 1981, EYE MOVEMENTS COGNIT, P181; Juttner M, 2006, BEHAV BRAIN RES, V175, P420, DOI 10.1016/j.bbr.2006.09.005; Juttner M, 2013, DEV PSYCHOL, V49, P161, DOI 10.1037/a0027707; Kimchi R, 2005, PSYCHOL SCI, V16, P282, DOI 10.1111/j.0956-7976.2005.01529.x; Kovacs I, 1999, P NATL ACAD SCI USA, V96, P12204, DOI 10.1073/pnas.96.21.12204; Kovacs I, 2000, VISION RES, V40, P1301, DOI 10.1016/S0042-6989(00)00055-9; Lavie N, 2009, J EXP PSYCHOL HUMAN, V35, P1346, DOI 10.1037/a0016454; Lawson R, 1996, J EXP PSYCHOL HUMAN, V22, P395, DOI 10.1037/0096-1523.22.2.395; MADOLE KL, 1995, DEV PSYCHOL, V31, P637, DOI 10.1037/0012-1649.31.4.637; Mareschal D, 2000, DEV PSYCHOL, V36, P635, DOI 10.1037//0012-1649.36.5.635; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Milner A. D., 1995, VISUAL BRAIN ACTION; Nishimura M, 2009, F1000 BIOL REP, V1, P2; ORAM MW, 1992, J NEUROPHYSIOL, V68, P70, DOI 10.1152/jn.1992.68.1.70; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Rakison DH, 1998, DEV PSYCHOL, V34, P49, DOI 10.1037/0012-1649.34.1.49; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Scherf KS, 2009, CHILD DEV, V80, P162, DOI 10.1111/j.1467-8624.2008.01252.x; Smith LB, 1996, COGNITION, V60, P143, DOI 10.1016/0010-0277(96)00709-3; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Stankiewicz BJ, 1998, J EXP PSYCHOL HUMAN, V24, P732, DOI 10.1037/0096-1523.24.3.732; Tanaka JW, 1998, VIS COGN, V5, P479, DOI 10.1080/713756795; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tarr MJ, 2003, TRENDS COGN SCI, V7, P23, DOI 10.1016/S1364-6613(02)00010-4; TARR MJ, 1995, J EXP PSYCHOL HUMAN, V21, P1494, DOI 10.1037/0096-1523.21.6.1494; Thoma V, 2006, EXP PSYCHOL, V53, P31, DOI 10.1027/1618-3169.53.1.31; Thoma V, 2004, J EXP PSYCHOL HUMAN, V30, P257, DOI 10.1037/0096-1523.30.2.257; Thoma V., 2007, OBJECT RECOGNITION A, P141; Thoma V, 2007, VIS COGN, V15, P179, DOI 10.1080/13506280500155627; Thoma V, 2011, NEUROIMAGE, V57, P513, DOI 10.1016/j.neuroimage.2011.04.035; ULLMAN S, 1989, COGNITION, V32, P193, DOI 10.1016/0010-0277(89)90036-X; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	51	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61041	10.1371/journal.pone.0061041	http://dx.doi.org/10.1371/journal.pone.0061041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RZ	23577188	Green Accepted, Green Published, gold			2022-12-27	WOS:000319109800120
J	Wang, WJ; Dang, SS; Li, YP; Sun, MZ; Jia, XL; Wang, R; Liu, JK				Wang, Wenjun; Dang, Shuangsuo; Li, Yaping; Sun, Mingzhu; Jia, Xiaoli; Wang, Rui; Liu, Jingkun			hOGG1 Ser326Cys Polymorphism and Risk of Hepatocellular Carcinoma among East Asians: A Meta-Analysis	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; REPAIR GENES; CANCER; OGG1; 8-HYDROXYGUANINE; EPIDEMIOLOGY; GLYCOSYLASE; ALCOHOL; DISEASE; PROTEIN	Background: The hOGG1 gene encodes a DNA glycosylase enzyme responsible for DNA repair. The Ser326Cys polymorphism in this gene may influence its repair ability and thus plays a role in carcinogenesis. Several case-control studies have been conducted on this polymorphism and its relationship with the risk of hepatocellular carcinoma (HCC) among East Asians. However, their results are inconsistent. Methods: We performed a meta-analysis of published case-control studies assessing the association of the hOGG1 Ser326Cys polymorphism with HCC risk among East Asians. PubMed, EMBASE, SCI, BIOSIS, CNKI and WanFang databases were searched. A random-effect model was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs). Analyses were conducted for additive, dominant and recessive genetic models. Results: Eight studies were identified involving 2369 cases and 2442 controls assessing the association of the hOGG1 Ser326Cys polymorphism with HCC risk among East Asians. Applying a dominant genetic model, only in the Chinese population, the Cys allele was significantly associated with increased risk of HCC (OR 1.56, 95% CI 1.12-2.17). However, two studies influenced this finding according to sensitivity analysis. Furthermore, considerable heterogeneity and bias existed among Chinese studies. Conclusion: There is limited evidence to support that the hOGG1 Ser326Cys polymorphism is associated with HCC risk among East Asians. Well-designed and large-sized studies are required to determine this relationship.	[Wang, Wenjun; Dang, Shuangsuo; Li, Yaping; Sun, Mingzhu; Jia, Xiaoli; Wang, Rui; Liu, Jingkun] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Infect Dis, Xian 710049, Peoples R China	Xi'an Jiaotong University	Dang, SS (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Infect Dis, Xian 710049, Peoples R China.	dang212@126.com		Wang, Wenjun/0000-0001-9861-1763				Aizhong W, 2008, CHIN J GASTROENTEROL, V17, P854; Audebert M, 2000, NUCLEIC ACIDS RES, V28, P2672, DOI 10.1093/nar/28.14.2672; Blons H, 1999, MOL CARCINOGEN, V26, P254; Chen SK, 2003, J RADIAT RES, V44, P31; CHENG KC, 1992, J BIOL CHEM, V267, P166; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; Donato F, 2002, AM J EPIDEMIOL, V155, P323, DOI 10.1093/aje/155.4.323; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hardie LJ, 2000, CARCINOGENESIS, V21, P167, DOI 10.1093/carcin/21.2.167; Janssen K, 2001, MUTAT RES-DNA REPAIR, V486, P207, DOI 10.1016/S0921-8777(01)00096-9; JI L, 2011, J HYGIENE RES, V7, P705; Jung SW, 2012, J HEPATOL, V57, P621, DOI 10.1016/j.jhep.2012.04.039; Jungst C, 2004, HEPATOLOGY, V39, P1663, DOI 10.1002/hep.20241; Kanvah S, 2010, ACCOUNTS CHEM RES, V43, P280, DOI 10.1021/ar900175a; Kondo S, 2000, CLIN CANCER RES, V6, P1394; Li DH, 2002, MUTAT RES-GEN TOX EN, V513, P37, DOI 10.1016/S1383-5718(01)00291-1; LITTLE J, 2006, HUGENET HUGE REV HDB; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005; Miyanishi K, 2011, GASTROENTEROLOGY, V140, pS971; Park YJ, 2001, EUR J CANCER, V37, P340, DOI 10.1016/S0959-8049(00)00388-9; Peng T, 2003, WORLD J GASTROENTERO, V9, P2186; Romilda C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-177; Sakamoto T, 2006, J EPIDEMIOL, V16, P233, DOI 10.2188/jea.16.233; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tang YunTian, 2011, Shandong Medical Journal, V51, P19; Tarng DC, 2001, J AM SOC NEPHROL, V12, P2338, DOI 10.1681/ASN.V12112338; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Weiss JM, 2005, MOL CARCINOGEN, V42, P127, DOI 10.1002/mc.20067; Yamane A, 2004, CARCINOGENESIS, V25, P1689, DOI 10.1093/carcin/bgh166; Yu Y, 2012, MOL BIOL REP, V39, P8457, DOI 10.1007/s11033-012-1699-4; Yuan T, 2012, DIGEST DIS SCI, V57, P2451, DOI 10.1007/s10620-012-2192-6; Zhang H, 2006, WORLD CHINESE J DIGE, V14, P2311; Zhu Z, 2004, THESIS 2 MILITARY ME	39	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60178	10.1371/journal.pone.0060178	http://dx.doi.org/10.1371/journal.pone.0060178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577090	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800032
J	Corey, EA; Bobkov, Y; Ukhanov, K; Ache, BW				Corey, Elizabeth A.; Bobkov, Yuriy; Ukhanov, Kirill; Ache, Barry W.			Ionotropic Crustacean Olfactory Receptors	PLOS ONE			English	Article							PHOSPHOLIPASE C-BETA; ODORANT RECEPTORS; AMILORIDE DERIVATIVES; CYCLIC-NUCLEOTIDE; SPINY LOBSTER; NEURONS; MECHANISMS; EXPRESSION; RESPONSES; MIXTURES	The nature of the olfactory receptor in crustaceans, a major group of arthropods, has remained elusive. We report that spiny lobsters, Panulirus argus, express ionotropic receptors (IRs), the insect chemosensory variants of ionotropic glutamate receptors. Unlike insects IRs, which are expressed in a specific subset of olfactory cells, two lobster IR subunits are expressed in most, if not all, lobster olfactory receptor neurons (ORNs), as confirmed by antibody labeling and in situ hybridization. Ligand-specific ORN responses visualized by calcium imaging are consistent with a restricted expression pattern found for other potential subunits, suggesting that cell-specific expression of uncommon IR subunits determines the ligand sensitivity of individual cells. IRs are the only type of olfactory receptor that we have detected in spiny lobster olfactory tissue, suggesting that they likely mediate olfactory signaling. Given long-standing evidence for G protein-mediated signaling in activation of lobster ORNs, this finding raises the interesting specter that IRs act in concert with second messenger-mediated signaling.	[Corey, Elizabeth A.; Bobkov, Yuriy; Ukhanov, Kirill; Ache, Barry W.] Univ Florida, Whitney Lab, Ctr Smell & Taste, Gainesville, FL 32610 USA; [Corey, Elizabeth A.; Bobkov, Yuriy; Ukhanov, Kirill; Ache, Barry W.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Ache, Barry W.] Univ Florida, Dept Biol, Gainesville, FL USA; [Ache, Barry W.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Corey, EA (corresponding author), Univ Florida, Whitney Lab, Ctr Smell & Taste, Gainesville, FL 32610 USA.	eacorey@whitney.ufl.edu			National Institutes of Health [R01 DC001655, F32 DC009730]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001655, F32DC009730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by National Institutes of Health (http://www.nidcd.nih.gov) Awards R01 DC001655 to B.W.A. and F32 DC009730 to E.A.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bobkov YV, 2007, CHEM SENSES, V32, P149, DOI 10.1093/chemse/bjl041; Bobkov Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034843; BOEKHOFF I, 1994, J NEUROSCI, V14, P3304; Bonfardin VDJ, 2010, J NEUROSCI, V30, P985, DOI 10.1523/JNEUROSCI.3389-09.2010; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Carr WES, 1996, BIOL BULL, V190, P149, DOI 10.2307/1542535; Colbourne JK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-45; Corey EA, 2010, J NEUROCHEM, V113, P341, DOI 10.1111/j.1471-4159.2010.06597.x; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605; FADOOL DA, 1995, CHEM SENSES, V20, P489, DOI 10.1093/chemse/20.5.489; Gentilcore LR, 1998, CHEM SENSES, V23, P269, DOI 10.1093/chemse/23.3.269; GIRARDOT MN, 1990, BRAIN RES, V513, P225, DOI 10.1016/0006-8993(90)90460-S; Gisselmann G, 2005, EUR J NEUROSCI, V21, P1635, DOI 10.1111/j.1460-9568.2005.03992.x; HATT H, 1994, P NATL ACAD SCI USA, V91, P6264, DOI 10.1073/pnas.91.14.6264; Hollins B, 2003, J COMP NEUROL, V455, P125, DOI 10.1002/cne.10489; Kain P, 2008, J NEUROSCI, V28, P4745, DOI 10.1523/JNEUROSCI.5306-07.2008; Kain P, 2009, J NEUROGENET, V23, P303, DOI 10.1080/01677060802372494; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Louhivuori LM, 2010, CELL CALCIUM, V48, P114, DOI 10.1016/j.ceca.2010.07.005; McClintock TS, 2006, INTEGR COMP BIOL, V46, P940, DOI 10.1093/icb/icj050; MCCLINTOCK TS, 1989, P NATL ACAD SCI USA, V86, P8137, DOI 10.1073/pnas.86.20.8137; MICHEL WC, 1992, J NEUROSCI, V12, P3979; MICHEL WC, 1993, J COMP PHYSIOL A, V171, P705, DOI 10.1007/BF00213067; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Pask GM, 2013, CHEM SENSES, V38, P221, DOI 10.1093/chemse/bjs100; Penalva-Arana DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-79; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rodriguez-Moreno A, 2007, J NEUROCHEM, V103, P2121, DOI 10.1111/j.1471-4159.2007.04924.x; Rollecke K, 2013, CHEM SENSES, V38, P231, DOI 10.1093/chemse/bjs140; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; Stepanyan R, 2006, PHYSIOL GENOMICS, V25, P224, DOI 10.1152/physiolgenomics.00276.2005; Stepanyan R, 2004, CHEM SENSES, V29, P179, DOI 10.1093/chemse/bjh023; Steullet P, 2000, J COMP NEUROL, V418, P270; Sung DY, 1996, COMP BIOCHEM PHYS B, V115, P19, DOI 10.1016/0305-0491(96)00083-1; Tadesse T, 2011, DEV NEUROBIOL, V71, P316, DOI 10.1002/dneu.20862; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Traynelis SF, 2011, PHARMACOL REV, V62, P405; Ukhanov K, 2011, CELL CALCIUM, V49, P100, DOI 10.1016/j.ceca.2010.10.009; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xu FQ, 1998, J NEUROBIOL, V36, P525, DOI 10.1002/(SICI)1097-4695(19980915)36:4<525::AID-NEU6>3.0.CO;2-Y; Xu FQ, 1999, J NEUROSCI, V19, P4881; Zhainazarov AB, 1997, J NEUROPHYSIOL, V77, P2235, DOI 10.1152/jn.1997.77.5.2235	51	41	41	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60551	10.1371/journal.pone.0060551	http://dx.doi.org/10.1371/journal.pone.0060551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573266	gold, Green Submitted, Green Published			2022-12-27	WOS:000318840100084
J	Hassali, MA; Yahaya, AHM; Shafie, AA; Saleem, F; Chua, GN; Aljadhey, H				Hassali, Mohamed Azmi; Yahaya, Abdul Haniff Mohamad; Shafie, Asrul Akmal; Saleem, Fahad; Chua, Gin Nie; Aljadhey, Hisham			Patterns and Predictors of Non-Prescription Medicine Use among Malaysian Pharmacy Patrons: A National Cross Sectional Study	PLOS ONE			English	Article							DRUGS; RISK; OLD	Objective: The study aims to evaluate the predictors of non-prescription medicine purchasing patterns among pharmacy patrons in Malaysia. Methods: A cross-sectional nationwide study was undertaken in 2011 in sixty randomly selected community pharmacies across 14 Malaysian states. A pharmacy exit survey was conducted over a 6-month period across Malaysia. A one-stage random cluster sampling technique was employed as there was no national sampling framework available for conducting this survey. Face-to-face interviews using a validated and pre-tested questionnaire were conducted by trained data collectors. The non-prescription medicine purchasing pattern was explored and analysed descriptively. Chi-square/Fisher exact test was used to determine the association between study variables. Multinomial logistic regression analysis was used to determine the predictors of type of non-prescription medicine purchased. Results: A total of 2729 pharmacy patrons agreed to participate in 60 selected pharmacy outlets. A total of 3462 non-prescription medicine were purchased during the study period with an average of 1.3 medicines per participant. Most of the non-prescription medicine purchased was meant for alimentary tract and metabolism (31.8%), followed by respiratory system (19.4%) and musculoskeletal system (15.8%) usage. Factors found to be associated with the choice of non-prescription medicine purchased were age group [chi 2 = 170.75, (df = 57), p < 0.01], locality [chi 2 = 48.16, (df = 19), p<0.01], gender [chi 2 = 32.93, (df = 13), p = 0.002], ethnic group [chi 2 = 118.89, (df = 39), p<0.01] and type of occupation [chi 2 = 222.434, (df = 117), p<0.01]. Non-prescription medicine purchased defined about 20% of the variance in the combination of predictors such as locality, gender, age, ethnicity, type of occupation and household income. Conclusion: The predictors for selection of non-prescription medicine were locality (urban or rural), gender, age, ethnicity, type of occupation and household income per month. Future studies need to explore the safety and effectiveness of using these non-prescription medicines.	[Hassali, Mohamed Azmi; Yahaya, Abdul Haniff Mohamad; Shafie, Asrul Akmal; Saleem, Fahad; Chua, Gin Nie] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, George Town, Malaysia; [Saleem, Fahad] Univ Balochistan, Dept Pharm, Quetta, Pakistan; [Aljadhey, Hisham] King Saud Univ, Coll Pharm, Riyadh, Saudi Arabia	Universiti Sains Malaysia; University of Balochistan; King Saud University	Saleem, F (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, George Town, Malaysia.	fahaduob@gmail.com	Shafie, Asrul Akmal/F-7026-2010; Hassali, Azmi/D-3716-2014; Saleem, Fahad/D-8321-2014; Hassali, Mohamed Azmi/A-6895-2011	Shafie, Asrul Akmal/0000-0002-5629-9270; Hassali, Azmi/0000-0001-8269-885X; Saleem, Fahad/0000-0001-8100-8992; Hassali, Mohamed Azmi/0000-0001-9575-403X	Universiti Sains Malaysia through Universiti Research Grant	Universiti Sains Malaysia through Universiti Research Grant(Universiti Sains Malaysia)	The study was funded by the Universiti Sains Malaysia through Universiti Research Grant (COMPACT Study 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, AM J HEALTH-SYST PH, V54, P2664; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Benrimoj S, 1988, NONPRESCRIPTION MEDI; BOND C, 2001, PRIM CARE PHARM, V2, P5; Bradley C, 1996, BRIT MED J, V312, P835; Cabecas JM, 2006, ENTERPRISE WORK INNO, V2, P95; CARSON JL, 1987, ARCH INTERN MED, V147, P85, DOI 10.1001/archinte.147.1.85; Covington TR, 2006, AM J PHARM EDUC, V70, DOI 10.5688/aj7006137; Dharmender S, 2010, STAR; Emmerton L, 2011, J PHARM MARK MANAGE, V15, P97; Euromonitor International, 2007, OTC HEALTHC MAL; Hassali MA, 2012, DRUG INF J, V46, P723, DOI 10.1177/0092861512457777; Malinauskiene V, 2002, OCCUP ENVIRON MED, V59, P745, DOI 10.1136/oem.59.11.745; PERNEGER TV, 1994, NEW ENGL J MED, V331, P1675, DOI 10.1056/NEJM199412223312502; Porteous T, 2005, FAM PRACT, V22, P78, DOI 10.1093/fampra/cmh719; QUAH S R, 1985, SMJ Singapore Medical Journal, V26, P123; Raosoft, 2011, SAMPL SIZ CALC; Tsai AC, 2006, AUSTRALAS J AGEING, V25, P191, DOI 10.1111/j.1741-6612.2006.00183.x; World Health Organization, 2003, INV MENT HLTH, P1	19	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59231	10.1371/journal.pone.0059231	http://dx.doi.org/10.1371/journal.pone.0059231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573195	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100014
J	Ji, AX; Prive, GG				Ji, Alan X.; Prive, Gilbert G.			Crystal Structure of KLHL3 in Complex with Cullin3	PLOS ONE			English	Article							UBIQUITIN LIGASE; BTB DOMAIN; MOLECULAR-MECHANISMS; PROTEIN-STRUCTURE; HYPERTENSION; MUTATIONS; PATHWAY; ACTIVATION; EXPRESSION; INSIGHTS	KLHL3 is a BTB-BACK-Kelch family protein that serves as a substrate adapter in Cullin3 (Cul3) E3 ubiquitin ligase complexes. KLHL3 is highly expressed in distal nephron tubules where it is involved in the regulation of electrolyte homeostasis and blood pressure. Mutations in KLHL3 have been identified in patients with inherited hypertension disorders, and several of the disease-associated mutations are located in the presumed Cul3 binding region. Here, we report the crystal structure of a complex between the KLHL3 BTB-BACK domain dimer and two copies of an N terminal fragment of Cul3. We use isothermal titration calorimetry to directly demonstrate that several of the disease mutations in the KLHL3 BTB-BACK domains disrupt the association with Cul3. Both the BTB and BACK domains contribute to the Cul3 interaction surface, and an extended model of the dimeric CRL3 complex places the two E2 binding sites in a suprafacial arrangement with respect to the presumed substrate-binding sites.	[Ji, Alan X.; Prive, Gilbert G.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Prive, Gilbert G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Prive, Gilbert G.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Canc Res, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Prive, GG (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	prive@uhnres.utoronto.ca		Prive, Gilbert/0000-0002-0712-4319	Canadian Cancer Society; Cancer Research Society; Ontario Ministry of Health and Long Term Care (OMOHLTC); U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	Canadian Cancer Society(Canadian Cancer Society (CCS)); Cancer Research Society; Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported by the Canadian Cancer Society and the Cancer Research Society. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Wes Errington for reagents and helpful discussions. We thank the Advanced Photon Source at the Argonne National Laboratory for access to the SBC-CAT 19-ID synchrotron facilities. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Aikawa Y, 2012, J BIOL CHEM, V287, P32312, DOI 10.1074/jbc.M112.374322; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; [Anonymous], PYMOL MOL GRAPHICS S; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Canning P, 2013, J BIOL CHEM, DOI DOI 10.1074/JBC.M112.437996.AC-CESSED; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Dietmann S, 2001, NUCLEIC ACIDS RES, V29, P55, DOI 10.1093/nar/29.1.55; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Eggler AL, 2009, BIOCHEM J, V422, P171, DOI 10.1042/BJ20090471; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Fykerud TA, 2012, J CELL SCI, V125, P3966, DOI 10.1242/jcs.093500; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Guo J, 2012, J BIOL CHEM, V287, P33132, DOI 10.1074/jbc.M112.389643; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Higashimura Y, 2011, BIOCHEM BIOPH RES CO, V413, P201, DOI 10.1016/j.bbrc.2011.08.058; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hu CQ, 2011, CHEM RES TOXICOL, V24, P515, DOI 10.1021/tx100389r; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Ko B, 2010, AM J PHYSIOL-RENAL, V299, pF300, DOI 10.1152/ajprenal.00441.2009; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai F, 2000, GENOMICS, V66, P65, DOI 10.1006/geno.2000.6181; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mooij WTM, 2009, NUCLEIC ACIDS RES, V37, pW402, DOI 10.1093/nar/gkp256; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Rondou P, 2010, CELL SIGNAL, V22, P900, DOI 10.1016/j.cellsig.2010.01.014; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Schwarz LA, 2010, J NEUROSCI, V30, P16718, DOI 10.1523/JNEUROSCI.3686-10.2010; Stogios PJ, 2007, PROTEIN SCI, V16, P336, DOI 10.1110/ps.062660907; Stogios PJ, 2010, J MOL BIOL, V400, P983, DOI 10.1016/j.jmb.2010.05.028; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	61	50	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60445	10.1371/journal.pone.0060445	http://dx.doi.org/10.1371/journal.pone.0060445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573258	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100074
J	Morisco, F; Aprea, E; Lembo, V; Fogliano, V; Vitaglione, P; Mazzone, G; Cappellin, L; Gasperi, F; Masone, S; De Palma, GD; Marmo, R; Caporaso, N; Biasioli, F				Morisco, Filomena; Aprea, Eugenio; Lembo, Vincenzo; Fogliano, Vincenzo; Vitaglione, Paola; Mazzone, Giovanna; Cappellin, Luca; Gasperi, Flavia; Masone, Stefania; De Palma, Giovanni Domenico; Marmo, Riccardo; Caporaso, Nicola; Biasioli, Franco			Rapid "Breath-Print" of Liver Cirrhosis by Proton Transfer Reaction Time-of-Flight Mass Spectrometry. A Pilot Study	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; INSULIN-RESISTANCE; METABOLISM; LIMONENE; DISEASE; CANCER; TESTS; RATS; GC; MS	The aim of the present work was to test the potential of Proton Transfer Reaction Time-of-Flight Mass Spectrometry (PTR-ToF-MS) in the diagnosis of liver cirrhosis and the assessment of disease severity by direct analysis of exhaled breath. Twenty-six volunteers have been enrolled in this study: 12 patients (M/F 8/4, mean age 70.5 years, min-max 42-80 years) with liver cirrhosis of different etiologies and at different severity of disease and 14 healthy subjects (M/F 5/9, mean age 52.3 years, min-max 35-77 years). Real time breath analysis was performed on fasting subjects using a buffered end-tidal on-line sampler directly coupled to a PTR-ToF-MS. Twelve volatile organic compounds (VOCs) resulted significantly differently in cirrhotic patients (CP) compared to healthy controls (CTRL): four ketones (2-butanone, 2- or 3-pentanone, C8-ketone, C9-ketone), two terpenes (monoterpene, monoterpene related), four sulphur or nitrogen compounds (sulfoxide-compound, S-compound, NS-compound, N-compound) and two alcohols (heptadienol, methanol). Seven VOCs (2- butanone, C8-ketone, a monoterpene, 2,4-heptadienol and three compounds containing N, S or NS) resulted significantly differently in compensate cirrhotic patients (Child-Pugh A; CP-A) and decompensated cirrhotic subjects (Child-Pugh B+C; CP-B+C). ROC (Receiver Operating Characteristic) analysis was performed considering three contrast groups: CP vs CTRL, CP-A vs CTRL and CP-A vs CP-B+C. In these comparisons monoterpene and N-compound showed the best diagnostic performance. Conclusions: Breath analysis by PTR-ToF-MS was able to distinguish cirrhotic patients from healthy subjects and to discriminate those with well compensated liver disease from those at more advanced severity stage. A breath-print of liver cirrhosis was assessed for the first time.	[Morisco, Filomena; Lembo, Vincenzo; Mazzone, Giovanna; Masone, Stefania; De Palma, Giovanni Domenico; Caporaso, Nicola] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Morisco, Filomena; Fogliano, Vincenzo; Vitaglione, Paola] Univ Naples Federico II, Dept Agr, Naples, Italy; [Aprea, Eugenio; Cappellin, Luca; Gasperi, Flavia; Biasioli, Franco] IASMA Res & Innovat Ctr, Food Qual & Nutr Dept, S Michele Aa, Trento, Italy; [Marmo, Riccardo] Polla Hosp, Gastroenterol Unit, Salerno, Italy	University of Naples Federico II; University of Naples Federico II; Fondazione Edmund Mach	Morisco, F (corresponding author), Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy.	filomena.morisco@unina.it	Aprea, Eugenio/C-1218-2010; Gasperi, Flavia/AAD-3961-2022; Vitaglione, Paola/AAB-9196-2022; Gasperi, Flavia/B-8104-2011; biasioli, franco/AAM-4121-2021; Biasioli, Franco/AGZ-3915-2022; Cappellin, Luca/C-1955-2012; fogliano, vincenzo/A-1419-2009; De Palma, Giovanni D/G-6895-2012; Morisco, Filomena/AHI-0851-2022; fogliano, vincenzo/W-6885-2019; Vitaglione, Paola/B-2864-2010; Fogliano, Vincenzo/M-8166-2019; Biasioli, Franco/A-3278-2012	Aprea, Eugenio/0000-0003-3648-0459; Gasperi, Flavia/0000-0003-0055-9464; Vitaglione, Paola/0000-0002-6608-5209; Gasperi, Flavia/0000-0003-0055-9464; Biasioli, Franco/0000-0001-5715-9686; Cappellin, Luca/0000-0001-6740-3638; fogliano, vincenzo/0000-0001-8786-9355; fogliano, vincenzo/0000-0001-8786-9355; Vitaglione, Paola/0000-0002-6608-5209; Biasioli, Franco/0000-0001-5715-9686; De Palma, Giovanni Domenico/0000-0001-7474-7180	Autonomous Province of Trento (PAT-AP); FP7 ITN Project "PIMMS"	Autonomous Province of Trento (PAT-AP); FP7 ITN Project "PIMMS"	This work has been partly supported by Autonomous Province of Trento (PAT-AP 2011) and by FP7 ITN Project "PIMMS." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DF, 2013, BRIT J SURG, V100, P144, DOI 10.1002/bjs.8942; Aprea E, 2012, J MASS SPECTROM, V47, P1098, DOI 10.1002/jms.3009; Beauchamp J, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/4/046001; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Biasioli F, 2011, TRAC-TREND ANAL CHEM, V30, P1003, DOI 10.1016/j.trac.2011.04.005; Blake RS, 2009, CHEM REV, V109, P861, DOI 10.1021/cr800364q; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cappellin L, 2011, SENSOR ACTUAT B-CHEM, V155, P183, DOI 10.1016/j.snb.2010.11.044; Cappellin L, 2010, INT J MASS SPECTROM, V295, P43, DOI 10.1016/j.ijms.2010.06.023; CHEN S, 1970, J LAB CLIN MED, V75, P622; Corder G. W., 2009, NONPARAMETRIC STAT N, DOI DOI 10.1002/; CROWELL PL, 1994, CANCER CHEMOTH PHARM, V35, P31, DOI 10.1007/s002800050189; Di Francesco F, 2005, MICROCHEM J, V79, P405, DOI 10.1016/j.microc.2004.10.008; FRIEDMAN MI, 1994, DIGEST DIS SCI, V39, P1672, DOI 10.1007/BF02087774; Herbig J, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/2/027004; Herbig J, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037008; Ilan Y, 2007, ALIMENT PHARM THER, V26, P1293, DOI 10.1111/j.1365-2036.2007.03519.x; Jordan A, 2009, INT J MASS SPECTROM, V286, P122, DOI 10.1016/j.ijms.2009.07.005; Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169; Kostikas K, 2008, CLIN EXP ALLERGY, V38, P557, DOI 10.1111/j.1365-2222.2008.02940.x; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Libardoni M, 2006, J CHROMATOGR B, V842, P13, DOI 10.1016/j.jchromb.2006.05.008; Lindinger W, 1998, INT J MASS SPECTROM, V173, P191, DOI 10.1016/S0168-1176(97)00281-4; Lindinger W, 1997, ALCOHOL CLIN EXP RES, V21, P939; Mathews JM, 1997, TOXICOL APPL PHARM, V146, P255, DOI 10.1006/taap.1997.8257; Miekisch W, 2004, CLIN CHIM ACTA, V347, P25, DOI 10.1016/j.cccn.2004.04.023; Miekisch W, 2006, TRAC-TREND ANAL CHEM, V25, P665, DOI 10.1016/j.trac.2006.05.006; Miyazawa M, 2002, DRUG METAB DISPOS, V30, P602, DOI 10.1124/dmd.30.5.602; Muller M, 2011, INT J MASS SPECTROM, V306, P1, DOI 10.1016/j.ijms.2011.04.007; Romagnuolo J, 2002, AM J GASTROENTEROL, V97, P1113, DOI 10.1111/j.1572-0241.2002.05664.x; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Schwarz K, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/2/027002; Shan WF, 2011, J ZHEJIANG UNIV-SC B, V12, P677, DOI 10.1631/jzus.B1100001; TANGERMAN A, 1994, LANCET, V343, P483, DOI 10.1016/S0140-6736(94)92729-4; Van den Velde S, 2008, J CHROMATOGR B, V875, P344, DOI 10.1016/j.jchromb.2008.08.031; Zhang W, 2010, EUR J GASTROEN HEPAT, V22, P1481, DOI 10.1097/MEG.0b013e32833eb8b0	36	53	53	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59658	10.1371/journal.pone.0059658	http://dx.doi.org/10.1371/journal.pone.0059658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573204	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100023
J	Wathlet, S; Adriaenssens, T; Segers, I; Verheyen, G; Van Landuyt, L; Coucke, W; Devroey, P; Smitz, J				Wathlet, Sandra; Adriaenssens, Tom; Segers, Ingrid; Verheyen, Greta; Van Landuyt, Lisbet; Coucke, Wim; Devroey, Paul; Smitz, Johan			Pregnancy Prediction in Single Embryo Transfer Cycles after ICSI Using QPCR: Validation in Oocytes from the Same Cohort	PLOS ONE			English	Article							HUMAN CUMULUS CELLS; GROWTH-FACTOR-BETA; GENE-EXPRESSION; IN-VITRO; OXIDATIVE STRESS; IDENTIFICATION; FERTILIZATION; PROGESTERONE; COMPETENCE; QUALITY	Cumulus cell (CC) gene expression is being explored as an additional method to morphological scoring to choose the embryo with the highest chance to pregnancy. In 47 ICSI patients with single embryo transfer (SET), from which individual CC samples had been stored, 12 genes using QPCR were retrospectively analyzed. The CC samples were at the same occasion also used to validate a previously obtained pregnancy prediction model comprising three genes (ephrin-B2 (EFNB2), calcium/calmodulin-dependent protein kinase ID, stanniocalcin 1). Latter validation yielded a correct pregnant/non-pregnant classification in 72% of the samples. Subsequently, 9 new genes were analyzed on the same samples and new prediction models were built. Out of the 12 genes analyzed a combination of the best predictive genes was obtained by stepwise multiple regression. One model retained EFNB2 in combination with glutathione S-transferase alpha 3 and 4, progesterone receptor and glutathione peroxidase 3, resulting in 93% correct predictions when 3 patient and treatment cycle characteristics were included into the model. This large patient group allowed to do an intra-patient analysis for 7 patients, an analysis mimicking the methodology that would ultimately be used in clinical routine. CC related to a SET that did not give pregnancy and CC related to their subsequent frozen/thawed embryos which ended in pregnancy were analyzed. The models obtained in the between-patient analysis were used to rank the oocytes within-patients for their chance to pregnancy and resulted in 86% of correct predictions. In conclusion, prediction models built on selected quantified transcripts in CC might help in the decision making process which is currently only based on subjective embryo morphology scoring. The validity of our current models for routine application still need prospective assessment in a larger and more diverse patient population allowing intra-patient analysis.	[Wathlet, Sandra; Adriaenssens, Tom; Segers, Ingrid; Smitz, Johan] UZ Brussel, Follicle Biol Lab, Brussels, Belgium; [Verheyen, Greta; Van Landuyt, Lisbet; Devroey, Paul] UZ Brussel, Ctr Reprod Med, Brussels, Belgium; [Coucke, Wim] Sci Inst Publ Hlth, Dept Biol Clin, Brussels, Belgium	University Hospital Brussels; University Hospital Brussels; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Wathlet, S (corresponding author), UZ Brussel, Follicle Biol Lab, Brussels, Belgium.	swathlet@vub.ac.be	Coucke, Wim/ABA-9949-2020	Coucke, Wim/0000-0002-4290-4628; Verheyen, Greta/0000-0003-4677-2084; Smitz, Johan/0000-0002-5857-6542; Adriaenssens, Tom/0000-0001-9618-0330; Segers, Ingrid/0000-0002-3391-2669	Agency for Innovation by Science and Technology in Flanders [IWT 070719, 071439]; Research Foundation Flanders (FWO) [KN 1.5.040.09]	Agency for Innovation by Science and Technology in Flanders; Research Foundation Flanders (FWO)(FWO)	This research has been supported by funds from the Agency for Innovation by Science and Technology in Flanders (IWT 070719 and 071439) www.iwt.be and the Research Foundation Flanders (FWO nr KN 1.5.040.09) www.fwo.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 1997, INT J BIOCHEM CELL B, V29, P861, DOI 10.1016/S1357-2725(96)00171-9; Adriaenssens T, 2010, HUM REPROD, V25, P1259, DOI 10.1093/humrep/deq049; Adriaenssens T, 2009, BIOL REPROD, V80, P1015, DOI 10.1095/biolreprod.107.067462; Anderson RA, 2009, REPRODUCTION, V138, P629, DOI 10.1530/REP-09-0144; Assidi M, 2011, J ASSIST REPROD GEN, V28, P173, DOI 10.1007/s10815-010-9491-7; Assou S, 2008, MOL HUM REPROD, V14, P711, DOI 10.1093/molehr/gan067; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Cillo F, 2007, REPRODUCTION, V134, P645, DOI 10.1530/REP-07-0182; Egawa M, 2003, J CLIN ENDOCR METAB, V88, P4384, DOI 10.1210/jc.2002-021910; Feuerstein P, 2007, HUM REPROD, V22, P3069, DOI 10.1093/humrep/dem336; Fragouli E, 2012, HUM REPROD; Gebhardt KM, 2011, FERTIL STERIL, V96, P47, DOI 10.1016/j.fertnstert.2011.04.033; Govinden R, 2003, PHARMACOL THERAPEUT, V98, P257, DOI 10.1016/S0163-7258(03)00035-4; Grondahl ML, 2009, FERTIL STERIL, V91, P1820, DOI 10.1016/j.fertnstert.2008.02.137; Hamel M, 2010, MOL HUM REPROD, V16, P548, DOI 10.1093/molehr/gaq051; Hasegawa J, 2005, HUM REPROD, V20, P2194, DOI 10.1093/humrep/dei005; Hayashi H, 2012, HEPATOLOGY, V55, P1562, DOI 10.1002/hep.24800; Huang ZW, 2010, MOL HUM REPROD, V16, P715, DOI 10.1093/molehr/gaq031; Lee MS, 2010, J ASSIST REPROD GEN, V27, P629, DOI 10.1007/s10815-010-9459-7; Liu XW, 1999, ENDOCRINOLOGY, V140, P2480, DOI 10.1210/en.140.6.2480; Luo CW, 2005, ENDOCRINOLOGY, V146, P469, DOI 10.1210/en.2004-1197; Luo CW, 2004, MOL ENDOCRINOL, V18, P2085, DOI 10.1210/me.2004-0066; Makrigiannakis A, 2000, ANN NY ACAD SCI, V900, P16; McKenzie LJ, 2004, HUM REPROD, V19, P2869, DOI 10.1093/humrep/deh535; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Ouandaogo ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027179; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Raffalli-Mathieu F, 2008, BIOCHEM J, V414, P103, DOI 10.1042/BJ20080397; Tatemoto H, 2000, BIOL REPROD, V63, P805, DOI 10.1095/biolreprod63.3.805; Van Landuyt L, 2005, FERTIL STERIL, V83, P1397, DOI 10.1016/j.fertnstert.2004.10.054; Van Landuyt L, 2011, HUM REPROD, V26, P316, DOI 10.1093/humrep/deq338; van Montfoort APA, 2008, MOL HUM REPROD, V14, P157, DOI 10.1093/molehr/gam088; Verploegen S, 2000, BLOOD, V96, P3215; Wathlet S, 2011, HUM REPROD, V26, P1035, DOI 10.1093/humrep/der036; Wathlet S, 2012, FERTIL STERIL; Zhang XQ, 2005, FERTIL STERIL, V83, P1169, DOI 10.1016/j.fertnstert.2004.11.030	37	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e54226	10.1371/journal.pone.0054226	http://dx.doi.org/10.1371/journal.pone.0054226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573182	Green Submitted, gold, Green Published			2022-12-27	WOS:000318840100001
J	Alen, F; Crespo, I; Ramirez-Lopez, MT; Jagerovic, N; Goya, P; de Fonseca, FR; de Heras, RG; Orio, L				Alen, Francisco; Crespo, Inmaculada; Teresa Ramirez-Lopez, Maria; Jagerovic, Nadine; Goya, Pilar; Rodriguez de Fonseca, Fernando; Gomez de Heras, Raquel; Orio, Laura			Ghrelin-Induced Orexigenic Effect in Rats Depends on the Metabolic Status and Is Counteracted by Peripheral CB1 Receptor Antagonism	PLOS ONE			English	Article							HORMONE SECRETAGOGUE RECEPTOR; CANNABINOID CB1; ENDOCANNABINOID SYSTEM; PLASMA GHRELIN; FOOD-INTAKE; RIMONABANT; BRAIN; STOMACH; RNA; LOCALIZATION	Ghrelin is an endogenous regulator of energy homeostasis synthesized by the stomach to stimulate appetite and positive energy balance. Similarly, the endocannabinoid system is part of our internal machinery controlling food intake and energy expenditure. Both peripheral and central mechanisms regulate CB1-mediated control of food intake and a functional relationship between hypothalamic ghrelin and cannabinoid CB1 receptor has been proposed. First of all, we investigated brain ghrelin actions on food intake in rats with different metabolic status (negative or equilibrate energy balance). Secondly, we tested a sub-anxiogenic ultra-low dose of the CB1 antagonist SR141716A (Rimonabant) and the peripheral-acting CB1 antagonist LH-21 on ghrelin orexigenic actions. We found that: 1) central administration of ghrelin promotes food intake in free feeding animals but not in 24 h food-deprived or chronically food-restricted animals; 2) an ultra-low dose of SR141716A (a subthreshold dose 75 folds lower than the EC50 for induction of anxiety) completely counteracts the orexigenic actions of central ghrelin in free feeding animals; 3) the peripheral-restricted CB1 antagonist LH-21 blocks ghrelin-induced hyperphagia in free feeding animals. Our study highlights the importance of the animals metabolic status for the effectiveness of ghrelin in promoting feeding, and suggests that the peripheral endocannabinoid system may interact with ghrelins signal in the control of food intake under equilibrate energy balance conditions.	[Alen, Francisco; Crespo, Inmaculada; Teresa Ramirez-Lopez, Maria; Rodriguez de Fonseca, Fernando; Gomez de Heras, Raquel; Orio, Laura] Univ Complutense Madrid, Dept Psicobiol, Fac Psicol, E-28040 Madrid, Spain; [Jagerovic, Nadine; Goya, Pilar] Ctr Super Invest Cient, Inst Quim Med, Madrid, Spain; [Rodriguez de Fonseca, Fernando] Fdn Publ Andaluza Invest Malaga Biomed & Salud FI, Hosp Carlos Haya, Malaga, Spain; [Rodriguez de Fonseca, Fernando] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Inst Salud Carlos III, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); Hospital Carlos Haya; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	de Fonseca, FR (corresponding author), Univ Complutense Madrid, Dept Psicobiol, Fac Psicol, E-28040 Madrid, Spain.	fernando.rodriguez@fundacionimabis.org; lorio@psi.ucm.es	Goya, Pilar/I-3243-2015; Crespo, Inmaculada/AAB-5451-2019; Orio, Laura/F-4827-2016; Alen, Francisco/I-3890-2017; Ramírez-López, María Teresa/AAB-5705-2021; de Heras, Raquel Gomez/F-3484-2016	Crespo, Inmaculada/0000-0003-3086-9762; Orio, Laura/0000-0002-9614-4062; Alen, Francisco/0000-0002-3847-3503; Ramírez-López, María Teresa/0000-0002-3944-5264; de Heras, Raquel Gomez/0000-0002-5846-1059; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795; Jagerovic, Nadine/0000-0003-2642-6969	European Union [Health-F2-2008-223713]; Spanish Ministry of Science and Innovation [SAF2010-20521]; National Institute of Health National Institute of Health 'CarlosIII' [PI07/1226]; Red de Trastornos Adictivos EU-ERDF [RD06/0001/0000]; CIBERobn EU-ERDF [CB06/03/1008]; grant EU-ERDF PAIDI [CTS-433]; Andalusian Ministry of Economy, Science and Innovation [PI45403]; Spanish Ministry of Education [PR 28/11-18295]; Fundacion Eugenio Rodriguez Pascual	European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institute of Health National Institute of Health 'CarlosIII'; Red de Trastornos Adictivos EU-ERDF; CIBERobn EU-ERDF; grant EU-ERDF PAIDI; Andalusian Ministry of Economy, Science and Innovation; Spanish Ministry of Education(Spanish Government); Fundacion Eugenio Rodriguez Pascual	The present work has been supported by grants from the European Union 7th Framework Programme (Health-F2-2008-223713, REPROBESITY); the following grants from the Spanish Ministry of Science and Innovation: fundamental research project (SAF2010-20521), National Institute of Health National Institute of Health 'CarlosIII' (PI07/1226), Red de Trastornos Adictivos EU-ERDF (RD06/0001/0000), and CIBERobn EU-ERDF(CB06/03/1008); grant EU-ERDF PAIDI CTS-433 and grant PI45403 from the Andalusian Ministry of Economy, Science and Innovation; grant PR 28/11-18295 from Spanish Ministry of Education and grant from the Fundacion Eugenio Rodriguez Pascual. MTRL is a recipient of a FPU fellowship from the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Massadi O, 2010, J NEUROENDOCRINOL, V22, P1127, DOI 10.1111/j.1365-2826.2010.02065.x; Alonso M, 2012, BRIT J PHARMACOL, V165, P2274, DOI 10.1111/j.1476-5381.2011.01698.x; Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Bermudez-Silva FJ, 2008, DIABETOLOGIA, V51, P476, DOI 10.1007/s00125-007-0890-y; Bermudez-Silva FJ, 2010, PHARMACOL BIOCHEM BE, V95, P375, DOI 10.1016/j.pbb.2010.03.012; Breivogel CS, 1998, NEUROBIOL DIS, V5, P417, DOI 10.1006/nbdi.1998.0229; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Burdyga G, 2006, AM J PHYSIOL-GASTR L, V290, pG1289, DOI 10.1152/ajpgi.00543.2005; Cani PD, 2004, BRIT J NUTR, V92, P757, DOI 10.1079/BJN20041256; Cota D, 2007, DIABETES-METAB RES, V23, P507, DOI 10.1002/dmrr.764; Crespo I, 2008, NEUROPHARMACOLOGY, V54, P219, DOI 10.1016/j.neuropharm.2007.05.027; Cummings DE, 2004, AM J PHYSIOL-ENDOC M, V287, pE297, DOI 10.1152/ajpendo.00582.2003; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Date Y, 2005, ENDOCRINOLOGY, V146, P3518, DOI 10.1210/en.2004-1240; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Di Marzo V, 2009, NAT REV ENDOCRINOL, V5, P633, DOI 10.1038/nrendo.2009.197; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Gomez R, 2002, J NEUROSCI, V22, P9612; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hernandez-Folgado L, 2008, BIOORG MED CHEM LETT, V18, P2977, DOI 10.1016/j.bmcl.2008.03.060; Hilairet S, 2003, J BIOL CHEM, V278, P23731, DOI 10.1074/jbc.M212369200; Hojo M, 2008, J PHARMACOL SCI, V108, P308, DOI 10.1254/jphs.08244FP; Hornby PJ, 2004, BRIT J PHARMACOL, V141, P1335, DOI 10.1038/sj.bjp.0705783; Bermudez-Silva FJ, 2012, J PSYCHOPHARMACOL, V26, P114, DOI 10.1177/0269881111408458; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Kirkham TC, 2001, PSYCHOPHARMACOLOGY, V153, P267, DOI 10.1007/s002130000596; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Kola B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001797; Kunos G, 2011, BRIT J PHARMACOL, V163, P1423, DOI 10.1111/j.1476-5381.2011.01352.x; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Madsen AN, 2009, NEUROSCI LETT, V449, P20, DOI 10.1016/j.neulet.2008.10.001; Matias I, 2008, NEUROPHARMACOLOGY, V54, P206, DOI 10.1016/j.neuropharm.2007.06.011; MERCHENTHALER I, 1991, NEUROSCIENCE, V44, P655, DOI 10.1016/0306-4522(91)90085-3; Mondal MS, 2005, REGUL PEPTIDES, V126, P55, DOI 10.1016/j.regpep.2004.08.038; Moreira FA, 2009, REV BRAS PSIQUIATR, V31, P145, DOI 10.1590/S1516-44462009000200012; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Navarro M, 1997, NEUROREPORT, V8, P491, DOI 10.1097/00001756-199701200-00023; Navarro M, 2001, J NEUROSCI, V21, P5344, DOI 10.1523/JNEUROSCI.21-14-05344.2001; Orio L, 2011, PHARMACOL BIOCHEM BE, V98, P220, DOI 10.1016/j.pbb.2010.12.007; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Pavon FJ, 2008, J NEUROENDOCRINOL, V20, P116, DOI 10.1111/j.1365-2826.2008.01693.x; Pavon FJ, 2006, NEUROPHARMACOLOGY, V51, P358, DOI 10.1016/j.neuropharm.2006.03.029; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Popovic V, 2003, J CLIN ENDOCR METAB, V88, P3450, DOI 10.1210/jc.2003-030211; Przybyla JA, 2010, J PHARMACOL EXP THER, V332, P710, DOI 10.1124/jpet.109.162701; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Sakata I, 2002, PEPTIDES, V23, P531, DOI 10.1016/S0196-9781(01)00633-7; Schellekens H, 2013, J BIOL CHEM, V288, P181, DOI 10.1074/jbc.M112.382473; Shiiya T, 2002, J CLIN ENDOCR METAB, V87, P240, DOI 10.1210/jc.87.1.240; SIM LJ, 1995, P NATL ACAD SCI USA, V92, P7242, DOI 10.1073/pnas.92.16.7242; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Tucci SA, 2004, BRIT J PHARMACOL, V143, P520, DOI 10.1038/sj.bjp.0705968; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; van Thuijl H, 2008, VITAM HORM, V77, P121, DOI 10.1016/S0083-6729(06)77006-6; Verty ANA, 2004, NEUROPHARMACOLOGY, V47, P593, DOI 10.1016/j.neuropharm.2004.06.002; Verty ANA, 2004, ENDOCRINOLOGY, V145, P3224, DOI 10.1210/en.2004-0059; Viveros M. P., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P220, DOI 10.2174/187153008785700082; Ward RJ, 2011, J BIOL CHEM, V286, P37414, DOI 10.1074/jbc.M111.287649	64	28	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60918	10.1371/journal.pone.0060918	http://dx.doi.org/10.1371/journal.pone.0060918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565287	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300160
J	Isik, G; van Montfort, T; Boot, M; Jimenez, VC; Kootstra, NA; Sanders, RW				Isik, Gozde; van Montfort, Thijs; Boot, Maikel; Jimenez, Viviana Cobos; Kootstra, Neeltje A.; Sanders, Rogier W.			Chimeric HIV-1 Envelope Glycoproteins with Potent Intrinsic Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Activity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; 2ND HYPERVARIABLE REGION; NEUTRALIZING ANTIBODIES; BIOLOGICAL-ACTIVITY; IMMUNE-RESPONSES; VACCINE EFFICACY; RECEPTOR-BINDING; PARTIAL DELETION; DENDRITIC CELLS; DISULFIDE BONDS	HIV-1 acquisition can be prevented by broadly neutralizing antibodies (BrNAbs) that target the envelope glycoprotein complex (Env). An ideal vaccine should therefore be able to induce BrNAbs that can provide immunity over a prolonged period of time, but the low intrinsic immunogenicity of HIV-1 Env makes the elicitation of such BrNAbs challenging. Costimulatory molecules can increase the immunogenicity of Env and we have engineered a soluble chimeric Env trimer with an embedded granulocyte-macrophage colony-stimulating factor (GM-CSF) domain. This chimeric molecule induced enhanced B and helper T cell responses in mice compared to Env without GM-CSF. We studied whether we could optimize the activity of the embedded GM-CSF as well as the antigenic structure of the Env component of the chimeric molecule. We assessed the effect of truncating GM-CSF, removing glycosylation-sites in GM-CSF, and adjusting the linker length between GM-CSF and Env. One of our designed Env(GM-CSF) chimeras improved GM-CSF-dependent cell proliferation by 6-fold, reaching the same activity as soluble recombinant GM-CSF. In addition, we incorporated GM-CSF into a cleavable Env trimer and found that insertion of GM-CSF did not compromise Env cleavage, while Env cleavage did not compromise GM-CSF activity. Importantly, these optimized EnvGM-CSF proteins were able to differentiate human monocytes into cells with a macrophage-like phenotype. Chimeric EnvGM-CSF should be useful for improving humoral immunity against HIV-1 and these studies should inform the design of other chimeric proteins.	[Isik, Gozde; van Montfort, Thijs; Boot, Maikel; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Jimenez, Viviana Cobos; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Expt Immunol,Sanquin Res,Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Med Microbiol,Lab Expt Virol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl		Kootstra, Neeltje A./0000-0001-9429-7754; Isik, Gozde/0000-0002-1329-6782	Aids Fonds Netherlands grants [2008013, 2009012]; Netherlands Organization for Scientific Research; European Research Council [ERC-StG-2011-280829-SHEV]; Academic Medical Center of the University of Amsterdam	Aids Fonds Netherlands grants; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); Academic Medical Center of the University of Amsterdam	This research was supported by the Aids Fonds Netherlands grants #2008013 and #2009012. RWS is a recipient of a Vidi fellowship from the Netherlands Organization for Scientific Research, and a Starting Investigator grant from the European Research Council (ERC-StG-2011-280829-SHEV). This work was also supported by the Academic Medical Center of the University of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee K, 2012, AIDS RES HUM RETROV, V28, P206, DOI 10.1089/aid.2011.0101; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bontjer I, 2010, J BIOL CHEM, V285, P36456, DOI 10.1074/jbc.M110.156588; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; CEBON J, 1990, J BIOL CHEM, V265, P4483; Chroneos Z, 1995, AM J PHYSIOL-LUNG C, V269, pL721, DOI 10.1152/ajplung.1995.269.6.L721; Chung NPY, 2012, J IMMUNOL, V189, P5257, DOI 10.4049/jimmunol.1201905; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; Cutalo JM, 2004, J AM SOC MASS SPECTR, V15, P1545, DOI 10.1016/j.jasms.2004.07.008; Denecker G, 1997, CYTOKINE, V9, P631, DOI 10.1006/cyto.1997.0218; Deresinski SC, 1999, AIDS, V13, P633, DOI 10.1097/00002030-199904160-00003; Dey AK, 2009, VIROLOGY, V385, P275, DOI 10.1016/j.virol.2008.12.009; Eggink D, 2011, RETROVIROLO IN PRESS; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Forno G, 2004, EUR J BIOCHEM, V271, P907, DOI 10.1111/j.1432-1033.2004.03993.x; Ghirelli C, 2010, BLOOD, V115, P5037, DOI 10.1182/blood-2010-01-266932; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Jimenez VC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00763; JUST U, 1993, GROWTH FACTORS, V9, P291, DOI 10.3109/08977199308991589; KLEIN B, 1982, EXP HEMATOL, V10, P373; Kumar R, 2011, VACCINE, V29, P9064, DOI 10.1016/j.vaccine.2011.09.057; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Lopez AF, 2010, IUBMB LIFE, V62, P509, DOI 10.1002/iub.350; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; McCormick AL, 2001, J INFECT DIS, V184, P1423, DOI 10.1086/324371; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Melchers M, 2012, J VIROL, V86, P2488, DOI 10.1128/JVI.06259-11; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MOONEN P, 1987, P NATL ACAD SCI USA, V84, P4428, DOI 10.1073/pnas.84.13.4428; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Nimal S, 2006, VACCINE, V24, P3298, DOI 10.1016/j.vaccine.2006.01.020; Nimal S, 2005, VACCINE, V23, P3984, DOI 10.1016/j.vaccine.2005.01.160; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Parren PWHI, 1997, CHEM IMMUNOL, V65, P18; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; SHANAFELT AB, 1989, P NATL ACAD SCI USA, V86, P4872, DOI 10.1073/pnas.86.13.4872; Si ZH, 2003, AIDS RES HUM RETROV, V19, P217, DOI 10.1089/088922203763315722; Srivastava IK, 2003, J VIROL, V77, P2310, DOI 10.1128/JVI.77.4.2310-2320.2003; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; van Anken E, 2008, MOL BIOL CELL, V19, P4298, DOI 10.1091/mbc.E07-12-1282; Van Montfort T, 2011, J BIOL CHEM, V286, P22250, DOI 10.1074/jbc.M111.229625; VONFELDT JM, 1992, DNA CELL BIOL, V11, P183, DOI 10.1089/dna.1992.11.183; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	62	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60126	10.1371/journal.pone.0060126	http://dx.doi.org/10.1371/journal.pone.0060126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565193	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300062
J	Michiels, B; Van Puyenbroeck, K; Verhoeven, V; Vermeire, E; Coenen, S				Michiels, Barbara; Van Puyenbroeck, Karolien; Verhoeven, Veronique; Vermeire, Etienne; Coenen, Samuel			The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews	PLOS ONE			English	Review							RESPIRATORY-TRACT COMPLICATIONS; INHALED ZANAMIVIR; OSELTAMIVIR TREATMENT; HEALTHY-ADULTS; DOUBLE-BLIND; TREATING INFLUENZA; ANTIVIRAL THERAPY; HIGH-RISK; B INFECTION; SAFETY	Controversy has arisen regarding the effectiveness of neuraminidase inhibitors (NIs), especially against influenza-related complications. A literature search was performed to critically assess the evidence collected by the available systematic reviews (SRs) regarding the benefits and disadvantages of NIs (oseltamivir, zanamivir) compared to placebos in healthy and at-risk individuals of all ages for prophylaxis and treatment of seasonal influenza. A SR was done using the Cochrane Database of Systematic Reviews, Health Technology Assessment Database, Database of Abstracts of Reviews of Effects, and Medline (January 2006-July 2012). Two reviewers selected SRs based on randomized clinical trials, which were restricted to intention-to-treat results, and they assessed review (AMSTAR) and study quality indicators (GRADE). The SRs included (N = 9) were of high quality. The efficacy of NIs in prophylaxis ranged from 64% (16-85) to 92% (37-99); the absolute risk reduction ranged from 1.2% to 12.1% (GRADE moderate to low). Clinically relevant treatment benefits of NIs were small in healthy adults and children suffering from influenza-like illness (GRADE high to moderate). Oseltamivir reduced antibiotic usage in healthy adults according to one SR, but this was not confirmed by other reviews (GRADE low). Zanamivir showed a preventive effect on antibiotic usage in children (95% (77-99); GRADE moderate) and on the occurrence of bronchitis in at-risk individuals (59% (30-76); GRADE moderate). No evidence was available on the treatment benefits of NIs in elderly and at-risk groups and their effects on hospitalization and mortality. In oseltamivir trials, nausea, vomiting and diarrhea were significant side-effects. For zanamivir trials, no adverse effects have been reported. The combination of diagnostic uncertainty, the risk for virus strain resistance, possible side effects and financial cost outweigh the small benefits of oseltamivir or zanamivir for the prophylaxis and treatment of healthy individuals. No relevant benefits of these NIs on complications in at-risk individuals have been established.	[Michiels, Barbara; Van Puyenbroeck, Karolien; Verhoeven, Veronique; Vermeire, Etienne; Coenen, Samuel] Univ Antwerp, Fac Med & Hlth Sci, Ctr Gen Practice, Dept Primary & Interdisciplinary Care Antwerp, B-2020 Antwerp, Belgium; [Vermeire, Etienne] Univ Antwerp, Fac Med & Hlth Sci, Ctr Res & Innovat Care, B-2020 Antwerp, Belgium; [Coenen, Samuel] Univ Antwerp, Fac Med & Hlth Sci, Lab Med Microbiol, Vaccine & Infect Dis Inst VAXINFECTIO, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	Michiels, B (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Ctr Gen Practice, Dept Primary & Interdisciplinary Care Antwerp, B-2020 Antwerp, Belgium.	barbara.michiels@ua.ac.be	Coenen, Samuel JA/A-6410-2011; Michiels, Barbara/J-4046-2016; Verhoeven, Veronique/B-5915-2017	Coenen, Samuel JA/0000-0002-1238-8052; Michiels, Barbara/0000-0001-6904-9919; Verhoeven, Veronique/0000-0002-3708-6501	governmental organization NIHDI (National Institute for Health and Disability Insurance) in Belgium	governmental organization NIHDI (National Institute for Health and Disability Insurance) in Belgium	This systematic literature search was funded by the governmental organization NIHDI (National Institute for Health and Disability Insurance) in Belgium. The sponsor played a role in the study design but had no influence on the collection, analysis, and interpretation of data, on the writing of the report or on the decision to submit the paper for publication. The researchers were independent from the funders.	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P1897, DOI 10.1093/jac/dkr190; Ambrozaitis Arvydas, 2005, J Am Med Dir Assoc, V6, P367, DOI 10.1016/j.jamda.2005.08.007; [Anonymous], 2012, MED LETT DRUGS THER, V54, P1; [Anonymous], 2009, MED LETT DRUGS THER, V51, P89; [Anonymous], 2006, REV MED LETT DRUGS T, V48, P87; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Bettis R, 2006, CLIN DRUG INVEST, V26, P329, DOI 10.2165/00044011-200626060-00004; Bijl D, 2011, Int J Risk Saf Med, V23, P65, DOI 10.3233/JRS-2011-0521; Boivin G, 2000, J INFECT DIS, V181, P1471, DOI 10.1086/315392; Burch J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13580; Burch J, 2009, LANCET INFECT DIS, V9, P537, DOI 10.1016/S1473-3099(09)70199-9; Chidiac Christian, 2008, Rev Prat, V58, P445; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Del Mar C, 2011, CLIN INFECT DIS, V53, P1302, DOI 10.1093/cid/cir706; Deng Wei-wu, 2004, Zhonghua Yi Xue Za Zhi, V84, P2132; Deonandan R, 2006, OSELTAMIVIR ZANAMIVI; Doshi P, 2011, COCHRANE DB SYST REV, P1; Doshi P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7898; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Dutkowski R, 2010, J ANTIMICROB CHEMOTH, V65, pII11, DOI 10.1093/jac/dkq012; Ebell MH, 2012, FAM PRACT; Excellence N.I.f.H.a.C., 2008, NICE TECHN APPR GUID; Falagas ME, 2010, J ANTIMICROB CHEMOTH, V65, P1330, DOI 10.1093/jac/dkq158; Ferraris O, 2010, Pathol Biol (Paris), V58, pe69, DOI 10.1016/j.patbio.2010.01.011; Freemantle N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5248; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Health Technology Assessment, 2010, HTA32010000424; Hedrick JA, 2000, PEDIATR INFECT DIS J, V19, P410, DOI 10.1097/00006454-200005000-00005; Heinonen S, 2010, CLIN INFECT DIS, V51, P887, DOI 10.1086/656408; Heneghan CJ, 2011, HTA32011001126 NIHR; Hernan MA, 2011, CLIN INFECT DIS, V53, P1303, DOI 10.1093/cid/cir717; Hernan MA, 2011, CLIN INFECT DIS, V53, P277, DOI 10.1093/cid/cir400; Higgins J., 2009, COCHRANE HDB SYSTEMA; Holzgrabe Ulrike, 2011, Pharm Unserer Zeit, V40, P151, DOI 10.1002/pauz.201100411; Jackson RJ, 2011, J INFECTION, V62, P14, DOI 10.1016/j.jinf.2010.10.003; Jamieson B, 2009, CAN FAM PHYSICIAN, V55, P1199; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub3; Jefferson T, 2010, HEALTH TECHNOL ASSES, V14, P355, DOI 10.3310/hta14460-05; Jefferson TO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub2; Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub3; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Johnston SL, 2005, PEDIATR INFECT DIS J, V24, P225, DOI 10.1097/01.inf.0000154322.38267.ce; Jones M, 2006, EXPERT OPIN DRUG SAF, V5, P603, DOI 10.1517/14740338.5.5.603; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Kaiser L, 2000, CLIN INFECT DIS, V30, P587, DOI 10.1086/313696; Kashiwagi S, 2000, Kansenshogaku Zasshi, V74, P1062; Kawai N, 2011, J INFECT CHEMOTHER, V17, P375, DOI 10.1007/s10156-010-0179-9; Khazeni N, 2009, ANN INTERN MED, V151, P464, DOI 10.7326/0003-4819-151-7-200910060-00143; Klebe Gerhard, 2011, Pharm Unserer Zeit, V40, P144, DOI 10.1002/pauz.201100410; LaForce C, 2007, CLIN THER, V29, P1579, DOI 10.1016/j.clinthera.2007.08.023; Lalezari J, 2001, ARCH INTERN MED, V161, P212, DOI 10.1001/archinte.161.2.212; Lee N, 2012, ANTIVIR THER, V17, P143, DOI 10.3851/IMP2059; Lee TW, 2010, COCHRANE DB SYST REV, V3; Lee VJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-76; Li LY, 2003, CHINESE MED J-PEKING, V116, P44; Lin Jiang-tao, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P455; Liu Guan J, 2010, COCHRANE DB SYST REV; Lynch JP, 2007, SEMIN RESP CRIT CARE, V28, P144, DOI 10.1055/s-2007-976487; Makela MJ, 2000, J INFECTION, V40, P42, DOI 10.1053/jinf.1999.0602; Mallia Patrick, 2007, Int J Chron Obstruct Pulmon Dis, V2, P55, DOI 10.2147/copd.2007.2.1.55; Martin C, 2001, INT CONGR SER, V1219, P807, DOI 10.1016/S0531-5131(01)00359-4; Matheson NJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002744.pub2; Matsumoto K, 1999, ANTIVIR THER, V4, P61; McCullers JA, 2011, ANTIVIR THER, V16, P123, DOI 10.3851/IMP1730; Michiels B, 2011, VACCINE, V29, P9159, DOI 10.1016/j.vaccine.2011.08.008; Michiels B, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-4; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Murphy KR, 2000, CLIN DRUG INVEST, V20, P337, DOI 10.2165/00044011-200020050-00005; Nayak JL, 2009, PEDIATR ANN, V38, P667, DOI 10.3928/00904481-20091117-07; NHG Standaard [Practice guideline], 2008, INFL INFL; NICE, 2009, HTA32011000098 NICE; NICE, 2008, HTA32011000382 NICE; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Nuesch R, 2007, Ther Umsch, V64, P635, DOI 10.1024/0040-5930.64.11.635; Oxford JS, 2007, INFLUENZA OTHER RESP, V1, P27, DOI 10.1111/j.1750-2659.2006.00006.x; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x; Preziosi P, 2011, EXPERT OPIN PHARMACO, V12, P1523, DOI 10.1517/14656566.2011.566557; Puhakka T, 2003, SCAND J INFECT DIS, V35, P52, DOI 10.1080/0036554021000026981; Rong Dong Bi, 2010, COCHRANE DB SYST REV; Ruf BR, 2008, DEUT MED WOCHENSCHR, V133, P1259, DOI 10.1055/s-2008-1077250; Ruf BR, 2009, INFECTION, V37, P186, DOI 10.1007/s15010-009-8241-1; Salzberger B, 2006, INTERNIST, V47, P1245, DOI 10.1007/s00108-006-1721-9; Schirmer P, 2009, EXPERT OPIN DRUG SAF, V8, P357, DOI [10.1517/14740330902840519, 10.1517/14740330902840519 ]; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; Silagy C, 1998, LANCET, V352, P1877, DOI 10.1016/S0140-6736(98)10190-3; Smith JR, 2011, ADV THER, V28, P927, DOI 10.1007/s12325-011-0072-7; Sugaya N, 2010, ANTIMICROB AGENTS CH, V54, P2575, DOI 10.1128/AAC.01755-09; Tambyah PA, 2008, RESPIROLOGY, V13, pS19, DOI 10.1111/j.1440-1843.2008.01249.x; Tan W, 2002, CLIN MED J CHINA, V9, P528; Tappenden P, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13110; Tappenden P, 2009, HTA32008100360; Thorlund K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-134; Toovey S, 2008, DRUG SAFETY, V31, P1097, DOI 10.2165/0002018-200831120-00006; Townsend KA, 2006, PHARMACOTHERAPY, V26, P95, DOI 10.1592/phco.2006.26.1.95; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Tullu MS, 2009, J POSTGRAD MED, V55, P225, DOI 10.4103/0022-3859.57411; Van de Vyver N, 2006, KCE REPORTS A, V49 A; Wang K, 2012, COCHRANE DATABASE SY, V2012; Webster A, 1999, CLIN PHARMACOKINET, V36, P51, DOI 10.2165/00003088-199936001-00006; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Wesseling Geertjan, 2007, Int J Chron Obstruct Pulmon Dis, V2, P5, DOI 10.2147/copd.2007.2.1.5; Whitley RJ, 2007, EXPERT OPIN DRUG MET, V3, P755, DOI 10.1517/17425255.3.5.755; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002	117	70	76	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60348	10.1371/journal.pone.0060348	http://dx.doi.org/10.1371/journal.pone.0060348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565231	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300101
J	Tian, YP; Chen, BZ; Guan, PF; Kang, YJ; Lu, ZX				Tian, Yingpu; Chen, Baozhen; Guan, Pengfei; Kang, Yujia; Lu, Zhongxian			A Prognosis Classifier for Breast Cancer Based on Conserved Gene Regulation between Mammary Gland Development and Tumorigenesis: A Multiscale Statistical Model	PLOS ONE			English	Article							EXPRESSION PATTERNS; EPITHELIAL-CELLS; MOLECULAR PORTRAITS; MICROARRAY ANALYSIS; GRADE INDEX; THERAPY; REVEALS; GROWTH; TUMORS; CHEMOTHERAPY	Identification of novel cancer genes for molecular therapy and diagnosis is a current focus of breast cancer research. Although a few small gene sets were identified as prognosis classifiers, more powerful models are still needed for the definition of effective gene sets for the diagnosis and treatment guidance in breast cancer. In the present study, we have developed a novel statistical approach for systematic analysis of intrinsic correlations of gene expression between development and tumorigenesis in mammary gland. Based on this analysis, we constructed a predictive model for prognosis in breast cancer that may be useful for therapy decisions. We first defined developmentally associated genes from a mouse mammary gland epithelial gene expression database. Then, we found that the cancer modulated genes were enriched in this developmentally associated genes list. Furthermore, the developmentally associated genes had a specific expression profile, which associated with the molecular characteristics and histological grade of the tumor. These result suggested that the processes of mammary gland development and tumorigenesis share gene regulatory mechanisms. Then, the list of regulatory genes both on the developmental and tumorigenesis process was defined an 835-member prognosis classifier, which showed an exciting ability to predict clinical outcome of three groups of breast cancer patients (the predictive accuracy 64 similar to 72%) with a robust prognosis prediction (hazard ratio 3.3 similar to 3.8, higher than that of other clinical risk factors (around 2.0-2.8)). In conclusion, our results identified the conserved molecular mechanisms between mammary gland development and neoplasia, and provided a unique potential model for mining unknown cancer genes and predicting the clinical status of breast tumors. These findings also suggested that developmental roles of genes may be important criteria for selecting genes for prognosis prediction in breast cancer.	[Lu, Zhongxian] Xiamen Univ, Xiamen City Key Lab Metab Dis, Xiamen, Fujian, Peoples R China; Xiamen Univ, Metab Dis Res Ctr, Inst Biomed Res, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Lu, ZX (corresponding author), Xiamen Univ, Xiamen City Key Lab Metab Dis, Xiamen, Fujian, Peoples R China.	zhongxian@xmu.edu.cn	Lu, ZX/G-4586-2010; Guan, Peng/GWM-9170-2022		National Basic Research Program of China [2010CB945004]; National Natural Science Foundation of China [30772546]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Basic Research Program of China Grants 2010CB945004, and National Natural Science Foundation of China Grants 30772546. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; Chang JC, 2005, BREAST CANCER RES, V7, P100, DOI 10.1186/bcr1018; Chengalvala MV, 2007, CURR GENOMICS, V8, P262; Chow M, 1999, IN VITRO CELL DEV-AN, V35, P449; Cianfrocca M, 2005, ONCOLOGIST, V10, P766, DOI 10.1634/theoncologist.10-10-766; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Coletta RD, 2004, J MAMMARY GLAND BIOL, V9, P39, DOI 10.1023/B:JOMG.0000023587.40966.f6; Colombo PE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2890; Coulouarn C, 2005, J HEPATOL, V42, P860, DOI 10.1016/j.jhep.2005.01.027; de Snoo F, 2009, SURG ONCOL, V18, P366, DOI 10.1016/j.suronc.2009.07.005; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Galanina N, 2011, CANCER J, V17, P96, DOI 10.1097/PPO.0b013e318212dee3; Gradishar WJ, 2005, BREAST CANCER RES TR, V89, pS17, DOI 10.1007/s10549-005-0144-y; Groner B, 2002, DOMEST ANIM ENDOCRIN, V23, P25, DOI 10.1016/S0739-7240(02)00142-X; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; Hu M, 2005, CANCER RES, V65, P8715, DOI 10.1158/0008-5472.CAN-05-0700; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Knauer M, 2010, BREAST CANCER RES TR, V120, P655, DOI 10.1007/s10549-010-0814-2; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Liedtke C, 2009, J CLIN ONCOL, V27, P3185, DOI 10.1200/JCO.2008.18.5934; Liu HY, 2006, PLOS MED, V3, P1090, DOI 10.1371/journal.pmed.0030232; Ma XJ, 2008, CLIN CANCER RES, V14, P2601, DOI 10.1158/1078-0432.CCR-07-5026; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Master SR, 2002, MOL ENDOCRINOL, V16, P1185, DOI 10.1210/me.16.6.1185; Misra J, 2002, GENOME RES, V12, P1112, DOI 10.1101/gr.225302; Moulder S, 2010, MOL CANCER THER, V9, P1120, DOI 10.1158/1535-7163.MCT-09-1117; NEEDHAM JOSEPH, 1936, PROC ROY SOC MED, V29, P1577; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Rahman KMW, 2002, J STEROID BIOCHEM, V80, P191, DOI 10.1016/S0960-0760(01)00186-8; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rosfjord EC, 1999, J MAMMARY GLAND BIOL, V4, P229, DOI 10.1023/A:1018789527533; Rudolph MC, 2003, J MAMMARY GLAND BIOL, V8, P287, DOI 10.1023/B:JOMG.0000010030.73983.57; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sommer S, 2001, SEMIN CANCER BIOL, V11, P339, DOI 10.1006/scbi.2001.0389; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Visvader JE, 2003, INT J BIOCHEM CELL B, V35, P1034, DOI 10.1016/S1357-2725(03)00030-X; Waddington CH, 1935, NATURE, V135, P606, DOI 10.1038/135606a0; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Witmer BS, 2008, CLIN CANCER RES, V14, P2988, DOI 10.1158/1078-0432.CCR-07-4723	50	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60131	10.1371/journal.pone.0060131	http://dx.doi.org/10.1371/journal.pone.0060131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565194	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300063
J	Zhang, CT				Zhang, Chun-Ting			The h '-Index, Effectively Improving the h-Index Based on the Citation Distribution	PLOS ONE			English	Article							HIRSCH-INDEX; VARIANTS; CORE	Background: Although being a simple and effective index that has been widely used to evaluate academic output of scientists, the h-index suffers from drawbacks. One critical disadvantage is that only h-squared citations can be inferred from the h-index, which completely ignores excess and h-tail citations, leading to unfair and inaccurate evaluations in many cases. Methodology/Principal Findings: To solve this problem, I propose the h'-index, in which h-squared, excess and h-tail citations are all considered. Based on the citation data of the 100 most prolific economists, comparing to h-index, the h'-index shows better correlation with indices of total-citation number and citations per publication, which, although relatively reliable and widely used, do not carry the information of the citation distribution. In contrast, the h'-index possesses the ability to discriminate the shapes of citation distributions, thus leading to more accurate evaluation. Conclusions/Significance: The h'-index improves the h-index, as well as indices of total-citation number and citations per publication, by possessing the ability to discriminate shapes of citation distribution, thus making the h'-index a better single-number index for evaluating scientific output in a way that is fairer and more reasonable.	Tianjin Univ, Dept Phys, Tianjin 300072, Peoples R China	Tianjin University	Zhang, CT (corresponding author), Tianjin Univ, Dept Phys, Tianjin 300072, Peoples R China.	ctzhang@tju.edu.cn						Abbas AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033699; [Anonymous], 2011, SCI WATCH; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P830, DOI 10.1002/asi.20806; Bornmann L, 2010, J INFORMETR, V4, P407, DOI 10.1016/j.joi.2010.03.005; Bornmann L, 2009, EMBO REP, V10, P2, DOI 10.1038/embor.2008.233; Burrell QL, 2007, J INFORMETR, V1, P170, DOI 10.1016/j.joi.2007.01.003; COLE S, 1967, AM SOCIOL REV, V32, P377, DOI 10.2307/2091085; Dodson MV, 2009, BIOCHEM BIOPH RES CO, V387, P625, DOI 10.1016/j.bbrc.2009.07.091; Egghe L, 2007, J AM SOC INF SCI TEC, V58, P452, DOI 10.1002/asi.20473; Egghe L, 2006, SCIENTOMETRICS, V69, P121, DOI 10.1007/s11192-006-0143-8; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Egghe L, 2010, ANNU REV INFORM SCI, V44, P65, DOI 10.1002/aris.2010.1440440109; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jin B., 2006, SCI FOCUS, V1, P8; Jin B., 2007, ISSI NEWSLETTER, V3, P6; Jin BH, 2007, CHINESE SCI BULL, V52, P855, DOI 10.1007/s11434-007-0145-9; Kosmulski M., 2006, ISSI NEWSLETTER, V2, P4; Liang LM, 2006, SCIENTOMETRICS, V69, P153, DOI 10.1007/s11192-006-0145-6; Rousseau R., 2006, SIMPLE MODELS CORRES; Rousseau R, 2008, J AM SOC INF SCI TEC, V59, P1853, DOI 10.1002/asi.20890; Rousseau R, 2013, J INFORMETR, V7, P294, DOI 10.1016/j.joi.2012.11.012; Ruane F, 2008, SCIENTOMETRICS, V75, P395, DOI 10.1007/s11192-007-1869-7; Schreiber M, 2012, J INFORMETR, V6, P347, DOI 10.1016/j.joi.2012.02.001; Schreiber M, 2007, ANN PHYS-BERLIN, V16, P640, DOI 10.1002/andp.200710252; Schubert A, 2007, J INFORMETR, V1, P179, DOI 10.1016/j.joi.2006.12.002; Tol RSJ, 2009, SCIENTOMETRICS, V80, P317, DOI 10.1007/s11192-008-2079-7; Van Raan AFJ, 2006, SCIENTOMETRICS, V67, P491, DOI 10.1556/Scient.67.2006.3.10; Ye FY, 2010, SCIENTOMETRICS, V84, P431, DOI 10.1007/s11192-009-0099-6; Zhang CT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01023; Zhang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005429; Zhang L, 2011, J INFORMETR, V5, P583, DOI 10.1016/j.joi.2011.05.004	31	136	139	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59912	10.1371/journal.pone.0059912	http://dx.doi.org/10.1371/journal.pone.0059912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565174	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300043
J	Barve, A; Ghaskadbi, S; Ghaskadbi, S				Barve, Apurva; Ghaskadbi, Saroj; Ghaskadbi, Surendra			Conservation of the Nucleotide Excision Repair Pathway: Characterization of Hydra Xeroderma Pigmentosum Group F Homolog	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO3A; INTERSTITIAL CELL LINEAGE; DNA-REPAIR; DEVELOPMENTAL MECHANISMS; GENETIC-ANALYSIS; REVEALS; RESTRICTION; SENESCENCE; EXPRESSION; ERCC1-XPF	Hydra, one of the earliest metazoans with tissue grade organization and nervous system, is an animal with a remarkable regeneration capacity and shows no signs of organismal aging. We have for the first time identified genes of the nucleotide excision repair (NER) pathway from hydra. Here we report cloning and characterization of hydra homolog of xeroderma pigmentosum group F (XPF) gene that encodes a structure-specific 5' endonuclease which is a crucial component of NER. In silico analysis shows that hydra XPF amino acid sequence is very similar to its counterparts from other animals, especially vertebrates, and shows all features essential for its function. By in situ hybridization, we show that hydra XPF is expressed prominently in the multipotent stem cell niche in the central region of the body column. Ectoderm of the diploblastic hydra was shown to express higher levels of XPF as compared to the endoderm by semi-quantitative RT-PCR. Semi-quantitative RT-PCR analysis also demonstrated that interstitial cells, a multipotent and rapidly cycling stem cell lineage of hydra, express higher levels of XPF mRNA than other cell types. Our data show that XPF and by extension, the NER pathway is highly conserved during evolution. The prominent expression of an NER gene in interstitial cells may have implications for the lack of senescence in hydra.	[Barve, Apurva; Ghaskadbi, Surendra] Agharkar Res Inst, Div Anim Sci, Pune, Maharashtra, India; [Ghaskadbi, Saroj] Univ Pune, Dept Zool, Pune, Maharashtra, India	Department of Science & Technology (India); Agharkar Research Institute (ARI); Savitribai Phule Pune University	Ghaskadbi, S (corresponding author), Agharkar Res Inst, Div Anim Sci, Pune, Maharashtra, India.	ghaskadbi@gmail.com			JRF-NET scholarship from Council for Scientific and Industrial Research, Govt. of India; German Academic Exchange Service (DAAD); Agharkar Research Institute, Pune; Department of Biotechnology, Govt. of India, New Delhi under Centre of Excellence in Epigenetics	JRF-NET scholarship from Council for Scientific and Industrial Research, Govt. of India; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Agharkar Research Institute, Pune(Department of Science & Technology (India)); Department of Biotechnology, Govt. of India, New Delhi under Centre of Excellence in Epigenetics	AB was supported by the JRF-NET scholarship from Council for Scientific and Industrial Research, Govt. of India, and a short term research fellowship from the German Academic Exchange Service (DAAD). This work was supported by Agharkar Research Institute, Pune, and Department of Biotechnology, Govt. of India, New Delhi under Centre of Excellence in Epigenetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Ahmad A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000871; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baarends WM, 2001, REPRODUCTION, V121, P31, DOI 10.1530/rep.0.1210031; Baruch R, 2005, J EXP BIOL, V208, P843, DOI 10.1242/jeb.01496; Batel R, 1998, MUTAT RES-DNA REPAIR, V409, P123, DOI 10.1016/S0921-8777(98)00050-0; Bode HR, 1996, J CELL SCI, V109, P1155; Bode HR, 2003, DEV DYNAM, V226, P225, DOI 10.1002/dvdy.10225; Bosch TCG, 2007, DEV BIOL, V303, P421, DOI 10.1016/j.ydbio.2006.12.012; Bosch TCG, 2009, BIOESSAYS, V31, P478, DOI 10.1002/bies.200800183; Bosch Thomas C. G., 2008, P37, DOI 10.1007/978-1-4020-8274-0_3; Bridge D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011686; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Galliot B, 2002, INT J DEV BIOL, V46, P39; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; HOEIJMAKERS JHJ, 1993, TRENDS GENET, V9, P211, DOI 10.1016/0168-9525(93)90121-W; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Lange C, 2011, MOL BIOL EVOL, V28, P1687, DOI 10.1093/molbev/msq349; Le May N, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/616342; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Martinez DE, 1998, EXP GERONTOL, V33, P217, DOI 10.1016/S0531-5565(97)00113-7; Martinez DE, 1997, DEV BIOL, V192, P523, DOI 10.1006/dbio.1997.8715; Mochizuki K, 2000, DEV GENES EVOL, V210, P591, DOI 10.1007/s004270000105; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Nishino T, 2003, STRUCTURE, V11, P445, DOI 10.1016/S0969-2126(03)00046-7; Rahn JJ, 2010, ENVIRON MOL MUTAGEN, V51, P567, DOI 10.1002/em.20583; Schaerer OD, 2008, CHEMBIOCHEM, V9, P21, DOI 10.1002/cbic.200700619; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Strome S, 2005, C ELEGANS RES COMMUN, DOI 10.1895/wormbook.1.9.1; SUGIYAMA T, 1977, DEV GROWTH DIFFER, V19, P187; SUGIYAMA T, 1978, J CELL SCI, V29, P35; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TERADA H, 1988, DEV BIOL, V126, P263, DOI 10.1016/0012-1606(88)90137-6; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tripsianes K, 2005, STRUCTURE, V13, P1849, DOI 10.1016/j.str.2005.08.014; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Walter Christi A, 2003, Sci Aging Knowledge Environ, V2003, pPE4; White MF, 2003, BIOCHEM SOC T, V31, P690, DOI 10.1042/BST0310690.	46	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61062	10.1371/journal.pone.0061062	http://dx.doi.org/10.1371/journal.pone.0061062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577191	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000097
J	Guzzetta, G; Kirschner, D				Guzzetta, Giorgio; Kirschner, Denise			The Roles of Immune Memory and Aging in Protective Immunity and Endogenous Reactivation of Tuberculosis	PLOS ONE			English	Article							CD8(+) T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; ANTIGEN PRESENTATION; GRANULOMA-FORMATION; INTERFERON-GAMMA; INFECTION; DYNAMICS; MODEL; CD4(+); MECHANISMS	Finding more effective vaccines against tuberculosis (TB) and improved preventive treatments against endogenous reactivation of latent TB is strategic to block transmission and reach the WHO goal of eliminating TB by 2050. Key related open questions in TB research include: i) what are the determinants of a strong memory response upon primary infection? ii) what is the role of cytokines towards protective memory response against a secondary infection? iii) what are the mechanisms responsible for the increased risk of reactivation in elderly individuals? To address these questions, we explored a computational model of the immune response to Mycobacterium tuberculosis including a mathematical description of immunosenescence and the generation and maintenance of immune memory. Sensitivity analysis techniques, together with extensive model characterization and in silico experiments, were applied to identify key mechanisms controlling TB reactivation and immunological memory. Key findings of this study are summarized by the following model predictions: i) increased strength and duration of memory protection is associated with higher levels of Tumor Necrosis Factor-alpha (TNF) during primary infection; ii) production of TNF, but not of interferon-gamma, by memory T cells during secondary infection is a major determinant of effective protection; iii) impaired recruitment of CD4+ T cells may promote reactivation of latent TB infections in aging hosts. This study is a first attempt to consider the immune dynamics of a persistent infection throughout the lifetime of the host, taking into account immunosenescence and memory. While the model is TB specific, the results are applicable to other persistent bacterial infections and can aid in the development, evaluation and refinement of TB treatment and/or vaccine protocols.	[Guzzetta, Giorgio] Univ Pisa, Dept Stat & Math Appl Econ, Pisa, Italy; [Guzzetta, Giorgio] Fdn Bruno Kessler, Trento, Italy; [Kirschner, Denise] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Pisa; Fondazione Bruno Kessler; University of Michigan System; University of Michigan	Guzzetta, G (corresponding author), Univ Pisa, Dept Stat & Math Appl Econ, Pisa, Italy.	guzzetta@fbk.eu		Guzzetta, Giorgio/0000-0002-9296-9470	National Institutes of Health [R33 HL092853, R01 HL106804, R01 EB012579]; Fondazione Bruno Kessler; University of Trento; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL092853, R01HL110811, R01HL106804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Bruno Kessler; University of Trento; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by National Institutes of Health Grants R33 HL092853 and R01 HL106804 and R01 EB012579 (awarded to DEK). Partial financial support was provided by the PhD scholarship awarded to GG by the Fondazione Bruno Kessler and University of Trento.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; [Anonymous], 2008, TECHNICAL REPORT; Antia R, 1998, P NATL ACAD SCI USA, V95, P14926, DOI 10.1073/pnas.95.25.14926; Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Bajaria SH, 2005, DETERMINISTIC AND STOCHASTIC MODELS OF AIDS EPIDEMICS AND HIV INFECTIONS WITH INTERVENTION, P219, DOI 10.1142/9789812569264_0010; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Buchholz VR, 2011, CURRENT OPINION IMMU, V23, P1; Caccamo N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005528; Chang ST, 2005, P NATL ACAD SCI USA, V102, P4530, DOI 10.1073/pnas.0500362102; Clark-Curtiss JE, 2003, ANNU REV MICROBIOL, V57, P517, DOI 10.1146/annurev.micro.57.030502.090903; Connor LM, 2010, EUR J IMMUNOL, V40, P2482, DOI 10.1002/eji.200940279; Dahari H, 2007, J VIROL, V81, P750, DOI 10.1128/JVI.01304-06; Dahari H, 2009, GASTROENTEROLOGY, V136, P1402, DOI 10.1053/j.gastro.2008.12.060; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; De Boer RJ, 2001, J VIROL, V75, P10663, DOI 10.1128/JVI.75.22.10663-10669.2001; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Fallahi-Sichani M, 2012, J IMMUNOL, V188, P3169, DOI 10.4049/jimmunol.1103298; Fallahi-Sichani M, 2011, J IMMUNOL, V186, P3472, DOI 10.4049/jimmunol.1003299; Finch CE, 1990, LONGEVITY SENESCENCE; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Forde JE, 2010, MATH BIOSCI ENG, V7, P765, DOI 10.3934/mbe.2010.7.765; France AM, 2007, AM J EPIDEMIOL, V166, P662, DOI 10.1093/aje/kwm135; Gerlach C, 2011, ANN NY ACAD SCI, V1217, P139, DOI 10.1111/j.1749-6632.2010.05830.x; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Haynes L, 2003, P NATL ACAD SCI USA, V100, P15053, DOI 10.1073/pnas.2433717100; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Jeyanathan M, 2010, AM J RESP CRIT CARE, V181, P862, DOI 10.1164/rccm.200910-1583OC; Joseph IM, 2004, J THEOR BIOL, V228, P55, DOI 10.1016/j.jtbi.2003.12.004; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Kaufmann SHE, 2002, ANN RHEUM DIS, V61, P54; Kirschner D, 1999, THEOR POPUL BIOL, V55, P94, DOI 10.1006/tpbi.1998.1382; Kohlmeier JE, 2006, CURR OPIN IMMUNOL, V18, P357, DOI 10.1016/j.coi.2006.03.012; Kumararatne DS, 1997, CLIN EXP IMMUNOL, V107, P11, DOI 10.1046/j.1365-2249.1997.d01-910.x; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Lillebaek T, 2003, J INFECT DIS, V188, P1032, DOI 10.1086/378240; Maglione PJ, 2009, EUR J IMMUNOL, V39, P676, DOI 10.1002/eji.200839148; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Marino S, 2004, J IMMUNOL, V173, P494, DOI 10.4049/jimmunol.173.1.494; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marino S, 2011, J THEOR BIOL, V280, P50, DOI 10.1016/j.jtbi.2011.03.022; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Miller RA, 2005, IMMUNOL REV, V205, P94, DOI 10.1111/j.0105-2896.2005.00254.x; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Nikolich-Zugich J, 2010, CURR OPIN IMMUNOL, V22, P535, DOI 10.1016/j.coi.2010.06.011; Olshansky SJ, 1997, DEMOGRAPHY, V34, P1, DOI 10.2307/2061656; ORME IM, 1993, CELL IMMUNOL, V147, P222, DOI 10.1006/cimm.1993.1062; ORME IM, 1987, J IMMUNOL, V138, P293; PERELSON AS, 1993, MATH BIOSCI, V114, P81, DOI 10.1016/0025-5564(93)90043-A; Ray JCJ, 2009, J IMMUNOL, V182, P3706, DOI 10.4049/jimmunol.0802297; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Singh V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016097; Styblo K, 1976, TUBERCLE; Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296; Surh CD, 2002, MICROBES INFECT, V4, P51, DOI 10.1016/S1286-4579(01)01509-X; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Walrath E, 2005, AM J RESP CELL MOL, V33, P48, DOI 10.1165/rcmb.2005-0060OC; Wigginton JE, 2001, J IMMUNOL, V166, P1951, DOI 10.4049/jimmunol.166.3.1951; Woodland DL, 2006, TRENDS IMMUNOL, V27, P303, DOI 10.1016/j.it.2006.05.002; Ye P, 2002, CRIT REV IMMUNOL, V22, P483	73	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60425	10.1371/journal.pone.0060425	http://dx.doi.org/10.1371/journal.pone.0060425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580062	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000031
J	Chida, J; Ono, R; Yamane, K; Hiyoshi, M; Nishimura, M; Onodera, M; Nakataki, E; Shichijo, K; Matushita, M; Kido, H				Chida, Junji; Ono, Rie; Yamane, Kazuhiko; Hiyoshi, Mineyoshi; Nishimura, Masaji; Onodera, Mutsuo; Nakataki, Emiko; Shichijo, Koichi; Matushita, Masatami; Kido, Hiroshi			Blood Lactate/ATP Ratio, as an Alarm Index and Real-Time Biomarker in Critical Illness	PLOS ONE			English	Article							ATP-BIOLUMINESCENCE; INTENSIVE-CARE; METABOLISM; ACTIVATORS; SEVERITY; SURVIVAL; SCORE; ASSAY	Objective: The acute physiology, age and chronic health evaluation (APACHE) II score and other related scores have been used for evaluation of illness severity in the intensive care unit (ICU), but there is still a need for real-time and sensitive prognostic biomarkers. Recently, alarmins from damaged tissues have been reported as alarm-signaling molecules. Although ATP is a member of the alarmins and its depletion in tissues closely correlates with multiple-organ failure, blood ATP level has not been evaluated in critical illness. To identify real-time prognostic biomarker of critical illness, we measured blood ATP levels and the lactate/ATP ratio (ATP-lactate energy risk score, A-LES) in critically ill patients. Methods and Results: Blood samples were collected from 42 consecutive critically ill ICU patients and 155 healthy subjects. The prognostic values of blood ATP levels and A-LES were compared with APACHE II score. The mean ATP level (SD) in healthy subjects was 0.62 (0.19) mM with no significant age or gender differences. The median ATP level in severely ill patients at ICU admission was significantly low at 0.31 mM (interquartile range 0.25 to 0.44) than the level in moderately ill patient at 0.56 mM (0.38 to 0.70) (P<0.01). Assessment with ATP was further corrected by lactate and expressed as A-LES. The median A-LES was 2.7 (2.1 to 3.3) in patients with satisfactory outcome at discharge but was significantly higher in non-survivors at 38.9 (21.0 to 67.9) (P<0.01). Receiver operating characteristic analysis indicated that measurement of blood ATP and A-LES at ICU admission are as useful as APACHE II score for prediction of mortality. Conclusion: Blood ATP levels and A-LES are sensitive prognostic biomarkers of mortality at ICU admission. In addition, A-LES provided further real-time evaluation score of illness severity during ICU stay particularly for critically ill patients with APACHE II scores of >= 20.0.	[Chida, Junji; Yamane, Kazuhiko; Hiyoshi, Mineyoshi; Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan; [Ono, Rie; Nishimura, Masaji; Onodera, Mutsuo; Nakataki, Emiko] Univ Tokushima, Tokushima Univ Hosp, Emergency & Crit Care Unit, Tokushima 770, Japan; [Shichijo, Koichi; Matushita, Masatami] Tokushima Red Cross Hosp, Dept Pediat, Tokushima, Japan	Tokushima University; Tokushima University	Kido, H (corresponding author), Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan.	kido@tokushima-u.ac.jp			JSPS [23791180]; JST [AS232Z00497F]; Intellectual Property Office of The University of Tokushima; Grants-in-Aid for Scientific Research [23659846] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Intellectual Property Office of The University of Tokushima; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by a Grant-in-Aid for Exploratory Research (No. 23791180) from JSPS and from JST (AS232Z00497F). This work was also funded by a grant from Intellectual Property Office of The University of Tokushima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Chida J, 2012, ANAL CHIM ACTA, V727, P8, DOI 10.1016/j.aca.2012.03.022; Cook SP, 2000, NATURE, V407, P951, DOI 10.1038/35039648; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Fredriksson K, 2006, AM J PHYSIOL-ENDOC M, V291, pE1044, DOI 10.1152/ajpendo.00218.2006; GAREWAL HS, 1986, J NATL CANCER I, V77, P1039; Garland JM, 1997, J BIOL CHEM, V272, P4680, DOI 10.1074/jbc.272.8.4680; Holtfreter B, 2006, ACTA ANAESTH SCAND, V50, P970, DOI 10.1111/j.1399-6576.2006.01096.x; ISHIZAKA A, 1984, J IMMUNOL METHODS, V72, P127, DOI 10.1016/0022-1759(84)90440-X; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kobayashi T, 2010, J IMMUNOL, V184, P6350, DOI 10.4049/jimmunol.0902673; Kubota M, 2012, BRAIN DEV-JPN, V34, P20, DOI 10.1016/j.braindev.2010.12.012; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; Nakamura N, 2000, CELL DEATH DIFFER, V7, P477, DOI 10.1038/sj.cdd.4400677; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Pan HY, 2011, CARDIOVASC RES, V89, P595, DOI 10.1093/cvr/cvq358; Robinson K, 2010, US RESP DIS, V6, P52; Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0; Schoenhofer B., 2002, Intensivmedizin und Notfallmedizin, V39, P240, DOI 10.1007/s003900200033; SEVIN BU, 1988, GYNECOL ONCOL, V31, P191, DOI 10.1016/0090-8258(88)90293-4; Sprague RS, 1996, AM J PHYSIOL-HEART C, V271, pH2717, DOI 10.1152/ajpheart.1996.271.6.H2717; TEASDALE G, 1974, LANCET, V2, P81; Tornroth-Horsefield S, 2008, P NATL ACAD SCI USA, V105, P19565, DOI 10.1073/pnas.0810654106; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WEIL MH, 1987, CRIT CARE MED, V15, P489	30	15	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60561	10.1371/journal.pone.0060561	http://dx.doi.org/10.1371/journal.pone.0060561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577122	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800062
J	Raisanen, S; Gissler, M; Saari, J; Kramer, M; Heinonen, S				Raisanen, Sari; Gissler, Mika; Saari, Juho; Kramer, Michael; Heinonen, Seppo			Contribution of Risk Factors to Extremely, Very and Moderately Preterm Births - Register-Based Analysis of 1,390,742 Singleton Births	PLOS ONE			English	Article							FINNISH PERINATAL HEALTH; SOCIOECONOMIC DIFFERENCES; GESTATIONAL-AGE; SMOKING; TRENDS; PREGNANCY; OUTCOMES; INFANTS; FINLAND	Background: Preterm birth, defined as birth occurring before 37 weeks gestation, is one of the most significant contributors to neonatal mortality and morbidity, with long-term adverse consequences for health, and cognitive outcome. Objective: The aim of the present study was to identify risk factors of preterm birth (<= 36+6 weeks gestation) among singleton births and to quantify the contribution of risk factors to socioeconomic disparities in preterm birth. Methods: A retrospective population-based case-control study using data derived from the Finnish Medical Birth Register. A total population of singleton births in Finland from 1987-2010 (n = 1,390,742) was reviewed. Results: Among all singleton births (n = 1,390,742), 4.6% (n = 63,340) were preterm (<37 weeks), of which 0.3% (n = 4,452) were classed as extremely preterm, 0.4% (n = 6,213) very preterm and 3.8% (n = 54,177) moderately preterm. Smoking alone explained up to 33% of the variation in extremely, very and moderately preterm birth incidence between high and the low socioeconomic status (SES) groups. Reproductive risk factors (placental abruption, placenta previa, major congenital anomaly, amniocentesis, chorionic villus biopsy, anemia, stillbirth, small for gestational age (SGA) and fetal sex) altogether explained 7.7-25.0% of the variation in preterm birth between SES groups. Conclusions: Smoking explained about one third of the variation in preterm birth groups between SES groups whereas the contribution of reproductive risk factors including placental abruption, placenta previa, major congenital anomaly, amniocentesis, chorionic villus biopsy, anemia, stillbirth, SGA and fetal sex was up to one fourth.	[Raisanen, Sari; Heinonen, Seppo] Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland; [Gissler, Mika] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Gissler, Mika] Nordic Sch Publ Hlth, Gothenburg, Sweden; [Saari, Juho] Univ Eastern Finland, Dept Social Sci, Kuopio Welf Res Ctr, Kuopio, Finland; [Kramer, Michael] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Eastern Finland; Emory University; Rollins School Public Health	Raisanen, S (corresponding author), Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland.	shraisan@student.uef.fi	Kramer, Michael R/A-3195-2013	Kramer, Michael R/0000-0002-6372-6170; Gissler, Mika/0000-0001-8254-7525	MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Cheong JLY, 2012, J PAEDIATR CHILD H, V48, P784, DOI 10.1111/j.1440-1754.2012.02536.x; *EURO PERISTAT PRO, 2008, EUR PER HLTH REP; Gissler M, 2003, J EPIDEMIOL COMMUN H, V57, P433, DOI 10.1136/jech.57.6.433; Gissler M, 1999, INT J EPIDEMIOL, V28, P276, DOI 10.1093/ije/28.2.276; GISSLER M, 1995, SCAND J SOC MED, V23, P75, DOI 10.1177/140349489502300113; Gissler M, 2009, J EPIDEMIOL COMMUN H, V63, P420, DOI 10.1136/jech.2008.079921; Holmgren PA, 2001, ACTA OBSTET GYN SCAN, V80, P525, DOI 10.1034/j.1600-0412.2001.080006525.x; Jaakkola N, 2001, AM J PUBLIC HEALTH, V91, P284, DOI 10.2105/AJPH.91.2.284; Jakobsson M, 2008, BJOG-INT J OBSTET GY, V115, P38, DOI 10.1111/j.1471-0528.2007.01565.x; Keirse MJNC, 2009, PAEDIATR PERINAT EP, V23, P522, DOI 10.1111/j.1365-3016.2009.01067.x; Kyrklund-Blomberg NB, 1998, AM J OBSTET GYNECOL, V179, P1051, DOI 10.1016/S0002-9378(98)70214-5; Laine K, 2009, EUR J OBSTET GYN R B, V146, P71, DOI 10.1016/j.ejogrb.2009.04.033; Luo ZC, 2006, CAN MED ASSOC J, V174, P1415, DOI 10.1503/cmaj.051096; Martius JA, 1998, EUR J OBSTET GYN R B, V80, P183, DOI 10.1016/S0301-2115(98)00130-4; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; Mercer BM, 1999, AM J OBSTET GYNECOL, V181, P1216, DOI 10.1016/S0002-9378(99)70111-0; Morken NH, 2005, ACTA OBSTET GYN SCAN, V84, P558, DOI 10.1111/j.0001-6349.2005.00765.x; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Tepper NK, 2012, MATERN CHILD HLTH J, V16, P807, DOI 10.1007/s10995-011-0787-8; vandeMheen H, 1997, SOC SCI MED, V44, P13, DOI 10.1016/S0277-9536(96)00090-1; Williams MC, 2000, AM J OBSTET GYNECOL, V183, P1094, DOI 10.1067/mob.2000.108866; Wong HS, 2012, MATERN CHIL IN PRESS; Xiong X, 2000, AM J PERINAT, V17, P137, DOI 10.1055/s-2000-9508	25	71	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60660	10.1371/journal.pone.0060660	http://dx.doi.org/10.1371/journal.pone.0060660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RZ	23577142	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800083
J	Smith, DH; Christensen, IJ; Jensen, NF; Markussen, B; Romer, MU; Nygard, SB; Muller, S; Nielsen, HJ; Brunner, N; Nielsen, KV				Smith, David Hersi; Christensen, Ib Jarle; Jensen, Niels Frank; Markussen, Bo; Romer, Maria Unni; Nygard, Sune Boris; Muller, Sven; Nielsen, Hans Jorgen; Brunner, Nils; Nielsen, Kirsten Vang			Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort	PLOS ONE			English	Article							CHROMOSOME-ABERRATIONS; MRC FOCUS; AMPLIFICATION; CARCINOMA; ADENOMA; CGH; IDENTIFICATION; CHEMOTHERAPY; PROGRESSION; EXPRESSION	Background: Topoisomerase I (Top1) is the target of Top1 inhibitor chemotherapy. The TOP1 gene, located at 20q12-q13.1, is frequently detected at elevated copy numbers in colorectal cancer (CRC). The present study explores the mechanism, frequency and prognostic impact of TOP1 gene aberrations in stage III CRC and how these can be detected by fluorescent in situ hybridization (FISH). Methods: Nine CRC cell line metaphase spreads were analyzed by FISH with a TOP1 probe in combination with a reference probe covering either the centromeric region of chromosome 20 (CEN-20) or chromosome 2 (CEN-2). Tissue sections from 154 chemonaive stage III CRC patients, previously studied with TOP1/CEN-20, were analyzed with TOP1/CEN-2. Relationships between biomarker status and overall survival (OS), time to recurrence (TTR) in CRC and time to local recurrence (LR; rectal cancer only) were determined. Results: TOP1 aberrations were observed in four cell line metaphases. In all cell lines CEN-2 was found to reflect chromosomal ploidy levels and therefore the TOP1/CEN-2 probe combination was selected to identify TOP1 gene gains (TOP1/CEN-2 >= 1.5). One hundred and three patients (68.2%) had TOP1 gain, of which 15 patients (14.6%) harbored an amplification (TOP1/CEN-20 >= 2.0). TOP1 gene gain did not have any association with clinical endpoints, whereas TOP1 amplification showed a non-significant trend towards longer TTR (multivariate HR: 0.50, p = 0.08). Once amplified cases were segregated from other cases of gene gain, non-amplified gene increases (TOP1/CEN-2 >= 1.5 and TOP1/CEN-20<2.0) showed a trend towards shorter TTR (univariate HR: 1.57, p = 0.07). Conclusions: TOP1 gene copy number increase occurs frequently in stage III CRC in a mechanism that often includes CEN-20. Using CEN-2 as a measurement for tumor ploidy levels, we were able to discriminate between different mechanisms of gene gain, which appeared to differ in prognostic impact. TOP1 FISH guidelines have been updated.	[Smith, David Hersi; Muller, Sven; Nielsen, Kirsten Vang] Dako AS, R&D, Glostrup, Denmark; Univ Copenhagen, Fac Hlth & Med Sci, Sect Pathobiol, Dept Vet Dis Biol, Frederiksberg, Denmark; [Christensen, Ib Jarle] Univ Copenhagen, Finsen Lab, Rigshosp, Copenhagen Bioctr, Copenhagen N, Denmark; [Christensen, Ib Jarle] Univ Copenhagen, Copenhagen Bioctr, BRIC, Copenhagen N, Denmark; [Markussen, Bo] Univ Copenhagen, Dept Math Sci, Lab Appl Stat, Fac Sci, Copenhagen O, Denmark; [Nielsen, Hans Jorgen] Univ Copenhagen, Hvidovre Hosp, Dept Surg Gastroenterol 360, DK-2650 Hvidovre, Denmark; [Nielsen, Hans Jorgen] Univ Copenhagen, Inst Clin Med, Fac Hlth & Med Sci, Copenhagen N, Denmark	Dako Denmark; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Smith, DH (corresponding author), Dako AS, R&D, Glostrup, Denmark.	dhsmith@dako.com	Markussen, Bo/M-2161-2014	Markussen, Bo/0000-0001-7793-9620; Nielsen, Kirsten Vang/0000-0001-7956-1748; Nielsen, Hans Jorgen/0000-0003-2619-4379	Danish Agency for Science, Technology and Innovation through the Industrial PhD program; Danish Council for Strategic Research; Simon Fougner Hartmanns Family Foundation; IMK Almene Foundation; Kathrine og Vigo Skovgaards Foundation; Tomrermester Johannes Fog Foundation; Fabrikant Einar Willumsens Memorial Trust; Danish Cancer Society; Danish Medical Research Council; Hede Nielsen Foundation; Director Ib Henriksens Foundation; Sawmill owner Jeppe Juhl and Wife Ovita Juhl Foundation; Kornerup Fund; Aase and Ejnar Danielsen Fund; Aage and Johanne Louis-Hansen Fund	Danish Agency for Science, Technology and Innovation through the Industrial PhD program; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Simon Fougner Hartmanns Family Foundation; IMK Almene Foundation; Kathrine og Vigo Skovgaards Foundation; Tomrermester Johannes Fog Foundation; Fabrikant Einar Willumsens Memorial Trust; Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hede Nielsen Foundation; Director Ib Henriksens Foundation; Sawmill owner Jeppe Juhl and Wife Ovita Juhl Foundation; Kornerup Fund; Aase and Ejnar Danielsen Fund; Aage and Johanne Louis-Hansen Fund	This study was supported by the Danish Agency for Science, Technology and Innovation through the Industrial PhD program. Nils Brunner and Hans Jorgen Nielsen were supported by The Danish Council for Strategic Research, Simon Fougner Hartmanns Family Foundation, IMK Almene Foundation, Kathrine og Vigo Skovgaards Foundation, Tomrermester Johannes Fog Foundation, Fabrikant Einar Willumsens Memorial Trust, Danish Cancer Society, The Danish Medical Research Council, The Hede Nielsen Foundation, Director Ib Henriksens Foundation, Sawmill owner Jeppe Juhl and Wife Ovita Juhl Foundation, The Kornerup Fund, The Aase and Ejnar Danielsen Fund and The Aage and Johanne Louis-Hansen Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Bardi G, 2004, J CLIN ONCOL, V22, P2623, DOI 10.1200/JCO.2004.11.014; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boonsong A, 2000, CANCER GENET CYTOGEN, V121, P56, DOI 10.1016/S0165-4608(00)00242-9; Braun MS, 2008, J CLIN ONCOL, V26, P2690, DOI 10.1200/JCO.2007.15.5580; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Colucci G, 2005, J CLIN ONCOL, V23, P4866, DOI 10.1200/JCO.2005.07.113; De Angelis PM, 1999, BRIT J CANCER, V80, P526; Dyrso T, 2011, CANCER GENET-NY, V204, P84, DOI 10.1016/j.cancergencyto.2010.08.019; Fan BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029824; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Hermsen M, 2002, GASTROENTEROLOGY, V123, P1109, DOI 10.1053/gast.2002.36051; Hirsch D, 2012, GENE CHROMOSOME CANC, V51, P490, DOI 10.1002/gcc.21937; HSIANG YH, 1988, CANCER RES, V48, P1722; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Koopman M, 2009, EJC SUPPL, V7, P321, DOI 10.1016/S1359-6349(09)71098-5; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Markova B, 2010, ONCOGENE, V29, P739, DOI 10.1038/onc.2009.374; Matthiesen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040675; Meijer GA, 1998, J CLIN PATHOL, V51, P901, DOI 10.1136/jcp.51.12.901; Myllykangas S, 2006, CANCER LETT, V232, P79, DOI 10.1016/j.canlet.2005.07.045; Nielsen HJ, 1998, GI CANCER, V2, P227; Nielsen KV, 2012, MOL ONCOL, V6, P88, DOI 10.1016/j.molonc.2011.11.006; Nielsen KV, 2011, JNCI-J NATL CANCER I, V103, P352, DOI 10.1093/jnci/djq528; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Romer MU, 2013, MOL ONCOL, V7, P101, DOI 10.1016/j.molonc.2012.09.001; Romer MU, 2012, SCAND J GASTROENTERO, V47, P68, DOI 10.3109/00365521.2011.638393; Rooney PH, 2001, BRIT J CANCER, V85, P1492, DOI 10.1054/bjoc.2001.2095; Ryan D, 2010, PIGM CELL MELANOMA R, V23, P542, DOI 10.1111/j.1755-148X.2010.00720.x; Seymour MT, 2007, LANCET, V370, P143, DOI 10.1016/S0140-6736(07)61087-3; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Tabach Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014632; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	37	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60613	10.1371/journal.pone.0060613	http://dx.doi.org/10.1371/journal.pone.0060613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577133	Green Submitted, gold, Green Published			2022-12-27	WOS:000319109800073
J	Sugyo, A; Tsuji, AB; Sudo, H; Nagatsu, K; Koizumi, M; Ukai, Y; Kurosawa, G; Zhang, MR; Kurosawa, Y; Saga, T				Sugyo, Aya; Tsuji, Atsushi B.; Sudo, Hitomi; Nagatsu, Kotaro; Koizumi, Mitsuru; Ukai, Yoshinori; Kurosawa, Gene; Zhang, Ming-Rong; Kurosawa, Yoshikazu; Saga, Tsuneo			Evaluation of Zr-89-Labeled Human Anti-CD147 Monoclonal Antibody as a Positron Emission Tomography Probe in a Mouse Model of Pancreatic Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EMMPRIN EXPRESSION; IMMUNO-PET; BIODISTRIBUTION; DEFEROXAMINE; METUXIMAB; GA-67; ZR-89; MICE	Introduction: Pancreatic cancer is an aggressive cancer and its prognosis remains poor. Therefore, additional effective therapy is required to augment and/or complement current therapy. CD147, high expression in pancreatic cancer, is involved in the metastatic process and is considered a good candidate for targeted therapy. CD147-specfic imaging could be useful for selection of appropriate patients. Therefore, we evaluated the potential of a fully human anti-CD147 monoclonal antibody 059-053 as a new positron emission tomography (PET) probe for pancreatic cancer. Methods: CD147 expression was evaluated in four pancreatic cancer cell lines (MIA Paca-2, PANC-1, BxPC-3, and AsPC-1) and a mouse cell line A4 as a negative control. Cell binding, competitive inhibition and internalization assays were conducted with I-125-, Ga-67-, or Zr-89-labeled 059-053. In vivo biodistribution of I-125- or Zr-89-labeled 059-053 was conducted in mice bearing MIA Paca-2 and A4 tumors. PET imaging with [Zr-89]059-053 was conducted in subcutaneous and orthotopic tumor mouse models. Results: Among four pancreatic cancer cell lines, MIA Paca-2 cells showed the highest expression of CD147, while A4 cells had no expression. Immunohistochemical staining showed that MIA Paca-2 xenografts also highly expressed CD147 in vivo. Radiolabeled 059-053 specifically bound to MIA Paca-2 cells with high affinity, but not to A4. [Zr-89]059-053 uptake in MIA Paca-2 tumors increased with time from 11.0 +/- 1.3% injected dose per gram (ID/g) at day 1 to 16.9 +/- 3.2% ID/g at day 6, while [I-125]059-053 uptake was relatively low and decreased with time, suggesting that 059-053 was internalized into tumor cells in vivo and I-125 was released from the cells. PET with [Zr-89]059-053 clearly visualized subcutaneous and orthotopic tumors. Conclusion: [Zr-89]059-053 is a promising PET probe for imaging CD147 expression in pancreatic cancer and has the potential to select appropriate patients with CD147-expressing tumors who could gain benefit from anti-CD147 therapy.	[Sugyo, Aya; Tsuji, Atsushi B.; Sudo, Hitomi; Koizumi, Mitsuru; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Grp, Chiba 260, Japan; [Nagatsu, Kotaro; Zhang, Ming-Rong] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Probe Program, Chiba 260, Japan; [Ukai, Yoshinori; Kurosawa, Gene; Kurosawa, Yoshikazu] Fujita Hlth Univ, Sch Med, Div Antibody Project, Toyoake, Aichi 47011, Japan	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; Fujita Health University	Tsuji, AB (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Grp, Chiba 260, Japan.	a_tsuji@nirs.go.jp	Kurosawa, Gene/R-6508-2018; TSUJI, Atsushi B/I-9922-2019	Kurosawa, Gene/0000-0001-9477-7467; TSUJI, Atsushi B/0000-0003-2726-288X; Ukai, Yoshinori/0000-0001-7661-7777	National Institute of Radiological Sciences	National Institute of Radiological Sciences	This study was funded by National Institute of Radiological Sciences to TS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZN, 2006, INT J RADIAT ONCOL, V65, P435, DOI 10.1016/j.ijrobp.2005.12.034; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; Govindan SV, 2005, NUCL MED BIOL, V32, P513, DOI 10.1016/j.nucmedbio.2005.04.009; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ju XZ, 2008, CLIN CANCER RES, V14, P494, DOI 10.1158/1078-0432.CCR-07-1072; Kurosawa G, 2008, P NATL ACAD SCI USA, V105, P7287, DOI 10.1073/pnas.0712202105; Kurosawa G, 2011, CANCER SCI, V102, P175, DOI 10.1111/j.1349-7006.2010.01739.x; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Nagatsu K, 2012, NUCL MED BIOL, V39, P1281, DOI 10.1016/j.nucmedbio.2012.05.010; Nayak TK, 2012, J NUCL MED, V53, P113, DOI 10.2967/jnumed.111.094169; Perk LR, 2010, EUR J NUCL MED MOL I, V37, P250, DOI 10.1007/s00259-009-1263-1; Perk LR, 2005, J NUCL MED, V46, P1898; Riethdorf S, 2006, INT J CANCER, V119, P1800, DOI 10.1002/ijc.22062; SAGA T, 1991, CANCER RES, V51, P990; Shah N, 2012, MOL IMAGING BIOL, V14, P237, DOI 10.1007/s11307-011-0491-5; Sogawa C, 2012, NUCL MED COMMUN, V33, P719, DOI 10.1097/MNM.0b013e3283531d68; Sogawa C, 2010, NUCL MED BIOL, V37, P179, DOI 10.1016/j.nucmedbio.2009.10.008; Stenzinger A, 2012, HUM PATHOL, V43, P1471, DOI 10.1016/j.humpath.2011.10.023; Sudo H, 2012, CANCER SCI, V103, P203, DOI 10.1111/j.1349-7006.2011.02126.x; Verel I, 2003, J NUCL MED, V44, P1663; Vosjan MJWD, 2011, EUR J NUCL MED MOL I, V38, P753, DOI 10.1007/s00259-010-1700-1; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P157; Weinberg R.A., 2007, BIOL CANC; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; Xu J, 2007, HEPATOLOGY, V45, P269, DOI 10.1002/hep.21465; Xue YJ, 2011, MED ONCOL, V28, P1363, DOI 10.1007/s12032-010-9582-4; YOKOYAMA A, 1982, J NUCL MED, V23, P909; Zhang Z, 2006, CANCER BIOL THER, V5, P318, DOI 10.4161/cbt.5.3.2431; Zucker S, 2001, AM J PATHOL, V158, P1921, DOI 10.1016/S0002-9440(10)64660-3	32	28	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61230	10.1371/journal.pone.0061230	http://dx.doi.org/10.1371/journal.pone.0061230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577210	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800132
J	Yang, ZQ; Hu, BH; Zhang, YH; Luo, QM; Gong, H				Yang, Zhongqin; Hu, Bihe; Zhang, Yuhui; Luo, Qingming; Gong, Hui			Development of a Plastic Embedding Method for Large-Volume and Fluorescent-Protein-Expressing Tissues	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; MOUSE-BRAIN; ZEBRAFISH EMBRYOS; TOMOGRAPHY; LIGHT; SECTION; CELLS; RESIN; GFP	Fluorescent proteins serve as important biomarkers for visualizing both subcellular organelles in living cells and structural and functional details in large-volume tissues or organs. However, current techniques for plastic embedding are limited in their ability to preserve fluorescence while remaining suitable for micro-optical sectioning tomography of large-volume samples. In this study, we quantitatively evaluated the fluorescence preservation and penetration time of several commonly used resins in a Thy1-eYFP-H transgenic whole mouse brain, including glycol methacrylate (GMA), LR White, hydroxypropyl methacrylate (HPMA) and Unicryl. We found that HMPA embedding doubled the eYFP fluorescence intensity but required long durations of incubation for whole brain penetration. GMA, Unicryl and LR White each penetrated the brain rapidly but also led to variable quenching of eYFP fluorescence. Among the fast-penetrating resins, GMA preserved fluorescence better than LR White and Unicryl. We found that we could optimize the GMA formulation by reducing the polymerization temperature, removing 4-methoxyphenol and adjusting the pH of the resin solution to be alkaline. By optimizing the GMA formulation, we increased percentage of eYFP fluorescence preservation in GMA-embedded brains nearly two-fold. These results suggest that modified GMA is suitable for embedding large-volume tissues such as whole mouse brain and provide a novel approach for visualizing brain-wide networks.	[Yang, Zhongqin; Hu, Bihe; Zhang, Yuhui; Luo, Qingming; Gong, Hui] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China; [Yang, Zhongqin; Hu, Bihe; Zhang, Yuhui; Luo, Qingming; Gong, Hui] Huazhong Univ Sci & Technol, MoE Key Lab Biomed Photon, Dept Biomed Engn, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Gong, H (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China.	huigong@mail.hust.edu.cn		Luo, Qingming/0000-0002-6725-9311	National Natural Science Foundation of China [81127002, 81171067]; Science Fund for Creative Research Group of China [61121004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Group of China(Science Fund for Creative Research Groups)	This work was supported by the National Natural Science Foundation of China (Grant No. 81127002, 81171067), Science Fund for Creative Research Group of China (Grant No. 61121004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Bogers JJ, 1996, J HISTOCHEM CYTOCHEM, V44, P43, DOI 10.1177/44.1.8543781; Chen XB, 2008, J NEUROSCI, V28, P9321, DOI 10.1523/JNEUROSCI.2992-08.2008; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GLAUERT AM, 1958, J BIOPHYS BIOCHEM CY, V4, P191, DOI 10.1083/jcb.4.2.191; Horstmann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035172; Keene DR, 2008, MICROSC MICROANAL, V14, P342, DOI 10.1017/S1431927608080306; Kiernan J.A., 2008, HISTOLOGICAL HISTOCH, P606; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; LEDUC EH, 1965, J CELL BIOL, V26, P137, DOI 10.1083/jcb.26.1.137; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Lidke DS, 2012, J CELL SCI, V125, P2571, DOI 10.1242/jcs.090027; Luby-Phelps K, 2003, J HISTOCHEM CYTOCHEM, V51, P271, DOI 10.1177/002215540305100301; Mayerich D, 2008, J MICROSC-OXFORD, V231, P134, DOI 10.1111/j.1365-2818.2008.02024.x; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Nanguneri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038098; Newman GR, 1999, HISTOCHEM J, V31, P495, DOI 10.1023/A:1003850921869; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; PIEKUT DT, 1983, J HISTOCHEM CYTOCHEM, V31, P669, DOI 10.1177/31.5.6341457; Porrero C, 2010, BRAIN RES, V1345, P59, DOI 10.1016/j.brainres.2010.05.061; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; Robinson JM, 2001, J HISTOCHEM CYTOCHEM, V49, P803, DOI 10.1177/002215540104900701; Sims Paul A, 2007, Methods Mol Biol, V369, P291; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Sullivan-Brown J, 2011, NAT PROTOC, V6, P46, DOI 10.1038/nprot.2010.165; Ward WW, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P45; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Zhang B, 2011, J NEUROSCI METH, V197, P1, DOI 10.1016/j.jneumeth.2010.10.001; Zhang C, 2009, APPL MICROBIOL BIOT, V84, P511, DOI 10.1007/s00253-009-2006-8	32	26	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60877	10.1371/journal.pone.0060877	http://dx.doi.org/10.1371/journal.pone.0060877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577174	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800111
J	Zanotti-Fregonara, P; Hirvonen, J; Lyoo, CH; Zoghbi, SS; Rallis-Frutos, D; Huestis, MA; Morse, C; Pike, VW; Innis, RB				Zanotti-Fregonara, Paolo; Hirvonen, Jussi; Lyoo, Chul Hyoung; Zoghbi, Sami S.; Rallis-Frutos, Denise; Huestis, Marilyn A.; Morse, Cheryl; Pike, Victor W.; Innis, Robert B.			Population-Based Input Function Modeling for [F-18]FMPEP-d(2), an Inverse Agonist Radioligand for Cannabinoid CB1 Receptors: Validation in Clinical Studies	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL METABOLIC-RATE; GLUCOSE-METABOLISM; PET; IMAGE; QUANTIFICATION; BINDING	Background: Population-based input function (PBIF) may be a valid alternative to full blood sampling for quantitative PET imaging. PBIF is typically validated by comparing its quantification results with those obtained via arterial sampling. However, for PBIF to be employed in actual clinical research studies, its ability to faithfully capture the whole spectrum of results must be assessed. The present study validated a PBIF for [F-18]FMPEP-d(2), a cannabinoid CB1 receptor radioligand, in healthy volunteers, and also attempted to utilize PBIF to replicate three previously published clinical studies in which the input function was acquired with arterial sampling. Methods: The PBIF was first created and validated with data from 42 healthy volunteers. This PBIF was used to assess the retest variability of [F-18]FMPEP-d(2), and then to quantify CB1 receptors in alcoholic patients (n = 18) and chronic daily cannabis smokers (n = 29). Both groups were scanned at baseline and after 2-4 weeks of monitored drug abstinence. Results: PBIF yielded accurate results in the 42 healthy subjects (average Logan-distribution volume (V-T) was 13.3 +/- 3.8 mL/cm(3) for full sampling and 13.2 +/- 3.8 mL/cm(3) for PBIF; R-2 = 0.8765, p < 0.0001) and test-retest results were comparable to those obtained with full sampling (variability: 16%; intraclass correlation coefficient: 0.89). PBIF accurately replicated the alcoholism study, showing a widespread similar to 20% reduction of CB1 receptors in alcoholic subjects, without significant change after abstinence. However, a small PBIF-V-T bias of -9% was unexpectedly observed in cannabis smokers. This bias led to substantial errors, including a V-T decrease in regions that had shown no downregulation in the full input function. Simulated data showed that the original findings could only have been replicated with a PBIF bias between -6% and +4%. Conclusions: Despite being initially well validated in healthy subjects, PBIF may misrepresent clinical protocol results and be a source of variability between different studies and institutions.	[Zanotti-Fregonara, Paolo; Hirvonen, Jussi; Lyoo, Chul Hyoung; Zoghbi, Sami S.; Rallis-Frutos, Denise; Morse, Cheryl; Pike, Victor W.; Innis, Robert B.] NIMH, Mol Imaging Branch, NIH, Bethesda, MD 20892 USA; [Huestis, Marilyn A.] NIDA, Chem & Drug Metab Sect, NIH, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Innis, RB (corresponding author), NIMH, Mol Imaging Branch, NIH, Bethesda, MD 20892 USA.	robert.innis@nih.gov	Pike, Victor/AAJ-4139-2020; Hirvonen, Jussi/AAC-1864-2020; Hirvonen, Jussi/H-2521-2012	Lyoo, Chul Hyoung/0000-0003-2231-672X	National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002852, ZIAMH002793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake GM, 2012, NUCL MED COMMUN, V33, P881, DOI 10.1097/MNM.0b013e3283550275; Brock CS, 2005, INT J ONCOL, V26, P1377; Contractor KB, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-11; Cook GJR, 1999, EUR J NUCL MED, V26, P1424, DOI 10.1007/s002590050474; Donohue SR, 2008, J MED CHEM, V51, P5833, DOI 10.1021/jm800416m; Eberl S, 1997, EUR J NUCL MED, V24, P299, DOI 10.1007/s002590050056; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GANDELMAN MS, 1994, J PHARM SCI, V83, P1014, DOI 10.1002/jps.2600830718; Guillin O, 2007, INT REV NEUROBIOL, V78, P1, DOI 10.1016/S0074-7742(06)78001-1; Hirata T, 2005, NUCL MED COMMUN, V26, P519, DOI 10.1097/00006231-200506000-00007; Hirvonen J, 2012, MOL PSYCHIATR, V17, P642, DOI 10.1038/mp.2011.82; Hirvonen J, 2012, MOL PSYCHIAT; Hoekstra CJ, 1999, EUR J NUCL MED, V26, P1489, DOI 10.1007/s002590050484; Iida H, 1994, Eur J Nucl Med, V21, P1072; Komar G, 2012, NUCL MED COMMUN; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Meyer PT, 2006, EUR J NUCL MED MOL I, V33, P948, DOI 10.1007/s00259-006-0121-7; Parsey RV, 2010, BIOL PSYCHIAT, V68, P170, DOI 10.1016/j.biopsych.2010.03.023; Seike Y, 2004, ANN NUCL MED, V18, P563, DOI 10.1007/BF02984577; Shiozaki T, 2000, J NUCL MED, V41, P1612; Shrestha S, 2012, NEUROIMAGE, V59, P3243, DOI 10.1016/j.neuroimage.2011.11.029; Sim-Selley Laura J., 2003, Critical Reviews in Neurobiology, V15, P91, DOI 10.1615/CritRevNeurobiol.v15.i2.10; Takagi S, 2004, ANN NUCL MED, V18, P297, DOI 10.1007/BF02984467; TAKIKAWA S, 1994, J NUCL MED, V35, P955; TAKIKAWA S, 1993, RADIOLOGY, V188, P131, DOI 10.1148/radiology.188.1.8511286; Terry GE, 2010, J NUCL MED, V51, P112, DOI 10.2967/jnumed.109.067074; Tsuchida T, 1999, J NUCL MED, V40, P1441; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vriens D, 2009, J NUCL MED, V50, P1933, DOI 10.2967/jnumed.109.065243; Wakita K, 2000, J NUCL MED, V41, P1484; Zanotti-Fregonara P, 2012, NEUROIMAGE, V63, P1532, DOI 10.1016/j.neuroimage.2012.08.007; Zanotti-Fregonara P, 2012, EUR J NUCL MED MOL I, V39, P651, DOI 10.1007/s00259-011-2004-9; Zanotti-Fregonara P, 2011, J CEREBR BLOOD F MET, V31, P1986, DOI 10.1038/jcbfm.2011.107; Zanotti-Fregonara P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017056; Zanotti-Fregonara P, 2009, J CEREBR BLOOD F MET, V29, P1825, DOI 10.1038/jcbfm.2009.93	35	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60231	10.1371/journal.pone.0060231	http://dx.doi.org/10.1371/journal.pone.0060231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577094	Green Submitted, gold, Green Published			2022-12-27	WOS:000319109800036
J	Agalliu, I; Wang, ZM; Wang, T; Dunn, A; Parikh, H; Myers, T; Burk, RD; Amundadottir, L				Agalliu, Ilir; Wang, Zhaoming; Wang, Tao; Dunn, Anne; Parikh, Hemang; Myers, Timothy; Burk, Robert D.; Amundadottir, Laufey			Characterization of SNPs Associated with Prostate Cancer in Men of Ashkenazic Descent from the Set of GWAS Identified SNPs: Impact of Cancer Family History and Cumulative SNP Risk Prediction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; GENETIC-VARIANTS; MULTIPLE; RELATIVES; ADMIXTURE; BREAST	Background: Genome-wide association studies (GWAS) have identified multiple SNPs associated with prostate cancer (PrCa). Population isolates may have different sets of risk alleles for PrCa constituting unique population and individual risk profiles. Methods: To test this hypothesis, associations between 31 GWAS SNPs of PrCa were examined among 979 PrCa cases and 1,251 controls of Ashkenazic descent using logistic regression. We also investigated risks by age at diagnosis, pathological features of PrCa, and family history of cancer. Moreover, we examined associations between cumulative number of risk alleles and PrCa and assessed the utility of risk alleles in PrCa risk prediction by comparing the area under the curve (AUC) for different logistic models. Results: Of the 31 genotyped SNPs, 8 were associated with PrCa at p <= 0.002 (corrected p-value threshold) with odds ratios (ORs) ranging from 1.22 to 1.42 per risk allele. Four SNPs were associated with aggressive PrCa, while three other SNPs showed potential interactions for PrCa by family history of PrCa (rs8102476; 19q13), lung cancer (rs17021918; 4q22), and breast cancer (rs10896449; 11q13). Men in the highest vs. lowest quartile of cumulative number of risk alleles had ORs of 3.70 (95% CI 2.76-4.97); 3.76 (95% CI 2.57-5.50), and 5.20 (95% CI 2.94-9.19) for overall PrCa, aggressive cancer and younger age at diagnosis, respectively. The addition of cumulative risk alleles to the model containing age at diagnosis and family history of PrCa yielded a slightly higher AUC (0.69 vs. 0.64). Conclusion: These data define a set of risk alleles associated with PrCa in men of Ashkenazic descent and indicate possible genetic differences for PrCa between populations of European and Ashkenazic ancestry. Use of genetic markers might provide an opportunity to identify men at highest risk for younger age of onset PrCa; however, their clinical utility in identifying men at highest risk for aggressive cancer remains limited.	[Agalliu, Ilir; Wang, Tao; Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Wang, Zhaoming; Myers, Timothy] NCI, Canc Genom Res Lab CGR, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Dunn, Anne; Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat Genet, Bronx, NY 10467 USA; [Parikh, Hemang; Myers, Timothy; Amundadottir, Laufey] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Burk, Robert D.] Albert Einstein Coll Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine	Agalliu, I (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	ilir.agalliu@einstein.yu.edu	Agalliu, Ilir/ABB-6611-2021; Wang, Zhaoming/R-5527-2018; Parikh, Hemang/AAY-7174-2021; Amundadottir, Laufey T/L-7656-2016	Wang, Zhaoming/0000-0001-7556-3869; Amundadottir, Laufey T/0000-0003-1859-8971; Agalliu, Ilir/0000-0002-6248-5790	U.S. Army, Department of Defense grant [PC001076]; Einstein Cancer Research Center from the National Cancer Institute [P30CA013330]; Translational-Medicine grant from the Albert Einstein College of Medicine; Intramural Program of the National Cancer Institute/National Institutes of Health; Mentored Research Scholar Grant from the American Cancer Society [MRSG-11-112-01-CNE]; NATIONAL CANCER INSTITUTE [P30CA013330, ZIACP010201] Funding Source: NIH RePORTER	U.S. Army, Department of Defense grant(United States Department of Defense); Einstein Cancer Research Center from the National Cancer Institute; Translational-Medicine grant from the Albert Einstein College of Medicine; Intramural Program of the National Cancer Institute/National Institutes of Health; Mentored Research Scholar Grant from the American Cancer Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported in part by the U.S. Army, Department of Defense grant (PC001076), the Einstein Cancer Research Center (P30CA013330) from the National Cancer Institute, by a Translational-Medicine grant from the Albert Einstein College of Medicine, and from the Intramural Program of the National Cancer Institute/National Institutes of Health. Dr. Ilir Agalliu was supported in part by a Mentored Research Scholar Grant (MRSG-11-112-01-CNE) from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalliu I, 2010, PROSTATE, V70, P1716, DOI 10.1002/pros.21207; Agalliu I, 2010, CANCER CAUSE CONTROL, V21, P289, DOI 10.1007/s10552-009-9461-5; Agalliu I, 2009, CLIN CANCER RES, V15, P1112, DOI 10.1158/1078-0432.CCR-08-1822; Ahn J, 2011, CLIN CANCER RES, V17, P1075, DOI 10.1158/1078-0432.CCR-10-0881; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; American Cancer Society, 2012, CANC FACTS FIG; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107; Breslow N E, 1980, IARC Sci Publ, P5; Bruner DW, 2003, INT J CANCER, V107, P797, DOI 10.1002/ijc.11466; Cooper PR, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.05.035; DUBIN N, 1986, AM J EPIDEMIOL, V123, P1101, DOI 10.1093/oxfordjournals.aje.a114338; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; FitzGerald LM, 2011, CANCER EPIDEM BIOMAR, V20, P1196, DOI 10.1158/1055-9965.EPI-10-1299; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Ghosh A, 2012, EPIDEMIOLOGY, V23, P616, DOI 10.1097/EDE.0b013e31825583a0; Good P, 2005, PERMUTATION PARAMETR; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001513; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Haiman CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001387; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hsu FC, 2009, CANCER RES, V69, P2720, DOI 10.1158/0008-5472.CAN-08-3347; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kicinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027130; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Kupper L, 2007, APPL REGRESSION ANAL; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lindstrom S, 2012, CANCER EPIDEM BIOMAR, V21, P437, DOI 10.1158/1055-9965.EPI-11-1038; Parikh H, 2011, HUM GENET, V129, P675, DOI 10.1007/s00439-011-0953-5; Pashayan N, 2011, BRIT J CANCER, V104, P1656, DOI 10.1038/bjc.2011.118; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Vijai J, 2011, BRIT J CANCER, V105, P864, DOI 10.1038/bjc.2011.307; Waters KM, 2009, CANCER EPIDEM BIOMAR, V18, P1285, DOI 10.1158/1055-9965.EPI-08-1142; Wiklund FE, 2009, CANCER EPIDEM BIOMAR, V18, P1659, DOI 10.1158/1055-9965.EPI-08-1148; Witte JS, 2009, NAT REV GENET, V10, P77, DOI 10.1038/nrg2507; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Xu JF, 2008, CLIN CANCER RES, V14, P5819, DOI 10.1158/1078-0432.CCR-08-0934; Xu JF, 2010, P NATL ACAD SCI USA, V107, P2136, DOI 10.1073/pnas.0914061107; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Zeegers MPA, 2003, CANCER-AM CANCER SOC, V97, P1894, DOI 10.1002/cncr.11262; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	51	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60083	10.1371/journal.pone.0060083	http://dx.doi.org/10.1371/journal.pone.0060083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573233	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100047
J	Chen, ZY; Luo, F; Feng, J; Yang, WS; Zeng, DY; Zhao, RM; Cao, ZJ; Liu, ML; Li, WX; Jiang, L; Wu, YL				Chen, Zongyun; Luo, Fan; Feng, Jing; Yang, Weishan; Zeng, Danyun; Zhao, Ruiming; Cao, Zhijian; Liu, Maili; Li, Wenxin; Jiang, Ling; Wu, Yingliang			Genomic and Structural Characterization of Kunitz-Type Peptide LmKTT-1a Highlights Diversity and Evolution of Scorpion Potassium Channel Toxins	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; NMR STRUCTURE; INHIBITOR; PURIFICATION; SEQUENCE; PROTEASE; DATABASE; PROGRAM; CLONING; ORIGIN	Background: Recently, a new subfamily of long-chain toxins with a Kunitz-type fold was found in scorpion venom glands. Functionally, these toxins inhibit protease activity and block potassium channels. However, the genomic organization and three-dimensional (3-D) structure of this kind of scorpion toxin has not been reported. Principal Findings: Here, we characterized the genomic organization and 3-D nuclear magnetic resonance structure of the scorpion Kunitz-type toxin, LmKTT-1a, which has a unique cysteine pattern. The LmKTT-1a gene contained three exons, which were interrupted by two introns located in the mature peptide region. Despite little similarity to other Kunitz-type toxins and a unique pattern of disulfide bridges, LmKTT-1a possessed a conserved Kunitz-type structural fold with one alpha-helix and two beta-sheets. Comparison of the genomic organization, 3-D structure, and functional data of known toxins from the alpha-KTx, beta-KTx, gamma-KTx, and kappa-KTx subfamily suggested that scorpion Kunitz-type potassium channel toxins might have evolved from a new ancestor that is completely different from the common ancestor of scorpion toxins with a CS alpha/beta fold. Thus, these analyses provide evidence of a new scorpion potassium channel toxin subfamily, which we have named delta-KTx. Conclusions/Significance: Our results highlight the genomic, structural, and evolutionary diversity of scorpion potassium channel toxins. These findings may accelerate the design and development of diagnostic and therapeutic peptide agents for human potassium channelopathies.	[Chen, Zongyun; Feng, Jing; Yang, Weishan; Zhao, Ruiming; Cao, Zhijian; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Luo, Fan; Zeng, Danyun; Liu, Maili; Jiang, Ling] Chinese Acad Sci, Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Inst Phys & Math,Wuhan Ctr Magnet Resonance, Wuhan, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Li, WX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liwxlab@whu.edu.cn; lingjiang@wipm.ac.cn; ylwu@whu.edu.cn	Liu, Maili/A-8543-2011; Zhao, Ruiming/C-1817-2017; Feng, Jing/C-1729-2018	Liu, Maili/0000-0002-9359-915X; Feng, Jing/0000-0001-6726-7912	National Basic Research Program of China [2010CB529800, 2009CB918600]; National High Technology Research and Development Program of China [2012AA020304]; National Natural Sciences Foundation of China [30530140, 31071942, 31200557, 21173257]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (2010CB529800 and 2009CB918600), National High Technology Research and Development Program of China (2012AA020304), and National Natural Sciences Foundation of China (number 30530140, 31071942, 31200557 and 21173257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; Chagot B, 2005, BIOCHEM J, V388, P263, DOI 10.1042/BJ20041705; Chakrabarty A, 2006, GENE, V373, P35, DOI 10.1016/j.gene.2005.12.033; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; Cheng YC, 2005, BBA-PROTEINS PROTEOM, V1747, P213, DOI 10.1016/j.bbapap.2004.11.006; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GIMENEZGALLEGO G, 1988, P NATL ACAD SCI USA, V85, P3329, DOI 10.1073/pnas.85.10.3329; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Hansen D, 2007, BIOCHEM BIOPH RES CO, V360, P735, DOI 10.1016/j.bbrc.2007.06.144; Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8; He QY, 2008, NUCLEIC ACIDS RES, V36, pD293, DOI 10.1093/nar/gkm832; Kharrat R, 1997, FEBS LETT, V406, P284, DOI 10.1016/S0014-5793(97)00285-8; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Peigneur S, 2011, BIOCHEM PHARMACOL, V82, P81, DOI 10.1016/j.bcp.2011.03.023; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Smith JJ, 2011, P NATL ACAD SCI USA, V108, P10478, DOI 10.1073/pnas.1103501108; SMITH LA, 1993, BIOCHEMISTRY-US, V32, P5692, DOI 10.1021/bi00072a026; SZOPA J, 1974, ACTA BIOCHIM POL, V21, P151; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Wu YL, 2004, BIOPHYS J, V87, P105, DOI 10.1529/biophysj.103.039156; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Zhang M, 2003, BIOPHYS J, V84, P3022, DOI 10.1016/S0006-3495(03)70028-9; Zhao RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027548; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452; Zhu SY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002832; Zhu SY, 2004, PROTEINS, V54, P361, DOI 10.1002/prot.10588; Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje	35	42	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60201	10.1371/journal.pone.0060201	http://dx.doi.org/10.1371/journal.pone.0060201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573241	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100053
J	Cheng, Z; Zhao, HQ; Ze, YG; Su, JJ; Li, B; Sheng, L; Zhu, LY; Guan, N; Gui, SX; Sang, XZ; Zhao, XY; Sun, QQ; Wang, L; Cheng, J; Hu, RP; Hong, FS				Cheng, Zhe; Zhao, Haiquan; Ze, Yuguan; Su, Junju; Li, Bing; Sheng, Lei; Zhu, Liyuan; Guan, Ning; Gui, Suxin; Sang, Xuezi; Zhao, Xiaoyang; Sun, Qingqing; Wang, Ling; Cheng, Jie; Hu, Renping; Hong, Fashui			Gene-Expression Changes in Cerium Chloride-Induced Injury of Mouse Hippocampus	PLOS ONE			English	Article							CHOLINE TRANSPORTER; ADENYLYL-CYCLASE; OXIDATIVE STRESS; OVER-EXPRESSION; NERVOUS-SYSTEM; TERM EXPOSURE; PROTEIN; MICE; TRAFFICKING; RECEPTORS	Cerium is widely used in many aspects of modern society, including agriculture, industry and medicine. It has been demonstrated to enter the ecological environment, is then transferred to humans through food chains, and causes toxic actions in several organs including the brain of animals. However, the neurotoxic molecular mechanisms are not clearly understood. In this study, mice were exposed to 0.5, 1, and 2 mg/kg BW cerium chloride (CeCl3) for 90 consecutive days, and their learning and memory ability as well as hippocampal gene expression profile were investigated. Our findings suggested that exposure to CeCl3 led to hippocampal lesions, apoptosis, oxidative stress and impairment of spatial recognition memory. Furthermore, microarray data showed marked alterations in the expression of 154 genes involved in learning and memory, immunity and inflammation, signal transduction, apoptosis and response to stress in the 2 mg/kg CeCl3 exposed hippocampi. Specifically, the significant up-regulation of Axud1, Cdc37, and Ube2v1 caused severe apoptosis, and great suppression of Adcy8, Fos, and Slc5a7 expression led to impairment of mouse cognitive ability. Therefore, Axud1, Cdc37, Ube2v1, Adcy8, Fos, and Slc5a7 may be potential biomarkers of hippocampal toxicity caused by CeCl3 exposure.	[Cheng, Zhe; Zhao, Haiquan; Ze, Yuguan; Su, Junju; Li, Bing; Sheng, Lei; Zhu, Liyuan; Guan, Ning; Gui, Suxin; Sang, Xuezi; Zhao, Xiaoyang; Sun, Qingqing; Wang, Ling; Cheng, Jie; Hu, Renping; Hong, Fashui] Soochow Univ, Coll Med, Suzhou, Peoples R China; [Zhao, Haiquan] Anhui Agr Univ, Coll Life Sci, Hefei, Peoples R China	Soochow University - China; Anhui Agricultural University	Hong, FS (corresponding author), Soochow Univ, Coll Med, Suzhou, Peoples R China.	Hongfsh_cn@sina.com	li, bing/GWQ-9617-2022		National Natural Science Foundation of China [81273036, 30901218]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Bringing New Ideas Foundation of Student of Soochow University [201210285036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; National Bringing New Ideas Foundation of Student of Soochow University	This work was supported by the National Natural Science Foundation of China (grant No. 81273036, 30901218), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, and the National Bringing New Ideas Foundation of Student of Soochow University (grant No. 201210285036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwa Y, 2001, P NATL ACAD SCI USA, V98, P14033, DOI 10.1073/pnas.241503698; Alili L, 2013, ANTIOXID RE IN PRESS; Cheng J, 2011, CHEMOSPHERE, V83, P612, DOI 10.1016/j.chemosphere.2010.12.013; Cheng Z, 2012, ENVIRON TOXICOL, V27, P707, DOI 10.1002/tox.20696; Chigurupati S, 2013, BIOMATERIALS, V34, P2194, DOI 10.1016/j.biomaterials.2012.11.061; Clayton TA, 2003, ARCH TOXICOL, V77, P208, DOI 10.1007/s00204-002-0431-x; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Davis RS, 2004, INT IMMUNOL, V16, P1343, DOI 10.1093/intimm/dxh137; Dedesma C, 2006, J COMP NEUROL, V496, P773, DOI 10.1002/cne.20958; Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919; Di Certo MG, 2007, J CELL SCI, V120, P1852, DOI 10.1242/jcs.03454; Fei M, 2011, BIOL TRACE ELEM RES, V140, P317, DOI 10.1007/s12011-010-8698-x; Fei M, 2011, BIOL TRACE ELEM RES, V139, P72, DOI 10.1007/s12011-010-8638-9; Feng JH, 2002, ANAL BIOCHEM, V301, P1, DOI 10.1006/abio.2001.5471; Feng LX, 2006, TOXICOL LETT, V165, P112, DOI 10.1016/j.toxlet.2006.02.003; Ferguson SM, 2004, P NATL ACAD SCI USA, V101, P8762, DOI 10.1073/pnas.0401667101; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Gingras S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000808; GORBUNOV AV, 1992, SCI TOTAL ENVIRON, V122, P337, DOI 10.1016/0048-9697(92)90051-S; HAYWARD MD, 1990, BRAIN RES, V525, P256, DOI 10.1016/0006-8993(90)90872-9; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Kacharmina JE, 1999, METHOD ENZYMOL, V303, P3; Kelai S, 2008, NEUROREPORT, V19, P751, DOI 10.1097/WNR.0b013e3282fda231; Kostova Irena, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P29, DOI 10.2174/1568011053352550; Li N, 2010, BIOL TRACE ELEM RES, V134, P68, DOI 10.1007/s12011-009-8448-0; Li ZF, 2006, CHEM J CHINESE U, V27, P438; LIANG L, 1991, ANAL CHEM, V63, P423, DOI 10.1021/ac00005a007; Liapi C, 2009, BIOMETALS, V22, P329, DOI 10.1007/s10534-008-9169-0; Liu J, 2010, J ALLOY COMPD, V489, P708, DOI 10.1016/j.jallcom.2009.09.158; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; MASUR J, 1971, PSYCHOPHARMACOLOGIA, V19, P388, DOI 10.1007/BF00404383; Miller TL, 2007, PEDIATR CRIT CARE ME, V8, P40, DOI 10.1097/01.PCC.0000253022.10607.61; Misawa H, 2008, EUR J NEUROSCI, V27, P3109, DOI 10.1111/j.1460-9568.2008.06268.x; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Ni JZ, 2002, BIOINORGANIC CHEM RA, P285; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Razzoli M, 2010, NEUROSCIENCE, V170, P429, DOI 10.1016/j.neuroscience.2010.07.022; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Schenk GJ, 2010, PHYSIOL BEHAV, V101, P541, DOI 10.1016/j.physbeh.2010.08.002; Schenk GJ, 2010, BRAIN RES, V1352, P21, DOI 10.1016/j.brainres.2010.07.068; Schmidlin PR, 2012, ARCH ORAL BIOL, V57, P892, DOI 10.1016/j.archoralbio.2012.01.010; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Syed NA, 2006, APOPTOSIS, V11, P2147, DOI 10.1007/s10495-006-0197-3; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tian J, 1997, ACTA SCI NAT U SUNYA, V38, P121; Vrana KE, 2003, NEUROTOXICOLOGY, V24, P321, DOI 10.1016/S0161-813X(02)00193-6; Wang HB, 2003, J NEUROSCI, V23, P9710; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Yang J, 2007, FREE RADICAL RES, V41, P1099, DOI 10.1080/10715760701499356; Zha HQ, 2011, BIOL TRACE ELEM RES, V144, P872, DOI 10.1007/s12011-011-9045-6; Zhao HQ, 2012, ARCH ENVIRON CON TOX, V62, P154, DOI 10.1007/s00244-011-9672-0; Zhao HQ, 2011, BIOL TRACE ELEM RES, V142, P174, DOI 10.1007/s12011-010-8759-1; Zhu WF, 1996, CHINESE SCI BULL, V41, P1977; Zhu WF, 1997, BIOL TRACE ELEM RES, V57, P71, DOI 10.1007/BF02803871	61	8	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60092	10.1371/journal.pone.0060092	http://dx.doi.org/10.1371/journal.pone.0060092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573234	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100048
J	Lotta, LA; Maino, A; Tuana, G; Rossio, R; Lecchi, A; Artoni, A; Peyvandi, F				Lotta, Luca A.; Maino, Alberto; Tuana, Giacomo; Rossio, Raffaella; Lecchi, Anna; Artoni, Andrea; Peyvandi, Flora			Prevalence of Disease and Relationships between Laboratory Phenotype and Bleeding Severity in Platelet Primary Secretion Defects	PLOS ONE			English	Article							VON-WILLEBRAND-DISEASE; RELEASE; QUESTIONNAIRE; METABOLISM; DISORDERS; SYMPTOMS; PATIENT	Background: The prevalence of platelet primary secretion defects (PSD) among patients with bleeding diathesis is unknown. Moreover, there is paucity of data on the determinants of bleeding severity in PSD patients. Objective: To determine the prevalence of PSD in patients with clinical bleeding and to study the relationships between the type of platelet defect and bleeding severity. Methods: Data on patients referred for bleeding to the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan (Italy) in the years between 2008 and 2012 were retrieved to study the prevalence of PSD. Demographic, clinical and laboratory information on 32 patients with a diagnosis of PSD was used to compare patients with or without associated medical conditions and to investigate whether or not the type and extension of platelet defects were associated with the bleeding severity score (crude and age-normalized) or with the age at first bleeding requiring medical attention. Results: The estimated prevalence of PSD among 207 patients with bleeding diathesis and bleeding severity score above 4 was 18.8% (95% confidence interval [CI]: 14.1-24.7%). Patients without associated medical conditions had earlier age of first bleeding (18 vs 45 years; difference: -27 years; 95% CI: -46 to -9 years) and different platelet functional defect patterns (Fisher's exact test of the distribution of patterns, P = 0.007) than patients with accompanying medical conditions. The type and extension of platelet defect was not associated with the severity of bleeding. Conclusions: PSD is found in approximately one fifth of patients with clinical bleeding. In patients with PSD, the type and extension of laboratory defect was not associated with bleeding severity.	[Lotta, Luca A.; Maino, Alberto; Tuana, Giacomo; Rossio, Raffaella; Lecchi, Anna; Artoni, Andrea; Peyvandi, Flora] Univ Milan, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Fdn Ist Ricovero & Cura Carattere Sci Ca Granda O, Milan, Italy; [Lotta, Luca A.; Maino, Alberto; Tuana, Giacomo; Rossio, Raffaella; Lecchi, Anna; Artoni, Andrea; Peyvandi, Flora] Fdn Luigi Villa, Milan, Italy; [Tuana, Giacomo] Fdn Ist Ricovero & Cura Carattere Sci Ca Granda O, Hematol CTMO 1, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Peyvandi, F (corresponding author), Univ Milan, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Fdn Ist Ricovero & Cura Carattere Sci Ca Granda O, Milan, Italy.	flora.peyvandi@unimi.it	Maino, Alberto/H-4486-2019; Lecchi, Anna/AAC-7785-2022; Peyvandi, Flora/AAK-7437-2020	Maino, Alberto/0000-0001-5909-9189; Lecchi, Anna/0000-0002-5730-4473; Peyvandi, Flora/0000-0001-7423-9864; Artoni, Andrea/0000-0003-0625-8320; Lotta, Luca Andrea/0000-0002-2619-5956	Luca A Lotta; Flora Peyvandi; Bayer Healthcare	Luca A Lotta; Flora Peyvandi; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals)	The study was supported by the 2012 Bayer Hemophilia Award - Early Career Award (recipient: Luca A Lotta) and the 2011 Bayer Hemophilia Award Special Project Award (recipient: Flora Peyvandi), consisting of research grants by Bayer Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Bowman M, 2008, J THROMB HAEMOST, V6, P2062, DOI 10.1111/j.1538-7836.2008.03182.x; Castaman G, 2006, J THROMB HAEMOST, V4, P2164, DOI 10.1111/j.1538-7836.2006.02070.x; Cattaneo M, 2003, J THROMB HAEMOST, V1, P1628, DOI 10.1046/j.1538-7836.2003.00266.x; Cattaneo M, 2000, ARTERIOSCL THROM VAS, V20, pE101, DOI 10.1161/01.ATV.20.11.e101; Cattaneo M, 2011, PURINERG SIGNAL, V7, P333, DOI 10.1007/s11302-011-9217-z; Cattaneo M, 2009, SEMIN THROMB HEMOST, V35, P158, DOI 10.1055/s-0029-1220324; COWAN DH, 1975, J CLIN INVEST, V56, P188, DOI 10.1172/JCI108067; Fuse I, 1996, CRIT REV ONCOL HEMAT, V22, P1, DOI 10.1016/1040-8428(94)00167-7; FUSE I, 1986, SCAND J HAEMATOL, V36, P44; Hayward CPM, 2011, BLOOD REV, V25, P169, DOI 10.1016/j.blre.2011.03.004; HILLBOM M, 1987, BRIT MED J, V295, P581, DOI 10.1136/bmj.295.6598.581; Lotta LA, 2011, J THROMB HAEMOST, V9, P1744, DOI 10.1111/j.1538-7836.2011.04428.x; MANNUCCI PM, 1989, EUR J CANCER CLIN ON, V25, P1413, DOI 10.1016/0277-5379(89)90098-9; Nurden A, 2011, J THROMB HAEMOST, V9, P76, DOI 10.1111/j.1538-7836.2011.04274.x; O'Brien SH, 2012, HEMATOL-AM SOC HEMAT, P152, DOI 10.1182/asheducation-2012.1.152; Philipp CS, 2003, J THROMB HAEMOST, V1, P477, DOI 10.1046/j.1538-7836.2003.00061.x; Podda G, 2012, PLATELETS, V23, P552, DOI 10.3109/09537104.2012.724737; Quiroga T, 2007, HAEMATOLOGICA, V92, P357, DOI 10.3324/haematol.10816; Rao AK, 2004, SEMIN THROMB HEMOST, V30, P525, DOI 10.1055/s-2004-835673; Rodeghiero F, 2010, J THROMB HAEMOST, V8, P2063, DOI 10.1111/j.1538-7836.2010.03975.x; STUART MJ, 1981, BLOOD, V58, P326; Tosetto A, 2006, J THROMB HAEMOST, V4, P766, DOI 10.1111/j.1538-7836.2006.01847.x; Tosetto A, 2011, J THROMB HAEMOST, V9, P1143, DOI 10.1111/j.1538-7836.2011.04265.x	24	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60396	10.1371/journal.pone.0060396	http://dx.doi.org/10.1371/journal.pone.0060396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565241	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300111
J	Nol, P; Rhyan, JC; Robbe-Austerman, S; McCollum, MP; Rigg, TD; Saklou, NT; Salman, MD				Nol, Pauline; Rhyan, Jack C.; Robbe-Austerman, Suelee; McCollum, Matt P.; Rigg, Tara D.; Saklou, Nadia T.; Salman, Mo D.			The Potential for Transmission of BCG from Orally Vaccinated White-Tailed Deer (Odocoileus virginianus) to Cattle (Bos taurus) through a Contaminated Environment: Experimental Findings	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-BOVIS; IMMUNE-RESPONSES; TUBERCULOSIS; INFECTION; MICHIGAN; WILDLIFE; ROUTES	White-tailed deer (Odocoileus virginianus) experimentally infected with a virulent strain of Mycobacterium bovis have been shown to transmit the bacterium to other deer and cattle (Bos taurus) by sharing of pen waste and feed. The risk of transmission of M. bovis bacille Calmette-Guerin (BCG) vaccine from orally vaccinated white-tailed deer to other deer and cattle, however, is not well understood. In order to evaluate this risk, we orally vaccinated 14 white-tailed deer with 1610 9 colony forming units BCG in lipid-formulated baits and housed them with nine non-vaccinated deer. Each day we exposed the same seven naive cattle to pen space utilized by the deer to look for transmission between the two species. Before vaccination and every 60 days until the end of the study, we performed tuberculin skin testing on deer and cattle, as well as interferon-gamma testing in cattle, to detect cellular immune response to BCG exposure. At approximately 27 weeks all cattle and deer were euthanized and necropsied. None of the cattle converted on either caudal fold, comparative cervical tests, or interferon-gamma assay. None of the cattle were culture positive for BCG. Although there was immunological evidence that BCG transmission occurred from deer to deer, we were unable to detect immunological or microbiological evidence of transmission to cattle. This study suggests that the risk is likely to be low that BCG-vaccinated white-tailed deer would cause domestic cattle to react to the tuberculin skin test or interferon-gamma test through exposure to a BCG-contaminated environment.	[Nol, Pauline; Rhyan, Jack C.; McCollum, Matt P.] USDA, Anim & Plant Hlth Inspect Serv, Vet Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Robbe-Austerman, Suelee] USDA, Anim & Plant Hlth Inspect Serv, Vet Serv, Natl Vet Serv Labs, Ames, IA USA; [Rigg, Tara D.] USDA, Anim & Plant Hlth Inspect Serv, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Saklou, Nadia T.; Salman, Mo D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Anim Populat Hlth Inst, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Colorado State University	Nol, P (corresponding author), USDA, Anim & Plant Hlth Inspect Serv, Vet Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA.	pauline.nol@aphis.usda.gov			United States Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services	United States Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services	This study was funded by the United States Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buddle BM, 2005, VACCINE, V23, P3581, DOI 10.1016/j.vaccine.2005.01.150; Buddle BM, 2008, TUBERCULOSIS, V88, P595, DOI 10.1016/j.tube.2008.01.005; de Lisle GW, 2002, REV SCI TECH OIE, V21, P317, DOI 10.20506/rst.21.2.1339; Harris BN, 2010, J VACCINES VACCINATI, P1; Lamy B, 2008, INT J SYST EVOL MICR, V58, P486, DOI 10.1099/ijs.0.65222-0; Nol P, 2008, J WILDLIFE DIS, V44, P247, DOI 10.7589/0090-3558-44.2.247; O'Brien DJ, 2006, VET MICROBIOL, V112, P313, DOI 10.1016/j.vetmic.2005.11.014; Palmer MV, 2007, VACCINE, V25, P6589, DOI 10.1016/j.vaccine.2007.06.056; Palmer MV, 2010, ZOONOSES PUBLIC HLTH, V57, pE206, DOI 10.1111/j.1863-2378.2010.01329.x; Palmer MV, 2009, ZOONOSES PUBLIC HLTH, V56, P243, DOI 10.1111/j.1863-2378.2008.01198.x; Palmer MV, 2004, AM J VET RES, V65, P1483, DOI 10.2460/ajvr.2004.65.1483; Palmer MV, 2004, J WILDLIFE DIS, V40, P87, DOI 10.7589/0090-3558-40.1.87; Palmer MV, 2001, AM J VET RES, V62, P692, DOI 10.2460/ajvr.2001.62.692; Schmitt SM, 1997, J WILDLIFE DIS, V33, P749, DOI 10.7589/0090-3558-33.4.749; Shojaei H, 2011, JPN J INFECT DIS, V64, P234; Toro A, 2008, EMERG INFECT DIS, V14, P1330, DOI 10.3201/eid1408.080179; USDA, 2005, APHIS BOV TUB ER UN; Waters WR, 2006, CLIN VACCINE IMMUNOL, V13, P611, DOI 10.1128/CVI.00054-06	18	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60257	10.1371/journal.pone.0060257	http://dx.doi.org/10.1371/journal.pone.0060257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565211	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300080
J	Rachakonda, PS; Bauer, AS; Xie, HP; Campa, D; Rizzato, C; Canzian, F; Beghelli, S; Greenhalf, W; Costello, E; Schanne, M; Heller, A; Scarpa, A; Neoptolemos, JP; Werner, J; Buchler, M; Hoheisel, JD; Hemminki, K; Giese, N; Kumar, R				Rachakonda, P. Sivaramakrishna; Bauer, Andrea S.; Xie, Huaping; Campa, Daniele; Rizzato, Cosmeri; Canzian, Federico; Beghelli, Stefania; Greenhalf, William; Costello, Eithne; Schanne, Michaela; Heller, Anette; Scarpa, Aldo; Neoptolemos, John P.; Werner, Jens; Buechler, Markus; Hoheisel, Joerg D.; Hemminki, Kari; Giese, Nathalia; Kumar, Rajiv			Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient Survival	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; K-RAS; DUCTAL ADENOCARCINOMA; INTRAEPITHELIAL NEOPLASIA; KRAS MUTATIONS; THERAPY; BRAF; EXPRESSION; MELANOMA; GENE	KRAS mutations are major factors involved in initiation and maintenance of pancreatic tumors. The impact of different mutations on patient survival has not been clearly defined. We screened tumors from 171 pancreatic cancer patients for mutations in KRAS and CDKN2A genes. Mutations in KRAS were detected in 134 tumors, with 131 in codon 12 and only 3 in codon 61. The GGT>GAT (G12D) was the most frequent mutation and was present in 60% (80/134). Deletions and mutations in CDKN2A were detected in 43 tumors. Analysis showed that KRAS mutations were associated with reduced patient survival in both malignant exocrine and ductal adenocarcinomas (PDAC). Patients with PDACs that had KRAS mutations showed a median survival of 17 months compared to 30 months for those without mutations (log-rank P = 0.07) with a multivariate hazard ratio (HR) of 2.19 (95% CI 1.09-4.42). The patients with G12D mutation showed a median survival of 16 months (log-rank-test P = 0.03) and an associated multivariate HR 2.42 (95% CI 1.14-2.67). Although, the association of survival in PDAC patients with CDKN2A aberrations in tumors was not statistically significant, the sub-group of patients with concomitant KRAS mutations and CDKN2A alterations in tumors were associated with a median survival of 13.5 months compared to 22 months without mutation (log-rank-test P = 0.02) and a corresponding HR of 3.07 (95% CI 1.33-7.10). Our results are indicative of an association between mutational status and survival in PDAC patients, which if confirmed in subsequent studies can have potential clinical application.	[Rachakonda, P. Sivaramakrishna; Xie, Huaping; Campa, Daniele; Rizzato, Cosmeri; Canzian, Federico; Hemminki, Kari; Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Bauer, Andrea S.; Schanne, Michaela; Hoheisel, Joerg D.] German Canc Res Ctr, Div Funct Genome Anal, Heidelberg, Germany; [Xie, Huaping] Huazhong Univ Sci & Technol, Dept Gastroenterol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Beghelli, Stefania; Scarpa, Aldo] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Greenhalf, William; Costello, Eithne; Neoptolemos, John P.] Natl Inst Hlth Res, Pancreas Biomed Res Unit, Liverpool, Merseyside, England; [Greenhalf, William; Costello, Eithne; Neoptolemos, John P.] Canc Res UK Ctr, Liverpool, Merseyside, England; [Heller, Anette; Werner, Jens; Buechler, Markus; Giese, Nathalia] Univ Heidelberg Hosp, Dept Gen Surg, Heidelberg, Germany; [Hemminki, Kari] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Huazhong University of Science & Technology; University of Verona; University of Liverpool; Cancer Research UK; Ruprecht Karls University Heidelberg; Lund University	Rachakonda, PS (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.	s.rachakonda@dkfz.de	Greenhalf, William/A-2680-2013; Rizzato, Cosmeri/AAI-1261-2020; Campa, Daniele/K-1617-2016; Canzian, Federico/I-2804-2014; scarpa, aldo/K-6832-2016; Neoptolemos, John/HGU-7742-2022; Kumar, Rajiv/H-6431-2019	Campa, Daniele/0000-0003-3220-9944; scarpa, aldo/0000-0003-1678-739X; Kumar, Rajiv/0000-0002-6093-0395; Neoptolemos, John/0000-0002-6201-7399; Costello, Eithne/0000-0002-0104-8992; Canzian, Federico/0000-0002-4261-4583; Xie, Huaping/0000-0003-1474-2470; Bauer, Andrea/0000-0002-7919-0497; Rachakonda, Sivaramakrishna/0000-0002-2319-2821	Cancer Research UK [15957] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10126] Funding Source: researchfish; Pancreatic Cancer UK [2013 RIF - Greenhalf] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Pancreatic Cancer UK		Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Alhamdani MSS, 2009, GENOME MED, V1, DOI 10.1186/gm68; Benvenuti S, 2005, FEBS LETT, V579, P1884, DOI 10.1016/j.febslet.2005.02.015; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Dergham ST, 1997, INT J PANCREATOL, V21, P127; Fendrich V, 2010, GUT, V59, P630, DOI 10.1136/gut.2009.188961; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Franko J, 2008, J GASTROINTEST SURG, V12, P1664, DOI 10.1007/s11605-008-0577-9; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hayden EC, 2011, NATURE, V479, P281, DOI 10.1038/479281a; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Howard T J, 1996, Curr Probl Cancer, V20, P281, DOI 10.1016/S0147-0272(96)80001-8; HRUBAN RH, 1993, AM J PATHOL, V143, P545; Hruban RHPM, 2007, TUMORS PANCREAS AM R; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kawesha A, 2000, INT J CANCER, V89, P469, DOI 10.1002/1097-0215(20001120)89:6<469::AID-IJC1>3.0.CO;2-L; Kim ST, 2011, MOL CANCER THER, V10, P1993, DOI 10.1158/1535-7163.MCT-11-0269; Landi L, 2011, NAT REV CLIN ONCOL, V8, P571, DOI 10.1038/nrclinonc.2011.135; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Martini M, 2012, NAT REV CLIN ONCOL, V9, P87, DOI 10.1038/nrclinonc.2011.164; Mistry SH, 2005, GENE CHROMOSOME CANC, V44, P292, DOI 10.1002/gcc.20238; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Moore PS, 2001, BRIT J CANCER, V84, P253, DOI 10.1054/bjoc.2000.1567; Ottenhof NA, 2009, ARCH PATHOL LAB MED, V133, P375, DOI 10.1043/1543-2165-133.3.375; Ribas A, 2011, NAT REV CLIN ONCOL, V8, P426, DOI 10.1038/nrclinonc.2011.69; Santos GD, 2010, CANCER-AM CANCER SOC, V116, P5599, DOI 10.1002/cncr.25393; Schneider Gunter, 2003, Mol Cancer, V2, P15, DOI 10.1186/1476-4598-2-15; Shi CJ, 2009, MOL CANCER RES, V7, P230, DOI 10.1158/1541-7786.MCR-08-0206; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Yachida S, 2012, CLIN CANC RES; Youns M, 2009, BIOCHEM PHARMACOL, V78, P273, DOI 10.1016/j.bcp.2009.04.014	38	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60870	10.1371/journal.pone.0060870	http://dx.doi.org/10.1371/journal.pone.0060870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565280	Green Published, gold			2022-12-27	WOS:000317717300153
J	Van Diessen, E; Otte, WM; Braun, KPJ; Stam, CJ; Jansen, FE				Van Diessen, Eric; Otte, Willem M.; Braun, Kees P. J.; Stam, Cornelis J.; Jansen, Floor E.			Improved Diagnosis in Children with Partial Epilepsy Using a Multivariable Prediction Model Based on EEG Network Characteristics	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; EPILEPTOGENIC NETWORKS; SMALL-WORLD; SYNCHRONIZATION; CLASSIFICATION; VALIDATION; CENTRALITY; FREQUENCY; SEIZURE	Background: Electroencephalogram (EEG) acquisition is routinely performed to support an epileptic origin of paroxysmal events in patients referred with a possible diagnosis of epilepsy. However, in children with partial epilepsies the interictal EEGs are often normal. We aimed to develop a multivariable diagnostic prediction model based on electroencephalogram functional network characteristics. Methodology/Principal Findings: Routinely performed interictal EEG recordings at first presentation of 35 children diagnosed with partial epilepsies, and of 35 children in whom the diagnosis epilepsy was excluded (control group), were used to develop the prediction model. Children with partial epilepsy were individually matched on age and gender with children from the control group. Periods of resting-state EEG, free of abnormal slowing or epileptiform activity, were selected to construct functional networks of correlated activity. We calculated multiple network characteristics previously used in functional network epilepsy studies and used these measures to build a robust, decision tree based, prediction model. Based on epileptiform EEG activity only, EEG results supported the diagnosis of with a sensitivity and specificity of 0.77 and 0.91 respectively. In contrast, the prediction model had a sensitivity of 0.96 [95% confidence interval: 0.78-1.00] and specificity of 0.95 [95% confidence interval: 0.76-1.00] in correctly differentiating patients from controls. The overall discriminative power, quantified as the area under the receiver operating characteristic curve, was 0.89, defined as an excellent model performance. The need of a multivariable network analysis to improve diagnostic accuracy was emphasized by the lack of discriminatory power using single network characteristics or EEG's power spectral density. Conclusions/Significance: Diagnostic accuracy in children with partial epilepsy is substantially improved with a model combining functional network characteristics derived from multi-channel electroencephalogram recordings. Early and accurate diagnosis is important to start necessary treatment as soon as possible and inform patients and parents on possible risks and psychosocial aspects in relation to the diagnosis.	[Van Diessen, Eric; Otte, Willem M.; Braun, Kees P. J.; Jansen, Floor E.] Univ Med Ctr Utrecht, Dept Pediat Neurol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Otte, Willem M.] Univ Med Ctr Utrecht, Biomed MR Imaging & Spect Grp, Image Sci Inst, Utrecht, Netherlands; [Stam, Cornelis J.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam	Van Diessen, E (corresponding author), Univ Med Ctr Utrecht, Dept Pediat Neurol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	E.vanDiessen-3@umcutrecht.nl	Otte, Willem M/I-1228-2013; Otte, Willem M./J-6140-2019	Otte, Willem M/0000-0003-1511-6834; Otte, Willem M./0000-0003-1511-6834; Stam, Cornelis/0000-0001-9163-7274	Epilepsy Fund of the Netherlands [NEF 09-93, NEF 08-10]	Epilepsy Fund of the Netherlands	EvD was supported by the Epilepsy Fund of the Netherlands (NEF 09-93), this project is performed under supervision of CJS, KPJB and FEJ. WMO was supported by the Epilepsy Fund of the Netherlands (NEF 08-10). Furthermore, CJS serves on the scientific board of the Epilepsy Fund of the Netherlands and as an associate editor of Clinical Neurophysiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg J, 2003, CLIN NEUROPHYSIOL, V114, P50, DOI 10.1016/S1388-2457(02)00322-X; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Boersma M, 2011, HUM BRAIN MAPP, V32, P413, DOI 10.1002/hbm.21030; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Dalponte M, 2007, ELECTRON LETT, V43, P1406, DOI 10.1049/el:20072428; Douw L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010839; Ferri R, 2004, CLIN NEUROPHYSIOL, V115, P1202, DOI 10.1016/j.clinph.2003.12.014; GOODIN DS, 1990, ANN NEUROL, V27, P330, DOI 10.1002/ana.410270317; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Hamiwka LD, 2007, EPILEPSIA, V48, P1062, DOI 10.1111/j.1528-1167.2007.01018.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013; Kung M, 2007, CARET CLASSIFICATION; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Negishi M, 2011, EPILEPSIA, V52, P1733, DOI 10.1111/j.1528-1167.2011.03191.x; Newman MEJ, 2005, CONTEMP PHYS, V46, P29; Newman MEJ, 2007, MATH NETWORKS NEW PA; Niedermeyer E., 1987, ELECTROENCEPHALOGRAP; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Ripley BD, 2001, MSOR CONNECTIONS NEW, P3; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Vlooswijk MCG, 2011, NEUROLOGY, V77, P938, DOI 10.1212/WNL.0b013e31822cfc2f; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Zou KH, 2003, ACAD RADIOL, V10, P1359, DOI 10.1016/S1076-6332(03)00538-5	40	50	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59764	10.1371/journal.pone.0059764	http://dx.doi.org/10.1371/journal.pone.0059764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565166	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300035
J	Gan, VC; Lye, DC; Thein, TL; Dimatatac, F; Tan, AS; Leo, YS				Gan, Victor C.; Lye, David C.; Thein, Tun L.; Dimatatac, Frederico; Tan, Adriana S.; Leo, Yee-Sin			Implications of Discordance in World Health Organization 1997 and 2009 Dengue Classifications in Adult Dengue	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; HOSPITALIZATION; MULTICENTER; MANAGEMENT; NEED	Background: Revised dengue guidelines were published by the World Health Organization (WHO) in 2009 addressing severe dengue cases not classified by dengue hemorrhagic fever (DHF) and shock syndrome (DSS). Methods and Principal Findings: We conducted a retrospective cohort study to compare WHO 2009 and 1997 classifications using 1278 adult dengue cases confirmed by polymerase chain reaction assay from Singapore epidemics in 2004 and 2007 (predominantly serotype 1 and 2 respectively). DHF occurred in 14.3%, DSS 2.7% and severe dengue 16.0%. The two WHO dengue classifications were discordant in defining severe disease (p <0.001). Five DSS patients (15%) were classified as non-severe dengue without warning signs. Of severe dengue patients, 107 did not fulfil DHF criteria. Of these, 14.9% had self-resolving isolated elevated aminotransferases, 18.7% gastrointestinal bleeding without hemodynamic compromise and 56.1% plasma leakage with isolated tachycardia. We compared both guidelines against requirement for intensive care including the single death in this series: all six had severe dengue; only four had DHF as two lacked bleeding manifestations but had plasma leakage. Increasing length of hospitalization was noted among severe cases with both classifications but the trend was only statistically significant for WHO 2009. Length of hospitalization was significantly longer for severe plasma leakage compared with severe bleeding or organ impairment. Requirement for hospitalization increased using WHO 2009 from 17.0% to 51.3%. Conclusions: While the WHO 2009 dengue classification is clinically useful, we propose retaining criteria for plasma leakage and hemodynamic compromise from WHO 1997, and refining definitions of severe bleeding and organ impairment to improve clinical relevance having found that differences in these accounted for the discordance between classifications. Findings from our retrospective study may be limited by the study site - a tertiary referral center in a hyperendemic country - and should be evaluated in a wider range of geographic settings.	[Gan, Victor C.; Lye, David C.; Thein, Tun L.; Dimatatac, Frederico; Tan, Adriana S.; Leo, Yee-Sin] Tan Tock Seng Hosp, Communicable Dis Ctr, Singapore, Singapore; [Lye, David C.; Leo, Yee-Sin] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore	Tan Tock Seng Hospital; National University of Singapore	Gan, VC (corresponding author), Tan Tock Seng Hosp, Communicable Dis Ctr, Singapore, Singapore.	Victor.Gan@mohh.com.sg	Lye, David/ABF-4402-2021; Thein, Tun-Linn/Y-9520-2018; Thein, Tun-Linn/K-5281-2019	Thein, Tun-Linn/0000-0002-5254-032X; Thein, Tun-Linn/0000-0002-5254-032X; Lye, David/0000-0003-0324-0205; Gan, Victor/0000-0002-6966-2729	National Medical Research Council; Translational and Clinical Research Flagship Programme [NMRC/TCR/005]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Translational and Clinical Research Flagship Programme	This study was funded by a National Medical Research Council (http://www.nmrc.gov.sg) Translational and Clinical Research Flagship Programme Grant NMRC/TCR/005 for Scientific exploration, Translational research, Operational evaluation of disease prevention and Preventative measures through new treatment strategies against Dengue (STOP Dengue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x; Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; Barkham TM, 2006, T ROY SOC TROP MED H, V100, P142, DOI 10.1016/j.trstmh.2005.05.015; Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106; Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; Egger JR, 2007, EMERG INFECT DIS, V13, P924, DOI 10.3201/eid1306.070008; Garcia-Rivera EJ, 2002, LANCET, V360, P261, DOI 10.1016/S0140-6736(02)09481-3; GOH KT, 1995, LANCET, V346, P1098, DOI 10.1016/S0140-6736(95)91771-3; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Ingram PR, 2009, T ROY SOC TROP MED H, V103, P203, DOI 10.1016/j.trstmh.2008.07.007; Kalayanarooj Siripen, 2011, J Med Assoc Thai, V94 Suppl 3, pS74; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Lee LK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001676; Lee LK, 2012, T ROYAL SOC IN PRESS; Lee VJ, 2009, TROP MED INT HEALTH, V14, P1154, DOI 10.1111/j.1365-3156.2009.02337.x; Lee VJ, 2008, J CLIN VIROL, V42, P34, DOI 10.1016/j.jcv.2007.12.017; Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191; Lye D, 2005, EPIDEMIOL NEWS B, V31, P44; Lye DC, 2008, SINGAP MED J, V49, P476; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Ministry of Health Singapore, 2005, COMM DIS SURV SING 2; Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397; Ooi EE, 2001, DENGUE B, V25, P41; Polson J, 2005, HEPATOLOGY, V41, P1179, DOI 10.1002/hep.20703; Programme for Research and Training in Tropical Diseases, 2009, Dengue: guidelines for diagnosis, treatment, prevention and control; Rigau-Perez JG, 2006, LANCET INFECT DIS, V6, P297, DOI 10.1016/S1473-3099(06)70465-0; Santamaria R, 2009, INT HEALTH, V1, P133, DOI 10.1016/j.inhe.2009.08.006; Seet RCS, 2005, J CLIN VIROL, V33, P336, DOI 10.1016/j.jcv.2005.03.002; Srikiatkhachorn A, 2011, CLIN INFECT DIS, V53, P563, DOI 10.1093/cid/cir451; van de Weg CAM, 2012, AM J TROP MED HYG, V86, P166, DOI 10.4269/ajtmh.2012.11-0491; WHO, 1997, DENG HAEM FEV DIAGN; WHO Regional Office for South-East Asia, 2011, COMPR GUID PREV CONT	33	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60946	10.1371/journal.pone.0060946	http://dx.doi.org/10.1371/journal.pone.0060946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573291	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900083
J	Hilton, S; Bennett, AJ; Keane, G; Bending, GD; Chandler, D; Stobart, R; Mills, P				Hilton, Sally; Bennett, Amanda J.; Keane, Gary; Bending, Gary D.; Chandler, David; Stobart, Ron; Mills, Peter			Impact of Shortened Crop Rotation of Oilseed Rape on Soil and Rhizosphere Microbial Diversity in Relation to Yield Decline	PLOS ONE			English	Article							RESTRICTION-FRAGMENT-LENGTH; BACTERIAL COMMUNITIES; OLPIDIUM-BRASSICAE; SEQUENCES; SYSTEMS; TOMATO; WHEAT	Oilseed rape (OSR) grown in monoculture shows a decline in yield relative to virgin OSR of up to 25%, but the mechanisms responsible are unknown. A long term field experiment of OSR grown in a range of rotations with wheat was used to determine whether shifts in fungal and bacterial populations of the rhizosphere and bulk soil were associated with the development of OSR yield decline. The communities of fungi and bacteria in the rhizosphere and bulk soil from the field experiment were profiled using terminal restriction fragment length polymorphism (TRFLP) and sequencing of cloned internal transcribed spacer regions and 16S rRNA genes, respectively. OSR cropping frequency had no effect on rhizosphere bacterial communities. However, the rhizosphere fungal communities from continuously grown OSR were significantly different to those from other rotations. This was due primarily to an increase in abundance of two fungi which showed 100% and 95% DNA identity to the plant pathogens Olpidium brassicae and Pyrenochaeta lycopersici, respectively. Real-time PCR confirmed that there was significantly more of these fungi in the continuously grown OSR than the other rotations. These two fungi were isolated from the field and used to inoculate OSR and Brassica oleracea grown under controlled conditions in a glasshouse to determine their effect on yield. At high doses, Olpidium brassicae reduced top growth and root biomass in seedlings and reduced branching and subsequent pod and seed production. Pyrenochaeta sp. formed lesions on the roots of seedlings, and at high doses delayed flowering and had a negative impact on seed quantity and quality.	[Hilton, Sally; Bennett, Amanda J.; Keane, Gary; Bending, Gary D.; Chandler, David; Mills, Peter] Univ Warwick, Sch Life Sci, Wellesbourne, Warwick, England; [Stobart, Ron] Natl Inst Agr Bot, Wymondham, Norfolk, England	University of Warwick	Hilton, S (corresponding author), Univ Warwick, Sch Life Sci, Wellesbourne, Warwick, England.	s.hilton.1@warwick.ac.uk	bending, Gary d/A-1197-2010	Keane, Gary/0000-0002-4762-5644; Bending, Gary/0000-0002-9740-5244	DEFRA (Department for Environment Food and Rural Affairs) [IF028]; HGCA (Home Grown Cereals Authority) [RD-2003-2922]	DEFRA (Department for Environment Food and Rural Affairs)(Department for Environment, Food & Rural Affairs (DEFRA)); HGCA (Home Grown Cereals Authority)	Funding was provided by DEFRA (Department for Environment Food and Rural Affairs) project IF028, www.defra.gov.uk/; and HGCA (Home Grown Cereals Authority) project RD-2003-2922, http://www.hgca.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvey S, 2003, BIOL FERT SOILS, V37, P73, DOI 10.1007/s00374-002-0573-2; Herrera-Vasquez JA, 2009, MYCOL RES, V113, P602, DOI 10.1016/j.mycres.2009.01.007; BAKKER AW, 1987, SOIL BIOL BIOCHEM, V19, P451, DOI 10.1016/0038-0717(87)90037-X; Bennett AJ, 2012, BIOL REV, V87, P52, DOI 10.1111/j.1469-185X.2011.00184.x; Berry PM, 2006, J AGR SCI-CAMBRIDGE, V144, P381, DOI 10.1017/S0021859606006423; CAMPBELL RN, 1985, CAN J BOT, V63, P2288, DOI 10.1139/b85-326; CHRISTEN O, 1995, J AGRON CROP SCI, V174, P265, DOI 10.1111/j.1439-037X.1995.tb01112.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CROOKSTON RK, 1991, AGRON J, V83, P108, DOI 10.2134/agronj1991.00021962008300010026x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Germida JJ, 1998, FEMS MICROBIOL ECOL, V27, P133, DOI 10.1111/j.1574-6941.1998.tb00531.x; Hartwright LM, 2010, FUNGAL BIOL-UK, V114, P26, DOI 10.1016/j.mycres.2009.09.008; Hasna MK, 2009, CROP PROT, V28, P155, DOI 10.1016/j.cropro.2008.09.011; Hauben L, 1997, INT J SYST BACTERIOL, V47, P328, DOI 10.1099/00207713-47-2-328; Kaplan CW, 2003, J MICROBIOL METH, V54, P121, DOI 10.1016/S0167-7012(03)00003-4; KARLEN DL, 1994, ADV AGRON, V53, P1, DOI 10.1016/S0065-2113(08)60611-2; Kelley KW, 2003, FIELD CROP RES, V83, P41, DOI 10.1016/S0378-4290(03)00055-8; Kirkegaard J, 2008, FIELD CROP RES, V107, P185, DOI 10.1016/j.fcr.2008.02.010; Larkin RP, 2006, PHYTOPATHOLOGY, V96, P68, DOI 10.1094/PHYTO-96-0068; Larkin RP, 2003, SOIL BIOL BIOCHEM, V35, P1451, DOI 10.1016/S0038-0717(03)00240-2; Lei JL, 2006, ALLELOPATHY J, V18, P141; Li CG, 2010, PLANT SOIL, V330, P423, DOI 10.1007/s11104-009-0216-6; Li QH, 2009, ACTA AGR SCAND B-S P, V59, P431, DOI 10.1080/09064710802342319; Lupwayi NZ, 1998, SOIL BIOL BIOCHEM, V30, P1733, DOI 10.1016/S0038-0717(98)00025-X; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Marsh TL, 2005, METHOD ENZYMOL, V397, P308, DOI 10.1016/S0076-6879(05)97018-3; Pankhurst CE, 2005, SOIL BIOL BIOCHEM, V37, P1121, DOI 10.1016/j.soilbio.2004.11.011; Sasaya Takahide, 2006, Journal of General Plant Pathology, V72, P20, DOI 10.1007/s10327-005-0239-7; SCHIPPERS B, 1987, ANNU REV PHYTOPATHOL, V25, P339, DOI 10.1146/annurev.py.25.090187.002011; SINGH SL, 1977, MYCOPATHOLOGIA, V62, P47, DOI 10.1007/BF00491995; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Stobart R., 2009, ASPECTS APPL BIOL, V91, P147; Stobart RM., 2013, IMPACT PREVIOUS CROP; Varela AR, 2009, ACTA AGR SCAND B-S P, V59, P379, DOI 10.1080/09064710802263218; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weightman R, 2011, RSC ENERGY ENVIRON S, P116; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; Zare R, 2007, NOVA HEDWIGIA, V85, P463, DOI 10.1127/0029-5035/2007/0085-0463	39	58	60	3	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59859	10.1371/journal.pone.0059859	http://dx.doi.org/10.1371/journal.pone.0059859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573215	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900031
J	Hong, ZH; Jiang, J; Ma, JL; Dai, SK; Xu, T; Li, H; Yasui, A				Hong, Zehui; Jiang, Jie; Ma, Jiaolong; Dai, Shikui; Xu, Ting; Li, Hui; Yasui, Akira			The Role of hnRPUL1 Involved in DNA Damage Response Is Related to PARP1	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HUMAN-CELLS; REPAIR; PROTEINS; PROMOTES; RECRUITMENT; POLY(ADP-RIBOSE); INTERACTS; E1B-AP5; PATHWAY	Heterogeneous nuclear ribonucleoprotein U-like 1 (hnRPUL1) -also known as adenovirus early region 1B-associated proteins 5 (E1B-AP5) - plays a role in RNA metabolism. Recently, hnRPUL1 has also been shown to be involved in DNA damage response, but the function of hnRPUL1 in response to DNA damage remains unclear. Here, we have demonstrated that hnRPUL1 is associated with PARP1 and recruited to DNA double-strand breaks (DSBs) sites in a PARP1-mediated poly (ADP-ribosyl) ation dependent manner. In turn, hnRPUL1 knockdown enhances the recruitment of PARP1 to DSBs sites. Specifically, we showed that hnRPUL1 is also implicated in the transcriptional regulation of PARP1 gene. Thus, we propose hnRPUL1 as a new component related to PARP1 in DNA damage response and repair.	[Hong, Zehui; Ma, Jiaolong; Dai, Shikui; Li, Hui] Southeast Univ, Sch Med, Dept Genet & Dev Biol, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Jiang, Jie] Nanjing Municipal Govt Hosp, Dept Internal Med, Nanjing, Jiangsu, Peoples R China; [Xu, Ting] Jiangsu Canc Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Hong, Zehui; Jiang, Jie; Yasui, Akira] Tohoku Univ, Div Dynam Proteome, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Southeast University - China; Nanjing Medical University; Tohoku University	Hong, ZH (corresponding author), Southeast Univ, Sch Med, Dept Genet & Dev Biol, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing, Jiangsu, Peoples R China.	hongzehui@seu.edu.cn; ayasui@idac.tohoku.ac.jp			National Natural Science Foundation of China [90919007, 30900812]; New-Century Training Program Foundation for the Talents by the State Education Commission; Youth Foundation of southeast university; Ministry of Education, Culture, Sports, Science and Technology, Japan [20241011, 22131005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New-Century Training Program Foundation for the Talents by the State Education Commission; Youth Foundation of southeast university; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by National Natural Science Foundation of China (90919007 and 30900812), New-Century Training Program Foundation for the Talents by the State Education Commission and Youth Foundation of southeast university to ZH; and the Ministry of Education, Culture, Sports, Science and Technology, Japan to AY (20241011 and 22131005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Barral PM, 2005, FEBS LETT, V579, P2752, DOI 10.1016/j.febslet.2005.03.095; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Cheng Q, 2011, NUCLEIC ACIDS RES, V39, P9605, DOI 10.1093/nar/gkr656; Gabler S, 1998, J VIROL, V72, P7960, DOI 10.1128/JVI.72.10.7960-7971.1998; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Haince JF, 2007, J BIOL CHEM, V282, P16441, DOI 10.1074/jbc.M608406200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Iwanaga K, 2005, BIOCHEM BIOPH RES CO, V333, P888, DOI 10.1016/j.bbrc.2005.05.180; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kzhyshkowska J, 2001, BIOCHEM J, V358, P305, DOI 10.1042/0264-6021:3580305; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Lee SY, 2005, BIOCHEM J, V388, P7, DOI 10.1042/BJ20042033; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Polo SE, 2012, MOL CELL, V45, P505, DOI 10.1016/j.molcel.2011.12.035; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shiffman D, 2006, ARTERIOSCL THROM VAS, V26, P1613, DOI 10.1161/01.ATV.0000226543.77214.e4; Shin KH, 2007, DNA REPAIR, V6, P830, DOI 10.1016/j.dnarep.2007.01.013; Zhang SS, 2004, NUCLEIC ACIDS RES, V32, P1, DOI 10.1093/nar/gkg933	29	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60208	10.1371/journal.pone.0060208	http://dx.doi.org/10.1371/journal.pone.0060208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577092	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800034
J	Houspie, L; Lemey, P; Keyaerts, E; Reijmen, E; Vergote, V; Vankeerberghen, A; Vaeyens, F; De Beenhouwer, H; Van Ranst, M				Houspie, Lieselot; Lemey, Philippe; Keyaerts, Els; Reijmen, Eva; Vergote, Valentijn; Vankeerberghen, Anne; Vaeyens, Freya; De Beenhouwer, Hans; Van Ranst, Marc			Circulation of HRSV in Belgium: From Multiple Genotype Circulation to Prolonged Circulation of Predominant Genotypes	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; AMINO-ACID CHANGES; G-PROTEIN GENE; SUBGROUP-A; MOLECULAR EPIDEMIOLOGY; G-GLYCOPROTEIN; SOUTH-AFRICA; EVOLUTION; VARIABILITY; PATTERNS	Molecular surveillance of HRSV in Belgium for 15 consecutive seasons (1996-2011) revealed a shift from a regular 3-yearly cyclic pattern, into a yearly alternating periodicity where HRSV-B is replaced by HRSV-A. Phylogenetic analysis for HRSV-A demonstrated the stable circulation of GA2 and GA5, with GA2 being dominant over GA5 during 5 consecutive seasons (2006-2011). We also identified 2 new genotype specific amino acid mutations of the GA2 genotype (A122 and Q156) and 7 new GA5 genotype specific amino acid mutations (F102, I108, T111, I125, D161, S191 and L217). Several amino acid positions, all located in the second hypervariable region of HRSV-A were found to be under positive selection. Phylogenetic analysis of HRSV-B showed the circulation of GB12 and GB13, where GB13 represented 100% of the isolated strains in 4 out of 5 consecutive seasons (2007-2011). Amino acids under positive selection were all located in the aminoterminal hypervariable region of HRSV-B, except one amino acid located in the conserved region. The genotype distribution within the HRSV-B subgroup has evolved from a co-circulation of multiple genotypes to the circulation of a single predominant genotype. The Belgian GB13 strains circulating since 2006, all clustered under the BAIV branch and contained several branch specific amino acid substitutions. The demographic history of genotypes GA2, GA5 and GB13 demonstrated a decrease in the total GA2 and GA5 population size, coinciding with the global expansion of the GB13 population. The emergence of the GB13 genotype resulted in a newly established balance between the predominant genotypes.	[Houspie, Lieselot; Keyaerts, Els; Reijmen, Eva; Vergote, Valentijn; Van Ranst, Marc] Univ Louvain, Lab Clin Virol, Rega Inst Med Res, Louvain, Belgium; [Lemey, Philippe; De Beenhouwer, Hans] Univ Louvain, Lab Clin & Epidemiol Virol, Rega Inst Med Res, Louvain, Belgium; [Vankeerberghen, Anne; Vaeyens, Freya] Onze Lieve Vrouw Hosp, Mol Biol Lab, Aalst, Belgium	KU Leuven; KU Leuven	Houspie, L (corresponding author), Univ Louvain, Lab Clin Virol, Rega Inst Med Res, Louvain, Belgium.	lieselot.houspie@uzleuven.be	Lemey, Philippe/C-3755-2018; Vergote, Valentijn/F-5831-2018; Van Ranst, Marc/P-7522-2017; Keyaerts, Els/F-2305-2018	Lemey, Philippe/0000-0003-2826-5353; Vergote, Valentijn/0000-0002-4436-3212; Van Ranst, Marc/0000-0002-1674-4157; Keyaerts, Els/0000-0002-1849-3240	Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT) [070005]	Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was supported in part by a grant of the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT), project number 070005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; [Anonymous], J VIROL; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; CANE PA, 1991, J GEN VIROL, V72, P2091, DOI 10.1099/0022-1317-72-9-2091; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ducoffre G, 2009, PEDIAT INFECT DIS J, P28; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Fodha I, 2008, PATHOL BIOL, V56, P50, DOI 10.1016/j.patbio.2007.06.001; GARCIA O, 1994, J VIROL, V68, P5448; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Montieri S, 2007, J MED VIROL, V79, P1935, DOI 10.1002/jmv.21012; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Ostlund MR, 2008, J MED VIROL, V80, P159, DOI 10.1002/jmv.21066; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Ratiefard F, 2004, VIRUS RES, V105, P137, DOI 10.1016/j.virusres.2004.05.004; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Salter A, 2011, J MED VIROL, V83, P337, DOI 10.1002/jmv.21957; Scott PD, 2006, J INFECT DIS, V193, P59, DOI 10.1086/498246; Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262; Sloan C, 2011, CTS-CLIN TRANSL SCI, V4, P48, DOI 10.1111/j.1752-8062.2010.00257.x; Sovero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022111; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; SULLENDER WM, 1991, J VIROL, V65, P5425, DOI 10.1128/JVI.65.10.5425-5434.1991; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Venter M, 2002, J MED VIROL, V68, P452, DOI 10.1002/jmv.10225; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Viegas M, 2005, J MED VIROL, V77, P302, DOI 10.1002/jmv.20457; Wertz GW, 2004, PEDIATR INFECT DIS J, V23, pS19, DOI 10.1097/01.inf.0000108189.87181.7c; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yamaguchi M, 2011, J CLIN MICROBIOL, V49, P1034, DOI 10.1128/JCM.02132-10; Zhang RF, 2010, J CLIN MICROBIOL, V48, P4193, DOI 10.1128/JCM.00179-10; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005; Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004	44	29	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60416	10.1371/journal.pone.0060416	http://dx.doi.org/10.1371/journal.pone.0060416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577109	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800049
J	Lampel, A; Bram, Y; Levy-Sakin, M; Bacharach, E; Gazit, E				Lampel, Ayala; Bram, Yaron; Levy-Sakin, Michal; Bacharach, Eran; Gazit, Ehud			The Effect of Chemical Chaperones on the Assembly and Stability of HIV-1 Capsid Protein	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C-TERMINAL DOMAIN; IN-VITRO; INTERSUBUNIT INTERACTIONS; CONFORMATIONAL-CHANGES; HYDROSTATIC-PRESSURE; DIMERIZATION DOMAIN; MISFOLDING DISEASES; ORGANIC OSMOLYTES; AMYLOID FORMATION	Chemical chaperones are small organic molecules which accumulate in a broad range of organisms in various tissues under different stress conditions and assist in the maintenance of a correct proteostasis under denaturating environments. The effect of chemical chaperones on protein folding and aggregation has been extensively studied and is generally considered to be mediated through non-specific interactions. However, the precise mechanism of action remains elusive. Protein self-assembly is a key event in both native and pathological states, ranging from microtubules and actin filaments formation to toxic amyloids appearance in degenerative disorders, such as Alzheimer's and Parkinson's diseases. Another pathological event, in which protein assembly cascade is a fundamental process, is the formation of virus particles. In the late stage of the virus life cycle, capsid proteins self-assemble into highly-ordered cores, which encapsulate the viral genome, consequently protect genome integrity and mediate infectivity. In this study, we examined the effect of different groups of chemical chaperones on viral capsid assembly in vitro, focusing on HIV-1 capsid protein as a system model. We found that while polyols and sugars markedly inhibited capsid assembly, methylamines dramatically enhanced the assembly rate. Moreover, chemical chaperones that inhibited capsid core formation, also stabilized capsid structure under thermal denaturation. Correspondingly, trimethylamine N-oxide, which facilitated formation of high-order assemblies, clearly destabilized capsid structure under similar conditions. In contrast to the prevailing hypothesis suggesting that chemical chaperones affect proteins through preferential exclusion, the observed dual effects imply that different chaperones modify capsid assembly and stability through different mechanisms. Furthermore, our results indicate a correlation between the folding state of capsid to its tendency to assemble into highly-ordered structures.	[Lampel, Ayala; Bram, Yaron; Levy-Sakin, Michal; Gazit, Ehud] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Bacharach, Eran] Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Bacharach, E (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	eranbac@post.tau.ac.il; ehudg@post.tau.ac.il	Lampel, Ayala/ABC-6216-2021; Gazit, Ehud/M-8026-2019; Gazit, Ehud/C-3715-2011; Gazit, Ehud/AHE-9332-2022	Lampel, Ayala/0000-0003-2733-9197; Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Bacharach, Eran/0000-0001-8341-2833	Ministry of Science and Technology of Israel	Ministry of Science and Technology of Israel(Ministry of Science, Technology and Space (MOST), Israel)	The Levi Eshkol Fellowship from the Ministry of Science and Technology of Israel http://most.gov.il/ProgramTashtiot/melagot/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Arakawa T, 2006, BBA-PROTEINS PROTEOM, V1764, P1677, DOI 10.1016/j.bbapap.2006.08.012; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; Chen B, 2010, PROTEIN SCI, V19, P716, DOI 10.1002/pro.348; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cho SS, 2011, J PHYS CHEM B, V115, P13401, DOI 10.1021/jp207289b; Chow MKM, 2001, BIOL CHEM, V382, P1593, DOI 10.1515/BC.2001.194; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Ehrlich LS, 2001, BIOPHYS J, V81, P586, DOI 10.1016/S0006-3495(01)75725-6; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Fung J, 2005, BIOCHEM BIOPH RES CO, V328, P1067, DOI 10.1016/j.bbrc.2005.01.068; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gazit E, 2010, NAT CHEM, V2, P1010, DOI 10.1038/nchem.912; Gottlinger HG, 2001, AIDS, V15, pS13; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Gross I, 2000, EMBO J, V19, P103, DOI 10.1093/emboj/19.1.103; Harries D, 2008, METHOD CELL BIOL, V84, P679, DOI 10.1016/S0091-679X(07)84022-2; Holthauzen LMF, 2007, PROTEIN SCI, V16, P293, DOI 10.1110/ps.062610407; Holthauzen LMF, 2010, BIOCHEMISTRY-US, V49, P1310, DOI 10.1021/bi9015499; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Kim YS, 2001, J BIOL CHEM, V276, P1626, DOI 10.1074/jbc.M007766200; Lanman J, 2002, J VIROL, V76, P6900, DOI 10.1128/JVI.76.14.6900-6908.2002; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Lidon-Moya MC, 2005, PROTEIN SCI, V14, P2387, DOI 10.1110/ps.041324305; Mateu MG, 2009, FEBS J, V276, P6098, DOI 10.1111/j.1742-4658.2009.07313.x; Mateu MG, 2002, J MOL BIOL, V318, P519, DOI 10.1016/S0022-2836(02)00091-8; Nayak A, 2009, BIOTECHNOL PROGR, V25, P1508, DOI 10.1002/btpr.255; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Philp D, 1996, ANGEW CHEM INT EDIT, V35, P1154, DOI 10.1002/anie.199611541; Prevelige PE, 2011, J MOL BIOL, V410, P634, DOI 10.1016/j.jmb.2011.03.074; Qi W, 2009, BIOCHEMISTRY-US, V48, P8908, DOI 10.1021/bi9006397; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Sukenik S, 2012, PRION, V6, P26, DOI 10.4161/pri.6.1.18132; Sukenik S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015608; Vogt VM, 2005, NAT STRUCT MOL BIOL, V12, P638, DOI 10.1038/nsmb0805-638; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Yancey Paul H., 2004, Science Progress, V87, P1, DOI 10.3184/003685004783238599; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yancey PH, 2002, COMP BIOCHEM PHYS A, V133, P667, DOI 10.1016/S1095-6433(02)00182-4; Yancey PH, 2001, J EXP ZOOL, V289, P172, DOI 10.1002/1097-010X(20010215)289:3<172::AID-JEZ3>3.0.CO;2-J; YANCEY PH, 1990, AM J PHYSIOL, V258, pR198, DOI 10.1152/ajpregu.1990.258.1.R198; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zlotnick A, 2011, TRENDS MICROBIOL, V19, P14, DOI 10.1016/j.tim.2010.11.003	58	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60867	10.1371/journal.pone.0060867	http://dx.doi.org/10.1371/journal.pone.0060867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577173	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800110
J	Eynon, N; Nasibulina, ES; Banting, LK; Cieszczyk, P; Maciejewska-Karlowska, A; Sawczuk, M; Bondareva, EA; Shagimardanova, RR; Raz, M; Sharon, Y; Williams, AG; Ahmetov, II; Lucia, A; Birk, R				Eynon, Nir; Nasibulina, Emiliya S.; Banting, Lauren K.; Cieszczyk, Pawel; Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek; Bondareva, Elvira A.; Shagimardanova, Roza R.; Raz, Maytal; Sharon, Yael; Williams, Alun G.; Ahmetov, Ildus I.; Lucia, Alejandro; Birk, Ruth			The FTO A/T Polymorphism and Elite Athletic Performance: A Study Involving Three Groups of European Athletes	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; GENE; ASSOCIATION; GLY482SER; MASS; FAT; TRP64ARG; FITNESS; VARIANT; ALLELE	Objective: The FTO A/T polymorphism (rs9939609) is a strong candidate to influence obesity-related traits. Elite athletes from many different sporting disciplines are characterized by low body fat. Therefore, the aim of this study was to assess whether athletic status is associated with the FTO A/T polymorphism. Subjects and Methods: A large cohort of European Caucasians from Poland, Russia and Spain were tested to examine the association between FTO A/T polymorphism (rs9939609) and athletic status. A total of 551 athletes were divided by type of sport (endurance athletes, n = 266 vs. sprint/power athletes, n = 285) as well as by level of competition (elite-level vs. national-level). The control group consisted of 1,416 ethnically-matched, non-athletic participants, all Europeans. Multinomial logistic regression analyses were conducted to assess the association between FTO A/T genotypes and athletic status/competition level. Results: There were no significantly greater/lesser odds of harbouring any type of genotype when comparing across athletic status (endurance athletes, sprint/power athletes or control participants). These effects were observed after controlling for sex and nationality. Furthermore, no significantly greater/lesser odds ratios were observed for any of the genotypes in respect to the level of competition (elite-level vs. national-level). Conclusion: The FTO A/T polymorphism is not associated with elite athletic status in the largest group of elite athletes studied to date. Large collaborations and data sharing between researchers, as presented here, are strongly recommended to enhance the research in the field of exercise genomics.	[Eynon, Nir] Victoria Univ, Sch Sports & Exercise Sci, Melbourne, Vic 8001, Australia; [Eynon, Nir; Banting, Lauren K.] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Nasibulina, Emiliya S.; Shagimardanova, Roza R.; Ahmetov, Ildus I.] Kazan State Med Univ, Mol Genet Lab, Kazan, Russia; [Cieszczyk, Pawel] Acad Phys Educ & Sport, Fac Tourism & Recreat, Gdansk, Poland; [Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek] Univ Szczecin, Fac Phys Culture & Heath Promot, Szczecin, Poland; [Bondareva, Elvira A.] Moscow MV Lomonosov State Univ, Inst & Museum Anthropol, Moscow, Russia; [Raz, Maytal; Sharon, Yael; Birk, Ruth] Ariel Univ Ctr, Dept Nutr, Fac Hlth Sci, Ariel, Israel; [Williams, Alun G.] Manchester Metropolitan Univ, Ctr Genom Res Exercise Performance & Hlth, Manchester M15 6BH, Lancs, England; [Ahmetov, Ildus I.] Volga Reg State Acad Phys Culture Sport & Tourism, Sport Technol Educ Res Lab, Kazan, Russia; [Lucia, Alejandro] European Univ Madrid, Sch Doctorate Studies & Res, Madrid, Spain	Victoria University; Victoria University; Kazan State Medical University; Gdansk University of Physical Education & Sport; University of Szczecin; Lomonosov Moscow State University; Ariel University; Manchester Metropolitan University; Volga Region State Academy of Physical Culture, Sport & Tourism; European University of Madrid	Eynon, N (corresponding author), Victoria Univ, Sch Sports & Exercise Sci, Melbourne, Vic 8001, Australia.	Nir.Eynon@vu.edu.au	Sawczuk, Marek/S-3609-2017; Williams, Alun G/B-6817-2008; Cieszczyk, Pawel/AFK-4645-2022; Ahmetov, Ildus I/C-6163-2009; Cieszczyk, Pawel/AAG-3328-2022; Lucia, Alejandro/M-2759-2014	Williams, Alun G/0000-0002-8052-8184; Cieszczyk, Pawel/0000-0002-7735-7580; Ahmetov, Ildus I/0000-0002-6335-4020; Cieszczyk, Pawel/0000-0002-7735-7580; Lucia, Alejandro/0000-0002-3025-2060; birk, ruth/0000-0001-5770-4277; Eynon, Nir/0000-0003-4046-8276; Maciejewska-Skrendo, Agnieszka/0000-0003-4587-2411; Lucia, Alejandro/0000-0002-5565-0997; Bondareva, Elvira/0000-0003-3321-7575; Sawczuk, Marek/0000-0002-5730-5249				Ahmetov II, 2009, HUM GENET, V126, P751, DOI 10.1007/s00439-009-0728-4; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P191, DOI 10.1001/jama.2008.946; Baturin A. K., 2012, Voprosy Pitaniya, V81, P23; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Cook CM, 2011, CURR OPIN CLIN NUTR, V14, P419, DOI 10.1097/MCO.0b013e328349b9ff; Demerath EW, 2011, OBESITY, V19, P1866, DOI 10.1038/oby.2011.131; Esterbauer H, 2002, DIABETES, V51, P1281, DOI 10.2337/diabetes.51.4.1281; Eynon N, 2010, SCAND J MED SCI SPOR, V20, pE145, DOI 10.1111/j.1600-0838.2009.00930.x; Eynon N, 2011, J PHYSIOL-LONDON, V589, P3063, DOI 10.1113/jphysiol.2011.207035; Eynon N, 2009, EXP PHYSIOL, V94, P1147, DOI 10.1113/expphysiol.2009.049668; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Grunnet LG, 2009, J CLIN ENDOCR METAB, V94, P596, DOI 10.1210/jc.2008-1592; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Kujala UM, 2001, JAMA-J AM MED ASSOC, V285, P44, DOI 10.1001/jama.285.1.44; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Lopez-Bermejo A, 2008, J CLIN ENDOCR METAB, V93, P1501, DOI 10.1210/jc.2007-2343; Lucia A, 2005, J APPL PHYSIOL, V99, P344, DOI 10.1152/japplphysiol.00037.2005; Maciejewska A, 2012, J SPORT SCI, V30, P101, DOI 10.1080/02640414.2011.623709; Mengelkoch LJ, 1997, J AM GERIATR SOC, V45, P1446, DOI 10.1111/j.1532-5415.1997.tb03194.x; Ridderstrale M, 2006, DIABETOLOGIA, V49, P496, DOI 10.1007/s00125-005-0129-8; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Roth SM, 2012, MED SCI SPORT EXER, V44, P809, DOI 10.1249/MSS.0b013e31824f28b6; Ruiz JR, 2009, J PHYSIOL-LONDON, V587, P1527, DOI 10.1113/jphysiol.2008.166645; Santiago C, 2011, BRIT J SPORT MED, V45, P147, DOI 10.1136/bjsm.2009.061366; SARNA S, 1993, MED SCI SPORT EXER, V25, P237; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Tsunekawa K, 2011, ENDOCR J, V58, P1079, DOI 10.1507/endocrj.EJ11-0148; Williams AG, 2008, J PHYSIOL-LONDON, V586, P113, DOI 10.1113/jphysiol.2007.141887; Wolfarth B, 2007, METABOLISM, V56, P1649, DOI 10.1016/j.metabol.2007.07.006	35	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60570	10.1371/journal.pone.0060570	http://dx.doi.org/10.1371/journal.pone.0060570			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573268	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000318840100086
J	Fujita, M; Sasanuma, H; Yamamoto, KN; Harada, H; Kurosawa, A; Adachi, N; Omura, M; Hiraoka, M; Takeda, S; Hirota, K				Fujita, Mari; Sasanuma, Hiroyuki; Yamamoto, Kimiyo N.; Harada, Hiroshi; Kurosawa, Aya; Adachi, Noritaka; Omura, Masato; Hiraoka, Masahiro; Takeda, Shunichi; Hirota, Kouji			Interference in DNA Replication Can Cause Mitotic Chromosomal Breakage Unassociated with Double-Strand Breaks	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; REPAIR PATHWAYS; ABERRATION PRODUCTION; MOLECULAR-MECHANISMS; TRANSLOCATIONS; CELLS; ROLES; GENE; ENDONUCLEASE; MAINTENANCE	Morphological analysis of mitotic chromosomes is used to detect mutagenic chemical compounds and to estimate the dose of ionizing radiation to be administered. It has long been believed that chromosomal breaks are always associated with double-strand breaks (DSBs). We here provide compelling evidence against this canonical theory. We employed a genetic approach using two cell lines, chicken DT40 and human Nalm-6. We measured the number of chromosomal breaks induced by three replication-blocking agents (aphidicolin, 5-fluorouracil, and hydroxyurea) in DSB-repair-proficient wild-type cells and cells deficient in both homologous recombination and nonhomologous end-joining (the two major DSB-repair pathways). Exposure of cells to the three replication-blocking agents for at least two cell cycles resulted in comparable numbers of chromosomal breaks for RAD54(-/-/)KU70(-/-) DT40 clones and wild-type cells. Likewise, the numbers of chromosomal breaks induced in RAD54(-/-/)LIG4(-/-) Nalm-6 clones and wild-type cells were also comparable. These data indicate that the replication-blocking agents can cause chromosomal breaks unassociated with DSBs. In contrast with DSB-repair-deficient cells, chicken DT40 cells deficient in PIF1 or ATRIP, which molecules contribute to the completion of DNA replication, displayed higher numbers of mitotic chromosomal breaks induced by aphidicolin than did wild-type cells, suggesting that single-strand gaps left unreplicated may result in mitotic chromosomal breaks.	[Fujita, Mari; Sasanuma, Hiroyuki; Yamamoto, Kimiyo N.; Omura, Masato; Takeda, Shunichi; Hirota, Kouji] Kyoto Univ, Dept Radiat Genet, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Harada, Hiroshi] Kyoto Univ, Grp Radiat & Tumor Biol, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto, Japan; [Kurosawa, Aya; Adachi, Noritaka] Yokohama City Univ, Int Grad Sch Arts & Sci, Yokohama, Kanagawa 232, Japan; [Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Radiat Oncol & Image Appl Therapy, Kyoto, Japan	Kyoto University; Kyoto University; Yokohama City University; Kyoto University	Hirota, K (corresponding author), Kyoto Univ, Dept Radiat Genet, Grad Sch Med, Sakyo Ku, Kyoto, Japan.	khirota@rg.med.kyoto-u.ac.jp	Kurosawa, Aya/O-5165-2018	Kurosawa, Aya/0000-0001-8909-2789; Takeda, Shunichi/0000-0002-7924-7991	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [RF-1005]; CERI	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); CERI	This work was supported by the Environment Research and Technology Development Fund (RF-1005) of the Ministry of the Environment, Japan and a research grant from CERI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Noritaka, 2008, V435, P17, DOI 10.1007/978-1-59745-232-8_2; Amstutz U, 2011, PHARMACOGENOMICS, V12, P1321, DOI [10.2217/pgs.11.72, 10.2217/PGS.11.72]; Anand RP, 2012, NUCLEIC ACIDS RES, V40, P1091, DOI 10.1093/nar/gkr836; BECKLOFF GERALD L., 1965, CANCER CHEMO THERAP REP, V48, P57; BENDER MA, 1974, MUTAT RES, V23, P197, DOI 10.1016/0027-5107(74)90140-7; BRYANT PE, 1993, MUTAT RES, V299, P289, DOI 10.1016/0165-1218(93)90105-M; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Cimino MC, 2006, ENVIRON MOL MUTAGEN, V47, P362, DOI 10.1002/em.20216; COHEN MM, 1975, CYTOGENET CELL GENET, V15, P338, DOI 10.1159/000130530; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; El Achkar E, 2005, P NATL ACAD SCI USA, V102, P18069, DOI 10.1073/pnas.0506497102; Eppink B, 2011, DNA REPAIR, V10, P1095, DOI 10.1016/j.dnarep.2011.08.006; Evans TJ, 2010, DNA REPAIR, V9, P1292, DOI 10.1016/j.dnarep.2010.09.017; Freudenreich CH, 2007, FRONT BIOSCI-LANDMRK, V12, P4911, DOI 10.2741/2437; GALLOWAY SM, 1994, ENVIRON MOL MUTAGEN, V23, P44, DOI 10.1002/em.2850230612; GEBHART E, 1981, HUM GENET, V58, P235, DOI 10.1007/BF00294917; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; *ISCN, 1985, BIRTH DEFECTS ORIG A, V21, P1; Kanaar R, 1996, CURR BIOL, V6, P828, DOI 10.1016/S0960-9822(02)00606-1; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kikuchi K, 2009, J BIOL CHEM, V284, P26360, DOI 10.1074/jbc.M109.029348; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Marusyk A, 2007, MOL CELL BIOL, V27, P5336, DOI 10.1128/MCB.01316-06; Mills KD, 2004, GENE DEV, V18, P1283, DOI 10.1101/gad.1204304; NATARAJAN AT, 1980, MUTAT RES, V69, P293, DOI 10.1016/0027-5107(80)90094-9; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Pinter SF, 2008, MOL CELL BIOL, V28, P6594, DOI 10.1128/MCB.00191-08; Revet I, 2011, P NATL ACAD SCI USA, V108, P8663, DOI 10.1073/pnas.1105866108; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Sachs RK, 2000, TRENDS GENET, V16, P143, DOI 10.1016/S0168-9525(99)01960-5; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Shigechi T, 2012, CANCER RES, V72, P1149, DOI 10.1158/0008-5472.CAN-11-2904; Shimada K, 2012, CURR BIOL, V22, pR404, DOI 10.1016/j.cub.2012.04.015; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; TRUJILLO JM, 1974, HUM PATHOL, V5, P675, DOI 10.1016/S0046-8177(74)80038-9; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wang TSF, 1999, EUKARYOTIC DNA REPLI, P67; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; Wlodarska I, 1997, BLOOD, V89, P1716, DOI 10.1182/blood.V89.5.1716.1716_1716_1722; Yamamoto KN, 2011, ENVIRON MOL MUTAGEN, V52, P547, DOI 10.1002/em.20656	52	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60043	10.1371/journal.pone.0060043	http://dx.doi.org/10.1371/journal.pone.0060043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573231	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100045
J	Lim, MLM; Li, DQ				Lim, Matthew L. M.; Li, Daiqin			UV-Green Iridescence Predicts Male Quality during Jumping Spider Contests	PLOS ONE			English	Article							COSMOPHASIS-UMBRATICA; 2 POPULATIONS; ARANEAE; COLOR; BEHAVIOR; SENSITIVITY; SALTICIDAE; DURATION; HISTORY; SIGNALS	Animal colour signals used in intraspecies communications can generally be attributed to a composite effect of structural and pigmentary colours. Notably, the functional role of iridescent coloration that is 'purely' structural (i.e., absence of pigments) is poorly understood. Recent studies reveal that iridescent colorations can reliably indicate individual quality, but evidence of iridescence as a pure structural coloration indicative of male quality during contests and relating to an individual's resource-holding potential (RHP) is lacking. In age- and size-controlled pairwise male-male contests that escalate from visual displays of aggression to more costly physical fights, we demonstrate that the ultraviolet-green iridescence of Cosmophasis umbratica predicts individual persistence and relates to RHP. Contest initiating males exhibited significantly narrower carapace band separation (i.e., relative spectral positions of UV and green hues) than non-initiators. Asymmetries in carapace and abdomen brightness influenced overall contest duration and escalation. As losers retreated upon having reached their own persistence limits in contests that escalated to physical fights, losers with narrower carapace band separation were significantly more persistence. We propose that the carapace UV-green iridescence of C. umbratica predicts individual persistence and is indicative of a male's RHP. As the observed UV-green hues of C. umbratica are 'pure' optical products of a multilayer reflector system, we suggest that intrasexual variations in the optical properties of the scales' chitin-air-chitin microstructures are responsible for the observed differences in carapace band separations.	[Lim, Matthew L. M.; Li, Daiqin] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Li, Daiqin] Hubei Univ, Coll Life Sci, Wuhan, Peoples R China	National University of Singapore; Hubei University	Lim, MLM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	matlim@nus.edu.sg; dbslidq@nus.edu.sg	Lim, Matthew LM/D-4154-2011; Li, Daiqin/D-6922-2013; Lim, Matthew/Q-7406-2019; Li, Daiqin/CAH-3746-2022	Lim, Matthew LM/0000-0002-0888-3595; Li, Daiqin/0000-0001-8269-7734; Lim, Matthew/0000-0002-0888-3595; Li, Daiqin/0000-0001-8269-7734	Ministry of Education Academic Research Fund (AcRF) [R-154-000-140-112, R-154-000-234-112]; National Science Foundation of China [30470229]	Ministry of Education Academic Research Fund (AcRF); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial assistance was provided by the Ministry of Education Academic Research Fund (AcRF)(R-154-000-140-112 and R-154-000-234-112) and the National Science Foundation of China (30470229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajer K, 2011, BIOL LETTERS, V7, P866, DOI 10.1098/rsbl.2011.0520; Bean D, 2001, ANIM BEHAV, V62, P535, DOI 10.1006/anbe.2001.1779; Brandt Yoni, 1999, Animal Behaviour Forum, V57, pF13, DOI 10.1006/anbe.1998.1073; Doucet SM, 2009, J R SOC INTERFACE, V6, pS115, DOI 10.1098/rsif.2008.0395.focus; Elias DO, 2008, ANIM BEHAV, V76, P901, DOI 10.1016/j.anbehav.2008.01.032; Fitzstephens DM, 2000, ANIM BEHAV, V60, P851, DOI 10.1006/anbe.2000.1548; Fromhage L, 2005, ANIM BEHAV, V70, P1099, DOI 10.1016/j.anbehav.2005.02.020; Gammell MP, 2003, TRENDS ECOL EVOL, V18, P491, DOI 10.1016/S0169-5347(03)00222-2; Jackson R.R., 1982, P213; Jennings DJ, 2004, ANIM BEHAV, V68, P213, DOI 10.1016/j.anbehav.2003.11.005; Kemp DJ, 2007, EVOLUTION, V61, P168, DOI 10.1111/j.1558-5646.2007.00014.x; Kemp DJ, 2012, BEHAV ECOL, V23, P233, DOI 10.1093/beheco/arr153; Kemp DJ, 2006, ETHOLOGY, V112, P471, DOI 10.1111/j.1439-0310.2005.01173.x; Kramer RM, 2007, NAT MATER, V6, P533, DOI 10.1038/nmat1930; Kuitunen K, 2011, ZOOLOGY, V114, P129, DOI 10.1016/j.zool.2011.01.003; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; Land MF, 2007, P R SOC B, V274, P1583, DOI 10.1098/rspb.2007.0328; Li JJ, 2008, BIOL J LINN SOC, V94, P7, DOI 10.1111/j.1095-8312.2008.00968.x; Lim MLM, 2008, BEHAV ECOL, V19, P61, DOI 10.1093/beheco/arm100; Lim MLM, 2007, SCIENCE, V315, P481, DOI 10.1126/science.1134254; Lim MLM, 2007, P ROY SOC B-BIOL SCI, V274, P569, DOI 10.1098/rspb.2006.0020; Lim MLM, 2006, BIOL J LINN SOC, V89, P397, DOI 10.1111/j.1095-8312.2006.00704.x; Lim MLM, 2006, J COMP PHYSIOL A, V192, P871, DOI 10.1007/s00359-006-0126-5; Lim MLM, 2004, RAFFLES B ZOOL, V52, P435; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Meadows MG, 2012, J EXP BIOL, V215, P2742, DOI 10.1242/jeb.069351; Midamegbe A, 2011, ANIM BEHAV, V82, P245, DOI 10.1016/j.anbehav.2011.04.020; OLSSON M, 1994, ANIM BEHAV, V48, P607, DOI 10.1006/anbe.1994.1280; Parker AR, 2000, J OPT A-PURE APPL OP, V2, pR15, DOI 10.1088/1464-4258/2/6/201; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; PEASLEE AG, 1989, J COMP PHYSIOL A, V164, P359, DOI 10.1007/BF00612995; Sarfaty A, 2010, INT J ODONATOL, V13, P167, DOI 10.1080/13887890.2010.9748372; Schultz TD, 2009, FUNCT ECOL, V23, P724, DOI 10.1111/j.1365-2435.2009.01584.x; Taylor PW, 2003, ANIM BEHAV, V65, P1195, DOI 10.1006/anbe.2003.2169; Taylor PW, 2001, BEHAV ECOL SOCIOBIOL, V50, P403, DOI 10.1007/s002650100390; Tsyr-Huei Chiou, 2005, Proceedings of the SPIE - The International Society for Optical Engineering, V5888, p58881B, DOI 10.1117/12.613117; Vukusic P, 2000, NATURE, V404, P457, DOI 10.1038/35006561; Whiting MJ, 2006, ANIM BEHAV, V72, P353, DOI 10.1016/j.anbehav.2005.10.018; Wilts BD, 2012, P ROY SOC B-BIOL SCI, V279, P2524, DOI 10.1098/rspb.2011.2651	39	17	17	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59774	10.1371/journal.pone.0059774	http://dx.doi.org/10.1371/journal.pone.0059774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573210	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100027
J	Decuypere, JP; Kindt, D; Luyten, T; Welkenhuyzen, K; Missiaen, L; De Smedt, H; Bultynck, G; Parys, JB				Decuypere, Jean-Paul; Kindt, Dimphny; Luyten, Tomas; Welkenhuyzen, Kirsten; Missiaen, Ludwig; De Smedt, Humbert; Bultynck, Geert; Parys, Jan B.			mTOR-Controlled Autophagy Requires Intracellular Ca2+ Signaling	PLOS ONE			English	Article							KINASE KINASE-BETA; INOSITOL 1,4,5-TRISPHOSPHATE; CALCIUM; ACTIVATION; INCREASES; COMPLEX; TARGETS; STORES; STATE; LC3	Autophagy is a lysosomal degradation pathway important for cellular homeostasis and survival. Inhibition of the mammalian target of rapamycin (mTOR) is the best known trigger for autophagy stimulation. In addition, intracellular Ca2+ regulates autophagy, but its exact role remains ambiguous. Here, we report that the mTOR inhibitor rapamycin, while enhancing autophagy, also remodeled the intracellular Ca2+-signaling machinery. These alterations include a) an increase in the endoplasmic-reticulum (ER) Ca2+-store content, b) a decrease in the ER Ca2+-leak rate, and c) an increased Ca2+ release through the inositol 1,4,5-trisphosphate receptors (IP(3)Rs), the main ER-resident Ca2+-release channels. Importantly, buffering cytosolic Ca2+ with BAPTA impeded rapamycin-induced autophagy. These results reveal intracellular Ca2+ signaling as a crucial component in the canonical mTOR-dependent autophagy pathway.	[Decuypere, Jean-Paul; Kindt, Dimphny; Luyten, Tomas; Welkenhuyzen, Kirsten; Missiaen, Ludwig; De Smedt, Humbert; Bultynck, Geert; Parys, Jan B.] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Mol & Cellular Signaling, Louvain, Belgium	KU Leuven	Bultynck, G (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Mol & Cellular Signaling, Louvain, Belgium.	geert.bultynck@med.kuleuven.be		Parys, Jan/0000-0002-3591-4967; Bultynck, Geert/0000-0002-5968-4828	Research Council of the K.U. Leuven [GOA/09/12, OT START1/10/044]; Research Foundation Flanders (FWO) [G.0731.09, G063413N]; Interuniversity Attraction Poles Programme; Belgian Science Policy Office [IAP P6/28, P7/13]	Research Council of the K.U. Leuven(KU Leuven); Research Foundation Flanders (FWO)(FWO); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office)	This research has been funded by Grant GOA/09/12 and OT START1/10/044 from the Research Council of the K.U. Leuven, by grant G.0731.09 and G063413N from the Research Foundation Flanders (FWO), and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (IAP P6/28 and P7/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Decuypere JP, 2011, AUTOPHAGY, V7, P1472, DOI 10.4161/auto.7.12.17909; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Dumont FJ, 1995, LIFE SCI, V58, P373, DOI 10.1016/0024-3205(95)02233-3; Fregeau MO, 2011, J CELL BIOCHEM, V112, P723, DOI 10.1002/jcb.23006; Ghislat G, 2012, J BIOL CHEM, V287, P38625, DOI 10.1074/jbc.M112.365767; Gniadek TJ, 2007, TRAFFIC, V8, P339, DOI 10.1111/j.1600-0854.2007.00538.x; Grotemeier A, 2010, CELL SIGNAL, V22, P914, DOI 10.1016/j.cellsig.2010.01.015; Guerrero-Hernandez A, 2010, CELL CALCIUM, V48, P143, DOI 10.1016/j.ceca.2010.08.001; Harr MW, 2010, AUTOPHAGY, V6, P912, DOI 10.4161/auto.6.7.13290; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Khan MT, 2010, J BIOL CHEM, V285, P16912, DOI 10.1074/jbc.M110.114207; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Marino G, 2011, CURR OPIN CELL BIOL, V23, P198, DOI 10.1016/j.ceb.2010.10.001; Missiaen L, 1996, BIOCHEM J, V317, P849, DOI 10.1042/bj3170849; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; MISSIAEN L, 1990, J PHYSIOL-LONDON, V427, P171, DOI 10.1113/jphysiol.1990.sp018166; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Parys JB, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-17; Pfisterer SG, 2011, MOL PHARMACOL, V80, P1066, DOI 10.1124/mol.111.071761; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Regimbald-Dumas Y, 2011, CELL SIGNAL, V23, P71, DOI 10.1016/j.cellsig.2010.08.005; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang SH, 2008, CELL MOL LIFE SCI, V65, P3640, DOI 10.1007/s00018-008-8383-9; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79	37	75	80	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e61020	10.1371/journal.pone.0061020	http://dx.doi.org/10.1371/journal.pone.0061020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565295	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300168
J	Pietrolongo, E; Giordano, A; Kleinefeld, M; Confalonieri, P; Lugaresi, A; Tortorella, C; Pugliatti, M; Radice, D; Goss, C; Heesen, C; Solari, A				Pietrolongo, Erika; Giordano, Andrea; Kleinefeld, Monica; Confalonieri, Paolo; Lugaresi, Alessandra; Tortorella, Carla; Pugliatti, Maura; Radice, Davide; Goss, Claudia; Heesen, Christoph; Solari, Alessandra		AutoMS Project	Decision-Making in Multiple Sclerosis Consultations in Italy: Third Observer and Patient Assessments	PLOS ONE			English	Article							DISEASE-MODIFYING THERAPIES; RANDOMIZED CONTROLLED-TRIAL; OPTION SCALE; HOSPITAL ANXIETY; DEPRESSION; SUPPORT; SKILLS; PARTICIPATION; IMMUNOTHERAPY; COMMUNICATION	Objective: To assess decision-making in multiple sclerosis (MS) from third observer and patient perspectives. Method: Audio recordings of first-ever consultations with a participating physician (88 outpatients, 10 physicians) at four tertiary MS care clinics in Italy, were rated by a third observer using the Observing Patient Involvement in Shared Decision Making (OPTION) and by patients using the Perceived Involvement in Care Scale (PICS). Results: Mean patient age was 37.5, 66% were women, 72% had MS, and 28% had possible MS or other disease. Mean PICS subscale scores (range 0 poor, 100 best possible) were 71.9 (SD 24.3) for "physician facilitation" (PICS-F); 74.6 (SD 22.9) for "patient information exchange" (PICS-I); and only 22.5 (SD 16.2) for "patient decision making" (PICS-DM). Mean OPTION total score (0 poor, 100 best possible) was 29.6 (SD 10.3). Poorest OPTION scores were found for items assessing "preferred patient approach to receiving information" and "preferred patient level of involvement." Highest scores were for "clinician drawing attention to identified problem", "indicating need for decision making," and "need to review the decision." Consultation time, woman physician, patient-physician gender concordance and PICS-F were associated with higher OPTION total score; older physician and second opinion consultation were associated with lower OPTION score. Conclusions: In line with findings in other settings, our third observer findings indicated limited patient involvement abilities of MS physicians during first consultations. Patient perceptions of physician skills were better than third observers', although they correlated. Consultations with women physicians, and younger physicians, were associated with higher third observer and patient-based scores. Our findings reveal a need to empower Italian MS physicians with better communication and shared decision-making skills, and show in particular that attention to MS patient preferences for reception of information and involvement in health decisions, need to be improved.	[Pietrolongo, Erika; Lugaresi, Alessandra] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Giordano, Andrea; Kleinefeld, Monica; Solari, Alessandra] Fdn IRCCS Neurol Inst C Besta, Unit Neuroepidemiol, Milan, Italy; [Confalonieri, Paolo] Fdn IRCCS Neurol Inst C Besta, Unit Neuromuscular Dis, Milan, Italy; [Tortorella, Carla] Univ Bari, Dept Neurol Sci, Bari, Italy; [Tortorella, Carla] Univ Bari, Dept Psychiat Sci, Bari, Italy; [Pugliatti, Maura] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Radice, Davide] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Goss, Claudia] Univ Verona, Dept Publ Hlth & Community Med, I-37100 Verona, Italy; [Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, Hamburg, Germany	G d'Annunzio University of Chieti-Pescara; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Sassari; IRCCS European Institute of Oncology (IEO); University of Verona; University of Hamburg; University Medical Center Hamburg-Eppendorf	Solari, A (corresponding author), Fdn IRCCS Neurol Inst C Besta, Unit Neuroepidemiol, Milan, Italy.	solari@istituto-besta.it	Lugaresi, Alessandra/C-7743-2012; Confalonieri, Paolo/AAS-8513-2021; Antozzi, Carlo/AAB-8787-2019; Radice, Davide/B-7462-2016; Pugliatti, Maura/K-4071-2016; pietrolongo, erika/AAC-5694-2020; Giordano, Andrea/AAN-3738-2021; Solari, Alessandra/AAO-1741-2021; tortorella, carla/J-2557-2012	Lugaresi, Alessandra/0000-0003-2902-5589; Confalonieri, Paolo/0000-0001-8030-5725; Antozzi, Carlo/0000-0001-9270-5224; Radice, Davide/0000-0002-5075-1895; Pugliatti, Maura/0000-0001-9396-8683; pietrolongo, erika/0000-0002-6311-5994; Giordano, Andrea/0000-0003-4466-9788; Solari, Alessandra/0000-0001-9930-7579; tortorella, carla/0000-0001-9037-7300	Fondazione Italiana Sclerosi Multipla (FISM) [2010/R/37]; German Hertie Foundation as part of the AutoMS project; FISM; Biogen Idec; Merck Serono; Novartis; Sanofi Aventis; Bayer Schering; Teva	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); German Hertie Foundation as part of the AutoMS project; FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Biogen Idec(Biogen); Merck Serono(Merck & Company); Novartis(Novartis); Sanofi Aventis(Sanofi-Aventis); Bayer Schering(Bayer AG); Teva(Teva Pharmaceutical Industries)	This study was supported by grants from the Fondazione Italiana Sclerosi Multipla (FISM) (grant No. 2010/R/37) and by the German Hertie Foundation as part of the AutoMS project. The FISM also supported AG with a research fellowship. The funding sources had no role in study design, data collection, data analysis, data interpretation, or report writing.; PC has received speaker honoraria from Biogen Idec, and travel grants from Biogen Idec, Merck Serono, Novartis and Sanofi Aventis. AL was a board member for Bayer Schering, Biogen Idec, and Merck Serono; she has received travel grants and honoraria from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis and Teva. CT has received speaker honoraria from Bayer Shering, Biogen Idec, Novartis, and Sanofi-Aventis. CH has received financial support from Bayer Schering, Biogen Idec, Merck Serono and Teva. AS was a board member for Biogen Idec and Novartis, and has received speaker honoraria from Genzyme and Merck Serono. All other authors declare that they have no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bunge M, 2010, PATIENT EDUC COUNS, V78, P316, DOI 10.1016/j.pec.2009.10.029; Burton D, 2010, PATIENT EDUC COUNS, V80, P173, DOI 10.1016/j.pec.2009.10.013; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Costantini M, 1999, SUPPORT CARE CANCER, V7, P121, DOI 10.1007/s005200050241; Coulter, 2006, ENGAGING PATIENTS TH; Degner L F, 1997, Can J Nurs Res, V29, P21; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Elwyn G, 2005, HEALTH EXPECT, V8, P34, DOI 10.1111/j.1369-7625.2004.00311.x; Elwyn G, 2005, SHARED DECISION MAKI; Geiger F, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-232; Giordano A, 2011, J NEUROL SCI, V307, P86, DOI 10.1016/j.jns.2011.05.008; Giordano A, 2008, J NEUROL SCI, V275, P86, DOI 10.1016/j.jns.2008.07.026; Goossensen A, 2007, PATIENT EDUC COUNS, V67, P50, DOI 10.1016/j.pec.2007.01.017; Goss C, 2008, BRIT J PSYCHIAT, V193, P416, DOI 10.1192/bjp.bp.107.048728; Goss C, 2007, EPIDEMIOL PSICHIAT S, V16, P339, DOI 10.1017/S1121189X00002529; Goss C, 2007, PATIENT EDUC COUNS, V66, P296, DOI 10.1016/j.pec.2007.01.002; Goss C, 2011, Z EVIDENZ FORTBILD Q, V105, P277, DOI 10.1016/j.zefq.2011.04.003; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Heesen C, 2011, J NEUROL SCI, V306, P192, DOI 10.1016/j.jns.2010.09.012; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Kasper J, 2008, EUR J NEUROL, V15, P1345, DOI 10.1111/j.1468-1331.2008.02313.x; Kasper J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034849; Kasper J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026255; Legare F, 2006, MED DECIS MAKING, V26, P373, DOI 10.1177/0272989X06290492; Lenzi R, 2011, EUR J CANCER CARE, V20, P196, DOI 10.1111/j.1365-2354.2010.01189.x; LERMAN CE, 1990, J GEN INTERN MED, V5, P29, DOI 10.1007/BF02602306; Melbourne E, 2010, PATIENT EDUC COUNS, V78, P177, DOI 10.1016/j.pec.2009.07.009; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pellerin MA, 2011, ACAD MED, V86, P1010, DOI 10.1097/ACM.0b013e31822220c5; Rimondini M, 2010, PSYCHOL MED, V40, P467, DOI 10.1017/S0033291709990730; Roter DL, 2004, ANNU REV PUBL HEALTH, V25, P497, DOI 10.1146/annurev.publhealth.25.101802.123134; Sandhu H, 2009, PATIENT EDUC COUNS, V76, P348, DOI 10.1016/j.pec.2009.07.010; Scardovi A, 2003, FAM PRACT, V20, P363, DOI 10.1093/fampra/cmg404; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith A, 2011, PATIENT EDUC COUNS, V82, P233, DOI 10.1016/j.pec.2010.04.001; Stacey D, 2006, J TELEMED TELECARE, V12, P410, DOI 10.1258/135763306779378663; King JS, 2006, AM J LAW MED, V32, P429, DOI 10.1177/009885880603200401; Stewart M, 2003, PATIENT CENTERED MED; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Turner L, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-16; Vegni Elena, 2004, Educ Health (Abingdon), V17, P163, DOI 10.1080/13576280410001710987; Wild D, 2009, VALUE HEALTH, V12, P430, DOI 10.1111/j.1524-4733.2008.00471.x; Yadav V, 2012, CURR NEUROL NEUROSCI, V12, P489, DOI 10.1007/s11910-012-0295-2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann C, 1999, Epidemiol Psichiatr Soc, V8, P71	45	31	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60721	10.1371/journal.pone.0060721	http://dx.doi.org/10.1371/journal.pone.0060721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565270	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300141
J	Song, J; Ji, H; Shia, BC; Ma, SG				Song, Jie; Ji, Hong; Shia, Benchang; Ma, Shuangge			Distribution of Illness and Medical Expenditure: A Survey in Two Villages in Rural Beijing	PLOS ONE			English	Article							OUT-OF-POCKET; HEALTH-INSURANCE; CHRONIC DISEASE; CARE; CHINA	Background: The main goal of this study is to examine the distributions of illness conditions and resulting medical expenditures and their associated factors. To achieve this goal, an in-house survey was conducted in August of 2012 in rural Beijing, the capital city of China. Results: The survey was conducted in Nanjianchang and Beijianchang, which are two villages 20 KM away from Miyun, a satellite city of Beijing. Data was collected on 346 households, which included 834 members. Variables measured included household characteristics, household head characteristics, illness conditions, and medical expenditures. Illness conditions and corresponding expenditure were measured for inpatient treatment, outpatient treatment, and self-treatment separately. Multivariate analysis suggested that the presence of inpatient treatment was associated with household head characteristics including age, gender, and education. The presence of a high level of outpatient treatment was associated with household head characteristics including gender and education. The presence of a high level of self-treatment was significantly associated with household size. In the analysis of overall out-of-pocket (OOP) medical expenditure, only age of household head was borderline significant. In the analysis of OOP inpatient expenditure, age and gender of household head were borderline significant. The OOP outpatient expenditure was associated with household size, presence of members older than 60, household head's gender, marital status, and occupation. The OOP self-treatment expenditure was not associated with any household characteristic. Conclusions: For the surveyed households, medical expenditure made up a considerable proportion of the total consumption. This study suggested that the presence of illness conditions and resulting OOP medical expenditure were associated with certain household and household head characteristics. Such results may help identify the subgroup that is the most affected by illness conditions. As this study collected recent data on inpatient, outpatient, and self-treatment separately, it may provide a useful complement to the existing studies.	[Song, Jie; Ji, Hong; Shia, Benchang; Ma, Shuangge] Capital Univ Econ & Business, Sch Stat, Beijing, Peoples R China; [Shia, Benchang] FuJen Catholic Univ, Dept Stat & Informat, New Taipei City, Peoples R China; [Ma, Shuangge] Yale Univ, Sch Publ Hlth, New Haven, CT USA	Capital University of Economics & Business; Yale University	Ma, SG (corresponding author), Capital Univ Econ & Business, Sch Stat, Beijing, Peoples R China.	shuangge.ma@yale.edu			Beijing municipal education commission	Beijing municipal education commission(Beijing Municipal Commission of Education)	This study has been supported by The Beijing municipal education commission research project: The study of impact of household consumption on healthcare spending. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2012, BLOOMBERG; Chen Wen-Xian, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P243; Fang KN, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-442; Fang KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039157; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; FOSTER AD, 1994, AM ECON REV, V84, P216; Jian WY, 2010, HEALTH AFFAIR, V29, P2189, DOI 10.1377/hlthaff.2009.0989; Nguyen KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047423; Nguyen KT, 2012, SOC SCI MED, V74, P724, DOI 10.1016/j.socscimed.2011.10.027; Li Y, 2010, ELECTRICAL CONDUCTIVE ADHESIVES WITH NANOTECHNOLOGIES, P25, DOI 10.1007/978-0-387-88783-8_2; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Ma S, 2012, PLOS ONE IN PRESS; Morrison J, 2008, FIELD NOTE PERSPECTI, V10, P141; National Bureau of Statistics of China, 2012, INC URB RUR RES 2011; Setboonsarng S, 2008, 129 ADB I; Sun Q, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-42; Wagstaff A, 2007, J HEALTH ECON, V26, P82, DOI 10.1016/j.jhealeco.2006.07.001; Wang H, 2006, HEALTH POLICY, V78, P167, DOI 10.1016/j.healthpol.2005.09.008; Xiao SB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-695; You X, 2011, APPL HEALTH ECON HEA, V9, P39, DOI 10.2165/11530730-000000000-00000	20	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e61068	10.1371/journal.pone.0061068	http://dx.doi.org/10.1371/journal.pone.0061068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565297	gold, Green Submitted, Green Published			2022-12-27	WOS:000317717300170
J	Vercruysse, T; Boons, E; Venken, T; Vanstreels, E; Voet, A; Steyaert, J; De Maeyer, M; Daelemans, D				Vercruysse, Thomas; Boons, Eline; Venken, Tom; Vanstreels, Els; Voet, Arnout; Steyaert, Jan; De Maeyer, Marc; Daelemans, Dirk			Mapping the Binding Interface between an HIV-1 Inhibiting Intrabody and the Viral Protein Rev	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; SMALL-MOLECULE INHIBITORS; NUCLEAR EXPORT; RESPONSE ELEMENT; TRANS-ACTIVATOR; IN-VIVO; HUMAN ASTROCYTES; TARGET SEQUENCE; GENE-EXPRESSION; RNA HELICASE	HIV-1 Rev is the key protein in the nucleocytoplasmic export and expression of the late viral mRNAs. An important aspect for its function is its ability to multimerize on these mRNAs. We have recently identified a llama single-domain antibody (Nb-190) as the first inhibitor targeting the Rev multimerization function in cells. This nanobody is a potent intracellular antibody that efficiently inhibits HIV-1 viral production. In order to gain insight into the Nb-190-Rev interaction interface, we performed mutational and docking studies to map the interface between the nanobody paratope and the Rev epitope. Alanine mutants of the hyper-variable domains of Nb-190 and the Rev multimerization domains were evaluated in different assays measuring Nb-190-Rev interaction or viral production. Seven residues within Nb-190 and five Rev residues are demonstrated to be crucial for epitope recognition. These experimental data were used to perform docking experiments and map the Nb-190-Rev structural interface. This Nb-190-Rev interaction model can guide further studies of the Nb-190 effect on HIV-1 Rev function and could serve as starting point for the rational development of smaller entities binding to the Nb190 epitope, aimed at interfering with protein-protein interactions of the Rev N-terminal domain.	[Vercruysse, Thomas; Boons, Eline; Vanstreels, Els; Daelemans, Dirk] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium; [Venken, Tom; Voet, Arnout; De Maeyer, Marc] Katholieke Univ Leuven, Dept Chem, Div Biochem Mol & Struct Biol, Louvain, Belgium; [Steyaert, Jan] Vrije Univ Brussel, Dept Mol Interact, Struct Biol Brussel Lab, Brussels, Belgium	KU Leuven; KU Leuven; Vrije Universiteit Brussel	Daelemans, D (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.	dirk.daelemans@rega.kuleuven.be	steyaert, jan/GQP-7811-2022; Daelemans, Dirk/P-7923-2017; Steyaert, Jan/H-4662-2011; Vanstreels, Els/I-2366-2018; Vercruysse, Thomas/AAK-8879-2020; voet, arnout/O-5248-2014	Daelemans, Dirk/0000-0001-7092-1153; Steyaert, Jan/0000-0002-3825-874X; Vanstreels, Els/0000-0002-7814-8035; voet, arnout/0000-0002-3329-2703; Venken, Tom/0000-0003-0773-1810; Vercruysse, Thomas/0000-0002-8649-777X	'Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie' (IWT); research council of the K.U. Leuven; 'Fonds voor Wetenschappelijk Onderzoek Vlaanderen' (FWO) [1.5.104.07, 1.5.165.10]; Belgian Government under the framework of the Interuniversity Attraction Poles [I.A.P. P6/19]; K.U. Leuven Impulsfinanciering	'Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie' (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); research council of the K.U. Leuven(KU Leuven); 'Fonds voor Wetenschappelijk Onderzoek Vlaanderen' (FWO)(FWO); Belgian Government under the framework of the Interuniversity Attraction Poles(Belgian Federal Science Policy Office); K.U. Leuven Impulsfinanciering	Eline Boons was funded by a Ph.D grant of the 'Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie' (IWT) (www.iwt.be). Tom Venken and Arnout Voet thank the research council of the K.U. Leuven for financial support. This work was further supported by the 'Fonds voor Wetenschappelijk Onderzoek Vlaanderen' (FWO) (grant 1.5.104.07 and 1.5.165.10) (www.fwo.be), the Belgian Government under the framework of the Interuniversity Attraction Poles (I.A.P. P6/19), and the 'K.U. Leuven Impulsfinanciering'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; AUER M, 1994, BIOCHEMISTRY-US, V33, P2988, DOI 10.1021/bi00176a031; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Daelemans D, 2005, MOL CELL BIOL, V25, P728, DOI 10.1128/MCB.25.2.728-739.2005; Daelemans D, 2004, J BIOL CHEM, V279, P50167, DOI 10.1074/jbc.M407713200; Daelemans D, 2002, P NATL ACAD SCI USA, V99, P14440, DOI 10.1073/pnas.212285299; Daelemans D, 2006, CURR OPIN HIV AIDS, V1, P388, DOI 10.1097/01.COH.0000239851.22614.6a; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; Daugherty MD, 2008, MOL CELL, V31, P824, DOI 10.1016/j.molcel.2008.07.016; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Fang JH, 2005, VIROLOGY, V336, P299, DOI 10.1016/j.virol.2005.03.017; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; FISHER AG, 1985, NATURE, V316, P262, DOI 10.1038/316262a0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jain C, 2001, MOL CELL, V7, P603, DOI 10.1016/S1097-2765(01)00207-6; JARVIS RA, 1973, IEEE T COMPUT, VC-22, P1025, DOI 10.1109/T-C.1973.223640; KALLAND KH, 1994, MOL CELL BIOL, V14, P7436, DOI 10.1128/MCB.14.11.7436; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lefranc Marie-Paule, 2004, Methods Mol Biol, V248, P27; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; Ludwig E, 1999, J VIROL, V73, P8279, DOI 10.1128/JVI.73.10.8279-8289.1999; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; MEYER BE, 1994, GENE DEV, V8, P1538, DOI 10.1101/gad.8.13.1538; NEUMANN M, 1995, J VIROL, V69, P2159, DOI 10.1128/JVI.69.4.2159-2167.1995; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Robertson-Anderson RM, 2011, J MOL BIOL, V410, P959, DOI 10.1016/j.jmb.2011.04.026; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Van Neck T, 2008, BIOORGAN MED CHEM, V16, P9487, DOI 10.1016/j.bmc.2008.09.051; Venken T, COMPUTATIONAL UNPUB; Vercruysse T, 2011, RNA BIOL, V8, P316, DOI 10.4161/rna.8.2.13782; Vercruysse T, 2010, J BIOL CHEM, V285, P21768, DOI 10.1074/jbc.M110.112490; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Yin H, 2005, ANGEW CHEM INT EDIT, V44, P4130, DOI 10.1002/anie.200461786; Zheng CH, 2007, BIOORGAN MED CHEM, V15, P6407, DOI 10.1016/j.bmc.2007.06.052	50	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60259	10.1371/journal.pone.0060259	http://dx.doi.org/10.1371/journal.pone.0060259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565213	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300082
J	Su, RJ; Yang, YD; Neises, A; Payne, KJ; Wang, J; Viswanathan, K; Wakeland, EK; Fang, XD; Zhang, XB				Su, Rui-Jun; Yang, Yadong; Neises, Amanda; Payne, Kimberly J.; Wang, Jasmin; Viswanathan, Kasthuribai; Wakeland, Edward K.; Fang, Xiangdong; Zhang, Xiao-Bing			Few Single Nucleotide Variations in Exomes of Human Cord Blood Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HUMAN SOMATIC-CELLS; COPY NUMBER; GENOMIC STABILITY; CODING MUTATIONS; IPS CELLS; GENERATION; DERIVATION; PLASMID; OCT4; EXPRESSION	The effect of the cellular reprogramming process per se on mutation load remains unclear. To address this issue, we performed whole exome sequencing analysis of induced pluripotent stem cells (iPSCs) reprogrammed from human cord blood (CB) CD34(+) cells. Cells from a single donor and improved lentiviral vectors for high-efficiency (2-14%) reprogramming were used to examine the effects of three different combinations of reprogramming factors: OCT4 and SOX2 (OS), OS and ZSCAN4 (OSZ), OS and MYC and KLF4 (OSMK). Five clones from each group were subject to whole exome sequencing analysis. We identified 14, 11, and 9 single nucleotide variations (SNVs), in exomes, including untranslated regions (UTR), in the five clones of OSMK, OS, and OSZ iPSC lines. Only 8, 7, and 4 of these, respectively, were protein-coding mutations. An average of 1.3 coding mutations per CB iPSC line is remarkably lower than previous studies using fibroblasts and low-efficiency reprogramming approaches. These data demonstrate that point nucleotide mutations during cord blood reprogramming are negligible and that the inclusion of genome stabilizers like ZSCAN4 during reprogramming may further decrease reprogramming-associated mutations. Our findings provide evidence that CB is a superior source of cells for iPSC banking.	[Su, Rui-Jun; Neises, Amanda; Wang, Jasmin; Zhang, Xiao-Bing] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA; [Yang, Yadong; Fang, Xiangdong] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci, Beijing, Peoples R China; [Su, Rui-Jun; Payne, Kimberly J.] Loma Linda Univ, Div Anat, Loma Linda, CA 92350 USA; [Su, Rui-Jun; Payne, Kimberly J.] Loma Linda Univ, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Viswanathan, Kasthuribai; Wakeland, Edward K.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Viswanathan, Kasthuribai; Wakeland, Edward K.] Univ Texas SW Med Ctr Dallas, Genom Core Facil, Dallas, TX 75390 USA	Loma Linda University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Loma Linda University; Loma Linda University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fang, XD (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci, Beijing, Peoples R China.	fangxd@big.ac.cn; xzhang@llu.edu	Payne, Kimberly/AAS-6814-2020	Payne, Kimberly/0000-0002-7025-5821	Loma Linda University Department of Medicine; DOD [W81XWH-11-1-0607]; Department of Pathology and Human Anatomy; Center for Health Disparities and Molecular Medicine at Loma Linda University; Ministry of Science and Technology of China [2011AA020118]; "Strategic Priority Research Program'' of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research [XDA01040405]	Loma Linda University Department of Medicine; DOD(United States Department of Defense); Department of Pathology and Human Anatomy; Center for Health Disparities and Molecular Medicine at Loma Linda University; Ministry of Science and Technology of China(Ministry of Science and Technology, China); "Strategic Priority Research Program'' of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research	This research was supported by Loma Linda University Department of Medicine (XBZ), and DOD Concept Award W81XWH-11-1-0607 (XBZ), the Department of Pathology and Human Anatomy and the Center for Health Disparities and Molecular Medicine at Loma Linda University (KJP and RJS). This work was also supported by the "863 Projects'' of Ministry of Science and Technology of China (2011AA020118 to XF) and the "Strategic Priority Research Program'' of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research (XDA01040405 to XF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Broxmeyer HE, 2010, CELL STEM CELL, V6, P21, DOI 10.1016/j.stem.2009.12.008; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Dowey SN, 2012, NAT PROTOC, V7, P2013, DOI 10.1038/nprot.2012.121; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Foja S, 2013, CELL REPROGRAM, V15, P68, DOI 10.1089/cell.2012.0037; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hayden EC, 2011, NATURE, V472, P403, DOI 10.1038/472403a; Hirata T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00208; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Hu KJ, 2011, BLOOD, V117, pE109, DOI 10.1182/blood-2010-07-298331; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Jin ZB, 2012, STEM CELL TRANSL MED, V1, P503, DOI 10.5966/sctm.2012-0005; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Mack AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027956; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037569; Meng XM, 2012, MOL THER, V20, P408, DOI 10.1038/mt.2011.258; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Okita K, 2012, STEM CELLS; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042855; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ruiz S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2381; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017557; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhang XB, 2006, PLOS MED, V3, P687, DOI 10.1371/journal.pmed.0030173; Zhang XB, 2007, STEM CELLS, V25, P2074, DOI 10.1634/stemcells.2006-0742; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	56	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59908	10.1371/journal.pone.0059908	http://dx.doi.org/10.1371/journal.pone.0059908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573220	gold, Green Published, Green Submitted			2022-12-27	WOS:000316930900033
J	Balbuena, JA; Miguez-Lozano, R; Blasco-Costa, I				Antonio Balbuena, Juan; Miguez-Lozano, Raul; Blasco-Costa, Isabel			PACo: A Novel Procrustes Application to Cophylogenetic Analysis	PLOS ONE			English	Article							PARASITE PHYLOGENIES; DISPARATE RATES; HOST; EVOLUTION; CONGRUENCE; RECONSTRUCTION; COMMUNITIES; DIVERGENCE; BONFERRONI; EFFICIENT	We present Procrustean Approach to Cophylogeny (PACo), a novel statistical tool to test for congruence between phylogenetic trees, or between phylogenetic distance matrices of associated taxa. Unlike previous tests, PACo evaluates the dependence of one phylogeny upon the other. This makes it especially appropriate to test the classical coevolutionary model that assumes that parasites that spend part of their life in or on their hosts track the phylogeny of their hosts. The new method does not require fully resolved phylogenies and allows for multiple host-parasite associations. PACo produces a Procrustes superimposition plot enabling a graphical assessment of the fit of the parasite phylogeny onto the host phylogeny and a goodness-of-fit statistic, whose significance is established by randomization of the host-parasite association data. The contribution of each individual host-parasite association to the global fit is measured by means of jackknife estimation of their respective squared residuals and confidence intervals associated to each host-parasite link. We carried out different simulations to evaluate the performance of PACo in terms of Type I and Type II errors with respect to two similar published tests. In most instances, PACo performed at least as well as the other tests and showed higher overall statistical power. In addition, the jackknife estimation of squared residuals enabled more elaborate validations about the nature of individual links than the ParaFitLink1 test of the program ParaFit. In order to demonstrate how it can be used in real biological situations, we applied PACo to two published studies using a script written in the public-domain statistical software R.	[Antonio Balbuena, Juan; Miguez-Lozano, Raul] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Blasco-Costa, Isabel] Acad Sci Czech Republ, Inst Parasitol, CR-37005 Ceske Budejovice, Czech Republic	University of Valencia; Czech Academy of Sciences	Balbuena, JA (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain.	j.a.balbuena@uv.es	Balbuena, Juan Antonio/O-6404-2014; Blasco-Costa, Isabel/P-3898-2014	Balbuena, Juan Antonio/0000-0003-4006-1353; Blasco-Costa, Isabel/0000-0002-5001-5986	National Scientific Research, Development and Technological Innovation Plan of Spain [CGL2008-02701]; Generalitat Valenciana [2011-040]; Marie Curie Outgoing International Fellowship within European Commission [PIOF-GA-2009-252124]	National Scientific Research, Development and Technological Innovation Plan of Spain; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Marie Curie Outgoing International Fellowship within European Commission	This study was funded by the National Scientific Research, Development and Technological Innovation Plan of Spain (CGL2008-02701) and the Generalitat Valenciana (Prometeo Grant 2011-040). IBC benefits from a Marie Curie Outgoing International Fellowship for Career Development (PIOF-GA-2009-252124) within the 7th Framework Programme of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Banks JC, 2005, INT J PARASITOL, V35, P741, DOI 10.1016/j.ijpara.2005.03.003; BARKER SC, 1994, INT J PARASITOL, V24, P643, DOI 10.1016/0020-7519(94)90116-3; Baum BR, 2010, TAXON, V59, P1843, DOI 10.1002/tax.596015; Borer M, 2012, J BIOGEOGR, V39, P1487, DOI 10.1111/j.1365-2699.2012.02703.x; BROOKS DR, 1981, SYST ZOOL, V30, P229, DOI 10.2307/2413247; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Charleston MA, 1998, MATH BIOSCI, V149, P191, DOI 10.1016/S0025-5564(97)10012-8; CHARLESTON MA, 2002, LECT NOTES PHYS, V585, P122; Choi K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-423; Clayton DH, 2003, P NATL ACAD SCI USA, V100, P15694, DOI 10.1073/pnas.2533751100; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; De Vienne DM, 2007, J EVOLUTION BIOL, V20, P1428, DOI 10.1111/j.1420-9101.2007.01340.x; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; de Vienne DM, 2012, MOL BIOL EVOL, V29, P1587, DOI 10.1093/molbev/msr317; de Vienne DM, 2011, SYST BIOL, V60, P826, DOI 10.1093/sysbio/syr066; Desdevises Y, 2007, Parassitologia, V49, P125; Deza M. M, 2013, ENCY DISTANCES, P387; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; Hafner MS, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P195; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Holmes S, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P91; Hommola K, 2009, MOL BIOL EVOL, V26, P1457, DOI 10.1093/molbev/msp062; Huelsenbeck JP, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P93; Huelsenbeck JP, 1997, EVOLUTION, V51, P410, DOI [10.1111/j.1558-5646.1997.tb02428.x, 10.2307/2411113]; Huggins P, 2009, ARXIV08091908V3QBIOP; Huyse T, 2005, SYST BIOL, V54, P710, DOI 10.1080/10635150500221036; Hypsa V, 2006, INT J PARASITOL, V36, P141, DOI 10.1016/j.ijpara.2005.10.010; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Jousselin E, 2008, EVOLUTION, V62, P1777, DOI 10.1111/j.1558-5646.2008.00406.x; Karvonen Anssi, 2012, International Journal of Ecology, P1; Kenobi K, 2012, BAYESIAN ANAL, V7, P547, DOI 10.1214/12-BA718; King JR, 2003, FISHERIES MANAG ECOL, V10, P249, DOI 10.1046/j.1365-2400.2003.00359.x; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Legendre P., 2012, NUMERICAL ECOLOGY; Light JE, 2007, MOL PHYLOGENET EVOL, V45, P997, DOI 10.1016/j.ympev.2007.09.001; Martinez-Abrain A, 2008, ACTA OECOL, V34, P9, DOI 10.1016/j.actao.2008.02.004; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Meier-Kolthoff JP, 2007, BIOINFORMATICS, V23, P898, DOI 10.1093/bioinformatics/btm027; Merkle D, 2005, THEOR BIOSCI, V123, P277, DOI 10.1016/j.thbio.2005.01.003; Merkle D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S60; Micheas AC, 2010, J APPL STAT, V37, P41, DOI 10.1080/02664760802653560; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Munoz J, 2004, SCIENCE, V304, P1144, DOI 10.1126/science.1095210; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nieberding C., 2010, BIOGEOGRAPHY HOST PA, P59; Oksanen J, 2013, MULTIVARIATE ANAL EC; Olden JD, 2001, OECOLOGIA, V127, P572, DOI 10.1007/s004420000620; Page RDM, 1996, SYST BIOL, V45, P151, DOI 10.2307/2413612; PAGE RDM, 1993, COMPONENT TREE COMP; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Puigbo P, 2007, BIOINFORMATICS, V23, P1556, DOI 10.1093/bioinformatics/btm135; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ronquist F, 1997, ZOOL SCR, V26, P313, DOI 10.1111/j.1463-6409.1997.tb00421.x; Schardl CL, 2008, SYST BIOL, V57, P483, DOI 10.1080/10635150802172184; Schneider JW, 2007, J AM SOC INF SCI TEC, V58, P1596, DOI 10.1002/asi.20642; Segraves Kari A., 2010, Evolution Education and Outreach, V3, P62; Shade A, 2008, ENVIRON MICROBIOL, V10, P1057, DOI 10.1111/j.1462-2920.2007.01527.x; SIEGEL AF, 1982, BIOMETRICS, V38, P341, DOI 10.2307/2530448; Simkova A, 2004, EVOLUTION, V58, P1001, DOI 10.1111/j.0014-3820.2004.tb00434.x; Soininen J, 2004, ECOGRAPHY, V27, P330, DOI 10.1111/j.0906-7590.2004.03749.x; Sokal R. R., 1981, BIOMETRY; Stamatakis A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-405; Stevens J, 2004, BRIEF BIOINFORM, V5, P339, DOI 10.1093/bib/5.4.339; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wang CL, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1493; Weber MG, 2012, TRENDS ECOL EVOL, V27, P394, DOI 10.1016/j.tree.2012.04.010; Wojcicki M, 2005, J BIOGEOGR, V32, P755, DOI 10.1111/j.1365-2699.2004.01148.x; Xiong HL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-25	74	162	163	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61048	10.1371/journal.pone.0061048	http://dx.doi.org/10.1371/journal.pone.0061048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580325	Green Submitted, gold, Green Published			2022-12-27	WOS:000317898000096
J	Hassan, WAW; Hamerton, I; Howlin, BJ				Hassan, Wan Aminah Wan; Hamerton, Ian; Howlin, Brendan J.			Prediction of Selected Physical and Mechanical Properties of a Telechelic Polybenzoxazine by Molecular Simulation	PLOS ONE			English	Article							DYNAMICS	Molecular simulation is becoming an important tool for both understanding polymeric structures and predicting their physical and mechanical properties. In this study, temperature ramped molecular dynamics simulations are used to predict two physical properties (i.e., glass transition temperature and thermal degradation temperature) of a previously synthesised and published telechelic benzoxazine. Plots of simulated density versus temperature show decreases in density within the same temperature range as experimental values for the thermal degradation. The predicted value for the thermal degradation temperature for the cured polybenzoxazine based on the telechelic polyetherketone (PEK) monomer was ca. 400 degrees C, in line with the experimental thermal degradation temperature range of 450 degrees C to 500 degrees C. Mechanical Properties of both the unmodified PEK and the telechelic benzoxazines are simulated and compared to experimental values (where available). The introduction of the benoxazine moieties are predicted to increase the elastic moduli in line with the increase of crosslinking in the system.	[Hassan, Wan Aminah Wan; Hamerton, Ian; Howlin, Brendan J.] Univ Surrey, Dept Chem, Guildford GU2 5XH, Surrey, England	University of Surrey	Howlin, BJ (corresponding author), Univ Surrey, Dept Chem, Guildford GU2 5XH, Surrey, England.	b.howlin@surrey.ac.uk	Howlin, Brendan J/F-3343-2011; Hamerton, Ian/AAV-8918-2021	Howlin, Brendan J/0000-0002-9398-7152; Hamerton, Ian/0000-0003-3113-0345	Hunstman Advanced Materials for studentship; Malaysian Government (MARA)	Hunstman Advanced Materials for studentship; Malaysian Government (MARA)	We thank Hunstman Advanced Materials for studentship support for WAWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Huntsman Advanced Materials provided one year's studentship funding to WAWH; the other two year's funding was provided by the Malaysian Government (MARA). The work presented here was not funded or influenced by Huntsman in any way and does not form part of their sponsorship. Hence this does not alter the authors' adherence to all PLOS One policies on sharing data and materials.	Abed JC, 1993, POLYM MAT SCI ENG, V69, P291; [Anonymous], 2010, ACC MAT STUD VERS V; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; FOX TG, 1955, J POLYM SCI, V15, P371, DOI 10.1002/pol.1955.120158006; Grishchuk S, 2011, EXPRESS POLYM LETT, V5, P273, DOI 10.3144/expresspolymlett.2011.27; Hall SA, 2008, MOL SIMULAT, V34, P1259, DOI 10.1080/08927020802534835; Hall SA, 2012, SOLVING PROBLEM BUIL, DOI DOI 10.1371/J0URNAL.P0NE.0042928.T002; Hall SA, 2012, THESIS U SURREY; Hamerton I, 1997, J MATER CHEM, V7, P169, DOI 10.1039/a604782c; Hamerton I, 2011, HDB BENZOXAZINE RESI; Hamerton I, 2010, POLYMER, V51, P5857, DOI 10.1016/j.polymer.2010.09.068; HANSCH C, 1964, J AM CHEM SOC, V86, P1616, DOI 10.1021/ja01062a035; Hemvichian K, 2002, POLYMER, V43, P4391, DOI 10.1016/S0032-3861(02)00281-1; Holly FW, 1944, J AM CHEM SOC, V66, P1875, DOI 10.1021/ja01239a022; Ishida H, 2011, HANDBOOK OF BENZOXAZINE RESINS, P1; Ishida H, 2006, J APPL POLYM SCI, V101, P1670, DOI 10.1002/app.22499; Ishida H, 2011, HANDBOOK OF BENZOXAZINE RESINS, P3, DOI 10.1016/B978-0-444-53790-4.00046-1; Kimura H, 1998, J APPL POLYM SCI, V68, P1903, DOI 10.1002/(SICI)1097-4628(19980620)68:12<1903::AID-APP2>3.0.CO;2-P; Leach A. R., 2001, MOL MODELLING PRINCI; LIU JP, 1993, ABSTR PAP AM CHEM S, V206, P80; Liu X, 2002, J APPL POLYM SCI, V84, P1107, DOI 10.1002/app.10267; Liu YL, 2004, J POLYM SCI POL CHEM, V42, P3178, DOI 10.1002/pola.20162; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Nakamura M, 2009, POLYMER, V50, P2688, DOI 10.1016/j.polymer.2009.03.053; SUN H, 1994, J AM CHEM SOC, V116, P2978, DOI 10.1021/ja00086a030; Tsai CJ, 1997, RAPID COMMUN MASS SP, V11, P1987, DOI 10.1002/(SICI)1097-0231(199712)11:18<1987::AID-RCM100>3.0.CO;2-Q; van Duin AC, 2010, ABSTR PAP AM CHEM S, V240	27	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61179	10.1371/journal.pone.0061179	http://dx.doi.org/10.1371/journal.pone.0061179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577206	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000109
J	Allen, IC; McElvania-TeKippe, E; Wilson, JE; Lich, JD; Arthur, JC; Sullivan, JT; Braunstein, M; Ting, JPY				Allen, Irving C.; McElvania-TeKippe, Erin; Wilson, Justin E.; Lich, John D.; Arthur, Janelle C.; Sullivan, Jonathan T.; Braunstein, Miriam; Ting, Jenny P. Y.			Characterization of NLRP12 during the In Vivo Host Immune Response to Klebsiella pneumoniae and Mycobacterium tuberculosis	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; CUTTING EDGE; SIGNALING PATHWAYS; COLON INFLAMMATION; ACTIVATION; LIPOPOLYSACCHARIDE; INFECTION; PROTEIN; RECOGNITION	The majority of nucleotide binding domain leucine rich repeats-containing (NLR) family members has yet to be functionally characterized. Of the described NLRs, most are considered to be proinflammatory and facilitate IL-1 beta production. However, a newly defined sub-group of NLRs that function as negative regulators of inflammation have been identified based on their abilities to attenuate NF-kappa B signaling. NLRP12 (Monarch-1) is a prototypical member of this sub-group that negatively regulates both canonical and noncanonical NF-kappa B signaling in biochemical assays and in colitis and colon cancer models. The role of NLRP12 in infectious diseases has not been extensively studied. Here, we characterized the innate immune response of Nlrp12(-/-) mice following airway exposure to LPS, Klebsiella pneumoniae and Mycobacterium tuberculosis. In response to E. coli LPS, Nlrp12(-/-) mice showed a slight decrease in IL-1 beta and increase in IL-6 production, but these levels were not statistically significant. During K. pneumoniae infection, we observed subtle differences in cytokine levels and significantly reduced numbers of monocytes and lymphocytes in Nlrp12(-/-) mice. However, the physiological relevance of these findings is unclear as no overt differences in the development of lung disease were observed in the Nlrp12(-/-) mice. Likewise, Nlrp12(-/-) mice demonstrated pathologies similar to those observed in the wild type mice following M. tuberculosis infection. Together, these data suggest that NLRP12 does not significantly contribute to the in vivo host innate immune response to LPS stimulation, Klebsiella pneumonia infection or Mycobacterium tuberculosis.	[Allen, Irving C.; Wilson, Justin E.; Lich, John D.; Ting, Jenny P. Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Allen, Irving C.] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Virginia Tech, Blacksburg, VA 24061 USA; [Allen, Irving C.; McElvania-TeKippe, Erin; Arthur, Janelle C.; Sullivan, Jonathan T.; Braunstein, Miriam; Ting, Jenny P. Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Virginia Polytechnic Institute & State University; University of North Carolina; University of North Carolina Chapel Hill	Allen, IC (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	icallen@vt.edu; jenny_ting@med.unc.edu		Allen, Irving/0000-0001-9573-5250; Arthur, Janelle/0000-0002-4796-0207	National Institutes of Health [U19-AI067798, U19-AI077437, F32-AI-082895-01, T32-AR007416, T32-CA009156]; National Institutes of Health National Research Service Trainee Award; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA009156, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077437, F32AI082895, U19AI067798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK092355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Research Service Trainee Award; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health U19-AI067798 and U19-AI077437(JPYT); F32-AI-082895-01, T32-AR007416 and T32-CA009156 (ICA). This work was also supported by a National Institutes of Health National Research Service Trainee Award (JCA) and the American Cancer Society (JDL and ICA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allen IC, 2006, AM J PHYSIOL-LUNG C, V291, pL1005, DOI 10.1152/ajplung.00174.2006; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Allen IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030612; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Bean AGD, 1999, J IMMUNOL, V162, P3504; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935; Cai SS, 2009, J IMMUNOL, V183, P6629, DOI 10.4049/jimmunol.0901033; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Kumar H, 2011, J IMMUNOL, V186, P994, DOI 10.4049/jimmunol.1002094; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Rammaert B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-3; Rao KMK, 2006, J TOXICOL ENV HEAL A, V69, P481, DOI 10.1080/15287390500247025; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Sikarwar AS, 2011, INT J BIOSCIENCE BIO, V1, P211; Simpson A, 2010, CLIN EXP ALLERGY, V40, P209, DOI 10.1111/j.1365-2222.2009.03391.x; Souvannavong V, 2007, INFECT IMMUN, V75, P4998, DOI 10.1128/IAI.00545-07; Soysa NS, 2011, J PERIODONTAL RES, V46, P280, DOI 10.1111/j.1600-0765.2010.01333.x; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Theivanthiran B, 2012, INFECT IMMUN, V80, P2558, DOI 10.1128/IAI.06230-11; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Williams KL, 2003, J IMMUNOL, V170, P5354, DOI 10.4049/jimmunol.170.11.5354; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; World Health Organization, 2011, WHO TUB FACTS SHEET; Yamada H, 2001, INFECT IMMUN, V69, P7100, DOI 10.1128/IAI.69.11.7100-7105.2001; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; ZHANG YH, 1994, P NATL ACAD SCI USA, V91, P2225, DOI 10.1073/pnas.91.6.2225; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	48	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60842	10.1371/journal.pone.0060842	http://dx.doi.org/10.1371/journal.pone.0060842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577168	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800106
J	Evans, TA; Seaton, SE; Manktelow, BN				Evans, T. Alun; Seaton, Sarah E.; Manktelow, Bradley N.			Quantifying the Potential Bias when Directly Comparing Standardised Mortality Ratios for In-Unit Neonatal Mortality	PLOS ONE			English	Article							QUALITY-OF-CARE; OCCUPATIONAL MORTALITY; PRETERM INFANTS; PERFORMANCE; STATISTICS	Introduction: The Standardised Mortality Ratio (SMR) is increasingly used to compare the performance of different healthcare providers. However, it has long been known that differences in the populations of the providers can cause biased results when directly comparing two SMRs. This is potentially a particular problem in neonatal medicine where units provide different levels of care. Methods: Using data from The Neonatal Survey (TNS), babies born at 24 to 31 weeks gestational age from 2002 to 2011 and admitted to one of 11 UK neonatal units were identified. Risk-adjusted SMRs were calculated for each unit using a previously published model to estimate the expected number of deaths. The model parameters were then re-estimated based on data from each individual neonatal unit ("reference" unit) and these then applied to each of the other units to estimate the number of deaths each unit would have observed if they had the same underlying mortality rates as each of the "reference" hospitals. The ratios of the SMRs were then calculated under the assumption of identical risk-specific probabilities of death. Results: 7243 babies were included in all analyses. When comparing between Network Neonatal Units (Level 3) the ratio of SMRs ranged from 0.92 to 1.00 and for the comparisons within Local Neonatal Units (Level 2) ranged from 0.79 to 1.56. However when comparing between neonatal units providing different levels of care ratios up to 1.68 were observed. Conclusions: If the populations of healthcare providers differ considerably then it is likely that bias will be an issue when directly comparing SMRs. In neonatal care, the comparison of Network Neonatal Units is likely to be useful but caution is required when comparing Local Neonatal Units or between units of different types. Tools to quantify the likely bias are required.	[Evans, T. Alun; Seaton, Sarah E.; Manktelow, Bradley N.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of Leicester	Manktelow, BN (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.	brad.manktelow@le.ac.uk	Seaton, Sarah/S-6875-2019; Manktelow, Bradley N/G-2794-2011	Seaton, Sarah/0000-0001-8711-4817; Manktelow, Bradley N/0000-0002-3264-0323	National Institute for Health Research; Primary Care Trust of the East Midland of England; Primary Care Trust of the East Midland of Yorkshire; National Institute for Health Research [MET-08-05-101, MET-11-03-101] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Primary Care Trust of the East Midland of England; Primary Care Trust of the East Midland of Yorkshire; National Institute for Health Research(National Institute for Health Research (NIHR))	Alun Evans is funded by a Research Methods Fellowship award from the National Institute for Health Research. This report is independent research arising from a Research Methods Fellowship supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TAE undertook key aspects of this work as part of his MSc in Medical Statistics at the University of Leicester under the supervision of BM. We thank The Neonatal Survey for the use of the data. The authors wish to acknowledge the continuing help and collaboration of the hospitals delivering perinatal care in the study area. The Neonatal Survey is one of The Infant Mortality and Morbidity Studies which are funded by the Primary Care Trusts of the East Midlands of England and Yorkshire.	[Anonymous], 1999, MATH STAT; Aylin P, 2007, PUBLIC HEALTH, V121, P905, DOI 10.1016/j.puhe.2006.06.020; Black N, 2010, BMJ-BRIT MED J, V340, P2066; Blackmon L, 2004, PEDIATRICS, V114, P1341, DOI 10.1542/peds.2004-1697; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; *BRIT ASS PER MED, 2001, STAND HOSP PROV NEON; Campbell M, 2011, EVALUATION SUMMARY R; COURT BV, 1995, LANCET, V346, P1432, DOI 10.1016/S0140-6736(95)92449-3; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Dr Foster Intelligence, 2011, INS YOUR HOSP DR FOS; Field D, 2011, NEONATAL SURVEY REPO; Field D, 2012, NEONATAL SURVEY REPO; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Goldman DA, 2000, STAT MED, V19, P1081, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1081::AID-SIM406>3.0.CO;2-A; Hallsworth M, 2008, PROVISION NEONATAL S; JULIOUS SA, 1994, BRIT MED J, V309, P1480, DOI 10.1136/bmj.309.6967.1480; Steven A, 2007, PUBLIC HEALTH, V121, P902, DOI 10.1016/j.puhe.2006.06.021; KEIDING N, 1985, BIOMETRICS, V41, P1096; Lee WC, 2003, STAT MED, V22, P1204, DOI 10.1002/sim.1354; Lee WC, 1999, EPIDEMIOLOGY, V10, P456, DOI 10.1097/00001648-199907000-00020; Manktelow BN, 2013, PEDIATRICS, V131, pE425, DOI 10.1542/peds.2012-2189; Marlow N, 2007, ARCH DIS CHILD-FETAL, V92, pF137, DOI 10.1136/adc.2005.086413; New York State Department of Health, 2012, AD CARD SURV NEW YOR; Nightingale F., 1863, NOTES ON HOSP; Penfold Robert B, 2008, Healthc Pap, V8, P8; Saint-Lary O, 2012, J MED ETHICS, V38, P485, DOI 10.1136/medethics-2011-100159; Scott IA, 2011, MED J AUSTRALIA, V194, P645, DOI 10.5694/j.1326-5377.2011.tb03150.x; Shahian DM, 2011, ANN THORAC SURG, V92, pS2, DOI 10.1016/j.athoracsur.2011.06.100; Signorini DF, 1999, BMJ-BRIT MED J, V318, P128, DOI 10.1136/bmj.318.7176.128a; SILCOCK H, 1959, POP STUD-J DEMOG, V13, P183, DOI 10.2307/2172410; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; The Canadian Institute for Health Information, 2007, HSMR NEW APPR MEAS H; Van Reempts P, 2007, PEDIATRICS, V120, pe815, DOI 10.1542/peds.2006-3122; Yule GU, 1934, J R STAT SOC, V97, P1, DOI 10.2307/2342014	34	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61237	10.1371/journal.pone.0061237	http://dx.doi.org/10.1371/journal.pone.0061237			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577213	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800135
J	Holmer, HK; Ogden, LA; Burda, BU; Norris, SL				Holmer, Haley K.; Ogden, Lauren A.; Burda, Brittany U.; Norris, Susan L.			Quality of Clinical Practice Guidelines for Glycemic Control in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							CONFLICTS-OF-INTEREST; AMERICAN-COLLEGE; MANAGEMENT; AMSTAR; AGREE; WOMEN; CARE	Background: Several studies have reported that clinical practice guidelines (CPGs) in a variety of clinical areas are of modest or variable quality. The objective of this study was to evaluate the quality of an international cohort of CPGs that provide recommendations on pharmaceutical management of glycemic control in patients with type 2 diabetes mellitus (DM2). Methods and Findings: We searched the National Guideline Clearinghouse (NGC) on February 15th and June 4th, 2012 for CPGs meeting inclusion criteria. Two independent assessors rated the quality of each CPG using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument. Twenty-four guidelines were evaluated, and most had high scores for clarity and presentation. However, scope and purpose, stakeholder involvement, rigor of development, and applicability domains varied considerably. The majority of guidelines scored low on editorial independence, and only seven CPGs were based on an underlying systematic review of the evidence. Conclusions: The overall quality of CPGs for glycemic control in DM2 is moderate, but there is substantial variability among quality domains within and across guidelines. Guideline users need to be aware of this variability and carefully appraise and select the guidelines that they apply to patient care.	[Holmer, Haley K.; Ogden, Lauren A.; Norris, Susan L.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Burda, Brittany U.] Kaiser Permanente, Ctr Hlth Res, Portland, OR USA	Oregon Health & Science University; Kaiser Permanente	Norris, SL (corresponding author), Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA.	norriss@ohsu.edu		Holmer, Haley/0000-0003-4198-8708	Agency for Healthcare Research and Quality [HS018500-01]; US Agency for Healthcare Research and Quality [1R01HS018500]; US Centers for Disease Control and Prevention (CDC); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018500] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); US Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This manuscript was the result of work performed for the Agency for Healthcare Research and Quality under grant HS018500-01 (S. L. Norris). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. declare.; S.L. Norris has received funding from the US Agency for Healthcare Research and Quality (grant number 1R01HS018500) to study conflict of interest in clinical practice guideline development. H.K. Holmer, L.A. Ogden and B.U. Burda received salary support from this same grant to study conflict of interest in clinical practice guideline development. S.L. Norris has received funding from the US Centers for Disease Control and Prevention (CDC) and from the US Agency for Healthcare Research and Quality for development of guidelines related to diabetes. B.U. Burda currently receives salary support from the US Agency for Healthcare Research and Quality for work on the US Preventive Services Task Force guidelines. The authors have no other competing interests to declare.	American Diabetes Association (ADA), 2012, DIABETES CARE S1, V35, pS16, DOI DOI 10.2337/DC11-2080; American Medical Directors Association, 2010, DIAB MAN LONG TERM C; [Anonymous], 2017, NATION; Bennett WL, 2012, ANN INTERN MED, V156, P27, DOI 10.7326/0003-4819-156-1-201201030-00005; Brehove T, 2007, ADAPTING YOUR PRACTI; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Burda BU, 2011, J CLIN EPIDEMIOL, V64, P968, DOI 10.1016/j.jclinepi.2010.12.005; Burgers JS, 2004, J CLIN ONCOL, V22, P2000, DOI 10.1200/JCO.2004.06.157; Canadian Agency for Drugs and Technologies in Health, 2009, OPT THER REC PRESCR; Canadian Agency for Drugs and Technologies in Health, 2010, OPT THER REC PRESCR; Canadian Agency for Drugs and Technologies in Health, 2010, 3 LIN THER PAT TYP 2; De Haas E, 2007, J EUR ACAD DERMATOL, V21, P1193, DOI 10.1111/j.1468-3083.2007.02216.x; Department of Veterans Affairs and Department of Defense, 2010, VA DOD CLIN PRACT GU; Greuter MJE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-58; Handelsman Y, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S2.1; Harpole LH, 2003, CHEST, V123, p7S, DOI 10.1378/chest.123.1_suppl.7S; Hogeveen SE, 2012, CURR ONCOL, V19, pE184, DOI 10.3747/co.19.930; Institute for Clinical Systems Improvement, 2012, DIAGN MAN TYP 2 DIAB; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; International Diabetes Center, 2009, PREV DET TREATM DIAB; International Diabetes Federation, 2007, GUIDELINE MANAGEMENT; Joslin Diabetes Center, 2007, GUID CAR OLD AD DIAB; Mahmud M, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-5; Mendelson TB, 2011, ARCH INTERN MED, V171, P577, DOI 10.1001/archinternmed.2011.96; National Collaborating Centre for Acute and Chronic Conditions, 2009, TYP 2 DIAB MAN TYP 2; National Collaborating Centre for Women's and Children's Health (UK), 2008, DIAB PREGN MAN DIAB; National Institute for Health and Clinical Excellence, 2010, LIR TREATM TYP 2 DIA; National Kidney Foundation, 2007, KDOQI CLIN GUID CLIN; Neuman J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5621; New York State Department of Health, 2007, PREV SEC DIS DIAB; Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047343; Norris SL, 2012, J CLIN EPIDEMIOL, V65, P725, DOI 10.1016/j.jclinepi.2011.12.011; Norris SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025153; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Qaseem A, 2011, ANN INTERN MED, V154, P260, DOI 10.7326/0003-4819-154-4-201102150-00007; Qatif Primary Health Care, 2011, CARD RISK MAN GUID P; Scottish Intercollegiate Guidelines Network, 2010, MAN DIAB NAT CLIN GU; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Stone MA, 2010, DIABETES RES CLIN PR, V87, P252, DOI 10.1016/j.diabres.2009.10.020; University of Michigan Health System, 2009, MAN TYP 2 DIAB MELL; Ward JE, 1996, MED J AUSTRALIA, V165, P574, DOI 10.5694/j.1326-5377.1996.tb138645.x; Wisconsin Diabetes Prevention and Control Program, 2011, WISC DIAB MELL ESS C; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; World Health Organization, 2012, DIAB FACT SHEET	45	60	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e58625	10.1371/journal.pone.0058625	http://dx.doi.org/10.1371/journal.pone.0058625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577058	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800005
J	Hsu, CS; Tung, CY; Yang, CY; Lin, CH				Hsu, Chih-Sin; Tung, Chien-Yi; Yang, Chih-Yung; Lin, Chi-Hung			Response to Stress in Early Tumor Colonization Modulates Switching of CD133-Positive and CD133-Negative Subpopulations in a Human Metastatic Colon Cancer Cell Line, SW620	PLOS ONE			English	Article							CD133 EXPRESSION; STEM-CELLS; MARKER CD133; POPULATION; PROGNOSIS; CULTURE	According to the cancer stem cell (CSC) model, higher CD133 expression in tumor tissue is associated with metastasis and poor prognosis in colon cancer. As such, the CD133-positive (CD133(+)) subpopulation of cancer cells is believed to play a central role in tumor development and metastatic progression. Although CD13(3)+ cells are believed to display more CSC-like behavior and be solely responsible for tumor colonization, recent research indicates that CD133(-) cells from metastatic colon tumors not only also possess colonization capacity but also promote the growth of larger tumors in a mouse model than CD133(+) cells, suggesting that an alternative mechanism of metastasis exists. This study investigated this possibility by examining the cell viability, tumorigenicity, and proliferation and growth capacity of the CD133(+) and CD133(-) subpopulations of the SW620 cell line, a human metastatic colon cancer cell line, in both an in vitro cell model and an in vivo mouse model. While both SW620(CD133-) and SW620(CD133+) cells were found to engage in bidirectional cell-type switching in reaction to exposure to environmental stressors, including hypoxia, a cell adhesion-free environment, and extracellular matrix stimulation, both in vitro and in vivo, CD133(-) cells were found to have a growth advantage during early colonization due to their greater resistance to proliferation inhibition. Based on these findings, a hypothetical model in which colon cancer cells engage in cell-type switching in reaction to exposure to environmental stressors is proposed. Such switching may provide a survival advantage during early colonization, as well as that explain previous conflicting observations.	[Hsu, Chih-Sin; Tung, Chien-Yi; Yang, Chih-Yung; Lin, Chi-Hung] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Lin, Chi-Hung] VGH Yang Ming Genome Res Ctr, Taipei, Taiwan; [Yang, Chih-Yung; Lin, Chi-Hung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital	Lin, CH (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	linch@ym.edu.tw			National Science Council [NSC 97-3112-B-075-002, NSC 98-3112-B-010-023-B4, NSC 97-2320-B-010-024-MY3]; Aim for the Top University Plan from the Ministry of Education, Republic of China	National Science Council(Ministry of Science and Technology, Taiwan); Aim for the Top University Plan from the Ministry of Education, Republic of China	This work was supported by research grants NSC 97-3112-B-075-002, NSC 98-3112-B-010-023-B4, and NSC 97-2320-B-010-024-MY3 from the National Science Council and by the Aim for the Top University Plan from the Ministry of Education, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Davies JM, 2011, SEMIN ONCOL, V38, P552, DOI 10.1053/j.seminoncol.2011.05.009; Dittfeld C, 2009, RADIOTHER ONCOL, V92, P353, DOI 10.1016/j.radonc.2009.06.034; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; Feng HL, 2010, CANC BIOL THER, V9; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hashimoto O, 2011, PATHOBIOLOGY, V78, P181, DOI 10.1159/000325538; Hongo K, 2011, J SURG RES; Horst D, 2008, BRIT J CANCER, V99, P1285, DOI 10.1038/sj.bjc.6604664; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Iida H, 2012, INT J ONCOL, V40, P71, DOI 10.3892/ijo.2011.1207; Iinuma H, 2011, J CLIN ONCOL, V29, P1547, DOI 10.1200/JCO.2010.30.5151; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kolenda J, 2011, J NEURO-ONCOL, V103, P43, DOI 10.1007/s11060-010-0357-8; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li CY, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-56; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Navarro-Alvarez N, 2010, CELL TRANSPLANT, V19, P865, DOI 10.3727/096368910X508997; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Puglisi MA, 2009, EUR REV MED PHARMACO, V13, P55; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sampieri K, 2012, SEMIN CANCER BIOL, V22, P187, DOI 10.1016/j.semcancer.2012.03.002; Sanoff HK, 2008, J CLIN ONCOL, V26, P5721, DOI 10.1200/JCO.2008.17.7147; Shibue T, 2011, SEMIN CANCER BIOL, V21, P99, DOI 10.1016/j.semcancer.2010.12.003; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Soltanian S, 2011, TUMOR BIOL, V32, P425, DOI 10.1007/s13277-011-0155-8; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Vaiopoulos AG, 2012, STEM CELLS, V30, P363, DOI 10.1002/stem.1031; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wang Q, 2009, HISTOPATHOLOGY, V55, P284, DOI 10.1111/j.1365-2559.2009.03378.x; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Yang ZL, 2011, WORLD J GASTROENTERO, V17, P932, DOI 10.3748/wjg.v17.i7.932; You HN, 2010, HEPATOLOGY, V51, P1635, DOI 10.1002/hep.23544	43	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61133	10.1371/journal.pone.0061133	http://dx.doi.org/10.1371/journal.pone.0061133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577199	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800124
J	Ramamurthy, D; Pazhani, GP; Sarkar, A; Nandy, RK; Rajendran, K; Sur, D; Manna, B; Ramamurthy, T				Ramamurthy, Dharanidharan; Pazhani, Gururaja P.; Sarkar, Anirban; Nandy, Ranjan K.; Rajendran, Krishnan; Sur, Dipika; Manna, Bamkesh; Ramamurthy, Thandavarayan			Case-Control Study on the Role of Enterotoxigenic Bacteroides fragilis as a Cause of Diarrhea among Children in Kolkata, India	PLOS ONE			English	Article							METALLOPROTEASE TOXIN GENE; ANTIMICROBIAL SUSCEPTIBILITY; BFT GENE; PREVALENCE; STRAINS; ASSOCIATION; RESISTANCE; BACTERIA; ETIOLOGY; SUBTYPES	A total of 874 fecal specimens (446 diarrheal cases and 428 controls) from diarrheal children admitted in the Infectious Diseases Hospital, Kolkata and age and sex matched asymptomatic subjects from an urban community were assessed for the prevalence of enterotoxigenic Bacteroides fragilis (ETBF). Isolates of B. fragilis were tested for the presence of enterotoxin gene (bft) by PCR. The detection rate of ETBF was 7.2% (63 of 874 specimens) that prevailed equally in diarrheal cases and controls (7.2% each; 32 of 446 cases and 31 of 428 controls). Male children up to one year age group was significantly (p, 0.05) associated with ETBF infection as compared to children. 2 years of age in cases and controls. In 25 ETBF isolates, the bft gene was genotyped using PCR-RFLP and only two alleles were identified with prevalence rate of 40% and 60% for bft-1 and bft-3, respectively. All the ETBF isolates were susceptible for chloramphenicol and imipenem but resistant to clindamycin (48%), moxifloxacin (44%) and metronidazole (32%). Resistance of ETBF to moxifloxacin (44%) and metronidazole is an emerging trend. Pulsed-field gel electrophoresis (PFGE) revealed that majority of the ETBF isolates are genetically diverse. In the dendrogram analysis, two clusters were identified, one with ETBF resistant to 5-8 antimicrobials and the other cluster with metronidazole and moxifloxacin susceptible isolates from diarrheal cases. To our knowledge, this is the first detailed report on ETBF from India indicating its clinical importance and molecular characteristics.	[Ramamurthy, Dharanidharan; Pazhani, Gururaja P.; Sarkar, Anirban; Nandy, Ranjan K.; Rajendran, Krishnan; Sur, Dipika; Manna, Bamkesh; Ramamurthy, Thandavarayan] Natl Inst Cholera & Enter Dis, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Ramamurthy, T (corresponding author), Natl Inst Cholera & Enter Dis, Kolkata, India.	tramu@vsnl.net	KRISHNAN, RAJENDRAN/L-6274-2019	Pazhani, Gururaja Perumal/0000-0001-9500-006X; Ramamurthy, Dharanidharan/0000-0002-0485-4308; Nandy, Ranjan Kumar/0000-0002-0012-9803	Global Enteric Multicentric Study, University of Maryland, Baltimore, USA; Indian Council of Medical Research (ICMR), India; National Academy of Sciences, Allahabad, India	Global Enteric Multicentric Study, University of Maryland, Baltimore, USA; Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR)); National Academy of Sciences, Allahabad, India	This study was supported by grants from Global Enteric Multicentric Study, University of Maryland, Baltimore, USA, and Indian Council of Medical Research (ICMR), India. AS is a recipient of Junior Research Fellowship from the National Academy of Sciences, Allahabad, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpinar M, 2010, ANAEROBE, V16, P505, DOI 10.1016/j.anaerobe.2010.08.002; Albert MJ, 1999, J CLIN MICROBIOL, V37, P3458, DOI 10.1128/JCM.37.11.3458-3464.1999; Antunes ENF, 2004, RES MICROBIOL, V155, P522, DOI 10.1016/j.resmic.2004.04.008; Balamurugan R, 2008, J PEDIATR GASTR NUTR, V46, P514, DOI 10.1097/MPG.0b013e31815ce599; Caceres M, 2000, ANAEROBE, V6, P143, DOI 10.1006/anae.2000.0341; Chaudhry R, 2001, EMERG INFECT DIS, V7, P485, DOI 10.3201/eid0703.017332; Chung GT, 1999, INFECT IMMUN, V67, P4945, DOI 10.1128/IAI.67.9.4945-4949.1999; Claros MC, 2006, ANAEROBE, V12, P17, DOI 10.1016/j.anaerobe.2005.06.005; CLSI, 2009, M11S1 CLSI, pM11; Cohen SH, 2006, DIAGN MICR INFEC DIS, V55, P251, DOI 10.1016/j.diagmicrobio.2006.01.026; d'Abusco AS, 2000, J CLIN MICROBIOL, V38, P607, DOI 10.1128/JCM.38.2.607-612.2000; Durmaz B, 2005, ANAEROBE, V11, P318, DOI 10.1016/j.anaerobe.2005.06.001; Galvao BPGV, 2011, ANAEROBE, V17, P142, DOI 10.1016/j.anaerobe.2011.02.009; Hill DR, 2010, CURR OPIN INFECT DIS, V23, P481, DOI 10.1097/QCO.0b013e32833dfca5; Jiang ZD, 2010, J CLIN MICROBIOL, V48, P1417, DOI 10.1128/JCM.01709-09; Kato N, 2000, FEMS MICROBIOL LETT, V182, P171, DOI 10.1111/j.1574-6968.2000.tb08892.x; Krzyzanowsky Flávio, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P225, DOI 10.1590/S0036-46652003000400010; LALITHA MK, 1980, INDIAN J MED RES, V71, P701; Lee Y, 2010, ANTIMICROB AGENTS CH, V54, P3993, DOI 10.1128/AAC.00481-10; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Merino VRC, 2011, J CLIN MICROBIOL, V49, P416, DOI 10.1128/JCM.01556-10; Nair GB, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-4; Nakano V, 2004, RES MICROBIOL, V155, P843, DOI 10.1016/j.resmic.2004.06.011; Nguyen TV, 2005, ANAEROBE, V11, P109, DOI 10.1016/j.anaerobe.2004.10.004; Nimri LF, 2004, FEMS IMMUNOL MED MIC, V42, P255, DOI 10.1016/j.femsim.2004.05.014; Niyogi SK, 1997, INDIAN J MED RES, V105, P167; Obuch-Woszczatynski Piotr, 2004, Polish Journal of Microbiology, V53, P35; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754; Pantosti A, 1997, CLIN INFECT DIS, V24, P12, DOI 10.1093/clinids/24.1.12; Papaparaskevas J, 2008, J ANTIMICROB CHEMOTH, V62, P137, DOI 10.1093/jac/dkn134; Pathela P, 2005, J INFECT DIS, V191, P1245, DOI 10.1086/428947; Paula GR, 2004, INT J ANTIMICROB AG, V24, P53, DOI 10.1016/j.ijantimicag.2003.11.011; Rennie RP, 2012, J CLIN MICROBIOL, V50, P1153, DOI 10.1128/JCM.05397-11; Rokosz A., 2001, Medycyna Doswiadczalna i Mikrobiologia, V53, P167; ROSENBLATT JE, 1995, DIAGN MICR INFEC DIS, V22, P279, DOI 10.1016/0732-8893(95)00049-G; SACK RB, 1994, J CLIN MICROBIOL, V32, P960, DOI 10.1128/JCM.32.4.960-963.1994; SACK RB, 1992, J DIARRHOEAL DIS RES, V10, P4; SANJOAQUIN VH, 1995, SCAND J INFECT DIS, V27, P211, DOI 10.3109/00365549509019011; Sears CL, 2008, CLIN INFECT DIS, V47, P797, DOI 10.1086/591130; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; Ulger N, 2006, ANAEROBE, V12, P71, DOI 10.1016/j.anaerobe.2005.11.001; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wick EC, 2010, CURR OPIN INFECT DIS, V23, P470, DOI 10.1097/QCO.0b013e32833da1eb; Yamasaki S, 1997, MICROBIOL IMMUNOL, V41, P1, DOI 10.1111/j.1348-0421.1997.tb01165.x; Zhang GM, 1999, CLIN INFECT DIS, V29, P590, DOI 10.1086/598639	47	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60622	10.1371/journal.pone.0060622	http://dx.doi.org/10.1371/journal.pone.0060622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577134	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800074
J	Dai, YK; Wang, YP; Wang, L; Wu, GR; Shi, F; Shen, DG				Dai, Yakang; Wang, Yaping; Wang, Li; Wu, Guorong; Shi, Feng; Shen, Dinggang		Alzheimers Dis Neuroimaging	aBEAT: A Toolbox for Consistent Analysis of Longitudinal Adult Brain MRI	PLOS ONE			English	Article							GRAY-MATTER VOLUME; HIPPOCAMPAL VOLUME; SEGMENTATION; IMAGES; REGISTRATION; OPTIMIZATION; PSYCHOSIS; TEMPLATE; DYNAMICS; DISEASE	Longitudinal brain image analysis is critical for revealing subtle but complex structural and functional changes of brain during aging or in neurodevelopmental disease. However, even with the rapid increase of clinical research and trials, a software toolbox dedicated for longitudinal image analysis is still lacking publicly. To cater for this increasing need, we have developed a dedicated 4D Adult Brain Extraction and Analysis Toolbox (aBEAT) to provide robust and accurate analysis of the longitudinal adult brain MR images. Specially, a group of image processing tools were integrated into aBEAT, including 4D brain extraction, 4D tissue segmentation, and 4D brain labeling. First, a 4D deformable-surface-based brain extraction algorithm, which can deform serial brain surfaces simultaneously under temporal smoothness constraint, was developed for consistent brain extraction. Second, a level-sets-based 4D tissue segmentation algorithm that incorporates local intensity distribution, spatial cortical-thickness constraint, and temporal cortical-thickness consistency was also included in aBEAT for consistent brain tissue segmentation. Third, a longitudinal groupwise image registration framework was further integrated into aBEAT for consistent ROI labeling by simultaneously warping a pre-labeled brain atlas to the longitudinal brain images. The performance of aBEAT has been extensively evaluated on a large number of longitudinal MR T1 images which include normal and dementia subjects, achieving very promising results. A Linux-based standalone package of aBEAT is now freely available at http://www.nitrc.org/projects/abeat.	[Dai, Yakang; Wang, Yaping; Wang, Li; Wu, Guorong; Shi, Feng; Shen, Dinggang] Univ N Carolina, Dept Radiol, IDEA Lab, Chapel Hill, NC 27515 USA; [Dai, Yakang; Wang, Yaping; Wang, Li; Wu, Guorong; Shi, Feng; Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC USA; [Dai, Yakang] Chinese Acad Sci, Dept Med Imaging, Suzhou Inst Biomed Engn & Technol, Suzhou, Jiangsu, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Sciences; Suzhou Institute of Biomedical Engineering & Technology, CAS	Shen, DG (corresponding author), Univ N Carolina, Dept Radiol, IDEA Lab, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Preda, Adrian/K-8889-2013; Hsiung, Robin/AAT-1661-2021; Shen, Dinggang/ABF-6812-2020; Levey, Allan/F-2104-2011; Wu, Guorong/G-3744-2014; wang, li/O-1425-2015; Saykin, Andrew/A-1318-2007	Preda, Adrian/0000-0003-3373-2438; Hsiung, Robin/0000-0002-8017-0856; Shen, Dinggang/0000-0002-7934-5698; Levey, Allan/0000-0002-3153-502X; Ponto, Laura/0000-0003-1197-6714; wang, li/0000-0001-8927-6772; Saykin, Andrew/0000-0002-1376-8532	National Institutes of Health [EB006733, EB008374, EB009634, AG041721]; National Basic Research Program of China (973 Program) [2010CB732505]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006733, R01EB008374, R01EB009634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702, P30AG013846, U01AG024904, R01AG041721, P30AG008051, P50AG005138, R01AG042599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health grants EB006733, EB008374, EB009634, and AG041721, and also by The National Basic Research Program of China (973 Program) grant number 2010CB732505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.ucla.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.ucla.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. The following statements from ADNI on the ADNI database are cited: "Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles."	Balci S. K., 2007, P INT C MED IM COMP, V10, P105; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Colliot O, 2008, RADIOLOGY, V248, P194, DOI 10.1148/radiol.2481070876; Dai Y, 2012, NEUROINFORMATICS; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; Holland D, 2009, P NATL ACAD SCI USA, V106, P20954, DOI 10.1073/pnas.0906053106; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Ibanez L, 2003, ITK SOFTWARE GUIDE I; Iglesias JE, 2011, IEEE T MED IMAGING, V30, P1617, DOI 10.1109/TMI.2011.2138152; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kitayama N, 2001, NUCL MED COMMUN, V22, P473, DOI 10.1097/00006231-200105000-00002; Leung KK, 2011, NEUROIMAGE, V55, P1091, DOI 10.1016/j.neuroimage.2010.12.067; Li G, 2012, NEUROIMAGE, V59, P3805, DOI 10.1016/j.neuroimage.2011.11.012; Li Y, 2010, LECT NOTES COMPUT SC, V6362, P133; Li Y, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.008; Nakamura M, 2007, BIOL PSYCHIAT, V62, P773, DOI 10.1016/j.biopsych.2007.03.030; Pantelis C, 2003, LANCET, V361, P281, DOI 10.1016/S0140-6736(03)12323-9; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sadananthan SA, 2010, NEUROIMAGE, V49, P225, DOI 10.1016/j.neuroimage.2009.08.050; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Shattuck DW, 2001, IEEE T MED IMAGING, V20, P1167, DOI 10.1109/42.963819; Shen DG, 2004, NEUROIMAGE, V21, P1508, DOI 10.1016/j.neuroimage.2003.12.015; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Shi F, 2011, LECT NOTES COMPUT SC, V6893, P313, DOI 10.1007/978-3-642-23626-6_39; Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thambisetty M, 2010, NEUROIMAGE, V52, P1215, DOI 10.1016/j.neuroimage.2010.04.258; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; Thompson PM, 2003, J NEUROSCI, V23, P994; Toga AW, 2003, ANNU REV BIOMED ENG, V5, P119, DOI 10.1146/annurev.bioeng.5.040202.121611; Wang L, 2012, MICCAI WORKSH SPAT I; Wang L, 2011, NEUROIMAGE, V58, P805, DOI 10.1016/j.neuroimage.2011.06.064; Wang Y, 2013, SPIE MED IMAGING; Wang YP, 2011, LECT NOTES COMPUT SC, V6893, P635, DOI 10.1007/978-3-642-23626-6_78; Wu G, 2012, MICCAI 2012 NIC FRAN; Wu GR, 2012, NEUROIMAGE, V59, P404, DOI 10.1016/j.neuroimage.2011.07.026; Xue Z, 2006, NEUROIMAGE, V30, P388, DOI 10.1016/j.neuroimage.2005.09.054; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; ZENG X, 1999, IEEE T MED IMAGING, V18, P100; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	48	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60344	10.1371/journal.pone.0060344	http://dx.doi.org/10.1371/journal.pone.0060344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23577105	gold, Green Published			2022-12-27	WOS:000318840100062
J	Liu, RL; Vaishnav, RA; Roberts, AM; Friedland, RP				Liu, Ruolan; Vaishnav, Radhika A.; Roberts, Andrew M.; Friedland, Robert P.			Humans Have Antibodies against a Plant Virus: Evidence from Tobacco Mosaic Virus	PLOS ONE			English	Article							PARKINSONS-DISEASE; MOLECULAR MIMICRY; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; CIGARETTE-SMOKING; PROTEIN; RISK; AUTOIMMUNITY; SUBUNIT; LOCALIZATION	Tobacco mosaic virus (TMV), a widespread plant pathogen, is found in tobacco (including cigarettes and smokeless tobacco) as well as in many other plants. Plant viruses do not replicate or cause infection in humans or other mammals. This study was done to determine whether exposure to tobacco products induces an immune response to TMV in humans. Using a sandwich ELISA assay, we detected serum anti-TMV antibodies (IgG, IgG1, IgG3, IgG4, IgA, and IgM) in all subjects enrolled in the study (20 healthy smokers, 20 smokeless-tobacco users, and 20 non-smokers). Smokers had a higher level of serum anti-TMV IgG antibodies than non-smokers, while the serum level of anti-TMV IgA from smokeless tobacco users was lower than smokers and non-smokers. Using bioinformatics, we also found that the human protein TOMM40L (an outer mitochondrial membrane 40 homolog - like translocase) contains a strong homology of six contiguous amino acids to the TMV coat protein, and TOMM40L peptide exhibited cross-reactivity with anti-TMV antibodies. People who smoke cigarettes or other tobacco products experience a lower risk of developing Parkinson's disease, but the mechanism by which this occurs is unclear. Our results showing molecular mimicry between TMV and human TOMM40L raise the question as to whether TMV has a potential role in smokers against Parkinson's disease development. The potential mechanisms of molecular mimicry between plant viruses and human disease should be further explored.	[Liu, Ruolan; Vaishnav, Radhika A.; Friedland, Robert P.] Univ Louisville, Sch Med, Dept Neurol, Louisville, KY 40292 USA; [Roberts, Andrew M.] Univ Louisville, Sch Med, Dept Physiol & Biophys, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Friedland, RP (corresponding author), Univ Louisville, Sch Med, Dept Neurol, Louisville, KY 40292 USA.	robert.friedland@louisville.edu	Vaishnav, Radhika/AAN-4556-2021; Friedland, Robert/A-2834-2010	Friedland, Robert/0000-0001-5721-1843	National Institues of Health [AG017173]; University of Louisville Clinical Translational Sciences Health [CTSPGP 20073]; Mary and Mason Rudd family; MBL Fund, Inc.; NATIONAL INSTITUTE ON AGING [U01AG017173, R01AG017173] Funding Source: NIH RePORTER	National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Louisville Clinical Translational Sciences Health; Mary and Mason Rudd family; MBL Fund, Inc.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from the National Institues of Health (AG017173 to RPF), the University of Louisville Clinical Translational Sciences Health (CTSPGP 20073 to RPF), the Mary and Mason Rudd family, and the MBL Fund, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOUDALLAL Z, 1985, EMBO J, V4, P1231, DOI 10.1002/j.1460-2075.1985.tb03765.x; ALTSCHUH D, 1983, MOL IMMUNOL, V20, P271, DOI 10.1016/0161-5890(83)90066-4; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Beraud Dawn, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS17, DOI 10.1016/S1353-8020(11)70008-6; BLOOMER AC, 1978, NATURE, V276, P362, DOI 10.1038/276362a0; CARPENTER CM, 1968, DIS CHEST, V54, P42, DOI 10.1378/chest.54.1.42; Chastain EML, 2012, IMMUNOL REV, V245, P227, DOI 10.1111/j.1600-065X.2011.01076.x; Checkoway H, 2002, AM J EPIDEMIOL, V155, P732, DOI 10.1093/aje/155.8.732; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; Colson P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010041; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; Croxford JL, 2005, J VIROL, V79, P8581, DOI 10.1128/JVI.79.13.8581-8590.2005; EMRE M, 1992, ARCH NEUROL-CHICAGO, V49, P1243, DOI 10.1001/archneur.1992.00530360041015; Folwarczna J, 2012, PROTEIN EXPRES PURIF, V85, P152, DOI 10.1016/j.pep.2012.07.008; Friedland RP, 2008, J BIOL CHEM, V283, P22550, DOI 10.1074/jbc.M802088200; Himoto T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/871401; Holzem A, 2001, J GEN VIROL, V82, P9, DOI 10.1099/0022-1317-82-1-9; Hu QO, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-41; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Hymowitz N, 2011, J NATL MED ASSOC, V103, P695, DOI 10.1016/S0027-9684(15)30408-9; Jefferis R, 1986, Monogr Allergy, V20, P26; Jun GyunGah, 2012, Archives of Neurology, V69, P1; Kimura A, 2012, J ALZHEIMERS DIS, V29, P373, DOI 10.3233/JAD-2011-111343; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109; Liu RL, 2005, J IMMUNOL, V175, P7898, DOI 10.4049/jimmunol.175.12.7898; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Mandal B, 2010, INDIAN J VIROL, V21, P92, DOI 10.1007/s13337-010-0014-z; Miller FW, 2012, J AUTOIMMUN; Olszewska W, 2003, VIROLOGY, V310, P183, DOI 10.1016/S0042-6822(03)00118-1; Powers KM, 2008, MOVEMENT DISORD, V23, P88, DOI 10.1002/mds.21782; Prochaska JJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2856; Quik M, 2004, TRENDS NEUROSCI, V27, P561, DOI 10.1016/j.tins.2004.06.008; Quik M, 2012, MOVEMENT DISORD, V27, P947, DOI 10.1002/mds.25028; Rae CS, 2005, VIROLOGY, V343, P224, DOI 10.1016/j.virol.2005.08.017; Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990; Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69; Rubin RL, 2005, TOXICOL SCI, V87, P86, DOI 10.1093/toxsci/kfi217; Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6; SCHWIMMBECK PL, 1989, J CLIN INVEST, V84, P1174, DOI 10.1172/JCI114282; Sergeyeva TN, 2011, B EXP BIOL MED+, V150, P348, DOI 10.1007/s10517-011-1139-9; Shriver LP, 2009, J NEUROIMMUNOL, V211, P66, DOI 10.1016/j.jneuroim.2009.03.015; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Tan EM, 2012, J CLIN INVEST, V122, P3835, DOI 10.1172/JCI66510; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8	49	51	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60621	10.1371/journal.pone.0060621	http://dx.doi.org/10.1371/journal.pone.0060621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573274	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100093
J	Mcgowan, I; Hoesley, C; Cranston, RD; Andrew, P; Janocko, L; Dai, JY; Carballo-Dieguez, A; Ayudhya, RKN; Piper, J; Hladik, F; Mayer, K				Mcgowan, Ian; Hoesley, Craig; Cranston, Ross D.; Andrew, Philip; Janocko, Laura; Dai, James Y.; Carballo-Dieguez, Alex; Ayudhya, Ratiya Kunjara Na; Piper, Jeanna; Hladik, Florian; Mayer, Ken			A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)	PLOS ONE			English	Article							ANAL INTERCOURSE; ULCERATIVE-COLITIS; HIV-INFECTION; MICROBICIDE; MEN; INFLAMMATION; TRIALS; MODEL; RISK; SEX	Objective: Rectal microbicides are needed to reduce the risk of HIV acquisition associated with unprotected receptive anal intercourse. The MTN-007 study was designed to assess the safety (general and mucosal), adherence, and acceptability of a new reduced glycerin formulation of tenofovir 1% gel. Methods: Participants were randomized 1:1:1:1 to receive the reduced glycerin formulation of tenofovir 1% gel, a hydroxyethyl cellulose placebo gel, a 2% nonoxynol-9 gel, or no treatment. Each gel was administered as a single dose followed by 7 daily doses. Mucosal safety evaluation included histology, fecal calprotectin, epithelial sloughing, cytokine expression (mRNA and protein), microarrays, flow cytometry of mucosal T cell phenotype, and rectal microflora. Acceptability and adherence were determined by computer-administered questionnaires and interactive telephone response, respectively. Results: Sixty-five participants (45 men and 20 women) were recruited into the study. There were no significant differences between the numbers of >= Grade 2 adverse events across the arms of the study. Likelihood of future product use (acceptability) was 87% (reduced glycerin formulation of tenofovir 1% gel), 93% (hydroxyethyl cellulose placebo gel), and 63% (nonoxynol-9 gel). Fecal calprotectin, rectal microflora, and epithelial sloughing did not differ by treatment arms during the study. Suggestive evidence of differences was seen in histology, mucosal gene expression, protein expression, and T cell phenotype. These changes were mostly confined to comparisons between the nonoxynol-9 gel and other study arms. Conclusions: The reduced glycerin formulation of tenofovir 1% gel was safe and well tolerated rectally and should be advanced to Phase 2 development.	[Mcgowan, Ian; Cranston, Ross D.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Mcgowan, Ian; Janocko, Laura; Ayudhya, Ratiya Kunjara Na] Magee Womens Res Inst, Microbicide Trials Network, Pittsburgh, PA USA; [Hoesley, Craig] Univ Alabama Birmingham, Birmingham, AL USA; [Andrew, Philip] FHI 360, Durham, NC USA; [Dai, James Y.; Hladik, Florian] Univ Washington, Seattle, WA 98195 USA; [Dai, James Y.; Hladik, Florian] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Carballo-Dieguez, Alex] Columbia Univ, New York, NY USA; [Piper, Jeanna] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Mayer, Ken] Fenway Hlth, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; University of Alabama System; University of Alabama Birmingham; FHI 360; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fenway Health	Mcgowan, I (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.	imcgowan@pitt.edu	M, i/HCI-9242-2022; Hladik, Florian/AAR-8852-2021; M, Ian/AAP-1032-2021; Hladik, Florian/G-1041-2012	Hladik, Florian/0000-0002-0375-2764; M, Ian/0000-0002-6470-8476; Hladik, Florian/0000-0002-0375-2764; Cranston, Ross/0000-0002-2687-6217	Microbicide Trials Network (MTN); National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Mental Health; U.S. National Institutes of Health [5UM1AI068633]; NIH [UM1AI068615]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068633, UM1AI068615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	Microbicide Trials Network (MTN); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Microbicide Trials Network (MTN) grant, an HIV/AIDS clinical trials network funded by the National Institute of Allergy and Infectious Diseases with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health (5UM1AI068633). This cooperative agreement involved the active collaboration of the sponsor, NIH, with the grant recipients within the MTN. SCHARP received funding under a separate NIH cooperative grant (UM1AI068615). NIH and the Statistical Center for HIV/AIDS Research & Prevention (SCHARP) employees are authors on this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton PA, 2012, AIDS RES HUM RETROV, V28, P1412, DOI [10.1089/aid.2012.0262, 10.1089/AID.2012.0262]; Anton PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023243; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen SY, 2003, JAIDS-J ACQ IMM DEF, V33, P166, DOI 10.1097/00126334-200306010-00008; Dezzutti CS, 2012, J ANTIMICROB CHEMOTH, V67, P2139, DOI 10.1093/jac/dks173; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Gaya DR, 2005, QJM-INT J MED, V98, P435, DOI 10.1093/qjmed/hci069; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Gorbach PM, 2009, SEX TRANSM DIS, V36, P193, DOI 10.1097/OLQ.0b013e3181901ccf; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lane T, 2006, AIDS, V20, P123, DOI 10.1097/01.aids.0000198083.55078.02; McGowan I, 2007, JAIDS-J ACQ IMM DEF, V46, P417, DOI 10.1097/QAI.0b013e318156ef16; McGowan I, 2011, AIDS BEHAV, V15, pS66, DOI 10.1007/s10461-011-9899-9; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Patton DL, 2002, SEX TRANSM DIS, V29, P581, DOI 10.1097/00007435-200210000-00004; Patton DL, 2009, SEX TRANSM DIS, V36, P350, DOI 10.1097/OLQ.0b013e318195c31a; Rabe LK, 2003, J CLIN MICROBIOL, V41, P3260, DOI 10.1128/JCM.41.7.3260-3264.2003; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Schwartz JL, 2007, CONTRACEPTION, V75, P136, DOI 10.1016/j.contraception.2006.09.003; Smithson JE, 1997, GUT, V40, P234, DOI 10.1136/gut.40.2.234; Stoner KA, 2008, J CLIN MICROBIOL, V46, P2739, DOI 10.1128/JCM.00161-08; Tabet SR, 1999, SEX TRANSM DIS, V26, P564, DOI 10.1097/00007435-199911000-00005	25	70	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60147	10.1371/journal.pone.0060147	http://dx.doi.org/10.1371/journal.pone.0060147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573238	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100050
J	Werling, M; Olbers, T; Fandriks, L; Bueter, M; Lonroth, H; Stenlof, K; le Roux, CW				Werling, Malin; Olbers, Torsten; Fandriks, Lars; Bueter, Marco; Lonroth, Hans; Stenlof, Kaj; le Roux, Carel W.			Increased Postprandial Energy Expenditure May Explain Superior Long Term Weight Loss after Roux-en-Y Gastric Bypass Compared to Vertical Banded Gastroplasty	PLOS ONE			English	Article							BODY-COMPOSITION; OBESE WOMEN; ADAPTIVE THERMOGENESIS; BARIATRIC SURGERY; MORBIDLY OBESE; DIETARY-INTAKE; TASTE ACUITY; PERSISTENCE; MORTALITY	Background and Aims: Gastric bypass results in greater weight loss than Vertical banded gastroplasty (VBG), but the underlying mechanisms remain unclear. In addition to effects on energy intake the two bariatric techniques may differentially influence energy expenditure (EE). Gastric bypass in rats increases postprandial EE enough to result in elevated EE over 24 hours. This study aimed to investigate alterations in postprandial EE after gastric bypass and VBG in humans. Methods: Fourteen women from a randomized clinical trial between gastric bypass (n = 7) and VBG (n = 7) were included. Nine years postoperatively and at weight stability patients were assessed for body composition and calorie intake. EE was measured using indirect calorimetry in a respiratory chamber over 24 hours and focused on the periods surrounding meals and sleep. Blood samples were analysed for postprandial gut hormone responses. Results: Groups did not differ regarding body composition or food intake either preoperatively or at study visit. Gastric bypass patients had higher EE postprandially (p = 0.018) and over 24 hours (p = 0.048) compared to VBG patients. Postprandial peptide YY (PYY) and glucagon like peptide 1 (GLP-1) levels were higher after gastric bypass (both p<0.001). Conclusions: Gastric bypass patients have greater meal induced EE and total 24 hours EE compared to VBG patients when assessed 9 years postoperatively. Postprandial satiety gut hormone responses were exaggerated after gastric bypass compared to VBG. Long-term weight loss maintenance may require significant changes in several physiological mechanisms which will be important to understand if non-surgical approaches are to mimic the effects of bariatric surgery.	[Werling, Malin; Olbers, Torsten; Fandriks, Lars; Lonroth, Hans; le Roux, Carel W.] Univ Gothenburg, Sahlgrenska Univ Hosp Sahlgrenska, Sahlgrenska Acad, Dept Gastrosurg Res & Educ, Gothenburg, Sweden; [Bueter, Marco] Univ Zurich Hosp, Div Visceral & Transplantat Surg, Dept Surg, CH-8091 Zurich, Switzerland; [Stenlof, Kaj] Sahlgrens Univ Hosp, Dept Clin Res, Gothenburg, Sweden; [le Roux, Carel W.] Univ Coll Dublin, UCD Conway Inst, Sch Med & Med Sci, Dublin 2, Ireland	Sahlgrenska University Hospital; University of Gothenburg; University of Zurich; University Zurich Hospital; Sahlgrenska University Hospital; University College Dublin	Werling, M (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp Sahlgrenska, Sahlgrenska Acad, Dept Gastrosurg Res & Educ, Gothenburg, Sweden.	malin.werling@gmail.com		Olbers, Torsten/0000-0002-7218-3390; Le Roux, Carel/0000-0001-5521-5445	Swedish Research Council [K2010-55X-21432-01-2]; University of Gothenburg; Sahlgrenska University Hospital; Gothenburg Medical Association; Ethicon Endosurgery; Deutsche Forschungsgemeinschaft; Department of Health Clinician; Integrative Mammalian Biology (IMB) Capacity Building Award, a EurOCHIP grant [FP7-HEALTH-2009-241592]; NIHR Biomedical Research Centre Funding Scheme	Swedish Research Council(Swedish Research CouncilEuropean Commission); University of Gothenburg; Sahlgrenska University Hospital; Gothenburg Medical Association; Ethicon Endosurgery; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Department of Health Clinician; Integrative Mammalian Biology (IMB) Capacity Building Award, a EurOCHIP grant; NIHR Biomedical Research Centre Funding Scheme(National Institute for Health Research (NIHR))	This study received financial support by the Swedish Research Council (LF; grant no K2010-55X-21432-01-2), the University of Gothenburg (LF, MW) and Sahlgrenska University Hospital (ALF: LF, HL), the Gothenburg Medical Association (MW), Ethicon Endosurgery (HL), the Deutsche Forschungsgemeinschaft (MB). CleR was supported by a Department of Health Clinician scientist award. Imperial College London receives support from an Integrative Mammalian Biology (IMB) Capacity Building Award, a FP7-HEALTH-2009-241592 EurOCHIP grant and a NIHR Biomedical Research Centre Funding Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Allison DB, 2000, MED CLIN N AM, V84, P305, DOI 10.1016/S0025-7125(05)70223-6; BESSARD T, 1983, AM J CLIN NUTR, V38, P680, DOI 10.1093/ajcn/38.5.680; Borg CM, 2006, BRIT J SURG, V93, P210, DOI 10.1002/bjs.5227; BROLIN RE, 1994, ANN SURG, V220, P782, DOI 10.1097/00000658-199412000-00012; BROWN EK, 1982, J AM DIET ASSOC, V80, P437; Buchwald H, 2009, OBES SURG, V19, P1605, DOI 10.1007/s11695-009-0014-5; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; BURGE JC, 1995, J AM DIET ASSOC, V95, P666, DOI 10.1016/S0002-8223(95)00182-4; Carrasco F, 2007, OBES SURG, V17, P608, DOI 10.1007/s11695-007-9117-z; Cesar MD, 2008, OBES SURG, V18, P1376, DOI 10.1007/s11695-008-9460-8; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Das SK, 2003, AM J CLIN NUTR, V78, P22, DOI 10.1093/ajcn/78.1.22; Flancbaum L, 1997, SURGERY, V122, P943, DOI 10.1016/S0039-6060(97)90336-6; FROIDEVAUX F, 1993, AM J CLIN NUTR, V57, P35, DOI 10.1093/ajcn/57.1.35; Galtier F, 2006, INT J OBESITY, V30, P1104, DOI 10.1038/sj.ijo.0803247; Greenway FL, 1996, ENDOCRIN METAB CLIN, V25, P1005, DOI 10.1016/S0889-8529(05)70367-4; HALMI KA, 1981, INT J OBESITY, V5, P457; Henning B, 1996, MED BIOL ENG COMPUT, V34, P207, DOI 10.1007/BF02520075; Kaplan LM, 2005, GASTROENTEROL CLIN N, V34, P91, DOI 10.1016/j.gtc.2004.12.002; KREYMANN B, 1987, LANCET, V2, P1300; Laurenius A, 2012, INT J OBES LOND; le Roux CW, 2007, ANN SURG, V246, P780, DOI 10.1097/SLA.0b013e3180caa3e3; le Roux CW, 2010, ANN SURG, V252, P50, DOI 10.1097/SLA.0b013e3181d3d21f; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; LINDROOS AK, 1993, EUR J CLIN NUTR, V47, P461; Olbers T, 2003, OBES SURG, V13, P364, DOI 10.1381/096089203765887679; Olbers T, 2005, BRIT J SURG, V92, P557, DOI 10.1002/bjs.4974; Olbers T, 2001, OBES SURG, V11, P726, DOI 10.1381/09608920160558669; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; Rosenbaum M, 2010, INT J OBESITY, V34, pS47, DOI 10.1038/ijo.2010.184; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; SCRUGGS DM, 1994, OBES SURG, V4, P24, DOI 10.1381/096089294765558854; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Stefater MA, 2010, GASTROENTEROLOGY, V138, P2426, DOI 10.1053/j.gastro.2010.02.059; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Tamboli RA, 2010, OBESITY, V18, P1718, DOI 10.1038/oby.2010.89; Thomsen TK, 1998, EUR J SURG, V164, P133; THORNE A, 1990, CLIN PHYSIOL, V10, P99, DOI 10.1111/j.1475-097X.1990.tb00087.x; van Gemert WG, 1998, INT J OBESITY, V22, P343, DOI 10.1038/sj.ijo.0800592; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355	46	61	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60280	10.1371/journal.pone.0060280	http://dx.doi.org/10.1371/journal.pone.0060280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573244	Green Accepted, Green Published, gold			2022-12-27	WOS:000318840100058
J	Yeung, B; Ho, KC; Yang, XL				Yeung, Benjamin; Ho, King-Ching; Yang, Xiaolong			WWP1 E3 Ligase Targets LATS1 for Ubiquitin-Mediated Degradation in Breast Cancer Cells	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; PROTEIN LIGASE; TUMOR-SUPPRESSOR; NEGATIVE REGULATION; GROWTH; YAP; EXPRESSION; STABILITY; FAMILY; PIRH2	The Large Tumor Suppressor 1 (LATS1) is a serine/threonine kinase and tumor suppressor found down-regulated in various human cancers. LATS1 has recently been identified as a central player of the emerging Hippo signaling pathway, which plays important roles in organ size control, tumorigenesis, and stem cell differentiation and renewal, etc. Although mounting evidence supports a role of LATS1 in tumor suppression and tumorigenesis, how LATS1 is regulated at the molecular level is not fully understood. Recently several positive regulators of LATS1 (Mst1/2, MOB1, Kibra, etc) have been identified but how LATS1 is negatively regulated is still largely unknown. We have recently identified Itch, a member of the NEDD4-like family E3 ubiquitin ligases, as a novel negative regulator of LATS1. However, whether other ubiquitin ligases modulate LATS1 stability and function is unclear. By screening many E3 ligases of the NEDD4-like family using overexpression and short-interference RNA knockdown approaches, we have identified WWP1 E3 ligase as another novel negative regulator of LATS1. We have provided in vitro and in vivo evidence that WWP1 is essential for LATS1 stability and negatively regulate LATS1 by promoting LATS1 degradation through polyubiquitination and the 26S proteasome pathway. Importantly, we also showed that degradation of LATS1 is critical in mediating WWP1-induced increased cell proliferation in breast cancer cells. Since WWP1 is an oncogene and LATS1 is a tumor suppressor gene in breast cancer, our studies provide a promising therapeutic strategy in which developed drugs targeting WWP1 cause activation of LATS1 in suppressing breast cancer cell growth.	[Yeung, Benjamin; Yang, Xiaolong] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Ho, King-Ching] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada	McMaster University; Queens University - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Yang, XL (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada.	yang@path.queensu.ca			Canadian Institute of Health Research (CIHR) [119325]; Canadian Breast Cancer Foundation (CBCF); Cancer Research Society	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation (CBCF); Cancer Research Society	1. Canadian Institute of Health Research (CIHR), grant No. 119325; website:http://www.cihr-irsc.gc.ca/e/193.html 2. Canadian Breast Cancer Foundation (CBCF), No grant number; website: http://www.cbcf.org/Pages/default.aspx 3. Cancer Research Society; No grant number; Website: http://www.src-crs.ca/en-CA/Donate%20to%20the%20CRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Yawei Hao for technical support and funding support from the Canadian Institute of Health Research (CIHR) and Canadian Breast Cancer Foundation (CBCF) to Xiaolong Yang.	Ande SR, 2009, EUR J PHARMACOL, V625, P199, DOI 10.1016/j.ejphar.2009.08.042; Badouel C, 2011, CELL, V145, P484, DOI 10.1016/j.cell.2011.04.009; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Cao XX, 2011, J BIOL CHEM, V286, P33447, DOI 10.1074/jbc.M111.225565; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CS, 2009, INT J CANCER, V124, P2829, DOI 10.1002/ijc.24266; Chow A, 2010, INT J CANCER, V126, P2079, DOI 10.1002/ijc.24878; Duan WR, 2004, JNCI-J NATL CANCER I, V96, P1718, DOI 10.1093/jnci/djh292; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Ho KC, 2011, P NATL ACAD SCI USA, V108, P4870, DOI 10.1073/pnas.1101273108; Huu NSN, 2008, J PATHOL, V216, P93, DOI 10.1002/path.2385; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Love Ian M, 2012, Genes Cancer, V3, P249, DOI 10.1177/1947601912455198; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tapon N, 2012, SEMIN CELL DEV BIOL, V23, P768, DOI 10.1016/j.semcdb.2012.08.007; Tremblay AM, 2012, SEMIN CELL DEV BIOL, V23, P818, DOI 10.1016/j.semcdb.2012.08.001; Visser S, 2010, CELL CYCLE, V9, P3892, DOI 10.4161/cc.9.19.13386; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang ZH, 2011, CANCER SCI, V102, P909, DOI 10.1111/j.1349-7006.2011.01899.x; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070; Zhi X, 2012, CELL MOL LIFE SCI, V69, P1425, DOI 10.1007/s00018-011-0871-7	45	58	62	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e61027	10.1371/journal.pone.0061027	http://dx.doi.org/10.1371/journal.pone.0061027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573293	gold, Green Submitted, Green Published			2022-12-27	WOS:000318840100111
J	Bell, AJ; Satchwell, TJ; Heesom, KJ; Hawley, BR; Kupzig, S; Hazell, M; Mushens, R; Herman, A; Toye, AM				Bell, Amanda J.; Satchwell, Timothy J.; Heesom, Kate J.; Hawley, Bethan R.; Kupzig, Sabine; Hazell, Matthew; Mushens, Rosey; Herman, Andrew; Toye, Ashley M.			Protein Distribution during Human Erythroblast Enucleation In Vitro	PLOS ONE			English	Article							CELLS; TRANSPORTER; MECHANISM	Enucleation is the step in erythroid terminal differentiation when the nucleus is expelled from developing erythroblasts creating reticulocytes and free nuclei surrounded by plasma membrane. We have studied protein sorting during human erythroblast enucleation using fluorescence activated cell sorting (FACS) to obtain pure populations of reticulocytes and nuclei produced by in vitro culture. Nano LC mass spectrometry was first used to determine the protein distribution profile obtained from the purified reticulocyte and extruded nuclei populations. In general cytoskeletal proteins and erythroid membrane proteins were preferentially restricted to the reticulocyte alongside key endocytic machinery and cytosolic proteins. The bulk of nuclear and ER proteins were lost with the nucleus. In contrast to the localization reported in mice, several key erythroid membrane proteins were detected in the membrane surrounding extruded nuclei, including band 3 and GPC. This distribution of key erythroid membrane and cytoskeletal proteins was confirmed using western blotting. Protein partitioning during enucleation was investigated by confocal microscopy with partitioning of cytoskeletal and membrane proteins to the reticulocyte observed to occur at a late stage of this process when the nucleus is under greatest constriction and almost completely extruded. Importantly, band 3 and CD44 were shown not to restrict specifically to the reticulocyte plasma membrane. This highlights enucleation as a stage at which excess erythroid membrane proteins are discarded in human erythroblast differentiation. Given the striking restriction of cytoskeleton proteins and the fact that membrane proteins located in macromolecular membrane complexes (e. g. GPA, Rh and RhAG) are segregated to the reticulocyte, we propose that the membrane proteins lost with the nucleus represent an excess mobile population of either individual proteins or protein complexes.	[Bell, Amanda J.; Satchwell, Timothy J.; Heesom, Kate J.; Hawley, Bethan R.; Herman, Andrew; Toye, Ashley M.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Kupzig, Sabine; Hazell, Matthew; Mushens, Rosey; Toye, Ashley M.] NHS Blood & Transplant, Bristol Inst Transfus Sci, Bristol, Avon, England	University of Bristol	Toye, AM (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	ash.m.toye@bristol.ac.uk	Toye, Ashley Mark/AAV-7199-2021; Toye, Ashley Mark/AFO-2320-2022	Toye, Ashley Mark/0000-0003-4395-9396; Toye, Ashley Mark/0000-0003-4395-9396	Wellcome Trust [094277]; National Institute for Health Research [RP-PG-0310-1004 -AMT]; NHSBT RD; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NHSBT RD; National Institute for Health Research(National Institute for Health Research (NIHR))	AB was funded by a Wellcome Trust PhD studentship and TJS by a Wellcome Trust project grant (094277). This work was funded in part by National Institute for Health Research programme grant to NHSBT (RP-PG-0310-1004 -AMT) and by NHSBT R&D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betin VM, 2012, BLOOD; GEIDUSCHEK JB, 1979, CELL, V16, P149, DOI 10.1016/0092-8674(79)90196-X; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Jiang WH, 2006, BIOCHEM BIOPH RES CO, V339, P1255, DOI 10.1016/j.bbrc.2005.11.138; Keerthivasan G, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/139851; KOURY ST, 1989, J CELL BIOL, V109, P3005, DOI 10.1083/jcb.109.6.3005; Lee JCM, 2004, BLOOD, V103, P1912, DOI 10.1182/blood-2003-03-0928; Marfatia SM, 1997, J BIOL CHEM, V272, P24191, DOI 10.1074/jbc.272.39.24191; May JM, 2007, BIOCHEM BIOPH RES CO, V360, P295, DOI 10.1016/j.bbrc.2007.06.072; PATEL VP, 1987, J CELL BIOL, V105, P3105, DOI 10.1083/jcb.105.6.3105; Pellegrin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038356; Salomao M, 2010, BLOOD, V116, P267, DOI 10.1182/blood-2010-02-264127; Satchwell TJ, 2011, BLOOD, V118, P182, DOI 10.1182/blood-2010-10-314187; SIMPSON CF, 1967, J CELL BIOL, V35, P237, DOI 10.1083/jcb.35.1.237; SKUTELSKY E, 1967, J CELL BIOL, V33, P625, DOI 10.1083/jcb.33.3.625; Soni S, 2006, J BIOL CHEM, V281, P20181, DOI 10.1074/jbc.M603226200; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1594, DOI 10.3324/haematol.2009.019828; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1278, DOI 10.3324/haematol.2009.021063; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Wang JX, 2012, J CELL SCI, V125, P340, DOI 10.1242/jcs.088286; Zhang JZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1277, DOI 10.1152/ajpcell.2001.280.5.C1277	22	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60300	10.1371/journal.pone.0060300	http://dx.doi.org/10.1371/journal.pone.0060300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565219	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300088
J	Czibula, G; Bocicor, IM; Czibula, IG				Czibula, Gabriela; Bocicor, Iuliana M.; Czibula, Istvan-Gergely			Temporal Ordering of Cancer Microarray Data through a Reinforcement Learning Based Approach	PLOS ONE			English	Article							TREE MODELS; ONCOGENESIS; HYBRIDIZATION; PROGRESSION; PATHWAYS	Temporal modeling and analysis and more specifically, temporal ordering are very important problems within the fields of bioinformatics and computational biology, as the temporal analysis of the events characterizing a certain biological process could provide significant insights into its development and progression. Particularly, in the case of cancer, understanding the dynamics and the evolution of this disease could lead to better methods for prediction and treatment. In this paper we tackle, from a computational perspective, the temporal ordering problem, which refers to constructing a sorted collection of multi-dimensional biological data, collection that reflects an accurate temporal evolution of biological systems. We introduce a novel approach, based on reinforcement learning, more precisely, on Q-learning, for the biological temporal ordering problem. The experimental evaluation is performed using several DNA microarray data sets, two of which contain cancer gene expression data. The obtained solutions are correlated either to the given correct ordering (in the cases where this is provided for validation), or to the overall survival time of the patients (in the case of the cancer data sets), thus confirming a good performance of the proposed model and indicating the potential of our proposal.	[Czibula, Gabriela; Bocicor, Iuliana M.; Czibula, Istvan-Gergely] Univ Babes Bolyai, Dept Comp Sci, R-3400 Cluj Napoca, Romania	Babes Bolyai University from Cluj	Czibula, IG (corresponding author), Univ Babes Bolyai, Dept Comp Sci, R-3400 Cluj Napoca, Romania.	istvanc@cs.ubbcluj.ro	Czibula, Gabriela/C-3332-2012	Czibula, Gabriela/0000-0001-7852-681X; Czibula, Istvan Gergely/0000-0003-0076-584X	Sectoral Operational Programme for Human Resources Development; European Social Fund [POSDRU/107/1.5/S/76841]	Sectoral Operational Programme for Human Resources Development; European Social Fund(European Social Fund (ESF))	This work was partially supported by the Sectoral Operational Programme for Human Resources Development 2007-2013, co-financed by the European Social Fund, under the project number POSDRU/107/1.5/S/76841 with the title "Modern Doctoral Studies: Internationalization and Interdisciplinarity". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Attolini CSO, 2010, P NATL ACAD SCI USA, V107, P17604, DOI 10.1073/pnas.1009117107; Beerenwinkel N, 2005, J COMPUT BIOL, V12, P584, DOI 10.1089/cmb.2005.12.584; Beerenwinkel N, 2005, BIOINFORMATICS, V21, P2106, DOI 10.1093/bioinformatics/bti274; Bramsen Philip, 2006, AMIA Annu Symp Proc, P81; Buck CE, 2000, J R STAT SOC C-APPL, V49, P423, DOI 10.1111/1467-9876.00203; Cheng Y, 2012, PLOS COMPUTATIONAL B, V8, P1; Cohen WW, 1999, J ARTIF INTELL RES, V10, P243, DOI 10.1613/jair.587; Czibula I., 2011, P KEPT 2011, VLVI, P3; DAYAN P, 1994, MACH LEARN, V14, P295; Desper R, 1999, J COMPUT BIOL, V6, P37, DOI 10.1089/cmb.1999.6.37; Desper R, 2000, J COMPUT BIOL, V7, P789, DOI 10.1089/10665270050514936; Frank S, 2007, DYNAMICS CANC; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gerstung M., 2011, PLOS ONE, V6, P1; Gerstung M, 2009, BIOINFORMATICS, V25, P2809, DOI 10.1093/bioinformatics/btp505; Gupta A, 2008, IEEE ACM T COMPUT BI, V5, P172, DOI 10.1109/TCBB.2007.70233; Harmon ME, 1996, REINFORCEMENT LEARNI; Hibbard B, 2012, J ARTIFICIAL GEN INT, V3, P1, DOI DOI 10.2478/V10229-011-0013-5; Hjelm M, 2006, J COMPUT BIOL, V13, P853, DOI 10.1089/cmb.2006.13.853; Kaelbling LP, 1991, P 13 INT JOINT C ART, V2, P726; LIN LJ, 1992, MACH LEARN, V8, P293, DOI 10.1007/BF00992699; Magwene PM, 2003, BIOINFORMATICS, V19, P842, DOI 10.1093/bioinformatics/btg081; Mani I, 2004, AMST STUD THEORY HIS, V260, P45; Mitchell T.M, 2003, MACH LEARN; Nugues P, 2006, P EACL 2006 TRENT IT; Nutt CL, 2003, CANCER RES, V63, P1602; Pathare S, 2009, INT J CANCER, V124, P2864, DOI 10.1002/ijc.24267; Perez-Uribe A., 1998, INTRO REINFORCEMENT; Ramakrishnan N, 2009, COMPUTER, V42, P97, DOI 10.1109/MC.2009.267; Rogers A, 2012, 26 AAAI C ART INT AA, P2166; Schiffman B, 2003, P HUM LANG TECHN C H, P55; Schindler G, 2007, IEEE COMP SOC C COMP; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Susnea I, 2009, STUD INFORM CONTROL, V18, P233; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Theriot JA, 2002, GENOME BIOL, V4, P4241; Thrun S.B., 1992, EFFICIENT EXPLORATIO; Tuffery S., 2011, DATA MINING STAT DEC; van der Hoek W, 2008, FOUND ARTIF INTELL, P887, DOI 10.1016/S1574-6526(07)03024-6; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698	42	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60883	10.1371/journal.pone.0060883	http://dx.doi.org/10.1371/journal.pone.0060883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565283	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300156
J	Hu, AY; Yang, Z; Yu, CP; Jiao, NZ				Hu, Anyi; Yang, Zao; Yu, Chang-Ping; Jiao, Nianzhi			Dynamics of Autotrophic Marine Planktonic Thaumarchaeota in the East China Sea	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; CHANGJIANG ESTUARY; GENOME SEQUENCE; MESOPHILIC CRENARCHAEOTA; SUMMER BACTERIOPLANKTON; TEMPORAL DISTRIBUTION; NITRITE REDUCTASE; DIVERSITY; ASSEMBLAGES; COMMUNITY	The ubiquitous and abundant distribution of ammonia-oxidizing Thaumarchaeota in marine environments is now well documented, and their crucial role in the global nitrogen cycle has been highlighted. However, the potential contribution of Thaumarchaeota in the carbon cycle remains poorly understood. Here we present for the first time a seasonal investigation on the shelf region (bathymetry <= 200 m) of the East China Sea (ECS) involving analysis of both thaumarchaeal 16S rRNA and autotrophy-related genes (acetyl-CoA carboxylase gene, accA). Quantitative PCR results clearly showed a higher abundance of thaumarchaeal 16S and accA genes in late-autumn (November) than summer (August), whereas the diversity and community structure of autotrophic Thaumarchaeota showed no statistically significant difference between different seasons as revealed by thaumarchaeal accA gene clone libraries. Phylogenetic analysis indicated that shallow ecotypes dominated the autotrophic Thaumarchaeota in the ECS shelf (86.3% of total sequences), while a novel non-marine thaumarchaeal accA lineage was identified in the Changjiang estuary in summer (when freshwater plumes become larger) but not in autumn, implying that Changjiang freshwater discharge played a certain role in transporting terrestrial microorganisms to the ECS. Multivariate statistical analysis indicated that the biogeography of the autotrophic Thaumarchaeota in the shelf water of the ECS was influenced by complex hydrographic conditions. However, an in silico comparative analysis suggested that the diversity and abundance of the autotrophic Thaumarchaeota might be biased by the 'universal' thaumarchaeal accA gene primers Cren529F/Cren981R since this primer set is likely to miss some members within particular phylogenetic groups. Collectively, this study improved our understanding of the biogeographic patterns of the autotrophic Thaumarchaeota in temperate coastal waters, and suggested that new accA primers with improved coverage and sensitivity across phylogenetic groups are needed to gain a more thorough understanding of the role of the autotrophic Thaumarchaeota in the global carbon cycle.	[Hu, Anyi; Yu, Chang-Ping] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China; [Yang, Zao; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS; Xiamen University	Yu, CP (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China.	cpyu@iue.ac.cn; jiao@xmu.edu.cn	Yu, Chang-Ping/E-9422-2010; CAS, KLUEH/T-5743-2019; Hu, Anyi/E-6836-2018	Hu, Anyi/0000-0001-6226-2741	NSFC [41106096, 41191021]; SOA project [201105021]; Science and Technology Planning Project of Xiamen, China [3502Z20102017]; State Key Laboratory of Marine Environmental Science at Xiamen University [MELRS1026]	NSFC(National Natural Science Foundation of China (NSFC)); SOA project; Science and Technology Planning Project of Xiamen, China; State Key Laboratory of Marine Environmental Science at Xiamen University	This work was supported by the NSFC projects (41106096 and 41191021), the SOA project (201105021) and the Science and Technology Planning Project of Xiamen (3502Z20102017), China. AH was also partially supported by the MEL Young Scientist Visiting Fellowship (MELRS1026) from the State Key Laboratory of Marine Environmental Science at Xiamen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Biller SJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00252; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Boyle B, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-75; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Christman GD, 2011, APPL ENVIRON MICROB, V77, P2026, DOI 10.1128/AEM.01907-10; Church MJ, 2003, LIMNOL OCEANOGR, V48, P1893, DOI 10.4319/lo.2003.48.5.1893; Dang HY, 2008, MICROBIOL-SGM, V154, P2084, DOI 10.1099/mic.0.2007/013581-0; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; DeLong EF, 1998, CURR OPIN GENET DEV, V8, P649, DOI 10.1016/S0959-437X(98)80032-4; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Feng BW, 2009, FEMS MICROBIOL ECOL, V70, P236, DOI 10.1111/j.1574-6941.2009.00772.x; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Galand PE, 2010, LIMNOL OCEANOGR, V55, P2117, DOI 10.4319/lo.2010.55.5.2117; Galand PE, 2009, ENVIRON MICROBIOL, V11, P971, DOI 10.1111/j.1462-2920.2008.01822.x; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Gao XL, 2006, J COASTAL RES, V22, P1330, DOI 10.2112/03-0124.1; Grzymski JJ, 2012, ISME J, V6, P1901, DOI 10.1038/ismej.2012.31; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Herfort L, 2007, FEMS MICROBIOL ECOL, V62, P242, DOI 10.1111/j.1574-6941.2007.00397.x; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Hu AY, 2011, APPL ENVIRON MICROB, V77, P7469, DOI 10.1128/AEM.00294-11; Hu AY, 2011, MICROB ECOL, V62, P549, DOI 10.1007/s00248-011-9866-z; Jiao NZ, 2005, CONT SHELF RES, V25, P1265, DOI 10.1016/j.csr.2005.01.002; Jiao NZ, 2002, AQUAT MICROB ECOL, V30, P37; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kim BK, 2011, J BACTERIOL, V193, P5539, DOI 10.1128/JB.05717-11; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liu M, 2011, CAN J MICROBIOL, V57, P504, DOI [10.1139/w11-037, 10.1139/W11-037]; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lund MB, 2012, ISME J, V6, P1966, DOI 10.1038/ismej.2012.40; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Molina V, 2010, ENVIRON MICROBIOL, V12, P2450, DOI 10.1111/j.1462-2920.2010.02218.x; Mosier AC, 2012, J BACTERIOL, V194, P2121, DOI 10.1128/JB.00013-12; Mosier AC, 2012, J BACTERIOL, V194, P2119, DOI 10.1128/JB.00007-12; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Offre P, 2011, ENV MICROBIOL REP, V3, P245, DOI 10.1111/j.1758-2229.2010.00217.x; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Pitcher A, 2011, LIMNOL OCEANOGR, V56, P2308, DOI 10.4319/lo.2011.56.6.2308; Santoro AE, 2010, ENVIRON MICROBIOL, V12, P1989, DOI 10.1111/j.1462-2920.2010.02205.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shang SL, 2011, REMOTE SENS ENVIRON, V115, P180, DOI 10.1016/j.rse.2010.08.016; Sintes E, 2013, ENVIRON MICROBIOL, V15, P1647, DOI 10.1111/j.1462-2920.2012.02801.x; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Tully BJ, 2012, ENVIRON MICROBIOL, V14, P254, DOI 10.1111/j.1462-2920.2011.02628.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Williams TJ, 2012, ISME J, V6, P1883, DOI 10.1038/ismej.2012.28; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Yakimov MM, 2011, ISME J, V5, P945, DOI 10.1038/ismej.2010.197; Yakimov MM, 2009, DEEP-SEA RES PT II, V56, P748, DOI 10.1016/j.dsr2.2008.07.024; Yan WJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003575; Zeng YH, 2007, MICROBIOL RES, V162, P26, DOI 10.1016/j.micres.2006.03.007; Zhang J, 2007, PROG OCEANOGR, V74, P449, DOI 10.1016/j.pocean.2007.04.019; Zhang Y, 2007, FEMS MICROBIOL ECOL, V61, P459, DOI 10.1111/j.1574-6941.2007.00355.x	68	14	14	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e61087	10.1371/journal.pone.0061087	http://dx.doi.org/10.1371/journal.pone.0061087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565298	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300171
J	Wang, Y; Hamilton, AFD				Wang, Yin; Hamilton, Antonia F. de C.			Understanding the Role of the 'Self' in the Social Priming of Mimicry	PLOS ONE			English	Article							IMITATIVE RESPONSE TENDENCIES; MODERATING ROLE; EYE CONTACT; BEHAVIOR; ACTIVATION; INHIBITION; RELEVANCE; CONTRAST; ASSIMILATION; AUTOMATICITY	People have a tendency to unconsciously mimic other's actions. This mimicry has been regarded as a prosocial response which increases social affiliation. Previous research on social priming of mimicry demonstrated an assimilative relationship between mimicry and prosociality of the primed construct: prosocial primes elicit stronger mimicry whereas antisocial primes decrease mimicry. The present research extends these findings by showing that assimilative and contrasting prime-to-behavior effect can both happen on mimicry. Specifically, experiment 1 showed a robust contrast priming effect where priming antisocial behaviors induces stronger mimicry than priming prosocial behaviors. In experiment 2, we manipulated the self-relatedness of the pro/antisocial primes and further revealed that prosocial primes increase mimicry only when the social primes are self-related whereas antisocial primes increase mimicry only when the social primes are self-unrelated. In experiment 3, we used a novel cartoon movie paradigm to prime pro/antisocial behaviors and manipulated the perspective-taking when participants were watching these movies. Again, we found that prosocial primes increase mimicry only when participants took a first-person point of view whereas antisocial primes increase mimicry only when participants took a third-person point of view, which replicated the findings in experiment 2. We suggest that these three studies can be best explained by the active-self theory, which claims that the direction of prime-to-behavior effects depends on how primes are processed in relation to the 'self'.	[Wang, Yin; Hamilton, Antonia F. de C.] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England	University of Nottingham	Wang, Y (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.	mirrorneuronwang@gmail.com	Hamilton, Antonia/AAC-6648-2019; Hamilton, Antonia/ABC-4196-2021; Hamilton, Antonia F/B-3612-2008	Hamilton, Antonia/0000-0001-8000-0219; Hamilton, Antonia F/0000-0001-8000-0219	Economic and Social Research Council (ESRC) [ES/J006793/1]; ESRC [ES/J006793/1] Funding Source: UKRI; Economic and Social Research Council [ES/J006793/1] Funding Source: researchfish	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by Economic and Social Research Council (ESRC: http://www.esrc.ac.uk/) Small Research Grant ES/J006793/1 (to AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2002, BRIT J SOC PSYCHOL, V41, P123, DOI 10.1348/014466602165090; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; Bengtsson SL, 2011, SOC COGN AFFECT NEUR, V6, P417, DOI 10.1093/scan/nsq048; Bertenthal BI, 2006, J EXP PSYCHOL HUMAN, V32, P210, DOI 10.1037/0096-1523.32.2.210; Boehm C, 2000, J CONSCIOUSNESS STUD, V7, P79; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2005, NEUROPSYCHOLOGIA, V43, P89, DOI 10.1016/j.neuropsychologia.2004.06.018; Brass M, 2003, NEUROPSYCHOLOGY, V17, P265, DOI 10.1037/0894-4105.17.2.265; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Brass M, 2001, NEUROIMAGE, V14, P1416, DOI 10.1006/nimg.2001.0944; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Cesario J, 2006, J PERS SOC PSYCHOL, V90, P893, DOI 10.1037/0022-3514.90.6.893; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X; Chartrand Tanya L, 2003, SOCIAL JUDGMENTS IMP, P290; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cook J, 2011, EXP BRAIN RES, V211, P601, DOI 10.1007/s00221-011-2584-4; Cook JL, 2012, J AUTISM DEV DISORD, V42, P1045, DOI 10.1007/s10803-011-1341-7; DeMarree KG, 2009, J EXP SOC PSYCHOL, V45, P440, DOI 10.1016/j.jesp.2008.10.009; Dijksterhuis A, 2000, SOC COGNITION, V18, P55, DOI 10.1521/soco.2000.18.1.55; Dijksterhuis A, 1998, J PERS SOC PSYCHOL, V75, P862, DOI 10.1037/0022-3514.75.4.862; Dijksterhuis A, 2001, J EXP SOC PSYCHOL, V37, P286, DOI 10.1006/jesp.2000.1449; Dijksterhuis A., 2007, SOCIAL PSYCHOL UNCON, P51; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Fujisawa KK, 2006, J COMP PSYCHOL, V120, P48, DOI 10.1037/0735-7036.120.1.48; Fujisawa KK, 2005, AGGRESSIVE BEHAV, V31, P138, DOI 10.1002/ab.20076; Galinsky AD, 2008, J PERS SOC PSYCHOL, V95, P404, DOI 10.1037/0022-3514.95.2.404; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Lakin JL, 2008, PSYCHOL SCI, V19, P816, DOI 10.1111/j.1467-9280.2008.02162.x; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; LeBoeuf RA, 2004, SOC COGNITION, V22, P607, DOI 10.1521/soco.22.6.607.54817; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; Lombardo MV, 2010, BRAIN, V133, P611, DOI 10.1093/brain/awp306; Marx DM, 2006, J EXP SOC PSYCHOL, V42, P768, DOI 10.1016/j.jesp.2005.08.005; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; McBride J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00082; Moran JM, 2009, SOC NEUROSCI-UK, V4, P197, DOI 10.1080/17470910802250519; Mussweiler T, 2003, PSYCHOL REV, V110, P472, DOI 10.1037/0033-295X.110.3.472; Obhi SS, 2011, J NEUROSCI, V31, P14531, DOI 10.1523/JNEUROSCI.3186-11.2011; Over H, 2009, DEVELOPMENTAL SCI, V12, pF1, DOI 10.1111/j.1467-7687.2008.00820.x; Prabhakaran R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00105; Rameson LT, 2012, J COGNITIVE NEUROSCI, V24, P235, DOI 10.1162/jocn_a_00130; Rameson LT, 2010, NEUROIMAGE, V50, P701, DOI 10.1016/j.neuroimage.2009.12.098; Schubert TW, 2003, J EXP SOC PSYCHOL, V39, P577, DOI 10.1016/S0022-1031(03)00034-9; Sebastian C, 2008, TRENDS COGN SCI, V12, P441, DOI 10.1016/j.tics.2008.07.008; Smeesters D, 2009, J PERS SOC PSYCHOL, V96, P395, DOI 10.1037/a0012959; Smeesters D, 2009, J EXP SOC PSYCHOL, V45, P211, DOI 10.1016/j.jesp.2008.09.002; Spengler S, 2010, CONSCIOUS COGN, V19, P98, DOI 10.1016/j.concog.2009.12.014; SRULL TK, 1979, J PERS SOC PSYCHOL, V37, P1660, DOI 10.1037/0022-3514.37.10.1660; van Baaren RB, 2003, J PERS SOC PSYCHOL, V84, P1093, DOI 10.1037/0022-3514.84.5.1093; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; Wang Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00153; Wang Y, 2011, J NEUROSCI, V31, P12001, DOI 10.1523/JNEUROSCI.0845-11.2011; Wang Y, 2011, BIOL LETTERS, V7, P7, DOI 10.1098/rsbl.2010.0279; Wheeler SC, 2007, PERS SOC PSYCHOL REV, V11, P234, DOI 10.1177/1088868307302223; Wheeler SC, 2001, J EXP SOC PSYCHOL, V37, P173, DOI 10.1006/jesp.2000.1448	63	28	28	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60249	10.1371/journal.pone.0060249	http://dx.doi.org/10.1371/journal.pone.0060249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565208	Green Published, gold			2022-12-27	WOS:000317717300077
J	Nallu, S; Silverstein, KAT; Samac, DA; Bucciarelli, B; Vance, CP; VandenBosch, KA				Nallu, Sumitha; Silverstein, Kevin A. T.; Samac, Deborah A.; Bucciarelli, Bruna; Vance, Carroll P.; VandenBosch, Kathryn A.			Regulatory Patterns of a Large Family of Defensin-Like Genes Expressed in Nodules of Medicago truncatula	PLOS ONE			English	Article							NITROGEN-FIXATION; ANTIMICROBIAL PEPTIDES; DNA ELEMENTS; ROOT-NODULES; PLANT; ALFALFA; PROTEIN; DIFFERENTIATION; IDENTIFICATION; NODULATION	Root nodules are the symbiotic organ of legumes that house nitrogen-fixing bacteria. Many genes are specifically induced in nodules during the interactions between the host plant and symbiotic rhizobia. Information regarding the regulation of expression for most of these genes is lacking. One of the largest gene families expressed in the nodules of the model legume Medicago truncatula is the nodule cysteine-rich (NCR) group of defensin-like (DEFL) genes. We used a custom Affymetrix microarray to catalog the expression changes of 566 NCRs at different stages of nodule development. Additionally, bacterial mutants were used to understand the importance of the rhizobial partners in induction of NCRs. Expression of early NCRs was detected during the initial infection of rhizobia in nodules and expression continued as nodules became mature. Late NCRs were induced concomitantly with bacteroid development in the nodules. The induction of early and late NCRs was correlated with the number and morphology of rhizobia in the nodule. Conserved 41 to 50 bp motifs identified in the upstream 1,000 bp promoter regions of NCRs were required for promoter activity. These cis-element motifs were found to be unique to the NCR family among all annotated genes in the M. truncatula genome, although they contain sub-regions with clear similarity to known regulatory motifs involved in nodule-specific expression and temporal gene regulation.	[Nallu, Sumitha; Silverstein, Kevin A. T.; VandenBosch, Kathryn A.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Samac, Deborah A.; Bucciarelli, Bruna; Vance, Carroll P.] ARS, USDA, Plant Sci Res Unit, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA)	Samac, DA (corresponding author), ARS, USDA, Plant Sci Res Unit, St Paul, MN USA.	dasamac@umn.edu	Nallu, Sumitha/D-5382-2017; Samac, Deborah/ABC-8744-2021	Samac, Deborah/0000-0002-1847-0508	National Science Foundation [OB-0516811]; University of Minnesota, College of Biological Sciences	National Science Foundation(National Science Foundation (NSF)); University of Minnesota, College of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Science Foundation award OB-0516811 and by funds from the University of Minnesota, College of Biological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2008, PLANTA, V227, P331, DOI 10.1007/s00425-007-0620-1; Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Ane Jean-Michel, 2008, Int J Plant Genomics, V2008, P256597, DOI 10.1155/2008/256597; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Dresselhaus T, 2009, CURR OPIN PLANT BIOL, V12, P773, DOI 10.1016/j.pbi.2009.09.015; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; Fedorova M, 2002, PLANT PHYSIOL, V130, P519, DOI 10.1104/pp.006833; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Fruhling M, 2000, PLANT SCI, V152, P67, DOI 10.1016/S0168-9452(99)00219-8; GLAZEBROOK J, 1993, GENE DEV, V7, P1485, DOI 10.1101/gad.7.8.1485; Godiard L, 2007, MOL PLANT MICROBE IN, V20, P321, DOI 10.1094/MPMI-20-3-0321; Graham MA, 2004, PLANT PHYSIOL, V135, P1179, DOI 10.1104/pp.104.037531; Gyorgyey J, 2000, MOL PLANT MICROBE IN, V13, P62, DOI 10.1094/MPMI.2000.13.1.62; Haag AF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001169; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; HEARD J, 1995, P NATL ACAD SCI USA, V92, P5273, DOI 10.1073/pnas.92.12.5273; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; HIRSCH AM, 1983, J BACTERIOL, V155, P367, DOI 10.1128/JB.155.1.367-380.1983; Huang H, 1996, PLANT CELL, V8, P81, DOI 10.1105/tpc.8.1.81; JENSEN EO, 1988, EMBO J, V7, P1265, DOI 10.1002/j.1460-2075.1988.tb02940.x; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kaijalainen S, 2002, PHYSIOL PLANTARUM, V114, P588, DOI 10.1034/j.1399-3054.2002.1140412.x; Kozaki A, 2004, NUCLEIC ACIDS RES, V32, P1710, DOI 10.1093/nar/gkh337; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; LONG SR, 1989, ANNU REV GENET, V23, P483, DOI 10.1146/annurev.ge.23.120189.002411; LULLIEN V, 1987, PLANT MOL BIOL, V9, P469, DOI 10.1007/BF00015878; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Mathesius U, 2008, FUNCT PLANT BIOL, V35, P651, DOI 10.1071/FP08177; Maunoury N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009519; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Mitra RM, 2004, PLANT PHYSIOL, V134, P595, DOI 10.1104/pp.103.031518; Moreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016463; Moussart A, 2006, MEDICAGO TRUNCATULA; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; MYLONA P, 1995, PLANT CELL, V7, P869, DOI 10.1105/tpc.7.7.869; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Oono R, 2010, NEW PHYTOL, V187, P508, DOI 10.1111/j.1469-8137.2010.03261.x; Oono R, 2009, NEW PHYTOL, V183, P967, DOI 10.1111/j.1469-8137.2009.02941.x; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pumplin N, 2010, PLANT J, V61, P482, DOI 10.1111/j.1365-313X.2009.04072.x; QUANDT HJ, 1993, MOL PLANT MICROBE IN, V6, P699, DOI 10.1094/MPMI-6-699; Samac DA, 2011, MOL PLANT PATHOL, V12, P786, DOI [10.1111/j.1364-3703.2011.00712.x, 10.1111/J.1364-3703.2011.00712.X]; SANDAL NN, 1987, NUCLEIC ACIDS RES, V15, P1507, DOI 10.1093/nar/15.4.1507; Sbabou L, 2010, J EXP BOT, V61, P1351, DOI 10.1093/jxb/erp400; SCHERES B, 1990, PLANT CELL, V2, P687, DOI 10.1105/tpc.2.8.687; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Starker CG, 2006, PLANT PHYSIOL, V140, P671, DOI 10.1104/pp.105.072132; Stotz HU, 2009, PLANT MOL BIOL, V71, P131, DOI 10.1007/s11103-009-9512-z; SZCZYGLOWSKI K, 1994, PLANT CELL, V6, P317, DOI 10.1105/tpc.6.3.317; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Tesfaye M, 2006, MOL PLANT MICROBE IN, V19, P330, DOI 10.1094/MPMI-19-0330; Tesfaye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058992; Tesfaye M, 2009, BIOENERG RES, V2, P59, DOI 10.1007/s12155-009-9034-1; Thomma BPHJ, 1998, PLANT PHYSIOL BIOCH, V36, P533, DOI 10.1016/S0981-9428(98)80179-4; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; VANCE CP, 1979, PLANT PHYSIOL, V64, P1, DOI 10.1104/pp.64.1.1; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990; Verdaguer B, 1996, PLANT MOL BIOL, V31, P1129, DOI 10.1007/BF00040830; Wang D, 2010, SCIENCE, V327, P1126, DOI 10.1126/science.1184096; Yanagisawa S, 1999, PLANT J, V17, P209, DOI 10.1046/j.1365-313X.1999.00363.x; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	73	33	33	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60355	10.1371/journal.pone.0060355	http://dx.doi.org/10.1371/journal.pone.0060355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573247	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900067
J	Mehta, I; Chakraborty, S; Rao, BJ				Mehta, Ishita; Chakraborty, Sandeep; Rao, Basuthkar J.			IMACULAT - An Open Access Package for the Quantitative Analysis of Chromosome Localization in the Nucleus	PLOS ONE			English	Article							SPATIAL GENOME ORGANIZATION; CELL-NUCLEUS; INTERPHASE; DNA; ARCHITECTURE; GENES; REPLICATION; ARRANGEMENTS; TERRITORIES; METAPHASE	The alteration in the location of the chromosomes within the nucleus upon action of internal or external stimuli has been implicated in altering genome function. The effect of stimuli at a whole genome level is studied by using two-dimensional fluorescence in situ hybridization (FISH) to delineate whole chromosome territories within a cell nucleus, followed by a quantitative analysis of the spatial distribution of the chromosome. However, to the best of our knowledge, open access software capable of quantifying spatial distribution of whole chromosomes within cell nucleus is not available. In the current work, we present a software package that computes localization of whole chromosomes - Image Analysis of Chromosomes for computing localization (IMACULAT). We partition the nucleus into concentric elliptical compartments of equal area and the variance in the quantity of any chromosome in these shells is used to determine its localization in the nucleus. The images are pre-processed to remove the smudges outside the cell boundary. Automation allows high throughput analysis for deriving statistics. Proliferating normal human dermal fibroblasts were subjected to standard a two-dimensional FISH to delineate territories for all human chromosomes. Approximately 100 images from each chromosome were analyzed using IMACULAT. The analysis corroborated that these chromosome territories have non-random gene density based organization within the interphase nuclei of human fibroblasts. The ImageMagick Perl API has been used for pre-processing the images. The source code is made available at www.sanchak.com/imaculat.html.	[Mehta, Ishita; Chakraborty, Sandeep; Rao, Basuthkar J.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Chakraborty, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	sanchak@gmail.com			Tata Institute of Fundamental Research (Department of Atomic Energy)	Tata Institute of Fundamental Research (Department of Atomic Energy)	This work was funded by the Tata Institute of Fundamental Research (Department of Atomic Energy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Bridger JM, 1998, TRENDS GENET, V14, P403, DOI 10.1016/S0168-9525(98)01572-8; Bridger JM, 2007, FEBS J, V274, P1354, DOI 10.1111/j.1742-4658.2007.05694.x; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Cooper G. M., 2000, CELL MOL APPROACH, DOI DOI 10.1007/978-1-4615-6484-3_4; CREMER C, 1974, Microscopica Acta, V75, P331; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; CREMER T, 1988, HUM GENET, V80, P235, DOI 10.1007/BF01790091; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Delaire S, 2004, J EXP MED, V200, P1427, DOI 10.1084/jem.20041041; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; Federico C, 2008, CHROMOSOMA, V117, P399, DOI 10.1007/s00412-008-0160-x; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Folle GA, 2008, MUTAT RES-REV MUTAT, V658, P172, DOI 10.1016/j.mrrev.2007.08.005; Foster HA, 2005, CHROMOSOMA, V114, P212, DOI 10.1007/s00412-005-0016-6; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Gazave E, 2005, CHROMOSOME RES, V13, P377, DOI 10.1007/s10577-005-3254-9; Gilbert N, 2005, INT REV CYTOL, V242, P283; Goucher DR, 2005, BIOINFORMATICS, V21, P3248, DOI 10.1093/bioinformatics/bti531; Grasser F, 2008, J CELL SCI, V121, P1876, DOI 10.1242/jcs.026989; Hewitt SL, 2004, EUR J IMMUNOL, V34, P3604, DOI 10.1002/eji.200425469; Kim SH, 2004, CYTOGENET GENOME RES, V105, P292, DOI 10.1159/000078201; Kuroda M, 2004, J CELL SCI, V117, P5897, DOI 10.1242/jcs.01508; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; MANUELIDIS L, 1985, ANN NY ACAD SCI, V450, P205, DOI 10.1111/j.1749-6632.1985.tb21494.x; Martinez-Lopez W, 2001, CHROMOSOME RES, V9, P69, DOI 10.1023/A:1026747801728; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Mehta IS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r5; Nogami M, 2000, CHROMOSOMA, V108, P514, DOI 10.1007/s004120050403; Panning MM, 2005, J CELL BIOCHEM, V95, P74, DOI 10.1002/jcb.20395; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; Sanders MH, 2004, CYTOGENET GENOME RES, V104, P35, DOI 10.1159/000077464; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Strouboulis J, 1996, J CELL SCI, V109, P1991; Szczerbal I, 2009, CHROMOSOMA, V118, P647, DOI 10.1007/s00412-009-0225-5; VANDRIEL R, 1991, J CELL BIOCHEM, V47, P311, DOI 10.1002/jcb.240470405; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030632; Zinchuk V, 2009, PROG HISTOCHEM CYTO, V44, P125, DOI 10.1016/j.proghi.2009.03.001; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107; ZORN C, 1979, EXP CELL RES, V124, P111, DOI 10.1016/0014-4827(79)90261-1	52	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61386	10.1371/journal.pone.0061386	http://dx.doi.org/10.1371/journal.pone.0061386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577217	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000131
J	Kwak, SS; Jeong, M; Choi, JH; Kim, D; Min, H; Yoon, Y; Hwang, O; Meadows, GG; Joe, CO				Kwak, Sang Su; Jeong, Mikyoung; Choi, Ji Hye; Kim, Daesoo; Min, Hyesun; Yoon, Yoosik; Hwang, Onyou; Meadows, Gary G.; Joe, Cheol O.			Amelioration of Behavioral Abnormalities in BH4-deficient Mice by Dietary Supplementation of Tyrosine	PLOS ONE			English	Article							NEUTRAL AMINO-ACIDS; PARKINSONS-DISEASE; MOVEMENT INITIATION; ALZHEIMERS-DISEASE; MEMORY FORMATION; RAG GTPASES; MTOR; TETRAHYDROBIOPTERIN; BRAIN; INHIBITION	This study reports an amelioration of abnormal motor behaviors in tetrahydrobiopterin (BH4)-deficient Spr(-/-) mice by the dietary supplementation of tyrosine. Since BH4 is an essential cofactor for the conversion of phenylalanine into tyrosine as well as the synthesis of dopamine neurotransmitter within the central nervous system, the levels of tyrosine and dopamine were severely reduced in brains of BH4-deficient Spr(-/-) mice. We found that Spr(-/-) mice display variable 'open-field' behaviors, impaired motor functions on the 'rotating rod', and dystonic 'hind-limb clasping'. In this study, we report that these aberrant motor deficits displayed by Spr(-/-) mice were ameliorated by the therapeutic tyrosine diet for 10 days. This study also suggests that dopamine deficiency in brains of Spr(-/-) mice may not be the biological feature of aberrant motor behaviors associated with BH4 deficiency. Brain levels of dopamine (DA) and its metabolites in Spr(-/-) mice were not substantially increased by the dietary tyrosine therapy. However, we found that mTORC1 activity severely suppressed in brains of Spr(-/-) mice fed a normal diet was restored 10 days after feeding the mice the tyrosine diet. The present study proposes that brain mTORC1 signaling pathway is one of the potential targets in understanding abnormal motor behaviors associated with BH4-deficiency.	[Kwak, Sang Su; Jeong, Mikyoung; Choi, Ji Hye; Kim, Daesoo; Joe, Cheol O.] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Min, Hyesun] HanNam Univ, Dept Food & Nutr, Taejon, South Korea; [Yoon, Yoosik] Chung Ang Univ, Coll Med, Seoul 156756, South Korea; [Hwang, Onyou] Univ Ulsan, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea; [Meadows, Gary G.] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Pullman, WA 99164 USA	Korea Advanced Institute of Science & Technology (KAIST); Hannam University; Chung Ang University; Chung Ang University Hospital; University of Ulsan; Washington State University	Meadows, GG (corresponding author), Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Pullman, WA 99164 USA.	meadows@wsu.edu; cojoe@kaist.ac.kr	Joe, Cheol O/C-1917-2011; Kim, Daesoo/C-1625-2011	Kim, Daesoo/0000-0001-9915-1463	National Research Foundation of Korea [2012R1A1A2007843]; KAIST Future Systems Healthcare Project	National Research Foundation of Korea(National Research Foundation of Korea); KAIST Future Systems Healthcare Project	This project was supported by grants from National Research Foundation of Korea (2012R1A1A2007843) and KAIST Future Systems Healthcare Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Avale ME, 2004, MOL PSYCHIATR, V9, P718, DOI 10.1038/sj.mp.4001474; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Chano T, 2007, BRAIN RES, V1168, P97, DOI 10.1016/j.brainres.2007.06.075; Cousins MS, 1996, NEUROSCIENCE, V70, P849, DOI 10.1016/0306-4522(95)00407-6; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Elzaouk L, 2003, J BIOL CHEM, V278, P28303, DOI 10.1074/jbc.M303986200; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Foxton RH, 2007, NEUROCHEM RES, V32, P751, DOI 10.1007/s11064-006-9201-0; Gilbert JA, 2000, CLIN CANCER RES, V6, P4365; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hauber W, 1996, NEUROSCIENCE, V73, P121, DOI 10.1016/0306-4522(96)00036-X; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Homma D, 2011, J BIOL CHEM, V286, P1445, DOI 10.1074/jbc.M110.159426; Ichinose H, 2008, CHEM REC, V8, P378, DOI 10.1002/tcr.20166; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2011, J NEUROSCI, V31, P4063, DOI 10.1523/JNEUROSCI.4493-10.2011; Kim WS, 2009, BRAIN RES, V1248, P176, DOI 10.1016/j.brainres.2008.11.009; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; Kwak SS, 2011, AUTOPHAGY, V7, P1323, DOI 10.4161/auto.7.11.16627; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li X, 2005, FEBS J, V272, P4211, DOI 10.1111/j.1742-4658.2005.04833.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matalon R, 2006, J INHERIT METAB DIS, V29, P732, DOI 10.1007/s10545-006-0395-8; Matalon R, 2003, PEDIATRICS, V112, P1570; OLDENDORF WH, 1976, AM J PHYSIOL, V230, P94, DOI 10.1152/ajplegacy.1976.230.1.94; Poewe Werner, 2009, Parkinsonism Relat Disord, V15 Suppl 4, pS28, DOI 10.1016/S1353-8020(09)70831-4; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Shen LH, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/259349; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Talos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035885; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xia RP, 2012, NEUROSCI BULL, V28, P39, DOI 10.1007/s12264-012-1050-z; Yang S, 2006, AM J HUM GENET, V78, P575, DOI 10.1086/501372; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60803	10.1371/journal.pone.0060803	http://dx.doi.org/10.1371/journal.pone.0060803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577163	Green Published, gold, Green Submitted			2022-12-27	WOS:000319109800101
J	Liang, SQ; Du, J; Yan, H; Zhou, QQ; Zhou, Y; Yuan, ZN; Yan, SD; Fu, QX; Wang, XH; Jia, SZ; Peng, JC; Zhang, YG; Zhan, LS				Liang, Sheng-qiang; Du, Juan; Yan, Hu; Zhou, Qian-Qian; Zhou, Yong; Yuan, Zhen-nan; Yan, Shao-duo; Fu, Qiu-xia; Wang, Xiao-hui; Jia, Shuai-zheng; Peng, Jian-chun; Zhang, Yang-gen; Zhan, Lin-sheng			A Mouse Model for Studying the Clearance of Hepatitis B Virus In Vivo Using a Luciferase Reporter	PLOS ONE			English	Article							T-CELLS; EXPRESSION; INFECTION; THERAPY; DNA; REPLICATION; MICE	Hepatitis B virus(HBV) infection remains a global problem, despite the effectiveness of the Hepatitis B vaccine in preventing infection. The resolution of Hepatitis B virus infection has been believed to be attributable to virus-specific immunity. In vivo direct evaluation of anti-HBV immunity in the liver is currently not possible. We have developed a new assay system that detects HBV clearance in the liver after the hydrodynamic transfer of a reporter gene and over-length, linear HBV DNA into hepatocytes, followed by bioluminescence imaging of the reporter gene (Fluc). We employed bioluminescence detection of luciferase expression in HBV-infected hepatocytes to measure the Hepatitis B core antigen (HBcAg)-specific immune responses directed against these infected hepatocytes. Only HBcAg-immunized, but not mock-treated, animals decreased the amounts of luciferase expression, HBsAg and viral DNA from the liver at day 28 after hydrodynamic infection with over-length HBV DNA, indicating that control of luciferase expression correlates with viral clearance from infected hepatocytes.	[Liang, Sheng-qiang; Du, Juan; Yan, Hu; Zhou, Qian-Qian; Zhou, Yong; Yuan, Zhen-nan; Yan, Shao-duo; Fu, Qiu-xia; Wang, Xiao-hui; Jia, Shuai-zheng; Peng, Jian-chun; Zhan, Lin-sheng] Beijing Inst Transfus Med, Lab Blood Borne Viruses, Beijing, Peoples R China; [Liang, Sheng-qiang; Zhang, Yang-gen] Xiamen Univ, Affiliated Dong nan Hosp, PLA, Dept Clin Lab,Hosp 175, Zhang Zhou, Peoples R China	Xiamen University	Zhan, LS (corresponding author), Beijing Inst Transfus Med, Lab Blood Borne Viruses, Beijing, Peoples R China.	lszhan91@yahoo.com	Zhan, Linsheng/AAR-5687-2021; Zhou, Qianqian/GXG-4345-2022; zhan, lin/AAP-5149-2020; ZHANG, LIN/GYD-9123-2022		Mega-Project of Science Research for the 12th FiveYear Plan [2012ZX10004-502, 2011ZXJ092-031]; National Nature Science Foundation of China [30900824, 7112104, 81170387]	Mega-Project of Science Research for the 12th FiveYear Plan; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding under the Mega-Project of Science Research for the 12th FiveYear Plan (#2012ZX10004-502 and #2011ZXJ092-031), National Nature Science Foundation of China (30900824, 7112104 and 81170387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI K, 1989, P NATL ACAD SCI USA, V86, P207, DOI 10.1073/pnas.86.1.207; BARKER LF, 1973, J INFECT DIS, V127, P648, DOI 10.1093/infdis/127.6.648; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; Cook SH, 2003, J VIROL, V77, P5333, DOI 10.1128/JVI.77.9.5333-5338.2003; Hardy J, 2004, SCIENCE, V303, P851, DOI 10.1126/science.1092712; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Huang LR, 2012, GASTROENTEROLOGY, DOI [10.1053/j.gas-tro.2012.03.006, DOI 10.1053/J.GAS-TR0.2012.03.006]; Jawhara S, 2004, ANTIMICROB AGENTS CH, V48, P3436, DOI 10.1128/AAC.48.9.3436-3441.2004; Jung MC, 1999, VIROLOGY, V261, P165, DOI 10.1006/viro.1999.9833; Korba BE, 2004, ANTIVIR THER, V9, P937; Lau GKK, 2002, GASTROENTEROLOGY, V122, P614, DOI 10.1053/gast.2002.31887; Lecocq M, 2003, J GENE MED, V5, P142, DOI 10.1002/jgm.328; Lin YJ, 2010, P NATL ACAD SCI USA, V107, P9340, DOI 10.1073/pnas.1004762107; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Luker GD, 2002, J VIROL, V76, P12149, DOI 10.1128/JVI.76.23.12149-12161.2002; MAUPAS P, 1976, LANCET, V1, P1367; Osorio JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006592; Peng JL, 2007, ACTA PHARMACOL SIN, V28, P1024, DOI 10.1111/j.1745-7254.2007.00591.x; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; Sobao Y, 2002, J HEPATOL, V36, P105, DOI 10.1016/S0168-8278(01)00264-1; Stabenow D, 2010, HEPATOLOGY, V51, P1430, DOI 10.1002/hep.23575; Tang TJ, 2004, J MED VIROL, V72, P215, DOI 10.1002/jmv.10565; Trepo C, 2003, J HEPATOL, V39, pS220, DOI 10.1016/S0168-8278(03)00330-1; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Zhang YX, 2007, IMMUNOLOGY, V121, P105, DOI 10.1111/j.1365-2567.2007.02543.x; Zhao F, 2010, VIRUS RES, V149, P162, DOI 10.1016/j.virusres.2010.01.012	29	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60005	10.1371/journal.pone.0060005	http://dx.doi.org/10.1371/journal.pone.0060005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577080	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800023
J	Sun, LY; Li, J; Zhou, KJ; Zhang, M; Yang, JL; Li, Y; Ji, BH; Zhang, Z; Zhu, H; Yang, L; He, G; Gao, LH; Wei, ZY; Wang, KJ; Han, X; Liu, WQ; Tan, LW; Yu, YH; He, L; Wan, CL				Sun, Liya; Li, Juan; Zhou, Kejun; Zhang, Ming; Yang, Jinglei; Li, Yang; Ji, Baohu; Zhang, Zhao; Zhu, Hui; Yang, Lun; He, Guang; Gao, Linghan; Wei, Zhiyun; Wang, Kejian; Han, Xue; Liu, Weiqing; Tan, Liwen; Yu, Yihua; He, Lin; Wan, Chunling			Metabolomic Analysis Reveals Metabolic Disturbance in the Cortex and Hippocampus of Subchronic MK-801 Treated Rats	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; POLYGLUTAMINE-EXPANDED HUNTINGTIN; GLIAL-NEURONAL INTERACTIONS; PROTON MRS; GLUTAMATERGIC NEURONS; CHRONIC-SCHIZOPHRENIA; ANTERIOR CINGULATE; PREFRONTAL CORTEX; PROTEOME ANALYSIS; MOUSE MODEL	Background: Although a number of proteins and genes relevant to schizophrenia have been identified in recent years, few are known about the exact metabolic pathway involved in this disease. Our previous proteomic study has revealed the energy metabolism abnormality in subchronic MK-801 treated rat, a well-established animal model for schizophrenia. This prompted us to further investigate metabolite levels in the same rat model to better delineate the metabolism dysfunctions and provide insights into the pathology of schizophrenia. Methods: Metabolomics, a high-throughput investigatory strategy developed in recent years, can offer comprehensive metabolite-level insights that complement protein and genetic findings. In this study, we employed a nondestructive metabolomic approach (1H-MAS-NMR) to investigate the metabolic traits in cortex and hippocampus of MK-801 treated rats. Multivariate statistics and ingenuity pathways analyses (IPA) were applied in data processing. The result was further integrated with our previous proteomic findings by IPA analysis to obtain a systematic view on our observations. Results: Clear distinctions between the MK-801 treated group and the control group in both cortex and hippocampus were found by OPLS-DA models (with (RX)-X-2 = 0.441, Q(2)Y = 0.413 and (RX)-X-2 = 0.698, Q(2)Y = 0.677,respectively). The change of a series of metabolites accounted for the separation, such as glutamate, glutamine, citrate and succinate. Most of these metabolites fell in a pathway characterized by down-regulated glutamate synthesis and disturbed Krebs cycle. IPA analysis further confirmed the involvement of energy metabolism abnormality induced by MK-801 treatment. Conclusions: Our metabolomics findings reveal systematic changes in pathways of glutamate metabolism and Krebs cycle in the MK-801 treated rats' cortex and hippocampus, which confirmed and improved our previous proteomic observation and served as a valuable reference to the etiology research of schizophrenia.	[Sun, Liya; Zhou, Kejun; Zhang, Ming; Yang, Jinglei; Li, Yang; Ji, Baohu; Zhang, Zhao; Zhu, Hui; Yang, Lun; He, Guang; Gao, Linghan; He, Lin; Wan, Chunling] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Sun, Liya; Zhou, Kejun; Zhang, Ming; Yang, Jinglei; Li, Yang; Ji, Baohu; Zhang, Zhao; Zhu, Hui; Yang, Lun; He, Guang; Gao, Linghan; Wei, Zhiyun; Wang, Kejian; He, Lin; Wan, Chunling] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Li, Juan; Yu, Yihua] E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China; [Han, Xue; Liu, Weiqing; Tan, Liwen] Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha 410083, Peoples R China; [Li, Juan] CSIRO Anim Food & Hlth Sci, Queensland Biosci Precinct, St Lucia, Qld, Australia	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; East China Normal University; Central South University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Yu, YH (corresponding author), E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China.	yhyu@phy.ecnu.edu.cn; helin@bio-x.cn; clwan@sjtu.edu.cn	Yu, Yihua/AAP-1496-2020; Wei, Zhiyun/E-2008-2016; Ji, Baohu/D-2281-2014; Yang, Jinglei/B-1933-2008; gao, linghan/E-5667-2013; Zhang, Zhao/I-1162-2019; Li, Yang/R-9468-2018; Tang, Huiru/F-9849-2011	Wei, Zhiyun/0000-0002-3554-4142; Yang, Jinglei/0000-0002-9413-9016; Zhang, Zhao/0000-0002-1133-4191; Li, Yang/0000-0002-1914-5598; Tang, Huiru/0000-0002-7139-2756	973 Program [2012CB910100, 2010CB529600]; National Nature Science Foundation of China [31071159, 81271486, 81121001]; National Key Technology RD Program [2006BAI05A09]; 863 Program [2009AA022701]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]	973 Program(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); 863 Program(National High Technology Research and Development Program of China); Shanghai Municipal Commission of Science and Technology Program	This work was supported by the 973 Program (2012CB910100, 2010CB529600) (http://www.973.gov.cn/), the National Nature Science Foundation of China (31071159, 81271486, 81121001) (http://www.nsfc.gov.cn/), the National Key Technology R&D Program (2006BAI05A09), the 863 Program (2009AA022701) (http://www.863.gov.cn/), and the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601) (http://www.shanghai.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyannur PS, 2010, BRAIN RES, V1335, P1, DOI 10.1016/j.brainres.2010.04.008; Brenner E, 2005, J NEUROCHEM, V94, P1594, DOI 10.1111/j.1471-4159.2005.03311.x; Bubenikova-Valesova V, 2008, NEUROSCI BIOBEHAV R, V32, P1014, DOI 10.1016/j.neubiorev.2008.03.012; Cotter D, 2002, BIOL PSYCHIAT, V51, P377, DOI 10.1016/S0006-3223(01)01243-4; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Erhardt S, 2007, PHYSIOL BEHAV, V92, P203, DOI 10.1016/j.physbeh.2007.05.025; Eyjolfsson EM, 2006, NEUROCHEM INT, V48, P541, DOI 10.1016/j.neuint.2005.11.019; Eyjolfsson EM, 2010, J CEREB BLOOD FLOW M; Faideau M, 2010, HUM MOL GENET, V19, P3053, DOI 10.1093/hmg/ddq212; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Jenkins TA, 2010, NEUROSCI LETT, V471, P144, DOI 10.1016/j.neulet.2010.01.028; KIM JS, 1980, NEUROSCI LETT, V20, P379, DOI 10.1016/0304-3940(80)90178-0; Knapp M, 2004, SCHIZOPHRENIA BULL, V30, P279, DOI 10.1093/oxfordjournals.schbul.a007078; Kondziella D, 2007, NEUROCHEM INT, V50, P291, DOI 10.1016/j.neuint.2006.09.006; Kondziella D, 2006, NEUROPSYCHOPHARMACOL, V31, P1880, DOI 10.1038/sj.npp.1300993; Leavitt BR, 2006, J NEUROCHEM, V96, P1121, DOI 10.1111/j.1471-4159.2005.03605.x; LOSCHER W, 1991, NEUROSCI LETT, V124, P115, DOI 10.1016/0304-3940(91)90835-H; Lutkenhoff ES, 2010, MOL PSYCHIATR, V15, P308, DOI 10.1038/mp.2008.87; Martins-de-Souza D, 2011, ANTIOXID REDOX SIGN, V15, P2067, DOI 10.1089/ars.2010.3459; Meloni BP, 2005, PROTEOMICS, V5, P4743, DOI 10.1002/pmic.200500107; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Moghaddam B, 2012, NEUROPSYCHOPHARMACOL, V37, P4, DOI 10.1038/npp.2011.181; Ongur D, 2010, BIOL PSYCHIAT, V68, P667, DOI 10.1016/j.biopsych.2010.05.016; Ohnuma T, 2008, PROG NEURO-PSYCHOPH, V32, P1905, DOI 10.1016/j.pnpbp.2008.07.022; Ohrmann P, 2005, SCHIZOPHR RES, V73, P153, DOI 10.1016/j.schres.2004.08.021; Ozeki Y, 2011, NEUROSCI RES, V69, P154, DOI 10.1016/j.neures.2010.10.003; Paulson L, 2004, PROTEOMICS, V4, P819, DOI 10.1002/pmic.200300622; Pears MR, 2005, J BIOL CHEM, V280, P42508, DOI 10.1074/jbc.M507380200; Purdon SE, 2008, SCHIZOPHR RES, V99, P218, DOI 10.1016/j.schres.2007.11.028; Reynolds GP, 2001, J CHEM NEUROANAT, V22, P95, DOI 10.1016/S0891-0618(01)00113-2; Rogers DP, 2009, EXPERT REV NEUROTHER, V9, P47, DOI 10.1586/14737175.9.1.47; Rung JP, 2005, PROG NEURO-PSYCHOPH, V29, P827, DOI 10.1016/j.pnpbp.2005.03.004; Salek RM, 2010, NEUROCHEM INT, V56, P937, DOI 10.1016/j.neuint.2010.04.001; Schousboe A, 2003, NEUROCHEM INT, V43, P311, DOI 10.1016/S0197-0186(03)00017-2; Sun Y, 2001, J BIOL CHEM, V276, P24713, DOI 10.1074/jbc.M103501200; Tayoshi S, 2009, SCHIZOPHR RES, V108, P69, DOI 10.1016/j.schres.2008.11.014; Theberge J, 2003, AM J PSYCHIAT, V160, P2231, DOI 10.1176/appi.ajp.160.12.2231; Ting L, 2009, MOL CELL PROTEOMICS, V8, P2227, DOI 10.1074/mcp.M800462-MCP200; Tsang TM, 2005, MAGN RESON MED, V53, P1018, DOI 10.1002/mrm.20447; Tsang TM, 2009, NEUROCHEM RES, P1; van Elst LT, 2005, BIOL PSYCHIAT, V58, P724, DOI 10.1016/j.biopsych.2005.04.041; Vita A, 1997, SCHIZOPHR RES, V23, P25, DOI 10.1016/S0920-9964(96)00085-0; Waagepetersen HS, 2000, J NEUROCHEM, V75, P471, DOI 10.1046/j.1471-4159.2000.0750471.x; Xiao XL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-72; Zhou K, 2010, SCHIZOPHR B; Zuo DY, 2006, LIFE SCI, V78, P2172, DOI 10.1016/j.lfs.2005.09.022	47	23	23	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60598	10.1371/journal.pone.0060598	http://dx.doi.org/10.1371/journal.pone.0060598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577129	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800069
J	Tan, XL; Wang, S; Zhang, F				Tan, Xiao-Ling; Wang, Su; Zhang, Fan			Optimization an Optimal Artificial Diet for the Predatory Bug Orius sauteri (Hemiptera: Anthocoridae)	PLOS ONE			English	Article							AUGMENTATIVE BIOLOGICAL-CONTROL; PURIFIED NUTRITIONAL FACTOR; INSIDIOUS FLOWER BUG; POPPIUS HETEROPTERA; PREY; REPRODUCTION; OVIPOSITION; MICROENCAPSULATION; THYSANOPTERA; TEMPERATURE	Background: The flower bug Orius sauteri is an important polyphagous predator that is widely used for the biological control of mites and aphids. However, the optimal conditions for mass rearing of this insect are still unclear, thus limiting its application. Methodology: In this study, we investigated the optimal ingredients of an artificial diet for raising O. sauteri using a microencapsulation technique. The ingredients included egg yolk (vitellus), whole-pupa homogenate of the Tussah silk moth (Antheraea paphia), honey, sucrose, rapeseed (Brassica napus) pollen and sinkaline. We tested 25 combinations of the above ingredients using an orthogonal experimental design. Using statistical analysis, we confirmed the main effect factors amongst the components, and selected five optimal combinations based on different biological and physiological characters. Principal Findings: The results showed that, although different artificial diet formats significantly influenced the development and reproductive ability of O. sauteri, the complete development of O. sauteri to sexual maturity could only be achieved by optimizing the artificial diet according to specific biological characters. In general, pupae of A. paphia had more influence on O sauteri development than did artificial components. The results of a follow-up test of locomotory and respiratory capacity indicated that respiratory quotient, metabolic rate and average creeping speed were all influenced by different diets. Furthermore, the field evaluations of mating preference, predatory consumption and population dispersion also demonstrated the benefits that could be provided by optimal artificial diets. Conclusions: A microencapsulated artificial diet overcame many of the difficulties highlighted by previous studies on the mass rearing of O. sauteri. Optimization of the microencapsulated artificial diet directly increased the biological and physiological characters investigated. Successive physiological tests and field investigations were used to evaluate the outcome of different artificial diet combinations on the quality of the reared O. sauteri.	[Tan, Xiao-Ling; Wang, Su; Zhang, Fan] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Tan, Xiao-Ling] Northwest A&F Univ, Key Lab Appl Entomol, Yangling, Shannxi, Peoples R China	Beijing Academy of Agriculture & Forestry; Northwest A&F University - China	Wang, S (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China.	septempunctata@yahoo.com.cn	wang, su/AAC-6313-2019; tan, xiao/GZL-0264-2022		State Key Development Program for Basic Research of China (973 plan) [2013CB127605]; Special Fund for Agro-scientific Research in the Public Interest [201303024, 201303108]	State Key Development Program for Basic Research of China (973 plan); Special Fund for Agro-scientific Research in the Public Interest	The present study was supported by the funds from the State Key Development Program for Basic Research of China (973 plan, No. 2013CB127605) (provided partial financial support to the first author's research and salary for XLT and SW) and the Special Fund for Agro-scientific Research in the Public Interest (No. 201303024 and No. 201303108) (provided partial salary for FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT PJ, 1982, J CHEM ECOL, V8, P233, DOI 10.1007/BF00984019; Arijs Y, 2004, BIOCONTROL, V49, P505, DOI 10.1023/B:BICO.0000036440.02590.fa; Arijs Y, 2001, BIOL CONTROL, V21, P79, DOI 10.1006/bcon.2000.0910; ASKARI A, 1972, J ECON ENTOMOL, V65, P132, DOI 10.1093/jee/65.1.132; Blaeser P, 2004, J PEST SCI, V77, P211, DOI 10.1007/s10340-004-0057-2; Bonte M, 2011, J APPL ENTOMOL, V135, P343, DOI 10.1111/j.1439-0418.2010.01554.x; Bonte M, 2010, BIOCONTROL, V55, P625, DOI 10.1007/s10526-010-9275-0; Castane C, 2000, INTEGRATED PEST DIS, P244; CHAMBERS DL, 1977, ANNU REV ENTOMOL, V22, P289, DOI 10.1146/annurev.en.22.010177.001445; CLANCY KM, 1992, J CHEM ECOL, V18, P543, DOI 10.1007/BF00987818; Cocuzza GE, 1997, ENTOMOL EXP APPL, V82, P101, DOI 10.1023/A:1002931622011; Cohen A, 1993, APPL GENETICS ARTHRO, P122; Cohen AC, 2004, INSECT DIETS SCI TEC; de Carvalho Livia M., 2003, IOBC-WPRS Bulletin, V26, P131; De Clercq P, 1998, BIOL CONTROL, V12, P137, DOI 10.1006/bcon.1998.0611; Ehlers RU, 2011, REGULATION OF BIOLOGICAL CONTROL AGENTS, P1, DOI 10.1007/978-90-481-3664-3; Ferkovich SM, 2005, FLA ENTOMOL, V88, P253, DOI 10.1653/0015-4040(2005)088[0253:EOITIF]2.0.CO;2; Ferkovich SM, 2004, BIOL CONTROL, V31, P57, DOI 10.1016/j.biocontrol.2004.04.005; Ferkovich SM, 2004, BIOL CONTROL, V31, P11, DOI 10.1016/j.biocontrol.2004.04.004; Ferkovich SM, 2007, FLA ENTOMOL, V90, P502, DOI 10.1653/0015-4040(2007)90[502:POADEO]2.0.CO;2; Ferkovich SM, 2007, FLA ENTOMOL, V90, P321, DOI 10.1653/0015-4040(2007)90[321:IFITPO]2.0.CO;2; FUNAO T, 1995, JPN J APPL ENTOMOL Z, V39, P84, DOI 10.1303/jjaez.39.84; Ghadamyari M, 2001, J AGR SCI, V7, P31; Gharsallaoui A, 2007, FOOD RES INT, V40, P1107, DOI 10.1016/j.foodres.2007.07.004; Guo JianYing, 2001, Chinese Journal of Biological Control, V17, P53; Honda JY, 1998, APPL ENTOMOL ZOOL, V33, P449, DOI 10.1303/aez.33.449; Ito K, 1998, ENTOMOL EXP APPL, V89, P271, DOI 10.1023/A:1003507708633; Ito K, 2000, APPL ENTOMOL ZOOL, V35, P101, DOI 10.1303/aez.2000.101; Jha RK, 2012, ENVIRON ENTOMOL, V41, P30, DOI 10.1603/EN11206; Jiang YL, 2010, CHINESE J BIOL CONTR, V26, P414; Joyce AL, 2010, BIOCONTROL, V55, P573, DOI 10.1007/s10526-010-9278-x; KAWAI A, 1995, APPL ENTOMOL ZOOL, V30, P1; Kawamoto Keiko, 1999, Research Bulletin of the Plant Protection Service Japan, P87; KIMAN ZB, 1985, ANN ENTOMOL SOC AM, V78, P464, DOI 10.1093/aesa/78.4.464; Kondo A., 1979, MICROCAPSULE PROCESS; Kurogi S., 1997, Proceedings of the Association for Plant Protection of Kyushu, V43, P106; Leon-Beck M, 2007, J INSECT BEHAV, V20, P67, DOI 10.1007/s10905-006-9063-y; Mochizuki M, 2007, ENTOMOL EXP APPL, V123, P57, DOI 10.1111/j.1570-7458.2007.00525.x; Moulton B, 1970, INT J BIOCHEM, V1, P659; Murai T, 2001, APPL ENTOMOL ZOOL, V36, P489, DOI 10.1303/aez.2001.489; Murai T., 1988, Bulletin of the Shimane Agricultural Experiment Station, P1; Murata T, 2011, J CHEM ECOL, V37, P1099, DOI 10.1007/s10886-011-0022-5; Nakashima Y, 2003, ENTOMOL EXP APPL, V106, P79, DOI 10.1046/j.1570-7458.2003.00002.x; NAKATA T, 1995, APPL ENTOMOL ZOOL, V30, P145, DOI 10.1303/aez.30.145; Paik Chae-Hoon, 2003, Korean Journal of Applied Entomology, V42, P35; Penn S, 1998, MASS REARED NATURAL; Riddick EW, 2009, BIOCONTROL, V54, P325, DOI 10.1007/s10526-008-9171-z; SCHMIDT JM, 1995, CAN ENTOMOL, V127, P445, DOI 10.4039/Ent127445-3; Schrooyen PMM, 2001, P NUTR SOC, V60, P475, DOI 10.1079/PNS2001112; SCRIBER JM, 1981, ANNU REV ENTOMOL, V26, P183, DOI 10.1146/annurev.en.26.010181.001151; Silva RB, 2009, PHYTOPARASITICA, V37, P115, DOI 10.1007/s12600-008-0015-2; Smith J, 1966, ANNU REV ENTOMOL, V44, P561; Tan Xiao-Ling, 2010, Acta Entomologica Sinica, V53, P891; Thompson S.N., 1999, P594, DOI 10.1016/B978-012257305-7/50069-2; Vacante V, 1997, ENTOMOPHAGA, V42, P493, DOI 10.1007/BF02769809; van Lenteren JC, 2012, BIOCONTROL, V57, P1, DOI 10.1007/s10526-011-9395-1; Vandekerkhove B, 2011, INSECT SCI, V18, P682, DOI 10.1111/j.1744-7917.2011.01414.x; VANDERZANT ES, 1974, ANNU REV ENTOMOL, V19, P139, DOI 10.1146/annurev.en.19.010174.001035; Wang Fang-hai, 1996, Chinese Journal of Biological Control, V12, P49; WILLIS NP, 1970, INT J BIOCHEM, V1, P659, DOI 10.1016/0020-711X(70)90040-6; Yano E, 2002, J APPL ENTOMOL, V126, P389, DOI 10.1046/j.1439-0418.2002.00598.x; Yano Eizi, 1996, IOBC-WPRS Bulletin, V19, P203; Zhang GF, 2007, MOL ECOL NOTES, V7, P947, DOI 10.1111/j.1471-8286.2007.01819.x; Zhang Shi-Chang, 2008, Acta Entomologica Sinica, V51, P997; Zhou W., 1989, Chinese Journal of Biological Control, V5, P9	65	13	17	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61129	10.1371/journal.pone.0061129	http://dx.doi.org/10.1371/journal.pone.0061129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577198	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800123
J	Heneberg, P				Heneberg, Petr			Effects of Print Publication Lag in Dual Format Journals on Scientometric Indicators	PLOS ONE			English	Article							CITATION IMPACT; OPEN ACCESS; SCHOLARLY COMMUNICATION; ONLINE; AVAILABILITY; DELAY	Background: Publication lag between manuscript submission and its final publication is considered as an important factor affecting the decision to submit, the timeliness of presented data, and the scientometric measures of the particular journal. Dual-format peer-reviewed journals (publishing both print and online editions of their content) adopted a broadly accepted strategy to shorten the publication lag: to publish the accepted manuscripts online ahead of their print editions, which may follow days, but also years later. Effects of this widespread habit on the immediacy index (average number of times an article is cited in the year it is published) calculation were never analyzed. Methodology/Principal Findings: Scopus database (which contains nearly up-to-date documents in press, but does not reveal citations by these documents until they are finalized) was searched for the journals with the highest total counts of articles in press, or highest counts of articles in press appearing online in 2010-2011. Number of citations received by the articles in press available online was found to be nearly equal to citations received within the year when the document was assigned to a journal issue. Thus, online publication of in press articles affects severely the calculation of immediacy index of their source titles, and disadvantages online-only and print-only journals when evaluating them according to the immediacy index and probably also according to the impact factor and similar measures. Conclusions/Significance: Caution should be taken when evaluating dual-format journals supporting long publication lag. Further research should answer the question, on whether the immediacy index should be replaced by an indicator based on the date of first publication (online or in print, whichever comes first) to eliminate the problems analyzed in this report. Information value of immediacy index is further questioned by very high ratio of authors' self-citations among the citation window used for its calculation.	Charles Univ Prague, Fac Med 3, Prague, Czech Republic	Charles University Prague	Heneberg, P (corresponding author), Charles Univ Prague, Fac Med 3, Prague, Czech Republic.	petr.heneberg@lf3.cuni.cz	Heneberg, Petr/C-1881-2012	Heneberg, Petr/0000-0002-0703-951X				Aksnes DW, 2003, SCIENTOMETRICS, V56, P235, DOI 10.1023/A:1021919228368; Amat CB, 2008, SCIENTOMETRICS, V74, P379, DOI 10.1007/s11192-007-1823-8; Bar-Ilan J, 2009, CYBERMETRICS, V13, P4; Bar-Ilan J, 2008, J INFORMETR, V2, P1, DOI 10.1016/j.joi.2007.11.001; Borgman CL, 2002, ANNU REV INFORM SCI, V36, P3; Bouton E. N., 1995, Vistas in Astronomy, V39, P149, DOI 10.1016/0083-6656(95)00068-X; Brown C, 2001, J AM SOC INF SCI TEC, V52, P187, DOI 10.1002/1097-4571(2000)9999:9999<::AID-ASI1586>3.3.CO;2-4; Brown CM, 1999, J AM SOC INFORM SCI, V50, P929, DOI 10.1002/(SICI)1097-4571(1999)50:10<929::AID-ASI8>3.0.CO;2-G; Conley JP, 2013, ECON INQ, V51, P1251, DOI 10.1111/j.1465-7295.2012.00480.x; Craig ID, 2007, J INFORMETR, V1, P239, DOI 10.1016/j.joi.2007.04.001; Das A, 2006, LIBR INFORM SCI RES, V28, P453, DOI 10.1016/j.lisr.2006.03.019; Fassoulaki A, 2002, ACTA ANAESTH SCAND, V46, P902, DOI 10.1034/j.1399-6576.2002.460723.x; Glanzel W, 2004, SCIENTOMETRICS, V59, P63, DOI 10.1023/B:SCIE.0000013299.38210.74; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Huang G-L, 2006, APPL MICROB IN PRESS, DOI [10.1007/s00253-006-0723-9, DOI 10.1007/S00253-006-0723-9]; Jacso P, 2009, ONLINE INFORM REV, V33, P376, DOI 10.1108/14684520910951276; Kumar M. Muthu, 2009, INT J ADV MANUF TECH, P1, DOI [10.1007/s00170-008-1875-9., DOI 10.1007/S00170-008-1875-9]; Lawrence S, 2001, NATURE, V411, P521, DOI 10.1038/35079151; McDonald JD, 2007, J AM SOC INF SCI TEC, V58, P39, DOI 10.1002/asi.20420; Metcalfe TS, 2006, SOL PHYS, V239, P549, DOI 10.1007/s11207-006-0262-7; Moed HF, 2007, J AM SOC INF SCI TEC, V58, P2047, DOI 10.1002/asi.20663; Morse DH, 2000, ISSUES SCI TECH LIB, V28; Natarajan E., 2009, INT J ADV MANUF TECH, V43, P746, DOI [10.1007/s00170-008-1876-8, DOI 10.1007/S00170-008-1876-8]; Patil P., 2009, INT J ADV MANUF TECH, V37, P853, DOI [10.1007/s00170-008-1870-1, DOI 10.1007/S00170-008-1870-1]; Peng D, 2006, SCIENTOMETRICS, V69, P271, DOI 10.1007/s11192-006-0148-3; Rogers SA, 2001, COLL RES LIBR, V62, P25, DOI 10.5860/crl.62.1.25; Rousseau S, 2012, J AM SOC INF SCI TEC, V63, P1213, DOI 10.1002/asi.22637; Schloegl C, 2010, SCIENTOMETRICS, V82, P567, DOI 10.1007/s11192-010-0172-1; Seglen PO, 1997, BRIT MED J, V314, P498; Shuai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047523; Taubes G, 1996, SCIENCE, V273, P304, DOI 10.1126/science.273.5273.304; Tort ABL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053374; Xia JF, 2011, J INF SCI, V37, P19, DOI 10.1177/0165551510389358	33	21	22	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59877	10.1371/journal.pone.0059877	http://dx.doi.org/10.1371/journal.pone.0059877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143BA	23573216	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100031
J	Starowicz, K; Makuch, W; Korostynski, M; Malek, N; Slezak, M; Zychowska, M; Petrosino, S; De Petrocellis, L; Cristino, L; Przewlocka, B; Di Marzo, V				Starowicz, Katarzyna; Makuch, Wioletta; Korostynski, Michal; Malek, Natalia; Slezak, Michal; Zychowska, Magdalena; Petrosino, Stefania; De Petrocellis, Luciano; Cristino, Luigia; Przewlocka, Barbara; Di Marzo, Vincenzo			Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism	PLOS ONE			English	Article							FATTY-ACID AMIDE; VANILLOID RECEPTORS; CANNABINOID RECEPTOR; ENDOCANNABINOID LEVELS; SENSORY NEURONS; TRP CHANNELS; PAIN; 2-ARACHIDONOYLGLYCEROL; PHARMACOLOGY; CB1	Neuropathic pain elevates spinal anandamide (AEA) levels in a way further increased when URB597, an inhibitor of AEA hydrolysis by fatty acid amide hydrolase (FAAH), is injected intrathecally. Spinal AEA reduces neuropathic pain by acting at both cannabinoid CB1 receptors and transient receptor potential vanilloid-1 (TRPV1) channels. Yet, intrathecal URB597 is only partially effective at counteracting neuropathic pain. We investigated the effect of high doses of intrathecal URB597 on allodynia and hyperalgesia in rats with chronic constriction injury (CCI) of the sciatic nerve. Among those tested, the 200 mu g/rat dose of URB597 was the only one that elevated the levels of the FAAH non-endocannabinoid and anti-inflammatory substrates, oleoylethanolamide (OEA) and palmitoylethanolamide (PEA), and of the endocannabinoid FAAH substrate, 2-arachidonoylglycerol, and fully inhibited thermal and tactile nociception, although in a manner blocked almost uniquely by TRPV1 antagonism. Surprisingly, this dose of URB597 decreased spinal AEA levels. RT-qPCR and western blot analyses demonstrated altered spinal expression of lipoxygenases (LOX), and baicalein, an inhibitor of 12/15-LOX, significantly reduced URB597 analgesic effects, suggesting the occurrence of alternative pathways of AEA metabolism. Using immunofluorescence techniques, FAAH, 15-LOX and TRPV1 were found to co-localize in dorsal spinal horn neurons of CCI rats. Finally, 15-hydroxy-AEA, a 15-LOX derivative of AEA, potently and efficaciously activated the rat recombinant TRPV1 channel. We suggest that intrathecally injected URB597 at full analgesic efficacy unmasks a secondary route of AEA metabolism via 15-LOX with possible formation of 15-hydroxy-AEA, which, together with OEA and PEA, may contribute at producing TRPV1-mediated analgesia in CCI rats.	[Starowicz, Katarzyna; Makuch, Wioletta; Malek, Natalia; Zychowska, Magdalena; Przewlocka, Barbara] Polish Acad Sci, Inst Pharmacol, Dept Pain Pharmacol, Krakow, Poland; [Korostynski, Michal; Slezak, Michal] Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, Krakow, Poland; [Petrosino, Stefania; Di Marzo, Vincenzo] CNR, Ist Chim Biomol, Endocannabinoid Res Grp, I-80125 Naples, Italy; [De Petrocellis, Luciano; Cristino, Luigia] CNR, Ist Cibernet, Endocannabinoid Res Grp, I-80125 Naples, Italy	Polish Academy of Sciences; Polish Academy of Sciences; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Cibernetica "Eduardo Caianiello" (ICIB-CNR)	Przewlocka, B (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Pain Pharmacol, Krakow, Poland.	przebar@if-pan.krakow.pl; vdimarzo@icmib.na.cnr.it	Di Marzo, Vincenzo/AAD-7742-2019; Cristino, Luigia/AAE-3934-2020; Korostynski, Michal/AAS-2626-2021; Malek, Natalia/AAF-2857-2019; Starowicz, Katarzyna/AAB-8595-2022	Di Marzo, Vincenzo/0000-0002-1490-3070; Cristino, Luigia/0000-0002-0182-4699; Korostynski, Michal/0000-0002-4273-7401; Malek, Natalia/0000-0003-3602-5122; Starowicz, Katarzyna/0000-0003-0091-0066; PRZEWLOCKA, BARBARA/0000-0002-6672-1906; Slezak, Michal/0000-0003-2224-3989; Makuch, Wioletta/0000-0002-1579-3643	Dept.'s of Pain Pharmacology statutory funds from Ministry of Science and Higher Education, Warsaw, Poland; Ministry of Science and Higher Education, Warsaw, Poland [N N401 015235]; National Institutes of Health [DA009789]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789] Funding Source: NIH RePORTER	Dept.'s of Pain Pharmacology statutory funds from Ministry of Science and Higher Education, Warsaw, Poland(Ministry of Science and Higher Education, Poland); Ministry of Science and Higher Education, Warsaw, Poland(Ministry of Science and Higher Education, Poland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Dept.'s of Pain Pharmacology statutory funds and by a grant (N N401 015235), both of which were from Ministry of Science and Higher Education, Warsaw, Poland. Dr. V. Di Marzo is grateful to the National Institutes of Health for partly funding this study (grant nr. DA009789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alawi K, 2010, PHARMACOL THERAPEUT, V125, P181, DOI 10.1016/j.pharmthera.2009.10.005; Amadio D, 2010, BIOCHIMIE, V92, P378, DOI 10.1016/j.biochi.2010.01.001; Ambrosino P, 2013, BRIT J PHARMACOL, V168, P1430, DOI 10.1111/bph.12029; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bisogno T, 1997, BIOCHEM J, V322, P671, DOI 10.1042/bj3220671; Brownjohn PW, 2012, NEUROSCIENCE, V203, P180, DOI 10.1016/j.neuroscience.2011.12.028; Chung MK, 2011, ADV EXP MED BIOL, V704, P615, DOI 10.1007/978-94-007-0265-3_33; Cortright DN, 2009, CURR PHARM DESIGN, V15, P1736, DOI 10.2174/138161209788186308; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Craib SJ, 2001, BRIT J PHARMACOL, V134, P30, DOI 10.1038/sj.bjp.0704223; de Lago E, 2005, BIOCHEM PHARMACOL, V70, P446, DOI 10.1016/j.bcp.2005.05.011; De Petrocellis L, 2001, J BIOL CHEM, V276, P12856, DOI 10.1074/jbc.M008555200; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Di Marzo V, 2002, CURR OPIN NEUROBIOL, V12, P372, DOI 10.1016/S0959-4388(02)00340-9; Di Marzo V, 2008, TRENDS PHARMACOL SCI, V29, P229, DOI 10.1016/j.tips.2008.03.001; Di Marzo V, 2012, PHILOS T R SOC B, V367, P3216, DOI 10.1098/rstb.2011.0382; Dinh TP, 2002, CHEM PHYS LIPIDS, V121, P149, DOI 10.1016/S0009-3084(02)00150-0; Edgemond WS, 1998, MOL PHARMACOL, V54, P180, DOI 10.1124/mol.54.1.180; Forsell PKA, 2012, LIPIDS, V47, P781, DOI 10.1007/s11745-012-3684-z; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; Gonsiorek W, 2000, MOL PHARMACOL, V57, P1045; Goparaju SK, 1998, FEBS LETT, V422, P69, DOI 10.1016/S0014-5793(97)01603-7; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; Kinsey SG, 2010, J PAIN, V11, P1420, DOI 10.1016/j.jpain.2010.04.001; Kozak KR, 2002, J BIOL CHEM, V277, P23278, DOI 10.1074/jbc.M201084200; Lang WS, 1999, J MED CHEM, V42, P896, DOI 10.1021/jm980461j; Mabalirajan U, 2012, P NATL ACAD SCI USA, V109, pE1, DOI 10.1073/pnas.1118477109; Maione S, 2006, J PHARMACOL EXP THER, V316, P969, DOI 10.1124/jpet.105.093286; Matias I, 2004, J PHARMACOL EXP THER, V309, P745, DOI 10.1124/jpet.103.061705; Movahed P, 2005, J BIOL CHEM, V280, P38496, DOI 10.1074/jbc.M507429200; Petrosino S, 2007, NEUROPHARMACOLOGY, V52, P415, DOI 10.1016/j.neuropharm.2006.08.011; Re G, 2007, VET J, V173, P21, DOI 10.1016/j.tvjl.2005.10.003; Rice ASC, 2002, PROSTAG LEUKOTR ESS, V66, P243, DOI 10.1054/plef.2001.0362; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Ross RA, 2001, BRIT J PHARMACOL, V132, P631, DOI 10.1038/sj.bjp.0703850; Starowicz K, 2012, NEUROPHARMACOLOGY, V62, P1746, DOI 10.1016/j.neuropharm.2011.11.021; Starowicz K, 2008, CURR PHARM DESIGN, V14, P42; Starowicz K, 2007, J NEUROSCI, V27, P13739, DOI 10.1523/JNEUROSCI.3258-07.2007; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Suardiaz M, 2007, PAIN, V133, P99, DOI 10.1016/j.pain.2007.03.008; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Talwar R, 2011, CNS NEUROL DISORD-DR, V10, P536, DOI 10.2174/187152711796235005; Tarzia G, 2003, J MED CHEM, V46, P2352, DOI 10.1021/jm021119g; Umar A, 2012, J NATL CANCER I, V104, P645, DOI 10.1093/jnci/djs192; Veldhuis WB, 2003, J NEUROSCI, V23, P4127; Wahl P, 2001, MOL PHARMACOL, V59, P9, DOI 10.1124/mol.59.1.9; Wang XB, 2005, J PHYSIOL-LONDON, V564, P541, DOI 10.1113/jphysiol.2004.081844; Woodward DF, 2008, PHARMACOL THERAPEUT, V120, P71, DOI 10.1016/j.pharmthera.2008.08.001; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	52	66	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60040	10.1371/journal.pone.0060040	http://dx.doi.org/10.1371/journal.pone.0060040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573230	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100044
J	Hildemann, SK; Eberlein, J; Davenport, B; Nguyen, TT; Victorino, F; Homann, D				Hildemann, Steven K.; Eberlein, Jens; Davenport, Bennett; Nguyen, Tom T.; Victorino, Francisco; Homann, Dirk			High Efficiency of Antiviral CD4(+) Killer T Cells	PLOS ONE			English	Article							CUTTING EDGE; CLASS-II; IN-VIVO; LISTERIA-MONOCYTOGENES; TRANSGENIC MICE; MOUSE GRANZYME; VIRUS; MEMORY; CD8(+); CYTOTOXICITY	The destruction of infected cells by cytotxic T lymphocytes (CTL) is integral to the effective control of viral and bacterial diseases, and CTL function at large has long been regarded as a distinctive property of the CD8(+)T cell subset. In contrast, and despite their first description more than three decades ago, the precise contribution of cytotoxic CD4(+)T cells to the resolution of infectious diseases has remained a matter of debate. In particular, the CTL activity of pathogen-specific CD4(+) "helper" T cells constitutes a single trait among a diverse array of other T cell functionalities, and overall appears considerably weaker than the cytolytic capacity of CD8(+) effector T cells. Here, using an in vivo CTL assay, we report that cytotoxic CD4(+)T cells are readily generated against both viral and bacterial pathogens, and that the efficiency of MHC-II-restricted CD4(+)T cell killing adjusted for effector: target cell ratios, precise specificities and functional avidities is comparable in magnitude to that of CD8(+)T cells. In fact, the only difference between specific CD4(+) and CD8(+)T cells pertains to the slightly delayed killing kinetics of the former demonstrating that potent CTL function is a cardinal property of both antiviral CD8(+) and CD4(+)T cells.	[Hildemann, Steven K.] Univ Heart Ctr, Univ Clin Cardiol & Angiol 1, Freiburg, Germany; [Hildemann, Steven K.] Merck Res Labs MSD Global Clin Trial Operat, Haar, Germany; [Eberlein, Jens; Davenport, Bennett; Nguyen, Tom T.; Victorino, Francisco; Homann, Dirk] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Davenport, Bennett; Victorino, Francisco; Homann, Dirk] Univ Colorado, Integrated Dept Immunol, Denver, CO 80202 USA; [Davenport, Bennett; Victorino, Francisco; Homann, Dirk] Natl Jewish Hlth, Denver, CO USA; [Davenport, Bennett; Nguyen, Tom T.; Homann, Dirk] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA	Universitats Herzzentrum Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Denver; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Homann, D (corresponding author), Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA.	dirk.homann@ucdenver.edu		Homann, Dirk/0000-0002-7622-5754	NIH [AG026518, AI093637]; JDRF [CDA 2-2007-240]; BDC PF grant; Diabetes and Endocrinology Research Center (DERC) grant [P30-DK057516]; MSD/Merck; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG026518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); BDC PF grant; Diabetes and Endocrinology Research Center (DERC) grant; MSD/Merck(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AG026518 and AI093637, JDRF CDA 2-2007-240 and a BDC P&F grant (D. H.), and the Diabetes and Endocrinology Research Center (DERC) grant P30-DK057516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. SKH leads the clinical research operations of MSD/Merck in Europe and is a full time employee of MSD/Merck. The current work is unrelated to any preclinical or clinical research ongoing at Merck and has received no financial or other support from MSD/Merck. Dirk Homann is a PLOS ONE Editorial Board member. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Aichele P, 1997, IMMUNITY, V6, P519, DOI 10.1016/S1074-7613(00)80340-4; Appay V, 2004, CLIN EXP IMMUNOL, V138, P10, DOI 10.1111/j.1365-2249.2004.02605.x; Balkow S, 2001, J VIROL, V75, P8781, DOI 10.1128/JVI.75.18.8781-8791.2001; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Barchet W, 2000, EUR J IMMUNOL, V30, P1356, DOI 10.1002/(SICI)1521-4141(200005)30:5<1356::AID-IMMU1356>3.0.CO;2-K; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; Brown DM, 2010, CELL IMMUNOL, V262, P89, DOI 10.1016/j.cellimm.2010.02.008; Byers AM, 2003, J IMMUNOL, V171, P17, DOI 10.4049/jimmunol.171.1.17; de Berg PJV, 2008, CURR OPIN IMMUNOL, V20, P339, DOI 10.1016/j.coi.2008.03.007; Eberlein J, 2012, J VIROL, V86, P1955, DOI 10.1128/JVI.05949-11; Eberlein J, 2010, J CLIN INVEST, V120, P907, DOI 10.1172/JCI40645; Fang M, 2012, P NATL ACAD SCI USA, V109, P9983, DOI 10.1073/pnas.1202143109; Geginat G, 2001, J IMMUNOL, V166, P1877, DOI 10.4049/jimmunol.166.3.1877; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Homann D, 2006, J VIROL, V80, P270, DOI 10.1128/JVI.80.1.270-280.2006; Homann D, 2004, J IMMUNOL, V172, P6239, DOI 10.4049/jimmunol.172.10.6239; Homann D, 1998, J VIROL, V72, P9208, DOI 10.1128/JVI.72.11.9208-9216.1998; Homann D, 2007, VIROLOGY, V363, P113, DOI 10.1016/j.virol.2006.12.025; Hudrisier D, 1996, J BIOL CHEM, V271, P17829, DOI 10.1074/jbc.271.30.17829; Hudrisier D, 2001, J VIROL, V75, P2468, DOI 10.1128/JVI.75.5.2468-2471.2001; Jellison ER, 2005, J IMMUNOL, V174, P614, DOI 10.4049/jimmunol.174.2.614; Jellison ER, 2007, EUR J IMMUNOL, V37, P119, DOI 10.1002/eji.200636516; Jenkins MR, 2008, VIRAL IMMUNOL, V21, P341, DOI 10.1089/vim.2008.0036; Joeckel LT, 2011, CELL DEATH DIFFER, V18, P1112, DOI 10.1038/cdd.2011.5; Johnson DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037337; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAUFMANN SHE, 1987, EUR J IMMUNOL, V17, P237, DOI 10.1002/eji.1830170214; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; Martorelli D, 2010, INT REV IMMUNOL, V29, P371, DOI 10.3109/08830185.2010.489658; Matter MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024772; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Regner M, 2009, J IMMUNOL, V183, P37, DOI 10.4049/jimmunol.0900466; Rode M, 2004, J VIROL, V78, P12395, DOI 10.1128/JVI.78.22.12395-12405.2004; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Serody JS, 1996, IMMUNOLOGY, V88, P544, DOI 10.1046/j.1365-2567.1996.d01-698.x; SHEN H, 1995, P NATL ACAD SCI USA, V92, P3987, DOI 10.1073/pnas.92.9.3987; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132; Stuller KA, 2010, J IMMUNOL, V184, P3850, DOI 10.4049/jimmunol.0902935; Stuller KA, 2009, J VIROL, V83, P4700, DOI 10.1128/JVI.02240-08; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; WALSH CM, 1994, P NATL ACAD SCI USA, V91, P10854, DOI 10.1073/pnas.91.23.10854; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Whitmire JK, 2011, VIROLOGY, V411, P216, DOI 10.1016/j.virol.2010.12.015; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Woodworth JS, 2008, J IMMUNOL, V181, P8595, DOI 10.4049/jimmunol.181.12.8595; Yates A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001301; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709	58	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60420	10.1371/journal.pone.0060420	http://dx.doi.org/10.1371/journal.pone.0060420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565245	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300115
J	Pagarigan, KT; Bunn, BW; Goodchild, J; Rahe, TK; Weis, JF; Saucedo, LJ				Pagarigan, Krystle T.; Bunn, Bryce W.; Goodchild, Jake; Rahe, Travis K.; Weis, Julie F.; Saucedo, Leslie J.			Drosophila PRL-1 Is a Growth Inhibitor That Counteracts the Function of the Src Oncogene	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASIS; REGENERATING LIVER-3; COLORECTAL-CANCER; GASTRIC-CANCER; DOWN-REGULATION; BREAST-CANCER; EXPRESSION; INVASION	Phosphatase of Regenerating Liver (PRL) family members have emerged as molecular markers that significantly correlate to the ability of many cancers to metastasize. However, contradictory cellular responses to PRL expression have been reported, including the inhibition of cell cycle progression. An obvious culprit for the discrepancy is the use of dozens of different cell lines, including many isolated from tumors or cultured cells selected for immortalization which may have missing or mutated modulators of PRL function. We created transgenic Drosophila to study the effects of PRL overexpression in a genetically controlled, organismal model. Our data support the paradigm that the normal cellular response to high levels of PRL is growth suppression and furthermore, that PRL can counter oncogenic activity of Src. The ability of PRL to inhibit growth under normal conditions is dependent on a CAAX motif that is required to localize PRL to the apical edge of the lateral membrane. However, PRL lacking the CAAX motif can still associate indiscriminately with the plasma membrane and retains its ability to inhibit Src function. We propose that PRL binds to other membrane-localized proteins that are effectors of Src or to Src itself. This first examination of PRL in a model organism demonstrates that PRL performs as a tumor suppressor and underscores the necessity of identifying the conditions that enable it to transform into an oncogene in cancer.	[Pagarigan, Krystle T.; Bunn, Bryce W.; Goodchild, Jake; Rahe, Travis K.; Weis, Julie F.; Saucedo, Leslie J.] Univ Puget Sound, Dept Biol, Tacoma, WA 98416 USA; [Rahe, Travis K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Saucedo, LJ (corresponding author), Univ Puget Sound, Dept Biol, Tacoma, WA 98416 USA.	lsaucedo@pugetsound.edu			National Istitutes of Health [1R15CA141519-01]; NATIONAL CANCER INSTITUTE [R15CA141519] Funding Source: NIH RePORTER	National Istitutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Istitutes of Health grant: 1R15CA141519-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Da N, 2009, WORLD J GASTROENTERO, V15, P1499, DOI 10.3748/wjg.15.1499; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Diamond RH, 1996, AM J PHYSIOL-GASTR L, V271, pG121, DOI 10.1152/ajpgi.1996.271.1.G121; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Forte E, 2008, BBA-MOL CELL RES, V1783, P334, DOI 10.1016/j.bbamcr.2007.11.004; Guo K, 2004, CANCER BIOL THER, V3, P945, DOI 10.4161/cbt.3.10.1111; Guo K, 2008, CANCER BIOL THER, V7, P750, DOI 10.4161/cbt.7.5.5764; Hao RT, 2010, J CANCER RES CLIN, V136, P1349, DOI 10.1007/s00432-010-0786-y; Hassan NMM, 2011, ASIAN PAC J CANCER P, V12, P947; Hatate K, 2008, ONCOL REP, V20, P737, DOI 10.3892/or_00000068; Jeong DG, 2005, J MOL BIOL, V345, P401, DOI 10.1016/j.jmb.2004.10.061; Kato H, 2004, CLIN CANCER RES, V10, P7318, DOI 10.1158/1078-0432.CCR-04-0485; Kong L, 2007, NEUROPATHOLOGY, V27, P516, DOI 10.1111/j.1440-1789.2007.00818.x; Kong WH, 2000, AM J PHYSIOL-GASTR L, V279, pG613, DOI 10.1152/ajpgi.2000.279.3.G613; Kozlov G, 2004, J BIOL CHEM, V279, P11882, DOI 10.1074/jbc.M312905200; Li ZR, 2006, BIOCHEM BIOPH RES CO, V348, P229, DOI 10.1016/j.bbrc.2006.07.043; Liang F, 2008, J BIOL CHEM, V283, P10339, DOI 10.1074/jbc.M708285200; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Liu YQ, 2008, ARCH PATHOL LAB MED, V132, P1307, DOI 10.1043/1543-2165(2008)132[1307:EOPORL]2.0.CO;2; Luo Y, 2009, BIOCHEMISTRY-US, V48, P1838, DOI 10.1021/bi8020789; Ma YX, 2011, MED ONCOL, V28, P775, DOI 10.1007/s12032-010-9514-3; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; Min SH, 2009, ONCOGENE, V28, P545, DOI 10.1038/onc.2008.409; Min SH, 2010, LIFE SCI, V86, P66, DOI 10.1016/j.lfs.2009.11.010; Miskad UA, 2007, VIRCHOWS ARCH, V450, P303, DOI 10.1007/s00428-006-0361-8; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; MOHN KL, 1991, MOL CELL BIOL, V11, P1393, DOI 10.1128/MCB.11.3.1393; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; O'Reilly AM, 2006, DEVELOPMENT, V133, P2627, DOI 10.1242/dev.02423; Ooki A, 2010, INT J CANCER, V127, P543, DOI 10.1002/ijc.25082; Ooki A, 2009, ONCOL REP, V21, P1467, DOI 10.3892/or_00000376; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Peng LR, 2004, J CANCER RES CLIN, V130, P521, DOI 10.1007/s00432-004-0563-x; Peters CS, 2001, J BIOL CHEM, V276, P13718, DOI 10.1074/jbc.M011562200; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Reich R, 2011, INT J MOL SCI, V12, P1133, DOI 10.3390/ijms12021133; Ren TT, 2009, PATHOL ONCOL RES, V15, P555, DOI 10.1007/s12253-009-9153-1; Rudrapatna VA, 2012, DEV DYNAM, V241, P107, DOI 10.1002/dvdy.22771; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Skinner AL, 2009, BIOCHEMISTRY-US, V48, P4262, DOI 10.1021/bi900241k; Song R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004450; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Sun JP, 2007, J BIOL CHEM, V282, P29043, DOI 10.1074/jbc.M703537200; Sun JP, 2005, BIOCHEMISTRY-US, V44, P12009, DOI 10.1021/bi0509191; Vidal M, 2007, CANCER RES, V67, P10278, DOI 10.1158/0008-5472.CAN-07-1376; Wallin AR, 2006, INT J RADIAT ONCOL, V65, P452, DOI 10.1016/j.ijrobp.2005.12.043; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang L, 2006, ANN ONCOL, V17, P1517, DOI 10.1093/annonc/mdl159; Wang Y, 2012, ONCOGENE, V31, P818, DOI 10.1038/onc.2011.281; Wang Y, 2007, INT J COLORECTAL DIS, V22, P1179, DOI 10.1007/s00384-007-0303-1; Werner SR, 2003, CANCER LETT, V202, P201, DOI 10.1016/S0304-3835(03)00517-2; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Xing XF, 2009, HISTOPATHOLOGY, V54, P309, DOI 10.1111/j.1365-2559.2009.03226.x; XU T, 1993, DEVELOPMENT, V117, P1223; Xu YJ, 2010, PATHOL ONCOL RES, V16, P169, DOI 10.1007/s12253-009-9200-y; Yamashita Shin-ichi, 2007, Ann Thorac Cardiovasc Surg, V13, P236; Yu L, 2007, BBA-MOL CELL RES, V1773, P1473, DOI 10.1016/j.bbamcr.2007.06.005; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291; Zhao WB, 2008, INT J MOL MED, V22, P187, DOI 10.3892/ijmm_00000007; Zhou J, 2009, INT J CANCER, V124, P1879, DOI 10.1002/ijc.24096	70	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61084	10.1371/journal.pone.0061084	http://dx.doi.org/10.1371/journal.pone.0061084			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577193	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000098
J	Shen, XP; Li, S; Zhang, L; Li, HD; Hong, GN; Zhou, XX; Zheng, TT; Zhang, WJ; Hao, CX; Shi, TW; Liu, CY; Guo, Z				Shen, Xiaopei; Li, Shan; Zhang, Lin; Li, Hongdong; Hong, Guini; Zhou, XianXiao; Zheng, Tingting; Zhang, Wenjing; Hao, Chunxiang; Shi, Tongwei; Liu, Chunyang; Guo, Zheng			An Integrated Approach to Uncover Driver Genes in Breast Cancer Methylation Genomes	PLOS ONE			English	Article							DNA METHYLATION; TUMOR-SUPPRESSOR; EXPRESSION; HYPOMETHYLATION; DATABASE; CELLS; PROGRESSION; COMPONENT; NETWORK	Background: Cancer cells typically exhibit large-scale aberrant methylation of gene promoters. Some of the genes with promoter methylation alterations play "driver" roles in tumorigenesis, whereas others are only "passengers". Results: Based on the assumption that promoter methylation alteration of a driver gene may lead to expression alternation of a set of genes associated with cancer pathways, we developed a computational framework for integrating promoter methylation and gene expression data to identify driver methylation aberrations of cancer. Applying this approach to breast cancer data, we identified many novel cancer driver genes and found that some of the identified driver genes were subtype-specific for basal-like, luminal-A and HER2+ subtypes of breast cancer. Conclusion: The proposed framework proved effective in identifying cancer driver genes from genome-wide gene methylation and expression data of cancer. These results may provide new molecular targets for potential targeted and selective epigenetic therapy.	[Shen, Xiaopei; Li, Shan; Zhang, Lin; Li, Hongdong; Hong, Guini; Zhou, XianXiao; Zheng, Tingting; Zhang, Wenjing; Hao, Chunxiang; Shi, Tongwei; Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China; [Liu, Chunyang; Guo, Zheng] Fujian Med Univ, Sch Basic Med Sci, Dept Bioinformat, Fuzhou, Peoples R China	University of Electronic Science & Technology of China; Fujian Medical University	Guo, Z (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China.	guoz@ems.hrbmu.edu.cn	Shen, Xiaopei/B-2773-2017	Shen, Xiaopei/0000-0002-0004-4228	National Natural Science Foundation of China [30970668, 81201702, 81071646, 91029717]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Natural Science Foundation of China (30970668, 81201702, 81071646 and 91029717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Ambatipudi S, 2012, GENE CHROMOSOME CANC, V51, P161, DOI 10.1002/gcc.20940; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertucci Francois, 2008, J Biol, V7, P6, DOI 10.1186/jbiol67; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Dedeurwaerder S, 2011, EMBO MOL MED, V3, P726, DOI 10.1002/emmm.201100801; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Esteller M, 2000, CANCER RES, V60, P4366; Fan HZ, 1998, CANCER RES, V58, P1650; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Frau M, 2012, HEPATOLOGY, V56, P165, DOI 10.1002/hep.25643; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gong X, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-76; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kalari S, 2010, ADV GENET, V70, P277, DOI [10.1016/B978-0-12-380866-0.60010-1, 10.1016/S0065-2660(10)70010-9]; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawai H, 2003, INT J CANCER, V107, P353, DOI 10.1002/ijc.11403; Kim YA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001095; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Mewes HW, 2008, NUCLEIC ACIDS RES, V36, pD196, DOI 10.1093/nar/gkm980; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Potter C, 2004, CELL CYCLE, V3, P164; Pulukuri SMK, 2007, CANCER RES, V67, P930, DOI 10.1158/0008-5472.CAN-06-2892; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sawan C, 2010, ADV GENET, V70, P57, DOI [10.1016/S0065-2660(10)70003-1, 10.1016/B978-0-12-380866-0.60003-4]; Shen XP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044822; Son KS, 2010, BREAST, V19, P484, DOI 10.1016/j.breast.2010.05.011; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tate CR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3192; Ushijima T, 2010, CANCER SCI, V101, P300, DOI 10.1111/j.1349-7006.2009.01434.x; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang ZQ, 2006, INT J CANCER, V118, P1436, DOI 10.1002/ijc.21499; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yang YM, 2003, BIOINFORMATICS, V19, P2311, DOI 10.1093/bioinformatics/btg300; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zeller C, 2012, ONCOGENE; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhang Y, 2011, HISTOL HISTOPATHOL, V26, P87, DOI 10.14670/HH-26.87; Zou JF, 2012, COMPUT BIOL CHEM, V39, P1, DOI 10.1016/j.compbiolchem.2012.04.002	54	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61214	10.1371/journal.pone.0061214	http://dx.doi.org/10.1371/journal.pone.0061214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23579546	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000113
J	Vazquez-Prokopec, GM; Bisanzio, D; Stoddard, ST; Paz-Soldan, V; Morrison, AC; Elder, JP; Ramirez-Paredes, J; Halsey, ES; Kochel, TJ; Scott, TW; Kitron, U				Vazquez-Prokopec, Gonzalo M.; Bisanzio, Donal; Stoddard, Steven T.; Paz-Soldan, Valerie; Morrison, Amy C.; Elder, John P.; Ramirez-Paredes, Jhon; Halsey, Eric S.; Kochel, Tadeusz J.; Scott, Thomas W.; Kitron, Uriel			Using GPS Technology to Quantify Human Mobility, Dynamic Contacts and Infectious Disease Dynamics in a Resource-Poor Urban Environment	PLOS ONE			English	Article							HUMAN MOVEMENT; PANDEMIC INFLUENZA; TRANSMISSION; PATTERNS; CHALLENGES; STRATEGIES; NETWORKS; BEHAVIOR; IQUITOS	Empiric quantification of human mobility patterns is paramount for better urban planning, understanding social network structure and responding to infectious disease threats, especially in light of rapid growth in urbanization and globalization. This need is of particular relevance for developing countries, since they host the majority of the global urban population and are disproportionally affected by the burden of disease. We used Global Positioning System (GPS) data-loggers to track the fine-scale (within city) mobility patterns of 582 residents from two neighborhoods from the city of Iquitos, Peru. We used similar to 2.3 million GPS data-points to quantify age-specific mobility parameters and dynamic co-location networks among all tracked individuals. Geographic space significantly affected human mobility, giving rise to highly local mobility kernels. Most (similar to 80%) movements occurred within 1 km of an individual's home. Potential hourly contacts among individuals were highly irregular and temporally unstructured. Only up to 38% of the tracked participants showed a regular and predictable mobility routine, a sharp contrast to the situation in the developed world. As a case study, we quantified the impact of spatially and temporally unstructured routines on the dynamics of transmission of an influenza-like pathogen within an Iquitos neighborhood. Temporally unstructured daily routines (e.g., not dominated by a single location, such as a workplace, where an individual repeatedly spent significant amount of time) increased an epidemic's final size and effective reproduction number by 20% in comparison to scenarios modeling temporally structured contacts. Our findings provide a mechanistic description of the basic rules that shape human mobility within a resource-poor urban center, and contribute to the understanding of the role of fine-scale patterns of individual movement and co-location in infectious disease dynamics. More generally, this study emphasizes the need for careful consideration of human social interactions when designing infectious disease mitigation strategies, particularly within resource-poor urban environments.	[Vazquez-Prokopec, Gonzalo M.; Bisanzio, Donal; Kitron, Uriel] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; [Vazquez-Prokopec, Gonzalo M.; Stoddard, Steven T.; Scott, Thomas W.; Kitron, Uriel] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Stoddard, Steven T.; Morrison, Amy C.; Scott, Thomas W.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Paz-Soldan, Valerie] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA USA; [Elder, John P.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Ramirez-Paredes, Jhon; Halsey, Eric S.] US Naval Med Res Unit, Lima, Peru; [Ramirez-Paredes, Jhon; Halsey, Eric S.] US Naval Med Res Unit, Iquitos, Peru; [Kochel, Tadeusz J.] USN, Med Res Ctr, Silver Spring, MD USA	Emory University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of California System; University of California Davis; Tulane University; California State University System; San Diego State University; United States Department of Defense; United States Navy	Vazquez-Prokopec, GM (corresponding author), Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA.	gmvazqu@emory.edu	Halsey, Eric/AAC-8110-2022; Morrison, Amy/AAU-6511-2020	Halsey, Eric/0000-0001-6291-8923; Bisanzio, Donal/0000-0002-7832-2291; Kitron, Uriel/0000-0003-0493-2043; Paz-Soldan, Valerie/0000-0002-1065-4919; Morrison, Amy/0000-0001-6224-5984	U.S. National Institutes of Health - National Institute of Allergy and Infectious Diseases (NIH/NIAID) [R01 AI069341-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069341] Funding Source: NIH RePORTER	U.S. National Institutes of Health - National Institute of Allergy and Infectious Diseases (NIH/NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Development of the ideas presented here was assisted by support from the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, U.S. Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. This research was funded by a grant from the U.S. National Institutes of Health - National Institute of Allergy and Infectious Diseases (NIH/NIAID) award number R01 AI069341-01 (to TWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedeo D., 2009, PERSON ENV BEHAV RES; ANDERSON R M, 1991; Balcan D, 2012, J THEOR BIOL, V293, P87, DOI 10.1016/j.jtbi.2011.10.010; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Barton H, 2009, HEALTH PROMOT INT, V24, P91, DOI 10.1093/heapro/dap059; Boldrini C, 2010, COMPUT COMMUN, V33, P1056, DOI 10.1016/j.comcom.2010.01.013; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Buliung RN, 2008, TRANSPORTATION, V35, P697, DOI 10.1007/s11116-008-9178-4; Cohen B, 2004, WORLD DEV, V32, P23, DOI 10.1016/j.worlddev.2003.04.008; Danon L, 2009, EPIDEMICS-NETH, V1, P250, DOI 10.1016/j.epidem.2009.11.002; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Golledge RG., 1997, SPATIAL BEHAV GEOGRA; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hanson S, 2005, P NATL ACAD SCI USA, V102, P15301, DOI 10.1073/pnas.0507309102; Hu DH, 2007, LECT NOTES COMPUT SC, V4808, P309; Instituto Nacional de Estadistica e Informatica, 2008, CENS NAC 2007 11 POB; Kang CG, 2012, PHYSICA A, V391, P1702, DOI 10.1016/j.physa.2011.11.005; Keeling DJ, 2009, PROG HUM GEOG, V33, P516, DOI 10.1177/0309132508098100; Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Kostakos V, 2010, ACM T COMPUT-HUM INT, V17, DOI 10.1145/1721831.1721833; Krenn PJ, 2011, AM J PREV MED, V41, P508, DOI 10.1016/j.amepre.2011.06.046; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Montgomery MR, 2008, SCIENCE, V319, P761, DOI 10.1126/science.1153012; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Oshitani H, 2008, EMERG INFECT DIS, V14, P875, DOI 10.3201/eid1406.070839; Paz-Soldan VA, 2010, AM J TROP MED HYG, V82, P723, DOI 10.4269/ajtmh.2010.09-0496; Poletto C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00476; Rosenberg MS, 2004, J VEG SCI, V15, P277, DOI 10.1111/j.1654-1103.2004.tb02262.x; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Stoddard ST, 2012, P NATL ACAD SCI US; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; The World Bank, 2009, SYST CIT HARN URB GR, P28; United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD URB PROSP 2011; Vazquez-Prokopec GM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-68; Volz E, 2007, P ROY SOC B-BIOL SCI, V274, P2925, DOI 10.1098/rspb.2007.1159; Volz E, 2009, J R SOC INTERFACE, V6, P233, DOI 10.1098/rsif.2008.0218; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts Duncan J., 2003, SMALL WORLDS DYNAMIC; Webster P, 2009, HEALTH PROMOT INT, V24, P56, DOI 10.1093/heapro/dap055; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	49	140	142	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e58802	10.1371/journal.pone.0058802	http://dx.doi.org/10.1371/journal.pone.0058802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	130FG	23577059	Green Submitted, gold, Green Published			2022-12-27	WOS:000317898000005
J	Blasios, V; Bisson, AW; Castellen, P; Nogueira, MLC; Bettini, J; Portugal, RV; Zeri, ACM; Gueiros, FJ				Blasios, Valdir; Bisson-Filho, Alexandre W.; Castellen, Patricia; Nogueira, Maria Luiza C.; Bettini, Jefferson; Portugal, Rodrigo V.; Zeri, Ana Carolina M.; Gueiros-Filho, Frederico J.			Genetic and Biochemical Characterization of the MinC-FtsZ Interaction in Bacillus subtilis	PLOS ONE			English	Article							CELL-DIVISION PROTEIN; SITE SELECTION SYSTEM; C-TERMINAL TAIL; CRYSTAL-STRUCTURE; Z-RING; BACTERIAL CYTOKINESIS; ASSEMBLY DYNAMICS; MINICELL LOCUS; DIVIVA; LOCALIZATION	Cell division in bacteria is regulated by proteins that interact with FtsZ and modulate its ability to polymerize into the Z ring structure. The best studied of these regulators is MinC, an inhibitor of FtsZ polymerization that plays a crucial role in the spatial control of Z ring formation. Recent work established that E. coli MinC interacts with two regions of FtsZ, the bottom face of the H10 helix and the extreme C-terminal peptide (CTP). Here we determined the binding site for MinC on Bacillus subtilis FtsZ. Selection of a library of FtsZ mutants for survival in the presence of Min overexpression resulted in the isolation of 13 Min-resistant mutants. Most of the substitutions that gave rise to Min resistance clustered around the H9 and H10 helices in the C-terminal domain of FtsZ. In addition, a mutation in the CTP of B. subtilis FtsZ also produced MinC resistance. Biochemical characterization of some of the mutant proteins showed that they exhibited normal polymerization properties but reduced interaction with MinC, as expected for binding site mutations. Thus, our study shows that the overall architecture of the MinC-FtsZ interaction is conserved in E. coli and B. subtilis. Nevertheless, there was a clear difference in the mutations that conferred Min resistance, with those in B. subtilis FtsZ pointing to the side of the molecule rather than to its polymerization interface. This observation suggests that the mechanism of Z ring inhibition by MinC differs in both species.	[Blasios, Valdir; Bisson-Filho, Alexandre W.; Castellen, Patricia; Gueiros-Filho, Frederico J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Castellen, Patricia; Nogueira, Maria Luiza C.; Zeri, Ana Carolina M.] CNPEM, Brazilian Biosci Natl Lab LNBio, Campinas, SP, Brazil; [Bettini, Jefferson; Portugal, Rodrigo V.] CNPEM, Nanotechnol Natl Lab LNNano, Campinas, SP, Brazil	Universidade de Sao Paulo	Gueiros, FJ (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	fgueiros@iq.usp.br	NOGUEIRA, MARIA LUIZA CALDAS/ABD-4713-2020; Bisson Filho, Alexandre Wilson/D-4248-2015; Bettini, Jefferson/G-4554-2013; Portugal, Rodrigo V/H-3951-2012; Gueiros-Filho, Frederico J./D-2160-2013; Zeri, Ana/AAY-4799-2021	NOGUEIRA, MARIA LUIZA CALDAS/0000-0003-2548-6564; Bisson Filho, Alexandre Wilson/0000-0002-5940-7230; Bettini, Jefferson/0000-0001-7316-0804; Portugal, Rodrigo V/0000-0002-8136-904X; Gueiros-Filho, Frederico J./0000-0001-5425-2439; Zeri, Ana/0000-0003-4169-4523	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/58821-1, 10/51866-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478019/2009-2]; FAPESP; CAPES; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants 08/58821-1 and 10/51866-0 (Smolbnet 2.0) from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and 478019/2009-2, from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). V.B.J. and A.W.B.F. were recipients of doctoral fellowships from FAPESP, P.C. was a recipient of a postdoctoral fellowship by FAPESP. M.L.C.N. was a recipient of a CAPES doctoral fellowship. F.J.G.F was a recipient of a PQ-2 fellowship of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; ADLER HI, 1967, P NATL ACAD SCI USA, V57, P321, DOI 10.1073/pnas.57.2.321; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bramkamp M, 2008, MOL MICROBIOL, V70, P1556, DOI 10.1111/j.1365-2958.2008.06501.x; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Cha JH, 1997, J BACTERIOL, V179, P1671, DOI 10.1128/jb.179.5.1671-1683.1997; Chen YD, 2011, BIOCHEMISTRY-US, V50, P4675, DOI 10.1021/bi200106d; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Cordell SC, 2003, P NATL ACAD SCI USA, V100, P7889, DOI 10.1073/pnas.1330742100; Cordell SC, 2001, EMBO J, V20, P2454, DOI 10.1093/emboj/20.10.2454; DAI K, 1994, J BACTERIOL, V176, P130, DOI 10.1128/JB.176.1.130-136.1994; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; Dajkovic A, 2010, MOL MICROBIOL, V78, P651, DOI 10.1111/j.1365-2958.2010.07352.x; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Diaz-Espinoza R, 2007, PROTEIN SCI, V16, P1543, DOI 10.1110/ps.072807607; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Erickson HP, 2001, CURR OPIN CELL BIOL, V13, P55, DOI 10.1016/S0955-0674(00)00174-5; Fadda D, 2003, J BACTERIOL, V185, P6209, DOI 10.1128/JB.185.20.6209-6214.2003; de Oliveira IFF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012048; Feucht A, 2005, MICROBIOL-SGM, V151, P2053, DOI 10.1099/mic.0.27899-0; Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Gueiros F, 2012, BACILLUS: CELLULAR AND MOLECULAR BIOLOGY, SECOND EDITION, P85; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Handler AA, 2008, MOL MICROBIOL, V68, P588, DOI 10.1111/j.1365-2958.2008.06173.x; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Huang J, 1996, J BACTERIOL, V178, P5080, DOI 10.1128/jb.178.17.5080-5085.1996; Krol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043293; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; NANNINGA N, 1991, MOL MICROBIOL, V5, P791, DOI 10.1111/j.1365-2958.1991.tb00751.x; Nguyen L, 2007, J BACTERIOL, V189, P7896, DOI 10.1128/JB.00726-07; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Peters PC, 2007, MOL MICROBIOL, V64, P487, DOI 10.1111/j.1365-2958.2007.05673.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Radhakrishnan SK, 2010, DEV CELL, V18, P90, DOI 10.1016/j.devcel.2009.10.024; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramirez-Arcos S, 2005, MICROBIOL-SGM, V151, P1381, DOI 10.1099/mic.0.27718-0; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Raymond A, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-37; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; REEVE JN, 1973, J BACTERIOL, V114, P860, DOI 10.1128/JB.114.2.860-873.1973; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shiomi D, 2007, J BACTERIOL, V189, P236, DOI 10.1128/JB.00666-06; Singh JK, 2008, J BIOL CHEM, V283, P31116, DOI 10.1074/jbc.M805910200; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; Stricker J, 2003, J BACTERIOL, V185, P4796, DOI 10.1128/JB.185.16.4796-4805.2003; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Zhou HJ, 2005, J BACTERIOL, V187, P2846, DOI 10.1128/JB.187.8.2846-2857.2005	75	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60690	10.1371/journal.pone.0060690	http://dx.doi.org/10.1371/journal.pone.0060690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577149	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800090
J	Dong, JH; Sakurai, A; Nomura, N; Park, EY; Shibasaki, F; Ueda, H				Dong, Jinhua; Sakurai, Akira; Nomura, Namiko; Park, Enoch Y.; Shibasaki, Futoshi; Ueda, Hiroshi			Isolation of Recombinant Phage Antibodies Targeting the Hemagglutinin Cleavage Site of Highly Pathogenic Avian Influenza Virus	PLOS ONE			English	Article							OPEN-SANDWICH ELISA; H5N1 INFLUENZA; A VIRUS; SOUTHERN CHINA; EVOLUTION; PCR; ACTIVATION; VIRULENCE; CHICKENS; SEQUENCE	Highly pathogenic avian influenza (HPAI) H5N1 viruses, which have emerged in poultry and other wildlife worldwide, contain a characteristic multi-basic cleavage site (CS) in the hemagglutinin protein (HA). Because this arginine-rich CS is unique among influenza virus subtypes, antibodies against this site have the potential to specifically diagnose pathogenic H5N1. By immunizing mice with the CS peptide and screening a phage display library, we isolated four antibody Fab fragment clones that specifically bind the antigen peptide and several HPAI H5N1 HA proteins in different clades. The soluble Fab fragments expressed in Escherichia coli bound the CS peptide and the H5N1 HA protein with nanomolar affinity. In an immunofluorescence assay, these Fab fragments stained cells infected with HPAI H5N1 but not those infected with a less virulent strain. Lastly, all the Fab clones could detect the CS peptide and H5N1 HA protein by open sandwich ELISA. Thus, these recombinant Fab fragments will be useful novel reagents for the rapid and specific detection of HPAI H5N1 virus.	[Dong, Jinhua; Park, Enoch Y.] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka, Japan; [Dong, Jinhua; Ueda, Hiroshi] Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo, Japan; [Sakurai, Akira; Nomura, Namiko; Shibasaki, Futoshi] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Mol Med Project, Setagaya Ku, Tokyo 113, Japan	Shizuoka University; University of Tokyo; Tokyo Metropolitan Institute of Medical Science	Ueda, H (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 227, Japan.	hueda@chembio.t.u-tokyo.ac.jp	Ueda, Hiroshi/A-3515-2011; Park, Enoch/AAU-2614-2020; Dong, Jinhua/D-2510-2015	Ueda, Hiroshi/0000-0001-8849-4217; Dong, Jinhua/0000-0002-7417-1932; Park, Enoch Y./0000-0002-7840-1424	Japan Society for the Promotion of Science (JSPS) [B24360336, 23659069]; Global COE Program for Chemistry Innovation (Ministry of Education, Culture, Sports, Science and Technology (MEXT); Promotion of Nanobio-Technology Research; Grants-in-Aid for Scientific Research [23656517] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program for Chemistry Innovation (Ministry of Education, Culture, Sports, Science and Technology (MEXT); Promotion of Nanobio-Technology Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by a Grant-In-Aid for Scientific Research (B24360336 to HU) and Grant-In-Aid for Exploratory Research (23659069 to AS) from Japan Society for the Promotion of Science (JSPS). This work was also funded by the Global COE Program for Chemistry Innovation (Ministry of Education, Culture, Sports, Science and Technology (MEXT)), and the Promotion of Nanobio-Technology Research to support Aging and Welfare Society (MEXT). JHD was supported by JSPS Postdoctoral Fellowships for Foreign Researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Dong JH, 2012, J IMMUNOL METHODS, V377, P1, DOI 10.1016/j.jim.2012.01.005; Dong J, 2009, ANAL BIOCHEM, V386, P36, DOI 10.1016/j.ab.2008.11.045; Du A, 2009, BIOCHEM BIOPH RES CO, V378, P197, DOI 10.1016/j.bbrc.2008.11.022; Eccles R, 2005, LANCET INFECT DIS, V5, P718, DOI 10.1016/S1473-3099(05)70270-X; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gall A, 2008, J CLIN MICROBIOL, V46, P2561, DOI 10.1128/JCM.00466-08; Hoffmann B, 2007, J CLIN MICROBIOL, V45, P600, DOI 10.1128/JCM.01681-06; Hoffmann E, 2000, J VIROL, V74, P6309, DOI 10.1128/JVI.74.14.6309-6315.2000; HORIMOTO T, 1995, J VET MED SCI, V57, P927, DOI 10.1292/jvms.57.927; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Islam KN, 2011, ANAL CHEM, V83, P1008, DOI 10.1021/ac102801r; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; KIDO H, 1993, FEBS LETT, V322, P115, DOI 10.1016/0014-5793(93)81549-F; Kristensen P, 1998, FOLD DES, V3, P321, DOI 10.1016/S1359-0278(98)00044-3; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Liljebjelke KA, 2010, VACCINE, V28, P4430, DOI 10.1016/j.vaccine.2010.04.009; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-130; Londt BZ, 2007, AVIAN PATHOL, V36, P347, DOI 10.1080/03079450701589134; Martin J, 1998, VIROLOGY, V241, P101, DOI 10.1006/viro.1997.8958; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Sakurai A, 2011, J VIROL METHODS, V178, P75, DOI 10.1016/j.jviromet.2011.08.015; Soda K, 2008, JPN J VET RES, V55, P93; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Ueda H, 1996, NAT BIOTECHNOL, V14, P1714, DOI 10.1038/nbt1296-1714; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO, 2012, CUM NUMB CONF HUM CA; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	32	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61158	10.1371/journal.pone.0061158	http://dx.doi.org/10.1371/journal.pone.0061158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577205	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800128
J	Jiang, HB; Chen, W; Zhu, GC; Zhang, LJ; Tucker, BR; Hao, L; Feng, SM; Ci, HL; Ma, JQ; Wang, L; Stashenko, P; Li, YP				Jiang, Hongbing; Chen, Wei; Zhu, Guochun; Zhang, Lijie; Tucker, Byron; Hao, Liang; Feng, Shengmei; Ci, Hongliang; Ma, Junqing; Wang, Lin; Stashenko, Philip; Li, Yi-Ping			RNAi-Mediated Silencing of Atp6i and Atp6i Haploinsufficiency Prevents Both Bone Loss and Inflammation in a Mouse Model of Periodontal Disease	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; IN-VITRO; T-CELL; OSTEOCLAST DIFFERENTIATION; ALLOGRAFT-REJECTION; PARKINSONS-DISEASE; MEMBRANE-PROTEIN; IMMUNE-RESPONSE; B-LYMPHOCYTE; GENE-THERAPY	Periodontal disease affects about 80% of adults in America, and is characterized by oral bacterial infection-induced gingival inflammation, oral bone resorption, and tooth loss. Periodontitis is also associated with other diseases such as rheumatoid arthritis, diabetes, and heart disease. Although many efforts have been made to develop effective therapies for this disease, none have been very effective and there is still an urgent need for better treatments and preventative strategies. Herein we explored for the first time the possibility that adeno-associated virus (AAV)-mediated RNAi knockdown could be used to treat periodontal disease with improved efficacy. For this purpose, we used AAV-mediated RNAi knockdown of Atp6i/TIRC7 gene expression to target bone resorption and gingival inflammation simultaneously. Mice were infected with the oral pathogen Porphyromonas gingivalis W50 (P. gingivalis) in the maxillary periodontium to induce periodontitis. We found that Atp6i depletion impaired extracellular acidification and osteoclast-mediated bone resorption. Furthermore, local injection of AAV-shRNA-Atp6i/TIRC7 into the periodontal tissues in vivo protected mice from P. gingivalis infection-stimulated bone resorption by >85% and decreased the T-cell number in periodontal tissues. Notably, AAV-mediated Atp6i/TIRC7 knockdown also reduced the expression of osteoclast marker genes and inflammation-induced cytokine genes. Atp6i(+/-) mice with haploinsufficiency were similarly protected from P. gingivalis infection-stimulated bone loss and gingival inflammation. This suggests that AAV-shRNA-Atp6i/TIRC7 therapeutic treatment may significantly improve the health of millions who suffer from P. gingivalis-mediated periodontal disease.	[Jiang, Hongbing; Chen, Wei; Zhu, Guochun; Tucker, Byron; Hao, Liang; Feng, Shengmei; Ci, Hongliang; Ma, Junqing; Li, Yi-Ping] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Jiang, Hongbing; Ma, Junqing; Wang, Lin] Nanjing Med Univ, Coll Stomatol, Nanjing, Jiangsu, Peoples R China; [Tucker, Byron] Harvard Univ, Sch Dent Med, Dept Restorat Dent & Endodont, Boston, MA 02115 USA; [Zhang, Lijie; Stashenko, Philip] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA; [Zhang, Lijie] Hebei Med Univ, Hosp 3, Dept Clin Lab, Shijiazhuang, Hebei Province, Peoples R China	University of Alabama System; University of Alabama Birmingham; Nanjing Medical University; Harvard University; Harvard School of Dental Medicine; Harvard University; Forsyth Institute; Hebei Medical University	Chen, W (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	wechen@uab.edu; ypli@uab.edu	Jiang, Hongbing/AAQ-6331-2021	Jiang, Hongbing/0000-0002-3748-0381; Hao, Liang/0000-0003-2071-7044	National Institutes of Health [DE-020533-01, R01-AR-055307]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044741, R01AR055307, P30AR046031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants DE-020533-01 (Y.P.L.) and R01-AR-055307 (Y.P.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001079; Allaire JM, 2011, AM J PHYSIOL-GASTR L, V300, pG586, DOI 10.1152/ajpgi.00041.2010; Buff SM, 2010, GENE THER, V17, P567, DOI 10.1038/gt.2010.28; Carter BJ, 2005, HUM GENE THER, V16, P541, DOI 10.1089/hum.2005.16.541; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Cirelli JA, 2009, GENE THER, V16, P426, DOI 10.1038/gt.2008.174; Cottard V, 2000, GENE THER, V7, P1930, DOI 10.1038/sj.gt.3301324; Evans C, 2010, J RHEUMATOL, V37, P683, DOI 10.3899/jrheum.100055; Feng SM, 2009, BIOCHEM J, V417, P195, DOI 10.1042/BJ20081073; Gasmi M, 2007, MOL THER, V15, P62, DOI 10.1038/sj.mt.6300010; Goodson JM, 2012, J CLIN PERIODONTOL, V39, P526, DOI 10.1111/j.1600-051X.2012.01870.x; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Heinemann T, 1999, GENOMICS, V57, P398, DOI 10.1006/geno.1999.5751; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Irwin C R, 1998, Oral Dis, V4, P43; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2092, DOI 10.1210/en.139.4.2092; Kumamoto Y, 2006, TRANSPL IMMUNOL, V16, P238, DOI 10.1016/j.trim.2006.09.027; Kunze M, 2009, J DENT, V37, P502, DOI 10.1016/j.jdent.2009.03.001; KURLAND JI, 1977, J EXP MED, V146, P1420, DOI 10.1084/jem.146.5.1420; Li Qiyan, 2012, J Signal Transduct, V2012, P308943, DOI 10.1155/2012/308943; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Lin XP, 2011, INFECT IMMUN, V79, P911, DOI 10.1128/IAI.00944-10; Lourbakos A, 2001, INFECT IMMUN, V69, P5121, DOI 10.1128/IAI.69.8.5121-5130.2001; Ma JQ, 2013, INFECT IMMUN, V81, P1021, DOI 10.1128/IAI.00756-12; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Muzylak M, 2007, J CELL PHYSIOL, V213, P144, DOI 10.1002/jcp.21103; Nijenhuis T, 2008, J BONE MINER RES, V23, P1815, DOI 10.1359/JBMR.080613; Pera M, 2012, ORAL HLTH TOTAL HLTH; Ramamurthy HS, 2005, J PERIODONTOL, V76, P229, DOI 10.1902/jop.2005.76.2.229; Sasaki H, 2000, J IMMUNOL, V165, P3626, DOI 10.4049/jimmunol.165.7.3626; Sasaki H, 2004, J PERIODONTAL RES, V39, P432, DOI 10.1111/j.1600-0765.2004.00760.x; Sasaki H, 2008, J IMMUNOL, V180, P6193, DOI 10.4049/jimmunol.180.9.6193; Shay K, 2002, CLIN INFECT DIS, V34, P1215, DOI 10.1086/339865; Tomar RS, 2003, ONCOGENE, V22, P5712, DOI 10.1038/sj.onc.1206733; Trepagnier C M, 1977, J Endod, V3, P194, DOI 10.1016/S0099-2399(77)80096-4; Tu QS, 2009, J CELL PHYSIOL, V218, P135, DOI 10.1002/jcp.21576; Ulrich-Vinther M, 2007, ACTA ORTHOP, V78, P5; Utku N, 2004, J IMMUNOL, V173, P2342, DOI 10.4049/jimmunol.173.4.2342; Utku N, 1998, IMMUNITY, V9, P509, DOI 10.1016/S1074-7613(00)80634-2; Utku N, 2007, CURR OPIN INVEST DR, V8, P401; Wilensky A, 2009, J CLIN PERIODONTOL, V36, P915, DOI 10.1111/j.1600-051X.2009.01464.x; Yang SY, 2007, J CELL SCI, V120, P3362, DOI 10.1242/jcs.008300; Yang SY, 2007, GENE DEV, V21, P1803, DOI 10.1101/gad.1544107; Yang SY, 2007, J BONE MINER RES, V22, P45, DOI 10.1359/JBMR.061007; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yu H, 2011, GENE THER, V18, P344, DOI 10.1038/gt.2010.139; Zhang L, 2010, GENE THER, V17, P1262, DOI 10.1038/gt.2010.64; Zhou Q, 2011, ARTHRITIS RHEUM-US, V63, P2318, DOI 10.1002/art.30421	54	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e58599	10.1371/journal.pone.0058599	http://dx.doi.org/10.1371/journal.pone.0058599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577057	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800004
J	Jyothi, KU; Jayaraj, M; Subburaj, KS; Prasad, KJ; Kumuda, I; Lakshmi, V; Reddy, BM				Jyothi, Kommoju Uma; Jayaraj, Maruda; Subburaj, Kadarkarai Samy; Prasad, Kotla Jaya; Kumuda, Irgam; Lakshmi, Velaga; Reddy, Battini Mohan			Association of TCF7L2 Gene Polymorphisms with T2DM in the Population of Hyderabad, India	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; GENOME-WIDE ASSOCIATION; COMMON VARIANTS; RISK LOCI; SUSCEPTIBILITY; REPLICATION; SLC30A8; IGF2BP2; IMPACT; KCNJ11	We attempt to evaluate the nature of association of TCF7L2 gene variants with T2DM, for the first time in the population of Hyderabad, which is considered to be diabetic capital of India. It is a case-control study of the three SNPs of TCF7L2, rs7903146, rs12255372 and rs11196205, genotyped on Sequenom Massarray platform, in a sample of 758 patients and 621 controls. The risk allele frequency of the three SNPs was found to be significantly higher in the T2DM cases than controls, implicating susceptibility for diabetes (p < 0.01). The greatest risk of developing the disease was conferred by rs7903146. Further, the logistic regression of genotypes of each SNP under log additive model, and the haplotypes constituted by at least one of the three risk alleles also show significantly greater risk of developing T2DM when compared to the wild type haplotype. Further, BMI and WHR emerge as significant covariates with confounding effects. The strong association of the TCF7L2 SNPs with T2DM is consistent with the findings among other Indian and Non-Indian populations, suggesting universal phenomena of its association across ethnic groups globally, both within and outside the Indian subcontinent, albeit the functional relevance of these SNPs needs yet to be established.	[Jyothi, Kommoju Uma; Jayaraj, Maruda; Subburaj, Kadarkarai Samy; Kumuda, Irgam; Reddy, Battini Mohan] Indian Stat Inst, Mol Anthropol Grp, Biol Anthropol Unit, Hyderabad, Andhra Pradesh, India; [Prasad, Kotla Jaya] JP Endocrine Ctr, Hyderabad, Andhra Pradesh, India; [Lakshmi, Velaga] Andhra Univ, Dept Human Genet, Visakhapatnam, Andhra Pradesh, India	Indian Statistical Institute; Andhra University	Reddy, BM (corresponding author), Indian Stat Inst, Mol Anthropol Grp, Biol Anthropol Unit, Hyderabad, Andhra Pradesh, India.	bmrisi@gmail.com			Indian Statistical Institute	Indian Statistical Institute	This work was supported by the Indian Statistical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami FM, 2012, GENET MOL BIOL, V35, P413, DOI 10.1590/S1415-47572012005000029; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Amoli MM, 2010, GENET MOL BIOL, V33, P449, DOI 10.1590/S1415-47572010005000056; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; Bodhini D, 2007, METABOLISM, V56, P1174, DOI 10.1016/j.metabol.2007.04.012; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chang YC, 2007, DIABETES, V56, P2631, DOI 10.2337/db07-0421; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; De Silva NMG, 2007, DIABETIC MED, V24, P1067, DOI 10.1111/j.1464-5491.2007.02253.x; Ereqat S, 2010, ACTA DIABETOL, V47, pS195, DOI 10.1007/s00592-009-0161-0; Ezzidi I, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-33; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Guo TW, 2007, DIABETES, V56, P3082, DOI 10.2337/db07-0621; Gupta V, 2008, INT J HUM GENET, V8, P199, DOI 10.1080/09723757.2008.11886031; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Jin T, 2008, DIABETOLOGIA, V51, P1771, DOI 10.1007/s00125-008-1084-y; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Kifagi C, 2011, GENET TEST MOL BIOMA, V15, P399, DOI 10.1089/gtmb.2010.0199; Kunika K, 2008, J HUM GENET, V53, P972, DOI 10.1007/s10038-008-0339-2; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Marquezine GF, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-106; Mayans S, 2007, EUR J HUM GENET, V15, P342, DOI 10.1038/sj.ejhg.5201773; Moczulski D, 2007, DIABETOLOGIA DOSWIAD, V7, P109; Mtiraoui N, 2012, DIABETES METAB, V38, P444, DOI 10.1016/j.diabet.2012.05.002; Ng MCY, 2007, J CLIN ENDOCR METAB, V92, P3733, DOI 10.1210/jc.2007-0849; Palizban A, 2012, CLIN EXP MED, V12, P115, DOI 10.1007/s10238-011-0144-7; Park SE, 2012, J HUM GENET, V57, P265, DOI 10.1038/jhg.2012.16; Rees SD, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-8; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Ren Q, 2008, DIABETOLOGIA, V51, P1146, DOI 10.1007/s00125-008-1039-3; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanghera DK, 2008, ANN HUM GENET, V72, P499, DOI 10.1111/j.1469-1809.2008.00443.x; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; Shetty P, 2012, NATURE, V485, pS14, DOI 10.1038/485S14a; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith U, 2007, DIABETOLOGIA, V50, P5, DOI 10.1007/s00125-006-0521-z; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; van Vliet-Ostaptchouk JV, 2007, DIABETOLOGIA, V50, P59, DOI 10.1007/s00125-006-0477-z; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang CL, 2006, DIABETES, V55, P2645, DOI 10.2337/db06-0643; Zheng XY, 2012, MOL BIOL REP, V39, P17, DOI 10.1007/s11033-011-0705-6	53	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60212	10.1371/journal.pone.0060212	http://dx.doi.org/10.1371/journal.pone.0060212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577093	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800035
J	Karlsson, T; Bolshakova, A; Magalhaes, MAO; Loitto, VM; Magnusson, KE				Karlsson, Thommie; Bolshakova, Anastasia; Magalhaes, Marco A. O.; Loitto, Vesa M.; Magnusson, Karl-Eric			Fluxes of Water through Aquaporin 9 Weaken Membrane-Cytoskeleton Anchorage and Promote Formation of Membrane Protrusions	PLOS ONE			English	Article							CELL-MIGRATION; GROWTH CONES; MYOSIN-X; ACTIN POLYMERIZATION; FILOPODIA INITIATION; MOTILITY DRIVEN; PROTEIN; PROTEOLYSIS; EXPRESSION; MECHANISM	All modes of cell migration require rapid rearrangements of cell shape, allowing the cell to navigate within narrow spaces in an extracellular matrix. Thus, a highly flexible membrane and a dynamic cytoskeleton are crucial for rapid cell migration. Cytoskeleton dynamics and tension also play instrumental roles in the formation of different specialized cell membrane protrusions, viz. lamellipodia, filopodia, and membrane blebs. The flux of water through membrane-anchored water channels, known as aquaporins (AQPs) has recently been implicated in the regulation of cell motility, and here we provide novel evidence for the role of AQP9 in the development of various forms of membrane protrusion. Using multiple imaging techniques and cellular models we show that: (i) AQP9 induced and accumulated in filopodia, (ii) AQP9-associated filopodial extensions preceded actin polymerization, which was in turn crucial for their stability and dynamics, and (iii) minute, local reductions in osmolarity immediately initiated small dynamic bleb-like protrusions, the size of which correlated with the reduction in osmotic pressure. Based on this, we present a model for AQP9-induced membrane protrusion, where the interplay of water fluxes through AQP9 and actin dynamics regulate the cellular protrusive and motile activity of cells.	[Karlsson, Thommie; Bolshakova, Anastasia; Loitto, Vesa M.; Magnusson, Karl-Eric] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Med Microbiol, Linkoping, Sweden; [Magalhaes, Marco A. O.] Univ Toronto, Fac Dent, Toronto, ON, Canada	Linkoping University; University of Toronto	Magnusson, KE (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Med Microbiol, Linkoping, Sweden.	karl-eric.magnusson@liu.se	Bolshakova, Anastasiya Viktorovna/AAH-1797-2020; Magalhaes, Marco Antonio/P-2535-2018	Bolshakova, Anastasiya Viktorovna/0000-0002-4427-5458; Magalhaes, Marco Antonio/0000-0002-5060-7738; Magnusson, Karl-Eric/0000-0002-7809-8437	Swedish Research Council [2007-3483, 2009-6649, 2010-3045]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was supported by the Swedish Research Council (Grant Nos 2007-3483, 2009-6649 and 2010-3045, www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1994, J CLIN INVEST, V94, P1050, DOI 10.1172/JCI117419; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; FRIEDL P, 1995, CANCER RES, V55, P4557; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Grabham PW, 2000, J CELL SCI, V113, P3003; HEIDEMANN SR, 1990, J CELL BIOL, V111, P1949, DOI 10.1083/jcb.111.5.1949; Huebert RC, 2010, HEPATOLOGY, V52, P238, DOI 10.1002/hep.23628; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252; Jelen S, 2011, J BIOL CHEM, V286, P44319, DOI 10.1074/jbc.M111.297002; Karlsson T, 2011, J LEUKOCYTE BIOL, V90, P963, DOI 10.1189/jlb.0910540; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Liu YJ, 2009, BIOL CELL, V101, P133, DOI 10.1042/BC20080083; Loitto VM, 2007, EXP CELL RES, V313, P1295, DOI 10.1016/j.yexcr.2007.01.023; Loitto VM, 2009, CELL MOTIL CYTOSKEL, V66, P237, DOI 10.1002/cm.20357; Loitto VM, 2002, J LEUKOCYTE BIOL, V71, P212; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mellor H, 2010, BBA-MOL CELL RES, V1803, P191, DOI 10.1016/j.bbamcr.2008.12.018; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Oda K, 1999, CYTOGENET CELL GENET, V84, P75, DOI 10.1159/000015219; OTTO JJ, 1979, CELL, V17, P285, DOI 10.1016/0092-8674(79)90154-5; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Persson YAZ, 2008, MICROBES INFECT, V10, P233, DOI 10.1016/j.micinf.2007.11.007; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Ridley AJ, 2001, J CELL SCI, V114, P2713; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yang CS, 2011, CELL ADHES MIGR, V5, P402, DOI 10.4161/cam.5.5.16971; Yang CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005678; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	66	40	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59901	10.1371/journal.pone.0059901	http://dx.doi.org/10.1371/journal.pone.0059901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573219	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100033
J	Lorda-Diez, CI; Montero, JA; Rodriguez-Leon, J; Garcia-Porrero, JA; Hurle, JM				Lorda-Diez, Carlos I.; Montero, Juan A.; Rodriguez-Leon, Joaquin; Garcia-Porrero, Juan A.; Hurle, Juan M.			Expression and Functional Study of Extracellular BMP Antagonists during the Morphogenesis of the Digits and Their Associated Connective Tissues	PLOS ONE			English	Article							BRACHYDACTYLY TYPE A2; TWISTED-GASTRULATION; SIGNALING PATHWAYS; CHORDIN-LIKE; LIMB CHONDROGENESIS; JOINT DEVELOPMENT; SHORT-RANGE; MOUSE LIMB; BONE; PROTEIN	The purpose of this study is to gain insight into the role of BMP signaling in the diversification of the embryonic limb mesodermal progenitors destined to form cartilage, joints, and tendons. Given the importance of extracellular BMP modulators in in vivo systems, we performed a systematic search of those expressed in the developing autopod during the formation of the digits. Here, we monitored the expression of extracellular BMP modulators including: Noggin, Chordin, Chordin-like 1, Chordin-like 2, Twisted gastrulation, Dan, BMPER, Sost, Sostdc1, Follistatin, Follistatin-like 1, Follistatin-like 5 and Tolloid. These factors show differential expression domains in cartilage, joints and tendons. Furthermore, they are induced in specific temporal patterns during the formation of an ectopic extra digit, preceding the appearance of changes that are identifiable by conventional histology. The analysis of gene regulation, cell proliferation and cell death that are induced by these factors in high density cultures of digit progenitors provides evidence of functional specialization in the control of mesodermal differentiation but not in cell proliferation or apoptosis. We further show that the expression of these factors is differentially controlled by the distinct signaling pathways acting in the developing limb at the stages covered by this study. In addition, our results provide evidence suggesting that TWISTED GASTRULATION cooperates with CHORDINS, BMPER, and NOGGIN in the establishment of tendons or cartilage in a fashion that is dependent on the presence or absence of TOLLOID.	[Lorda-Diez, Carlos I.; Montero, Juan A.; Garcia-Porrero, Juan A.; Hurle, Juan M.] Univ Cantabria, Dept Anat & Biol Celular, E-39005 Santander, Spain; [Lorda-Diez, Carlos I.; Montero, Juan A.; Garcia-Porrero, Juan A.; Hurle, Juan M.] Univ Cantabria, IFIMAV, E-39005 Santander, Spain; [Rodriguez-Leon, Joaquin] Univ Extremadura, Dept Anat, Badajoz, Spain	Universidad de Cantabria; Universidad de Cantabria; Universidad de Extremadura	Hurle, JM (corresponding author), Univ Cantabria, Dept Anat & Biol Celular, E-39005 Santander, Spain.	hurlej@unican.es	Montero, Juan A/K-4395-2014; Leon, Joaquin Maria Rodriguez/C-6957-2013; Leon, Joaquin Maria Rodriguez/S-9814-2019; Lorda-Diez, Carlos I./J-7990-2019	Montero, Juan A/0000-0001-9099-5344; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Lorda-Diez, Carlos I./0000-0002-3248-9918; Hurle, Juan M/0000-0002-4685-025X	Spanish Science and Innovation Ministry [BFU2011-24169]	Spanish Science and Innovation Ministry(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by a grant from the Spanish Science and Innovation Ministry to JMH (BFU2011-24169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2007, GENE EXPR PATTERNS, V7, P491, DOI 10.1016/j.modgep.2006.10.009; Ambrosio AL, 2008, DEV CELL, V15, P248, DOI 10.1016/j.devcel.2008.06.013; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Bachiller D, 2003, DEVELOPMENT, V130, P3567, DOI 10.1242/dev.00581; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Benazet JD, 2012, DEVELOPMENT, V139, P4250, DOI 10.1242/dev.084822; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Branam AM, 2010, DEV BIOL, V341, P444, DOI 10.1016/j.ydbio.2010.03.001; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; Clark TG, 1999, DEVELOPMENT, V126, P2631; Collette NM, 2010, DEV BIOL, V342, P169, DOI 10.1016/j.ydbio.2010.03.021; D'Souza D, 1999, ANAT EMBRYOL, V200, P367, DOI 10.1007/s004290050286; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Dranse HJ, 2011, J CELL SCI, V124, P2723, DOI 10.1242/jcs.084699; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; Fernandes H, 2010, CELLS TISSUES ORGANS, V191, P443, DOI 10.1159/000281825; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Gazzerro E, 2006, BONE, V39, P1252, DOI 10.1016/j.bone.2006.06.028; Geetha-Loganathan P, 2006, ANAT EMBRYOL, V211, pS87, DOI 10.1007/s00429-006-0129-6; Gunnell LM, 2010, J BONE MINER RES, V25, P1784, DOI 10.1002/jbmr.79; Hentschel HGE, 2004, P ROY SOC B-BIOL SCI, V271, P1713, DOI 10.1098/rspb.2004.2772; Hung WT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096172; HURLE JM, 1990, CELL DIFFER DEV, V30, P97, DOI 10.1016/0922-3371(90)90078-B; Ikeya M, 2008, MECH DEVELOP, V125, P832, DOI 10.1016/j.mod.2008.06.011; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Kamimura M, 2004, DEV DYNAM, V230, P434, DOI 10.1002/dvdy.20069; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Katagiri T, 1998, DEV GENET, V22, P340, DOI 10.1002/(SICI)1520-6408(1998)22:4<340::AID-DVG4>3.0.CO;2-6; Katsu K, 2012, DEV BIOL, V363, P15, DOI 10.1016/j.ydbio.2011.12.015; Knosp WM, 2007, J BIOL CHEM, V282, P6843, DOI 10.1074/jbc.M610775200; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Larrain J, 2001, DEVELOPMENT, V128, P4439; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Lorda-Diez CI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024546; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Merino R, 1999, DEVELOPMENT, V126, P2161; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Montero JA, 2012, J TISSUE ENG REGEN M, V6, P337, DOI 10.1002/term.436; Nakayama N, 2004, DEVELOPMENT, V131, P229, DOI 10.1242/dev.00901; Nakayama N, 2001, DEV BIOL, V232, P372, DOI 10.1006/dbio.2001.0200; Nosaka T, 2003, MOL CELL BIOL, V23, P2969, DOI 10.1128/MCB.23.8.2969-2980.2003; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Ormerod MG, 2002, J IMMUNOL METHODS, V265, P73, DOI 10.1016/S0022-1759(02)00071-6; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Peluso CE, 2011, DEV CELL, V21, P375, DOI 10.1016/j.devcel.2011.06.025; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; Ploper D, 2011, DEV BIOL, V352, P317, DOI 10.1016/j.ydbio.2011.01.029; Plouhinec JL, 2011, CURR OPIN GENET DEV, V21, P696, DOI 10.1016/j.gde.2011.09.001; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Rodriguez-Guzman M, 2007, DEV BIOL, V302, P267, DOI 10.1016/j.ydbio.2006.09.034; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Serpe M, 2008, DEV CELL, V14, P940, DOI 10.1016/j.devcel.2008.03.023; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Sharov AA, 2009, AM J PATHOL, V175, P1303, DOI 10.2353/ajpath.2009.090163; Shigetani Y, 2007, DEV DYNAM, V236, P2277, DOI 10.1002/dvdy.21234; Sohaskey ML, 2008, DEVELOPMENT, V135, P2215, DOI 10.1242/dev.019950; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; Stafford DA, 2011, DEVELOPMENT, V138, P1005, DOI 10.1242/dev.051938; Staines KA, 2012, CELL BIOCH FUNCT; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Tsumaki N, 2002, J BONE MINER RES, V17, P898, DOI 10.1359/jbmr.2002.17.5.898; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wills A, 2006, DEV BIOL, V289, P166, DOI 10.1016/j.ydbio.2005.10.022; Xie J, 2005, DEVELOPMENT, V132, P383, DOI 10.1242/dev.01577; Yamamoto Y, 2004, NATURWISSENSCHAFTEN, V91, P519, DOI 10.1007/s00114-004-0575-z; Yi SE, 2000, DEVELOPMENT, V127, P621; Zakin L, 2010, DEV BIOL, V347, P204, DOI 10.1016/j.ydbio.2010.08.025; Zakin L, 2010, CURR BIOL, V20, pR89, DOI 10.1016/j.cub.2009.11.021; Zhang DH, 2002, J BONE MINER RES, V17, P293, DOI 10.1359/jbmr.2002.17.2.293; Zhu JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010892; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191; Zuzarte-Luis V, 2004, DEV BIOL, V272, P39, DOI 10.1016/j.ydbio.2004.04.015	88	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60423	10.1371/journal.pone.0060423	http://dx.doi.org/10.1371/journal.pone.0060423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573253	Green Published, gold			2022-12-27	WOS:000318840100068
J	Kaur, S; Qureshi, OS; Sansom, DM				Kaur, Satdip; Qureshi, Omar S.; Sansom, David M.			Comparison of the Intracellular Trafficking Itinerary of CTLA-4 Orthologues	PLOS ONE			English	Article							CELL-SURFACE EXPRESSION; COATED PIT FORMATION; COSTIMULATORY RECEPTORS; T-CELLS; ENDOCYTOSIS; CD28; ANTIGEN-4; ACTIVATION; LYSOSOMES; PROTEIN	CTLA-4 is an essential inhibitor of T cell immune responses. At steady state, most CTLA-4 resides in intracellular compartments due to constitutive internalisation mediated via a tyrosine based endocytic motif (YVKM) within the cytoplasmic domain. This domain is highly conserved in mammals suggesting strong selective pressure. In contrast, the C-terminal domain varies considerably in non-mammals such as fish, xenopus and birds. We compared the ability of the C-terminus of these species to direct the trafficking of CTLA-4 with human CTLA-4. Using a chimeric approach, endocytosis was found to be conserved between human, xenopus and chicken CTLA-4 but was reduced substantially in trout CTLA-4, which lacks the conserved YXXM motif. Nevertheless, we identified an alternative YXXF motif in trout CTLA-4 that permitted limited endocytosis. Post-internalisation, CTLA-4 was either recycled or targeted for degradation. Human and chicken CTLA-4, which contain a YVKM motif, showed efficient recycling compared to xenopus CTLA-4 which contains a less efficient YEKM motif. Specific mutation of this motif in human CTLA-4 reduced receptor recycling. These findings suggest evolutionary development in the endocytic and recycling potential of CTLA-4, which may facilitate more refined functions of CTLA-4 within the mammalian immune system.	[Kaur, Satdip; Qureshi, Omar S.; Sansom, David M.] Univ Birmingham, Sch Med, Sch Immun & Infect, MRC Ctr Immune Regulat, Birmingham, W Midlands, England	University of Birmingham	Sansom, DM (corresponding author), Univ Birmingham, Sch Med, Sch Immun & Infect, MRC Ctr Immune Regulat, Birmingham, W Midlands, England.	d.m.sansom@bham.ac.uk	Qureshi, Omar/CAF-4545-2022	Sansom, David/0000-0001-6506-3115; Kaur, Satdip/0000-0002-0901-9141	College of Medical and Dental Sciences, University of Birmingham UK; BBSRC; BBSRC [BB/H013598/2, BB/H013598/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H013598/2, BB/H013598/1] Funding Source: researchfish	College of Medical and Dental Sciences, University of Birmingham UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a PhD studentship from the College of Medical and Dental Sciences, University of Birmingham UK to SK. OSQ was funded by the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard D, 2007, DEV COMP IMMUNOL, V31, P255, DOI 10.1016/j.dci.2006.06.003; Bernard D, 2006, J IMMUNOL, V176, P4191, DOI 10.4049/jimmunol.176.7.4191; Boehm T, 2012, TRENDS IMMUNOLOGY; Chuang E, 1997, J IMMUNOL, V159, P144; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; IACOPETTA BJ, 1988, CELL, V54, P485, DOI 10.1016/0092-8674(88)90069-4; Iida T, 2000, J IMMUNOL, V165, P5062, DOI 10.4049/jimmunol.165.9.5062; Lane PJL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00024; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Obermuller S, 2002, J CELL SCI, V115, P185; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Qureshi OS, 2012, J BIOL CHEM, V287, P9429, DOI 10.1074/jbc.M111.304329; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Schneider H, 1999, J IMMUNOL, V163, P1868; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	21	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60903	10.1371/journal.pone.0060903	http://dx.doi.org/10.1371/journal.pone.0060903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565286	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000317717300159
J	Qian, XJ; Mruk, DD; Cheng, CY				Qian, Xiaojing; Mruk, Dolores D.; Cheng, C. Yan			Rai14 (Retinoic Acid Induced Protein 14) Is Involved in Regulating F-Actin Dynamics at the Ectoplasmic Specialization in the Rat Testis	PLOS ONE			English	Article							TRANSEPITHELIAL ELECTRICAL-RESISTANCE; SERTOLI-CELL MONOLAYERS; SEMINIFEROUS EPITHELIUM; TUBULOBULBAR COMPLEXES; ADULT-RAT; BARRIER DYNAMICS; GERM-CELLS; IN-VITRO; JUNCTIONS; EXPRESSION	Rai14 (retinoic acid induced protein 14) is an actin binding protein first identified in the liver, highly expressed in the placenta, the testis, and the eye. In the course of studying actin binding proteins that regulate the organization of actin filament bundles in the ectoplasmic specialization (ES), a testis-specific actin-rich adherens junction (AJ) type, Rai14 was shown to be one of the regulatory proteins at the ES. In the rat testis, Rai14 was found to be expressed by Sertoli and germ cells, structurally associated with actin and an actin cross-linking protein palladin. Its expression was the highest at the ES in the seminiferous epithelium of adult rat testes, most notably at the apical ES at the Sertoli-spermatid interface, and expressed stage-specifically during the epithelial cycle in stage VII-VIII tubules. However, Rai14 was also found at the basal ES near the basement membrane, associated with the blood-testis barrier (BTB) in stage VIII-IX tubules. A knockdown of Rai14 in Sertoli cells cultured in vitro by RNAi was found to perturb the Sertoli cell tight junction-permeability function in vitro, mediated by a disruption of F-actin, which in turn led to protein mis-localization at the Sertoli cell BTB. When Rai14 in the testis in vivo was knockdown by RNAi, defects in spermatid polarity and adhesion, as well as spermatid transport were noted mediated via changes in F-actin organization and mis-localization of proteins at the apical ES. In short, Rai14 is involved in the re-organization of actin filaments in Sertoli cells during the epithelial cycle, participating in conferring spermatid polarity and cell adhesion in the testis.	[Qian, Xiaojing; Mruk, Dolores D.; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, New York, NY 10021 USA; [Qian, Xiaojing] Peking Union Med Coll, Sch Basic Med, Dept Anat Histol & Embryol, Beijing 100021, Peoples R China	Population Council; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10021 USA.	Y-Cheng@popcbr.rockefeller.edu		Cheng, C Yan/0000-0003-3117-3791	National Institutes of Health (NICHD) [R01 HD056034, U54 HD029990]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD029990, R01HD056034] Funding Source: NIH RePORTER	National Institutes of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Studies from the authors' laboratory were supported by grants from the National Institutes of Health (NICHD, R01 HD056034 to CYC; U54 HD029990 Project 5 to CYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitei M, 2012, NAT CELL BIOL, V14, P11, DOI 10.1038/ncb2409; Aravindan GR, 1996, J CELL PHYSIOL, V168, P123; Brodsky FM, 2002, ANNU REV CELL DEV BI, V28, P309; BYERS SW, 1986, J ANDROL, V7, P59; Cheng C Yan, 2011, Spermatogenesis, V1, P291; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Cheng CY, 2009, CRIT REV BIOCHEM MOL, V44, P245, DOI 10.1080/10409230903061207; DEPHILIP RM, 1982, P NATL ACAD SCI-BIOL, V79, P6551, DOI 10.1073/pnas.79.21.6551; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Fawcett D W, 1970, J Reprod Fertil Suppl, V10, P105; Fawcett DW, 1975, HDB PHYSIOLOGY     7, VV, P21; Franca LR, 2013, ADV EXP MED BIOL, V763, P237; GALDIERI M, 1981, J ANDROL, V2, P249; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; GRIMA J, 1992, MOL CELL ENDOCRINOL, V89, P127, DOI 10.1016/0303-7207(92)90219-V; HESS RA, 1990, BIOL REPROD, V43, P517, DOI 10.1095/biolreprod43.3.517; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; JANECKI A, 1992, TOXICOL APPL PHARM, V112, P51, DOI 10.1016/0041-008X(92)90278-Z; JANECKI A, 1991, MOL CELL ENDOCRINOL, V82, P61, DOI 10.1016/0303-7207(91)90009-H; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; Kotula L, 2012, FEBS LETT, V586, P2790, DOI 10.1016/j.febslet.2012.05.015; Kutty RK, 2006, BIOCHEM BIOPH RES CO, V345, P1333, DOI 10.1016/j.bbrc.2006.04.184; Kutty RK, 2001, J BIOL CHEM, V276, P2831, DOI 10.1074/jbc.M007421200; Lee NPY, 2004, J ANDROL, V25, P200; Li JCH, 2001, J ANDROL, V22, P266; Li Michelle Wm, 2011, Spermatogenesis, V1, P123, DOI 10.4161/spmg.1.2.16393; Lie PPY, 2006, J ENDOCRINOL, V191, P571, DOI 10.1677/joe.1.06996; Lie PPY, 2012, P NATL ACAD SCI USA, V109, P12562, DOI 10.1073/pnas.1202316109; Lie PPY, 2011, INT REV CEL MOL BIO, V286, P223, DOI 10.1016/B978-0-12-385859-7.00005-7; Lie PPY, 2010, P NATL ACAD SCI USA, V107, P11411, DOI 10.1073/pnas.1001823107; Lie PPY, 2009, FASEB J, V23, P2555, DOI 10.1096/fj.06-070573; MATHER JP, 1979, EXP CELL RES, V124, P215, DOI 10.1016/0014-4827(79)90271-4; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Mruk DD, 2008, PHARMACOL REV, V60, P146, DOI 10.1124/pr.107.07105; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; Nightingale TD, 2012, TRENDS CELL BIOL, V22, P329, DOI 10.1016/j.tcb.2012.03.003; Okanlawon A, 1996, J ANDROL, V17, P249; ORTH JM, 1982, ANAT REC, V203, P485, DOI 10.1002/ar.1092030408; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Pelletier RM, 2011, PROG HISTOCHEM CYTO, V46, P49, DOI 10.1016/j.proghi.2011.05.001; Peng YF, 2000, GENES CELLS, V5, P1001, DOI 10.1046/j.1365-2443.2000.00381.x; RUSSELL L, 1976, ANAT REC, V185, P259, DOI 10.1002/ar.1091850302; RUSSELL L, 1977, TISSUE CELL, V9, P475, DOI 10.1016/0040-8166(77)90007-6; Russell L. D., 1993, SERTOLI CELL, P1; RUSSELL LD, 1988, BIOL REPROD, V39, P105, DOI 10.1095/biolreprod39.1.105; RUSSELL LD, 1985, INT REV CYTOL, V94, P177, DOI 10.1016/S0074-7696(08)60397-6; RUSSELL LD, 1978, ANAT REC, V190, P99, DOI 10.1002/ar.1091900109; RUSSELL LD, 1979, AM J ANAT, V155, P259, DOI 10.1002/aja.1001550208; Salanova M, 1998, BIOL REPROD, V58, P371, DOI 10.1095/biolreprod58.2.371; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; Su LL, 2010, INT J BIOCHEM CELL B, V42, P1864, DOI 10.1016/j.biocel.2010.08.004; Su WH, 2012, ENDOCRINOLOGY, V153, P6041, DOI 10.1210/en.2012-1670; Su WH, 2012, ENDOCRINOLOGY, V153, P5023, DOI 10.1210/en.2012-1286; TRES LL, 1983, P NATL ACAD SCI-BIOL, V80, P3377, DOI 10.1073/pnas.80.11.3377; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Vogl AW, 2000, ARCH HISTOL CYTOL, V63, P1, DOI 10.1679/aohc.63.1; WEBER JE, 1983, AM J ANAT, V167, P163, DOI 10.1002/aja.1001670203; Wolski KM, 2005, J ANDROL, V26, P354, DOI 10.2164/jandrol.04142; Wong EWP, 2008, P NATL ACAD SCI USA, V105, P9657, DOI 10.1073/pnas.0801527105; WRIGHT WW, 1989, ANN NY ACAD SCI, V564, P173, DOI 10.1111/j.1749-6632.1989.tb25896.x; WRIGHT WW, 1981, P NATL ACAD SCI-BIOL, V78, P7565, DOI 10.1073/pnas.78.12.7565; Xiao XA, 2011, INT J BIOCHEM CELL B, V43, P651, DOI 10.1016/j.biocel.2011.01.008; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200; Young J'nelle S, 2012, Spermatogenesis, V2, P63; Young JS, 2012, REPRODUCTION, V143, P347, DOI 10.1530/REP-11-0317; Young JS, 2009, BIOL REPROD, V80, P162, DOI 10.1095/biolreprod.108.070623; Young JS, 2009, BIOL REPROD, V80, P153, DOI 10.1095/biolreprod.108.070615; Yuan W, 2005, ASIAN J ANDROL, V7, P277, DOI 10.1111/j.1745-7262.2005.00040.x	73	16	17	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60656	10.1371/journal.pone.0060656	http://dx.doi.org/10.1371/journal.pone.0060656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565266	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300137
J	Sun, J; Li, YH; Graziani, GM; Filion, L; Allan, DS				Sun, Jie; Li, Yuhua; Graziani, Gina M.; Filion, Lionel; Allan, David S.			E-Selectin Mediated Adhesion and Migration of Endothelial Colony Forming Cells Is Enhanced by SDF-1 alpha/CXCR4	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; PROGENITOR CELLS; GENE-EXPRESSION; POSTNATAL NEOVASCULARIZATION; MOBILIZATION; STEM; RECRUITMENT; ALPHA; SDF-1; ERYTHROPOIETIN	Objective: Endothelial-colony forming cells (ECFCs) can be readily expanded from human umbilical cord blood and can facilitate repair of endothelial injury. E-selectin and SDF-1 alpha are produced following endothelial injury and can regulate endothelial progenitor homing. Mechanisms of vascular repair specific to the mode of injury have not been well described in homogenous cell populations such as ECFCs and are needed for development of more effective vascular repair strategies. Methods and Results: Lipopolysaccharide (LPS)-induced endotoxic injury to mature human umbilical vein endothelial cells (HUVEC) was compared with hypoxic and radiation injury. E-selectin expression in HUVEC cells is markedly increased (208-fold) following LPS-induced injury and facilitates increased ECFC adhesion and migration function in vitro. SDF-1 alpha expression remains unchanged in LPS-treated HUVEC cells but increases more than 2 fold in fibroblasts undergoing similar endotoxic injury. SDF-1 alpha induces expression of E-selectin ligands on ECFCs and facilitates greater E-selectin-mediated adhesion and migration of ECFCs in a CXCR4-dependent manner. Induction of E-selectin expression in HUVECs following hypoxic or radiation injury is negligible, however, while SDF-1 alpha is increased markedly following hypoxia, highlighting injury-specific synergism between mediators of vascular repair. Conclusion: E-selectin mediates adhesion and migration of ECFCs following endotoxic endothelial injury. SDF-1 alpha augments E-selectin mediated ECFC adhesion and migration in a CXCR4-dependent manner.	[Sun, Jie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Jie; Li, Yuhua; Allan, David S.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON, Canada; [Graziani, Gina M.; Filion, Lionel; Allan, David S.] Univ Ottawa, Dept Biochem, Ottawa, ON, Canada; [Graziani, Gina M.; Filion, Lionel; Allan, David S.] Univ Ottawa, Dept Microbiol, Ottawa, ON, Canada; [Graziani, Gina M.; Filion, Lionel; Allan, David S.] Univ Ottawa, Dept Immunol, Ottawa, ON, Canada; [Allan, David S.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	Zhejiang University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa	Allan, DS (corresponding author), Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON, Canada.	daallan@ohri.ca	Li, yu/HHZ-5236-2022; SUN, JIE/AAC-3145-2022	Allan, David/0000-0003-3261-8289	National Natural Science Foundation of China [30600256]; Ottawa Hospital Foundation Blood and Marrow Transplantation Research and Education Fund; Canadian Institutes of Health Research; Department of Medicine, University of Ottawa	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ottawa Hospital Foundation Blood and Marrow Transplantation Research and Education Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Department of Medicine, University of Ottawa	The authors gratefully acknowledge funding for a research stipend (to JS) provided by the National Natural Science Foundation of China (Project No. 30600256), and The Ottawa Hospital Foundation Blood and Marrow Transplantation Research and Education Fund (to JS). DSA is a recipient of a New Investigator Award from the Canadian Institutes of Health Research and is supported by the Department of Medicine, University of Ottawa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bahlmann FH, 2003, KIDNEY INT, V64, P1648, DOI 10.1046/j.1523-1755.2003.00279.x; Beck GC, 2006, CLIN EXP IMMUNOL, V143, P523, DOI 10.1111/j.1365-2249.2006.03005.x; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Critser PJ, 2010, CURR OPIN ORGAN TRAN, V15, P68, DOI 10.1097/MOT.0b013e32833454b5; Duan HX, 2006, THROMB HAEMOSTASIS, V96, P807, DOI 10.1160/TH06-04-0199; Egan CG, 2008, DIABETOLOGIA, V51, P1296, DOI 10.1007/s00125-008-0939-6; Foubert P, 2007, J CLIN INVEST, V117, P1527, DOI 10.1172/JCI28338; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hristov M, 2007, THROMB HAEMOSTASIS, V98, P274, DOI 10.1160/TH07-03-0181; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Huo YQ, 2001, J CLIN INVEST, V108, P1307, DOI 10.1172/JCI12877; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Inoue T, 2007, CIRCULATION, V115, P553, DOI 10.1161/CIRCULATIONAHA.106.621714; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Lemoli RM, 2006, STEM CELLS, V24, P2817, DOI 10.1634/stemcells.2006-0333; Lerman OZ, 2010, BLOOD, V116, P3669, DOI 10.1182/blood-2009-03-213629; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Lipsic E, 2006, CARDIOVASC DRUG THER, V20, P135, DOI 10.1007/s10557-006-7680-5; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Liu ZJ, 2010, ANN SURG, V252, P625, DOI 10.1097/SLA.0b013e3181f5a079; Lush CW, 2000, AM J PHYSIOL-HEART C, V278, pH853, DOI 10.1152/ajpheart.2000.278.3.H853; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; Magder S, 2006, J VASC RES, V43, P447, DOI 10.1159/000095162; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Mizuno K, 2005, CLIN EXP IMMUNOL, V139, P490, DOI 10.1111/j.1365-2249.2005.02721.x; Nonaka-Sarukawa M, 2007, INT J CARDIOL, V119, P344, DOI 10.1016/j.ijcard.2006.07.191; Oh IY, 2007, BLOOD, V110, P3891, DOI 10.1182/blood-2006-10-048991; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Perros F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-125; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Riederer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015339; Rohde E, 2007, STEM CELLS, V25, P1746, DOI 10.1634/stemcells.2006-0833; Sermsathanasawadi N, 2009, J RADIAT RES, V50, P469, DOI 10.1269/jrr.09036; Shao HW, 2008, STEM CELLS, V26, P1376, DOI 10.1634/stemcells.2007-0785; Shen L, 2012, MOL CELL BIOCHEM, V365, P1, DOI 10.1007/s11010-011-1083-z; Shepherd RM, 2006, BLOOD, V108, P3662, DOI 10.1182/blood-2006-06-030577; Shioiri T, 2009, BBA-MOL BASIS DIS, V1792, P1011, DOI 10.1016/j.bbadis.2009.06.006; Smith C, 2006, J AM COLL CARDIOL, V48, P1591, DOI 10.1016/j.jacc.2006.06.060; Sobrino T, 2007, STROKE, V38, P2759, DOI 10.1161/STROKEAHA.107.484386; Stellos K, 2007, THROMB HAEMOSTASIS, V98, P922, DOI 10.1160/TH07-02-0147; Strunk D, 2011, CURR PHARM DESIGN, V17, P3245, DOI 10.2174/138161211797904127; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Walter DH, 2004, CIRCULATION, V110, P36, DOI 10.1161/01.CIR.0000133324.38115.0A; Wysocki SJ, 1996, J CELL BIOCHEM, V62, P303, DOI 10.1002/(SICI)1097-4644(199609)62:3<303::AID-JCB1>3.0.CO;2-V; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Youn SW, 2011, BLOOD, V117, P4376, DOI 10.1182/blood-2010-07-295964; Zheng H, 2007, J CARDIOVASC PHARM, V50, P274, DOI 10.1097/FJC.0b013e318093ec8f	56	17	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60890	10.1371/journal.pone.0060890	http://dx.doi.org/10.1371/journal.pone.0060890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565284	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300157
J	Lannes, N; Summerfield, A				Lannes, Nils; Summerfield, Artur			Regulation of Porcine Plasmacytoid Dendritic Cells by Cytokines	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; INTERFERON-PRODUCING CELLS; NECROSIS-FACTOR-ALPHA; PROSTAGLANDIN E-2; RECEPTOR; IDENTIFICATION; OPSONIZATION; ACTIVATION; ANTIBODIES; SWINE	Plasmacytoid dendritic cells (pDC) are the most potent producers of type-I interferon (IFN) and represent the main interferon (IFN)-alpha source in response to many viruses. Considering the important roles played by type I IFN's, not only as antiviral effectors but also as potent alarming cytokine of the immune system, we investigated how such responses are regulated by various cytokines. To this end, we stimulated enriched pDC in the presence or absence of particular cytokines with a strong activator, CpG DNA, or a weak activator of pDC, foot-and-mouth disease virus (FMDV). Alternatively, we pre-incubated pDC for 16 h before stimulation. The pro-inflammatory cytokines tested Interleukin (IL)-6, IL17A, tumour necrosis factor (TNF)-alpha did not influence IFN-alpha responses except TNF-alpha, which promoted responses induced by FMDV. The haematopoietic cytokines Fms-related tyrosine kinase 3 ligand (Flt3-L) and granulocyte-macrophage colony-stimulating factor (GM-CSF) had enhancing effects on pDC activation at least in one of the protocols tested. IFN-beta and IFN-gamma were the most potent at enhancing FMDV-induced IFN-alpha, up to 10-fold. Interestingly, also the Th2 cytokine IL-4 was an efficient promoter of pDC activity, while IL-10 was the only negative regulator of IFN-alpha in pDC identified. The cytokines enhancing IFN-alpha responses also promoted pDC survival in cell culture with the exception of GM-CSF. Taken together this work illustrates how the cytokine network can influence pDC activation, a knowledge of relevance for improving vaccines and therapeutic interventions during virus infections, cancers and autoimmune diseases in which pDC play a role.	[Lannes, Nils; Summerfield, Artur] Inst Virol & Immunoprophylaxis, Mittelhausern, Switzerland		Summerfield, A (corresponding author), Inst Virol & Immunoprophylaxis, Mittelhausern, Switzerland.	artur.summerfield@ivi.admin.ch	Summerfield, Artur/K-2105-2016; Summerfield, Artur/H-6025-2019	Summerfield, Artur/0000-0001-8292-4634; Summerfield, Artur/0000-0001-8292-4634; Lannes, Nils/0000-0002-2926-6182	EU FP7 project FMD-Disconvac [226556]; 3R Research Foundation Switzerland [11308]	EU FP7 project FMD-Disconvac; 3R Research Foundation Switzerland	This present work was supported by EU FP7 project FMD-Disconvac (grant agreement 226556) and 3R Research Foundation Switzerland (project 11308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmelli C, 2005, J LEUKOCYTE BIOL, V77, P923, DOI 10.1189/jlb.1204701; Bautista EM, 2007, VET IMMUNOL IMMUNOP, V115, P56, DOI 10.1016/j.vetimm.2006.09.010; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P439, DOI 10.1111/j.1365-2567.2009.03134.x; Calzada-Nova G, 2010, VET IMMUNOL IMMUNOP, V135, P20, DOI 10.1016/j.vetimm.2009.10.026; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Chinsangaram J, 2003, J VIROL, V77, P1621, DOI 10.1128/JVI.77.2.1621-1625.2003; Chinsangaram J, 2001, J VIROL, V75, P5498, DOI 10.1128/JVI.75.12.5498-5503.2001; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Contractor N, 2007, J IMMUNOL, V179, P2690, DOI 10.4049/jimmunol.179.5.2690; Fabricius D, 2010, J IMMUNOL, V184, P677, DOI 10.4049/jimmunol.0902028; Fiebach AR, 2011, J VIROL, V85, P8002, DOI 10.1128/JVI.00330-11; Gary-Gouy H, 2002, J INTERF CYTOK RES, V22, P653, DOI 10.1089/10799900260100132; Georg P, 2012, AUTOIMMUNITY; Grehan JF, 2005, J IMMUNOL, V175, P1903, DOI 10.4049/jimmunol.175.3.1903; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Guzylack-Piriou L, 2004, IMMUNOLOGY, V112, P28, DOI 10.1111/j.1365-2567.2004.01856.x; Guzylack-Piriou L, 2006, EUR J IMMUNOL, V36, P1674, DOI 10.1002/eji.200635866; Guzylack-Piriou L, 2010, DEV COMP IMMUNOL, V34, P455, DOI 10.1016/j.dci.2009.12.006; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Husser L, 2011, VIRUS RES, V159, P9, DOI 10.1016/j.virusres.2011.04.005; Lahoud MH, 2012, P NATL ACAD SCI USA, V109, P16270, DOI 10.1073/pnas.1208796109; Lannes N, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-64; Li L, 2008, J IMMUNOL, V180, P2951, DOI 10.4049/jimmunol.180.5.2951; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; MCCULLOUGH KC, 1982, ARCH VIROL, V74, P1, DOI 10.1007/BF01320777; MCCULLOUGH KC, 1988, IMMUNOLOGY, V65, P187; McCullough KC, 1999, IMMUNOLOGY, V98, P203, DOI 10.1046/j.1365-2567.1999.00867.x; Murtaugh MP, 2009, DEV COMP IMMUNOL, V33, P344, DOI 10.1016/j.dci.2008.06.014; Nfon CK, 2010, VIRAL IMMUNOL, V23, P29, DOI 10.1089/vim.2009.0078; Nishimori JH, 2012, INFECT IMMUN; Onai N, 2007, ANN NY ACAD SCI, V1106, P253, DOI 10.1196/annals.1392.015; Raymond CR, 2004, VACCINE, V22, P1016, DOI 10.1016/j.vaccine.2003.08.026; Reid E, 2011, J VIROL, V85, P4297, DOI 10.1128/JVI.02495-10; Ronnblom L, 2001, J EXP MED, V194, pF59, DOI 10.1084/jem.194.12.f59; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Son Y, 2006, IMMUNOLOGY, V119, P36, DOI 10.1111/j.1365-2567.2006.02402.x; Summerfield A, 2003, J IMMUNOL METHODS, V280, P113, DOI 10.1016/S0022-1759(03)00273-4; Summerfield A, 2003, IMMUNOLOGY, V110, P440, DOI 10.1111/j.1365-2567.2003.01755.x; Summerfield A, 2009, DEV COMP IMMUNOL, V33, P299, DOI 10.1016/j.dci.2008.05.005; VONNIEDERHAUSERN B, 1993, VET IMMUNOL IMMUNOP, V38, P57, DOI 10.1016/0165-2427(93)90113-I; Wang D, 2011, J VIROL, V85, P3758, DOI 10.1128/JVI.02589-10	41	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60893	10.1371/journal.pone.0060893	http://dx.doi.org/10.1371/journal.pone.0060893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577175	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000081
J	Spiess, M; de Craene, JO; Michelot, A; Rinaldi, B; Huber, A; Drubin, DG; Winsor, B; Friant, S				Spiess, Matthias; de Craene, Johan-Owen; Michelot, Alphee; Rinaldi, Bruno; Huber, Aline; Drubin, David G.; Winsor, Barbara; Friant, Sylvie			Lsb1 Is a Negative Regulator of Las17 Dependent Actin Polymerization Involved in Endocytosis	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; CLATHRIN-MEDIATED ENDOCYTOSIS; SACCHAROMYCES-CEREVISIAE; ARP2/3 COMPLEX; INTERNALIZATION STEP; BUDDING YEAST; I MYOSINS; SH3 DOMAIN; DYNAMICS; CYTOSKELETON	The spatial and temporal regulation of actin polymerization is crucial for various cellular processes. Members of the Wiskott-Aldrich syndrome protein (WASP) family activate the Arp2/3-complex leading to actin polymerization. The yeast Saccharomyces cerevisiae contains only one WASP homolog, Las17, that requires additional factors for its regulation. Lsb1 and Lsb2/Pin3 are two yeast homologous proteins bearing an SH3 domain that were identified as Las17-binding proteins. Lsb2/Pin3 that promotes prion induction was suggested to link this prion formation to the actin cytoskeleton. However, the cellular role of Lsb1 and the molecular function of both Lsb1 and Lsb2 remain unknown. In this study, we show that Lsb1 and/or Lsb2 full-length proteins inhibit Las17-mediated actin polymerization in vitro, Lsb2 being a less potent inhibitor of Las17 activity compared to Lsb1. Addition of Lsb1 or Lsb2 to the corresponding full-length Lsb1/2 further inhibits Las17 activity. Lsb1 and Lsb2 form homo-and hetero-oligomeric complexes suggesting that these two proteins could regulate Las17 activity via dimerization or cooperative binding. In vivo, overexpressed Lsb1 and Lsb2 proteins cluster Las17-CFP in few cytoplasmic punctate structures that are also positive for other Arp2/3-dependent actin polymerization effectors like Sla1 or Abp1. But, only Lsb1 overexpression blocks the internalization step of receptor-mediated endocytosis. This shows a specific function of Lsb1 in endocytosis.	[Spiess, Matthias; de Craene, Johan-Owen; Rinaldi, Bruno; Huber, Aline; Winsor, Barbara; Friant, Sylvie] Univ Strasbourg, Dept Mol & Cellular Genet, UMR7156, Strasbourg, France; [Spiess, Matthias; de Craene, Johan-Owen; Rinaldi, Bruno; Huber, Aline; Winsor, Barbara; Friant, Sylvie] CNRS, Strasbourg, France; [Michelot, Alphee; Drubin, David G.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California Berkeley	Friant, S (corresponding author), Univ Strasbourg, Dept Mol & Cellular Genet, UMR7156, Strasbourg, France.	S.Friant@unistra.fr	Friant, Sylvie/L-9244-2019; De Craene, Johan-Owen/J-6461-2019; Friant, Sylvie/F-5409-2019; Michelot, Alphee/C-8953-2014	Friant, Sylvie/0000-0002-5412-6288; De Craene, Johan-Owen/0000-0001-9654-2143; Friant, Sylvie/0000-0002-5412-6288; Michelot, Alphee/0000-0003-2023-8094	Marie Curie Research Training Network "Penelope" [MRTN-CT-2006-036076]; Agence National de la Recherche [ANR-07-PCV-0035, ANR-07-BLAN-0065]; CNRS [ATIP-CNRS 05-00932, ATIP-Plus 2008-3098]; Fondation Recherche Medicale [FRM INE20051105238, FRM-Comite Alsace 2006CX67-1]; Association pour la Recherche sur le Cancer [ARC JR/MLD/MDV-CR306/7901]; National Institutes of Health (NIH) [GM 1 R01 42759]	Marie Curie Research Training Network "Penelope"; Agence National de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation Recherche Medicale; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Marie Curie Research Training Network "Penelope" (MRTN-CT-2006-036076 to BW and MS), the Agence National de la Recherche (ANR-07-PCV-0035 to BW and ANR-07-BLAN-0065 to SF), the CNRS (ATIP-CNRS 05-00932 and ATIP-Plus 2008-3098 to SF), the Fondation Recherche Medicale (FRM INE20051105238 and FRM-Comite Alsace 2006CX67-1 to SF and FRM Postdoctoral fellowship to J-ODC), the Association pour la Recherche sur le Cancer (ARC JR/MLD/MDV-CR306/7901 to SF) and the National Institutes of Health (NIH) grant GM 1 R01 42759 to DGD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; Boettner DR, 2009, CURR BIOL, V19, P1979, DOI 10.1016/j.cub.2009.10.062; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; D'Agostino JL, 2005, GENETICS, V171, P35, DOI 10.1534/genetics.105.040634; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Galletta BJ, 2010, CURR OPIN BIOTECH, V21, P604, DOI 10.1016/j.copbio.2010.06.006; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Geli MI, 2000, EMBO J, V19, P4281, DOI 10.1093/emboj/19.16.4281; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kaminska J, 2011, EUR J CELL BIOL, V90, P1016, DOI 10.1016/j.ejcb.2011.08.002; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Kukulski W, 2012, CELL, V150, P508, DOI 10.1016/j.cell.2012.05.046; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; Madania A, 1999, MOL BIOL CELL, V10, P3521, DOI 10.1091/mbc.10.10.3521; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; MANDERS EMM, 1992, J CELL SCI, V103, P857; Martin AC, 2005, J CELL BIOL, V168, P315, DOI 10.1083/jcb.200408177; Merrifield CJ, 2004, TRENDS CELL BIOL, V14, P352, DOI 10.1016/j.tcb.2004.05.008; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Michelot A, 2010, CURR BIOL, V20, P1890, DOI 10.1016/j.cub.2010.10.016; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; SIKORSKI RS, 1989, GENETICS, V122, P19; Soulard A, 2002, MOL CELL BIOL, V22, P7889, DOI 10.1128/MCB.22.22.7889-7906.2002; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; Sun YD, 2006, DEV CELL, V11, P33, DOI 10.1016/j.devcel.2006.05.008; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Warren DT, 2002, J CELL SCI, V115, P1703; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71	48	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61147	10.1371/journal.pone.0061147	http://dx.doi.org/10.1371/journal.pone.0061147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577202	Green Published, gold			2022-12-27	WOS:000317898000105
J	Costa, DJ; Carvalho, RMD; Abbehusen, M; Teixeira, C; Pitombo, M; Trigo, J; Nascimento, F; Amorim, L; Abreu-Silva, AL; Cruz, MDP; Miranda, JC; Fukutani, K; de Oliveira, CI; Barral, A; Barral-Netto, M; Brodskyn, C				Costa, Dirceu Joaquim; de Araujo Carvalho, Rayssa M.; Abbehusen, Melissa; Teixeira, Clarissa; Pitombo, Maiana; Trigo, Joelma; Nascimento, Flavia; Amorim, Lucilene; Abreu-Silva, Ana Lucia; Pires Cruz, Maria do Socorro; Miranda, Jose Carlos; Fukutani, Kyoshi; de Oliveira, Camila I.; Barral, Aldina; Barral-Netto, Manoel; Brodskyn, Claudia			Experimental Infection of Dogs with Leishmania and Saliva as a Model to Study Canine Visceral Leishmaniasis	PLOS ONE			English	Article							SAND FLY SALIVA; ASYMPTOMATIC DOGS; IMMUNE-RESPONSE; IGG2 ANTIBODY; CUTANEOUS LEISHMANIASIS; PROTECTIVE IMMUNITY; VECTOR SALIVA; NATURAL MODEL; MURINE MODEL; INFANTUM	Background: Canine Visceral Leishmaniasis (CVL) is a zoonotic disease caused by Leishmania infantum, transmitted by the bite of Lutzomyia longipalpis sand flies. Dogs are the main domestic reservoir of the parasite. The establishment of an experimental model that partially reproduces natural infection in dogs is very important to test vaccine candidates, mainly regarding those that use salivary proteins from the vector and new therapeutical approaches. Methodology/Principal Findings: In this report, we describe an experimental infection in dogs, using intradermal injection of Leishmania infantum plus salivary gland homogenate (SGH) of Lutzomyia longipalpis. Thirty-five dogs were infected with 1 x 10(7) parasites combined with five pairs of Lutzomyia longipalpis salivary glands and followed for 450 days after infection and clinical, immunological and parasitological parameters were evaluated. Two hundred and ten days after infection we observed that 31,4% of dogs did not display detectable levels of anti-Leishmania antibodies but all presented different numbers of parasites in the lymph nodes. Animals with a positive xenodiagnosis had at least 3,35 x 10(5) parasites in their lymph nodes. An increase of IFN-gamma and IL-10 levels was detected during infection. Twenty two percent of dogs developed symptoms of CVL during infection. Conclusion: The infection model described here shows some degree of similarity when compared with naturally infected dogs opening new perspectives for the study of CVL using an experimental model that employs the combination of parasites and sand fly saliva both present during natural transmission.	[Costa, Dirceu Joaquim; de Araujo Carvalho, Rayssa M.; Abbehusen, Melissa; Teixeira, Clarissa; Pitombo, Maiana; Trigo, Joelma; Miranda, Jose Carlos; Fukutani, Kyoshi; de Oliveira, Camila I.; Barral, Aldina; Barral-Netto, Manoel; Brodskyn, Claudia] FIOCRUZ BA, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil; [Barral, Aldina; Barral-Netto, Manoel] Univ Fed Bahia, Fac Med, BR-41170290 Salvador, BA, Brazil; [Brodskyn, Claudia] Univ Fed Bahia, Inst Ciencias Saude, BR-41170290 Salvador, BA, Brazil; [Pires Cruz, Maria do Socorro; Brodskyn, Claudia] Univ Fed Piaui, Ctr Ciencias Agr, Dept Morfofisiol Vet, Teresina, Piaui, Brazil; [de Oliveira, Camila I.; Barral, Aldina; Barral-Netto, Manoel] Inst Invest Imunol, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal do Piaui	Brodskyn, C (corresponding author), FIOCRUZ BA, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.	brodskyn@bahia.fiocruz.br	Silva, Ana Lúcia Abreu/AAR-9739-2020; Miranda, Jose/HCI-6099-2022; Brodskyn, Cláudia/AAO-3288-2021; Barral, Aldina/B-4191-2009; CRUZ, MARIA S/AAD-9243-2020; de Oliveira, Camila I/B-4358-2009; Fukutani, Kiyoshi/N-7905-2016; Fukutani, Kiyoshi/T-1630-2019; Barral-Netto, Manoel/B-3904-2009; Nascimento, Flavia/F-8173-2016	Brodskyn, Cláudia/0000-0003-3367-5365; Barral, Aldina/0000-0002-7177-464X; de Oliveira, Camila I/0000-0002-7868-5164; Fukutani, Kiyoshi/0000-0003-2223-0918; Barral-Netto, Manoel/0000-0002-5823-7903; Nascimento, Flavia/0000-0001-9328-1806; Abreu-Silva, Ana Lucia/0000-0003-2167-3725	RENORBIO/CNPq [554753/2006-5]	RENORBIO/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was funded by RENORBIO/CNPq, number 554753/2006-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MAO, 2005, VET IMMUNOL IMMUNOP, V106, P151, DOI 10.1016/j.vetimm.2004.08.024; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Andrade BB, 2007, SCAND J IMMUNOL, V66, P122, DOI 10.1111/j.1365-3083.2007.01964.x; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Boggiatto PM, 2010, CLIN VACCINE IMMUNOL, V17, P267, DOI 10.1128/CVI.00456-09; Bourdoiseau G, 1997, VET IMMUNOL IMMUNOP, V59, P21, DOI 10.1016/S0165-2427(97)00072-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campino L, 2000, VET PARASITOL, V92, P269, DOI 10.1016/S0304-4017(00)00313-7; Cavalcanti MD, 2009, VET J, V182, P356, DOI 10.1016/j.tvjl.2008.05.018; Collin N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000441; DEPLAZES P, 1995, PARASITE IMMUNOL, V17, P451, DOI 10.1111/j.1365-3024.1995.tb00914.x; Dos-Santos WLC, 2008, VET IMMUNOL IMMUNOP, V123, P251, DOI 10.1016/j.vetimm.2008.02.004; DYE C, 1992, PARASITOLOGY, V105, P35, DOI 10.1017/S0031182000073662; Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125; Ferreira JFL, 2008, VACCINE, V26, P677, DOI 10.1016/j.vaccine.2007.11.044; Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; Leandro C, 2001, VET IMMUNOL IMMUNOP, V79, P273, DOI 10.1016/S0165-2427(01)00270-7; Lemesre JL, 2005, VACCINE, V23, P2825, DOI 10.1016/j.vaccine.2004.11.061; Lima HC, 1996, INFECT IMMUN, V64, P5442, DOI 10.1128/IAI.64.12.5442-5445.1996; Manna L, 2009, RES VET SCI, V87, P76, DOI 10.1016/j.rvsc.2008.12.009; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004; Nieto CG, 1999, VET IMMUNOL IMMUNOP, V67, P117, DOI 10.1016/S0165-2427(98)00213-X; PINELLI E, 1994, INFECT IMMUN, V62, P229, DOI 10.1128/IAI.62.1.229-235.1994; Pinelli E, 1999, IMMUNOGENETICS, V49, P696, DOI 10.1007/s002510050667; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Riera C, 1999, VET PARASITOL, V84, P33, DOI 10.1016/S0304-4017(99)00084-9; Roatt BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049780; Sanchez MA, 2004, AM J TROP MED HYG, V70, P618, DOI 10.4269/ajtmh.2004.70.618; Santos-Gomes GM, 2002, VET IMMUNOL IMMUNOP, V88, P21, DOI 10.1016/S0165-2427(02)00134-4; SCOTT P, 1987, J IMMUNOL, V139, P221; Sherlock IA, 1996, MEM I OSWALDO CRUZ, V91, P671, DOI 10.1590/S0074-02761996000600003; Silvestre R, 2007, J IMMUNOL, V179, P3161, DOI 10.4049/jimmunol.179.5.3161; Solano-Gallego L, 2001, VET PARASITOL, V102, P163, DOI 10.1016/S0304-4017(01)00527-1; Solano-Gallego L, 2000, VET PARASITOL, V90, P37, DOI 10.1016/S0304-4017(00)00223-5; Tafuri Wagner Luiz, 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P81, DOI 10.1590/S0036-46651996000200001; Tafuri WL, 2004, J IMMUNOL METHODS, V292, P17, DOI 10.1016/j.jim.2004.05.009; THEODOS CM, 1991, INFECT IMMUN, V59, P1592, DOI 10.1128/IAI.59.5.1592-1598.1991; Thiakaki M, 2005, MICROBES INFECT, V7, P760, DOI 10.1016/j.micinf.2005.01.013; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; Travi BL, 2001, AM J TROP MED HYG, V64, P119, DOI 10.4269/ajtmh.2001.64.119; Travi BL, 2009, AM J TROP MED HYG, V81, P994, DOI 10.4269/ajtmh.2009.09-0229; Vercosa BLA, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-45; Volpini AC, 2001, PARASITOL RES, V87, P1056; Zer R, 2001, INT J PARASITOL, V31, P810, DOI 10.1016/S0020-7519(01)00190-4	48	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60535	10.1371/journal.pone.0060535	http://dx.doi.org/10.1371/journal.pone.0060535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577121	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800061
J	Lawson, B; Clulow, S; Mahony, MJ; Clulow, J				Lawson, Bianca; Clulow, Simon; Mahony, Michael J.; Clulow, John			Towards Gene Banking Amphibian Maternal Germ Lines: Short-Term Incubation, Cryoprotectant Tolerance and Cryopreservation of Embryonic Cells of the Frog, Limnodynastes peronii	PLOS ONE			English	Article							ZEBRAFISH EMBRYOS; XENOPUS-LAEVIS; ICE NUCLEATION; BLASTOMERES; STAGE; PERMEABILITY; DANIO; RERIO; OPTIMIZATION; BLASTODERMS	Gene banking is arguably the best method available to prevent the loss of genetic diversity caused by declines in wild populations, when the causes of decline cannot be halted or reversed. For one of the most impacted vertebrate groups, the amphibians, gene banking technologies have advanced considerably, and gametes from the male line can be banked successfully for many species. However, cryopreserving the female germ line remains challenging, with attempts at cryopreserving oocytes unsuccessful due to their large size and yolk content. One possible solution is to target cryopreservation of early embryos that contain the maternal germ line, but consist of smaller cells. Here, we investigate the short term incubation, cryoprotectant tolerance, and cryopreservation of dissociated early embryonic cells from gastrulae and neurulae of the Striped Marsh Frog, Limnodynastes peronii. Embryos were dissociated and cells were incubated for up to 24 hours in various media. Viability of both gastrula and neurula cells remained high (means up to 40-60%) over 24 hours of incubation in all media, although viability was maintained at a higher level in Ca2+-free Simplified Amphibian Ringer; low speed centrifugation did not reduce cell viability. Tolerance of dissociated embryonic cells was tested for two cryoprotectants, glycerol and dimethyl sulphoxide; dissociated cells of both gastrulae and neurulae were highly tolerant to both-indeed, cell viability over 24 hours was higher in media containing low-to-medium concentrations than in equivalent cryoprotectant-free media. Viability over 24 hours was lower in concentrations of cryoprotectant higher than 10%. Live cells were recovered following cryopreservation of both gastrula and neurula cells, but only at low rates. Optimal cryodiluents were identified for gastrula and neurula cells. This is the first report of a slow cooling protocol for cryopreservation of amphibian embryonic cells, and sets future research directions for cryopreserving amphibian maternal germ lines.	[Lawson, Bianca; Clulow, Simon; Mahony, Michael J.; Clulow, John] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	University of Newcastle	Clulow, J (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	john.clulow@newcastle.edu.au	Moreira, Nei/AAK-1357-2020; CLULOW, SIMON/G-7821-2013	Moreira, Nei/0000-0002-9236-667X; Clulow, Simon/0000-0002-5700-6345; Clulow, John/0000-0001-8991-1449	University of Newcastle	University of Newcastle	This work was supported by the University of Newcastle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 1998, DEV BIOL, V198, P366, DOI 10.1006/dbio.1998.8906; Armitage WJ, 2000, CRYOBIOLOGY, V41, P58, DOI 10.1006/cryo.2000.2266; Bishop P. J., 2012, AMPHIBIAN EXTINCTION; Calvi SL, 1999, AQUAT LIVING RESOUR, V12, P71, DOI 10.1016/S0990-7440(99)80016-3; Calvi SL, 1998, CRYOBIOLOGY, V36, P255, DOI 10.1006/cryo.1998.2084; Cardona-Costa J, 2007, CRYOLETTERS, V28, P303; Clulow J., 1999, DECLINES DISAPPEARAN, P219; Clulow J, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-60; Dash SN, 2008, CURR STEM CELL RES T, V3, P277, DOI 10.2174/157488808786733999; Edwards DL, 2004, REPROD FERT DEVELOP, V16, P347, DOI 10.1071/RD02079; Faure S, 2005, DEV BIOL, V277, P472, DOI 10.1016/j.ydbio.2004.10.005; Fitzsimmons C, 2007, REPROD FERT DEVELOP, V19, P594, DOI 10.1071/RD06124; Gosner K. L., 1960, Herpetologica, V16, P183; Guenther JF, 2006, CRYOBIOLOGY, V52, P401, DOI 10.1016/j.cryobiol.2006.02.002; Hagedorn M, 1997, CRYOBIOLOGY, V34, P251, DOI 10.1006/cryo.1997.2002; Hagedorn M, 1998, BIOL REPROD, V59, P1240, DOI 10.1095/biolreprod59.5.1240; Hagedorn M, 2004, CRYOBIOLOGY, V49, P181, DOI 10.1016/j.cryobiol.2004.07.001; Hagedorn M, 1997, CRYOBIOLOGY, V34, P335, DOI 10.1006/cryo.1997.2014; HARVEY B, 1983, CRYOBIOLOGY, V20, P440, DOI 10.1016/0011-2240(83)90034-2; Higaki S, 2010, REPRODUCTION, V139, P733, DOI 10.1530/REP-09-0549; Hong N, 2012, STEM CELLS DEV, V21, P2333, DOI 10.1089/scd.2011.0630; Maya-Soriano MJ, 2012, BIOPRESERV BIOBANK, V10, P22, DOI [10.1089/bio.2011.0036, 10.1089/bio.2011.1013]; Kleinhans FW, 2006, CRYOBIOLOGY, V52, P128, DOI 10.1016/j.cryobiol.2005.10.008; Kusuda S, 2004, J EXP ZOOL PART A, V301A, P131, DOI 10.1002/jez.a.20017; Kusuda S, 2002, CRYOBIOLOGY, V45, P60, DOI 10.1016/S0011-2240(02)00106-2; Lermen D, 2009, MOL ECOL, V18, P1030, DOI 10.1111/j.1365-294X.2008.04062.x; Lin C, 2009, CRYOLETTERS, V30, P132; LIN S, 1992, P NATL ACAD SCI USA, V89, P4519, DOI 10.1073/pnas.89.10.4519; Mahony MJ, 2011, GUIDELINES MINIMISIN; McKinnell R. G., 1978, CLONING NUCL TRANSPL; Murray K., 2010, Ecology, V91, P1557, DOI 10.1890/09-1608.1; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; NILSSON EE, 1992, P NATL ACAD SCI USA, V89, P9425, DOI 10.1073/pnas.89.20.9425; Nilsson E, 1993, AQUAT LIVING RESOUR, V6, P77, DOI 10.1051/alr:1993009; NOMURA K, 1986, DEV GROWTH DIFFER, V28, P311; Routray P, 2010, AQUAC RES, V41, P579, DOI 10.1111/j.1365-2109.2009.02456.x; Rugh R, 1962, INDUCED BREEDING EXP, P91; Shoo LP, 2011, J APPL ECOL, V48, P487, DOI 10.1111/j.1365-2664.2010.01942.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Strussmann CA, 1999, CRYOBIOLOGY, V39, P252, DOI 10.1006/cryo.1999.2208; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; SZE LC, 1953, J EXP ZOOL, V122, P577, DOI 10.1002/jez.1401220311; Uteshev V., 2005, Russian Journal of Herpetology, V12, P233; Uteshev VK, 2002, BIOFIZIKA+, V47, P539; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; WALLACE RA, 1963, BIOCHIM BIOPHYS ACTA, V74, P495, DOI 10.1016/0006-3002(63)91392-1; Wang P, 2000, J EXP ZOOL, V287, P128, DOI 10.1002/1097-010X(20000701)287:2<128::AID-JEZ3>3.0.CO;2-G; Yamaha E, 1997, FISHERIES SCI, V63, P514, DOI 10.2331/fishsci.63.514; Yasui GS, 2011, J ANIM SCI, V89, P2380, DOI 10.2527/jas.2010-3633	49	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60760	10.1371/journal.pone.0060760	http://dx.doi.org/10.1371/journal.pone.0060760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577155	gold, Green Published			2022-12-27	WOS:000319109800097
J	Rieder, SR; Brunner, I; Daniel, O; Liu, B; Frey, B				Rieder, Stephan Raphael; Brunner, Ivano; Daniel, Otto; Liu, Bian; Frey, Beat			Methylation of Mercury in Earthworms and the Effect of Mercury on the Associated Bacterial Communities	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; LUMBRICUS-TERRESTRIS; PORCELLIO-SCABER; EISENIA-FOETIDA; REDUCTASE GENES; LONG-TERM; SOIL; GUT; RESISTANCE; METHYLMERCURY	Methylmercury compounds are very toxic for most organisms. Here, we investigated the potential of earthworms to methylate inorganic-Hg. We hypothesized that the anaerobic and nutrient-rich conditions in the digestive tracts of earthworm's promote the methylation of Hg through the action of their gut bacteria. Earthworms were either grown in sterile soils treated with an inorganic (HgCl2) or organic (CH3HgCl) Hg source, or were left untreated. After 30 days of incubation, the total-Hg and methyl-Hg concentrations in the soils, earthworms, and their casts were analyzed. The impact of Hg on the bacterial community compositions in earthworms was also studied. Tissue concentrations of methyl-Hg in earthworms grown in soils treated with inorganic-Hg were about six times higher than in earthworms grown in soils without Hg. Concentrations of methyl-Hg in the soils and earthworm casts remained at significantly lower levels suggesting that Hg was mainly methylated in the earthworms. Bacterial communities in earthworms were mostly affected by methyl-Hg treatment. Terminal-restriction fragments (T-RFs) affiliated to Firmicutes were sensitive to inorganic and methyl-Hg, whereas T-RFs related to Betaproteobacteria were tolerant to the Hg treatments. Sulphate-reducing bacteria were detected in earthworms but not in soils.	[Rieder, Stephan Raphael; Brunner, Ivano; Frey, Beat] Swiss Fed Res Inst WSL, Rhizosphere Proc Grp, Birmensdorf, Switzerland; [Rieder, Stephan Raphael] ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Daniel, Otto] Agroscope Changins Wadenswil, Ecotoxicol Grp, Wadenswil, Switzerland; [Liu, Bian] Columbia Univ, New York, NY USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Research Station Agroscope; Columbia University	Frey, B (corresponding author), Swiss Fed Res Inst WSL, Rhizosphere Proc Grp, Birmensdorf, Switzerland.	beat.frey@wsl.ch	Brunner, Ivano L./J-8661-2014; Frey, Beat/AAE-1745-2022	Brunner, Ivano L./0000-0003-3436-995X; Frey, Beat/0000-0002-6391-3574; Liu, Bian/0000-0001-9166-693X	Federal Office for the Environment [10-0022.PJ/K314-0658, 00.0365.PZ/K414-1024]	Federal Office for the Environment	Financial support was provided by the Federal Office for the Environment (10-0022.PJ/K314-0658 and 00.0365.PZ/K414-1024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkay T, 2005, ADV APPL MICROBIOL, V57, P1, DOI 10.1016/S0065-2164(05)57001-1; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Barkay T, 2010, ENVIRON MICROBIOL, V12, P2904, DOI 10.1111/j.1462-2920.2010.02260.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; BROWN GG, 1995, PLANT SOIL, V170, P209, DOI 10.1007/BF02183068; Chadhain SMN, 2006, ENVIRON MICROBIOL, V8, P1746, DOI 10.1111/j.1462-2920.2006.01114.x; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Dhillon A, 2003, APPL ENVIRON MICROB, V69, P2765, DOI 10.1128/AEM.69.5.2765-2772.2003; Drake HL, 2007, ANNU REV MICROBIOL, V61, P169, DOI 10.1146/annurev.micro.61.080706.093139; Drott A, 2007, ENVIRON SCI TECHNOL, V41, P2270, DOI 10.1021/es061724z; Ernst G, 2007, SOIL BIOL BIOCHEM, V39, P386, DOI 10.1016/j.soilbio.2006.07.020; Ernst G, 2008, ENVIRON POLLUT, V156, P1304, DOI 10.1016/j.envpol.2008.03.002; FAL, 1997, SCHRIFT FAL, V24; Frey B, 2008, ENVIRON MICROBIOL, V10, P1433, DOI 10.1111/j.1462-2920.2007.01556.x; Frey B, 2006, SOIL BIOL BIOCHEM, V38, P1745, DOI 10.1016/j.soilbio.2005.11.032; Frey B, 2011, APPL ENVIRON MICROB, V77, P6060, DOI 10.1128/AEM.05206-11; Hinton J.J., 2002, GEOCHEM-EXPLOR ENV A, V2, P269, DOI [10.1144/1467-787302-031, DOI 10.1144/1467-787302-031]; Holloway JM, 2009, CHEM GEOL, V267, P85, DOI 10.1016/j.chemgeo.2009.03.031; Holtze MS, 2003, SOIL BIOL BIOCHEM, V35, P1175, DOI 10.1016/S0038-0717(03)00178-0; Horn MA, 2003, APPL ENVIRON MICROB, V69, P1662, DOI 10.1128/AEM.69.3.1662-1669.2003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ireland M.P., 1983, P247; Kizilkaya R, 2004, ECOL ENG, V22, P141, DOI 10.1016/j.ecoleng.2004.04.002; Klein M, 2001, J BACTERIOL, V183, P6028, DOI 10.1128/JB.183.20.6028-6035.2001; Knapp BA, 2009, SOIL BIOL BIOCHEM, V41, P2299, DOI 10.1016/j.soilbio.2009.08.011; Lapanje A, 2008, ENVIRON POLLUT, V153, P537, DOI 10.1016/j.envpol.2007.09.016; Lapanje A, 2007, ENVIRON TOXICOL CHEM, V26, P755, DOI 10.1897/06-099R.1; Lapanje A, 2010, ENVIRON POLLUT, V158, P3186, DOI 10.1016/j.envpol.2010.07.001; Limper U, 2008, J APPL ENTOMOL, V132, P168, DOI 10.1111/j.1439-0418.2007.01236.x; Liu B, 2012, ENVIRON POLLUT, V160, P109, DOI 10.1016/j.envpol.2011.09.023; Lock K, 2001, BIOL FERT SOILS, V34, P219, DOI 10.1007/s003740100392; Morel FMM, 1998, ANNU REV ECOL SYST, V29, P543, DOI 10.1146/annurev.ecolsys.29.1.543; Mosher JJ, 2012, AQUAT MICROB ECOL, V66, P271, DOI 10.3354/ame01563; Nechitaylo TY, 2009, ENVIRON MICROBIOL, V11, P1016, DOI 10.1111/j.1462-2920.2008.01837.x; Nevado JJB, 2008, ANAL CHIM ACTA, V608, P30, DOI 10.1016/j.aca.2007.12.001; Oregaard G, 2007, ISME J, V1, P453, DOI 10.1038/ismej.2007.56; PANDAZIS GEORG, 1931, ZENTRALBL BAKT I ABT ORIG, V120, P440; Peretyazhko T, 2006, SCI TOTAL ENVIRON, V364, P260, DOI 10.1016/j.scitotenv.2005.06.016; Philippot L, 2008, FEMS MICROBIOL LETT, V285, P51, DOI 10.1111/j.1574-6968.2008.01210.x; Pinel N, 2008, INT J SYST EVOL MICR, V58, P2147, DOI 10.1099/ijs.0.65174-0; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Ranjard L, 2006, APPL ENVIRON MICROB, V72, P1684, DOI 10.1128/AEM.72.2.1684-1687.2006; Rasmussen LD, 2008, APPL ENVIRON MICROB, V74, P3795, DOI 10.1128/AEM.00049-08; Rasmussen LD, 2001, FEMS MICROBIOL ECOL, V36, P1, DOI 10.1111/j.1574-6941.2001.tb00820.x; Razin S, 2007, B INSECTOL, V60, P101; Rieder SR, 2011, ENVIRON POLLUT, V159, P2861, DOI 10.1016/j.envpol.2011.04.040; ROBINSON JB, 1984, MICROBIOL REV, V48, P95, DOI 10.1128/MMBR.48.2.95-124.1984; Santillano D, 2010, APPL ENVIRON MICROB, V76, P5308, DOI 10.1128/AEM.03004-09; Schramm A, 2003, ENVIRON MICROBIOL, V5, P804, DOI 10.1046/j.1462-2920.2003.00474.x; Schroeder WH, 1998, ATMOS ENVIRON, V32, P809, DOI 10.1016/S1352-2310(97)00293-8; Schulze R, 1999, SYST APPL MICROBIOL, V22, P205, DOI 10.1016/S0723-2020(99)80067-8; Sellers P, 1996, NATURE, V380, P694, DOI 10.1038/380694a0; Shao DD, 2012, SCI TOTAL ENVIRON, V424, P331, DOI 10.1016/j.scitotenv.2011.09.042; Singleton DR, 2003, SOIL BIOL BIOCHEM, V35, P1547, DOI 10.1016/S0038-0717(03)00244-X; Sirand-Pugnet P, 2007, RES MICROBIOL, V158, P754, DOI 10.1016/j.resmic.2007.09.007; Skyllberg U, 2010, ENVIRON SCI TECHNOL, V44, P1254, DOI 10.1021/es902091w; SPANGLER WJ, 1973, SCIENCE, V180, P192, DOI 10.1126/science.180.4082.192; Swain EB, 2007, AMBIO, V36, P45, DOI 10.1579/0044-7447(2007)36[45:SCOMUA]2.0.CO;2; Tipping E, 2010, ENVIRON POLLUT, V158, P2465, DOI 10.1016/j.envpol.2010.03.027; Vishnivetskaya TA, 2011, APPL ENVIRON MICROB, V77, P302, DOI 10.1128/AEM.01715-10; Wagner M, 2005, METHOD ENZYMOL, V397, P469, DOI 10.1016/S0076-6879(05)97029-8; WALSH CT, 1988, FASEB J, V2, P124, DOI 10.1096/fasebj.2.2.3277886; Wiatrowski HA, 2006, ENVIRON SCI TECHNOL, V40, P6690, DOI 10.1021/es061046g; WILLEMS A, 1990, INT J SYST BACTERIOL, V40, P384, DOI 10.1099/00207713-40-4-384; Wust PK, 2011, ISME J, V5, P92, DOI 10.1038/ismej.2010.99; Yu RQ, 2010, FEMS MICROBIOL ECOL, V74, P655, DOI 10.1111/j.1574-6941.2010.00978.x; Zumsteg A, 2012, MICROB ECOL, V63, P552, DOI 10.1007/s00248-011-9991-8	67	31	33	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61215	10.1371/journal.pone.0061215	http://dx.doi.org/10.1371/journal.pone.0061215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577209	Green Published, gold			2022-12-27	WOS:000319109800131
J	Jensen, FH; Rocco, A; Mansur, RM; Smith, BD; Janik, VM; Madsen, PT				Jensen, Frants H.; Rocco, Alice; Mansur, Rubaiyat M.; Smith, Brian D.; Janik, Vincent M.; Madsen, Peter T.			Clicking in Shallow Rivers: Short-Range Echolocation of Irrawaddy and Ganges River Dolphins in a Shallow, Acoustically Complex Habitat	PLOS ONE			English	Article							SUNDARBANS MANGROVE FOREST; TRANSMISSION BEAM PATTERN; HIGH-FREQUENCY CLICKS; BOTTLE-NOSED-DOLPHIN; HARBOR PORPOISES; NARROW-BAND; LAGENORHYNCHUS-OBSCURUS; SOURCE PARAMETERS; TARGET DETECTION; SPERM-WHALES	Toothed whales (Cetacea, odontoceti) use biosonar to navigate their environment and to find and catch prey. All studied toothed whale species have evolved highly directional, high-amplitude ultrasonic clicks suited for long-range echolocation of prey in open water. Little is known about the biosonar signals of toothed whale species inhabiting freshwater habitats such as endangered river dolphins. To address the evolutionary pressures shaping the echolocation signal parameters of non-marine toothed whales, we investigated the biosonar source parameters of Ganges river dolphins (Platanista gangetica gangetica) and Irrawaddy dolphins (Orcaella brevirostris) within the river systems of the Sundarban mangrove forest. Both Ganges and Irrawaddy dolphins produced echolocation clicks with a high repetition rate and low source level compared to marine species. Irrawaddy dolphins, inhabiting coastal and riverine habitats, produced a mean source level of 195 dB (max 203 dB) re 1 mu Pa-pp whereas Ganges river dolphins, living exclusively upriver, produced a mean source level of 184 dB (max 191) re 1 mu Pa-pp. These source levels are 1-2 orders of magnitude lower than those of similar sized marine delphinids and may reflect an adaptation to a shallow, acoustically complex freshwater habitat with high reverberation and acoustic clutter. The centroid frequency of Ganges river dolphin clicks are an octave lower than predicted from scaling, but with an estimated beamwidth comparable to that of porpoises. The unique bony maxillary crests found in the Platanista forehead may help achieve a higher directionality than expected using clicks nearly an octave lower than similar sized odontocetes.	[Jensen, Frants H.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Rocco, Alice; Mansur, Rubaiyat M.] Shonadanga RA, Bangladesh Cetacean Divers Project, Wildlife Conservat Soc, Khulna, Bangladesh; [Smith, Brian D.] Asian Freshwater & Coastal Cetacean Program, Wildlife Conservat Soc, Bronx, NY USA; [Janik, Vincent M.] Univ St Andrews, Sch Biol, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Madsen, Peter T.] Aarhus Univ, Dept Biosci, Aarhus, Denmark	Woods Hole Oceanographic Institution; Wildlife Conservation Society; University of St Andrews; Aarhus University	Jensen, FH (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	frants.jensen@gmail.com	Jensen, Frants H/G-3438-2013; Madsen, Peter T/K-5832-2013	Jensen, Frants H/0000-0001-8776-3606; Madsen, Peter T/0000-0002-5208-5259; Janik, Vincent/0000-0001-7894-0121	Danish Natural Science Foundation; PhD School of Aquatic Sciences, Denmark; Danish Council for Independent Research \ Natural Sciences; Wissenschaftskolleg Berlin; Natural Environment Research Council [smru10001] Funding Source: researchfish	Danish Natural Science Foundation(Danish Natural Science Research Council); PhD School of Aquatic Sciences, Denmark; Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Wissenschaftskolleg Berlin; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was made possible through the logistical and field support of the Bangladesh Cetacean Diversity Project of the Wildlife Conservation Society, and funded by frame grants from the Danish Natural Science Foundation to PTM. FHJ was supported by the PhD School of Aquatic Sciences, Denmark, and is currently funded by a postdoctoral fellowship from the Danish Council for Independent Research vertical bar Natural Sciences. VMJ was supported by a fellowship of the Wissenschaftskolleg Berlin. PTM was supported by frame grants from the Danish Natural Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Andersen S.H., 1976, Aquatic Mamm, V4, P56; Au W. W., 1993, SONAR DOLPHINS; AU WWL, 1974, J ACOUST SOC AM, V56, P1280, DOI 10.1121/1.1903419; Au WWL, 2004, ACOUST PHYS+, V50, P454, DOI 10.1134/1.1776224; AU WWL, 1983, J ACOUST SOC AM, V73, P1676, DOI 10.1121/1.389389; Au WWL, 2004, J ACOUST SOC AM, V115, P2307, DOI 10.1121/1.1690082; AU WWL, 1992, J ACOUST SOC AM, V92, P1822, DOI 10.1121/1.403838; Au WWL, 2003, J ACOUST SOC AM, V113, P598, DOI 10.1121/1.1518980; AU WWL, 1995, J ACOUST SOC AM, V98, P51, DOI 10.1121/1.413643; AU WWL, 1987, J ACOUST SOC AM, V82, P807, DOI 10.1121/1.395278; Au WWL, 1999, J ACOUST SOC AM, V106, P3699, DOI 10.1121/1.428221; Bahl R., 2007, OCEANS 2007, P1; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Berta A, 2005, MARINE MAMMALS; BRENOWITZ EA, 1982, BEHAV ECOL SOCIOBIOL, V10, P29, DOI 10.1007/BF00296393; Brinklov S, 2010, BEHAV ECOL SOCIOBIOL, V64, P1867, DOI 10.1007/s00265-010-0998-9; Cranford TW, 1996, J MORPHOL, V228, P223; FRASER FC, 1960, PROC R SOC SER B-BIO, V152, P62, DOI 10.1098/rspb.1960.0024; Griffin D.R., 1958, LISTENING DARK ACOUS; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; HERALD ES, 1969, SCIENCE, V166, P1408, DOI 10.1126/science.166.3911.1408; Jaquet N, 2001, J ACOUST SOC AM, V109, P2254, DOI 10.1121/1.1360718; Jefferson T., 2015, MARINE MAMMALS WORLD; Jensen FH, 2009, J EXP BIOL, V212, P1078, DOI 10.1242/jeb.025619; Johnson M, 2006, J EXP BIOL, V209, P5038, DOI 10.1242/jeb.02596; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; KADANE J, 1983, J ACOUST SOC AM, V74, P1059, DOI 10.1121/1.389940; Koblitz JC, 2012, J ACOUST SOC AM, V131, P2315, DOI 10.1121/1.3683254; Kyhn LA, 2010, J EXP BIOL, V213, P1940, DOI 10.1242/jeb.042440; Kyhn LA, 2012, J ACOUST SOC AM, V131, P550, DOI 10.1121/1.3662070; Kyhn LA, 2009, J ACOUST SOC AM, V125, P1783, DOI 10.1121/1.3075600; Li SH, 2005, J ACOUST SOC AM, V117, P3288, DOI 10.1121/1.1882945; Liu Y, 2010, CURR BIOL, V20, P1834, DOI 10.1016/j.cub.2010.09.008; Madsen PT, 2007, AQUAT BIOL, V1, P141, DOI 10.3354/ab00014; Madsen PT, 2007, DEEP-SEA RES PT I, V54, P1421, DOI 10.1016/j.dsr.2007.04.020; Madsen PT, 2004, J ACOUST SOC AM, V116, P1909, DOI 10.1121/1.1788726; Madsen PT, 2004, J EXP BIOL, V207, P1811, DOI 10.1242/jeb.00966; Madsen PT, 2002, BEHAV ECOL SOCIOBIOL, V53, P31, DOI 10.1007/s00265-002-0548-1; Madsen PT, 2002, J EXP BIOL, V205, P1899; Madsen PT, 2005, J ACOUST SOC AM, V117, P3952, DOI 10.1121/1.1921508; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; McBride A. F., 1956, DEEP-SEA RES, V54, P437, DOI [10.1016/0146-6313(56)90096-X, DOI 10.1016/0146-6313(56)90096-X, 10.1016/0146-6313(56)90096-X.]; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mohl B, 2003, J ACOUST SOC AM, V114, P1143, DOI 10.1121/1.1586258; Mohl B, 2000, J ACOUST SOC AM, V107, P638, DOI 10.1121/1.428329; Moore PW, 2008, J ACOUST SOC AM, V124, P3324, DOI 10.1121/1.2980453; Morisaka T, 2007, J EVOLUTION BIOL, V20, P1439, DOI 10.1111/j.1420-9101.2007.01336.x; Murchison A.E., 1980, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V28, P43; NORRIS KS, 1974, J ACOUST SOC AM, V56, P659, DOI 10.1121/1.1903305; Pilleri G., 1976, P11; Purves PE, 1974, INVEST CETACEA, V5, P13; Rasmussen MH, 2002, J ACOUST SOC AM, V111, P1122, DOI 10.1121/1.1433814; Reeves R.R., 1989, HDB MARINE MAMMALS, P69; Schnitzler Hans-Ulrich, 1998, P183; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schotten M., 2004, ECHOLOCATION BATS DO, P393; Searby A, 2003, P ROY SOC B-BIOL SCI, V270, P1765, DOI 10.1098/rspb.2003.2442; Smith BD, 2009, AQUAT CONSERV, V19, P209, DOI 10.1002/aqc.987; Smith BD, 2012, J MAR BIOL, V2012, P11; Smith BD, 2002, ENCY MARINE MAMMALS, P1208; Smith BD, 2006, MAR MAMMAL SCI, V22, P527, DOI 10.1111/j.1748-7692.2006.00041.x; Smith BD, 2010, ORYX, V44, P241, DOI 10.1017/S0030605309990159; SPIESBERGER JL, 1990, AM NAT, V135, P107, DOI 10.1086/285035; Stacey Pam J., 1997, Asian Marine Biology, V14, P195; Supin AY, 2008, J ACOUST SOC AM, V124, P648, DOI 10.1121/1.2918544; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; URICK RJ, 1962, J ACOUST SOC AM, V34, P547, DOI 10.1121/1.1918166; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Verfuss UK, 2009, J EXP BIOL, V212, P823, DOI 10.1242/jeb.022137; Villadsgaard A, 2007, J EXP BIOL, V210, P56, DOI 10.1242/jeb.02618; Wahlberg M, 2001, J ACOUST SOC AM, V109, P397, DOI 10.1121/1.1329619; Wahlberg M, 2011, J ACOUST SOC AM, V130, P3077, DOI 10.1121/1.3641434; Wahlberg M, 2011, J ACOUST SOC AM, V130, P2263, DOI 10.1121/1.3624822; Wang KX, 2005, J ACOUST SOC AM, V118, P1180, DOI 10.1121/1.1945487; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Webber M.A, 1994, MARINE MAMMALS WORLD; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	81	50	51	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59284	10.1371/journal.pone.0059284	http://dx.doi.org/10.1371/journal.pone.0059284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573197	Green Published, gold			2022-12-27	WOS:000318840100016
J	Oberoi, P; Jabulowsky, RA; Bahr-Mahmud, H; Wels, WS				Oberoi, Pranav; Jabulowsky, Robert A.; Baehr-Mahmud, Hayat; Wels, Winfried S.			EGFR-Targeted Granzyme B Expressed in NK Cells Enhances Natural Cytotoxicity and Mediates Specific Killing of Tumor Cells	PLOS ONE			English	Article							IN-VIVO; CYTOLYTIC ACTIVITY; LENTIVIRAL VECTOR; MEMBRANE-BINDING; PLASMA-MEMBRANE; KILLER-CELLS; CANCER-CELLS; DELIVERY; RECEPTOR; ACTIVATION	Natural killer (NK) cells are highly specialized effectors of the innate immune system that hold promise for adoptive cancer immunotherapy. Their cell killing activity is primarily mediated by the pro-apoptotic serine protease granzyme B (GrB), which enters targets cells with the help of the pore-forming protein perforin. We investigated expression of a chimeric GrB fusion protein in NK cells as a means to augment their antitumoral activity. For selective targeting to tumor cells, we fused the epidermal growth factor receptor (EGFR) peptide ligand transforming growth factor alpha (TGF alpha) to human pre-pro-GrB. Established human NKL natural killer cells transduced with a lentiviral vector expressed this GrB-TGF alpha (GrB-T) molecule in amounts comparable to endogenous wildtype GrB. Activation of the genetically modified NK cells by cognate target cells resulted in the release of GrB-T together with endogenous granzymes and perforin, which augmented the effector cells' natural cytotoxicity against NK-sensitive tumor cells. Likewise, GrB-T was released into the extracellular space upon induction of degranulation with PMA and ionomycin. Secreted GrB-T fusion protein displayed specific binding to EGFR-overexpressing tumor cells, enzymatic activity, and selective target cell killing in the presence of an endosomolytic activity. Our data demonstrate that ectopic expression of a targeted GrB fusion protein in NK cells is feasible and can enhance antitumoral activity of the effector cells.	[Oberoi, Pranav; Jabulowsky, Robert A.; Baehr-Mahmud, Hayat; Wels, Winfried S.] Chemotherapeut Forschungsinst, Frankfurt, Germany		Wels, WS (corresponding author), Chemotherapeut Forschungsinst, Georg Speyer Haus, Frankfurt, Germany.	wels@em.uni-frankfurt.de		Wels, Winfried/0000-0001-9858-3643	Deutsche Forschungsgemeinschaft (DFG) [WE 2589/2-1]; DFG Graduiertenkolleg [GRK1172]; LOEWE Center for Cell and Gene Therapy Frankfurt; Georg-Speyer-Haus; German Federal Ministry of Health (BMG); Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK); HMWK [III L 4- 518/17.004 (2010)]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Graduiertenkolleg(German Research Foundation (DFG)); LOEWE Center for Cell and Gene Therapy Frankfurt; Georg-Speyer-Haus; German Federal Ministry of Health (BMG); Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK); HMWK	This work was supported by Deutsche Forschungsgemeinschaft (DFG) grant WE 2589/2-1, DFG Graduiertenkolleg GRK1172, LOEWE Center for Cell and Gene Therapy Frankfurt, and institutional funds of the Georg-Speyer-Haus. The Georg-Speyer-Haus is funded jointly by the German Federal Ministry of Health (BMG) and the Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK). The LOEWE Center for Cell and Gene Therapy Frankfurt is funded by HMWK, reference number: III L 4- 518/17.004 (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; CHATILA T, 1989, J IMMUNOL, V143, P1283; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Cullen SP, 2010, CELL DEATH DIFFER, V17, P616, DOI 10.1038/cdd.2009.206; Dalken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014404; Dalken B, 2006, CELL DEATH DIFFER, V13, P576, DOI 10.1038/sj.cdd.4401773; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Gehrmann M, 2011, J IMMUNOL METHODS, V371, P8, DOI 10.1016/j.jim.2011.06.007; Giesubel U, 2006, BIOCHEM J, V394, P563, DOI 10.1042/BJ20050687; Groner B, 2004, CURR MOL MED, V4, P539, DOI 10.2174/1566524043360483; HENKART PA, 1984, J EXP MED, V160, P75, DOI 10.1084/jem.160.1.75; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Imai C, 2005, BLOOD, V106, P376, DOI 10.1182/blood-2004-12-4797; ISHIURA S, 1990, MOL IMMUNOL, V27, P803; Jabulowsky RA, 2012, BIOCONJUGATE CHEM, V23, P1567, DOI 10.1021/bc3000657; Kurschus FC, 2004, FEBS LETT, V562, P87, DOI 10.1016/S0014-5793(04)00187-5; Kurschus FC, 2008, P NATL ACAD SCI USA, V105, P13799, DOI 10.1073/pnas.0801724105; Kurschus FC, 2010, IMMUNOL REV, V235, P159, DOI 10.1111/j.0105-2896.2010.00894.x; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Liu YY, 2006, NEOPLASIA, V8, P125, DOI 10.1593/neo.05556; Liu YY, 2003, MOL CANCER THER, V2, P1341; Mahmud H, 2009, MOL CANCER THER, V8, P1526, DOI 10.1158/1535-7163.MCT-08-1149; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Muller T, 2008, CANCER IMMUNOL IMMUN, V57, P411, DOI 10.1007/s00262-007-0383-3; MURTHY U, 1987, ARCH BIOCHEM BIOPHYS, V252, P549, DOI 10.1016/0003-9861(87)90062-2; Pegram HJ, 2008, J IMMUNOL, V181, P3449, DOI 10.4049/jimmunol.181.5.3449; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Rosenblum MG, 2009, CURR PHARM DESIGN, V15, P2676, DOI 10.2174/138161209788923958; Sahm C, 2012, CANCER IMMUNOL IMMUN, V61, P1451, DOI 10.1007/s00262-012-1212-x; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Stahnke B, 2008, MOL CANCER THER, V7, P2924, DOI 10.1158/1535-7163.MCT-08-0554; Stewart SE, 2012, BBA-PROTEINS PROTEOM, V1824, P59, DOI 10.1016/j.bbapap.2011.05.020; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Uherek C, 2002, BLOOD, V100, P1265, DOI 10.1182/blood.V100.4.1265.h81602001265_1265_1273; von Minckwitz G, 2005, BREAST CANCER RES, V7, pR617, DOI 10.1186/bcr1264; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Wels W, 2004, CANCER IMMUNOL IMMUN, V53, P217, DOI 10.1007/s00262-003-0482-8; ZENKE M, 1990, P NATL ACAD SCI USA, V87, P3655, DOI 10.1073/pnas.87.10.3655; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	45	22	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e61267	10.1371/journal.pone.0061267	http://dx.doi.org/10.1371/journal.pone.0061267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573299	Green Published, Green Submitted, gold			2022-12-27	WOS:000318840100120
J	Zhao, Q; Yan, P; Wang, RF; Zhang, CL; Li, L; Yin, L				Zhao, Qian; Yan, Ping; Wang, Rong Fu; Zhang, Chun Li; Li, Ling; Yin, Lei			A Novel Tc-99m-Labeled Molecular Probe for Tumor Angiogenesis Imaging in Hepatoma Xenografts Model: A Pilot Study	PLOS ONE			English	Article							PEPTIDE; BINDING; BIODISTRIBUTION; CANCER	Introduction: Visualization of tumor angiogenesis using radionuclide targeting provides important diagnostic information. In previous study, we proved that an arginine-arginine-leucine (RRL) peptide should be a tumor endothelial cell specific binding sequence. The overall aim of this study was to evaluate whether Tc-99m-radiolabeled RRL could be noninvasively used for imaging of malignant tumors in vivo, and act as a new molecular probe targeting tumor angiogenesis. Methods: The RRL peptide was designed and radiosynthesized with Tc-99m by a one-step method. The radiolabeling efficiency and radiochemical purity were then characterized in vitro. Tc-99m-RRL was injected intravenously in HepG2 xenograft-bearing BALB/c nude mice. Biodistribution and in vivo imaging were performed periodically. The relationship between tumor size and %ID uptake of Tc-99m-RRL was also explored. Results: The labeling efficiencies of Tc-99m-RRL reached 76.9%+/- 64.5% (n = 6) within 30-60 min at room temperature, and the radiochemical purity exceeded 96% after purification. In vitro stability experiment revealed the radiolabeled peptide was stable. Biodistribution data showed that Tc-99m-RRL rapidly cleared from the blood and predominantly accumulated in the kidneys and tumor. The specific uptake of Tc-99m-RRL in tumor was significantly higher than that of unlabeled RRL blocking and free pertechnetate control test after injection (p<0.05). The ratio of the tumor-to-muscle exceeded 6.5, tumor-to-liver reached 1.98 and tumor-to-blood reached 1.95. In planar gamma imaging study, the tumors were imaged clearly at 2-6 h after injection of Tc-99m-RRL, whereas the tumor was not imaged clearly in blocking group. The tumor-to-muscle ratio of images with Tc-99m-RRL was comparable with that of F-18-FDG PET images. Immunohistochemical analysis verified the excessive vasculature of tumor. There was a linear relationship between the tumor size and uptake of Tc-99m-RRL with R-2 = 0.821. Conclusion: Tc-99m-RRL can be used as a potential candidate for visualization of tumor angiogenesis in malignant carcinomas.	[Zhao, Qian; Yan, Ping; Wang, Rong Fu; Zhang, Chun Li; Li, Ling; Yin, Lei] Peking Univ, Hosp 1, Dept Nucl Med, Beijing 100871, Peoples R China	Peking University	Wang, RF (corresponding author), Peking Univ, Hosp 1, Dept Nucl Med, Beijing 100871, Peoples R China.	rongfu_wang2003@yahoo.com.cn			Natural Science Foundation of China [NSFC 30870729, 81071183]; Ministry of Science and Technology of China [2011YQ030114, 2011YQ03011409]; Research Fund for the Medicine and Engineering of Peking University [BMU20120297]; Research Fund Key Laboratory of Radiopharmaceuticals (Beijing Normal University), Ministry of Education, Department of Chemistry, Beijing Normal University, Beijing, China [120201]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Research Fund for the Medicine and Engineering of Peking University; Research Fund Key Laboratory of Radiopharmaceuticals (Beijing Normal University), Ministry of Education, Department of Chemistry, Beijing Normal University, Beijing, China	This work was supported by grants from Natural Science Foundation of China (NSFC 30870729, 81071183) (http://www.nsfc.gov.cn/Portal0/default152.htm); Ministry of Science and Technology of China (project 2011YQ030114 and 2011YQ03011409)(http://www.most.gov.cn/eng/); Research Fund for the Medicine and Engineering of Peking University (Fund BMU20120297)(http://en.coe.pku.edu.cn/); and Research Fund Key Laboratory of Radiopharmaceuticals (Beijing Normal University), Ministry of Education, Department of Chemistry, Beijing Normal University, Beijing, China (120201)(http://radiopharm.bnu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr TM, 1998, EUR J NUCL MED, V25, P201, DOI 10.1007/s002590050216; Brown CK, 2000, ANN SURG ONCOL, V7, P743, DOI 10.1007/s10434-000-0743-0; Edwards WB, 2009, MOL IMAGING, V8, P101, DOI 10.2310/7290.2009.00014; Engle JW, 2012, MOL PHARMACEUT, V9, P1441, DOI 10.1021/mp300019c; Fan F, 2012, J ONCOL, V2012, DOI 10.1155/2012/281261; Fani M, 2006, ANTICANCER RES, V26, P431; Glunde K, 2007, TRENDS MOL MED, V13, P287, DOI 10.1016/j.molmed.2007.05.002; HP V, 1995, NUCL MED BIOL, V33, P325; Kim YH, 2011, SMALL, V7, P2052, DOI 10.1002/smll.201100927; Knight LC, 2007, NUCL MED BIOL, V34, P855, DOI 10.1016/j.nucmedbio.2007.03.014; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kume T, 2012, J ONCOL, V2012, DOI 10.1155/2012/204593; Larsen AK, 2011, PHARMACOL THERAPEUT, V131, P80, DOI 10.1016/j.pharmthera.2011.03.012; Li WW, 2012, J ONCOL, V2012, DOI 10.1155/2012/879623; Liu S, 2007, BIOCONJUGATE CHEM, V18, P438, DOI 10.1021/bc0603081; Liu SL, 2011, EUR J NUCL MED MOL I, V38, P1732, DOI 10.1007/s00259-011-1847-4; Lu X, 2012, CHINESE J CANCER RES, V24, P52, DOI 10.1007/s11670-012-0052-8; Lu X, 2011, J RADIOANAL NUCL CH, V290, P623, DOI 10.1007/s10967-011-1342-1; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Liu M, 2007, J NUCL MED, V48, P2028, DOI 10.2967/jnumed.107.042622; Nannuru Kalyan C, 2011, J Carcinog, V10, P40, DOI 10.4103/1477-3163.92308; Okarvi SM, 1999, NUCL MED COMMUN, V20, P1093, DOI 10.1097/00006231-199912000-00002; Pathuri G, 2012, BIOCONJUGATE CHEM, V23, P115, DOI 10.1021/bc200546b; Priyadarshani A, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-10; Rodriguez S, 2012, J ONCOL, V2012, DOI 10.1155/2012/141236; Saharinen P, 2011, TRENDS MOL MED, V17, P347, DOI 10.1016/j.molmed.2011.01.015; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Weller GER, 2005, CANCER RES, V65, P533; Yu MM, 2010, ANN NUCL MED, V24, P13, DOI 10.1007/s12149-009-0328-3; Zhou Y, 2011, THERANOSTICS, V1, P58, DOI 10.7150/thno/v01p0058	30	2	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e61043	10.1371/journal.pone.0061043	http://dx.doi.org/10.1371/journal.pone.0061043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573294	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100112
J	Bao, YL; Ye, ZF				Bao Yingling; Ye Zhengfang			Application of an Integrated Statistical Design for Optimization of Culture Condition for Ammonium Removal by Nitrosomonas europaea	PLOS ONE			English	Article							PLACKETT-BURMAN DESIGN; OXIDATION	Statistical methodology was applied to the optimization of the ammonium oxidation by Nitrosomonas europaea for biomass concentration (C-B), nitrite yield (Y-N) and ammonium removal (R-A). Initial screening by Plackett-Burman design was performed to select major variables out of nineteen factors, among which NH4Cl concentration (C-N), trace element solution (TES), agitation speed (AS), and fermentation time (T) were found to have significant effects. Path of steepest ascent and response surface methodology was applied to optimize the levels of the selected factors. Finally, multi-objective optimization was used to obtain optimal condition by compromise of the three desirable objectives through a combination of weighted coefficient method coupled with entropy measurement methodology. These models enabled us to identify the optimum operation conditions (C-N = 84.1 mM; TES = 0.74 ml; AS = 100 rpm and T = 78 h), under which C-B = 3.386x10(8) cells/ml; Y-N = 1.98 mg/mg and R-A = 97.76% were simultaneously obtained. The optimized conditions were shown to be feasible through verification tests.	[Bao Yingling; Ye Zhengfang] Peking Univ, Dept Environm Engn, Key Lab Water & Sediment Sci, Minist Educ, Beijing 100871, Peoples R China	Peking University	Ye, ZF (corresponding author), Peking Univ, Dept Environm Engn, Key Lab Water & Sediment Sci, Minist Educ, Beijing 100871, Peoples R China.	yezhengfang@iee.pku.edu.cn			National Natural Science Foundation of China; Japan Science and Technology Agency [20877001]; China Postdoctoral Science Foundation [2012M520122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China and Japan Science and Technology Agency (20877001)(http://isisn.nsfc.gov.cn/egrantweb/), China Postdoctoral Science Foundation (2012M520122 (http://res.chinapostdoctor.org.cn/Program/7e30ab7b-569c-4036-bc08-fb6418f6993a/3175153e-4370-4ea5-9727-cbfcb96b5492.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2008, BIOTECHNOL BIOENG, V100, P1078, DOI 10.1002/bit.21863; Ahn YH, 2006, PROCESS BIOCHEM, V41, P1709, DOI 10.1016/j.procbio.2006.03.033; Akikazu A, 2000, J BIOSCI BIOENG, V90, P654; Bao YL, 2011, BIORESOURCE TECHNOL, V102, P8077, DOI 10.1016/j.biortech.2011.05.078; Berube PM, 2007, J BACTERIOL, V189, P3935, DOI 10.1128/JB.01861-06; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Chapman BD, 2006, J MICROBIOL METH, V65, P96, DOI 10.1016/j.mimet.2005.06.013; CLARK C, 1967, J BACTERIOL, V93, P1309, DOI 10.1128/JB.93.4.1309-1315.1967; CLARK C, 1966, J BACTERIOL, V91, P367, DOI 10.1128/JB.91.1.367-373.1966; Cui R, 2005, BIOSENS BIOELECTRON, V20, P1788, DOI 10.1016/j.bios.2004.07.004; Datta S, 2009, J MANUF SYST, V28, P55, DOI 10.1016/j.jmsy.2009.08.001; Eaton A.D., 2005, STANDARD METHODS EXA, V21st; Gilch S, 2010, BIOMETALS, V23, P613, DOI 10.1007/s10534-010-9308-2; GROENEWEG J, 1994, WATER RES, V28, P2561, DOI 10.1016/0043-1354(94)90074-4; Guven D, 2009, PROCESS BIOCHEM, V44, P516, DOI 10.1016/j.procbio.2009.01.005; Gujer W, 2010, WATER RES, V44, P1, DOI 10.1016/j.watres.2009.08.038; Hommes NG, 2003, J BACTERIOL, V185, P6809, DOI 10.1128/JB.185.23.6809-6814.2003; Liu SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026825; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Naveena BJ, 2005, BIORESOURCE TECHNOL, V96, P485, DOI 10.1016/j.biortech.2004.05.020; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Schmidt I, 2004, J BACTERIOL, V186, P2781, DOI 10.1128/JB.186.9.2781-2788.2004; Stein LY, 1998, APPL ENVIRON MICROB, V64, P1514; SUZUKI I, 1970, BIOCHEM BIOPH RES CO, V39, P950, DOI 10.1016/0006-291X(70)90416-X; Wang SY, 2011, CHEMOSPHERE, V82, P565, DOI 10.1016/j.chemosphere.2010.10.007; Wankel SD, 2011, APPL ENVIRON MICROB, V77, P269, DOI 10.1128/AEM.01318-10; Yu R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-70; Zhou JY, 2011, J ENVIRON SCI, V23, P22, DOI 10.1016/S1001-0742(10)60369-5	28	5	5	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60322	10.1371/journal.pone.0060322	http://dx.doi.org/10.1371/journal.pone.0060322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565225	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300095
J	Fernandes, P; Santiago, VM; Rodrigues, AF; Tomas, H; Kremer, EJ; Alves, PM; Coroadinha, AS				Fernandes, Paulo; Santiago, Virginia M.; Rodrigues, Ana F.; Tomas, Helio; Kremer, Eric J.; Alves, Paula M.; Coroadinha, Ana S.			Impact of E1 and Cre on Adenovirus Vector Amplification: Developing MDCK CAV-2-E1 and E1-Cre Transcomplementing Cell Lines	PLOS ONE			English	Article							IN-VIVO; GENE-TRANSFER; TRANSGENE EXPRESSION; MEDIATED EXCISION; PACKAGING SIGNAL; PROTEIN; RECOMBINASE; DNA; TRANSFORMATION; INFECTION	Adenovirus vectors have been extensively studied through the manipulation of viral genome. However, little attention is being paid to their producer cell-lines; cells are selected according to virus yields, neglecting the expression profile of transcomplementing gene products underlying cell performance. This work evaluates the impact of E1 (E1A and E1B) and Cre recombinase levels in the production of E1-deleted and helper-dependent canine adenovirus type 2 (CAV-2) vectors using MDCK cells. E1A and E1B gene expression and Cre activity were evaluated in different cell clones and compared with the corresponding cell productivity and susceptibility to oxidative stress injury. CAV-2 production was proportional to E1A expression (the highest levels of E1A corresponding to productivities of 3000-5000 I.P./cell), while E1B prolonged host cell viability after infection, conferring protection against apoptosis. Cre recombinase counteracted E1B anti-apoptotic properties, however viral production was maintained under high levels of Cre. Yet, Cre recombinase side effects can be reduced using cell lines with lower Cre-activities, without compromising the excision efficiency of helper vector packaging signal. These results highlight the influence of transcomplementing gene products on CAV-2 producer cell line performance, and the ability to express high levels of E1A and E1B as an important feature for cell line establishment and high adenovirus titers.	[Fernandes, Paulo; Santiago, Virginia M.; Rodrigues, Ana F.; Tomas, Helio; Alves, Paula M.; Coroadinha, Ana S.] iBET, Oeiras, Portugal; [Fernandes, Paulo; Rodrigues, Ana F.; Tomas, Helio; Alves, Paula M.; Coroadinha, Ana S.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Kremer, Eric J.] Univ Montpellier I, CNRS, Inst Genet Mol Montpellier, Montpellier, France; [Kremer, Eric J.] Univ Montpellier 2, CNRS, Inst Genet Mol Montpellier, Montpellier, France	Universidade Nova de Lisboa; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Coroadinha, AS (corresponding author), iBET, Oeiras, Portugal.	avalente@itqb.unl.pt	Kremer, Eric J/D-3734-2013; Coroadinha, Ana/L-5693-2013; Alves, Paula M/C-1070-2008; Coroadinha, Ana/AAS-5733-2021; Kremer, EJ/P-9838-2019; Rodrigues, Ana Filipa/C-7769-2011	Coroadinha, Ana/0000-0001-9728-6890; Alves, Paula M/0000-0003-1445-3556; Kremer, EJ/0000-0001-6114-7530; Rodrigues, Ana Filipa/0000-0002-1705-3243; Antunes Tomas, Helio/0000-0001-9638-1087	Fundacao para a Ciencia e a Tecnologia (FCT) - Portugal [PTDC/BIO/69452/2006, PTDC/EBB-BIO/118615/2010]; European Community [222992 - BrainCAV]; FCT [SFRH/BD/70810/2010, SFRH/BD/48393/2008, SFRH/BD/79022/2011]; Institut National de la Sante et de la Recherche Medicale (Inserm) fellow	Fundacao para a Ciencia e a Tecnologia (FCT) - Portugal(Portuguese Foundation for Science and Technology); European Community(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Institut National de la Sante et de la Recherche Medicale (Inserm) fellow	This work was supported by the Fundacao para a Ciencia e a Tecnologia (FCT) - Portugal (through the projects PTDC/BIO/69452/2006 and PTDC/EBB-BIO/118615/2010) and by the European Community's Seventh Framework programme (FP7/2007-2013) under grant agreement no 222992 - BrainCAV. Paulo Fernandes, Ana F. Rodrigues and Helio Toma's are recipients of Ph.D. grants from FCT (SFRH/BD/70810/2010, SFRH/BD/48393/2008 and SFRH/BD/79022/2011, respectively). Eric J. Kremer is an Institut National de la Sante et de la Recherche Medicale (Inserm) fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Araujo FD, 2005, J VIROL, V79, P11382, DOI 10.1128/JVI.79.17.11382-11391.2005; Baker A, 2007, J VIROL, V81, P7034, DOI 10.1128/JVI.00029-07; Bangari DS, 2006, CURR GENE THER, V6, P215, DOI 10.2174/156652306776359478; BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401; BERK AJ, 1986, CANCER SURV, V5, P367; BERNARDS R, 1986, VIROLOGY, V150, P126, DOI 10.1016/0042-6822(86)90272-2; Blackford AN, 2009, J VIROL, V83, P4000, DOI 10.1128/JVI.02417-08; BRAMSON JL, 1995, CURR OPIN BIOTECH, V6, P590, DOI 10.1016/0958-1669(95)80097-2; Coroadinha AS, 2006, J BIOTECHNOL, V124, P457, DOI 10.1016/j.jbiotec.2006.01.037; Coroadinha AS, 2012, GENE THER; Curriel DT, 2002, ADENOVIRAL VECTORS G; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; Dormond E, 2009, J BIOTECHNOL, V142, P142, DOI 10.1016/j.jbiotec.2009.03.021; Dormond E, 2009, BIOTECHNOL ADV, V27, P133, DOI 10.1016/j.biotechadv.2008.10.003; Dormond E, 2009, BIOTECHNOL BIOENG, V102, P800, DOI 10.1002/bit.22113; Gallimore PH, 2001, ONCOGENE, V20, P7824, DOI 10.1038/sj.onc.1204913; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Henaff D, 2010, VIRULENCE, V1, P188, DOI 10.4161/viru.1.3.11379; HOUWELING A, 1980, VIROLOGY, V105, P537, DOI 10.1016/0042-6822(80)90054-9; Keriel A, 2006, J VIROL, V80, P1487, DOI 10.1128/JVI.80.3.1487-1496.2006; Klonjkowski B, 1997, HUM GENE THER, V8, P2103, DOI 10.1089/hum.1997.8.17-2103; Kovesdi I, 2010, VIRUSES-BASEL, V2, P1681, DOI 10.3390/v2081681; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Liao Y, 2007, ADV EXP MED BIOL, V608, P144; Lieber A, 1996, J VIROL, V70, P8944, DOI 10.1128/JVI.70.12.8944-8960.1996; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; MORAN E, 1993, CURR OPIN GENET DEV, V3, P63, DOI 10.1016/S0959-437X(05)80342-9; Ng P, 2002, J VIROL, V76, P4181, DOI 10.1128/JVI.76.9.4181-4189.2002; Paillard F, 1997, HUM GENE THER, V8, P2007, DOI 10.1089/hum.1997.8.17-2007; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Perreau M, 2005, J VIROL, V79, P14595, DOI 10.1128/JVI.79.23.14595-14605.2005; RAO L, 1992, P NATL ACAD SCI USA, V89, P7742, DOI 10.1073/pnas.89.16.7742; Rodrigues AF, 2011, BIOTECHNOL BIOENG, V108, P2623, DOI 10.1002/bit.23231; Salinas S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000442; Schmitz ML, 1996, MOL CELL BIOL, V16, P4052; SHIBATA R, 1989, VIROLOGY, V172, P460, DOI 10.1016/0042-6822(89)90188-8; Soudais C, 2003, FASEB J, V17, P391, DOI 10.1096/fj.03-0438fje; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Soudais C, 2001, MOL THER, V3, P631, DOI 10.1006/mthe.2001.0263; Thomas CE, 2001, MOL THER, V3, P36, DOI 10.1006/mthe.2000.0224; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; WHITE E, 1992, MOL CELL BIOL, V12, P2570, DOI 10.1128/MCB.12.6.2570; White E, 1998, SEMIN VIROL, V8, P505, DOI 10.1006/smvy.1998.0155; Yang YP, 1996, J VIROL, V70, P7209, DOI 10.1128/JVI.70.10.7209-7212.1996	45	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60342	10.1371/journal.pone.0060342	http://dx.doi.org/10.1371/journal.pone.0060342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565229	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300099
J	Friese, M; Binder, J; Luechinger, R; Boesiger, P; Rasch, B				Friese, Malte; Binder, Julia; Luechinger, Roger; Boesiger, Peter; Rasch, Bjoern			Suppressing Emotions Impairs Subsequent Stroop Performance and Reduces Prefrontal Brain Activation	PLOS ONE			English	Article							SELF-CONTROL; EGO-DEPLETION; COGNITIVE CONTROL; STRENGTH MODEL; GLUCOSE; CORTEX; WILLPOWER; TALAIRACH; FAILURE; MNI	Abundant behavioral evidence suggests that the ability to self-control is limited, and that any exertion of self-control will increase the likelihood of subsequent self-control failures. Here we investigated the neural correlates underlying the aftereffects of self-control on future control processes using functional magnetic resonance imaging (fMRI). An initial act of self-control (suppressing emotions) impaired subsequent performance in a second task requiring control (Stroop task). On the neural level, increased activity during emotion suppression was followed by a relative decrease in activity during the Stroop task in a cluster in the right lateral prefrontal cortex (PFC) including the dorsolateral prefrontal cortex (DLPFC), an area engaged in the effortful implementation of control. There was no reliable evidence for reduced activity in the medial frontal cortex (MFC) including the anterior cingulate cortex (ACC), which is involved in conflict detection processes and has previously also been implicated in self-control. Follow-up analyses showed that the detected cluster in the right lateral PFC and an area in the MFC were involved in both the emotion suppression task and the Stroop task, but only the cluster in the right lateral PFC showed reduced activation after emotion suppression during the Stroop task. Reduced activity in lateral prefrontal areas relevant for the implementation of control may be a critical consequence of prior self-control exertion if the respective areas are involved in both self-control tasks.	[Friese, Malte] Univ Saarland, Dept Psychol, Saarbrucken, Germany; [Binder, Julia; Rasch, Bjoern] Univ Zurich, Dept Psychol, Zurich, Switzerland; [Luechinger, Roger; Boesiger, Peter] Swiss Fed Inst Technol Zurich, Inst Biomed Engn, Zurich, Switzerland; [Luechinger, Roger; Boesiger, Peter] Univ Zurich, Zurich, Switzerland	Saarland University; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Friese, M (corresponding author), Univ Saarland, Dept Psychol, Saarbrucken, Germany.	malte.friese@uni-saarland.de; bjoern.rasch@uzh.ch	Luechinger, Roger/AAD-5192-2019; Friese, Malte/A-3788-2016; Rasch, Björn/A-3119-2015	Luechinger, Roger/0000-0002-7365-0421; Friese, Malte/0000-0003-0055-513X; Rasch, Björn/0000-0001-7607-3415	Voluntary Academic Society, Basel, Switzerland; Swiss National Science Foundation [100014_138630]	Voluntary Academic Society, Basel, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Voluntary Academic Society, Basel, Switzerland (http://www.fag-basel.ch/) to Malte Friese and Bjorn Rasch and by a grant from the Swiss National Science Foundation to Malte Friese and Bjorn Rasch (grant number 100014_138630; http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2008, CURR DIR PSYCHOL SCI, V17, P124, DOI 10.1111/j.1467-8721.2008.00561.x; Baumeister RF, 1996, PSYCHOL INQ, V7, P1, DOI 10.1207/s15327965pli0701_1; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2007, SOC PERSONAL PSYCHOL, V1, P115, DOI 10.1111/j.1751-9004.2007.00001.x; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Beedie CJ, 2012, PERS SOC PSYCHOL REV, V16, P143, DOI 10.1177/1088868311419817; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Cohen J.R., 2010, SELF CONTROL SOC MIN, P141, DOI [10.1093/acprof:oso/9780195391381.003.0008, DOI 10.1093/ACPROF:OSO/9780195391381.003.0008]; Demos KE, 2011, J COGNITIVE NEUROSCI, V23, P1952, DOI 10.1162/jocn.2010.21568; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; DeWall CN, 2007, J EXP SOC PSYCHOL, V43, P62, DOI 10.1016/j.jesp.2005.12.005; Duckworth AL, 2011, J RES PERS, V45, P259, DOI 10.1016/j.jrp.2011.02.004; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Freeman N, 2010, SOC PSYCHOL PERS SCI, V1, P175, DOI 10.1177/1948550609360421; Gailliot MT, 2007, PERS SOC PSYCHOL REV, V11, P303, DOI 10.1177/1088868307303030; Gailliot MT, 2007, J PERS SOC PSYCHOL, V92, P325, DOI 10.1037/0022-3514.92.2.325; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Govorun O, 2006, SOC COGNITION, V24, P111, DOI 10.1521/soco.2006.24.2.111; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hagger MS, 2013, PERS SOC PSYCHOL B, V39, P28, DOI 10.1177/0146167212459912; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; HOLM S, 1979, SCAND J STAT, V6, P65; Inzlicht M, 2007, PSYCHOL SCI, V18, P933, DOI 10.1111/j.1467-9280.2007.02004.x; Inzlicht M, 2012, PERSPECT PSYCHOL SCI, V7, P450, DOI 10.1177/1745691612454134; Job V, 2010, PSYCHOL SCI, V21, P1686, DOI 10.1177/0956797610384745; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knoch D, 2007, ANN NY ACAD SCI, V1104, P123, DOI 10.1196/annals.1390.004; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Kober H, 2010, P NATL ACAD SCI USA, V107, P14811, DOI 10.1073/pnas.1007779107; Kuehn S, 2011, PLOS ONE, V6; Kurzban R, 2010, EVOL PSYCHOL-US, V8, P244, DOI 10.1177/147470491000800208; Laird AR, 2010, NEUROIMAGE, V51, P677, DOI 10.1016/j.neuroimage.2010.02.048; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lang P. J., 2005, INT AFFECTIVE PICTUR; Lieberman M. D., 2007, FUNDAMENTALS SOCIAL, P290; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell JP, 2007, PSYCHOL SCI, V18, P292, DOI 10.1111/j.1467-9280.2007.01891.x; Molden DC, 2012, PSYCHOL SCI, V23, P1137, DOI 10.1177/0956797612439069; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Muraven M, 2003, PERS SOC PSYCHOL B, V29, P894, DOI 10.1177/0146167203029007008; Muraven M, 2006, J PERS SOC PSYCHOL, V91, P524, DOI 10.1037/0022-3514.91.3.524; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Richeson JA, 2003, NAT NEUROSCI, V6, P1323, DOI 10.1038/nn1156; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Sanders MA, 2012, PSYCHOL SCI, V23, P1470, DOI 10.1177/0956797612450034; Schmeichel BJ, 2003, J PERS SOC PSYCHOL, V85, P33, DOI 10.1037/0022-3514.85.1.33; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vohs K., 2016, HDB SELF REGULATION; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Wyland CL, 2003, NEUROPSYCHOLOGIA, V41, P1863, DOI 10.1016/j.neuropsychologia.2003.08.001	59	58	61	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60385	10.1371/journal.pone.0060385	http://dx.doi.org/10.1371/journal.pone.0060385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565239	Green Published, gold, Green Accepted			2022-12-27	WOS:000317717300109
J	Kim, HM; Kim, CS; Lee, JH; Jang, SJ; Hwang, JJ; Ro, S; Choi, J				Kim, Hyun Mi; Kim, Choung-Soo; Lee, Je-Hwan; Jang, Se Jin; Hwang, Jung Jin; Ro, Seonggu; Choi, Jene			CG0009, a Novel Glycogen Synthase Kinase 3 Inhibitor, Induces Cell Death through Cyclin D1 Depletion in Breast Cancer Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; THERAPEUTIC TARGET; KINASE-3-BETA; GLYCOGEN-SYNTHASE-KINASE-3-BETA; LEUKEMIA; PATHWAY; TRANSCRIPTION; INACTIVATION; EXPRESSION; APOPTOSIS	Glycogen synthase kinase 3 alpha/beta (GSK3 alpha/beta) is a constitutively active serine/threonine kinase involved in multiple physiological processes, such as protein synthesis, stem cell maintenance and apoptosis, and acts as a key suppressor of the Wnt-beta-catenin pathway. In the present study, we examined the therapeutic potential of a novel GSK3 inhibitor, CG0009, in the breast cancer cell lines, BT549, HS578T, MDA-MB-231, NCI/ADR-RES, T47D, MCF7 and MDA-MB-435, from the NCI-60 cancer cell line panel. Assessment of cytotoxicity, apoptosis and changes in estrogen-signaling proteins was performed using cell viability assays, Western blotting and quantitative real-time PCR. CG0009 enhanced the inactivating phosphorylation of GSK3 alpha at Ser21 and GSK3 beta at Ser9 and simultaneously decreased activating phosphorylation of GSK3 beta at Tyr216, and induced caspase-dependent apoptosis independently of estrogen receptor alpha (ER alpha) expression status, which was not observed with the other GSK3 inhibitors examined, including SB216763, kenpaullone and LiCl. CG0009 treatment (1 mu mol/L) completely ablated cyclin D1 expression in a time-dependent manner in all the cell lines examined, except T47D. CG0009 alone significantly activated p53, leading to relocation of p53 and Bax to the mitochondria. GSK3 inhibition by CG0009 led to slight upregulation of the beta-catenin target genes, c-Jun and c-Myc, but not cyclin D1, indicating that CG0009-mediated cyclin D1 depletion overwhelms the pro-survival signal of beta-catenin, resulting in cell death. Our findings suggest that the novel GSK3 inhibitor, CG0009, inhibits breast cancer cell growth through cyclin D1 depletion and p53 activation, and may thus offer an innovative therapeutic approach for breast cancers resistant to hormone-based therapy.	[Kim, Hyun Mi; Jang, Se Jin; Choi, Jene] Univ Ulsan, Dept Pathol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Kim, Choung-Soo] Univ Ulsan, Dept Urol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Lee, Je-Hwan] Univ Ulsan, Dept Hematol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Hwang, Jung Jin] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Kim, Hyun Mi; Kim, Choung-Soo; Lee, Je-Hwan; Jang, Se Jin; Hwang, Jung Jin; Choi, Jene] Asan Med Ctr, Inst Innovat Canc Res, Seoul, South Korea; [Ro, Seonggu] CrystalGenomics Inc, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Choi, J (corresponding author), Univ Ulsan, Dept Pathol, Asan Med Ctr, Coll Med, Seoul, South Korea.	jenec@amc.seoul.kr	Hwang, Jung Jin/F-3424-2014		Korea Health 21 R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea [A062254]; Mid-career Researcher Program through an NRF grant; MEST [2009-0081016]; Asan Institute for Life Science [2003-309]	Korea Health 21 R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Mid-career Researcher Program through an NRF grant(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Asan Institute for Life Science	This work was supported by a grant (A062254) from the Korea Health 21 R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea, the Mid-career Researcher Program through an NRF grant funded by the MEST (No. 2009-0081016), and a grant from the Asan Institute for Life Science (2003-309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanious H, 2010, HUM PATHOL, V41, P1657, DOI 10.1016/j.humpath.2010.04.015; Bilim V, 2009, BRIT J CANCER, V101, P2005, DOI 10.1038/sj.bjc.6605437; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Grisouard J, 2007, MOL ENDOCRINOL, V21, P2427, DOI 10.1210/me.2007-0129; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Holmes T, 2008, CURR MED CHEM, V15, P1493, DOI 10.2174/092986708784638834; Johnson N, 2008, BREAST CANCER RES TR, V111, P55, DOI 10.1007/s10549-007-9758-6; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Kunnimalaiyaan M, 2007, MOL CANCER THER, V6, P1151, DOI 10.1158/1535-7163.MCT-06-0665; Kwek SS, 2009, ONCOGENE, V28, P1892, DOI 10.1038/onc.2009.34; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rivest P, 2011, CHEM-BIOL INTERACT, V189, P177, DOI 10.1016/j.cbi.2010.11.008; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Tan J, 2005, CANCER RES, V65, P9012, DOI 10.1158/0008-5472.CAN-05-1226; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Watcharasit P, 2003, J BIOL CHEM, V278, P48872, DOI 10.1074/jbc.M305870200; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	30	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60383	10.1371/journal.pone.0060383	http://dx.doi.org/10.1371/journal.pone.0060383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565238	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300108
J	Long, WX; Zang, RG; Ding, Y; Huang, YF				Long, Wenxing; Zang, Runguo; Ding, Yi; Huang, Yunfeng			Effects of Competition and Facilitation on Species Assemblage in Two Types of Tropical Cloud Forest	PLOS ONE			English	Article							STRESS-GRADIENT HYPOTHESIS; POSITIVE INTERACTIONS; PLANT COMPETITION; SPATIAL-PATTERNS; HAINAN ISLAND; INTENSITY; DISTURBANCE; DIVERSITY; HETEROGENEITY; COMMUNITIES	Competition and facilitation between tree individuals are two kinds of non-random processes influencing the structure and functioning of forest communities, but how these two plant-plant interactions change along gradient of resources or environments remains very much a matter of debate. We developed a null model to test the size-distance regression, and assessed the effects of competition and facilitation (including interspecific interactions, intraspecific interactions and overall species interactions) on each adult tree species assemblage [diameter at breast height (dbh) >= 5 cm] across two types of tropical cloud forest with different environmental and resource regimes. The null model test revealed that 17% to 27% tree species had positive dbh-distance correlations while 11% to 19% tree species showed negative dbh-distance correlations within these two forest types, indicating that both competition and facilitation processes existed during the community assembly. The importance of competition for heterospecific species, and the intensity of competition for both heterospecific and overall species increased from high to low resources for all the shared species spanning the two forests. The importance of facilitation for conspecific and overall species, as well as that the intensity of facilitation for both heterospecific and conspecific species increased with increasing low air temperature stress for all the shared species spanning the two forests. Our results show that both competition and facilitation processes simultaneously affect parts of species assemblage in the tropical cloud forests. Moreover, the fact that nearly 50% species assemblage is not detected with our approaches suggest that tree species in these tropical forest systems are assembled with multiple ecological processes, and that there is a need to explore the processes other than the two biotic interactions in further researches.	[Long, Wenxing] Hainan Univ, Coll Hort & Landscape Agr, Minist Educ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Haikou, Peoples R China; [Long, Wenxing; Zang, Runguo; Ding, Yi; Huang, Yunfeng] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Key Lab Forest Ecol & Environm, State Forestry Adm, Beijing, Peoples R China	Hainan University; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Zang, RG (corresponding author), Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Key Lab Forest Ecol & Environm, State Forestry Adm, Beijing, Peoples R China.	zangrung@caf.ac.cn	Ding, Yi/HDN-1663-2022; Long, Wenxing/P-1440-2018	Zang, Runguo/0000-0001-5392-8193; Long, Wenxing/0000-0002-9195-5878	National Natural Science Foundation of China [30430570, 31260109]; Hainan University Science Foundation for Youths [qnjj1161]; Scientific Research Foundation of Hainan University [kyqd1201]; Natural Science Foundation of Hainan Province [312064]; Educational Commission of Hainan Province of China [Hjkj2012-03]; State key subject of Botany at Hainan University [071001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hainan University Science Foundation for Youths; Scientific Research Foundation of Hainan University; Natural Science Foundation of Hainan Province; Educational Commission of Hainan Province of China; State key subject of Botany at Hainan University	This work was supported by the National Natural Science Foundation of China (30430570 and 31260109), by the Hainan University Science Foundation for Youths (qnjj1161), by Scientific Research Foundation of Hainan University (kyqd1201), by the Natural Science Foundation of Hainan Province (312064), by Educational Commission of Hainan Province of China (key project Hjkj2012-03), and by the State key subject of Botany at Hainan University (071001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH M., 1997, WCMC BIODIVERSITY B, V2, P1; Armas C, 2011, J VEG SCI, V22, P818, DOI 10.1111/j.1654-1103.2011.01301.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Boughton EH, 2011, J ECOL, V99, P1263, DOI 10.1111/j.1365-2745.2011.01850.x; Brooker RW, 2008, J ECOL, V96, P703, DOI 10.1111/j.1365-2745.2008.01373.x; Bubb P., 2004, CLOUD FOREST AGENDA; Cahill JF, 1999, ECOLOGY, V80, P466, DOI 10.1890/0012-9658(1999)080[0466:FEOIBA]2.0.CO;2; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Carlyle CN, 2010, J VEG SCI, V21, P1025, DOI 10.1111/j.1654-1103.2010.01207.x; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Dhondt AA, 2010, J ANIM ECOL, V79, P257, DOI 10.1111/j.1365-2656.2009.01624.x; DITOMMASO A, 1991, J VEG SCI, V2, P513, DOI 10.2307/3236033; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; Freckleton RP, 2009, J ECOL, V97, P379, DOI 10.1111/j.1365-2745.2009.01497.x; Gardner RH, 2008, PERSPECT PLANT ECOL, V9, P211, DOI 10.1016/j.ppees.2007.08.003; Gaucherand S, 2006, J VEG SCI, V17, P455, DOI 10.1111/j.1654-1103.2006.tb02466.x; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; Gotelli NJ, 1996, NULL MODELS ECOLOGY; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; Hamilton LS, 2000, IHP HUMID TROPICS PR, V13; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Holt AR, 2004, J ANIM ECOL, V73, P841, DOI 10.1111/j.0021-8790.2004.00862.x; Holz I, 2002, BRYOLOGIST, V105, P334, DOI 10.1639/0007-2745(2002)105[0334:BDMDAD]2.0.CO;2; HU YJ, 1992, TROPICAL RAIN FOREST; Hubbell Stephen P., 2001, V32, pi; Keddy PA, 2007, PLANTS AND VEGETATION: ORIGINS, PROCESSES, CONSEQUENCES, P1, DOI 10.1017/CBO9780511812989; Kikvidze Z, 2011, TRENDS ECOL EVOL, V26, P383, DOI 10.1016/j.tree.2011.04.003; Long Wen-Xing, 2011, Chinese Journal of Plant Ecology, V35, P137, DOI 10.3724/SP.J.1258.2011.00137; Long WX, 2011, FLORA, V206, P896, DOI 10.1016/j.flora.2011.05.007; Long WX, 2011, OECOLOGIA, V167, P1103, DOI 10.1007/s00442-011-2050-9; LONSDALE WM, 1983, J ECOL, V71, P285, DOI 10.2307/2259977; Maestre FT, 2009, OIKOS, V118, P1015, DOI 10.1111/j.1600-0706.2009.17362.x; PIELOU EC, 1962, J ECOL, V50, P357, DOI 10.2307/2257448; R Core Team, 2021, R LANGUAGE ENV STAT; Rajaniemi TK, 2012, PERSPECT PLANT ECOL, V14, P373, DOI 10.1016/j.ppees.2012.09.004; Roiloa SR, 2006, ANN BOT-LONDON, V98, P1043, DOI 10.1093/aob/mcl185; Schamp BS, 2009, OIKOS, V118, P564, DOI 10.1111/j.1600-0706.2009.16589.x; Seidl R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033301; Shackleton C, 2002, PLANT ECOL, V158, P65, DOI 10.1023/A:1014795505362; Tilman D, 1987, FUNCT ECOL, V1, P304, DOI 10.2307/2389785; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1988; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; WELDEN CW, 1986, Q REV BIOL, V61, P23, DOI 10.1086/414724; Wundrow EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048444; Zang RG, 2005, ACTA OECOL, V28, P39, DOI 10.1016/j.actao.2005.02.001; Zhang H.D., 1998, FLORA REIPUBLICAE PO, P3	51	10	13	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60252	10.1371/journal.pone.0060252	http://dx.doi.org/10.1371/journal.pone.0060252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565209	gold, Green Submitted, Green Published			2022-12-27	WOS:000317717300078
J	Wang, L; Wang, M; Wang, SY; Qi, TY; Guo, LJ; Li, JJ; Qi, WJ; Ampah, KK; Ba, XQ; Zeng, XL				Wang, Ling; Wang, Min; Wang, Shuyan; Qi, Tianyang; Guo, Lijing; Li, Jinjiao; Qi, Wenjing; Ampah, Khamal Kwesi; Ba, Xueqing; Zeng, Xianlu			Actin Polymerization Negatively Regulates p53 Function by Impairing Its Nuclear Import in Response to DNA Damage	PLOS ONE			English	Article							WILD-TYPE P53; CELL-CYCLE; CANCER-CELLS; PROTEIN; PHOSPHORYLATION; DYNAMICS; EXPORT; LOCALIZATION; INHIBITION; APOPTOSIS	Actin, one of the most evolutionarily conservative proteins in eukaryotes, is distributed both in the cytoplasm and the nucleus, and its dynamics plays important roles in numerous cellular processes. Previous evidence has shown that actin interacts with p53 and this interaction increases in the process of p53 responding to DNA damage, but the physiological significance of their interaction remains elusive. Here, we show that DNA damage induces both actin polymerization and p53 accumulation. To further understand the implication of actin polymerization in p53 function, cells were treated with actin aggregation agent. We find that the protein level of p53 decrease. The change in p53 is a consequence of the polymeric actin anchoring p53 in the cytoplasm, thus impairing p53 nuclear import. Analysis of phosphorylation and ubiquitination of p53 reveals that actin polymerization promotes the p53 phosphorylation at Ser315 and reduces the stabilization of p53 by recruiting Aurora kinase A. Taken together, our results suggest that the actin polymerization serves as a negative modulator leading to the impairment of nuclear import and destabilization of p53. On the basis of our results, we propose that actin polymerization might be a factor participating in the process of orchestrating p53 function in response to DNA damage.	[Ba, Xueqing] NE Normal Univ, MOE, Key Lab Mol Epigenet, Changchun, Jilin, Peoples R China; NE Normal Univ, Inst Cytol & Genet, Changchun, Jilin, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Ba, XQ (corresponding author), NE Normal Univ, MOE, Key Lab Mol Epigenet, Changchun, Jilin, Peoples R China.	baxq755@nenu.edu.cn; zengx779@nenu.edu.cn		Ba, Xueqing/0000-0002-1075-5496	National Natural Science Foundation of China [90608021, 30971498, 31050015]; Program for Introducing Talents to Universities [B07017]; National Basic Research Program of China [2010 CB529704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Introducing Talents to Universities; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grant 90608021; 30971498; 31050015), the Program for Introducing Talents to Universities (B07017), and the National Basic Research Program of China (Grant 2010 CB529704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Asker C, 1999, BIOCHEM BIOPH RES CO, V265, P1, DOI 10.1006/bbrc.1999.1446; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BOSARI S, 1995, AM J PATHOL, V147, P790; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Carlsson AE, 2010, ANNU REV BIOPHYS, V39, P91, DOI 10.1146/annurev.biophys.093008.131207; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fogal V, 2005, EMBO J, V24, P2768, DOI 10.1038/sj.emboj.7600735; Gillotin S, 2010, CELL CYCLE, V9, P1390, DOI 10.4161/cc.9.7.11253; Hild G, 2010, CYTOSKELETON, V67, P609, DOI 10.1002/cm.20473; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jiang M, 2001, ONCOGENE, V20, P5449, DOI 10.1038/sj.onc.1204705; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Katsumoto T, 1995, BIOL CELL, V84, P167, DOI 10.1016/0248-4900(96)89426-3; Korwek Z, 2012, DNA REPAIR, V11, P864, DOI 10.1016/j.dnarep.2012.08.006; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li JQ, 2004, J CELL SCI, V117, P4673, DOI 10.1242/jcs.01339; Maciver SK, 2002, GENOME BIOL, V3; Marine JC, 2010, CELL DEATH DIFFER, V17, P191, DOI 10.1038/cdd.2009.183; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; May JA, 1998, PLATELETS, V9, P227, DOI 10.1080/09537109876744; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; MERCER WE, 1990, P NATL ACAD SCI USA, V87, P6166, DOI 10.1073/pnas.87.16.6166; Metcalfe S, 1999, ONCOGENE, V18, P2351, DOI 10.1038/sj.onc.1202559; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Ngoka LCM, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-30; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; SHAULSKY G, 1990, ONCOGENE, V5, P1707; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Sionov RV, 2001, MOL CELL BIOL, V21, P5869; Smart DJ, 2008, MUTAT RES-FUND MOL M, V641, P43, DOI 10.1016/j.mrfmmm.2008.03.005; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang XX, 2006, CELL RES, V16, P356, DOI 10.1038/sj.cr.7310046; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Yap DBS, 2004, CANCER RES, V64, P4749, DOI 10.1158/0008-5472.CAN-1305-2; Zuchero JB, 2012, MOL BIOL CELL, V23, P853, DOI 10.1091/mbc.E11-12-0992	52	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60179	10.1371/journal.pone.0060179	http://dx.doi.org/10.1371/journal.pone.0060179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565200	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300069
J	Xu, BX; Liu, CB; Wang, RM; Shao, MZ; Fu, LP; Li, YG; Tian, JH				Xu, Bai-xuan; Liu, Chang-bin; Wang, Rui-min; Shao, Ming-zhe; Fu, Li-ping; Li, Yun-gang; Tian, Jia-he			The Influence of Interpreters' Professional Background and Experience on the Interpretation of Multimodality Imaging of Pulmonary Lesions Using F-18-3 '-Deoxy-Fluorothymidine and F-18-Fluorodeoxyglucose PET/CT	PLOS ONE			English	Article							CT; TOMOGRAPHY; F-18-FDG; CANCER	Objective: Based on the results of a recently accomplished multicenter clinical trial for the incremental value of a dual-tracer (18F-FDG and 18F-FLT), dual-modality (PET and CT) imaging in the differential diagnosis of pulmonary lesions, we investigate some issues that might affect the image interpretation and result reporting. Methods: The images were read in two separate sessions. Firstly the images were read and reported by physician(s) of the imaging center on completion of each PET/CT scanning. By the end of MCCT, all images collected during the trial were reread by a collective of readers in an isolated, blinded, and independent way. Results: One hundred sixty two patients successfully passed the data verification and entered into the final analysis. The primary reporting result showed adding 18F-FDG image information did not change the clinical performance much in sensitivity, specifity and accuracy, but the ratio between SUVFLT and SUVFDG did help the differentiation efficacy among the three subgroups of patients. The collective reviewing result showed the diagnostic achievement varied with reading strategies. ANOVA indicated significant differences among F-18-FDG, F-18-FLT in SUV (F = 14.239, p = 0.004). CT had almost the same diagnostic performance as 18F-FLT. When the 18F-FDG, 18F- FLT and CT images read in pair, both diagnostic sensitivity and specificity improved. The best diagnostic figures were obtained in full-modality strategy, when dual-tracer PET worked in combination with CT. Conclusions: With certain experience and training both radiologists and nuclear physicians are qualified to read and to achieve the similar diagnostic accuracy in PET/CT study. Making full use of modality combination and selecting right criteria seems more practical than professional back ground and personal experience in the new hybrid imaging technology, at least when novel tracer or application is concerned.	[Xu, Bai-xuan; Liu, Chang-bin; Wang, Rui-min; Shao, Ming-zhe; Fu, Li-ping; Li, Yun-gang; Tian, Jia-he] Chinese Peoples Liberat Army Gen Hosp, Dept Nucl Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Tian, JH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Nucl Med, Beijing, Peoples R China.	jiahe_tian@yahoo.cn						[Anonymous], 2006, J NUCL MED, V47, p13N; Blodgett TM, 2006, SEMIN NUCL MED, V36, P157, DOI 10.1053/j.semnuclmed.2005.12.004; Fletcher JW, 2005, J NUCL MED, V46, P385; Glaser M, 2003, INT J ONCOL, V22, P253; Hsu AR, 2007, J NUCL MED, V48, P445; Jeong HS, 2007, J NUCL MED, V48, P1237, DOI 10.2967/jnumed.107.041350; Kim SK, 2007, J NUCL MED, V48, P214; Linden HM, 2006, J CLIN ONCOL, V24, P2793, DOI 10.1200/JCO.2005.04.3810; Ng S, 2007, J NUCL MED, V48, P547, DOI 10.2967/jnumed.106.037762; Osman MM, 2005, J NUCL MED, V46, P1352; Rajendran JG, 2007, J NUCL MED, V48, P855, DOI 10.2967/jnumed.107.039768; Rischin D, 2006, J CLIN ONCOL, V24, P2098, DOI 10.1200/JCO.2005.05.2878; Schoder H, 2005, J NUCL MED, V46, P1249; Taylor SA, 2004, EUR RADIOL, V14, P1025, DOI 10.1007/s00330-004-2262-z; Tian JH, 2008, J NUCL MED, V49, P186, DOI 10.2967/jnumed.107.044966; Wagner Jr HN, 2006, J NUCL MED, V47, p22N; Wagner Jr HN, 2006, J NUCL MED, V47, p17N; Yi CA, 2006, J NUCL MED, V47, P443	18	1	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60104	10.1371/journal.pone.0060104	http://dx.doi.org/10.1371/journal.pone.0060104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565188	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300057
J	Acin, C; Martin-Burriel, I; Monleon, E; Lyahyai, J; Pitarch, JL; Serrano, C; Monzon, M; Zaragoza, P; Badiola, JJ				Acin, Cristina; Martin-Burriel, Inmaculada; Monleon, Eva; Lyahyai, Jaber; Luis Pitarch, Jose; Serrano, Carmen; Monzon, Marta; Zaragoza, Pilar; Jose Badiola, Juan			Prion Protein Gene Variability in Spanish Goats. Inference through Susceptibility to Classical Scrapie Strains and Pathogenic Distribution of Peripheral PrPsc	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; NATURAL SCRAPIE; CYPRUS GOATS; POLYMORPHISMS; SHEEP; DIAGNOSIS; IDENTIFICATION; ASSOCIATION; RESISTANCE; MUTATION	Classical scrapie is a neurological disorder of the central nervous system (CNS) characterized by the accumulation of an abnormal, partially protease resistant prion protein (PrPsc) in the CNS and in some peripheral tissues in domestic small ruminants. Whereas the pathological changes and genetic susceptibility of ovine scrapie are well known, caprine scrapie has been less well studied. We report here a pathological study of 13 scrapie-affected goats diagnosed in Spain during the last 9 years. We used immunohistochemical and biochemical techniques to discriminate between classical and atypical scrapie and bovine spongiform encephalopathy (BSE). All the animals displayed PrPsc distribution patterns and western blot characteristics compatible with classical scrapie. In addition, we determined the complete open reading frame sequence of the PRNP in these scrapie-affected animals. The polymorphisms observed were compared with those of the herd mates (n = 665) and with the frequencies of healthy herds (n = 581) of native Spanish goats (Retinta, Pirenaica and Moncaina) and other worldwide breeds reared in Spain (Saanen, Alpine and crossbreed). In total, sixteen polymorphic sites were identified, including the known amino acid substitutions at codons G37V, G127S, M137I, I142M, H143R, R151H, R154H, R211Q, Q222K, G232W, and P240S, and new polymorphisms at codons G74D, M112T, R139S, L141F and Q215R. In addition, the known 42, 138 and 179 silent mutations were detected, and one new one is reported at codon 122. The genetic differences observed in the population studied have been attributed to breed and most of the novel polymorphic codons show frequencies lower than 5%. This work provides the first basis of polymorphic distribution of PRNP in native and worldwide goat breeds reared in Spain.	[Acin, Cristina; Monleon, Eva; Luis Pitarch, Jose; Monzon, Marta; Jose Badiola, Juan] Univ Zaragoza, Fac Vet, Ctr Invest Encefalopatias & Enfermedades Transmis, Zaragoza, Spain; [Martin-Burriel, Inmaculada; Lyahyai, Jaber; Serrano, Carmen; Zaragoza, Pilar] Univ Zaragoza, Fac Vet, Lab Genet Bioquim LAGENBIO, Zaragoza, Spain; [Monleon, Eva] Univ Zaragoza, Fac Med, Dept Anat & Histol Humanas, Zaragoza, Spain; [Lyahyai, Jaber] Univ Mohammed V Souissi, Fac Med & Pharm, Ctr Genom Humaine, Rabat, Morocco	University of Zaragoza; University of Zaragoza; University of Zaragoza; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Acin, C (corresponding author), Univ Zaragoza, Fac Vet, Ctr Invest Encefalopatias & Enfermedades Transmis, Zaragoza, Spain.	crisacin@unizar.es	zaragoza, pilar/AAN-9479-2021; Martin-Burriel, Inmaculada/K-3724-2014; Acin, Cristina/C-9502-2017; MONZÓN, MARTA/R-6162-2017; Lyahyai, Jaber/C-4341-2011	Martin-Burriel, Inmaculada/0000-0001-6016-4726; Acin, Cristina/0000-0001-5105-6133; MONZÓN, MARTA/0000-0002-2787-9671; 	CICYT [EET 2001-4033]; EU project Goat-BSE [FOOD-CT-2006-36353]; Research Consolidated Groups of the Aragon government; Fondo Social Europeo	CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); EU project Goat-BSE; Research Consolidated Groups of the Aragon government; Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was performed as part of the EET 2001-4033 project (CICYT), EU project Goat-BSE (FOOD-CT-2006-36353), Research Consolidated Groups of the Aragon government and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin C, 2004, VET REC, V155, P370, DOI 10.1136/vr.155.12.370; Acin C, 2004, J GEN VIROL, V85, P2103, DOI 10.1099/vir.0.80047-0; Acutis PL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-8; Acutis PL, 2006, J GEN VIROL, V87, P1029, DOI 10.1099/vir.0.81440-0; Amills M, 2004, J DAIRY RES, V71, P257, DOI 10.1017/S0022029904000342; [Anonymous], REP MON TEST RUM PRE; Azor PJ, 2005, ANIM GENET, V36, P423, DOI 10.1111/j.1365-2052.2005.01327.x; Barillet F, 2009, J GEN VIROL, V90, P769, DOI 10.1099/vir.0.006114-0; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Billinis C, 2002, J GEN VIROL, V83, P713, DOI 10.1099/0022-1317-83-3-713; BLAIRWEST JR, 1962, J CLIN INVEST, V41, P1606, DOI 10.1172/JCI104619; Bossers A, 1996, J GEN VIROL, V77, P2669, DOI 10.1099/0022-1317-77-10-2669; Breugelmans S, 2011, ANAT HISTOL EMBRYOL, V40, P426, DOI 10.1111/j.1439-0264.2011.01088.x; Casalone C, 2005, J VIROL, V79, P5847, DOI 10.1128/JVI.79.9.5847-5849.2005; Corona C, 2009, J VIROL, V83, P3657, DOI 10.1128/JVI.01966-08; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; FURUKAWA H, 1995, MOL BRAIN RES, V30, P385, DOI 10.1016/0169-328X(95)00034-P; Garcia-Crespo D, 2004, VET REC, V154, P717, DOI 10.1136/vr.154.23.717; Gavier-Widen D, 2005, J VET DIAGN INVEST, V17, P509, DOI 10.1177/104063870501700601; Goldmann W, 2004, VET REC, V155, P177, DOI 10.1136/vr.155.6.177; Goldmann W, 1996, J GEN VIROL, V77, P2885, DOI 10.1099/0022-1317-77-11-2885; Goldmann W, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-110; Gonzalez L, 2005, VET REC, V156, P846, DOI 10.1136/vr.156.26.846-b; Gonzalez L, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-55; Gonzalez L, 2010, J GEN VIROL, V91, P2630, DOI 10.1099/vir.0.022574-0; Gravenor MB, 2004, EPIDEMIOL INFECT, V132, P751, DOI 10.1017/S0950268804002110; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Hunter N, 1996, ARCH VIROL, V141, P809, DOI 10.1007/BF01718157; Hussain A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-246; Jeffrey M, 2006, J COMP PATHOL, V134, P171, DOI 10.1016/j.jcpa.2005.10.003; Jeffrey M, 2001, J COMP PATHOL, V125, P271, DOI 10.1053/jcpa.2001.0499; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; LAPLANCHE JL, 1993, GENOMICS, V15, P30, DOI 10.1006/geno.1993.1006; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Mastrianni JA, 1996, NEUROLOGY, V47, P1305, DOI 10.1212/WNL.47.5.1305; Monleon E, 2003, J HISTOCHEM CYTOCHEM, V51, P15, DOI 10.1177/002215540305100103; Moum T, 2005, J GEN VIROL, V86, P231, DOI 10.1099/vir.0.80437-0; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Papasavva-Stylianou P, 2007, VET J, V173, P459, DOI 10.1016/j.tvjl.2005.09.013; Papasavva-Stylianou P, 2011, VET J, V187, P245, DOI 10.1016/j.tvjl.2009.10.015; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Saunders GC, 2009, J GEN VIROL, V90, P2569, DOI 10.1099/vir.0.012724-0; Serrano C, 2009, ANIM GENET, V40, P565, DOI 10.1111/j.1365-2052.2009.01873.x; Siso S, 2010, J COMP PATHOL, V142, P300, DOI 10.1016/j.jcpa.2009.12.003; Siso Silvia, 2010, Interdiscip Perspect Infect Dis, V2010, P747892, DOI 10.1155/2010/747892; Smits MA, 1997, VET QUART, V19, P101, DOI 10.1080/01652176.1997.9694751; Thuring CMA, 2005, J COMP PATHOL, V132, P59, DOI 10.1016/j.jcpa.2004.06.004; Vaccari G, 2006, J GEN VIROL, V87, P1395, DOI 10.1099/vir.0.81485-0; Vaccari G, 2009, VET RES, V40, DOI 10.1051/vetres/2009031; van Keulen LJM, 2008, VET RES, V39, DOI 10.1051/vetres:2007061; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831	53	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61118	10.1371/journal.pone.0061118	http://dx.doi.org/10.1371/journal.pone.0061118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580248	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000101
J	Dermentzaki, G; Dimitriou, E; Xilouri, M; Michelakakis, H; Stefanis, L				Dermentzaki, Georgia; Dimitriou, Evangelia; Xilouri, Maria; Michelakakis, Helen; Stefanis, Leonidas			Loss of beta-Glucocerebrosidase Activity Does Not Affect Alpha-Synuclein Levels or Lysosomal Function in Neuronal Cells	PLOS ONE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; GAUCHER-DISEASE; PARKINSONS-DISEASE; CORTICAL-NEURONS; PROTEIN-DEGRADATION; INCLUSION FORMATION; SELECTIVE PATHWAY; GENE-MUTATIONS; DEATH; SUSCEPTIBILITY	To date, a plethora of studies have provided evidence favoring an association between Gaucher disease (GD) and Parkinson's disease (PD). GD, the most common lysosomal storage disorder, results from the diminished activity of the lysosomal enzyme beta-glucocerebrosidase (GCase), caused by mutations in the beta-glucocerebrosidase gene (GBA). Alpha-synuclein (ASYN), a presynaptic protein, has been strongly implicated in PD pathogenesis. ASYN may in part be degraded by the lysosomes and may itself aberrantly impact lysosomal function. Therefore, a putative link between deficient GCase and ASYN, involving lysosomal dysfunction, has been proposed to be responsible for the risk for PD conferred by GBA mutations. In this current work, we aimed to investigate the effects of pharmacological inhibition of GCase on ASYN accumulation/aggregation, as well as on lysosomal function, in differentiated SH-SY5Y cells and in primary neuronal cultures. Following profound inhibition of the enzyme activity, we did not find significant alterations in ASYN levels, or any changes in the clearance or formation of its oligomeric species. We further observed no significant impairment of the lysosomal degradation machinery. These findings suggest that additional interaction pathways together with aberrant GCase and ASYN must govern this complex relation between GD and PD.	[Dermentzaki, Georgia; Xilouri, Maria; Stefanis, Leonidas] Acad Athens, Biomed Res Fdn, Div Basic Neurosci, Athens, Greece; [Dimitriou, Evangelia; Michelakakis, Helen] Inst Child Hlth, Dept Enzymol & Cellular Funct, Athens, Greece; [Stefanis, Leonidas] Univ Athens, Dept Neurol 2, Sch Med, Athens 11528, Greece	Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens	Stefanis, L (corresponding author), Acad Athens, Biomed Res Fdn, Div Basic Neurosci, Athens, Greece.	lstefanis@bioacademy.gr	Stefanis, Leonidas/AAD-7192-2019	Xilouri, Maria/0000-0001-7038-0780	Hellenic Ministry of Health; grant "Herakleitos"	Hellenic Ministry of Health; grant "Herakleitos"	This work was supported by a grant from the Hellenic Ministry of Health to LS. Additional funds were provided by grant "Herakleitos" to GD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Argyriou A, 2012, NEUROSCI LETT, V528, P205, DOI 10.1016/j.neulet.2012.08.069; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Bras J, 2009, NEUROBIOL AGING, V30, P1515, DOI 10.1016/j.neurobiolaging.2007.11.016; Choi JH, 2011, MOL GENET METAB, V104, P185, DOI 10.1016/j.ymgme.2011.06.008; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dietrich P, 2003, MOL CELL NEUROSCI, V24, P430, DOI 10.1016/S1044-7431(03)00201-X; Franklin JL, 1998, J CELL BIOL, V142, P1313, DOI 10.1083/jcb.142.5.1313; Goker-Alpan O, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.028019; Goker-Alpan O, 2010, ACTA NEUROPATHOL, V120, P641, DOI 10.1007/s00401-010-0741-7; Goldin E, 2010, MOL GENET METAB, V101, P307, DOI 10.1016/j.ymgme.2010.08.004; Kalinderi K, 2009, NEUROSCI LETT, V452, P87, DOI 10.1016/j.neulet.2009.01.029; Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lesage S, 2011, HUM MOL GENET, V20, P202, DOI 10.1093/hmg/ddq454; Liu ZH, 2009, P NATL ACAD SCI USA, V106, P4635, DOI 10.1073/pnas.0806474106; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Manning-Bog AB, 2009, NEUROTOXICOLOGY, V30, P1127, DOI 10.1016/j.neuro.2009.06.009; Mata IF, 2008, ARCH NEUROL-CHICAGO, V65, P379, DOI 10.1001/archneurol.2007.68; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; MICHELAKAKIS H, 1995, J INHERIT METAB DIS, V18, P609, DOI 10.1007/BF02436006; Mitsui J, 2009, ARCH NEUROL-CHICAGO, V66, P571, DOI 10.1001/archneurol.2009.72; Moraitou M, 2008, BLOOD CELL MOL DIS, V41, P196, DOI 10.1016/j.bcmd.2008.03.007; Moraitou M, 2011, MOL GENET METAB, V104, P149, DOI 10.1016/j.ymgme.2011.06.015; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Nichols WC, 2009, NEUROLOGY, V72, P310, DOI 10.1212/01.wnl.0000327823.81237.d1; Olanow CW, 2009, P NATL ACAD SCI USA, V106, P12571, DOI 10.1073/pnas.0906759106; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Sidransky E, 2004, MOL GENET METAB, V83, P6, DOI 10.1016/j.ymgme.2004.08.015; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Stefanis L, 1999, J NEUROSCI, V19, P6235; Vekrellis K, 2009, J NEUROCHEM, V109, P1348, DOI 10.1111/j.1471-4159.2009.06054.x; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Xilouri M, 2010, CNS NEUROL DISORD-DR, V9, P701, DOI 10.2174/187152710793237421; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Yap TL, 2011, J BIOL CHEM, V286, P28080, DOI 10.1074/jbc.M111.237859	45	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60674	10.1371/journal.pone.0060674	http://dx.doi.org/10.1371/journal.pone.0060674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580063	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000051
J	Hatanaka, E; Dermargos, A; Hirata, AE; Vinolo, MAR; Carpinelli, AR; Newsholme, P; Armelin, HA; Curi, R				Hatanaka, Elaine; Dermargos, Alexandre; Hirata, Aparecida Emiko; Ramirez Vinolo, Marco Aurelio; Carpinelli, Angelo Rafael; Newsholme, Philip; Armelin, Hugo Aguirre; Curi, Rui			Oleic, Linoleic and Linolenic Acids Increase ROS Production by Fibroblasts via NADPH Oxidase Activation	PLOS ONE			English	Article							CONNECTED OXYGEN-CONSUMPTION; SERUM AMYLOID-A; FATTY-ACIDS; RESPIRATORY BURST; OXIDATIVE STRESS; CELLS; GENERATION; LEUKOCYTES; PHYSIOLOGY	The effect of oleic, linoleic and gamma-linolenic acids on ROS production by 3T3 Swiss and Rat 1 fibroblasts was investigated. Using lucigenin-amplified chemiluminescence, a dose-dependent increase in extracellular superoxide levels was observed during the treatment of fibroblasts with oleic, linoleic and gamma-linolenic acids. ROS production was dependent on the addition of beta-NADH or NADPH to the medium. Diphenyleneiodonium inhibited the effect of oleic, linoleic and gamma-linolenic acids on fibroblast superoxide release by 79%, 92% and 82%, respectively. Increased levels of p47(phox) phosphorylation due to fatty acid treatment were detected by Western blotting analyses of fibroblast proteins. Increased p47(phox) mRNA expression was observed using real-time PCR. The rank order for the fatty acid stimulation of the fibroblast oxidative burst was as follows: gamma-linolenic > linoleic > oleic. In conclusion, oleic, linoleic and gamma-linolenic acids stimulated ROS production via activation of the NADPH oxidase enzyme complex in fibroblasts.	[Hatanaka, Elaine] Cruzeiro do Sul Univ, Inst Phys Act & Sport Sci, Sao Paulo, Brazil; [Hatanaka, Elaine; Ramirez Vinolo, Marco Aurelio; Carpinelli, Angelo Rafael; Curi, Rui] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Dermargos, Alexandre; Armelin, Hugo Aguirre] Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil; [Dermargos, Alexandre; Armelin, Hugo Aguirre] Inst Butantan, Lab Especial Ciclo Celular, Sao Paulo, Brazil; [Hirata, Aparecida Emiko] Univ Fed Sao Paulo, Dept Fisiol, Sao Paulo, Brazil; [Ramirez Vinolo, Marco Aurelio] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Sao Paulo, Brazil; [Newsholme, Philip] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Newsholme, Philip] Curtin Univ, Sch Biomed Sci, Perth, WA, Australia	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual de Campinas; University College Dublin; Curtin University	Hatanaka, E (corresponding author), Cruzeiro do Sul Univ, Inst Phys Act & Sport Sci, Sao Paulo, Brazil.	ehata@usp.br	Curi, Rui/C-9351-2012; Armelin, Hugo/P-4390-2015; Hatanaka Dermargos, Elaine/HHZ-1180-2022; Dermargos, Alexandre/B-8484-2015; Carpinelli, Angelo R/G-8566-2011; Hatanaka, Elaine/D-6337-2012; Hatanaka, Elaine/AFL-1791-2022; Vinolo, Marco Aurélio R/K-3753-2012; Newsholme, Philip/D-4939-2016	Armelin, Hugo/0000-0001-9557-0804; Dermargos, Alexandre/0000-0001-8955-1498; Carpinelli, Angelo R/0000-0002-0781-4934; Hatanaka, Elaine/0000-0002-9716-1163; Newsholme, Philip/0000-0002-0500-6984; Vinolo, Marco Aurelio/0000-0003-1335-760X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/51273-9, 2006/52043-1, 2004/12466-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [306004/2008-9, 480769/2007-9]; Health Research Board of Ireland	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Health Research Board of Ireland	This research is supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant numbers: 08/51273-9, 2006/52043-1 and 2004/12466-5, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant numbers:306004/2008-9 and 480769/2007-9, and the Health Research Board of Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bellin C, 2006, HORM METAB RES, V38, P732, DOI 10.1055/s-2006-955084; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Fujita K, 2006, CIRC J, V70, P1437, DOI 10.1253/circj.70.1437; GYLLENHAMMAR H, 1987, J IMMUNOL METHODS, V97, P209, DOI 10.1016/0022-1759(87)90461-3; HARDY SJ, 1994, J IMMUNOL, V153, P1754; Hatanaka E, 2003, FEMS IMMUNOL MED MIC, V38, P81, DOI 10.1016/S0928-8244(03)00112-3; Hatanaka E, 2007, IMMUNOL LETT, V108, P160, DOI 10.1016/j.imlet.2006.12.005; Hatanaka E, 2006, FREE RADICAL BIO MED, V41, P1124, DOI 10.1016/j.freeradbiomed.2006.06.014; HIGUCHI R, 1992, BIO-TECHNOL, V10, P413, DOI 10.1038/nbt0492-413; HONG D, 1984, PHARMACOLOGY, V28, P281, DOI 10.1159/000137975; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Iwata NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029600; Jacquot J, 2008, INT J BIOCHEM CELL B, V40, P1703, DOI 10.1016/j.biocel.2008.02.002; Kisseleva Tatiana, 2008, Proc Am Thorac Soc, V5, P338, DOI 10.1513/pats.200711-168DR; KOENDERMAN L, 1989, J IMMUNOL, V142, P623; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Mayer K, 2003, INTENS CARE MED, V29, P1472, DOI 10.1007/s00134-003-1900-2; Maziere C, 1999, BIOCHEM BIOPH RES CO, V265, P116, DOI 10.1006/bbrc.1999.1644; MEIER B, 1991, BIOCHEM J, V275, P241, DOI 10.1042/bj2750241; Morgan D, 2007, DIABETOLOGIA, V50, P359, DOI 10.1007/s00125-006-0462-6; NAKAMURA M, 1981, J LAB CLIN MED, V97, P39; NAKAMURA M, 1981, BIOCHEM BIOPH RES CO, V98, P743, DOI 10.1016/0006-291X(81)91175-X; ODonnell VB, 1996, BIOCHEM J, V318, P805, DOI 10.1042/bj3180805; Okino AM, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/47297; PICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3; Rey FE, 2002, ARTERIOSCL THROM VAS, V22, P1962, DOI 10.1161/01.ATV.0000043452.30772.18; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; SHIMOMURA Y, 1986, J CHROMATOGR, V383, P9, DOI 10.1016/S0378-4347(00)83435-0; Uchizono Y, 2006, LIFE SCI, V80, P133, DOI 10.1016/j.lfs.2006.08.031; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726; Zeng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002329	36	35	35	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e58626	10.1371/journal.pone.0058626	http://dx.doi.org/10.1371/journal.pone.0058626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23579616	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000004
J	Nho, RS; Peterson, M; Hergert, P; Henke, CA				Nho, Richard Seonghun; Peterson, Mark; Hergert, Polla; Henke, Craig A.			FoxO3a (Forkhead Box O3a) Deficiency Protects Idiopathic Pulmonary Fibrosis (IPF) Fibroblasts from Type I Polymerized Collagen Matrix-Induced Apoptosis via Caveolin-1 (cav-1) and Fas	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; DEPENDENT REGULATION; LUNG FIBROBLASTS; GENE-EXPRESSION; INSULIN; CELLS; AKT; PHOSPHORYLATION; PROLIFERATION; PROMOTES	Idiopathic Pulmonary Fibrosis is a lethal fibrotic disease characterized by the unrelenting proliferation and persistence of fibroblasts in a type I collagen-rich matrix that result in an expanding reticular network of fibrotic tissue. However, the underlying mechanism responsible for the persistence of myofibroblasts in IPF remains unclear. During normal tissue repair, unwanted fibroblasts are eliminated during collagen-matrix contraction by a mechanism whereby high PTEN activity suppresses Akt. We have previously found that FoxO3a, a transcriptional activator of apoptosis-inducing proteins, is inactivated in IPF fibroblasts resulting from aberrantly high PI3K/Akt activity due to inappropriately low PTEN activity. Here we demonstrate that this low FoxO3a activity confers IPF fibroblasts with resistance to collagen-mediated apoptosis. We show that the mechanism by which low FoxO3a activity confers IPF fibroblasts with an apoptotic resistant phenotype involves suppression of Fas expression as a result of down regulation of cav-1 expression via a PTEN/Akt-dependent pathway. We demonstrate that PTEN over-expression or Akt inhibition increases FoxO3a expression in IPF fibroblasts, resulting in up-regulation of caveolin-1. We show that FoxO3a binds to the cav-1 promoter region and ectopic expression of FoxO3a transcriptionally increases cav-1 mRNA and protein expression. In turn, we show that overexpression of caveolin-1 increases Fas levels and caspase-3/7 activity and promotes IPF fibroblast apoptosis on polymerized type I collagen. We have found that the expression of caveolin-1, Fas and cleaved caspase-3 proteins in fibroblasts within the fibroblastic foci of IPF patient specimens is low. Our data indicate that the pathologically altered PTEN/Akt axis inactivates FoxO3a down-regulating cav-1 and Fas expression. This confers IPF fibroblasts with an apoptosis-resistant phenotype and may be responsible for IPF progression.	[Nho, Richard Seonghun; Peterson, Mark; Hergert, Polla; Henke, Craig A.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Nho, RS (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	nhoxx002@umn.edu			National Institutes of Health (NIH) [R21 RHL096567A, P01 HL 091775]; American Lung Association; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091775] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) R21 RHL096567A (RSN & CH), NIH P01 HL 091775 (CH), Pulmonary Fibrosis Research Grant (RSN) from the American Lung Association and Scientist Development Grant (RSN) from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Ask Kjetil, 2006, Proc Am Thorac Soc, V3, P389, DOI 10.1513/pats.200602-021TK; Behzad H, 2007, CYTOKINE, V38, P74, DOI 10.1016/j.cyto.2007.05.004; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; Cornforth AN, 2008, ONCOGENE, V27, P4422, DOI 10.1038/onc.2008.80; Dabrowska A, 2008, J IMMUNOL, V181, P8460, DOI 10.4049/jimmunol.181.12.8460; de Souza PM, 2005, CURR OPIN PHARMACOL, V5, P232, DOI 10.1016/j.coph.2005.01.012; Demou ZN, 2005, CANCER RES, V65, P5674, DOI 10.1158/0008-5472.CAN-04-1682; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gharaee-Kermani M, 2007, PHARM RES-DORDR, V24, P819, DOI 10.1007/s11095-006-9216-x; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Ho WC, 2012, J BIOL CHEM, V287, P15458, DOI 10.1074/jbc.M112.349308; Horowitz Jeffrey C, 2006, Treat Respir Med, V5, P325, DOI 10.2165/00151829-200605050-00004; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Huang Haojie, 2006, Future Oncol, V2, P83, DOI 10.2217/14796694.2.1.83; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; KUHN C, 1991, AM J PATHOL, V138, P1257; Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC; Kuznetsova N, 1999, J BIOL CHEM, V274, P36083, DOI 10.1074/jbc.274.51.36083; Li GN, 2007, TISSUE ENG, V13, P1035, DOI 10.1089/ten.2006.0251; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakao T, 2008, CELL CYCLE, V7, P257, DOI 10.4161/cc.7.2.5148; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Nho RS, 2011, AM J PATHOL, V179, P2420, DOI 10.1016/j.ajpath.2011.07.020; Nho RS, 2010, J BIOL CHEM, V285, P14195, DOI 10.1074/jbc.M109.052845; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Ryu JH, 1998, MAYO CLIN PROC, V73, P1085, DOI 10.4065/73.11.1085; Sato K, 2000, J BIOL CHEM, V275, P25870, DOI 10.1074/jbc.M003700200; Shukla S, 2009, INT J ONCOL, V34, P1613, DOI 10.3892/ijo_00000291; Sotgia F, 2006, AM J PATHOL, V168, P292, DOI 10.2353/ajpath.2006.050429; Thomas S, 2011, CANCER RES, V71, P832, DOI 10.1158/0008-5472.CAN-10-0730; Tsai KL, 2007, NUC ACIDS RES, V35, P6894; van den Heuvel APJ, 2005, BIOCHEM J, V385, P795, DOI 10.1042/BJ20041449; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Wynes MW, 2011, J IMMUNOL, V187, P527, DOI 10.4049/jimmunol.1100447; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; Yamashita M, 2009, HUM PATHOL, V40, P1278, DOI 10.1016/j.humpath.2009.01.014; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071; Zhang M, 2011, FREE RADICAL BIO MED, V50, P1252, DOI 10.1016/j.freeradbiomed.2011.02.031; Zhang M, 2009, AM J PHYSIOL-LUNG C, V297, pL945, DOI 10.1152/ajplung.00081.2009; Zheng WH, 2000, J BIOL CHEM, V275, P39152, DOI 10.1074/jbc.M002417200	54	58	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61017	10.1371/journal.pone.0061017	http://dx.doi.org/10.1371/journal.pone.0061017			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580232	gold, Green Published, Green Submitted			2022-12-27	WOS:000317898000089
J	Bryant, RA; Hung, L				Bryant, Richard A.; Hung, Lynette			Oxytocin Enhances Social Persuasion during Hypnosis	PLOS ONE			English	Article							RESPONSES; BEHAVIOR	It has long been argued that hypnosis cannot promote behaviors that people will not otherwise engage in. Oxytocin can enhance trust in others, and may promote the extent to which a hypnotized person complies with the suggestion of a hypnotist. This double-blind placebo study administered oxytocin or placebo to high hypnotizable participants (N = 28), who were then administered hypnotic suggestions for socially unorthodox behaviors, including swearing during the experiment, singing out loud, and dancing in response to a posthypnotic cue. Participants who received oxytocin were significantly more likely to swear and dance than those who received the placebo. This finding may be interpreted in terms of oxytocin increasing social compliance in response as a function of (a) increased trust in the hypnotist, (b) reduced social anxiety, or (c) enhanced sensitivity to cues to respond to experimental expectations. These results point to the potential role of oxytocin in social persuasion.	[Bryant, Richard A.; Hung, Lynette] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Bryant, RA (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	r.bryant@unsw.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X	Australian Research Council	Australian Research Council(Australian Research Council)	This project was supported by an Australian Research Council Discovery Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz J, 2011, SOC COGN AFFECT NEUR, V6, P556, DOI 10.1093/scan/nsq085; Bartz JA, 2006, HORM BEHAV, V50, P518, DOI 10.1016/j.yhbeh.2006.06.018; Bartz JA, 2010, P NATL ACAD SCI USA, V107, P21371, DOI 10.1073/pnas.1012669107; Bogousslavsky J, 2009, EUR NEUROL, V62, P193, DOI 10.1159/000228252; Breuer Josef., 1955, STANDARD EDITION COM; BRYANT RA, 1989, J ABNORM PSYCHOL, V98, P71, DOI 10.1037/0021-843X.98.1.71; Bryant RA, 2012, PSYCHONEUROENDOCRINO, V37, P162, DOI 10.1016/j.psyneuen.2011.05.010; Burbach JPH, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P3055; De Dreu CKW, 2011, P NATL ACAD SCI USA, V108, P1262, DOI 10.1073/pnas.1015316108; Declerck CH, 2010, HORM BEHAV, V57, P368, DOI 10.1016/j.yhbeh.2010.01.006; DEGROOT HP, 1988, J PERS SOC PSYCHOL, V54, P1049, DOI 10.1037/0022-3514.54.6.1049; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; GFELLER JD, 1987, J PERS SOC PSYCHOL, V52, P586, DOI 10.1037/0022-3514.52.3.586; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; INSEL TR, 1992, ANN NY ACAD SCI, V652, P122, DOI 10.1111/j.1749-6632.1992.tb34350.x; Janet P, 1907, MAJOR SYMPTOMS HYSTE, DOI 10.1037/10008-000; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Lynn S., 2012, OXFORD HDB HYPNOSIS, P111, DOI DOI 10.1093/OXFORDHB/9780198570097.013.0005; Mikolajczak M, 2010, PSYCHOL SCI, V21, P1072, DOI 10.1177/0956797610377343; Neumann ID, 2002, PROG BRAIN RES, V139, P147; ORNE MT, 1972, INT J CLIN EXP HYP, V20, P101, DOI 10.1080/00207147208409281; ORNE MT, 1965, J PERS SOC PSYCHOL, V1, P189, DOI 10.1037/h0021933; PICCIONE C, 1989, J PERS SOC PSYCHOL, V56, P289, DOI 10.1037/0022-3514.56.2.289; Ring RH, 2006, PSYCHOPHARMACOLOGY, V185, P218, DOI 10.1007/s00213-005-0293-z; Scheele D, 2012, J NEUROSCI, V32, P16074, DOI 10.1523/JNEUROSCI.2755-12.2012; Shamay-Tsoory SG, 2009, BIOL PSYCHIAT, V66, P864, DOI 10.1016/j.biopsych.2009.06.009; Sheehan P.W., 1982, HYPNOSIS EXPERIENCE; SHEEHAN PW, 1980, J ABNORM PSYCHOL, V89, P263, DOI 10.1037/0021-843X.89.2.263; Shor R. E., 1962, HARVARD GROUP SCALE; SJOBERG BM, 1965, PSYCHOPHARMACOLOGIA, V8, P251, DOI 10.1007/BF00407857; SPANOS NP, 1986, BEHAV BRAIN SCI, V9, P449, DOI 10.1017/S0140525X00046537; Striepens N, 2012, P NATL ACAD SCI USA, V109, P18144, DOI 10.1073/pnas.1208852109; UVNASMOBERG K, 1994, PHARMACOL BIOCHEM BE, V49, P101, DOI 10.1016/0091-3057(94)90462-6; Weitzenhoffer AM, 1962, STANFORD HYPNOTIC SU, V27; Woody EZ, 2005, PSYCHOL ASSESSMENT, V17, P200, DOI 10.1037/1040-3590.17.2.200; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Young PC, 1952, EXPT HYPNOSIS, P376	40	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60711	10.1371/journal.pone.0060711	http://dx.doi.org/10.1371/journal.pone.0060711			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146RZ	23577153	Green Published, gold			2022-12-27	WOS:000319109800095
J	Jorgensen, LH; Sellathurai, J; Davis, EE; Thedchanamoorthy, T; Al-Bader, RWA; Jensen, CH; Schroder, HD				Jorgensen, Louise H.; Sellathurai, Jeeva; Davis, Erica E.; Thedchanamoorthy, Tania; Al-Bader, Rua W. A.; Jensen, Charlotte H.; Schroder, Henrik D.			Like 1 Homolog (Dlk1): A Marker for Rhabdomyosarcomas Implicated in Skeletal Muscle Regeneration	PLOS ONE			English	Article							NEUROENDOCRINE TUMORS; CALLIPYGE PHENOTYPE; IMPRINTED GENES; MOUSE MODEL; CELLS; MYOSTATIN; DIFFERENTIATION; EXPRESSION; PROTEIN; GROWTH	Dlk1, a member of the Epidermal Growth Factor family, is expressed in multiple tissues during development, and has been detected in carcinomas and neuroendocrine tumors. Dlk1 is paternally expressed and belongs to a group of imprinted genes associated with rhabdomyosarcomas but not with other primitive childhood tumors to date. Here, we investigate the possible roles of Dlk1 in skeletal muscle tumor formation. We analyzed tumors of different mesenchymal origin for expression of Dlk1 and various myogenic markers and found that Dlk1 was present consistently in myogenic tumors. The coincident observation of Dlk1 with a highly proliferative state in myogenic tumors led us to subsequently investigate the involvement of Dlk1 in the control of the adult myogenic programme. We performed an injury study in Dlk1 transgenic mice, ectopically expressing ovine Dlk1 (membrane bound C2 variant) under control of the myosin light chain promotor, and detected an early, enhanced formation of myotubes in Dlk1 transgenic mice. We then stably transfected the mouse myoblast cell line, C2C12, with full-length Dlk1 (soluble A variant) and detected an inhibition of myotube formation, which could be reversed by adding Dlk1 antibody to the culture supernatant. These results suggest that Dlk1 is involved in controlling the myogenic programme and that the various splice forms may exert different effects. Interestingly, both in the Dlk1 transgenic mice and the DLK1-C2C12 cells, we detected reduced myostatin expression, suggesting that the effect of Dlk1 on the myogenic programme might involve the myostatin signaling pathway. In support of a relationship between Dlk1 and myostatin we detected reciprocal expression of these two transcripts during different cell cycle stages of human myoblasts. Together our results suggest that Dlk1 is a candidate marker for skeletal muscle tumors and might be involved directly in skeletal muscle tumor formation through a modulatory effect on the myogenic programme.	[Jorgensen, Louise H.; Sellathurai, Jeeva; Thedchanamoorthy, Tania; Al-Bader, Rua W. A.; Schroder, Henrik D.] Univ Southern Denmark, Dept Pathol, Inst Clin Res, SMRC, Odense, Denmark; [Jorgensen, Louise H.; Sellathurai, Jeeva; Thedchanamoorthy, Tania; Al-Bader, Rua W. A.; Schroder, Henrik D.] Odense Univ Hosp, DK-5000 Odense, Denmark; [Jensen, Charlotte H.] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Lab Mol & Cellular Cardiol, DK-5000 Odense, Denmark; [Jensen, Charlotte H.] Univ Southern Denmark, Dept Cardiovasc & Renal Res, Inst Mol Med, Odense, Denmark; [Davis, Erica E.] Duke Univ, Med Ctr, Dept Pediat, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Davis, Erica E.] Univ Liege, Fac Vet Med, Liege, Belgium	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Duke University; University of Liege	Schroder, HD (corresponding author), Univ Southern Denmark, Dept Pathol, Inst Clin Res, SMRC, Odense, Denmark.	Henrik.Daa.Schroeder@ouh.regionsyddanmark.dk	Jensen, Charlotte Harken/P-4612-2014; Schrøder, Henrik Daa/E-2077-2013; Jensen, Charlotte Harken/AAZ-1738-2020	Jensen, Charlotte Harken/0000-0001-9683-8761; Schrøder, Henrik Daa/0000-0001-7588-235X; Jensen, Charlotte Harken/0000-0001-9683-8761; Davis, Erica/0000-0002-2412-8397	Lundbeck Foundation [R19-A2177]; Villum Foundation; Carlsberg Foundation; Danish Council for Strategic Research [SFI 10-093757]	Lundbeck Foundation(Lundbeckfonden); Villum Foundation(Villum Fonden); Carlsberg Foundation(Carlsberg Foundation); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was supported by the Lundbeck Foundation (LHJ) (grant number R19-A2177, http://www.lundbeckfonden.com), Villum Foundation (LHJ) (http://villumfonden.dk), Carlsberg Foundation (CHJ) (www.carlsbergfondet.dk) and The Danish Council for Strategic Research (HDS) (grant number SFI 10-093757, http://www.fi.dk/raad-og-udvalg/det-strategiske-forskningsraad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Andersen DC, 2009, STEM CELLS, V27, P898, DOI 10.1634/stemcells.2008-0826; Binh MBN, 2007, AM J SURG PATHOL, V31, P1557, DOI 10.1097/PAS.0b013e31804b4109; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Davies CE, 2010, SEMIN MUSCULOSKEL R, V14, P245, DOI 10.1055/s-0030-1253165; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Gaster M, 2001, APMIS, V109, P726, DOI 10.1034/j.1600-0463.2001.d01-139.x; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Hatley ME, 2012, CANCER CELL, V22, P536, DOI 10.1016/j.ccr.2012.09.004; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jensen CH, 2004, AM J PATHOL, V164, P1347, DOI 10.1016/S0002-9440(10)63221-X; JENSEN CH, 1994, EUR J BIOCHEM, V225, P83, DOI 10.1111/j.1432-1033.1994.00083.x; Kocamis H, 2004, ACTA VET HUNG, V52, P135, DOI 10.1556/AVet.52.2004.2.1; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Langley B, 2004, ONCOGENE, V23, P524, DOI 10.1038/sj.onc.1207144; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Marchal JA, 2000, JPN J CANCER RES, V91, P934, DOI 10.1111/j.1349-7006.2000.tb01037.x; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McCroskery S, 2005, J CELL SCI, V118, P3531, DOI 10.1242/jcs.02482; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Milasincic DJ, 1996, IN VITRO CELL DEV-AN, V32, P90; Parham DM, 2012, PEDIATR DEVEL PATHOL, V15, P211, DOI 10.2350/10-12-0953-PB.1; Rezvani G, 2012, PEDIATR RES, V71, P32, DOI 10.1038/pr.2011.6; Ricaud S, 2003, ONCOGENE, V22, P8221, DOI 10.1038/sj.onc.1207177; SMAS CM, 1994, BIOCHEMISTRY-US, V33, P9257, DOI 10.1021/bi00197a029; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voortman J, 2010, P NATL ACAD SCI USA, V107, P13040, DOI 10.1073/pnas.1008132107; Waddell JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015055; Weintraub M, 1997, Sarcoma, V1, P135, DOI 10.1080/13577149778218; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x; Yanai H, 2010, J BIOCHEM, V148, P85, DOI 10.1093/jb/mvq034; Yang ZH, 2009, GENE DEV, V23, P694, DOI 10.1101/gad.1765109; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200	40	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60692	10.1371/journal.pone.0060692	http://dx.doi.org/10.1371/journal.pone.0060692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577150	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800091
J	Saman, DM; Kavanagh, KT; Johnson, B; Lutfiyya, MN				Saman, Daniel M.; Kavanagh, Kevin T.; Johnson, Brian; Lutfiyya, M. Nawal			Can Inpatient Hospital Experiences Predict Central Line-Associated Bloodstream Infections?	PLOS ONE			English	Article							QUALITY	Background: Factors that increase the risk of central line-associated bloodstream infections (CLABSIs) are not fully understood. Recently, Hospital Compare began compiling data from hospital-required reporting to the CDC's National Healthcare Safety Network on CLABSIs in intensive care units (ICUs), at over 4,000 Medicare-certified hospitals in the United States, and made this data accessible on a central website. Also available on the same website are results from the Hospital Consumer Assessment of Healthcare Providers and Systems survey of patients' hospital experiences. Utilizing both databases, our objective was to determine whether patients' hospital experiences were significantly associated with increased risk for reported ICU CLABSI. Methods and Findings: We conducted a zero-inflated Poisson regression analysis at the hospital level on CLABSI-observed cases by ICUs in acute care hospitals (n = 1987) in the United States between January 1, 2011, and December 31, 2011. During this period there were a total of 10,866 CLABSI cases and 9,543,765 central line days. In our final model, the percent of patients who reported that they "sometimes" or "never" received help as soon as they wanted was significantly associated with an increased risk for CLABSIs. Conclusions: Using national datasets, we found that inpatients' hospital experiences were significantly associated with an increased risk of ICU reported CLABSIs. This study suggests that hospitals with lower staff responsiveness, perhaps because of an understaffing of nurse and supportive personnel, are at an increased risk for CLABSIs. This study bolsters the evidence that patient surveys may be a useful surrogate to predicting the incidence of hospital acquired conditions, including CLABSIs. Moreover, our study found that poor staff responsiveness may be indicative of greater hospital problems and generally poorly performing hospitals; and that this finding may be a symptom of hospitals with a multitude of problems, including patient safety problems, and not a direct cause.	[Saman, Daniel M.; Johnson, Brian; Lutfiyya, M. Nawal] Essentia Inst Rural Hlth, Duluth, MN USA; [Saman, Daniel M.; Kavanagh, Kevin T.] Hlth Watch USA, Somerset, KY USA		Saman, DM (corresponding author), Essentia Inst Rural Hlth, Duluth, MN USA.	dsaman@eirh.org		Kavanagh, Kevin/0000-0002-4588-6509; Saman, Daniel/0000-0002-8372-4615				Agency for Healthcare Research and Quality, 2012, HEALTHC ASS INF; Aiken LH, 2011, MED CARE, V49, P1047, DOI 10.1097/MLR.0b013e3182330b6e; Allison, 2001, LOGISTIC REGRESSION; [Anonymous], 2012, CONSUMER REPORTS; Barrera L, 2011, AM J INFECT CONTROL, V39, P633, DOI 10.1016/j.ajic.2010.11.004; Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Birnbaum D, 2011, INFECT CONT HOSP EP, V32, P276, DOI 10.1086/658331; Center for Disease Control and Prevention, 2011, NAT STAT HEALTHC ASS; Centers for Disease Control and Prevention, 2011, HEALTHC FAC REP VIA; Centers for Disease Control and Prevention, 2012, NAT STAT HEALTHC INF; Centers for Disease Control and Prevention, 2012, CENTR LIN ASS BLOODS; Centers for Medicare & Medicaid Services, 2011, DAT MED GOV SURV PAT; Centers for Medicare & Medicaid Services, 2012, HOSP COMP DAT MED GO; Cimiotti JP, 2012, AM J INFECT CONTROL, V40, P486, DOI 10.1016/j.ajic.2012.02.029; Dixon-Woods M, 2011, MILBANK Q, V89, P167, DOI 10.1111/j.1468-0009.2011.00625.x; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Gawande A., 2009, COST CONUNDRUM NEW Y; Glance LG, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-247; Greaves F, 2012, ARCH INTERN MED, V172, P435, DOI 10.1001/archinternmed.2011.1675; Guerin K, 2010, AM J INFECT CONTROL, V38, P430, DOI 10.1016/j.ajic.2010.03.007; HCAHPS, 2012, CAHPS HOSP SURV QUAL; Institute for Digital Research and Education idre UCLA, 2012, SAS DAT AN EXP ZER I; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kane R. L., 2007, AHRQ PUBLICATION, V07-E005; Kavanagh KT, 2012, J NURS SCHOLARSHIP, V44, P385, DOI 10.1111/j.1547-5069.2012.01469.x; Kutney-Lee A, 2009, HEALTH AFFAIR, V28, pW669, DOI 10.1377/hlthaff.28.4.w669; PRONOVOST P, 2008, AM J INFECT CONTROL, V36; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Saman DM, 2013, J PATIENT S IN PRESS; Santa J, 2012, CONSUMER REPORTS ACC; SAS Institute Inc, 2011, SAS 9 3; Scott RD, 2009, DIRECT MED COSTS HEA; Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243; Witherington EMA, 2008, QUAL SAF HEALTH CARE, V17, P71, DOI 10.1136/qshc.2006.020842	34	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e61097	10.1371/journal.pone.0061097	http://dx.doi.org/10.1371/journal.pone.0061097			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577195	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800122
J	Zhang, BH; Wang, WY; Wang, HX; Yin, JM; Zeng, XJ				Zhang, Bao-hai; Wang, Wenying; Wang, Hongxia; Yin, Jiming; Zeng, Xiang-jun			Promoting Effects of the Adipokine, Apelin, on Diabetic Nephropathy	PLOS ONE			English	Article							STRUCTURAL-CHANGES; ANGIOGENIC FACTOR; EARLY-STAGE; EXPRESSION; PEPTIDE; NEOVASCULARIZATION; PATHOGENESIS; VASCULATURE; PROTEINURIA; ACTIVATION	Angiogenesis, increased glomerular permeability, and albuminuria are thought to contribute to the progression of diabetic nephropathy (DN). Apelin receptor (APLNR) and the endogenous ligand of APLNR, apelin, induce the sprouting of endothelial cells in an autocrine or paracrine manner, which may be one of the mechanisms of DN. The aim of this study was to investigate the role of apelin in the pathogenesis of DN. Therefore, we observed apelin/APLNR expression in kidneys from patients with type 2 diabetes as well as the correlation between albuminuria and serum apelin in patients with type 2 diabetes. We also measured the proliferating, migrating, and chemotactic effects of apelin on glomerular endothelial cells. To measure the permeability of apelin in glomerular endothelial cells, we used transwells to detect FITC-BSA penetration through monolayered glomerular endothelial cells. The results showed that serum apelin was significantly higher in the patients with type 2 diabetes compared to healthy people (p<0.05, Fig. 1B) and that urinary albumin was positively correlated with serum apelin (R = 0.78, p<0.05). Apelin enhanced the migration, proliferation, and chemotaxis of glomerular endothelial cells in a dose-dependent manner (p<0.05). Apelin also promoted the permeability of glomerular endothelial cells (p<0.05) and upregulated the expression of VEGFR2 and Tie2 in glomerular endothelial cells (p<0.05). These results indicated that upregulated apelin in type 2 diabetes, which may be attributed to increased fat mass, promotes angiogenesis in glomeruli to form abnormal vessels and that enhanced apelin increases permeability via upregulating the expression of VEGFR2 and Tie2 in glomerular endothelial cells.	[Zhang, Bao-hai; Wang, Hongxia; Zeng, Xiang-jun] Capital Med Univ, Dept Pathophysiol, Beijing, Peoples R China; [Zhang, Bao-hai] Capital Med Univ, Beijing Tiantan Hosp, Div Cardiol, Beijing, Peoples R China; [Wang, Wenying] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing, Peoples R China; [Yin, Jiming] Capital Med Univ, Beijing You An Hosp, Beijing Inst Hepatol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Zeng, XJ (corresponding author), Capital Med Univ, Dept Pathophysiol, Beijing, Peoples R China.	megan_zeng@163.com			Natural Science Foundation of China [30900573]; Beijing Talents Education Project; Basic-clinical cooperation foundation of Capital Medial University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Talents Education Project; Basic-clinical cooperation foundation of Capital Medial University	This project was supported by the Natural Science Foundation of China (Grant No. 30900573), Beijing Talents Education Project and Basic-clinical cooperation foundation of Capital Medial University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; CONTI FG, 1989, BIOCHEM BIOPH RES CO, V163, P952, DOI 10.1016/0006-291X(89)92314-0; Cox CM, 2006, DEV BIOL, V296, P177, DOI 10.1016/j.ydbio.2006.04.452; Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016; Devic E, 1999, MECH DEVELOP, V84, P199, DOI 10.1016/S0925-4773(99)00081-7; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Gavin JR, 1999, DIABETES CARE, V22, pS5; Goligorsky MS, 2001, HYPERTENSION, V37, P744, DOI 10.1161/01.HYP.37.2.744; Guo M, 2005, J ANAT, V207, P813, DOI 10.1111/j.1469-7580.2005.00492.x; Haraldsson B, 2004, NEWS PHYSIOL SCI, V19, P7, DOI 10.1152/nips.01461.2003; Hohenstein B, 2006, KIDNEY INT, V69, P1654, DOI 10.1038/sj.ki.5000294; Ichinose K, 2006, DIABETES, V55, P1232, DOI 10.2337/db05-1367; Japp AG, 2008, J AM COLL CARDIOL, V52, P908, DOI 10.1016/j.jacc.2008.06.013; Kanesaki Y, 2005, AM J KIDNEY DIS, V45, P288, DOI 10.1053/j.ajkd.2004.09.020; Kasai A, 2004, BIOCHEM BIOPH RES CO, V325, P395, DOI 10.1016/j.bbrc.2004.10.042; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kleinz MJ, 2004, REGUL PEPTIDES, V118, P119, DOI 10.1016/j.regpep.2003.11.002; Li F, 2008, FRONT BIOSCI, V13, P3786, DOI 10.2741/2967; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; NYENGAARD JR, 1993, DIABETOLOGIA, V36, P189, DOI 10.1007/BF00399948; OSTERBY R, 1992, DIABETOLOGIA, V35, P803, DOI 10.1007/BF00399925; Osterby R, 2002, DIABETOLOGIA, V45, P542, DOI 10.1007/s00125-002-0780-2; Osterby R, 1999, NEPHROL DIAL TRANSPL, V14, P348, DOI 10.1093/ndt/14.2.348; Osterby R, 1987, J Diabet Complications, V1, P122, DOI 10.1016/S0891-6632(87)80069-7; Ott IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042623; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Rosenson RS, 2011, ATHEROSCLEROSIS, V218, P13, DOI 10.1016/j.atherosclerosis.2011.06.029; Soriguer F, 2009, OBES SURG, V19, P1574, DOI 10.1007/s11695-009-9955-y; Tanimoto M, 2004, METABOLISM, V53, P1473, DOI 10.1016/j.metabol.2004.06.016; Tasaki Y, 2010, CONGENIT ANOM, V50, P186, DOI 10.1111/j.1741-4520.2010.00287.x; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Vivian EM, 2006, CURR MED RES OPIN, V22, P297, DOI 10.1185/030079906X80495; Wang LY, 2011, PEPTIDES, V32, P2436, DOI 10.1016/j.peptides.2011.10.001; Ward NL, 2002, SEMIN CELL DEV BIOL, V13, P19, DOI 10.1006/scdb.2001.0288; WEHNER H, 1991, VIRCHOWS ARCH A, V419, P231, DOI 10.1007/BF01626353; Wendt TM, 2003, AM J PATHOL, V162, P1123, DOI 10.1016/S0002-9440(10)63909-0; Yamamoto Y, 2004, DIABETES, V53, P1831, DOI 10.2337/diabetes.53.7.1831; Zhu J, 2012, DIABETES RES CLIN PR, V96, P53, DOI 10.1016/j.diabres.2011.12.009; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370	41	26	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60457	10.1371/journal.pone.0060457	http://dx.doi.org/10.1371/journal.pone.0060457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577111	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800051
J	Elsenberg, EHAM; Hillaert, MA; den Ruijter, HM; Sels, JWEM; Scholtes, VPW; Nathoe, HM; Kuiper, J; Jukema, JW; Doevendans, PA; Pasterkamp, G; Hoefer, IE				Elsenberg, Ellen H. A. M.; Hillaert, Marieke A.; den Ruijter, Hester M.; Sels, Jan-Willem E. M.; Scholtes, Vincent P. W.; Nathoe, Hendrik M.; Kuiper, Johan; Jukema, J. Wouter; Doevendans, Pieter A.; Pasterkamp, Gerard; Hoefer, Imo E.			Toll-Like Receptor Induced CD11b and L-Selectin Response in Patients with Coronary Artery Disease	PLOS ONE			English	Article							INCREASED EXPRESSION; ADHESION MOLECULES; MONOCYTES; ACTIVATION; INFLAMMATION; TOLL-LIKE-RECEPTOR-4; ATHEROSCLEROSIS; ASSOCIATION; DECREASE; SURFACE	Toll-Like Receptor (TLR) -2 and -4 expression and TLR-induced cytokine response of inflammatory cells are related to atherogenesis and atherosclerotic plaque progression. We examined whether immediate TLR induced changes in CD11b and L-selectin (CD62L) expression are able to discriminate the presence and severity of atherosclerotic disease by exploring single dose whole blood TLR stimulation and detailed dose-response curves. Blood samples were obtained from 125 coronary artery disease (CAD) patients and 28 controls. CD11b and L-selectin expression on CD14+ monocytes was measured after whole blood stimulation with multiple concentrations of the TLR4 ligand LPS (0.01-10 ng/ml) and the TLR2 ligand P3C (0.5-500 ng/ml). Subsequently, dose-response curves were created and the following parameters were calculated: hillslope, EC50, area under the curve (AUC) and delta. These parameters provide information about the maximum response following activation, as well as the minimum trigger required to induce activation and the intensity of the response. CAD patients showed a significantly higher L-selectin, but not CD11b response to TLR ligation than controls after single dose stimulations as well as significant differences in the hillslope and EC50 of the dose-response curves. Within the CAD patient group, dose-response curves of L-selectin showed significant differences in the presence of hypertension, dyslipidemia, coronary occlusion and degree of stenosis, whereas CD11b expression had the strongest discriminating power after single dose stimulation. In conclusion, single dose stimulations and dose-response curves of CD11b and L-selectin expression after TLR stimulation provide diverse but limited information about atherosclerotic disease severity in stable angina patients. However, both single dose stimulation and dose-response curves of LPS-induced L-selectin expression can discriminate between controls and CAD patients.	[Elsenberg, Ellen H. A. M.; den Ruijter, Hester M.; Scholtes, Vincent P. W.; Pasterkamp, Gerard; Hoefer, Imo E.] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Hillaert, Marieke A.; Nathoe, Hendrik M.; Doevendans, Pieter A.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Sels, Jan-Willem E. M.] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands; [Kuiper, Johan] Leiden Univ, Div Biopharmaceut, Leiden, Netherlands; [Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Catharina Hospital; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hoefer, IE (corresponding author), Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands.	I.Hoefer@umcutrecht.nl	Jukema, J. Wouter/ABD-6503-2021	Jukema, J. Wouter/0000-0002-3246-8359; den Ruijter, Hester/0000-0001-9762-014X	project CIRCULATING CELLS [01C-102]; Netherlands Heart Foundation	project CIRCULATING CELLS; Netherlands Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Centre for Translational Molecular Medicine (www.ctmm.nl), project CIRCULATING CELLS (grant 01C-102), and supported by the Netherlands Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNAOUT MA, 1990, BLOOD, V75, P1037; Ashida K, 2005, J ATHEROSCLER THROMB, V12, P53, DOI 10.5551/jat.12.53; Choi YH, 2000, JPN HEART J, V41, P605, DOI 10.1536/jhj.41.605; DESERVI S, 1995, J AM COLL CARDIOL, V26, P1146, DOI 10.1016/0735-1097(95)00308-8; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Elsenberg EHAM, 2012, CLIN SCI, V122, P527, DOI 10.1042/CS20110323; Eriksson EE, 2001, J EXP MED, V194, P205, DOI 10.1084/jem.194.2.205; Gomes NE, 2010, BRAZ J MED BIOL RES, V43, P853, DOI 10.1590/S0100-879X2010000900007; Ishikawa Y, 2008, CLIN SCI, V115, P133, DOI 10.1042/CS20070379; Kassirer M, 1999, AM HEART J, V138, P555, DOI 10.1016/S0002-8703(99)70160-2; Liuzzo G, 2001, CIRCULATION, V103, P2236; MAZZONE A, 1993, CIRCULATION, V88, P358, DOI 10.1161/01.CIR.88.2.358; MAZZONE A, 1995, HAEMATOLOGICA, V80, P161; Mazzone A, 1997, EUR J CLIN INVEST, V27, P648, DOI 10.1046/j.1365-2362.1997.1610710.x; Methe H, 2005, CIRCULATION, V111, P2654, DOI 10.1161/CIRCULATIONAHA.104.498865; Rainer TH, 2002, RESUSCITATION, V52, P127, DOI 10.1016/S0300-9572(01)00444-0; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Scholtes VPW, 2011, CLIN SCI, V121, P205, DOI 10.1042/CS20100601; Versteeg D, 2008, HEART, V94, P770, DOI 10.1136/hrt.2007.117259; Versteeg D, 2009, SHOCK, V31, P21, DOI 10.1097/SHK.0b013e31817d43bf; Vink A, 2002, CIRCULATION, V106, P1985, DOI 10.1161/01.CIR.0000032146.75113.EE; Wedepohl S, 2012, EUR J CELL BIOL, V91, P257, DOI 10.1016/j.ejcb.2011.02.007; Wei YS, 2011, J THROMB THROMBOLYS, V32, P110, DOI 10.1007/s11239-011-0587-4; Zhou XM, 2005, AM J PHYSIOL-LUNG C, V288, pL655, DOI 10.1152/ajplung.00327.2004	24	3	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60467	10.1371/journal.pone.0060467	http://dx.doi.org/10.1371/journal.pone.0060467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573259	Green Published, gold, Green Submitted			2022-12-27	WOS:000318840100076
J	Gilbert, EH; Kwak, SJ; Chen, R; Mardon, G				Gilbert, Erin Haase; Kwak, Su-Jin; Chen, Rui; Mardon, Graeme			Drosophila Signal Peptidase Complex Member Spase12 Is Required for Development and Cell Differentiation	PLOS ONE			English	Article							YEAST SEC11 PROTEIN; MEMBRANE TOPOLOGY; IMMUNE-RESPONSE; GENE; MELANOGASTER; NOTCH; EYE; GLYCOPROTEIN; PATHWAY; PHOTORECEPTOR	It is estimated that half of all proteins expressed in eukaryotic cells are transferred across or into at least one cellular membrane to reach their functional location. Protein translocation into the endoplasmic reticulum (ER) is critical to the subsequent localization of secretory and transmembrane proteins. A vital component of the translocation machinery is the signal peptidase complex (SPC) - which is conserved from yeast to mammals - and functions to cleave the signal peptide sequence (SP) of secretory and membrane proteins entering the ER. Failure to cleave the SP, due to mutations that abolish the cleavage site or reduce SPC function, leads to the accumulation of uncleaved proteins in the ER that cannot be properly localized resulting in a wide range of defects depending on the protein(s) affected. Despite the obvious importance of the SPC, in vivo studies investigating its function in a multicellular organism have not been reported. The Drosophila SPC comprises four proteins: Spase18/21, Spase22/23, Spase25 and Spase12. Spc1p, the S. cerevisiae homolog of Spase12, is not required for SPC function or viability; Drosophila spase12 null alleles, however, are embryonic lethal. The data presented herein show that spase12 LOF clones disrupt development of all tissues tested including the eye, wing, leg, and antenna. In the eye, spase12 LOF clones result in a disorganized eye, defective cell differentiation, ectopic interommatidial bristles, and variations in support cell size, shape, number, and distribution. In addition, spase12 mosaic tissue is susceptible to melanotic mass formation suggesting that spase12 LOF activates immune response pathways. Together these data demonstrate that spase12 is an essential gene in Drosophila where it functions to mediate cell differentiation and development. This work represents the first reported in vivo analysis of a SPC component in a multicellular organism.	[Gilbert, Erin Haase; Chen, Rui; Mardon, Graeme] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kwak, Su-Jin; Mardon, Graeme] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Chen, Rui; Mardon, Graeme] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Mardon, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	gmardon@bcm.edu			Retina Research Foundation [R01 EY11232]; National Eye Institute [T32 EY007102]; National Institutes of Health [T32 GM008307]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002520, T32EY007102, R01EY011232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	Retina Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds awards to GM by the Retina Research Foundation www.retinaresearchfnd.org (R01 EY11232) and funds awards to EHG by the National Eye Institute www.nei.nih.gov (T32 EY007102) and the National Institutes of Health www.nih.gov (T32 GM008307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Avet-Rochex A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-65; BAKER RK, 1987, BIOCHEMISTRY-US, V26, P8561, DOI 10.1021/bi00400a010; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; BRENNAN MD, 1980, J CELL BIOL, V87, P516, DOI 10.1083/jcb.87.2.516; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Dearolf CR, 1998, BBA-REV CANCER, V1377, pM13, DOI 10.1016/S0304-419X(97)00031-0; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; Fang H, 1996, J BIOL CHEM, V271, P16460, DOI 10.1074/jbc.271.28.16460; Fang H, 1997, J BIOL CHEM, V272, P13125; Green C, 2000, GENETICS, V156, P1117; GREENBURG G, 1989, J BIOL CHEM, V264, P15762; GREENBURG G, 1994, J BIOL CHEM, V269, P25354; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kalies KU, 1996, J BIOL CHEM, V271, P3925; Kilic A, 2010, EUR J CELL BIOL, V89, P449, DOI 10.1016/j.ejcb.2010.02.001; Kumar JP, 2009, BBA-GENE REGUL MECH, V1789, P306, DOI 10.1016/j.bbagrm.2008.10.001; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; LIVELY MO, 1994, METHOD ENZYMOL, V244, P301; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4; Meyer HA, 1997, J BIOL CHEM, V272, P13159, DOI 10.1074/jbc.272.20.13159; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; Mullins C, 1996, J BIOL CHEM, V271, P29094, DOI 10.1074/jbc.271.46.29094; Murali T, 2011, NUCLEIC ACIDS RES, V39, pD736, DOI 10.1093/nar/gkq1092; NEWSOME AL, 1992, BIOCHEM J, V282, P447, DOI 10.1042/bj2820447; Newsome TP, 2000, DEVELOPMENT, V127, P851; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pepple KL, 2008, DEVELOPMENT, V135, P4071, DOI 10.1242/dev.028951; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Roman G, 2000, GENETICS, V155, P1281; SHELNESS GS, 1988, J BIOL CHEM, V263, P17063; SHELNESS GS, 1990, J BIOL CHEM, V265, P9512; SHELNESS GS, 1993, J BIOL CHEM, V268, P5201; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wang DL, 2006, P NATL ACAD SCI USA, V103, P13520, DOI 10.1073/pnas.0604661103; WARREN TG, 1979, P NATL ACAD SCI USA, V76, P2848, DOI 10.1073/pnas.76.6.2848; WATSON KL, 1991, DEV GENET, V12, P173, DOI 10.1002/dvg.1020120302; WOLFF T, 1991, DEVELOPMENT, V113, P841; Wolff Tanya, 2011, Cold Spring Harb Protoc, V2011, P1383, DOI 10.1101/pdb.prot066506; YADEAU JT, 1991, P NATL ACAD SCI USA, V88, P517, DOI 10.1073/pnas.88.2.517; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461	54	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60908	10.1371/journal.pone.0060908	http://dx.doi.org/10.1371/journal.pone.0060908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573290	Green Submitted, Green Published, gold			2022-12-27	WOS:000318840100108
J	Nair, P; Misra, A; Singh, A; Shukla, AK; Gupta, MM; Gupta, AK; Gupta, V; Khanuja, SPS; Shasany, AK				Nair, Priya; Misra, Amita; Singh, Alka; Shukla, Ashutosh K.; Gupta, Madan M.; Gupta, Anil K.; Gupta, Vikrant; Khanuja, Suman P. S.; Shasany, Ajit K.			Differentially Expressed Genes during Contrasting Growth Stages of Artemisia annua for Artemisinin Content	PLOS ONE			English	Article							BIOSYNTHETIC-PATHWAY; MOLECULAR-CLONING; L.; CYTOCHROME-P450; LOCALIZATION; ACCUMULATION; TRICHOMES; SINGLE; MARKER; NUMBER	Artemisia annua is the source of antimalarial phytomolecule, artemisinin. It is mainly produced and stored in the glandular secretory trichomes present in the leaves of the plant. Since, the artemisinin biosynthesis steps are yet to be worked out, in this investigation a microarray chip was strategized for the first time to shortlist the differentially expressing genes at a stage of plant producing highest artemisinin compared to the stage with no artemisinin. As the target of this study was to analyze differential gene expression associated with contrasting artemisinin content in planta and a genotype having zero/negligible artemisinin content was unavailable, it was decided to compare different stages of the same genotype with contrasting artemisinin content (seedling - negligible artemisinin, mature leaf - high artemisinin). The SCAR-marked artemisinin-rich (similar to 1.2%) Indian variety 'CIM-Arogya' was used in the present study to determine optimal plant stage and leaf ontogenic level for artemisinin content. A representative EST dataset from leaf trichome at the stage of maximal artemisinin biosynthesis was established. The high utility small scale custom microarray chip of A. annua containing all the significant artemisinin biosynthesis-related genes, the established EST dataset, gene sequences isolated in-house and strategically selected candidates from the A. annua Unigene database (NCBI) was employed to compare the gene expression profiles of two stages. The expression data was validated through semiquantitative and quantitative RT-PCR followed by putative annotations through bioinformatics-based approaches. Many candidates having probable role in artemisinin metabolism were identified and described with scope for further functional characterization.	[Nair, Priya; Misra, Amita; Singh, Alka; Shukla, Ashutosh K.; Gupta, Madan M.; Gupta, Anil K.; Gupta, Vikrant; Khanuja, Suman P. S.; Shasany, Ajit K.] Cent Inst Med & Aromat Plants, CSIR, Lucknow 226016, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Shasany, AK (corresponding author), Cent Inst Med & Aromat Plants, CSIR, Lucknow 226016, Uttar Pradesh, India.	ak.shasany@cimap.res.in		Gupta, Vikrant/0000-0002-3479-8749	Department of Biotechnology (DBT), India; Council of Scientific and Industrial Research (CSIR), India [GAP138 (BT/PR6544/PBD/17/405/2005), NWP08]; CSIR	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Department of Biotechnology (DBT), India, and the Council of Scientific and Industrial Research (CSIR), India, financially supported this study through grants GAP138 (BT/PR6544/PBD/17/405/2005) and NWP08 (XI Five Year Plan Network Project), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Help from Director, CSIR-CIMAP for the facility is acknowledged. PN and AM thank CSIR for their Senior Research Fellowships.	Brown GD, 2007, TETRAHEDRON, V63, P9536, DOI 10.1016/j.tet.2007.06.016; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Delabays N, 2001, CURR MED CHEM, V8, P1795, DOI 10.2174/0929867013371635; Djakovic-Petrovic T, 2007, PLANT J, V51, P117, DOI 10.1111/j.1365-313X.2007.03122.x; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; DUKE MV, 1994, INT J PLANT SCI, V155, P365, DOI 10.1086/297173; DUKE SO, 1993, INT J PLANT SCI, V154, P107, DOI 10.1086/297096; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Gupta SK, 2002, IND CROP PROD, V16, P217, DOI 10.1016/S0926-6690(02)00049-3; Hsu E, 2006, BRIT J CLIN PHARMACO, V61, P666, DOI 10.1111/j.1365-2125.2006.02673.x; Jain DC, 1996, PHYTOCHEMISTRY, V43, P993, DOI 10.1016/S0031-9422(96)00369-X; Khanuja S. P. S., 2005, Journal of Medicinal and Aromatic Plant Sciences, V27, P520; Khanuja SPS, 2008, US Patent, Patent No. [7,375,260, 7375260]; Laughlin J. C., 1993, Acta Horticulturae, P53; LIERSCH R, 1986, PLANTA MED, P387, DOI 10.1055/s-2007-969193; Liu BY, 2011, PLANT CELL REP, V30, P689, DOI 10.1007/s00299-010-0967-9; Liu CZ, 2006, APPL MICROBIOL BIOT, V72, P11, DOI 10.1007/s00253-006-0452-0; Liu SQ, 2009, PLANTA MED, V75, P1542, DOI 10.1055/s-0029-1185809; Lommen WJM, 2006, PLANTA MED, V72, P336, DOI 10.1055/s-2005-916202; Misra A, 2012, GENE, V510, P193, DOI 10.1016/j.gene.2012.09.015; Olsson ME, 2009, PHYTOCHEMISTRY, V70, P1123, DOI 10.1016/j.phytochem.2009.07.009; Paul S, 2010, PLANTA MED, V76, P1468, DOI 10.1055/s-0029-1240940; RAY A, 1994, P NATL ACAD SCI USA, V91, P5761, DOI 10.1073/pnas.91.13.5761; Shanker S, 1999, BIOL PLANTARUM, V42, P379, DOI 10.1023/A:1002461101852; Shukla Ashutosh K., 2005, Indian Journal of Experimental Biology, V43, P197; Shukla AK, 2006, J EXP BOT, V57, P3921, DOI 10.1093/jxb/erl146; Teoh KH, 2009, BOTANY, V87, P635, DOI 10.1139/B09-032; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; Wallaart TE, 1999, J NAT PROD, V62, P430, DOI 10.1021/np980370p; Wallaart TE, 2001, PLANTA, V212, P460, DOI 10.1007/s004250000428; Wang H, 2007, PLANT BIOLOGY, V9, P442, DOI 10.1055/s-2006-924634; Wang HH, 2009, PLANTA MED, V75, P1625, DOI 10.1055/s-0029-1185814; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Weathers PJ, 2006, IN VITRO CELL DEV-PL, V42, P309, DOI 10.1079/IVP2006782; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zeng QP, 2008, SCI CHINA SER C, V51, P232, DOI 10.1007/s11427-008-0032-x; Zhang L, 2006, J INTEGR PLANT BIOL, V48, P1054, DOI 10.1111/j.1744-7909.2006.00288.x; Zhang Y, 2008, J BIOL CHEM, V283, P21501, DOI 10.1074/jbc.M803090200; Zoschke R, 2007, PLANT J, V50, P710, DOI 10.1111/j.1365-313X.2007.03084.x	39	26	26	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60375	10.1371/journal.pone.0060375	http://dx.doi.org/10.1371/journal.pone.0060375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573249	Green Published, gold			2022-12-27	WOS:000318840100064
J	Sellers, SL; Iwasaki, A; Payne, GW				Sellers, Stephanie L.; Iwasaki, Akiko; Payne, Geoffrey W.			Nitric Oxide and TNF alpha Are Critical Regulators of Reversible Lymph Node Vascular Remodeling and Adaptive Immune Response	PLOS ONE			English	Article							HIGH ENDOTHELIAL VENULES; INDUCED ANGIOGENESIS; CELL PROLIFERATION; DENDRITIC CELLS; T-CELLS; SYNTHASE; ADHESION; CD4(+); GROWTH; INHIBITION	Lymph node (LN) vascular growth, at the level of the main arteriole, was recently characterized for the first time during infection. Arteriole diameter was shown to increase for at least seven days and to occur via a CD4(+) T cell dependent mechanism, with vascular expansion playing a critical role in regulating induction of adaptive immune response. Here, using intravital microscopy of the inguinal LN during herpes simplex type II (HSV-2) infection, the data provides the first studies that demonstrate arteriole expansion during infection is a reversible vascular event that occurs via eutrophic outward remodeling. Furthermore, using genetic ablation models, and pharmacological blockade, we reveal arteriole remodeling and LN hypertrophy to be dependent upon both endothelial nitric oxide synthase (eNOS) and TNF alpha expression. Additionally, we reveal transient changes in nitric oxide (NO) levels to be a notable feature of response to viral infection and LN vascular remodeling and provide evidence that mast cells are the critical source of TNF alpha required to drive arteriole remodeling. Overall, this study is the first to fully characterize LN arteriole vascular changes throughout the course of infection. It effectively reveals a novel role for NO and TNF alpha in LN cellularity and changes in LN vascularity, which represent key advances in understanding LN vascular physiology and adaptive immune response.	[Sellers, Stephanie L.] Univ Northern BC, Prince George, BC, Canada; Yale Univ, Sch Med, New Haven, CT USA; [Payne, Geoffrey W.] Univ Northern BC, Northern Med Program, Prince George, BC, Canada	University of Northern British Columbia; Yale University; University of Northern British Columbia	Payne, GW (corresponding author), Univ Northern BC, Northern Med Program, Prince George, BC, Canada.	Geoff.Payne@unbc.ca	Iwasaki, Akiko/Z-1591-2019; Payne, Geoffrey/AAG-8282-2019	Iwasaki, Akiko/0000-0002-7824-9856; Sellers, Stephanie/0000-0002-3539-5730	Canadian Institutes of Health Studentship; Northern Medical Program seed grant	Canadian Institutes of Health Studentship(Canadian Institutes of Health Research (CIHR)); Northern Medical Program seed grant	Funding for the proposal was through the following: Canadian Institutes of Health Studentship: SL; Northern Medical Program seed grant: GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMITSU T, 1995, J APPL PHYSIOL, V78, P1725, DOI 10.1152/jappl.1995.78.5.1725; Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626; Behrens G, 2004, IMMUNOL CELL BIOL, V82, P84, DOI 10.1111/j.1440-1711.2004.01211.x; Benest AV, 2008, ARTERIOSCL THROM VAS, V28, P1462, DOI 10.1161/ATVBAHA.108.169375; Bhandari V, 2006, P NATL ACAD SCI USA, V103, P11021, DOI 10.1073/pnas.0601057103; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Dajnowiec D, 2007, CLIN SCI, V113, P15, DOI 10.1042/CS20060337; Daley E, 2008, J EXP MED, V205, P361, DOI 10.1084/jem.20071008; Ezaki T, 2001, AM J PATHOL, V158, P2043, DOI 10.1016/S0002-9440(10)64676-7; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; HERMAN PG, 1972, J EXP MED, V136, P697, DOI 10.1084/jem.136.4.697; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Kumamoto Y, 2011, P NATL ACAD SCI USA, V108, P8749, DOI 10.1073/pnas.1100567108; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; MARCHESI VT, 1964, PROC R SOC SER B-BIO, V159, P283, DOI 10.1098/rspb.1964.0002; McLachlan JB, 2008, NAT MED, V14, P536, DOI 10.1038/nm1757; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; MEBIUS RE, 1990, IMMUNOLOGY, V71, P423; Metaxa E, 2008, AM J PHYSIOL-HEART C, V295, pH736, DOI 10.1152/ajpheart.01156.2007; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; MYKING AO, 1980, VIRCHOWS ARCH B, V35, P63, DOI 10.1007/BF02889149; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Norman MU, 2008, EUR J IMMUNOL, V38, P1368, DOI 10.1002/eji.200737847; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; POLVERINI PJ, 1977, J IMMUNOL, V118, P529; Pries AR, 2002, MICROCIRCULATION, V9, P305, DOI 10.1038/sj.mn.7800144; Sellers SL, 2011, JOVE-J VIS EXP, DOI 10.3791/2551; SIDKY YA, 1975, J EXP MED, V141, P1084, DOI 10.1084/jem.141.5.1084; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Soderberg KA, 2005, P NATL ACAD SCI USA, V102, P16315, DOI 10.1073/pnas.0506190102; Sundrani R, 2000, CRIT CARE MED, V28, P2898, DOI 10.1097/00003246-200008000-00035; Takedachi M, 2008, J IMMUNOL, V180, P6288, DOI 10.4049/jimmunol.180.9.6288; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102	40	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60741	10.1371/journal.pone.0060741	http://dx.doi.org/10.1371/journal.pone.0060741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573281	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100101
J	Sinues, PML; Kohler, M; Zenobi, R				Sinues, Pablo Martinez-Lozano; Kohler, Malcolm; Zenobi, Renato			Human Breath Analysis May Support the Existence of Individual Metabolic Phenotypes	PLOS ONE			English	Article							ELECTROSPRAY-IONIZATION; CANCER	The metabolic phenotype varies widely due to external factors such as diet and gut microbiome composition, among others. Despite these temporal fluctuations, urine metabolite profiling studies have suggested that there are highly individual phenotypes that persist over extended periods of time. This hypothesis was tested by analyzing the exhaled breath of a group of subjects during nine days by mass spectrometry. Consistent with previous metabolomic studies based on urine, we conclude that individual signatures of breath composition exist. The confirmation of the existence of stable and specific breathprints may contribute to strengthen the inclusion of breath as a biofluid of choice in metabolomic studies. In addition, the fact that the method is rapid and totally non-invasive, yet individualized profiles can be tracked, makes it an appealing approach.	[Sinues, Pablo Martinez-Lozano; Zenobi, Renato] ETH, Dept Chem & Appl Biosci, Zurich, Switzerland; [Kohler, Malcolm] Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland; [Kohler, Malcolm] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Zenobi, R (corresponding author), ETH, Dept Chem & Appl Biosci, Zurich, Switzerland.	zenobi@org.chem.ethz.ch	Sinues, Pablo/X-2311-2019; Sinues, Pablo/A-9576-2014	Sinues, Pablo/0000-0001-5602-2880; Sinues, Pablo/0000-0001-5602-2880	Marie Curie European Reintegration Grant (PMLS) within the 7th European Community Framework Programme [276860]	Marie Curie European Reintegration Grant (PMLS) within the 7th European Community Framework Programme	This research was supported by a Marie Curie European Reintegration Grant (PMLS) within the 7th European Community Framework Programme (276860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Bajtarevic A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-348; Bernini P, 2009, J PROTEOME RES, V8, P4264, DOI 10.1021/pr900344m; Chen HW, 2007, ANGEW CHEM INT EDIT, V46, P580, DOI 10.1002/anie.200602942; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Dallmann R, 2012, P NATL ACAD SCI; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Gamez G, 2011, CHEM COMMUN, V47, P4884, DOI 10.1039/c1cc10343a; Kasukawa T, 2012, P NATL ACAD SCI; Martinez-Lozano P, 2007, INT J MASS SPECTROM, V265, P68, DOI 10.1016/j.ijms.2007.05.008; Martinez-Lozano P, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/1/016002; Martinez-Lozano P, 2008, ANAL CHEM, V80, P8210, DOI 10.1021/ac801185e; Napoli C, 2012, J PROTEOME RES, V11, P1274, DOI 10.1021/pr200960u; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; PAULING L, 1971, P NATL ACAD SCI USA, V68, P2374, DOI 10.1073/pnas.68.10.2374; Rencher AC, 2002, METHODS MULTIVARIATE; Sinues PML, 2013, ANAL CHEM, V85, P369, DOI 10.1021/ac3029097; Spanel P, 2011, PHYSIOL MEAS, V32, pN23, DOI 10.1088/0967-3334/32/8/N01; Turner C, 2006, RAPID COMMUN MASS SP, V20, P61, DOI 10.1002/rcm.2275; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; Vidakovic B., 2011, STAT BIOENGINEERING; Wu C, 2000, ANAL CHEM, V72, P396, DOI 10.1021/ac9907235	23	51	52	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59909	10.1371/journal.pone.0059909	http://dx.doi.org/10.1371/journal.pone.0059909			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573221	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000318840100034
J	Gavina, A; Antunes, SC; Pinto, G; Claro, MT; Santos, C; Goncalves, F; Pereira, R				Gavina, Ana; Antunes, Sara C.; Pinto, Gloria; Claro, Maria Teresa; Santos, Conceicao; Goncalves, Fernando; Pereira, Ruth			Can Physiological Endpoints Improve the Sensitivity of Assays with Plants in the Risk Assessment of Contaminated Soils?	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; SEED-GERMINATION; HEAVY-METALS; LEMNA-MINOR; GROWTH; PHYTOTOXICITY; CADMIUM; L.; PHOTOSYNTHESIS; RESPONSES	Site-specific risk assessment of contaminated areas indicates prior areas for intervention, and provides helpful information for risk managers. This study was conducted in the Ervedosa mine area (Braganc, a, Portugal), where both underground and open pit exploration of tin and arsenic minerals were performed for about one century (1857 - 1969). We aimed at obtaining ecotoxicological information with terrestrial and aquatic plant species to integrate in the risk assessment of this mine area. Further we also intended to evaluate if the assessment of other parameters, in standard assays with terrestrial plants, can improve the identification of phytotoxic soils. For this purpose, soil samples were collected on 16 sampling sites distributed along four transects, defined within the mine area, and in one reference site. General soil physical and chemical parameters, total and extractable metal contents were analyzed. Assays were performed for soil elutriates and for the whole soil matrix following standard guidelines for growth inhibition assay with Lemna minor and emergence and seedling growth assay with Zea mays. At the end of the Z. mays assay, relative water content, membrane permeability, leaf area, content of photosynthetic pigments (chlorophylls and carotenoids), malondialdehyde levels, proline content, and chlorophyll fluorescence (F-v/F-m and Phi(PSII)) parameters were evaluated. In general, the soils near the exploration area revealed high levels of Al, Mn, Fe and Cu. Almost all the soils from transepts C, D and F presented total concentrations of arsenic well above soils screening benchmark values available. Elutriates of several soils from sampling sites near the exploration and ore treatment areas were toxic to L. minor, suggesting that the retention function of these soils was seriously compromised. In Z. mays assay, plant performance parameters (other than those recommended by standard protocols), allowed the identification of more phytotoxic soils. The results suggest that these parameters could improve the sensitivity of the standard assays.	[Gavina, Ana; Pinto, Gloria; Claro, Maria Teresa; Santos, Conceicao; Goncalves, Fernando] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Gavina, Ana; Antunes, Sara C.; Pinto, Gloria; Claro, Maria Teresa; Santos, Conceicao; Goncalves, Fernando; Pereira, Ruth] Univ Aveiro, CESAM Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [Antunes, Sara C.; Pereira, Ruth] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade do Porto	Pereira, R (corresponding author), Univ Porto, Fac Ciencias, Dept Biol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ruthp@ua.pt	Pinto, Glória Catarina/B-1271-2011; Pereira, Ruth/AAY-3535-2021; Gavina, Ana Catarina Soares/T-8943-2017; Santos, Conceição/ABE-6172-2020; Antunes, Sara Cristina FM/C-7150-2008; santos, conceição/GQQ-7378-2022; Santos, Conceição LV/A-8651-2008; Gonçalves, Fernando J. M./B-8000-2008	Pinto, Glória Catarina/0000-0001-7735-5131; Pereira, Ruth/0000-0001-6857-5968; Gavina, Ana Catarina Soares/0000-0001-5085-2197; Santos, Conceição/0000-0003-4129-6381; Antunes, Sara Cristina FM/0000-0002-6686-9919; Santos, Conceição LV/0000-0003-4129-6381; Gonçalves, Fernando J. M./0000-0002-9326-187X				[Anonymous], 1126927 ISO; [Anonymous], TERR PLANT TEST SEED; [Anonymous], 2005, 103902005 ISO; Azevedo H, 2005, J PLANT NUTR, V28, P2211, DOI 10.1080/01904160500324782; Bedell JP, 2006, CHEMOSPHERE, V62, P1311, DOI 10.1016/j.chemosphere.2005.07.012; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Briat JF, 1999, CR ACAD SCI III-VIE, V322, P43, DOI 10.1016/S0764-4469(99)80016-X; CARACAS, 1998, CONC ACT RISK ASS CO; CEC-Commission of the European Communities, 2006, COM2006231FINAL CEC; Chapman EEV, 2010, ECOTOX ENVIRON SAFE, V73, P961, DOI 10.1016/j.ecoenv.2010.02.014; Cherif J, 2010, J PHOTOCH PHOTOBIO B, V101, P332, DOI 10.1016/j.jphotobiol.2010.08.005; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Correa AXDR, 2006, SCI TOTAL ENVIRON, V357, P120, DOI 10.1016/j.scitotenv.2005.05.002; Cruz T, 2010, CAPTAR, V2, P29; Dinakar N, 2008, J ENVIRON SCI, V20, P199, DOI 10.1016/S1001-0742(08)60032-7; Duester L, 2011, MICROCHEM J, V97, P30, DOI 10.1016/j.microc.2010.05.007; Elkahoui S, 2005, PLANT SCI, V168, P607, DOI 10.1016/j.plantsci.2004.09.006; FAOUN, 1984, UN SOIL B, V10, P1; Fatima RA, 2005, SCI TOTAL ENVIRON, V346, P256, DOI 10.1016/j.scitotenv.2004.12.004; Gao YP, 2011, MAR POLLUT BULL, V62, P1628, DOI 10.1016/j.marpolbul.2011.06.014; Gong P, 2001, CHEMOSPHERE, V44, P491, DOI 10.1016/S0045-6535(00)00280-0; HALLIWELL B, 1987, CHEM PHYS LIPIDS, V44, P327, DOI 10.1016/0009-3084(87)90056-9; Houba VJG, 2000, COMMUN SOIL SCI PLAN, V31, P1299, DOI 10.1080/00103620009370514; Jansch S, 2007, ENVIRON SCI POLLUT R, V14, P308, DOI 10.1065/espr2006.06.310; JENSEN J, 2006, 711701047 RIVM NAT I; Jiang WS, 2000, SCI TOTAL ENVIRON, V256, P59, DOI 10.1016/S0048-9697(00)00470-8; Khedr AHA, 2003, J EXP BOT, V54, P2553, DOI 10.1093/jxb/erg277; Kranner I, 2011, ENVIRON EXP BOT, V72, P93, DOI 10.1016/j.envexpbot.2010.05.005; Krugh BW, 1996, ENVIRON TOXICOL CHEM, V15, P495, DOI [10.1897/1551-5028(1996)015&lt;0495:MTEOFN&gt;2.3.CO;2, 10.1002/etc.5620150413]; Kupper H, 1996, J EXP BOT, V47, P259, DOI 10.1093/jxb/47.2.259; Li CX, 2007, J ENVIRON SCI, V19, P725, DOI 10.1016/S1001-0742(07)60121-1; Li G, 2010, IND CROP PROD, V31, P13, DOI 10.1016/j.indcrop.2009.07.015; Li R., 2006, AGR SCI CHINA, V5, P751, DOI DOI 10.1016/S1671-2927(06)60120-X; Lima MPR, 2011, ENVIRON POLLUT, V159, P1844, DOI 10.1016/j.envpol.2011.03.029; Loureiro S, 2006, ARCH ENVIRON CON TOX, V50, P182, DOI 10.1007/s00244-004-0261-3; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; MacFarlane GR, 2002, MAR POLLUT BULL, V44, P244, DOI 10.1016/S0025-326X(01)00255-7; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Menzies NW, 2007, ENVIRON POLLUT, V145, P121, DOI 10.1016/j.envpol.2006.03.021; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Novais HJGSQ, 2006, THESIS U TRAS OS MON; OECD, 2006, GROWTH INH TEST OECD, P221; OECD - Organization for Economic Cooperation and Development, 1984, TERR PLANTS GROWTH T, P208; Pavlik M, 2010, ECOTOX ENVIRON SAFE, V73, P1309, DOI 10.1016/j.ecoenv.2010.07.008; Pereira R, 2009, APPL SOIL ECOL, V42, P209, DOI 10.1016/j.apsoil.2009.04.002; Pfleeger TG, 1993, ASTM STP, V1216; Radic S, 2010, ECOTOXICOLOGY, V19, P216, DOI 10.1007/s10646-009-0408-0; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Singh RP, 2010, B ENVIRON CONTAM TOX, V84, P606, DOI 10.1007/s00128-010-0007-z; SPAC, 2000, HDB REF METH SOIL PL; Stoeva N, 2003, BIOL PLANTARUM, V47, P449, DOI 10.1023/B:BIOP.0000023893.12939.48; Sun BY, 2010, J HAZARD MATER, V183, P833, DOI 10.1016/j.jhazmat.2010.07.102; Sun YH, 2008, ENVIRON EXP BOT, V64, P264, DOI 10.1016/j.envexpbot.2008.05.009; Szabo I, 2005, EMBO REP, V6, P629, DOI 10.1038/sj.embor.7400460; Teisseire H, 1998, ECOTOX ENVIRON SAFE, V40, P194, DOI 10.1006/eesa.1998.1682; USEPA, 2004, EPA630P04068B; Van Assche F, 2002, SETAC PRESS, V128, P59; VERKLEIJ JAC, 1994, SETAC SP P, P139; Vernay P, 2008, CHEMOSPHERE, V72, P763, DOI 10.1016/j.chemosphere.2008.03.018; Vernay P, 2007, CHEMOSPHERE, V68, P1563, DOI 10.1016/j.chemosphere.2007.02.052; Zar J. H., 1996, BIOSTATISTICAL ANAL	61	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59748	10.1371/journal.pone.0059748	http://dx.doi.org/10.1371/journal.pone.0059748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565165	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300034
J	Lalremruata, A; Ball, M; Bianucci, R; Welte, B; Nerlich, AG; Kun, JFJ; Pusch, CM				Lalremruata, Albert; Ball, Markus; Bianucci, Raffaella; Welte, Beatrix; Nerlich, Andreas G.; Kun, Juergen F. J.; Pusch, Carsten M.			Molecular Identification of Falciparum Malaria and Human Tuberculosis Co-Infections in Mummies from the Fayum Depression (Lower Egypt)	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MYCOBACTERIUM-TUBERCULOSIS; ANCIENT-EGYPT; INFECTION; DNA	Due to the presence of the lake Quarun and to the particular nature of its irrigation system, it has been speculated that the Fayum, a large depression 80 kilometers south-west of modern Cairo, was exposed to the hazards of malaria in historic times. Similarly, it has been speculated that, in the same area, also human tuberculosis might have been far more widespread in the antiquity than in its recent past. If these hypotheses were confirmed, it would imply that frequent cases of co-infection between the two pathogens might have occurred in ancient populations. To substantiate those speculations, molecular analyses were carried out on sixteen mummified heads recovered from the necropolis of Abusir el Meleq (Fayum) dating from the 3rd Intermediate Period (1064-656 BC) to the Roman Period (30 BC- 300 AD). Soft tissue biopsies were used for DNA extractions and PCR amplifications using well-suited protocols. A partial 196-bp fragment of Plasmodium falciparum apical membrane antigen 1 gene and a 123-bp fragment of the Mycobacterium tuberculosis complex insertion sequence IS6110 were amplified and sequenced in six and five of the sixteen specimens, respectively. A 100% concordance rates between our sequences and those of P. falciparum and M. tuberculosis complex ones were obtained. Lastly, concomitant PCR amplification of P. falciparum and M. tuberculosis complex DNA specific fragments was obtained in four mummies, three of which are (14) C dated to the Late and Graeco-Roman Periods. Our data confirm that the hydrography of Fayum was extremely conducive to the spread of malaria. They also support the notion that the agricultural boom and dense crowding occurred in this region, especially under the Ptolemies, highly increased the probability for the manifestation and spread of tuberculosis. Here we extend back-wards to ca. 800 BC new evidence for malaria tropica and human tuberculosis co-occurrence in ancient Lower Egypt.	[Lalremruata, Albert; Kun, Juergen F. J.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Lalremruata, Albert; Ball, Markus; Pusch, Carsten M.] Univ Tubingen, Inst Human Genet, Dept Med Genet, Tubingen, Germany; [Bianucci, Raffaella] Univ Turin, Lab Phys Anthropol, Dept Publ Hlth & Paediat Sci, Turin, Italy; [Bianucci, Raffaella] Univ Pisa, Div Paleopathol Hist Med & Bioeth, Dept Oncol Transplants & Adv Technol Med, Pisa, Italy; [Welte, Beatrix] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Inst Pre & Protohist & Medieval Archaeol, Tubingen, Germany; [Nerlich, Andreas G.] Acad Clin Munchen Bogenhausen, Div Paleopathol, Inst Pathol, Munich, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Turin; University of Pisa; Eberhard Karls University of Tubingen; Munchen Klinik	Nerlich, AG (corresponding author), Acad Clin Munchen Bogenhausen, Div Paleopathol, Inst Pathol, Munich, Germany.	Andreas.Nerlich@extern.lrz-muenchen.de; carsten.pusch@uni-tuebingen.de	Ball, Markus/ABF-2661-2020; Lalremruata, Albert/S-6453-2019; Bianucci, Raffaella/AAW-1433-2020	Lalremruata, Albert/0000-0002-4692-7835; Ball, Markus/0000-0002-2312-8360; Nerlich, Andreas/0000-0001-6562-1017	Landesgraduiertenfoderung, University of Tubingen; German Academic Exchange Service (DAAD)	Landesgraduiertenfoderung, University of Tubingen; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The study was supported by Landesgraduiertenfoderung, University of Tubingen, and The German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andavo KS, 2009, LINKAGES AGR MALARIA, P21; Bassiouny H K, 2001, East Mediterr Health J, V7, P895; Bianucci R, 2008, J ARCHAEOL SCI, V35, P1880, DOI 10.1016/j.jas.2007.11.019; Boraschi D, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000255; Colombatti R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-57; Crubezy E, 1998, CR ACAD SCI III-VIE, V321, P941, DOI 10.1016/S0764-4469(99)80009-2; Davoli P., 2012, OXFORD HDB ROMAN EGY, DOI [10.1093/oxfordhb/9780199571451.001.0001, DOI 10.1093/OXFORDHB/9780199571451.001.0001]; Donoghue HD, 2010, P R SOC B, V277, P51, DOI 10.1098/rspb.2009.1484; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; Enwere GC, 1999, ANN TROP MED PARASIT, V93, P669, DOI 10.1080/00034989957907; Hassan FA, 2012, QUATERN INT, V266, P175, DOI 10.1016/j.quaint.2011.11.024; Hassan FA, 1997, WORLD ARCHAEOL, V29, P51, DOI 10.1080/00438243.1997.9980363; Hassan FA, 2010, RIPARIA EMPIRE ROMAI; Hawass Z, 2010, JAMA-J AM MED ASSOC, V303, P638, DOI 10.1001/jama.2010.121; Hawkes M, 2010, MICROBES INFECT, V12, P864, DOI 10.1016/j.micinf.2010.05.013; Ikram S, 2003, DEATH BURIAL ANCIENT, P207; Keiser J, 2005, AM J TROP MED HYG, V72, P392, DOI 10.4269/ajtmh.2005.72.392; Kiwanuka GN, 2009, J VECTOR DIS, V46, P1; Koopman Annelies, 2012, ETOPOI, V3, P63; MCBRIDE JS, 1985, J EXP MED, V161, P160, DOI 10.1084/jem.161.1.160; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nerlich A, 2000, Anthropol Anz, V58, P321; Nerlich AG, 1997, LANCET, V350, P1404, DOI 10.1016/S0140-6736(05)65185-9; Nerlich AG, 2008, EMERG INFECT DIS, V14, P1317, DOI 10.3201/eid1408.080235; Page KR, 2005, INFECT IMMUN, V73, P8369, DOI 10.1128/IAI.73.12.8369-8380.2005; Pahl WM, 1982, THESIS U TUBINGEN; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Scheidel W, 2001, DEATH NILE DIS DEMOG, P82; Schlott A, 2007, DOKUMENTE HERKUNFT A, V213; SCHOLZ M, 1997, TRENDS GENET, V13, P249; Scott CP, 2004, AM J TROP MED HYG, V70, P144, DOI 10.4269/ajtmh.2004.70.144; Spigelman M, 1993, INT J OSTEOARCHAEOL, V3, P137, DOI DOI 10.1002/0A.1390030211; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wiwanitkit Viroj, 2006, Journal of Vector Borne Diseases, V43, P195; Zink A, 2001, J MED MICROBIOL, V50, P355, DOI 10.1099/0022-1317-50-4-355; Zink AR, 2003, EPIDEMIOL INFECT, V130, P239, DOI 10.1017/S0950268802008257; Zink AR, 2003, J CLIN MICROBIOL, V41, P359, DOI 10.1128/JCM.41.1.359-367.2003	38	42	43	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60307	10.1371/journal.pone.0060307	http://dx.doi.org/10.1371/journal.pone.0060307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565222	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300092
J	Lazenby, BT; Dickman, CR				Lazenby, Billie T.; Dickman, Christopher R.			Patterns of Detection and Capture Are Associated with Cohabiting Predators and Prey	PLOS ONE			English	Article							MESOPREDATOR RELEASE; TASMANIAN DEVIL; VULPES-VULPES; COMPETITION; CARNIVORES; POPULATION; RESPONSES; ECOLOGY; HABITAT; COOCCURRENCE	Avoidance behaviour can play an important role in structuring ecosystems but can be difficult to uncover and quantify. Remote cameras have great but as yet unrealized potential to uncover patterns arising from predatory, competitive or other interactions that structure animal communities by detecting species that are active at the same sites and recording their behaviours and times of activity. Here, we use multi-season, two-species occupancy models to test for evidence of interactions between introduced (feral cat Felis catus) and native predator (Tasmanian devil Sarcophilus harrisii) and predator and small mammal (swamp rat Rattus lutreolus velutinus) combinations at baited camera sites in the cool temperate forests of southern Tasmania. In addition, we investigate the capture rates of swamp rats in traps scented with feral cat and devil faecal odours. We observed that one species could reduce the probability of detecting another at a camera site. In particular, feral cats were detected less frequently at camera sites occupied by devils, whereas patterns of swamp rat detection associated with devils or feral cats varied with study site. Captures of swamp rats were not associated with odours on traps, although fewer captures tended to occur in traps scented with the faecal odour of feral cats. The observation that a native carnivorous marsupial, the Tasmanian devil, can suppress the detectability of an introduced eutherian predator, the feral cat, is consistent with a dominant predator - mesopredator relationship. Such a relationship has important implications for the interaction between feral cats and the lower trophic guilds that form their prey, especially if cat activity increases in places where devil populations are declining. More generally, population estimates derived from devices such as remote cameras need to acknowledge the potential for one species to change the detectability of another, and incorporate this in assessments of numbers and survival.	[Lazenby, Billie T.; Dickman, Christopher R.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Lazenby, Billie T.] Dept Primary Ind Pk Water & Environm, Hobart, Tas, Australia	University of Sydney	Lazenby, BT (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	Billie.Lazenby@dpipwe.tas.gov.au	Dickman, Christopher/Q-4662-2019	Dickman, Christopher/0000-0002-1067-3730	WV Scott Estate; University of Sydney; Australian Postgraduate Award	WV Scott Estate; University of Sydney(University of Sydney); Australian Postgraduate Award(Australian Government)	This project was funded by grants from the WV Scott Estate, the University of Sydney postgraduate research support scheme, and an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Atickem A, 2010, AFR J ECOL, V48, P401, DOI 10.1111/j.1365-2028.2009.01126.x; Banks PB, 1998, J MAMMAL, V79, P1260, DOI 10.2307/1383017; Banks PB, 2007, TRENDS ECOL EVOL, V22, P229, DOI 10.1016/j.tree.2007.02.006; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Blumstein DT, 2000, BEHAV ECOL, V11, P528, DOI 10.1093/beheco/11.5.528; BOONSTRA R, 1982, CAN J ZOOL, V60, P438, DOI 10.1139/z82-059; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; Dickman C., 1996, OVERVIEW IMPACTS FER; DICKMAN CR, 1991, OECOLOGIA, V85, P464, DOI 10.1007/BF00323757; DICKMAN CR, 1984, J ZOOL, V204, P521, DOI 10.1111/j.1469-7998.1984.tb02384.x; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; DPIPWE, 2009, TASVEG 2 0 TASM VEG; DPIPWE, 2012, LOC FOX ACT TASM; Driessen M.M., 1987, THESIS U TASMANIA HO; Durant SM, 2000, ANIM BEHAV, V60, P121, DOI 10.1006/anbe.2000.1433; Elton CS, 1967, ANIMAL ECOLOGY; Frank DA, 2008, OIKOS, V117, P1718, DOI 10.1111/j.1600-0706.2008.16846.x; Grether GF, 2009, BIOL REV, V84, P617, DOI 10.1111/j.1469-185X.2009.00089.x; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Hayes RA, 2006, ANIM BEHAV, V71, P1307, DOI 10.1016/j.anbehav.2005.08.017; Hines J., 2006, PRESENCE2 SOFTWARE E; Johnson C, 2006, AUSTR MAMMAL EXTINCT; Jones M, 2011, EC SOC AUSTR C HOB T; Jones ME, 1998, J ANIM ECOL, V67, P410, DOI 10.1046/j.1365-2656.1998.00203.x; Jones ME, 2004, ANIM CONSERV, V7, P155, DOI 10.1017/S136794300400126X; King C., 1984, IMMIGRANT KILLERS IN; Kovacs EK, 2012, OECOLOGIA, V168, P947, DOI 10.1007/s00442-011-2168-9; Lazenby BT, 2012, THESIS U SYDNEY SYDN; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Linnell John D. C., 2000, Diversity and Distributions, V6, P169, DOI 10.1046/j.1472-4642.2000.00069.x; Long RA, 2008, NONINVASIVE SURVEY M; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; Mahon PS, 1998, WILDLIFE RES, V25, P11, DOI 10.1071/WR97007; McEvoy J, 2008, AUSTRAL ECOL, V33, P922, DOI 10.1111/j.1442-9993.2008.01863.x; Monamy V, 1999, J MAMMAL, V80, P232, DOI 10.2307/1383223; Nersesian CL, 2012, BEHAV ECOL SOCIOBIOL, V66, P47, DOI 10.1007/s00265-011-1250-y; Owen D, 2005, TASMANIAN DEVIL UNIQ; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Pemberton D., 1990, SOCIAL ORG BEHAV TAS; Pemberton David, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P13; RALLS K, 1971, SCIENCE, V171, P443, DOI 10.1126/science.171.3970.443; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Risbey DA, 2000, WILDLIFE RES, V27, P223, DOI 10.1071/WR98092; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Ritchie EG, 2009, J ANIM ECOL, V78, P724, DOI 10.1111/j.1365-2656.2008.01520.x; Rogers CM, 1998, OECOLOGIA, V116, P227, DOI 10.1007/s004420050583; Ruscoe WA, 2011, ECOL LETT, V14, P1035, DOI 10.1111/j.1461-0248.2011.01673.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; SOULE M E, 1988, Conservation Biology, V2, P75, DOI 10.1111/j.1523-1739.1988.tb00337.x; TAYLOR R J, 1986, Papers and Proceedings of the Royal Society of Tasmania, V120, P7; THIESSEN D, 1976, PSYCHOL BULL, V83, P505, DOI 10.1037/0033-2909.83.4.505; Waddle JH, 2010, ECOL APPL, V20, P1467, DOI 10.1890/09-0850.1; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535	60	40	42	2	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59846	10.1371/journal.pone.0059846	http://dx.doi.org/10.1371/journal.pone.0059846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565172	Green Published, gold			2022-12-27	WOS:000317717300041
J	Stock, SJ; Ferguson, E; Duffy, A; Ford, I; Chalmers, J; Norman, JE				Stock, Sarah J.; Ferguson, Evelyn; Duffy, Andrew; Ford, Ian; Chalmers, James; Norman, Jane E.			Outcomes of Induction of Labour in Women with Previous Caesarean Delivery: A Retrospective Cohort Study Using a Population Database	PLOS ONE			English	Article							ATTEMPTING VAGINAL BIRTH; UTERINE RUPTURE; EXPECTANT MANAGEMENT; ELECTIVE INDUCTION; SECTION; TRIAL; RISK; PREGNANCY; MORBIDITY	Background: There is evidence that induction of labour (IOL) around term reduces perinatal mortality and caesarean delivery rates when compared to expectant management of pregnancy (allowing the pregnancy to continue to await spontaneous labour or definitive indication for delivery). However, it is not clear whether IOL in women with a previous caesarean section confers the same benefits. The aim of this study was to describe outcomes of IOL at 39-41 weeks in women with one previous caesarean delivery and to compare outcomes of IOL or planned caesarean delivery to those of expectant management. Methods and Findings: We performed a population-based retrospective cohort study of singleton births greater than 39 weeks gestation, in women with one previous caesarean delivery, in Scotland, UK 1981-2007 (n = 46,176). Outcomes included mode of delivery, perinatal mortality, neonatal unit admission, postpartum hemorrhage and uterine rupture. 40.1% (2,969/7,401) of women who underwent IOL 39-41 weeks were ultimately delivered by caesarean. When compared to expectant management IOL was associated with lower odds of caesarean delivery (adjusted odds ratio [AOR] after IOL at 39 weeks of 0.81 [95% CI 0.71-0.91]). There was no significant effect on the odds of perinatal mortality but greater odds of neonatal unit admission (AOR after IOL at 39 weeks of 1.29 [95% CI 1.08-1.55]). In contrast, when compared with expectant management, elective repeat caesarean delivery was associated with lower perinatal mortality (AOR after planned caesarean at 39 weeks of 0.23 [95% CI 0.07-0.75]) and, depending on gestation, the same or lower neonatal unit admission (AOR after planned caesarean at 39 weeks of 0.98 [0.90-1.07] at 40 weeks of 1.08 [0.94-1.23] and at 41 weeks of 0.77 [0.60-1.00]). Conclusions: A more liberal policy of IOL in women with previous caesarean delivery may reduce repeat caesarean delivery, but increases the risks of neonatal complications.	[Stock, Sarah J.; Norman, Jane E.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Ferguson, Evelyn] Wishaw Gen Hosp, NHS Lanarkshire Dept Obstet & Gynaecol, Wishaw, Scotland; [Duffy, Andrew; Chalmers, James] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland	University of Edinburgh; NHS National Services Scotland; University of Glasgow	Stock, SJ (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	sarah.stock@ed.ac.uk	Ford, Ian/ABE-6145-2020; Duffy, Alex/A-4040-2010	Duffy, Alex/0000-0002-5661-4314; Norman, Jane/0000-0001-6031-6953	Chief Scientist Office of the Scottish Government Health Directorate [CZG/2/292]; charity Tommy's; Medical Research Council [G1002033] Funding Source: researchfish; MRC [G1002033] Funding Source: UKRI	Chief Scientist Office of the Scottish Government Health Directorate; charity Tommy's; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by research grant CZG/2/292 from the Chief Scientist Office of the Scottish Government Health Directorate and by the charity Tommy's. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zirqi I, 2010, BJOG-INT J OBSTET GY, V117, P809, DOI 10.1111/j.1471-0528.2010.02533.x; [Anonymous], OBSTET GYNECOL, V116, P450; Caughey AB, 2009, ANN INTERN MED, V151, P252, DOI 10.7326/0003-4819-151-4-200908180-00007; Crowther CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001192; D'Alton ME, 2006, OBSTET GYNECOL, V107, P1386; Dekker GA, 2010, BJOG-INT J OBSTET GY, V117, P1358, DOI 10.1111/j.1471-0528.2010.02688.x; Delaney T, 2003, OBSTET GYNECOL, V102, P39, DOI 10.1016/S0029-7844(03)00355-7; Gulmezoglu AM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945.pub3; Guise JM, 2010, OBSTET GYNECOL, V115, P1267, DOI 10.1097/AOG.0b013e3181df925f; Heimstad R, 2006, OBSTET GYNECOL, V108, P500, DOI 10.1097/01.AOG.0000227783.65800.0f; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Knight M, 2008, OBSTET GYNECOL, V111, P97, DOI 10.1097/01.AOG.0000296658.83240.6d; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Locatelli A, 2004, BJOG-INT J OBSTET GY, V111, P1394, DOI 10.1111/j.1471-0528.2004.00287.x; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; Macones GA, 2005, AM J OBSTET GYNECOL, V193, P1656, DOI 10.1016/j.ajog.2005.04.002; Martel MJ, 2005, J OBSTET GYNAECOL CA, V27, P164; Martin Joyce A., 2011, BIRTHS FINAL DATA 20; Mason M, 2010, DATA QUALITY ASSURAN; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Ravasia DJ, 2000, AM J OBSTET GYNECOL, V183, P1176, DOI 10.1067/mob.2000.109037; Royal College of Obstetricians and Gynaecologists (RCOG), 2007, BIRTH PREV CAES BIRT; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; Smith GCS, 2005, PLOS MED, V2, P871, DOI 10.1371/journal.pmed.0020252; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; Steer PJ, 2009, LANCET, V374, P675, DOI 10.1016/S0140-6736(09)61544-0; Stock SJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2838; Wen SW, 2004, AM J OBSTET GYNECOL, V191, P1263, DOI 10.1016/j.ajog.2004.03.022	28	18	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60404	10.1371/journal.pone.0060404	http://dx.doi.org/10.1371/journal.pone.0060404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565242	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300112
J	Krabbe, G; Halle, A; Matyash, V; Rinnenthal, JL; Eom, GD; Bernhardt, U; Miller, KR; Prokop, S; Kettenmann, H; Heppner, FL				Krabbe, Grietje; Halle, Annett; Matyash, Vitali; Rinnenthal, Jan L.; Eom, Gina D.; Bernhardt, Ulrike; Miller, Kelly R.; Prokop, Stefan; Kettenmann, Helmut; Heppner, Frank L.			Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like Pathology	PLOS ONE			English	Article							IN-VIVO; A-BETA; TRANSGENIC MICE; BRAIN; DISEASE; PHAGOCYTOSIS; SENESCENCE; CLEARANCE; PLAQUES; MAINTENANCE	Microglial cells closely interact with senile plaques in Alzheimer's disease and acquire the morphological appearance of an activated phenotype. The significance of this microglial phenotype and the impact of microglia for disease progression have remained controversial. To uncover and characterize putative changes in the functionality of microglia during Alzheimer's disease, we directly assessed microglial behavior in two mouse models of Alzheimer's disease. Using in vivo two-photon microscopy and acute brain slice preparations, we found that important microglial functions - directed process motility and phagocytic activity - were strongly impaired in mice with Alzheimer's disease-like pathology compared to age-matched non-transgenic animals. Notably, impairment of microglial function temporally and spatially correlated with A beta plaque deposition, and phagocytic capacity of microglia could be restored by interventionally decreasing amyloid burden by A beta vaccination. These data suggest that major microglial functions progressively decline in Alzheimer's disease with the appearance of A beta plaques, and that this functional impairment is reversible by lowering A beta burden, e.g. by means of A beta vaccination.	[Krabbe, Grietje; Matyash, Vitali; Kettenmann, Helmut] Max Delbrueck Ctr Mol Med MDC, Berlin, Germany; [Halle, Annett; Rinnenthal, Jan L.; Eom, Gina D.; Bernhardt, Ulrike; Miller, Kelly R.; Prokop, Stefan; Heppner, Frank L.] Charite, Dept Neuropathol, D-13353 Berlin, Germany; [Halle, Annett] Ctr Adv European Studies & Res Caesar, Bonn, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Center of Advanced European Studies & Research (CAESAR)	Kettenmann, H (corresponding author), Max Delbrueck Ctr Mol Med MDC, Berlin, Germany.	kettenmann@mdc-berlin.de; frank.heppner@charite.de	Heppner, Frank/ABH-8393-2020; Kettenmann, Helmut/AAJ-5142-2021	Heppner, Frank/0000-0001-9816-8917; Kettenmann, Helmut/0000-0001-8208-0291; Prokop, Stefan/0000-0002-5633-2149	Deutsche Forschungsgemeinschaft [SFB TRR 43, research school GRK 1258, NeuroCure Exc 257]; United States National Institutes of Health [NINDS R01 NS046006]; European Union (FP7 HEALTH, Project LUPAS); Jung-Stiftung fur Wissenschaft und Forschung; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046006] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union (FP7 HEALTH, Project LUPAS); Jung-Stiftung fur Wissenschaft und Forschung; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB TRR 43, research school GRK 1258 and NeuroCure Exc 257 to FLH and HK), the United States National Institutes of Health (NINDS R01 NS046006 to FLH), the European Union (FP7 HEALTH, Project LUPAS to FLH) and Jung-Stiftung fur Wissenschaft und Forschung (to AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Combs CK, 1999, J NEUROSCI, V19, P928; Cramer PE, 2012, SCIENCE; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Farfara D, 2011, ANN NEUROL, V69, P170, DOI 10.1002/ana.22191; Flanary BE, 2007, REJUV RES, V10, P61, DOI 10.1089/rej.2006.9096; Frautschy SA, 1998, AM J PATHOL, V152, P307; Giulian D, 1996, J NEUROSCI, V16, P6021; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Koenigsknecht-Talboo J, 2008, J NEUROSCI, V28, P14156, DOI 10.1523/JNEUROSCI.4147-08.2008; Krabbe G, 2012, BRAIN BEHAV IMMUN, V26, P419, DOI 10.1016/j.bbi.2011.12.002; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; McLellan ME, 2003, J NEUROSCI, V23, P2212; MEDA L, 1995, J NEUROIMMUNOL, V59, P29, DOI 10.1016/0165-5728(95)00021-S; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Miller KR, 2007, NEURON GLIA BIOL, V3, P245, DOI 10.1017/S1740925X08000136; Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Prinz M, 1999, J NEUROPATH EXP NEUR, V58, P1078, DOI 10.1097/00005072-199910000-00006; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; vom Berg JPS, 2012, NATURE IN PRESS; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346	41	318	329	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60921	10.1371/journal.pone.0060921	http://dx.doi.org/10.1371/journal.pone.0060921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577177	Green Accepted, Green Published, gold			2022-12-27	WOS:000317898000084
J	Smith, ER; Hanssen, E; McMahon, LP; Holt, SG				Smith, Edward R.; Hanssen, Eric; McMahon, Lawrence P.; Holt, Stephen G.			Fetuin-A-Containing Calciprotein Particles Reduce Mineral Stress in the Macrophage	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CRYSTALS; SMOOTH-MUSCLE-CELLS; SCAVENGER RECEPTOR EXPRESSION; PROTEIN-KINASE-C; VASCULAR CALCIFICATION; GLYCOPROTEIN/FETUIN-A; SIGNALING MECHANISMS; MOLECULAR-MECHANISM; HUMAN FIBROBLASTS; SERUM	The formation of fetuin-A-containing calciprotein particles (CPP) may facilitate the clearance of calcium phosphate nanocrystals from the extracellular fluid. These crystals may otherwise seed extra-osseous mineralization. Fetuin-A is a partially phosphorylated glycoprotein that plays a critical role in stabilizing these particles, inhibiting crystal growth and aggregation. CPP removal is thought to be predominantly mediated by cells of the reticuloendothelial system via type I and type II class A scavenger receptor (SR-AI/II). Naked calcium phosphate crystals are known to stimulate macrophages and other cell types in vitro, but little is known of the effect of CPP on these cells. We report here, for the first time, that CPP induce expression and secretion of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1 beta in murine RAW 264.7 macrophages. Importantly, however, CPP induced significantly lower cytokine secretion than hydroxyapatite (HAP) crystals of equivalent size and calcium content. Furthermore, CPP only had a modest effect on macrophage viability and apoptosis, even at very high levels, compared to HAP crystals, which were strongly pro-apoptotic at much lower levels. Fetuin-A phosphorylation was found to modulate the effect of CPP on cytokine secretion and apoptosis, but not uptake via SR-AI/II. Prolonged exposure of macrophages to CPP was found to result in up-regulated expression of SR-AI/II. CPP formation may help protect against some of the pro-inflammatory and harmful effects of calcium phosphate nanocrystals, perhaps representing a natural defense system for calcium mineral stress. However, in pathological states where production exceeds clearance capacity, these particles may still stimulate pro-inflammatory and pro-apoptotic cascades in macrophages, which may be important in the pathogenesis of vascular calcification.	[Smith, Edward R.; McMahon, Lawrence P.; Holt, Stephen G.] Monash Univ, Eastern Hlth Clin Sch, Dept Renal Med, Melbourne, Vic 3004, Australia; [Hanssen, Eric] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Electron Microscopy Unit, Melbourne, Vic, Australia	Monash University; University of Melbourne	Smith, ER (corresponding author), Monash Univ, Eastern Hlth Clin Sch, Dept Renal Med, Melbourne, Vic 3004, Australia.	ed.smith@monash.edu	Smith, Edward/AAY-1174-2021; Hanssen, Eric/A-7217-2013; Holt, Stephen/AAU-7808-2020	Smith, Edward/0000-0002-2651-1787; Hanssen, Eric/0000-0002-4064-1844; Holt, Stephen/0000-0001-5004-5539; Holt, Steve/0000-0001-6936-9736	Eastern Health, Monash University; Amgen Australia Pty.; Amgen; Baxter; Gilead; Shire; Roche	Eastern Health, Monash University; Amgen Australia Pty.; Amgen(Amgen); Baxter; Gilead(Gilead Sciences); Shire; Roche(Roche Holding)	This work was kindly supported by funding from Eastern Health, Monash University and an unrestricted investigator-initated research grant from Amgen Australia Pty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. This study was partly funded by an unrestricted investigator-initated research grant from Amgen Australia Pty. SGH has received research funding and or honoraria from Amgen, Baxter, Gilead & Shire. LPM has received research funding and or honoraria from Amgen, Roche & Shire. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ando M, 1997, KIDNEY INT, V51, P785, DOI 10.1038/ki.1997.110; Ando M, 1996, KIDNEY INT, V49, P773, DOI 10.1038/ki.1996.107; Brogley MA, 1999, J CELL PHYSIOL, V180, P215, DOI 10.1002/(SICI)1097-4652(199908)180:2<215::AID-JCP9>3.0.CO;2-J; Chen XJ, 2007, BIOL PHARM BULL, V30, P128, DOI 10.1248/bpb.30.128; CHERTOV OY, 1994, IMMUNOL LETT, V42, P97, DOI 10.1016/0165-2478(94)90042-6; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Dziegielewska KM, 1998, BIOL NEONATE, V74, P372, DOI 10.1159/000014055; Ea HK, 2008, ANN RHEUM DIS, V67, P1617, DOI 10.1136/ard.2008.087718; Ea HK, 2009, CURR OPIN RHEUMATOL, V21, P150, DOI 10.1097/BOR.0b013e3283257ba9; Ea HK, 2005, ARTHRITIS RES THER, V7, pR915, DOI 10.1186/ar1763; Ewence AE, 2008, CIRC RES, V103, pE28, DOI 10.1161/CIRCRESAHA.108.181305; Gostring L, 2010, INT J ONCOL, V36, P757, DOI 10.3892/ijo_00000551; Greig FH, 2012, FREE RADICAL BIO MED, V52, P266, DOI 10.1016/j.freeradbiomed.2011.10.481; Haglund AC, 2001, BIOCHEM J, V357, P437, DOI 10.1042/0264-6021:3570437; Halverson PB, 1998, OSTEOARTHR CARTILAGE, V6, P324, DOI 10.1053/joca.1998.0131; Hamano T, 2010, J AM SOC NEPHROL, V21, P1998, DOI 10.1681/ASN.2009090944; Hamilton JA, 2001, ARTHRITIS RES, V3, P242, DOI 10.1186/ar308; Han GH, 2008, PROTEOMICS, V8, P1346, DOI 10.1002/pmic.200700884; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Hellmann M, 2012, TRENDS CARDIOVAS MED, V22, P197, DOI 10.1016/j.tcm.2012.07.020; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Jin CC, 2011, P NATL ACAD SCI USA, V108, P14867, DOI 10.1073/pnas.1111101108; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9; Li W, 2006, FASEB J, V20, P2281, DOI 10.1096/fj.06-6114com; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; Liu YW, 2011, FRONT BIOSCI-LANDMRK, V16, P1302, DOI 10.2741/3790; London GM, 2005, CURR OPIN NEPHROL HY, V14, P525, DOI 10.1097/01.mnh.0000168336.67499.c0; Matsui I, 2009, KIDNEY INT, V75, P915, DOI 10.1038/ki.2008.700; McCarthy Geraldine M, 2009, Curr Rheumatol Rep, V11, P141; McCarthy GM, 1998, J BIOL CHEM, V273, P35161, DOI 10.1074/jbc.273.52.35161; Meng ZH, 1997, J RHEUMATOL, V24, P2385; Merx MW, 2005, J AM SOC NEPHROL, V16, P3357, DOI 10.1681/ASN.2005040365; Mietus-Snyder M, 2000, J BIOL CHEM, V275, P17661, DOI 10.1074/jbc.275.23.17661; Moe SM, 2005, KIDNEY INT, V67, P2295, DOI 10.1111/j.1523-1755.2005.00333.x; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Morgan MP, 2002, CURR OPIN RHEUMATOL, V14, P292, DOI 10.1097/00002281-200205000-00017; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; Nadra I, 2008, ATHEROSCLEROSIS, V196, P98, DOI 10.1016/j.atherosclerosis.2007.02.005; Nagayama S, 2007, INT J PHARMACEUT, V329, P192, DOI 10.1016/j.ijpharm.2006.08.025; Narayan S, 2011, ARTHRITIS RHEUM-US, V63, P422, DOI 10.1002/art.30147; Ombrellino M, 2001, SHOCK, V15, P181, DOI 10.1097/00024382-200115030-00004; Pasch A, 2012, J AM SOC NEPHROL, V23, P1744, DOI 10.1681/ASN.2012030240; Pazar B, 2011, J IMMUNOL, V186, P2495, DOI 10.4049/jimmunol.1001284; Reuben PM, 2002, J BIOL CHEM, V277, P15190, DOI 10.1074/jbc.M200278200; Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895; Sage AP, 2011, KIDNEY INT, V79, P414, DOI 10.1038/ki.2010.390; Samouilidou EC, 2012, RENAL FAILURE, V34, P160, DOI 10.3109/0886022X.2011.641515; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; SCHMID K, 1980, ATHEROSCLEROSIS, V37, P199, DOI 10.1016/0021-9150(80)90005-2; Smith ER, 2013, NEPHROLOGY, V18, P215, DOI 10.1111/nep.12021; Smith ER, 2012, NEPHROL DIAL TRANSPL, V27, P1957, DOI 10.1093/ndt/gfr609; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; TERKELTAUB RA, 1988, ARTHRITIS RHEUM, V31, P1081, DOI 10.1002/art.1780310901; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Wang HC, 1998, P NATL ACAD SCI USA, V95, P14429, DOI 10.1073/pnas.95.24.14429; Westenfeld R, 2009, J AM SOC NEPHROL, V20, P1264, DOI 10.1681/ASN.2008060572; WU H, 1994, MOL CELL BIOL, V14, P2129, DOI 10.1128/MCB.14.3.2129; Zhou WD, 2009, J PROTEOME RES, V8, P5523, DOI 10.1021/pr900603n	63	112	117	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60904	10.1371/journal.pone.0060904	http://dx.doi.org/10.1371/journal.pone.0060904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23577176	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000082
J	Chang, HJ; Liao, CC; Hu, CJ; Shen, WW; Chen, TL				Chang, Hsiu-Ju; Liao, Chien-Chang; Hu, Chaur-Jong; Shen, Winston W.; Chen, Ta-Liang			Psychiatric Disorders after Epilepsy Diagnosis: A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							SOMATIC COMORBIDITY; RISK-FACTORS; DEPRESSION; HEALTH; EPIDEMIOLOGY; ASSOCIATION; PREVALENCE; PSYCHOSIS; COMMUNITY; MORTALITY	Background: Psychiatric manifestations after occurrence of epilepsy have often been noted. However, the association between newly diagnosed epilepsy and psychiatric disorders afterward is not completely understood. We conducted two longitudinal cohorts for patients with and without epilepsy to investigate the risk factors and hazard ratios of developing psychiatric disorders after patients were newly diagnosed with epilepsy. Methods: We identified 938 patients with a new diagnosis of epilepsy and 518,748 participants without epilepsy from the National Health Insurance Research Database in 2000-2002 and tracked them until 2008. We compared the incidence of developing psychiatric disorders between the two cohorts, evaluated risk factors and measured the associated hazard ratios (HRs) and 95% confidence intervals (CIs) of developing psychiatric disorders. Findings: The incidences of psychiatric disorders for people with and without epilepsy were 94.1 and 22.6 per 1000 person-years, respectively. After adjusting the covariates, the epilepsy cohort showed the highest risks in mental retardation (HR 31.5, 95% CI 18.9 to 52.4), bipolar disorder (HR 23.5, 95% CI 11.4 to 48.3) and alcohol or drug psychosis (HR 18.8, 95% CI 11.1 to 31.8) among psychiatric complications developed after newly diagnosed epilepsy. The risk increased with epileptic general seizure and frequency of outpatient visits for epilepsy, as well as with emergency room visits and hospitalizations for epilepsy, and with older age. Chronologically, the highest risk occurred in the first year after epilepsy diagnosis (HR 11.4, 95% CI 9.88 to 13.2). Conclusion: Various psychiatric disorders were demonstrated after newly diagnosed epilepsy and closely related to general seizure and use of medical services for epilepsy. This shows a need for integrated psychiatric care for patients newly diagnosed with epilepsy, especially in the first year.	[Chang, Hsiu-Ju] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ, Dept Anesthesiol, Coll Med, Taipei, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Taipei, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Coll Med, Taipei, Taiwan; [Shen, Winston W.] Taipei Med Univ, Dept Psychiat, Wan Fang Med Ctr, Coll Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Chen, TL (corresponding author), Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan.	tlc@tmu.edu.tw		Chang, Hsiu-Ju/0000-0002-8544-0712	Foundation for Anesthesia Education and Research fellowship grant through Taipei Medical University Hospital	Foundation for Anesthesia Education and Research fellowship grant through Taipei Medical University Hospital	This research was supported by a Foundation for Anesthesia Education and Research fellowship grant through Taipei Medical University Hospital without conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K., 2007, WORLD CULT PSYCHIAT, P47; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Annegers J. F., 2001, TREATMENT EPILEPSY P, V3, P131; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Berg AT, 2008, EPILEPSIA, V49, P608, DOI 10.1111/j.1528-1167.2007.01461.x; Brodie MJ, 2000, LANCET, V356, P323, DOI 10.1016/S0140-6736(00)02515-0; Chang CC, 2012, EPILEPSIA, V53, P987, DOI 10.1111/j.1528-1167.2012.03448.x; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Clarke MC, 2012, BIOL PSYCHIAT, V71, P836, DOI 10.1016/j.biopsych.2012.01.011; EBERT D, 1994, J AFFECT DISORDERS, V32, P253, DOI 10.1016/0165-0327(94)90089-2; Edeh J., 1990, NEUROPSY NEUROPSY BE, V3, P180; Ettinger AB, 2005, NEUROLOGY, V65, P535, DOI 10.1212/01.wnl.0000172917.70752.05; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Fuller-Thomson E, 2009, EPILEPSIA, V50, P1051, DOI 10.1111/j.1528-1167.2008.01803.x; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Gaitatzis A, 2002, EPILEPSY RES, V50, P233, DOI 10.1016/S0920-1211(02)00031-1; Gaitatzis A, 2004, EPILEPSIA, V45, P1613, DOI 10.1111/j.0013-9580.2004.17504.x; Gaitatzis A, 2012, EPILEPSIA, V53, P1282, DOI 10.1111/j.1528-1167.2012.03528.x; Grabowska-Grzyb A, 2006, EPILEPSY BEHAV, V8, P411, DOI 10.1016/j.yebeh.2005.12.005; Greenlee Brian A, 2003, Curr Psychiatry Rep, V5, P410, DOI 10.1007/s11920-003-0076-3; Hamdi E, 1997, ACTA PSYCHIAT SCAND, V96, P416, DOI 10.1111/j.1600-0447.1997.tb09942.x; Hara E, 2009, PSYCHIAT CLIN NEUROS, V63, P225, DOI 10.1111/j.1440-1819.2009.01932.x; Hesdorffer DC, 2006, ANN NEUROL, V59, P35, DOI 10.1002/ana.20685; Hesdorffer DC, 2000, ANN NEUROL, V47, P246, DOI 10.1002/1531-8249(200002)47:2<246::AID-ANA17>3.3.CO;2-5; Jones JE, 2007, EPILEPSIA, V48, P2357; Kanner AM, 2002, NEUROLOGY, V58, pS27, DOI 10.1212/WNL.58.8_suppl_5.S27; Kanner Andres M, 2006, Epilepsy Curr, V6, P141, DOI 10.1111/j.1535-7511.2006.00125.x; Karceski SC, 2005, PRACT NEUROL, V4, P24; Karouni M, 2010, EUR J CLIN PHARMACOL, V66, P1151, DOI 10.1007/s00228-010-0861-y; LaFrance WC, 2008, INT REV NEUROBIOL, V83, P347, DOI 10.1016/S0074-7742(08)00020-2; Lambert MV, 1999, EPILEPSIA, V40, pS21, DOI 10.1111/j.1528-1157.1999.tb00884.x; Lhatoo SD, 2001, ANN NEUROL, V49, P336; Linehan C, 2011, EPILEPSY BEHAV, V22, P112, DOI 10.1016/j.yebeh.2011.06.006; Marcangelo MJ, 2007, PSYCHIAT CLIN N AM, V30, P781, DOI 10.1016/j.psc.2007.07.005; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mattoo SK, 2009, INDIAN J MED RES, V130, P702; Mensah SA, 2007, EPILEPSY BEHAV, V11, P118, DOI 10.1016/j.yebeh.2007.04.012; Mula M, 2008, EPILEPSY BEHAV, V13, P658, DOI 10.1016/j.yebeh.2008.08.002; Ng RMK, 2008, ASIAN J PSYCHIATR, V1, P28, DOI 10.1016/j.ajp.2008.09.009; NG SKC, 1990, AM J EPIDEMIOL, V132, P47, DOI 10.1093/oxfordjournals.aje.a115642; Ottman R, 2011, EPILEPSIA, V52, P308, DOI 10.1111/j.1528-1167.2010.02927.x; Prevots D R, 2000, MMWR Recomm Rep, V49, P1; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Qin P, 2005, BMJ-BRIT MED J, V331, P23, DOI 10.1136/bmj.38488.462037.8F; Shih CC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-191; Smoller JW, 2011, AM J PSYCHIAT, V168, P457, DOI 10.1176/appi.ajp.2011.11020336; Swinkels WAM, 2003, SEIZURE-EUR J EPILEP, V12, P587, DOI 10.1016/S1059-1311(03)00098-0; Tellez-Zenteno JF, 2005, EPILEPSIA, V46, P1955, DOI 10.1111/j.1528-1167.2005.00344.x; Vazquez B, 2003, EPILEPSY BEHAV, V4, pS20, DOI 10.1016/j.yebeh.2003.10.005; WOLF P, 1982, ADV EPILEPTOL, P237; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064; Yeh CC, 2012, J NEUROL NEUROSURG P; Zhao J, 2010, SEIZURE-EUR J EPILEP, V19, P326, DOI 10.1016/j.seizure.2010.04.014	53	19	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e59999	10.1371/journal.pone.0059999	http://dx.doi.org/10.1371/journal.pone.0059999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577079	gold, Green Published, Green Submitted			2022-12-27	WOS:000319109800022
J	Des Roches, S; Shurin, JB; Schluter, D; Harmon, LJ				Des Roches, Simone; Shurin, Jonathan B.; Schluter, Dolph; Harmon, Luke J.			Ecological and Evolutionary Effects of Stickleback on Community Structure	PLOS ONE			English	Article							CHARACTER DISPLACEMENT; NATURAL-SELECTION; RAPID EVOLUTION; DIVERSITY; FISH; BIODIVERSITY; GASTEROSTEUS; PHYTOPLANKTON; SIZE; METAANALYSIS	Species' ecology and evolution can have strong effects on communities. Both may change concurrently when species colonize a new ecosystem. We know little, however, about the combined effects of ecological and evolutionary change on community structure. We simultaneously examined the effects of top-predator ecology and evolution on freshwater community parameters using recently evolved generalist and specialist ecotypes of three-spine stickleback (Gasterosteus aculeatus). We used a mesocosm experiment to directly examine the effects of ecological (fish presence and density) and evolutionary (phenotypic diversity and specialization) factors on community structure at lower trophic levels. We evaluated zooplankton biomass and composition, periphyton and phytoplankton chlorophyll-alpha concentration, and net primary production among treatments containing different densities and diversities of stickleback. Our results showed that both ecological and evolutionary differences in the top-predator affect different aspects of community structure and composition. Community structure, specifically the abundance of organisms at each trophic level, was affected by stickleback presence and density, whereas composition of zooplankton was influenced by stickleback diversity and specialization. Primary productivity, in terms of chlorophyll-alpha concentration and net primary production was affected by ecological but not evolutionary factors. Our results stress the importance of concurrently evaluating both changes in density and phenotypic diversity on the structure and composition of communities.	[Des Roches, Simone; Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Shurin, Jonathan B.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Schluter, Dolph] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	Idaho; University of Idaho; University of California System; University of California San Diego; University of British Columbia	Des Roches, S (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	simone.desroches@gmail.com		Schluter, Dolph/0000-0003-1683-7836; Harmon, Luke/0000-0002-4985-5750	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support for this study was supplied by Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert AYK, 2004, EVOLUTION, V58, P1099; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; Bell T, 2003, OECOLOGIA, V134, P578, DOI 10.1007/s00442-002-1135-x; BENTZEN P, 1984, CAN J ZOOL, V62, P2280, DOI 10.1139/z84-331; Bolnick DI, 2010, P ROY SOC B-BIOL SCI, V277, P1789, DOI 10.1098/rspb.2010.0018; Brett MT, 1996, P NATL ACAD SCI USA, V93, P7723, DOI 10.1073/pnas.93.15.7723; CAMERON JN, 1973, J FISH RES BOARD CAN, V30, P1179, DOI 10.1139/f73-188; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; CASE TJ, 1975, ECOLOGY, V56, P3, DOI 10.2307/1935296; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Edwards RW, 1962, J ECOL, V50, P14; Gislason GM, 1998, INT VER THEOR ANGEW, V26, P2244; Grant P. R., 2008, WHY SPECIES MULTIPLY; Griffin JN, 2008, ECOLOGY, V89, P298, DOI 10.1890/07-1220.1; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; HAMBRIGHT KD, 1994, LIMNOL OCEANOGR, V39, P897, DOI 10.4319/lo.1994.39.4.0897; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jakobsen TS, 2004, MAR ECOL PROG SER, V279, P305, DOI 10.3354/meps279305; Lande R, 2009, PHILOS T R SOC B, V364, P1511, DOI 10.1098/rstb.2009.0017; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Losos JB, 1997, NATURE, V387, P70, DOI 10.1038/387070a0; Lowe RL, 1996, HYDROBIOLOGIA, V328, P135, DOI 10.1007/BF00018710; MAC ARTHUR ROBERT H., 1967; MAZUMDER A, 1990, SCIENCE, V247, P312, DOI 10.1126/science.247.4940.312; McCauley E., 1984, IBP HDB, P228; McCollum EW, 1998, ECOLOGY, V79, P1980; MCPHAIL JD, 1993, CAN J ZOOL, V71, P515, DOI 10.1139/z93-072; MCQUEEN DJ, 1989, ECOL MONOGR, V59, P289, DOI 10.2307/1942603; Nomura M, 2005, POPULATION STU UNPUB; Norberg J, 2012, NAT CLIM CHANGE, V2, P747, DOI [10.1038/NCLIMATE1588, 10.1038/nclimate1588]; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; Palkovacs EP, 2009, ECOLOGY, V90, P300, DOI 10.1890/08-1673.1; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; Persson A, 2006, FRESHWATER BIOL, V51, P1298, DOI 10.1111/j.1365-2427.2006.01569.x; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; Polis Gary A., 1996, P435; Post DM, 2008, ECOLOGY, V89, P2019, DOI 10.1890/07-1216.1; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Shurin JB, 2001, ECOLOGY, V82, P3404, DOI 10.2307/2680161; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Skelly DK, 2002, ECOLOGY, V83, P2097, DOI 10.1890/0012-9658(2002)083[2097:EVAEOI]2.0.CO;2; SLOBODKIN LAWRENCE B., 1961; Strauss SY, 2008, ECOL LETT, V11, P199, DOI 10.1111/j.1461-0248.2007.01128.x; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Tabachnick B. G., 2006, USING MULTIVARIATE S; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; THRELKELD ST, 1988, LIMNOL OCEANOGR, V33, P1362, DOI 10.4319/lo.1988.33.6.1362; VANNI MJ, 1990, ECOLOGY, V71, P921, DOI 10.2307/1937363; Vanni MJ, 1997, ECOLOGY, V78, P21; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wootton RJ, 2000, BEHAVIOUR, V137, P981, DOI 10.1163/156853900502385; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x	67	31	31	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59644	10.1371/journal.pone.0059644	http://dx.doi.org/10.1371/journal.pone.0059644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573203	gold, Green Submitted, Green Published			2022-12-27	WOS:000318840100022
J	Xie, L; Hu, LF; Teo, XQ; Tiong, CX; Tazzari, V; Sparatore, A; Del Soldato, P; Dawe, GS; Bian, JS				Xie, Li; Hu, Li-Fang; Teo, Xing Qi; Tiong, Chi Xin; Tazzari, Valerio; Sparatore, Anna; Del Soldato, Piero; Dawe, Gavin Stewart; Bian, Jin-Song			Therapeutic Effect of Hydrogen Sulfide-Releasing L-Dopa Derivative ACS84 on 6-OHDA-Induced Parkinson's Disease Rat Model	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; RESPONSE ELEMENT; HEME OXYGENASE-1; PROTEIN-KINASE; SH-SY5Y CELLS; 2 PARTS; LEVODOPA; SULFHYDRATION; ASTROCYTES	Parkinson's disease (PD), characterized by loss of dopaminergic neurons in the substantia nigra, is a neurodegenerative disorder of central nervous system. The present study was designed to investigate the therapeutic effect of ACS84, a hydrogen sulfide-releasing-L-Dopa derivative compound, in a 6-hydroxydopamine (6-OHDA)-induced PD model. ACS84 protected the SH-SY5Y cells against 6-OHDA-induced cell injury and oxidative stress. The protective effect resulted from stimulation of Nrf-2 nuclear translocation and promotion of anti-oxidant enzymes expression. In the 6-OHDA-induced PD rat model, intragastric administration of ACS84 relieved the movement dysfunction of the model animals. Immunofluorescence staining and High-performance liquid chromatography analysis showed that ACS84 alleviated the loss of tyrosine-hydroxylase positive neurons in the substantia nigra and the declined dopamine concentration in the injured striatums of the 6-OHDA-induced PD model. Moreover, ACS84 reversed the elevated malondialdehyde level and the decreased glutathione level in vivo. In conclusion, ACS84 may prevent neurodegeneration via the anti-oxidative mechanism and has potential therapeutic values for Parkinson's disease.	[Xie, Li; Teo, Xing Qi; Tiong, Chi Xin; Dawe, Gavin Stewart; Bian, Jin-Song] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Hu, Li-Fang] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Hu, Li-Fang] Soochow Univ, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China; [Tazzari, Valerio; Sparatore, Anna] Univ Milan, Dipartimento Sci Farmaceut, Milan, Italy; [Del Soldato, Piero] CTG Pharma, Milan, Italy	National University of Singapore; Soochow University - China; Soochow University - China; University of Milan	Bian, JS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore.	phcbjs@nus.edu.sg	Sparatore, Anna/J-8634-2015; Xie, Li/ABE-2011-2020	Sparatore, Anna/0000-0003-2135-2649; Xie, Li/0000-0002-5555-5762; Bian, Jinsong/0000-0002-7741-598X; Dawe, Gavin/0000-0001-6119-701X	Singapore National Medical Research Council [1183 / 2008]	Singapore National Medical Research Council(National Medical Research Council, Singapore)	This work was supported by a research grant from Singapore National Medical Research Council [1183 / 2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Alam J, 2003, CURR PHARM DESIGN, V9, P2499, DOI 10.2174/1381612033453730; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Cao TT, 2005, J NEUROCHEM, V95, P406, DOI 10.1111/j.1471-4159.2005.03377.x; Chakraborty A, 2011, P NATL ACAD SCI USA, V108, P2205, DOI 10.1073/pnas.1019381108; Double KL, 2010, PROG NEUROBIOL, V92, P316, DOI 10.1016/j.pneurobio.2010.06.001; Drukarch B, 2006, J NEURAL TRANSM, V113, P593, DOI 10.1007/s00702-005-0350-0; Fuso A, 2005, MOL CELL NEUROSCI, V28, P195, DOI 10.1016/j.mcn.2004.09.007; Hattori N, 2009, PARKINSONISM RELAT D, V15, pS35, DOI 10.1016/S1353-8020(09)70010-0; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Hu LF, 2010, AGING CELL, V9, P135, DOI 10.1111/j.1474-9726.2009.00543.x; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Jankovic J, 2007, CNS DRUGS, V21, P677, DOI 10.2165/00023210-200721080-00005; Kida K, 2010, ANTIOXID REDOX SIGNA; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; KUTTY RK, 1994, ANN NY ACAD SCI, V738, P427; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lee M, 2010, J BIOL CHEM, V285, P17318, DOI 10.1074/jbc.M110.115261; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Li J, 2002, PHYSIOL GENOMICS, V9, P137, DOI 10.1152/physiolgenomics.00003.2002; Liu YY, 2010, J ALZHEIMERS DIS, V22, P1189, DOI 10.3233/JAD-2010-101002; Liu YY, 2011, NEUROCHEM INT; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Minelli A, 2010, FREE RADICAL BIO MED, V49, P31, DOI 10.1016/j.freeradbiomed.2010.03.011; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; MYTILINEOU C, 1993, J NEUROCHEM, V61, P1470, DOI 10.1111/j.1471-4159.1993.tb13642.x; Mytilineou C, 2003, J PHARMACOL EXP THER, V304, P792, DOI 10.1124/jpet.102.042267; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Nagatsu T, 2009, PARKINSONISM RELAT D, V15, pS3, DOI 10.1016/S1353-8020(09)70004-5; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Schapira AHV, 2008, MOVEMENT DISORD, V23, pS515, DOI 10.1002/mds.22146; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Sparatore Anna, 2011, Expert Rev Clin Pharmacol, V4, P109, DOI 10.1586/ecp.10.122; Taniguchi S, 2011, BRIT J PHARMACOL, V162, P1171, DOI 10.1111/j.1476-5381.2010.01119.x; Tao BB, 2012, ANTIOXID REDOX SIGNA; Tiong CX, 2010, BRIT J PHARMACOL, V161, P467, DOI 10.1111/j.1476-5381.2010.00887.x; Tolwani RJ, 1999, LAB ANIM SCI, V49, P363; Weiner WJ, 2006, NAT CLIN PRACT NEURO, V2, P518, DOI 10.1038/ncpneuro0293; Xu ZS, 2011, FREE RADIC BIOL MED; Yang G., 2012, ANTIOXID REDOX SIGNA; Zhu W, 2007, FASEB J, V21, P3835, DOI 10.1096/fj.07-8386com	48	47	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60200	10.1371/journal.pone.0060200	http://dx.doi.org/10.1371/journal.pone.0060200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573240	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100052
J	Zhang, Y; Lopez-Gatell, H; Alpuche-Aranda, CM; Stoto, MA				Zhang, Ying; Lopez-Gatell, Hugo; Alpuche-Aranda, Celia M.; Stoto, Michael A.			Did Advances in Global Surveillance and Notification Systems Make a Difference in the 2009 H1N1 Pandemic?-A Retrospective Analysis	PLOS ONE			English	Article								Background: The 2009 H1N1 outbreak provides an opportunity to identify strengths and weaknesses of disease surveillance and notification systems that have been implemented in the past decade. Methods: Drawing on a systematic review of the scientific literature, official documents, websites, and news reports, we constructed a timeline differentiating three kinds of events: (1) the emergence and spread of the pH1N1 virus, (2) local health officials' awareness and understanding of the outbreak, and (3) notifications about the events and their implications. We then conducted a "critical event'' analysis of the surveillance process to ascertain when health officials became aware of the epidemiologic facts of the unfolding pandemic and whether advances in surveillance notification systems hastened detection. Results: This analysis revealed three critical events. First, medical personnel identified pH1N1in California children because of an experimental surveillance program, leading to a novel viral strain being identified by CDC. Second, Mexican officials recognized that unconnected outbreaks represented a single phenomenon. Finally, the identification of a pH1N1 outbreak in a New York City high school was hastened by awareness of the emerging pandemic. Analysis of the timeline suggests that at best the global response could have been about one week earlier (which would not have stopped spread to other countries), and could have been much later. Conclusions: This analysis shows that investments in global surveillance and notification systems made an important difference in the 2009 H1N1 pandemic. In particular, enhanced laboratory capacity in the U.S. and Canada led to earlier detection and characterization of the 2009 H1N1. This includes enhanced capacity at the federal, state, and local levels in the U.S., as well as a trilateral agreement enabling collaboration among U.S., Canada, and Mexico. In addition, improved global notification systems contributed by helping health officials understand the relevance and importance of their own information.	[Zhang, Ying; Stoto, Michael A.] Georgetown Univ, Dept Hlth Syst Adm, Washington, DC 20007 USA; [Lopez-Gatell, Hugo; Alpuche-Aranda, Celia M.] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico	Georgetown University; Instituto Nacional de Salud Publica	Stoto, MA (corresponding author), Georgetown Univ, Dept Hlth Syst Adm, Washington, DC 20007 USA.	stotom@georgetown.edu		Zhang, Ying/0000-0003-3697-6702; Stoto, Michael/0000-0001-8293-471X	Harvard School of Public Health; U.S. Centers for Disease Control and Prevention (CDC) [5P01TP000307-01]; O'Neill Institute for National and Global Health Law at Georgetown University	Harvard School of Public Health; U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); O'Neill Institute for National and Global Health Law at Georgetown University	This article was developed with funding support awarded to the Harvard School of Public Health under a cooperative agreement with the U.S. Centers for Disease Control and Prevention (CDC) grant number 5P01TP000307-01 (Preparedness and Emergency Response Research Center). The content of this publication as well as the views and discussions expressed in it are solely those of the authors and do not necessarily represent the views of the CDC or the U.S. Department of Health and Human Services nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. The authors would also like to thank the O'Neill Institute for National and Global Health Law at Georgetown University for its support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman LK, 2011, NY TIMES, pD1; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; Brownstein JS, 2010, NEW ENGL J MED, V362, P1731, DOI 10.1056/NEJMsr1002707; Centers for Disease Control and Prevention, 2010, 2009 H1N1 PANDEMIC S; Centers for Disease Control and Prevention (CDC), 2009, CDC SEAS INFL FLU WE; Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107; CHAN M, 2009, SWINE INFLUENZA STAT; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Cohen J, 2009, EXCLUSIVE INTERVIEW; Cohen J, 2009, YET ANOTHER NEW PATI; Cohen J, 2009, SWINE FLU OUTBREAK D; Cordova-Villalobos Jose A, 2009, Health Res Policy Syst, V7, P21, DOI 10.1186/1478-4505-7-21; Division of State and Local Readiness in the Office of Public Health Preparedness and Response (OPHPR) Centers for Disease Control and Prevention (CDC), PUBL HLTH PREP CAP N; Frenk J, 2009, NY TIMES, pA23; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Gostin LO, 2004, JAMA-J AM MED ASSOC, V291, P2623, DOI 10.1001/jama.291.21.2623; Harris G, 2009, NY TIMES, pA7; Hitchcock P, 2007, BIOSECUR BIOTERROR, V5, P206, DOI 10.1089/bsp.2007.0041; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Jordan H. T., 2009, Morbidity and Mortality Weekly Report, V58, P470; Katz R, 2009, EMERG INFECT DIS, V15, P1165, DOI 10.3201/eid1508.090665; Lezana M, 2009, A H1N1 EPIDEMIC MEXI; Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007; Lopez-Gatell H, 2009, 30 NAT C MEX ASS INF; Lopez-Gatell H, 2009, EMERGENCY NOTIFICATI; March JG, 1991, ORGAN SCI, V2, P1, DOI 10.1287/orsc.2.1.1; Ministry of Health Mexico, 2010, INFL EST SIT ACT EP; [Ministry of Health Mexico Centro nacional de vigilancia epidemiologica y control de enfermedades (national center of epidemiological surveillance and diseases control)], 2012, CTR NACL VIGILANCIA; Office of Public Health Preparedness and Response (OPHPR), 2010, 2010 REP PUBL HLTH P; Pandemic Influenza Preparedness Team, 2011, UK INFL PAND PREP ST; Paquet C, 2006, Euro Surveill, V11, P212; ProMED, 2009, PRO AH EDR INFL H1N1; Stoto MA, LEARN ACT R IN PRESS; Stoto MA, 2005, TR285DHHS RAND HLTH; Stoto MA, 2007, INFECTIOUS DIS SURVE, P63; Swerdlow DL, 2011, CLIN INFECT DIS, V52, pS1, DOI 10.1093/cid/ciq005; Trust for America's Health (TFAH), 2010, READ NOT 2010 PROT P; U.S. Department of Health and Human Services, 2009, HHS DECL PUBL HLTH E; U.S. Department of Health and Human Services, 2009, INT IMPL GUID NAT HL; US Department of Health and Human Services, 2009, NAT HLTH SEC STRAT U; Weaver M, 2009, MEXICAN SWINE FLU DE; Weick KE, 2011, MANAGING UNEXPECTED; Zhong N, 2006, BRIT MED J, V333, P389, DOI 10.1136/bmj.333.7564.389	44	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59893	10.1371/journal.pone.0059893	http://dx.doi.org/10.1371/journal.pone.0059893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573217	Green Published, gold			2022-12-27	WOS:000318840100032
J	Cai, XY; Li, Y				Cai, Xueya; Li, Yue			Are AMI Patients with Comorbid Mental Illness More Likely to be Admitted to Hospitals with Lower Quality of AMI Care?	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; MEDICAL-CARE; HEALTH-CARE; ADMINISTRATIVE DATA; MORTALITY-RATES; UNITED-STATES; DISORDERS; PERFORMANCE; DEPRESSION	Objective: Older patients with comorbid mental illness are shown to receive less appropriate care for their medical conditions. This study analyzed Medicare patients hospitalized for acute myocardial infarction (AMI) and determined whether those with comorbid mental illness were more likely to present to hospitals with lower quality of AMI care. Methods: Retrospective analyses of Medicare claims in 2008. Hospital quality was measured using the five "Hospital Compare'' process indicators (aspirin at admission/discharge, beta-blocker at admission/discharge, and angiotension-converting enzyme inhibitor or angiotension receptor blocker for left ventricular dysfunction). Multinomial logit model determined the association of mental illness with admission to low-quality hospitals (rank of the composite process score <10th percentile) or high-quality hospitals (rank>90th percentile), compared to admissions to other hospitals with medium quality. Multivariate analyses further determined the effects of hospital type and mental diagnosis on outcomes. Results: Among all AMI admissions to 2,845 hospitals, 41,044 out of 287,881 patients were diagnosed with mental illness. Mental illness predicted a higher likelihood of admission to low-quality hospitals (unadjusted rate 2.9% vs. 2.0%; adjusted odds ratio [OR]1.25, 95% confidence interval [CI] 1.17-1.34, p<0.01), and an equal likelihood to high-quality hospitals (unadjusted rate 9.8% vs. 10.3%; adjusted OR 0.97, 95% CI 0.93-1.01, p = 0.11). Both lower hospital quality and mental diagnosis predicted higher rates of 30-day readmission, 30-day mortality, and 1-year mortality. Conclusions: Among Medicare myocardial infarction patients, comorbid mental illness was associated with an increased risk for admission to lower-quality hospitals. Both lower hospital quality and mental illness predicted worse post-AMI outcomes.	[Cai, Xueya; Li, Yue] Univ Rochester, Sch Med & Dent, Dept Biostat & Computat Biol, Rochester, NY 14627 USA; [Cai, Xueya; Li, Yue] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, Rochester, NY USA	University of Rochester; University of Rochester	Cai, XY (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biostat & Computat Biol, Rochester, NY 14627 USA.	xueya_cai@urmc.rochester.edu			National Institute on Aging (NIA) [R01AG033202]; NATIONAL INSTITUTE ON AGING [R01AG033202] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institute on Aging (NIA) under grant R01AG033202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2005, CIRCULATION, V111, P480, DOI 10.1161/01.CIR.0000153813.64165.5D; [Anonymous], 2005, RURAL HLTH RES CTR R; Barefoot JC, 1996, CIRCULATION, V93, P1976, DOI 10.1161/01.CIR.93.11.1976; BLUSTEIN J, 1995, AM J PUBLIC HEALTH, V85, P345, DOI 10.2105/AJPH.85.3.345; Bunde J, 2006, PSYCHOSOM MED, V68, P51, DOI 10.1097/01.psy.0000195724.58085.f0; Desai MM, 2002, J NERV MENT DIS, V190, P51, DOI 10.1097/00005053-200201000-00014; Druss BG, 2007, J CLIN PSYCHIAT, V68, P40, DOI 10.4088/JCP.0407e09; Druss BG, 2000, JAMA-J AM MED ASSOC, V283, P506, DOI 10.1001/jama.283.4.506; Druss BG, 2001, ARCH GEN PSYCHIAT, V58, P565, DOI 10.1001/archpsyc.58.6.565; Druss BG, 1998, AM J PSYCHIAT, V155, P1775, DOI 10.1176/ajp.155.12.1775; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508; Hippisley-Cox J, 2007, HEART, V93, P1256, DOI 10.1136/hrt.2006.110171; Horvitz-Lennon M, 2006, HEALTH AFFAIR, V25, P659, DOI 10.1377/hlthaff.25.3.659; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Jha AK, 2010, ANN INTERN MED, V153, P299, DOI 10.7326/0003-4819-153-5-201009070-00004; KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225; Kisely S, 2009, BRIT J PSYCHIAT, V195, P545, DOI 10.1192/bjp.bp.109.067082; Kovner C, 2002, HEALTH SERV RES, V37, P611; Landrum MB, 2000, HLTH SERVICES OUTCOM, V1, P23, DOI [10.1023/A:1010093701870, DOI 10.1023/A:1010093701870]; Li Y, 2007, MED CARE, V45, P587, DOI 10.1097/MLR.0b013e31803d3b54; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Newcomer JW, 2007, JAMA-J AM MED ASSOC, V298, P1794, DOI 10.1001/jama.298.15.1794; Phibbs CS, 1995, MED CARE RES REV, V52, P532, DOI 10.1177/107755879505200406; Popescu I, 2010, ARCH INTERN MED, V170, P1209, DOI 10.1001/archinternmed.2010.227; Popescu I, 2009, CIRC-CARDIOVASC QUAL, V2, P221, DOI 10.1161/CIRCOUTCOMES.108.813790; Rieckmann N, 2006, AM HEART J, V152, P922, DOI 10.1016/j.ahj.2006.05.014; Shaller D, 2003, HEALTH AFFAIR, V22, P95, DOI 10.1377/hlthaff.22.2.95; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Werner RM, 2010, HEALTH AFFAIR, V29, P1319, DOI 10.1377/hlthaff.2008.0770; Williams SC, 2006, CIRCULATION, V114, P558, DOI 10.1161/CIRCULATIONAHA.105.600973	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60258	10.1371/journal.pone.0060258	http://dx.doi.org/10.1371/journal.pone.0060258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565212	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300081
J	Darkins, R; Cooke, EJ; Ghahramani, Z; Kirk, PDW; Wild, DL; Savage, RS				Darkins, Robert; Cooke, Emma J.; Ghahramani, Zoubin; Kirk, Paul D. W.; Wild, David L.; Savage, Richard S.			Accelerating Bayesian Hierarchical Clustering of Time Series Data with a Randomised Algorithm	PLOS ONE			English	Article							EXPRESSION	We live in an era of abundant data. This has necessitated the development of new and innovative statistical algorithms to get the most from experimental data. For example, faster algorithms make practical the analysis of larger genomic data sets, allowing us to extend the utility of cutting-edge statistical methods. We present a randomised algorithm that accelerates the clustering of time series data using the Bayesian Hierarchical Clustering (BHC) statistical method. BHC is a general method for clustering any discretely sampled time series data. In this paper we focus on a particular application to microarray gene expression data. We define and analyse the randomised algorithm, before presenting results on both synthetic and real biological data sets. We show that the randomised algorithm leads to substantial gains in speed with minimal loss in clustering quality. The randomised time series BHC algorithm is available as part of the R package BHC, which is available for download from Bioconductor (version 2.10 and above) via http://bioconductor.org/packages/2.10/bioc/html/BHC. html. We have also made available a set of R scripts which can be used to reproduce the analyses carried out in this paper. These are available from the following URL. https://sites.google. com/site/randomisedbhc/.	[Darkins, Robert; Kirk, Paul D. W.; Wild, David L.; Savage, Richard S.] Univ Warwick, Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Cooke, Emma J.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Ghahramani, Zoubin] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England	University of Warwick; University of Warwick; University of Cambridge	Savage, RS (corresponding author), Univ Warwick, Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England.	r.s.savage@warwick.ac.uk	Kirk, Paul/T-4991-2018	Kirk, Paul/0000-0002-5931-7489	EPSRC [EP/F027400/1, EP/I036575/1]; MRC Biostatistics Fellowship; Warwick MOAC Doctoral Training Centre; Engineering and Physical Sciences Research Council [EP/I036575/1, EP/F027400/1] Funding Source: researchfish; Medical Research Council [G0902104] Funding Source: researchfish; MRC [G0902104] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC Biostatistics Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Warwick MOAC Doctoral Training Centre; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge support from EPSRC grants EP/F027400/1 (DLW, PDWK, RD and ZG) and EP/I036575/1 (DLW, PDWK and ZG). RSS acknowledges support from an MRC Biostatistics Fellowship. EJC acknowledges support from the Warwick MOAC Doctoral Training Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Bar-Joseph Z, 2003, J COMPUT BIOL, V10, P341, DOI 10.1089/10665270360688057; Bauwens L, 2007, ECONOMET REV, V26, P365, DOI 10.1080/07474930701220576; Beal M.J., 2006, P P 22 C ANN C UNC A, P23; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu W, 2005, BIOINFORMATICS, V21, P3385, DOI 10.1093/bioinformatics/bti526; Cooke EJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-399; Datta S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-397; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fruehwirth-Schnatter S, 2008, J BUS ECON STAT, V26, P78, DOI 10.1198/073500107000000106; Heard NA, 2006, J AM STAT ASSOC, V101, P18, DOI 10.1198/016214505000000187; Heard NA, 2005, P NATL ACAD SCI USA, V102, P16939, DOI 10.1073/pnas.0408393102; Heller, 2005, PASCAL WORKSH STAT O, V2005, P1; Heller K, 2009, AISTATS 2009 C; Heller K. A., 2005, 22 INT C MACH LEARN; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jackson E, 2007, INT CONF ACOUST SPEE, P1077; Kirk PDW, 2009, BIOINFORMATICS, V25, P1300, DOI 10.1093/bioinformatics/btp139; Liverani S, 2010, LECT N BIOINFORMAT, V6160, P240; Ma P, 2006, NUCLEIC ACIDS RES, V34, P1261, DOI 10.1093/nar/gkl013; Motwani R., 1995, RANDOMISED ALGORITHM, DOI 10.1017/CBO9780511814075; Savage RS, 2010, BIOINFORMATICS, V26, pi158, DOI 10.1093/bioinformatics/btq210; Savage RS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-242; Schliep A, 2005, IEEE ACM T COMPUT BI, V2, P179, DOI 10.1109/TCBB.2005.31	25	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59795	10.1371/journal.pone.0059795	http://dx.doi.org/10.1371/journal.pone.0059795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565168	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300037
J	Mondal, A; Aizawa, S; Sakata, I; Goswami, C; Oda, S; Sakai, T				Mondal, Anupom; Aizawa, Sayaka; Sakata, Ichiro; Goswami, Chayon; Oda, Sen-ichi; Sakai, Takafumi			Mechanism of Ghrelin-Induced Gastric Contractions in Suncus murinus (House Musk Shrew): Involvement of Intrinsic Primary Afferent Neurons	PLOS ONE			English	Article							GUINEA-PIG ILEUM; MIGRATING MOTOR COMPLEX; III-LIKE CONTRACTIONS; MYENTERIC AH NEURONS; GASTROINTESTINAL-TRACT; IN-VITRO; SMALL-INTESTINE; NEUROCHEMICAL CLASSIFICATION; CIRCULAR MUSCLE; DISTAL COLON	Here, we have reported that motilin can induce contractions in a dose-dependent manner in isolated Suncus murinus (house musk shrew) stomach. We have also shown that after pretreatment with a low dose of motilin (10(-10) M), ghrelin also induces gastric contractions at levels of 10(-10) M to 10(-7) M. However, the neural mechanism of ghrelin action in the stomach has not been fully revealed. In the present study, we studied the mechanism of ghrelin-induced contraction in vitro using a pharmacological method. The responses to ghrelin in the stomach were almost completely abolished by hexamethonium and were significantly suppressed by the administration of phentolamine, prazosin, ondansetron, and naloxone. Additionally, N-nitro-L-arginine methylester significantly potentiated the contractions. Importantly, the mucosa is essential for ghrelin-induced, but not motilin-induced, gastric contractions. To evaluate the involvement of intrinsic primary afferent neurons (IPANs), which are multiaxonal neurons that pass signals from the mucosa to the myenteric plexus, we examined the effect of the IPAN-related pathway on ghrelin-induced contractions and found that pretreatment with adenosine and tachykinergic receptor 3 antagonists (SR142801) significantly eliminated the contractions and GR113808 (5-hydroxytryptamine receptor 4 antagonist) almost completely eliminated it. The results indicate that ghrelin stimulates and modulates suncus gastric contractions through cholinergic, adrenergic, serotonergic, opioidergic neurons and nitric oxide synthases in the myenteric plexus. The mucosa is also important for ghrelin-induced gastric contractions, and IPANs may be the important interneurons that pass the signal from the mucosa to the myenteric plexus.	[Mondal, Anupom; Aizawa, Sayaka; Sakata, Ichiro; Goswami, Chayon; Sakai, Takafumi] Saitama Univ, Grad Sch Sci & Engn, Area Regulatory Biol, Saitama 3388570, Japan; [Oda, Sen-ichi] Okayama Univ Sci, Lab Anim Management & Resources, Dept Zool, Okayama, Japan	Saitama University; Okayama University of Science	Sakai, T (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Area Regulatory Biol, Saitama 3388570, Japan.	tsakai@mail.saitama-u.ac.jp	AIZAWA, SAYAKA/AAF-3284-2019; Sakata, Ichiro/F-9194-2012	Sakata, Ichiro/0000-0002-6067-0407; Goswami, Chayon/0000-0002-2301-6692	Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [21590785]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for the Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI (grant number 21590785). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SW, 2010, ARCH PHARM RES, V33, P479, DOI 10.1007/s12272-010-0319-x; Alex G, 2001, NEUROSCIENCE, V104, P263, DOI 10.1016/S0306-4522(01)00064-1; Amemiya N, 1997, EUR J PHARMACOL, V339, P173, DOI 10.1016/S0014-2999(97)01366-6; Ariga H, 2007, NEUROGASTROENT MOTIL, V19, P675, DOI 10.1111/j.1365-2982.2007.00945.x; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Bassil AK, 2006, EUR J PHARMACOL, V544, P146, DOI 10.1016/j.ejphar.2006.06.039; BERTRAND PP, 1995, AM J PHYSIOL-GASTR L, V269, pG710, DOI 10.1152/ajpgi.1995.269.5.G710; Bertrand PP, 1997, AM J PHYSIOL-GASTR L, V273, pG422; BULBRING E, 1958, BRIT J PHARM CHEMOTH, V13, P444; CHRISTOFI FL, 1994, BRIT J PHARMACOL, V113, P703, DOI 10.1111/j.1476-5381.1994.tb17050.x; Clerc N, 2004, NEUROGASTROENT MOTIL, V16, P24, DOI 10.1111/j.1743-3150.2004.00470.x; Cooke HJ, 1997, NEUROGASTROENT MOTIL, V9, P181, DOI 10.1046/j.1365-2982.1997.d01-41.x; Cosola C, 2006, J PHYSIOL PHARMACOL, V57, P439; Costa M, 1996, NEUROSCIENCE, V75, P949, DOI 10.1016/0306-4522(96)00275-8; Dass NB, 2003, NEUROSCIENCE, V120, P443, DOI 10.1016/S0306-4522(03)00327-0; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Depoortere I, 2005, EUR J PHARMACOL, V515, P160, DOI 10.1016/j.ejphar.2005.04.008; Depoortere I, 2003, J PHARMACOL EXP THER, V305, P660, DOI 10.1124/jpet.102.047563; Douady CJ, 2003, MOL PHYLOGENET EVOL, V28, P285, DOI 10.1016/S1055-7903(03)00119-2; Edholm T, 2004, REGUL PEPTIDES, V121, P25, DOI 10.1016/j.regpep.2004.04.001; FONTAINE J, 1989, BRIT J PHARMACOL, V96, P583, DOI 10.1111/j.1476-5381.1989.tb11856.x; Fujino K, 2003, J PHYSIOL-LONDON, V550, P227, DOI 10.1113/jphysiol.2003.040600; Fukuda H, 2004, SCAND J GASTROENTERO, V39, P1209, DOI 10.1080/00365520410007908; Furness JB, 2004, PROG NEUROBIOL, V72, P143, DOI 10.1016/j.pneurobio.2003.12.004; Furness JB, 1998, PROG NEUROBIOL, V54, P1, DOI 10.1016/S0301-0082(97)00051-8; Gershon MD, 2005, J CLIN GASTROENTEROL, V39, pS184, DOI 10.1097/01.mcg.0000156403.37240.30; Ishida Y, 2009, PEPTIDES, V30, P982, DOI 10.1016/j.peptides.2009.01.006; Ito H, 2002, EXP ANIM TOKYO, V51, P19, DOI 10.1538/expanim.51.19; ITOH Z, 1976, SCAND J GASTROENTERO, V11, P93; JANSSENS J, 1983, REGUL PEPTIDES, V6, P363, DOI 10.1016/0167-0115(83)90265-3; Javid FA, 1999, BRIT J PHARMACOL, V127, P1867, DOI 10.1038/sj.bjp.0702729; Jenkinson KM, 1999, HISTOCHEM CELL BIOL, V112, P233, DOI 10.1007/s004180050411; Johnson PJ, 1996, BRIT J PHARMACOL, V118, P973, DOI 10.1111/j.1476-5381.1996.tb15495.x; KILBINGER H, 1992, N-S ARCH PHARMACOL, V345, P270; KIRCHGESSNER AL, 1992, J NEUROSCI, V12, P235; Kirchgessner AL, 1996, J COMP NEUROL, V371, P270; Kitazawa T, 2005, GUT, V54, P1078, DOI 10.1136/gut.2005.065896; KITAZAWA T, 1994, BRIT J PHARMACOL, V111, P288, DOI 10.1111/j.1476-5381.1994.tb14058.x; Kitazawa T, 2002, NEUROGASTROENT MOTIL, V14, P3, DOI 10.1046/j.1365-2982.2002.00298.x; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; KUNZE WAA, 1995, NEUROSCIENCE, V66, P1, DOI 10.1016/0306-4522(95)00067-S; Liang SD, 1997, J PHARMACOL EXP THER, V280, P650; Lomax AE, 2000, CELL TISSUE RES, V302, P59, DOI 10.1007/s004410000260; MAGGI CA, 1994, BRIT J PHARMACOL, V112, P161, DOI 10.1111/j.1476-5381.1994.tb13046.x; Mann PT, 1997, CELL TISSUE RES, V289, P1, DOI 10.1007/s004410050846; Masuda Y, 2000, BIOCHEM BIOPH RES CO, V276, P905, DOI 10.1006/bbrc.2000.3568; Mondal A, 2011, NEUROGASTROENT MOTIL, V23, P1123, DOI 10.1111/j.1365-2982.2011.01801.x; Mondal A, 2012, AM J PHYSIOL-GASTR L, V302, pG1207, DOI 10.1152/ajpgi.00379.2011; Moneta NA, 1997, AM J PHYSIOL-GASTR L, V272, pG38, DOI 10.1152/ajpgi.1997.272.1.G38; MORITA K, 1985, NEUROSCIENCE, V14, P661, DOI 10.1016/0306-4522(85)90317-3; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Ohno T, 2006, NEUROGASTROENT MOTIL, V18, P129, DOI 10.1111/j.1365-2982.2005.00747.x; Peeters TL, 2005, GUT, V54, P1638, DOI 10.1136/gut.2004.062604; PINEIROCARRERO VM, 1991, AM J PHYSIOL, V260, pG232, DOI 10.1152/ajpgi.1991.260.2.G232; Poole DP, 2006, CELL TISSUE RES, V325, P413, DOI 10.1007/s00441-006-0181-9; Prins NH, 2000, BRIT J PHARMACOL, V129, P1601, DOI 10.1038/sj.bjp.0703254; Sakahara S, 2010, AM J PHYSIOL-REG I, V299, pR1106, DOI 10.1152/ajpregu.00278.2010; Sakata I, 2003, NEUROSCI LETT, V342, P183, DOI 10.1016/S0304-3940(03)00294-5; Suzuki A, 2012, PEPTIDES, V36, P29, DOI 10.1016/j.peptides.2012.04.019; Takahashi T, 2012, J NEUROGASTROENTEROL, V18, P246, DOI 10.5056/jnm.2012.18.3.246; Taniguchi H, 2008, AM J PHYSIOL-GASTR L, V295, pG403, DOI 10.1152/ajpgi.90260.2008; Tsutsui C, 2009, PEPTIDES, V30, P318, DOI 10.1016/j.peptides.2008.10.006; Zheng J, 2009, NEUROGASTROENT MOTIL, V21, P78, DOI 10.1111/j.1365-2982.2008.01179.x	64	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60365	10.1371/journal.pone.0060365	http://dx.doi.org/10.1371/journal.pone.0060365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565235	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300105
J	Raimbourg, Q; Perez, J; Vandermeersch, S; Prignon, A; Hanouna, G; Haymann, JP; Baud, L; Letavernier, E				Raimbourg, Quentin; Perez, Joelle; Vandermeersch, Sophie; Prignon, Aurelie; Hanouna, Guillaume; Haymann, Jean-Philippe; Baud, Laurent; Letavernier, Emmanuel			The Calpain/Calpastatin System Has Opposing Roles in Growth and Metastatic Dissemination of Melanoma	PLOS ONE			English	Article							M-CALPAIN; EMBRYONIC-DEVELOPMENT; CALPASTATIN; CLEAVAGE; EXPRESSION; MECHANISM; GENE; GLOMERULONEPHRITIS; OVEREXPRESSION; DEGRADATION	Conventional calpains are ubiquitous cysteine proteases whose activity is promoted by calcium signaling and specifically limited by calpastatin. Calpain expression has been shown to be increased in human malignant cells, but the contribution of the calpain/calpastatin system in tumorigenesis remains unclear. It may play an important role in tumor cells themselves (cell growth, migration, and a contrario cell death) and/or in tumor niche (tissue infiltration by immune cells, neo-angiogenesis). In this study, we have used a mouse model of melanoma as a tool to gain further understanding of the role of calpains in tumor progression. To determine the respective importance of each target, we overexpressed calpastatin in tumor and/or host in isolation. Our data demonstrate that calpain inhibition in both tumor and host blunts tumor growth, while paradoxically increasing metastatic dissemination to regional lymph nodes. Specifically, calpain inhibition in melanoma cells limits tumor growth in vitro and in vivo but increases dissemination by amplifying cell resistance to apoptosis and accelerating migration process. Meanwhile, calpain inhibition restricted to host cells blunts tumor infiltration by immune cells and angiogenesis required for antitumor immunity, allowing tumor cells to escape tumor niche and disseminate. The development of highly specific calpain inhibitors with potential medical applications in cancer should take into account the opposing roles of the calpain/calpastatin system in initial tumor growth and subsequent metastatic dissemination.	[Raimbourg, Quentin; Perez, Joelle; Vandermeersch, Sophie; Hanouna, Guillaume] Univ Paris 06, Unite Mixte Rech UMR S 702 702, Paris, France; [Raimbourg, Quentin; Perez, Joelle; Vandermeersch, Sophie; Hanouna, Guillaume] Hop Tenon, INSERM, F-75970 Paris, France; [Prignon, Aurelie] Dept Nucl Med, Paris, France; [Prignon, Aurelie] Univ Paris 06, Hop Tenon, Paris, France; [Haymann, Jean-Philippe; Baud, Laurent; Letavernier, Emmanuel] Univ Paris 06, INSERM, Unite Mixte Rech UMR S 702 702, Paris, France; [Haymann, Jean-Philippe; Baud, Laurent; Letavernier, Emmanuel] Hop Tenon, AP HP, F-75970 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Letavernier, E (corresponding author), Univ Paris 06, INSERM, Unite Mixte Rech UMR S 702 702, Paris, France.	emmanuel.letavernier@tnn.aphp.fr	Prignon, Aurelie/HGB-6946-2022	Prignon, Aurelie/0000-0002-3963-863X; VANDERMEERSCH, sophie/0000-0001-6021-1334	Association pour la Recherche contre le Cancer (ARC)	Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	Quentin Raimbourg received grants from the Association pour la Recherche contre le Cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Bai DS, 2009, HEPATOLOGY, V49, P460, DOI 10.1002/hep.22638; BECKERLE MC, 1987, CELL, V51, P569, DOI 10.1016/0092-8674(87)90126-7; Bellocq A, 1999, J BIOL CHEM, V274, P36891, DOI 10.1074/jbc.274.52.36891; Benetti R, 2005, J BIOL CHEM, V280, P22070, DOI 10.1074/jbc.M501810200; Braun C, 1999, INT J CANCER, V84, P6, DOI 10.1002/(SICI)1097-0215(19990219)84:1<6::AID-IJC2>3.3.CO;2-K; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; Dewitt S, 2007, J LEUKOCYTE BIOL, V81, P1160, DOI 10.1189/jlb.1106710; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Fenouille N, 2012, J PATHOL, V227, P118, DOI 10.1002/path.3034; Frances CP, 2007, J GASTROEN HEPATOL, V22, P2298, DOI 10.1111/j.1440-1746.2007.04843.x; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Frangie C, 2006, J BIOL CHEM, V281, P26624, DOI 10.1074/jbc.M603007200; Gafni J, 2009, J BIOL CHEM, V284, P25441, DOI 10.1074/jbc.M109.038174; Gao G, 2000, J CELL BIOCHEM, V80, P53; Getz GS, 2012, AM J PATHOL, V181, P388, DOI 10.1016/j.ajpath.2012.04.027; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Han YQ, 1999, J BIOL CHEM, V274, P787, DOI 10.1074/jbc.274.2.787; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; HIRAI S, 1991, FEBS LETT, V287, P57, DOI 10.1016/0014-5793(91)80015-U; Ho WC, 2012, J BIOL CHEM, V287, P15458, DOI 10.1074/jbc.M112.349308; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Kimura Y, 1998, NAT MED, V4, P915, DOI 10.1038/nm0898-915; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; Leloup L, 2011, EXPERT OPIN THER TAR, V15, P309, DOI 10.1517/14728222.2011.553611; Letavernier B, 2012, ARTERIOSCL THROM VAS, V32, P335, DOI 10.1161/ATVBAHA.111.240242; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Letavernier E, 2011, EUR J IMMUNOL, V41, P473, DOI 10.1002/eji.201040437; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Moreno-Luna R, 2011, HEAD NECK-J SCI SPEC, V33, P72, DOI 10.1002/hed.21404; Moretti D, 2009, CARCINOGENESIS, V30, P960, DOI 10.1093/carcin/bgp098; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Peltier J, 2006, J AM SOC NEPHROL, V17, P3415, DOI 10.1681/ASN.2006050542; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; Salehin D, 2010, ANTICANCER RES, V30, P2837; Shiba, 1996, Breast Cancer, V3, P13, DOI 10.1007/BF02966957; Squier MKT, 1999, J CELL PHYSIOL, V178, P311, DOI 10.1002/(SICI)1097-4652(199903)178:3<311::AID-JCP5>3.3.CO;2-K; Storr SJ, 2011, BREAST, V20, P413, DOI 10.1016/j.breast.2011.04.002; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Yoshikawa Y, 2000, JPN J CANCER RES, V91, P459, DOI 10.1111/j.1349-7006.2000.tb00967.x; Youn JY, 2009, CIRC RES, V104, P50, DOI 10.1161/CIRCRESAHA.108.178467	51	18	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60469	10.1371/journal.pone.0060469	http://dx.doi.org/10.1371/journal.pone.0060469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565252	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300123
J	Vafadari, R; Kraaijeveld, R; Weimar, W; Baan, CC				Vafadari, Ramin; Kraaijeveld, Rens; Weimar, Willem; Baan, Carla C.			Tacrolimus Inhibits NF-kappa B Activation in Peripheral Human T Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; NUCLEAR-FACTOR; CYCLOSPORINE-A; DEPENDENT TRANSCRIPTION; CALCINEURIN INHIBITORS; SIGNALING PATHWAYS; PHOSPHORYLATION; FAMILY; TOLERANCE	The calcineurin inhibitor, tacrolimus (TAC), inhibits the protein phosphatase activity of calcineurin, leading to suppression of the nuclear translocation of NFAT and inhibition of T cell activation. Apart from NFAT also the transcription factor NF-kappa B plays a key functional role in T cell activation. Therefore, blockade of the NF-kappa B activation cascade by immunosuppressive drugs prevents immune activation. Here we studied whether TAC blocks NF-kappa B activation in peripheral human T cells. After anti-CD3/CD28-activation of T cells from healthy volunteers, NF-kappa B (p65) phosphorylation was measured by flow cytometry in CD3+ T cells, CD4+ helper T cells and CD8+ cytotoxic T cells in the absence and presence of TAC 10 mu g/mL, sotrastaurin 500 nM (positive control) and mycophenolic acid 10 mg/mL (negative control; n = 6). NF-kappa B transcriptional activity was measured by ELISA and intracellular TNF alpha protein, a downstream target, was measured by flow cytometry to assess the functional consequences of NF-kappa B blockade. Anti-CD3/28-activation induced NF-kappa B phosphorylation in CD3+ T cells, CD4+ T cells and CD8+ T cells by 34% (mean), 38% and 30% resp. (p <0.01). Sotrastaurin inhibited NF-kappa B activation in the respective T cell subsets by 93%, 95% and 86% (p <0.01 vs. no drug), while mycophenolic acid did not affect this activation pathway. Surprisingly, TAC also inhibited NF-kappa B phosphorylation, by 55% (p < 0.01) in CD3+ T cells, by 56% (p < 0.01) in CD4+ T cells and by 51% in CD8+ T cells (p <0.01). In addition, TAC suppressed NF-kappa B DNA binding capacity by 55% (p < 0.05) in CD3+ T cells and TNF alpha protein expression was inhibited in CD3+ T cells, CD4+ T cells and CD8+ T cells by 76%, 71% and 93% resp. (p <0.01 vs. no drug), confirming impaired NF-kappa B signaling. This study shows the suppressive effect of TAC on NF-kappa B signaling in peripheral human T cell subsets, measured at three specific positions in the NF-kappa B activation cascade.	[Vafadari, Ramin; Kraaijeveld, Rens; Weimar, Willem; Baan, Carla C.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Baan, CC (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	c.c.baan@erasmusmc.com	Agena, Fabiana A/C-5819-2015	Agena, Fabiana A/0000-0002-4526-4857; Baan, Carla/0000-0003-2274-2788				Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; BAIER G, 1993, J BIOL CHEM, V268, P4997; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Blanchet B, 2006, FUND CLIN PHARMACOL, V20, P137, DOI 10.1111/j.1472-8206.2006.00399.x; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cecka J Michael, 2005, Clin Transpl, P1; Ekberg H, 2007, AM J TRANSPLANT, V7, P560, DOI 10.1111/j.1600-6143.2006.01645.x; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; Friman S, 2011, AM J TRANSPLANT, V11, P1444, DOI 10.1111/j.1600-6143.2011.03538.x; Frischbutter S, 2011, EUR J IMMUNOL, V41, P2349, DOI 10.1002/eji.201041052; GHOSH P, 1993, P NATL ACAD SCI USA, V90, P1696, DOI 10.1073/pnas.90.5.1696; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang CS, 1998, INT J ONCOL, V13, P711; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Kanno T, 1996, J IMMUNOL, V157, P5277; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; Kovarik JM, 2011, TRANSPLANTATION, V91, P317, DOI 10.1097/TP.0b013e318203860d; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Matsuda S, 2003, CURR TOP MED CHEM, V3, P1358, DOI 10.2174/1568026033451916; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; Meier-Kriesche HU, 2006, AM J TRANSPLANT, V6, P1111, DOI 10.1111/j.1600-6143.2006.01270.x; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Pazderka F, 1996, Transpl Immunol, V4, P23, DOI 10.1016/S0966-3274(96)80029-3; Porras DL, 2012, TRANSPLANTATION, V93, P976, DOI 10.1097/TP.0b013e31824d11d7; RANSOM JT, 1995, THER DRUG MONIT, V17, P681, DOI 10.1097/00007691-199512000-00023; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; San Segundo D, 2006, TRANSPL P, V38, P2391, DOI 10.1016/j.transproceed.2006.08.081; Sellar KJ, 2006, ANAL BIOCHEM, V358, P104, DOI 10.1016/j.ab.2006.08.013; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Son JS, 2011, BIOCHEM BIOPH RES CO, V407, P141, DOI 10.1016/j.bbrc.2011.02.126; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; Tang IY, 2007, SEMIN NEPHROL, V27, P377, DOI 10.1016/j.semnephrol.2007.03.002; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Vafadari R, 2012, TRANSPLANTATION; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Rossum HH, 2010, THER DRUG MONIT, V32, P3, DOI 10.1097/FTD.0b013e3181c0eecb; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Wang HJ, 2006, TRANSPLANTATION, V82, P1484, DOI 10.1097/01.tp.0000246312.89689.17; Weil R, 2006, CELL DEATH DIFFER, V13, P826, DOI 10.1038/sj.cdd.4401856; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Wu CC, 2003, MOL CELL BIOL, V23, P6442, DOI 10.1128/MCB.23.18.6442-6454.2003; Zhou P, 2003, AM J TRANSPLANT, V3, P139, DOI 10.1034/j.1600-6143.2003.00033.x	52	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e60784	10.1371/journal.pone.0060784	http://dx.doi.org/10.1371/journal.pone.0060784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573283	Green Published, gold, Green Submitted			2022-12-27	WOS:000316930900076
J	Fan, LF; Lin, JR; Zhong, YS; Liu, JY				Fan, Lanfen; Lin, Jianrong; Zhong, Yangsheng; Liu, Jingyi			Shotgun Proteomic Analysis on the Diapause and Non-Diapause Eggs of Domesticated Silkworm Bombyx mori	PLOS ONE			English	Article							HEAT-SHOCK-PROTEINS; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; CDNA CLONING; 14-3-3-PROTEIN; IDENTIFICATION; CONSTRUCTION; PURIFICATION; QUANTITATION; INITIATION	To clarify the molecular mechanisms of silkworm diapause, it is necessary to investigate the molecular basis at protein level. Here, the spectra of peptides digested from silkworm diapause and non-diapause eggs were obtained from liquid chromatography tandem mass spectrometry (LC-MS/MS) and were analyzed by bioinformatics methods. A total of 501 and 562 proteins were identified from the diapause and non-diapause eggs respectively, of which 309 proteins were shared commonly. Among these common-expressed proteins, three main storage proteins (vitellogenin precursor, egg-specific protein and low molecular lipoprotein 30 K precursor), nine heat shock proteins (HSP19.9, 20.1, 20.4, 20.8, 21.4, 23.7, 70, 90-kDa heat shock protein and heat shock cognate protein), 37 metabolic enzymes, 22 ribosomal proteins were identified. There were 192 and 253 unique proteins identified in the diapause and non-diapause eggs respectively, of which 24 and 48 had functional annotations, these unique proteins indicated that the metabolism, translation of the mRNA and synthesis of proteins were potentially more highly represented in the non-dipause eggs than that in the diapause eggs. The relative mRNA levels of four identified proteins in the two kinds of eggs were also compared using quantitative reverse transcription PCR (qRT-PCR) and showed some inconsistencies with protein expression. GO signatures of 486 out of the 502 and 545 out of the 562 proteins identified in the diapause and non-diapause eggs respectively were available. In addition, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed the Metabolism, Translation and Transcription pathway were potentially more active in the non-dipause eggs at this stage.	[Fan, Lanfen; Lin, Jianrong; Zhong, Yangsheng; Liu, Jingyi] South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Fan, Lanfen] S China Normal Univ, Coll Life Sci, Guangdong Prov Key Lab Hlth & Safe Aquaculture, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Normal University	Lin, JR (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.	jrlin2010@yahoo.com.cn	Fan, Lanfen/AAB-6918-2022	Fan, Lanfen/0000-0002-8154-1516	National Natural Science Foundation of China [30771634]; Natural Science Foundation of Guangdong Province [8451064201000953]; Science and Technology Project of Guangdong Province [2007B020706005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Project of Guangdong Province	This work was supported by the National Natural Science Foundation of China (Grant No. 30771634), Natural Science Foundation of Guangdong Province (Grant No. 8451064201000953), and Science and Technology Project of Guangdong Province (Grant No. 2007B020706005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-242; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Coppolino MG, 1998, INT J BIOCHEM CELL B, V30, P553, DOI 10.1016/S1357-2725(97)00153-2; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; DASGUPTA S, 1992, EXP EYE RES, V54, P461, DOI 10.1016/0014-4835(92)90058-Z; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Dunaway S, 2005, J CELL SCI, V118, P39, DOI 10.1242/jcs.01570; Feng YM, 2005, BIOCHEM BIOPH RES CO, V331, P1503, DOI 10.1016/j.bbrc.2005.04.078; Fujiwara Y, 2006, INSECT BIOCHEM MOLEC, V36, P47, DOI 10.1016/j.ibmb.2005.10.005; Gao YK, 2006, CELL RES, V16, P539, DOI 10.1038/sj.cr.7310071; Goo TW, 2005, MOL BIOL REP, V32, P133, DOI 10.1007/s11033-004-5908-7; Gurusamy N, 2006, FEBS LETT, V580, P1932, DOI 10.1016/j.febslet.2006.02.056; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hong SM, 2006, ZOOL SCI, V23, P517, DOI 10.2108/zsj.23.517; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; JIANG Z, 1986, BIOCHIM BIOPHYS ACTA, V882, P427; Jin S, 2008, J PROTEOME RES, V7, P164, DOI 10.1021/pr0704175; Kankare Maaria, 2010, BMC Ecology, V10, P3, DOI 10.1186/1472-6785-10-3; Klein LL, 2008, REPROD SCI, V15, P263, DOI 10.1177/1933719107311189; Lee CL, 2003, PROTEOMICS, V3, P2472, DOI 10.1002/pmic.200300586; Li AQ, 2009, J MED ENTOMOL, V46, P1382, DOI 10.1603/033.046.0618; Li AQ, 2009, PEPTIDES, V30, P518, DOI 10.1016/j.peptides.2008.10.008; Li J, 2010, AMINO ACIDS; Li JY, 2009, INSECT MOL BIOL, V18, P649, DOI 10.1111/j.1365-2583.2009.00903.x; Li JY, 2010, INSECT BIOCHEM MOLEC, V40, P293, DOI 10.1016/j.ibmb.2010.01.008; Li JY, 2009, J PROTEOME RES, V8, P2620, DOI 10.1021/pr8006123; Li YP, 2009, INT J BIOL SCI, V5, P451; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Macrae TH, 2010, CELL MOL LIFE SCI; Maki N, 1997, INSECT BIOCHEM MOLEC, V27, P721, DOI 10.1016/S0965-1748(97)00050-7; NAKAGAKI M, 1991, ROUX ARCH DEV BIOL, V200, P223, DOI 10.1007/BF00361341; Ogawa M, 2009, CLIN MICROBIOL INFEC, V15, P239, DOI 10.1111/j.1469-0691.2008.02157.x; Quan GX, 2001, INSECT BIOCHEM MOLEC, V31, P97, DOI 10.1016/S0965-1748(00)00112-0; Reynolds JA, 2009, J EXP BIOL, V212, P2074, DOI 10.1242/jeb.027367; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rinehart JP, 2010, J INSECT PHYSIOL, V56, P603, DOI 10.1016/j.jinsphys.2009.12.007; Robich RM, 2007, J INSECT PHYSIOL, V53, P235, DOI 10.1016/j.jinsphys.2006.08.008; Sahoo SS, 2008, J BIOMED INFORM, V41, P752, DOI 10.1016/j.jbi.2008.02.006; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Siva AB, 2010, MOL HUM REPROD, V16, P452, DOI 10.1093/molehr/gaq009; Somarelli JA, 2007, BIOL CELL, V99, P311, DOI 10.1042/BC20060125; SONOBE H, 1979, J INSECT PHYSIOL, V25, P381, DOI 10.1016/0022-1910(79)90003-9; Sonoda S, 2006, ARCH INSECT BIOCHEM, V63, P36, DOI 10.1002/arch.20138; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; TAYLOR F, 1986, SCIENCE, V232, P1152, DOI 10.1126/science.232.4754.1152-a; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Wang HS, 2007, INSECT MOL BIOL, V16, P207, DOI 10.1111/j.1365-2583.2006.00715.x; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Waters ER, 2008, CELL STRESS CHAPERON, V13, P127, DOI 10.1007/s12192-008-0023-7; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; XU WH, 1995, BBA-GENE STRUCT EXPR, V1261, P83, DOI 10.1016/0167-4781(94)00238-X; YAGINUMA T, 1990, J COMP PHYSIOL B, V160, P277, DOI 10.1007/BF00302593; Yamamoto Y, 1999, ARCH INSECT BIOCHEM, V42, P119, DOI 10.1002/(SICI)1520-6327(199910)42:2&lt;119::AID-ARCH2&gt;3.0.CO;2-C; Yamashita O, 1996, J INSECT PHYSIOL, V42, P669, DOI 10.1016/0022-1910(96)00003-0; Yang HJ, 2010, AMINO ACIDS, V38, P1333, DOI 10.1007/s00726-009-0342-8; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yocum GD, 2009, J INSECT PHYSIOL, V55, P32, DOI 10.1016/j.jinsphys.2008.10.003; Yoshiga T, 2002, INSECT BIOCHEM MOLEC, V32, P477, DOI 10.1016/S0965-1748(01)00125-4; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang QR, 2010, J INSECT PHYSIOL, V56, P138, DOI 10.1016/j.jinsphys.2009.09.013; Zhou ZH, 2008, J PROTEOME RES, V7, P5103, DOI 10.1021/pr800383r	67	27	34	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60386	10.1371/journal.pone.0060386	http://dx.doi.org/10.1371/journal.pone.0060386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580252	Green Submitted, Green Published, gold			2022-12-27	WOS:000317898000030
J	Hills, TT; Kalff, C; Wiener, JM				Hills, Thomas T.; Kalff, Christopher; Wiener, Jan M.			Adaptive Levy Processes and Area-Restricted Search in Human Foraging	PLOS ONE			English	Article							WANDERING ALBATROSSES; MARINE PREDATOR; SCALING LAWS; PATTERNS; BEHAVIOR; DOPAMINE; WALK; DROSOPHILA; RESPONSES; ANIMALS	A considerable amount of research has claimed that animals' foraging behaviors display movement lengths with power-law distributed tails, characteristic of Levy flights and Levy walks. Though these claims have recently come into question, the proposal that many animals forage using Levy processes nonetheless remains. A Levy process does not consider when or where resources are encountered, and samples movement lengths independently of past experience. However, Levy processes too have come into question based on the observation that in patchy resource environments resource-sensitive foraging strategies, like area-restricted search, perform better than Levy flights yet can still generate heavy-tailed distributions of movement lengths. To investigate these questions further, we tracked humans as they searched for hidden resources in an open-field virtual environment, with either patchy or dispersed resource distributions. Supporting previous research, for both conditions logarithmic binning methods were consistent with Levy flights and rank-frequency methods-comparing alternative distributions using maximum likelihood methods-showed the strongest support for bounded power-law distributions (truncated Levy flights). However, goodness-of-fit tests found that even bounded power-law distributions only accurately characterized movement behavior for 4 (out of 32) participants. Moreover, paths in the patchy environment (but not the dispersed environment) showed a transition to intensive search following resource encounters, characteristic of area-restricted search. Transferring paths between environments revealed that paths generated in the patchy environment were adapted to that environment. Our results suggest that though power-law distributions do not accurately reflect human search, Levy processes may still describe movement in dispersed environments, but not in patchy environments-where search was area-restricted. Furthermore, our results indicate that search strategies cannot be inferred without knowing how organisms respond to resources-as both patched and dispersed conditions led to similar Levy-like movement distributions.	[Hills, Thomas T.] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England; [Kalff, Christopher] Univ Freiburg, Ctr Cognit Sci, D-79106 Freiburg, Germany; [Wiener, Jan M.] Bournemouth Univ, Psychol Res Ctr, Bournemouth, Dorset, England	University of Warwick; University of Freiburg; Bournemouth University	Hills, TT (corresponding author), Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England.	t.t.hills@warwick.ac.uk	Wiener, Jan/H-4657-2013	Wiener, Jan/0000-0002-9583-298X	Volkswagen-Stiftung; German Research Foundation (DFG) [SFB/TR8]; Swiss National Science Foundation [100014 130397/1]	Volkswagen-Stiftung(Volkswagen); German Research Foundation (DFG)(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Volkswagen-Stiftung, and the SFB/TR8 of the German Research Foundation (DFG), and a grant from the Swiss National Science Foundation (100014 130397/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEBAUM D, 2004, LEVY PROCESSES STOCH; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; BELL WJ, 1990, ANNU REV ENTOMOL, V35, P447, DOI 10.1146/annurev.en.35.010190.002311; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benichou O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198101; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brown CT, 2007, HUM ECOL, V35, P129, DOI 10.1007/s10745-006-9083-4; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Edwards AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045174; Edwards AM, 2011, ECOLOGY, V92, P1247, DOI 10.1890/10-1182.1; Grunbaum D, 1998, AM NAT, V151, P97, DOI 10.1086/286105; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hills TT, 2006, COGNITIVE SCI, V30, P3, DOI 10.1207/s15516709cog0000_50; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kello CT, 2010, TRENDS COGN SCI, V14, P223, DOI 10.1016/j.tics.2010.02.005; Plank MJ, 2008, J R SOC INTERFACE, V5, P1077, DOI 10.1098/rsif.2008.0006; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2006, EUROPHYS LETT, V75, P517, DOI 10.1209/epl/i2006-10157-x; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Reynolds AM, 2007, J EXP BIOL, V210, P3763, DOI 10.1242/jeb.009563; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618; Rhodes T, 2007, PHYSICA A, V385, P255, DOI 10.1016/j.physa.2007.07.001; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Viswanathan GM, 2002, PHYSICA A, V314, P208, DOI 10.1016/S0378-4371(02)01157-3; Walsh PD, 1996, J THEOR BIOL, V183, P351, DOI 10.1006/jtbi.1996.0227; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1	37	62	62	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60488	10.1371/journal.pone.0060488	http://dx.doi.org/10.1371/journal.pone.0060488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577118	Green Submitted, Green Published, gold			2022-12-27	WOS:000319109800057
J	Koelsch, KA; Wang, YJ; Maier-Moore, JS; Sawalha, AH; Wren, JD				Koelsch, Kristi A.; Wang, YuJing; Maier-Moore, Jacen S.; Sawalha, Amr H.; Wren, Jonathan D.			GFP Affects Human T Cell Activation and Cytokine Production following In Vitro Stimulation	PLOS ONE			English	Article							ACTIN-MYOSIN INTERACTIONS; RED FLUORESCENT PROTEIN; CRYSTAL-STRUCTURE; EXPRESSION; MATURATION; RECEPTOR	There are many Green Fluorescent Proteins (GFPs) originating from diverse species that are invaluable to cell biologists today because of their ability to provide experimental visualization of protein expression. Since their initial discovery, they have been modified and improved to provide more stable variants with emission ranges spanning a wide array of colors. Due to their ease of expression both in-vitro and in-vivo, they are an attractive choice for use as markers in molecular biology. GFPs are generally assumed to have negligible effects on the cells to which they have been introduced. However, a growing number of reports indicate that this is not always the case. Consequently, because of GFP's ubiquitous use, it is important to document the nature and extent of unintended effects. In this report, we find that GFP affects T cell activation, leading to defects in clustering, upregulation of the activation marker CD25 and IL-2 cytokine production following stimulation in human primary T cells that also express TurboGFP. We utilized a reporter assay which has been routinely used to assay the NF-kappa B pathway and found reduced NF-kappa B activitation in stimulated HEK293 and HeLa cells that were co-transfected with TurboGFP, suggesting that GFP interferes with signaling through the NF-kappa B pathway. These findings indicate that the utilization of GFP-tagged vectors may negatively impact in vitro experiments in T cells, emphasizing the critical importance of controls to identify any GFP-induced effects.	[Koelsch, Kristi A.; Wang, YuJing; Maier-Moore, Jacen S.; Sawalha, Amr H.; Wren, Jonathan D.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Maier-Moore, Jacen S.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Sawalha, Amr H.] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA; [Wren, Jonathan D.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Michigan System; University of Michigan; University of Oklahoma System; University of Oklahoma Health Sciences Center	Koelsch, KA (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Kristi-Koelsch@omrf.org; jdwren@gmail.com	Wren, Jonathan D/E-5611-2011	Wren, Jonathan D/0000-0003-2776-3545	National Institutes of Health [P20GM103456, 5R21ES019248]; Arthritis Foundation Postdoctoral Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation Postdoctoral Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like acknowledge support from the National Institutes of Health (grant #s P20GM103456 and 5R21ES019248 to JDW). KAK is a recipient of an Arthritis Foundation Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbulut O, 2006, NAT METHODS, V3, P331, DOI 10.1038/nmeth0506-331; Agbulut O, 2007, J BIOL CHEM, V282, P10465, DOI 10.1074/jbc.M610418200; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Hanazono Y, 1997, HUM GENE THER, V8, P1313, DOI 10.1089/hum.1997.8.11-1313; Lai W, 2003, J IMMUNOL METHODS, V282, P93, DOI 10.1016/j.jim.2003.07.015; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long MX, 2006, J IMMUNOL, V177, P4257, DOI 10.4049/jimmunol.177.7.4257; Mak GWY, 2007, ANAL BIOCHEM, V362, P296, DOI 10.1016/j.ab.2006.12.017; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; REEM GH, 1984, SCIENCE, V225, P429, DOI 10.1126/science.6429853; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455; SALDANHAARAUJO F, 2011, J CELLULAR MOL MED; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; WALDMANN TA, 1986, SCIENCE, V232, P727, DOI 10.1126/science.3008337; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Zhang F, 2003, BLOOD, V102, P2115, DOI 10.1182/blood-2003-01-0049; Zhou J, 2011, FEBS LETT, V585, P821, DOI 10.1016/j.febslet.2011.02.013	24	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e50068	10.1371/journal.pone.0050068	http://dx.doi.org/10.1371/journal.pone.0050068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577054	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800001
J	Lindberg, K; Olauson, H; Amin, R; Ponnusamy, A; Goetz, R; Taylor, RF; Mohammadi, M; Canfield, A; Kublickiene, K; Larsson, TE				Lindberg, Karolina; Olauson, Hannes; Amin, Risul; Ponnusamy, Arvind; Goetz, Regina; Taylor, Rebecca F.; Mohammadi, Moosa; Canfield, Ann; Kublickiene, Karolina; Larsson, Tobias E.			Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-23; RECEPTOR; DELETION; DISEASE	Recent studies support a role for FGF23 and its co-receptor Klotho in cardiovascular pathology, yet the underlying mechanisms remain largely elusive. Herein, we analyzed the expression of Klotho in mouse arteries and generated a novel mouse model harboring a vascular smooth muscle cell specific deletion of Klotho (Sm22-KL-/-). Arterial Klotho expression was detected at very low levels with quantitative real-time PCR; Klotho protein levels were undetectable by immunohistochemistry and Western blot. There was no difference in arterial Klotho between Sm22-KL-/- and wild-type mice, as well as no changes in serum markers of mineral metabolism. Intravenous delivery of FGF23 elicited a rise in renal (0.005; p<0.01) but not arterial Egr-1 expression, a marker of Klotho-dependent FGF23 signaling. Further, the impact of FGF23 on vascular calcification and endothelial response was evaluated in bovine vascular smooth muscle cells (bVSMC) and in a murine ex vivo model of endothelial function, respectively. FGF23 treatment (0.125-2 ng/mL) did not modify calcification in bVSMCs or dilatory, contractile and structural properties in mice arterial specimen ex vivo. Collectively, these results demonstrate that FGF23-Klotho signaling is absent in mouse arteries and that the vascular response was unaffected by FGF23 treatment. Thus, our data do not support Klotho-mediated FGF23 effects in the vasculature although confirmative studies in humans are warranted.	[Lindberg, Karolina; Olauson, Hannes; Amin, Risul; Larsson, Tobias E.] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden; [Ponnusamy, Arvind; Taylor, Rebecca F.; Canfield, Ann] Univ Manchester, Fac Med & Human Sci, Inst Cardiovasc Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Goetz, Regina; Mohammadi, Moosa] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Kublickiene, Karolina] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Obstet & Gynecol, Stockholm, Sweden; [Larsson, Tobias E.] Karolinska Univ Hosp, Dept Nephrol, Stockholm, Sweden	Karolinska Institutet; University of Manchester; New York University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Larsson, TE (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden.	tobias.larsson@ki.se	kasaei, fahime/T-7197-2018; Goetz, Regina/M-2411-2019; Amin, Risul/AAA-3093-2019; Mohammadi, Moosa/ABA-6745-2020	Goetz, Regina/0000-0003-3681-4703; Mohammadi, Moosa/0000-0003-2434-9437; Canfield, Ann/0000-0002-8983-5674; Kublickiene, Karolina/0000-0002-4841-6836; Amin, Risul/0000-0002-7628-6522; Taylor, Rebecca/0000-0003-4033-3793	Swedish Foundation for Strategic Research; Swedish Research Council; Swedish Kidney Foundation; Centre for Gender Medicine at Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Kidney Foundation; Centre for Gender Medicine at Karolinska Institutet(Karolinska Institutet); Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Swedish Foundation for Strategic Research, Swedish Research Council, Swedish Kidney Foundation, Centre for Gender Medicine at Karolinska Institutet and grants from Karolinska Institutet and Karolinska University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2009, CARDIOVASC RES, V81, P260, DOI 10.1093/cvr/cvn279; Arnlov J, 2012, KIDNEY INT; Collett GDM, 2007, CIRC RES, V100, P502, DOI 10.1161/01.RES.0000258854.03388.02; Donate-Correa J., 2011, INT J CARDIOL; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Ix JH, 2012, J AM COLL CARDIOL, V60, P200, DOI 10.1016/j.jacc.2012.03.040; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; MIRZA MA, 2009, ATHEROSCLEROSIS; Mirza MAI, 2009, NEPHROL DIAL TRANSPL, V24, P3125, DOI 10.1093/ndt/gfp205; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; Siddals KW, 2011, J BIOL CHEM, V286, P16623, DOI 10.1074/jbc.M110.202929; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293	22	101	103	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60658	10.1371/journal.pone.0060658	http://dx.doi.org/10.1371/journal.pone.0060658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577141	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800082
J	Madrid, PB; Chopra, S; Manger, ID; Gilfillan, L; Keepers, TR; Shurtleff, AC; Green, CE; Iyer, LV; Dilks, HH; Davey, RA; Kolokoltsov, AA; Carrion, R; Patterson, JL; Bavari, S; Panchal, RG; Warren, TK; Wells, JB; Moos, WH; Burke, RL; Tanga, MJ				Madrid, Peter B.; Chopra, Sidharth; Manger, Ian D.; Gilfillan, Lynne; Keepers, Tiffany R.; Shurtleff, Amy C.; Green, Carol E.; Iyer, Lalitha V.; Dilks, Holli Hutcheson; Davey, Robert A.; Kolokoltsov, Andrey A.; Carrion, Ricardo, Jr.; Patterson, Jean L.; Bavari, Sina; Panchal, Rekha G.; Warren, Travis K.; Wells, Jay B.; Moos, Walter H.; Burke, RaeLyn L.; Tanga, Mary J.			A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents	PLOS ONE			English	Article							VIRAL-INFECTIONS; VIRUS-INFECTION; EBOLA-VIRUS; OLD DRUGS; IN-VITRO; Q-FEVER; CHLOROQUINE; 4-AMINOQUINOLINE; CHIKUNGUNYA; HIV	Background: The rapid development of effective medical countermeasures against potential biological threat agents is vital. Repurposing existing drugs that may have unanticipated activities as potential countermeasures is one way to meet this important goal, since currently approved drugs already have well-established safety and pharmacokinetic profiles in patients, as well as manufacturing and distribution networks. Therefore, approved drugs could rapidly be made available for a new indication in an emergency. Methodology/Principal Findings: A large systematic effort to determine whether existing drugs can be used against high containment bacterial and viral pathogens is described. We assembled and screened 1012 FDA-approved drugs for off-label broad-spectrum efficacy against Bacillus anthracis; Francisella tularensis; Coxiella burnetii; and Ebola, Marburg, and Lassa fever viruses using in vitro cell culture assays. We found a variety of hits against two or more of these biological threat pathogens, which were validated in secondary assays. As expected, antibiotic compounds were highly active against bacterial agents, but we did not identify any non-antibiotic compounds with broad-spectrum antibacterial activity. Lomefloxacin and erythromycin were found to be the most potent compounds in vivo protecting mice against Bacillus anthracis challenge. While multiple virus-specific inhibitors were identified, the most noteworthy antiviral compound identified was chloroquine, which disrupted entry and replication of two or more viruses in vitro and protected mice against Ebola virus challenge in vivo. Conclusions/Significance: The feasibility of repurposing existing drugs to face novel threats is demonstrated and this represents the first effort to apply this approach to high containment bacteria and viruses.	[Madrid, Peter B.; Chopra, Sidharth; Manger, Ian D.; Gilfillan, Lynne; Keepers, Tiffany R.; Shurtleff, Amy C.; Green, Carol E.; Iyer, Lalitha V.; Dilks, Holli Hutcheson; Moos, Walter H.; Burke, RaeLyn L.; Tanga, Mary J.] SRI Int, Ctr Infect Dis & Biodefense Res, Menlo Pk, CA 94025 USA; [Davey, Robert A.; Kolokoltsov, Andrey A.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Carrion, Ricardo, Jr.; Patterson, Jean L.] Texas Biomed Res Inst, San Antonio, TX USA; [Panchal, Rekha G.; Warren, Travis K.; Wells, Jay B.] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA	SRI International; University of Texas System; University of Texas Medical Branch Galveston; Texas Biomedical Research Institute	Madrid, PB (corresponding author), SRI Int, Ctr Infect Dis & Biodefense Res, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	peter.madrid@sri.com	Bavari, Sina/L-3642-2019; Panchal, Rekha/None	Bavari, Sina/0000-0001-8424-5635; Davey, Robert/0000-0001-9168-2892; Chopra, Sidharth/0000-0001-8823-6074; Moos, Walter/0000-0001-7244-811X; Madrid, Peter/0000-0002-4895-5610; Panchal, Rekha/0000-0001-8621-9078	Defense Threat Reduction Agency [HDTRA1-07-C-0083]; SRI International	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); SRI International	This work was supported by the Defense Threat Reduction Agency contract HDTRA1-07-C-0083 and internal grants of SRI International. The views expressed in this publication are those of the authors and not necessarily those of the funding organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2008, VIRUS RES, V135, P203, DOI 10.1016/j.virusres.2008.03.014; Aronson JK, 2007, BRIT J CLIN PHARMACO, V64, P563, DOI 10.1111/j.1365-2125.2007.03058.x; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Boguski MS, 2009, SCIENCE, V324, P1394, DOI 10.1126/science.1169920; Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292; Center for Disease Control and Prevention, 2012, VIR HEM FEV; Center for Disease Control and Prevention, 2012, TUL; Center for Disease Control and Prevention, 2012, ANTHR; Centers for disease control and prevention, 2013, BIOT AG DIS; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; De DYD, 1998, J MED CHEM, V41, P4918, DOI 10.1021/jm980146x; De Lamballerie X, 2008, VECTOR-BORNE ZOONOT, V8, P837, DOI 10.1089/vbz.2008.0049; de Lamballerie Xavier, 2009, Infectious Disorders - Drug Targets, V9, P101; Di Trani L, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-39; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Egan Timothy J., 2001, Mini-Reviews in Medicinal Chemistry, V1, P113, DOI 10.2174/1389557013407188; Eli Lilly and Company and NIH Chemical Genomics Center, 2008, ASS GUID MAN VERS 5; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Freiberg AN, 2010, J GEN VIROL, V91, P765, DOI 10.1099/vir.0.017269-0; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; JOHNSON E, 1995, INT J EXP PATHOL, V76, P227; KADIR F, 1992, INT J CLIN PHARM TH, V30, P374; Kuhn JH, 2011, BIOSECUR BIOTERROR, V9, P361, DOI 10.1089/bsp.2011.0051; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; Marzi A, 2007, J INFECT DIS, V196, pS237, DOI 10.1086/520607; National Research Council of the National Academy of Sciences, 2011, GUIDE CARE USE LAB A; O'Neill PM, 2006, CURR TOP MED CHEM, V6, P479, DOI 10.2174/156802606776743147; O'Neill PM, 2003, J MED CHEM, V46, P4933, DOI 10.1021/jm030796n; Pallister J, 2009, J VIROL, V83, P11979, DOI 10.1128/JVI.01847-09; Panchal RG, 2010, J BIOMOL SCREEN, V15, P755, DOI 10.1177/1087057110374357; PEETERS PAM, 1989, PARASITOLOGY, V98, P381, DOI 10.1017/S003118200006145X; PEETERS PAM, 1989, BIOCHIM BIOPHYS ACTA, V981, P269, DOI 10.1016/0005-2736(89)90037-0; Rolain JM, 2007, INT J ANTIMICROB AG, V30, P297, DOI 10.1016/j.ijantimicag.2007.05.015; Saeed MF, 2006, J VIROL METHODS, V135, P143, DOI 10.1016/j.jviromet.2006.02.011; Savarino A, 2004, JAIDS-J ACQ IMM DEF, V35, P223, DOI 10.1097/00126334-200403010-00002; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Savarino A, 2001, AIDS, V15, P2221, DOI 10.1097/00002030-200111230-00002; Savarino A, 2007, LANCET INFECT DIS, V7, P633, DOI 10.1016/S1473-3099(07)70217-7; Schornberg KL, 2009, P NATL ACAD SCI USA, V106, P8003, DOI 10.1073/pnas.0807578106; Solomon VR, 2005, BIOORGAN MED CHEM, V13, P2157, DOI 10.1016/j.bmc.2004.12.051; TIGERTT WD, 1961, BACTERIOL REV, V25, P285, DOI 10.1128/MMBR.25.3.285-293.1961; TITULAER HAC, 1990, J PHARM PHARMACOL, V42, P529, DOI 10.1111/j.2042-7158.1990.tb07052.x; Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785; US Food and Drug Administration, 2011, OR BOOK APPR DRUG PR; Vigerust DJ, 2007, INFLUENZA OTHER RESP, V1, P189, DOI 10.1111/j.1750-2659.2007.00027.x; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	48	175	189	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60579	10.1371/journal.pone.0060579	http://dx.doi.org/10.1371/journal.pone.0060579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577127	Green Submitted, gold, Green Published			2022-12-27	WOS:000319109800067
J	Rao, L; Xue, YF; Zheng, YY; Lu, JR; Ma, YH				Rao, Lang; Xue, Yanfen; Zheng, Yingying; Lu, Jian R.; Ma, Yanhe			A Novel Alkaliphilic Bacillus Esterase Belongs to the 13th Bacterial Lipolytic Enzyme Family	PLOS ONE			English	Article							THERMOSTABLE ESTERASE; ALKALINE LIPASE; CARBOXYL ESTERASES; MICROBIAL LIPASES; MOLECULAR-CLONING; PURIFICATION; EXPRESSION; CLASSIFICATION; HYDROLASE; CLEAVAGE	Background: Microbial derived lipolytic hydrolysts are an important class of biocatalysts because of their huge abundance and ability to display bioactivities under extreme conditions. In spite of recent advances, our understanding of these enzymes remains rudimentary. The aim of our research is to advance our understanding by seeking for more unusual lipid hydrolysts and revealing their molecular structure and bioactivities. Methodology/Principal Findings: Bacillus. pseudofirmus OF4 is an extreme alkaliphile with tolerance of pH up to 11. In this work we successfully undertook a heterologous expression of a gene estof4 from the alkaliphilic B. pseudofirmus sp OF4. The recombinant protein called EstOF4 was purified into a homologous product by Ni-NTA affinity and gel filtration. The purified EstOF4 was active as dimer with the molecular weight of 64 KDa. It hydrolyzed a wide range of substrates including pnitrophenyl esters (C2-C12) and triglycerides (C2-C6). Its optimal performance occurred at pH 8.5 and 50 degrees C towards pnitrophenyl caproate and triacetin. Sequence alignment revealed that EstOF4 shared 71% identity to esterase Est30 from Geobacillus stearothermophilus with a typical lipase pentapeptide motif G91LS93LG95. A structural model developed from homology modeling revealed that EstOF4 possessed a typical esterase 6 alpha/7 beta hydrolase fold and a cap domain. Site-directed mutagenesis and inhibition studies confirmed the putative catalytic triad Ser93, Asp190 and His220. Conclusion: EstOF4 is a new bacterial esterase with a preference to short chain ester substrates. With a high sequence identity towards esterase Est30 and several others, EstOF4 was classified into the same bacterial lipolytic family, Family XIII. All the members in this family originate from the same bacterial genus, bacillus and display optimal activities from neutral pH to alkaline conditions with short and middle chain length substrates. However, with roughly 70% sequence identity, these enzymes showed hugely different thermal stabilities, indicating their diverse thermal adaptations via just changing a few amino acid residues.	[Rao, Lang; Xue, Yanfen; Zheng, Yingying; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Rao, Lang; Zheng, Yingying] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Lu, Jian R.] Univ Manchester, Sch Phys & Astron, Phys Biol Lab, Manchester, Lancs, England	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Manchester	Lu, JR (corresponding author), Univ Manchester, Sch Phys & Astron, Phys Biol Lab, Manchester, Lancs, England.	j.lu@manchester.ac.uk; mayanhe@im.ac.cn	Rao, Lang/N-3886-2015; MA, YAN/HHN-2912-2022; Lu, Jian/GRY-4556-2022	Yu, Hai/0000-0002-6386-9761	Natural Sciences Foundation of China (NSFC) [30621005]; Ministry of Sciences and Technology (MOST) of China [2007CB707801, 2009CB724705, 2006AA020201, 2007AA021306]; UK Engineering and Physical Sciences Research Council (EPSRC) [EP/F062966/1]	Natural Sciences Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology (MOST) of China; UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Natural Sciences Foundation of China (NSFC) Grant 30621005 and Ministry of Sciences and Technology (MOST) of China Grants (973 Program: 2007CB707801 and 2009CB724705, 863 Programs: 2006AA020201 and 2007AA021306). JRL thanks UK Engineering and Physical Sciences Research Council (EPSRC) for funding support (EP/F062966/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; Chen SX, 2007, PROCESS BIOCHEM, V42, P988, DOI 10.1016/j.procbio.2007.03.010; Dalal S, 2008, BIOTECHNOL APPL BIOC, V51, P23, DOI 10.1042/BA20070186; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dutta S, 2009, APPL BIOCHEM BIOTECH, V159, P142, DOI 10.1007/s12010-009-8543-x; Ewis HE, 2004, GENE, V329, P187, DOI 10.1016/j.gene.2003.12.029; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GUFFANTI AA, 1986, J BACTERIOL, V167, P766, DOI 10.1128/jb.167.3.766-773.1986; Handrick R, 2001, J BIOL CHEM, V276, P36215, DOI 10.1074/jbc.M101106200; Henke E, 2002, APPL MICROBIOL BIOT, V60, P320, DOI 10.1007/s00253-002-1126-1; Hong MC, 1998, BIOTECHNOL LETT, V20, P1027, DOI 10.1023/A:1005407005371; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; Kaiser P, 2006, PROTEIN EXPRES PURIF, V45, P262, DOI 10.1016/j.pep.2005.08.030; Karpushova A, 2005, APPL MICROBIOL BIOT, V67, P59, DOI 10.1007/s00253-004-1780-6; Kim EY, 2009, APPL ENVIRON MICROB, V75, P257, DOI 10.1128/AEM.01400-08; Kontkanen H, 2006, ENZYME MICROB TECH, V39, P265, DOI 10.1016/j.enzmictec.2005.10.013; Krulwich TA, 1997, EXTREMOPHILES, V1, P163, DOI 10.1007/s007920050030; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee MH, 2006, APPL ENVIRON MICROB, V72, P7406, DOI 10.1128/AEM.01157-06; Levisson M, 2007, FEBS J, V274, P2832, DOI 10.1111/j.1742-4658.2007.05817.x; Liu P, 2004, J MOL BIOL, V342, P551, DOI 10.1016/j.jmb.2004.06.069; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mnisi SM, 2005, CURR MICROBIOL, V50, P196, DOI 10.1007/s00284-004-4423-3; Montoro-Garcia S, 2009, J BACTERIOL, V191, P3076, DOI 10.1128/JB.01060-08; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Niehaus F, 1999, APPL MICROBIOL BIOT, V51, P711, DOI 10.1007/s002530051456; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pandey A, 1999, BIOTECHNOL APPL BIOC, V29, P119; Park HJ, 2007, PROTEIN EXPRES PURIF, V52, P340, DOI 10.1016/j.pep.2006.10.010; Rao L, 2011, BBA-PROTEINS PROTEOM, V1814, P1695, DOI 10.1016/j.bbapap.2011.08.013; Soliman NA, 2007, PROCESS BIOCHEM, V42, P1090, DOI 10.1016/j.procbio.2007.05.005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang XQ, 2009, ENZYME MICROB TECH, V45, P94, DOI 10.1016/j.enzmictec.2009.05.004	38	55	59	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60645	10.1371/journal.pone.0060645	http://dx.doi.org/10.1371/journal.pone.0060645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577139	gold, Green Submitted, Green Published			2022-12-27	WOS:000319109800079
J	Su, JM; Bao, P; Bai, TL; Deng, L; Liu, F; He, J				Su, Jianmei; Bao, Peng; Bai, Tenglong; Deng, Lin; Liu, Fan; He, Jin			CotA, a Multicopper Oxidase from Bacillus pumilus WH4, Exhibits Manganese-Oxidase Activity	PLOS ONE			English	Article							LEPTOTHRIX-DISCOPHORA SS-1; MN(II) OXIDATION; MN2+ OXIDATION; LACCASE; SUBTILIS; IDENTIFICATION; SPORES; STRAIN; GENE; SUBSTRATE	Multicopper oxidases (MCOs) are a family of enzymes that use copper ions as cofactors to oxidize various substrates. Previous research has demonstrated that several MCOs such as MnxG, MofA and MoxA can act as putative Mn(II) oxidases. Meanwhile, the endospore coat protein CotA from Bacillus species has been confirmed as a typical MCO. To study the relationship between CotA and the Mn(II) oxidation, the cotA gene from a highly active Mn(II)-oxidizing strain Bacillus pumilus WH4 was cloned and overexpressed in Escherichia coli strain M15. The purified CotA contained approximately four copper atoms per molecule and showed spectroscopic properties typical of blue copper oxidases. Importantly, apart from the laccase activities, the CotA also displayed substantial Mn(II)-oxidase activities both in liquid culture system and native polyacrylamide gel electrophoresis. The optimum Mn(II) oxidase activity was obtained at 53 degrees C in HEPES buffer (pH 8.0) supplemented with 0.8 mM CuCl2. Besides, the addition of o-phenanthroline and EDTA both led to a complete suppression of Mn(II)-oxidizing activity. The specific activity of purified CotA towards Mn(II) was 0.27 U/mg. The K-m, V-max and k(cat) values towards Mn(II) were 14.85+/-1.17 mM, 3.01x10(-6)+/-0.21 M.min(-1) and 0.32+/-0.02 s(-1), respectively. Moreover, the Mn(II)oxidizing activity of the recombinant E. coli strain M15-pQE-cotA was significantly increased when cultured both in Mn-containing K liquid medium and on agar plates. After 7-day liquid cultivation, M15-pQE-cotA resulted in 18.2% removal of Mn(II) from the medium. Furthermore, the biogenic Mn oxides were clearly observed on the cell surfaces of M15-pQE-cotA by scanning electron microscopy. To our knowledge, this is the first report that provides the direct observation of Mn(II) oxidation with the heterologously expressed protein CotA, Therefore, this novel finding not only establishes the foundation for in-depth study of Mn(II) oxidation mechanisms, but also offers a potential biocatalyst for Mn(II) removal.	[Su, Jianmei; Bao, Peng; Bai, Tenglong; Deng, Lin; He, Jin] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Liu, Fan] Huazhong Agr Univ, Coll Resources & Environm, Minist Agr, Key Lab Arable Land Conservat, Wuhan, Hunan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	He, J (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	hejin@mail.hzau.edu.cn	Liu, fan/B-2289-2012		Chinese National Natural Science Funds [40830527]; National Basic Research Program of China (973 Program) [2010CB126105]; National High Technology Research and Development Program of China (863 project) [2011AA10A205]; Fundamental Research Funds for Central Universities of China [2011PY092]	Chinese National Natural Science Funds(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 project)(National High Technology Research and Development Program of China); Fundamental Research Funds for Central Universities of China	This work was supported by the Chinese National Natural Science Funds (grant 40830527), the National Basic Research Program of China (973 Program, grant 2010CB126105), the National High Technology Research and Development Program of China (863 project, grant 2011AA10A205), and the Fundamental Research Funds for Central Universities of China (grant 2011PY092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2011, ENVIRON MICROBIOL, V13, P1561, DOI 10.1111/j.1462-2920.2011.02462.x; Anderson CR, 2009, APPL ENVIRON MICROB, V75, P4130, DOI 10.1128/AEM.02890-08; Ausec L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025724; BOOGERD FC, 1987, J BACTERIOL, V169, P489, DOI 10.1128/jb.169.2.489-494.1987; Brouwers GJ, 2000, GEOMICROBIOL J, V17, P1, DOI 10.1080/014904500270459; Brouwers GJ, 2000, GEOMICROBIOL J, V17, P25, DOI 10.1080/014904500270468; Brouwers GJ, 1999, APPL ENVIRON MICROB, V65, P1762; Corstjens PLAM, 1997, GEOMICROBIOL J, V14, P91, DOI 10.1080/01490459709378037; Dick GJ, 2008, APPL ENVIRON MICROB, V74, P1527, DOI 10.1128/AEM.01240-07; DOUKA CE, 1980, APPL ENVIRON MICROB, V39, P74, DOI 10.1128/AEM.39.1.74-80.1980; Durao P, 2006, J BIOL INORG CHEM, V11, P514, DOI 10.1007/s00775-006-0102-0; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; El Gheriany IA, 2011, ARCH MICROBIOL, V193, P89, DOI 10.1007/s00203-010-0645-x; El Gheriany IA, 2009, APPL ENVIRON MICROB, V75, P1229, DOI 10.1128/AEM.02291-08; Enguita FJ, 2003, J BIOL CHEM, V278, P19416, DOI 10.1074/jbc.M301251200; Enguita FJ, 2004, J BIOL CHEM, V279, P23472, DOI 10.1074/jbc.M314000200; Francis CA, 2002, ARCH MICROBIOL, V178, P450, DOI 10.1007/s00203-002-0472-9; Francis CA, 2002, APPL ENVIRON MICROB, V68, P874, DOI 10.1128/AEM.68.2.874-880.2002; Francis CA, 2001, APPL ENVIRON MICROB, V67, P4272, DOI 10.1128/AEM.67.9.4272-4278.2001; Geszvain K., 2012, APPL ENV MICROBIOL A, DOI [10.1128/AEM.01850-12, DOI 10.1128/AEM.01850-12]; Geszvain K, 2010, APPL ENVIRON MICROB, V76, P1224, DOI 10.1128/AEM.02473-09; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Gupta N, 2010, PROTEIN ENG DES SEL, V23, P679, DOI 10.1093/protein/gzq036; Hall SJ, 2008, J BACTERIOL, V190, P8075, DOI 10.1128/JB.00821-08; He JZ, 2010, J SOIL SEDIMENT, V10, P767, DOI 10.1007/s11368-009-0139-0; He JZ, 2008, GEOMICROBIOL J, V25, P14, DOI 10.1080/01490450701829014; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Johannes C, 2000, J BIOTECHNOL, V78, P193, DOI 10.1016/S0168-1656(00)00208-X; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Koschorreck K, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-12; KRUMBEIN WE, 1973, HELGOLAND WISS MEER, V25, P347, DOI 10.1007/BF01611203; Lang ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033985; Larsen EI, 1999, ARCH MICROBIOL, V171, P257, DOI 10.1007/s002030050708; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Meng YT, 2009, ENVIRON POLLUT, V157, P2577, DOI 10.1016/j.envpol.2009.02.035; Mohammadian M, 2010, J IND MICROBIOL BIOT, V37, P863, DOI 10.1007/s10295-010-0734-5; Okazaki M, 1997, APPL ENVIRON MICROB, V63, P4793, DOI 10.1128/AEM.63.12.4793-4799.1997; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Ridge JP, 2007, ENVIRON MICROBIOL, V9, P944, DOI 10.1111/j.1462-2920.2006.01216.x; ROSSON RA, 1982, J BACTERIOL, V151, P1027, DOI 10.1128/JB.151.2.1027-1034.1982; Sakasegawa S, 2006, APPL ENVIRON MICROB, V72, P972, DOI 10.1128/AEM.72.1.972-975.2006; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sujith P P, 2011, Prog Mol Subcell Biol, V52, P49, DOI 10.1007/978-3-642-21230-7_3; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Tebo BM, 2007, MANUAL OF ENVIRONMENTAL MICROBIOLOGY, 3RD ED, P1223; Tebo BM, 2010, GEOMICROBIOLOGY: MOLECULAR AND ENVIRONMENTAL PERSPECTIVE, P285, DOI 10.1007/978-90-481-9204-5_13; Toner B, 2005, APPL ENVIRON MICROB, V71, P1300, DOI 10.1128/AEM.71.3.1300-1310.2005; vanWaasbergen LG, 1996, J BACTERIOL, V178, P3517, DOI 10.1128/JB.178.12.3517-3530.1996; Wang XH, 2011, MAR DRUGS, V9, P1, DOI 10.3390/md9010001; Webb SM, 2005, P NATL ACAD SCI USA, V102, P5558, DOI 10.1073/pnas.0409119102; Zhang LM, 2008, SOIL BIOL BIOCHEM, V40, P1364, DOI 10.1016/j.soilbio.2007.01.004	52	53	61	4	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60573	10.1371/journal.pone.0060573	http://dx.doi.org/10.1371/journal.pone.0060573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23577125	Green Published, Green Submitted, gold			2022-12-27	WOS:000319109800065
J	Canto, GJ; Guerrero, RI; Olvera-Ramirez, AM; Milian, F; Mosqueda, J; Aguilar-Tipacamu, G				Canto, Germinal J.; Guerrero, Roberto I.; Olvera-Ramirez, Andrea M.; Milian, Feliciano; Mosqueda, Juan; Aguilar-Tipacamu, Gabriela			Prevalence of Fleas and Gastrointestinal Parasites in Free-Roaming Cats in Central Mexico	PLOS ONE			English	Article							PUBLIC-HEALTH SIGNIFICANCE; STRAY CATS; DOMESTIC DOGS; ECHIDNOPHAGA-GALLINACEA; INTESTINAL HELMINTHS; RICKETTSIA-FELIS; TOXOCARA-CATI; FERAL CATS; VETERINARY; INFESTATION	The prevalence of fleas and gastrointestinal parasites in free-roaming and domestic cats in central Mexico was evaluated. Three hundred and fifty eight cats captured in the street or brought in by owners to the Animal Control Center Unit, a unit of State Government, from June 2010 to May 2011, were included in the study. All cats were examined for the presence of fleas and gastrointestinal worms. One-hundred and ninety (53%) cats were infested with at least one flea species. Single infestations were observed in 106 (30%) cats and mixed infestations in 84 (23%) cats. Four species of fleas were recovered: Ctenocephalides felis in 53% of the cats, C. canis in 18%, Echidnophaga gallinacea in 7% and Pulex irritans in 1%. One-hundred and sixty three (45%) cats were infected with one or more species of gastrointestinal parasites: 48 (13%) with nematodes, 145 (40%) with cestodes, and one animal presented Moniliformis moniliformis. Prevalences and mean intensity of infection were: Physaloptera praeputialis 7 and 18; T. cati 3 and 2; Ancylostoma tubaeforme 2.5 and 2; Toxascaris leonina 0.5 and 2; Dipylidium caninum 36 and 32; Taenia taeniformis 4 and 3 and Moniliformis moniliformis 0.3 and 106, respectively. There was significant association (P<0.01), between season and ectoparasites load, more fleas were obtained in the summer and autumn than in the winter and spring; however, no statistical difference was observed for endoparasites load (P>0.05). The correlation between the total number of ectoparasites and endoparasites was not significant (r = 0.089, P = 0.094).	[Canto, Germinal J.; Guerrero, Roberto I.; Olvera-Ramirez, Andrea M.; Milian, Feliciano; Mosqueda, Juan; Aguilar-Tipacamu, Gabriela] Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro, Qro, Mexico	Universidad Autonoma de Queretaro	Canto, GJ (corresponding author), Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro, Qro, Mexico.	gcanto07@uaq.mx	Guerrero, Roberto/GXN-3257-2022		Universidad Autonoma de Queretaro, CONACYT	Universidad Autonoma de Queretaro, CONACYT	Universidad Autonoma de Queretaro, CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Madi MA, 2010, VET PARASITOL, V168, P284, DOI 10.1016/j.vetpar.2009.11.027; Akucewich LH, 2002, VET PARASITOL, V109, P129, DOI 10.1016/S0304-4017(02)00205-4; Alcaino HA, 2002, VET PARASITOL, V105, P261, DOI 10.1016/S0304-4017(01)00626-4; Aluja A, 2002, TECNICAS NECROPSIA A, P5; Ambrosio R.E., 1990, Revue Scientifique et Technique Office International des Epizooties, V9, P759; [Anonymous], DIARIO OFICIAL  0616; Beck W, 2006, VET PARASITOL, V137, P130, DOI 10.1016/j.vetpar.2005.12.021; BERESFORDJONES WP, 1981, J SMALL ANIM PRACT, V22, P27, DOI 10.1111/j.1748-5827.1981.tb01388.x; Bond R, 2007, VET REC, V160, P503, DOI 10.1136/vr.160.15.503; Boughton RK, 2006, J PARASITOL, V92, P941, DOI 10.1645/GE-769R.1; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Calvete C, 1998, VET PARASITOL, V75, P235, DOI 10.1016/S0304-4017(97)00182-9; Carleton RE, 2004, VET PARASITOL, V119, P319, DOI 10.1016/j.vetpar.2003.10.019; CEA, 2010, CLIM PRON REP MENS C; CHESNEY CJ, 1995, VET REC, V136, P356, DOI 10.1136/vr.136.14.356; Coffin DL, 1986, LAB CIINICO MED VET; COOPER JE, 1992, VET REC, V130, P108, DOI 10.1136/vr.130.5.108; Cruz-Vazquez C, 2001, J MED ENTOMOL, V38, P111, DOI 10.1603/0022-2585-38.1.111; Durden LA, 2005, VET PARASITOL, V130, P157, DOI 10.1016/j.vetpar.2005.03.016; EDWARDS FB, 1969, VET REC, V85, P665; Eldredge D.M., 2008, CATS OWNERS HOME VET; ENGBAEK K, 1984, Z PARASITENKD, V70, P87, DOI 10.1007/BF00929578; Farkas R, 2009, MED VET ENTOMOL, V23, P187, DOI 10.1111/j.1365-2915.2009.00798.x; Gracia MJ, 2008, VET PARASITOL, V151, P312, DOI 10.1016/j.vetpar.2007.10.006; Gracia MJ, 2012, MED VET ENTOMOLOGY; HARMAN DW, 1987, VET PARASITOL, V23, P135, DOI 10.1016/0304-4017(87)90031-8; Irwin PJ, 2002, INT J PARASITOL, V32, P581, DOI 10.1016/S0020-7519(01)00361-7; KOUTINAS AF, 1995, VET PARASITOL, V58, P109, DOI 10.1016/0304-4017(94)00706-I; KRISTENSEN S, 1978, NORD VET MED, V30, P401; Labarthe N, 2004, VET PARASITOL, V123, P133, DOI 10.1016/j.vetpar.2004.06.002; Loftis AD, 2006, AM J TROP MED HYG, V75, P41, DOI 10.4269/ajtmh.2006.75.41; Guerrero JHM, 2010, J ANIM VET ADV, V9, P601; Mircean V, 2010, VET PARASITOL, V171, P163, DOI 10.1016/j.vetpar.2010.03.005; NATHWANI D, 1992, BRIT J CLIN PRACT, V46, P271; NICHOL S, 1981, VET PARASITOL, V9, P107, DOI 10.1016/0304-4017(81)90028-5; Overgaauw PAM, 1997, VET QUART, V19, P14, DOI 10.1080/01652176.1997.9694730; Overgaauw PAM, 2009, VET PARASITOL, V163, P115, DOI 10.1016/j.vetpar.2009.03.044; Palmer CS, 2008, VET PARASITOL, V151, P181, DOI 10.1016/j.vetpar.2007.10.015; Palmer CS, 2007, VET PARASITOL, V145, P304, DOI 10.1016/j.vetpar.2006.12.018; Ramirez-Barrios RA, 2008, REV CIENT-FAC CIEN V, V18, P374; ROBERTS LS, 2005, FDN PARASITOLOGY; Robertson ID, 2000, INT J PARASITOL, V30, P1369, DOI 10.1016/S0020-7519(00)00134-X; Robertson ID, 2002, MICROBES INFECT, V4, P867, DOI 10.1016/S1286-4579(02)01607-6; Rodriguez-Vivas RI, 2001, REV BIOMED, V12, P19; Rust MK, 2005, TRENDS PARASITOL, V21, P232, DOI 10.1016/j.pt.2005.03.010; Rust MK, 1997, ANNU REV ENTOMOL, V42, P451, DOI 10.1146/annurev.ento.42.1.451; Sharif M, 2007, J HELMINTHOL, V81, P63, DOI 10.1017/S0022149X07214117; SILVERMAN J, 1981, J MED ENTOMOL, V18, P78, DOI 10.1093/jmedent/18.1.78; Slapeta J, 2011, VET PARASITOL, V180, P383, DOI 10.1016/j.vetpar.2011.03.035; Slater MR, 2001, PREV VET MED, V48, P273, DOI 10.1016/S0167-5877(00)00201-4; Thompson RCA, 1999, PARASITOL TODAY, V15, P320, DOI 10.1016/S0169-4758(99)01481-7; Trusfield M, 1990, EPIDEMIOLOGIA VET AC, P39; Vant Woudt B.D., 1990, P 14 SUP VERT PEST C, P291; Wall R., 2001, VET ECTOPARASITE BIO, DOI [10.1002/9780470690505, DOI 10.1002/9780470690505]; Xhaxhiu D, 2009, PARASITOL RES, V105, P1577, DOI 10.1007/s00436-009-1591-x; Zarate Ramos J. J., 1991, Veterinaria Mexico, V22, P185; Zavala-Velazquez E, 2002, VECTOR-BORNE ZOONOT, V2, P69, DOI 10.1089/153036602321131869; Zavala-Velazquez J, 2006, ARCH MED RES, V37, P419, DOI 10.1016/j.arcmed.2005.08.003; Zibaei M, 2007, TROP BIOMED, V24, P39	59	18	21	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e60744	10.1371/journal.pone.0060744	http://dx.doi.org/10.1371/journal.pone.0060744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573282	Green Submitted, gold, Green Published			2022-12-27	WOS:000318840100102
J	Dux, PE; Roseboom, W; Olivers, CNL				Dux, Paul E.; Roseboom, Warrick; Olivers, Christian N. L.			Attentional Tuning Resets after Failures of Perceptual Awareness	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; RESOURCE DEPLETION; BLINK; TASK; SELECTION; INFORMATION; ACTIVATION; TARGETS	Key to successfully negotiating our environment is our ability to adapt to current settings based on recent experiences and behaviour. Response conflict paradigms (e. g., the Stroop task) have provided evidence for increases in executive control after errors, leading to slowed responses that are more likely to be correct, and less susceptible to response congruency effects. Here we investigate whether failures of perceptual awareness, rather than failures at decisional or response stages of information processing, lead to similar adjustments in visual attention. We employed an attentional blink task in which subjects often fail to consciously register the second of two targets embedded in a rapid serial visual presentation stream of distractors, and examined how target errors influence performance on subsequent trials. Performance was inferior after Target 2 errors and these inter-trial effects were independent of the temporal lag between the targets and were not due to more global changes in attention across runs of trials. These results shed light on the nature of attentional calibration in response to failures of perceptual consciousness.	[Dux, Paul E.; Roseboom, Warrick] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Roseboom, Warrick] NTT Corp, Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa, Japan; [Olivers, Christian N. L.] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	University of Queensland; Nippon Telegraph & Telephone Corporation; Vrije Universiteit Amsterdam	Dux, PE (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	paul.e.dux@gmail.com	Dux, Paul/I-1098-2014	Dux, Paul/0000-0002-4270-2583; Olivers, Christian/0000-0001-7470-5378	ARC [DP0986387, FT120100033]; NWO Vidi grant [452-06-007]	ARC(Australian Research Council); NWO Vidi grant(Netherlands Organization for Scientific Research (NWO))	This work was supported by an ARC discovery grant and fellowships (DP0986387; FT120100033; http://www.arc.gov.au/) to PED, and a NWO Vidi grant (452-06-007; http://www.nwo.nl/) to CNLO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend I, 2006, PSYCHON B REV, V13, P600, DOI 10.3758/BF03193969; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Dell'Acqua R, 2012, PSYCHON B REV, V19, P232, DOI 10.3758/s13423-011-0209-3; Dell'Acqua R, 2009, J EXPT PSYCHOL HUMAN, V21, P109; Della Libera C, 2006, PSYCHOL SCI, V17, P222; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Dux PE, 2008, PSYCHON B REV, V15, P809, DOI 10.3758/PBR.15.4.809; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Dux PE, 2009, PSYCHON B REV, V16, P219, DOI 10.3758/PBR.16.1.219; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Itti L., 2005, NEUROBIOLOGY ATTENTI; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Kawahara JI, 2006, PSYCHOL RES-PSYCH FO, V70, P405, DOI 10.1007/s00426-005-0007-5; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Liu X, 2006, CEREB CORTEX, V16, P827, DOI 10.1093/cercor/bhj026; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MacLean MH, 2011, BRAIN RES, V1387, P99, DOI 10.1016/j.brainres.2011.02.069; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Olivers CNL, 2002, J EXP PSYCHOL HUMAN, V28, P22, DOI 10.1037//0096-1523.28.1.22; Pascucci D, PSYCHOL SCI IN PRESS; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pincham HL, 2012, CEREB CORTEX, V22, P2346, DOI 10.1093/cercor/bhr314; POTTER MC, 1969, J EXP PSYCHOL, V81, P10, DOI 10.1037/h0027470; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Sergent C, 2004, PSYCHOL SCI, V15, P720, DOI 10.1111/j.0956-7976.2004.00748.x; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Verbruggen F, 2006, PSYCHON B REV, V13, P328, DOI 10.3758/BF03193852; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P324, DOI 10.1037/a0013903; Yashar A, 2010, PSYCHOL SCI, V21, P243, DOI 10.1177/0956797609357928; Zauner A, 2012, NEUROIMAGE, V63, P674, DOI 10.1016/j.neuroimage.2012.06.075	47	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60623	10.1371/journal.pone.0060623	http://dx.doi.org/10.1371/journal.pone.0060623			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	127RY	23565262	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300133
J	Hollmann, A; Matos, PM; Augusto, MT; Castanho, MARB; Santos, NC				Hollmann, Axel; Matos, Pedro M.; Augusto, Marcelo T.; Castanho, Miguel A. R. B.; Santos, Nuno C.			Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action	PLOS ONE			English	Article							LIPID RAFTS; MODEL SYSTEMS; FLUORESCENCE; INFECTION; ENFUVIRTIDE; TYPE-1; ENTRY; GP41; MECHANISMS; EXTRUSION	Recently, the covalent binding of a cholesterol moiety to a classical HIV-1 fusion inhibitor peptide, C34, was shown to potentiate its antiviral activity. Our purpose was to evaluate the interaction of cholesterol-conjugated and native C34 with membrane model systems and human blood cells to understand the effects of this derivatization. Lipid vesicles and monolayers with defined compositions were used as model membranes. C34-cholesterol partitions more to fluid phase membranes that mimic biological membranes. Importantly, there is a preference of the conjugate for liquid ordered membranes, rich in cholesterol and/or sphingomyelin, as observed both from partition and surface pressure studies. In human erythrocytes and peripheral blood mononuclear cells (PBMC), C34-cholesterol significantly decreases the membrane dipole potential. In PBMC, the conjugate was 14- and 115-fold more membranotropic than T-1249 and enfuvirtide, respectively. C34 or cholesterol alone did not show significant membrane activity. The enhanced interaction of C34-cholesterol with biological membranes correlates with its higher antiviral potency. Higher partitions for lipid-raft like compositions direct the drug to the receptor-rich domains where membrane fusion is likely to occur. This intermediary membrane binding step may facilitate the drug delivery to gp41 in its pre-fusion state.	[Hollmann, Axel; Matos, Pedro M.; Augusto, Marcelo T.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal	Universidade de Lisboa	Santos, NC (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal.	nsantos@fm.ul.pt	Santos, Nuno/N-7248-2013; Hollmann, Axel/J-4931-2013; Matos, Pedro/B-4718-2010	Santos, Nuno/0000-0002-0580-0475; Matos, Pedro/0000-0002-8386-6613; Augusto, Marcelo/0000-0002-6536-3924; Hollmann, Axel/0000-0002-8060-2997; FCCN, Bogus/0000-0003-1034-3552; Castanho, Miguel/0000-0001-7891-7562	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/72037/2010, SFRH/BD/42205/2007, PTDC/QUI-BIQ/104787/2008, PTDC/QUI-BIQ/112929/2009, VIH/SAU/0047/2011]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was funded by Fundacao para a Ciencia e Tecnologia, Portugal (fellowships SFRH/BPD/72037/2010 and SFRH/BD/42205/2007 to A. H. and P. M. M., respectively, and projects PTDC/QUI-BIQ/104787/2008, PTDC/QUI-BIQ/112929/2009 and VIH/SAU/0047/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008297; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Campbell S, 2004, J VIROL, V78, P10556, DOI 10.1128/JVI.78.19.10556-10565.2004; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Castanho MARB, 2006, EUR BIOPHYS J BIOPHY, V35, P92, DOI 10.1007/s00249-005-0007-9; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chiu SW, 1999, BIOPHYS J, V76, P1939, DOI 10.1016/S0006-3495(99)77353-4; Cladera J, 1998, BIOPHYS J, V74, P2434, DOI 10.1016/S0006-3495(98)77951-2; Clarke RJ, 1997, BBA-BIOMEMBRANES, V1323, P223, DOI 10.1016/S0005-2736(96)00188-5; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; Fernandes MX, 2002, ANAL BIOCHEM, V307, P1, DOI 10.1016/S0003-2697(02)00024-6; Franquelim HG, 2008, J AM CHEM SOC, V130, P6215, DOI 10.1021/ja711247n; Franquelim HG, 2011, PEPTIDE DRUG DISCOVERY AND DEVELOPMENT: TRANSLATIONAL RESEARCH IN ACADEMIA AND INDUSTRY, P209; Gerber D, 2004, J MOL BIOL, V339, P243, DOI 10.1016/j.jmb.2004.03.004; Greenwood AI, 2006, CHEM PHYS LIPIDS, V143, P1, DOI 10.1016/j.chemphyslip.2006.04.002; GROSS E, 1994, BIOPHYS J, V67, P208, DOI 10.1016/S0006-3495(94)80471-0; Haldar S, 2012, BIOPHYS J, V102, P1561, DOI 10.1016/j.bpj.2012.03.004; Harman S, 2012, ANTIMICROB AGENTS CH, V56, P2347, DOI 10.1128/AAC.06108-11; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; He YX, 2013, CURR PHARM DESIGN, V19, P1800, DOI 10.2174/1381612811319100004; Hess C, 2002, LANCET, V359, P2230, DOI 10.1016/S0140-6736(02)09291-7; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; KUBISTA M, 1994, ANALYST, V119, P417, DOI 10.1039/an9941900417; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Lieberman-Blum SS, 2008, CLIN THER, V30, P1228, DOI 10.1016/S0149-2918(08)80048-3; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Matos PM, 2010, BIOCHEM BIOPH RES CO, V403, P270, DOI 10.1016/j.bbrc.2010.11.013; Matos PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009830; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; NAGLE JF, 1988, BIOCHIM BIOPHYS ACTA, V942, P1, DOI 10.1016/0005-2736(88)90268-4; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Peisajovich SG, 2003, J BIOL CHEM, V278, P21012, DOI 10.1074/jbc.M212773200; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Santos NC, 1998, BIOCHEMISTRY-US, V37, P8674, DOI 10.1021/bi9803933; Stoddart CA, 2008, J BIOL CHEM, V283, P34045, DOI 10.1074/jbc.M805536200; SZOKA F, 1980, BIOCHIM BIOPHYS ACTA, V601, P559, DOI 10.1016/0005-2736(80)90558-1; Vanpouille C, 2012, TRENDS MICROBIOL, V20, P369, DOI 10.1016/j.tim.2012.05.005; Veiga AS, 2004, J AM CHEM SOC, V126, P14758, DOI 10.1021/ja0459882; Veiga S, 2004, BIOCHEM J, V377, P107, DOI 10.1042/BJ20031350; Wexler-Cohen Y, 2007, FASEB J, V21, P3677, DOI 10.1096/fj.07-8582com; Xie D, 2010, ANTIMICROB AGENTS CH, V54, P191, DOI 10.1128/AAC.00976-09; YAMAZAKI M, 1994, BIOPHYS J, V66, P729, DOI 10.1016/S0006-3495(94)80848-3; Zhang HY, 2008, ORG PROCESS RES DEV, V12, P101, DOI 10.1021/op7002198	51	44	45	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60302	10.1371/journal.pone.0060302	http://dx.doi.org/10.1371/journal.pone.0060302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565220	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300089
J	Rochlin, I; Ninivaggi, DV; Hutchinson, ML; Farajollahi, A				Rochlin, Ilia; Ninivaggi, Dominick V.; Hutchinson, Michael L.; Farajollahi, Ary			Climate Change and Range Expansion of the Asian Tiger Mosquito (Aedes albopictus) in Northeastern USA: Implications for Public Health Practitioners	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; CHIKUNGUNYA VIRUS; DIPTERA; CULICIDAE; SURVIVAL; INVASION; POPULATIONS; TRISERIATUS; EMERGENCE; VECTORS	The Asian tiger mosquito, Aedes albopictus (Skuse), is an invasive species with substantial biting activity, high disease vector potential, and a global distribution that continues to expand. New Jersey, southern New York, and Pennsylvania are currently the northernmost boundary of established Ae. albopictus populations in the eastern United States. Using positive geographic locations from these areas, we modeled the potential future range expansion of Ae. albopictus in northeastern USA under two climate change scenarios. The land area with environmental conditions suitable for Ae. albopictus populations is expected to increase from the current 5% to 16% in the next two decades and to 43%-49% by the end of the century. Presently, about one-third of the total human population of 55 million in northeastern USA reside in urban areas where Ae. albopictus is present. This number is predicted to double to about 60% by the end of the century, encompassing all major urban centers and placing over 30 million people under the threat of dense Ae. albopictus infestations. This mosquito species presents unique challenges to public health agencies and has already strained the resources available to mosquito control programs within its current range. As it continues to expand into areas with fewer resources and limited organized mosquito control, these challenges will be further exacerbated. Anticipating areas of potential establishment, while planning ahead and gathering sufficient resources will be the key for successful public health campaigns. A broad effort in community sanitation and education at all levels of government and the private sector will be required until new control techniques are developed that can be applied efficiently and effectively at reasonable cost to very large areas.	[Rochlin, Ilia; Ninivaggi, Dominick V.] Suffolk Cty Vector Control, Yaphank, NY USA; [Hutchinson, Michael L.] Penn Dept Environm Protect, Div Vector Management, Harrisburg, PA USA; [Farajollahi, Ary] Mercer Cty Mosquito Control, West Trenton, NJ USA; [Farajollahi, Ary] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Rochlin, I (corresponding author), Suffolk Cty Vector Control, Yaphank, NY USA.	ilia.rochlin@suffolkcountyny.gov			USDA grant [USDA-ARS-58-6615-8-105]	USDA grant(United States Department of Agriculture (USDA))	This study was conducted by government agencies, with the financial support provided by the state and the county taxpayers. Partial funding for this project was provided by a USDA grant (USDA-ARS-58-6615-8-105) entitled "Area-wide Pest Management Program for the Asian Tiger Mosquito in New Jersey". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646; Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Farajollahi A, 2012, BIOL INVASIONS; Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181; Farajollahi A, 2009, J MED ENTOMOL, V46, P1220, DOI 10.1603/033.046.0533; Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; HANSON SM, 1995, J MED ENTOMOL, V32, P599, DOI 10.1093/jmedent/32.5.599; HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Hughes MT, 2006, J MED ENTOMOL, V43, P757, DOI 10.1603/0022-2585(2006)43[757:CPOATA]2.0.CO;2; KOMAR N, 1994, ANN NY ACAD SCI, V740, P157, DOI 10.1111/j.1749-6632.1994.tb19866.x; Leisnham PT, 2012, ECOHEALTH, V9, P217, DOI 10.1007/s10393-012-0773-7; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; MITCHELL CJ, 1992, SCIENCE, V257, P526, DOI 10.1126/science.1321985; Nasci RS, 2001, EMERG INFECT DIS, V7, P742; NAWROCKI SJ, 1987, J AM MOSQUITO CONTR, V3, P314; Nayar JK, 1985, FLA AGR EXP STA B, V852, P1; NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rochlin I, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-35; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; TURELL MJ, 1994, J MED ENTOMOL, V31, P287, DOI 10.1093/jmedent/31.2.287; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x	42	214	225	2	166	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60874	10.1371/journal.pone.0060874	http://dx.doi.org/10.1371/journal.pone.0060874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565282	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300155
J	Wu, L; Li, X; Zhu, HG; Xu, P; Gao, X				Wu, Lin; Li, Xiang; Zhu, Hongguang; Xu, Ping; Gao, Xin			A Prescribed Chinese Herbal Medicine Improves Glucose Profile and Ameliorates Oxidative Stress in Goto-Kakisaki Rats Fed with High Fat Diet	PLOS ONE			English	Article							BETA-CELLS; ENDOTHELIAL FUNCTION; METABOLIC SYNDROME; INSULIN-SECRETION; DIABETIC-RATS; ANTIOXIDANT; OBESITY; DYSFUNCTION; TETRAMETHYLPYRAZINE; INFLAMMATION	Oxidative stress (OS) plays a role in hyperglycemia induced islet beta cell dysfunction, however, studies on classic anti-oxidants didn't show positive results in treating diabetes. We previously demonstrated that the prescribed Chinese herbal medicine preparation "Qing Huo Yi Hao'' (QHYH) improved endothelial function in type 2 diabetic patients. QHYH protected endothelial cells from high glucose-induced damages by scavenging superoxide anion and reducing production of reactive oxygen species. Its active component protected C2C12 myotubes against palmitate-induced oxidative damage and mitochondrial dysfunction. In the present study, we investigated whether QHYH protected islet beta cell function exacerbated by high fat diet (HFD) in hyperglycemic GK rats. 4-week-old male rats were randomly divided into high HFD feeding group (n = 20) and chow diet feeding group (n = 10). Each gram of HFD contained 4.8 kcal of energy, 52% of which from fat. Rats on HFD were further divided into 2 groups given either QHYH (3 ml/Kg/d) or saline through gastric tube. After intervention, serum glucose concentrations were monitored; IPGTTs were performed without anesthesia on 5 fasting rats randomly chosen from each group on week 4 and 16. Serum malondialdehyde (MDA) concentrations and activities of serum antioxidant enzymes were measured on week 4 and 16. Islet beta cell mass and OS marker staining was done by immunohistochemistry on week 16. QHYH prevented the exacerbation of hyperglycemia in HFD feeding GK rats for 12 weeks. On week 16, it improved the exacerbated glucose tolerance and prevented the further loss of islet beta cell mass induced by HFD. QHYH markedly decreased serum MDA concentration, increased serum catalase (CAT) and SOD activities on week 4. However, no differences of serum glucose concentration or OS were observed on week 16. We concluded that QHYH decreased hyperglycemia exacerbated by HFD in GK rats by improving beta cell function partly via its antioxidant effect.	[Li, Xiang; Gao, Xin] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Wu, Lin] Fudan Univ, Zhongshan Hosp, Dept Geriatr, Shanghai 200433, Peoples R China; [Zhu, Hongguang] Fudan Univ, Dept Pathol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xu, Ping] Chinese Acad Sci, Shanghai Lab Anim Ctr, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences	Gao, X (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China.	gao.xin@zs-hospital.sh.cn			National Basic Research Program of China [2012CB524906, 2011CB504004]; National Natural Science Foundation of China [30871196]; Specialized Research Fund for the Doctoral Program of Higher Education [20060246076]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by: 1. Grants from the National Basic Research Program of China (2012CB524906 and 2011CB504004 to XG) (www.973.gov.cn); 2. The National Natural Science Foundation of China (No 30871196 to XG) (www.nsfc.gov.cn); 3. Specialized Research Fund for the Doctoral Program of Higher Education (20060246076 to XG) (www.cutech.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin KA, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-17; Bjelakovic G, 2008, ALIMENT PHARM THER, V28, P689, DOI 10.1111/j.1365-2036.2008.03785.x; Blixt M, 2010, J ENDOCRINOL, V206, P47, DOI 10.1677/JOE-10-0074; Briaud I, 2002, DIABETES, V51, P662, DOI 10.2337/diabetes.51.3.662; Cerf ME, 2007, PANCREAS, V34, P347, DOI 10.1097/MPA.0b013e31802ee9ae; Ceriello A, 2007, DIABETES CARE, V30, P649, DOI 10.2337/dc06-2048; Ceriello A, 2009, DIABETES CARE, V32, pS232, DOI 10.2337/dc09-S316; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; de Oliveira AM, 2011, DIABETES RES CLIN PR, V92, P253, DOI 10.1016/j.diabres.2011.02.010; Defronzo R.A., 2011, J CLIN ENDOCRINOL ME; Drews G, 2010, PFLUG ARCH EUR J PHY, V460, P703, DOI 10.1007/s00424-010-0862-9; Speretta GFF, 2012, CLINICS, V67, P1469, DOI 10.6061/clinics/2012(12)19; Gao X, 2011, LIFE SCI, V88, P803, DOI 10.1016/j.lfs.2011.02.025; Hutton MJH, 2010, ISLETS, V2, P104, DOI 10.4161/isl.2.2.11209; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kang YX, 2009, LIFE SCI, V84, P428, DOI 10.1016/j.lfs.2009.01.003; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Koeck T, 2009, ARCH BIOCHEM BIOPHYS, V484, P221, DOI 10.1016/j.abb.2009.01.021; Lacraz G, 2010, AM J PHYSIOL-ENDOC M, V298, pE17, DOI 10.1152/ajpendo.90871.2008; Lacraz G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006500; Li XL, 2009, INT J BIOCHEM CELL B, V41, P1526, DOI 10.1016/j.biocel.2009.01.002; Louro T, 2011, J PHYSL BIOCH; Lu TH, 2011, TOXICOL LETT, V201, P15, DOI 10.1016/j.toxlet.2010.11.019; Markovits N, 2009, ISR MED ASSOC J, V11, P598; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Plaisance V, 2011, DIABETOLOGIA; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; Robertson P, 2005, MEDICOGRAPHIA, V27, P320; Robertson RP, 2007, CELL BIOCHEM BIOPHYS, V48, P139, DOI 10.1007/s12013-007-0026-5; Rudge MVC, 2007, BRAZ J MED BIOL RES, V40, P1095, DOI 10.1590/S0100-879X2006005000132; Sena CM, 2008, BRIT J PHARMACOL, V153, P894, DOI 10.1038/sj.bjp.0707474; Sena CM, 2009, PHYSIOL RES, V58, P203, DOI 10.33549/physiolres.931480; Shang WB, 2002, PANCREAS, V25, P393, DOI 10.1097/00006676-200211000-00012; Sjoholm A, 2010, PHARMACEUTICALS-BASE, V3, P764, DOI 10.3390/ph3030764; Tabur S, 2010, EUR J ENDOCRINOL, V162, P535, DOI 10.1530/EJE-09-0732; Takase H, 2012, EUR J CLIN INVEST, V42, P1287, DOI 10.1111/eci.12000; Tamai M, 2006, DIABETES RES CLIN PR, V71, P140, DOI 10.1016/j.diabres.2005.05.006; Xu Q, 2012, ACTA PHARMACOL SIN, V33, P496, DOI 10.1038/aps.2011.191; [余丹箐 Yu Danqing], 2004, [上海医学, Shanghai medical journal], V27, P466	39	2	2	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60262	10.1371/journal.pone.0060262	http://dx.doi.org/10.1371/journal.pone.0060262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565214	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300083
J	Zhou, YC; Fan, JW; Harris, W; Zhong, HP; Zhang, WY; Cheng, XL				Zhou, Yong-Chun; Fan, Jiang-Wen; Harris, Warwick; Zhong, Hua-Ping; Zhang, Wen-Yan; Cheng, Xi-Lei			Relationships between C-3 Plant Foliar Carbon Isotope Composition and Element Contents of Grassland Species at High Altitudes on the Qinghai-Tibet Plateau, China	PLOS ONE			English	Article							WATER-USE EFFICIENCY; ASH CONTENT; GRAIN-YIELD; METROSIDEROS-POLYMORPHA; POTASSIUM CONCENTRATION; MINERAL-NUTRITION; STABLE-ISOTOPES; PICEA-MARIANA; DURUM-WHEAT; DISCRIMINATION	Relationships of foliar carbon isotope composition (delta C-13) with foliar C, N, P, K, Ca, Mg contents and their ratios of 219 C-3 species leaf samples, obtained in August in 2004 to 2007 from 82 high altitude grassland sites on the Qinghai-Tibet Plateau China, were examined. This was done with reference to the proposition that foliar delta C-13 increases with altitude and separately for the life-form groups of graminoids, forbs and shrubs and for the genera Stipa and Kobresia. For all samples, foliar delta C-13 was negatively related to foliar K, P and Sigma(K+ Ca+ Mg), and positively correlated to foliar C, C/N and C/P. The significance of these correlations differed for the taxonomic and life-form groups. Lack of a relationship of foliar delta C-13 with foliar N was inconsistent with the majority of studies that have shown foliar delta C-13 to be positively related to foliar N due to a decrease of C-i/C-a (the ratio between intercellular and atmospheric concentration of CO2) and explained as a result of greater photosynthetic capacity at higher foliar N concentration. However this inconsistency relates to other high altitude studies that have found that photosynthetic capacity remains constant as foliar N increases. After accounting for the altitudinal relationship with foliar delta C-13, of the elements only the K effect was significant and was most strongly expressed for Kobresia. It is concluded that factors critical to plant survival and growth at very high altitudes, such as low atmospheric pressure and low temperatures, may preclude expression of relationships between foliar delta C-13 and foliar elements that have been observed at lower altitudes.	[Zhou, Yong-Chun; Fan, Jiang-Wen; Zhong, Hua-Ping; Zhang, Wen-Yan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Cheng, Xi-Lei] Liaoning Acad Environm Sci, Shenyang, Liaoning Provin, Peoples R China; [Harris, Warwick] NZ Ltd, Landcare Res, Canterbury, New Zealand	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Landcare Research - New Zealand	Fan, JW (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	fanjw@igsnrr.ac.cn			National Key Basic Research Program of China [2010CB950902]; National Natural Science Foundation of China [31070427]; National Key Technologies R&D Program of Ministry of Science and Technology of the People's Republic of China [2009BAC61B01]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of Ministry of Science and Technology of the People's Republic of China	The research was funded by the National Key Basic Research Program of China (2010CB950902), the National Natural Science Foundation of China (grant no. 31070427) and National Key Technologies R&D Program of Ministry of Science and Technology of the People's Republic of China (grant no. 2009BAC61B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Amrutha RN, 2007, PLANT SCI, V172, P708, DOI 10.1016/j.plantsci.2006.11.019; Araus JL, 1998, AUST J PLANT PHYSIOL, V25, P835, DOI 10.1071/PP98071; Ares A, 1999, OECOLOGIA, V121, P458, DOI 10.1007/s004420050952; ATKINSON CJ, 1990, NEW PHYTOL, V116, P19, DOI 10.1111/j.1469-8137.1990.tb00506.x; Cao SK, 2009, PHOTOSYNTHETICA, V47, P499, DOI 10.1007/s11099-009-0075-7; Cernusak LA, 2007, J EXP BOT, V58, P3549, DOI 10.1093/jxb/erm201; Cernusak LA, 2007, NEW PHYTOL, V173, P294, DOI 10.1111/j.1469-8137.2006.01913.x; Cernusak LA, 2010, NEW PHYTOL, V185, P770, DOI 10.1111/j.1469-8137.2009.03106.x; [陈拓 Chen Tuo], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P767; CLARKSON DT, 1980, ANNU REV PLANT PHYS, V31, P239, DOI 10.1146/annurev.pp.31.060180.001323; Condon AG, 2002, CROP SCI, V42, P122, DOI 10.2135/cropsci2002.0122; Cordell S, 1998, OECOLOGIA, V113, P188, DOI 10.1007/s004420050367; Cordell S, 1999, FUNCT ECOL, V13, P811, DOI 10.1046/j.1365-2435.1999.00381.x; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Elumalai RP, 2002, PLANT CELL, V14, P119, DOI 10.1105/tpc.010322; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Field C. H., 1986, EC FORM FUNCTION, P25; Gerdol R, 2000, OIKOS, V88, P19, DOI 10.1034/j.1600-0706.2000.880104.x; Grassi G, 2000, TREE PHYSIOL, V20, P645; Hamerlynck EP, 2004, OECOLOGIA, V138, P210, DOI 10.1007/s00442-003-1437-7; Heckathorn SA, 1997, PHYSIOL PLANTARUM, V101, P173, DOI 10.1034/j.1399-3054.1997.1010123.x; Karst AL, 2007, NEW PHYTOL, V173, P306, DOI 10.1111/j.1469-8137.2006.01914.x; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; Li CY, 2009, TREES-STRUCT FUNCT, V23, P1109, DOI 10.1007/s00468-009-0354-8; Mae T, 1997, PLANT SOIL, V196, P201, DOI 10.1023/A:1004293706242; Major JE, 2007, TREES-STRUCT FUNCT, V21, P677, DOI 10.1007/s00468-007-0161-z; Major JE, 2007, TREE PHYSIOL, V27, P353, DOI 10.1093/treephys/27.3.353; MASLE J, 1992, AUST J PLANT PHYSIOL, V19, P709, DOI 10.1071/PP9920709; Merah O, 1999, PHYSIOL PLANTARUM, V107, P387, DOI 10.1034/j.1399-3054.1999.100403.x; Merah O, 2001, CR ACAD SCI III-VIE, V324, P355, DOI 10.1016/S0764-4469(01)01307-5; Merah O, 2001, NEW PHYTOL, V149, P275, DOI 10.1046/j.1469-8137.2001.00012.x; Raeini-Sarjaz M, 1998, J AGRON CROP SCI, V180, P173, DOI 10.1111/j.1439-037X.1998.tb00387.x; Rascio A, 2001, PLANT SCI, V160, P441, DOI 10.1016/S0168-9452(00)00404-0; Reich PB, 1998, FUNCT ECOL, V12, P948, DOI 10.1046/j.1365-2435.1998.00274.x; SAURER M, 1995, TELLUS B, V47, P320, DOI 10.1034/j.1600-0889.47.issue3.4.x; Schulze ED, 2006, TREE PHYSIOL, V26, P479, DOI 10.1093/treephys/26.4.479; TAKAGI S, 1992, BOT MAG TOKYO, V105, P687, DOI 10.1007/BF02489443; Tsialtas JT, 2008, FIELD CROP RES, V107, P70, DOI 10.1016/j.fcr.2007.12.017; Tsialtas JT, 2006, FIELD CROP RES, V99, P125, DOI 10.1016/j.fcr.2006.04.004; Tsialtas JT, 2002, J AGRON CROP SCI, V188, P168, DOI 10.1046/j.1439-037X.2002.00555.x; Tsialtas JT, 2001, FUNCT ECOL, V15, P605, DOI 10.1046/j.0269-8463.2001.00555.x; Walia A, 2010, TREE PHYSIOL, V30, P728, DOI 10.1093/treephys/tpq020; WALKER DA, 1986, PHILOS T R SOC B, V313, P305, DOI 10.1098/rstb.1986.0039; Warren CR, 2002, TREE PHYSIOL, V22, P11, DOI 10.1093/treephys/22.1.11; Wittmer MHOM, 2008, BIOGEOSCIENCES, V5, P913, DOI 10.5194/bg-5-913-2008; Zhao LJ, 2007, ENVIRON GEOL, V51, P1049, DOI 10.1007/s00254-006-0374-2; Zhao LJ, 2006, ENVIRON GEOL, V50, P285, DOI 10.1007/s00254-006-0209-1; Zhou YC, 2011, ALPINE BOT, V121, P79, DOI 10.1007/s00035-011-0093-5; Zhu L, 2010, J AGRON CROP SCI, V196, P175, DOI 10.1111/j.1439-037X.2009.00404.x; Zhu L, 2009, PLANT SCI, V176, P758, DOI 10.1016/j.plantsci.2009.02.018; Zhu Y, 2010, OECOLOGIA, V162, P853, DOI 10.1007/s00442-009-1515-6	53	18	21	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60794	10.1371/journal.pone.0060794	http://dx.doi.org/10.1371/journal.pone.0060794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565275	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300147
J	Xu, J; Ji, PF; Wang, BS; Zhao, L; Wang, J; Zhao, ZX; Zhang, Y; Li, JT; Xu, P; Sun, XW				Xu, Jian; Ji, Peifeng; Wang, Baosen; Zhao, Lan; Wang, Jian; Zhao, Zixia; Zhang, Yan; Li, Jiongtang; Xu, Peng; Sun, Xiaowen			Transcriptome Sequencing and Analysis of Wild Amur Ide (Leuciscus waleckii) Inhabiting an Extreme Alkaline-Saline Lake Reveals Insights into Stress Adaptation	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; CARBONIC-ANHYDRASE; CHANNEL CATFISH; GENE; EXPRESSION; GENOME; SALT; BIOMARKERS	Background: Amur ide (Leuciscus waleckii) is an economically and ecologically important species in Northern Asia. The Dali Nor population inhabiting Dali Nor Lake, a typical saline-alkaline lake in Inner Mongolia, is well-known for its adaptation to extremely high alkalinity. Genome information is needed for conservation and aquaculture purposes, as well as to gain further understanding into the genetics of stress tolerance. The objective of the study is to sequence the transcriptome and obtain a well-assembled transcriptome of Amur ide. Results: The transcriptome of Amur ide was sequenced using the Illumina platform and assembled into 53,632 cDNA contigs, with an average length of 647 bp and a N50 length of 1,094 bp. A total of 19,338 unique proteins were identified, and gene ontology and KEGG (Kyoto Encyclopedia of Genes and Genomes) analyses classified all contigs into functional categories. Open Reading Frames (ORFs) were detected from 34,888 (65.1%) of contigs with an average length of 577 bp, while 9,638 full-length cDNAs were identified. Comparative analyses revealed that 31,790 (59.3%) contigs have a significant similarity to zebrafish proteins, and 27,096 (50.5%), 27,524 (51.3%) and 27,996 (52.2%) to teraodon, medaka and three-spined stickleback proteins, respectively. A total of 10,395 microsatellites and 34,299 SNPs were identified and classified. A dN/dS analysis on unigenes was performed, which identified that 61 of the genes were under strong positive selection. Most of the genes are associated with stress adaptation and immunity, suggesting that the extreme alkaline-saline environment resulted in fast evolution of certain genes. Conclusions: The transcriptome of Amur ide had been deeply sequenced, assembled and characterized, providing a valuable resource for a better understanding of the Amur ide genome. The transcriptome data will facilitate future functional studies on the Amur ide genome, as well as provide insight into potential mechanisms for adaptation to an extreme alkaline-saline environment.	[Xu, Jian; Ji, Peifeng; Wang, Baosen; Zhao, Lan; Wang, Jian; Zhao, Zixia; Zhang, Yan; Li, Jiongtang; Xu, Peng; Sun, Xiaowen] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Wang, Baosen] Tianjin Normal Univ, Coll Life Sci, Tianjin, Peoples R China	Chinese Academy of Fishery Sciences; Tianjin Normal University	Xu, P (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China.	xupeng@cafs.ac.cn; sunxw2002@163.com	Xu, Jian/H-5349-2019; Wang, Jian/M-4594-2018; Zhao, Zi-Xia/AAM-8065-2021; Xu, Peng/J-4018-2012	Xu, Jian/0000-0003-0274-4268; Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Peng/0000-0002-1531-5078; Zhao, Lan/0000-0003-2681-7695	National Natural Science Foundation of China [31101893]; National Department Public Benefit Research Foundation [200903045]; National High-tech R&D Program of China [2011AA100401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation; National High-tech R&D Program of China(National High Technology Research and Development Program of China)	This study was supported by the grants from National Natural Science Foundation of China (No. 31101893), National Department Public Benefit Research Foundation (No. 200903045), National High-tech R&D Program of China (2011AA100401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy JW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-176; Celino FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016938; Chen JH, 2012, PLANT PHYSIOL, V158, P340, DOI 10.1104/pp.111.181875; [池炳杰 CHI Bingjie], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P228; Cirulli F, 2009, FRONT NEUROENDOCRIN, V30, P379, DOI 10.1016/j.yfrne.2009.05.002; Corona E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012236; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Fisher M, 1996, J BIOL CHEM, V271, P17718, DOI 10.1074/jbc.271.30.17718; Gomes SIL, 2012, NANOTOXICOLOGY, V6, P134, DOI 10.3109/17435390.2011.562327; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GUPTA AS, 1993, P NATL ACAD SCI USA, V90, P1629, DOI 10.1073/pnas.90.4.1629; Hale MC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-404; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; Henry RP, 2003, COMP BIOCHEM PHYS A, V136, P243, DOI 10.1016/S1095-6433(03)00113-2; Hepburn JJ, 2009, J ANIM SCI, V87, P4161, DOI 10.2527/jas.2009-1978; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Ji W, 2010, BIOTECHNOL LETT, V32, P1173, DOI 10.1007/s10529-010-0269-x; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Li J, 2009, J MOL EVOL, V68, P414, DOI 10.1007/s00239-009-9222-9; [刘金亮 Liu Jinliang], 2011, [华北农学报, Acta Agriculturae Boreali-Sinica], V26, P87; MI T D F, 2005, MSATFINDER DETECTION; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW669, DOI 10.1093/nar/gki436; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nandi S, 2007, GENETICA, V131, P81, DOI 10.1007/s10709-006-9115-4; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Qi YC, 2010, RUSS J PLANT PHYSL+, V57, P233, DOI 10.1134/S102144371002010X; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Santovito G, 2012, POLAR BIOL, V35, P1587, DOI 10.1007/s00300-012-1200-9; Sha Z, 2008, MOL IMMUNOL, V45, P1458, DOI 10.1016/j.molimm.2007.08.012; Tan YY, 2008, MOL CELL BIOCHEM, V318, P109, DOI 10.1007/s11010-008-9862-x; Tim-Tim ALS, 2009, CHEMOSPHERE, V77, P1465, DOI 10.1016/j.chemosphere.2009.10.014; Towle DW, 2011, COMP BIOCHEM PHYS D, V6, P115, DOI 10.1016/j.cbd.2010.11.001; Tsuji G, 2011, J DERMATOL SCI, V62, P42, DOI 10.1016/j.jdermsci.2010.10.017; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Wan Q, 2009, COMP BIOCHEM PHYS C, V150, P558, DOI 10.1016/j.cbpc.2009.08.003; Wang B, 2012, COMPLETE MITOCHONDRI; Wang Q, 2006, MOL IMMUNOL, V43, P1676, DOI 10.1016/j.molimm.2005.09.023; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; Wu ZH, 2007, J BIOL CHEM, V282, P22414, DOI 10.1074/jbc.M702321200; Xiao J, 2008, J PALEOLIMNOL, V40, P519, DOI 10.1007/s10933-007-9179-x; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Xu P, 2011, MAR BIOTECHNOL, V13, P215, DOI 10.1007/s10126-010-9283-1; Zhang J, 2008, J INNER MONGOLIA AGR, V29, P197; Zhang Y, 2008, PLANT PHYSIOL, V148, P2121, DOI 10.1104/pp.108.126912; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhang Z, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-44; Zhou J, 2009, COMP BIOCHEM PHYS C, V150, P224, DOI 10.1016/j.cbpc.2009.04.012	52	43	50	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e59703	10.1371/journal.pone.0059703	http://dx.doi.org/10.1371/journal.pone.0059703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	23573207	Green Published, Green Submitted, gold			2022-12-27	WOS:000316930900024
J	Li, YC; Li, CI; Lin, WY; Liu, CS; Hsu, HS; Lee, CC; Chen, FN; Li, TC; Lin, CC				Li, Yi-Chun; Li, Chia-Ing; Lin, Wen-Yuan; Liu, Chiu-Shong; Hsu, Hua-Shui; Lee, Cheng-Chun; Chen, Fei-Na; Li, Tsai-Chung; Lin, Cheng-Chieh			Percentage of Body Fat Assessment Using Bioelectrical Impedance Analysis and Dual-Energy X-ray Absorptiometry in a Weight Loss Program for Obese or Overweight Chinese Adults	PLOS ONE			English	Article							QUANTITATIVE ULTRASOUND; CARDIOVASCULAR-DISEASE; ADIPONECTIN; WOMEN; ADOLESCENTS; PREVALENCE; CHILDREN; GROWTH; CANCER; DEXA	The current study aimed to compare the estimates of body fat percentage (%BF) by performing bioelectrical impedance analysis (BIA) and dual energy X-ray absorptiometry (DXA) in a sample of obese or overweight Chinese adults who participated in a weight-loss randomized control trial stratified by gender to determine whether or not BIA is a valid measurement tool. Among 189 adults [73 males, 116 females; age = 41 to 74 years; mean body mass index (BMI) = 27.3 kg/m(2)], assessments of %BF at the baseline and six months from the baseline were conducted by performing BIA and DXA. Bland-Altman analyses and multiple regression analyses were used to assess the relationships between %BFBIA and %BFDXA. Compared with DXA, BIA underestimated %BF [in males: 4.6, -2.4 to 11.7 (mean biases, 95% limit of agreement) at the baseline, 1.4, -7.4 to 10.2 at the endpoint, and 3.2, -4.8 to 11.3 in changes; in females: 5.1, -2.4 to 12.7; 2.2, -6.1 to 10.4; and 3.0, -4.8 to 10.7, respectively]. For males and females, %BFDXA proved to be a significant predictor of the difference between DXA and BIA at the baseline, the endpoint, and in changes when BMI and age were considered (in males: p<0.01 and R-2 = 23.1%, 24.1%, 20.7%, respectively; for females: p<0.001 and R-2 = 40.4%, 48.8%, 25.4%, respectively). The current study suggests that BIA provides a relatively accurate prediction of %BF in individuals with normal weight, overweight, or obesity after the end of weight-loss program, but less accurate prediction of %BF in obese individuals at baseline or weight change during the weight-loss intervention program.	[Li, Yi-Chun; Li, Tsai-Chung] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung, Taiwan; [Li, Chia-Ing; Lin, Wen-Yuan; Liu, Chiu-Shong; Lee, Cheng-Chun; Chen, Fei-Na; Lin, Cheng-Chieh] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Wen-Yuan; Liu, Chiu-Shong; Hsu, Hua-Shui; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Lee, Cheng-Chun] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Hlth Sci, Inst Hlth Care Adm, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Chen, FN (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.	feina@mail.cmu.edu.tw; tcli@mail.cmu.edu.tw; cclin@mail.cmuh.org.tw	Li, Tsai-Chung/P-2052-2015; Lin, Cheng-Chieh/P-2564-2015; qin, yuanyuan/G-4351-2010	Li, Tsai-Chung/0000-0002-3346-7462; Lin, Cheng-Chieh/0000-0002-9625-6216; qin, yuanyuan/0000-0002-0673-3200	National Science Council of Taiwan [NSC93-2314-B-039-025, NSC94-2314-B-039-024, NSC96-2628-B-039-011-MY3]; Department of Health, Executive Yuan, Taiwan [DOH97-TD-F-113-96002]; Taiwan Department of Health Clinical Trial and Research Center for Excellence [DOH102-TD-B-111-004]; National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan; Taiwan Department of Health Clinical Trial and Research Center for Excellence; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (NSC93-2314-B-039-025 & NSC94-2314-B-039-024 & NSC96-2628-B-039-011-MY3), the Department of Health, Executive Yuan, Taiwan (DOH97-TD-F-113-96002), the Taiwan Department of Health Clinical Trial and Research Center for Excellence (DOH102-TD-B-111-004), the National Science Council of Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp=7), and the Department of Health, Executive Yuan, Taiwan (http://www.doh.gov.tw/EN2006/index_EN.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Aslam M, 2009, OBES RES CLIN PRACT, V3, P209, DOI 10.1016/j.orcp.2009.03.005; Bosy-Westphal A, 2008, OBESITY FACTS, V1, P319, DOI 10.1159/000176061; Carroll KK, 1998, LIPIDS, V33, P1055, DOI 10.1007/s11745-998-0305-8; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; Consultation W, 2000, WHO TECH REP SER, V894, p[i, 1]; Crepaldi G, 2006, DIABETES VOICE, V51, P8; De Schepper J, 2012, J CYST FIBROS, V11, P119, DOI 10.1016/j.jcf.2011.10.004; Dee A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-343; Department of Health Executive Yuan R.O.C., 2002, DEF OB INT PRINC COM; DEURENBERG P, 1991, INT J OBESITY, V15, P17; Ellis KJ, 1998, J BONE MINER RES, V13, P1613, DOI 10.1359/jbmr.1998.13.10.1613; Erceg DN, 2010, NUTR RES, V30, P297, DOI 10.1016/j.nutres.2010.04.009; Evans EM, 2010, EUR J CLIN NUTR, V64, P218, DOI 10.1038/ejcn.2009.128; Festen DAM, 2007, J CLIN ENDOCR METAB, V92, P1549, DOI 10.1210/jc.2006-2241; Frisard MI, 2005, OBES RES, V13, P845, DOI 10.1038/oby.2005.97; Gomez-Ambrosi J, 2011, OBESITY, V19, P1439, DOI 10.1038/oby.2011.36; Houtkooper L. B., 1996, AM J CLIN NUTR S, V64, p436S; Kannel William B., 1996, American Journal of Clinical Nutrition, V63, p419S, DOI 10.1093/ajcn/87.6.1602; Kim HJ, 2005, AM J CHINESE MED, V33, P851, DOI 10.1142/S0192415X05003454; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Lazzer S, 2003, BRIT J NUTR, V90, P987, DOI 10.1079/BJN2003983; Liu CR, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-70; Lloret Linares C, 2011, OBES SURG, V21, P1; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Neovius M, 2006, OBESITY, V14, P1731, DOI 10.1038/oby.2006.199; Newton RL, 2005, INT J OBESITY, V29, P594, DOI 10.1038/sj.ijo.0802968; Newton RL, 2006, OBESITY, V14, P415, DOI 10.1038/oby.2006.55; Roubenoff Ronenn, 1996, American Journal of Clinical Nutrition, V64, p459S, DOI 10.1093/ajcn/64.3.459S; Sato Susumu, 2007, Journal of Physiological Anthropology, V26, P533, DOI 10.2114/jpa2.26.533; Seidell JC, 1996, ARCH INTERN MED, V156, P958, DOI 10.1001/archinte.156.9.958; Shafer KJ, 2009, NUTRITION, V25, P25, DOI 10.1016/j.nut.2008.07.004; Shea JL, 2012, NUTR METAB CARDIOVAS, V22, P741, DOI 10.1016/j.numecd.2010.11.009; Staiger H, 2003, OBES RES, V11, P368, DOI 10.1038/oby.2003.48; Taylor R., 1990, J DIAGNOSTIC MED SON, V1, P35; Verdich C, 2011, DIABETES METAB, V37, P222, DOI 10.1016/j.diabet.2010.10.007; Xu B, 2009, SPIE, V7443; Yamashita K, 2012, CIRC J, V76, P2435, DOI 10.1253/circj.CJ-12-0337; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723	41	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2013	8	4							e58272	10.1371/journal.pone.0058272	http://dx.doi.org/10.1371/journal.pone.0058272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117CY	24019905	Green Submitted, Green Published, gold			2022-12-27	WOS:000316930900003
J	Gong, ZH; Tang, JL; Xiang, TX; Zhang, LL; Liao, QH; Liu, W; Wang, YL				Gong, Zhenghua; Tang, Jialin; Xiang, Tianxin; Zhang, Lunli; Liao, Qinghua; Liu, Wei; Wang, Yalin			Association between Regulated upon Activation, Normal T Cells Expressed and Secreted (RANTES)-28C/G Polymorphism and Susceptibility to HIV-1 Infection: A Meta-Analysis	PLOS ONE			English	Article							DISEASE PROGRESSION; GENETIC-VARIATION; TYPE-1 INFECTION; DENDRITIC CELLS; VIRUS-INFECTION; CC-CHEMOKINES; RANTES; PROMOTER; INDIVIDUALS; ENTRY	Background: Many studies have investigated the distributions of RANTES genotypes between HIV-1 infected patients and uninfected individuals. However, no definite results have been put forward about whether the RANTES -28C/G polymorphism can affect HIV-1 susceptibility. Methods: We performed a meta-analysis of 12 studies including 7473 subjects for whom the RANTES -28C/G polymorphism was genotyped. Odds ratios (ORs) with 95% confidence intervals (CIs) were employed to assess the association of the polymorphism with HIV-1 susceptibility. By dividing the controls into healthy controls and HIV-1 exposed but seronegative (HESN) controls, we explored the both allelic and dominant genetic models. Results: By using the healthy controls, we found a marginally significant association between the -28C/G polymorphism and susceptibility to HIV-1 infection in the allelic model (OR = 0.82, 95%CI = 0.70-0.97). But sensitivity analysis suggested that the association was driven by one study. We further performed stratified analysis according to ethnicity. The -28G allele decreased susceptibility to HIV-1 infection in the allelic model among Asians (OR = 0.79, 95%CI = 0.66-0.94). By using the HESN controls, no association between the polymorphism -28C/G and the susceptibility to HIV-1 infection was revealed in either the allelic model (OR = 0.84, 95%CI = 0.60-1.17) or the dominant model (OR = 0.77, 95%CI = 0.54-1.10). Conclusions: Our findings suggested that the RANTES -28G allele might play a role in resistance to HIV-1 infection among Asians. Additional well-designed studies were required for the validation of this association.	[Gong, Zhenghua; Tang, Jialin; Liao, Qinghua; Liu, Wei; Wang, Yalin] Ctr Dis Control & Prevent Jiangxi Prov, Dept Publ Hlth, Nanchang, Peoples R China; [Xiang, Tianxin; Zhang, Lunli] Nanchang Univ, Hosp 1, Dept Infect Dis, Nanchang, Peoples R China	Nanchang University	Wang, YL (corresponding author), Ctr Dis Control & Prevent Jiangxi Prov, Dept Publ Hlth, Nanchang, Peoples R China.	yalinwang2012@hotmail.com		gong, zhenghua/0000-0002-4363-1043	National Natural Science Foundation of China [81060127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81060127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2005, WORLD J GASTROENTERO, V11, P7631, DOI 10.3748/wjg.v11.i48.7631; Aouizerat Bradley E, 2011, Curr HIV/AIDS Rep, V8, P38, DOI 10.1007/s11904-010-0065-1; Crawford A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002098; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Ding DL, 2011, MOL MED REP, V4, P181, DOI 10.3892/mmr.2010.400; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; DONLON TA, 1990, GENOMICS, V6, P548, DOI 10.1016/0888-7543(90)90485-D; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Fernandez RM, 2003, AIDS RES HUM RETROV, V19, P349, DOI 10.1089/088922203765551692; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Guergnon J, 2012, IMMUNOL LETT, V145, P15, DOI 10.1016/j.imlet.2012.04.010; Jang DH, 2008, INT J IMMUNOGENET, V35, P101, DOI 10.1111/j.1744-313X.2007.00743.x; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042972; Lim JK, 2010, J INFECT DIS, V201, P178, DOI 10.1086/649426; Liu HL, 1999, P NATL ACAD SCI USA, V96, P4581, DOI 10.1073/pnas.96.8.4581; Liu HL, 1999, AIDS, V13, P2602, DOI 10.1097/00002030-199912240-00020; Liu SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035020; [刘雪林 Liu Xuelin], 2004, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V29, P489; Loetscher P, 1996, J IMMUNOL, V156, P322; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; McDermott DH, 2000, AIDS, V14, P2671, DOI 10.1097/00002030-200012010-00006; Nair MPN, 2011, LIFE SCI, V88, P987, DOI 10.1016/j.lfs.2010.09.019; Pantaleo G, 1997, RES IMMUNOL, V148, P417, DOI 10.1016/S0923-2494(97)82875-1; Rathore A, 2008, J MED VIROL, V80, P1133, DOI 10.1002/jmv.21201; Sironi M, 2012, J IMMUNOL, V188, P818, DOI 10.4049/jimmunol.1102179; Sobieszczyk ME, 2011, CURR OPIN HIV AIDS, V6, P427, DOI 10.1097/COH.0b013e3283497155; Suresh P, 2006, J CLIN IMMUNOL, V26, P476, DOI 10.1007/s10875-006-9036-0; Vidal F, 2006, JAIDS-J ACQ IMM DEF, V41, P17, DOI 10.1097/01.qai.0000188335.86466.ea; Young JM, 2011, AIDS RES HUM RETROV, V27, P737, DOI [10.1089/aid.2010.0313, 10.1089/AID.2010.0313]; Zeremski M, 2011, J HEPATOL, V55, P545, DOI 10.1016/j.jhep.2010.12.033; Zhao XY, 2004, EUR J IMMUNOGENET, V31, P179, DOI 10.1111/j.1365-2370.2004.00466.x	35	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60683	10.1371/journal.pone.0060683	http://dx.doi.org/10.1371/journal.pone.0060683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	24386362	Green Submitted, gold, Green Published			2022-12-27	WOS:000319109800087
J	Wei, YW; Li, MH; Chen, H; Lewis, BJ; Yu, DP; Zhou, L; Zhou, WM; Fang, XM; Zhao, W; Dai, LM				Wei, Yawei; Li, Maihe; Chen, Hua; Lewis, Bernard J.; Yu, Dapao; Zhou, Li; Zhou, Wangming; Fang, Xiangmin; Zhao, Wei; Dai, Limin			Variation in Carbon Storage and Its Distribution by Stand Age and Forest Type in Boreal and Temperate Forests in Northeastern China	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; GLOBAL CLIMATE-CHANGE; OLD-GROWTH FORESTS; BIOMASS; PLANT; CHRONOSEQUENCE; DECOMPOSITION; LITTERFALL; PATTERNS; WORLDS	The northeastern forest region of China is an important component of total temperate and boreal forests in the northern hemisphere. But how carbon (C) pool size and distribution varies among tree, understory, forest floor and soil components, and across stand ages remains unclear. To address this knowledge gap, we selected three major temperate and two major boreal forest types in northeastern (NE) China. Within both forest zones, we focused on four stand age classes (young, mid-aged, mature and over-mature). Results showed that total C storage was greater in temperate than in boreal forests, and greater in older than in younger stands. Tree biomass C was the main C component, and its contribution to the total forest C storage increased with increasing stand age. It ranged from 27.7% in young to 62.8% in over-mature stands in boreal forests and from 26.5% in young to 72.8% in over-mature stands in temperate forests. Results from both forest zones thus confirm the large biomass C storage capacity of old-growth forests. Tree biomass C was influenced by forest zone, stand age, and forest type. Soil C contribution to total forest C storage ranged from 62.5% in young to 30.1% in over-mature stands in boreal and from 70.1% in young to 26.0% in over-mature in temperate forests. Thus soil C storage is a major C pool in forests of NE China. On the other hand, understory and forest floor C jointly contained less than 13% and <5%, in boreal and temperate forests respectively, and thus play a minor role in total forest C storage in NE China.	[Wei, Yawei; Li, Maihe; Chen, Hua; Lewis, Bernard J.; Yu, Dapao; Zhou, Li; Zhou, Wangming; Fang, Xiangmin; Zhao, Wei; Dai, Limin] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Li, Maihe] Swiss Fed Res Inst WSL, Tree Physiol Grp, Birmensdorf, Switzerland; [Chen, Hua] Univ Illinois, Springfield, IL USA; [Wei, Yawei; Fang, Xiangmin; Zhao, Wei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Illinois System; University of Illinois Springfield; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Dai, LM (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	lmdai@iae.ac.cn	Li, Mai-He/L-6390-2013	Li, Mai-He/0000-0002-7029-2841; Fang, Yi-ping/0000-0003-2966-9528; Yu, Dapao/0000-0001-6991-2807; Wei, Yanqiang/0000-0003-1301-528X	"Strategic Priority Research Program'' of the Chinese Academy of Sciences [XDA05060200]; National Key Technologies R&D Program of China [2012BAD22B04]; Chinese Academy of Sciences visiting professorship for senior international scientists [2012T1Z0006]	"Strategic Priority Research Program'' of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Technologies R&D Program of China(National Key Technology R&D Program); Chinese Academy of Sciences visiting professorship for senior international scientists	This work was supported by the "Strategic Priority Research Program'' of the Chinese Academy of Sciences, Grant No. XDA05060200, National Key Technologies R&D Program of China (2012BAD22B04) and the Chinese Academy of Sciences visiting professorship for senior international scientists (2012T1Z0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bousquet P, 1999, J GEOPHYS RES-ATMOS, V104, P26161, DOI 10.1029/1999JD900342; BROWN S, 1984, SCIENCE, V223, P1290, DOI 10.1126/science.223.4642.1290; Bu R, 2008, FOREST ECOL MANAG, V254, P407, DOI 10.1016/j.foreco.2007.09.080; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Chen C., 1989, HDB MAIN TREE SPECIE; Fonseca W, 2011, FOREST ECOL MANAG, V262, P1400, DOI 10.1016/j.foreco.2011.06.036; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Han M., 1994, LONG TERM RES CHINAS, P451; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jonsson M, 2010, BIOL LETTERS, V6, P116, DOI 10.1098/rsbl.2009.0613; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Khatiwala S, 2009, NATURE, V462, P346, DOI 10.1038/nature08526; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Law BE, 2003, GLOBAL CHANGE BIOL, V9, P510, DOI 10.1046/j.1365-2486.2003.00624.x; Liu CJ, 2004, GLOBAL ECOL BIOGEOGR, V13, P105, DOI 10.1111/j.1466-882X.2004.00072.x; Lu R, 1999, METHODS SOIL AGR CHE; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Martin JL, 2005, GLOBAL CHANGE BIOL, V11, P1883, DOI 10.1111/j.1365-2486.2005.01019.x; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Ostertag R, 2008, ECOSYSTEMS, V11, P701, DOI 10.1007/s10021-008-9152-1; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Piao SL, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000014; Piao SL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037381; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Saha SK, 2009, AGROFOREST SYST, V76, P53, DOI 10.1007/s10457-009-9228-8; Smith P, 2010, NATURE, V464, P499, DOI 10.1038/464499a; Smithwick EAH, 2002, ECOL APPL, V12, P1303, DOI 10.1890/1051-0761(2002)012[1303:PUBOCS]2.0.CO;2; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tan K, 2007, FOREST ECOL MANAG, V240, P114, DOI 10.1016/j.foreco.2006.12.018; Vivanco L, 2008, J ECOL, V96, P727, DOI 10.1111/j.1365-2745.2008.01393.x; Wang CK, 2003, GLOBAL CHANGE BIOL, V9, P1066, DOI 10.1046/j.1365-2486.2003.00645.x; Wang CK, 2006, FOREST ECOL MANAG, V222, P9, DOI 10.1016/j.foreco.2005.10.074; Wang CK, 2001, GLOBAL CHANGE BIOL, V7, P719, DOI 10.1046/j.1354-1013.2001.00441.x; Wang Hui, 2005, Journal of Forestry Research (Harbin), V16, P27, DOI 10.1007/BF02856849; Wang XP, 2008, FOREST ECOL MANAG, V255, P4007, DOI 10.1016/j.foreco.2008.03.055; Wang XP, 2006, FOREST ECOL MANAG, V234, P264, DOI 10.1016/j.foreco.2006.07.007; [王雪军 WANG XueJun], 2008, [生态学报, Acta Ecologica Sinica], V28, P4757; Wiesmeier M, 2012, GLOBAL CHANGE BIOL, V18, P2233, DOI 10.1111/j.1365-2486.2012.02699.x; Wynn JG, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002576; Xing Y, 2005, THESIS NE FORESTRY U; Yanai RD, 2003, ECOSYSTEMS, V6, P197, DOI 10.1007/s10021-002-0206-5; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Zhang Na, 2003, Yingyong Shengtai Xuebao, V14, P659; Zhang Xin-Ping, 2008, Zhiwu Shengtai Xuebao, V32, P1031, DOI 10.3773/j.issn.1005-264x.2008.05.008; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168; Zhou L, 2011, ANN FOREST SCI, V68, P953, DOI 10.1007/s13595-011-0101-3; Zhu BA, 2010, J PLANT RES, V123, P439, DOI 10.1007/s10265-009-0301-1	49	81	91	11	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72201	10.1371/journal.pone.0072201	http://dx.doi.org/10.1371/journal.pone.0072201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977252	gold, Green Published			2022-12-27	WOS:000324527300071
J	Wei, YQ; Fang, YP				Wei, Yanqiang; Fang, Yiping			Spatio-Temporal Characteristics of Global Warming in the Tibetan Plateau during the Last 50 Years Based on a Generalised Temperature Zone - Elevation Model	PLOS ONE			English	Article							CLIMATE-CHANGE; SPATIAL INTERPOLATION; MASS-BALANCE; IMPACTS; PERMAFROST; GLACIERS; RETREAT; MIGRATION; GREENLAND; PATTERNS	Temperature is one of the primary factors influencing the climate and ecosystem, and examining its change and fluctuation could elucidate the formation of novel climate patterns and trends. In this study, we constructed a generalised temperature zone elevation model (GTEM) to assess the trends of climate change and temporal-spatial differences in the Tibetan Plateau (TP) using the annual and monthly mean temperatures from 1961-2010 at 144 meteorological stations in and near the TP. The results showed the following: (1) The TP has undergone robust warming over the study period, and the warming rate was 0.318 degrees C/decade. The warming has accelerated during recent decades, especially in the last 20 years, and the warming has been most significant in the winter months, followed by the spring, autumn and summer seasons. (2) Spatially, the zones that became significantly smaller were the temperature zones of -6 degrees C and -4 degrees C, and these have decreased 499.44 and 454.26 thousand sq km from 1961 to 2010 at average rates of 25.1% and 11.7%, respectively, over every 5-year interval. These quickly shrinking zones were located in the northwestern and central TP. (3) The elevation dependency of climate warming existed in the TP during 1961-2010, but this tendency has gradually been weakening due to more rapid warming at lower elevations than in the middle and upper elevations of the TP during 1991-2010. The higher regions and some low altitude valleys of the TP were the most significantly warming regions under the same categorizing criteria. Experimental evidence shows that the GTEM is an effective method to analyse climate changes in high altitude mountainous regions.	[Wei, Yanqiang; Fang, Yiping] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Sichuan, Peoples R China; [Wei, Yanqiang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wei, YQ (corresponding author), Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Sichuan, Peoples R China.	weiyq@imde.ac.cn	Li, Mai-He/L-6390-2013	Li, Mai-He/0000-0002-7029-2841; Fang, Yi-ping/0000-0003-2966-9528; Yu, Dapao/0000-0001-6991-2807; Wei, Yanqiang/0000-0003-1301-528X	National Basic Research Program of China (973 Program) [2010CB951704]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was financially supported by the research grant from the National Basic Research Program of China (973 Program, No. 2010CB951704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Aizen VB, 2002, QUATERN INT, V97-8, P27, DOI 10.1016/S1040-6182(02)00049-6; Diaz-Varela RA, 2010, ECOL MODEL, V221, P621, DOI 10.1016/j.ecolmodel.2009.11.010; AZZALINI A, 1985, SCAND J STAT, V12, P171; Baker BB, 2007, ARCT ANTARCT ALP RES, V39, P200, DOI 10.1657/1523-0430(2007)39[200:ATARGI]2.0.CO;2; Beardall J, 2009, PLANT ECOL DIVERS, V2, P191, DOI 10.1080/17550870903271363; Beniston M, 1996, THEOR APPL CLIMATOL, V53, P231, DOI 10.1007/BF00871739; Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Benn DI, 2000, QUATERN INT, V65-6, P15, DOI 10.1016/S1040-6182(99)00034-8; Berthier E, 2008, REMOTE SENS ENVIRON, V112, P2443, DOI 10.1016/j.rse.2007.11.004; Bolch T, 2007, GLOBAL PLANET CHANGE, V56, P1, DOI 10.1016/j.gloplacha.2006.07.009; Bonnaventure PP, 2011, CLIMATIC CHANGE, V105, P293, DOI 10.1007/s10584-010-9818-5; Bradley RS, 2006, SCIENCE, V312, P1755, DOI 10.1126/science.1128087; Byg A, 2009, GLOBAL ENVIRON CHANG, V19, P156, DOI 10.1016/j.gloenvcha.2009.01.010; Casal TGD, 2004, CLIM DYNAM, V23, P407, DOI 10.1007/s00382-004-0441-x; Chen B, 2003, CLIM DYNAM, V20, P401, DOI 10.1007/s00382-002-0282-4; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025008; China Meteorological Administration, 2006, CLIM ENV CHIN; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cui XF, 2006, GLOBAL PLANET CHANGE, V54, P33, DOI 10.1016/j.gloplacha.2005.07.006; DeGaetano AT, 2007, J APPL METEOROL CLIM, V46, P1981, DOI 10.1175/2007JAMC1536.1; Ding YJ, 2006, ANN GLACIOL-SER, V43, P97, DOI 10.3189/172756406781812005; Du MY, 2004, GLOBAL PLANET CHANGE, V41, P241, DOI 10.1016/j.gloplacha.2004.01.010; Duan AM, 2005, CLIM DYNAM, V24, P793, DOI 10.1007/s00382-004-0488-8; Fang YP, 2011, J MT SCI-ENGL, V8, P437, DOI 10.1007/s11629-011-1004-3; Francou B, 2004, CR GEOSCI, V337, P97; Harley CDG, 2009, P NATL ACAD SCI USA, V106, P11172, DOI 10.1073/pnas.0904946106; Hughes L, 2011, REG ENVIRON CHANGE, V11, pS189, DOI 10.1007/s10113-010-0158-9; IPCC, 2007, SUMM POL CLIM CHANG, DOI [10.1260/095830507781076194, DOI 10.1260/095830507781076194]; Jacobson M. Z, 2005, FUNDAMENTALS ATMOSPH; Jin HJ, 2008, COLD REG SCI TECHNOL, V53, P317, DOI 10.1016/j.coldregions.2007.07.005; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kang SC, 2010, ENV RES LETT; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Kintisch E, 2007, SCIENCE, V318, P1846, DOI 10.1126/science.318.5858.1846; Kurtzman D, 1999, CLIMATE RES, V13, P33, DOI 10.3354/cr013033; Kutuzov S, 2009, GLOBAL PLANET CHANGE, V69, P59, DOI 10.1016/j.gloplacha.2009.07.001; Lahsen M, 2010, CURR OPIN ENV SUST, V2, P364, DOI 10.1016/j.cosust.2010.10.009; Lee TD, 2005, FOREST ECOL MANAG, V212, P75, DOI 10.1016/j.foreco.2005.03.007; Leemans R, 2004, GLOBAL ENVIRON CHANG, V14, P219, DOI 10.1016/j.gloenvcha.2004.04.009; Li ZX, 2010, QUATERN INT, V218, P166, DOI 10.1016/j.quaint.2008.09.005; Li ZX, 2010, QUATERN INT, V218, P13, DOI 10.1016/j.quaint.2009.05.010; Liao SB, 2010, COMPUTAT GEOSCI, V14, P539, DOI 10.1007/s10596-009-9169-3; [廖顺宝 Liao Shunbao], 2004, [地理研究, Geographical Research], V23, P633; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Liu XD, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006915; Liu XD, 2009, GLOBAL PLANET CHANGE, V68, P164, DOI 10.1016/j.gloplacha.2009.03.017; Loczy, 1899, ENCY BRITANNICA NEW; Lowell TV, 2000, P NATL ACAD SCI USA, V97, P1351, DOI 10.1073/pnas.97.4.1351; Meintanis SG, 2007, J STAT PLAN INFER, V137, P2681, DOI 10.1016/j.jspi.2006.04.012; Mudholkar GS, 2000, J STAT PLAN INFER, V83, P291, DOI 10.1016/S0378-3758(99)00096-8; Ninyerola M, 2007, INT J CLIMATOL, V27, P1231, DOI 10.1002/joc.1462; Oerlemans J, 2006, GLOBAL PLANET CHANGE, V50, P148, DOI 10.1016/j.gloplacha.2005.12.002; OERLEMANS J, 1994, SCIENCE, V264, P243, DOI 10.1126/science.264.5156.243; Oerlemans J, 2009, NATURE, V462, P572, DOI 10.1038/462572a; Parolo G, 2008, BASIC APPL ECOL, V9, P100, DOI 10.1016/j.baae.2007.01.005; Penuelas J, 2007, ECOGRAPHY, V30, P829, DOI 10.1111/j.2007.0906-7590.05247.x; Pepin NC, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005047; Schwalb A, 2010, QUATERN INT, V218, P1, DOI 10.1016/j.quaint.2010.02.017; Shortridge AM, 2004, INT J GEOGR INF SCI, V18, P539, DOI 10.1080/13658810410001702012; Sivakumar MVK, 2011, CLIMATE CHANGE AND FOOD SECURITY IN SOUTH ASIA, P13, DOI 10.1007/978-90-481-9516-9_2; Soini E, 2005, AGR SYST, V85, P306, DOI 10.1016/j.agsy.2005.06.013; Sundal AV, 2011, NATURE, V469, P522, DOI 10.1038/nature09740; Thornton PK, 2009, AGR SYST, V101, P113, DOI 10.1016/j.agsy.2009.05.002; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Wang B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034330; Xue X, 2009, GEOMORPHOLOGY, V108, P182, DOI 10.1016/j.geomorph.2009.01.004; Yang B, 2008, GLOBAL PLANET CHANGE, V60, P126, DOI 10.1016/j.gloplacha.2006.07.035; Yang B, 2009, GLOBAL PLANET CHANGE, V69, P71, DOI 10.1016/j.gloplacha.2009.07.008; Yang MX, 2010, EARTH-SCI REV, V103, P31, DOI 10.1016/j.earscirev.2010.07.002; Yang T, 2012, GLOBAL PLANET CHANGE, V80-81, P1, DOI 10.1016/j.gloplacha.2011.08.006; Yao T, 2007, ARCT ANTARCT ALP RES, V39, P642, DOI 10.1657/1523-0430(07-510)[YAO]2.0.CO;2; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; You QL, 2010, GLOBAL PLANET CHANGE, V72, P11, DOI 10.1016/j.gloplacha.2010.04.003; You QL, 2010, GLOBAL PLANET CHANGE, V71, P124, DOI 10.1016/j.gloplacha.2010.01.020; You QL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032669; Zemp M, 2007, GLOBAL PLANET CHANGE, V56, P83, DOI 10.1016/j.gloplacha.2006.07.002; [张镱锂 Zhang Yili], 2002, [地理研究, Geographical Research], V21, P1; Zhao L, 2004, GLOBAL PLANET CHANGE, V43, P19, DOI 10.1016/j.gloplacha.2004.02.003	81	81	91	11	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60044	10.1371/journal.pone.0060044	http://dx.doi.org/10.1371/journal.pone.0060044			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23977252	Green Published, Green Submitted, gold			2022-12-27	WOS:000317717300051
J	Blatteau, JE; Brubakk, AO; Gempp, E; Castagna, O; Risso, JJ; Vallee, N				Blatteau, Jean-Eric; Brubakk, Alf O.; Gempp, Emmanuel; Castagna, Olivier; Risso, Jean-Jacques; Vallee, Nicolas			Sidenafil Pre-Treatment Promotes Decompression Sickness in Rats	PLOS ONE			English	Article							BUBBLE FORMATION; NITRIC-OXIDE; SILDENAFIL; DIVE; PEROXYNITRITE; ACTIVATION; DAMAGE; PDE5	Vascular bubble formation after decompression contributes to endothelial injuries which form the basis for the development of decompression sickness (DCS). Nitric oxide (NO) is a powerful vasodilator that contributes to vessel homeostasis. It has been shown that NO-releasing agent may reduce bubble formation and prevent serious decompression sickness. The use of sildenafil, a well-known, phosphodiesterase-5 blocker, which act by potentiating the vasodilatory effect on smooth muscle relaxation, has never been studied in DCS. The purpose of the present study was to evaluate the clinical effects of sildenafil pre-treatment on DCS in a rat model. 67 rats were subjected to a simulated dive at 90 msw for 45 min before staged decompression. The experimental group received 10 mg/kg of sildenafil one hour before exposure (n = 35) while controls were not treated (n = 32). Clinical assessment took place over a period of 30 min after surfacing. At the end, blood samples were collected for blood cells counts and the level of circulating bubbles in the right cavities was quantified. There were significantly more manifestations of DCS in the sildenafil group than in the controls (34.3% vs 6.25%, respectively, p = 0.012). Platelet count was more reduced in treated rats than in controls (-21.7% vs -7%, respectively, p = 0.029), whereas bubble grades did not differ between groups. We concluded that pre-treatment with sildenafil promotes the onset and severity of neurological DCS. When considering the use of phosphodiesterase-5 blockers in the context of diving, careful discussion with physician should be recommended.	[Blatteau, Jean-Eric; Castagna, Olivier; Risso, Jean-Jacques; Vallee, Nicolas] Inst Rech Biomed Armees, Dept Environm Operat Environm Extremes, Equipe Residante Rech Subaquat Operat, Toulon, France; [Brubakk, Alf O.] Norwegian Univ Sci & Technol, Med Technol Ctr, Fac Med, Dept Physiol & Biomed Engn, N-7034 Trondheim, Norway; [Castagna, Olivier] Univ Toulon & Var, Lab Motricite Humaine Educ Sport & Sante, Equipe Accueil 6309, Toulon, France; [Gempp, Emmanuel] HIA St Anne, Serv Med Hyperbare & Expertise Plonge, Toulon, France	Norwegian University of Science & Technology (NTNU); Universite de Toulon; Hospital Instruction Of Armees Sainte-Anne	Blatteau, JE (corresponding author), Inst Rech Biomed Armees, Dept Environm Operat Environm Extremes, Equipe Residante Rech Subaquat Operat, Toulon, France.	je.blatteau@infonie.fr						AHN HS, 1991, ELECTRON LETT, V27, P191, DOI 10.1049/el:19910123; Barnett CF, 2006, VASC HEALTH RISK MAN, V2, P411, DOI 10.2147/vhrm.2006.2.4.411; BERGHAGE TE, 1979, UNDERSEA BIOMED RES, V6, P1; Bert P, 1878, BAROMETRIC PRESSURE; Blatteau JE, 2006, AVIAT SPACE ENVIR MD, V77, P1068; Blatteau JE, 2011, NEUROCRIT CARE, V15, P120, DOI 10.1007/s12028-010-9370-1; Blatteau JE, 2008, AVIAT SPACE ENVIR MD, V79, P1100, DOI 10.3357/ASEM.2377.2008; Byoun HS, 2010, J KOREAN NEUROSURG S, V47, P210, DOI 10.3340/jkns.2010.47.3.210; Demchenko IT, 2009, J APPL PHYSIOL, V106, P1234, DOI 10.1152/japplphysiol.91407.2008; Dujic Z, 2006, MED SCI SPORT EXER, V38, P1432, DOI 10.1249/01.mss.0000228936.78916.23; Francis T. J. R., 2003, BENNETT ELLIOTTS PHY, P530; Gempp E, 2010, RES SPORTS MED, V18, P205, DOI 10.1080/15438627.2010.490189; GIRY PBL, 1977, UNDERSEA BIOMED RES, V4, P147; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Gopal VK, 2001, EUR J BIOCHEM, V268, P3304, DOI 10.1046/j.1432-1327.2001.02233.x; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hurlimann D, 2002, EUR HEART J SUPPL, V4, pA1, DOI 10.1016/S1520-765X(02)90067-2; Kotera J, 2000, J HISTOCHEM CYTOCHEM, V48, P685, DOI 10.1177/002215540004800512; LABORIT. H., 1961, AGRESSOLOGIE, V2, P229; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Lin CS, 2006, CURR PHARM DESIGN, V12, P3439, DOI 10.2174/138161206778343064; Mollerlokken A, 2006, J APPL PHYSIOL, V101, P1541, DOI 10.1152/japplphysiol.01191.2005; Montcalm-Smith EA, 2008, AVIAT SPACE ENVIR MD, V79, P7, DOI 10.3357/ASEM.2071.2008; Nishi R. Y., 2003, BENNETT ELLIOTTS PHY, P501; Nossum V, 1999, UNDERSEA HYPERBAR M, V26, P1; Nyquist PA, 2004, AVIAT SPACE ENVIR MD, V 75, P211; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Padma-Nathan H, 1998, INT J CLIN PRACT, V52, P375; Phillips BG, 2000, CIRCULATION, V102, P3068; PHILP R B, 1974, Undersea Biomedical Research, V1, P117; Pontier JM, 2008, AVIAT SPACE ENVIR MD, V79, P1096, DOI 10.3357/ASEM.2352.2008; Sawatzky KD, 1991, THESIS YORK U TORONT; Takizawa Shunya, 2003, J Stroke Cerebrovasc Dis, V12, P196, DOI 10.1016/S1052-3057(03)00074-0; THORSEN T, 1987, UNDERSEA BIOMED RES, V14, P45; Wisloff U, 2004, J PHYSIOL-LONDON, V555, P825, DOI 10.1113/jphysiol.2003.055467; Wisloff U, 2003, J PHYSIOL-LONDON, V546, P577, DOI 10.1113/jphysiol.2002.030338; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73	37	20	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60639	10.1371/journal.pone.0060639	http://dx.doi.org/10.1371/journal.pone.0060639			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580342	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000044
J	Hodgson, AB; Randell, RK; Jeukendrup, AE				Hodgson, Adrian B.; Randell, Rebecca K.; Jeukendrup, Asker E.			The Metabolic and Performance Effects of Caffeine Compared to Coffee during Endurance Exercise	PLOS ONE			English	Article							SKELETAL-MUSCLE; INTERMITTENT EXERCISE; PERCEIVED EXERTION; PROLONGED EXERCISE; FAT-METABOLISM; INGESTION; RESPONSES; HUMANS; CARBOHYDRATE; METAANALYSIS	There is consistent evidence supporting the ergogenic effects of caffeine for endurance based exercise. However, whether caffeine ingested through coffee has the same effects is still subject to debate. The primary aim of the study was to investigate the performance enhancing effects of caffeine and coffee using a time trial performance test, while also investigating the metabolic effects of caffeine and coffee. In a single-blind, crossover, randomised counter-balanced study design, eight trained male cyclists/triathletes (Mean +/- SD: Age 41 +/- 7y, Height 1.80 +/- 0.04 m, Weight 78.9 +/- 4.1 kg, VO2 max 58 +/- 3 ml.kg(-1).min(-1)) completed 30 min of steady-state (SS) cycling at approximately 55% VO(2)max followed by a 45 min energy based target time trial (TT). One hour prior to exercise each athlete consumed drinks consisting of caffeine (5 mg CAF/kg BW), instant coffee (5 mg CAF/kg BW), instant decaffeinated coffee or placebo. The set workloads produced similar relative exercise intensities during the SS for all drinks, with no observed difference in carbohydrate or fat oxidation. Performance times during the TT were significantly faster (similar to 5.0%) for both caffeine and coffee when compared to placebo and decaf (38.35 +/- 1.53, 38.27 +/- 1.80, 40.23 +/- 1.98, 40.31 +/- 1.22 min respectively, p<0.05). The significantly faster performance times were similar for both caffeine and coffee. Average power for caffeine and coffee during the TT was significantly greater when compared to placebo and decaf (294 +/- 21 W, 291 +/- 22 W, 277 +/- 14 W, 276 +/- 23 W respectively, p<0.05). No significant differences were observed between placebo and decaf during the TT. The present study illustrates that both caffeine (5 mg/kg/BW) and coffee (5 mg/kg/BW) consumed 1 h prior to exercise can improve endurance exercise performance.	[Hodgson, Adrian B.; Randell, Rebecca K.; Jeukendrup, Asker E.] Univ Birmingham, Human Performance Lab, Sch Sport & Exercise Sci, Birmingham, W Midlands, England; [Jeukendrup, Asker E.] PepsiCo, Gatorade Sport Sci Inst, Barrington, IL USA	University of Birmingham; PepsiCo	Jeukendrup, AE (corresponding author), Univ Birmingham, Human Performance Lab, Sch Sport & Exercise Sci, Birmingham, W Midlands, England.	a.e.jeukendrup@bham.ac.uk		Hodgson, Amanda/0000-0002-9479-3018; Kelly, Nat/0000-0002-9664-354X				Beaudoin Marie-Soleil, 2011, Handb Exp Pharmacol, P509, DOI 10.1007/978-3-642-13443-2_21; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BUTTS NK, 1985, RES Q EXERCISE SPORT, V56, P301, DOI 10.1080/02701367.1985.10605333; Chesley A, 1998, AM J PHYSIOL-REG I, V275, pR596, DOI 10.1152/ajpregu.1998.275.2.R596; COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155; Cox GR, 2002, J APPL PHYSIOL, V93, P990, DOI 10.1152/japplphysiol.00249.2002; Crozier TWM, 2012, FOOD FUNCT, V3, P30, DOI 10.1039/c1fo10240k; Currell K, 2008, SPORTS MED, V38, P297, DOI 10.2165/00007256-200838040-00003; de Paulis T, 2002, EUR J PHARMACOL, V442, P215, DOI 10.1016/S0014-2999(02)01540-6; Desbrow B, 2006, INT J SPORT NUTR EXE, V16, P545, DOI 10.1123/ijsnem.16.5.545; Desbrow B, 2012, J SPORT SCI, V30, P115, DOI 10.1080/02640414.2011.632431; Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x; Doherty M, 2004, INT J SPORT NUTR EXE, V14, P626, DOI 10.1123/ijsnem.14.6.626; Ganio MS, 2009, J STRENGTH COND RES, V23, P315, DOI 10.1519/JSC.0b013e31818b979a; Graham TE, 1998, J APPL PHYSIOL, V85, P883, DOI 10.1152/jappl.1998.85.3.883; GRAHAM TE, 1995, J APPL PHYSIOL, V78, P867, DOI 10.1152/jappl.1995.78.3.867; GRAHAM TE, 1991, J APPL PHYSIOL, V71, P2292, DOI 10.1152/jappl.1991.71.6.2292; Graham TE, 2000, J PHYSIOL-LONDON, V529, P837, DOI 10.1111/j.1469-7793.2000.00837.x; Graham TE, 2008, APPL PHYSIOL NUTR ME, V33, P1311, DOI 10.1139/H08-129; Irwin C, 2011, J SPORT SCI, V29, P509, DOI 10.1080/02640414.2010.541480; Jenkins NT, 2008, INT J SPORT NUTR EXE, V18, P328, DOI 10.1123/ijsnem.18.3.328; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Jeukendrup AE, 2005, INT J SPORTS MED, V26, pS28, DOI 10.1055/s-2004-830512; KATHER H, 1985, J CLIN INVEST, V76, P1559, DOI 10.1172/JCI112137; Lamina S, 2009, AFR HEALTH SCI, V9, P270; McLellan TM, 2004, INT J SPORT NUTR EXE, V14, P698, DOI 10.1123/ijsnem.14.6.698; Mohr M, 2011, J APPL PHYSIOL, V111, P1372, DOI 10.1152/japplphysiol.01028.2010; Mohr T, 1998, J APPL PHYSIOL, V85, P979, DOI 10.1152/jappl.1998.85.3.979; Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718; Raguso CA, 1996, METABOLISM, V45, P1153, DOI 10.1016/S0026-0495(96)90016-5; SPRIET LL, 1992, AM J PHYSIOL, V262, pE891, DOI 10.1152/ajpendo.1992.262.6.E891; Stalmach A, 2012, COFFEE EMERGING HLTH; Tallis J, 2012, J APPL PHYSIOL, V112, P64, DOI 10.1152/japplphysiol.00801.2011; Tarnopolsky M, 2000, J APPL PHYSIOL, V89, P1719, DOI 10.1152/jappl.2000.89.5.1719; Tarnopolsky MA, 2008, APPL PHYSIOL NUTR ME, V33, P1284, DOI 10.1139/H08-121; TRICE I, 1995, INT J SPORT NUTR, V5, P37, DOI 10.1123/ijsn.5.1.37; TSE SYH, 1992, J PHARM SCI, V81, P449, DOI 10.1002/jps.2600810512; Tsuda S, 2012, J NUTR BIOCH; vanSoeren M, 1996, J APPL PHYSIOL, V80, P999, DOI 10.1152/jappl.1996.80.3.999; VERGAUWEN L, 1994, J CLIN INVEST, V93, P974, DOI 10.1172/JCI117104; WAHLBERG G, 1992, SCAND J CLIN LAB INV, V52, P547, DOI 10.3109/00365519209090132; Wiles J D, 1992, Br J Sports Med, V26, P116	42	195	202	2	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59561	10.1371/journal.pone.0059561	http://dx.doi.org/10.1371/journal.pone.0059561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573201	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100020
J	Leao, SC; Matsumoto, CK; Carneiro, A; Ramos, RT; Nogueira, CL; Lima, JD; Lima, KV; Lopes, ML; Schneider, H; Azevedo, VA; da Silva, AD				Leao, Sylvia Cardoso; Matsumoto, Cristianne Kayoko; Carneiro, Adriana; Ramos, Rommel Thiago; Nogueira, Christiane Lourenco; Lima Junior, James Daltro; Lima, Karla Valeria; Lopes, Maria Luiza; Schneider, Horacio; Azevedo, Vasco Ariston; da Silva, Artur da Costa			The Detection and Sequencing of a Broad-Host-Range Conjugative IncP-1 beta Plasmid in an Epidemic Strain of Mycobacterium abscessus subsp bolletii	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; SURGICAL-SITE INFECTIONS; COMPLETE GENOME SEQUENCE; POSTSURGICAL INFECTIONS; MOLECULAR CHARACTERIZATION; MERCURIC REDUCTASE; PROVIDES EVIDENCE; LINEAR PLASMIDS; RESISTANCE; MASSILIENSE	Background: An extended outbreak of mycobacterial surgical infections occurred in Brazil during 2004-2008. Most infections were caused by a single strain of Mycobacterium abscessus subsp. bolletii, which was characterized by a specific rpoB sequevar and two highly similar pulsed-field gel electrophoresis (PFGE) patterns differentiated by the presence of a similar to 50 kb band. The nature of this band was investigated. Methodology/Principal Findings: Genomic sequencing of the prototype outbreak isolate INCQS 00594 using the SOLiD platform demonstrated the presence of a 56,264-bp circular plasmid, designated pMAB01. Identity matrices, genetic distances and phylogeny analyses indicated that pMAB01 belongs to the broad-host-range plasmid subgroup IncP-1 beta and is highly related to BRA100, pJP4, pAKD33 and pB10. The presence of pMAB01-derived sequences in 41 M. abscessus subsp. bolletii isolates was evaluated using PCR, PFGE and Southern blot hybridization. Sixteen of the 41 isolates showed the presence of the plasmid. The plasmid was visualized as a similar to 50-kb band using PFGE and Southern blot hybridization in 12 isolates. The remaining 25 isolates did not exhibit any evidence of this plasmid. The plasmid was successfully transferred to Escherichia coli by conjugation and transformation. Lateral transfer of pMAB01 to the high efficient plasmid transformation strain Mycobacterium smegmatis mc(2)155 could not be demonstrated. Conclusions/Significance: The occurrence of a broad-host-range IncP-1 beta plasmid in mycobacteria is reported for the first time. Thus, genetic exchange could result in the emergence of specific strains that might be better adapted to cause human disease.	[Leao, Sylvia Cardoso; Matsumoto, Cristianne Kayoko; Nogueira, Christiane Lourenco; Lima Junior, James Daltro] Univ Fed Sao Paulo, Disciplina Microbiol, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil; [Carneiro, Adriana; Ramos, Rommel Thiago; da Silva, Artur da Costa] Fed Univ Para, Inst Ciencias Biol, Lab Polimorfismo DNA, BR-66059 Belem, Para, Brazil; [Lima, Karla Valeria; Lopes, Maria Luiza] Inst Evandro Chagas, Secao Bacteriol & Micol, Ananindeua, PA, Brazil; [Schneider, Horacio] Fed Univ Para, Inst Estudos Costeiros, Braganca, PA, Brazil; [Azevedo, Vasco Ariston] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Para; Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal de Minas Gerais	Leao, SC (corresponding author), Univ Fed Sao Paulo, Disciplina Microbiol, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil.	sylvia.leao@unifesp.br	Lopes, Maria/GXF-7507-2022; Folador, Adriana R.C./H-6410-2016; Luiz Silva, Artur da Costa da/AAI-3516-2021; Lima, Karla Valéria/AAF-8256-2021; Ramos, Rommel Thiago Juca/L-9329-2013; Lima, Karla Valeria Batista/N-6531-2016; Azevedo, Vasco A.C/F-4315-2011; Leao, Sylvia/O-9637-2016; Folador, Adriana Ribeiro Carneiro/R-2658-2019; Leao, Sylvia/F-4431-2012; Schneider, Horacio/J-7131-2012; Azevedo, Vasco/B-1556-2019	Folador, Adriana R.C./0000-0003-1522-9871; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Lima, Karla Valéria/0000-0001-5807-0392; Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Lima, Karla Valeria Batista/0000-0001-5807-0392; Azevedo, Vasco A.C/0000-0002-4775-2280; Leao, Sylvia/0000-0003-2083-0119; Leao, Sylvia/0000-0003-2083-0119; Schneider, Horacio/0000-0002-5987-6395; Azevedo, Vasco/0000-0002-4775-2280	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP - 06/01533-9]; Fundao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP - 8/01451-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundao de Amparo a Pesquisa do Estado de Sao Paulo	This study received financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br) (FAPESP - 06/01533-9). CKM received a fellowship from the Fundao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br) (FAPESP - 8/01451-8). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adamczyk M, 2003, ACTA BIOCHIM POL, V50, P425; Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bahl MI, 2007, PLASMID, V58, P31, DOI 10.1016/j.plasmid.2006.11.007; BEVERLEY SM, 1988, NUCLEIC ACIDS RES, V16, P925, DOI 10.1093/nar/16.3.925; Brandis G, 2012, MICROBIOLOGY; Cardoso AM, 2011, MINIM INVASIVE SURG, V2011, DOI 10.1155/2011/724635; Cardoso AM, 2008, MICROBES INFECT, V10, P1552, DOI 10.1016/j.micinf.2008.09.008; Rabello MCD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029884; De Gelder L, 2007, MICROBIOL-SGM, V153, P452, DOI 10.1099/mic.0.2006/001784-0; Lorena NSDO, 2010, ACTA CIR BRAS, V25, P455, DOI 10.1590/S0102-86502010000500013; DOMENECH P, 1994, FEMS MICROBIOL LETT, V116, P19, DOI 10.1016/0378-1097(94)90101-5; Droge M, 2000, MOL GEN GENET, V263, P471, DOI 10.1007/s004380051191; Duarte RS, 2009, J CLIN MICROBIOL, V47, P2149, DOI 10.1128/JCM.00027-09; Haines AS, 2006, MICROBIOL-SGM, V152, P2689, DOI 10.1099/mic.0.28941-0; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harada KM, 2006, PLASMID, V56, P11, DOI 10.1016/j.plasmid.2005.12.002; Heuer H, 2004, MICROBIOL-SGM, V150, P3591, DOI 10.1099/mic.0.27304-0; Kallimanis A, 2011, STAND GENOMIC SCI, V5, P144, DOI 10.4056/sigs.2265047; Kamachi K, 2006, MICROBIOL-SGM, V152, P3477, DOI 10.1099/mic.0.29056-0; Leao SC, 2010, FUTURE MICROBIOL, V5, P971, DOI 10.2217/FMB.10.49; Leao SC, 2009, J CLIN MICROBIOL, V47, P2691, DOI 10.1128/JCM.00808-09; LEVENE SD, 1987, P NATL ACAD SCI USA, V84, P4054, DOI 10.1073/pnas.84.12.4054; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Matsumoto CK, 2012, MEM I OSWALDO CRUZ, V107, P969, DOI 10.1590/S0074-02762012000800002; Matsumoto CK, 2011, J CLIN MICROBIOL, V49, P62, DOI 10.1128/JCM.01665-10; MEISSNER PS, 1984, J BACTERIOL, V157, P669, DOI 10.1128/JB.157.2.669-672.1984; MIZUGUCHI Y, 1971, JPN J MICROBIOL, V15, P359, DOI 10.1111/j.1348-0421.1971.tb00592.x; Monego F, 2012, MICROB DRUG RESIST, V18, P1, DOI 10.1089/mdr.2011.0047; Monego F, 2011, BRAZ J INFECT DIS, V15, P436, DOI [10.1590/S1413-86702011000500004, 10.1016/S1413-8670(11)70224-0]; Norberg P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1267; Oliveira CS, 2012, PLASMID, V67, P252, DOI 10.1016/j.plasmid.2011.11.002; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Petrovski S, 2011, MICROBIOL-SGM, V157, P1714, DOI 10.1099/mic.0.047761-0; Picardeau M, 1998, MICROBIOL-UK, V144, P1981, DOI 10.1099/00221287-144-7-1981; Picardeau M, 1997, J BACTERIOL, V179, P2753, DOI 10.1128/jb.179.8.2753-2756.1997; Poh RPC, 2002, PLASMID, V48, P1, DOI 10.1016/S0147-619X(02)00018-5; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rabello MCDS, 2010, J CLIN MICROBIOL, V48, P2257, DOI 10.1128/JCM.02256-09; Ramos Rommel Tj, 2011, BMC Res Notes, V4, P130, DOI 10.1186/1756-0500-4-130; RAUZIER J, 1988, GENE, V71, P315, DOI 10.1016/0378-1119(88)90048-0; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2001, MOL CLONING LAB MANU; Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x; Schluter A, 2005, PLASMID, V54, P135, DOI 10.1016/j.plasmid.2005.03.001; Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI 10.1099/mic.0.26570-0; Sen D, 2011, APPL ENVIRON MICROB, V77, P7975, DOI 10.1128/AEM.05439-11; Smalla K, 2006, APPL ENVIRON MICROB, V72, P7253, DOI 10.1128/AEM.00922-06; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STEINGRUBE VA, 1991, ANTIMICROB AGENTS CH, V35, P819, DOI 10.1128/AAC.35.5.819; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stinear TP, 2005, MICROBIOL-SGM, V151, P683, DOI 10.1099/mic.0.27674-0; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tauch A, 2003, MOL GENET GENOMICS, V268, P570, DOI 10.1007/s00438-002-0785-z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorsted PA, 1998, J MOL BIOL, V282, P969, DOI 10.1006/jmbi.1998.2060; Trefault N, 2004, ENVIRON MICROBIOL, V6, P655, DOI 10.1111/j.1462-2920.2004.00596.x; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; Vedler E, 2004, J BACTERIOL, V186, P7161, DOI 10.1128/JB.186.21.7161-7174.2004; Viana-Niero C, 2008, J CLIN MICROBIOL, V46, P850, DOI 10.1128/JCM.02052-07; Wang J, 2003, NAT GENET, V34, P80, DOI 10.1038/ng1139	63	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60746	10.1371/journal.pone.0060746	http://dx.doi.org/10.1371/journal.pone.0060746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565273	Green Published, gold, Green Submitted			2022-12-27	WOS:000317717300145
J	Wang, XX; Towers, S; Panchanathan, S; Chowell, G				Wang, Xiaoxia; Towers, Sherry; Panchanathan, Sarada; Chowell, Gerardo			A Population Based Study of Seasonality of Skin and Soft Tissue Infections: Implications for the Spread of CA-MRSA	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ACQUIRED METHICILLIN-RESISTANT; SPECTRAL-ANALYSIS; UNITED-STATES; HOSPITALIZATIONS; PREVALENCE; EMERGENCE; CARRIAGE	Methicillin resistant Staphylococcus aureus (MRSA) is currently a major cause of skin and soft tissue infections (SSTI) in the United States. Seasonal variation of MRSA infections in hospital settings has been widely observed. However, systematic time-series analysis of incidence data is desirable to understand the seasonality of community acquired (CA)-MRSA infections at the population level. In this paper, using data on monthly SSTI incidence in children aged 0-19 years and enrolled in Medicaid in Maricopa County, Arizona, from January 2005 to December 2008, we carried out time-series and nonlinear regression analysis to determine the periodicity, trend, and peak timing in SSTI incidence in children at different age: 0-4 years, 5-9 years, 10-14 years, and 15-19 years. We also assessed the temporal correlation between SSTI incidence and meteorological variables including average temperature and humidity. Our analysis revealed a strong annual seasonal pattern of SSTI incidence with peak occurring in early September. This pattern was consistent across age groups. Moreover, SSTIs followed a significantly increasing trend over the 4-year study period with annual incidence increasing from 3.36% to 5.55% in our pediatric population of approximately 290,000. We also found a significant correlation between the temporal variation in SSTI incidence and mean temperature and specific humidity. Our findings could have potential implications on prevention and control efforts against CA-MRSA.	[Wang, Xiaoxia; Towers, Sherry; Chowell, Gerardo] Arizona State Univ, Math Computat & Modeling Sci Ctr, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Panchanathan, Sarada] Maricopa Integrated Hlth Syst, Dept Pediat, Phoenix, AZ USA; [Panchanathan, Sarada] Arizona State Univ, Dept Biomed Informat, Tempe, AZ USA; [Chowell, Gerardo] NIH, Div Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA	Arizona State University; Arizona State University-Tempe; Maricopa County General Hospital; Arizona State University; Arizona State University-Tempe; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Wang, XX (corresponding author), Arizona State Univ, Math Computat & Modeling Sci Ctr, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	xwang248@asu.edu	Chowell, Gerardo/F-5038-2012	Chowell, Gerardo/0000-0003-2194-2251	Arizona Biomedical Research Commission [1216]	Arizona Biomedical Research Commission	This work was supported by the Arizona Biomedical Research Commission (http://azdhs.gov/biomedical/) with Commission Contract No. 1216. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerlaan HSM, 2009, CLIN INFECT DIS, V48, P922, DOI 10.1086/597291; Bratu Simona, 2006, Ann Clin Microbiol Antimicrob, V5, P29, DOI 10.1186/1476-0711-5-29; Creech CB, 2005, PEDIATR INFECT DIS J, V24, P617, DOI 10.1097/01.inf.0000168746.62226.a4; Crum NF, 2006, AM J MED, V119, P943, DOI 10.1016/j.amjmed.2006.01.004; Eber MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025298; ELEGBE IA, 1983, J ROY SOC HEALTH, V103, P118, DOI 10.1177/146642408310300308; Frazee BW, 2005, ANN EMERG MED, V45, P311, DOI 10.1016/j.annemergmed.2004.10.011; Frei CR, 2010, J PEDIATR SURG, V45, P1967, DOI 10.1016/j.jpedsurg.2010.05.009; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Fritz SA, 2008, PEDIATRICS, V121, P1090, DOI 10.1542/peds.2007-2104; Fritz SA, 2013, ANTIMICROB AGENTS CH, V57, P559, DOI 10.1128/AAC.01633-12; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; Kaier K, 2010, INFECT CONT HOSP EP, V31, P1154, DOI 10.1086/656748; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kuehnert MJ, 2005, EMERG INFECT DIS, V11, P868; Leekha S, 2012, CLIN MICROBIOL INFEC, V18, P927, DOI 10.1111/j.1469-0691.2012.03955.x; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mermel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017925; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Munckhof WJ, 2008, EUR J CLIN MICROBIOL, V27, P355, DOI 10.1007/s10096-007-0449-3; Nicolle LE, 2012, FUTURE MICROBIOL, V7, P171, DOI [10.2217/FMB.11.145, 10.2217/fmb.11.145]; Pallin DJ, 2008, ANN EMERG MED, V51, P291, DOI 10.1016/j.annemergmed.2007.12.004; Panchanathan SS, 2010, J BIOMED INFORM, V43, P602, DOI 10.1016/j.jbi.2010.03.013; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; PRESS WH, 1989, ASTROPHYS J, V338, P277, DOI 10.1086/167197; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Szczesiul JM, 2007, PEDIATR INFECT DIS J, V26, P852, DOI 10.1097/INF.0b013e318124aa5c; Vaska VL, 2012, EUR J CLIN MICROBIOL, V31, P93, DOI 10.1007/s10096-011-1281-3; Walraven CJ, 2012, J EMERG MED, V42, P392, DOI 10.1016/j.jemermed.2011.03.009	31	67	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60872	10.1371/journal.pone.0060872	http://dx.doi.org/10.1371/journal.pone.0060872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565281	Green Published, gold			2022-12-27	WOS:000317717300154
J	Schmid, MC; Franco, I; Kang, SW; Hirsch, E; Quilliam, LA; Varner, JA				Schmid, Michael C.; Franco, Irene; Kang, Sang Won; Hirsch, Emilio; Quilliam, Lawrence A.; Varner, Judith A.			PI3-Kinase gamma Promotes Rap1a-Mediated Activation of Myeloid Cell Integrin alpha 4 beta 1, Leading to Tumor Inflammation and Growth	PLOS ONE			English	Article							LEUKOCYTE ADHESION; SUPPRESSOR-CELLS; ANGIOGENESIS; MICE; PROGRESSION; RECRUITMENT; CANCER; RAP; GERANYLGERANYL; MACROPHAGES	Tumor inflammation, the recruitment of myeloid lineage cells into the tumor microenvironment, promotes angiogenesis, immunosuppression and metastasis. CD11b+Gr1lo monocytic lineage cells and CD11b+Gr1hi granulocytic lineage cells are recruited from the circulation by tumor-derived chemoattractants, which stimulate PI3-kinase gamma (PI3K gamma)-mediated integrin alpha 4 activation and extravasation. We show here that PI3K gamma activates PLC gamma, leading to RasGrp/CalDAG-GEF-I&II mediated, Rap1a-dependent activation of integrin alpha 4 beta 1, extravasation of monocytes and granulocytes, and inflammation-associated tumor progression. Genetic depletion of PLC gamma, CalDAG-GEFI or II, Rap1a, or the Rap1 effector RIAM was sufficient to prevent integrin alpha 4 activation by chemoattractants or activated PI3K gamma (p110 gamma CAAX), while activated Rap (RapV12) promoted constitutive integrin activation and cell adhesion that could only be blocked by inhibition of RIAM or integrin alpha 4 beta 1. Similar to blockade of PI3K gamma or integrin alpha 4 beta 1, blockade of Rap1a suppressed both the recruitment of monocytes and granulocytes to tumors and tumor progression. These results demonstrate critical roles for a PI3K gamma-Rap1a-dependent pathway in integrin activation during tumor inflammation and suggest novel avenues for cancer therapy.	[Schmid, Michael C.; Varner, Judith A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Franco, Irene; Hirsch, Emilio] Univ Turin, Sch Med, Ctr Mol Biotechnol, Dept Genet, I-10124 Turin, Italy; [Franco, Irene; Hirsch, Emilio] Univ Turin, Sch Med, Ctr Mol Biotechnol, Dept Biol, I-10124 Turin, Italy; [Franco, Irene; Hirsch, Emilio] Univ Turin, Sch Med, Ctr Mol Biotechnol, Dept Biochem, I-10124 Turin, Italy; [Kang, Sang Won] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Quilliam, Lawrence A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Varner, Judith A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Varner, Judith A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Turin; University of Turin; University of Turin; Ewha Womans University; Indiana University System; Indiana University Bloomington; University of California System; University of California San Diego; University of California System; University of California San Diego	Varner, JA (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	jvarner@ucsd.edu	Quilliam, Lawrence/Q-4987-2019; Quilliam, Lawrence/B-6447-2015; Hirsch, Emilio/F-4848-2013; Franco, Irene/AAA-9170-2022	Hirsch, Emilio/0000-0002-9073-6024; Franco, Irene/0000-0002-4272-239X; Mayr, Andreas/0000-0001-7106-9732; Schmid, Matthias/0000-0002-0788-0317; Schmid, Michael/0000-0002-3445-0013; Varner, Judith/0000-0002-9251-0600	NIH [CA83133, CA126820]; NATIONAL CANCER INSTITUTE [R01CA083133, R01CA126820, R01CA167426] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants CA83133 and CA126820 to JAV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 2005, J CELL BIOL, V171, P1073, DOI 10.1083/jcb.200503155; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Costa C, 2007, P NATL ACAD SCI USA, V104, P14354, DOI 10.1073/pnas.0703175104; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Feral CC, 2006, J CLIN INVEST, V116, P715, DOI 10.1172/JCI26091; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hsieh YT, 2013, BLOOD, V2013; Jin H, 2006, CANCER RES, V66, P2146, DOI 10.1158/0008-5472.CAN-05-2704; Kappos L, 2013, J NEUROL; Kawamoto E, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/357101; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kleinschmidt-DeMasters BK, 2012, J NEUROPATH EXP NEUR, V71, P604, DOI 10.1097/NEN.0b013e31825caf2c; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Letschka T, 2008, BLOOD, V112, P4617, DOI 10.1182/blood-2007-11-121111; Li EY, 2006, CANCER RES, V66, P11238; Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322; LOBB RR, 1994, J CLIN INVEST, V94, P1722, DOI 10.1172/JCI117519; Lobell RB, 2001, CANCER RES, V61, P8758; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Manrique SZ, 2011, J EXP MED, V208, P1485, DOI 10.1084/jem.20100730; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Pasvolsky R, 2007, J EXP MED, V204, P1571, DOI 10.1084/jem.20070058; Peak JC, 2008, ONCOGENE, V27, P2823, DOI 10.1038/sj.onc.1210954; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Schmid MC, 2011, CANCER RES, V71, P6965, DOI 10.1158/0008-5472.CAN-11-0588; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Sun JZ, 2003, CANCER RES, V63, P8922; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wiemer AJ, 2007, BIOCHEM BIOPH RES CO, V353, P921, DOI 10.1016/j.bbrc.2006.12.094; Wittchen Erika S, 2011, Small GTPases, V2, P65; Yan JL, 2008, MOL CELL BIOL, V28, P5803, DOI 10.1128/MCB.00393-08; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031	54	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60226	10.1371/journal.pone.0060226	http://dx.doi.org/10.1371/journal.pone.0060226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23565202	gold, Green Published, Green Submitted			2022-12-27	WOS:000317717300071
J	Li, FZ; Li, LB; Zhong, Y; Xie, QD; Huang, JH; Kang, XJ; Wang, D; Xu, L; Huang, TH				Li, FangZheng; Li, LianBing; Zhong, Ying; Xie, QingDong; Huang, JiHua; Kang, XiangJin; Wang, Dian; Xu, Lan; Huang, TianHua			Relationship between LTR Methylation and gag Expression of HIV-1 in Human Spermatozoa and SpermDerived Embryos	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GERM-CELL DEVELOPMENT; PATERNAL GENOME; ACTIVE DEMETHYLATION; DNA METHYLATION; HUMAN-SPERM; VERTICAL TRANSMISSION; PARENTAL ALLELES; MOUSE EMBRYO; GENE	Objective: Studying the methylation status of long terminal repeats (LTR) and its relationship to gag expression of HIV-1 in order to explore regulation mechanism of HIV-1 gene expression in vertical transmission from sperm to embryo. Methods/Principal Findings: Sperm samples were collected from a healthy donor and seven patients with HIV/AIDS. Zona-free hamster ova were fertilized by donor's spermatozoa transfected with pIRES2-EGFP-LTR-gag and patient's spermatozoa to obtain zygotes and 2-cell embryos, respectively. Interspecific in vitro fertilization, bisulfite sequencing PCR (BSP), RT-PCR, nested RT-PCR, nested real-time qRT-PCR and 2(-Delta Delta Ct) method, indirect immunofluoresence (IF) assay were performed. For donor's samples, the methylation rates of HIV-1 LTR were 0.56%, 1.67%, 0.56%, 0.56% in plasmid, spermatozoa, zygotes and 2-cell embryos, respectively while spermatozoa were transfected with unmethylated plasmid, and were 95.0%, 84.44%, 3.3%, 1.67% while transfected with methylated plasmid. The positive bands for HIV-1 gag cDNA were detected in spermatozoa and 2-cell embryos. The positive signals for HIV-1 p24 Gag protein were detected in 2-cell embryos but not in spermatozoa. For patient's samples, methylation rates of HIV-1 LTR were different in spermatozoa among patients. After fertilization, CpG sites in HIV-1 LTR were highly demethylated in zygotes and 2-cell embryos. The gag transcription levels increased with decreasing of methylation rates of HIV-1 LTR, which showed a strong negative correlations between gag transcription levels and methylation rates of HIV-LTR ether in the spermatozoa (r = -0.9877, P < 0.0001) or in the sperm-derived 2-cell embryos (r = 20.9092, P = 0.0045). Conclusion: LTR methylation regulates expression of HIV-1 gag in vertical transmission from sperm to embryo.	[Li, FangZheng; Xie, QingDong; Huang, JiHua; Kang, XiangJin; Wang, Dian; Xu, Lan; Huang, TianHua] Shantou Univ, Coll Med, Res Ctr Reprod Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China; [Li, LianBing] Key Lab Birth Defects & Reprod Hlth, Chongqing, Peoples R China; [Zhong, Ying] Chengdu Jinjiang Hosp Maternal & Child Hlth Care, Ctr Reprod Med, Chengdu, Sichuan, Peoples R China	Shantou University	Huang, TH (corresponding author), Shantou Univ, Coll Med, Res Ctr Reprod Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China.	thhuang@stu.edu.cn	; Scott, Maxwell/J-1935-2015	li, feng/0000-0003-2227-9893; Scott, Maxwell/0000-0001-6536-4735	National Natural Science Foundation of China; Li Ka Shing Shantou University Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Ka Shing Shantou University Foundation	This work was financially supported by the National Natural Science Foundation of China and the Li Ka Shing Shantou University Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla H, 2009, J REPROD DEVELOP, V55, P356, DOI 10.1262/jrd.20234; Ali BA, 2006, ASIAN J ANDROL, V8, P273, DOI 10.1111/j.1745-7262.2006.00141.x; BACCETTI B, 1994, J CELL BIOL, V127, P903, DOI 10.1083/jcb.127.4.903; BACHILLER D, 1991, MOL REPROD DEV, V30, P194, DOI 10.1002/mrd.1080300305; BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005; BAGASRA O, 1988, J ACQ IMMUN DEF SYND, V1, P431; Beaujean N, 2004, P NATL ACAD SCI USA, V101, P7636, DOI 10.1073/pnas.0400730101; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001; Detich N, 2003, J BIOL CHEM, V278, P20812, DOI 10.1074/jbc.M211813200; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gao YS, 2009, CURR HIV RES, V7, P562, DOI 10.2174/157016209789346237; GOEDERT JJ, 1986, SCIENCE, V231, P992, DOI 10.1126/science.3003917; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Huang JM, 2002, ASIAN J ANDROL, V4, P209; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KOHLER M, 1995, INFUSIONSTHERAPIE, V22, P46; La Salle S, 2006, DEV BIOL, V296, P71, DOI 10.1016/j.ydbio.2006.04.436; McGowan JP, 2000, J ANTIMICROB CHEMOTH, V46, P657, DOI 10.1093/jac/46.5.657; Miller D, 2006, HUM REPROD UPDATE, V12, P757, DOI 10.1093/humupd/dml037; MONK M, 1990, PHILOS T R SOC B, V326, P299, DOI 10.1098/rstb.1990.0013; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; RAHE B, 1983, NUCLEIC ACIDS RES, V11, P7947, DOI 10.1093/nar/11.22.7947; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Tritel M, 2000, J VIROL, V74, P5845, DOI 10.1128/JVI.74.13.5845-5855.2000; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028586; Wang DA, 2011, J MED VIROL, V83, P16, DOI 10.1002/jmv.21767; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zuccotti M, 2002, MOL REPROD DEV, V61, P14, DOI 10.1002/mrd.1126	37	122	130	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54801	10.1371/journal.pone.0054801	http://dx.doi.org/10.1371/journal.pone.0054801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23409170	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500028
J	Tang, CK; Aoshi, T; Jounai, N; Ito, J; Ohata, K; Kobiyama, K; Dessailly, BH; Kuroda, E; Akira, S; Mizuguchi, K; Coban, C; Ishii, KJ				Tang, Choon Kit; Aoshi, Taiki; Jounai, Nao; Ito, Junichi; Ohata, Keiichi; Kobiyama, Kouji; Dessailly, Benoit H.; Kuroda, Etsushi; Akira, Shizuo; Mizuguchi, Kenji; Coban, Cevayir; Ishii, Ken J.			The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant	PLOS ONE			English	Article							VASCULAR DISRUPTING AGENT; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID DMXAA; INNATE; ACTIVATION; IMMUNOGENICITY; CARBOPLATIN; PACLITAXEL; ASA404; PLAYS; CELLS	5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a potent type I interferon (IFN) inducer, was evaluated as a chemotherapeutic agent in mouse cancer models and proved to be well tolerated in human cancer clinical trials. Despite its multiple biological functions, DMXAA has not been fully characterized for the potential application as a vaccine adjuvant. In this report, we show that DMXAA does act as an adjuvant due to its unique property as a soluble innate immune activator. Using OVA as a model antigen, DMXAA was demonstrated to improve on the antigen specific immune responses and induce a preferential Th2 (Type-2) response. The adjuvant effect was directly dependent on the IRF3-mediated production of type-I-interferon, but not IL-33. DMXAA could also enhance the immunogenicity of influenza split vaccine which led to significant increase in protective responses against live influenza virus challenge in mice compared to split vaccine alone. We propose that DMXAA can be used as an adjuvant that targets a specific innate immune signaling pathway via IRF3 for potential applications including vaccines against influenza which requires a high safety profile.	[Tang, Choon Kit] Agcy Sci & Technol Res, Singapore Immunol Network, Singapore, Singapore; [Tang, Choon Kit; Ohata, Keiichi; Coban, Cevayir] Osaka Univ, Immunol Frontier Res Ctr IFReC, Malaria Immunol Lab, Suita, Osaka 565, Japan; [Tang, Choon Kit; Akira, Shizuo] Osaka Univ, IFReC, Host Def Lab, Suita, Osaka 565, Japan; [Tang, Choon Kit; Aoshi, Taiki; Kobiyama, Kouji; Kuroda, Etsushi; Ishii, Ken J.] Osaka Univ, IFReC, Vaccine Sci Lab, Suita, Osaka 565, Japan; [Aoshi, Taiki; Jounai, Nao; Kobiyama, Kouji; Kuroda, Etsushi; Ishii, Ken J.] NIBIO, Lab Adjuvant Innovat, Osaka, Japan; [Ito, Junichi; Dessailly, Benoit H.; Mizuguchi, Kenji] Natl Inst Biomed Innovat NIBIO, Lab Bioinformat, Osaka, Japan	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Osaka University; Osaka University; Osaka University	Ishii, KJ (corresponding author), Osaka Univ, IFReC, Vaccine Sci Lab, Suita, Osaka 565, Japan.	kenishii@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009; Ishii, Ken J/B-1685-2012; Mizuguchi, Kenji/GVS-5857-2022; COBAN, Cevayir/P-1928-2019; Coban, Cevayir/B-2129-2012	Ishii, Ken J/0000-0002-6728-3872; Mizuguchi, Kenji/0000-0003-3021-7078; COBAN, Cevayir/0000-0002-4467-7799; Ohata, Keiichi/0000-0002-5635-4292	Japanese Ministry of Health, Labour and Welfare; A*STAR, Singapore	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a Health and Labour Sciences Research Grant 'Adjuvant database Project' of the Japanese Ministry of Health, Labour and Welfare. CKT was funded by A*STAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauer R, 2010, NEOPLASIA, V12, P755, DOI 10.1593/neo.10636; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cheng GJ, 2011, AM J RESP CELL MOL, V45, P480, DOI 10.1165/rcmb.2010-0288OC; Cheng GJ, 2010, J BIOL CHEM, V285, P10553, DOI 10.1074/jbc.M109.065631; Ching LM, 2004, BRIT J CANCER, V90, P906, DOI 10.1038/sj.bjc.6601606; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Lara PN, 2011, J CLIN ONCOL, V29, P2965, DOI 10.1200/JCO.2011.35.0660; LAWS AL, 1995, BRIT J CANCER, V71, P1204, DOI 10.1038/bjc.1995.234; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; McKeage MJ, 2008, BRIT J CANCER, V99, P2006, DOI 10.1038/sj.bjc.6604808; Peng SW, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-21; Perkins DJ, 2012, J IMMUNOL; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Sun J, 2011, BIOCHEM PHARMACOL, V82, P1175, DOI 10.1016/j.bcp.2011.07.086; Tang CK, 2009, BIOMATERIALS, V30, P1389, DOI 10.1016/j.biomaterials.2008.11.010; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Wallace A, 2007, CANCER RES, V67, P7011, DOI 10.1158/0008-5472.CAN-06-3757; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720; Zhao LL, 2005, INT J CANCER, V116, P322, DOI 10.1002/ijc.21005	30	124	128	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e60038	10.1371/journal.pone.0060038	http://dx.doi.org/10.1371/journal.pone.0060038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	24066172	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400077
J	Yu, HC; Hou, DR; Liu, CY; Lin, CS; Shiau, CW; Cheng, AL; Chen, KF				Yu, Hui-Chuan; Hou, Duen-Ren; Liu, Chun-Yu; Lin, Chen-Si; Shiau, Chung-Wai; Cheng, Ann-Lii; Chen, Kuen-Feng			Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TUMOR-SUPPRESSOR; CIP2A EXPRESSION; CELL-SURVIVAL; PP2A; UBIQUITIN; AKT; APOPTOSIS; PHOSPHORYLATION	Previously, we reported that cancerous inhibitor of protein phosphatase 2A (CIP2A) mediates the apoptotic effect of bortezomib in hepatocellular carcinoma (HCC). Here, we report a proteasome-independent mechanism by which bortezomib induces autophagy in HCC. Our data indicate that bortezomib activated autophagy in a dose-and time-dependent manner in HCC cell lines including Huh-7, Sk-Hep1, and Hep3B. Bortezomib downregulated CIP2A, phospho-Akt (P-Akt) and phospho-4EBP1 (P-4EBP1) in a dose-and time-dependent manner in all tested HCC cells. Ectopic expression of CIP2A abolished the effect of bortezomib on autophagy. Co-treatment of bortezomib and calyculin A, a PP2A inhibitor, reduced the effect of bortezomib on P-Akt, P-4EBP1, and autophagy. Increased phosphorylation of either Akt or 4EBP1 by ectopic overexpression protected cells from bortezomib-induced autophagy. Furthermore, we examined the effect of Delta Btz, a bortezomib derivative that closely resembles bortezomib structurally but has no proteasome activity, in HCC. Interestingly, Delta Btz demonstrated similar effects to bortezomib on autophagy, CIP2A, P-Akt and P-4EBP1, suggesting that the effect of bortezomib on autophagy is independent of proteasome inhibition. Moreover, our in vivo data showed that both bortezomib and Delta Btz inhibited tumor growth, downregulated CIP2A, P-Akt and induced autophagy in Huh-7 tumors. In conclusion, bortezomib induces autophagy in HCC through a CIP2A-PP2A-Akt-4EBP1 pathway.	[Yu, Hui-Chuan; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Yu, Hui-Chuan; Cheng, Ann-Lii; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Lin, Chen-Si; Chen, Kuen-Feng] Natl Taiwan Univ, Sch Vet Med, Taipei 10764, Taiwan; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Hou, Duen-Ren] Natl Cent Univ, Dept Chem, Tao Yuan, Taiwan; [Liu, Chun-Yu] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Shiau, Chung-Wai] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, KF (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan.	kfchen1970@ntu.edu.tw	Lin, Chen-Si/AAD-3733-2019	Lin, Chen-Si/0000-0003-2254-8344; Chen, Kuen-Feng/0000-0002-4686-7019; HOU, Duen-Ren/0000-0003-1072-2915; Yu, Hongbo/0000-0002-3384-7772; Liu, Jinting/0000-0003-2136-8560; Cheng, Ann-Lii/0000-0002-9152-6512; Suiyi, Zhu/0000-0002-9784-2698	National Taiwan University Hospital [NTUH 101P01]; National Science Council, Taiwan [NSC99-2314-B-002-017-MY2, NSC100-2325-B- 002-036]	National Taiwan University Hospital(National Taiwan University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study is supported by grants, NTUH 101P01 (KFC) from National Taiwan University Hospital; NSC99-2314-B-002-017-MY2 (KFC), and NSC100-2325-B- 002-036 (KFC) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Chen KF, 2009, J BIOL CHEM, V284, P11121, DOI 10.1074/jbc.M806268200; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dong QZ, 2011, ANN SURG ONCOL, V18, P857, DOI 10.1245/s10434-010-1313-8; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Eskelinen EL, 2005, CELL DEATH DIFFER, V12, P1468, DOI 10.1038/sj.cdd.4401721; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Katz J, 2010, CANCER BIOL THER, V10, P694, DOI 10.4161/cbt.10.7.12895; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Li CY, 2012, CANCER LETT, V314, P102, DOI 10.1016/j.canlet.2011.09.020; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Ling YH, 2002, MOL CANCER THER, V1, P841; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Qu W, 2010, MED ONCOL; Richardson Paul G, 2003, Cancer Control, V10, P361; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Roy S, 2010, SEMIN IMMUNOPATHOL, V32, P383, DOI 10.1007/s00281-010-0213-0; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Verslype C, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp281; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Wang J, 2011, INT J LAB HEMATOL, V33, P290, DOI 10.1111/j.1751-553X.2010.01288.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhu Keyi, 2009, Proceedings of the American Association for Cancer Research Annual Meeting, V50, P451, DOI 10.1038/onc.2009.343	50	88	89	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55705	10.1371/journal.pone.0055705	http://dx.doi.org/10.1371/journal.pone.0055705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23799106	Green Submitted, gold, Green Published			2022-12-27	WOS:000314597900052
J	Kim, J; Kim, G; An, S; Kwon, YK; Yoon, S				Kim, Jinkyu; Kim, Gunn; An, Sungbae; Kwon, Young-Kyun; Yoon, Sungroh			Entropy-Based Analysis and Bioinformatics-Inspired Integration of Global Economic Information Transfer	PLOS ONE			English	Article							FALSE DISCOVERY RATE; TIME-SERIES; STOCK-MARKET; NETWORK; MODEL; COINTEGRATION; RETURNS; GENES; FLOW	The assessment of information transfer in the global economic network helps to understand the current environment and the outlook of an economy. Most approaches on global networks extract information transfer based mainly on a single variable. This paper establishes an entirely new bioinformatics-inspired approach to integrating information transfer derived from multiple variables and develops an international economic network accordingly. In the proposed methodology, we first construct the transfer entropies (TEs) between various intra- and inter-country pairs of economic time series variables, test their significances, and then use a weighted sum approach to aggregate information captured in each TE. Through a simulation study, the new method is shown to deliver better information integration compared to existing integration methods in that it can be applied even when intra-country variables are correlated. Empirical investigation with the real world data reveals that Western countries are more influential in the global economic network and that Japan has become less influential following the Asian currency crisis.	[Kim, Jinkyu; Yoon, Sungroh] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea; [Kim, Gunn] Sejong Univ, Dept Phys, Seoul, South Korea; [An, Sungbae] Singapore Management Univ, Sch Econ, Singapore, Singapore; [Kwon, Young-Kyun] Kyung Hee Univ, Dept Phys, Seoul, South Korea; [Kwon, Young-Kyun] Kyung Hee Univ, Res Inst Basic Sci, Seoul, South Korea	Seoul National University (SNU); Sejong University; Singapore Management University; Kyung Hee University; Kyung Hee University	Yoon, S (corresponding author), Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea.	sryoon@snu.ac.kr	Kwon, Young-Kyun/G-1833-2011; AN, Sungbae/D-1416-2009	Kwon, Young-Kyun/0000-0001-6027-8408; Kim, Joonyup/0000-0002-9950-6663; Binder, Brad/0000-0002-8172-2034; Dotson, Bradley/0000-0002-1003-3733	National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0009963, 2012R1A2A4A01008475]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (Grant No. 2011-0009963 to SY and Grant No. 2012R1A2A4A01008475 to SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MACR DAT EM DEV MARK; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanchard O., 1989, LECT MACROECONOMICS; Box G., 1970, TIME SERIES ANAL; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; CARLSTEIN E, 1986, ANN STAT, V14, P1171, DOI 10.1214/aos/1176350057; Corsetti G, 1999, JPN WORLD ECON, V11, P305, DOI 10.1016/S0922-1425(99)00019-5; Dees S, 2007, J APPL ECONOMET, V22, P1, DOI 10.1002/jae.932; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Freeman C, 1987, TECHNOLOGY POLICY EC; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Granger CWJ, 2004, AM ECON REV, V94, P421, DOI 10.1257/0002828041464669; Hahs DW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.128701; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Kim K, 2004, PHYSICA A, V344, P272, DOI 10.1016/j.physa.2004.06.131; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, DOI 10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241]; Kwon O, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/68003; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Matia K, 2003, EUROPHYS LETT, V61, P422, DOI 10.1209/epl/i2003-00194-y; McCauley JL, 2003, PHYSICA A, V329, P178, DOI 10.1016/S0378-4371(03)00589-2; Park JB, 2007, PHYSICA A, V379, P179, DOI 10.1016/j.physa.2006.12.042; Peter FJ, 2011, THESIS EBERHARD KARL; Ragwitz M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056201; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Silva AC, 2004, PHYSICA A, V344, P227, DOI 10.1016/j.physa.2004.06.122; Stanley HE, 2001, PHYSICA A, V299, P1, DOI 10.1016/S0378-4371(01)00351-X; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Thurow L., 1993, HEAD HEAD COMING EC; Vincente R, 2011, J COMPUT NEUROSCI, V30, P45; Vogel E. F., 1979, JAPAN NUMBER ONE LES; Yang JS, 2006, PHYSICA A, V363, P377, DOI 10.1016/j.physa.2005.12.039; Yook SH, 2001, PHYS REV LETT, V86, P5835, DOI 10.1103/PhysRevLett.86.5835	37	191	195	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51986	10.1371/journal.pone.0051986	http://dx.doi.org/10.1371/journal.pone.0051986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23922872	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900015
J	Kim, JE; Ryu, HJ; Kang, TC				Kim, Ji-Eun; Ryu, Hea Jin; Kang, Tae-Cheon			Status Epilepticus Induces Vasogenic Edema via Tumor Necrosis Factor-alpha/Endothelin-1-Mediated Two Different Pathways	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; RAT PIRIFORM CORTEX; NADPH-OXIDASE; FACTOR-ALPHA; KAINIC ACID; NITRIC-OXIDE; RECEPTOR; PERMEABILITY; ENDOTHELIN; SEIZURE	Status epilepticus (SE) induces vasogenic edema in the piriform cortex with disruptions of the blood-brain barrier (BBB). However, the mechanisms of vasogenic edema formation following SE are still unknown. Here we investigated the endothelin B (ETB) receptor-mediated pathway of SE-induced vasogenic edema. Following SE, the release of tumor necrosis factor-alpha (TNF-alpha) stimulated endothelin-1 (ET-1) release and expression in neurons and endothelial cells. In addition, TNF-a-induced ET-1 increased BBB permeability via ETB receptor-mediated endothelial nitric oxide synthase (eNOS) activation in endothelial cells. ETB receptor activation also increased intracellular reactive oxygen species by NADPH oxidase production in astrocytes. These findings suggest that SE results in BBB dysfunctions via endothelial-astroglial interactions through the TNF-alpha-ET-1-eNOS/ NADPH oxidase pathway, and that these ETB receptor-mediated interactions may be an effective therapeutic strategy for vasogenic edema in various neurological diseases.	[Kim, Ji-Eun; Ryu, Hea Jin; Kang, Tae-Cheon] Hallym Univ, Coll Med, Dept Anat & Neurobiol, Chunchon, Kangwon Do, South Korea; [Kim, Ji-Eun; Ryu, Hea Jin; Kang, Tae-Cheon] Hallym Univ, Coll Med, Inst Epilepsy Res, Chunchon, Kangwon Do, South Korea	Hallym University; Hallym University	Kang, TC (corresponding author), Hallym Univ, Coll Med, Dept Anat & Neurobiol, Chunchon, Kangwon Do, South Korea.	tckang@hallym.ac.kr	Kwon, Young-Kyun/G-1833-2011; AN, Sungbae/D-1416-2009	Kwon, Young-Kyun/0000-0001-6027-8408; Kim, Joonyup/0000-0002-9950-6663; Binder, Brad/0000-0002-8172-2034; Dotson, Bradley/0000-0002-1003-3733	Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs [A111313]; National Research Foundation of Korea [2012R1A2A1A01001775]; Korean government	Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs; National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government)	This study was supported by grants from the Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs (Grant number A111313) and the National Research Foundation of Korea (MEST No. 2012R1A2A1A01001775), funded by the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BD, 1989, J INVEST DERMATOL, V93, P280, DOI 10.1111/1523-1747.ep12277592; BEDI KS, 1991, J COMP NEUROL, V311, P425, DOI 10.1002/cne.903110311; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bengtsson SH, 2003, CLIN EXP PHARMACOL P, V30, P849, DOI 10.1046/j.1440-1681.2003.03929.x; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Davenport AP, 2004, J CARDIOVASC PHARM, V44, pS276, DOI 10.1097/01.fjc.0000166284.08657.64; DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316; Dong F, 2006, HYPERTENSION, V47, P222, DOI 10.1161/01.HYP.0000198555.51645.f1; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Emerson MR, 1999, BRAIN RES, V825, P189, DOI 10.1016/S0006-8993(99)01195-6; Farkas G, 1998, NEUROSCI LETT, V242, P147, DOI 10.1016/S0304-3940(98)00060-3; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Kang TC, 2006, GLIA, V54, P258, DOI 10.1002/glia.20380; Kim JE, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-6; Kim JE, 2011, J CLIN INVEST, V121, P2037, DOI 10.1172/JCI44818; Kim JE, 2010, J COMP NEUROL, V518, P4612, DOI 10.1002/cne.22482; Kleeberg J, 2004, AM J PHYSIOL-HEART C, V286, pH1339, DOI 10.1152/ajpheart.00227.2003; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Luscher TF, 2000, CIRCULATION, V102, P2434, DOI 10.1161/01.CIR.102.19.2434; Lv S, 2010, LIVER INT, V30, P1198, DOI 10.1111/j.1478-3231.2010.02211.x; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; McCann SK, 2008, J NEUROSCI RES, V86, P2524, DOI 10.1002/jnr.21700; Miller AA, 2006, BRAIN RES, V1111, P111, DOI 10.1016/j.brainres.2006.06.082; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; NITSCH C, 1985, J NEUROL SCI, V67, P67, DOI 10.1016/0022-510X(85)90023-1; Paravicini TM, 2003, CLIN EXP PHARMACOL P, V30, P855, DOI 10.1046/j.1440-1681.2003.03920.x; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ryu HJ, 2010, NEUROSCIENCE, V170, P711, DOI 10.1016/j.neuroscience.2010.07.048; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P81; Sheen SH, 2011, BRAIN RES, V1369, P173, DOI 10.1016/j.brainres.2010.10.080; Skopal J, 1998, J CARDIOVASC PHARM, V31, pS370, DOI 10.1097/00005344-199800001-00104; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Tack I, 1997, AM J PHYSIOL-RENAL, V272, pF31, DOI 10.1152/ajprenal.1997.272.1.F31; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; TSUKAHARA H, 1994, J BIOL CHEM, V269, P21778; Wui MZ, 2009, GLIA, V57, P1204, DOI 10.1002/glia.20842; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375	47	191	195	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74458	10.1371/journal.pone.0074458	http://dx.doi.org/10.1371/journal.pone.0074458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	23922872	Green Submitted, gold, Green Published			2022-12-27	WOS:000324481600131
J	Wang, CJ; Song, XD; Li, YJ; Han, F; Gao, SY; Wang, XZ; Xie, SY; Lv, CJ				Wang, Congjie; Song, Xiaodong; Li, Youjie; Han, Fang; Gao, Shuyan; Wang, Xiaozhi; Xie, Shuyang; Lv, Changjun			Low-Dose Paclitaxel Ameliorates Pulmonary Fibrosis by Suppressing TGF-beta 1/Smad3 Pathway via miR-140 Upregulation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; MONOCLONAL-ANTIBODY; CELLS; SMAD3; INHIBITION; MODEL; FIBROBLASTS; TISSUE	Abnormal TGF-beta 1/Smad3 activation plays an important role in the pathogenesis of pulmonary fibrosis, which can be prevented by paclitaxel (PTX). This study aimed to investigate an antifibrotic effect of the low-dose PTX (10 to 50 nM in vitro, and 0.6 mg/kg in vivo). PTX treatment resulted in phenotype reversion of epithelial-mesenchymal transition (EMT) in alveolar epithelial cells (AECs) with increase of miR-140. PTX resulted in an amelioration of bleomycin (BLM)-induced pulmonary fibrosis in rats with reduction of the wet lung weight to body weight ratios and the collagen deposition. Our results further demonstrated that PTX inhibited the effect of TGF-beta 1 on regulating the expression of Smad3 and phosphorylated Smad3 (p-Smad3), and restored the levels of E-cadherin, vimentin and alpha-SMA. Moreover, lower miR-140 levels were found in idiopathic pulmonary fibrosis (IPF) patients, TGF-beta 1-treated AECs and BLM-instilled rat lungs. Through decreasing Smad3/p-Smad3 expression and upregulating miR-140, PTX treatment could significantly reverse the EMT of AECs and prevent pulmonary fibrosis of rats. The action of PTX to ameliorate TGF-beta 1-induced EMT was promoted by miR-140, which increased E-cadherin levels and reduced the expression of vimentin, Smad3 and p-Smad3. Collectively, our results demonstrate that low-dose PTX prevents pulmonary fibrosis by suppressing the TGF-beta 1/Smad3 pathway via upregulating miR-140.	[Wang, Congjie; Han, Fang; Gao, Shuyan; Lv, Changjun] Binzhou Med Univ, Dept Clin Med, Yantai, Peoples R China; [Song, Xiaodong] Binzhou Med Univ, Med Res Ctr, Yantai, Peoples R China; [Li, Youjie; Gao, Shuyan; Xie, Shuyang] Binzhou Med Univ, Key Lab Tumor Mol Biol, Dept Biochem & Mol Biol, Yantai, Peoples R China; [Wang, Xiaozhi] Binzhou Med Univ, Affiliated Hosp, Dept Resp Med, Binzhou, Peoples R China	Binzhou Medical University; Binzhou Medical University; Binzhou Medical University; Binzhou Medical University	Lv, CJ (corresponding author), Binzhou Med Univ, Dept Clin Med, Yantai, Peoples R China.	shuyangxie@yahoo.com.cn	Wang, Che/A-2784-2015; Li, Song/C-6701-2014; Zheng, Po Xing/M-3244-2014	Li, Song/0000-0003-2713-9136; Chiang-Ni, Chuan/0000-0002-0753-035X; Zheng, Po Xing/0000-0001-5827-5865; Jiang, Xun/0000-0002-3344-4797	National Natural Science Foundation of China [81273957]; Taishan Scholar Project; Important Project of Science and Technology of Shandong Province [2010GWZ20254, 2011GHY11501];  [NCET-10-0919]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Project; Important Project of Science and Technology of Shandong Province; 	This work was supported by the National Natural Science Foundation of China (Grant No. 81273957), NCET-10-0919, "Taishan Scholar Project" and Important Project of Science and Technology of Shandong Province (Grant No. 2010GWZ20254, 2011GHY11501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; ALLEN EM, 1977, J IMMUNOL, V119, P343; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; BRAHN E, 1994, ARTHRITIS RHEUM, V37, P839, DOI 10.1002/art.1780370611; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Choi HS, 2007, J SURG RES, V141, P183, DOI 10.1016/j.jss.2006.12.558; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Dutsch-Wicherek M, 2010, AM J REPROD IMMUNOL, V63, P181, DOI 10.1111/j.1600-0897.2009.00803.x; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Hay ED, 1995, ACTA ANAT, V154, P8; HAY J, 1991, ARCH TOXICOL, V65, P81, DOI 10.1007/BF02034932; JULESELYSEE K, 1990, CLIN CHEST MED, V11, P1; Kage H, 2012, CURR OPIN PULM MED, V18, P517, DOI 10.1097/MCP.0b013e3283566721; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Kim JH, 2007, J KOREAN MED SCI, V22, P898, DOI 10.3346/jkms.2007.22.5.898; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; Liu SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047482; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; MCDONALD JA, 1986, J CLIN INVEST, V78, P1237, DOI 10.1172/JCI112707; Mitsuhashi H, 1996, AM J RESP CRIT CARE, V153, P369, DOI 10.1164/ajrccm.153.1.8542145; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; Sato N, 2000, AM J RESP CRIT CARE, V161, P1681, DOI 10.1164/ajrccm.161.5.9907104; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sharma SK, 1996, AM J RESP CRIT CARE, V154, P193, DOI 10.1164/ajrccm.154.1.8680680; Silva CIS, 2007, J THORAC IMAG, V22, P221, DOI 10.1097/01.rti.0000213588.52343.13; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; SZAPIEL SV, 1979, AM REV RESPIR DIS, V120, P893; Tanaka KI, 2010, AM J PHYSIOL-LUNG C, V298, pL348, DOI 10.1152/ajplung.00289.2009; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Tardif G, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-148; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; THRALL RS, 1979, AM J PATHOL, V95, P117; Tran PL, 1997, J CLIN INVEST, V99, P608, DOI 10.1172/JCI119203; Uhal Bruce D., 1998, American Journal of Physiology, V275, pL1192; Vanderburg CR, 1996, ACTA ANAT, V157, P87; Venkatesan N, 2004, AM J PHYSIOL-LUNG C, V287, pL1342, DOI 10.1152/ajplung.00035.2004; Wang HD, 2002, AM J RESP CRIT CARE, V165, P406, DOI 10.1164/ajrccm.165.3.2003149; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001; Zhao LJ, 2011, J SURG RES, V171, P819, DOI 10.1016/j.jss.2010.04.059; Zhou J, 2010, WORLD J GASTROENTERO, V16, P3330, DOI 10.3748/wjg.v16.i26.3330; Zhou YC, 2011, INT J RADIAT ONCOL, V81, P1530, DOI 10.1016/j.ijrobp.2011.06.1956; Zhu SK, 2004, CIRC RES, V94, P617, DOI 10.1161/01.RES.0000118599.25944.D5	68	107	118	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70725	10.1371/journal.pone.0070725	http://dx.doi.org/10.1371/journal.pone.0070725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967091	Green Published, Green Submitted, gold			2022-12-27	WOS:000323378000012
J	Wang, C; Tian, LL; Li, S; Li, HB; Zhou, Y; Wang, H; Yang, QZ; Ma, LJ; Shang, DJ				Wang, Che; Tian, Li-Li; Li, Song; Li, Hui-Bing; Zhou, Yang; Wang, He; Yang, Qing-Zhu; Ma, Li-Jie; Shang, De-Jing			Rapid Cytotoxicity of Antimicrobial Peptide Tempoprin-1CEa in Breast Cancer Cells through Membrane Destruction and Intracellular Calcium Mechanism	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; CHINESE BROWN FROG; SYSTEMIC INOCULATION; RANA-CHENSINENSIS; TUMOR-GROWTH; APOPTOSIS; DEATH; LINES; PHOSPHATIDYLSERINE; MITOCHONDRIA	Temporin-1CEa is an antimicrobial peptide isolated from the skin secretions of the Chinese brown frog (Rana chensinensis). We have previously reported the rapid and broad-spectrum anticancer activity of temporin-1CEa in vitro. However, the detailed mechanisms for temporin-1CEa-induced cancer cell death are still weakly understood. In the present study, the mechanisms of temporin-1CEa-induced rapid cytotoxicity on two human breast cancer cell lines, MDA-MB-231 and MCF-7, were investigated. The MTT assay and the LDH leakage assay indicated that one-hour of incubation with temporin-1CEa led to cytotoxicity in a dose-dependent manner. The morphological observation using electronic microscopes suggested that one-hour exposure of temporin-1CEa resulted in profound morphological changes in both MDA-MB-231 and MCF-7 cells. The membrane-disrupting property of temporin-1CEa was further characterized by induction of cell-surface exposure of phosphatidylserine, elevation of plasma membrane permeability and rapid depolarization of transmembrane potential. Moreover, temporin-1CEa evoked intracellular calcium ion and reactive oxygen species (ROS) elevations as well as collapse of mitochondrial membrane potential (Delta phi m). In summary, the present study indicates that temporin-1CEa triggers rapid cell death in breast cancer cells. This rapid cytotoxic activity might be mediated by both membrane destruction and intracellular calcium mechanism.	[Wang, Che; Tian, Li-Li; Wang, He; Yang, Qing-Zhu; Shang, De-Jing] Liaoning Normal Univ, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China; [Wang, Che; Li, Hui-Bing; Zhou, Yang; Ma, Li-Jie] Liaoning Normal Univ, Dept Pharm, Sch Chem & Chem Engn, Dalian, Peoples R China; [Li, Song] Dalian Univ Technol, Lab Biophys & Pharmacol, Sch Phys & Optoelect Engn, Dalian, Peoples R China; [Shang, De-Jing] Liaoning Normal Univ, Fac Life Sci, Dalian, Peoples R China	Liaoning Normal University; Liaoning Normal University; Dalian University of Technology; Liaoning Normal University	Shang, DJ (corresponding author), Liaoning Normal Univ, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China.	dejingshang@yahoo.com	Wang, Che/A-2784-2015; Li, Song/C-6701-2014; Zheng, Po Xing/M-3244-2014	Li, Song/0000-0003-2713-9136; Chiang-Ni, Chuan/0000-0002-0753-035X; Zheng, Po Xing/0000-0001-5827-5865; Jiang, Xun/0000-0002-3344-4797	National Natural Science Foundation of China [30970352, 81202448, 31272314]; Scientific Research Fund of Liaoning Provincial Education Department [L2012382]; Program for Liaoning Innovative Research Team in University [LT2012019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Liaoning Provincial Education Department; Program for Liaoning Innovative Research Team in University	This work was supported by the National Natural Science Foundation of China (30970352, 81202448 and 31272314), the Scientific Research Fund of Liaoning Provincial Education Department (L2012382), and the Program for Liaoning Innovative Research Team in University (LT2012019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Benna S, 2011, INT J MOL SCI, V12, P8027, DOI 10.3390/ijms12118027; Ausbacher D, 2012, BBA-BIOMEMBRANES, V1818, P2917, DOI 10.1016/j.bbamem.2012.07.005; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; Chan SC, 1998, ANTICANCER RES, V18, P4467; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Dennis J W, 1991, Semin Cancer Biol, V2, P411; Dobrzynska I, 2005, MOL CELL BIOCHEM, V276, P113, DOI 10.1007/s11010-005-3557-3; Eliassen LT, 2006, INT J CANCER, V119, P493, DOI 10.1002/ijc.21886; Franco R, 2006, J MEMBRANE BIOL, V209, P43, DOI 10.1007/s00232-005-0837-5; Helmerhorst EJ, 1999, J BIOL CHEM, V274, P7286, DOI 10.1074/jbc.274.11.7286; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; Li J, 2000, NAT MED, V6, P49, DOI 10.1038/71527; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lin VCL, 2003, AM J PATHOL, V162, P1781, DOI 10.1016/S0002-9440(10)64313-1; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mader JS, 2007, EXP CELL RES, V313, P2634, DOI 10.1016/j.yexcr.2007.05.015; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; Mader JS, 2005, MOL CANCER THER, V4, P612, DOI 10.1158/1535-7163.MCT-04-0077; Makovitzki A, 2009, CANCER RES, V69, P3458, DOI 10.1158/0008-5472.CAN-08-3021; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Papo N, 2006, CANCER RES, V66, P5371, DOI 10.1158/0008-5472.CAN-05-4569; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Segura C, 2007, BIOCHEM BIOPH RES CO, V353, P908, DOI 10.1016/j.bbrc.2006.12.113; Shang DJ, 2009, ZOOL SCI, V26, P220, DOI 10.2108/zsj.26.220; Steinstraesser L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018321; Sureda FX, 1997, CYTOMETRY, V28, P74, DOI 10.1002/(SICI)1097-0320(19970501)28:1<74::AID-CYTO9>3.0.CO;2-H; Tan JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022836; Tu YF, 2011, BBA-BIOENERGETICS, V1807, P1125, DOI 10.1016/j.bbabio.2011.04.015; UTSUGI T, 1991, CANCER RES, V51, P3062; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang C, 2012, BIOCHIMIE, V94, P434, DOI 10.1016/j.biochi.2011.08.011; Yoon WH, 1996, BIOCHEM BIOPH RES CO, V222, P694, DOI 10.1006/bbrc.1996.0806	36	107	118	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60462	10.1371/journal.pone.0060462	http://dx.doi.org/10.1371/journal.pone.0060462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23967091	gold, Green Published			2022-12-27	WOS:000319109800052
J	Lin, YL; Tsai, YJ; Liu, YF; Cheng, YC; Hung, CM; Lee, YJ; Pan, HC; Li, C				Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Cheng, Yi-Chuan; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan			The Critical Role of Protein Arginine Methyltransferase prmt8 in Zebrafish Embryonic and Neural Development Is Non-Redundant with Its Paralogue prmt1	PLOS ONE			English	Article							METHYLATION; PROTEIN-ARGININE-METHYLTRANSFERASE-8; IDENTIFICATION; BINDING; FAMILY; DOMAIN; GENES; BRAIN; REST	Protein arginine methyltransferase (PRMT) 1 is the most conserved and widely distributed PRMT in eukaryotes. PRMT8 is a vertebrate-restricted paralogue of PRMT1 with an extra N-terminal sequence and brain-specific expression. We use zebrafish (Danio rerio) as a vertebrate model to study PRMT8 function and putative redundancy with PRMT1. The transcripts of zebrafish prmt8 were specifically expressed in adult zebrafish brain and ubiquitously expressed from zygotic to early segmentation stage before the neuronal development. Whole-mount in situ hybridization revealed ubiquitous prmt8 expression pattern during early embryonic stages, similar to that of prmt1. Knockdown of prmt8 with antisense morpholino oligonucleotide phenocopied prmt1-knockdown, with convergence/extension defects at gastrulation. Other abnormalities observed later include short body axis, curled tails, small and malformed brain and eyes. Catalytically inactive prmt8 failed to complement the morphants, indicating the importance of methyltransferase activity. Full-length prmt8 but not prmt1 cRNA can rescue the phenotypic changes. Nevertheless, cRNA encoding Prmt1 fused with the N-terminus of Prmt8 can rescue the prmt8 morphants. In contrast, N-terminus-deleted but not full-length prmt8 cRNA can rescue the prmt1 morphants as efficiently as prmt1 cRNA. Abnormal brain morphologies illustrated with brain markers and loss of fluorescent neurons in a transgenic fish upon prmt8 knockdown confirm the critical roles of prmt8 in neural development. In summery, our study is the first report showing the expression and function of prmt8 in early zebrafish embryogenesis. Our results indicate that prmt8 may play important roles non-overlapping with prmt1 in embryonic and neural development depending on its specific N-terminus.	[Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Liu, Yu-Fang; Pan, Huichin; Li, Chuan] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Cheng, Yi-Chuan] Chang Gung Univ, Dept Biochem & Mol Biol, Tao Yuan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chang Gung University	Li, C (corresponding author), Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan.	cli@csmu.edu.tw	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833	National Science Council [95-2320-B-040-042, 96-2320-B-040-022-MY2, 98-2320-B-040-011-MY3]; Chung Shan Medical University [CSMU 94-OM-A-023, 97-OM-A-136, 98OM-A-060]	National Science Council(Ministry of Science and Technology, Taiwan); Chung Shan Medical University	The project was supported by 95-2320-B-040-042, 96-2320-B-040-022-MY2 and 98-2320-B-040-011-MY3 from National Science Council and CSMU 94-OM-A-023, 97-OM-A-136 and 98OM-A-060 from Chung Shan Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Batut J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025427; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Gates KP, 2010, DEV BIOL, V340, P293, DOI 10.1016/j.ydbio.2010.01.029; Hung CJ, 2007, J BIOCHEM MOL BIOL, V40, P617; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kousaka A, 2009, NEUROSCIENCE, V163, P1146, DOI 10.1016/j.neuroscience.2009.06.061; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lin CH, 2002, J PROTEIN CHEM, V21, P447, DOI 10.1023/A:1021394903025; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lu JG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-246; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Pahlich S, 2008, PROTEINS, V72, P1125, DOI 10.1002/prot.22004; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Tsai YJ, 2011, FEBS J, V278, P905, DOI 10.1111/j.1742-4658.2011.08006.x; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	29	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e55221	10.1371/journal.pone.0055221	http://dx.doi.org/10.1371/journal.pone.0055221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	24349335	gold, Green Published, Green Submitted			2022-12-27	WOS:000316252500001
J	Liu, Y; Zhang, AQ; Cao, L; Xia, HT; Ma, JJ				Liu, Yong; Zhang, An-Qiang; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie			Taurolidine Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							HOME PARENTERAL-NUTRITION; CENTRAL VENOUS CATHETERS; TARGETED USE; HEMODIALYSIS; BACTEREMIA; CITRATE; HEPARIN; SEPSIS; CANCER; TAUROLOCK(R)	Background: Catheter-related bloodstream infections (CRBSIs) are a significant cause of morbidity and mortality in critically ill patients, contributing to prolonged hospital stays and increased costs. Whether taurolidine lock solutions (TLS) are beneficial for the prevention of CRBSIs remains controversial. In this meta-analysis, we aim to assess the efficacy of TLS for preventing CRBSIs. Methods: We conducted a systematic search of PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. Eligible studies included randomized controlled trials that reported on the effects of TLS for preventing CRBSIs. The primary outcome in these studies was catheter-related bloodstream infections, with microbial distribution of CRBSI and catheter-associated thrombosis as secondary outcomes. Data were combined using random-effects models owing to significant clinical heterogeneity. Results: Six randomized controlled trials (RCTs) conducted from 2004 through 2013 involving 431 patients and 86,078 catheter-days were included in the review. TLS were significantly associated with a lower incidence of CRBSIs when compared to heparin lock solutions (Risk Ratio [RR], 0.34; 95% Confidence Interval [CI], 0.21-0.55). Use of TLS significantly decreased the incidence of CRBSIs from gram-negative (G-) bacteria (P = 0.004; RR, 0.27; CI, 0.11-0.65), and was associated with a non-significant decrease in gram-positive (G+) bacterial infections (P = 0.07; RR, 0.41; CI, 0.15-1.09). No significant association was observed with TLS and catheter-associated thrombosis (RR, 1.99; CI, 0.75-5.28). Conclusions: The use of TLS reduced the incidence of CRBSIs without obvious adverse effects or bacterial resistance. However, the susceptibility of G+ and G- bacteria to taurolidine and the risk for catheter-associated thrombosis of TLS are indeterminate due to limited data. The results should be treated with caution due to the limited sample sizes and methodological deficiencies of included studies. Therefore, additional well-designed and adequately powered RCTs are needed to confirm these findings.	[Liu, Yong; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie] Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China; [Zhang, An-Qiang] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University	Liu, Y (corresponding author), Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China.	616756156@qq.com	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833				Akyuz C, 2010, PEDIATR BLOOD CANCER, V55, P949; Al-Amin A, 2012, BRIT J SURG, V99, P158; Allon M, 2003, CLIN INFECT DIS, V36, P1539, DOI 10.1086/375234; Betjes MGH, 2004, NEPHROL DIAL TRANSPL, V19, P1546, DOI 10.1093/ndt/gfh014; Bisseling TM, 2010, CLIN NUTR, V29, P464, DOI 10.1016/j.clnu.2009.12.005; Bradshaw JH, 2008, J PEDIATR GASTR NUTR, V47, P179, DOI 10.1097/MPG.0b013e318162c428; Branger B, 2008, ARTIF ORGANS, V32, P918, DOI 10.1111/j.1525-1594.2008.00684.x; Braumann C, 2005, J SURG RES, V129, P129, DOI 10.1016/j.jss.2005.03.012; Chu HP, 2012, J PEDIATR GASTR NUTR, V55, P403, DOI 10.1097/MPG.0b013e31825bb0ae; Dumichen MJ, 2012, J HOSP INFECT, V80, P304, DOI 10.1016/j.jhin.2012.01.003; Filiopoulos V, 2011, AM J NEPHROL, V33, P260, DOI 10.1159/000324685; Geron R, 2006, HAREFUAH, V145, P943; Geron Ronit, 2006, Harefuah, V145, P881; GORMAN SP, 1987, J APPL BACTERIOL, V62, P315, DOI 10.1111/j.1365-2672.1987.tb04926.x; Haag GM, 2011, J VASC ACCESS, V12, P244, DOI 10.5301/JVA.2011.6265; Handrup MM, 2012, APMIS, V120, P794, DOI 10.1111/j.1600-0463.2012.02910.x; Handrup MM, 2013, PEDIAT BLOOD CANC; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill SM, 2011, J PEDIAT GASTROEN S1, V52, pE64; Jonkers C., 2012, CLIN NUTR S, V7, P203; Jurewitsch B, 2005, CLIN NUTR, V24, P462, DOI 10.1016/j.clnu.2005.02.001; Jurewitsch B, 1998, JPEN-PARENTER ENTER, V22, P242, DOI 10.1177/0148607198022004242; Labriola L, 2008, NEPHROL DIAL TRANSPL, V23, P1666, DOI 10.1093/ndt/gfm847; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Novikov A, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-40; O'Grady NP, 2011, CLIN INFECT DIS, V52, P1087, DOI 10.1093/cid/cir138; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Horo JC, 2011, AM J NEPHROL, V34, P415, DOI 10.1159/000331262; Oliveira C, 2012, PEDIATRICS, V129, P318, DOI 10.1542/peds.2011-1602; Olthof ED, 2012, CLIN NUTR; Olthof ED, 2012, CLIN NUTR S7, V7, P149; Rafferty GP, 2010, GUT, V59, pA35, DOI 10.1136/gut.2009.208991f; Rommes JH, 2001, CURR ANAESTH CRIT CA, V12, P25; Schiavone PA, 2010, PRACT GASTROENTEROL, V34, P22; Schiffer CA, 2013, J CLIN ONCOL; Shah CB, 2002, ANTIMICROB AGENTS CH, V46, P1674, DOI 10.1128/AAC.46.6.1674-1679.2002; Simon A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-102; Solomon LR, 2012, SEMIN DIALYSIS, V25, P233, DOI 10.1111/j.1525-139X.2011.00951.x; Solomon LR, 2010, AM J KIDNEY DIS, V55, P1060, DOI 10.1053/j.ajkd.2009.11.025; Sweet S, 2009, AM J KIDNEY DIS, V53, pA74; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; Taylor C, 2008, J REN CARE, V34, P116, DOI 10.1111/j.1755-6686.2008.00027.x; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Torres-Viera C, 2000, ANTIMICROB AGENTS CH, V44, P1720, DOI 10.1128/AAC.44.6.1720-1724.2000; Toure A, 2012, CLIN NUTR, V31, P567, DOI 10.1016/j.clnu.2012.01.001; van de Wetering MD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003295.pub2; Vernon MA, 2006, SCOT MED J, V51, P54; Weber M, 2009, ZBL CHIR, V134, P350, DOI 10.1055/s-0028-1098929; Yahav D, 2008, CLIN INFECT DIS, V47, P83, DOI 10.1086/588667; Zwiech R, 2013, AM J THER	53	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79417	10.1371/journal.pone.0079417	http://dx.doi.org/10.1371/journal.pone.0079417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24349335	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800007
J	Liu, Y; Lai, NW; Gao, K; Chen, FJ; Yuan, LX; Mi, GH				Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua			Ammonium Inhibits Primary Root Growth by Reducing the Length of Meristem and Elongation Zone and Decreasing Elemental Expansion Rate in the Root Apex in Arabidopsis thaliana	PLOS ONE			English	Article							AUXIN TRANSPORT; GRAVITROPISM; STRESS; EFFLUX; NH4+; ORGANIZATION; SENSITIVITY; MUTATIONS; TOXICITY; NITROGEN	The inhibitory effect of ammonium on primary root growth has been well documented; however the underlying physiological and molecular mechanisms are still controversial. To avoid ammonium toxicity to shoot growth, we used a vertical two-layer split plate system, in which the upper layer contained nitrate and the lower layer contained ammonium. In this way, nitrogen status was maintained and only the apical part of the root system was exposed to ammonium. Using a kinematic approach, we show here that 1 mM ammonium reduces primary root growth, decreasing both elemental expansion and cell production. Ammonium inhibits the length of elongation zone and the maximum elemental expansion rate. Ammonium also decreases the apparent length of the meristem as well as the number of dividing cells without affecting cell division rate. Moreover, ammonium reduces the number of root cap cells but appears to affect neither the status of root stem cell niche nor the distal auxin maximum at the quiescent center. Ammonium also inhibits root gravitropism and concomitantly down-regulates the expression of two pivotal auxin transporters, AUX1 and PIN2. Insofar as ammonium inhibits root growth rate in AUX1 and PIN2 loss-of-function mutants almost as strongly as in wild type, we conclude that ammonium inhibits root growth and gravitropism by largely distinct pathways.	[Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China	China Agricultural University	Mi, GH (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	miguohua@cau.edu.cn	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833	NSFC [30771289, 31121062]	NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by NSFC (No.30771289), the innovative group grant of NSFC (No.31121062) [http://isisn.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, SOIL SOLUTION CHEM A; Baskin TI, 2013, WIRES DEV BIOL, V2, P65, DOI 10.1002/wdev.94; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; CAO YW, 1993, PLANT PHYSIOL, V102, P983, DOI 10.1104/pp.102.3.983; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Gazzarrini S, 1999, PLANT CELL, V11, P937, DOI 10.1105/tpc.11.5.937; Geisler M, 2002, PLANT PHYSIOL, V130, P1747, DOI 10.1104/pp.011197; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Jiang K, 2005, ANNU REV CELL DEV BI, V21, P485, DOI 10.1146/annurev.cellbio.21.122303.114753; Kudoyarova GR, 1997, PLANT GROWTH REGUL, V23, P207, DOI 10.1023/A:1005990725068; Lewis DR, 2007, PLANT CELL, V19, P1838, DOI 10.1105/tpc.107.051599; Li Q, 2010, PLANT CELL ENVIRON, V33, P1529, DOI 10.1111/j.1365-3040.2010.02162.x; Ma Z, 2003, PLANT PHYSIOL, V131, P1381, DOI 10.1104/pp.012161; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; MORRIS AK, 1992, B MATH BIOL, V54, P1069, DOI 10.1007/BF02460667; Mosier AR, 2004, AGR NITROGEN CYCLE A; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; PICKETT FB, 1990, PLANT PHYSIOL, V94, P1462, DOI 10.1104/pp.94.3.1462; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Rogato A, 2010, PLANT PHYSIOL, V154, P784, DOI 10.1104/pp.110.160309; ROMAN G, 1995, GENETICS, V139, P1393; SHARP RE, 1988, PLANT PHYSIOL, V87, P50, DOI 10.1104/pp.87.1.50; SILK WK, 1992, INT J PLANT SCI, V153, pS49, DOI 10.1086/297063; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Walch-Liu P, 2000, J EXP BOT, V51, P227, DOI 10.1093/jexbot/51.343.227; West G, 2004, PLANT PHYSIOL, V135, P1050, DOI 10.1104/pp.104.040022; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P223, DOI 10.1111/j.1365-3040.2009.02073.x; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zou N, 2012, J EXP BOT, V63, P3777, DOI 10.1093/jxb/ers068	44	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61031	10.1371/journal.pone.0061031	http://dx.doi.org/10.1371/journal.pone.0061031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	24349335	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000091
J	Liu, YX; van den Berg, A; Veenstra, R; Rutgers, B; Nolte, I; van Imhoff, G; Visser, L; Diepstra, A				Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Nolte, Ilja; van Imhoff, Gustaaf; Visser, Lydia; Diepstra, Arjan			PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV plus Hodgkin Lymphoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; REED-STERNBERG CELLS; ARCHITECTURE; RESPONSES; CHROMATIN	Tumor cells of classical Hodgkin lymphoma (cHL) are characterized by a general loss of B cell phenotype, whereas antigen presenting properties are commonly retained. HLA class I is expressed in most EBV+ cHL cases, with an even enhanced expression in a proportion of the cases. Promyelocytic leukemia protein (PML) and special AT-rich region binding protein 1 (SATB1) are two global chromatin organizing proteins that have been shown to regulate HLA class I expression in Jurkat cells. We analyzed HLA class I, number of PML nuclear bodies (NBs) and SATB1 expression in tumor cells of 54 EBV+ cHL cases and used 27 EBV- cHL cases as controls. There was a significant difference in presence of HLA class I staining between EBV+ and EBV2 cases (p < 0.0001). We observed normal HLA class I expression in 35% of the EBV+ and in 19% of the EBV- cases. A stronger than normal HLA class I expression was observed in approximately 40% of EBV+ cHL and not in EBV- cHL cases. 36 EBV+ cHL cases contained less than 10 PML-NBs per tumor cell, whereas 16 cases contained more than 10 PMLNBs. The number of PML-NBs was positively correlated to the level of HLA class I expression (p < 0.01). The percentage of SATB1 positive cells varied between 0% to 100% in tumor cells and was inversely correlated with the level of HLA class I expression, but only between normal and strong expression (p < 0.05). Multivariable analysis indicated that the number of PML-NBs and the percentage of SATB1+ tumor cells are independent factors affecting HLA class I expression in EBV+ cHL. In conclusion, both PML and SATB1 are correlated to HLA class I expression levels in EBV+ cHL.	[Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Visser, Lydia; Diepstra, Arjan] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Nolte, Ilja] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Imhoff, Gustaaf] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Diepstra, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.diepstra@umcg.nl	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF) [RUG 2009-4313]	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	This work was supported by grants from Abel Tasman Talent Program (ATTP), University Medical Center Groningen and the Dutch Cancer Society (KWF: RUG 2009-4313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chang SK, 2002, MOL CELLS, V14, P130; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; DELABIE J, 1995, LEUKEMIA LYMPHOMA, V18, P35, DOI 10.3109/10428199509064920; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Diepstra A, 2008, TISSUE ANTIGENS, V71, P219, DOI 10.1111/j.1399-0039.2008.01005.x; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; Diepstra A, 2009, J CLIN ONCOL, V27, P3815, DOI 10.1200/JCO.2008.20.5138; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Huang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010865; Jarrett RF, 2002, ANN ONCOL, V13, P23, DOI 10.1093/annonc/13.S1.23; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kuppers R, 2006, TRENDS IMMUNOL, V27, P203, DOI 10.1016/j.it.2006.03.001; Lallemand-Breitenbach V, COLD SPRING HARB PER, V2; Lee SP, 1997, J IMMUNOL, V158, P3325; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; ROWE M, 1995, EUR J IMMUNOL, V25, P1374, DOI 10.1002/eji.1830250536; Shiels C, 2001, J CELL SCI, V114, P3705; Sides MD, 2011, VIROLOGY, V416, P86, DOI 10.1016/j.virol.2011.04.005; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Stein H, 2008, WHO CLASSIFICATION T, V2, P321; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Woodberry T, 2005, J INFECT DIS, V192, P1513, DOI 10.1086/491741; Zuo J, 2008, J VIROL, V82, P2385, DOI 10.1128/JVI.01946-07; Zuo JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000255	29	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72930	10.1371/journal.pone.0072930	http://dx.doi.org/10.1371/journal.pone.0072930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24349335	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600043
